PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Wang, WJ; Yan, JQ; Wang, HK; Shi, MM; Zhang, MJ; Yang, WP; Peng, CH; Li, HW				Wang, Weijie; Yan, Jiqi; Wang, Huakai; Shi, Minmin; Zhang, Mingjun; Yang, Weiping; Peng, Chenghong; Li, Hongwei			Rapamycin Ameliorates Inflammation and Fibrosis in the Early Phase of Cirrhotic Portal Hypertension in Rats through Inhibition of mTORC1 but Not mTORC2	PLOS ONE			English	Article							HEPATIC STELLATE CELL; GROWTH-FACTOR RECEPTOR; LIVER FIBROSIS; HEPATOCYTE PROLIFERATION; INDUCED APOPTOSIS; PATHWAYS; ACTIVATION; EXPRESSION; SURVIVAL; KINASE	Objective: Hepatic stellate cells (HSCs) transdifferentiation and subsequent inflammation are important pathological processes involved in the formation of cirrhotic portal hypertension. This study characterizes the pathogenetic mechanisms leading to cholestatic liver fibrosis and portal hypertension, and focuses on mammalian target of rapamycin (mTOR) pathway as a potential modulator in the early phase of cirrhotic portal hypertension. Methods: Early cirrhotic portal hypertension was induced by bile duct ligation (BDL) for three weeks. One week after operation, sham-operated (SHAM) and BDL rats received rapamycin (2 mg/kg/day) by intraperitoneal injection for fourteen days. Vehicle-treated SHAM and BDL rats served as controls. Fibrosis, inflammation, and portal pressure were evaluated by histology, morphometry, and hemodynamics. Expressions of pro-fibrogenic and pro-inflammatory genes in liver were measured by RT-PCR; alpha smooth muscle actin (alpha-SMA) and antigen Ki67 were detected by immunohistochemistry; expressions of AKT/mTOR signaling molecules, extracellular-signal-regulated kinase 1/2 (ERK1/2), p-ERK1/2, and interleukin-1 beta (IL-1 beta) were assessed by western blot. Results: The AKT/mTOR signaling pathway was markedly activated in the early phase of cirrhotic portal hypertension induced by BDL in rats. mTOR blockade by rapamycin profoundly improved liver function by limiting inflammation, fibrosis and portal pressure. Rapamycin significantly inhibited the expressions of phosphorylated 70KD ribosomal protein S6 kinase (p-P70S6K) and phosphorylated ribosomal protein S6 (p-S6) but not p-AKT Ser473 relative to their total proteins in BDL-Ra rats. Those results suggested that mTOR Complex 1 (mTORC1) rather than mTORC2 was inhibited by rapamycin. Interestingly, we also found that the level of p-ERK1/2 to ERK1/2 was significantly increased in BDL rats, which was little affected by rapamycin. Conclusions: The AKT/mTOR signaling pathway played an important role in the early phase of cirrhotic portal hypertension in rats, which could be a potential target for therapeutic intervention in the early phase of such pathophysiological progress.	[Wang, Weijie; Yan, Jiqi; Wang, Huakai; Yang, Weiping; Peng, Chenghong; Li, Hongwei] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Surg, Shanghai 200030, Peoples R China; [Wang, Weijie; Yan, Jiqi; Wang, Huakai; Shi, Minmin; Zhang, Mingjun] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai Inst Digest Surg,Key Lab Syst Biomed Ver, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yan, JQ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Surg, Shanghai 200030, Peoples R China.	jiqiyan@yahoo.com	Yang, Wei/HIA-0360-2022	Liang, Ying/0000-0002-4939-8705; Luo, Chunxiong/0000-0001-8974-7693; Fu, Qibin/0000-0002-1419-5676; Peng, Chenghong/0000-0002-5573-7873	Foundation of Shanghai Natural Science [09ZR1418600]; National Natural Science of China [81070358]	Foundation of Shanghai Natural Science; National Natural Science of China(National Natural Science Foundation of China (NSFC))	This study was jointly supported by the Foundation of Shanghai Natural Science (09ZR1418600) and the National Natural Science (81070358) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvaro D, 2002, HEPATOLOGY, V36, P297, DOI 10.1053/jhep.2002.34741; Biecker E, 2005, J PHARMACOL EXP THER, V313, P952, DOI 10.1124/jpet.104.079616; Bridle KR, 2009, LIVER TRANSPLANT, V15, P1315, DOI 10.1002/lt.21804; Chen GQG, 2012, ACTA MATH SCI, V32, P1; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Cichoz-Lach H, 2008, J PHYSIOL PHARMACOL, V59, P231; Coutant A, 2002, HEPATOLOGY, V36, P1079, DOI 10.1053/jhep.2002.36160; Dixon M, 1999, HEPATOLOGY, V29, P1418, DOI 10.1002/hep.510290516; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Fernandez M, 2007, HEPATOLOGY, V46, P1208, DOI 10.1002/hep.21785; Friedman SL, 2008, TOXICOLOGY, V254, P120, DOI 10.1016/j.tox.2008.06.013; Gabele E, 2005, J BIOL CHEM, V280, P13374, DOI 10.1074/jbc.M409444200; Gabele E, 2003, FRONT BIOSCI-LANDMRK, V8, pD69, DOI 10.2741/887; Geerts AM, 2008, HEPATOL RES, V38, P1130, DOI 10.1111/j.1872-034X.2008.00369.x; Giron-Gonzalez JA, 2004, LIVER INT, V24, P437, DOI 10.1111/j.1478-3231.2004.0951.x; Gujral JS, 2003, HEPATOLOGY, V38, P355, DOI 10.1053/jhep.2003.50341; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Inoki K, 2006, TRENDS CELL BIOL, V16, P206, DOI 10.1016/j.tcb.2006.02.002; Kolb M, 2001, J CLIN INVEST, V107, P1529, DOI 10.1172/JCI12568; Lee DF, 2007, CELL CYCLE, V6, P3011, DOI 10.4161/cc.6.24.5085; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Mehal WZ, 2007, LIVER IMMUNOLOGY PRI, V9, P111; Mejias M, 2010, J HEPATOL, V52, P529, DOI 10.1016/j.jhep.2010.01.004; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Neef M, 2006, J HEPATOL, V45, P786, DOI 10.1016/j.jhep.2006.07.030; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Patsenker E, 2011, J HEPATOL, V55, P388, DOI 10.1016/j.jhep.2010.10.044; Qiao L, 2002, HEPATOLOGY, V35, P779, DOI 10.1053/jhep.2002.32533; Rao YP, 2002, HEPATOLOGY, V35, P307, DOI 10.1053/jhep.2002.31104; Reif S, 2003, J BIOL CHEM, V278, P8083, DOI 10.1074/jbc.M212927200; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Schoemaker MH, 2004, HEPATOLOGY, V39, P1563, DOI 10.1002/hep.20246; Shegogue D, 2004, J BIOL CHEM, V279, P23166, DOI 10.1074/jbc.M401238200; Svegliati-Baroni G, 2005, GASTROENTEROLOGY, V128, P1042, DOI 10.1053/j.gastro.2005.01.007; Svegliati-Baroni G, 2003, J HEPATOL, V39, P528, DOI 10.1016/S0168-8278(03)00291-5; Tao YX, 2005, J AM SOC NEPHROL, V16, P46, DOI 10.1681/ASN.2004080660; Tugues S, 2007, HEPATOLOGY, V46, P1919, DOI 10.1002/hep.21921; Wang Y, 2008, WORLD J GASTROENTERO, V14, P5186, DOI 10.3748/wjg.14.5186; Werneburg NW, 2003, AM J PHYSIOL-GASTR L, V285, pG31, DOI 10.1152/ajpgi.00536.2002; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; Zhang HH, 2006, MOL CELL, V24, P185, DOI 10.1016/j.molcel.2006.09.019	44	183	191	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e83908	10.1371/journal.pone.0083908	http://dx.doi.org/10.1371/journal.pone.0083908			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24416258	Green Submitted, gold, Green Published			2022-12-27	WOS:000329460800022
J	Liu, P; Liu, Y; Wang, JN; Guo, Y; Zhang, YJ; Xiao, SQ				Liu, Ping; Liu, Yi; Wang, Jianning; Guo, Yang; Zhang, Yujie; Xiao, Shuiqing			Detection of Fusobacterium Nucleatum and fadA Adhesin Gene in Patients with Orthodontic Gingivitis and Non-Orthodontic Periodontal Inflammation	PLOS ONE			English	Article							MICROBIOLOGIC CHANGES; HEALTH	Fusobacterium nucleatum is one of the most abundant gram-negative bacilli colonizing the subgingival plaque and closely associated with periodontal disease. However it is unclear whether F. nucleatum is involved in gingival inflammation under orthodontic appliance. A novel adhesin, FadA, which is unique to oral Fusobacteria, is required for F. nucleatum binding and invasion to epithelial cells and thus may play an important role in colonization of Fusobacterium in the host. In this study, we evaluated the prevalence of F. nucleatum and its virulence factor FadA adhesion gene (fadA) in 169 subgingival biofilm samples from 55 cases of gingivitis patients with orthodontic appliances, 49 cases of gingivitis patients without orthodontic treatment, 35 cases of periodontitis patients and 30 cases of periodontally healthy people via PCR. The correlations between the F. nucleatum/fadA and gingivitis index(GI) was also analyzed. The detection rate of F. nucleatum/fadA in periodontitis group and non-orthodontic gingivitis group was higher than the other two groups (p<0.01) while it was higher in orthodontic gingivitis group than in health people (p<0.05). An obviously positive correlation was observed between the prevalence of F. nucleatum/fadA and GI. F. nucleatum carrying fadA may be more closely related to the development of gingivitis and periodontal disease compared with orthodontic gingivitis.	[Liu, Ping; Guo, Yang; Zhang, Yujie; Xiao, Shuiqing] Jinan Stomatol Hosp, Dept Orthodont, Jinan, Peoples R China; [Liu, Yi] Shandong Univ, Qilu Childrens Hosp, Pediat Res Inst, Jinan 250100, Peoples R China; [Wang, Jianning] Jinan Stomatol Hosp, Dept Periodont, Jinan, Peoples R China	Shandong University	Xiao, SQ (corresponding author), Jinan Stomatol Hosp, Dept Orthodont, Jinan, Peoples R China.	shqxiao@126.com			Jinan Science and Technology Committee [JK200905034]	Jinan Science and Technology Committee	This work was funded by Jinan science and technology research project (JK200905034) from Jinan Science and Technology Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER SA, 1991, AM J ORTHOD DENTOFAC, V100, P337, DOI 10.1016/0889-5406(91)70071-4; Belibasakis GN, 2013, APMIS, DOI [10.1111/apm.12151, DOI 10.1111/APM.12151.[]; Bollen AM, 2008, J AM DENT ASSOC, V139, P413, DOI 10.14219/jada.archive.2008.0184; Conrads G, 1997, J ENDODONT, V23, P433, DOI 10.1016/S0099-2399(97)80297-X; Edwards AM, 2006, INFECT IMMUN, V74, P654, DOI 10.1128/IAI.74.1.654-662.2006; Feng X, 2013, J PERIODONTOL; Gursoy UK, 2008, ORAL MICROBIOL IMMUN, V23, P432, DOI 10.1111/j.1399-302X.2008.00453.x; Gursoy UK, 2012, J PERIODONTOL, V83, P242, DOI 10.1902/jop.2011.110177; HALL ER, 1994, ORAL MICROBIOL IMMUN, V9, P327, DOI 10.1111/j.1399-302X.1994.tb00282.x; Han YW, 2005, J BACTERIOL, V187, P5330, DOI 10.1128/JB.187.15.5330-5340.2005; Jewett A, 2000, INFECT IMMUN, V68, P1893, DOI 10.1128/IAI.68.4.1893-1898.2000; Joshi Vinayak M, 2007, Indian J Dent Res, V18, P6; Kim SH, 2012, ANGLE ORTHOD, V82, P254, DOI 10.2319/030311-156.1; Lee SM, 2005, J MICROBIOL, V43, P260; Liu HY, 2011, ANGLE ORTHOD, V81, P609, DOI 10.2319/082310-352.1; Liu X, 2009, CHIN J LAB DIAGN, V13, P1579; Liu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061028; LOE HARALD, 1963, ACTA ODONTOL SCAND, V21, P533, DOI 10.3109/00016356309011240; MOMBELLI A, 1989, J CLIN PERIODONTOL, V16, P451, DOI 10.1111/j.1600-051X.1989.tb01674.x; Moore W E, 1994, Periodontol 2000, V5, P66, DOI 10.1111/j.1600-0757.1994.tb00019.x; POLSON AM, 1988, AM J ORTHOD DENTOFAC, V93, P51, DOI 10.1016/0889-5406(88)90193-X; Sallum EJ, 2004, AM J ORTHOD DENTOFAC, V126, P363, DOI 10.1016/j.ajodo.2004.04.017; Signat B, 2011, CURR ISSUES MOL BIOL, V13, P25; Stingu CS, 2012, QUINTESSENCE INT, V43, pE23	24	35	38	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85280	10.1371/journal.pone.0085280	http://dx.doi.org/10.1371/journal.pone.0085280			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416378	Green Published, Green Submitted, gold			2022-12-27	WOS:000329866300064
J	Pyatnitskiy, M; Mazo, I; Shkrob, M; Schwartz, E; Kotelnikova, E				Pyatnitskiy, Mikhail; Mazo, Ilya; Shkrob, Maria; Schwartz, Elena; Kotelnikova, Ekaterina			Clustering Gene Expression Regulators: New Approach to Disease Subtyping	PLOS ONE			English	Article							SET ENRICHMENT ANALYSIS; BREAST-CANCER; PATHWAY; MICROARRAY; CLASSIFICATION; SIGNATURE; ADENOMA; PROTEIN; TOOL; IDENTIFICATION	One of the main challenges in modern medicine is to stratify different patient groups in terms of underlying disease molecular mechanisms as to develop more personalized approach to therapy. Here we propose novel method for disease subtyping based on analysis of activated expression regulators on a sample-by-sample basis. Our approach relies on SubNetwork Enrichment Analysis algorithm (SNEA) which identifies gene subnetworks with significant concordant changes in expression between two conditions. Subnetwork consists of central regulator and downstream genes connected by relations extracted from global literature-extracted regulation database. Regulators found in each patient separately are clustered together and assigned activity scores which are used for final patients grouping. We show that our approach performs well compared to other related methods and at the same time provides researchers with complementary level of understanding of pathway-level biology behind a disease by identification of significant expression regulators. We have observed the reasonable grouping of neuromuscular disorders (triggered by structural damage vs triggered by unknown mechanisms), that was not revealed using standard expression profile clustering. For another experiment we were able to suggest the clusters of regulators, responsible for colorectal carcinoma vs adenoma discrimination and identify frequently genetically changed regulators that could be of specific importance for the individual characteristics of cancer development. Proposed approach can be regarded as biologically meaningful feature selection, reducing tens of thousands of genes down to dozens of clusters of regulators. Obtained clusters of regulators make possible to generate valuable biological hypotheses about molecular mechanisms related to a clinical outcome for individual patient.	[Pyatnitskiy, Mikhail] RAMS, Inst Biomed Chem, Moscow, Russia; [Pyatnitskiy, Mikhail; Mazo, Ilya; Schwartz, Elena; Kotelnikova, Ekaterina] Ariadne Diagnost LLC, Rockville, MD USA; [Shkrob, Maria] Elsevier Inc, Rockville, MD USA; [Kotelnikova, Ekaterina] RAMS, Inst Informat Transmiss Problems, Moscow, Russia	Russian Academy of Medical Sciences; Institute of Biomedical Chemistry; Reed Elsevier; Elsevier; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Medical Sciences	Pyatnitskiy, M (corresponding author), RAMS, Inst Biomed Chem, Moscow, Russia.	mpyat@bioinformatics.ru	Pyatnitskiy, Mikhail/F-1588-2017; Mazo, Ilya A/G-6549-2014; Kotelnikova, Elena/N-8496-2013	Pyatnitskiy, Mikhail/0000-0002-4803-8150; Mazo, Ilya A/0000-0002-8587-4895; Kotelnikova, Ekaterina/0000-0002-8026-078X	Russian Ministry of Education and Science [14.512.11.0042]	Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation)	This work was partly supported by the Russian Ministry of Education and Science, contract #14.512.11.0042. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abraham G, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-277; Alexeyenko A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-226; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bakay M, 2006, BRAIN, V129, P996, DOI 10.1093/brain/awl023; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Breslin T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-163; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cheng WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038650; Cleven AHG, 2008, BRIT J CANCER, V99, P727, DOI 10.1038/sj.bjc.6604547; Cui GL, 2012, SCAND J GASTROENTERO, V47, P1304, DOI 10.3109/00365521.2012.725089; Daraselia N, 2004, BIOINFORMATICS, V20, P604, DOI 10.1093/bioinformatics/btg452; Daraselia N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-243; Efroni S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002901; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Galamb O, 2008, DIS MARKERS, V25, P1, DOI 10.1155/2008/586721; Gerlach K, 2012, CANCER RES, V72, P4340, DOI 10.1158/0008-5472.CAN-11-4155; Greenblum SI, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-133; Guo Z, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-58; Gyorffy B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005645; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Haury AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028210; He ZY, 2010, COMPUT BIOL CHEM, V34, P215, DOI 10.1016/j.compbiolchem.2010.07.002; Huang YC, 2005, EUR J HUM GENET, V13, P721, DOI 10.1038/sj.ejhg.5201414; Hummel M, 2008, BIOINFORM BIOL INSIG, V2, P329; Hung JH, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r23; Ince PG, 2011, ACTA NEUROPATHOL, V122, P657, DOI 10.1007/s00401-011-0913-0; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kappeler A, 2000, HISTOL HISTOPATHOL, V15, P167, DOI 10.14670/HH-15.167; Kaufman L., 2005, FINDING GROUPS DATA; Kel A, 2008, SAR QSAR ENVIRON RES, V19, P481, DOI 10.1080/10629360802083806; Ko Y, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-54; Koch M, 2006, ANN SURG, V244, P986, DOI 10.1097/01.sla.0000247058.43243.7b; Koscielny S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000313; Kotelnikova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002365; Kressner U, 1997, BRIT J CANCER, V76, P526, DOI 10.1038/bjc.1997.419; Larsson L, 2008, ADV EXP MED BIOL, V642, P92; Lee E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000217; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nistala K, 2013, CURR OPIN RHEUMATOL, V25, P742, DOI 10.1097/01.bor.0000434674.62644.02; Novichkova S, 2003, BIOINFORMATICS, V19, P1699, DOI 10.1093/bioinformatics/btg207; Ottaviani A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000394; Pollard KS, 2005, STAT BIOL HEALTH, P209; Pusztai L, 2006, CLIN CANCER RES, V12, P7209, DOI 10.1158/1078-0432.CCR-06-2649; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Sillars-Hardebol AH, 2010, TUMOR BIOL, V31, P89, DOI 10.1007/s13277-009-0012-1; Sis B, 2004, PATHOL RES PRACT, V200, P379, DOI 10.1016/j.prp.2004.02.012; Sivachenko AY, 2007, J BIOINF COMPUT BIOL, V5, P429, DOI 10.1142/S0219720007002795; Sivachenko AY, 2007, EXPERT OPIN THER TAR, V11, P411, DOI 10.1517/14728222.11.3.411; Su JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008161; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sugiyama D, 2013, P NATL ACAD SCI US; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Thalamuthu A, 2006, BIOINFORMATICS, V22, P2405, DOI 10.1093/bioinformatics/btl406; Tomfohr J, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-225; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Walhout AJM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-109; Yuryev A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-171; Yuryev A, 2009, EXPERT OPIN DRUG DIS, V4, P1307, DOI 10.1517/17460440903413488	61	24	25	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84955	10.1371/journal.pone.0084955	http://dx.doi.org/10.1371/journal.pone.0084955			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416320	Green Submitted, Green Published, gold			2022-12-27	WOS:000329866300043
J	Winberg, J; Gustavsson, P; Papadogiannakis, N; Sahlin, E; Bradley, F; Nordenskjold, E; Svensson, PJ; Anneren, G; Iwarsson, E; Nordgren, A; Nordenskjold, A				Winberg, Johanna; Gustavsson, Peter; Papadogiannakis, Nikos; Sahlin, Ellika; Bradley, Frideborg; Nordenskjold, Edvard; Svensson, Par-Johan; Anneren, Goran; Iwarsson, Erik; Nordgren, Ann; Nordenskjold, Agneta			Mutation Screening and Array Comparative Genomic Hybridization Using a 180K Oligonucleotide Array in VACTERL Association	PLOS ONE			English	Article							ESOPHAGEAL ATRESIA; FANCONI-ANEMIA; CHD7 GENE; IDENTIFICATION; HETEROTAXY; DISORDERS; PATIENT	In order to identify genetic causes of VACTERL association (V vertebral defects, A anorectal malformations, C cardiac defects, T tracheoesofageal fistula, E esophageal atresia, R renal anomalies, L limb deformities), we have collected DNA samples from 20 patients diagnosed with VACTERL or with a VACTERL-like phenotype as well as samples from 19 aborted fetal cases with VACTERL. To investigate the importance of gene dose alterations in the genetic etiology of VACTERL association we have performed a systematic analysis of this cohort using a 180K array comparative genomic hybridization (array-CGH) platform. In addition, to further clarify the significance of PCSK5, HOXD13 and CHD7 genes in the VACTERL phenotype, mutation screening has been performed. We identified pathogenic gene dose imbalances in two fetal cases; a hemizygous deletion of the FANCB gene and a (9;18)(p24;q12) unbalanced translocation. In addition, one pathogenic mutation in CHD7 was detected, while no apparent disease-causing mutations were found in HOXD13 or PCSK5. Our study shows that although large gene dose alterations do not seem to be a common cause in VACTERL association, array-CGH is still important in clinical diagnostics to identify disease cause in individual cases.	[Winberg, Johanna; Gustavsson, Peter; Sahlin, Ellika; Bradley, Frideborg; Nordenskjold, Edvard; Iwarsson, Erik; Nordgren, Ann] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Winberg, Johanna; Gustavsson, Peter; Sahlin, Ellika; Bradley, Frideborg; Nordenskjold, Edvard; Svensson, Par-Johan; Iwarsson, Erik; Nordgren, Ann; Nordenskjold, Agneta] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [Gustavsson, Peter; Sahlin, Ellika; Iwarsson, Erik; Nordgren, Ann] Karolinska Univ Hosp, Clin Genet Unit, Stockholm, Sweden; [Papadogiannakis, Nikos] Karolinska Inst, Dept Lab Med, Div Pathol, Stockholm, Sweden; [Svensson, Par-Johan; Nordenskjold, Agneta] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Svensson, Par-Johan; Nordenskjold, Agneta] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Stockholm, Sweden; [Anneren, Goran] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Uppsala University	Winberg, J (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.	johanna.winberg@ki.se	Iwarsson, Erik/J-4677-2019; Nordgren, Ann/AAQ-9142-2021; Nordgren, Ann C/N-4057-2013	Iwarsson, Erik/0000-0002-3827-0263; Nordgren, Ann/0000-0003-3285-4281; Nordgren, Ann C/0000-0003-3285-4281; Sahlin, Ellika/0000-0002-2564-4406; Nordenskjold, Agneta/0000-0001-6638-4631	Swedish Research Council [K2012-64X-14506-10-5]; Stockholm City Council; H R H Crown Princess Lovisa's Association for Child Medical Care; Torsten and Ragnar Soderbergs Foundation at Center for Molecular Medicine, Karolinska Institutet; KID-scholarship; Board of Doctoral Education at Karolinska Institutet; A research internship at Karolinska Institutet/Karolinska University Hospital	Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm City Council; H R H Crown Princess Lovisa's Association for Child Medical Care; Torsten and Ragnar Soderbergs Foundation at Center for Molecular Medicine, Karolinska Institutet; KID-scholarship; Board of Doctoral Education at Karolinska Institutet; A research internship at Karolinska Institutet/Karolinska University Hospital	The work was supported by: 1. The Swedish Research Council (grant number K2012-64X-14506-10-5) http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html. 2. The Stockholm City Council, http://www.forskningsstod.sll.se/Ansokan/start.asp. 3. H R H Crown Princess Lovisa's Association for Child Medical Care, http://www.kronprinsessanlovisa.se/pages/ansoekan/om-ansoekan.php. 4. Torsten and Ragnar Soderbergs Foundation at Center for Molecular Medicine, Karolinska Institutet. http://ragnarsoderbergsstiftelse.se/. 5. KID-scholarship granted by the Board of Doctoral Education at Karolinska Institutet (J.W.), http://ki.se/ki/jsp/polopoly.jsp;jsessionid = aXF-gX4gZdQgYzl7Nd? l = en&d = 13467. 6. A research internship at Karolinska Institutet/Karolinska University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter BP, 2013, MOL SYNDROMOL, V4, P87, DOI 10.1159/000346035; Arrington CB, 2010, AM J MED GENET A; Bartels CF, 2010, GENET TEST MOL BIOMA, V14, P881, DOI 10.1089/gtmb.2010.0101; Bartels E, 2012, CLIN DYSMORPHOL, V21, P191, DOI 10.1097/MCD.0b013e328358243c; Bartels E, 2012, PEDIATR SURG INT, V28, P681, DOI 10.1007/s00383-012-3100-z; Brosens E, 2013, MOL SYNDROMOL, V4, P20, DOI 10.1159/000345577; Chung B, 2011, AM J MED GENET A, V155A, P1123, DOI 10.1002/ajmg.a.33859; Cowley MJ, 2012, NUCLEIC ACIDS RES, V40, pD862, DOI 10.1093/nar/gkr967; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Garcia-Barcelo MM, 2008, AM J MED GENET A, V146A, P3181, DOI 10.1002/ajmg.a.32426; Gordon CT, 2012, J MED GENET, V49, P737, DOI 10.1136/jmedgenet-2012-101173; Hernandez-Garcia A, 2012, AM J MED GENET A, V158A, P1785, DOI 10.1002/ajmg.a.35391; Hilger A, 2013, EUR J HUM GENET; Hilger A, 2012, PEDIATR SURG INT, V28, P725, DOI 10.1007/s00383-012-3073-y; Holden ST, 2006, J MED GENET, V43, P750, DOI 10.1136/jmg.2006.041673; Nagamani SCS, 2011, EUR J HUM GENET, V19, P280, DOI 10.1038/ejhg.2010.184; Qi Qiu-feng, 2008, Zhonghua Yixue Yichuanxue Zazhi, V25, P637; Ramalingam A, 2011, J HUM GENET, V56, P541, DOI 10.1038/jhg.2011.42; Reutter H, 2013, MOL SYNDROMOL, V4, P16, DOI 10.1159/000345300; Rittler M, 1996, AM J MED GENET, V63, P529, DOI 10.1002/(SICI)1096-8628(19960628)63:4<529::AID-AJMG4>3.0.CO;2-J; Sanlaville D, 2002, CLIN GENET, V61, P135, DOI 10.1034/j.1399-0004.2002.610208.x; Schramm C, 2010, EUR J MED GENET; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Solomon BD, 2013, MOL SYNDROMOL, V4, P27, DOI 10.1159/000345406; Solomon BD, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-56; Solomon BD, 2010, AM J MED GENET A, V152A, P2236, DOI 10.1002/ajmg.a.33572; Stankiewicz P, 2009, AM J HUM GENET, V84, P780, DOI 10.1016/j.ajhg.2009.05.005; Stevenson RE, 2013, MOL SYNDROMOL, V4, P7, DOI 10.1159/000346192; Szumska D, 2008, GENE DEV, V22, P1465, DOI 10.1101/gad.479408; Tyreman M, 2009, J MED GENET, V46, P531, DOI 10.1136/jmg.2008.065482; Umana LA, 2011, AM J MED GENET A, V155A, P3071, DOI 10.1002/ajmg.a.34296; van der Veken LT, 2010, MOL CYTOGENET, V3, DOI 10.1186/1755-8166-3-13; Walsh LE, 2001, AM J MED GENET, V98, P137, DOI 10.1002/1096-8628(20010115)98:2<137::AID-AJMG1022>3.0.CO;2-5; Wessels MW, 2010, J MED GENET, V47, P351, DOI 10.1136/jmg.2008.060913; Zu SL, 2011, J PEDIATR SURG, V46, P1390, DOI 10.1016/j.jpedsurg.2011.02.039	35	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85313	10.1371/journal.pone.0085313	http://dx.doi.org/10.1371/journal.pone.0085313			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416387	Green Published, gold, Green Submitted			2022-12-27	WOS:000329866300069
J	Beck, C; Kardatzki, B; Ethofer, T				Beck, Claudia; Kardatzki, Bernd; Ethofer, Thomas			Mondegreens and Soramimi as a Method to Induce Misperceptions of Speech Content - Influence of Familiarity, Wittiness, and Language Competence	PLOS ONE			English	Article							MEMORY; MUSIC; VASE; FACE	Expectations and prior knowledge can strongly influence our perception. In vision research, such top-down modulation of perceptual processing has been extensively studied using ambiguous stimuli, such as reversible figures. Here, we propose a novel method to address this issue in the auditory modality during speech perception by means of Mondgreens and Soramimi which represent song lyrics with the potential for misperception within one or across two languages, respectively. We demonstrate that such phenomena can be induced by visual presentation of the alternative percept and occur with a sufficient probability to exploit them in neuroscientific experiments. Song familiarity did not influence the occurrence of such altered perception indicating that this tool can be employed irrespective of the participants' knowledge of music. On the other hand, previous knowledge of the alternative percept had a strong impact on the strength of altered perception which is in line with frequent reports that these phenomena can have long-lasting effects. Finally, we demonstrate that the strength of changes in perception correlated with the extent to which they were experienced as amusing as well as the vocabulary of the participants as source of potential interpretations. These findings suggest that such perceptional phenomena might be linked to the pleasant experience of resolving ambiguity which is in line with the long-existing theory of Hermann von Helmholtz that perception and problem-solving recruit similar processes.	[Beck, Claudia; Kardatzki, Bernd; Ethofer, Thomas] Univ Tubingen, Dept Biomed Magnet Resonance, Tubingen, Germany; [Ethofer, Thomas] Univ Tubingen, Univ Clin Psychiat & Psychotherapy, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Ethofer, T (corresponding author), Univ Tubingen, Dept Biomed Magnet Resonance, Tubingen, Germany.	thomas.ethofer@med.uni-tuebingen.de			University of Tubingen	University of Tubingen	The study was supported by the Open Access Publishing Fund of the University of Tubingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AK, 2005, J EXP PSYCHOL GEN, V134, P258, DOI 10.1037/0096-3445.134.2.258; Andrews TJ, 2002, NEUROIMAGE, V17, P890, DOI 10.1006/nimg.2002.1243; [Anonymous], SCI AM MIND; Atlas LY, 2010, J NEUROSCI, V30, P12964, DOI 10.1523/JNEUROSCI.0057-10.2010; Bond Z. S, 1999, SLIPS EAR ERRORS PER; Bond ZS, 1999, BRAIN LANG, V68, P144, DOI 10.1006/brln.1999.2071; Cahill L, 1995, CONSCIOUS COGN, V4, P410, DOI 10.1006/ccog.1995.1048; CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0; Cahill L, 2009, EMOTIONAL LEARNING H; Dean ME, 2006, J ROY SOC MED, V99, P375, DOI 10.1258/jrsm.99.7.375; Eschrich S, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-48; Ethofer T, 2006, HUM BRAIN MAPP, V27, P707, DOI 10.1002/hbm.20212; Hasson U, 2001, J COGNITIVE NEUROSCI, V13, P744, DOI 10.1162/08989290152541412; Helmholtz v, 1866, PERCEPTIONS GEN; Kensinger EA, 2004, REV NEUROSCIENCE, V15, P241, DOI 10.1515/REVNEURO.2004.15.4.241; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Melloni L, 2011, J NEUROSCI, V31, P1386, DOI 10.1523/JNEUROSCI.4570-10.2011; Meyer S, 2011, HNO, V59, P926, DOI 10.1007/s00106-011-2335-7; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pereira CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027241; Platel H, 2003, NEUROIMAGE, V20, P244, DOI 10.1016/S1053-8119(03)00287-8; Plato, CHARMIDES, p155C; Rubin E, 1915, VISUELL WASHRGENOMME; Stalinski SM, 2013, J EXP PSYCHOL LEARN, V39, P700, DOI 10.1037/a0029671; Woods AT, 2011, NEUROREPORT, V22, P365, DOI 10.1097/WNR.0b013e3283469581; Wright S., 1954, HARPERS MAGAZINE, V209, P48	26	8	8	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84667	10.1371/journal.pone.0084667	http://dx.doi.org/10.1371/journal.pone.0084667			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291WL	24416261	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500147
J	Liao, K; Xiao, R; Gonzalez, J; Ding, L				Liao, Ke; Xiao, Ran; Gonzalez, Jania; Ding, Lei			Decoding Individual Finger Movements from One Hand Using Human EEG Signals	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACE; ONLINE CLASSIFICATION; MOTOR IMAGERY; MEG; COMMUNICATION; DESYNCHRONIZATION; DISCRIMINATION; EXECUTION; FEATURES; TRIALS	Brain computer interface (BCI) is an assistive technology, which decodes neurophysiological signals generated by the human brain and translates them into control signals to control external devices, e. g., wheelchairs. One problem challenging noninvasive BCI technologies is the limited control dimensions from decoding movements of, mainly, large body parts, e. g., upper and lower limbs. It has been reported that complicated dexterous functions, i.e., finger movements, can be decoded in electrocorticography (ECoG) signals, while it remains unclear whether noninvasive electroencephalography (EEG) signals also have sufficient information to decode the same type of movements. Phenomena of broadband power increase and low-frequency-band power decrease were observed in EEG in the present study, when EEG power spectra were decomposed by a principal component analysis (PCA). These movement-related spectral structures and their changes caused by finger movements in EEG are consistent with observations in previous ECoG study, as well as the results from ECoG data in the present study. The average decoding accuracy of 77.11% over all subjects was obtained in classifying each pair of fingers from one hand using movement-related spectral changes as features to be decoded using a support vector machine (SVM) classifier. The average decoding accuracy in three epilepsy patients using ECoG data was 91.28% with the similarly obtained features and same classifier. Both decoding accuracies of EEG and ECoG are significantly higher than the empirical guessing level (51.26%) in all subjects (p<0.05). The present study suggests the similar movement-related spectral changes in EEG as in ECoG, and demonstrates the feasibility of discriminating finger movements from one hand using EEG. These findings are promising to facilitate the development of BCIs with rich control signals using noninvasive technologies.	[Liao, Ke; Xiao, Ran; Ding, Lei] Univ Oklahoma, Sch Elect & Comp Engn, Norman, OK 73019 USA; [Gonzalez, Jania; Ding, Lei] Univ Oklahoma, Ctr Biomed Engn, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman	Ding, L (corresponding author), Univ Oklahoma, Sch Elect & Comp Engn, Norman, OK 73019 USA.	leiding@ou.edu	Xiao, Ran/AAN-5293-2020	Xiao, Ran/0000-0002-3689-1680	NSF CAREER [ECCS-0955260]; DOT-FAA [10-G-008]; OCAST [HR09-125S]; Directorate For Engineering [0955260] Funding Source: National Science Foundation	NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); DOT-FAA; OCAST; Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported in part by NSF CAREER ECCS-0955260, DOT-FAA 10-G-008, and OCAST HR09-125S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya S, 2010, J NEURAL ENG, V7, DOI [10.1088/1741-2560/7/4/046002, 10.2202/1553-3840.1324]; Bai O, 2007, CLIN NEUROPHYSIOL, V118, P2637, DOI 10.1016/j.clinph.2007.08.025; Ball T, 2008, NEUROIMAGE, V41, P302, DOI 10.1016/j.neuroimage.2008.02.032; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bin GY, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046002; Birbaumer N, 2006, PSYCHOPHYSIOLOGY, V43, P517, DOI 10.1111/j.1469-8986.2006.00456.x; Blankertz B, 2006, IEEE T NEUR SYS REH, V14, P147, DOI 10.1109/TNSRE.2006.875557; Boostani R, 2003, PHYSIOL MEAS, V24, P309, DOI 10.1088/0967-3334/24/2/307; Bradberry TJ, 2010, J NEUROSCI, V30, P3432, DOI 10.1523/JNEUROSCI.6107-09.2010; Bradberry TJ, 2009, NEUROIMAGE, V47, P1691, DOI 10.1016/j.neuroimage.2009.06.023; Brunner Clemens, 2008, INT J BIOELEKTROMAGN, V10, P52, DOI DOI 10.1.1.330.3349; Bundhoo V, 2005, 2005 12TH INTERNATIONAL CONFERENCE ON ADVANCED ROBOTICS, P368; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chang GC, 1996, MED ENG PHYS, V18, P529, DOI 10.1016/1350-4533(96)00006-9; Coyle SM, 2007, J NEURAL ENG, V4, P219, DOI 10.1088/1741-2560/4/3/007; Darvas F, 2010, NEUROIMAGE, V49, P930, DOI 10.1016/j.neuroimage.2009.08.041; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Ding L, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036008; Doud AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026322; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Nicolas-Alonso LF, 2012, SENSORS-BASEL, V12, P1211, DOI 10.3390/s120201211; Flamary R, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00029; Glaser E., 1976, PRINCIPLES NEUROBIOL; Gonzalez SL, 2006, NEUROIMAGE, V32, P170, DOI 10.1016/j.neuroimage.2006.02.041; Gu Y, 2009, CLIN NEUROPHYSIOL, V120, P1596, DOI 10.1016/j.clinph.2009.05.006; Han J, 2012, MOR KAUF D, P1; Hinterberger T., 2005, ADV NEURAL INFORM PR, V17, P737; Hochberg LR, 2006, IEEE ENG MED BIOL, V25, P32, DOI 10.1109/MEMB.2006.1705745; Hsu C.-W., 2010, PRACTICAL GUIDE SUPP; Huang DD, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046005; Huggins JE, 2011, AMYOTROPH LATERAL SC, V12, P318, DOI 10.3109/17482968.2011.572978; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; Ingram JN, 2008, EXP BRAIN RES, V188, P223, DOI 10.1007/s00221-008-1355-3; Jain RK, 2012, COMPUTATIONAL INTELL; Kauhanen L, 2006, CLIN NEUROPHYSIOL, V117, P430, DOI 10.1016/j.clinph.2005.10.024; Khan YU, 2010, IET SIGNAL PROCESS, V4, P510, DOI 10.1049/iet-spr.2008.0235; Kohlmorgen J., 2007, BRAIN COMPUTER INTER, P409; Kubanek J, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/6/066001; Lebedev MA, 2006, TRENDS NEUROSCI, V29, P536, DOI 10.1016/j.tins.2006.07.004; Lehtonen J, 2008, IEEE T BIO-MED ENG, V55, P713, DOI 10.1109/TBME.2007.912653; Li Y, 2004, IEEE T BIO-MED ENG, V51, P1019, DOI 10.1109/TBME.2004.826688; Liang NY, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00091; Liao X, 2007, IEEE T BIO-MED ENG, V54, P821, DOI 10.1109/TBME.2006.889206; Liyanage SR, 2009, CLASSIFICATION SELF; M³ller K-R., 2004, BIOMED TECH, V49, P11, DOI [DOI 10.13109/9783666351419.11, 10.13109/9783666351419.11]; Makeig S, 2012, P IEEE, V100, P1567, DOI 10.1109/JPROC.2012.2185009; McFarland DJ, 1997, ELECTROEN CLIN NEURO, V103, P386, DOI 10.1016/S0013-4694(97)00022-2; Miller KJ, 2009, J NEUROSCI, V29, P3132, DOI 10.1523/JNEUROSCI.5506-08.2009; Miller KJ, 2010, P NATL ACAD SCI USA, V107, P4430, DOI 10.1073/pnas.0913697107; Miller KJ, 2008, BCI COMPETITION; Mognon A, 2011, PSYCHOPHYSIOLOGY, V48, P229, DOI 10.1111/j.1469-8986.2010.01061.x; Mohamed AK, 2011, IEEE ENG MED BIO, P6289, DOI 10.1109/IEMBS.2011.6091552; Morash V, 2008, CLIN NEUROPHYSIOL, V119, P2570, DOI 10.1016/j.clinph.2008.08.013; Nunez PL, 2005, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; Obermaier B, 2001, PATTERN RECOGN LETT, V22, P1299, DOI 10.1016/S0167-8655(01)00075-7; Onaran I, 2011, IEEE ENG MED BIO, P5424, DOI 10.1109/IEMBS.2011.6091341; Pfurtscheller G, 2006, NEUROIMAGE, V31, P153, DOI 10.1016/j.neuroimage.2005.12.003; PFURTSCHELLER G, 1977, ELECTROEN CLIN NEURO, V42, P817, DOI 10.1016/0013-4694(77)90235-8; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pistohl T, 2012, NEUROIMAGE, V59, P248, DOI 10.1016/j.neuroimage.2011.06.084; Quandt F, 2012, NEUROIMAGE, V59, P3316, DOI 10.1016/j.neuroimage.2011.11.053; Samiee S, 2010, 2010 INT C INT ADV S, P1; Santello M, 1997, SOMATOSENS MOT RES, V14, P203; Schalk G, 2007, J NEURAL ENG, V4, P264, DOI 10.1088/1741-2560/4/3/012; Schalk G, 2004, IEEE T BIO-MED ENG, V51, P1034, DOI 10.1109/TBME.2004.827072; Scherer R, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.4.FOCUS0981; Schwartz AB, 2004, ANNU REV NEUROSCI, V27, P487, DOI 10.1146/annurev.neuro.27.070203.144233; Schwartz AB, 2006, NEURON, V52, P205, DOI 10.1016/j.neuron.2006.09.019; Shenoy P, 2008, IEEE T BIO-MED ENG, V55, P273, DOI 10.1109/TBME.2007.903528; Shenoy P, 2007, 2007 3RD INTERNATIONAL IEEE/EMBS CONFERENCE ON NEURAL ENGINEERING, VOLS 1 AND 2, P192, DOI 10.1109/CNE.2007.369644; Sitaram Ranganatha, 2007, Comput Intell Neurosci, P25487, DOI 10.1155/2007/25487; Soechting JF, 1997, J COMPUT NEUROSCI, V4, P29, DOI 10.1023/A:1008812426305; van den Broek SP, 1998, ELECTROEN CLIN NEURO, V106, P522, DOI 10.1016/S0013-4694(97)00147-8; Vapnik V., 1998, STAT LEARNING THEORY, V3, DOI DOI 10.1007/978-1-4419-1428-6_5864; Vapnik V., 2013, NATURE STAT LAERNING; Vuckovic A, 2009, CLIN NEUROPHYSIOL, V120, P1422, DOI 10.1016/j.clinph.2009.06.007; Waldert S, 2008, J NEUROSCI, V28, P1000, DOI 10.1523/JNEUROSCI.5171-07.2008; Wang W, 2009, IEEE ENG MED BIO, P586, DOI 10.1109/IEMBS.2009.5333704; Welford A.T., 1980, REACTION TIMES; Wilson JA, 2006, IEEE T NEUR SYS REH, V14, P246, DOI 10.1109/TNSRE.2006.875570; Wolpaw JR, 2000, IEEE T REHABIL ENG, V8, P164, DOI 10.1109/TRE.2000.847807; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Yoo SS, 2004, NEUROREPORT, V15, P1591, DOI 10.1097/01.wnr.0000133296.39160.fe; Zanos S, 2008, IEEE ENG MED BIO, P5939, DOI 10.1109/IEMBS.2008.4650569; Zhou J, 2009, COMPUT BIOL MED, V39, P443, DOI 10.1016/j.compbiomed.2009.02.004	86	85	88	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85192	10.1371/journal.pone.0085192	http://dx.doi.org/10.1371/journal.pone.0085192			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416360	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500225
J	Mbonye, MK; Burnett, SM; Burua, A; Colebunders, R; Crozier, I; Kinoti, SN; Ronald, A; Naikoba, S; Rubashembusya, T; Van Geertruyden, JP; Willis, KS; Weaver, MR				Mbonye, Martin Kayitale; Burnett, Sarah M.; Burua, Aldomoro; Colebunders, Robert; Crozier, Ian; Kinoti, Stephen N.; Ronald, Allan; Naikoba, Sarah; Rubashembusya, Timothy; Van Geertruyden, Jean-Pierre; Willis, Kelly S.; Weaver, Marcia R.			Effect of Integrated Capacity-Building Interventions on Malaria Case Management by Health Professionals in Uganda: A Mixed Design Study with Pre/Post and Cluster Randomized Trial Components	PLOS ONE			English	Article							UNCOMPLICATED MALARIA; LOW TRANSMISSION; MICROSCOPY; CHILDREN; TANZANIA; ZAMBIA; AREA	Background: The Integrated Infectious Diseases Capacity Building Evaluation (IDCAP) designed two interventions: Integrated Management of Infectious Disease (IMID) training program and On-Site Support (OSS). We evaluated their effects on 23 facility performance indicators, including malaria case management. Methodology: IMID, a three-week training with two follow-up booster courses, was for two mid-level practitioners, primarily clinical officers and registered nurses, from 36 primary care facilities. OSS was two days of training and continuous quality improvement activities for nine months at 18 facilities, to which all health workers were invited to participate. Facilities were randomized as clusters 1: 1 to parallel OSS "arm A" or control "arm B''. Outpatient data on four malaria case management indicators were collected for 14 months. Analysis compared changes before and during the interventions within arms (relative risk = RR). The effect of OSS was measured with the difference in changes across arms (ratio of RR = RRR). Findings: The proportion of patients with suspected malaria for whom a diagnostic test result for malaria was recorded decreased in arm B (adjusted RR (aRR) = 0.97; 99% CI: 0.82,1.14) during IMID, but increased 25% in arm A (aRR = 1.25; 99% CI: 0.94, 1.65) during IMID and OSS relative to baseline; (aRRR = 1.28; 99% CI: 0.93, 1.78). The estimated proportion of patients that received an appropriate antimalarial among those prescribed any antimalarial increased in arm B (aRR = 1.09; 99% CI: 0.87, 1.36) and arm A (aRR = 1.50; 99% CI: 1.04, 2.17); (aRRR = 1.38; 99% CI: 0.89, 2.13). The proportion of patients with a negative diagnostic test result for malaria prescribed an antimalarial decreased in arm B (aRR = 0.96; 99% CI: 0.84, 1.10) and arm A (aRR = 0.67; 99% CI: 0.46, 0.97); (aRRR = 0.70; 99% CI: 0.48, 1.00). The proportion of patients with a positive diagnostic test result for malaria prescribed an antibiotic did not change significantly in either arm. Interpretation: The combination of IMID and OSS was associated with statistically significant improvements in malaria case management.	[Mbonye, Martin Kayitale; Naikoba, Sarah; Rubashembusya, Timothy] Makerere Univ, Training Dept, Infect Dis Inst, Coll Hlth Sci, Kampala, Uganda; [Burnett, Sarah M.; Crozier, Ian; Willis, Kelly S.] Accordia Global Hlth Fdn, Washington, DC USA; [Burua, Aldomoro] Management Sci Hlth, Kampala, Uganda; [Colebunders, Robert; Van Geertruyden, Jean-Pierre] Univ Antwerp, Dept Epidemiol & Social Med, Fac Med & Hlth Sci, B-2020 Antwerp, Belgium; [Colebunders, Robert] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Kinoti, Stephen N.] Univ Res Co LLC, Ctr Human Serv, Bethesda, MD USA; [Kinoti, Stephen N.] Fio Corp, Toronto, ON, Canada; [Ronald, Allan] Univ Manitoba, Dept Med, Winnipeg, MB, Canada; [Weaver, Marcia R.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Weaver, Marcia R.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA	Makerere University; University of Antwerp; Institute of Tropical Medicine (ITM); University of Manitoba; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Mbonye, MK (corresponding author), Makerere Univ, Training Dept, Infect Dis Inst, Coll Hlth Sci, Kampala, Uganda.	mbonyemarti@yahoo.com	Van geertruyden, Jean-Pierre/S-3254-2019; Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Ronald, Allan/0000-0002-5746-3490; Colebunders, Robert/0000-0002-1919-1340	Bill & Melinda Gates Foundation [94298]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	This work was supported through grant number 94298 to Accordia Global Health Foundation from the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barat L, 1999, AM J TROP MED HYG, V60, P1024, DOI 10.4269/ajtmh.1999.60.1024; Batwala V, 2011, MALARIA J, V10, DOI [10.1186/1475-2875-10-377, 10.1186/1475-2875-10-373]; Government of Uganda, 2011, ANN HLTH SECT PERF R; Government of Uganda, 2004, HLTH SECT STRAT PLAN; Government of Uganda, 2011, UG NAT MAL CONTR STR; Government of Uganda, 2010, UG NAT HOUS SURV 200; Government of Uganda, 2005, NAT POL MAL TREATM 2; Hamer DH, 2007, JAMA-J AM MED ASSOC, V297, P2227, DOI 10.1001/jama.297.20.2227; Lumley T, 293 U WASH BIOST; Miceli A, 2012, INT J INFECT DIS, V16, pE708, DOI 10.1016/j.ijid.2012.07.003; Naikoba S, 2013, J CLIN CARE PATHWAYS, V0, P1; Namagembe A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-44; Ndyomugyenyi R, 2007, T ROY SOC TROP MED H, V101, P209, DOI 10.1016/j.trstmh.2006.06.004; Opoka RO, 2008, PEDIATR INFECT DIS J, V27, P319, DOI 10.1097/INF.0b013e31815d74dd; Osterholt DM, 2006, TROP MED INT HEALTH, V11, P1147, DOI 10.1111/j.1365-3156.2006.01666.x; Reyburn H, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-4; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; Ssekabira U, 2008, AM J TROP MED HYG, V79, P826, DOI 10.4269/ajtmh.2008.79.826; Sserwanga A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016316; Weaver MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051319; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2006, GUID TREATM MAL; Yeka A, 2005, PLOS MED, V2, P654, DOI 10.1371/journal.pmed.0020190; Yeka A, 2012, ACTA TROP, V121, P184, DOI 10.1016/j.actatropica.2011.03.004; Zurovac D, 2006, TROP MED INT HEALTH, V11, P432, DOI 10.1111/j.1365-3156.2006.01587.x	25	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84945	10.1371/journal.pone.0084945	http://dx.doi.org/10.1371/journal.pone.0084945			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416316	Green Submitted, Green Published			2022-12-27	WOS:000329862500193
J	Pang, LY; Gatenby, EL; Kamida, A; Whitelaw, BA; Hupp, TR; Argyle, DJ				Pang, Lisa Y.; Gatenby, Emma L.; Kamida, Ayako; Whitelaw, Bruce A.; Hupp, Ted R.; Argyle, David J.			Global Gene Expression Analysis of Canine Osteosarcoma Stem Cells Reveals a Novel Role for COX-2 in Tumour Initiation	PLOS ONE			English	Article							GASTROINTESTINAL STROMAL TUMORS; BREAST-CANCER CELLS; PROSPECTIVE IDENTIFICATION; MALIGNANT-TUMORS; BONE-MARROW; CYCLOOXYGENASE-2; SUBPOPULATION; MELOXICAM; PATHWAY; GROWTH	Osteosarcoma is the most common primary bone tumour of both children and dogs. It is an aggressive tumour in both species with a rapid clinical course leading ultimately to metastasis. In dogs and children distant metastasis occurs in.80% of individuals treated by surgery alone. Both canine and human osteosarcoma has been shown to contain a sub-population of cancer stem cells (CSCs), which may drive tumour growth, recurrence and metastasis, suggesting that naturally occurring canine osteosarcoma could act as a preclinical model for the human disease. Here we report the successful isolation of CSCs from primary canine osteosarcoma, as well as established cell lines. We show that these cells can form tumourspheres, and demonstrate relative resistance to chemotherapy. We demonstrate similar results for the human osteosarcma cell lines, U2OS and SAOS2. Utilizing the Affymetrix canine microarray, we are able to definitively show that there are significant differences in global gene expression profiles of isolated osteosarcoma stem cells and the daughter adherent cells. We identified 13,221 significant differences (p = 0.05), and significantly, COX-2 was expressed 141-fold more in CSC spheres than daughter adherent cells. To study the role of COX-2 expression in CSCs we utilized the COX-2 inhibitors meloxicam and mavacoxib. We found that COX-2 inhibition had no effect on CSC growth, or resistance to chemotherapy. However inhibition of COX-2 in daughter cells prevented sphere formation, indicating a potential significant role for COX-2 in tumour initiation.	[Pang, Lisa Y.; Gatenby, Emma L.; Kamida, Ayako; Whitelaw, Bruce A.; Argyle, David J.] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush, Midlothian, Scotland; [Pang, Lisa Y.; Gatenby, Emma L.; Kamida, Ayako; Whitelaw, Bruce A.; Argyle, David J.] Univ Edinburgh, Roslin Inst, Easter Bush, Midlothian, Scotland; [Hupp, Ted R.] Univ Edinburgh, Edinburgh Canc Res UK Ctr, Edinburgh, Midlothian, Scotland	University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Pang, LY (corresponding author), Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush, Midlothian, Scotland.	lisa.pang@ed.ac.uk		Hupp, Ted/0000-0003-0391-0352; Whitelaw, Bruce/0000-0002-2918-1605	Biotechnology and Biological Sciences Research Council (BBSRC) [BBSRC - BB/F008848/1]; Biotechnology and Biological Sciences Research Council [BB/F008848/1, BBS/E/D/20310000, BBS/E/D/20221658, BBS/E/D/05251444, BBS/E/D/05251443, BBS/E/D/05251445, BBS/E/D/05251442] Funding Source: researchfish; BBSRC [BBS/E/D/20221658, BBS/E/D/05251444, BBS/E/D/20310000, BBS/E/D/05251445, BB/F008848/1, BBS/E/D/05251443, BBS/E/D/05251442] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council (BBSRC) grant: BBSRC - BB/F008848/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Argyle DJ, 2008, DECISION MAKING SMAL, Vxi; Bapat SA, 2005, CANCER RES, V65, P3025, DOI 10.1158/0008-5472.CAN-04-3931; Bardsley MR, 2010, GASTROENTEROLOGY, V139, P942, DOI 10.1053/j.gastro.2010.05.083; Basu-Roy U, 2012, CANC LETT; Bj P, 2013, PLAST RECONSTR SURG; Blacking TM, 2007, VET COMP ONCOL, V5, P76, DOI 10.1111/j.1476-5829.2007.00127.x; Bozzi F, 2011, CYTOM PART B-CLIN CY, V80B, P238, DOI 10.1002/cyto.b.20589; Busch U, 1998, DRUG METAB DISPOS, V26, P576; Chen YT, 2012, KAOHSIUNG J MED SCI, V28, P545, DOI 10.1016/j.kjms.2012.04.017; Chiou YS, 2013, CARCINOGENESIS, V34, P1315, DOI 10.1093/carcin/bgt042; Christ O, 2007, HAEMATOLOGICA, V92, P1165, DOI 10.3324/haematol.11366; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Cotterill SJ, 2004, PEDIATR BLOOD CANCER, V42, P59, DOI 10.1002/pbc.10437; Cox SR, 2011, J VET PHARMACOL THER, V34, P1, DOI 10.1111/j.1365-2885.2010.01183.x; Dannhardt G, 2001, INFLAMM RES, V50, P262, DOI 10.1007/s000110050752; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Duan DP, 2012, ONCOL REP, V28, P1693, DOI 10.3892/or.2012.1992; Ek ETH, 2006, CRIT REV ONCOL HEMAT, V60, P1, DOI 10.1016/j.critrevonc.2006.03.006; El-Badawi Zeinab H, 2012, Malays J Pathol, V34, P15; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Fan TM, 2010, EXPERT REV ANTICANC, V10, P1327, DOI 10.1586/ERA.10.107; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Federman N, 2009, CURR TREAT OPTION ON, V10, P82, DOI 10.1007/s11864-009-0087-3; FRAUMENI JF, 1967, CANCER, V20, P967, DOI 10.1002/1097-0142(196706)20:6<967::AID-CNCR2820200606>3.0.CO;2-P; Gatta G, 2005, J CLIN ONCOL, V23, P3742, DOI 10.1200/JCO.2005.00.554; Gibbs CP, 2005, NEOPLASIA, V7, P967, DOI 10.1593/neo.05394; Gisina AM, 2012, B EXP BIOL MED+, V152, P739, DOI 10.1007/s10517-012-1620-0; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Hodgkiss-Geere HM, 2012, VET J, V194, P361, DOI 10.1016/j.tvjl.2012.05.011; Hong SH, 2011, VET COMP ONCOL, V9, P207, DOI 10.1111/j.1476-5829.2010.00249.x; Kanojia D, 2012, PROTEOMICS, V12, P3407, DOI 10.1002/pmic.201200103; Levings PP, 2009, CANCER RES, V69, P5648, DOI 10.1158/0008-5472.CAN-08-3580; Lewis IJ, 2007, JNCI-J NATL CANCER I, V99, P112, DOI 10.1093/jnci/djk015; Ma I, 2011, STEM CELL REV REP, V7, P292, DOI 10.1007/s12015-010-9208-4; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Meyers PA, 2005, J CLIN ONCOL, V23, P2004, DOI 10.1200/JCO.2005.06.031; Millanta F, 2012, J COMP PATHOL, V147, P153, DOI 10.1016/j.jcpa.2012.02.003; Mohammed SI, 2004, PROSTAG LEUKOTR ESS, V70, P479, DOI 10.1016/j.plefa.2003.10.002; Mueller F, 2007, ANTICANCER RES, V27, P155; Mullins MN, 2004, J VET INTERN MED, V18, P859, DOI 10.1892/0891-6640(2004)18&lt;859:CEICAO&gt;2.0.CO;2; MURRAY L, 1995, BLOOD, V85, P368; Muzio G, 2012, FREE RADICAL BIO MED, V52, P735, DOI 10.1016/j.freeradbiomed.2011.11.033; Naruse T, 2006, CARCINOGENESIS, V27, P584, DOI 10.1093/carcin/bgi240; Pan GJ, 2007, CELL RES, V17, P42, DOI 10.1038/sj.cr.7310125; Pang Lisa Y, 2011, Cancers (Basel), V3, P1744, DOI 10.3390/cancers3021744; Pang LY, 2010, VET J, V185, P15, DOI 10.1016/j.tvjl.2010.04.008; Pang LY, 2009, BBA-MOL BASIS DIS, V1792, P380, DOI 10.1016/j.bbadis.2009.02.010; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Saini V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041401; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Singh B, 2007, ONCOGENE, V26, P3789, DOI 10.1038/sj.onc.1210154; Singh B, 2008, J SURG RES, V147, P240, DOI 10.1016/j.jss.2008.02.026; Singh SK, 2003, CANCER RES, V63, P5821; Takahashi RH, 2012, PATHOL RES PRACT, V208, P736, DOI 10.1016/j.prp.2012.09.003; Takemitsu H, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-150; Urakawa H, 2009, CLIN ORTHOP RELAT R, V467, P2932, DOI 10.1007/s11999-009-0814-x; Wagemakers M, 2009, TRANSL ONCOL, V2, P1, DOI 10.1593/tlo.08160; Wang L, 2009, CANCER BIOL THER, V8, P543, DOI 10.4161/cbt.8.6.7695; Wilson H, 2008, VET J, V175, P69, DOI 10.1016/j.tvjl.2007.07.025; Wolfesberger B, 2006, RES VET SCI, V80, P308, DOI 10.1016/j.rvsc.2005.07.013; YOUNG JL, 1975, J PEDIATR-US, V86, P254, DOI 10.1016/S0022-3476(75)80484-7; Zhang XP, 2000, EXP CELL RES, V254, P232, DOI 10.1006/excr.1999.4758	63	34	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83144	10.1371/journal.pone.0083144	http://dx.doi.org/10.1371/journal.pone.0083144			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416158	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500031
J	Prins, SA; Przybycien-Szymanska, MM; Rao, YS; Pak, TR				Prins, Sarah A.; Przybycien-Szymanska, Magdalena M.; Rao, Yathindar S.; Pak, Toni R.			Long-Term Effects of Peripubertal Binge EtOH Exposure on Hippocampal microRNA Expression in the Rat	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; ETHANOL EXPOSURE; RNA-INTERFERENCE; ALCOHOL EXPOSURE; GENE-EXPRESSION; ADULT RATS; BRAIN; ADOLESCENCE; DRINKING; NEUROGENESIS	Adolescent binge alcohol abuse induces long-term changes in gene expression, which impacts the physiological stress response and memory formation, two functions mediated in part by the ventral (VH) and dorsal (DH) hippocampus. microRNAs (miRs) are small RNAs that play an important role in gene regulation and are potential mediators of long-term changes in gene expression. Two genes important for regulating hippocampal functions include brain-derived neurotrophic factor (BDNF) and sirtuin-1 (SIRT1), which we identified as putative gene targets of miR-10a-5p, miR-26a, miR-103, miR-495. The purpose of this study was to quantify miR-10a-5p, miR-26a, miR-103, miR-495 expression levels in the dorsal and ventral hippocampus of male Wistar rats during normal pubertal development and then assess the effects of repeated binge-EtOH exposure. In addition, we measured the effects of binge EtOH-exposure on hippocampal Drosha and Dicer mRNA levels, as well as the putative miR target genes, BDNF and SIRT1. Overall, mid/peri-pubertal binge EtOH exposure altered the normal expression patterns of all miRs tested in an age-and brain region-dependent manner and this effect persisted for up to 30 days post-EtOH exposure. Moreover, our data revealed that mid/peri-pubertal binge EtOH exposure significantly affected miR biosynthetic processing enzymes, Drosha and Dicer. Finally, EtOH-induced significant changes in the expression of a subset of miRs, which correlated with changes in the expression of their predicted target genes. Taken together, these data demonstrate that EtOH exposure during pubertal development has long-term effects on miRNA expression in the rat hippocampus.	[Prins, Sarah A.; Przybycien-Szymanska, Magdalena M.; Rao, Yathindar S.; Pak, Toni R.] Loyola Univ, Chicago Hlth Sci Div, Dept Cell & Mol Physiol, Maywood, IL 60153 USA	Loyola University Chicago	Pak, TR (corresponding author), Loyola Univ, Chicago Hlth Sci Div, Dept Cell & Mol Physiol, Maywood, IL 60153 USA.	tpak@lumc.edu			NIH [R01AA021517, R21AA018398, T32 AA013527]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA013527, R21AA018398, R01AA021517] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by NIH R01AA021517, NIH R21AA018398 and NIH T32 AA013527. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CD, 2011, NEUROSCIENCE, V182, P162, DOI 10.1016/j.neuroscience.2011.03.003; Autry AE, 2012, PHARMACOL REV, V64, P238, DOI 10.1124/pr.111.005108; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bava S, 2010, NEUROPSYCHOL REV, V20, P398, DOI 10.1007/s11065-010-9146-6; BENES FM, 1994, ARCH GEN PSYCHIAT, V51, P477; Caputo V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028656; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Coleman LG, 2011, ALCOHOL CLIN EXP RES, V35, P671, DOI 10.1111/j.1530-0277.2010.01385.x; Conway KP, 2006, J CLIN PSYCHIAT, V67, P247, DOI 10.4088/JCP.v67n0211; Crews FT, 2006, NEUROSCIENCE, V137, P437, DOI 10.1016/j.neuroscience.2005.08.090; Criado JR, 2008, ALCOHOL CLIN EXP RES, V32, P1752, DOI 10.1111/j.1530-0277.2008.00760.x; Ehlers CL, 2011, NEUROSCIENCE, V199, P333, DOI 10.1016/j.neuroscience.2011.10.011; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gogtay N, 2006, HIPPOCAMPUS, V16, P664, DOI 10.1002/hipo.20193; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hansen T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000873; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Inukai S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040028; Juhila J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021495; Karege F, 2002, PSYCHIAT RES, V109, P143, DOI 10.1016/S0165-1781(02)00005-7; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; KETELSLEGERS JM, 1978, ENDOCRINOLOGY, V103, P212, DOI 10.1210/endo-103-1-212; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Krebs MO, 2000, MOL PSYCHIATR, V5, P558, DOI 10.1038/sj.mp.4000749; Lauing K, 2008, ALCOHOL, V42, P649, DOI 10.1016/j.alcohol.2008.08.005; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Libert S, 2011, CELL, V147, P1459, DOI 10.1016/j.cell.2011.10.054; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Matthews DB, 2000, HIPPOCAMPUS, V10, P122, DOI 10.1002/(SICI)1098-1063(2000)10:1<122::AID-HIPO13>3.3.CO;2-M; McGough NNH, 2004, J NEUROSCI, V24, P10542, DOI 10.1523/JNEUROSCI.3714-04.2004; Michan S, 2010, J NEUROSCI, V30, P9695, DOI 10.1523/JNEUROSCI.0027-10.2010; Miranda RC, 2010, ALCOHOL CLIN EXP RES, V34, P575, DOI 10.1111/j.1530-0277.2009.01126.x; Montag C, 2010, PSYCHIAT RES, V179, P86, DOI 10.1016/j.psychres.2008.08.005; Morgan CP, 2011, J NEUROSCI, V31, P11748, DOI 10.1523/JNEUROSCI.1887-11.2011; Morris SA, 2010, HIPPOCAMPUS, V20, P596, DOI 10.1002/hipo.20665; Mulligan Megan K., 2013, Frontiers in Genetics, V4, P126, DOI 10.3389/fgene.2013.00126; Olsen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007225; Oscar-Berman Marlene, 2005, Neuropsychiatr Dis Treat, V1, P211; Pak TR, 2013, PFLUG ARCH EUR J PHY, V465, P655, DOI 10.1007/s00424-013-1227-y; Pappalardo-Carter DL, 2013, ALCOHOL CLIN EXP RES; Parada M, 2011, ALCOHOL CLIN EXP RES, V35, P1475, DOI 10.1111/j.1530-0277.2011.01484.x; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; PFEFFERBAUM A, 1995, ALCOHOL CLIN EXP RES, V19, P1177, DOI 10.1111/j.1530-0277.1995.tb01598.x; Pietrzykowski AZ, 2008, NEURON, V59, P274, DOI 10.1016/j.neuron.2008.05.032; Podolska A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014494; Przybycien-Szymanska MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026647; Przybycien-Szymanska MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018350; Przybycien-Szymanska MM, 2010, AM J PHYSIOL-ENDOC M, V298, pE320, DOI 10.1152/ajpendo.00615.2009; Read JP, 2008, ADDICT BEHAV, V33, P225, DOI 10.1016/j.addbeh.2007.09.001; Richardson HN, 2009, NEUROBIOL DIS, V36, P1, DOI 10.1016/j.nbd.2009.05.021; Ros-Simo C, 2013, J NEUROCHEMISTRY; Rosellini AJ, 2013, J PSYCHOPATHOL BEHAV, V35, P356, DOI 10.1007/s10862-013-9338-5; Sathyan P, 2007, J NEUROSCI, V27, P8546, DOI 10.1523/JNEUROSCI.1269-07.2007; Schaefer A, 2007, J EXP MED, V204, P1553, DOI 10.1084/jem.20070823; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Schulteis G, 2008, ALCOHOL, V42, P459, DOI 10.1016/j.alcohol.2008.05.002; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Silvers JM, 2003, ALCOHOL CLIN EXP RES, V27, P1606, DOI 10.1097/01.ALC.0000090141.66526.22; SODERSTEN P, 1975, HORM BEHAV, V6, P307, DOI 10.1016/0018-506X(75)90001-X; SODERSTEN P, 1977, HORM BEHAV, V8, P320, DOI 10.1016/0018-506X(77)90006-X; Strickland ER, 2011, NEUROSCIENCE, V186, P146, DOI 10.1016/j.neuroscience.2011.03.063; Toga AW, 2006, TRENDS NEUROSCI, V29, P148, DOI 10.1016/j.tins.2006.01.007; Uchida N, 2010, CELL STEM CELL, V6, P294, DOI 10.1016/j.stem.2010.03.010; Walker BM, 2009, PHARMACOL BIOCHEM BE, V91, P560, DOI 10.1016/j.pbb.2008.09.017; Wang GH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S19; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; White AM, 2006, ALCOHOL CLIN EXP RES, V30, P1006, DOI 10.1111/j.1530-0277.2006.00122.x	71	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83166	10.1371/journal.pone.0083166	http://dx.doi.org/10.1371/journal.pone.0083166			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416161	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500034
J	Victoni, T; Gleonnec, F; Lanzetti, M; Tenor, H; Valenca, S; Porto, LC; Lagente, V; Boichot, E				Victoni, Tatiana; Gleonnec, Florence; Lanzetti, Manuella; Tenor, Hermann; Valenca, Samuel; Porto, Luis Cristovao; Lagente, Vincent; Boichot, Elisabeth			Roflumilast N-Oxide Prevents Cytokine Secretion Induced by Cigarette Smoke Combined with LPS through JAK/STAT and ERK1/2 Inhibition in Airway Epithelial Cells	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; OBSTRUCTIVE PULMONARY-DISEASE; SIGNAL-REGULATED KINASE; PHOSPHODIESTERASE-4 INHIBITOR; KAPPA-B; INFLAMMATORY CYTOKINES; BACTERIAL-COLONIZATION; CHEMOKINE RELEASE; IL-8 EXPRESSION; SMOOTH-MUSCLE	Cigarette smoke is a major cause of chronic obstructive pulmonary disease (COPD). Airway epithelial cells and macrophages are the first defense cells against cigarette smoke and these cells are an important source of pro-inflammatory cytokines. These cytokines play a role in progressive airflow limitation and chronic airways inflammation. Furthermore, the chronic colonization of airways by Gram-negative bacteria, contributes to the persistent airways inflammation and progression of COPD. The current study addressed the effects of cigarette smoke along with lipolysaccharide (LPS) in airway epithelial cells as a representative in vitro model of COPD exacerbations. Furthermore, we evaluated the effects of PDE4 inhibitor, the roflumilast N-oxide (RNO), in this experimental model. A549 cells were stimulated with cigarette smoke extract (CSE) alone (0.4% to 10%) or in combination with a low concentration of LPS (0.1 mu g/ml) for 2 h or 24 h for measurement of chemokine protein and mRNAs and 5-120 min for protein phosphorylation. Cells were also pre-incubated with MAP kinases inhibitors and Prostaglandin E-2 alone or combined with RNO, before the addition of CSE+LPS. Production of cytokines was determined by ELISA and protein phosphorylation by western blotting and phospho-kinase array. CSE did not induce production of IL-8/CXCL8 and Gro-alpha/CXCL1 from A549 cells, but increase production of CCL2/MCP-1. However the combination of LPS 0.1 mu g/ml with CSE 2% or 4% induced an important production of these chemokines, that appears to be dependent of ERK1/2 and JAK/STAT pathways but did not require JNK and p38 pathways. Moreover, RNO associated with PGE(2) reduced CSE+LPS-induced cytokine release, which can happen by occur through of ERK1/2 and JAK/STAT pathways. We report here an in vitro model that can reflect what happen in airway epithelial cells in COPD exacerbation. We also showed a new pathway where CSE+LPS can induce cytokine release from A549 cells, which is reduced by RNO.	[Victoni, Tatiana; Gleonnec, Florence; Lagente, Vincent; Boichot, Elisabeth] Univ Rennes 1, INSERM, UMR991, Rennes, France; [Lanzetti, Manuella; Valenca, Samuel; Porto, Luis Cristovao] Univ Estado Rio De Janeiro, IBRAG, DHE, Lab Reparo Tecidual, Rio De Janeiro, Brazil; [Tenor, Hermann] Nycomed GmbH, Constance, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Universidade do Estado do Rio de Janeiro; Nycomed GmbH	Victoni, T (corresponding author), Univ Rennes 1, INSERM, UMR991, Rennes, France.	tatiana.victoni@univ-rennes1.fr	Lanzetti, Manuella/D-5915-2016; Porto, Luis Cristovao M S/I-2984-2013; Valenca, Samuel S/J-7986-2013; Porto, Luis Cristovao/U-6499-2019; dos Santos Valença, Samuel/C-7772-2009; Victoni, Tatiana/AAX-2629-2020	Lanzetti, Manuella/0000-0003-3913-608X; Porto, Luis Cristovao M S/0000-0003-1499-1821; Valenca, Samuel S/0000-0002-1868-9905; Porto, Luis Cristovao/0000-0003-1499-1821; dos Santos Valença, Samuel/0000-0002-1868-9905; Victoni, Tatiana/0000-0001-7263-8300; Lagente, Vincent/0000-0003-4920-009X; LORANT, Elisabeth/0000-0002-4914-0122	INSERM; Falcute de Pharmacie de Rennes 1; CAPES-COFECUB	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Falcute de Pharmacie de Rennes 1; CAPES-COFECUB(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by INSERM and Falcute de Pharmacie de Rennes 1. The authors M. L., T. V., V. L., L. C. P., and S. S. V. are grateful to the CAPES-COFECUB for funding and bilateral agreement (Brazil-France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock IM, 2006, EUR J PHARMACOL, V533, P118, DOI 10.1016/j.ejphar.2005.12.054; Barnes PJ, 2009, AM J RESP CELL MOL, V41, P631, DOI 10.1165/rcmb.2009-0220TR; Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; Bhattacharyya S, 2011, AM J PHYSIOL-LUNG C, V300, pL81, DOI 10.1152/ajplung.00051.2010; Biswas SK, 2002, INT IMMUNOPHARMACOL, V2, P1095, DOI 10.1016/S1567-5769(02)00055-3; Buenestado A, 2011, BRIT J PHARMACOL, V165, P1877; Choi SY, 2012, INFLAMM RES, V61, P493, DOI 10.1007/s00011-012-0437-7; Diamant Z, 2011, PULM PHARMACOL THER, V24, P353, DOI 10.1016/j.pupt.2010.12.011; Field SK, 2011, CLIN MED INSIGHTS-CI, V5, P57, DOI 10.4137/CCRPM.S7049; Fuke S, 2004, AM J RESP CELL MOL, V31, P405, DOI 10.1165/rcmb.2004-0131OC; Goyal A, 2010, BBA-GEN SUBJECTS, V1800, P574, DOI 10.1016/j.bbagen.2010.03.009; Gross NJ, 2010, COPD, V7, P141, DOI 10.3109/15412551003758304; Hatzelmann A, 2010, PULM PHARMACOL THER, V23, P235, DOI 10.1016/j.pupt.2010.03.011; Hellermann GR, 2002, RESP RES, V3, DOI 10.1186/rr172; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Ip WK, 2006, CLIN EXP IMMUNOL, V145, P162, DOI 10.1111/j.1365-2249.2006.03085.x; Issa R, 2006, AM J PHYSIOL-LUNG C, V291, pL66, DOI 10.1152/ajplung.00384.2005; Kitagawa D, 2002, J BIOL CHEM, V277, P366, DOI 10.1074/jbc.M107110200; Korsgren M, 2012, CLIN PHYSIOL FUNCT I, V32, P71, DOI 10.1111/j.1475-097X.2011.01058.x; Laan M, 2004, J IMMUNOL, V173, P4164, DOI 10.4049/jimmunol.173.6.4164; Liu R, 2001, J LEUKOCYTE BIOL, V70, P961; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; Ortiz JL, 2010, PULM PHARMACOL THER, V23, P222, DOI 10.1016/j.pupt.2009.11.001; Martorana PA, 2005, AM J RESP CRIT CARE, V172, P848, DOI 10.1164/rccm.200411-1549OC; Mata M, 2005, THORAX, V60, P144, DOI 10.1136/thx.2004.025692; Mercer Becky A, 2006, Int J Chron Obstruct Pulmon Dis, V1, P137, DOI 10.2147/copd.2006.1.2.137; Milara J, 2012, BRIT J PHARMACOL, V166, P2243, DOI 10.1111/j.1476-5381.2012.01929.x; Moodie FM, 2004, FASEB J, V18, P1897, DOI 10.1096/fj.04-1506fje; OSHEROV N, 1994, EUR J BIOCHEM, V225, P1047, DOI 10.1111/j.1432-1033.1994.1047b.x; Oyaizu T, 2012, INTENS CARE MED, V38, P894, DOI 10.1007/s00134-012-2498-z; Pace E, 2008, IMMUNOLOGY, V124, P401, DOI 10.1111/j.1365-2567.2007.02788.x; Papi A, 2006, AM J RESP CRIT CARE, V173, P1114, DOI 10.1164/rccm.200506-859OC; Patel IS, 2002, THORAX, V57, P759, DOI 10.1136/thorax.57.9.759; Reynolds PR, 2006, AM J RESP CELL MOL, V35, P314, DOI 10.1165/rcmb.2005-0428OC; Richter A, 2002, AM J RESP CELL MOL, V27, P85, DOI 10.1165/ajrcmb.27.1.4789; Sabatini F, 2010, PULM PHARMACOL THER, V23, P283, DOI 10.1016/j.pupt.2010.02.004; Scaltriti M, 2006, CLIN CANCER RES, V12, P5268, DOI 10.1158/1078-0432.CCR-05-1554; Severgnini M, 2004, AM J PHYSIOL-LUNG C, V286, pL1282, DOI 10.1152/ajplung.00349.2003; Su YC, 1998, AM J RESP CELL MOL, V19, P819, DOI 10.1165/ajrcmb.19.5.3091; Torphy TJ, 1998, AM J RESP CRIT CARE, V157, P351, DOI 10.1164/ajrccm.157.2.9708012; Tsuji T, 2010, RESPIRATION, V80, P59, DOI 10.1159/000268287; Underwood DC, 2000, AM J PHYSIOL-LUNG C, V279, pL895, DOI 10.1152/ajplung.2000.279.5.L895; Witherden IR, 2004, AM J RESP CELL MOL, V30, P500, DOI 10.1165/rcmb.4890; Wuyts WA, 2003, RESP MED, V97, P811, DOI 10.1016/S0954-6111(03)00036-2; Zalacain R, 1999, EUR RESPIR J, V13, P343, DOI 10.1034/j.1399-3003.1999.13b21.x	45	29	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85243	10.1371/journal.pone.0085243	http://dx.doi.org/10.1371/journal.pone.0085243			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416369	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500229
J	Zuo, XY; Pan, W; Feng, TT; Shi, XH; Dai, JF				Zuo, Xiangyang; Pan, Wen; Feng, Tingting; Shi, Xiaohong; Dai, Jianfeng			Matrix Metalloproteinase 3 Promotes Cellular Anti-Dengue Virus Response via Interaction with Transcription Factor NF kappa B in Cell Nucleus	PLOS ONE			English	Article							SIGNALING PATHWAY; GENE-EXPRESSION; INFLAMMATION; LOCALIZATION; INFECTION; MECHANISMS; MODULATORS; MICROGLIA; APOPTOSIS; ISCHEMIA	Dengue virus (DENV), the causative agent of human Dengue hemorrhagic fever, is a mosquito-borne virus of immense global health importance. Characterization of cellular factors promoting or inhibiting DENV infection is important for understanding the mechanism of DENV infection. In this report, MMP3 (stromelysin-1), a secretory endopeptidase that degrades extracellular matrices, has been shown promoting cellular antiviral response against DENV infection. Quantitative RT-PCR and Western Blot showed that the expression of MMP3 was upregulated in DENV-infected RAW264.7 cells. The intracellular viral loads were significantly higher in MMP3 silenced cells compared with controls. The expression level of selective anti-viral cytokines were decreased in MMP3 siRNA treated cells, and the transcription factor activity of NFkB was significantly impaired upon MMP3 silencing during DENV infection. Further, we found that MMP3 moved to cell nucleus upon DENV infection and colocalized with NF kappa B P65 in nucleus. Co-immunoprecipitation analysis suggested that MMP3 directly interacted with NF kappa B in nucleus during DENV infection and the C-terminal hemopexin-like domain of MMP3 was required for the interaction. This study suggested a novel role of MMP3 in nucleus during viral infection and provided new evidence for MMPs in immunomodulation.	[Zuo, Xiangyang; Pan, Wen; Feng, Tingting; Shi, Xiaohong; Dai, Jianfeng] Soochow Univ, Inst Biol & Med Sci, Jiangsu Key Lab Infect & Immun, Suzhou, Jiangsu, Peoples R China	Soochow University - China	Dai, JF (corresponding author), Soochow Univ, Inst Biol & Med Sci, Jiangsu Key Lab Infect & Immun, Suzhou, Jiangsu, Peoples R China.	daijianfeng@suda.edu.cn	Dai, Jianfeng/ACP-1114-2022		Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) [IRT1075]; National Natural Science Foundation of China (NSFC) [81172812, 81271792, 31200648]; Jiangsu Natural Science Foundation [BK2012180]	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province)	This work was supported by a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) (IRT1075), National Natural Science Foundation of China (NSFC) (81172812, 81271792, 31200648) and Jiangsu Natural Science Foundation (BK2012180), J.D. is a member of Jiangsu Provincial Innovative Research Team. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Cousin H, 2011, DEV CELL, V20, P256, DOI 10.1016/j.devcel.2010.12.009; Cuadrado E, 2009, J CEREBR BLOOD F MET, V29, P398, DOI 10.1038/jcbfm.2008.130; Dai JF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-468; Eguchi T, 2008, MOL CELL BIOL, V28, P2391, DOI 10.1128/MCB.01288-07; Ip YC, 2007, MOL CARCINOGEN, V46, P225, DOI 10.1002/mc.20270; Ivashkiv LB, 2011, EUR J IMMUNOL, V41, P2477, DOI 10.1002/eji.201141783; Kim EM, 2011, J NEUROCHEM, V116, P22, DOI 10.1111/j.1471-4159.2010.07082.x; Kim EM, 2010, J BIOL CHEM, V285, P16444, DOI 10.1074/jbc.M109.093799; Kim YS, 2005, J NEUROSCI, V25, P3701, DOI 10.1523/JNEUROSCI.4346-04.2005; Li CKF, 2004, J IMMUNOL, V173, P5171, DOI 10.4049/jimmunol.173.8.5171; Liu SY, 2011, CURR OPIN IMMUNOL, V23, P57, DOI 10.1016/j.coi.2010.11.003; Manicone AM, 2008, SEMIN CELL DEV BIOL, V19, P34, DOI 10.1016/j.semcdb.2007.07.003; Mannello F, 2012, PROG HISTOCHEM CYTO, V47, P27, DOI 10.1016/j.proghi.2011.12.002; McMillan SJ, 2004, J IMMUNOL, V172, P2586, DOI 10.4049/jimmunol.172.4.2586; Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Narvaez F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001397; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Pascual G, 2006, TRENDS ENDOCRIN MET, V17, P321, DOI 10.1016/j.tem.2006.08.005; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Ruta A, 2009, EXP LUNG RES, V35, P59, DOI 10.1080/01902140802406059; Schindler C, 2008, SEMIN CELL DEV BIOL, V19, P311, DOI 10.1016/j.semcdb.2008.08.010; Si-Tayeb K, 2006, AM J PATHOL, V169, P1390, DOI 10.2353/ajpath.2006.060005; Souslova V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009902; Thangaraju M, 2005, DEVELOPMENT, V132, P4675, DOI 10.1242/dev.02050; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Walker EJ, 2009, EXP NEUROL, V216, P122, DOI 10.1016/j.expneurol.2008.11.022; Wang PH, 2008, J VIROL, V82, P8978, DOI 10.1128/JVI.00314-08; Wetzel M, 2003, EUR J NEUROSCI, V18, P1050, DOI 10.1046/j.1460-9568.2003.02838.x; WHITE LA, 1987, J CLIN MICROBIOL, V25, P1221, DOI 10.1128/JCM.25.7.1221-1224.1987; Whitehorn J, 2011, VACCINE, V29, P7221, DOI 10.1016/j.vaccine.2011.07.022; Woo MS, 2008, J NEUROCHEM, V106, P770, DOI 10.1111/j.1471-4159.2008.05430.x	35	23	23	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84748	10.1371/journal.pone.0084748	http://dx.doi.org/10.1371/journal.pone.0084748			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416274	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500157
J	Dalvi, P; Wang, K; Mermis, J; Zeng, RX; Sanderson, M; Johnson, S; Dai, YQ; Sharma, G; Ladner, AO; Dhillon, NK				Dalvi, Pranjali; Wang, Kun; Mermis, Joel; Zeng, Ruoxi; Sanderson, Miles; Johnson, Sara; Dai, Yuqiao; Sharma, Garima; Ladner, Amy O'Brien; Dhillon, Navneet K.			HIV-1/Cocaine Induced Oxidative Stress Disrupts Tight Junction Protein-1 in Human Pulmonary Microvascular Endothelial Cells: Role of Ras/ERK1/2 Pathway	PLOS ONE			English	Article							HIV-1 TAT PROTEIN; BLOOD-BRAIN-BARRIER; GROWTH-FACTOR; IMMUNODEFICIENCY-VIRUS; ARTERIAL-HYPERTENSION; HYDROGEN-PEROXIDE; H2O2-MEDIATED PERMEABILITY; TYROSINE PHOSPHORYLATION; KINASE-ACTIVITY; NADPH OXIDASE	Intravenous drug use (IVDU) is the major risk factor in the development of HIV-related pulmonary arterial hypertension (HRPAH); however, the pathogenesis of HRPAH in association with IVDU has yet to be characterized. Endothelial injury is considered to be an initiating factor for pulmonary vascular remodeling in animal models of PAH. Our previous study shows that simultaneous exposure to HIV-Trans-activator of transcription (Tat) and cocaine exacerbates both disruption of tight junction proteins and permeability of human pulmonary artery endothelial cells compared with either treatment alone. We here now demonstrate that this HIV-Tat and cocaine mediated endothelial dysfunction accompanies with increase in hydrogen peroxide and superoxide radicals generation and involves redox sensitive signaling pathway. Pretreatment with antioxidant cocktail attenuated the cocaine and Tat mediated disassembly of Zonula Occludens (ZO)-1 and enhancement of endothelial monolayer permeability. Furthermore, inhibition of NADPH oxidase by apocynin or siRNA-mediated knockdown of gp-91(phox) abolished the Tat/cocaine-induced reactive oxygen species (ROS) production, suggesting the NADPH oxidase mediated generation of oxidative radicals. In addition, ROS dependent activation of Ras and ERK1/2 Kinase was observed to be mediating the TJP-1 disassembly, and endothelial dysfunction in response to cocaine and Tat exposure. In conclusion, our findings demonstrate that Tat/cocaine-mediated production of ROS activate Ras/Raf/ERK1/2 pathway that contributes to disruption of tight junction protein leading to pulmonary endothelial dysfunction associated with pulmonary vascular remodeling.	[Dalvi, Pranjali; Wang, Kun; Mermis, Joel; Zeng, Ruoxi; Sanderson, Miles; Johnson, Sara; Dai, Yuqiao; Sharma, Garima; Ladner, Amy O'Brien; Dhillon, Navneet K.] Univ Kansas, Med Ctr, Div Pulm & Crit Care Med, Kansas City, KS 66103 USA; [Dhillon, Navneet K.] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Dhillon, NK (corresponding author), Univ Kansas, Med Ctr, Div Pulm & Crit Care Med, Kansas City, KS 66103 USA.	ndhillon@kumc.edu	Wang, Kun/H-5227-2016; Dalvi, Pranjali/GRF-1132-2022	Dalvi, Pranjali/0000-0002-5247-9645	NIH [1R01DA034542, 1R03DA031589]; American Heart Association [11SDG7500016]; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA031589, R01DA034542] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grants: 1R01DA034542 and 1R03DA031589 and American Heart Association's Scientist Development grant: 11SDG7500016 awarded to N. K. D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksenov MY, 2006, NEUROTOXICOLOGY, V27, P217, DOI 10.1016/j.neuro.2005.10.003; Albini A, 1996, NAT MED, V2, P1371, DOI 10.1038/nm1296-1371; Allard JP, 1998, AM J CLIN NUTR, V67, P143, DOI 10.1093/ajcn/67.1.143; Andras IE, 2005, J CEREBR BLOOD F MET, V25, P1159, DOI 10.1038/sj.jcbfm.9600115; Aveleira CA, 2010, DIABETES, V59, P2872, DOI 10.2337/db09-1606; Barillari G, 1999, BLOOD, V94, P663; Barillari G, 2002, CLIN MICROBIOL REV, V15, P310, DOI 10.1128/CMR.15.2.310-326.2002; Basuroy S, 2006, BIOCHEM J, V393, P69, DOI 10.1042/BJ20050959; Bates DO, 2010, CARDIOVASC RES, V87, P262, DOI 10.1093/cvr/cvq105; Cai H, 2005, CARDIOVASC RES, V68, P26, DOI 10.1016/j.cardiores.2005.06.021; CHALIFOUX LV, 1992, LAB INVEST, V67, P338; Chang R, 2008, AM J PHYSIOL-LUNG C, V295, pL688, DOI 10.1152/ajplung.00504.2007; Chen YH, 2000, MOL BIOL CELL, V11, P849, DOI 10.1091/mbc.11.3.849; Denker BM, 1996, J BIOL CHEM, V271, P25750, DOI 10.1074/jbc.271.42.25750; Dhillon NK, 2008, J NEUROIMMUNE PHARM, V3, P52, DOI 10.1007/s11481-007-9091-1; Dhillon NK, 2011, AM J RESP CELL MOL, V45, P40, DOI 10.1165/rcmb.2010-0097OC; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; Foltin RW, 2003, DRUG ALCOHOL DEPEN, V70, P149, DOI 10.1016/S0376-8716(02)00343-5; Gil L, 2003, PHARMACOL RES, V47, P217, DOI 10.1016/S1043-6618(02)00320-1; Gorlach A, 2000, CIRC RES, V87, P26, DOI 10.1161/01.RES.87.1.26; GUMBINER BM, 1993, J CELL BIOL, V123, P1631, DOI 10.1083/jcb.123.6.1631; Gumbiner BM, 1998, ANNU REV PHYSIOL, V60, P121; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Hughes A, 2008, NSDUH SERIES H; Ishizaki T, 2003, EXP CELL RES, V290, P275, DOI 10.1016/S0014-4827(03)00354-9; Israel N, 1997, CELL MOL LIFE SCI, V53, P864, DOI 10.1007/s000180050106; Kevil CG, 2000, AM J PHYSIOL-CELL PH, V279, pC21, DOI 10.1152/ajpcell.2000.279.1.C21; Kevil CG, 2001, AM J PHYSIOL-CELL PH, V281, pC1940, DOI 10.1152/ajpcell.2001.281.6.C1940; Klings ES, 2003, ADV CARDIOL, V40, P71; LAMPUGNANI MG, 1995, J CELL BIOL, V129, P203, DOI 10.1083/jcb.129.1.203; Lederman MM, 2008, AIDS, V22, pS1, DOI 10.1097/01.aids.0000327509.30385.3b; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Lee HS, 2004, MICROVASC RES, V68, P231, DOI 10.1016/j.mvr.2004.07.005; Lei H, 2009, J BIOL CHEM, V284, P6329, DOI 10.1074/jbc.M808426200; Louboutin JP, 2012, SCI WORLD J, P1, DOI 10.1100/2012/482575; Marecki J, 2005, CHEST, V128, p621S, DOI 10.1378/chest.128.6_suppl.621S-a; Marecki JC, 2006, AM J RESP CRIT CARE, V174, P437, DOI 10.1164/rccm.200601-005OC; Matsumoto RR, 2003, EUR J PHARMACOL, V469, P1, DOI 10.1016/S0014-2999(03)01723-0; MATSUMOTO T, 2001, SCI STKE; Mermis J, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-103; Mitola S, 1997, BLOOD, V90, P1365, DOI 10.1182/blood.V90.4.1365.1365_1365_1372; Navarro G, 2010, P NATL ACAD SCI USA, V107, P18676, DOI 10.1073/pnas.1008911107; Nunes H, 2003, AM J RESP CRIT CARE, V167, P1433, DOI 10.1164/rccm.200204-330OC; Opravil M, 2008, AIDS, V22, pS35, DOI 10.1097/01.aids.0000327514.60879.47; Petecchia L, 2012, LAB INVEST, V92, P1140, DOI 10.1038/labinvest.2012.67; Pu H, 2003, MOL CELL NEUROSCI, V24, P224, DOI 10.1016/S1044-7431(03)00171-4; Pu H, 2005, J CEREBR BLOOD F MET, V25, P1325, DOI 10.1038/sj.jcbfm.9600125; Rao RK, 2002, BIOCHEM J, V368, P471, DOI 10.1042/BJ20011804; ROSENBERG HC, 1988, AM J PHYSIOL, V255, pH1484, DOI 10.1152/ajpheart.1988.255.6.H1484; Saez CG, 2011, THROMB RES, V128, pE18, DOI 10.1016/j.thromres.2011.04.019; Scharl M, 2009, J BIOL CHEM, V284, P27952, DOI 10.1074/jbc.M109.046292; Schreibelt G, 2007, FASEB J, V21, P3666, DOI 10.1096/fj.07-8329com; STADDON JM, 1995, J CELL SCI, V108, P609; Stuart RO, 1996, J BIOL CHEM, V271, P13636, DOI 10.1074/jbc.271.23.13636; Su TP, 2010, TRENDS PHARMACOL SCI, V31, P557, DOI 10.1016/j.tips.2010.08.007; Sun HR, 2006, MICROCIRCULATION, V13, P237, DOI 10.1080/10739680600556944; Sun Y, 1996, FREE RADICAL BIO MED, V21, P335, DOI 10.1016/0891-5849(96)00109-8; Tanimoto T, 2002, J BIOL CHEM, V277, P42997, DOI 10.1074/jbc.M204764200; Teng RJ, 2009, AM J PHYSIOL-LUNG C, V297, pL184, DOI 10.1152/ajplung.90455.2008; Ushio-Fukai M, 2002, CIRC RES, V91, P1160, DOI 10.1161/01.RES.0000046227.65158.F8; Ushio-Fukai M, 2008, CANCER LETT, V266, P37, DOI 10.1016/j.canlet.2008.02.044; Wang T, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-35; Wang W, 1996, AM J PHYSIOL-CELL PH, V271, pC1973, DOI 10.1152/ajpcell.1996.271.6.C1973; Wang Y, 2004, EXP EYE RES, V78, P125, DOI 10.1016/j.exer.2003.09.002; Weber DS, 2004, CIRC RES, V94, P1219, DOI 10.1161/01.RES.0000126848.54740.4A; Wojciak-Stothard B, 2005, AM J PHYSIOL-LUNG C, V288, pL749, DOI 10.1152/ajplung.00361.2004; Wong CM, 2012, ANTIOXID REDOX SIGNA; YAKEL DL, 1995, AM HEART J, V130, P398, DOI 10.1016/0002-8703(95)90459-X; Yao HH, 2010, BLOOD, V115, P4951, DOI 10.1182/blood-2010-01-266221; Yu WF, 2012, P NATL ACAD SCI USA, V109, P6680, DOI 10.1073/pnas.1116800109	70	35	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e85246	10.1371/journal.pone.0085246	http://dx.doi.org/10.1371/journal.pone.0085246			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409324	Green Published, Green Submitted, gold			2022-12-27	WOS:000329463500048
J	Del Turco, D; Schlaudraff, J; Bonin, M; Deller, T				Del Turco, Domenico; Schlaudraff, Jessica; Bonin, Michael; Deller, Thomas			Upregulation of APP, ADAM10 and ADAM17 in the Denervated Mouse Dentate Gyrus	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; TRAUMATIC BRAIN-INJURY; ENTORHINAL CORTEX LESION; BETA-SECRETASE ACTIVITY; RAT FASCIA-DENTATA; ALZHEIMERS-DISEASE; ALPHA-SECRETASE; REACTIVE ASTROCYTES; TRANSGENIC MICE; FAMILY-MEMBERS	The disintegrin and metalloproteinases ADAM10 and ADAM17 are regarded as the most important alpha-secretases involved in the physiological processing of amyloid precursor protein (APP) in brain. Since it has been suggested that processing of APP by alpha-secretases could be involved in the reorganization of the brain following injury, we studied mRNA expression of the two alpha-secretases Adam10 and Adam17, the beta-secretase Bace1, and the App-gene family (App, Aplp1, Aplp2) in the dentate gyrus of the mouse following entorhinal denervation. Using laser microdissection, tissue was harvested from the outer molecular layer and the granule cell layer of the denervated dentate gyrus. Expression levels of candidate genes were assessed using Affymetrix GeneChip Mouse Gene 1.0 ST arrays and reverse transcription-quantitative PCR, revealing an upregulation of Adam10 mRNA and Adam17 mRNA in the denervated outer molecular layer and an upregulation of Adam10 mRNA and App mRNA in the dentate granule cell layer. Immunolabeling for ADAM10 or ADAM17 in combination with markers for astro- and microglia revealed an increased labeling of ADAM10 and ADAM17 in the denervated outer molecular layer that was associated with reactive astrocytes but not with microglia. Collectively, these data show that denervation affects the expression level of APP and its two most important alpha-secretases. This suggests that APP-processing could be shifted towards the non-amyloidogenic pathway in denervated areas of the brain and, thus, towards the formation of neuroprotective APP cleavage products, such as APPs alpha.	[Del Turco, Domenico; Schlaudraff, Jessica; Deller, Thomas] Goethe Univ Frankfurt, Inst Clin Neuroanat, Ctr Neurosci, D-60054 Frankfurt, Germany; [Bonin, Michael] Univ Tubingen, Dept Med Genet, Inst Human Genet, Tubingen, Germany	Goethe University Frankfurt; Eberhard Karls University of Tubingen	Del Turco, D (corresponding author), Goethe Univ Frankfurt, Inst Clin Neuroanat, Ctr Neurosci, D-60054 Frankfurt, Germany.	DelTurco@em.uni-frankfurt.de			Deutsche Forschungsgemeinschaft [DE 551/11-1, DE 551/11-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The grant sponsor was Deutsche Forschungsgemeinschaft (http://www.dfg.de), Grant number: DE 551/11-1; DE 551/11-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydin D, 2012, EXP BRAIN RES, V217, P423, DOI 10.1007/s00221-011-2861-2; Bell KFS, 2008, NEUROBIOL AGING, V29, P554, DOI 10.1016/j.neurobiolaging.2006.11.004; Burbach GJ, 2003, J NEUROSCI METH, V131, P83, DOI 10.1016/S0165-0270(03)00232-2; Copanaki E, 2010, MOL CELL NEUROSCI, V44, P386, DOI 10.1016/j.mcn.2010.04.007; Corrigan F, 2012, J NEUROCHEM, V122, P208, DOI 10.1111/j.1471-4159.2012.07761.x; Corrigan F, 2012, BRAIN RES, V1451, P87, DOI 10.1016/j.brainres.2012.02.045; Corrigan F, 2012, NEUROSCI LETT, V515, P50, DOI 10.1016/j.neulet.2012.03.017; Del Turco D, 2003, HIPPOCAMPUS, V13, P685, DOI 10.1002/hipo.10118; Deller T, 1997, PROG NEUROBIOL, V53, P687, DOI 10.1016/S0301-0082(97)00044-0; Deller T, 2000, ANN NY ACAD SCI, V911, P207; Deller T, 2007, PROG BRAIN RES, V163, P501, DOI 10.1016/S0079-6123(07)63027-1; Endres K, 2012, EXP BRAIN RES, V217, P343, DOI 10.1007/s00221-011-2885-7; Fahrenholz F, 2007, CURR ALZHEIMER RES, V4, P412, DOI 10.2174/156720507781788837; Fahrenholz F, 2006, NEURODEGENER DIS, V3, P255, DOI 10.1159/000095264; Fahrenholz F, 2010, NEURODEGENER DIS, V7, P190, DOI 10.1159/000295662; Faissner A, 2010, BRAIN RES REV, V63, P26, DOI 10.1016/j.brainresrev.2010.01.001; Finsen B, 1999, ADV EXP MED BIOL, V468, P157; Fluhrer R, 2003, J BIOL CHEM, V278, P5531, DOI 10.1074/jbc.M211485200; Frank S, 2008, GLIA, V56, P1438, DOI 10.1002/glia.20710; Freese C, 2009, FEBS J, V276, P1568, DOI 10.1111/j.1742-4658.2009.06889.x; GAGE FH, 1988, EXP NEUROL, V102, P2, DOI 10.1016/0014-4886(88)90073-8; GALL C, 1979, J COMP NEUROL, V183, P539, DOI 10.1002/cne.901830306; GOODMAN Y, 1994, EXP NEUROL, V128, P1, DOI 10.1006/exnr.1994.1107; Haas CA, 1999, J NEUROSCI, V19, P9953; Heber S, 2000, J NEUROSCI, V20, P7951; Hiltunen M, 2009, J ALZHEIMERS DIS, V18, P401, DOI 10.3233/JAD-2009-1154; Itoh T, 2009, NEUROL RES, V31, P103, DOI 10.1179/016164108X323771; Jensen MB, 1999, NEUROSCIENCE, V93, P507, DOI 10.1016/S0306-4522(99)00139-6; KAWAJA MD, 1991, NEURON, V7, P1019, DOI 10.1016/0896-6273(91)90346-2; Kogel D, 2012, EXP BRAIN RES, V217, P471, DOI 10.1007/s00221-011-2932-4; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; MATTSON MP, 1994, J NEUROTRAUM, V11, P3, DOI 10.1089/neu.1994.11.3; Mattson MP, 1999, J NEUROCHEM, V73, P532, DOI 10.1046/j.1471-4159.1999.0730532.x; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Muller UC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006288; Murakami N, 1998, J NEUROTRAUM, V15, P993, DOI 10.1089/neu.1998.15.993; Nielsen HH, 2006, GLIA, V54, P105, DOI 10.1002/glia.20357; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Obregon D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1781; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Postina R, 2012, J NEUROCHEM, V120, P46, DOI 10.1111/j.1471-4159.2011.07459.x; Prinzen C, 2008, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-66; Ramirez MJ, 2001, BRAIN RES, V907, P222, DOI 10.1016/S0006-8993(01)02580-X; Reeves TM, 2003, J NEUROSCI, V23, P10182; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Saftig P, 2011, EUR J CELL BIOL, V90, P527, DOI 10.1016/j.ejcb.2010.11.005; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Skovronsky DM, 2001, J NEUROBIOL, V49, P40, DOI 10.1002/neu.1064; Soba P, 2005, EMBO J, V24, P3624, DOI 10.1038/sj.emboj.7600824; Steinbach JP, 1998, CELL DEATH DIFFER, V5, P858, DOI 10.1038/sj.cdd.4400391; STEWARD O, 1994, EXP NEUROL, V129, P103, DOI 10.1006/exnr.1994.1151; STEWARD O, 1993, EXP NEUROL, V124, P167, DOI 10.1006/exnr.1993.1187; Steward O., 1991, CEREB CORTEX, V9, P81; Thon N, 2000, EUR J NEUROSCI, V12, P2547, DOI 10.1046/j.1460-9568.2000.00109.x; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; Tian YA, 2010, J BIOL CHEM, V285, P32549, DOI 10.1074/jbc.M110.128439; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Van den Heuvel C, 1999, EXP NEUROL, V159, P441, DOI 10.1006/exnr.1999.7150; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt82; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Vuksic M, 2011, EXP NEUROL, V230, P176, DOI 10.1016/j.expneurol.2011.04.011; Walsh DM, 2007, BIOCHEM SOC T, V35, P416, DOI 10.1042/BST0350416; Wang ZL, 2009, J NEUROSCI, V29, P10788, DOI 10.1523/JNEUROSCI.2132-09.2009; Warren KM, 2012, J NEUROTRAUM, V29, P1922, DOI 10.1089/neu.2012.2383; Yang P, 2006, PROG NEUROBIOL, V79, P73, DOI 10.1016/j.pneurobio.2006.05.001; Zhang H, 2012, J NEUROCHEM, V120, P9, DOI 10.1111/j.1471-4159.2011.07519.x; Zhao J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-150	73	19	19	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84962	10.1371/journal.pone.0084962	http://dx.doi.org/10.1371/journal.pone.0084962			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404197	Green Submitted, Green Published, gold			2022-12-27	WOS:000329460800076
J	Feng, MC; Xiao, LJ; Zhang, MJ; Yang, WD; Ding, GW				Feng, Mei-chen; Xiao, Lu-jie; Zhang, Mei-jun; Yang, Wu-de; Ding, Guang-wei			Integrating Remote Sensing and GIS for Prediction of Winter Wheat (Triticum aestivum) Protein Contents in Linfen (Shanxi), China	PLOS ONE			English	Article							GRAIN-YIELD; NITROGEN STATUS	In this study, relationships between normalized difference vegetation index (NDVI) and plant (winter wheat) nitrogen content (PNC) and between PNC and grain protein content (GPC) were investigated using multi-temporal moderate-resolution imaging spectroradiometer (MODIS) data at the different stages of winter wheat in Linfen (Shanxi, P. R. China). The anticipating model for GPC of winter wheat was also established by the approach of NDVI at the different stages of winter wheat. The results showed that the spectrum models of PNC passed F test. The NDVI4.14 regression effect of PNC model of irrigated winter wheat was the best, and that in dry land was NDVI4.30. The PNC of irrigated and dry land winter wheat were significantly (P<0.01) and positively correlated to GPC. Both of protein spectral anticipating model of irrigated and dry land winter wheat passed a significance test (P<0.01). Multiple anticipating models (MAM) were established by NDVI from two periods of irrigated and dry land winter wheat and PNC to link GPC anticipating model. The coefficient of determination R-2 (R) of MAM was greater than that of the other two single-factor models. The relative root mean square error (R-RMSE) and relative error (RE) of MAM were lower than those of the other two single-factor models. Therefore, test effects of multiple proteins anticipating model were better than those of single-factor models. The application of multiple anticipating models for predication of protein content (PC) of irrigated and dry land winter wheat was more accurate and reliable. The regionalization analysis of GPC was performed using inverse distance weighted function of GIS, which is likely to provide the scientific basis for the reasonable winter wheat planting in Linfen city, China.	[Feng, Mei-chen; Xiao, Lu-jie; Zhang, Mei-jun; Yang, Wu-de] Shanxi Agr Univ, Inst Dryland Farming Engn, Taigu, Peoples R China; [Ding, Guang-wei] Northern State Univ, Dept Chem, Aberdeen, SD USA	Shanxi Agricultural University; Northern State University	Yang, WD (corresponding author), Shanxi Agr Univ, Inst Dryland Farming Engn, Taigu, Peoples R China.	sxauywd@126.com; guangwei.ding@northern.edu		Meichen, Feng/0000-0002-0338-7963	Key Technologies R&D Program of Shanxi Province, China [20060311140, 20110311038, 201203110012]; Scientific Research Starting Foundation of Shanxi Agricultural University [XB2009016]; Sci-tech Innovation Foundation of Shanxi Agricultural University [201222]	Key Technologies R&D Program of Shanxi Province, China; Scientific Research Starting Foundation of Shanxi Agricultural University; Sci-tech Innovation Foundation of Shanxi Agricultural University	This work was supported by grants from the Key Technologies R&D Program of Shanxi Province, China (20060311140, 20110311038, and 201203110012), the Scientific Research Starting Foundation of Shanxi Agricultural University (XB2009016), and the Sci-tech Innovation Foundation of Shanxi Agricultural University (201222). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2007, ENCY MEAS STAT, V648, P651, DOI [10.1007/springerreference_61039, DOI 10.1007/SPRINGERREFERENCE_61039]; Agrawal G, 2011, INT J ADV ENG SCI TE, V4, P178; Apan A., 2006, INT J GEOINFORMATICS, V2, P93; Boken VK, 2002, INT J REMOTE SENS, V23, P4155, DOI 10.1080/014311602320567955; BURT PJ, 1983, ACM T GRAPHIC, V2, P217, DOI 10.1145/245.247; Cohen Y., 2002, International Journal of Applied Earth Observation and Geoinformation, V4, P75, DOI 10.1016/S0303-2434(02)00003-X; DAUGHTRY CST, 1992, REMOTE SENS ENVIRON, V39, P141, DOI 10.1016/0034-4257(92)90132-4; Diago MP, 2012, SENSORS-BASEL, V12, P16988, DOI 10.3390/s121216988; Freeman KW, 2003, COMMUN SOIL SCI PLAN, V34, P1837, DOI 10.1081/CSS-120023219; Girodo M, 2006, SOL ENERGY, V80, P1145, DOI 10.1016/j.solener.2005.09.005; Gitelson AA, 1998, REMOTE SENS ENVIRON, V66, P343, DOI 10.1016/S0034-4257(98)00065-0; Guiarati DN, 1995, BASIC ECONOMETRICS; Hansen PM, 2002, J AGR SCI-CAMBRIDGE, V139, P307, DOI 10.1017/S0021859602002320; Huang WJ, 2008, INT FED INFO PROC, V259, P1299; Liu LY, 2006, INT J REMOTE SENS, V27, P737, DOI 10.1080/01431160500296867; Lu D, 2004, INT J REMOTE SENS, V25, P2365, DOI 10.1080/0143116031000139863; Manjunath KR, 2002, INT J REMOTE SENS, V23, P3023, DOI 10.1080/01431160110104692; Matheron G., 1963, ECON GEOL, V58, P1246, DOI [DOI 10.2113/GSECONGEO.58.8.1246, 10.2113/gsecongeo.58.8.1246]; Matsunaka T, 1997, SOIL SCI PLANT NUTR, V43, P127, DOI 10.1080/00380768.1997.10414721; Otis DL., 1982, CAPTURE RECAPTURE RE; Reyniers M, 2006, INT J REMOTE SENS, V27, P549, DOI 10.1080/01431160500117907; Reyniers M, 2006, EUR J AGRON, V24, P87, DOI 10.1016/j.eja.2005.05.002; Rouse Haas, 1973, MONITORING VERNAL AD, DOI DOI 10.1002/MRM.26868; SAHRAWAT KL, 1995, GEODERMA, V68, P219, DOI 10.1016/0016-7061(95)00031-I; Serrano L, 2000, CROP SCI, V40, P723, DOI 10.2135/cropsci2000.403723x; SHEWRY P. R, 2006, IMPACTS AGR HUMAN HL; SHIH SF, 1994, SOIL CROP SCI SOC FL, V53, P19; Shum HY, 2000, INT J COMPUT VISION, V36, P101, DOI 10.1023/A:1008195814169; Stark J, 2001, AM SOC AGR ANN M CHA; Stone ML, 1996, T ASAE, V39, P1623, DOI 10.13031/2013.27678; Tang QY, 2013, INSECT SCI, V20, P254, DOI 10.1111/j.1744-7917.2012.01519.x; TERMAN GL, 1969, AGRON J, V61, P755, DOI 10.2134/agronj1969.00021962006100050031x; Thomlinson JR, 1999, REMOTE SENS ENVIRON, V70, P16, DOI 10.1016/S0034-4257(99)00055-3; Wang ZJ, 2004, FIELD CROP RES, V90, P311, DOI 10.1016/j.fcr.2004.04.004; Wright D.L., 2004, GISCI REMOTE SENS, V41, P287, DOI 10.2747/1548-1603.41.4.287; Zhao CJ, 2005, INT J APPL EARTH OBS, V7, P1, DOI 10.1016/j.jag.2004.10.002; Zribi M, 2003, INT J REMOTE SENS, V24, P1335, DOI 10.1080/01431160210146668	37	8	8	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e80989	10.1371/journal.pone.0080989	http://dx.doi.org/10.1371/journal.pone.0080989			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404124	Green Published, Green Submitted, gold			2022-12-27	WOS:000329460800003
J	Guo, H; Peng, D; Yang, XG; Wang, Y; Xu, BC; Ni, JS; Meng, W; Jiang, YF				Guo, Hui; Peng, Di; Yang, Xi-Ge; Wang, Ye; Xu, Bing-Chuan; Ni, Jin-Song; Meng, Wei; Jiang, Yan-Fang			A Higher Frequency of Circulating IL-22(+)CD4(+) T Cells in Chinese Patients with Newly Diagnosed Hashimoto's Thyroiditis	PLOS ONE			English	Article							INTERLEUKIN 22; DISTINCT; LINEAGE	Background: IL-22 and IL-17A are implicated in the pathogenesis of autoimmune diseases. However, the role of IL-22(+) and IL-17A(+) CD4(+) T cells in the pathogenesis of Hashimoto's thyroiditis (HT) is not fully understood. This study investigates serum IL-22 and IL-17A levels and determines the frequency of circulating IL-22(+) CD4(+) T cells in HT patients to understand their roles in the pathogenesis of HT. Methods: The levels of serum IL-22, IL-17A and IFN-gamma and the frequency of circulating IL-22(+)D4(+) and IL-17A(+)CD4(+) T cells in 17 HT patients and 17 healthy controls (HC) were determined by enzyme-linked immunosorbent assay (ELISA) and flow cytometry. The levels of serum free triiodothyronine (FT4), free thyroxine (FT3), thyroid stimulating hormone (TSH), antithyroid peroxidase (TPO) and anti-thyroglobulin antibodies (TgAb) by chemiluminescent enzyme immunoassay and radioimmunoassay. Results: The percentages of circulating IL-22(+)CD4(+) and IL-17(+)CD4(+) T cells (p<0.0001, p<0.0001) and the levels of serum IL-22, IL-17A and IFN-gamma (p<0.0001, p<0.0001, p = 0.0210) in the HT patients were significantly higher than that in the HC. The percentages of IL-22(+)CD4(+) T cells were positively correlated with Th17 cells (r = 0.8815, p<0.0001) and IL-17A(+)IL-22(+)CD4(+) T cells (r = 0.8914, p<0.0001), but were negatively correlated with Th1 cells (r = -0.6110, p<0.0092) in the HT patients. The percentages of Th22 cells, Th17 cells and IL-17A(+)IL-22(+)CD4(+) T cells were negatively correlated with the levels of serum TSH in the HT patients (r = -0.8402, p<0.0001; r = -0.8589, p<0.0001; r = -0.8289 p<0.0001, respectively). Conclusions: A higher frequency of circulating IL-22(+)CD4(+) and IL-17A(+)CD4(+) T cells may be associated with the development of HT in Chinese patients.	[Peng, Di; Wang, Ye; Xu, Bing-Chuan; Jiang, Yan-Fang] Jilin Univ, Hosp 1, Dept Cent Lab, Key Lab Zoonosis Res, Changchun 130023, Peoples R China; [Guo, Hui; Peng, Di; Wang, Ye; Xu, Bing-Chuan] Jilin Univ, Part Hosp 1 2, Dept Endocrinol, Changchun 130023, Peoples R China; [Yang, Xi-Ge] Jilin Univ, Hosp 1, Dept Anesthesiol, Changchun 130023, Peoples R China; [Ni, Jin-Song] Jilin Univ, Part Hosp 1 2, Dept Pathol, Changchun 130023, Peoples R China; [Meng, Wei] Jilin Univ, Hosp 1, Dept Thyroid Surg, Changchun 130023, Peoples R China	Jilin University; Jilin University; Jilin University; Jilin University; Jilin University	Jiang, YF (corresponding author), Jilin Univ, Hosp 1, Dept Cent Lab, Key Lab Zoonosis Res, Changchun 130023, Peoples R China.	yanfangjiang@hotmail.com	Wang, Ye/GWQ-7482-2022					Baccarelli A, 2008, PLOS MED, V5, P1133, DOI 10.1371/journal.pmed.0050161; Bossowski Artur, 2012, Pediatr Endocrinol Diabetes Metab, V18, P89; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Figueroa-Vega N, 2010, J CLIN ENDOCR METAB, V95, P953, DOI 10.1210/jc.2009-1719; Gianoukakis AG, 2008, THYROID, V18, P953, DOI 10.1089/thy.2007.0405; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Kallmann BA, 1997, DIABETES, V46, P237, DOI 10.2337/diabetes.46.2.237; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pavuk M, 2003, ANN EPIDEMIOL, V13, P335, DOI 10.1016/S1047-2797(02)00422-2; Peng D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068446; Qin Q, 2012, BRAZ J MED BIOL RES, V45, P1202, DOI 10.1590/S0100-879X2012007500168; Qin WZ, 2011, CLIN EXP MED, V11, P245, DOI 10.1007/s10238-011-0134-9; Shi Y, 2010, SCAND J IMMUNOL, V72, P250, DOI 10.1111/j.1365-3083.2010.02425.x; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Watanabe M, 2002, THYROID, V12, P801, DOI 10.1089/105072502760339370; Xu W, 2013, J NEUROIMMUNOL; Zhang L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031000, 10.1371/journal.pone.0037865]; Zhang L, 2011, J CLIN IMMUNOL, V31, P606, DOI 10.1007/s10875-011-9540-8	19	12	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84545	10.1371/journal.pone.0084545	http://dx.doi.org/10.1371/journal.pone.0084545			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404171	Green Published, Green Submitted, gold			2022-12-27	WOS:000329460800050
J	Herrero-Fresno, A; Wallrodt, I; Leekitcharoenphon, P; Olsen, JE; Aarestrup, FM; Hendriksen, RS				Herrero-Fresno, Ana; Wallrodt, Inke; Leekitcharoenphon, Pimlapas; Olsen, John Elmerdahl; Aarestrup, Frank M.; Hendriksen, Rene S.			The Role of the st313-td Gene in Virulence of Salmonella Typhimurium ST313	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; INVASIVE NONTYPHOIDAL SALMONELLA; MULTIDRUG-RESISTANCE; CHROMOSOMAL GENES; BIOFILM FORMATION; BACTEREMIA; CHILDREN; INFECTIONS; DUBLIN; CELLS	Multidrug-resistant Salmonella enterica serovar Typhimurium ST313 has emerged in sub-Saharan Africa causing severe infections in humans. Therefore, it has been speculated that this specific sequence type, ST313, carries factors associated with increased pathogenicity. We assessed the role in virulence of a gene with a yet unknown function, st313-td, detected in ST313 through comparative genomics. Additionally, the structure of the genomic island ST313-GI, harbouring the gene was determined. The gene st313-td was cloned into wild type S. Typhimurium 4/74 (4/74-C) as well as knocked out in S. Typhimurium ST313 02-03/002 (Delta st313-td) followed by complementation (02-03/002-C). Delta st313-td was less virulent in mice following i.p. challenge than the wild type and this phenotype could be partly complemented in trans, indicating that st313td plays a role during systemic infection. The gene st313-td was shown not to affect invasion of cultured epithelial cells, while the absence of the gene significantly affects uptake and intracellular survival within macrophages. The gene st313-td was proven to be strongly associated to invasiveness, harboured by 92.5% of S. Typhimurium blood isolates (n = 82) and 100% of S. Dublin strains (n = 50) analysed. On the contrary, S. Typhimurium isolates of animal and food origin (n = 82) did not carry st313-td. Six human, non-blood isolates of S. Typhimurium from Belarus, China and Nepal harboured the gene and belonged to sequence types ST398 and ST19. Our data showed a global presence of the st313-td gene and in other sequence types than ST313. The gene st313-td was shown to be expressed during logarithmic phase of growth in 14 selected Salmonella strains carrying the gene. This study reveals that st313-td plays a role in S. Typhimurium ST313 pathogenesis and adds another chapter to understanding of the virulence of S. Typhimurium and in particular of the emerging sequence type ST313.	[Herrero-Fresno, Ana; Wallrodt, Inke; Olsen, John Elmerdahl] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Frederiksberg, Denmark; [Herrero-Fresno, Ana; Leekitcharoenphon, Pimlapas; Aarestrup, Frank M.; Hendriksen, Rene S.] Tech Univ Denmark, Natl Food Inst, WHO Collaborating Ctr Antimicrobial Resistance Fo, DK-2800 Lyngby, Denmark; [Herrero-Fresno, Ana; Leekitcharoenphon, Pimlapas; Aarestrup, Frank M.; Hendriksen, Rene S.] Tech Univ Denmark, Natl Food Inst, EU Reference Lab Antimicrobial Resistance, DK-2800 Lyngby, Denmark	University of Copenhagen; Technical University of Denmark; Technical University of Denmark	Herrero-Fresno, A (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Frederiksberg, Denmark.	ahefr@sund.ku.dk	Leekitcharoenphon, Pimlapas/AAB-5487-2021; Herrero Fresno, Ana/GLU-6728-2022; Olsen, John Elmerdahl/N-9271-2019	Leekitcharoenphon, Pimlapas/0000-0002-5674-0142; Aarestrup, Frank/0000-0002-7116-2723; Hendriksen, Rene S./0000-0003-2934-8214; Olsen, John Elmerdahl/0000-0001-6225-6587; Herrero-Fresno, Ana/0000-0001-5026-7852	Center for Genomic Epidemiology; World Health Organization Global Foodborne Infections Network	Center for Genomic Epidemiology; World Health Organization Global Foodborne Infections Network	This work was funded by the Center for Genomic Epidemiology (www.genomicepidemiology.org) and by the World Health Organization Global Foodborne Infections Network (www.who.int/gfn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Beuzon CR, 2001, MICROBES INFECT, V3, P1345, DOI 10.1016/S1286-4579(01)01496-4; Bhatta DR, 2007, LETT APPL MICROBIOL, V44, P588, DOI 10.1111/j.1472-765X.2007.02133.x; Bolton AJ, 1999, MICROBIOL-SGM, V145, P2431, DOI 10.1099/00221287-145-9-2431; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Jong HK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002933; Doublet B, 2008, J MICROBIOL METH, V75, P359, DOI 10.1016/j.mimet.2008.06.010; ENOMOTO M, 1974, VIROLOGY, V60, P503, DOI 10.1016/0042-6822(74)90344-4; Fashae K, 2010, J INFECT DEV COUNTR, V4, P484, DOI 10.3855/jidc.909; Feasey NA, 2012, LANCET, V379, P2489, DOI 10.1016/S0140-6736(11)61752-2; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; GILKS CF, 1990, LANCET, V336, P545, DOI 10.1016/0140-6736(90)92096-Z; Goh YS, 2013, J IMMUNOL METHODS, V387, P121, DOI 10.1016/j.jim.2012.10.005; Gondwe EN, 2010, P NATL ACAD SCI USA, V107, P3070, DOI 10.1073/pnas.0910497107; Gordon MA, 2008, J INFECTION, V56, P413, DOI 10.1016/j.jinf.2008.03.012; Gordon MA, 2008, CLIN INFECT DIS, V46, P963, DOI 10.1086/529146; Graham SM, 2010, CURR OPIN INFECT DIS, V23, P409, DOI 10.1097/QCO.0b013e32833dd25d; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hendriksen RS, 2011, FOODBORNE PATHOG DIS, V8, P887, DOI 10.1089/fpd.2010.0787; Hensel M, 1997, MOL MICROBIOL, V24, P155, DOI 10.1046/j.1365-2958.1997.3271699.x; Holzer SU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033220; Hohmann EL, 2001, CLIN INFECT DIS, V32, P263, DOI 10.1086/318457; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Issack MI, 2009, FOODBORNE PATHOG DIS, V6, P739, DOI 10.1089/fpd.2009.0283; Jarvik T, 2010, J BACTERIOL, V192, P560, DOI 10.1128/JB.01233-09; Jelsbak L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036149; Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109; Krauland MG, 2009, EMERG INFECT DIS, V15, P388, DOI 10.3201/eid1503.081131; Kundinger MM, 2008, J RAPID METH AUT MIC, V16, P273, DOI 10.1111/j.1745-4581.2008.00133.x; Latasa C, 2005, MOL MICROBIOL, V58, P1322, DOI 10.1111/j.1365-2958.2005.04907.x; Laupland KB, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-95; Ledeboer NA, 2006, INFECT IMMUN, V74, P3156, DOI 10.1128/IAI.01428-05; Leekitcharoenphon P, 2013, J INFECT DE IN PRESS; Marcus SL, 2000, MICROBES INFECT, V2, P145, DOI 10.1016/S1286-4579(00)00273-2; Mazurkiewicz P, 2008, MOL MICROBIOL, V67, P1371, DOI 10.1111/j.1365-2958.2008.06134.x; Msefula CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042085; Nyirenda TS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013667; OCALLAGHAN D, 1990, MOL GEN GENET, V223, P156, DOI 10.1007/BF00315809; Okoro CK, 2012, NAT GENET, V44, P1215, DOI 10.1038/ng.2423; Okoro CK, 2012, CLIN INFECT DIS, V54, P955, DOI 10.1093/cid/cir1032; Ou HY, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj005; Portillo FGD, 2001, MICROBES INFECT, V3, P1305, DOI 10.1016/S1286-4579(01)01491-5; Schlumberger MC, 2006, CURR OPIN MICROBIOL, V9, P46, DOI 10.1016/j.mib.2005.12.006; Sigauque B, 2009, PEDIATR INFECT DIS J, V28, P108, DOI 10.1097/INF.0b013e318187a87d; Siggins MK, 2011, J IMMUNOL, V186, P2365, DOI 10.4049/jimmunol.1000284; Stecher B, 2004, INFECT IMMUN, V72, P4138, DOI 10.1128/IAI.72.7.4138-4150.2004; Tapalski D, 2007, CLIN MICROBIOL INFEC, V13, P1030, DOI 10.1111/j.1469-0691.2007.01795.x; van der Velden AWM, 1998, INFECT IMMUN, V66, P2803, DOI 10.1128/IAI.66.6.2803-2808.1998; Vandenberg O, 2010, PEDIATR INFECT DIS J, V29, P504, DOI 10.1097/INF.0b013e3181cd615a; Wain J, 2013, J INFECT DEV COUNTR, V7, P1, DOI 10.3855/jidc.3080; WALLIS TS, 1995, INFECT IMMUN, V63, P2755, DOI 10.1128/IAI.63.7.2755-2761.1995; Wallrodt I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070829; WATSON PR, 1995, INFECT IMMUN, V63, P2743, DOI 10.1128/IAI.63.7.2743-2754.1995; Xia SL, 2009, J CLIN MICROBIOL, V47, P401, DOI 10.1128/JCM.01099-08; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zou QH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-729	57	32	32	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84566	10.1371/journal.pone.0084566	http://dx.doi.org/10.1371/journal.pone.0084566			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404174	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460800053
J	Orr, MT; Beebe, EA; Hudson, TE; Moon, JJ; Fox, CB; Reed, SG; Coler, RN				Orr, Mark T.; Beebe, Elyse A.; Hudson, Thomas E.; Moon, James J.; Fox, Christopher B.; Reed, Steven G.; Coler, Rhea N.			A Dual TLR Agonist Adjuvant Enhances the Immunogenicity and Protective Efficacy of the Tuberculosis Vaccine Antigen ID93	PLOS ONE			English	Article							INDUCED INTERLEUKIN-12P70 SECRETION; T-CELL RESPONSES; DENDRITIC CELLS; EXPRESSION; PATHWAYS; LIGANDS; FORMULATION; FREQUENCY; CORRELATE; LIGATION	With over eight million cases of tuberculosis each year there is a pressing need for the development of new vaccines against Mycobacterium tuberculosis. Subunit vaccines consisting of recombinant proteins are an attractive vaccine approach due to their inherent safety compared to attenuated live vaccines and the uniformity of manufacture. Addition of properly formulated TLR agonist-containing adjuvants to recombinant protein vaccines enhances the antigen-specific CD4(+) T cell response characterized by IFN-gamma and TNF, both of which are critical for the control of TB. We have developed a clinical stage vaccine candidate consisting of a recombinant fusion protein ID93 adjuvanted with the TLR4 agonist GLA-SE. Here we examine whether ID93+GLA-SE can be improved by the addition of a second TLR agonist. Addition of CpG containing DNA to ID93+GLA-SE enhanced the magnitude of the multi-functional T(H)1 response against ID93 characterized by co-production of IFN-gamma, TNF, and IL-2. Addition of CpG also improved the protective efficacy of ID93+GLA-SE. Finally we demonstrate that this adjuvant synergy between GLA and CpG is independent of TRIF signaling, whereas TRIF is necessary for the adjuvant activity of GLA-SE in the absence of CpG.	[Orr, Mark T.; Beebe, Elyse A.; Hudson, Thomas E.; Fox, Christopher B.; Reed, Steven G.; Coler, Rhea N.] Infect Dis Res Inst, Seattle, WA USA; [Moon, James J.] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA USA; [Moon, James J.] Massachusetts Gen Hosp, Pulm & Crit Care Unit, Charlestown, MA USA; [Moon, James J.] Harvard Univ, Sch Med, Charlestown, MA USA; [Coler, Rhea N.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; University of Washington; University of Washington Seattle	Coler, RN (corresponding author), Infect Dis Res Inst, Seattle, WA USA.	rhea.coler@idri.org	; moon, james/F-1031-2014	Orr, Mark/0000-0003-2684-4722; Fox, Christopher/0000-0002-4644-2619; moon, james/0000-0001-8071-1491	National Institute Of Allergy And Infectious Diseases [U01AI078054, HHSN272200800045C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI078054, U19AI095261] Funding Source: NIH RePORTER	National Institute Of Allergy And Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported by Grant No. U01AI078054 and Contract No. HHSN272200800045C from the National Institute Of Allergy And Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Bagchi A, 2007, J IMMUNOL, V178, P1164, DOI 10.4049/jimmunol.178.2.1164; Baldwin SL, 2012, J IMMUNOL, V188, P2189, DOI 10.4049/jimmunol.1102696; Bertholet S, 2008, J IMMUNOL, V181, P7948, DOI 10.4049/jimmunol.181.11.7948; Bertholet S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001094; Bohnenkamp HR, 2007, CELL IMMUNOL, V247, P72, DOI 10.1016/j.cellimm.2007.07.008; Coler RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016333; Coler RN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013677; Coler RN, 2012, J INFECT DIS; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Derrick SC, 2011, VACCINE, V29, P2902, DOI 10.1016/j.vaccine.2011.02.010; Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474; Duthie MS, 2011, IMMUNOL REV, V239, P178, DOI 10.1111/j.1600-065X.2010.00978.x; Gautier G, 2005, J EXP MED, V201, P1435, DOI 10.1084/jem.20041964; Hajjar AM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002963; Kagina BMN, 2010, AM J RESP CRIT CARE, V182, P1073, DOI 10.1164/rccm.201003-0334OC; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Kleinnijenhuis J, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/405310; Krummen M, 2010, J LEUKOCYTE BIOL, V88, P189, DOI 10.1189/jlb.0408228; Makela SM, 2009, J LEUKOCYTE BIOL, V85, P664, DOI 10.1189/jlb.0808503; Manicassamy S, 2009, SEMIN IMMUNOL, V21, P185, DOI 10.1016/j.smim.2009.05.005; Matthews K, 2012, J IMMUNOL, V189, P5729, DOI 10.4049/jimmunol.1200601; Meyer J, 2013, EXPERT REV VACCINES, V12, P443, DOI [10.1586/ERV.13.19, 10.1586/erv.13.19]; Mitchell D, 2010, J INFECT DIS, V202, P318, DOI 10.1086/653499; Mittrucker HW, 2007, P NATL ACAD SCI USA, V104, P12434, DOI 10.1073/pnas.0703510104; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Moon JJ, 2009, NAT PROTOC, V4, P565, DOI 10.1038/nprot.2009.9; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Olive C, 2012, EXPERT REV VACCINES, V11, P237, DOI [10.1586/erv.11.189, 10.1586/ERV.11.189]; Orr MT, 2013, J CONTROL RELEASE, V172, P190, DOI 10.1016/j.jconrel.2013.07.030; Orr MT, 2013, EUR J IMMUNOL, V43, P2398, DOI 10.1002/eji.201243124; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Raman VS, 2010, J IMMUNOL, V185, P1701, DOI 10.4049/jimmunol.1000238; Roelofs MF, 2005, ARTHRITIS RHEUM, V52, P2313, DOI 10.1002/art.21278; Rowland R, 2011, EXPERT REV VACCINES, V10, P645, DOI [10.1586/ERV.11.28, 10.1586/erv.11.28]; Schreibelt G, 2010, BLOOD, V116, P564, DOI 10.1182/blood-2009-11-251884; Schwarz TF, 2009, ADV THER, V26, P983, DOI 10.1007/s12325-009-0079-5; Tada H, 2005, INFECT IMMUN, V73, P7967, DOI 10.1128/IAI.73.12.7967-7976.2005; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Underhill DM, 2007, IMMUNOL REV, V219, P75, DOI 10.1111/j.1600-065X.2007.00548.x; Warger T, 2006, BLOOD, V108, P544, DOI 10.1182/blood-2005-10-4015; Zhu Q, 2008, P NATL ACAD SCI USA, V105, P16260, DOI 10.1073/pnas.0805325105; Zhu Q, 2010, J CLIN INVEST, V120, P607, DOI 10.1172/JCI39293	44	55	59	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e83884	10.1371/journal.pone.0083884	http://dx.doi.org/10.1371/journal.pone.0083884			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404140	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460800019
J	Zhou, JW; Liu, R; Zhou, YF; Hess, RF				Zhou, Jiawei; Liu, Rong; Zhou, Yifeng; Hess, Robert F.			Binocular Combination of Second-Order Stimuli	PLOS ONE			English	Article							CONTRAST-MODULATION; SPATIAL-FREQUENCY; STEREOPSIS; SUMMATION; LUMINANCE; ORIENTATION; SENSITIVITY; ADAPTATION; MECHANISMS; AMBLYOPIA	Phase information is a fundamental aspect of visual stimuli. However, the nature of the binocular combination of stimuli defined by modulations in contrast, so-called second-order stimuli, is presently not clear. To address this issue, we measured binocular combination for first-(luminance modulated) and second-order (contrast modulated) stimuli using a binocular phase combination paradigm in seven normal adults. We found that the binocular perceived phase of second-order gratings depends on the interocular signal ratio as has been previously shown for their first order counterparts; the interocular signal ratios when the two eyes were balanced was close to 1 in both first-and second-order phase combinations. However, second-order combination is more linear than previously found for first-order combination. Furthermore, binocular combination of second-order stimuli was similar regardless of whether the carriers in the two eyes were correlated, anti-correlated, or uncorrelated. This suggests that, in normal adults, the binocular phase combination of second-order stimuli occurs after the monocular extracting of the second-order modulations. The sensory balance associated with this second-order combination can be obtained from binocular phase combination measurements.	[Zhou, Jiawei; Liu, Rong; Zhou, Yifeng] Univ Sci & Technol China, CAS Key Lab Brain Funct & Dis, Hefei 230026, Anhui, Peoples R China; [Zhou, Jiawei; Liu, Rong; Zhou, Yifeng] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Zhou, Jiawei; Hess, Robert F.] McGill Univ, Dept Ophthalmol, McGill Vis Res, Montreal, PQ H3A 2T5, Canada	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; McGill University	Zhou, YF (corresponding author), Univ Sci & Technol China, CAS Key Lab Brain Funct & Dis, Hefei 230026, Anhui, Peoples R China.	zhouy@ustc.edu.cn; robert.hess@mcgill.ca	Zhou, Jiawei/AGN-8024-2022	Zhou, Jiawei/0000-0003-4220-344X	Canadian Institutes of Health Research [MOP-53346, CCI-125686, MT-10818]; National Natural Science Foundation of China [NSFC 81261120562]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Canadian Institutes of Health Research Grants (http://www.cihr.gc.ca/e/193.html) MOP-53346, CCI-125686 & MT-10818 to RFH and the National Natural Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default166.htm) NSFC 81261120562 to YZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON PA, 1989, VISION RES, V29, P1115, DOI 10.1016/0042-6989(89)90060-6; Anstis S, 1998, VISION RES, V38, P523, DOI 10.1016/S0042-6989(97)00167-3; Baker CL, 1999, CURR OPIN NEUROBIOL, V9, P461, DOI 10.1016/S0959-4388(99)80069-5; Baker DH, 2008, VISION RES, V48, P1625, DOI 10.1016/j.visres.2008.04.017; Baker DH, 2007, INVEST OPHTH VIS SCI, V48, P5332, DOI 10.1167/iovs.07-0194; Baker DH, 2012, VISION RES, V56, P1, DOI 10.1016/j.visres.2012.01.008; Black JM, 2011, OPTOMETRY VISION SCI, V88, pE334, DOI 10.1097/OPX.0b013e318205a162; BLAKE R, 1989, PSYCHOL REV, V96, P145, DOI 10.1037/0033-295X.96.1.145; BLAKE R, 1974, NATURE, V249, P488, DOI 10.1038/249488a0; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; CAVANAGH P, 1989, Spatial Vision, V4, P103, DOI 10.1163/156856889X00077; Cooper EA, 2013, J VISION, V13, DOI 10.1167/13.12.16; Dakin SC, 2000, VISION RES, V40, P311, DOI 10.1016/S0042-6989(99)00179-0; De Silva HR, 1930, B J PSYCHOL-GEN SECT, V20, P241; Ding J, 2006, P NATL ACAD SCI USA, V103, P1141, DOI 10.1073/pnas.0509629103; Ding J, 2013, J VISION, V13, P11; Dosher BA, 2006, VISION RES, V46, P1996, DOI 10.1016/j.visres.2005.11.025; Georgeson M, 2011, J VISION, V11, P305, DOI DOI 10.1167/11.11.305; He S, 1998, VISION RES, V38, P985, DOI 10.1016/S0042-6989(97)00290-3; Huang CB, 2009, J VISION, V9, DOI 10.1167/9.3.17; Huang CB, 2011, J VISION, V11, DOI 10.1167/11.6.4; Huang CB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015075; Kim YJ, 2013, J VISION, V13, DOI 10.1167/13.6.15; Klein SA, 1996, VISION RES, V36, P3167, DOI 10.1016/0042-6989(96)00051-X; Kovacs I, 1996, P NATL ACAD SCI USA, V93, P15508, DOI 10.1073/pnas.93.26.15508; LEGGE GE, 1984, VISION RES, V24, P385, DOI 10.1016/0042-6989(84)90064-6; LEGGE GE, 1984, VISION RES, V24, P373, DOI 10.1016/0042-6989(84)90063-4; LEGGE GE, 1989, VISION RES, V29, P989, DOI 10.1016/0042-6989(89)90114-4; LIU L, 1995, VISION RES, V35, P2559, DOI 10.1016/0042-6989(95)00009-O; Logothetis NK, 1996, NATURE, V380, P621, DOI 10.1038/380621a0; Meese TS, 2006, J VISION, V6, P1224, DOI 10.1167/6.11.7; Meese TS, 2004, J VISION, V4, P843, DOI 10.1167/4.10.2; OPPENHEIM AV, 1981, P IEEE, V69, P529, DOI 10.1109/PROC.1981.12022; PARDHAN S, 1992, DOC OPHTHALMOL, V82, P239, DOI 10.1007/BF00160771; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PICKFORD RW, 1947, NATURE, V159, P268, DOI 10.1038/159268a0; Reynaud A, 2013, J VISION, V13, DOI 10.1167/13.11.1; Schofield AJ, 2003, VISION RES, V43, P243, DOI 10.1016/S0042-6989(02)00542-4; Simmons DR, 2005, PERCEPTION, V34, P1035, DOI 10.1068/p5279; Simmons DR, 1998, PERCEPTION, V27, P1333, DOI 10.1068/p271333; Simmons DR, 1998, VISION RES, V38, P1063, DOI 10.1016/S0042-6989(97)00272-1; Smith AT, 1997, VISION RES, V37, P45, DOI 10.1016/S0042-6989(96)00147-2; Smith EL, 1997, J NEUROPHYSIOL, V78, P366, DOI 10.1152/jn.1997.78.1.366; Tanaka H, 2006, J NEUROSCI, V26, P4370, DOI 10.1523/JNEUROSCI.4379-05.2006; Tong F, 2006, TRENDS COGN SCI, V10, P502, DOI 10.1016/j.tics.2006.09.003; Wilcox LM, 1998, VISION RES, V38, P3671, DOI 10.1016/S0042-6989(98)00066-2; Wilcox LM, 1996, VISION RES, V36, P391, DOI 10.1016/0042-6989(95)00110-7; Zhou JW, 2013, J VISION, V13, P1, DOI 10.1167/13.5.12; Zhou JW, 2013, SCI REP-UK, V3, DOI 10.1038/srep02012	49	10	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84632	10.1371/journal.pone.0084632	http://dx.doi.org/10.1371/journal.pone.0084632			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404180	Green Published, Green Submitted, gold			2022-12-27	WOS:000329460800059
J	Cheng, CC; Chien, CC; Chen, HH; Hwu, Y; Ching, YT				Cheng, Chang-Chieh; Chien, Chia-Chi; Chen, Hsiang-Hsin; Hwu, Yeukuang; Ching, Yu-Tai			Image Alignment for Tomography Reconstruction from Synchrotron X-Ray Microscopic Images	PLOS ONE			English	Article							MUTUAL-INFORMATION; TRACKING; CELLS	A synchrotron X-ray microscope is a powerful imaging apparatus for taking high-resolution and high-contrast X-ray images of nanoscale objects. A sufficient number of X-ray projection images from different angles is required for constructing 3D volume images of an object. Because a synchrotron light source is immobile, a rotational object holder is required for tomography. At a resolution of 10 nm per pixel, the vibration of the holder caused by rotating the object cannot be disregarded if tomographic images are to be reconstructed accurately. This paper presents a computer method to compensate for the vibration of the rotational holder by aligning neighboring X-ray images. This alignment process involves two steps. The first step is to match the "projected feature points" in the sequence of images. The matched projected feature points in the x-theta plane should form a set of sine-shaped loci. The second step is to fit the loci to a set of sine waves to compute the parameters required for alignment. The experimental results show that the proposed method outperforms two previously proposed methods, Xradia and SPIDER. The developed software system can be downloaded from the URL, http://www.cs.nctu.edu.tw/similar to chengchc/SCTA or http://goo.gl/s4AMx.	[Cheng, Chang-Chieh; Ching, Yu-Tai] Natl Chiao Tung Univ, Dept Comp Sci, Hsinchu, Taiwan; [Chien, Chia-Chi; Chen, Hsiang-Hsin; Hwu, Yeukuang] Acad Sinica, Inst Phys, Taipei, Taiwan; [Chien, Chia-Chi; Hwu, Yeukuang] Natl Tsing Hua Univ, Dept Engn & Syst Sci, Hsinchu, Taiwan; [Chien, Chia-Chi] Univ S Australia, Ian Wark Res Inst, Adelaide, SA 5001, Australia; [Ching, Yu-Tai] Natl Chiao Tung Univ, Inst Biomed Engn, Hsinchu, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Tsing Hua University; University of South Australia; National Yang Ming Chiao Tung University	Ching, YT (corresponding author), Natl Chiao Tung Univ, Dept Comp Sci, Hsinchu, Taiwan.	ytc@cs.nctu.edu.tw	Hwu, Yeukuang/AAH-9947-2020; Petibois, Cyril/L-9049-2014; Hwu, Yeukuang/ABH-5311-2020; Chien, Chia-Chi/E-9932-2013	Petibois, Cyril/0000-0001-9027-4192; Chien, Chia-Chi/0000-0001-8704-0336	National Science Council (NSC) [101-2221-E-009-143-MY3]	National Science Council (NSC)(Ministry of Science and Technology, Taiwan)	This study was supported National Science Council (NSC), http://web1.nsc.gov.tw/. The grant number is 101-2221-E-009-143-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN AH, 1984, ULTRASONIC IMAGING, V6, P81, DOI 10.1016/0161-7346(84)90008-7; [Anonymous], 1988, ALVEY VISION C; Bay H., 2006, 9 EUR C COMP VIS GRA; Dowson N, 2008, IEEE T PATTERN ANAL, V30, P180, DOI 10.1109/TPAMI.2007.70757; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; FISCHLER MA, 1981, COMMUN ACM, V24, P381, DOI 10.1145/358669.358692; Frank J, 2006, 3 DIMENSIONAL ELECT; Gonzalez R. C., 2006, PEARSON ED, V3rd, P8; Hwu Y, 2004, PHYS MED BIOL, V49, P501, DOI 10.1088/0031-9155/49/4/002; Hwu Y, 2004, BIOPHYS J, V87, P4180, DOI 10.1529/biophysj.103.034991; Ikits M, 2004, VOLUME RENDERING TEC, P667; Kadir T, 2001, INT J COMPUT VISION, V45, P83, DOI 10.1023/A:1012460413855; Larabell CA, 2004, MOL BIOL CELL, V15, P957, DOI 10.1091/mbc.E03-07-0522; Lo TN, 2007, J PHYS D APPL PHYS, V40, P3172, DOI 10.1088/0022-3727/40/10/021; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Mao Y, 2010, IEEE T IMAGE PROCESS, V19, P1259, DOI 10.1109/TIP.2009.2039660; McDermott G, 2009, TRENDS CELL BIOL, V19, P587, DOI 10.1016/j.tcb.2009.08.005; Meuli R, 2004, EUR RADIOL, V14, P1550, DOI 10.1007/s00330-004-2361-x; Natterer F., 2001, MATH COMPUTERIZED TO, DOI DOI 10.1137/1.9780898719284; Pluim JPW, 2003, IEEE T MED IMAGING, V22, P986, DOI 10.1109/TMI.2003.815867; Rady S, 2008, IEEE SYS MAN CYBERN, P713, DOI 10.1109/ICSMC.2008.4811362; Shafique K, 2005, IEEE T PATTERN ANAL, V27, P51, DOI 10.1109/TPAMI.2005.1; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Shenoy G, 2003, STRUCT CHEM, V14, P3, DOI 10.1023/A:1021656723964; Suri S, 2009, AM SOC PHOT REM SENS; Szeliski R., 2010, COMPUTER VISION ALGO, DOI DOI 10.1007/978-3-030-34372-9; Tang F, 2008, IEEE T CIRC SYST VID, V18, P1064, DOI 10.1109/TCSVT.2008.927106; Viola P, 1997, INT J COMPUT VISION, V24, P137, DOI 10.1023/A:1007958904918; Xu F, 2005, IEEE T NUCL SCI, V52, P654, DOI 10.1109/TNS.2005.851398	29	8	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84675	10.1371/journal.pone.0084675	http://dx.doi.org/10.1371/journal.pone.0084675			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416264	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000329866300035
J	Liu, GFF; Bair, RJ; Bair, E; Liauw, SL; Koshy, M				Liu, Gene-Fu F.; Bair, Ryan J.; Bair, Eric; Liauw, Stanley L.; Koshy, Matthew			Clinical Outcomes for Gastric Cancer following Adjuvant Chemoradiation Utilizing Intensity Modulated versus Three-Dimensional Conformal Radiotherapy	PLOS ONE			English	Article							CHEMORADIOTHERAPY; DISPARITIES; RADIATION; THERAPY; CARE	Purpose/Objective(s): To determine if intensity modulated radiation therapy (IMRT) in the post-operative setting for gastric cancer was associated with reduced toxicity compared to 3D conformal radiation therapy (3DCRT). Materials/Methods: This retrospective study includes 24 patients with stage IB-IIIB gastric cancer consecutively treated from 2001-2010. All underwent surgery followed by adjuvant chemoradiation. Concurrent chemotherapy consisted of 5-FU/leucovorin (n = 21), epirubicin/cisplatin/5FU (n = 1), or none (n = 2). IMRT was utilized in 12 patients and 3DCRT in 12 patients. For both groups, the target volume included the tumor bed, anastomosis, gastric stump, and regional lymphatics. Results: Median follow-up for the entire cohort was 19 months (range 0.4-8.5 years), and 49 months (0.5-8.5 years) in surviving patients. The 3DCRT group received a median dose of 45 Gy, and the IMRT group received a median dose of 50.4 Gy (p = 0.0004). For the entire cohort, 3-year overall survival (OS) was 40% and 3-year disease free survival (DFS) was 41%. OS and DFS did not differ significantly between the groups. Acute toxicity was similar. Between 3DCRT and IMRT groups, during radiotherapy, median weight lost (3.2 vs. 3.3 kg, respectively; p = 0.47) and median percent weight loss were similar (5.0% vs. 4.3%, respectively; p = 0.43). Acute grade 2 toxicity was experienced by 8 patients receiving 3DCRT and 11 receiving IMRT (p = 0.32); acute grade 3 toxicity occurred in 1 patient receiving 3DCRT and none receiving IMRT (p = 1.0). No patients in either cohort experienced late grade 3 toxicity, including renal or gastrointestinal toxicity. At last follow up, the median increase in creatinine was 0.1 mg/dL in the IMRT group and 0.1 mg/dL in the 3DCRT group (p = 0.78). Conclusion: This study demonstrates that adjuvant chemoradiation for gastric cancer with IMRT to 50.4 Gy was well-tolerated and compared similarly in toxicity with 3DCRT to 45 Gy.	[Liu, Gene-Fu F.; Bair, Ryan J.; Liauw, Stanley L.; Koshy, Matthew] Univ Chicago, Med Ctr, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA; [Bair, Eric] Univ N Carolina, Dept Endodont, Chapel Hill, NC USA; [Bair, Eric] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Koshy, Matthew] Univ Illinois Hosp, Dept Radiat Oncol, Chicago, IL USA	University of Chicago; University of Chicago Medical Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Illinois System; University of Illinois Chicago	Koshy, M (corresponding author), Univ Chicago, Med Ctr, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA.	mkoshy@radonc.uchicago.edu		Bair, Eric/0000-0001-8733-7869; Koshy, Matthew/0000-0001-6937-7058; Liauw, Stanley/0000-0002-4701-2469				Boda-Heggemann J, 2009, INT J RADIAT ONCOL, V75, P1187, DOI 10.1016/j.ijrobp.2008.12.036; COX JD, 1995, INT J RADIAT ONCOL, V31, P1341, DOI 10.1016/0360-3016(95)00060-C; Edge S.B., 2010, AJCC CANC STAGING MA, V7th ed., P143; Hu WG, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-98; Jansen EPM, 2007, INT J RADIAT ONCOL, V67, P781, DOI 10.1016/j.ijrobp.2006.09.012; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Milano MT, 2006, BRIT J RADIOL, V79, P497, DOI 10.1259/bjr/43441736; Minn AY, 2010, CANCER-AM CANCER SOC, V116, P3943, DOI 10.1002/cncr.25246; Ringash J, 2005, INT J RADIAT ONCOL, V63, P732, DOI 10.1016/j.ijrobp.2005.03.013; Ringash J, 2001, CAN MED ASSOC J, V164, P469; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Stessin AM, 2011, CANCER EPIDEM BIOMAR, V20, P223, DOI 10.1158/1055-9965.EPI-10-0158	13	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e82642	10.1371/journal.pone.0082642	http://dx.doi.org/10.1371/journal.pone.0082642			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416146	gold, Green Published, Green Submitted			2022-12-27	WOS:000329866300011
J	Nunes, T; Etchevers, MJ; Sandi, MJ; Donnay, SP; Grandjean, T; Pellise, M; Panes, J; Ricart, E; Iovanna, JL; Dagorn, JC; Chamaillard, M; Sans, M				Nunes, Tiago; Josefina Etchevers, Maria; Sandi, Maria Jose; Pino Donnay, Susana; Grandjean, Teddy; Pellise, Maria; Panes, Julian; Ricart, Elena; Iovanna, Juan Lucio; Dagorn, Jean-Charles; Chamaillard, Mathias; Sans, Miquel			Pancreatitis-Associated Protein Does Not Predict Disease Relapse in Inflammatory Bowel Disease Patients	PLOS ONE			English	Article							FECAL CALPROTECTIN; GENE-EXPRESSION; CROHNS-DISEASE; BACTERIAL; LECTIN; MICE; PATHOGENS; CHILDREN; DIARRHEA; COLITIS	Background: The pancreatitis-associated protein (PAP) is increased in the serum of active inflammatory bowel disease (IBD) patients and its levels seem to be correlated with disease activity. Our aim was to evaluate the usefulness of serum and fecal PAP measurements to predict relapse in patients with inactive IBD. Materials and Methods: We undertook a 12-month prospective study that included 66 Crohn's disease (CD) and 74 ulcerative colitis (UC) patients. At inclusion, patients were in clinical remission, defined by a Harvey-Bradshaw (HB) Index <= 4 (CD) or a partial Mayo Score (MS)<3 (UC), along with a normal serum C reactive protein (CRP) and fecal calprotectin. Patients were followed every 3 months. Blood and stool samples were collected and a clinical evaluation was performed at each visit. Serum PAP and CRP levels as well as fecal concentrations of PAP and calprotectin were assessed. Results: Active CD patients had an increased mean serum PAP at the diagnosis of the flare (104.1 ng/ml) and 3 months prior to activity (22.68 ng/ml) compared with patients in remission (13.26 ng/ml), p<0.05. No significant change in serum PAP levels in UC and fecal PAP levels in CD and UC were detected during disease activity. In CD, serum PAP was a poor diagnostic predictor of disease activity, with an AUC of 0.69. In patients in remission, fecal PAP was barely detectable in UC compared with CD patients. Conclusion: Serum PAP is increased only in active CD patients, but this marker does not predict disease activity. Inactive UC patients have marked low levels of PAP in fecal samples compared with CD patients.	[Nunes, Tiago; Josefina Etchevers, Maria; Pino Donnay, Susana; Pellise, Maria; Panes, Julian; Ricart, Elena] Hosp Clin Barcelona, Dept Gastroenterol, IDIBAPS, Ctr Invest Biome Red Enfermedades Hepa & Digest C, Barcelona, Catalonia, Spain; [Sandi, Maria Jose; Iovanna, Juan Lucio; Dagorn, Jean-Charles] Aix Marseille Univ, CNRS, INSERM, U1068,UMR 7258,CRCM, Marseille, France; [Sandi, Maria Jose; Iovanna, Juan Lucio; Dagorn, Jean-Charles] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Grandjean, Teddy; Chamaillard, Mathias] Univ Lille Nord France, F-59000 Lille, France; [Grandjean, Teddy; Chamaillard, Mathias] Inst Pasteur, Ctr Infect & Immun Lille, F-59019 Lille, France; [Grandjean, Teddy; Chamaillard, Mathias] CNRS, UMR8204, F-59021 Lille, France; [Grandjean, Teddy; Chamaillard, Mathias] INSERM, U1019, Team 7, Equipe FRM, F-59019 Lille, France; [Sans, Miquel] Ctr Med Teknon, Dept Digest Dis, Barcelona, Catalonia, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Institut Paoli-Calmette (IPC); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille	Sans, M (corresponding author), Ctr Med Teknon, Dept Digest Dis, Barcelona, Catalonia, Spain.	sans@dr.teknon.es	Grandjean, Teddy/AAV-8005-2020; Iovanna, Juan/M-9805-2017; Pellise, Maria/ABC-3246-2021; Grandjean, Teddy/V-1309-2017; Chamaillard, Mathias/L-6542-2013; Panes, Julian/H-5991-2015	Grandjean, Teddy/0000-0002-6244-0154; Iovanna, Juan/0000-0003-1822-2237; Grandjean, Teddy/0000-0002-6244-0154; Chamaillard, Mathias/0000-0002-0243-9717; Panes, Julian/0000-0002-4971-6902; Pellise, Maria/0000-0001-9739-4998	Fondation pour la Recherche Medicale; Broad Medical Research Program on Inflammatory Bowel Disease, The Eli and Edythe Broad Foundation [IBD-0222R]	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Broad Medical Research Program on Inflammatory Bowel Disease, The Eli and Edythe Broad Foundation	This work was supported by the Fondation pour la Recherche Medicale and by the Broad Medical Research Program on Inflammatory Bowel Disease, The Eli and Edythe Broad Foundation grant number IBD-0222R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeza N, 2001, DIGESTION, V64, P233, DOI 10.1159/000048867; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Chen CC, 2012, J PEDIATR GASTR NUTR, V55, P541, DOI 10.1097/MPG.0b013e318262a718; Cosnes J, 2011, GASTROENTEROLOGY, V140, P1785, DOI 10.1053/j.gastro.2011.01.055; Desjeux A, 2002, GASTROEN CLIN BIOL, V26, P23; Dieckgraefe BK, 2000, PHYSIOL GENOMICS, V4, P1; Folch-Puy E, 2006, J IMMUNOL, V176, P3774, DOI 10.4049/jimmunol.176.6.3774; Gironella M, 2005, GUT, V54, P1244, DOI 10.1136/gut.2004.056309; Gironella M, 2007, GUT, V56, P1091, DOI 10.1136/gut.2006.116087; IOVANNA J, 1991, J BIOL CHEM, V266, P24664; IOVANNA JL, 1993, AM J PHYSIOL, V265, pG611, DOI 10.1152/ajpgi.1993.265.4.G611; Ismail AS, 2009, J IMMUNOL, V182, P3047, DOI 10.4049/jimmunol.0802705; Lawrance IC, 2001, HUM MOL GENET, V10, P445, DOI 10.1093/hmg/10.5.445; Mizoguchi E, 2003, GASTROENTEROLOGY, V125, P148, DOI 10.1016/S0016-5085(03)00665-6; Moniaux N, 2011, HEPATOLOGY, V53, P618, DOI 10.1002/hep.24087; MUNKHOLM P, 1995, SCAND J GASTROENTERO, V30, P699, DOI 10.3109/00365529509096316; Ogawa H, 2003, INFLAMM BOWEL DIS, V9, P162, DOI 10.1097/00054725-200305000-00003; Papi C, 2013, DIGEST LIVER DIS, V45, P978, DOI 10.1016/j.dld.2013.07.006; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; Shastri YM, 2008, AM J MED, V121, P1099, DOI 10.1016/j.amjmed.2008.06.034; Sykora J, 2010, ACTA PAEDIATR, V99, P1389, DOI 10.1111/j.1651-2227.2010.01843.x; van Ampting MTJ, 2012, INFECT IMMUN, V80, P1115, DOI 10.1128/IAI.06165-11; Van Assche G, 2010, J CROHNS COLITIS, V4, P7, DOI 10.1016/j.crohns.2009.12.003	23	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84957	10.1371/journal.pone.0084957	http://dx.doi.org/10.1371/journal.pone.0084957			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416322	Green Published, gold, Green Submitted			2022-12-27	WOS:000329866300044
J	Marino, JL; Moore, VM; Willson, KJ; Rumbold, A; Whitrow, MJ; Giles, LC; Davies, MJ				Marino, Jennifer L.; Moore, Vivienne M.; Willson, Kristyn J.; Rumbold, Alice; Whitrow, Melissa J.; Giles, Lynne C.; Davies, Michael J.			Perinatal Outcomes by Mode of Assisted Conception and Sub-Fertility in an Australian Data Linkage Cohort	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; LOW-BIRTH-WEIGHT; REPRODUCTIVE TECHNOLOGIES; SINGLETON PREGNANCIES; CRYOPRESERVED EMBRYOS; PRETERM DELIVERY; GESTATIONAL-AGE; CHILDREN BORN; TWIN BIRTHS; INFERTILITY	Background: Fertility treatment is associated with increased risk of major birth defects, which varies between in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI), and is significantly reduced by embryo freezing. We therefore examined a range of additional perinatal outcomes for these exposures. Methods: All patients in South Australia receiving assisted conception between Jan 1986-Dec 2002 were linked to the state-wide perinatal collection (all births/stillbirths >= 20 weeks gestation or 400 g birth weight, n = 306 995). We examined stillbirth, mean birth weight, low birth weight (, 2500 g, <1500 g), small size for gestational age (<10th percentile, <3rd percentile), large size for gestational age (>90th percentile), preterm birth (32-<37 weeks, <32 weeks gestation), postterm birth (>= 41 weeks gestation), Apgar <7 at 5 minutes and neonatal death. Results: Relative to spontaneous conceptions, singletons from assisted conception were more likely to be stillborn (OR = 1.82, 95% Confidence Interval (CI) 1.34-2.48), while survivors as a group were comprehensively disadvantaged at birth, including lower birth weight (2109 g, CI -129--89), very low birth weight (OR = 2.74, CI 2.19-3.43), very preterm birth (OR = 2.30, CI 1.82-2.90) and neonatal death (OR = 2.04, CI 1.27-3.26). Outcomes varied by type of assisted conception. Very low and low birth weight, very preterm and preterm birth, and neonatal death were markedly more common in singleton births from IVF and to a lesser degree, in births from ICSI. Using frozen-embryos eliminated all significant adverse outcomes associated with ICSI but not with IVF. However, frozen-embryo cycles were also associated with increased risk of macrosomia for IVF and ICSI singletons (OR = 1.36, CI 1.02-1.82; OR = 1.55, CI 1.05-2.28). Infertility status without treatment was also associated with adverse outcomes. Conclusions: Births after assisted conception show an extensive range of compromised outcomes that vary by treatment modality, that are substantially reduced after embryo freezing, but which co-occur with an increased risk of macrosomia.	[Marino, Jennifer L.] Univ Melbourne, Dept Obstet & Gynaecol, Royal Womens Hosp, Parkville, Vic 3052, Australia; [Moore, Vivienne M.; Willson, Kristyn J.; Whitrow, Melissa J.; Giles, Lynne C.] Univ Adelaide, Discipline Publ Hlth, Adelaide, SA, Australia; [Moore, Vivienne M.; Rumbold, Alice; Whitrow, Melissa J.; Giles, Lynne C.; Davies, Michael J.] Univ Adelaide, Robinson Inst, Adelaide, SA, Australia; [Rumbold, Alice; Davies, Michael J.] Univ Adelaide, Discipline Obstet & Gynaecol, Adelaide, SA, Australia	University of Melbourne; University of Adelaide; Robinson Research Institute; University of Adelaide; University of Adelaide	Davies, MJ (corresponding author), Univ Adelaide, Robinson Inst, Adelaide, SA, Australia.	michael.davies@adelaide.edu.au	Davies, Michael John/Y-3542-2018; Davies, Michael/GWV-2527-2022; Marino, Jennifer L/O-2909-2017	Davies, Michael John/0000-0003-1526-0801; Marino, Jennifer L/0000-0001-6742-1940; Giles, Lynne/0000-0001-9054-9088	National Health and Medical Research Council [349475, 349548, 453556, 465455]; Australian Research Council [FT100101018]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	Supported by grants from the National Health and Medical Research Council (349475, 349548, 453556, and 465455) and the Australian Research Council (FT100101018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addor V, 1998, FERTIL STERIL, V69, P210, DOI 10.1016/S0015-0282(97)00468-8; Ananth CV, 2005, ANN EPIDEMIOL, V15, P293, DOI 10.1016/j.annepidem.2004.08.007; Axmon A, 2005, FERTIL STERIL, V84, P966, DOI 10.1016/j.fertnstert.2005.04.030; Barnhart KT, 2013, FERTIL STERIL, V99, P299, DOI 10.1016/j.fertnstert.2012.12.032; Basso O, 2003, HUM REPROD, V18, P2478, DOI 10.1093/humrep/deg444; Boulet SL, 2008, HUM REPROD, V23, P1941, DOI 10.1093/humrep/den169; Bower C, 2005, REPROD FERT DEVELOP, V17, P329, DOI 10.1071/RD04095; Chason RJ, 2011, TRENDS ENDOCRIN MET, V22, P412, DOI 10.1016/j.tem.2011.05.005; Davies MJ, 2012, NEW ENGL J MED, V366, P1803, DOI 10.1056/NEJMoa1008095; De Geyter C, 2006, HUM REPROD, V21, P705, DOI 10.1093/humrep/dei378; Fujii M, 2010, FERTIL STERIL, V94, P2113, DOI 10.1016/j.fertnstert.2009.12.031; Helmerhorst FM, 2004, BRIT MED J, V328, P261, DOI 10.1136/bmj.37957.560278.EE; Jackson RA, 2004, OBSTET GYNECOL, V103, P551, DOI 10.1097/01.AOG.0000114989.84822.51; Jaques AM, 2010, FERTIL STERIL, V94, P2674, DOI 10.1016/j.fertnstert.2010.02.043; Kallen B, 2005, FERTIL STERIL, V84, P611, DOI 10.1016/j.fertnstert.2005.02.038; Kallen B, 2010, BJOG-INT J OBSTET GY, V117, P676, DOI 10.1111/j.1471-0528.2010.02517.x; Kallen B, 2010, HUM REPROD, V25, P1026, DOI 10.1093/humrep/deq003; Klemetti R, 2010, FERTIL STERIL, V93, P1157, DOI 10.1016/j.fertnstert.2008.12.025; Macaldowie A, 2012, ASSISTED REPROD TECH; Maheshwari A, 2012, FERTIL STERIL, V98, P368, DOI 10.1016/j.fertnstert.2012.05.019; Marino JL, 2011, HUM REPROD, V26, P473, DOI 10.1093/humrep/deq305; Myers E, 2008, 167 AG HEALTHC RES Q; Nelson SM, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000386; Nohr EA, 2005, OBSTET GYNECOL, V106, P250, DOI 10.1097/01.AOG.0000172422.81496.57; Ombelet W, 2006, HUM REPROD, V21, P1025, DOI 10.1093/humrep/dei419; Pelkonen S, 2010, HUM REPROD, V25, P914, DOI 10.1093/humrep/dep477; Pinborg A, 2013, HUM REPROD UPDATE, V19, P87, DOI 10.1093/humupd/dms044; Pinborg A, 2010, FERTIL STERIL, V94, P1320, DOI 10.1016/j.fertnstert.2009.05.091; Reddy UM, 2007, OBSTET GYNECOL, V109, P967, DOI 10.1097/01.AOG.0000259316.04136.30; Roberts CL, 1999, MED J AUSTRALIA, V170, P114, DOI 10.5694/j.1326-5377.1999.tb127678.x; Roberts CL, 1999, J PAEDIATR CHILD H, V35, P278, DOI 10.1046/j.1440-1754.1999.00354.x; Sazonova A, 2012, HUM REPROD, V27, P1343, DOI 10.1093/humrep/des036; Schieve LA, 2002, NEW ENGL J MED, V346, P731, DOI 10.1056/NEJMoa010806; Shebl O, 2008, J REPROD MED, V53, P798; Shih W, 2008, HUM REPROD, V23, P1644, DOI 10.1093/humrep/den150; South Australian Council on Reproductive Technology, 2007, ANN REP MIN HLTH; Thomson F, 2005, BJOG-INT J OBSTET GY, V112, P632, DOI 10.1111/j.1471-0528.2004.00489.x; WADA I, 1994, HUM REPROD, V9, P543, DOI 10.1093/oxfordjournals.humrep.a138542; WANG JX, 1994, HUM REPROD, V9, P141, DOI 10.1093/oxfordjournals.humrep.a138304; Wang YA, 2005, FERTIL STERIL, V83, P1650, DOI 10.1016/j.fertnstert.2004.12.033; Wennerholm UB, 2013, HUM REPROD, V28, P2545, DOI 10.1093/humrep/det272; Wennerholm UB, 2009, ACTA OBSTET GYN SCAN, V88, P6, DOI 10.1080/00016340802555948; Wisborg K, 2010, HUM REPROD, V25, P1312, DOI 10.1093/humrep/deq023; Wisborg K, 2010, FERTIL STERIL, V94, P2102, DOI 10.1016/j.fertnstert.2010.01.014; Zhu JL, 2007, OBSTET GYNECOL, V110, P1326, DOI 10.1097/01.AOG.0000290330.80256.97	45	91	93	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e80398	10.1371/journal.pone.0080398	http://dx.doi.org/10.1371/journal.pone.0080398			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416127	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500007
J	Qu, XH; Zhai, ZJ; Liu, XQ; Li, HW; Wu, CL; Li, Y; Li, HW; Zhu, ZN; Qin, A; Dai, KR				Qu, Xinhua; Zhai, Zanjing; Liu, Xuqiang; Li, Haowei; Wu, Chuanlong; Li, Yang; Li, Huiwu; Zhu, Zhenan; Qin, An; Dai, Kerong			Evaluation of White Cell Count and Differential in Synovial Fluid for Diagnosing Infections after Total Hip or Knee Arthroplasty	PLOS ONE			English	Article							PROSTHETIC JOINT INFECTION; PERIPROSTHETIC INFECTION; SYSTEMATIC REVIEWS; MARKERS; SEPSIS	Background: The accuracy of synovial fluid (SF) white cell count (WCC) and polymorphonuclear (PMN) cell evaluation for predicting prosthetic joint infection (PJI) at the total hip arthroplasty (THA) or total knee arthroplasty (TKA) site is unknown. Therefore, we performed a meta-analysis to summarize the diagnostic validity of SF-WCC and SF-PMN for diagnosing PJI. Methods: The MEDLINE, EMBASE, and OVID databases were searched for studies that had evaluated the diagnostic validity of SF-WCC and SF-PMN between January 1990 and May 2013. Meta-analysis methods were used to pool sensitivity, specificity, diagnostic odd ratios (DORs), the area under the receiver-operating characteristic curve (AUC), positive likelihood ratios (PLR), negative likelihood ratios (NLR), and post-test probability. We also conducted heterogeneity, publication bias, subgroup, and meta-regression analyses. Results: Fifteen articles (15 SF-WCC and 14 SF-PMN) that included a total of 2787 patients fulfilled the inclusion criteria and were considered for analysis. The pooled sensitivity and specificity for PJI detection was 0.88 (95% confidence intervals [CI], 0.81-0.93) and 0.93 (95% CI, 0.88-0.96) for SF-WCC and 0.90 (95% CI, 0.84-0.93) and 0.88 (95% CI, 0.83-0.92) for SF-PMN, respectively. The AUC was 0.96 for SF-WCC and 0.95 for SF-PMN. PLR and NLR were 13.3 and 0.13 for SF-WCC, and 7.6 and 0.12 for SF-PMN, respectively. There was no evidence of publication bias. Low-clinical-scenario (pre-test probability, 20%) post-test probabilities were 3% for both negative SF-WCC and SF-PMN results. The subgroup analyses indicated that the sensitivity/specificity of THA were 0.73/0.96 for SF-WCC and 0.85/0.83 for SF-PMN, whereas those of TKA were 0.90/0.91 for SF-WCC and 0.90/0.88 for SF-PMN. We also found that collection of SF-WCC preoperatively had a higher sensitivity than that obtained intraoperatively (0.91 vs. 0.77). Conclusions: SF-WCC and SF-PMN have an adequate and clinically acceptable diagnostic value for detecting PJI, particularly after TKA.	[Qu, Xinhua; Zhai, Zanjing; Liu, Xuqiang; Li, Haowei; Wu, Chuanlong; Li, Yang; Li, Huiwu; Zhu, Zhenan; Qin, An; Dai, Kerong] Shanghai Jiao Tong Univ, Dept Orthoped, Shanghai Key Lab Orthoped Implant, Sch Med,Shanghai Peoples Hosp 9, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Qin, A (corresponding author), Shanghai Jiao Tong Univ, Dept Orthoped, Shanghai Key Lab Orthoped Implant, Sch Med,Shanghai Peoples Hosp 9, Shanghai 200030, Peoples R China.	dr.qinan@gmail.com; krdai@163.com	Qu, Xinhua/Q-3950-2016	Qu, Xinhua/0000-0002-8889-0890	Fund for Key National Basic Research Program of China [2012CB619101]; Major Basic Research of Science and Technology Commission of Shanghai Municipality [11DJ1400303]; Scientific Research from the National Natural Science Foundation for the Youth of China [81201364]; Innovative Research from Shanghai Municipal Education Commission [13YZ031]	Fund for Key National Basic Research Program of China; Major Basic Research of Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Scientific Research from the National Natural Science Foundation for the Youth of China; Innovative Research from Shanghai Municipal Education Commission	This study was supported by the Fund for Key National Basic Research Program of China (Grant 2012CB619101), Major Basic Research of Science and Technology Commission of Shanghai Municipality (Grant No. 11DJ1400303), Scientific Research from the National Natural Science Foundation for the Youth of China (Grant No. 81201364), and Innovative Research from Shanghai Municipal Education Commission (Grant No. 13YZ031). The funding sources had no role in the study design, collection, analysis, data interpretation, or the writing of the report.	Berbari E, 2010, J BONE JOINT SURG AM, V92A, P2102, DOI 10.2106/JBJS.I.01199; Berlin JA, 1997, LANCET, V350, P185, DOI 10.1016/S0140-6736(05)62352-5; Cipriano CA, 2012, J BONE JOINT SURG AM, V94A, P594, DOI 10.2106/JBJS.J.01318; Clohisy JC, 2004, CLIN ORTHOP RELAT R, P188, DOI 10.1097/01.blo.0000150126.73024.42; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; Del Pozo JL, 2009, NEW ENGL J MED, V361, P787, DOI 10.1056/NEJMcp0905029; Della Valle C, 2011, J BONE JOINT SURG AM, V93A, P1355, DOI 10.2106/JBJS.9314ebo; Della Valle CJ, 2007, J ARTHROPLASTY, V22, P90, DOI 10.1016/j.arth.2007.04.013; Deville Walter L, 2002, BMC Med Res Methodol, V2, P9, DOI 10.1186/1471-2288-2-9; Dinneen A, 2013, BONE JOINT J, V95B, P554, DOI 10.1302/0301-620X.95B4.30388; Ghanem E, 2008, J BONE JOINT SURG AM, V90A, P1637, DOI 10.2106/JBJS.G.00470; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Kwee TC, 2008, EUR J NUCL MED MOL I, V35, P2122, DOI 10.1007/s00259-008-0887-x; Lee Su Chan, 2010, Orthopedics, V33, P725, DOI 10.3928/01477447-20100826-13; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Mason JB, 2003, J ARTHROPLASTY, V18, P1038, DOI 10.1016/S0883-5403(03)00448-0; MOSES LE, 1993, STAT MED, V12, P1293, DOI 10.1002/sim.4780121203; Nilsdotter-Augustinsson A, 2007, ACTA ORTHOP, V78, P629, DOI 10.1080/17453670710014329; Osmon DR, 2013, CLIN INFECT DIS, V56, DOI [10.1093/cid/cis803, 10.1093/cid/cis966]; Pakos EE, 2007, RADIOLOGY, V242, P101, DOI 10.1148/radiol.2421052011; Parvizi J, 2006, J BONE JOINT SURG AM, V88A, P138, DOI 10.2106/JBJS.F.00609; Parvizi Javad, 2012, J Bone Joint Surg Am, V94, pe104, DOI 10.2106/JBJS.K.01417; Parvizi J, 2011, J ARTHROPLASTY, V26, P1136, DOI 10.1016/j.arth.2011.09.026; Patel R, 2005, CLIN ORTHOP RELAT R, P55, DOI 10.1097/01.blo.0000175121.73675.fd; Qu XH, 2013, J CLIN MICROBIOL, V51, P3830, DOI 10.1128/JCM.01467-13; Qu XH, 2013, J CLIN MICROBIOL, V51, P2742, DOI 10.1128/JCM.00657-13; Schinsky MF, 2008, J BONE JOINT SURG AM, V90A, P1869, DOI 10.2106/JBJS.G.01255; Schwartz AJ, 2012, J ARTHROPLASTY, V27, P46, DOI 10.1016/j.arth.2012.03.033; Shukla SK, 2010, J ARTHROPLASTY, V25, P87, DOI 10.1016/j.arth.2010.05.006; Spangehl MJ, 1999, J BONE JOINT SURG AM, V81A, P672, DOI 10.2106/00004623-199905000-00008; Trampuz A, 2004, AM J MED, V117, P556, DOI 10.1016/j.amjmed.2004.06.022; Trampuz A, 2007, NEW ENGL J MED, V357, P654, DOI 10.1056/NEJMoa061588; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25	33	31	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84751	10.1371/journal.pone.0084751	http://dx.doi.org/10.1371/journal.pone.0084751			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416276	gold, Green Published, Green Submitted			2022-12-27	WOS:000329862500159
J	Somvanshi, RK; Kumar, U				Somvanshi, Rishi K.; Kumar, Ujendra			delta-Opioid Receptor and Somatostatin Receptor-4 Heterodimerization: Possible Implications in Modulation of Pain Associated Signaling	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; DORSAL-ROOT GANGLIA; RAT SPINAL-CORD; NEUROPATHIC PAIN; OCTAPEPTIDE ANALOGS; OPIATE RECEPTORS; KNOCKOUT MICE; H-3 CTOP; MU; MORPHINE	Pain relief is the principal action of opioids. Somatostatin (SST), a growth hormone inhibitory peptide is also known to alleviate pain even in cases when opioids fail. Recent studies have shown that mice are prone to sustained pain and devoid of analgesic effect in the absence of somatostatin receptor 4 (SSTR4). In the present study, using brain slices, cultured neurons and HEK-293 cells, we showed that SSTR4 and delta-Opioid receptor (delta OR) exist in a heteromeric complex and function in synergistic manner. SSTR4 and delta OR co-expressed in cortical/striatal brain regions and spinal cord. Using cultured neuronal cells, we describe the heterogeneous complex formation of SSTR4 and delta OR at neuronal cell body and processes. Cotransfected cells display inhibition of cAMP/PKA and co-activation of SSTR4 and delta OR oppose receptor trafficking induced by individual receptor activation. Furthermore, downstream signaling pathways either associated with withdrawal or pain relief are modulated synergistically with a predominant role of SSTR4. Inhibition of cAMP/PKA and activation of ERK1/2 are the possible cellular adaptations to prevent withdrawal induced by chronic morphine use. Our results reveal direct intra-membrane interaction between SSTR4 and delta OR and provide insights for the molecular mechanism for the anti-nociceptive property of SST in combination with opioids as a potential therapeutic approach to avoid undesirable withdrawal symptoms.	[Somvanshi, Rishi K.; Kumar, Ujendra] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada	University of British Columbia	Kumar, U (corresponding author), Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada.	ujkumar@mail.ubc.ca		Somvanshi, Rishi/0000-0002-7965-3068	Canadian Institute of Health Research [CIHR MOP 74465]; Canadian Breast Cancer Foundation BC/Yukon; NSERC	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Foundation BC/Yukon; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grants from Canadian Institute of Health Research (CIHR MOP 74465), Canadian Breast Cancer Foundation BC/Yukon and NSERC to UK. UK is a Senior Scholar of Michael Smith Foundation for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter BJ, 2010, J NEUROSCI, V30, P11537, DOI 10.1523/JNEUROSCI.6103-09.2010; Bagley EE, 2005, NEURON, V45, P433, DOI 10.1016/j.neuron.2004.12.049; Buzas B, 1997, NEUROSCIENCE, V76, P479, DOI 10.1016/S0306-4522(96)00242-4; Chrubasik J., 1993, Acta Neurobiologiae Experimentalis (Warsaw), V53, P289; CHRUBASIK J, 1984, LANCET, V1, P738; Ciruela A, 2003, BRIT J PHARMACOL, V138, P751, DOI 10.1038/sj.bjp.0705103; Coop A, 2000, DRUG NEWS PERSPECT, V13, P481; Cruz CD, 2007, CURR NEUROPHARMACOL, V5, P244, DOI 10.2174/157015907782793630; Csaba Z, 2001, NEUROPEPTIDES, V35, P1, DOI 10.1054/npep.2001.0848; Cunha TM, 2010, P NATL ACAD SCI USA, V107, P4442, DOI 10.1073/pnas.0914733107; Dai Min, 2002, J Anesth, V16, P211, DOI 10.1007/s005400200027; Dolan S, 2001, NEUROSCI LETT, V309, P157, DOI 10.1016/S0304-3940(01)02063-8; Foldes F F, 1991, Anaesthesiol Reanim, V16, P287; FOLDES FF, 1991, ANESTHESIOLOGY, V75, P191, DOI 10.1097/00000542-199108000-00004; Fraser GL, 2000, BRIT J PHARMACOL, V129, P1668, DOI 10.1038/sj.bjp.0703248; Freedman NJ, 1996, RECENT PROG HORM RES, V51, P319; Gaveriaux-Ruff C, 2002, NEUROPEPTIDES, V36, P62, DOI 10.1054/npep.2002.0900; Gaveriaux-Ruff C, 2011, PAIN, V152, P1238, DOI 10.1016/j.pain.2010.12.031; Grant M, 2004, J BIOL CHEM, V279, P38636, DOI 10.1074/jbc.M406276200; Grant M, 2008, MOL ENDOCRINOL, V22, P2278, DOI 10.1210/me.2007-0334; GULYA K, 1986, LIFE SCI, V38, P2221, DOI 10.1016/0024-3205(86)90574-6; Hammond DL, 1998, J PHARMACOL EXP THER, V284, P378; HAWKINS KN, 1989, J PHARMACOL EXP THER, V248, P73; HAWKINS KN, 1988, LIFE SCI, V42, P2541, DOI 10.1016/0024-3205(88)90322-0; He L, 2002, CELL, V108, P271, DOI 10.1016/S0092-8674(02)00613-X; Helyes Z, 2009, P NATL ACAD SCI USA, V106, P13088, DOI 10.1073/pnas.0900681106; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Jordan BA, 2000, NEUROPSYCHOPHARMACOL, V23, pS5, DOI 10.1016/S0893-133X(00)00143-3; Kieffer BL, 1995, CELL MOL NEUROBIOL, V15, P615, DOI 10.1007/BF02071128; Kieffer BL, 1999, TRENDS PHARMACOL SCI, V20, P19, DOI 10.1016/S0165-6147(98)01279-6; KNAPP RJ, 1995, FASEB J, V9, P516, DOI 10.1096/fasebj.9.7.7737460; Kovelowski CJ, 1999, BRAIN RES, V843, P12, DOI 10.1016/S0006-8993(99)01803-X; Kumar U, 2004, NEUROSCI RES, V49, P29, DOI 10.1016/j.neures.2004.01.011; Kumar U, 2007, J COMP NEUROL, V504, P185, DOI 10.1002/cne.21444; Lancranjan I, 1999, Pituitary, V1, P105; Law PY, 2000, ANNU REV PHARMACOL, V40, P389, DOI 10.1146/annurev.pharmtox.40.1.389; Macey TA, 2009, J PHARMACOL EXP THER, V331, P412, DOI 10.1124/jpet.109.152157; Mika J, 2001, EUR J PHARMACOL, V415, P31, DOI 10.1016/S0014-2999(01)00814-7; MOLLENHOLT P, 1994, ANESTHESIOLOGY, V81, P534, DOI 10.1097/00000542-199409000-00004; Nadal X, 2006, EUR J NEUROSCI, V23, P830, DOI 10.1111/j.1460-9568.2006.04569.x; Narita M, 2004, NEUROSCIENCE, V124, P515, DOI 10.1016/j.neuroscience.2003.11.023; Narita M, 2002, NEUROSCIENCE, V113, P647, DOI 10.1016/S0306-4522(02)00197-5; Notas G, 2004, J HEPATOL, V40, P792, DOI 10.1016/j.jhep.2004.01.016; Notas G, 2007, EUR J PHARMACOL, V555, P1, DOI 10.1016/j.ejphar.2006.10.018; Obata K, 2007, J NEUROCHEM, V102, P1569, DOI 10.1111/j.1471-4159.2007.04656.x; Patel YC, 1999, FRONT NEUROENDOCRIN, V20, P157, DOI 10.1006/frne.1999.0183; PELTON JT, 1986, J MED CHEM, V29, P2370, DOI 10.1021/jm00161a037; PELTON JT, 1985, P NATL ACAD SCI USA, V82, P236, DOI 10.1073/pnas.82.1.236; PENN RD, 1992, PAIN, V49, P13, DOI 10.1016/0304-3959(92)90182-B; Pfeiffer M, 2002, J BIOL CHEM, V277, P19762, DOI 10.1074/jbc.M110373200; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Pollandt S, 2006, EUR J NEUROSCI, V24, P1733, DOI 10.1111/j.1460-9568.2006.05049.x; Prinster SC, 2005, PHARMACOL REV, V57, P289, DOI 10.1124/pr.57.3.1; PUGSLEY TA, 1978, RES COMMUN CHEM PATH, V21, P153; Quock RM, 1999, PHARMACOL REV, V51, P503; Rajput PS, 2009, J CHEM NEUROANAT, V38, P20, DOI 10.1016/j.jchemneu.2009.05.004; Schulz R, 2002, J PHARMACOL EXP THER, V300, P376, DOI 10.1124/jpet.300.2.376; Schulz S, 1998, EUR J NEUROSCI, V10, P3700, DOI 10.1046/j.1460-9568.1998.00386.x; SICUTERI F, 1984, PAIN, V18, P359, DOI 10.1016/0304-3959(84)90048-4; Skyba D. A., 2004, DRUG DISCOV TODAY, V1, P115, DOI [10.1016/j.ddmod.2004.07.003, DOI 10.1016/J.DDMOD.2004.07.003]; Somvanshi RK, 2011, CELL SIGNAL, V23, P794, DOI 10.1016/j.cellsig.2011.01.002; Somvanshi RK, 2009, CELL SIGNAL, V21, P1396, DOI 10.1016/j.cellsig.2009.04.007; SterneMarr R, 1995, VITAM HORM, V51, P193, DOI 10.1016/S0083-6729(08)61039-0; STEWART PE, 1993, J PHARMACOL EXP THER, V266, P820; TERENIUS L, 1976, EUR J PHARMACOL, V38, P211, DOI 10.1016/0014-2999(76)90221-1; Van Op den Bosch J, 2009, J CELL MOL MED, V13, P3283, DOI 10.1111/j.1582-4934.2009.00760.x; VINCENT SR, 1982, NATURE, V298, P65, DOI 10.1038/298065a0; WALKER JM, 1987, PEPTIDES, V8, P869; WILLIAMS G, 1986, NEW ENGL J MED, V315, P1166; Xu JT, 2007, EXP NEUROL, V206, P269, DOI 10.1016/j.expneurol.2007.05.029	71	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85193	10.1371/journal.pone.0085193	http://dx.doi.org/10.1371/journal.pone.0085193			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416361	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500226
J	Thomas, RC; Willette, DA; Carpenter, KE; Santos, MD				Thomas, Rey C., Jr.; Willette, Demian A.; Carpenter, Kent E.; Santos, Mudjekeewis D.			Hidden Diversity in Sardines: Genetic and Morphological Evidence for Cryptic Species in the Goldstripe Sardinella, Sardinella gibbosa (Bleeker, 1849)	PLOS ONE			English	Article							HAPLOTYPE RECONSTRUCTION; MORPHOMETRIC VARIATION; POPULATION; MITOCHONDRIAL; DNA; DELIMITATION; TELEOSTEI; FISHES; LEVEL	Cryptic species continue to be uncovered in many fish taxa, posing challenges for fisheries conservation and management. In Sardinella gibbosa, previous investigations revealed subtle intra-species variations, resulting in numerous synonyms and a controversial taxonomy for this sardine. Here, we tested for cryptic diversity within S. gibbosa using genetic data from two mitochondrial and one nuclear gene regions of 248 individuals of S. gibbosa, collected from eight locations across the Philippine archipelago. Deep genetic divergence and subsequent clustering was consistent across both mitochondrial and nuclear markers. Clade distribution is geographically limited: Clade 1 is widely distributed in the central Philippines, while Clade 2 is limited to the northernmost sampling site. In addition, morphometric analyses revealed a unique head shape that characterized each genetic clade. Hence, both genetic and morphological evidence strongly suggests a hidden diversity within this common and commercially-important sardine.	[Thomas, Rey C., Jr.; Santos, Mudjekeewis D.] Natl Fisheries Res & Dev Inst, Genet Fingerprinting Lab, Quezon City, Metro Manila, Philippines; [Willette, Demian A.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Carpenter, Kent E.] Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA	University of California System; University of California Los Angeles; Old Dominion University	Thomas, RC (corresponding author), Natl Fisheries Res & Dev Inst, Genet Fingerprinting Lab, Quezon City, Metro Manila, Philippines.	reycthomas@gmail.com		Willette, Demian/0000-0002-2843-9715; Santos, Mudjekeewis/0000-0002-4770-1221	National Fisheries Research and Development Institute grant; National Science Foundation [NSF OISE-0730256]	National Fisheries Research and Development Institute grant; National Science Foundation(National Science Foundation (NSF))	This project was funded mainly through a National Fisheries Research and Development Institute grant to Mudjekeewis Santos, Demian Willette and Eunice Bognot. This research was partly supported by a grant from the National Science Foundation (NSF OISE-0730256) to Kent Carpenter and Paul Barber. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1963, ANIMAL SPECIES EVOLU; Atarhouch T, 2006, MOL PHYLOGENET EVOL, V39, P373, DOI 10.1016/j.ympev.2005.08.003; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beheregaray Luciano B, 2007, J Biol, V6, P9, DOI 10.1186/jbiol60; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Boissin E, 2008, MOL ECOL, V17, P1732, DOI 10.1111/j.1365-294X.2007.03652.x; Brown DM, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-57; Bruford Michael W., 1998, P287; Carolan JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029251; Chow S, 1998, MOL ECOL, V7, P1255; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Colborn J, 2001, EVOLUTION, V55, P807, DOI 10.1554/0014-3820(2001)055[0807:TEEOBA]2.0.CO;2; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Dupuis JR, 2012, MOL ECOL, V21, P4422, DOI 10.1111/j.1365-294X.2012.05642.x; DUTT S., 1961, JOUR ZOOL SOC INDIA, V13, P78; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FAO, 2006, NATL AQUACULTURE SEC; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Gill A, 1995, P BIOL SOC WASH, V117, P17; Gill Anthony C., 2011, Zootaxa, V3140, P49; Goodman SM, 2009, ZOOL SCR, V38, P339, DOI 10.1111/j.1463-6409.2008.00377.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haudorf B, 2011, EVOLUTION, V65, P923; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; HEDGECOCK D, 1989, FISH B-NOAA, V87, P653; Hey J, 2003, TRENDS ECOL EVOL, V18, P597, DOI 10.1016/j.tree.2003.08.014; Hubert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028987; KINSEY ST, 1994, MAR BIOL, V118, P309, DOI 10.1007/BF00349798; Kishinouye K., 1908, J FISH BUR, V14, P71; Knowlton N, 2000, HYDROBIOLOGIA, V420, P73, DOI 10.1023/A:1003933603879; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; Ladner JT, 2012, MOL ECOL, V21, P2224, DOI 10.1111/j.1365-294X.2012.05528.x; Lavoue S, 2003, BIOL J LINN SOC, V78, P273, DOI 10.1046/j.1095-8312.2003.00170.x; Lavoue S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036287; Lazarus S, 1975, INDIAN J FISH, V24, P107; LEE WJ, 1995, J MOL EVOL, V41, P54; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MALLET J, 1995, TRENDS ECOL EVOL, V10, P294, DOI 10.1016/0169-5347(95)90031-4; Mathews LM, 2009, MOL PHYLOGENET EVOL, V50, P268, DOI 10.1016/j.ympev.2008.10.026; McCune B, 1999, MULTIVARIATE ANAL EC; Nair R, 1973, CSIR ZOOLOGICAL MONO; Niemiller ML, 2012, EVOLUTION, V66, P846, DOI 10.1111/j.1558-5646.2011.01480.x; Nyunja Judith A., 2002, Western Indian Ocean Journal of Marine Science, V1, P181; OKERA W, 1974, J FISH BIOL, V6, P801, DOI 10.1111/j.1095-8649.1974.tb05123.x; Okera W, 1970, J E AFRICA NATURAL H, V28, P1; Palumbi S, 1996, MOL SYSTEMATICS; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Piggott MP, 2011, BIOL J LINN SOC, V102, P391, DOI 10.1111/j.1095-8312.2010.01571.x; RAJA B T A, 1969, Records of Oceanographic Works in Japan, V10, P75; Rao, 1969, INDIAN J FISH, V16, P156; Ross KG, 2010, SYST BIOL, V59, P162, DOI 10.1093/sysbio/syp089; Shaffer HB, 2007, SYST BIOL, V56, P896, DOI 10.1080/10635150701772563; Silva A, 2003, ICES J MAR SCI, V60, P1352, DOI 10.1016/S1054-3139(03)00141-3; SOKAL RR, 1970, AM NAT, V104, P127, DOI 10.1086/282646; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stuart BL, 2006, BIOL LETTERS, V2, P470, DOI 10.1098/rsbl.2006.0505; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Trontelj P, 2009, SYST BIODIVERS, V7, P1, DOI 10.1017/S1477200008002909; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Whitehead P.J.P., 1985, FAO FISH, V125, P1; WHITLEY G. P., 1940, AUSTRALIAN ZOOL, V9, P397; Willette D, 2014, B MARINE SC IN PRESS, V90; Willette D, 2011, BFAR TECHNICAL PAPER, V13, P1; Willette DA, 2011, J FISH BIOL, V79, P2087, DOI 10.1111/j.1095-8649.2011.03133.x	66	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84719	10.1371/journal.pone.0084719	http://dx.doi.org/10.1371/journal.pone.0084719			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416271	Green Published, gold			2022-12-27	WOS:000329862500154
J	Meng, J; Li, Y; Camarillo, C; Yao, Y; Zhang, YN; Xu, C; Jiang, LH				Meng, Jia; Li, Yan; Camarillo, Cynthia; Yao, Yue; Zhang, Yina; Xu, Chun; Jiang, Lihong			The Anti-Tumor Histone Deacetylase Inhibitor SAHA and the Natural Flavonoid Curcumin Exhibit Synergistic Neuroprotection against Amyloid-Beta Toxicity	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; INTERACTION NETWORKS; CASCADE HYPOTHESIS; PROTEIN; THERAPEUTICS; VISUALIZATION; MECHANISMS; EXPRESSION; CYTOSCAPE	With the trend of an increasing aged population worldwide, Alzheimer's disease (AD), an age-related neurodegenerative disorder, as one of the major causes of dementia in elderly people is of growing concern. Despite the many hard efforts attempted during the past several decades in trying to elucidate the pathological mechanisms underlying AD and putting forward potential therapeutic strategies, there is still a lack of effective treatments for AD. The efficacy of many potential therapeutic drugs for AD is of main concern in clinical practice. For example, large bodies of evidence show that the antitumor histone deacetylase (HDAC) inhibitor, suberoylanilidehydroxamic acid (SAHA), may be of benefit for the treatment of AD; however, its extensive inhibition of HDACs makes it a poor therapeutic. Moreover, the natural flavonoid, curcumin, may also have a potential therapeutic benefit against AD; however, it is plagued by low bioavailability. Therefore, the integrative effects of SAHA and curcumin were investigated as a protection against amyloid-beta neurotoxicity in vitro. We hypothesized that at low doses their synergistic effect would improve therapeutic selectivity, based on experiments that showed that at low concentrations SAHA and curcumin could provide comprehensive protection against A beta(25-35)-induced neuronal damage in PC12 cells, strongly implying potent synergism. Furthermore, network analysis suggested that the possible mechanism underlying their synergistic action might be derived from restoration of the damaged functional link between Akt and the CBP/p300 pathway, which plays a crucial role in the pathological development of AD. Thus, our findings provided a feasible avenue for the application of a synergistic drug combination, SAHA and curcumin, in the treatment of AD.	[Meng, Jia; Yao, Yue; Zhang, Yina; Jiang, Lihong] Harbin Med Univ, Affiliated Hosp 2, Dept Geriatr, Harbin, Heilongjiang, Peoples R China; [Li, Yan] Harbin Med Univ, Affiliated Hosp 4, Dept Pharm, Harbin, Heilongjiang, Peoples R China; [Camarillo, Cynthia; Xu, Chun] Texas Tech Univ, Hlth Sci Ctr, Ctr Excellence Neurosci, El Paso, TX USA	Harbin Medical University; Harbin Medical University; Texas Tech University System; Texas Tech University	Zhang, YN (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Geriatr, Harbin, Heilongjiang, Peoples R China.	yinazhlu@163.com; jianglihong2006@163.com			Heilongjiang Province Foundation for Returnees [LC2009C13]; Foundation of Heilongjiang Educational Committee [12521z019]	Heilongjiang Province Foundation for Returnees; Foundation of Heilongjiang Educational Committee	This study was supported by Heilongjiang Province Foundation for Returnees (LC2009C13) and Foundation of Heilongjiang Educational Committee (12521z019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Bajda M, 2011, CURR MED CHEM, V18, P4949, DOI 10.2174/092986711797535245; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Clark CM, 1999, ARCH NEUROL-CHICAGO, V56, P857, DOI 10.1001/archneur.56.7.857; Golde TE, 2011, NEURON, V69, P203, DOI 10.1016/j.neuron.2011.01.002; Goni J, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-52; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hegde AN, 2011, BBA-GENE REGUL MECH, V1809, P128, DOI 10.1016/j.bbagrm.2010.07.006; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jain S, 2010, NEURON, V68, P207, DOI 10.1016/j.neuron.2010.10.010; Jia J, 2009, NAT REV DRUG DISCOV, V8, P111, DOI 10.1038/nrd2683; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kilgore M, 2010, NEUROPSYCHOPHARMACOL, V35, P870, DOI 10.1038/npp.2009.197; Korzus E, 2010, NAT NEUROSCI, V13, P405, DOI 10.1038/nn0410-405; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Li S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S1-S10; Liu RG, 2012, NEUROBIOL DIS, V45, P902, DOI 10.1016/j.nbd.2011.12.007; Lopez Oscar L, 2011, Am J Manag Care, V17 Suppl 13, pS339; Lu X, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100138; Martin A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-91; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Noorbakhsh F, 2009, TRENDS NEUROSCI, V32, P88, DOI 10.1016/j.tins.2008.10.003; Patel L, 2011, DRUG AGING, V28, P539, DOI 10.2165/11591860-000000000-00000; Rouaux C, 2004, BIOCHEM PHARMACOL, V68, P1157, DOI 10.1016/j.bcp.2004.05.035; Sabbagh M, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-21; Satoh J, 2009, DIS MARKERS, V27, P239, DOI [10.1155/2009/618619, 10.3233/DMA-2009-0670]; Selvi BR, 2010, BBA-GENE REGUL MECH, V1799, P840, DOI 10.1016/j.bbagrm.2010.08.012; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Stilling RM, 2011, NEUROBIOL LEARN MEM, V96, P19, DOI 10.1016/j.nlm.2011.04.002; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; de la Torre AV, 2013, PHARMACOL RES, V70, P116, DOI 10.1016/j.phrs.2013.01.007; Vlasblom J, 2006, BIOINFORMATICS, V22, P2178, DOI 10.1093/bioinformatics/btl356; Wang YL, 2013, AM J CHINESE MED, V41, P59, DOI 10.1142/S0192415X13500055; Xu K, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/143269; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yamaguchi H, 1996, ACTA NEUROPATHOL, V92, P232, DOI 10.1007/s004010050513; Zhou HY, 2011, CURR DRUG TARGETS, V12, P332, DOI 10.2174/138945011794815356; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008	42	30	32	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e85570	10.1371/journal.pone.0085570	http://dx.doi.org/10.1371/journal.pone.0085570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409332	Green Published, gold, Green Submitted			2022-12-27	WOS:000329463500056
J	Williams, DM; Quinn, ACD; Porter, WF				Williams, David M.; Quinn, Amy C. Dechen; Porter, William F.			Informing Disease Models with Temporal and Spatial Contact Structure among GPS-Collared Individuals in Wild Populations	PLOS ONE			English	Article							WHITE-TAILED DEER; FACIAL TUMOR DISEASE; SARCOPHILUS-HARRISII; RABIES SPREAD; HOME RANGES; RATES; TRANSMISSION; DYNAMICS; BEHAVIOR; SEASONALITY	Contacts between hosts are essential for transmission of many infectious agents. Understanding how contacts, and thus transmission rates, occur in space and time is critical to effectively responding to disease outbreaks in free-ranging animal populations. Contacts between animals in the wild are often difficult to observe or measure directly. Instead, one must infer contacts from metrics such as proximity in space and time. Our objective was to examine how contacts between white-tailed deer (Odocoileus virginianus) vary in space and among seasons. We used GPS movement data from 71 deer in central New York State to quantify potential direct contacts between deer and indirect overlap in space use across time and space. Daily probabilities of direct contact decreased from winter (0.05-0.14), to low levels post-parturition through summer (0.00-0.02), and increased during the rut to winter levels. The cumulative distribution for the spatial structure of direct and indirect contact probabilities around a hypothetical point of occurrence increased rapidly with distance for deer pairs separated by 1,000 m - 7,000 m. Ninety-five percent of the probabilities of direct contact occurred among deer pairs within 8,500 m of one another, and 99% within 10,900 m. Probabilities of indirect contact accumulated across greater spatial extents: 95% at 11,900 m and 99% at 49,000 m. Contacts were spatially consistent across seasons, indicating that although contact rates differ seasonally, they occur proportionally across similar landscape extents. Distributions of contact probabilities across space can inform management decisions for assessing risk and allocating resources in response.	[Williams, David M.; Quinn, Amy C. Dechen; Porter, William F.] SUNY Coll Environm Sci & Forestry, Dept Environm & Forest Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry	Williams, DM (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA.	dmwill@msu.edu			New York State Department of Environmental Conservation (NYSDEC); United States Federal Aid in Wildlife Restoration Project [W-173-G]; United States Geological Survey; McIntire-Stennis Foundation at SUNY-ESF	New York State Department of Environmental Conservation (NYSDEC); United States Federal Aid in Wildlife Restoration Project; United States Geological Survey(United States Geological Survey); McIntire-Stennis Foundation at SUNY-ESF	Funding for this project was provided by the New York State Department of Environmental Conservation (NYSDEC) with partial support from the United States Federal Aid in Wildlife Restoration Project W-173-G. Additional support was provided by the United States Geological Survey and the McIntire-Stennis Foundation at SUNY-ESF. The NYSDEC assisted in the selection of the study areas and provided technicians to assist in deer-trapping efforts. The NYSDEC had no role in additional data collection, analysis, decision to publish, or preparation of the manuscript. All other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Aycrigg JL, 1997, J MAMMAL, V78, P468, DOI 10.2307/1382899; Bertrand MR, 1996, J WILDLIFE MANAGE, V60, P899, DOI 10.2307/3802391; Bolker BM, 1995, ECOLOGY INFECT DIS N, P384; CLOVER MELVIN R., 1956, CALIFORNIA FISH AND GAME, V42, P199; Courtenay O, 2001, VET MICROBIOL, V81, P9, DOI 10.1016/S0378-1135(01)00326-1; Finkenstadt BF, 2000, J R STAT SOC C-APPL, V49, P187, DOI 10.1111/1467-9876.00187; Grassly NC, 2006, P ROY SOC B-BIOL SCI, V273, P2541, DOI 10.1098/rspb.2006.3604; Hamede RK, 2008, AUSTRAL ECOL, V33, P614, DOI 10.1111/j.1442-9993.2007.01827.x; Hamede RK, 2009, ECOL LETT, V12, P1147, DOI 10.1111/j.1461-0248.2009.01370.x; Hosseini PR, 2004, P ROY SOC B-BIOL SCI, V271, P2569, DOI 10.1098/rspb.2004.2938; Ji WH, 2005, J APPL ECOL, V42, P595, DOI 10.1111/j.1365-2664.2005.01026.x; Johnson CJ, 2006, PLOS PATHOG, V2, P296, DOI 10.1371/journal.ppat.0020032; JORGENSEN CD, 1968, J MAMMAL, V49, P104, DOI 10.2307/1377732; Kauhala K, 2006, ANN ZOOL FENN, V43, P348; Keeling MJ, 1999, P ROY SOC B-BIOL SCI, V266, P859, DOI 10.1098/rspb.1999.0716; Long ES, 2008, BEHAV ECOL, V19, P1235, DOI 10.1093/beheco/arn082; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; MINTA SC, 1992, ECOL APPL, V2, P178, DOI 10.2307/1941774; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; NELSON ME, 1992, J MAMMAL, V73, P891, DOI 10.2307/1382212; NYS Streets-Public, NYS STREETS PUBL; OZOGA JJ, 1982, J WILDLIFE MANAGE, V46, P1, DOI 10.2307/3808402; Prange S, 2006, WILDLIFE SOC B, V34, P1333, DOI 10.2193/0091-7648(2006)34[1333:NRFTDO]2.0.CO;2; Quinn ACD, 2012, J MAMMAL, V93, P456, DOI 10.1644/10-MAMM-A-422.1; R Core Team, 2020, R LANG ENV STAT COMP; Richomme C, 2006, EPIDEMIOL INFECT, V134, P21, DOI 10.1017/S0950268805004693; Schauber EM, 2007, J WILDLIFE MANAGE, V71, P155, DOI 10.2193/2005-546; Swinton J., 2002, P83; Tamguney G, 2009, NATURE, V461, P529, DOI 10.1038/nature08289; TIERSON WC, 1985, J WILDLIFE MANAGE, V49, P760, DOI 10.2307/3801708; Totton SC, 2002, J WILDLIFE DIS, V38, P313, DOI 10.7589/0090-3558-38.2.313; United States Monthly Surface Data, US MONTHL SURF DAT; White PCL, 1995, J APPL ECOL, V32, P693, DOI 10.2307/2404809; White PCL, 2003, WILDLIFE RES, V30, P49, DOI 10.1071/WR01106; Williams DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048439	37	10	10	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84368	10.1371/journal.pone.0084368	http://dx.doi.org/10.1371/journal.pone.0084368			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409293	Green Submitted, Green Published, gold			2022-12-27	WOS:000329463500017
J	Wotton, KR; Jimenez-Guri, E; Matheu, BG; Jaeger, J				Wotton, Karl R.; Jimenez-Guri, Eva; Garcia Matheu, Belen; Jaeger, Johannes			A Staging Scheme for the Development of the Scuttle Fly Megaselia abdita	PLOS ONE			English	Article							TRIBOLIUM EMBRYOGENESIS; DROSOPHILA; EXPRESSION; DIPTERA; SPECIFICATION; GASTRULATION; CYTOSKELETON; VARIABILITY; AMNIOSEROSA; BLASTODERM	Model organisms, such as Drosophila melanogaster, provide powerful experimental tools for the study of development. However, approaches using model systems need to be complemented by comparative studies for us to gain a deeper understanding of the functional properties and evolution of developmental processes. New model organisms need to be established to enable such comparative work. The establishment of new model system requires a detailed description of its life cycle and development. The resulting staging scheme is essential for providing morphological context for molecular studies, and allows us to homologise developmental processes between species. In this paper, we provide a staging scheme and morphological characterisation of the life cycle for an emerging non-drosophilid dipteran model system: the scuttle fly Megaselia abdita. We pay particular attention to early embryogenesis (cleavage and blastoderm stages up to gastrulation), the formation and retraction of extraembryonic tissues, and the determination and formation of germ (pole) cells. Despite the large evolutionary distance between the two species (approximately 150 million years), we find that M. abdita development is remarkably similar to D. melanogaster in terms of developmental landmarks and their relative timing.	[Wotton, Karl R.; Jimenez-Guri, Eva; Garcia Matheu, Belen; Jaeger, Johannes] UPF, Ctr Genom Regulat CRG, EMBL CRG Res Unit Syst Biol, Barcelona, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); European Molecular Biology Laboratory (EMBL)	Jaeger, J (corresponding author), UPF, Ctr Genom Regulat CRG, EMBL CRG Res Unit Syst Biol, Barcelona, Spain.	yogi.jaeger@crg.eu		Wotton, Karl/0000-0002-8672-9948; Jaeger, Johannes/0000-0002-2568-2103; jimenez-guri, eva/0000-0002-9592-1077	MEC-EMBL; SGR grant from the Catalan funding agency AGAUR [406]; MINECO [BFU2009-10184, BFU2012-33775]; ERANet: ERASysBio+ grant [EUI2009-04045]	MEC-EMBL; SGR grant from the Catalan funding agency AGAUR; MINECO(Spanish Government); ERANet: ERASysBio+ grant	The laboratory of Johannes Jaeger and this study in particular was funded by the MEC-EMBL agreement for the EMBL/CRG Research Unit in Systems Biology, by SGR grant 406 from the Catalan funding agency AGAUR, by grants BFU2009-10184 & BFU2012-33775 from the Spanish Ministry of Science (MICINN, now called MINECO), and by ERANet: ERASysBio+ grant EUI2009-04045 (MODHEART). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abzhanov A, 2008, TRENDS GENET, V24, P353, DOI 10.1016/j.tig.2008.04.002; Ashyraliyev M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000548; Becker K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003281; Benton MA, 2013, DEVELOPMENT, V140, P3210, DOI 10.1242/dev.096271; Boehme P, 2010, INT J LEGAL MED, V124, P577, DOI 10.1007/s00414-010-0429-5; Bullock SL, 2004, DEVELOPMENT, V131, P4251, DOI 10.1242/dev.01289; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; Crombach A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046658; Crombach A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002589; Dawkins R., 2004, ANCESTORS TALE PILGR; Disney RHL, 2005, MED VET ENTOMOL, V19, P489, DOI 10.1111/j.1365-2915.2005.00593.x; FOE VE, 1983, J CELL SCI, V61, P31; FOE VE, 1989, DEVELOPMENT, V107, P1; Fritsch C, 2010, DEV GENES EVOL, V220, P235, DOI 10.1007/s00427-010-0341-5; Greenberg B, 1998, J MED ENTOMOL, V35, P205, DOI 10.1093/jmedent/35.3.205; Handel K, 2005, DEV GENES EVOL, V215, P13, DOI 10.1007/s00427-004-0446-9; Handel K, 2000, DEV GENES EVOL, V210, P167, DOI 10.1007/s004270050301; HAY B, 1988, DEVELOPMENT, V103, P625; HAY B, 1988, CELL, V55, P577, DOI 10.1016/0092-8674(88)90216-4; Jaeger J, 2004, GENETICS, V167, P1721, DOI 10.1534/genetics.104.027334; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Jaeger J, 2007, MECH DEVELOP, V124, P108, DOI 10.1016/j.mod.2006.11.001; Janssens H, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-1; Janssens H, 2013, DEV BIOL, V377, P305, DOI 10.1016/j.ydbio.2013.01.010; Jenner RA, 2007, NAT REV GENET, V8, P311, DOI 10.1038/nrg2062; Jimenez-Guri E, 2013, PLOS ONE IN PRESS; Jimenez-Guri E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-123; LASKO PF, 1988, NATURE, V335, P611, DOI 10.1038/335611a0; Lemke S, 2008, EVOL DEV, V10, P413, DOI 10.1111/j.1525-142X.2008.00252.x; Manlove JD, 2008, FORENSIC SCI INT, V175, P83, DOI 10.1016/j.forsciint.2007.08.001; Marshall SA, 2012, FLIES NATURAL HIST D; Rafiqi A.M., 2011, COLD SPRING HARBOR P, P2011, DOI [10.1101/pdb.prot5600, DOI 10.1101/PDB.PR0T5600]; Rafiqi AM, 2008, P NATL ACAD SCI USA, V105, P234, DOI 10.1073/pnas.0709145105; Rafiqi Ab Matteen, 2011, Cold Spring Harb Protoc, V2011, DOI 10.1101/pdb.prot5602; Rafiqi AM, 2012, DEVELOPMENT, V139, P3373, DOI 10.1242/dev.083873; Rafiqi AM, 2010, DEV BIOL, V341, P282, DOI 10.1016/j.ydbio.2010.01.040; Rafiqi AM, 2011, COLD SPRING HARBOR P, DOI [10.1101/pdb.emo143, DOI 10.1101/PDB.EM0143]; SCHEJTER ED, 1993, ANNU REV CELL BIOL, V9, P67, DOI 10.1146/annurev.cellbio.9.1.67; Schmidt-Ott U, 2000, DEV GENES EVOL, V210, P373, DOI 10.1007/s004270000068; Schmidt-Ott U, 2010, ADV EXP MED BIOL, V689, P133; SCHMIDTOTT U, 1994, ROUX ARCH DEV BIOL, V203, P298, DOI 10.1007/BF00457800; Sommer RJ, 2009, NAT REV GENET, V10, P416, DOI 10.1038/nrg2567; STANLEY MSM, 1970, ANN ENTOMOL SOC AM, V63, P1248, DOI 10.1093/aesa/63.5.1248; Stauber M, 2000, P NATL ACAD SCI USA, V97, P10844, DOI 10.1073/pnas.190095397; Stauber M, 1999, P NATL ACAD SCI USA, V96, P3786, DOI 10.1073/pnas.96.7.3786; SULLIVAN W, 1995, CURR OPIN CELL BIOL, V7, P18, DOI 10.1016/0955-0674(95)80040-9; Surkova S, 2008, DEV BIOL, V313, P844, DOI 10.1016/j.ydbio.2007.10.037; Surkova S, 2008, FLY, V2, P58, DOI 10.4161/fly.6060; Surkova S, 2013, DEV BIOL, V376, P99, DOI 10.1016/j.ydbio.2013.01.008; van der Zee M, 2005, CURR BIOL, V15, P624, DOI 10.1016/j.cub.2005.02.057; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108	51	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84421	10.1371/journal.pone.0084421	http://dx.doi.org/10.1371/journal.pone.0084421			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409295	Green Submitted, Green Published, gold			2022-12-27	WOS:000329463500019
J	Eini, R; Stoop, H; Gillis, AJM; Biermann, K; Dorssers, LCJ; Looijenga, LHJ				Eini, Ronak; Stoop, Hans; Gillis, Ad J. M.; Biermann, Katharina; Dorssers, Lambert C. J.; Looijenga, Leendert H. J.			Role of SOX2 in the Etiology of Embryonal Carcinoma, Based on Analysis of the NCCIT and NT2 Cell Lines	PLOS ONE			English	Article							TUMOR-INITIATING CELLS; STEM-CELLS; BREAST-CANCER; GERM-CELLS; DIFFERENTIATION; EXPRESSION; ONCOGENE; PROLIFERATION; INHIBITION; OCT3/4	The transcription factor SOX2, associated with amongst others OCT3/4, is essential for maintenance of pluripotency and self-renewal of embryonic stem cells. SOX2 is highly expressed in embryonal carcinoma (EC), the stem cell component of malignant nonseminomatous germ cell tumors, referred to as germ cell cancer (GCC). In fact, OCT3/4 together with SOX2 is an informative diagnostic tool for EC in a clinical setting. Several studies support the hypothesis that SOX2 is a relevant oncogenic factor in various cancers and recently, SOX2 has been suggested as a putative therapeutic target for early stage EC. We demonstrate the presence of genomic amplification of SOX2 in an EC cell line, NCCIT, using array comparative genome hybridization and fluorescence in situ hybridization. Down-regulation of SOX2 by targeted siRNA provokes NCCIT cells towards apoptosis, while inhibition of OCT3/4 expression induced differentiation, with retained SOX2 levels. Mice pluripotent xenografts from NCCIT (N-NCCIT and N2-NCCIT) show a consistent SOX2 expression, in spite of loss of the expression of OCT3/4, and differentiation, with retained presence of genomic amplification. No SOX2 amplification has been identified in primary pure and mixed EC in vivo patient samples so far. The data presented in this study are based on a single EC cell line with a SOX2 amplification, with NT2 as control EC cell line, showing no profound induction of apoptosis upon SOX2 downregulation. The findings are of relevance to identify mechanisms involved in the pathogenesis of EC tumors, and support the model of SOX2-oncogene dependency of EC, which however, does not exclude induction of differentiation. This finding is likely related to the presence of wild type p53 in GCC, resulting in expression of downstream target genes, amongst others miR-34a, miR-145 and SOX2, associated to the unique sensitivity of GCC to DNA damaging agents.	[Eini, Ronak; Stoop, Hans; Gillis, Ad J. M.; Biermann, Katharina; Dorssers, Lambert C. J.; Looijenga, Leendert H. J.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Pathol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Looijenga, LHJ (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Pathol, Rotterdam, Netherlands.	l.looijenga@erasmusmc.nl	Looijenga, Leendert/B-8145-2019	Looijenga, Leendert/0000-0002-8146-1911	Dutch Cancer Society [KWF: 2006-3607]	Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by a grant from the Dutch Cancer Society (KWF: 2006-3607). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews PW, 2005, BIOCHEM SOC T, V33, P1526, DOI 10.1042/BST0331526; ANDREWS PW, 1994, LAB INVEST, V71, P243; Andrews PW, 2002, PHILOS T R SOC B, V357, P405, DOI 10.1098/rstb.2002.1058; ANDREWS PW, 1987, INT J ANDROL, V10, P95, DOI 10.1111/j.1365-2605.1987.tb00170.x; Andrews PW, 1996, INT J CANCER, V66, P806, DOI 10.1002/(SICI)1097-0215(19960611)66:6<806::AID-IJC17>3.0.CO;2-0; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bae KM, 2010, J UROLOGY, V183, P2045, DOI 10.1016/j.juro.2009.12.092; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Bauer S, 2010, EUR UROL, V57, P679, DOI 10.1016/j.eururo.2009.06.014; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chen YP, 2008, J BIOL CHEM, V283, P17969, DOI 10.1074/jbc.M802917200; DAMJANOV I, 1983, CANCER RES, V43, P2190; DAMJANOV I, 1993, LAB INVEST, V68, P220; de Jong J, 2008, J PATHOL, V215, P21, DOI 10.1002/path.2332; de Jong J, 2005, J PATHOL, V206, P242, DOI 10.1002/path.1766; de Jong J, 2008, GENE CHROMOSOME CANC, V47, P185, DOI 10.1002/gcc.20520; Eini R, 2013, INT J DEV BIOL, V57, P319, DOI 10.1387/ijdb.130020re; Episkopou V, 2005, TRENDS NEUROSCI, V28, P219, DOI 10.1016/j.tins.2005.03.003; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Gearhart J, 1998, SCIENCE, V282, P1061, DOI 10.1126/science.282.5391.1061; Gillis AJM, 2007, J PATHOL, V213, P319, DOI 10.1002/path.2230; Gillis AJM, 2011, INT J ANDROL, V34, pE160, DOI 10.1111/j.1365-2605.2011.01148.x; Hay DC, 2004, STEM CELLS, V22, P225, DOI 10.1634/stemcells.22-2-225; Honecker F, 2006, J PATHOL, V208, P395, DOI 10.1002/path.1872; Horwich A, 2006, LANCET, V367, P754, DOI 10.1016/S0140-6736(06)68305-0; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Hussenet T, 2010, CELL CYCLE, V9, P1480, DOI 10.4161/cc.9.8.11203; Hussenet T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008960; Jain AK, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001268; Kersemaekers AMF, 2002, J CLIN ONCOL, V20, P1551, DOI 10.1200/JCO.20.6.1551; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Lengerke C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-42; Leung ELH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014062; Lim JH, 2012, AM J VET RES, V73, P1963, DOI 10.2460/ajvr.73.12.1963; Lin YJ, 2012, MOL CELL, V48, P627, DOI 10.1016/j.molcel.2012.08.030; Looijenga LHJ, 2003, CANCER RES, V63, P2244; LOOIJENGA LHJ, 1990, CYTOGENET CELL GENET, V53, P216, DOI 10.1159/000132934; Lu Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011022; Masters JR, 2003, BJU INT, V92, P661, DOI 10.1046/j.1464-410X.2003.04481.x; Nettersheim D, 2011, GENE CHROMOSOME CANC, V50, P1033, DOI 10.1002/gcc.20918; Oosterhuis JW, 2005, NAT REV CANCER, V5, P210, DOI 10.1038/nrc1568; Oren M, 2002, ANN NY ACAD SCI, V973, P374, DOI 10.1111/j.1749-6632.2002.tb04669.x; Park SW, 2012, FEBS LETT, V586, P3529, DOI 10.1016/j.febslet.2012.08.013; Preston SL, 2003, J CLIN PATHOL-MOL PA, V56, P86, DOI 10.1136/mp.56.2.86; Sharma SV, 2007, GENE DEV, V21, P3214, DOI 10.1101/gad.1609907; SHI SR, 1991, J HISTOCHEM CYTOCHEM, V39, P741, DOI 10.1177/39.6.1709656; Sinner D, 2007, MOL CELL BIOL, V27, P7802, DOI 10.1128/MCB.02179-06; SKAKKEBAEK NE, 1972, LANCET, V2, P516; Stolzenburg S, 2012, NUCLEIC ACIDS RES, V40, P6725, DOI 10.1093/nar/gks360; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TESHIMA S, 1988, LAB INVEST, V59, P328; ULBRIGHT TM, 1993, AM J SURG PATHOL, V17, P1075, DOI 10.1097/00000478-199311000-00001; Ushida H, 2012, J UROLOGY, V187, P1876, DOI 10.1016/j.juro.2011.12.058; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Walsh J, 2003, APMIS, V111, P197, DOI 10.1034/j.1600-0463.2003.1110124.x; Wang YL, 2009, J CELL PHYSIOL, V218, P251, DOI 10.1002/jcp.21607; Woodward PJ, 2004, WHO CLASSIFICATION T; Xu XL, 2010, CARCINOGENESIS, V31, P167, DOI 10.1093/carcin/bgp232; Yamada N, 2013, CANCER LETT, V335, P332, DOI 10.1016/j.canlet.2013.02.060; Yang S, 2012, CELL PROLIFERAT, V45, P299, DOI 10.1111/j.1365-2184.2012.00827.x; Yuan P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009112; Zhang Y, 2012, J BIOL CHEM; Zorn AM, 1999, MOL CELL, V4, P487, DOI 10.1016/S1097-2765(00)80200-2	65	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e83585	10.1371/journal.pone.0083585	http://dx.doi.org/10.1371/journal.pone.0083585			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404135	Green Submitted, Green Published, gold			2022-12-27	WOS:000329460800014
J	Darvekar, SR; Elvenes, J; Brenne, HB; Johansen, T; Sjottem, E				Darvekar, Sagar Ramesh; Elvenes, Julianne; Brenne, Hanne Britt; Johansen, Terje; Sjottem, Eva			SPBP Is a Sulforaphane Induced Transcriptional Coactivator of NRF2 Regulating Expression of the Autophagy Receptor p62/SQSTM1	PLOS ONE			English	Article							RNA-POLYMERASE-II; ANTIOXIDANT RESPONSE; IN-VIVO; P62; BINDING; DISEASE; DEGRADATION; NUCLEOSOME; INDUCTION; CHROMATIN	Organisms exposed to oxidative stress respond by orchestrating a stress response to prevent further damage. Intracellular levels of antioxidant agents increase, and damaged components are removed by autophagy induction. The KEAP1-NRF2 signaling pathway is the main pathway responsible for cell defense against oxidative stress and for maintaining the cellular redox balance at physiological levels. Sulforaphane, an isothiocyanate derived from cruciferous vegetables, is a potent inducer of KEAP1-NRF2 signaling and antioxidant response element driven gene expression. In this study, we show that sulforaphane enhances the expression of the transcriptional coregulator SPBP. The expression curve peaks 6-8 hours post stimulation, and parallels the sulforaphane-induced expression of NRF2 and the autophagy receptor protein p62/SQSTM1. Reporter gene assays show that SPBP stimulates the expression of p62/SQSTM1 via ARE elements in the promoter region, and siRNA mediated knock down of SPBP significantly decreases the expression of p62/SQSTM1 and the formation of p62/SQSTM1 bodies in HeLa cells. Furthermore, SPBP siRNA reduces the sulforaphane induced expression of NRF2, and the expression of the autophagy marker protein LC3B. Both these proteins contain ARE-like elements in their promoter regions. Over-expressed SPBP and NRF2 acts synergistically on the p62/SQSTM1 promoter and colocalize in nuclear speckles in HeLa cells. Collectively, these results suggest that SPBP is a coactivator of NRF2, and hence may be important for securing enhanced and sustained expression of NRF2 induced genes such as proteins involved in selective autophagy.	[Darvekar, Sagar Ramesh; Elvenes, Julianne; Brenne, Hanne Britt; Johansen, Terje; Sjottem, Eva] Univ Tromso, Dept Med Biol, Mol Canc Res Grp, Tromso, Norway	UiT The Arctic University of Tromso	Sjottem, E (corresponding author), Univ Tromso, Dept Med Biol, Mol Canc Res Grp, Tromso, Norway.	eva.sjottem@uit.no	Johansen, Terje/N-2971-2015; Johansen, Terje/AAY-1753-2021	Johansen, Terje/0000-0003-1451-9578; Johansen, Terje/0000-0003-1451-9578; Sjottem, Eva/0000-0003-2668-1708	Norwegian Research Council; Familien Blix Fond; Norwegian Cancer Society	Norwegian Research Council(Research Council of NorwayEuropean Commission); Familien Blix Fond; Norwegian Cancer Society(Norwegian Cancer Society)	This work was supported by the Norwegian Research Council, Familien Blix Fond and the Norwegian Cancer Society to Prof. Terje Johansen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae SH, 2013, CELL METAB, V17, P73, DOI 10.1016/j.cmet.2012.12.002; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boddupalli Sekhar, 2012, Frontiers in Genetics, V3, P7, DOI 10.3389/fgene.2012.00007; Chaturvedi RK, 2010, HUM MOL GENET, V19, P3190, DOI 10.1093/hmg/ddq229; Darvekar S, 2012, BIOCHEM J, V442, P65, DOI 10.1042/BJ20111230; Duran A, 2008, CANCER CELL, V13, P343, DOI 10.1016/j.ccr.2008.02.001; Elvenes J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024659; Fujita KI, 2011, P NATL ACAD SCI USA, V108, P1427, DOI 10.1073/pnas.1014156108; Gburcik V, 2005, MOL CELL BIOL, V25, P3421, DOI 10.1128/MCB.25.9.3421-3430.2005; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kitamura H, 2006, HISTOPATHOLOGY, V48, P157, DOI 10.1111/j.1365-2559.2005.02313.x; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Komatsu M, 2011, AUTOPHAGY, V7, P1088, DOI 10.4161/auto.7.9.16474; Kwak MK, 2010, TOXICOL APPL PHARM, V244, P66, DOI 10.1016/j.taap.2009.08.028; Kwak MK, 2003, MOL CELL BIOL, V23, P8786, DOI 10.1128/MCB.23.23.8786-8794.2003; Kwak MK, 2002, MOL CELL BIOL, V22, P2883, DOI 10.1128/MCB.22.9.2883-2892.2002; Kwak MK, 2001, MUTAT RES-FUND MOL M, V480, P305, DOI 10.1016/S0027-5107(01)00190-7; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Lee JS, 2011, P NATL ACAD SCI USA, V108, P13510, DOI 10.1073/pnas.1106106108; Lee JS, 2010, MOL CELL, V39, P71, DOI 10.1016/j.molcel.2010.06.008; Lee SH, 2012, J MOL CELL CARDIOL, V52, P718, DOI 10.1016/j.yjmcc.2011.12.002; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Lyngso C, 2000, J BIOL CHEM, V275, P26144, DOI 10.1074/jbc.M003405200; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Mauvezin C, 2010, EMBO REP, V11, P37, DOI 10.1038/embor.2009.242; Melvin A, 2012, CELL SIGNAL, V24, P35, DOI 10.1016/j.cellsig.2011.08.019; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Nowak J, 2009, MOL BIOL CELL, V20, P870, DOI 10.1091/mbc.E08-07-0671; Ohta K, 2007, BIOCHEM J, V402, P559, DOI 10.1042/BJ20061194; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Partensky PD, 2009, J MOL BIOL, V391, P12, DOI 10.1016/j.jmb.2009.04.085; Rajendran R, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/368276; Rao VA, 2010, J BIOL CHEM, V285, P34447, DOI 10.1074/jbc.M110.133579; Rekdal C, 2000, J BIOL CHEM, V275, P40288, DOI 10.1074/jbc.M006978200; Rolland P, 2007, ENDOCR-RELAT CANCER, V14, P73, DOI 10.1677/erc.1.01312; SANZ L, 1995, MOL CELL BIOL, V15, P3164; Schnitzler G, 1998, CELL, V94, P17, DOI 10.1016/S0092-8674(00)81217-9; Schwabish MA, 2007, MOL CELL BIOL, V27, P6987, DOI 10.1128/MCB.00717-07; Seillier M, 2012, CELL DEATH DIFFER; Sjottem E, 2007, NUCLEIC ACIDS RES, V35, P6648, DOI 10.1093/nar/gkm739; Solaimani P, 2013, TOXICOL SCI; Subtil-Rodriguez A, 2010, EMBO REP, V11, P751, DOI 10.1038/embor.2010.131; Sun Z, 2009, MOL CELL BIOL, V29, P2658, DOI 10.1128/MCB.01639-08; Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002; Tang DL, 2010, J CELL BIOL, V190, P881, DOI 10.1083/jcb.200911078; Tkachev VO, 2011, BIOCHEMISTRY-MOSCOW+, V76, P407, DOI 10.1134/S0006297911040031; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Uruno A, 2011, NITRIC OXIDE-BIOL CH, V25, P153, DOI 10.1016/j.niox.2011.02.007; Yun JH, 2010, BIOL PHARM BULL, V33, P1650, DOI 10.1248/bpb.33.1650; Zhu LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055695	63	29	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85262	10.1371/journal.pone.0085262	http://dx.doi.org/10.1371/journal.pone.0085262			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416372	Green Published, Green Submitted, gold			2022-12-27	WOS:000329866300060
J	Campbell, C; Grapov, D; Fiehn, O; Chandler, CJ; Burnett, DJ; Souza, EC; Casazza, GA; Gustafson, MB; Keim, NL; Newman, JW; Hunter, GR; Fernandez, JR; Garvey, WT; Harper, ME; Hoppel, CL; Meissen, JK; Take, K; Adams, SH				Campbell, Caitlin; Grapov, Dmitry; Fiehn, Oliver; Chandler, Carol J.; Burnett, Dustin J.; Souza, Elaine C.; Casazza, Gretchen A.; Gustafson, Mary B.; Keim, Nancy L.; Newman, John W.; Hunter, Gary R.; Fernandez, Jose R.; Garvey, W. Timothy; Harper, Mary-Ellen; Hoppel, Charles L.; Meissen, John K.; Take, Kohei; Adams, Sean H.			Improved Metabolic Health Alters Host Metabolism in Parallel with Changes in Systemic Xeno-Metabolites of Gut Origin	PLOS ONE			English	Article							GLUCOSE-TOLERANCE TEST; INSULIN-RESISTANCE; MENSTRUAL-CYCLE; ACID CYCLE; PLASMA; PROFILES; MOUSE; SENSITIVITY; MICROBIOME; OBESITY	Novel plasma metabolite patterns reflective of improved metabolic health (insulin sensitivity, fitness, reduced body weight) were identified before and after a 14-17 wk weight loss and exercise intervention in sedentary, obese insulin-resistant women. To control for potential confounding effects of diet- or microbiome-derived molecules on the systemic metabolome, sampling was during a tightly-controlled feeding test week paradigm. Pairwise and multivariate analysis revealed intervention-and insulin-sensitivity associated: (1) Changes in plasma xeno-metabolites ("non-self'' metabolites of dietary or gut microbial origin) following an oral glucose tolerance test (e.g. higher post-OGTT propane-1,2,3-tricarboxylate [tricarballylic acid]) or in the overnight-fasted state (e.g., lower gamma-tocopherol); (2) Increased indices of saturated very long chain fatty acid elongation capacity; (3) Increased post-OGTT alpha-ketoglutaric acid (alpha-KG), fasting alpha-KG inversely correlated with Matsuda index, and altered patterns of malate, pyruvate and glutamine hypothesized to stem from improved mitochondrial efficiency and more robust oxidation of glucose. The results support a working model in which improved metabolic health modifies host metabolism in parallel with altering systemic exposure to xeno-metabolites. This highlights that interpretations regarding the origins of peripheral blood or urinary "signatures'' of insulin resistance and metabolic health must consider the potentially important contribution of gut-derived metabolites toward the host's metabolome.	[Campbell, Caitlin; Chandler, Carol J.; Burnett, Dustin J.; Souza, Elaine C.; Gustafson, Mary B.; Keim, Nancy L.; Newman, John W.; Adams, Sean H.] ARS, USDA, Western Human Nutr Res Ctr, Davis, CA USA; [Grapov, Dmitry; Fiehn, Oliver] Univ Calif Davis, West Coast Metabol Ctr, Davis, CA USA; [Fiehn, Oliver; Meissen, John K.; Take, Kohei] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Casazza, Gretchen A.] Univ Calif Davis, Sch Med, Sports Med Program, Sacramento, CA 95817 USA; [Keim, Nancy L.; Newman, John W.; Adams, Sean H.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Hunter, Gary R.; Fernandez, Jose R.; Garvey, W. Timothy] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA; [Hunter, Gary R.] Univ Alabama Birmingham, Human Studies Dept, Birmingham, AL USA; [Harper, Mary-Ellen] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Hoppel, Charles L.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA	United States Department of Agriculture (USDA); University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Ottawa; Case Western Reserve University	Fiehn, O (corresponding author), Univ Calif Davis, West Coast Metabol Ctr, Davis, CA USA.	ofiehn@ucdavis.edu; sean.h.adams@ars.usda.gov	Casazza, Gretchen Ann/GPC-8610-2022; ADAMS, SEAN/N-9262-2018	ADAMS, SEAN/0000-0002-9515-2319; Newman, John/0000-0001-9632-6571; Harper, Mary-Ellen/0000-0003-3864-5886; Grapov, Dmitry/0000-0002-7204-3128	USDA-ARS intramural [5306-51530-016-00D, 5306-51530-019-00]; NIH-NIDDK [R01DK078328]; NIH [1 U24 DK097154, P20 HL113452]; West Coast Metabolomics Center; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024146] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P20HL113452] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079626, R01DK078328, U24DK097154] Funding Source: NIH RePORTER	USDA-ARS intramural; NIH-NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); West Coast Metabolomics Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by USDA-ARS intramural Projects 5306-51530-016-00D and 5306-51530-019-00 (JWN, NLK, SHA), NIH-NIDDK R01DK078328 (OF, NLK, JWN, GH, JF, WTG, CLH, MEH, SHA), NIH 1 U24 DK097154 for the West Coast Metabolomics Center (OF, JWN), and NIH P20 HL113452 (OF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SH, 2011, ADV NUTR, V2, P445, DOI 10.3945/an.111.000737; Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; Aguer C, FASEB J IN PRESS; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bingley CA, 2008, HORM METAB RES, V40, P901, DOI 10.1055/s-0028-1082081; Bjom-Helge Mevik R.W., 2011, PLS PARTIAL LEAST SQ; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Bowtell JL, 2002, NUTRITION, V18, P222, DOI 10.1016/S0899-9007(01)00795-X; Brunengraber H, 2006, J INHERIT METAB DIS, V29, P327, DOI 10.1007/s10545-006-0320-1; Buse John B, 2003, Diabetes Technol Ther, V5, P355, DOI 10.1089/152091503765691839; Cao Y, 2008, BIOINFORMATICS, V24, P1733, DOI 10.1093/bioinformatics/btn307; Cheng SS, 2012, CIRCULATION, V125, P2222, DOI 10.1161/CIRCULATIONAHA.111.067827; Claus SP, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.56; Deo RC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000692; Devaraj S, 2013, CLIN CHEM, V59, P617, DOI 10.1373/clinchem.2012.187617; Fiehn Oliver, 2007, V358, P3, DOI 10.1007/978-1-59745-244-1_1; Fiehn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015234; Floegel A, 2013, DIABETES, V62, P639, DOI 10.2337/db12-0495; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; GOODWIN BL, 1994, BIOCHEM PHARMACOL, V47, P2294, DOI 10.1016/0006-2952(94)90268-2; Grapov D, 2012, BIOINFORMATICS; Grapov D, 2012, APPL TARGETED METABO, P236; Hardt-Stremayr M, 2013, J SEP SCI, V36, P670, DOI 10.1002/jssc.201200768; Hardt-Stremayr M, 2012, J SEP SCI, V35, P2567, DOI 10.1002/jssc.201200251; Huffman KM, 2009, DIABETES CARE, V32, P1678, DOI 10.2337/dc08-2075; Hyotylainen T, 2012, MOL BIOSYST, V8, P2559, DOI 10.1039/c2mb25115a; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; Kernan WN, 2003, STROKE, V34, P1431, DOI 10.1161/01.STR.0000071108.00234.0E; Krug S, 2012, FASEB J, V26, P2607, DOI 10.1096/fj.11-198093; Laferrere B, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002043; LANOUE KF, 1971, METABOLISM, V20, P119, DOI 10.1016/0026-0495(71)90087-4; Marcobal A, 2013, ISME J; Martin FPJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100190; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MCDEVITT J, 1991, FOOD CHEM TOXICOL, V29, P107, DOI 10.1016/0278-6915(91)90164-3; Messier V, 2010, OBESITY, V18, P911, DOI 10.1038/oby.2009.364; Messier V, 2010, METABOLISM, V59, P20, DOI 10.1016/j.metabol.2009.06.020; Mihalik SJ, 2010, OBESITY, V18, P1695, DOI 10.1038/oby.2009.510; NOBLE BJ, 1983, MED SCI SPORT EXER, V15, P523; Palermo Giuseppe, 2009, Adv Appl Bioinform Chem, V2, P57; Patel CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010746; PETTERSEN JE, 1972, CLIN CHIM ACTA, V41, P199, DOI 10.1016/0009-8981(72)90512-8; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramos-Roman MA, 2012, METABOLISM, V61, P202, DOI 10.1016/j.metabol.2011.06.008; Romick-Rosendale LE, 2009, MAGN RESON CHEM, V47, pS36, DOI 10.1002/mrc.2511; RUSSELL JB, 1985, APPL ENVIRON MICROB, V49, P120, DOI 10.1128/AEM.49.1.120-126.1985; RUSSELL JB, 1986, BRIT J NUTR, V56, P153, DOI 10.1079/BJN19860095; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Salek RM, 2007, PHYSIOL GENOMICS, V29, P99, DOI 10.1152/physiolgenomics.00194.2006; Seifert EL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009834; Shah SH, 2012, DIABETOLOGIA, V55, P321, DOI 10.1007/s00125-011-2356-5; Shaham O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.50; Suhre K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013953; Swann JR, 2011, J PROTEOME RES, V10, P3590, DOI 10.1021/pr200243t; Tai ES, 2010, DIABETOLOGIA, V53, P757, DOI 10.1007/s00125-009-1637-8; Toledo FG, 2013, MOL CELL ENDOCRINOL; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wang-Sattler R, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.43; Wierckx N, 2011, APPL MICROBIOL BIOT, V92, P1095, DOI 10.1007/s00253-011-3632-5; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; WOLFFRAM S, 1993, EXP PHYSIOL, V78, P473, DOI 10.1113/expphysiol.1993.sp003699; Wopereis S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004525; Wurtz P, 2012, DIABETES CARE, V35, P1749, DOI 10.2337/dc11-1838; Wurtz P, 2012, DIABETES, V61, P1372, DOI 10.2337/db11-1355; Yap IKS, 2008, J PROTEOME RES, V7, P3718, DOI 10.1021/pr700864x; Yeung EH, 2010, J CLIN ENDOCR METAB, V95, P5435, DOI 10.1210/jc.2010-0702; Zhao XJ, 2010, METABOLOMICS, V6, P362, DOI 10.1007/s11306-010-0203-1; Zhao XJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE384, DOI 10.1152/ajpendo.90748.2008	71	36	36	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84260	10.1371/journal.pone.0084260	http://dx.doi.org/10.1371/journal.pone.0084260			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416208	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500106
J	Guil-Guerrero, JL; Tikhonov, A; Rodriguez-Garcia, I; Protopopov, A; Grigoriev, S; Ramos-Bueno, RP				Guil-Guerrero, Jose L.; Tikhonov, Alexei; Rodriguez-Garcia, Ignacio; Protopopov, Albert; Grigoriev, Semyon; Ramos-Bueno, Rebeca P.			The Fat from Frozen Mammals Reveals Sources of Essential Fatty Acids Suitable for Palaeolithic and Neolithic Humans	PLOS ONE			English	Article							SITE; ACCUMULATION	The elucidation of the sources of n-3 fatty acids available for the humans in the Upper Palaeolithic and Neolithic is highly relevant in order to ascertain the availability of such nutrients in that time frame as well as to draw useful conclusions about healthy dietary habits for present-day humans. To this end, we have analysed fat from several frozen mammals found in the permafrost of Siberia (Russia). A total of 6 specimens were included in this study: 2 mammoths, i.e. baby female calf called "Lyuba'' and a juvenile female called "Yuka'', both specimens approximately from the same time, i.e. Karginian Interstadial (41,000 and 34,000 years BP); two adult horses from the middle Holocene (4,600 and 4,400 years BP); and two bison very close to the Early Holocene (8,200 and 9,300 years BP). All samples were analysed by gas-liquid chromatography-mass spectrometry (GLC-MS) and GLC-flame ionization detector (GLC-FID). As demonstrated in this work, the fat of single-stomached mammals often consumed by Palaeolithic/Neolithic hunters contained suitable amounts of n-3 and n-6 fatty acids, possibly in quantities sufficient to meet the today's recommended daily intake for good health. Moreover, the results also suggest that mammoths and horses at that time were hibernators.	[Guil-Guerrero, Jose L.; Ramos-Bueno, Rebeca P.] Univ Almeria, CeiA3, Food Technol Div, Almeria, Spain; [Tikhonov, Alexei] Russian Acad Sci, Inst Zool, St Petersburg 199034, Russia; [Rodriguez-Garcia, Ignacio] Univ Almeria, CeiA3, Div Organ Chem, Almeria, Spain; [Protopopov, Albert] Sakha Yakutia Republ Acad Sci, Dept Mammoth Faunal Studies, Yakutsk, Russia; [Grigoriev, Semyon] North Eastern Fed Univ, Yakutsk Sci Res Inst Appl Ecol North, Yakutsk, Russia	Universidad de Almeria; Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences; Universidad de Almeria; North-Eastern Federal University in Yakutsk	Guil-Guerrero, JL (corresponding author), Univ Almeria, CeiA3, Food Technol Div, Almeria, Spain.	jlguil@ual.es	Tikhonov, Alexei/G-7478-2016; Rodriguez-Garcia, Ignacio/L-8924-2014; Протопопов, Альберт/AAV-1909-2021; Grigoriev, Semyon/F-8848-2014; Ramos, Rebeca/P-9190-2016	Rodriguez-Garcia, Ignacio/0000-0002-2985-8567; Grigoriev, Semyon/0000-0001-9932-6008; Ramos, Rebeca/0000-0002-5208-3843; Tikhonov, Alexei/0000-0002-7227-5797; Guil Guerrero, Jose Luis/0000-0003-2666-1774	"Plan Propio de Investigacion'' of the University of Almeria [FQM-010]	"Plan Propio de Investigacion'' of the University of Almeria	The authors acknowledge the funding received to perform this work by the "Plan Propio de Investigacion'' of the University of Almeria, made to the Research Group "Chemistry of Biomolecules and Food Processing (FQM-010)''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basilyan AE, 2011, J ARCHAEOL SCI, V38, P2461, DOI 10.1016/j.jas.2011.05.017; Bocherens Herve, 2003, Deinsea, V9, P57; Boeskorov G G, 2007, Dokl Biol Sci, V417, P480, DOI 10.1134/S0012496607060208; Brand-Miller J, 2009, ISS 2009 GENES GALAX, P28; Cordain L, 2001, WORLD REV NUTR DIET, V90, P44; Crawford MA, 1999, LIPIDS, V34, pS39, DOI 10.1007/BF02562227; DOREAU M, 1994, ANIM FEED SCI TECH, V45, P379, DOI 10.1016/0377-8401(94)90039-6; EATON SB, 1985, NEW ENGL J MED, V312, P283, DOI 10.1056/NEJM198501313120505; Fisher DC, 2011, QUARTER INT, V255, P94; Florant GL, 1998, AM ZOOL, V38, P331; Germonpre M, 2014, QUATERN INT, V337, P28, DOI 10.1016/j.quaint.2012.10.035; GLASS RL, 1971, COMP BIOCHEM PHYSIOL, V38, P353, DOI 10.1016/0305-0491(71)90014-9; Guil JL, 1996, J CHROMATOGR A, V719, P229, DOI 10.1016/0021-9673(95)00414-9; Guil-Guerrero J. L., 2013, International Food Research Journal, V20, P3249; Kakela R, 1996, COMP BIOCHEM PHYS B, V113, P113, DOI 10.1016/0305-0491(96)02007-X; Kosintsev PA, 2012, QUATERN INT, V255, P231, DOI 10.1016/j.quaint.2011.03.027; Makristathis A, 2002, J LIPID RES, V43, P2056, DOI 10.1194/jlr.M100424-JLR200; Meyer HHD, 1998, COMP BIOCHEM PHYS A, V120, P263, DOI 10.1016/S1095-6433(98)00028-2; Mordovskaya VI, 2006, ICCH13 P, P12; MORGAN ED, 1983, ARCTIC, V36, P356; Mussi M, 2008, J ARCHAEOL SCI, V35, P2606, DOI 10.1016/j.jas.2008.04.014; Nogues-Bravo D, 2008, PLOS BIOL, V6, P685, DOI 10.1371/journal.pbio.0060079; Obada T, 2012, QUATERN INT, V276, P227, DOI 10.1016/j.quaint.2012.04.015; Rezanka T, 1999, FOLIA MICROBIOL, V44, P643, DOI 10.1007/BF02825654; Cervera MAR, 2012, FOOD RES INT, V48, P769, DOI 10.1016/j.foodres.2012.06.029; Sampels S, 2005, THESIS SWEDISH U AGR; Svoboda J, 2005, QUATERN INT, V126, P209, DOI 10.1016/j.quaint.2004.04.024; Turner TD, 2005, THESIS U SASKATCHEWA; Wood JD, 2008, MEAT SCI, V78, P343, DOI 10.1016/j.meatsci.2007.07.019; Zalewski K, 2007, POL J ENVIRON STUD, V16, P645; Zenin V.N., 2006, ARCHAEOLOGY ETHNOLOG, V25, P41, DOI DOI 10.1134/S1563011006010038	31	24	25	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84480	10.1371/journal.pone.0084480	http://dx.doi.org/10.1371/journal.pone.0084480			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416235	gold, Green Published, Green Submitted			2022-12-27	WOS:000329862500130
J	Gundemir, S; Homan, AC; de Dreu, CKW; van Vugt, M				Gundemir, Seval; Homan, Astrid C.; de Dreu, Carsten K. W.; van Vugt, Mark			Think Leader, Think White? Capturing and Weakening an Implicit Pro-White Leadership Bias	PLOS ONE			English	Article							ASSOCIATION TEST; SOCIAL IDENTITY; GROUP PROTOTYPICALITY; POSITIVE ATTITUDE; SEX-DIFFERENCES; DIVERSITY; SELF; GENDER; MODEL; RACE	Across four studies, we found evidence for an implicit pro-White leadership bias that helps explain the underrepresentation of ethnic minorities in leadership positions. Both White-majority and ethnic minority participants reacted significantly faster when ethnically White names and leadership roles (e. g., manager; Study 1) or leadership traits (e. g., decisiveness; Study 2 & 3) were paired in an Implicit Association Test (IAT) rather than when ethnic minority names and leadership traits were paired. Moreover, the implicit pro-White leadership bias showed discriminant validity with the conventional implicit bias measures (Study 3). Importantly, results showed that the pro-White leadership bias can be weakened when situational cues increase the salience of a dual identity (Study 4). This, in turn, can diminish the explicit pro-White bias in promotion related decision making processes (Study 4). This research offers a new tool to measure the implicit psychological processes underlying the underrepresentation of ethnic minorities in leadership positions and proposes interventions to weaken such biases.	[Gundemir, Seval; Homan, Astrid C.] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Gundemir, Seval; de Dreu, Carsten K. W.; van Vugt, Mark] Vrije Univ Amsterdam, Dept Social & Org Psychol, Amsterdam, Netherlands	University of Amsterdam; Vrije Universiteit Amsterdam	Gundemir, S (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.	s.gundemir@uva.nl	Homan, Astrid C./L-5508-2013; De Dreu, Carsten K.W./X-7762-2019	Homan, Astrid C./0000-0002-6795-7494; De Dreu, Carsten K.W./0000-0003-3692-4611	Mosaic Grant (NWO from the Dutch Organization for Scientific Research) [017.007.012]	Mosaic Grant (NWO from the Dutch Organization for Scientific Research)	This work was financed by a Mosaic Grant (NWO grant no. 017.007.012) from the Dutch Organization for Scientific Research awarded to the first author. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams D, 2008, J PERS SOC PSYCHOL, V95, P662, DOI 10.1037/0022-3514.95.3.662; Agerstrom J, 2011, J APPL PSYCHOL, V96, P790, DOI 10.1037/a0021594; AIGNER DJ, 1977, IND LABOR RELAT REV, V30, P175, DOI 10.2307/2522871; Aiken L. S., 1991, MULTIPLE REGRESSION; Alliance for Board Diversity Census, 2010, MISS PIEC WOM MIN FO; Beaton AM, 2008, J EXP SOC PSYCHOL, V44, P808, DOI 10.1016/j.jesp.2007.07.002; Bechtel W., 2002, CONNECTIONISM MIND; Berdahl JL, 2006, J APPL PSYCHOL, V91, P426, DOI 10.1037/0021-9010.91.2.426; Berger Joseph, 1977, STATUS CHARACTERISTI; Blanton H, 2009, J APPL PSYCHOL, V94, P567, DOI 10.1037/a0014665; Bluemke M, 2008, EUR J SOC PSYCHOL, V38, P977, DOI 10.1002/ejsp.487; BREWER MB, 1991, PERS SOC PSYCHOL B, V17, P475, DOI 10.1177/0146167291175001; Carton AM, 2011, ACAD MANAGE J, V54, P1141, DOI 10.5465/amj.2009.0745; CBS, 2007, BER NIET WEST ALL LA; Dach-Gruschow K., 2006, ANAL SOC ISS PUB POL, V6, P125, DOI [10.1111/j.1530-2415.2006.00110.x, DOI 10.1111/J.1530-2415.2006.00110.X]; Dasgupta N, 2004, J EXP SOC PSYCHOL, V40, P642, DOI 10.1016/j.jesp.2004.02.003; De Dreu CKW, 2011, P NATL ACAD SCI USA, V108, P1262, DOI 10.1073/pnas.1015316108; Den Hartog D. N., 2001, HDB IND WORK ORG PSY, P166, DOI DOI 10.4135/9781848608320; Den Hartog DN, 1999, LEADERSHIP QUART, V10, P219, DOI 10.1016/S1048-9843(99)00018-1; Devos T, 2005, J PERS SOC PSYCHOL, V88, P447, DOI 10.1037/0022-3514.88.3.447; Dovidio JF, 2009, PERS SOC PSYCHOL REV, V13, P3, DOI 10.1177/1088868308326751; Eagly AH, 2002, PSYCHOL REV, V109, P573, DOI 10.1037//0033-295X.109.3.573; Eagly AH, 2010, AM PSYCHOL, V65, P216, DOI 10.1037/a0018957; Fiske ST, 2002, J PERS SOC PSYCHOL, V82, P878, DOI 10.1037//0022-3514.82.6.878; Gaertner S.L., 1993, EUROPEAN REV SOCIAL, V4, P1, DOI [https://doi.org/10.1080/14792779343000004, DOI 10.1080/14792779343000004, 10.1080/14792779343000004, 10.4135/9781446249222.n48, DOI 10.4135/9781446249222.N48]; Gaertner S. L., 2000, REDUCING INTERGROUP; Gonzalez R, 2003, EUR J SOC PSYCHOL, V33, P195, DOI 10.1002/ejsp.140; Gonzalez R, 2006, J EXP SOC PSYCHOL, V42, P753, DOI 10.1016/j.jesp.2005.11.008; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Hains SC, 1997, PERS SOC PSYCHOL B, V23, P1087, DOI 10.1177/01461672972310009; Ho GC, 2012, LEADERSHIP QUART, V23, P943, DOI 10.1016/j.leaqua.2012.06.003; Hofmann W, 2005, PERS SOC PSYCHOL B, V31, P1369, DOI 10.1177/0146167205275613; Hogg MA, 2003, ADV EXP SOC PSYCHOL, V35, P1, DOI 10.1016/S0065-2601(03)01001-3; Hogg MA, 2001, PERS SOC PSYCHOL REV, V5, P184, DOI 10.1207/S15327957PSPR0503_1; House Robert., 2004, CULTURE LEADERSHIP; Jost J., 2003, EUROPEAN REV SOCIAL, V13, P111, DOI [DOI 10.1080/10463280240000046, 10.1080/10463280240000046]; Karpinski A, 2006, J PERS SOC PSYCHOL, V91, P16, DOI 10.1037/0022-3514.91.1.16; Kirkpatrick S.A., 1991, ACAD MANAGE PERSPECT, V5, P48, DOI DOI 10.5465/AME.1991.4274679; Knight J. L., 2003, J LEADERSH ORG STUD, V9, P85, DOI [10.1177/107179190300900308, DOI 10.1177/107179190300900308]; Kurzban R, 2001, P NATL ACAD SCI USA, V98, P15387, DOI 10.1073/pnas.251541498; Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076; Livingston RW, 2012, PSYCHOL SCI, V23, P354, DOI 10.1177/0956797611428079; Lord R.G., 1993, LEADERSHIP INFORM PR; LORD RG, 1984, ORGAN BEHAV HUM PERF, V34, P343, DOI 10.1016/0030-5073(84)90043-6; Lord RG, 2001, LEADERSHIP QUART, V12, P311, DOI 10.1016/S1048-9843(01)00081-9; Lord RG, 2000, LEADERSHIP QUART, V11, P551, DOI 10.1016/S1048-9843(00)00060-6; Marx DM, 2009, J EXP SOC PSYCHOL, V45, P953, DOI 10.1016/j.jesp.2009.03.012; Marx DM, 2002, PERS SOC PSYCHOL B, V28, P1183, DOI 10.1177/01461672022812004; Maume DJ, 1999, WORK OCCUPATION, V26, P483, DOI 10.1177/0730888499026004005; McDonald MM, 2012, PHILOS T R SOC B, V367, P670, DOI 10.1098/rstb.2011.0301; Medvedeff M. E., 2007, FOLLOWER CENTERED PE, P19; MORRISON AM, 1990, AM PSYCHOL, V45, P200, DOI 10.1037/0003-066X.45.2.200; Moss-Racusin CA, 2012, P NATL ACAD SCI USA, V109, P16474, DOI 10.1073/pnas.1211286109; Newheiser AK, 2012, J EXP SOC PSYCHOL, V48, P264, DOI 10.1016/j.jesp.2011.08.011; Nier J.A., 2001, GROUP PROCESS INTERG, V4, P299, DOI DOI 10.1177/1368430201004004001; Nosek BA, 2002, GROUP DYN-THEOR RES, V6, P101, DOI 10.1037//1089-2699.6.1.101; Nosek BA, 2007, EUR REV SOC PSYCHOL, V18, P36, DOI 10.1080/10463280701489053; Pendry LF, 2007, J OCCUP ORGAN PSYCH, V80, P27, DOI 10.1348/096317906X118397; Penke L, 2006, EXP PSYCHOL, V53, P283, DOI 10.1027/1618-3169.53.4.283; PHELPS ES, 1972, AM ECON REV, V62, P659; Plant EA, 2009, J EXP SOC PSYCHOL, V45, P961, DOI 10.1016/j.jesp.2009.04.018; Purdie-Vaughns V, 2008, J PERS SOC PSYCHOL, V94, P615, DOI 10.1037/0022-3514.94.4.615; Rast DE, 2012, J EXP SOC PSYCHOL, V48, P646, DOI 10.1016/j.jesp.2011.12.013; RIDGEWAY C, 1991, SOC FORCES, V70, P367, DOI 10.2307/2580244; Rosch E., 1978, COGNITION CATEGORIZA, P27, DOI DOI 10.1037/0012-1649.16.5.391; Rosette AS, 2008, J APPL PSYCHOL, V93, P758, DOI 10.1037/0021-9010.93.4.758; Rudman LA, 2000, PERS SOC PSYCHOL B, V26, P1315, DOI 10.1177/0146167200263001; Rudman LaurieA., 2011, IMPLICIT MEASURES SO; Ryan MK, 2011, J APPL PSYCHOL, V96, P470, DOI 10.1037/a0022133; Schmader T, 2004, SEX ROLES, V50, P835, DOI 10.1023/B:SERS.0000029101.74557.a0; Schmader T, 2001, J SOC ISSUES, V57, P93, DOI 10.1111/0022-4537.00203; Shelton JN, 2010, J SOC ISSUES, V66, P618, DOI 10.1111/j.1540-4560.2010.01666.x; Shondrick SJ, 2010, LEADERSHIP QUART, V21, P959, DOI 10.1016/j.leaqua.2010.10.004; SMITH ER, 1992, PSYCHOL REV, V99, P3, DOI 10.1037/0033-295X.99.1.3; U.S. Bureau of Labor Statistics, 2011, LAB FORC CHAR RAC ET; van Knippenberg B, 2005, J APPL PSYCHOL, V90, P25, DOI 10.1037/0021-9010.90.1.25; van Knippenberg D, 2004, J APPL PSYCHOL, V89, P1008, DOI 10.1037/0021-9010.89.6.1008; van Knippenberg D, 2011, LEADERSHIP QUART, V22, P1078, DOI 10.1016/j.leaqua.2011.09.004; Van Vugt M, 2008, PSYCHOL SCI, V19, P854, DOI 10.1111/j.1467-9280.2008.02168.x; Van Vugt M, 2008, AM PSYCHOL, V63, P182, DOI 10.1037/0003-066X.63.3.182; Van Vugt M, 2006, PERS SOC PSYCHOL REV, V10, P354, DOI 10.1207/s15327957pspr1004_5; Walker LS, 2011, SOC SCI RES, V40, P1652, DOI 10.1016/j.ssresearch.2011.04.005; West TV, 2009, J EXP SOC PSYCHOL, V45, P1266, DOI 10.1016/j.jesp.2009.08.002; Wigboldus DHJ, 2003, SINGLE TARGET UNPUB; Wolsko C, 2000, J PERS SOC PSYCHOL, V78, P635, DOI 10.1037//0022-3514.78.4.635; Zebrowitz LA, 2005, SCIENCE, V308, P1565, DOI 10.1126/science.1114170	87	46	46	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83915	10.1371/journal.pone.0083915	http://dx.doi.org/10.1371/journal.pone.0083915			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291WL	24416181	gold, Green Submitted, Green Published			2022-12-27	WOS:000329862500084
J	Li, Y; Wang, SM; Zhen, SS; Chen, Y; Deng, W; Kilgore, PE; Wang, XY				Li, Yue; Wang, Song-Mei; Zhen, Shan-Shan; Chen, Ying; Deng, Wei; Kilgore, Paul E.; Wang, Xuan-Yi			Diversity of Rotavirus Strains Causing Diarrhea in < 5 Years Old Chinese Children: A Systematic Review	PLOS ONE			English	Review							REASSORTANT VACCINE; EPIDEMIOLOGY; SURVEILLANCE; INFANTS; METAANALYSIS; GENOTYPES; WC3	Background: We conducted a systematic review of the diversity and fluctuation of group A rotavirus strains circulating in China. Methods and Findings: Studies of rotavirus-based diarrhea among children less than 5 years, published in English or Chinese between 1994 and 2012, were searched in PubMed, SinoMed, and CNKI and reviewed by applying standardized algorithms. The temporal and spatial trends of genotyping and serotyping were analyzed using a random-effects model. Ninety-three studies met the inclusion/exclusion criteria and were included in the meta-analysis. Overall, 22,112 and 10,660 rotavirus samples had been examined for G and P types, respectively. The most common G types were G1 (39.5%), G3 (35.6%), G2 (1.3%), and G9 (0.1%). Among P types, P[8] (54.6%) was the predominant type, followed by P[4] (11.1%) and P6 (0.1%). The most common G-P combinations were G3P[8] (32.1%) and G1P[8] (24.5%), followed by G2P[6] (13.2%) and G2P[4] (10.1%). Before 2000, serotype G1 was the predominant strain and accounted for 74.3% of all rotavirus infections; however, since 2000, G3 (45.2%) has been the predominant strain. Rotavirus P types showed little variation over the study period. Conclusion: Despite the variation of serotypes observed in China, the G1, G2, G3, and G4 serotypes accounted for most rotavirus strains in recent decades. These results suggest that Chinese children will be adequately protected with currently available or forthcoming rotavirus vaccines.	[Li, Yue; Zhen, Shan-Shan; Chen, Ying; Wang, Xuan-Yi] Fudan Univ, Shanghai Med Coll, MoE MoH, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; [Li, Yue; Zhen, Shan-Shan; Chen, Ying; Wang, Xuan-Yi] Fudan Univ, Inst Biomed Sci, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Wang, Song-Mei] Fudan Univ, Shanghai Med Coll, Training Ctr Med Experiments, Shanghai 200433, Peoples R China; [Deng, Wei] Fudan Univ, Shanghai Med Coll, Sch Publ Hlth, Dept Hlth Stat & Social Med, Shanghai 200433, Peoples R China; [Kilgore, Paul E.] Wayne State Univ, Eugene Applebaum Coll Pharm & Hlth Sci, Detroit, MI USA	Fudan University; Fudan University; Fudan University; Fudan University; Wayne State University	Wang, XY (corresponding author), Fudan Univ, Shanghai Med Coll, MoE MoH, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China.	xywang@shmu.edu.cn	Kilgore, Paul E/L-1462-2013; Wang, Songmei/P-6499-2019; Deng, Wei/GWC-9207-2022; Kilgore, Paul/AAD-2869-2019	Kilgore, Paul E/0000-0003-3214-4482; Wang, Songmei/0000-0003-4487-2110; Kilgore, Paul/0000-0003-3214-4482				Banyai K, 2012, VACCINE, V30, pA122, DOI 10.1016/j.vaccine.2011.09.111; Chang RX, 2002, ZHONG HUA ER KE ZA Z, V40, P405; CLARK HF, 1990, VACCINE, V8, P327, DOI 10.1016/0264-410X(90)90089-5; Clark HF, 1996, J INFECT DIS, V174, pS73, DOI 10.1093/infdis/174.Supplement_1.S73; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Cunliffe NA, 1998, B WORLD HEALTH ORGAN, V76, P525; Cunliffe NA, 2002, J INFECTION, V45, P1, DOI 10.1053/jinf.2002.1012; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Editorial Office, 2002, ENC CHIN; Fang ZY, 2005, J INFECT DIS, V192, pS94, DOI 10.1086/431505; Iturriza-Gomara M, 2011, EPIDEMIOL INFECT, V139, P895, DOI 10.1017/S0950268810001810; Kirkwood CD, 2008, COMMUN DIS INTELL, V32, P425; Le VP, 2008, J MED VIROL, V80, P175, DOI 10.1002/jmv.21044; Li JH, 2012, PRACTICAL PREVENTIVE, V19, P337; Miles MG, 2012, VACCINE, V30, pA131, DOI 10.1016/j.vaccine.2011.10.002; Orenstein EW, 2007, VACCINE, V25, P406, DOI 10.1016/j.vaccine.2006.07.054; Qiao HP, 1999, J MED VIROL, V57, P390, DOI 10.1002/(SICI)1096-9071(199904)57:4&lt;390::AID-JMV11&gt;3.0.CO;2-0; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sun Li-wei, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P1010; Tang SW, 2004, HUA ZHONG YI XUE ZA, V28, P73; Tong Zhi-li, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P1100; TREANOR JJ, 1995, PEDIATR INFECT DIS J, V14, P301, DOI 10.1097/00006454-199504000-00010; Wang XY, 2009, CLIN INFECT DIS, V49, P1202, DOI 10.1086/605632; Wang XY, 2005, J INFECT DIS, V192, pS100, DOI 10.1086/431507; Wang XY, 2005, AM J TROP M IN PRESS; Wei KF, 2010, ZHONG GUO WEI SHENG, V20, P2025; Yang XL, 2008, INT J INFECT DIS, V12, pE11, DOI 10.1016/j.ijid.2008.03.022; Yu W L, 1989, Zhonghua Liu Xing Bing Xue Za Zhi, V10, P257	28	8	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84699	10.1371/journal.pone.0084699	http://dx.doi.org/10.1371/journal.pone.0084699			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416267	gold, Green Published, Green Submitted			2022-12-27	WOS:000329862500150
J	Liu, YH; Lv, XY; Tan, RZ; Liu, TM; Chen, TL; Li, M; Liu, YH; Nie, F; Wang, XY; Zhou, PH; Chen, MZ; Zhou, Q				Liu, Yunhong; Lv, Xiaoyan; Tan, Ruizhi; Liu, Tianming; Chen, Tielin; Li, Mi; Liu, Yuhang; Nie, Fang; Wang, Xiaoyan; Zhou, Puhui; Chen, Mianzhi; Zhou, Qin			A Modified TALEN-Based Strategy for Rapidly and Efficiently Generating Knockout Mice for Kidney Development Studies	PLOS ONE			English	Article							EMBRYO MICROINJECTION; III EFFECTORS; GENE	The transcription activator-like effector nucleases (TALENs) strategy has been widely used to delete and mutate genes in vitro. This strategy has begun to be used for in vivo systemic gene manipulation, but not in an organ-specific manner. In this study, we developed a modified, highly efficient TALEN strategy using a dual-fluorescence reporter. We used this modified strategy and, within 5 weeks, we successfully generated kidney proximal tubule-specific gene Ttc36 homozygous knockout mice. Unilateral nephrectomy was performed on the 6-week-old founders (F0) to identify the knockout genotype prior to the birth of the offspring. This strategy was found to have little effect on reproduction in the knockout mice and inheritability of the knockout genotypes. The modified TALEN knockout strategy in combination with unilateral nephrectomy can be readily used for studies of gene function in kidney development and diseases.	[Liu, Yunhong; Tan, Ruizhi; Li, Mi; Liu, Yuhang; Chen, Mianzhi; Zhou, Qin] Sichuan Univ, Core Facil Genetically Engn Mice, Regenerat Med Res Ctr, West China Hosp,West China Med Sch, Chengdu 610064, Sichuan, Peoples R China; [Lv, Xiaoyan] Sichuan Univ, Dept Dermatol, West China Hosp, West China Med Sch, Chengdu 610064, Sichuan, Peoples R China; [Liu, Tianming; Nie, Fang; Wang, Xiaoyan; Zhou, Puhui] Chongqing Med Univ, Lab Mol Nephrol, Chongqing, Peoples R China; [Chen, Tielin] Sichuan Univ, State Key Lab Biotherapy, Chengdu 610064, Sichuan, Peoples R China; [Chen, Tielin] Sichuan Univ, Ctr Canc, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; Sichuan University; Chongqing Medical University; Sichuan University; Sichuan University	Zhou, PH (corresponding author), Chongqing Med Univ, Lab Mol Nephrol, Chongqing, Peoples R China.	pkdzhou@126.com; zhouqin@scu.edu.cn	Liu, Tianming/AAA-4602-2022	, Mianzhi/0000-0002-9960-0588; Li, Mi/0000-0002-6038-4144	National Basic Research Program of China [2011CB944002]; National Natural Science Foundation of China [31271563]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2011CB944002) to Prof. Qin Zhou M. D. & Ph.D. and the Grant from National Natural Science Foundation of China (No. 31271563) to Prof. Qin Zhou M. D. & Ph.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Davies B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060216; Georgas K, 2009, DEV BIOL, V332, P273, DOI 10.1016/j.ydbio.2009.05.578; Hermann M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041796; Hou Z, 2013, P NATL ACAD SCI US; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Segev DL, 2010, JAMA-J AM MED ASSOC, V303, P959, DOI 10.1001/jama.2010.237; Snouber LC, 2012, BIOTECHNOL PROGR, V28, P474, DOI 10.1002/btpr.743; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Wefers B, 2013, P NATL ACAD SCI USA, V110, P3782, DOI 10.1073/pnas.1218721110; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zhang Z, 2013, BBA-MOL BASIS DIS, V1832, P805, DOI 10.1016/j.bbadis.2013.02.022	19	2	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84893	10.1371/journal.pone.0084893	http://dx.doi.org/10.1371/journal.pone.0084893			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416307	Green Submitted, gold, Green Published			2022-12-27	WOS:000329862500186
J	Rodriguez-Ramirez, A; Grove, CA; Zinke, J; Pandolfi, JM; Zhao, JX				Rodriguez-Ramirez, Alberto; Grove, Craig A.; Zinke, Jens; Pandolfi, John M.; Zhao, Jian-xin			Coral Luminescence Identifies the Pacific Decadal Oscillation as a Primary Driver of River Runoff Variability Impacting the Southern Great Barrier Reef	PLOS ONE			English	Article							INTERDECADAL CLIMATE VARIABILITY; FITZROY RIVER; MULTIDECADAL VARIABILITY; FLUORESCENT BANDS; EL-NINO; SPECTRAL LUMINESCENCE; RAINFALL VARIABILITY; EASTERN AUSTRALIA; SEDIMENT SOURCES; ENSO	The Pacific Decadal Oscillation (PDO) is a large-scale climatic phenomenon modulating ocean-atmosphere variability on decadal time scales. While precipitation and river flow variability in the Great Barrier Reef (GBR) catchments are sensitive to PDO phases, the extent to which the PDO influences coral reefs is poorly understood. Here, six Porites coral cores were used to produce a composite record of coral luminescence variability (runoff proxy) and identify drivers of terrestrial influence on the Keppel reefs, southern GBR. We found that coral skeletal luminescence effectively captured seasonal, inter-annual and decadal variability of river discharge and rainfall from the Fitzroy River catchment. Most importantly, although the influence of El Nino-Southern Oscillation (ENSO) events was evident in the luminescence records, the variability in the coral luminescence composite record was significantly explained by the PDO. Negative luminescence anomalies (reduced runoff) were associated with El Nino years during positive PDO phases while positive luminescence anomalies (increased runoff) coincided with strong/moderate La Nino years during negative PDO phases. This study provides clear evidence that not only ENSO but also the PDO have significantly affected runoff regimes at the Keppel reefs for at least a century, and suggests that upcoming hydrological disturbances and ecological responses in the southern GBR region will be mediated by the future evolution of these sources of climate variability.	[Rodriguez-Ramirez, Alberto; Zhao, Jian-xin] Univ Queensland, Sch Earth Sci, Radiogen Isotope Facil, Brisbane, Qld, Australia; [Grove, Craig A.] NIOZ Royal Netherlands Inst Sea Res, Dept Marine Geol, Den Burg, Texel, Netherlands; [Zinke, Jens] Univ Western Australia, Sch Earth & Environm, Nedlands, WA 6009, Australia; [Zinke, Jens] Australian Inst Marine Sci, Perth, WA, Australia; [Pandolfi, John M.] Univ Queensland, Sch Biol Sci, Ctr Marine Sci, Australian Res Council Ctr Excellence Coral Reef, Brisbane, Qld, Australia	University of Queensland; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); University of Western Australia; Australian Institute of Marine Science; University of Queensland	Rodriguez-Ramirez, A (corresponding author), Univ Queensland, Sch Earth Sci, Radiogen Isotope Facil, Brisbane, Qld, Australia.	alberto.rodriguez@uq.edu.au	Pandolfi, John M/A-3121-2009; Zhao, Jian-xin/A-5938-2008; Zinke, Jens/G-5026-2011	Pandolfi, John M/0000-0003-3047-6694; Zhao, Jian-xin/0000-0002-2413-6178; Zinke, Jens/0000-0002-0634-8281; Rodriguez-Ramirez, Alberto/0000-0003-4855-7345	University of Queensland and the PADI foundation; Royal Netherlands Institute for Sea Research (NIOZ); Marine and Tropical Science Research Facility (MTSRF) [1.1.4]; ARC [DP0773081]; NERP Tropical Ecosystems [1.3]; GBRMPA [G10/33402.1]; IOMRC UWA/AIMS/CSIRO	University of Queensland and the PADI foundation; Royal Netherlands Institute for Sea Research (NIOZ); Marine and Tropical Science Research Facility (MTSRF); ARC(Australian Research Council); NERP Tropical Ecosystems; GBRMPA; IOMRC UWA/AIMS/CSIRO	A Graduate School International Travel Award (GSITA) from The University of Queensland and the PADI foundation to ARR supported the luminescence analysis of the cores at the Royal Netherlands Institute for Sea Research (NIOZ). This work was partially funded by the Marine and Tropical Science Research Facility (MTSRF) Project 1.1.4 granted to JXZ, JMP and others; the ARC discovery project DP0773081 granted to JXZ, and others; the NERP Tropical Ecosystems Hub Project 1.3 to JXZ, JMP., and others. Sample collection was conducted under the GBRMPA permit number G10/33402.1. JZ was supported by an IOMRC UWA/AIMS/CSIRO postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2003, DISTLM FORWARD FORTR; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Arblaster JM, 2002, CLIM DYNAM, V18, P519, DOI 10.1007/s00382-001-0191-y; Ayliffe LK, 2004, CONT SHELF RES, V24, P2343, DOI 10.1016/j.csr.2004.07.013; Berkelmans R, 2012, CORAL REEFS, V31, P1103, DOI 10.1007/s00338-012-0930-z; BOM, 2012, ANN CLIM SUMM 2011; BOM, 2013, QUEENSL JAN 2013 EXT; Bostock HC, 2007, SEDIMENT GEOL, V201, P321, DOI 10.1016/j.sedgeo.2007.07.001; Cai WJ, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050820; Cai WJ, 2010, J CLIMATE, V23, P4944, DOI 10.1175/2010JCLI3501.1; Calvo E, 2007, PALAEOGEOGR PALAEOCL, V248, P190, DOI 10.1016/j.palaeo.2006.12.003; Chiba S, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052912; Chiew FHS, 1998, J HYDROL, V204, P138, DOI 10.1016/S0022-1694(97)00121-2; Devlin MJ, 2012, MAR POLLUT BULL, V65, P224, DOI 10.1016/j.marpolbul.2012.03.001; Douglas GB, 2008, ENVIRON CHEM, V5, P243, DOI 10.1071/EN07091; Douglas GB, 2006, ENVIRON CHEM, V3, P377, DOI 10.1071/EN06010; Evans MN, 2001, GEOPHYS RES LETT, V28, P3689, DOI 10.1029/2001GL013223; Felis T, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043572; Fensham RJ, 2003, J ENVIRON MANAGE, V68, P409, DOI 10.1016/S0301-4797(03)00110-5; Folland CK, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014201; Francis RC, 1998, FISH OCEANOGR, V7, P1, DOI 10.1046/j.1365-2419.1998.00052.x; Franks SW, 2002, WATER RESOUR RES, V38, DOI 10.1029/2001WR000232; Furnas M, 2001, OCEANOGRAPHIC PROCESSES OF CORAL REEFS : PHYSICAL AND BIOLOGICAL LINKS IN THE GREAT BARRIER REEF, P37; Furnas M., 2003, CATCHMENTS CORALS TE; Gedalof Z, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015824; Gilbert M., 2001, POPULATION MAJOR LAN; Grissino-Mayer, 2001, TREE-RING RES, V57, P205, DOI DOI 10.1016/J.DENDRO.2010.12.002; Grottoli AG, 2007, EARTH-SCI REV, V81, P67, DOI 10.1016/j.earscirev.2006.10.001; Grove CA, 2013, CLIM PAST, V9, P641, DOI 10.5194/cp-9-641-2013; Grove CA, 2012, BIOGEOSCIENCES, V9, P3063, DOI 10.5194/bg-9-3063-2012; Grove CA, 2010, CORAL REEFS, V29, P579, DOI 10.1007/s00338-010-0629-y; Hare SR, 1999, FISHERIES, V24, P6, DOI 10.1577/1548-8446(1999)024<0006:IPR>2.0.CO;2; Heinrich I, 2009, CLIM DYNAM, V33, P63, DOI 10.1007/s00382-009-0544-5; Hendy EJ, 2003, HOLOCENE, V13, P187, DOI 10.1191/0959683603hl606rp; Henley BJ, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR010034; Holbrook NJ, 2009, MARINE CLIMATE CHANG, P1; Hopley D, 2007, GEOMORPHOLOGY OF THE GREAT BARRIER REEF: DEVELOPMENT, DIVERSITY, AND CHANGE, P1, DOI 10.1017/CBO9780511535543; ISDALE P, 1984, NATURE, V310, P578, DOI 10.1038/310578a0; Isdale PJ, 1998, HOLOCENE, V8, P1, DOI 10.1191/095968398670905088; Johnston N, 2008, FITZROY BASIN WATER; Jones Alison M., 2011, Diversity, V3, P329, DOI 10.3390/d3030329; Jones PD, 2009, HOLOCENE, V19, P3, DOI 10.1177/0959683608098952; Jupiter S, 2008, CORAL REEFS, V27, P887, DOI 10.1007/s00338-008-0422-3; Kiem AS, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL015992; Kiem AS, 2004, HYDROL PROCESS, V18, P2039, DOI 10.1002/hyp.1460; King AD, 2013, GEOPHYS RES LETT, V40, P2271, DOI 10.1002/grl.50427; King B, 2001, OCEANOGRAPHIC PROCESSES OF CORAL REEFS : PHYSICAL AND BIOLOGICAL LINKS IN THE GREAT BARRIER REEF, P145; KLEIN R, 1990, NATURE, V345, P145, DOI 10.1038/345145a0; Klingaman NP, 2013, INT J CLIMATOL, V33, P2413, DOI 10.1002/joc.3593; Kroon FJ, 2012, MAR POLLUT BULL, V65, P167, DOI 10.1016/j.marpolbul.2011.10.018; Lee HS, 2012, PROG OCEANOGR, V105, P67, DOI 10.1016/j.pocean.2012.04.009; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Lewis SE, 2012, MAR POLLUT BULL, V65, P306, DOI 10.1016/j.marpolbul.2011.09.030; Lewis SE, 2007, PALAEOGEOGR PALAEOCL, V246, P471, DOI 10.1016/j.palaeo.2006.10.021; Linsley BK, 2000, SCIENCE, V290, P1145, DOI 10.1126/science.290.5494.1145; Linsley BK, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001539; LLOYD PL, 1984, BRIGALOW BELT AUSTR, P81, DOI DOI 10.1071/RJ06027; Lough JM, 2011, CORAL REEFS, V30, P169, DOI 10.1007/s00338-010-0688-0; Lough JM, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002050; Lough JM, 2010, WIRES CLIM CHANGE, V1, P318, DOI 10.1002/wcc.39; LOUGH JM, 1991, INT J CLIMATOL, V11, P745, DOI 10.1002/joc.3370110704; Lough JM, 2007, PALEOCEANOGRAPHY, V22, P1; Maina J, 2012, MAR POLLUT BULL, V64, P2047, DOI 10.1016/j.marpolbul.2012.06.027; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Martinez E, 2009, SCIENCE, V326, P1253, DOI 10.1126/science.1177012; Maue RN, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047711; McCulloch M, 2003, NATURE, V421, P727, DOI 10.1038/nature01361; McGowan HA, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL037049; McGowan JA, 1998, SCIENCE, V281, P210, DOI 10.1126/science.281.5374.210; McGregor S, 2010, CLIM PAST, V6, P1, DOI 10.5194/cp-6-1-2010; Meehl GA, 2001, CLIM DYNAM, V17, P515, DOI 10.1007/PL00007929; Meehl GA, 2010, J CLIMATE, V23, P2959, DOI 10.1175/2010JCLI3296.1; Menge BA, 2011, J EXP MAR BIOL ECOL, V400, P236, DOI 10.1016/j.jembe.2011.02.003; Micevski T, 2006, J HYDROL, V327, P219, DOI 10.1016/j.jhydrol.2005.11.017; Minobe S, 1999, GEOPHYS RES LETT, V26, P855, DOI 10.1029/1999GL900119; Nagtegaal R, 2012, CHEM GEOL, V318, P6, DOI 10.1016/j.chemgeo.2012.05.006; Neil DT, 2002, MAR FRESHWATER RES, V53, P733, DOI 10.1071/MF00151; Nott J, 2001, NATURE, V413, P508, DOI 10.1038/35097055; Nyberg J, 2002, PHILOS T ROY SOC A, V360, P749, DOI 10.1098/rsta.2001.0963; Nyberg J, 2007, NATURE, V447, P698, DOI 10.1038/nature05895; Paillard D., 1996, EOS T AM GEOPHYS UN, V77, P379, DOI 10.1029/96EO00259; Pelejero C, 2005, SCIENCE, V309, P2204, DOI 10.1126/science.1113692; Peterson WT, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017528; Pfeiffer M, 2009, INT J EARTH SCI, V98, P53, DOI 10.1007/s00531-008-0326-z; Power S, 1999, CLIM DYNAM, V15, P319, DOI 10.1007/s003820050284; Power S, 2006, J CLIMATE, V19, P4755, DOI 10.1175/JCLI3868.1; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Redondo-Rodriguez A, 2012, MAR FRESHWATER RES, V63, P34, DOI 10.1071/MF11151; Risbey JS, 2009, MON WEATHER REV, V137, P3233, DOI 10.1175/2009MWR2861.1; Schulz M, 2002, COMPUT GEOSCI-UK, V28, P421, DOI 10.1016/S0098-3004(01)00044-9; Shen CM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024804; Smith J, 2008, ENVIRON CHEM, V5, P231, DOI 10.1071/EN07094; Tan JCH, 2012, P 112 INT COR REEF S, p11E; Thompson A, 2011, REEF RESCUE MARINE M, DOI 10.13140/rg.2.1.1287.1206; van Woesik R, 1991, IMMEDIATE IMPACT JAN; VanWoesik R, 1995, MAR ECOL PROG SER, V128, P261, DOI 10.3354/meps128261; Verdon DC, 2004, WATER RESOUR RES, V40, DOI 10.1029/2004WR003234	97	33	34	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84305	10.1371/journal.pone.0084305	http://dx.doi.org/10.1371/journal.pone.0084305			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416214	gold, Green Published			2022-12-27	WOS:000329862500112
J	Sato, S; Kawauchi, S; Okuda, W; Nishidate, I; Nawashiro, H; Tsumatori, G				Sato, Shunichi; Kawauchi, Satoko; Okuda, Wataru; Nishidate, Izumi; Nawashiro, Hiroshi; Tsumatori, Gentaro			Real-Time Optical Diagnosis of the Rat Brain Exposed to a Laser-Induced Shock Wave: Observation of Spreading Depolarization, Vasoconstriction and Hypoxemia-Oligemia	PLOS ONE			English	Article							CLOSED-HEAD-INJURY; CONTROLLED CORTICAL IMPACT; INDUCED STRESS WAVES; FLUID-PERCUSSION MODEL; BLAST OVERPRESSURE; EXPLOSIVE BLAST; INDUCED NEUROTRAUMA; HIPPOCAMPAL SLICE; CEREBRAL-CORTEX; VISUAL-CORTEX	Despite many efforts, the pathophysiology and mechanism of blast-induced traumatic brain injury (bTBI) have not yet been elucidated, partially due to the difficulty of real-time diagnosis and extremely complex factors determining the outcome. In this study, we topically applied a laser-induced shock wave (LISW) to the rat brain through the skull, for which real-time measurements of optical diffuse reflectance and electroencephalogram (EEG) were performed. Even under conditions showing no clear changes in systemic physiological parameters, the brain showed a drastic light scattering change accompanied by EEG suppression, which indicated the occurrence of spreading depression, long-lasting hypoxemia and signal change indicating mitochondrial energy impairment. Under the standard LISW conditions examined, hemorrhage and contusion were not apparent in the cortex. To investigate events associated with spreading depression, measurement of direct current (DC) potential, light scattering imaging and stereomicroscopic observation of blood vessels were also conducted for the brain. After LISW application, we observed a distinct negative shift in the DC potential, which temporally coincided with the transit of a light scattering wave, showing the occurrence of spreading depolarization and concomitant change in light scattering. Blood vessels in the brain surface initially showed vasodilatation for 3-4 min, which was followed by long-lasting vasoconstriction, corresponding to hypoxemia. Computer simulation based on the inverse Monte Carlo method showed that hemoglobin oxygen saturation declined to as low as similar to 35% in the long-term hypoxemic phase. Overall, we found that topical application of a shock wave to the brain caused spreading depolarization/depression and prolonged severe hypoxemia-oligemia, which might lead to pathological conditions in the brain. Although further study is needed, our findings suggest that spreading depolarization/depression is one of the key events determining the outcome in bTBI. Furthermore, a rat exposed to an LISW(s) can be a reliable laboratory animal model for blast injury research.	[Sato, Shunichi; Kawauchi, Satoko] Natl Def Med Coll, Res Inst, Div Biomed Informat Sci, Tokorozawa, Saitama 359, Japan; [Okuda, Wataru; Nishidate, Izumi] Tokyo Univ Agr & Technol, Grad Sch Bioapplicat & Syst Engn, Tokyo, Japan; [Nawashiro, Hiroshi] Tokorozawa Cent Hosp, Div Neurosurg, Tokorozawa, Saitama, Japan; [Tsumatori, Gentaro] Natl Def Med Coll, Dept Def Med, Tokorozawa, Saitama 359, Japan	National Defense Medical College - Japan; Tokyo University of Agriculture & Technology; National Defense Medical College - Japan	Sato, S (corresponding author), Natl Def Med Coll, Res Inst, Div Biomed Informat Sci, Tokorozawa, Saitama 359, Japan.	shunsato@ndmc.ac.jp	NISHIDATE, IZUMI/C-8826-2013		Ministry of Defense; General Insurance Association of Japan	Ministry of Defense; General Insurance Association of Japan	This study was supported by the Research Promotion Program for Defense Medicine under the Ministry of Defense and a research grant from The General Insurance Association of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; Aizawa K, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3253325; Ando T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051744; ANDREW RD, 1994, NEUROSCIENCE, V62, P371, DOI 10.1016/0306-4522(94)90372-7; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Ba AM, 2002, J NEUROPHYSIOL, V88, P2726, DOI 10.1152/jn.00729.2001; Bahar S, 2000, J NEUROPHYSIOL, V84, P311; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Center for Chemical Process Safety, 1994, GUID EV CHAR VAP CLO, P351; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Cernak I., 1996, CHIN J TRAUMATOL, V12, P28; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chandra N, 2012, SHOCK WAVES, V22, P403, DOI 10.1007/s00193-012-0399-2; Chang JC, 2010, BRAIN, V133, P996, DOI 10.1093/brain/awp338; Chen Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039353; Courtney MW, 2011, NEUROIMAGE, V54, pS55, DOI 10.1016/j.neuroimage.2010.05.025; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dreckhahn C, 2012, BRAIN, V135, P853; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Ebersberger A, 2001, ANN NEUROL, V49, P7, DOI 10.1002/1531-8249(200101)49:1<7::AID-ANA4>3.3.CO;2-B; Elsayed NM, 1997, TOXICOLOGY, V121, P81, DOI 10.1016/S0300-483X(97)03657-3; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Fischer H, 2013, CRS REP C; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Guy RJ, 1998, J TRAUMA, V45, P983, DOI 10.1097/00005373-199812000-00001; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; HANSEN AJ, 1980, ACTA PHYSIOL SCAND, V108, P355, DOI 10.1111/j.1748-1716.1980.tb06544.x; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; Hartings JA, 2008, NEUROL RES, V30, P876, DOI 10.1179/174313208X309739; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Hartings JA, 2009, J NEUROTRAUM, V26, P1857, DOI [10.1089/neu.2009.0961, 10.1089/neu.2009-0961]; Hashemi P, 2009, J CEREBR BLOOD F MET, V29, P166, DOI 10.1038/jcbfm.2008.108; Hatano B, 2011, P SPIE, V7897; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hossmann KA, 1996, CEREBROVAS BRAIN MET, V8, P195; JAFFIN JH, 1987, J TRAUMA, V27, P349, DOI 10.1097/00005373-198704000-00002; KATAYAMA Y, 1995, BRAIN PATHOL, V5, P427, DOI 10.1111/j.1750-3639.1995.tb00621.x; Kato K, 2007, J NEUROSURG, V106, P667, DOI 10.3171/jns.2007.106.4.667; Kawauchi S, 2008, APPL OPTICS, V47, P4164, DOI 10.1364/AO.47.004164; Kawauchi S, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.1.015003; Kawauchi S, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3542046; Kurita A, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3628313; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; Leis JA, 2005, GLIA, V50, P407, DOI 10.1002/glia.20145; Leo L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002129; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Manor T, 2008, NEUROL RES, V30, P1075, DOI 10.1179/174313208X346107; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mayevsky A, 1996, BRAIN RES, V740, P268, DOI 10.1016/S0006-8993(96)00874-8; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Mourant J., 2003, ELASTIC SCATTERING S; NARAYAN SM, 1995, J CEREBR BLOOD F MET, V15, P754, DOI 10.1038/jcbfm.1995.95; NEDERGAARD M, 1988, BRAIN RES, V449, P395, DOI 10.1016/0006-8993(88)91062-1; Ogura M, 2004, LASER SURG MED, V34, P242, DOI 10.1002/lsm.20024; OKUSKY J, 1982, J COMP NEUROL, V210, P307, DOI 10.1002/cne.902100309; OZAWA Y, 1991, Neurologia Medico-Chirurgica, V31, P685, DOI 10.2176/nmc.31.685; PAINTAL AS, 1969, J PHYSIOL-LONDON, V203, P511, DOI 10.1113/jphysiol.1969.sp008877; PIPER RD, 1991, AM J PHYSIOL, V261, pH96, DOI 10.1152/ajpheart.1991.261.1.H96; Polischuk TM, 1998, NEUROBIOL DIS, V4, P423, DOI 10.1006/nbdi.1998.0172; Rogatsky GG, 2003, J NEUROTRAUM, V20, P1315, DOI 10.1089/089771503322686111; Sato S, 2011, OPT LETT, V36, P4545, DOI 10.1364/OL.36.004545; Satoh Y, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2128432; Satoh Y, 2010, LASER SURG MED, V42, P313, DOI 10.1002/lsm.20899; Schumacher RN, 1977, 2724 US BALL RES LAB; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; SHOHAMI E, 1988, NEUROSURGERY, V22, P859, DOI 10.1227/00006123-198805000-00007; Showstack R., 2013, EOS T AGU, V94, P87; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Somjen GG, 2008, J COMPUT NEUROSCI, V25, P349, DOI 10.1007/s10827-008-0083-9; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Sunami K, 1989, Neurol Med Chir (Tokyo), V29, P975, DOI 10.2176/nmc.29.975; Suneson A, 2000, MIL MED, V165, P119, DOI 10.1093/milmed/165.2.119; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Sword J, 2013, BRAIN, V136, P1446, DOI 10.1093/brain/awt026; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; VANDERZEE P, 1993, P SOC PHOTO-OPT INS, V1888, P454, DOI 10.1117/12.154665; VANHARREVELD A, 1956, AM J PHYSIOL, V184, P312; von Baumgarten L, 2008, J CEREBR BLOOD F MET, V28, P1353, DOI 10.1038/jcbfm.2008.30; Wharton D.C., 1966, BIOCH COPPER, P235; Windmuller O, 2005, BRAIN, V128, P2042, DOI 10.1093/brain/awh545; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; Zhang FY, 2002, J NEUROSURG, V97, P963, DOI 10.3171/jns.2002.97.4.0963; Zuckerman S, 1940, LANCET, V2, P219	96	33	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e82891	10.1371/journal.pone.0082891	http://dx.doi.org/10.1371/journal.pone.0082891			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416150	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500022
J	Stein, ML; van Steenbergen, JE; Chanyasanha, C; Tipayamongkholgul, M; Buskens, V; van der Heijden, PGM; Sabaiwan, W; Bengtsson, L; Lu, X; Thorson, AE; Kretzschmar, MEE				Stein, Mart L.; van Steenbergen, Jim E.; Chanyasanha, Charnchudhi; Tipayamongkholgul, Mathuros; Buskens, Vincent; van der Heijden, Peter G. M.; Sabaiwan, Wasamon; Bengtsson, Linus; Lu, Xin; Thorson, Anna E.; Kretzschmar, Mirjam E. E.			Online Respondent-Driven Sampling for Studying Contact Patterns Relevant for the Spread of Close-Contact Pathogens: A Pilot Study in Thailand	PLOS ONE			English	Article							INFECTIOUS-DISEASE; SOCIAL CONTACTS; MIXING PATTERNS; NETWORK; TRANSMISSION; RECRUITMENT; POPULATIONS; PARAMETERS; BEHAVIOR; MODELS	Background: Information on social interactions is needed to understand the spread of airborne infections through a population. Previous studies mostly collected egocentric information of independent respondents with self-reported information about contacts. Respondent-driven sampling (RDS) is a sampling technique allowing respondents to recruit contacts from their social network. We explored the feasibility of webRDS for studying contact patterns relevant for the spread of respiratory pathogens. Materials and Methods: We developed a webRDS system for facilitating and tracking recruitment by Facebook and email. One-day diary surveys were conducted by applying webRDS among a convenience sample of Thai students. Students were asked to record numbers of contacts at different settings and self-reported influenza-like-illness symptoms, and to recruit four contacts whom they had met in the previous week. Contacts were asked to do the same to create a network tree of socially connected individuals. Correlations between linked individuals were analysed to investigate assortativity within networks. Results: We reached up to 6 waves of contacts of initial respondents, using only non-material incentives. Forty-four (23.0%) of the initially approached students recruited one or more contacts. In total 257 persons participated, of which 168 (65.4%) were recruited by others. Facebook was the most popular recruitment option (45.1%). Strong assortative mixing was seen by age, gender and education, indicating a tendency of respondents to connect to contacts with similar characteristics. Random mixing was seen by reported number of daily contacts. Conclusions: Despite methodological challenges (e. g. clustering among respondents and their contacts), applying RDS provides new insights in mixing patterns relevant for close-contact infections in real-world networks. Such information increases our knowledge of the transmission of respiratory infections within populations and can be used to improve existing modelling approaches. It is worthwhile to further develop and explore webRDS for the detection of clusters of respiratory symptoms in social networks.	[Stein, Mart L.; Kretzschmar, Mirjam E. E.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Stein, Mart L.; van Steenbergen, Jim E.; Kretzschmar, Mirjam E. E.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [van Steenbergen, Jim E.] Leiden Univ, Med Ctr, Ctr Infect Dis, Leiden, Netherlands; [Chanyasanha, Charnchudhi] Mahidol Univ, Fac Publ Hlth, Dept Microbiol, Bangkok 10700, Thailand; [Tipayamongkholgul, Mathuros] Mahidol Univ, Fac Publ Hlth, Dept Epidemiol, Bangkok 10700, Thailand; [Buskens, Vincent; van der Heijden, Peter G. M.] Univ Utrecht, Fac Social & Behav Sci, Utrecht, Netherlands; [van der Heijden, Peter G. M.] Univ Southampton, Southampton Stat Sci Res Inst, Southampton, Hants, England; [Sabaiwan, Wasamon] Chulalongkorn Univ, Fac Commun Arts, Bangkok, Thailand; [Bengtsson, Linus; Lu, Xin; Thorson, Anna E.] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Lu, Xin] Natl Univ Def Technol, Coll Informat Syst & Management, Changsha, Hunan, Peoples R China	Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Mahidol University; Mahidol University; Utrecht University; University of Southampton; Chulalongkorn University; Karolinska Institutet; National University of Defense Technology - China	Stein, ML (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	m.l.stein-2@umcutrecht.nl	Buskens, Vincent/B-3134-2012; lu, xin/C-1940-2009; Stein, Mart/U-8914-2019; Buskens, Vincent/N-8762-2019	Buskens, Vincent/0000-0002-4483-7238; lu, xin/0000-0002-3547-6493; Buskens, Vincent/0000-0002-4483-7238; Kretzschmar, Mirjam/0000-0002-4394-7697; Tipayamongkholgul, Mathuros/0000-0002-2585-1659; Stein, Mart L./0000-0003-0502-7993; van der Heijden, Peter/0000-0002-3345-096X; Thorson, Anna/0000-0002-8703-6561	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	The Swedish Research Council (vr.se) has financed the programming of the RDS web-survey system and the technical implementation of the surveys in Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, NATURE, DOI DOI 10.1038/nature07634; Ball F, 2013, J MATH BIOL, V66, P979, DOI 10.1007/s00285-012-0609-7; Bansal S, 2007, J R SOC INTERFACE, V4, P879, DOI 10.1098/rsif.2007.1100; Bauermeister JA, 2012, J STUD ALCOHOL DRUGS, V73, P834, DOI 10.15288/jsad.2012.73.834; Bengtsson L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049417; Beutels P, 2006, EPIDEMIOL INFECT, V134, P1158, DOI 10.1017/S0950268806006418; Bolton KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030893; Brooks-Pollock E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-68; Chen CY, 2002, SAGE U PAPER SERIES; Dugas AF, 2012, CLIN INFECT DIS, V54, P463, DOI 10.1093/cid/cir883; Eames KTD, 2008, THEOR POPUL BIOL, V73, P104, DOI 10.1016/j.tpb.2007.09.007; Eames KTD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002425; Edmunds WJ, 1997, P ROY SOC B-BIOL SCI, V264, P949, DOI 10.1098/rspb.1997.0131; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Hox JJ., 2017, MULTILEVEL ANAL TECH, DOI DOI 10.4324/9781315650982; Johnston LG, 2010, AIDS CARE, V22, P784, DOI 10.1080/09540120903373557; Keeling MJ, 1999, P ROY SOC B-BIOL SCI, V266, P859, DOI 10.1098/rspb.1999.0716; Kretzschmar M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005931; Marquet RL, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-242; May RM, 2006, TRENDS ECOL EVOL, V21, P394, DOI 10.1016/j.tree.2006.03.013; Mccaw JM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-166; McCreesh N, 2012, EPIDEMIOLOGY, V23, P138, DOI 10.1097/EDE.0b013e31823ac17c; McCreesh N, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-56; Mikolajczyk RT, 2008, EPIDEMIOL INFECT, V136, P813, DOI 10.1017/S0950268807009181; Miller JC, 2009, J R SOC INTERFACE, V6, P1121, DOI 10.1098/rsif.2008.0524; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; National Statistical Office Ministry of Information and Communication Technology Thailand, 2012, INF COMM TECHN SURV; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Read JM, 2012, EPIDEMIOL INFECT, V140, P2117, DOI 10.1017/S0950268812000842; Read JM, 2008, J R SOC INTERFACE, V5, P1001, DOI 10.1098/rsif.2008.0013; Salathe M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002616; Salathe M, 2010, P NATL ACAD SCI USA, V107, P22020, DOI 10.1073/pnas.1009094108; Salathe M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000736; Salganik MJ, 2004, SOCIOL METHODOL, V34, P193, DOI 10.1111/j.0081-1750.2004.00152.x; Smieszek T, 2012, EPIDEMIOL INFECT, V140, P744, DOI 10.1017/S0950268811001130; Socialbakers, 2013, CHECKF FAC STAT THAI; Stehle J, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-87; Szendroi B, 2004, P ROY SOC B-BIOL SCI, V271, pS364, DOI 10.1098/rsbl.2004.0188; van der Weijden CP, 2013, HEALTH POLICY, V109, P52, DOI 10.1016/j.healthpol.2012.05.007; Volz E, 2008, J OFF STAT, V24, P79; Volz EM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002042; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Wejnert C, 2008, SOCIOL METHOD RES, V37, P105, DOI 10.1177/0049124108318333; Wejnert C, 2009, SOCIOL METHODOL, V39, P73, DOI 10.1111/j.1467-9531.2009.01216.x	46	24	24	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85256	10.1371/journal.pone.0085256	http://dx.doi.org/10.1371/journal.pone.0085256			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291WL	24416371	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000329862500230
J	Sun, YB; Jiang, CQ; Cheng, KK; Zhang, WS; Leung, GM; Lam, TH; Schooling, CM				Sun, Yangbo; Jiang, Chaoqiang; Cheng, Kar Keung; Zhang, Weisen; Leung, Gabriel M.; Lam, Tai Hing; Schooling, C. Mary			Milk Consumption and Cardiovascular Risk Factors in Older Chinese: The Guangzhou Biobank Cohort Study	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; CORONARY-HEART-DISEASE; VITAMIN-D; DAIRY CONSUMPTION; BLOOD-PRESSURE; CALCIUM; HEALTH; HYPERTENSION; METAANALYSIS; CHOLESTEROL	Background: Dairy products consumption is increasingly common globally. Most of the evidence concerning dairy products comes from observational studies in western populations which are inevitably open to confounding. To triangulate the evidence concerning dairy products, we examined the associations of whole cow's milk consumption with cardiovascular risk factors in a non-Western setting with a different pattern of milk consumption and cardiovascular diseases from Western populations. Methods: We used multivariable censored linear or logistic regression to examine cross-sectionally the adjusted associations of whole cow's milk consumption (none (n = 14892), 1-3/week (n = 2689) and 3+/week (n = 2754)) with cardiovascular risk factors in Chinese (>= 50 years) in the Guangzhou Biobank Cohort Study. Results: Whole cow's milk consumption was negatively associated with systolic blood pressure (3+/week compared to none -2.56 mmHg, 95% confidence interval (CI) -3.63 to -1.49), diastolic blood pressure (-1.32 mmHg, 95% CI -1.87 to -0.77) and triglycerides (-0.06 mmol/L, 95% CI -0.11 to -0.002), but was positively associated with HDL-cholesterol (0.02 mmol/L, 95% CI 0.01 to 0.04) and fasting glucose (0.08 mmol/L, 95% CI 0.01 to 0.16) adjusted for age, sex, phase of study, socio-economic position, lifestyle (smoking, alcohol use and physical activity) and adiposity, but had no obvious association with LDL-cholesterol or the presence of diabetes. Conclusions: Whole cow's milk consumption had heterogeneous associations with cardiovascular risk factors. Higher whole cow's milk consumption was associated with lower levels of specific cardiovascular risk factors which might suggest risk factor specific biological pathways with different relations to blood pressure and lipids than glucose.	[Sun, Yangbo; Leung, Gabriel M.; Lam, Tai Hing; Schooling, C. Mary] Univ Hong Kong, Lifestyle & Lifecourse Epidemiol Grp, Sch Publ Hlth, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Jiang, Chaoqiang; Zhang, Weisen] Guangzhou 12 Hosp, Guangzhou, Guangdong, Peoples R China; [Cheng, Kar Keung] Univ Birmingham, Dept Publ Hlth & Epidemiol, Birmingham, W Midlands, England; [Schooling, C. Mary] CUNY, Sch Publ Hlth, New York, NY 10021 USA	University of Hong Kong; University of Birmingham; City University of New York (CUNY) System	Lam, TH (corresponding author), Univ Hong Kong, Lifestyle & Lifecourse Epidemiol Grp, Sch Publ Hlth, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China.	hrmrlth@hkucc.hku.hk	Cheng, Kar/AAL-8899-2021; Lam, Tai Hing/C-4317-2009	Cheng, Kar/0000-0002-1516-1857; Schooling, Mary/0000-0001-9933-5887; Lam, Tai Hing/0000-0002-2033-9971; Leung, Gabriel/0000-0002-2503-6283	University of Hong Kong Foundation for Development and Research; University of Hong Kong University Research Committee Strategic Research Theme Public Health, Hong Kong; Guangzhou Public Health Bureau; Guangzhou Science and Technology Bureau, Guangzhou, China; University of Birmingham, UK	University of Hong Kong Foundation for Development and Research; University of Hong Kong University Research Committee Strategic Research Theme Public Health, Hong Kong; Guangzhou Public Health Bureau; Guangzhou Science and Technology Bureau, Guangzhou, China; University of Birmingham, UK	This work was supported by The University of Hong Kong Foundation for Development and Research, and the University of Hong Kong University Research Committee Strategic Research Theme Public Health, Hong Kong; Guangzhou Public Health Bureau, and Guangzhou Science and Technology Bureau, Guangzhou, China; and The University of Birmingham, UK. The funding sources had no role in any of the following: study design; the collection, analysis, and interpretation of data; the writing of the report; and the decision to submit the paper for publication.	Akinsete JA, 2012, CARCINOGENESIS, V33, P140, DOI 10.1093/carcin/bgr238; Almon R, 2010, EUR J NUTR, V49, P141, DOI 10.1007/s00394-009-0058-2; Alonso A, 2009, J HUM NUTR DIET, V22, P336, DOI 10.1111/j.1365-277X.2009.00967.x; AVALOS EE, 2012, PUBLIC HEALTH NUTR, P1; Barzi F, 2007, J EPIDEMIOL COMMUN H, V61, P115, DOI 10.1136/jech.2005.044842; Bolland MJ, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2040; Delgado CL, 2003, J NUTR, V133, p3907S, DOI 10.1093/jn/133.11.3907S; Franklin SS, 1999, CIRCULATION, V100, P354, DOI 10.1161/01.CIR.100.4.354; Galobardes B, 2006, ANN EPIDEMIOL, V16, P91, DOI 10.1016/j.annepidem.2005.06.053; Huth PJ, 2012, ADV NUTR, V3, P266, DOI 10.3945/an.112.002030; Itan Y, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-36; Jakala P, 2010, PHARMACEUTICALS-BASE, V3, P251, DOI 10.3390/ph3010251; James WPT, 1997, BMJ-BRIT MED J, V314, P1545, DOI 10.1136/bmj.314.7093.1545; Jiang CQ, 2006, INT J EPIDEMIOL, V35, P844, DOI 10.1093/ije/dyl131; Kinjo Y, 1999, J Epidemiol, V9, P268; Kipnis V, 2002, PUBLIC HEALTH NUTR, V5, P915, DOI 10.1079/PHN2002383; Kirii K, 2009, DIABETOLOGIA, V52, P2542, DOI 10.1007/s00125-009-1554-x; Larsson SC, 2009, EPIDEMIOLOGY, V20, P355, DOI 10.1097/EDE.0b013e3181935dd5; Li YC, 2004, J STEROID BIOCHEM, V89-90, P387, DOI 10.1016/j.jsbmb.2004.03.004; Margolis KL, 2008, HYPERTENSION, V52, P847, DOI 10.1161/HYPERTENSIONAHA.108.114991; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; NAITO C, 1990, ANN NY ACAD SCI, V598, P482, DOI 10.1111/j.1749-6632.1990.tb42318.x; Ponda MP, 2012, ARTERIOSCL THROM VAS, V32, P2510, DOI 10.1161/ATVBAHA.112.254110; Qiao R, 2011, BIOMED ENVIRON SCI, V24, P512, DOI 10.3967/0895-3988.2011.05.009; Ralston RA, 2012, J HUM HYPERTENS, V26, P3, DOI 10.1038/jhh.2011.3; ROSSOUW JE, 1981, AM J CLIN NUTR, V34, P351, DOI 10.1093/ajcn/34.3.351; Sanchez-Villegas A, 2003, EUR J CLIN NUTR, V57, P917, DOI 10.1038/sj.ejcn.1601626; Sauvaget C, 2003, INT J EPIDEMIOL, V32, P536, DOI 10.1093/ije/dyg151; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Schooling CM, 2010, J EPIDEMIOL COMMUN H, V64, DOI 10.1136/jech.2008.086553; SMITH AM, 1992, J EPIDEMIOL COMMUN H, V46, P409, DOI 10.1136/jech.46.4.409; Soedamah-Muthu SS, 2012, HYPERTENSION, V60, P1131, DOI 10.1161/HYPERTENSIONAHA.112.195206; Soedamah-Muthu SS, 2011, AM J CLIN NUTR, V93, P158, DOI 10.3945/ajcn.2010.29866; Stern MP, 2002, ANN INTERN MED, V136, P575, DOI 10.7326/0003-4819-136-8-200204160-00006; Tong X, 2011, EUR J CLIN NUTR, V65, P1027, DOI 10.1038/ejcn.2011.62; USDA, 2010, DIET GUID AM, DOI DOI 10.HTTP://WWW.CNPP.USDA.G0V/PUBLICATI0NS/DIETARYGUIDELINES/2010/P0LICYD0C/P0LICYD0C.PDF; Villegas R, 2009, AM J CLIN NUTR, V89, P1059, DOI 10.3945/ajcn.2008.27182; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Zemel MB, 2001, J AM COLL NUTR, V20, p428S, DOI 10.1080/07315724.2001.10719180	40	6	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84813	10.1371/journal.pone.0084813	http://dx.doi.org/10.1371/journal.pone.0084813			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416290	Green Published, gold			2022-12-27	WOS:000329862500172
J	Wilson, CL; Mann, J; Walsh, M; Perrugoria, MJ; Oakley, F; Wright, MC; Brignole, C; Di Paolo, D; Perri, P; Ponzoni, M; Karin, M; Mann, DA				Wilson, Caroline L.; Mann, Jelena; Walsh, Meagan; Perrugoria, Maria J.; Oakley, Fiona; Wright, Matthew C.; Brignole, Chiara; Di Paolo, Daniela; Perri, Patrizia; Ponzoni, Mirco; Karin, Michael; Mann, Derek A.			Quiescent Hepatic Stellate Cells Functionally Contribute to the Hepatic Innate Immune Response via TLR3	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-3; PATTERN-RECOGNITION RECEPTORS; NONPARENCHYMAL LIVER-CELLS; LARGE GRANULAR LYMPHOCYTES; NATURAL-KILLER ACTIVITY; DOUBLE-STRANDED-RNA; C VIRUS; FIBROSIS; AUGMENTATION; INFLAMMATION	Toll-like Receptor 3 (TLR3) is a pathogen pattern recognition receptor that plays a key role in innate immunity. TLR3 signalling has numerous functions in liver, both in health and disease. Here we report that TLR3 is expressed by quiescent hepatic stellate cells (HSC) where it functions to induce transcription and secretion of functional interferons as well as a number of other cytokines and chemokines. Upon transdifferentiation into myofibroblasts, HSCs rapidly loose the ability to produce interferon gamma (IFN gamma). Mechanistically, this gene silencing may be due to Polycomb complex mediated repression via methylation of histone H3 lysine 27. In contrast to wild type, quiescent HSC isolated from tlr3 knockout mice do not produce IFN gamma in response to Poly(I:C) treatment. Therefore, quiescent HSC may contribute to induction of the hepatic innate immune system in response to injury or infection.	[Wilson, Caroline L.; Mann, Jelena; Walsh, Meagan; Perrugoria, Maria J.; Oakley, Fiona; Wright, Matthew C.; Mann, Derek A.] Newcastle Univ, Fac Med Sci, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Brignole, Chiara; Di Paolo, Daniela; Perri, Patrizia; Ponzoni, Mirco] Ist Giannina Gaslini, Lab Oncol, Expt Therapy Unit, I-16148 Genoa, Italy; [Karin, Michael] Univ Calif San Diego, Sch Med, Dept Pharmacol & Pathol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA	Newcastle University - UK; University of Genoa; IRCCS Istituto Giannina Gaslini; University of California System; University of California San Diego	Mann, DA (corresponding author), Newcastle Univ, Fac Med Sci, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	Derek.Mann@ncl.ac.uk	Di Paolo, Daniela/J-7681-2016; Perri, Patrizia/AFV-5794-2022; Brignole, Chiara/H-9986-2018; Ponzoni, Mirco/J-7713-2016; Perri, Patrizia/I-8124-2018	Di Paolo, Daniela/0000-0001-7264-6888; Perri, Patrizia/0000-0003-2538-8278; Brignole, Chiara/0000-0002-2563-6991; Ponzoni, Mirco/0000-0002-6164-4286; Perri, Patrizia/0000-0003-2538-8278; Wright, Matthew/0000-0003-3167-6743; Mann, Derek/0000-0003-0950-243X; , Caroline/0000-0002-9016-6025	National Institutes of Health (NIH) [U01AA018663, P50AA11199, R24AA12885]; Newcastle Biomedical Research Centre; Wellcome Trust [WT086755MA]; Medical Research Council [MK/K001949/1, G0700890]; European Commission FP7 program grant 'INFLA-CARE' (EC) [223151]; Medical Research Council [MR/K001949/1] Funding Source: researchfish; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA018663, R24AA012885, P50AA011999] Funding Source: NIH RePORTER; MRC [MR/K001949/1, G0700890] Funding Source: UKRI	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Newcastle Biomedical Research Centre; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission FP7 program grant 'INFLA-CARE' (EC); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The present study was supported by the National Institutes of Health (NIH) grants (U01AA018663, P50AA11199, R24AA12885), Newcastle Biomedical Research Centre, the Wellcome Trust (WT086755MA to D. A. M. and M. K.), Medical Research Council grants (MK/K001949/1 to D. A. M., J.M., F.O. and G0700890 to D. A. M., M. C. W. and F.O.) and the European Commission FP7 program grant 'INFLA-CARE' (EC Contract No. 223151; http://inflacare.imbb.forth.gr/ to D. A. M., M. P., C. B., D. D. P. and P. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; BLOMHOFF R, 1991, FASEB J, V5, P271, DOI 10.1096/fasebj.5.3.2001786; Broering R, 2008, J HEPATOL, V48, P914, DOI 10.1016/j.jhep.2008.01.028; Byun JS, 2013, J HEPATOL, V58, P342, DOI 10.1016/j.jhep.2012.09.016; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Guillot L, 2005, J BIOL CHEM, V280, P5571, DOI 10.1074/jbc.M410592200; HENDRIKS HFJ, 1985, EXP CELL RES, V160, P138, DOI 10.1016/0014-4827(85)90243-5; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Jeong WI, 2006, HEPATOLOGY, V44, P1441, DOI 10.1002/hep.21419; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109; Lang KS, 2006, J CLIN INVEST, V116, P2456, DOI 10.1172/JCI28349; Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200; Mann J, 2010, GASTROENTEROLOGY, V138, P705, DOI 10.1053/j.gastro.2009.10.002; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Paik YH, 2006, LAB INVEST, V86, P676, DOI 10.1038/labinvest.3700422; Perugorria MJ, 2012, HEPATOLOGY, V56, P1129, DOI 10.1002/hep.25754; Radaeva S, 2006, GASTROENTEROLOGY, V130, P435, DOI 10.1053/j.gastro.2005.10.055; Saile B, 2004, EUR J CELL BIOL, V83, P469, DOI 10.1078/0171-9335-00409; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036; Wang N, 2009, J VIROL, V83, P9824, DOI 10.1128/JVI.01125-09; Watanabe A, 2007, HEPATOLOGY, V46, P1509, DOI 10.1002/hep.21867; Wilson CL, 2012, IMMUNOLOGY, V135, P344, DOI 10.1111/j.1365-2567.2011.03548.x; WILTROUT RH, 1989, J IMMUNOL, V143, P372; WILTROUT RH, 1984, J EXP MED, V160, P1431, DOI 10.1084/jem.160.5.1431; Wu J, 2010, IMMUNOLOGY, V129, P363, DOI 10.1111/j.1365-2567.2009.03179.x; Yin S, 2010, GASTROENT RES PRACT, P2010	35	30	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83391	10.1371/journal.pone.0083391	http://dx.doi.org/10.1371/journal.pone.0083391			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416163	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500045
J	Xie, L; Zhou, QM; Liu, SG; Wu, QY; Ji, YJ; Zhang, LJ; Xu, F; Gong, W; Melgiri, ND; Xie, P				Xie, Liang; Zhou, Qinming; Liu, Shigang; Wu, Qingyuan; Ji, Yongjia; Zhang, Lujun; Xu, Fan; Gong, Wei; Melgiri, Narayan D.; Xie, Peng			Normal Thoracic Radiographic Appearance of the Cynomolgus Monkey (Macaca fascicularis)	PLOS ONE			English	Article							MACAQUES; MODEL; SIZE	Background: The cynomolgus monkey (Macaca fascicularis) has been increasingly used as a non-human primate model in biomedical research. As establishing baseline thoracic radiography for the cynomolgus monkey is essential, we tested the hypothesis that age and sex may affect the thoracic radiography parameters of this species. Methods: Here, 697 healthy cynomolgus monkeys were segregated by sex and age (three age groups: 25-36 months, 37-48 months, 49-60 months). The lung length (LL), maximal interior thoracic depth (TD), maximal interior thoracic breadth (TBr), cardiac silhouette breadth (CBr), cardiothoracic ratio (CR), right and left costophrenic angles (RCA and LCA), and right hilar height ratio (R-HHR) were assessed by chest film. Statistical analysis was applied to examine the effect of age, sex, and age x sex interactions. Results: Significant effects by age were shown for LL, TD, TBr, CBr, and CR. Significant effects by sex were found for TD, TBr, CBr, CR, and R-HHR. Significant effects by age x sex were observed for TD, TBr, CBr, and CR. Both TD and TBr increased with age in both sexes, and both were significantly higher in males than in females in the group aged 49-60 months. CBr increased with age and was significantly higher in males than in females across all age groups. CR declined with age and was significantly higher in males than females across all age groups, and CR was similar or slightly higher relative to those previously found in other non-human primate species. As to the other parameters with no significant sex nor age-related differences, the R-HHR was greater than 1.00, and the angulation of bilateral costophrenic angles were sharp. Conclusions: The thoracic radiographic parameters for the healthy cynomolgus monkey presented here should prove useful in veterinary practice, research involving non-human primate models of respiratory or cardiovascular disorders, and morphological studies on cynomolgus monkeys.	[Xie, Liang; Zhou, Qinming; Wu, Qingyuan; Ji, Yongjia; Zhang, Lujun; Xu, Fan; Gong, Wei; Melgiri, Narayan D.; Xie, Peng] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China; [Xie, Liang; Zhou, Qinming; Wu, Qingyuan; Ji, Yongjia; Zhang, Lujun; Xu, Fan; Gong, Wei; Melgiri, Narayan D.; Xie, Peng] Chongqing Key Lab Neurobiol, Chongqing, Peoples R China; [Xie, Liang; Zhou, Qinming; Wu, Qingyuan; Ji, Yongjia; Xie, Peng] Chongqing Med Univ, Inst Neurosci, Chongqing, Peoples R China; [Liu, Shigang] Suzhou Xishan Zhongke Lab Anim Co Ltd, Suzhou, Peoples R China	Chongqing Medical University; Chongqing Medical University	Xie, P (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China.	xiepeng@cqmu.edu.cn	Zhou, Qinming/GWZ-7229-2022	Zhou, Qinming/0000-0001-6211-0588	National Basic Research Program of China (973 Program) [2009CB918300]; National Natural Science Foundation of China [31271189]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program; Grant No. 2009CB918300) and the National Natural Science Foundation of China (Grant No. 31271189). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves FR, 2012, PESQUISA VET BRASIL, V32, P1345, DOI 10.1590/S0100-736X2012001200021; Andrade MCR, 2004, MEM I OSWALDO CRUZ, V99, P581, DOI 10.1590/S0074-02762004000600009; Brining DL, 2010, COMPARATIVE MED, V60, P389; Campbell RM, 2003, J BONE JOINT SURG AM, V85A, P399, DOI 10.2106/00004623-200303000-00001; HAMMERMEISTER KE, 1979, CIRCULATION, V59, P89, DOI 10.1161/01.CIR.59.1.89; HOMER MJ, 1978, RADIOLOGY, V129, P11, DOI 10.1148/129.1.11; HUBBELL FA, 1985, NEW ENGL J MED, V312, P209, DOI 10.1056/NEJM198501243120404; Ji Y, 2013, J AM ASS LAB ANIM, V52, P1; Lawler JV, 2006, PLOS MED, V3, P677, DOI 10.1371/journal.pmed.0030149; LEIGH SR, 1992, J HUM EVOL, V23, P27, DOI 10.1016/0047-2484(92)90042-8; Liang Sao-Ling, 2005, Taiwan Veterinary Journal, V31, P85; Mattison LE, 1997, CHEST, V111, P1018, DOI 10.1378/chest.111.4.1018; REICH SB, 1985, AM J ROENTGENOL, V144, P695, DOI 10.2214/ajr.144.4.695; Schillaci MA, 2008, J MED PRIMATOL, V37, P141, DOI 10.1111/j.1600-0684.2007.00250.x; Schillaci MA, 2010, RADIOGRAPHY, V16, P163, DOI 10.1016/j.radi.2010.01.003; Schillaci MA, 2009, RADIOGRAPHY, V15, pE29, DOI 10.1016/j.radi.2009.05.005; Sharpe SA, 2010, CLIN VACCINE IMMUNOL, V17, P1170, DOI 10.1128/CVI.00079-10; SILVERMAN S, 1980, AM J VET RES, V41, P1704; Wagner WM, 2005, VET RADIOL ULTRASOUN, V46, P217, DOI 10.1111/j.1740-8261.2005.00044.x; Wolfe-Coote S, 2005, LAB PRIMATE, P371; Xie L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064892	21	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84599	10.1371/journal.pone.0084599	http://dx.doi.org/10.1371/journal.pone.0084599			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416248	gold, Green Published, Green Submitted			2022-12-27	WOS:000329862500139
J	Brielmann, AA; Stolarova, M				Brielmann, Aenne A.; Stolarova, Margarita			A New Standardized Stimulus Set for Studying Need-of-Help Recognition (NeoHelp)	PLOS ONE			English	Article							PROSOCIAL BEHAVIOR; EARLY ADOLESCENCE; YOUNG-CHILDREN; REACTION-TIME; IMAGES; FAMILIARITY; OBJECTS; COLOR; INTENTIONS; ATTENTION	This article presents the NeoHelp visual stimulus set created to facilitate investigation of need-of-help recognition with clinical and normative populations of different ages, including children. Need-of-help recognition is one aspect of socioemotional development and a necessary precondition for active helping. The NeoHelp consists of picture pairs showing everyday situations: The first item in a pair depicts a child needing help to achieve a goal; the second one shows the child achieving the goal. Pictures of birds in analogue situations are also included. These control stimuli enable implementation of a human-animal categorization task which serves to separate behavioral correlates specific to need-of-help recognition from general differentiation processes. It is a concern in experimental research to ensure that results do not relate to systematic perceptual differences when comparing responses to categories of different content. Therefore, we not only derived the NeoHelp-pictures within a pair from one another by altering as little as possible, but also assessed their perceptual similarity empirically. We show that NeoHelp-picture pairs are very similar regarding low-level perceptual properties across content categories. We obtained data from 60 children in a broad age range (4 to 13 years) for three different paradigms, in order to assess whether the intended categorization and differentiation could be observed reliably in a normative population. Our results demonstrate that children can differentiate the pictures' content regarding both need-of-help category as well as species as intended in spite of the high perceptual similarities. We provide standard response characteristics (hit rates and response times) that are useful for future selection of stimuli and comparison of results across studies. We show that task requirements coherently determine which aspects of the pictures influence response characteristics. Thus, we present NeoHelp, the first open-access standardized visual stimuli set for investigation of need-of-help recognition and invite researchers to use and extend it.	[Brielmann, Aenne A.; Stolarova, Margarita] Univ Konstanz, Dept Psychol & Zukunftskolleg, Constance, Germany; [Stolarova, Margarita] Rhine Waal Univ Appl Sci, Fac Soc & Econ, Kleve, Germany	University of Konstanz	Stolarova, M (corresponding author), Univ Konstanz, Dept Psychol & Zukunftskolleg, Constance, Germany.	margarita.stolarova@uni-konstanz.de	Brielmann, Aenne/L-5211-2019	Brielmann, Aenne/0000-0002-6742-2836	Zukunftskolleg of the University of Konstanz	Zukunftskolleg of the University of Konstanz	Funding was provided by the Zukunftskolleg of the University of Konstanz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anaki D, 2009, COGNITION, V111, P144, DOI 10.1016/j.cognition.2009.01.002; Bar-tal AD, 1982, CHILD DEV, V53, P396; Berlyne DE, 1965, ELECTROENCEPHALOGRAP, V8, P156; Blanz V, 1999, COMP GRAPH, P187, DOI 10.1145/311535.311556; Brink TT, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00080; Brodeur MB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010773; Bulthoff I, 2006, PROG BRAIN RES, V154, P315, DOI 10.1016/S0079-6123(06)54017-8; Burge J, 2011, P NATL ACAD SCI USA, V108, P16849, DOI 10.1073/pnas.1108491108; Cano ME, 2009, INT J PSYCHOPHYSIOL, V71, P17, DOI 10.1016/j.ijpsycho.2008.07.016; Carlo G, 1999, J EARLY ADOLESCENCE, V19, P133, DOI 10.1177/0272431699019002001; Carpenter M, 2013, CHILD DEV, V84, P1511, DOI 10.1111/cdev.12083; Covington JW, 1996, EVOKED POTENTIAL, V100, P579, DOI 10.1016/S0168-5597(96)96013-X; Davidson MC, 2006, NEUROPSYCHOLOGIA, V44, P2037, DOI 10.1016/j.neuropsychologia.2006.02.006; Dell'acqua R, 2000, BEHAV RES METH INS C, V32, P588, DOI 10.3758/BF03200832; Delplanque S, 2007, J NEUROSCI METH, V165, P144, DOI 10.1016/j.jneumeth.2007.05.030; Dunfield KA, 2010, PSYCHOL SCI, V21, P523, DOI 10.1177/0956797610364119; EISENBERG N, 1991, DEV PSYCHOL, V27, P849, DOI 10.1037/0012-1649.27.5.849; Eisenberg N, 2005, NEBR SYM MOTIV, V51, P73; Fabes RA, 1999, J EARLY ADOLESCENCE, V19, P5, DOI 10.1177/0272431699019001001; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Geisler WS, 2011, J VISION, V11, DOI 10.1167/11.12.14; Hamlin JK, 2007, NATURE, V450, P557, DOI 10.1038/nature06288; Moreno-Martinez FJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037527; Joseph J, 1979, STOELTING; Lang P. J., 1997, NIMH CTR STUDY EMOTI, P39; Lang PJ, 2010, BIOL PSYCHOL, V84, P437, DOI 10.1016/j.biopsycho.2009.10.007; LOFTUS GR, 1985, J EXP PSYCHOL GEN, V114, P342, DOI 10.1037/0096-3445.114.3.342; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; Luck S.J., 2005, INTRO EVENT RELATED; Malti T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052017; Pictures Feelings Instrument, 2004, SCHACK STON; Prinzmetal W, 2005, J EXP PSYCHOL GEN, V134, P73, DOI 10.1037/0096-3445.134.1.73; Sadr J, 2004, COGNITIVE SCI, V28, P259, DOI 10.1016/j.cogsci.2004.09.003; SANTEE JL, 1982, J EXP PSYCHOL HUMAN, V8, P489, DOI 10.1037/0096-1523.8.4.489; Sarfati Y, 1997, SCHIZOPHR RES, V25, P199, DOI 10.1016/S0920-9964(97)00025-X; Schupp HT, 2003, NEUROREPORT, V14, P1107, DOI 10.1097/00001756-200306110-00002; Spering M, 2005, J VISION, V5, P455, DOI 10.1167/5.5.6; Svetlova M, 2010, CHILD DEV, V81, P1814, DOI 10.1111/j.1467-8624.2010.01512.x; Tanaka J, 2001, TRENDS COGN SCI, V5, P211, DOI 10.1016/S1364-6613(00)01626-0; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P811, DOI 10.1073/pnas.95.3.811; Troje NF, 1996, VISION RES, V36, P1761, DOI 10.1016/0042-6989(95)00230-8; Umla-Runge K, 2012, BEHAV RES METHODS, V44, P946, DOI 10.3758/s13428-012-0189-x; Vaish A, 2010, CHILD DEV, V81, P1661, DOI 10.1111/j.1467-8624.2010.01500.x; VERFAILLIE K, 1995, PERCEPT PSYCHOPHYS, V57, P925, DOI 10.3758/BF03205454; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Warneken F, 2013, INFANCY, V18, P345, DOI 10.1111/j.1532-7078.2012.00120.x; Warneken F, 2009, TRENDS COGN SCI, V13, P397, DOI 10.1016/j.tics.2009.06.008; Wiseman ED, 1972, SELF CONCEPT PICTURE	50	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84373	10.1371/journal.pone.0084373	http://dx.doi.org/10.1371/journal.pone.0084373			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	286JC	24409294	Green Published, Green Submitted, gold			2022-12-27	WOS:000329463500018
J	Burchett, KM; Yan, Y; Ouellette, MM				Burchett, Katrina M.; Yan, Ying; Ouellette, Michel M.			Telomerase Inhibitor Imetelstat (GRN163L) Limits the Lifespan of Human Pancreatic Cancer Cells	PLOS ONE			English	Article							TUMOR-GROWTH; DNA; ADENOCARCINOMA; SHELTERIN; MAINTENANCE; TANKYRASE-1; ANTAGONIST; TISSUES	Telomerase is required for the unlimited lifespan of cancer cells. The vast majority of pancreatic adenocarcinomas overexpress telomerase activity and blocking telomerase could limit their lifespan. GRN163L (Imetelstat) is a lipid-conjugated N39RP59 thio-phosphoramidate oligonucleotide that blocks the template region of telomerase. The aim of this study was to define the effects of long-term GRN163L exposure on the maintenance of telomeres and lifespan of pancreatic cancer cells. Telomere size, telomerase activity, and telomerase inhibition response to GRN163L were measured in a panel of 10 pancreatic cancer cell lines. The cell lines exhibited large differences in levels of telomerase activity (46-fold variation), but most lines had very short telomeres (2-3 kb in size). GRN163L inhibited telomerase in all 10 pancreatic cancer cell lines, with IC50 ranging from 50 nM to 200 nM. Continuous GRN163L exposure of CAPAN1 (IC50 = 75 nM) and CD18 cells (IC50 = 204 nM) resulted in an initial rapid shortening of the telomeres followed by the maintenance of extremely short but stable telomeres. Continuous exposure to the drug eventually led to crisis and to a complete loss of viability after 47 (CAPAN1) and 69 (CD18) doublings. Crisis In these cells was accompanied by activation of a DNA damage response (gamma-H2AX) and evidence of both senescence (SA-b-galactosidase activity) and apoptosis (sub-G1 DNA content, PARP cleavage). Removal of the drug after long-term GRN163L exposure led to a reactivation of telomerase and re-elongation of telomeres in the third week of cultivation without GRN163L. These findings show that the lifespan of pancreatic cancer cells can be limited by continuous telomerase inhibition. These results should facilitate the design of future clinical trials of GRN163L in patients with pancreatic cancer.	[Burchett, Katrina M.; Yan, Ying; Ouellette, Michel M.] Univ Nebraska, Med Ctr, Eppley Inst Res Canc, Omaha, NE 68198 USA; [Ouellette, Michel M.] Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Ouellette, MM (corresponding author), Univ Nebraska, Med Ctr, Eppley Inst Res Canc, Omaha, NE 68198 USA.	mouellet@unmc.edu			National Cancer Institute (NCI) [P50 CA127297]; NCI [T32 CA09476]; NATIONAL CANCER INSTITUTE [P50CA127297, T32CA009476] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a National Cancer Institute (NCI) SPORE grant (P50 CA127297) and NCI training grant (T32 CA09476). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekker-Jensen S, 2010, DNA REPAIR, V9, P1219, DOI 10.1016/j.dnarep.2010.09.010; BLACKBURN EH, 1994, CELL, V77, P621, DOI 10.1016/0092-8674(94)90046-9; Blackburn EH, 2011, COLD SPRING HARB PER, V3, DOI DOI 10.1101/CSHPERSPECT.A003558; Cesare AJ, 2010, NAT REV GENET, V11, P319, DOI 10.1038/nrg2763; Chang W, 2003, GENE DEV, V17, P1328, DOI 10.1101/gad.1077103; Choi KH, 2009, ROLE TELOMERASE CANC; Choi KH, 2011, NUCLEIC ACIDS RES, V39, P9206, DOI 10.1093/nar/gkr665; Cook BD, 2002, MOL CELL BIOL, V22, P332, DOI 10.1128/MCB.22.1.332-342.2002; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; Dikmen ZG, 2005, CANCER RES, V65, P7866, DOI 10.1158/0008-5472.CAN-05-1215; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Djojosubroto MW, 2005, HEPATOLOGY, V42, P1127, DOI 10.1002/hep.20822; Duriez PJ, 1997, BIOCHEM CELL BIOL, V75, P337, DOI 10.1139/bcb-75-4-337; Gellert GC, 2006, BREAST CANCER RES TR, V96, P73, DOI 10.1007/s10549-005-9043-5; Gryaznov S, 2001, NUCLEOS NUCLEOT NUCL, V20, P401, DOI 10.1081/NCN-100002314; Gryaznov SM, 2010, CHEM BIODIVERS, V7, P477, DOI 10.1002/cbdv.200900187; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; HARLEY CB, 1991, MUTAT RES, V256, P271, DOI 10.1016/0921-8734(91)90018-7; Henson JD, 2009, NAT BIOTECHNOL, V27, P1181, DOI 10.1038/nbt.1587; Herbert BS, 2006, NAT PROTOC, V1, P1583, DOI 10.1038/nprot.2006.239; Hiyama E, 1997, CANCER RES, V57, P326; Hochreiter AE, 2006, CLIN CANCER RES, V12, P3184, DOI 10.1158/1078-0432.CCR-05-2760; Holt SE, 1997, P NATL ACAD SCI USA, V94, P10687, DOI 10.1073/pnas.94.20.10687; Ishii A, 2006, EXP GERONTOL, V41, P882, DOI 10.1016/j.exger.2006.06.036; Iwamura T, 1999, HUMAN CELL CULTURE, V1, P107; KIM YW, 1989, PANCREAS, V4, P353, DOI 10.1097/00006676-198906000-00013; Koorstra JBM, 2009, MODERN PATHOL, V22, P1439, DOI 10.1038/modpathol.2009.114; Lau LMS, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks781; Li ZK, 2004, CANCER-AM CANCER SOC, V101, P58, DOI 10.1002/cncr.20321; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; Marian CO, 2010, CLIN CANCER RES, V16, P154, DOI 10.1158/1078-0432.CCR-09-2850; Murnane JP, 2012, MUTAT RES-FUND MOL M, V730, P28, DOI 10.1016/j.mrfmmm.2011.04.008; Nakamura T, 2007, CANCER RES, V67, P139, DOI 10.1158/0008-5472.CAN-06-2563; Norton JC, 1996, NAT BIOTECHNOL, V14, P615, DOI 10.1038/nbt0596-615; Ouellette MM, 2011, J CELL MOL MED, V15, P1433, DOI 10.1111/j.1582-4934.2011.01279.x; Ouellette MM, 2000, J BIOL CHEM, V275, P10072, DOI 10.1074/jbc.275.14.10072; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pearson AS, 2000, INT J ONCOL, V17, P381; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Seimiya H, 2005, CANCER CELL, V7, P25, DOI 10.1016/j.ccr.2004.11.021; Shammas MA, 2008, LEUKEMIA, V22, P1410, DOI 10.1038/leu.2008.81; Shammas MA, 1999, ONCOGENE, V18, P6191, DOI 10.1038/sj.onc.1203069; Shammas MA, 2008, CLIN CANCER RES, V14, P4971, DOI 10.1158/1078-0432.CCR-08-0473; Shay JW, 2005, CANCER CELL, V7, P1, DOI 10.1016/j.ccr.2004.12.012; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2; Shea-Herbert B, 2002, ONCOGENE, V21, P638, DOI 10.1038/sj.onc.1205064; Siegel R, 2012, CANC FACTS FIGURES; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Tokutake Y, 1998, BIOCHEM BIOPH RES CO, V247, P765, DOI 10.1006/bbrc.1998.8876; Tsutsumi M, 1997, JPN J CANCER RES, V88, P971, DOI 10.1111/j.1349-7006.1997.tb00317.x; Ulaner GA, 1997, MOL HUM REPROD, V3, P769, DOI 10.1093/molehr/3.9.769; van Heek NT, 2002, AM J PATHOL, V161, P1541, DOI 10.1016/S0002-9440(10)64432-X; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; White LK, 2001, TRENDS BIOTECHNOL, V19, P114, DOI 10.1016/S0167-7799(00)01541-9; WRIGHT WE, 1992, EXP GERONTOL, V27, P383, DOI 10.1016/0531-5565(92)90069-C; Wright WE, 1996, DEV GENET, V18, P173; Zhang JH, 2000, CELL RES, V10, P205, DOI 10.1038/sj.cr.7290049; Zhang XL, 1999, GENE DEV, V13, P2388, DOI 10.1101/gad.13.18.2388; Zhao Y, 2011, MOL CELL, V42, P297, DOI 10.1016/j.molcel.2011.03.020	61	49	53	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e85155	10.1371/journal.pone.0085155	http://dx.doi.org/10.1371/journal.pone.0085155			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409321	Green Submitted, gold, Green Published			2022-12-27	WOS:000329463500045
J	Banerjee, A; Supakar, S; Banerjee, R				Banerjee, Aulie; Supakar, Subhrangshu; Banerjee, Raja			Melanin from the Nitrogen-Fixing Bacterium Azotobacter chroococcum: A Spectroscopic Characterization	PLOS ONE			English	Article							HUMAN HAIR MELANIN; 5,6-DIHYDROXYINDOLE-2-CARBOXYLIC ACID; MAGNETIC-RESONANCE; SUBSTANTIA-NIGRA; SEPIA MELANIN; H-1-NMR; C-13	Melanins, the ubiquitous hetero-polymer pigments found widely dispersed among various life forms, are usually dark brown/black in colour. Although melanins have variety of biological functions, including protection against ultraviolet radiation of sunlight and are used in medicine, cosmetics, extraction of melanin from the animal and plant kingdoms is not an easy task. Using complementary physicochemical techniques (i.e. MALDI-TOF, FTIR absorption and cross-polarization magic angle spinning solid-state C-13 NMR), we report here the characterization of melanins extracted from the nitrogen-fixing non-virulent bacterium Azotobacter chroococcum, a safe viable source. Moreover, considering dihydroxyindole moiety as the main constituent, an effort is made to propose the putative molecular structure of the melanin hetero-polymer extracted from the bacterium. Characterization of the melanin obtained from Azotobacter chroococcum would provide an inspiration in extending research activities on these hetero-polymers and their use as protective agent against UV radiation.	[Banerjee, Aulie; Supakar, Subhrangshu; Banerjee, Raja] West Bengal Univ Technol, Dept Bioinformat, Kolkata, W Bengal, India	Maulana Abul Kalam Azad University of Technology	Banerjee, R (corresponding author), West Bengal Univ Technol, Dept Bioinformat, Kolkata, W Bengal, India.	ban_raja@yahoo.com			Department of Biotechnology, Govt. of India [BT/BI/25/001/2006-Vol. II]	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India)	This study was supported by the Department of Biotechnology, Govt. of India, sanction number BT/BI/25/001/2006-Vol. II. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhyaru BB, 2003, MAGN RESON CHEM, V41, P466, DOI 10.1002/mrc.1193; Baraboy V. A., 1999, Ukrainskii Biokhimicheskii Zhurnal, V71, P5; Becking JH, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P759, DOI 10.1007/0-387-30746-x_26; Becking JH, 1981, PROKARYOTES HDB HABI, V1, P795; Burk D, 1930, J BACTERIOL, V19, P389, DOI 10.1128/JB.19.6.389-414.1930; Burk D, 1930, J PHYS CHEM-US, V34, P1195, DOI 10.1021/j150312a006; Castelvecchi D., 2009, SCI NEWS, V171, P325, DOI [10.1002/scin.2007.5591712106, DOI 10.1002/SCIN.2007.5591712106]; CHEDEKEL MR, 1982, PHOTOCHEM PHOTOBIOL, V35, P881, DOI 10.1111/j.1751-1097.1982.tb02663.x; CHEDEKEL MR, 1992, PIGM CELL RES, V5, P240, DOI 10.1111/j.1600-0749.1992.tb00543.x; Clarke HT, 1975, HDB ORGANIC ANAL; Dadachova E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000457; DALTON H, 1968, J GEN MICROBIOL, V54, P463, DOI 10.1099/00221287-54-3-463; Dobrzynska D, 1997, ACTA CRYSTALLOGR C, V53, P238, DOI 10.1107/S0108270196012802; Double KL, 2000, J NEUROCHEM, V75, P2583, DOI 10.1046/j.1471-4159.2000.0752583.x; DUFF GA, 1988, BIOCHEMISTRY-US, V27, P7112, DOI 10.1021/bi00418a067; ENOCHS WS, 1993, PIGM CELL RES, V6, P91, DOI 10.1111/j.1600-0749.1993.tb00587.x; Finar IL, 1986, ORGANIC CHEM, V1; Geng J, 2010, ARCH MICROBIOL, V192, P321, DOI 10.1007/s00203-010-0560-1; Ghiani S, 2008, MAGN RESON CHEM, V46, P471, DOI 10.1002/mrc.2202; GOWER RP, 1969, J CHEM EDUC, V46, P606, DOI 10.1021/ed046p606; Hamilton AJ, 2002, J MED MICROBIOL, V51, P189, DOI 10.1099/0022-1317-51-3-189; HERVE M, 1994, BBA-PROTEIN STRUCT M, V1204, P19, DOI 10.1016/0167-4838(94)90027-2; Hewedy M, 2009, AUST J BASIC APPL SC, V3; HILL HZ, 1992, BIOESSAYS, V14, P49, DOI 10.1002/bies.950140111; JENSEN HL, 1954, BACTERIOL REV, V18, P195, DOI 10.1128/MMBR.18.4.195-214.1954; Katritzky AR, 2002, PIGM CELL RES, V15, P93, DOI 10.1034/j.1600-0749.2002.1o062.x; Kemp W., 1987, ORGANIC SPECTROSCOPY; Lindgren J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1819; Magarelli M., 2010, Revista CES Medicina Veterinaria y Zootecnia, V5, P18; Moores OT, 1995, SCI MELANIN; Morzyk-Ociepa B, 2004, J MOL STRUCT, V688, P79, DOI 10.1016/j.molstruc.2003.09.027; Napolitano A, 1996, RAPID COMMUN MASS SP, V10, P204, DOI 10.1002/(SICI)1097-0231(19960131)10:2<204::AID-RCM460>3.0.CO;2-E; NICOLAUS RA, 1964, TETRAHEDRON, V20, P1163, DOI 10.1016/S0040-4020(01)98983-5; Peter MG, 1989, ANGEW CHEM INT EDIT, P28741; Pezzella A, 1996, TETRAHEDRON, V52, P7913, DOI 10.1016/0040-4020(96)00362-6; Pezzella A, 1997, TETRAHEDRON, V53, P8281, DOI 10.1016/S0040-4020(97)00494-8; Plonka PM, 2006, ACTA BIOCHIM POL, V53, P429, DOI 10.18388/abp.2006_3314; PYSH ES, 1977, J AM CHEM SOC, V99, P6211, DOI 10.1021/ja00461a007; Reinheimer P, 1999, BBA-GEN SUBJECTS, V1472, P240, DOI 10.1016/S0304-4165(99)00127-0; Schaefer J., 1979, TOP CARBON 13 NMR SP, P283, DOI [10.1021/acs.jafc.5b03206, DOI 10.1021/ACS.JAFC.5B03206]; Schneider HJ, 1989, THEIS I ANGEW CHEM, V101, P757; SCHNITZER M, 1986, SOIL SCI SOC AM J, V50, P67, DOI 10.2136/sssaj1986.03615995005000010013x; SHIVPRASAD S, 1989, APPL ENVIRON MICROB, V55, P1811, DOI 10.1128/AEM.55.7.1811-1817.1989; Solano F, 1997, APPL ENVIRON MICROB, V63, P3499, DOI 10.1128/AEM.63.9.3499-3506.1997; Swan G A, 1974, Fortschr Chem Org Naturst, V31, P521; Thompson JP, 1979, AZOTOBACTERACEAE TAX; Tine A, 1998, SPECTROCHIM ACTA A, V54, P1451, DOI 10.1016/S1386-1425(98)00046-8; TONIOLO C, 1988, BIOPOLYMERS, V27, P373, DOI 10.1002/bip.360270303; Wilson P.W., 1952, EXPT BACTERIAL PHYSL; ZECCA L, 1992, BIOCHIM BIOPHYS ACTA, V1138, P6, DOI 10.1016/0925-4439(92)90144-C	50	38	39	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84574	10.1371/journal.pone.0084574	http://dx.doi.org/10.1371/journal.pone.0084574			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416247	Green Submitted, Green Published, gold			2022-12-27	WOS:000329866300028
J	Belkaya, S; van Oers, NSC				Belkaya, Serkan; van Oers, Nicolai S. C.			Transgenic Expression of MicroRNA-181d Augments the Stress-Sensitivity of CD4(+)CD8(+) Thymocytes	PLOS ONE			English	Article							GLUCOCORTICOID-INDUCED APOPTOSIS; BONE-MARROW-TRANSPLANTATION; LEUKEMIA INHIBITORY FACTOR; THYMIC EPITHELIAL-CELLS; ROLES; MIRNA; RNA; MECHANISMS; WEBGESTALT; INVOLUTION	Physiological stress resulting from infections, trauma, surgery, alcoholism, malnutrition, and/or pregnancy results in a substantial depletion of immature CD4(+)CD8(+) thymocytes. We previously identified 18 distinct stress-responsive microRNAs (miRs) in the thymus upon systemic stress induced by lipopolysaccharide (LPS) or the synthetic glucocorticoid, dexamethasone (Dex). MiRs are short, non-coding RNAs that play critical roles in the immune system by targeting diverse mRNAs, suggesting that their modulation in the thymus in response to stress could impact thymopoiesis. MiR-181d is one such stress-responsive miR, exhibiting a 15-fold down-regulation in expression. We utilized both transgenic and gene-targeting approaches to study the impact of miR-181d on thymopoiesis under normal and stress conditions. The overexpression of miR-181d in developing thymocytes reduced the total number of immature CD4(+)CD8(+) thymocytes. LPS or Dex injections caused a 4-fold greater loss of these cells when compared with the wild type controls. A knockout mouse was developed to selectively eliminate miR-181d, leaving the closely spaced and contiguous family member miR-181c intact. The targeted elimination of just miR-181d resulted in a thymus stress-responsiveness similar to wild-type mice. These experiments suggest that one or more of three other miR-181 family members have overlapping or compensatory functions. Gene expression comparisons of thymocytes from the wild type versus transgenic mice indicated that miR-181d targets a number of stress, metabolic, and signaling pathways. These findings demonstrate that selected miRs enhance stress-mediated thymic involution in vivo.	[Belkaya, Serkan; van Oers, Nicolai S. C.] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [van Oers, Nicolai S. C.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [van Oers, Nicolai S. C.] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	van Oers, NSC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA.	nicolai.vanoers@utsouthwestern.edu	Van+Oers, Nicolai/ABA-2437-2021; Belkaya, Serkan/ABD-4504-2020	Belkaya, Serkan/0000-0003-4214-382X; van Oers, Nicolai/0000-0002-6545-8405	National Institutes of Health (NIH) [R21 AI083827-01]; University of Texas Southwestern Medical Center (Beecher Foundation); Childrens' Medical Center Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083827] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas Southwestern Medical Center (Beecher Foundation); Childrens' Medical Center Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by a grant from the National Institutes of Health (NIH) R21 AI083827-01 and internal grants from the University of Texas Southwestern Medical Center (Beecher Foundation) and Childrens' Medical Center Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGEEV AK, 1986, ARK PATOL, V48, P33; Ashwell JD, 2000, ANNU REV IMMUNOL, V18, P309, DOI 10.1146/annurev.immunol.18.1.309; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Becker AM, 2010, J IMMUNOL, V184, P6822, DOI 10.4049/jimmunol.0902058; Belkaya S, 2013, J BIOL CHEM, V288, P30752, DOI 10.1074/jbc.M113.503532; Belkaya S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027580; Billard MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017940; Chatham WW, 2001, LUPUS, V10, P140, DOI 10.1191/096120301675075008; Choi YI, 2001, P NATL ACAD SCI USA, V98, P10267, DOI 10.1073/pnas.181076198; Cichocki F, 2011, J IMMUNOL, V187, P6171, DOI 10.4049/jimmunol.1100835; de la Morena MT, 2013, CLIN IMMUNOL, V147, P11, DOI 10.1016/j.clim.2013.01.011; Deftos ML, 1998, IMMUNITY, V9, P777, DOI 10.1016/S1074-7613(00)80643-3; Dooley J, 2012, EUR J IMMUNOL, V42, P1073, DOI 10.1002/eji.201142305; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Dozmorov MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012657; Ebert PJR, 2009, NAT IMMUNOL, V10, P1162, DOI 10.1038/ni.1797; Fragoso R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002855; Frankfurt O, 2004, CURR OPIN ONCOL, V16, P553, DOI 10.1097/01.cco.0000142072.22226.09; Gruver AL, 2008, J LEUKOCYTE BIOL, V84, P915, DOI 10.1189/jlb.0108025; Hauri-Hohl MM, 2008, BLOOD, V112, P626, DOI 10.1182/blood-2007-10-115618; Haynes BF, 2000, ANNU REV IMMUNOL, V18, P529, DOI 10.1146/annurev.immunol.18.1.529; Heinonen KM, 2011, BLOOD, V118, P5163, DOI 10.1182/blood-2011-04-350553; Henao-Mejia J, 2013, IMMUNITY, V38, P984, DOI 10.1016/j.immuni.2013.02.021; Herold MJ, 2006, CELL MOL LIFE SCI, V63, P60, DOI 10.1007/s00018-005-5390-y; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Ji JF, 2009, HEPATOLOGY, V50, P472, DOI 10.1002/hep.22989; Kirigin FF, 2012, J IMMUNOL, V188, P3257, DOI 10.4049/jimmunol.1103175; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Liu G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003592; Liu ZP, 2005, DEV CELL, V9, P261, DOI 10.1016/j.devcel.2005.05.017; Luz C, 2003, MECH AGEING DEV, V124, P887, DOI 10.1016/S0047-6374(03)00148-9; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; MULLERHERMELINK HK, 1987, AM J PATHOL, V129, P242; Murgita R A, 1981, Prog Allergy, V29, P54; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; Ouyang YB, 2012, MITOCHONDRION, V12, P213, DOI 10.1016/j.mito.2011.09.001; Pall GS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm112; Papadopoulou AS, 2012, NAT IMMUNOL, V13, P181, DOI 10.1038/ni.2193; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; ROCKLIN RE, 1979, ANNU REV MED, V30, P375, DOI 10.1146/annurev.me.30.020179.002111; Sempowski GD, 2000, J IMMUNOL, V164, P2180, DOI 10.4049/jimmunol.164.4.2180; Sempowski GD, 2002, EUR J IMMUNOL, V32, P3066, DOI 10.1002/1521-4141(200211)32:11<3066::AID-IMMU3066>3.0.CO;2-J; Sionov Ronit Vogt, 2013, ISRN Hematol, V2013, P348212, DOI 10.1155/2013/348212; Smith LK, 2010, J BIOL CHEM, V285, P36698, DOI 10.1074/jbc.M110.162123; VACCHIO MS, 1994, J EXP MED, V179, P1835, DOI 10.1084/jem.179.6.1835; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; van Oers NSC, 2000, NAT IMMUNOL, V1, P322, DOI 10.1038/79774; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Webster JI, 2002, ANNU REV IMMUNOL, V20, P125, DOI 10.1146/annurev.immunol.20.082401.104914; Winoto A, 2002, CELL, V109, pS57, DOI 10.1016/S0092-8674(02)00710-9; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S; Zietara N, 2013, P NATL ACAD SCI USA, V110, P7407, DOI 10.1073/pnas.1221984110	62	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85274	10.1371/journal.pone.0085274	http://dx.doi.org/10.1371/journal.pone.0085274			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416377	Green Published, Green Submitted, gold			2022-12-27	WOS:000329866300063
J	Dhiman, P; Kai, J; Horsfall, L; Walters, K; Qureshi, N				Dhiman, Paula; Kai, Joe; Horsfall, Laura; Walters, Kate; Qureshi, Nadeem			Availability and Quality of Coronary Heart Disease Family History in Primary Care Medical Records: Implications for Cardiovascular Risk Assessment	PLOS ONE			English	Article							GENERAL-PRACTICE; VALIDATION	Background: The potential to use data on family history of premature disease to assess disease risk is increasingly recognised, particularly in scoring risk for coronary heart disease (CHD). However the quality of family health information in primary care records is unclear. Aim: To assess the availability and quality of family history of CHD documented in electronic primary care records Design: Cross-sectional study Setting: 537 UK family practices contributing to The Health Improvement Network database. Method: Data were obtained from patients aged 20 years or more, registered with their current practice between 1st January 1998 and 31st December 2008, for at least one year. The availability and quality of recorded CHD family history was assessed using multilevel logistic and ordinal logistic regression respectively. Results: In a cross-section of 1,504,535 patients, 19% had a positive or negative family history of CHD recorded. Multilevel logistic regression showed patients aged 50-59 had higher odds of having their family history recorded compared to those aged 20-29 (OR: 1.23 (1.21 to 1.25)), however most deprived patients had lower odds compared to those least deprived (OR: 0.86 (0.85 to 0.88)). Of the 140,058 patients with a positive family history recorded (9% of total cohort), age of onset was available in 45%; with data specifying both age of onset and relative affected available in only 11% of records. Multilevel ordinal logistic regression confirmed no statistical association between the quality of family history recording and age, gender, deprivation and year of registration. Conclusion: Family history of CHD is documented in a small proportion of primary care records; and where positive family history is documented the details are insufficient to assess familial risk or populate cardiovascular risk assessment tools. Data capture needs to be improved particularly for more disadvantaged patients who may be most likely to benefit from CHD risk assessment.	[Dhiman, Paula; Kai, Joe; Qureshi, Nadeem] Univ Nottingham, Sch Med, Div Primary Care, Nottingham, England; [Horsfall, Laura; Walters, Kate] UCL, Res Dept Primary Care & Populat Hlth, London, England	University of Nottingham; University of London; University College London	Qureshi, N (corresponding author), Univ Nottingham, Sch Med, Div Primary Care, Univ Pk, Nottingham, England.	nadeem.qureshi@nottingham.ac.uk		Kai, Joe/0000-0001-9040-9384; Walters, Kate/0000-0003-2173-2430; Qureshi, Nadeem/0000-0003-4909-0644	Faculty of Medicine, University of Nottingham	Faculty of Medicine, University of Nottingham	The study was supported by pump-primed funding from the Faculty of Medicine, University of Nottingham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheson LS, 2000, GENET MED, V2, P180, DOI 10.1097/00125817-200005000-00004; [Anonymous], 1997, Eur Heart J, V18, P1569; Bankhead C, 2001, FAM PRACT, V18, P475, DOI 10.1093/fampra/18.5.475; Bennett RL, 2004, PRIMARY CARE, V31, P479, DOI 10.1016/j.pop.2004.05.004; Berg AO, 2009, ANN INTERN MED, V151, P872, DOI [10.7326/0000605-200912150-00165, 10.7326/0003-4819-151-12-200912150-00165]; Blak Betina T, 2011, Inform Prim Care, V19, P251; Bourke Alison, 2004, Inform Prim Care, V12, P171; Collins GS, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2442; Cooper A, 2008, CLIN GUIDELINES EVID; Dave S, 2009, PHARMACOEPIDEM DR S, V18, P704, DOI 10.1002/pds.1770; de la Iglesia B, 2011, HEART, V97, P491, DOI 10.1136/hrt.2010.203364; de Lusignan S, 2006, FAM PRACT, V23, P253, DOI 10.1093/fampra/cmi106; *DEP HLTH, 1989, TERMS SERV DOCT GEN; Department of Health, 2009, PUTT PREV 1 VASC CHE; Frezzo TM, 2003, GENET MED, V5, P84, DOI 10.1097/01.GIM.0000055197.23822.5E; Hall R, 2007, FAM PRACT, V24, P435, DOI 10.1093/fampra/cmm037; Hawe E, 2003, ANN HUM GENET, V67, P97, DOI 10.1046/j.1469-1809.2003.00017.x; Hippisley-Cox J, 2008, HEART, V94, P34, DOI 10.1136/hrt.2007.134890; Hippisley-Cox J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6624; HUNT SC, 1986, J CHRON DIS, V39, P809, DOI 10.1016/0021-9681(86)90083-4; Kardia SLR, 2003, AM J PREV MED, V24, P143, DOI 10.1016/S0749-3797(02)00587-1; KEE F, 1993, BRIT MED J, V307, P1528, DOI 10.1136/bmj.307.6918.1528; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P393, DOI 10.1002/pds.1335; MANT D, 1991, BRIT MED J, V302, P1057, DOI 10.1136/bmj.302.6784.1057; Marston L, 2010, PHARMACOEPIDEM DR S, V19, P618, DOI 10.1002/pds.1934; Nieburg I, 2010, BLOOD PRESSURE, V19, P176, DOI 10.3109/08037051.2010.483053; O'Neill SM, 2009, AM J PREV MED, V36, P506, DOI 10.1016/j.amepre.2009.03.002; Pous Maria Font, 2010, Inform Prim Care, V18, P109; Qureshi N, 2012, ANN INTERN MED, V156, P253, DOI 10.7326/0003-4819-156-4-201202210-00002; Rabash J, 2011, MLWIN 2 23; Rafter N, 2008, NEW ZEAL MED J, V121, P24; Rich EC, 2004, J GEN INTERN MED, V19, P273, DOI 10.1111/j.1525-1497.2004.30401.x; Scheuner MT, 2009, GENET MED, V11, P510, DOI 10.1097/GIM.0b013e3181a53331; Sheerin Ian, 2007, N Z Med J, V120, pU2714; StataCorp, 2021, STATA STAT SOFTWARE; Summerton N, 1997, FAM PRACT, V14, P285, DOI 10.1093/fampra/14.4.285; Townsend PP., 1988, HLTH DEPRIVATION INE; Weiner Mark G, 2007, Inform Prim Care, V15, P121; Wilson BJ, 2009, ANN INTERN MED, V151, P878, DOI [10.7326/0000605-200912150-00177, 10.7326/0003-4819-151-12-200912150-00177]; Wood D, 2005, HEART, V91, P1, DOI 10.1136/hrt.2005.079988; Woodward M, 2007, HEART, V93, P172, DOI 10.1136/hrt.2006.108167	41	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e81998	10.1371/journal.pone.0081998	http://dx.doi.org/10.1371/journal.pone.0081998			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416135	Green Published, Green Submitted, gold			2022-12-27	WOS:000329866300007
J	Harari, D; Abramovich, R; Zozulya, A; Smith, P; Pouly, S; Koster, M; Hauser, H; Schreiber, G				Harari, Daniel; Abramovich, Renne; Zozulya, Alla; Smith, Paul; Pouly, Sandrine; Koester, Mario; Hauser, Hansjoerg; Schreiber, Gideon			Bridging the Species Divide: Transgenic Mice Humanized for Type-I Interferon Response	PLOS ONE			English	Article							RECEPTOR; PHARMACOKINETICS; PHARMACODYNAMICS; INVOLVEMENT; ALPHA/BETA; ACTIVATION; EXPRESSION; BINDING; PROTEIN; IMPACT	We have generated transgenic mice that harbor humanized type I interferon receptors (IFNARs) enabling the study of type I human interferons (Hu-IFN-Is) in mice. These "HyBNAR" (Hybrid IFNAR) mice encode transgenic variants of IFNAR1 and IFNAR2 with the human extracellular domains being fused to transmembrane and cytoplasmic segments of mouse sequence. B16F1 mouse melanoma cells harboring the HyBNAR construct specifically bound Hu-IFN-Is and were rendered sensitive to Hu-IFN-I stimulated anti-proliferation, STAT1 activation and activation of a prototypical IFN-I response gene (MX2). HyBNAR mice were crossed with a transgenic strain expressing the luciferase reporter gene under the control of the IFN-responsive MX2 promoter (MX2-Luciferase). Both the HyBNAR and HyBNAR/MX2-Luciferase mice were responsive to all Hu-IFN-Is tested, inclusive of IFN alpha 2A, IFN beta, and a human superagonist termed YNS alpha 8. The mice displayed dose-dependent pharmacodynamic responses to Hu-IFN-I injection, as assessed by measuring the expression of IFN-responsive genes. Our studies also demonstrated a weak activation of endogenous mouse interferon response, especially after high dose administration of Hu-IFNs. In sharp contrast to data published for humans, our pharmacodynamic readouts demonstrate a very short-lived IFN-I response in mice, which is not enhanced by sub-cutaneous (SC) injections in comparison to other administration routes. With algometric differences between humans and mice taken into account, the HyBNAR mice provides a convenient non-primate pre-clinical model to advance the study of human IFN-Is.	[Harari, Daniel; Abramovich, Renne; Schreiber, Gideon] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Zozulya, Alla; Smith, Paul; Pouly, Sandrine] Merck Serono, MS Platform, Geneva, Switzerland; [Koester, Mario; Hauser, Hansjoerg] Helmholtz Ctr Infect Res, Dept Gene Regulat & Differentiat, Braunschweig, Germany	Weizmann Institute of Science; Merck KGaA; EMD Serono Inc.; Helmholtz Association; Helmholtz-Center for Infection Research	Harari, D (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	daniel.harari@weizmann.ac.il; gideon.schreiber@weizmann.ac.il			Merck-KGaA	Merck-KGaA(Merck & Company)	This study was funded by a research grant awarded to GS from Merck-KGaA. Authors AZ, PS and SP are/were members of Merck-Serono, a division of Merck KGaA. The Weizmann Institute of Science holds patent rights to the interferon superagonists described in this paper. Scientists from the funding agency (AZ,PS,SP) have contributed to this paper with advice of how to enhance pharmacodynamic studies, and thus are listed as co-authors and have additionally contributed to proof-reading this manuscript. Members of the funding agency however have had no role in data collection and analysis, decision to publish, nor have constrained in any way conclusions reached by the senior authors of this study.	Apelbaum A, 2013, MOL CELL BIOL, V33, P800, DOI 10.1128/MCB.01430-12; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Carbone CJ, 2012, P NATL ACAD SCI USA, V109, P19226, DOI 10.1073/pnas.1211491109; Chen JB, 2004, J INTERF CYTOK RES, V24, P687, DOI 10.1089/jir.2004.24.687; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Fenner JE, 2006, NAT IMMUNOL, V7, P33, DOI 10.1038/ni1287; Francois-Newton V, 2012, BIOCHEM J, V446, P509, DOI 10.1042/BJ20120541; Fuchs SY, 2012, GROWTH FACTORS, V30, P141, DOI 10.3109/08977194.2012.669382; Kagan L, 2010, PHARM RES-DORDR, V27, P920, DOI 10.1007/s11095-010-0098-6; Kalie E, 2008, J BIOL CHEM, V283, P32925, DOI 10.1074/jbc.M806019200; Kalie E, 2007, J BIOL CHEM, V282, P11602, DOI 10.1074/jbc.M610115200; Kalincik T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050101; Kraus J, 2006, DRUG DISCOV TODAY, V11, P755, DOI 10.1016/j.drudis.2006.06.008; Lavoie TB, 2011, CYTOKINE, V56, P282, DOI 10.1016/j.cyto.2011.07.019; Levin D, 2011, MOL CELL BIOL, V31, P3252, DOI 10.1128/MCB.05251-11; Moraga I, 2009, MOL CELL BIOL, V29, P4778, DOI 10.1128/MCB.01808-08; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Neuhaus O, 2007, J NEUROL SCI, V259, P27, DOI 10.1016/j.jns.2006.05.071; Peleg-Shulman T, 2004, J MED CHEM, V47, P4897, DOI 10.1021/jm0497693; Pepinsky RB, 2001, J PHARMACOL EXP THER, V297, P1059; Piehler J, 2012, IMMUNOL REV, V250, P317, DOI 10.1111/imr.12001; Pulverer JE, 2010, J VIROL, V84, P8626, DOI 10.1128/JVI.00303-10; Radaeva S, 2004, BIOCHEM J, V379, P199, DOI 10.1042/BJ20031495; Roberts RM, 1998, J INTERF CYTOK RES, V18, P805, DOI 10.1089/jir.1998.18.805; Samarajiwa SA, 2009, NUCLEIC ACIDS RES, V37, pD852, DOI 10.1093/nar/gkn732; Schlapschy M, 2013, PROTEIN ENG DES SEL, V26, P489, DOI 10.1093/protein/gzt023; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Shen XN, 2000, FEBS LETT, V480, P132, DOI 10.1016/S0014-5793(00)01905-0; STAEHELI P, 1986, CELL, V44, P147, DOI 10.1016/0092-8674(86)90493-9; STAEHELI P, 1988, MOL CELL BIOL, V8, P4524, DOI 10.1128/MCB.8.10.4524; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Thomas C, 2011, CELL, V146, P621, DOI 10.1016/j.cell.2011.06.048; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; Williams GJ, 1998, J INTERF CYTOK RES, V18, P967, DOI 10.1089/jir.1998.18.967; Yong VW, 1998, NEUROLOGY, V51, P682; Zheng H, 2011, BLOOD, V118, P4003, DOI 10.1182/blood-2011-06-359745	36	20	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84259	10.1371/journal.pone.0084259	http://dx.doi.org/10.1371/journal.pone.0084259			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416207	Green Published, Green Submitted, gold			2022-12-27	WOS:000329866300021
J	Ji, DM; Zhang, Z; Cheng, L; Chang, JJ; Wang, SS; Zheng, BQ; Zheng, RL; Sun, ZJ; Wang, CC; Zhang, ZQ; Liu, RJ; Zhang, XW; Liu, X; Wang, XF; Li, J				Ji, Dongmei; Zhang, Zhe; Cheng, Lei; Chang, Jinjia; Wang, Shanshan; Zheng, Biqiang; Zheng, Rongliang; Sun, Zuojun; Wang, Chenchen; Zhang, Zhiqing; Liu, Rujiao; Zhang, Xiaowei; Liu, Xin; Wang, Xiaofeng; Li, Jin			The Combination of RAD001 and MK-2206 Exerts Synergistic Cytotoxic Effects against PTEN Mutant Gastric Cancer Cells: Involvement of MAPK-Dependent Autophagic, but Not Apoptotic Cell Death Pathway	PLOS ONE			English	Article							SIGNALING PATHWAY; PI3K/AKT/MTOR PATHWAY; MAMMALIAN TARGET; PROTEIN-KINASE; BREAST-CANCER; IN-VIVO; INHIBITION; MTOR; AKT; THERAPY	In the current study, we showed that the combination of mammalian target of rapamycin (mTOR) inhibitor RAD001 (everolimus) and Akt inhibitor MK-2206 exerted synergistic cytotoxic effects against low-phosphatase and tensin homolog (PTEN) gastric cancer cells (HGC-27 and SNU-601 lines). In HGC-27 cells, RAD001 and MK-2206 synergistically induced G1/S cell cycle arrest, growth inhibition, cell death but not apoptosis. RAD001 and MK-2206 synergistically induced light chain 3B (LC3B) and beclin-1 expression, two important autophagy indicators. Meanwhile, the autophagy inhibitor 3-methyladenine (3-MA) and chloroquine inhibited the cytotoxic effects by RAD001 and MK-2206, suggesting that autophagic, but not apoptotic cell death was important for the cytotoxic effects by the co-administration. We observed that the combination of RAD001 and MK-2206 exerted enhanced effects on Akt/mTOR inhibition, cyclin D1 down-regulation and ERK/MAPK(extracellular signal-regulated kinase/mitogen-activated protein kinases) activation. Intriguingly, MEK/ERK inhibitors PD98059 and U0126 suppressed RAD001 plus MK-2206-induced beclin-1 expression, autophagy induction and cytotoxicity in HGC-27 cells. In conclusion, these results suggested that the synergistic anti-gastric cancer cells ability by RAD001 and MK-2206 involves ERK-dependent autophagic cell death pathway.	[Ji, Dongmei; Zhang, Zhe; Chang, Jinjia; Wang, Shanshan; Zheng, Rongliang; Sun, Zuojun; Wang, Chenchen; Liu, Rujiao; Zhang, Xiaowei; Liu, Xin; Wang, Xiaofeng; Li, Jin] Fudan Univ, Shanghai Med Coll, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R China; [Cheng, Lei] Nanjing Med Univ, Suzhou Hosp, Dept Intervent Radiol, Suzhou, Jiangsu, Peoples R China; [Zheng, Biqiang] Fudan Univ, Shanghai Med Coll, Shanghai Canc Ctr, Dept Gastr Canc & Soft Tissue Sarcomas, Shanghai 200433, Peoples R China; [Zhang, Zhiqing] Soochow Univ, Inst Neurosci, Suzhou, Jiangsu, Peoples R China	Fudan University; Nanjing Medical University; Fudan University; Soochow University - China	Li, J (corresponding author), Fudan Univ, Shanghai Med Coll, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R China.	fudanlijin@163.com			Construction of new drug clinical research technology platform [JKB1101-1]	Construction of new drug clinical research technology platform	The source of funding for this study was the Construction of new drug clinical research technology platform, grant number JKB1101-1 (http://www.nmp.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2007, CLIN CANCER RES, V13, P3109, DOI 10.1158/1078-0432.CCR-06-2798; Almhanna K, 2011, ANTICANCER RES, V31, P4387; Brachmann S, 2009, CURR OPIN CELL BIOL, V21, P194, DOI 10.1016/j.ceb.2008.12.011; Brachmann SM, 2009, P NATL ACAD SCI USA, V106, P22299, DOI 10.1073/pnas.0905152106; Byun DS, 2003, INT J CANCER, V104, P318, DOI 10.1002/ijc.10962; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Cervantes A, 2013, CANCER TREAT REV, V39, P60, DOI 10.1016/j.ctrv.2012.09.007; Cheng Y, 2012, MOL CANCER THER, V11, P154, DOI 10.1158/1535-7163.MCT-11-0606; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Crazzolara R, 2009, AUTOPHAGY, V5, P727, DOI 10.4161/auto.5.5.8507; Din FVN, 2012, GASTROENTEROLOGY, V142, P1504, DOI 10.1053/j.gastro.2012.02.050; Gozuacik D, 2007, CURR TOP DEV BIOL, V78, P217, DOI 10.1016/S0070-2153(06)78006-1; Grabinski N, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-85; Gravalos C, 2008, ANN ONCOL, V19, P1523, DOI 10.1093/annonc/mdn169; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Lin CI, 2010, MOL CANCER RES, V8, P1217, DOI 10.1158/1541-7786.MCR-10-0162; Liu YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047049; LoPiccolo J, 2008, DRUG RESIST UPDATE, V11, P32, DOI 10.1016/j.drup.2007.11.003; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Marinov M, 2009, CLIN CANCER RES, V15, P1277, DOI 10.1158/1078-0432.CCR-08-2166; Martinez-Outschoorn UE, 2010, CELL CYCLE, V9, P2423, DOI 10.4161/cc.9.12.12048; Mezhir JJ, 2010, J SURG ONCOL, V101, P305, DOI 10.1002/jso.21483; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Pal SK, 2010, EXPERT OPIN INV DRUG, V19, P1355, DOI 10.1517/13543784.2010.520701; Ramirez-Fort MK, 2012, AM J CLIN ONCOL; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Smyth EC, 2012, CURR TREAT OPTION ON, V13, P377, DOI 10.1007/s11864-012-0192-6; Sukawa Y, 2012, WORLD J GASTROENTERO, V18, P6577, DOI 10.3748/wjg.v18.i45.6577; Wang JR, 2009, J BIOL CHEM, V284, P21412, DOI 10.1074/jbc.M109.026013; Wang XR, 2008, CANCER RES, V68, P7409, DOI 10.1158/0008-5472.CAN-08-1522; Wu CH, 2012, NANO LETT, V12, P5475, DOI 10.1021/nl301865c; Wu P, 2010, CURR MED CHEM, V17, P4326, DOI 10.2174/092986710793361234; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Xiong H, 2008, NEOPLASIA, V10, P287, DOI 10.1593/neo.07971; Yang Z, 2012, CLIN RES HEPATOL GAS; Yap TA, 2008, CURR OPIN PHARMACOL, V8, P393, DOI 10.1016/j.coph.2008.08.004; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang XW, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-114; Zhang XW, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-40; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008	45	37	38	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85116	10.1371/journal.pone.0085116	http://dx.doi.org/10.1371/journal.pone.0085116			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416349	gold, Green Submitted, Green Published			2022-12-27	WOS:000329866300050
J	Anfossi, S; Giordano, A; Gao, H; Cohen, EN; Tin, S; Wu, Q; Garza, RJ; Debeb, BG; Alvarez, RH; Valero, V; Hortobagyi, GN; Calin, GA; Ueno, NT; Woodward, WA; Reuben, JM				Anfossi, Simone; Giordano, Antonio; Gao, Hui; Cohen, Evan N.; Tin, Sanda; Wu, Qiong; Garza, Raul J.; Debeb, Bisrat G.; Alvarez, Ricardo H.; Valero, Vicente; Hortobagyi, Gabriel N.; Calin, George A.; Ueno, Naoto T.; Woodward, Wendy A.; Reuben, James M.			High Serum miR-19a Levels Are Associated with Inflammatory Breast Cancer and Are Predictive of Favorable Clinical Outcome in Patients with Metastatic HER2(+) Inflammatory Breast Cancer	PLOS ONE			English	Article							BLOOD-BASED MARKERS; CIRCULATING MICRORNAS; UP-REGULATION; EXPRESSION; BIOMARKERS; MIR-21; THERAPY; TRASTUZUMAB; MECHANISMS; RESISTANCE	Introduction: Altered serum microRNA (miRNA) levels may be correlated with a dysregulated expression pattern in parental tumor tissue and reflect the clinical evolution of disease. The overexpression of miR-21, miR-10b, and miR-19a is associated with the acquisition of malignant characteristics (increased tumor cell proliferation, migration, invasion, dissemination, and metastasis); thus, we determined their utility as serum biomarkers for aggressive breast cancer (HER2-overexpressed or -amplified [HER2(+)] and inflammatory breast cancer [IBC]). Experimental Design: In this prospective study, we measured miR-21, miR-10b, and miR-19a levels using quantitative reverse transcriptase-polymerase chain reaction in the serum of 113 breast cancer patients and determined their association with clinicopathologic factors and clinical outcome. Thirty healthy donors with no history of cancer were enrolled as controls. Results: Patients with non-metastatic HER2(+) breast cancer had higher serum miR-21 median levels than patients with non-metastatic HER2(-) disease (p = 0.044); whereas patients with metastatic HER2(+) breast cancer had higher serum miR-10b median levels than patients with metastatic HER2(-) disease (p = 0.0004). There were no significant differences in serum miR-19a median levels between HER2(+) and HER2(-) groups, regardless of the presence of metastases. High serum miR-19a levels were associated with IBC (p = 0.039). Patients with metastatic IBC had significantly higher serum miR-19a median levels than patients with metastatic non-IBC (p = 0.019). Finally, high serum miR-19a levels were associated with longer progression-free survival time (10.3 vs. 3.2 months; p = 0.022) and longer overall survival time (median not reached vs. 11.2 months; p = 0.003) in patients with metastatic HER2(+) IBC. Conclusion: High levels of miR-21 and miR-10b were present in the serum of patients with non-metastatic and metastatic HER2(+) breast cancer, respectively. High levels of serum miR-19a may represent a biomarker for IBC that is predictive for favorable clinical outcome in patients with metastatic HER2(+) IBC.	[Anfossi, Simone; Giordano, Antonio; Gao, Hui; Cohen, Evan N.; Tin, Sanda; Wu, Qiong; Garza, Raul J.; Reuben, James M.] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Anfossi, Simone; Giordano, Antonio; Gao, Hui; Cohen, Evan N.; Debeb, Bisrat G.; Alvarez, Ricardo H.; Valero, Vicente; Ueno, Naoto T.; Woodward, Wendy A.; Reuben, James M.] Univ Texas MD Anderson Canc Ctr, Morgan Welch Inflammatory Breast Canc Res Program, Houston, TX 77030 USA; [Debeb, Bisrat G.; Woodward, Wendy A.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Alvarez, Ricardo H.; Valero, Vicente; Hortobagyi, Gabriel N.; Ueno, Naoto T.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Calin, George A.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Anfossi, Simone; Cohen, Evan N.] Univ Texas MD Anderson Canc Ctr, Univ Texas Grad Sch Biomed Sci Houston, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Reuben, JM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA.	jreuben@mdanderson.org	Giordano, Antonio/AAU-1201-2020; Woodward, Wendy/AAX-6593-2020; Calin, George/E-9390-2011; Cohen, Evan N/AFP-3323-2022	Giordano, Antonio/0000-0002-5959-016X; Cohen, Evan N/0000-0003-4192-9644; Calin, George/0000-0001-6704-5615; Anfossi, Simone/0000-0001-5745-7587; Woodward, Wendy/0000-0002-7935-739X; Calin, George/0000-0002-7427-0578	Human Breast Cancer Stem Cell Surrogates, NIH/NCI [CA138239-02]; State of Texas Rare and Aggressive Breast Cancer Research Program, The Morgan Welch Inflammatory Breast Cancer Research Program and Clinic; Assessment of Circulating Breast Cancer Stem Cells To Predict Recurrent Disease, DOD [W81XWH-09-1-0031 01]; NATIONAL CANCER INSTITUTE [R01CA138239, P30CA016672] Funding Source: NIH RePORTER	Human Breast Cancer Stem Cell Surrogates, NIH/NCI; State of Texas Rare and Aggressive Breast Cancer Research Program, The Morgan Welch Inflammatory Breast Cancer Research Program and Clinic; Assessment of Circulating Breast Cancer Stem Cells To Predict Recurrent Disease, DOD; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was supported by: Human Breast Cancer Stem Cell Surrogates, CA138239-02, NIH/NCI; State of Texas Rare and Aggressive Breast Cancer Research Program, The Morgan Welch Inflammatory Breast Cancer Research Program and Clinic; Assessment of Circulating Breast Cancer Stem Cells To Predict Recurrent Disease, W81XWH-09-1-0031 01, DOD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson William F, 2005, Breast Dis, V22, P9; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Asaga S, 2011, CLIN CHEM, V57, P84, DOI 10.1373/clinchem.2010.151845; Brase JC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-306; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Cortez MA, 2009, EXPERT OPIN BIOL TH, V9, P703, DOI [10.1517/14712590902932889, 10.1517/14712590902932889 ]; Cristofanilli M, 2007, CANCER-AM CANCER SOC, V110, P1436, DOI 10.1002/cncr.22927; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Giordano A, 2012, MOL CANCER THER, V11, P2526, DOI 10.1158/1535-7163.MCT-12-0460; Gong C, 2011, J BIOL CHEM, V286, P19127, DOI 10.1074/jbc.M110.216887; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Hu ZB, 2010, J CLIN ONCOL, V28, P1721, DOI 10.1200/JCO.2009.24.9342; Huang TH, 2009, J BIOL CHEM, V284, P18515, DOI 10.1074/jbc.M109.006676; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kleer CG, 2000, BREAST CANCER RES, V2, P423, DOI 10.1186/bcr89; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Li GM, 2008, CELL RES, V18, P1, DOI 10.1038/cr.2008.9; Lin QY, 2013, J SURG ONCOL, V107, P767, DOI 10.1002/jso.23312; Liu LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019139; Liu SJ, 2009, CANCER RES, V69, P8742, DOI 10.1158/0008-5472.CAN-09-1541; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Mariani G, 2009, NAT CLIN PRACT ONCOL, V6, P93, DOI 10.1038/ncponc1298; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; Nahta R, 2006, CANCER LETT, V232, P123, DOI 10.1016/j.canlet.2005.01.041; Nahta R, 2006, NAT CLIN PRACT ONCOL, V3, P269, DOI 10.1038/ncponc0509; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Rechavi O, 2009, GENE DEV, V23, P1971, DOI 10.1101/gad.1789609; Roth C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2766; Sasaki K, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-17; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Schooneveld E, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3127; Vasilescu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007405; Wu TQ, 2012, P NATL ACAD SCI USA, V109, P9965, DOI 10.1073/pnas.1207327109; Yan LX, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2803; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610; Zhao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013735	44	65	66	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83113	10.1371/journal.pone.0083113	http://dx.doi.org/10.1371/journal.pone.0083113			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416156	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500029
J	Bengtsson, F; Jorntell, H				Bengtsson, Fredrik; Jorntell, Henrik			Specific Relationship between Excitatory Inputs and Climbing Fiber Receptive Fields in Deep Cerebellar Nuclear Neurons	PLOS ONE			English	Article							LATERAL RETICULAR NUCLEUS; NOCICEPTIVE WITHDRAWAL REFLEXES; PRE-CEREBULLAR AFFERENTS; INTERPOSITUS ANTERIOR; HORSERADISH-PEROXIDASE; IN-VIVO; TOPOGRAPHICAL ORGANIZATION; INHIBITORY PROJECTION; PURKINJE-CELLS; PRECISION GRIP	Many mossy fiber pathways to the neurons of the deep cerebellar nucleus (DCN) originate from the spinal motor circuitry. For cutaneously activated spinal neurons, the receptive field is a tag indicating the specific motor function the spinal neuron has. Similarly, the climbing fiber receptive field of the DCN neuron reflects the specific motor output function of the DCN neuron. To explore the relationship between the motor information the DCN neuron receives and the output it issues, we made patch clamp recordings of DCN cell responses to tactile skin stimulation in the forelimb region of the anterior interposed nucleus in vivo. The excitatory responses were organized according to a general principle, in which the DCN cell responses became stronger the closer the skin site was located to its climbing fiber receptive field. The findings represent a novel functional principle of cerebellar connectivity, with crucial importance for our understanding of the function of the cerebellum in movement coordination.	[Bengtsson, Fredrik; Jorntell, Henrik] Lund Univ, Dept Expt Med Sci, Lund, Sweden	Lund University	Jorntell, H (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.	henrik.jorntell@med.lu.se			NINDS/NIH [R01 NS040863]; Hand Embodied (THE) (Integrated Project, EU FP7) [248587]; Swedish Research Council (VR Medicine); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040863] Funding Source: NIH RePORTER	NINDS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Hand Embodied (THE) (Integrated Project, EU FP7); Swedish Research Council (VR Medicine)(Swedish Research Council); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by grants from NINDS/NIH (R01 NS040863), The Hand Embodied (THE) (Integrated Project, EU FP7, project no. 248587), and the Swedish Research Council (VR Medicine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstermark B, 2007, ACTA PHYSIOL, V189, P123, DOI 10.1111/j.1748-1716.2006.01655.x; ALSTERMARK B, 1984, EXP BRAIN RES, V56, P293, DOI 10.1007/BF00236285; Alstermark B, 2012, ANNU REV NEUROSCI, V35, P559, DOI 10.1146/annurev-neuro-062111-150527; Alvina K, 2008, NAT NEUROSCI, V11, P1256, DOI 10.1038/nn.2195; Apps R, 2005, NAT REV NEUROSCI, V6, P297, DOI 10.1038/nrn1646; Bengtsson F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018822; Bengtsson F, 2009, P NATL ACAD SCI USA, V106, P2389, DOI 10.1073/pnas.0808428106; Dum RP, 2013, CURR OPIN NEUROBIOL, V23, P245, DOI 10.1016/j.conb.2012.12.002; EKEROT CF, 1991, J PHYSIOL-LONDON, V441, P275, DOI 10.1113/jphysiol.1991.sp018751; EKEROT CF, 1990, EXP BRAIN RES, V79, P109, DOI 10.1007/BF00228879; Ekerot CF, 2003, CEREBELLUM, V2, P101, DOI 10.1080/14734220309411; EKEROT CF, 1991, J PHYSIOL-LONDON, V441, P257, DOI 10.1113/jphysiol.1991.sp018750; EKEROT CF, 1990, EXP BRAIN RES, V79, P129, DOI 10.1007/BF00228881; EKEROT CF, 1990, EXP BRAIN RES, V79, P120, DOI 10.1007/BF00228880; EKEROT CF, 1995, EXP BRAIN RES, V106, P365; Ekerot CF, 2001, EUR J NEUROSCI, V13, P1303, DOI 10.1046/j.0953-816x.2001.01499.x; Garwicz M, 1998, J PHYSIOL-LONDON, V512, P277, DOI 10.1111/j.1469-7793.1998.277bf.x; GARWICZ M, 1994, J PHYSIOL-LONDON, V474, P245, DOI 10.1113/jphysiol.1994.sp020017; Garwicz M, 1996, EUR J NEUROSCI, V8, P2726, DOI 10.1111/j.1460-9568.1996.tb01567.x; Gauck V, 2003, J NEUROSCI, V23, P8109; Hoebeek FE, 2010, P NATL ACAD SCI USA, V107, P8410, DOI 10.1073/pnas.0907118107; Holdefer RN, 2005, J NEUROPHYSIOL, V93, P35, DOI 10.1152/jn.00603.2004; Holmberg H, 1996, J PHYSIOL-LONDON, V493, P239, DOI 10.1113/jphysiol.1996.sp021379; Holmberg H, 1997, J NEUROSCI, V17, P2071; JAHNSEN H, 1986, J PHYSIOL-LONDON, V372, P129, DOI 10.1113/jphysiol.1986.sp016001; JANKOWSKA E, 1992, PROG NEUROBIOL, V38, P335, DOI 10.1016/0301-0082(92)90024-9; Jorntell H, 1999, J PHYSIOL-LONDON, V514, P551, DOI 10.1111/j.1469-7793.1999.551ae.x; Jorntell H, 2003, J NEUROSCI, V23, P9620; Jorntell H, 2002, NEURON, V34, P797, DOI 10.1016/S0896-6273(02)00713-4; Jorntell H, 2006, J NEUROSCI, V26, P11786, DOI 10.1523/JNEUROSCI.2939-06.2006; Jorntell H, 2011, FRONT NEURAL CIRCUIT, V5, DOI 10.3389/fncir.2011.00003; Kelly RM, 2003, J NEUROSCI, V23, P8432; Kinoshita M, 2012, NATURE, V487, P235, DOI 10.1038/nature11206; KITAI ST, 1977, BRAIN RES, V122, P197, DOI 10.1016/0006-8993(77)90289-X; KITAI ST, 1974, EXP BRAIN RES, V21, P419; Levinsson A, 2002, J NEUROSCI, V22, P8170; MACKAY WA, 1988, BRAIN RES, V442, P240, DOI 10.1016/0006-8993(88)91509-0; MACKAY WA, 1988, EXP BRAIN RES, V71, P47; Mason CR, 1998, J NEUROPHYSIOL, V79, P537, DOI 10.1152/jn.1998.79.2.537; Matsushita M, 1999, J COMP NEUROL, V412, P633, DOI 10.1002/(SICI)1096-9861(19991004)412:4<633::AID-CNE5>3.0.CO;2-Q; MATSUSHITA M, 1982, J COMP NEUROL, V208, P127, DOI 10.1002/cne.902080203; MCCREA RA, 1977, BRAIN RES, V122, P215, DOI 10.1016/0006-8993(77)90290-6; Medina JF, 2008, NAT NEUROSCI, V11, P1185, DOI 10.1038/nn.2197; Niedermayer E, 1993, ELECTROENCEPHALOGRAP; NOBLE R, 1988, J PHYSIOL-LONDON, V396, P497, DOI 10.1113/jphysiol.1988.sp016974; Oscarsson O., 1973, HDB SENSORY PHYSL VO, P339; Pasalar S, 2006, NAT NEUROSCI, V9, P1404, DOI 10.1038/nn1783; Person AL, 2012, NATURE, V481, P502, DOI 10.1038/nature10732; ROSEN I, 1972, BRAIN RES, V45, P580, DOI 10.1016/0006-8993(72)90486-6; Rowland NC, 2008, J NEUROPHYSIOL, V99, P704, DOI 10.1152/jn.01100.2007; Santello M, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00023; SCHOUENBORG J, 1995, EXP BRAIN RES, V106, P19; Spanne A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002979; Takei T, 2013, J NEUROSCI, V33, P8850, DOI 10.1523/JNEUROSCI.4032-12.2013; Takei T, 2010, J NEUROSCI, V30, P17041, DOI 10.1523/JNEUROSCI.4297-10.2010; TROTT JR, 1987, EXP BRAIN RES, V66, P318; VANKAN PLE, 1993, J NEUROPHYSIOL, V69, P57, DOI 10.1152/jn.1993.69.1.57; VANKAN PLE, 1994, J PHYSIOL-LONDON, V480, P171, DOI 10.1113/jphysiol.1994.sp020351; Wu HS, 1999, J COMP NEUROL, V411, P97, DOI 10.1002/(SICI)1096-9861(19990816)411:1<97::AID-CNE8>3.0.CO;2-O	59	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84616	10.1371/journal.pone.0084616	http://dx.doi.org/10.1371/journal.pone.0084616			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416251	Green Submitted, gold, Green Published			2022-12-27	WOS:000329862500140
J	Hossain, MS; Kypri, K; Rahman, B; Arslan, I; Akter, S; Milton, AH				Hossain, Mohammad Shakhawat; Kypri, Kypros; Rahman, Bayzidur; Arslan, Iqbal; Akter, Shahnaz; Milton, Abul Hasnat			Prevalence and Correlates of Smokeless Tobacco Consumption among Married Women in Rural Bangladesh	PLOS ONE			English	Article							BETEL QUID; COHORT; HEALTH; MUMBAI	Objective: To estimate the prevalence and identify correlates of smokeless tobacco consumption among married rural women with a history of at least one pregnancy in Madaripur, Bangladesh. Materials and Methods: We conducted a cross-sectional survey using an interviewer administered, pre-tested, semi-structured questionnaire. All women living in the study area, aged 18 years and above with at least one pregnancy in their lifetime, who were on the electoral roll and agreed to participate were included in the study. Information on socio-demographic characteristics and smokeless tobacco consumption was collected. Smokeless tobacco consumption was categorized as 'Current', 'Ever but not current' and 'Never'. Associations between smokeless tobacco consumption and the explanatory variables were estimated using simple and multiple binary logistic regression. Results: 8074 women participated (response rate 99.9%). The prevalence of 'Current consumption', 'Ever consumption but not current', and 'Never consumption' was 25%, 44% and 31%, respectively. The mean age at first use was 31.5 years. 87% of current consumers reported using either Shadapata or Hakimpuree Jarda. Current consumption was associated with age, level of education, religion, occupation, being an income earner, marital status, and age at first use of smokeless tobacco. After adjustment for demographic variables, current consumption was associated with being over 25 years of age, a lower level of education, being an income earner, being Muslim, and being divorced, separated or widowed. Conclusion: The prevalence of smokeless tobacco consumption is high among rural women in Bangladesh and the age of onset is considerably older than that for smoking. Smokeless tobacco consumption is likely to be producing a considerable burden of non-communicable disease in Bangladesh. Smokeless tobacco control strategies should be implemented.	[Hossain, Mohammad Shakhawat; Kypri, Kypros; Milton, Abul Hasnat] Univ Newcastle, Fac Hlth, Sch Med & Publ Hlth, New Lambton Hts, NSW, Australia; [Rahman, Bayzidur] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Arslan, Iqbal] Bangabandhu Sheikh Mujib Med Univ, Dhaka, Bangladesh; [Akter, Shahnaz] Directorate Gen Hlth Serv, Dhaka, Bangladesh	University of Newcastle; University of New South Wales Sydney; Bangabandhu Sheikh Mujib Medical University (BSMMU)	Milton, AH (corresponding author), Univ Newcastle, Fac Hlth, Sch Med & Publ Hlth, New Lambton Hts, NSW, Australia.	milton.hasnat@newcastle.edu.au	Rahman, Bayzidur/G-5910-2015; Kypri, Kypros/D-2809-2009	Kypri, Kypros/0000-0002-9657-9904	University of Newcastle; Bangladesh Medical Research Council (BMRC); National Health and Medical Research Council Senior Fellowship [APP 1041867]	University of Newcastle; Bangladesh Medical Research Council (BMRC)(Agency for Science Technology & Research (A*STAR)); National Health and Medical Research Council Senior Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	The research project was partially funded by the University of Newcastle under its research and training scheme (RTS) for research higher degree students and partially by the Bangladesh Medical Research Council (BMRC). Co-author KK's involvement in the research was funded by a National Health and Medical Research Council Senior Fellowship (APP 1041867). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 1997, BRIT J GEN PRACT, V47, P431; Alison P. D, 2012, LOGISTIC REGRESSION, V2; [Anonymous], ASIA PAC J PUBLIC HL; [Anonymous], 2012, LANCET; [Anonymous], 2021, GLOBAL ADULT TOBACCO; [Anonymous], COMMUNITY BASED HLTH; [Anonymous], WHY TOB IS PUBL HLTH; [Anonymous], STAT STAT SOFTW; [Anonymous], NONC DIS RISK FACT S; [Anonymous], COMM REP; [Anonymous], 1999, CURBING EPIDEMIC GOV; [Anonymous], BETEL CHEWING TRAIDI; [Anonymous], REP SYRV PREV MORB T; [Anonymous], 12 WORLD C TOB HLTH; [Anonymous], MILL DEV GOALS TOB C; [Anonymous], LEAD CAUS DAETH; [Anonymous], TOB CONTROL; [Anonymous], 2004, REP OR TOB US ITS IM; [Anonymous], SMOKELESS TOBACCO US; Bartal M, 2001, Monaldi Arch Chest Dis, V56, P545; Cohen-Smith D, 1999, Nicotine Tob Res, V1, P211, DOI 10.1080/14622299050011321; Ezzati M, 2004, TOB CONTROL, V13, P388, DOI 10.1136/tc.2003.005215; Flora MS, 2009, TOB CONTROL, V18, P445, DOI 10.1136/tc.2008.028142; Gupta PC, 2006, EPIDEMIOLOGY, V17, P47, DOI 10.1097/01.ede.0000190545.19168.c4; Gupta PC, 2004, BMJ-BRIT MED J, V328, P1538, DOI 10.1136/bmj.38113.687882.EB; Gupta PC, 2003, RESPIROLOGY, V8, P419, DOI 10.1046/j.1440-1843.2003.00507.x; Heck JE, 2012, INT J EPIDEMIOL, V41, P462, DOI 10.1093/ije/dyr191; Imam SZ, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-231; Johnson N, 2001, J Dent Educ, V65, P328; KRISHNAMURTHY S, 1991, Indian Journal of Pediatrics, V58, P863, DOI 10.1007/BF02825453; Rahman MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030584; World Health Organization, 2008, GUID IMPL ART 13 WHO; World Health Organization-WHO, 2013, WHO REP GLOB TOB EP	33	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84470	10.1371/journal.pone.0084470	http://dx.doi.org/10.1371/journal.pone.0084470			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416234	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500129
J	Neumann, S; Vladimirov, N; Krembel, AK; Wingreen, NS; Sourjik, V				Neumann, Silke; Vladimirov, Nikita; Krembel, Anna K.; Wingreen, Ned S.; Sourjik, Victor			Imprecision of Adaptation in Escherichia coli Chemotaxis	PLOS ONE			English	Article							BACTERIAL CHEMOTAXIS; INHIBITION; ROBUSTNESS; PROTEINS; KINETICS; SERINE; TARGET; CELLS	Adaptability is an essential property of many sensory systems, enabling maintenance of a sensitive response over a range of background stimulus levels. In bacterial chemotaxis, adaptation to the preset level of pathway activity is achieved through an integral feedback mechanism based on activity-dependent methylation of chemoreceptors. It has been argued that this architecture ensures precise and robust adaptation regardless of the ambient ligand concentration, making perfect adaptation a celebrated property of the chemotaxis system. However, possible deviations from such ideal adaptive behavior and its consequences for chemotaxis have not been explored in detail. Here we show that the chemotaxis pathway in Escherichia coli shows increasingly imprecise adaptation to higher concentrations of attractants, with a clear correlation between the time of adaptation to a step-like stimulus and the extent of imprecision. Our analysis suggests that this imprecision results from a gradual saturation of receptor methylation sites at high levels of stimulation, which prevents full recovery of the pathway activity by violating the conditions required for precise adaptation. We further use computer simulations to show that limited imprecision of adaptation has little effect on the rate of chemotactic drift of a bacterial population in gradients, but hinders precise accumulation at the peak of the gradient. Finally, we show that for two major chemoeffectors, serine and cysteine, failure of adaptation at concentrations above 1 mM might prevent bacteria from accumulating at toxic concentrations of these amino acids.	[Neumann, Silke; Vladimirov, Nikita; Krembel, Anna K.; Sourjik, Victor] Heidelberg Univ, Zentrum Mol Biol Univ Heidelberg ZMBH, DKFZ ZMBH Alliance, Heidelberg, Baden Wurttembe, Germany; [Wingreen, Ned S.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Princeton University	Sourjik, V (corresponding author), Heidelberg Univ, Zentrum Mol Biol Univ Heidelberg ZMBH, DKFZ ZMBH Alliance, Heidelberg, Baden Wurttembe, Germany.	v.sourjik@zmbh.uni-heidelberg.de			European Research Council (ERC) [294761-MicRobE]; National Institutes of Health (NIH) [R01 GM082938]; Deutsche Forschungsgemeinschaft (DFG) [SO 421/11-1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082938] Funding Source: NIH RePORTER	European Research Council (ERC)(European Research Council (ERC)European Commission); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by European Research Council (ERC, http://erc.europa.eu) advanced grant 294761-MicRobE, grant R01 GM082938 from the National Institutes of Health (NIH, www.nih.gov) and by grant SO 421/11-1 from the Deutsche Forschungsgemeinschaft (DFG, www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; AMOS H, 1954, BIOCHEM J, V57, P338, DOI 10.1042/bj0570338; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; BERG HC, 1975, P NATL ACAD SCI USA, V72, P3235, DOI 10.1073/pnas.72.8.3235; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; BORKOVICH KA, 1992, P NATL ACAD SCI USA, V89, P6756, DOI 10.1073/pnas.89.15.6756; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; HAMA H, 1990, BIOCHEM BIOPH RES CO, V168, P1211, DOI 10.1016/0006-291X(90)91157-N; HAMA H, 1991, J BIOCHEM-TOKYO, V109, P604, DOI 10.1093/oxfordjournals.jbchem.a123427; Hansen CH, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040001; HARRIS CL, 1981, J BACTERIOL, V145, P1031, DOI 10.1128/JB.145.2.1031-1035.1981; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; Hazelbauer GL, 2010, CURR OPIN MICROBIOL, V13, P124, DOI 10.1016/j.mib.2009.12.014; KEHRY MR, 1983, P NATL ACAD SCI-BIOL, V80, P3599, DOI 10.1073/pnas.80.12.3599; Lan G, 2012, NAT PHYS, V8, P422, DOI 10.1038/NPHYS2276; MACNAB RM, 1972, P NATL ACAD SCI USA, V69, P2509, DOI 10.1073/pnas.69.9.2509; Meir Y, 2010, BIOPHYS J, V99, P2766, DOI 10.1016/j.bpj.2010.08.051; MESIBOV R, 1972, J BACTERIOL, V112, P315, DOI 10.1128/JB.112.1.315-326.1972; Min TJL, 2012, P NATL ACAD SCI USA, V109, P9869, DOI 10.1073/pnas.1120218109; Neumann S, 2010, EMBO J, V29, P3484, DOI 10.1038/emboj.2010.224; Sambrock J, 2001, MOL CLONING LAB MANU, V3rd; Sourjik V, 2004, NATURE, V428, P437, DOI 10.1038/nature02406; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; Sourjik V, 2011, CURR OPIN CELL BIOL, V24, P1; Sourjik V, 2007, METHOD ENZYMOL, V423, P365, DOI 10.1016/S0076-6879(07)23017-4; SPRINGER MS, 1979, NATURE, V280, P279, DOI 10.1038/280279a0; Stocker R, 2012, MICROBIOL MOL BIOL R, V76, P792, DOI 10.1128/MMBR.00029-12; Vladimirov N, 2009, BIOL CHEM, V390, P1097, DOI 10.1515/BC.2009.130; Vladimirov N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000242; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649	30	21	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84904	10.1371/journal.pone.0084904	http://dx.doi.org/10.1371/journal.pone.0084904			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416308	gold, Green Published, Green Submitted			2022-12-27	WOS:000329862500187
J	Xu, HJ; Qin, W; Chen, H; Jiang, L; Li, KC; Yu, CS				Xu, Huijuan; Qin, Wen; Chen, Hai; Jiang, Lin; Li, Kuncheng; Yu, Chunshui			Contribution of the Resting-State Functional Connectivity of the Contralesional Primary Sensorimotor Cortex to Motor Recovery after Subcortical Stroke	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; LONGITUDINAL FMRI; BRAIN ACTIVATION; INTERHEMISPHERIC INTERACTIONS; CONTROLLED TRIAL; NEURAL ACTIVITY; HAND MOVEMENTS; REORGANIZATION; NETWORK; MECHANISMS	It remains uncertain if the contralesional primary sensorimotor cortex (CL_PSMC) contributes to motor recovery after stroke. Here we investigated longitudinal changes in the resting-state functional connectivity (rsFC) of the CL_PSMC and their association with motor recovery. Thirteen patients who had experienced subcortical stroke underwent a series of resting-state fMRI and clinical assessments over a period of 1 year at 5 time points, i.e., within the first week, at 2 weeks, 1 month, 3 months, and 1 year after stroke onset. Thirteen age-and gender-matched healthy subjects were recruited as controls. The CL_PSMC was defined as a region centered at the voxel that had greatest activation during hand motion task. The dynamic changes in the rsFCs of the CL_PSMC within the whole brain were evaluated and correlated with the Motricity Index (MI) scores. Compared with healthy controls, the rsFCs of the CL_PSMC with the bilateral PSMC were initially decreased, then gradually increased, and finally restored to the normal level 1 year later. Moreover, the dynamic change in the interhemispheric rsFC between the bilateral PSMC in these patients was positively correlated with the MI scores. However, the intra-hemispheric rsFC of the CL_PSMC was not correlated with the MI scores. This study shows dynamic changes in the rsFCs of the CL_PSMC after stroke and suggests that the increased inter-hemispheric rsFC between the bilateral PSMC may facilitate motor recovery in stroke patients. However, generalization of our findings is limited by the small sample size of our study and needs to be confirmed.	[Xu, Huijuan; Qin, Wen; Jiang, Lin; Yu, Chunshui] Tianjin Med Univ, Gen Hosp, Dept Radiol, Tianjin, Peoples R China; [Xu, Huijuan; Qin, Wen; Jiang, Lin; Yu, Chunshui] Tianjin Med Univ, Gen Hosp, Tianjin Key Lab Funct Imaging, Tianjin, Peoples R China; [Chen, Hai] Capital Med Univ, Dept Neurol, Xuanwu Hosp, Beijing, Peoples R China; [Li, Kuncheng] Capital Med Univ, Dept Radiol, Xuanwu Hosp, Beijing, Peoples R China	Tianjin Medical University; Tianjin Medical University; Capital Medical University; Capital Medical University	Yu, CS (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Radiol, Tianjin, Peoples R China.	chunshuiyu@tijmu.edu.cn	QIN, WEN/F-3783-2015	QIN, WEN/0000-0002-9121-8296; Yu, Chunshui/0000-0001-5648-5199	National Basic Research Program of China (973 program) [2011CB707804]; Natural Science Foundation of China [81271564]; Natural Science Foundation of Tianjin [12JCZDJC23800]	National Basic Research Program of China (973 program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin)	This study was supported by the National Basic Research Program of China (973 program, 2011CB707804), the Natural Science Foundation of China (81271564), and the Natural Science Foundation of Tianjin (12JCZDJC23800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS RJ, 1991, STROKE, V22, P943, DOI 10.1161/01.STR.22.7.943; Bohannon R., 1999, J PHYS THER SCI, V11, P59, DOI [10.1589/jpts.11.59, DOI 10.1589/JPTS.11.59]; Calautti C, 2001, STROKE, V32, P2534, DOI 10.1161/hs1101.097401; Cameron D, 2000, CLIN REHABIL, V14, P208, DOI 10.1191/026921500675786655; Carmichael ST, 2008, STROKE, V39, P1380, DOI 10.1161/STROKEAHA.107.499962; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; Carter AR, 2012, NEUROREHAB NEURAL RE, V26, P7, DOI 10.1177/1545968311411054; Carter AR, 2010, ANN NEUROL, V67, P365, DOI 10.1002/ana.21905; CHOLLET F, 1991, ANN NEUROL, V29, P63, DOI 10.1002/ana.410290112; Cowey A, 2011, BRAIN, V134, P2149, DOI 10.1093/brain/awr125; Cramer SC, 2008, ANN NEUROL, V63, P272, DOI 10.1002/ana.21393; Dancause N, 2006, REV NEUROSCIENCE, V17, P561; DEMEURISSE G, 1980, EUR NEUROL, V19, P382, DOI 10.1159/000115178; Duque J, 2005, NEUROIMAGE, V28, P940, DOI 10.1016/j.neuroimage.2005.06.033; FEENEY DM, 1986, STROKE, V17, P817, DOI 10.1161/01.STR.17.5.817; Feydy A, 2002, STROKE, V33, P1610, DOI 10.1161/01.STR.0000017100.68294.52; Gerloff C, 2006, BRAIN, V129, P791, DOI 10.1093/brain/awh713; GIBBONS RD, 1988, PSYCHOPHARMACOL BULL, V24, P438; Golestani AM, 2013, NEUROREHAB NEURAL RE, V27, P153, DOI 10.1177/1545968312457827; Grefkes C, 2008, NEUROIMAGE, V41, P1382, DOI 10.1016/j.neuroimage.2008.03.048; Grefkes C, 2010, NEUROIMAGE, V50, P233, DOI 10.1016/j.neuroimage.2009.12.029; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; He BJ, 2007, NEURON, V53, P905, DOI 10.1016/j.neuron.2007.02.013; Jaillard A, 2005, BRAIN, V128, P1122, DOI 10.1093/brain/awh456; Johansen-Berg H, 2002, P NATL ACAD SCI USA, V99, P14518, DOI 10.1073/pnas.222536799; Kwakkel G, 2004, RESTOR NEUROL NEUROS, V22, P281; Kwakkel G, 2006, STROKE, V37, P2348, DOI 10.1161/01.STR.0000238594.91938.1e; Lewis GN, 2004, J MOTOR BEHAV, V36, P174, DOI 10.3200/JMBR.36.2.174-188; Lotze M, 2006, J NEUROSCI, V26, P6096, DOI 10.1523/JNEUROSCI.4564-05.2006; Loubinoux I, 2003, NEUROIMAGE, V20, P2166, DOI 10.1016/j.neuroimage.2003.08.017; Luft AR, 2005, NEUROIMAGE, V26, P184, DOI 10.1016/j.neuroimage.2005.01.027; Luft AR, 2004, NEUROIMAGE, V21, P924, DOI 10.1016/j.neuroimage.2003.10.026; Mansur CG, 2005, NEUROLOGY, V64, P1802, DOI 10.1212/01.WNL.0000161839.38079.92; Marshall RS, 2000, STROKE, V31, P656, DOI 10.1161/01.STR.31.3.656; Murase N, 2004, ANN NEUROL, V55, P400, DOI 10.1002/ana.10848; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Nowak DA, 2008, ARCH NEUROL-CHICAGO, V65, P741, DOI 10.1001/archneur.65.6.741; Nudo RJ, 2006, CURR OPIN NEUROBIOL, V16, P638, DOI 10.1016/j.conb.2006.10.004; Park CH, 2011, STROKE, V42, P1357, DOI 10.1161/STROKEAHA.110.596155; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Rehme AK, 2012, NEUROIMAGE, V59, P2771, DOI 10.1016/j.neuroimage.2011.10.023; Rehme AK, 2011, CEREB CORTEX, V21, P756, DOI 10.1093/cercor/bhq140; Riecker A, 2010, HUM BRAIN MAPP, V31, P1017, DOI 10.1002/hbm.20914; Rose DK, 2005, CLIN REHABIL, V19, P452, DOI 10.1191/0269215505cr806oa; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Schaechter JD, 2008, NEUROIMAGE, V39, P1370, DOI 10.1016/j.neuroimage.2007.09.071; Swayne OBC, 2008, CEREB CORTEX, V18, P1909, DOI 10.1093/cercor/bhm218; Takeuchi N, 2005, STROKE, V36, P2681, DOI 10.1161/01.STR.0000189658.51972.34; Talelli P, 2012, NEUROREHAB NEURAL RE, V26, P976, DOI 10.1177/1545968312437940; Tombari D, 2004, NEUROIMAGE, V23, P827, DOI 10.1016/j.neuroimage.2004.07.058; van Meer MPA, 2012, J NEUROSCI, V32, P4495, DOI 10.1523/JNEUROSCI.3662-11.2012; van Meer MPA, 2010, J CEREBR BLOOD F MET, V30, P1707, DOI 10.1038/jcbfm.2010.124; van Meer MPA, 2010, J NEUROSCI, V30, P3964, DOI 10.1523/JNEUROSCI.5709-09.2010; Varkuti B, 2013, NEUROREHAB NEURAL RE, V27, P53, DOI 10.1177/1545968312445910; Wang L, 2010, BRAIN, V133, P1224, DOI 10.1093/brain/awq043; Ward NS, 2007, EUR J NEUROSCI, V25, P1865, DOI 10.1111/j.1460-9568.2007.05434.x; Ward NS, 2003, BRAIN, V126, P2476, DOI 10.1093/brain/awg245; Warren JE, 2009, BRAIN, V132, P3428, DOI 10.1093/brain/awp270; WEILLER C, 1992, ANN NEUROL, V31, P463, DOI 10.1002/ana.410310502; Werhahn KJ, 2003, ANN NEUROL, V54, P464, DOI 10.1002/ana.10686	60	45	46	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84729	10.1371/journal.pone.0084729	http://dx.doi.org/10.1371/journal.pone.0084729			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416273	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500156
J	Gross, R; Bellamy, SL; Chapman, J; Han, XY; O'Duor, J; Strom, BL; Houts, PS; Palmer, SC; Coyne, JC				Gross, Robert; Bellamy, Scarlett L.; Chapman, Jennifer; Han, Xiaoyan; O'Duor, Jacqueline; Strom, Brian L.; Houts, Peter S.; Palmer, Steven C.; Coyne, James C.			The Effects of a Problem Solving-Based Intervention on Depressive Symptoms and HIV Medication Adherence Are Independent	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; ANTIDEPRESSANT TREATMENT; CANCER-PATIENTS; DISORDERS; RISK; METAANALYSIS; HIV/AIDS; PROJECT; ANXIETY; TRIAL	Depression and depressive symptoms predict poor adherence to medical therapy, but the association is complex, nonspecific, and difficult to interpret. Understanding this association may help to identify the mechanism explaining the results of interventions that improve both medical therapy adherence and depressive symptoms as well as determine the importance of targeting depression in adherence interventions. We previously demonstrated that Managed Problem Solving (MAPS) focused on HIV medication adherence improved adherence and viral load in patients initiating a new antiretroviral regimen. Here, we assessed whether MAPS improved depressive symptoms and in turn, whether changes in depressive symptoms mediated changes in adherence and treatment outcomes. We compared MAPS to usual care with respect to presence of depressive symptoms during the trial using logistic regression. We then assessed whether MAPS' effect on depressive symptoms mediated the relationship between MAPS and adherence and virologic outcomes using linear and logistic regression, respectively. Mediation was defined by the disappearance of the mathematical association between MAPS and the outcomes when the proposed mediator was included in regression models. Although MAPS participants had a lower rate of depressive symptoms (OR = 0.45, 95% confidence interval 0.21-0.93), there was no evidence of mediation of the effects of MAPS on adherence and virological outcome by improvements in depression. Thus, interventions for medication adherence may not need to address depressive symptoms in order to impact both adherence and depression; this remains to be confirmed, however, in other data.	[Gross, Robert; Bellamy, Scarlett L.; Chapman, Jennifer; Han, Xiaoyan; O'Duor, Jacqueline; Strom, Brian L.] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Gross, Robert; Bellamy, Scarlett L.; Chapman, Jennifer; Han, Xiaoyan; O'Duor, Jacqueline; Strom, Brian L.] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Gross, Robert; Strom, Brian L.] Univ Penn, Perelman Sch Med, Ctr Pharmacoepidemiol Res & Training, Philadelphia, PA 19104 USA; [Gross, Robert] Univ Penn, Perelman Sch Med, Dept Med, Div Infect Dis, Philadelphia, PA 19104 USA; [Gross, Robert] Philadelphia Vet Affairs Med Ctr, Philadelphia, PA USA; [Houts, Peter S.] Penn State Univ, Coll Med, Hershey, PA USA; [Palmer, Steven C.; Coyne, James C.] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Coyne, James C.] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci, Hlth Psychol Sect, Groningen, Netherlands	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Pennsylvania; Pennsylvania Medicine; University of Groningen	Gross, R (corresponding author), Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA.	grossr@mail.med.upenn.edu	han, xiao/HDN-9782-2022	Bellamy, Scarlett/0000-0002-2906-4046; Chapman, Jennifer/0000-0001-7065-311X	National Institute Of Mental Health [R01 MH080701, R01 MH067498]; National Center for Research Resources [UL1 RR024134]; National Institute of Allergy and Infectious Diseases; Penn Center for AIDS Research [P30 AI045008]; Philadelphia Veterans Affairs Medical Center; Bristol-Myers Squibb; Abbott Laboratories; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI045008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH097488, R01MH067498, R01MH080701] Funding Source: NIH RePORTER	National Institute Of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Penn Center for AIDS Research; Philadelphia Veterans Affairs Medical Center(US Department of Veterans Affairs); Bristol-Myers Squibb(Bristol-Myers Squibb); Abbott Laboratories(Abbott Laboratories); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Research reported in this publication was supported by the National Institute Of Mental Health under Award Numbers R01 MH080701 and R01 MH067498, by the National Center for Research Resources under Award Number UL1 RR024134, by the National Institute of Allergy and Infectious Diseases via core services and support from the Penn Center for AIDS Research under Award Number P30 AI045008 and career support (RG) from the Philadelphia Veterans Affairs Medical Center. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. During the course of this study, Dr. Gross received research support via contracts with Bristol-Myers Squibb and Abbott Laboratories for work related to HIV and its treatment, but not for work on this study. Dr. Strom was supported in part by contracts with and received payment for consulting with numerous pharmaceutical companies, none of which was related to HIV or this study.	Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; Benazon NR, 2005, PSYCHOSOM MED, V67, P916, DOI 10.1097/01.psy.0000188399.80167.aa; Ciesla JA, 2001, AM J PSYCHIAT, V158, P725, DOI 10.1176/appi.ajp.158.5.725; Cruess DG, 2012, ANN BEHAV MED, V43, P189, DOI 10.1007/s12160-011-9322-9; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; DiMatteo MR, 2004, MED CARE, V42, P200, DOI 10.1097/01.mlr.0000114908.90348.f9; FECHNERBATES S, 1994, J CONSULT CLIN PSYCH, V62, P550, DOI 10.1037/0022-006X.62.3.550; Gonzalez JS, 2011, JAIDS-J ACQ IMM DEF, V58, P181, DOI [10.1097/QAI.0B013E31822D490A, 10.1097/QAI.0b013e31822d490a]; Gross R, 2013, JAMA INTERN MED, V173, P300, DOI 10.1001/jamainternmed.2013.2152; Katon W, 2007, GEN HOSP PSYCHIAT, V29, P147, DOI 10.1016/j.genhosppsych.2006.11.005; Klinkman MS, 1997, ARCH FAM MED, V6, P567, DOI 10.1001/archfami.6.6.567; Kumar V, 2009, PSYCHIAT QUART, V80, P131, DOI 10.1007/s11126-009-9100-z; Lucas GM, 1999, ANN INTERN MED, V131, P81, DOI 10.7326/0003-4819-131-2-199907200-00002; MCLELLAN AT, 1992, J SUBST ABUSE TREAT, V9, P199, DOI 10.1016/0740-5472(92)90062-S; Mohr DC, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1602; Nezu AM, 2003, J CONSULT CLIN PSYCH, V71, P1036, DOI 10.1037/0022-006X.71.6.1036; Palmer SC, 2012, CANCER-AM CANCER SOC, V118, P2735, DOI 10.1002/cncr.26603; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Safren SA, 2012, J CONSULT CLIN PSYCH, V80, P404, DOI 10.1037/a0028208; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Tsai AC, 2012, AM J PUBLIC HLTH; Walkup J, 2008, PSYCHIAT QUART, V79, P43, DOI 10.1007/s11126-007-9055-x; Yun LWH, 2005, JAIDS-J ACQ IMM DEF, V38, P432, DOI 10.1097/01.qai.0000147524.19122.fd; ZEGER SL, 1992, STAT MED, V11, P1825, DOI 10.1002/sim.4780111406	26	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84952	10.1371/journal.pone.0084952	http://dx.doi.org/10.1371/journal.pone.0084952			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	286IW	24400124	Green Submitted, gold, Green Published			2022-12-27	WOS:000329462700058
J	Fritz, C; Lamers, LPM; Riaz, M; van den Berg, LJL; Elzenga, TJTM				Fritz, Christian; Lamers, Leon P. M.; Riaz, Muhammad; van den Berg, Leon J. L.; Elzenga, Theo J. T. M.			Sphagnum Mosses - Masters of Efficient N-Uptake while Avoiding Intoxication	PLOS ONE			English	Article							ATMOSPHERIC NITROGEN DEPOSITION; NITRATE REDUCTASE-ACTIVITY; VASCULAR PLANTS; PHYSIOLOGICAL-RESPONSES; OMBROTROPHIC BOGS; WATER-TABLE; AMMONIUM; GROWTH; ACCUMULATION; BRYOPHYTES	Peat forming Sphagnum mosses are able to prevent the dominance of vascular plants under ombrotrophic conditions by efficiently scavenging atmospherically deposited nitrogen (N). N-uptake kinetics of these mosses are therefore expected to play a key role in differential N availability, plant competition, and carbon sequestration in Sphagnum peatlands. The interacting effects of rain N concentration and exposure time on moss N-uptake rates are, however, poorly understood. We investigated the effects of N-concentration (1, 5, 10, 50, 100, 500 mu M), N-form (N-15 - ammonium or nitrate) and exposure time (0.5, 2, 72 h) on uptake kinetics for Sphagnum magellanicum from a pristine bog in Patagonia (Argentina) and from a Dutch bog exposed to decades of N-pollution. Uptake rates for ammonium were higher than for nitrate, and N-binding at adsorption sites was negligible. During the first 0.5 h, N-uptake followed saturation kinetics revealing a high affinity (K-m 3.5-6.5 mu M). Ammonium was taken up 8 times faster than nitrate, whereas over 72 hours this was only 2 times. Uptake rates decreased drastically with increasing exposure times, which implies that many short-term N-uptake experiments in literature may well have overestimated long-term uptake rates and ecosystem retention. Sphagnum from the polluted site (i.e. long-term N exposure) showed lower uptake rates than mosses from the pristine site, indicating an adaptive response. Sphagnum therefore appears to be highly efficient in using short N pulses (e. g. rainfall in pristine areas). This strategy has important ecological and evolutionary implications: at high N input rates, the risk of N-toxicity seems to be reduced by lower uptake rates of Sphagnum, at the expense of its long-term filter capacity and related competitive advantage over vascular plants. As shown by our conceptual model, interacting effects of N-deposition and climate change (changes in rainfall) will seriously alter the functioning of Sphagnum peatlands.	[Fritz, Christian; Lamers, Leon P. M.; van den Berg, Leon J. L.] Radboud Univ Nijmegen, Dept Aquat Ecol & Environm Biol, NL-6525 ED Nijmegen, Netherlands; [Riaz, Muhammad] GC Univ, Dept Environm Sci, Faisalabad, Pakistan; [Fritz, Christian] Univ Groningen, Ctr Energy & Environm Studies, Groningen, Netherlands; [Riaz, Muhammad] Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England; [Elzenga, Theo J. T. M.] Univ Groningen, Lab Plant Physiol, Groningen, Netherlands	Radboud University Nijmegen; Government College University Faisalabad; University of Groningen; University of York - UK; University of Groningen	Fritz, C (corresponding author), Radboud Univ Nijmegen, Dept Expt Plant Ecol, NL-6525 ED Nijmegen, Netherlands.	f.c@gmx.li	Fritz, Christian/C-5501-2011; Lamers, Leon P.M./A-8718-2012	Fritz, Christian/0000-0003-2687-9749; Lamers, Leon P.M./0000-0003-3769-2154; Riaz, Muhammad/0000-0001-8074-3063; Elzenga, J. Theo M./0000-0003-4556-2093	ESF [EG/2835, EG/3356]	ESF(European Commission)	Muhammed Riaz received two ESF exchange grants 'NinE' to participate in this research (EG/2835 & EG/3356). We did not require further external funding source for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 1999, ECOLOGY, V80, P2170, DOI 10.1890/0012-9658(1999)080[2170:PMCONC]2.0.CO;2; AERTS R, 1995, TRENDS ECOL EVOL, V10, P402, DOI 10.1016/S0169-5347(00)89156-9; Aldous AR, 2002, NEW PHYTOL, V156, P241, DOI 10.1046/j.1469-8137.2002.00518.x; Aldous AR, 2002, CAN J BOT, V80, P721, DOI [10.1139/B02-054, 10.1139/b02-054]; Arroniz-Crespo M, 2008, NEW PHYTOL, V180, P864, DOI 10.1111/j.1469-8137.2008.02617.x; BAXTER R, 1992, NEW PHYTOL, V120, P265, DOI 10.1111/j.1469-8137.1992.tb05663.x; BAYLEY SE, 1987, CAN J FISH AQUAT SCI, V44, P194; Beijk R, 2007, JAAROVERZICHT LUCHTK, P1; Berendse F, 2001, GLOBAL CHANGE BIOL, V7, P591, DOI 10.1046/j.1365-2486.2001.00433.x; Blodau C, 2006, SCI TOTAL ENVIRON, V364, P215, DOI 10.1016/j.scitotenv.2005.06.002; Bragazza L, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002267; Bragazza L, 2004, NEW PHYTOL, V163, P609, DOI 10.1111/j.1469-8137.2004.01154.x; Bragazza L, 2008, GLOBAL CHANGE BIOL, V14, P2688, DOI 10.1111/j.1365-2486.2008.01699.x; Bragazza L, 2012, GLOBAL CHANGE BIOL, V18, P1163, DOI 10.1111/j.1365-2486.2011.02585.x; BREHM K, 1968, PLANTA, V79, P324, DOI 10.1007/BF00386916; BREUER K, 1990, OECOLOGIA, V82, P461, DOI 10.1007/BF00319786; Cagampan JP, 2008, HYDROL PROCESS, V22, P1776, DOI 10.1002/hyp.6802; CLYMO RS, 1973, J ECOL, V61, P849, DOI 10.2307/2258654; Curtis CJ, 2005, J APPL ECOL, V42, P507, DOI 10.1111/j.1365-2664.2005.01029.x; Fritz C, 2012, PLANT BIOLOGY, V14, P491, DOI 10.1111/j.1438-8677.2011.00527.x; Fritz C, 2008, HYDROL PROCESS, V22, P3264, DOI 10.1002/hyp.6912; Fritz C, 2011, NEW PHYTOL, V190, P398, DOI 10.1111/j.1469-8137.2010.03604.x; GIGNAC LD, 1990, BRYOLOGIST, V93, P7, DOI 10.2307/3243541; Granath G, 2009, OECOLOGIA, V161, P481, DOI 10.1007/s00442-009-1406-x; Grootjans A, 2010, MIRES PEAT, V6; Gundale MJ, 2011, GLOBAL CHANGE BIOL, V17, P2743, DOI 10.1111/j.1365-2486.2011.02407.x; Gunnarsson U, 2000, NEW PHYTOL, V147, P527, DOI 10.1046/j.1469-8137.2000.00717.x; Gunnarsson U, 2008, GLOBAL CHANGE BIOL, V14, P2152, DOI 10.1111/j.1365-2486.2008.01638.x; Heeschen V, 1996, PHYSIOL PLANTARUM, V97, P402, DOI 10.1034/j.1399-3054.1996.970227.x; Holden J, 2002, EUR J SOIL SCI, V53, P675, DOI 10.1046/j.1365-2389.2002.00486.x; Holden J, 2009, J HYDROL, V364, P342, DOI 10.1016/j.jhydrol.2008.11.010; Jauhiainen J, 1998, NEW PHYTOL, V138, P287, DOI 10.1046/j.1469-8137.1998.00110.x; Joosten H, 2002, WISE USE MIRES PEATL; Kahl S, 1997, PHYSIOL PLANTARUM, V101, P86, DOI 10.1111/j.1399-3054.1997.tb01823.x; Kielland K, 1997, ECOSCIENCE, V4, P75, DOI 10.1080/11956860.1997.11682379; Kip N, 2010, NAT GEOSCI, V3, P617, DOI 10.1038/NGEO939; Kleinebecker T, 2007, FOLIA GEOBOT, V42, P363, DOI 10.1007/BF02861700; KOCHIAN LV, 1982, PLANT PHYSIOL, V70, P1723, DOI 10.1104/pp.70.6.1723; Lafleur PM, 2005, HYDROL PROCESS, V19, P3533, DOI 10.1002/hyp.5842; Lamers LPM, 2000, GLOB CHANGE BIOL, V6, P583, DOI 10.1046/j.1365-2486.2000.00342.x; Limpens J, 2003, NEW PHYTOL, V157, P339, DOI 10.1046/j.1469-8137.2003.00667.x; Limpens J, 2004, ECOSYSTEMS, V7, P793, DOI 10.1007/s10021-004-0274-9; Limpens J, 2011, NEW PHYTOLOGIST, DOI j.1469-8137.2011.03680.x; Lindo Z, 2010, ECOSYSTEMS, V13, P612, DOI 10.1007/s10021-010-9336-3; Malmer N, 2003, OIKOS, V100, P469, DOI 10.1034/j.1600-0706.2003.12170.x; Marschall M, 1998, J BRYOL, V20, P273, DOI 10.1179/jbr.1998.20.2.273; Melzer A, 1989, OKOPHYSIOLOGISCHE UN, P1; Moore T, 2005, GLOBAL CHANGE BIOL, V11, P356, DOI 10.1111/j.1365-2486.2004.00882.x; Nakamura T, 2012, OECOLOGIA, V168, P913, DOI 10.1007/s00442-011-2161-3; Pearce ISK, 2003, NEW PHYTOL, V160, P145, DOI 10.1046/j.1469-8137.2003.00875.x; Pilkington MG, 2005, ENVIRON POLLUT, V135, P29, DOI 10.1016/j.envpol.2004.10.016; Pinheiro J., 2006, NLME R PACKAGE FITTI; R Team DC, 2009, LANG ENV STAT COMP; Robroek BJM, 2007, PLANT ECOL, V190, P97, DOI 10.1007/s11258-006-9193-5; Robroek BJM, 2009, GLOBAL CHANGE BIOL, V15, P680, DOI 10.1111/j.1365-2486.2008.01724.x; Rudolph H, 1993, ADV BRYOL, V5, P79; Sakamoto Y, 1986, AKAIKE INFORM CRITER; Schipperges B, 1998, NEW PHYTOL, V140, P677, DOI 10.1046/j.1469-8137.1998.00311.x; Shaw AJ, 2010, MOL PHYLOGENET EVOL, V55, P1139, DOI 10.1016/j.ympev.2010.01.020; Sheppard L, 2012, BIOGEOSCIENCES DISCU, V9, P8141; Smolders AJP, 2001, NEW PHYTOL, V152, P325, DOI 10.1046/j.0028-646X.2001.00261.x; Soares A, 1997, WATER AIR SOIL POLL, V93, P225, DOI 10.1007/BF02404758; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Tomassen HBM, 2004, J APPL ECOL, V41, P139, DOI 10.1111/j.1365-2664.2004.00870.x; Turetsky MR, 2010, CAN J FOREST RES, V40, P1237, DOI 10.1139/X10-072; Turetsky MR, 1999, ECOSCIENCE, V6, P587, DOI 10.1080/11956860.1999.11682559; TWENHOVEN FL, 1992, J BRYOL, V17, P71, DOI 10.1179/jbr.1992.17.1.71; Twenhoven FL, 1992, MITTEILUNGEN ARBEITS, V44, P1; VANBREEMEN N, 1995, TRENDS ECOL EVOL, V10, P270, DOI 10.1016/0169-5347(95)90007-1; Vergeer P, 2008, NEW PHYTOL, V179, P129, DOI 10.1111/j.1469-8137.2008.02445.x; Wanek W, 2005, NEW PHYTOL, V166, P577, DOI 10.1111/j.1469-8137.2005.01319.x; Wanek W, 2008, FUNCT PLANT BIOL, V35, P51, DOI 10.1071/FP07191; WANG MY, 1993, PLANT PHYSIOL, V103, P1259, DOI 10.1104/pp.103.4.1463; Wiedermann MM, 2009, OIKOS, V118, P449, DOI 10.1111/j.1600-0706.2008.17129.x; Wiedermann MM, 2009, NEW PHYTOL, V181, P208, DOI 10.1111/j.1469-8137.2008.02628.x; WOODIN S, 1985, NEW PHYTOL, V99, P381, DOI 10.1111/j.1469-8137.1985.tb03666.x; WOODIN SJ, 1987, ENVIRON POLLUT, V45, P61, DOI 10.1016/0269-7491(87)90016-9; Xing YP, 2011, BIOGEOCHEMISTRY, V103, P281, DOI 10.1007/s10533-010-9463-0; Yazaki T, 2006, J HYDROL, V319, P312, DOI 10.1016/j.jhydrol.2005.06.037; Zuur AF, 2007, STAT BIOL HEALTH, P163	80	60	60	6	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e79991	10.1371/journal.pone.0079991	http://dx.doi.org/10.1371/journal.pone.0079991			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416125	Green Published, gold			2022-12-27	WOS:000329866300003
J	Gardiner, DM; Upadhyaya, NM; Stiller, J; Ellis, JG; Dodds, PN; Kazan, K; Manners, JM				Gardiner, Donald M.; Upadhyaya, Narayana M.; Stiller, Jiri; Ellis, Jeff G.; Dodds, Peter N.; Kazan, Kemal; Manners, John M.			Genomic Analysis of Xanthomonas translucens Pathogenic on Wheat and Barley Reveals Cross-Kingdom Gene Transfer Events and Diverse Protein Delivery Systems	PLOS ONE			English	Article							III SECRETION SYSTEM; EFFECTORS; IDENTIFICATION; TRANSLOCATION; VIRULENCE; SEQUENCE; ALBILINEANS; EVOLUTION; ACCURATE; INSIGHTS	In comparison to dicot-infecting bacteria, only limited numbers of genome sequences are available for monocot-infecting and in particular cereal-infecting bacteria. Herein we report the characterisation and genome sequence of Xanthomonas translucens isolate DAR61454 pathogenic on wheat and barley. Based on phylogenetic analysis of the ATP synthase beta subunit (atpD) gene, DAR61454 is most closely related to other X. translucens strains and the sugarcane- and banana-infecting Xanthomonas strains, but shares a type III secretion system (T3SS) with X. translucens pv. graminis and more distantly related xanthomonads. Assays with an adenylate cyclase reporter protein demonstrate that DAR61454's T3SS is functional in delivering proteins to wheat cells. X. translucens DAR61454 also encodes two type VI secretion systems with one most closely related to those found in some strains of the rice infecting strain X. oryzae pv. oryzae but not other xanthomonads. Comparative analysis of 18 different Xanthomonas isolates revealed 84 proteins unique to cereal (i.e. rice) infecting isolates and the wheat/barley infecting DAR61454. Genes encoding 60 of these proteins are found in gene clusters in the X. translucens DAR61454 genome, suggesting cereal-specific pathogenicity islands. However, none of the cereal pathogen specific proteins were homologous to known Xanthomonas spp. effectors. Comparative analysis outside of the bacterial kingdom revealed a nucleoside triphosphate pyrophosphohydrolase encoding gene in DAR61454 also present in other bacteria as well as a number of pathogenic Fusarium species, suggesting that this gene may have been transmitted horizontally from bacteria to the Fusarium lineage of pathogenic fungi. This example further highlights the importance of horizontal gene acquisition from bacteria in the evolution of fungi.	[Gardiner, Donald M.; Stiller, Jiri; Kazan, Kemal; Manners, John M.] CSIRO, Brisbane, Qld, Australia; [Upadhyaya, Narayana M.; Ellis, Jeff G.; Dodds, Peter N.] CSIRO, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Gardiner, DM (corresponding author), CSIRO, Brisbane, Qld, Australia.	Donald.Gardiner@csiro.au	Kazan, Kemal/B-8032-2008; Stiller, Jiri/E-1564-2012; Upadhyaya, Narayana M/A-1480-2008; Gardiner, Donald/A-1297-2010; Ellis, Jeffrey G/A-1999-2010; Manners, John M/A-4922-2008; Dodds, Peter/D-1181-2009	Kazan, Kemal/0000-0002-5169-8934; Upadhyaya, Narayana M/0000-0002-3052-0416; Gardiner, Donald/0000-0002-2162-8716; Dodds, Peter/0000-0003-0620-5923	Australian Government National Collaborative Research Infrastructure Strategy and Education Investment Fund Super Science Initiative; Two Blades Foundation; Grains Research and Development Corporation (GRDC), an Australian Commonwealth Government Authority	Australian Government National Collaborative Research Infrastructure Strategy and Education Investment Fund Super Science Initiative(Australian GovernmentDepartment of Industry, Innovation and Science); Two Blades Foundation; Grains Research and Development Corporation (GRDC), an Australian Commonwealth Government Authority	This work was supported through access to facilities managed by Bioplatforms Australia and funded by the Australian Government National Collaborative Research Infrastructure Strategy and Education Investment Fund Super Science Initiative (www.bioplatforms.com.au/special-initiatives/agriculture/wheat-datasets) and through funding from the Two Blades Foundation. DMG was partially supported by the Grains Research and Development Corporation (GRDC), an Australian Commonwealth Government Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegria MC, 2005, J BACTERIOL, V187, P2315, DOI 10.1128/JB.187.7.2315-2325.2005; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Birch RG, 2001, MOL PLANT PATHOL, V2, P1, DOI 10.1046/j.1364-3703.2001.00046.x; Bladergroen MR, 2003, MOL PLANT MICROBE IN, V16, P53, DOI 10.1094/MPMI.2003.16.1.53; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Brunings AM, 2003, MOL PLANT PATHOL, V4, P141, DOI 10.1046/j.1364-3703.2003.00163.x; BRYSON V, 1952, SCIENCE, V116, P45, DOI 10.1126/science.116.3003.45; Buttner D, 2010, FEMS MICROBIOL REV, V34, P107, DOI 10.1111/j.1574-6976.2009.00192.x; Casper-Lindley C, 2002, P NATL ACAD SCI USA, V99, P8336, DOI 10.1073/pnas.122220299; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Coleman JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000618; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; da Silva FG, 2004, MOL PLANT MICROBE IN, V17, P593, DOI 10.1094/MPMI.2004.17.6.593; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Duveiller E., 1997, BACTERIAL DIS WHEAT, P25; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Gardiner DM, 2013, GENOME A, V1; Gardiner DM, 2013, PLANT SCI, V210, P151, DOI 10.1016/j.plantsci.2013.06.002; Gardiner DM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002952; Gross M, 2006, MOL MICROBIOL, V59, P590, DOI 10.1111/j.1365-2958.2005.04956.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hajri A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006632; Hayward AC, 2010, J APPL MICROBIOL, V108, P756, DOI 10.1111/j.1365-2672.2009.04471.x; Kleemann J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002643; Klosterman SJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002137; Lee BM, 2005, NUCLEIC ACIDS RES, V33, P577, DOI 10.1093/nar/gki206; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; LOPER JE, 1987, PHYTOPATHOLOGY, V77, P1449, DOI 10.1094/Phyto-77-1449; MINSAVAGE GV, 1990, MOL PLANT MICROBE IN, V3, P41, DOI 10.1094/MPMI-3-041; Moolhuljzen PM, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00670-13; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Parkinson N, 2009, INT J SYST EVOL MICR, V59, P264, DOI 10.1099/ijs.0.65825-0; Pieretti I, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-616; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Records AR, 2011, MOL PLANT MICROBE IN, V24, P751, DOI 10.1094/MPMI-11-10-0262; Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001; Schechter LM, 2010, APPL ENVIRON MICROB, V76, P3758, DOI 10.1128/AEM.03122-09; Schechter LM, 2004, J BACTERIOL, V186, P543, DOI 10.1128/JB.186.2.543-555.2004; Sohn KH, 2007, PLANT CELL, V19, P4077, DOI 10.1105/tpc.107.054262; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; Studholme DJ, 2011, GENES-BASEL, V2, P1050, DOI 10.3390/genes2041050; Tseng TT, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S2; Upadhyaya NM, 2013, MOL PLANT M IN PRESS; Wichmann F, 2013, MOL PLANT PATHOL, V14, P576, DOI 10.1111/mpp.12030; Yan Q, 2012, MOL PLANT MICROBE IN, V25, P69, DOI 10.1094/MPMI-05-11-0121; Yin CT, 2011, EUPHYTICA, V179, P57, DOI 10.1007/s10681-010-0285-x	49	20	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84995	10.1371/journal.pone.0084995	http://dx.doi.org/10.1371/journal.pone.0084995			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416331	gold, Green Submitted, Green Published			2022-12-27	WOS:000329866300047
J	Rajashekhar, G; Ramadan, A; Abburi, C; Callaghan, B; Traktuev, DO; Evans-Molina, C; Maturi, R; Harris, A; Kern, TS; March, KL				Rajashekhar, Gangaraju; Ramadan, Ahmed; Abburi, Chandrika; Callaghan, Breedge; Traktuev, Dmitry O.; Evans-Molina, Carmella; Maturi, Raj; Harris, Alon; Kern, Timothy S.; March, Keith L.			Regenerative Therapeutic Potential of Adipose Stromal Cells in Early Stage Diabetic Retinopathy	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; VASCULAR NETWORK FORMATION; IFATS COLLECTION; PROGENITOR CELLS; IN-VIVO; ENDOTHELIAL-CELLS; MOUSE MODEL; RETINAL ANGIOGENESIS; INTENSIVE TREATMENT; TACTILE ALLODYNIA	Diabetic retinopathy (DR) is the leading cause of blindness in working-age adults. Early stage DR involves inflammation, vascular leakage, apoptosis of vascular cells and neurodegeneration. In this study, we hypothesized that cells derived from the stromal fraction of adipose tissue (ASC) could therapeutically rescue early stage DR features. Streptozotocin (STZ) induced diabetic athymic nude rats received single intravitreal injection of human ASC into one eye and saline into the other eye. Two months post onset of diabetes, administration of ASC significantly improved "b" wave amplitude (as measured by electroretinogram) within 1-3 weeks of injection compared to saline treated diabetic eyes. Subsequently, retinal histopathological evaluation revealed a significant decrease in vascular leakage and apoptotic cells around the retinal vessels in the diabetic eyes that received ASC compared to the eyes that received saline injection. In addition, molecular analyses have shown down-regulation in inflammatory gene expression in diabetic retina that received ASC compared to eyes that received saline. Interestingly, ASC were found to be localized near retinal vessels at higher densities than seen in age matched non-diabetic retina that received ASC. In vitro, ASC displayed sustained proliferation and decreased apoptosis under hyperglycemic stress. In addition, ASC in co-culture with retinal endothelial cells enhance endothelial survival and collaborate to form vascular networks. Taken together, our findings suggest that ASC are able to rescue the neural retina from hyperglycemia-induced degeneration, resulting in importantly improved visual function. Our pre-clinical studies support the translational development of adipose stem cell-based therapy for DR to address both retinal capillary and neurodegeneration.	[Rajashekhar, Gangaraju; Traktuev, Dmitry O.; March, Keith L.] Indiana Univ Sch Med, Indiana Ctr Vasc Biol & Med, Indianapolis, IN 46202 USA; [Rajashekhar, Gangaraju; Ramadan, Ahmed; Abburi, Chandrika; Callaghan, Breedge; Maturi, Raj; Harris, Alon] Indiana Univ Sch Med, Eugene & Marilyn Glick Eye Inst, Indianapolis, IN 46202 USA; [Rajashekhar, Gangaraju; Traktuev, Dmitry O.; Evans-Molina, Carmella; March, Keith L.] Indiana Univ Sch Med, Vasc & Cardiac Ctr Adult Stem Cell Therapy, Indianapolis, IN 46202 USA; [Rajashekhar, Gangaraju; Traktuev, Dmitry O.; March, Keith L.] Indiana Univ Sch Med, VA Ctr Regenerat Med, Indianapolis, IN 46202 USA; [Rajashekhar, Gangaraju; Ramadan, Ahmed; Abburi, Chandrika; Callaghan, Breedge; Maturi, Raj; Harris, Alon] Indiana Univ Sch Med, Dept Ophthalmol, Indianapolis, IN 46202 USA; [Rajashekhar, Gangaraju; Evans-Molina, Carmella; Harris, Alon; March, Keith L.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Evans-Molina, Carmella] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Traktuev, Dmitry O.; Evans-Molina, Carmella; March, Keith L.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Evans-Molina, Carmella] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Maturi, Raj] Midwest Eye Inst, Indianapolis, IN USA; [Kern, Timothy S.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Kern, Timothy S.] Case Western Reserve Univ, Dept Ophthalmol, Cleveland, OH 44106 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Case Western Reserve University; Case Western Reserve University	Rajashekhar, G (corresponding author), Indiana Univ Sch Med, Indiana Ctr Vasc Biol & Med, Indianapolis, IN 46202 USA.	rgangara@iupui.edu	Traktuev, Dmitry/AAP-1160-2020; Gangaraju, Rajashekhar/I-7852-2019	Traktuev, Dmitry/0000-0002-6757-512X; Gangaraju, Rajashekhar/0000-0002-6664-8286; March, Keith/0000-0001-5677-0379	National Eye Institute [EY023427]; Ralph W. and Grace M. Showalter Research Trust; ICVBM/Signature Vascular and Cardiac Center for Adult Stem Cell Therapy; Indiana Center for Vascular Biology and Medicine; NIH [K08 DK080225, R03 DK 089147, R01 DK093954]; NIH/NCATS-Indiana Clinical and Translational Sciences Institute - K12 Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002529, UL1TR001108] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY023427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK089147, R01DK093954, K08DK080225] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001733] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Ralph W. and Grace M. Showalter Research Trust; ICVBM/Signature Vascular and Cardiac Center for Adult Stem Cell Therapy; Indiana Center for Vascular Biology and Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCATS-Indiana Clinical and Translational Sciences Institute - K12 Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by grants from the National Eye Institute (EY023427), Ralph W. and Grace M. Showalter Research Trust grant, an ICVBM/Signature Vascular and Cardiac Center for Adult Stem Cell Therapy grant, gifts from the Cryptic Masons Medical Research Foundation, support from the Indiana Center for Vascular Biology and Medicine to G.R and NIH, and grants K08 DK080225, R03 DK 089147, and R01 DK093954 to C.E.M. G.R is a recipient of NIH/NCATS-Indiana Clinical and Translational Sciences Institute - K12 Program (A. Shekhar, PI), 5/01/08-04/30/13. The funders played no role in the conduct of the study, collection of data, management of the study, analysis of data, interpretation of data, or preparation of the manuscript.	Al-Shabrawey M, 2012, MOL VIS, V18, P1895; Amos PJ, 2008, STEM CELLS, V26, P2682, DOI 10.1634/stemcells.2008-0030; Amos PJ, 2011, AM J PHYSIOL-CELL PH, V301, pC1378, DOI 10.1152/ajpcell.00460.2010; Antonetti D, 2009, NAT MED, V15, P1248, DOI 10.1038/nm1109-1248; Aung MH, 2013, INVEST OPHTH VIS SCI, V54, P1370, DOI 10.1167/iovs.12-10927; Barber AJ, 2011, INVEST OPHTH VIS SCI, V52, P1156, DOI 10.1167/iovs.10-6293; Bassi EJ, 2012, DIABETES, V61, P2534, DOI 10.2337/db11-0844; Block GJ, 2009, STEM CELLS, V27, P670, DOI [10.1634/stemcells.stemcells.2008-0742, 10.1002/stem.20080742]; Bourin P, 2013, CYTOTHERAPY, V15, P641, DOI 10.1016/j.jcyt.2013.02.006; Burch S, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1921887; Caballero S, 2007, DIABETES, V56, P960, DOI 10.2337/db06-1254; Cai J, 2008, INVEST OPHTH VIS SCI, V49, P2163, DOI 10.1167/iovs.07-1206; Cai L, 2007, STEM CELLS, V25, P3234, DOI 10.1634/stemcells.2007-0388; Cai LY, 2009, STEM CELLS, V27, P230, DOI 10.1634/stemcells.2008-0273; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Chen YJ, 2002, BLOOD, V100, P1373, DOI 10.1182/blood-2002-01-0174; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Dauchy RT, 2004, CANCER LETT, V209, P7, DOI 10.1016/j.canlet.2003.12.012; Dhong ES, 2012, J CRANIOFAC SURG, V23, P805, DOI 10.1097/SCS.0b013e31824e6c87; Dong N, 2012, INVEST OPHTH VIS SCI, V53, P7567, DOI 10.1167/iovs.12-9446; Du YP, 2010, INVEST OPHTH VIS SCI, V51, P2158, DOI 10.1167/iovs.09-3674; ESSER P, 1993, BRIT J OPHTHALMOL, V77, P731, DOI 10.1136/bjo.77.11.731; Feit-Leichman RA, 2005, INVEST OPHTH VIS SCI, V46, P4281, DOI 10.1167/iovs.04-1361; FESTING MFW, 1978, NATURE, V274, P365, DOI 10.1038/274365a0; Freeman WM, 2010, PHARMACOGENOMICS J, V10, P385, DOI 10.1038/tpj.2009.60; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Grimshaw MJ, 2002, EUR J IMMUNOL, V32, P2393, DOI 10.1002/1521-4141(200209)32:9<2393::AID-IMMU2393>3.0.CO;2-4; Hong SJ, 2010, CURR OPIN ORGAN TRAN, V15, P86, DOI 10.1097/MOT.0b013e328334f074; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Jarajapu YPR, 2010, CIRC RES, V106, P854, DOI 10.1161/CIRCRESAHA.109.213140; Joussen AM, 2002, FASEB J, V16, P76, DOI 10.1096/fj.02-0157fje; Joussen AM, 2001, AM J PATHOL, V158, P147, DOI 10.1016/S0002-9440(10)63952-1; Kempen JH, 2004, ARCH OPHTHALMOL-CHIC, V122, P552; Kern TS, 2010, MOL VIS, V16, P2121; Kern TS, 2010, MOL VIS, V16, P1629; Kern TS, 2008, J PHYSIOL-LONDON, V586, P4401, DOI 10.1113/jphysiol.2008.156695; Kern TS, 2007, EXP DIABETES RES, DOI 10.1155/2007/95103; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Krohne TU, 2012, STEM CELL TRANSL MED, V1, P96, DOI 10.5966/sctm.2011-0057; Li GY, 2012, DIABETES, V61, P3294, DOI 10.2337/db11-1249; Li QH, 2010, INVEST OPHTH VIS SCI, V51, P5240, DOI 10.1167/iovs.09-5147; LUNDQUIST O, 1994, GRAEF ARCH CLIN EXP, V232, P71, DOI 10.1007/BF00171666; MacIsaac ZM, 2012, EXP CELL RES, V318, P416, DOI 10.1016/j.yexcr.2011.12.002; Maier B, 2010, J CLIN INVEST, V120, P2156, DOI 10.1172/JCI38924; Maumus M, 2011, INT J OBESITY, V35, P1141, DOI 10.1038/ijo.2010.269; Mendel TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065691; Merfeld-Clauss S, 2010, TISSUE ENG PT A, V16, P2953, DOI [10.1089/ten.tea.2009.0635, 10.1089/ten.TEA.2009.0635]; Nie CL, 2011, CELL TRANSPLANT, V20, P205, DOI 10.3727/096368910X520065; Oh JY, 2008, STEM CELLS, V26, P1047, DOI 10.1634/stemcells.2007-0737; Otani A, 2002, NAT MED, V8, P1004, DOI 10.1038/nm744; Park SS, 2012, INVEST OPHTH VIS SCI, V53, P986, DOI 10.1167/iovs.11-8833; Rajashekhar G, 2005, J CELL BIOCHEM, V96, P36, DOI 10.1002/jcb.20507; Rajashekhar G, 2008, STEM CELLS, V26, P2674, DOI 10.1634/stemcells.2008-0277; Rattner A, 2005, J NEUROSCI, V25, P4540, DOI 10.1523/JNEUROSCI.0492-05.2005; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Rehman J, 2011, J MOL MED, V89, P943, DOI 10.1007/s00109-011-0799-2; Robinson R, 2012, DIS MODEL MECH, V5, P444, DOI 10.1242/dmm.009597; Rose WC, 2001, CLIN CANCER RES, V7, P2016; Rubenstein JL, 2000, NEOPLASIA, V2, P306, DOI 10.1038/sj.neo.7900102; SARAWAR SR, 1991, IMMUNOLOGY, V73, P334; Shah K, 2012, ADV DRUG DELIVER REV, V64, P739, DOI 10.1016/j.addr.2011.06.010; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sorrell JM, 2011, BIOMATERIALS, V32, P9667, DOI 10.1016/j.biomaterials.2011.08.090; Steffes MW, 2003, JAMA-J AM MED ASSOC, V290, P2159, DOI 10.1001/jama.290.16.2159; Tersey SA, 2012, DIABETES, V61, P818, DOI 10.2337/db11-1293; Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475; Traktuev DO, 2009, CIRC RES, V104, P1410, DOI 10.1161/CIRCRESAHA.108.190926; Tremolada G, 2012, EXP DIABETES RES, DOI 10.1155/2012/728325; Trudeau K, 2010, AM J PATHOL, V177, P447, DOI 10.2353/ajpath.2010.091029; von Tell D, 2006, EXP CELL RES, V312, P623, DOI 10.1016/j.yexcr.2005.10.019; Wei X, 2009, NEUROSCI LETT, V462, P76, DOI 10.1016/j.neulet.2009.06.054; Wei X, 2009, STEM CELLS, V27, P478, DOI 10.1634/stemcells.2008-0333; Wong Vickie H Y, 2011, J Ocul Biol Dis Infor, V4, P42, DOI 10.1007/s12177-011-9069-3; Yang YI, 2010, J CELL PHYSIOL, V224, P807, DOI 10.1002/jcp.22188; Yang ZK, 2010, GRAEF ARCH CLIN EXP, V248, P1415, DOI 10.1007/s00417-010-1384-z; Yuen TJ, 2013, BRAIN, V136, P1035, DOI 10.1093/brain/awt024; Zhang Y, 2012, CANCER RES, V72, P5198, DOI 10.1158/0008-5472.CAN-12-0294; Zografou A, 2013, ANN PLAS SURG, V71, P225, DOI 10.1097/SAP.0b013e31826af01a; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	80	69	70	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84671	10.1371/journal.pone.0084671	http://dx.doi.org/10.1371/journal.pone.0084671			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416262	Green Submitted, gold, Green Published			2022-12-27	WOS:000329866300034
J	Gobler, CJ; DePasquale, EL; Griffith, AW; Baumann, H				Gobler, Christopher J.; DePasquale, Elizabeth L.; Griffith, Andrew W.; Baumann, Hannes			Hypoxia and Acidification Have Additive and Synergistic Negative Effects on the Growth, Survival, and Metamorphosis of Early Life Stage Bivalves	PLOS ONE			English	Article							ELEVATED CARBON-DIOXIDE; OCEAN ACIDIFICATION; COASTAL WATERS; MERCENARIA-MERCENARIA; CLIMATE-CHANGE; OXYGEN; IMPACTS; FISH; CONSEQUENCES; ECOSYSTEM	Low oxygen zones in coastal and open ocean ecosystems have expanded in recent decades, a trend that will accelerate with climatic warming. There is growing recognition that low oxygen regions of the ocean are also acidified, a condition that will intensify with rising levels of atmospheric CO2. Presently, however, the concurrent effects of low oxygen and acidification on marine organisms are largely unknown, as most prior studies of marine hypoxia have not considered pH levels. We experimentally assessed the consequences of hypoxic and acidified water for early life stage bivalves (bay scallops, Argopecten irradians, and hard clams, Mercenaria mercenaria), marine organisms of significant economic and ecological value and sensitive to climate change. In larval scallops, experimental and naturally-occurring acidification (pH, total scale = 7.4-7.6) reduced survivorship (by >50%), low oxygen (30-50 mM) inhibited growth and metamorphosis (by >50%), and the two stressors combined produced additively negative outcomes. In early life stage clams, however, hypoxic waters led to 30% higher mortality, while acidified waters significantly reduced growth (by 60%). Later stage clams were resistant to hypoxia or acidification separately but experienced significantly (40%) reduced growth rates when exposed to both conditions simultaneously. Collectively, these findings demonstrate that the consequences of low oxygen and acidification for early life stage bivalves, and likely other marine organisms, are more severe than would be predicted by either individual stressor and thus must be considered together when assessing how ocean animals respond to these conditions both today and under future climate change scenarios.	[Gobler, Christopher J.; DePasquale, Elizabeth L.; Griffith, Andrew W.; Baumann, Hannes] SUNY Stony Brook, Sch Marine & Atmospher Sci, Southampton, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Gobler, CJ (corresponding author), SUNY Stony Brook, Sch Marine & Atmospher Sci, Southampton, NY USA.	christopher.gobler@stonybrook.edu	Baumann, Hannes/D-1435-2010	Baumann, Hannes/0000-0002-4039-4230	NOAA's Ocean Acidification Program through National Centers for Coastal Ocean Science [NA12NOS4780148]; New Tamarind Foundation; NSF's Biological Oceanography Program [1129622]; Division Of Ocean Sciences [1129622] Funding Source: National Science Foundation	NOAA's Ocean Acidification Program through National Centers for Coastal Ocean Science; New Tamarind Foundation; NSF's Biological Oceanography Program(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was supported by the NOAA's Ocean Acidification Program through award #NA12NOS4780148 from the National Centers for Coastal Ocean Science, the New Tamarind Foundation, and NSF's Biological Oceanography Program (Award #1129622). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, SUMMARY POLICYMAKERS; Arnold WS, 2008, REV FISH SCI, V16, P65, DOI 10.1080/10641260701678140; BAKER SM, 1994, MAR ECOL PROG SER, V104, P91, DOI 10.3354/meps104091; Barton A, 2012, LIMNOL OCEANOGR, V57, P698, DOI 10.4319/lo.2012.57.3.0698; Baumann H, 2012, NAT CLIM CHANGE, V2, P38, DOI 10.1038/NCLIMATE1291; Bignami S, 2013, P NATL ACAD SCI USA, V110, P7366, DOI 10.1073/pnas.1301365110; Breitburg DL, 1997, ECOL MONOGR, V67, P489, DOI 10.1890/0012-9615(1997)067[0489:VEOLDO]2.0.CO;2; Cai WJ, 2011, NAT GEOSCI, V4, P766, DOI [10.1038/ngeo1297, 10.1038/NGEO1297]; Carriker MR, 2001, DEV AQUAC FISH SCI, V31, P77; Clark MS, 2013, GLOBAL CHANGE BIOL, V19, P2251, DOI 10.1111/gcb.12197; Cooley SR, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/2/024007; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Cragg S.M., 2006, SCALLOPS BIOL ECOLOG, P45, DOI DOI 10.1016/S0167-9309(06)80029-3; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Dickson A., 2007, PICES SPECIAL PUBLIC, V3, DOI 10.25607/OBP-1342; DICKSON AG, 1993, DEEP-SEA RES PT I, V40, P107, DOI 10.1016/0967-0637(93)90055-8; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Duarte CM, 2013, ESTUAR COAST, V36, P221, DOI 10.1007/s12237-013-9594-3; Dupont S, 2010, ESTUAR COAST SHELF S, V89, P182, DOI 10.1016/j.ecss.2010.06.013; Eerkes-Medrano D, 2013, MAR ECOL PROG SER, V478, P139, DOI 10.3354/meps10130; Ekau W, 2010, BIOGEOSCIENCES, V7, P1669, DOI 10.5194/bg-7-1669-2010; Feely RA, 2010, ESTUAR COAST SHELF S, V88, P442, DOI 10.1016/j.ecss.2010.05.004; Frommel AY, 2012, NAT CLIM CHANGE, V2, P42, DOI 10.1038/nclimate1324; Gazeau F, 2013, MAR BIOL, V160, P2207, DOI 10.1007/s00227-013-2219-3; Gobler CJ, 2013, BIOGEOSCIENCES, V10, P2241, DOI 10.5194/bg-10-2241-2013; Gosselin LA, 1997, MAR ECOL PROG SER, V146, P265, DOI 10.3354/meps146265; Gracey AY, 2001, P NATL ACAD SCI USA, V98, P1993, DOI 10.1073/pnas.98.4.1993; Grantham BA, 2004, NATURE, V429, P749, DOI 10.1038/nature02605; Grasshoff K., 1983, VERLAG CHEMIE FRG, P419, DOI DOI 10.1002/IROH.19850700232; Gray JS, 2002, MAR ECOL PROG SER, V238, P249, DOI 10.3354/meps238249; GROSBERG RK, 1992, TRENDS ECOL EVOL, V7, P130, DOI 10.1016/0169-5347(92)90148-5; Gruber N, 2011, PHILOS T R SOC A, V369, P1980, DOI 10.1098/rsta.2011.0003; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Justic D, 1996, LIMNOL OCEANOGR, V41, P992, DOI 10.4319/lo.1996.41.5.0992; Keeling RF, 2010, ANNU REV MAR SCI, V2, P199, DOI 10.1146/annurev.marine.010908.163855; Kelly MW, 2013, GLOBAL CHANGE BIOL, V19, P2536, DOI 10.1111/gcb.12251; Kraeuter J.N., 2001, BIOL HARD CLAM; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; Levin LA, 2009, BIOGEOSCIENCES, V6, P2063, DOI 10.5194/bg-6-2063-2009; Llanso RJ, 2002, ESTUARIES, V25, P1231, DOI 10.1007/BF02692220; Maas AE, 2012, BIOGEOSCIENCES, V9, P747, DOI 10.5194/bg-9-747-2012; Melzner F, 2013, MAR BIOL, V160, P1875, DOI 10.1007/s00227-012-1954-1; Munday PL, 2010, P NATL ACAD SCI USA, V107, P12930, DOI 10.1073/pnas.1004519107; Newell RIE, 2004, J SHELLFISH RES, V23, P51; Norkko J, 2005, MAR ECOL PROG SER, V298, P205, DOI 10.3354/meps298205; Padilla DK, 2006, HARMFUL ALGAE, V5, P736, DOI 10.1016/j.hal.2006.03.004; Parker LM, 2012, GLOBAL CHANGE BIOL, V18, P82, DOI 10.1111/j.1365-2486.2011.02520.x; Parker LM, 2010, MAR BIOL, V157, P2435, DOI 10.1007/s00227-010-1508-3; Paulmier A, 2011, BIOGEOSCIENCES, V8, P239, DOI 10.5194/bg-8-239-2011; PIHL L, 1991, MAR BIOL, V108, P349, DOI 10.1007/BF01313644; Portner H.O., 2005, J GEOPHYS RES OCEANS, V110; Rabalais NN, 2002, ANNU REV ECOL SYST, V33, P235, DOI 10.1146/annurev.ecolsys.33.010802.150513; RENAUD ML, 1986, FISH B-NOAA, V84, P19; ROY RN, 1993, MAR CHEM, V44, P249, DOI 10.1016/0304-4203(93)90207-5; S.C.D.H.S, 2010, ANN REP SURF WAT QUA; Shaffer G, 2009, NAT GEOSCI, V2, P105, DOI 10.1038/NGEO420; Sokolova IM, 2013, INTEGR COMP BIOL, V53, P597, DOI 10.1093/icb/ict028; Stramma L, 2008, SCIENCE, V320, P655, DOI 10.1126/science.1153847; Swanson RL, 2010, MAR POLLUT BULL, V60, P804, DOI 10.1016/j.marpolbul.2010.03.007; Talmage SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026941; Talmage SC, 2010, P NATL ACAD SCI USA, V107, P17246, DOI 10.1073/pnas.0913804107; Talmage SC, 2009, LIMNOL OCEANOGR, V54, P2072, DOI 10.4319/lo.2009.54.6.2072; Tamburri MN, 1996, LIMNOL OCEANOGR, V41, P1188, DOI 10.4319/lo.1996.41.6.1188; United States Environmental Protection Agency, 2000, AMB AQ LIF WAT QUAL; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Waldbusser GG, 2011, ESTUAR COAST, V34, P221, DOI 10.1007/s12237-010-9307-0; Waldbusser GG, 2010, MAR ECOL PROG SER, V417, P171, DOI 10.3354/meps08809; Waldbusser GG, 2013, J GEOPHYS R IN PRESS; WANG WX, 1991, MAR ECOL PROG SER, V70, P223, DOI 10.3354/meps070223; Wang YJ, 2013, J MOLLUS STUD, V79, P42, DOI 10.1093/mollus/eys035; Wannamaker CM, 2000, J EXP MAR BIOL ECOL, V249, P145, DOI 10.1016/S0022-0981(00)00160-X	72	163	168	2	165	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83648	10.1371/journal.pone.0083648	http://dx.doi.org/10.1371/journal.pone.0083648			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416169	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500063
J	Kirchner, EA; Tabie, M; Seeland, A				Kirchner, Elsa Andrea; Tabie, Marc; Seeland, Anett			Multimodal Movement Prediction - Towards an Individual Assistance of Patients	PLOS ONE			English	Article							REHABILITATION ROBOT; ARMIN II; EXOSKELETON; THERAPY; STROKE	Assistive devices, like exoskeletons or orthoses, often make use of physiological data that allow the detection or prediction of movement onset. Movement onset can be detected at the executing site, the skeletal muscles, as by means of electromyography. Movement intention can be detected by the analysis of brain activity, recorded by, e. g., electroencephalography, or in the behavior of the subject by, e. g., eye movement analysis. These different approaches can be used depending on the kind of neuromuscular disorder, state of therapy or assistive device. In this work we conducted experiments with healthy subjects while performing self-initiated and self-paced arm movements. While other studies showed that multimodal signal analysis can improve the performance of predictions, we show that a sensible combination of electroencephalographic and electromyographic data can potentially improve the adaptability of assistive technical devices with respect to the individual demands of, e. g., early and late stages in rehabilitation therapy. In earlier stages for patients with weak muscle or motor related brain activity it is important to achieve high positive detection rates to support self-initiated movements. To detect most movement intentions from electroencephalographic or electromyographic data motivates a patient and can enhance her/his progress in rehabilitation. In a later stage for patients with stronger muscle or brain activity, reliable movement prediction is more important to encourage patients to behave more accurately and to invest more effort in the task. Further, the false detection rate needs to be reduced. We propose that both types of physiological data can be used in an and combination, where both signals must be detected to drive a movement. By this approach the behavior of the patient during later therapy can be controlled better and false positive detections, which can be very annoying for patients who are further advanced in rehabilitation, can be avoided.	[Kirchner, Elsa Andrea; Tabie, Marc] Univ Bremen, Robot Lab, D-28359 Bremen, Germany; [Kirchner, Elsa Andrea; Seeland, Anett] German Res Ctr Artificial Intelligence DFKI, RIC, Bremen, Germany	University of Bremen; German Research Center for Artificial Intelligence (DFKI)	Kirchner, EA (corresponding author), Univ Bremen, Robot Lab, D-28359 Bremen, Germany.	elsa.kirchner@dfki.de			German Ministry of Economics and Technology [50 RA 1011, 50 RA 1012]	German Ministry of Economics and Technology(Federal Ministry for Economic Affairs and Energy (BMWi))	The work was funded by the German Ministry of Economics and Technology (grant no. 50 RA 1011 and grant no. 50 RA 1012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai O, 2011, CLIN NEUROPHYSIOL, V122, P364, DOI 10.1016/j.clinph.2010.07.010; Benitez LMV, 2013, INT C BIOM EL DEV OA; Benitez LMV, 2013, J ROBOT, V2013, DOI 10.1155/2013/610589; Cavallaro EE, 2006, IEEE T BIO-MED ENG, V53, P2387, DOI 10.1109/TBME.2006.880883; Chan A. D. C., 2010, 2010 IEEE International Instrumentation & Measurement Technology Conference - I2MTC 2010, P1234, DOI 10.1109/IMTC.2010.5488293; Corbett EA, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036002; Cui RQ, 1999, BRAIN TOPOGR, V11, P233; DEECKE L, 1969, EXP BRAIN RES, V7, P158; Feess D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067543; Folgheraiter M, 2012, INT J SOC ROBOT, V4, P285, DOI 10.1007/s12369-012-0147-x; Folgheraiter M, 2011, BIODEVICES 2011, P150; Hogan N, 2011, PROG BRAIN RES, V192, P59, DOI 10.1016/B978-0-444-53355-5.00004-X; Huang H, 2011, IEEE T BIO-MED ENG, V58, P2867, DOI 10.1109/TBME.2011.2161671; Ibanez J, 2011, LECT NOTES COMPUT SC, V6691, P370, DOI 10.1007/978-3-642-21501-8_46; Kirchner Elsa Andrea, 2013, Proceedings of the 6th International Conference on Biomedical Electronics and Devices. BIODEVICES 2013, P168; Kirchner E. A., 2010, P 10 INT S ART INT R, P448; Kirchner EA, 2013, IND ROBOT, V40, P530, DOI 10.1108/IR-01-2013-318; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; Kwakkel G, 2008, NEUROREHAB NEURAL RE, V22, P111, DOI 10.1177/1545968307305457; Lew E., 2012, FRONT NEUROENG, V5, P13, DOI [10.3389/fneng.2012.00013, DOI 10.3389/FNENG.2012.00013]; Lo AC, 2010, NEW ENGL J MED, V362, P1772, DOI 10.1056/NEJMoa0911341; Mehrholz J, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006185.pub3; Mihelj M, 2007, IEEE INT CONF ROBOT, P4120, DOI 10.1109/ROBOT.2007.364112; Muralidharan A, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00039; Novak D, 2013, IEEE T BIO-MED ENG, V60, P2645, DOI 10.1109/TBME.2013.2262455; Pfurtscheller G, 2000, NEUROSCI LETT, V292, P211, DOI 10.1016/S0304-3940(00)01471-3; Platt JC, 2000, ADV NEUR IN, P61; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Popescu F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000637; Rivet B, 2009, IEEE T BIO-MED ENG, V56, P2035, DOI 10.1109/TBME.2009.2012869; Santucci E, 2009, NEUROPSYCHOL TRENDS, P59, DOI 10.7358/neur-2009-005-sant; Seeland A, 2013, I IEEE EMBS C NEUR E, P41, DOI 10.1109/NER.2013.6695866; Shibasaki H, 2006, CLIN NEUROPHYSIOL, V117, P2341, DOI 10.1016/j.clinph.2006.04.025; Staubli P, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-46; Tabie Marc, 2013, Proceedings of the 6th International Conference on Bio-inspired Systems and Signal Processing. BIOSIGNALS 2013, P242; Vapnik V., 2013, NATURE STAT LAERNING	36	33	33	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85060	10.1371/journal.pone.0085060	http://dx.doi.org/10.1371/journal.pone.0085060			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416341	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500211
J	Sahebjada, S; Schache, M; Richardson, AJ; Snibson, G; Daniell, M; Baird, PN				Sahebjada, Srujana; Schache, Maria; Richardson, Andrea J.; Snibson, Grant; Daniell, Mark; Baird, Paul N.			Association of the Hepatocyte Growth Factor Gene with Keratoconus in an Australian Population	PLOS ONE			English	Article							VSX1 GENE; INFLAMMATORY MOLECULES; POLYMORPHISMS; MUTATIONS; TEARS; PROMOTER; ETIOLOGY; BROWSER; DISEASE; SOD1	Purpose: A previous study has indicated suggestive association of the hepatocyte growth factor (HGF) gene with Keratoconus. We wished to assess this association in an independent Caucasian cohort as well as assess its association with corneal curvature. Participants: Keratoconus patients were recruited from private and public clinics in Melbourne, Australia. Non-keratoconic individuals were identified from the Genes in Myopia (GEM) study from Australia. A total of 830 individuals were used for the analysis including 157 keratoconic and 673 non keratoconic subjects. Methods: Tag single nucleotide polymorphisms (tSNPs) were chosen to encompass the hepatocyte growth factor gene as well as 2 kb upstream of the start codon through to 2 kb downstream of the stop codon. Logistic and linear regression including age and gender as covariates were applied in statistical analysis with subsequent Bonferroni correction. Results: Ten tSNPs were genotyped. Following statistical analysis and multiple testing correction, a statistically significant association was found for the tSNP rs2286194 {p = 1.1x10-(3) Odds Ratio 0.52, 95% CI - 0.35, 0.77} for keratoconus. No association was found between the 10 tSNPs and corneal curvature. Conclusions: These findings provide additional evidence of significant association of the HGF gene with Keratoconus. This association does not appear to act through the corneal curvature route.	[Sahebjada, Srujana; Schache, Maria; Richardson, Andrea J.; Snibson, Grant; Daniell, Mark; Baird, Paul N.] Ctr Eye Res Australia, Melbourne, Vic, Australia; [Sahebjada, Srujana] Univ Melbourne, Melbourne, Vic, Australia; [Snibson, Grant] Royal Victorian Eye & Ear Hosp, Melbourne, Vic 3002, Australia	Centre for Eye Research Australia; University of Melbourne; Royal Victorian Eye & Ear Hospital	Sahebjada, S (corresponding author), Ctr Eye Res Australia, Melbourne, Vic, Australia.	s.sahebjada@pgrad.unimelb.edu.au	Daniell, Mark/AAS-1363-2020	Daniell, Mark/0000-0001-9528-7005; Sahebjada, Srujana/0000-0002-1945-7209; Baird, Paul/0000-0002-1305-3502	National Health and Medical Research Council (NHMRC) [529923, 1028444]; Angior Family Foundation	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Angior Family Foundation	This project was funded by the National Health and Medical Research Council (NHMRC) Clinical Research Excellence grant 529923 - Translational Clinical Research in Major Eye Diseases, NHMRC Senior Research Fellowship 1028444 (PNB) and the Angior Family Foundation. The Centre for Eye Research Australia (CERA) receives Operational Infrastructure Support from the Victorian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldave AJ, 2006, INVEST OPHTH VIS SCI, V47, P2820, DOI 10.1167/iovs.05-1530; Baird PN, 2010, PROG RETIN EYE RES, V29, P520, DOI 10.1016/j.preteyeres.2010.05.004; Balasubramanian SA, 2012, ACTA OPHTHALMOL, V90, pE303, DOI 10.1111/j.1755-3768.2011.02369.x; Bawazeer AM, 2000, BRIT J OPHTHALMOL, V84, P834, DOI 10.1136/bjo.84.8.834; Bisceglia L, 2005, INVEST OPHTH VIS SCI, V46, P39, DOI 10.1167/iovs.04-0533; Burdon KP, 2011, INVEST OPHTH VIS SCI, V52, P8514, DOI 10.1167/iovs.11-8261; Bykhovskaya Y, 2012, INVEST OPHTH VIS SCI, V53, P4152, DOI 10.1167/iovs.11-9268; Colin J, 2000, J CATARACT REFR SURG, V26, P1117, DOI 10.1016/S0886-3350(00)00451-X; Coster D., 2012, AUSTR CORNEAL GRAFT; Dash DP, 2010, EYE, V24, P1085, DOI 10.1038/eye.2009.217; Eran P, 2008, OPHTHALMIC GENET, V29, P53, DOI 10.1080/13816810802008242; FALLS HF, 1969, J GENET HUM, V17, P317; HARTSTEIN J, 1968, ARCH OPHTHALMOL-CHIC, V80, P345, DOI 10.1001/archopht.1968.00980050347009; Heon E, 2002, HUM MOL GENET, V11, P1029, DOI 10.1093/hmg/11.9.1029; JAEGER MJ, 1987, CORNEA, V6, P131; KARSERAS AG, 1976, BRIT J OPHTHALMOL, V60, P522, DOI 10.1136/bjo.60.7.522; Kim SH, 2008, MOL VIS, V14, P2109; Lema I, 2005, OPHTHALMOLOGY, V112, P654, DOI 10.1016/j.ophtha.2004.11.050; Lema I, 2009, BRIT J OPHTHALMOL, V93, P820, DOI 10.1136/bjo.2008.144253; Li Q, 1996, INVEST OPHTH VIS SCI, V37, P727; Li W, 2001, HEPATOLOGY, V33, P1377, DOI 10.1053/jhep.2001.24431; Li XH, 2007, EXP EYE RES, V85, P502, DOI 10.1016/j.exer.2007.06.016; Liskova P, 2007, MOL VIS, V13, P1887; LIU YH, 1994, J BIOL CHEM, V269, P4152; Lu Y, 2013, NAT GENET, V45, P155, DOI 10.1038/ng.2506; McMahon TT, 1999, CORNEA, V18, P444, DOI 10.1097/00003226-199907000-00010; Mok JW, 2008, J HUM GENET, V53, P842, DOI 10.1007/s10038-008-0319-6; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Owens H, 2003, CORNEA, V22, P122, DOI 10.1097/00003226-200303000-00008; Paliwal P, 2009, MOL VIS, V15, P2475; Rabinowitz Yaron S, 2003, Ophthalmol Clin North Am, V16, P607, DOI 10.1016/S0896-1549(03)00099-3; Rabinowitz YS, 1998, SURV OPHTHALMOL, V42, P297, DOI 10.1016/S0039-6257(97)00119-7; Sekundo W, 2001, J REFRACT SURG, V17, P69; Snibson GR, 2010, CLIN EXP OPHTHALMOL, V38, P141, DOI 10.1111/j.1442-9071.2010.02228.x; Stabuc-Silih M, 2009, MOL VIS, V15, P2848; Stabuc-Silih M, 2010, CORNEA, V29, P172, DOI 10.1097/ICO.0b013e3181aebf7a; Tang YMG, 2008, CORNEA, V27, P189, DOI 10.1097/ICO.0b013e31815a50e7; Udar N, 2006, INVEST OPHTH VIS SCI, V47, P3345, DOI 10.1167/iovs.05-1500; Veerappan S, 2010, OPHTHALMOLOGY, V117, P239, DOI 10.1016/j.ophtha.2009.07.002; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Wang Y, 2000, AM J MED GENET, V93, P403, DOI 10.1002/1096-8628(20000828)93:5<403::AID-AJMG11>3.0.CO;2-A; WILSON SE, 1993, INVEST OPHTH VIS SCI, V34, P2544; Yanovitch T, 2009, MOL VIS, V15, P1028	43	38	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84067	10.1371/journal.pone.0084067	http://dx.doi.org/10.1371/journal.pone.0084067			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416191	Green Published, gold			2022-12-27	WOS:000329862500091
J	Saito, K; Masuda, N				Saito, Kodai; Masuda, Naoki			Two Types of Well Followed Users in the Followership Networks of Twitter	PLOS ONE			English	Article								In the Twitter blogosphere, the number of followers is probably the most basic and succinct quantity for measuring popularity of users. However, the number of followers can be manipulated in various ways; we can even buy follows. Therefore, alternative popularity measures for Twitter users on the basis of, for example, users' tweets and retweets, have been developed. In the present work, we take a purely network approach to this fundamental question. First, we find that two relatively distinct types of users possessing a large number of followers exist, in particular for Japanese, Russian, and Korean users among the seven language groups that we examined. A first type of user follows a small number of other users. A second type of user follows approximately the same number of other users as the number of follows that the user receives. Then, we compare local (i.e., egocentric) followership networks around the two types of users with many followers. We show that the second type, which is presumably uninfluential users despite its large number of followers, is characterized by high link reciprocity, a large number of friends (i.e., those whom a user follows) for the followers, followers' high link reciprocity, large clustering coefficient, large fraction of the second type of users among the followers, and a small PageRank. Our network-based results support that the number of followers used alone is a misleading measure of user's popularity. We propose that the number of friends, which is simple to measure, also helps us to assess the popularity of Twitter users.	[Saito, Kodai; Masuda, Naoki] Univ Tokyo, Dept Math Informat, Tokyo, Japan	University of Tokyo	Masuda, N (corresponding author), Univ Tokyo, Dept Math Informat, Tokyo, Japan.	masuda@mist.i.u-tokyo.ac.jp		Masuda, Naoki/0000-0003-1567-801X	MEXT, Japan [23681033]; JST ERATO Kawarabayashi Large Graph Project	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST ERATO Kawarabayashi Large Graph Project	The authors acknowledge the financial support provided through Grants-in-Aid for Scientific Research (No. 23681033) from MEXT, Japan, and JST ERATO Kawarabayashi Large Graph Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakshy E., 2011, P 4 ACM INT C WEB SE, P65, DOI DOI 10.1145/1935826.1935845; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Cha M., 2010, ICWSM, P10, DOI DOI 10.1093/JSCR/2010.10.10; Chang Y., 2013, PROC 6 ACM INT C WEB, P527; Donato D, 2004, EUR PHYS J B, V38, P239, DOI 10.1140/epjb/e2004-00056-6; Fortunato S, 2008, LECT NOTES COMPUT SC, V4936, P59, DOI 10.1007/978-3-540-78808-9_6; Ghosh S., 2012, P 21 INT C WORLD WID, P61, DOI DOI 10.1145/2187836.2187846; Ghoshal G, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1396; Hopcroft J.E., 2011, P 20 ACM INT C INFOR, P1137, DOI DOI 10.1145/2063576.2063740; Java Akshay, 2007, P JOINT 9 WEBKDD 1 S, P56, DOI 10.1145/1348549.1348556; Kwak H., 2010, WWW, P591, DOI DOI 10.1145/1772690.1772751; Langville A N, 2006, GOOGLES PAGERANK; Leavitt A, 2010, INFLUENTIALS NEW APP; Masuda N, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033012; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Romero D., 2010, P INT AAAI C WEB SOC, P138, DOI DOI 10.1016/J.REGPEP.2010.05.014; Russell M. A., 2011, MINING SOCIAL WEB AN; Saito K, 2013, 2013 IEEE/ACM INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM), P1425; Suh B, 2010, 2010 IEEE 2 INT C SO, V2, P177, DOI [10.1109/SocialCom.2010.33, DOI 10.1109/SOCIALCOM.2010.33]; Takhteyev Y, 2012, SOC NETWORKS, V34, P73, DOI 10.1016/j.socnet.2011.05.006; Tuffery S., 2011, DATA MINING STAT DEC; Welch M.J., P 4 ACM INT C WEB SE, P327, DOI DOI 10.1145/1935826.1935882; Weng J., 2010, P 3 ACM INT C WEB SE, P261, DOI [10.1145/1718487.1718520, DOI 10.1145/1718487.1718520]	24	5	6	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84265	10.1371/journal.pone.0084265	http://dx.doi.org/10.1371/journal.pone.0084265			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416209	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500107
J	Dhar, P; Sharma, VK; Hota, KB; Das, SK; Hota, SK; Srivastava, RB; Singh, SB				Dhar, Priyanka; Sharma, Vijay K.; Hota, Kalpana B.; Das, Saroj K.; Hota, Sunil K.; Srivastava, Ravi B.; Singh, Shashi B.			Autonomic Cardiovascular Responses in Acclimatized Lowlanders on Prolonged Stay at High Altitude: A Longitudinal Follow Up Study	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; DENSITY-LIPOPROTEIN CHOLESTEROL; EDUCATION-PROGRAM RECOMMENDATIONS; BLOOD-PRESSURE; INTERMITTENT HYPOXIA; NERVOUS-SYSTEM; NITRIC-OXIDE; SYMPATHETIC ACTIVATION; PLASMA HOMOCYSTEINE; ARTERIAL STIFFNESS	Acute exposure to hypobaric hypoxia at high altitude is reported to cause sympathetic dominance that may contribute to the pathophysiology of high altitude illnesses. The effect of prolonged stay at high altitude on autonomic functions, however, remains to be explored. Thus, the present study aimed at investigating the effect of high altitude on autonomic neural control of cardiovascular responses by monitoring heart rate variability (HRV) during chronic hypobaric hypoxia. Baseline electrocardiography (ECG) data was acquired from the volunteers at mean sea level (MSL) (<250 m) in Rajasthan. Following induction of the study population to high altitude (4500-4800 m) in Ladakh region, ECG data was acquired from the volunteers after 6 months (ALL 6) and 18 months of induction (ALL 18). Out of 159 volunteers who underwent complete investigation during acquisition of baseline data, we have only included the data of 104 volunteers who constantly stayed at high altitude for 18 months to complete the final follow up after 18 months. HRV parameters, physiological indices and biochemical changes in serum were investigated. Our results show sympathetic hyperactivation along with compromise in parasympathetic activity in ALL 6 and ALL 18 when compared to baseline data. Reduction of sympathetic activity and increased parasympathetic response was however observed in ALL 18 when compared to ALL 6. Our findings suggest that autonomic response is regulated by two distinct mechanisms in the ALL 6 and ALL 18. While the autonomic alterations in the ALL 6 group could be attributed to increased sympathetic activity resulting from increased plasma catecholamine concentration, the sympathetic activity in ALL 18 group is associated with increased concentration of serum coronary risk factors and elevated homocysteine. These findings have important clinical implications in assessment of susceptibility to cardio-vascular risks in acclimatized lowlanders staying for prolonged duration at high altitude.	[Dhar, Priyanka; Sharma, Vijay K.; Hota, Kalpana B.; Das, Saroj K.; Hota, Sunil K.; Srivastava, Ravi B.] Def Res & Dev Org, Def Inst High Altitude Res, Leh Ladakh, Jammu & Kashmir, India; [Singh, Shashi B.] Def Res & Dev Org, Def Inst Physiol & Allied Sci, Delhi, India	Defence Research & Development Organisation (DRDO); Defence Institute of High Altitude Research (DIHAR); Defence Research & Development Organisation (DRDO); Defence Institute of Physiology & Allied Sciences (DIPAS)	Singh, SB (corresponding author), Def Res & Dev Org, Def Inst Physiol & Allied Sci, Lucknow Rd, Delhi, India.	sbs_1958@yahoo.co.in	Das, Saroj Kumar/W-5452-2019; Singh, Shashi Bala/AAS-9889-2021	Das, Saroj Kumar/0000-0002-5717-5333; Srivastava, Rakesh/0000-0002-0065-4069; Sharma, Vijay Kumar/0000-0002-9327-0397; Srivastava, Rakesh/0000-0003-3112-4252	Defence Research and Development Organisation, Ministry of Defence, Govt of India	Defence Research and Development Organisation, Ministry of Defence, Govt of India	The research was financially supported by Defence Research and Development Organisation, Ministry of Defence, Govt of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acampa M, 2011, CLIN TRANSPLANT, V25, P119, DOI 10.1111/j.1399-0012.2009.01126.x; Acharya UR, 2006, MED BIOL ENG COMPUT, V44, P1031, DOI 10.1007/s11517-006-0119-0; Albert CM, 2008, JAMA-J AM MED ASSOC, V299, P2027, DOI 10.1001/jama.299.17.2027; ALLAIN CC, 1974, CLIN CHEM, V20, P470; ALLEN R H, 1981, Ligand Quarterly, V4, P37; Amitabh, 2009, INDIAN J MED RES, V129, P138; Ashraf H M, 2006, J Coll Physicians Surg Pak, V16, P71; Aubert AE, 2003, SPORTS MED, V33, P889, DOI 10.2165/00007256-200333120-00003; BACHORIK PS, 1995, CLIN CHEM, V41, P1414; BAHRKE MS, 1993, SPORTS MED, V16, P97, DOI 10.2165/00007256-199316020-00003; Baker F, 2002, CIRCULATION, V106, P741; Beall C M, 2000, High Alt Med Biol, V1, P25, DOI 10.1089/152702900320658; Beall CM, 2001, ANNU REV ANTHROPOL, V30, P423, DOI 10.1146/annurev.anthro.30.1.423; Beall CM, 2012, FREE RADICAL BIO MED, V52, P1123, DOI 10.1016/j.freeradbiomed.2011.12.028; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bernardi L, 2001, EUR HEART J, V22, P879, DOI 10.1053/euhj.2000.2466; Bernardi L, 1998, CLIN SCI, V95, P565, DOI 10.1042/cs0950565; Bernardi L, 2007, P ANN INT IEEE EMBS, P6679; Billett H. H., 1990, CLIN METHODS HIST PH; BOWERS LD, 1980, CLIN CHEM, V26, P555; Brito J, 2007, HIGH ALT MED BIOL, V8, P236, DOI 10.1089/ham.2007.8310; Calbet JAL, 2003, J PHYSIOL-LONDON, V551, P379, DOI 10.1113/jphysiol.2003.045112; Chao WH, 1999, J NUTR, V129, P2009, DOI 10.1093/jn/129.11.2009; Chen YC, 2008, AM J MED SCI, V336, P248, DOI 10.1097/MAJ.0b013e3181629a32; Clarke R, 1998, ARCH NEUROL-CHICAGO, V55, P1449, DOI 10.1001/archneur.55.11.1449; Coello SD, 2000, INT J EPIDEMIOL, V29, P65, DOI 10.1093/ije/29.1.65; Cornolo J, 2004, J APPL PHYSIOL, V97, P935, DOI 10.1152/japplphysiol.00239.2004; DEMENDOZA S, 1979, ARCH ENVIRON HEALTH, V34, P308, DOI 10.1080/00039896.1979.10667422; Dumont Lionel, 2005, Travel Med Infect Dis, V3, P183, DOI 10.1016/j.tmaid.2004.12.001; Duplain H, 1999, CIRCULATION, V99, P1713, DOI 10.1161/01.CIR.99.13.1713; Fagan K A, 2001, Respir Res, V2, P306, DOI 10.1186/rr74; FARINELLI CCJ, 1994, EUR J APPL PHYSIOL O, V69, P502, DOI 10.1007/BF00239867; FEREZOU J, 1988, EUR J APPL PHYSIOL O, V57, P740, DOI 10.1007/BF01075997; Forslund L, 2002, HEART, V87, P415, DOI 10.1136/heart.87.5.415; FOSTER LB, 1971, CLIN CHEM, V17, P921; Gargya, 1999, INDIAN J MED SCI, V53, P471; Guasti L, 2001, ACTA CARDIOL, V56, P289, DOI 10.2143/AC.56.5.2005689; Guger C, 2008, NEUROSCI LETT, V442, P123, DOI 10.1016/j.neulet.2008.06.075; Guyton A.C., 2006, TXB MED PHYSL; Hainsworth R, 2007, CLIN AUTON RES, V17, P13, DOI 10.1007/s10286-006-0395-7; HAMILTON AJ, 1991, AVIAT SPACE ENVIR MD, V62, P759; HAMMILL SC, 1979, CIRC RES, V44, P569, DOI 10.1161/01.RES.44.4.569; Hansen J, 2003, J PHYSIOL-LONDON, V546, P921, DOI 10.1113/jphysiol.2002.031765; HARTLEY LH, 1974, J APPL PHYSIOL, V36, P362, DOI 10.1152/jappl.1974.36.3.362; Hashimoto F, 1997, WILD ENVIRON MED, V8, P214, DOI 10.1580/1080-6032(1997)008[0214:PVFDIP]2.3.CO;2; Hopkins SR, 2003, J PHYSIOL-LONDON, V550, P605, DOI 10.1113/jphysiol.2003.040568; Huang HH, 2010, CLIN J SPORT MED, V20, P58, DOI 10.1097/JSM.0b013e3181cae6ba; HUGHSON RL, 1994, J APPL PHYSIOL, V77, P2537; Kanai M, 2001, WILD ENVIRON MED, V12, P8, DOI 10.1580/1080-6032(2001)012[0008:AIANCO]2.0.CO;2; Kanani PM, 1999, CIRCULATION, V100, P1161, DOI 10.1161/01.CIR.100.11.1161; Kazory A, 2010, AM J CARDIOL, V106, P694, DOI 10.1016/j.amjcard.2010.04.024; Kemp AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030777; KLAIN GJ, 1968, P SOC EXP BIOL MED, V129, P646; Koehle MS, 2010, EUR J EMERG MED, V17, P119, DOI 10.1097/MEJ.0b013e32832fa099; KOLLER EA, 1988, EUR J APPL PHYSIOL O, V57, P163, DOI 10.1007/BF00640657; Kriemler S, 2008, EUR RESPIR J, V32, P664, DOI 10.1183/09031936.00166407; Lanfranchi PA, 2005, AM J PHYSIOL-HEART C, V289, pH2364, DOI 10.1152/ajpheart.00004.2005; LIPSITZ LA, 1995, BRIT HEART J, V74, P390; Liu X X, 2001, Space Med Med Eng (Beijing), V14, P328; Long Min, 2006, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V23, P1195; LOUHIJA A, 1969, EXPERIENTIA, V25, P248, DOI 10.1007/BF02034371; Lusina SJC, 2006, J PHYSIOL-LONDON, V575, P961, DOI 10.1113/jphysiol.2006.114660; MALHOTRA MS, 1976, AVIAT SPACE ENVIR MD, V47, P1076; Malpas SC, 2010, PHYSIOL REV, V90, P513, DOI 10.1152/physrev.00007.2009; Vanderlei LCM, 2009, REV BRAS CIR CARDIOV, V24, P205, DOI 10.1590/S0102-76382009000200018; MAZZEO RS, 1991, AM J PHYSIOL, V261, pE419, DOI 10.1152/ajpendo.1991.261.4.E419; McNeely MDD, 1984, CLIN CHEM, P1402; Mindicino H J, 2002, Clin Lab, V48, P493; Moller S, 2010, AM J PHYSIOL-GASTR L, V299, pG784, DOI 10.1152/ajpgi.00078.2010; Muntzel MS, 2006, ATHEROSCLEROSIS, V184, P290, DOI 10.1016/j.atherosclerosis.2005.04.009; Naeije R, 2010, PROG CARDIOVASC DIS, V52, P456, DOI 10.1016/j.pcad.2010.03.004; Napoli AM, 2009, AM J EMERG MED, V27, P1081, DOI 10.1016/j.ajem.2008.09.025; Niermeyer S, 2003, HIGH ALT MED BIOL, V4, P225, DOI 10.1089/152702903322022820; Nishihara F, 1998, INT ARCH OCC ENV HEA, V71, P520, DOI 10.1007/s004200050317; Niskanen JP, 2004, COMPUT METH PROG BIO, V76, P73, DOI 10.1016/j.cmpb.2004.03.004; Panjwani Usha, 2006, Indian J Physiol Pharmacol, V50, P250; Passino Claudio, 1996, Clinical Science (London), V91, P81; Penaloza D, 2008, HIGH ALT MED BIOL, V9, P199, DOI 10.1089/ham.2008.1004; Perini R, 1996, EUR J APPL PHYSIOL O, V73, P521, DOI 10.1007/BF00357674; PONCHIA A, 1994, EUR HEART J, V15, P1463, DOI 10.1093/oxfordjournals.eurheartj.a060415; Povea C, 2005, HIGH ALT MED BIOL, V6, P215, DOI 10.1089/ham.2005.6.215; Prabhakaran P, 2011, AVIAT SPACE ENVIR MD, V82, P863, DOI 10.3357/ASEM.2135.2011; Pugh L G, 1964, Sci Basis Med Annu Rev, P32; Ramirez-Villegas JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017060; Rhodes HL, 2011, J ROY ARMY MED CORPS, V157, P110, DOI 10.1136/jramc-157-01-18; Richalet JP, 1985, 4 HYP S LAK LOUIS CA; ROACH RC, 1993, HYPOXIA AND MOLECULAR MEDICINE, P272; Roche F, 2002, CLIN PHYSIOL FUNCT I, V22, P301, DOI 10.1046/j.1475-097X.2002.00434.x; Rostrup M, 1998, ACTA PHYSIOL SCAND, V162, P389, DOI 10.1046/j.1365-201X.1998.00335.x; Schobersberger W, 2003, EUR J APPL PHYSIOL, V88, P506, DOI 10.1007/s00421-002-0736-8; Sevre K, 2001, ACTA PHYSIOL SCAND, V173, P409, DOI 10.1046/j.1365-201X.2001.00925.x; Sharma VS, 2003, BIOCHEMISTRY-US, V42, P8900, DOI 10.1021/bi034469t; Shukitt-Hale B, 1998, INT J AVIAT PSYCHOL, V8, P319, DOI 10.1207/s15327108ijap0804_1; Siques P, 2009, HIGH ALT MED BIOL, V10, P329, DOI 10.1089/ham.2008.1103; Smith JD, 2011, WILD ENVIRON MED, V22, P107, DOI 10.1016/j.wem.2011.01.003; Stanger O, 2003, CLIN CHEM LAB MED, V41, P1444, DOI 10.1515/CCLM.2003.222; Strain JJ, 2004, P NUTR SOC, V63, P597, DOI 10.1079/PNS2004390; Syed V S, 2010, Med J Armed Forces India, V66, P261, DOI 10.1016/S0377-1237(10)80052-8; Tannheimer M, 2010, SLEEP BREATH, V14, P193, DOI 10.1007/s11325-009-0284-0; Tayama J, 2006, HYPERTENS RES, V29, P403, DOI 10.1291/hypres.29.403; Temte JL, 1996, WILD ENVIRON MED, V7, P216, DOI 10.1580/1080-6032(1996)007[0216:EOSCAH]2.3.CO;2; Thomas L., 1998, CLIN LAB DIAGNOSTICS, P55; UELAND PM, 1989, J LAB CLIN MED, V114, P473; UELAND PM, 1993, CLIN CHEM, V39, P1764; Vearrier D, 2011, CLIN TOXICOL, V49, P629, DOI 10.3109/15563650.2011.607169; Vigo DE, 2010, WILD ENVIRON MED, V21, P4, DOI 10.1016/j.wem.2009.12.022; von Borell E, 2007, PHYSIOL BEHAV, V92, P293, DOI 10.1016/j.physbeh.2007.01.007; WARD MP, 2000, HIGH ALTITUDE MED PH; WARNICK GR, 1995, CLIN CHEM, V41, P1427; Weil JV, 2004, HIGH ALT MED BIOL, V5, P180, DOI 10.1089/1527029041352162; WERNER M, 1981, CLIN CHEM, V27, P268; Windsor JS, 2010, HIGH ALT MED BIOL, V11, P51, DOI 10.1089/ham.2009.1065; Woods DR, 2008, CARDIOLOGY, V111, P239, DOI 10.1159/000127445; World Health Organization Switzerland, 2008, WHO STEPS SURV; Wu GQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004323; Wu JT, 2007, J BIOMED LAB SCI, V19, P107; Xie AL, 2001, J APPL PHYSIOL, V91, P1555, DOI 10.1152/jappl.2001.91.4.1555; Zubieta-Calleja GR, 2007, J PHYSIOL PHARMACOL, V58, P811; Zuzewicz K, 1999, Int J Occup Saf Ergon, V5, P337	119	24	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84274	10.1371/journal.pone.0084274	http://dx.doi.org/10.1371/journal.pone.0084274			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404157	Green Published, Green Submitted, gold			2022-12-27	WOS:000329460800036
J	Tang, HL; Wang, ZY; Liu, Q; Liu, XP; Wu, MH; Li, GY				Tang, Hailin; Wang, Zeyou; Liu, Qing; Liu, Xiaoping; Wu, Minghua; Li, Guiyuan			Disturbing miR-182 and-381 Inhibits BRD7 Transcription and Glioma Growth by Directly Targeting LRRC4	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; PROLIFERATION; CELLS; EXPRESSION; PROTEIN; APOPTOSIS; MIGRATION; PATHWAYS; INVASION; CLUSTER	Inactivated LRRC4 has been clinically detected in gliomas, and promoter hypermethylation has been implicated as the mechanism of inactivation in some of those tumors. Our previous researches indicated that LRRC4 is a target gene of miR-381, the interaction of miR-381 and LRRC4 is involved in glioma growth. In this study, we demonstrate that LRRC4 is a target gene of the other microRNA, miR-182. We found that the high expression of miR-182 and miR-381 in gliomas are involved in pathological malignant progression. The silencing of miR-182 and miR-381 inhibited the proliferation in vitro and growth of glioma cell with in vivo magnetic resonance imaging by intracranial transplanted tumor model in rats. We also demonstrated that BRD7, a transcriptional cofactor for p53, is highly expressed and negatively correlated with LRRC4 expression in gliomas. Disturbing miR-182 and miR-381 affected transcriptional regulation of the BRD7 gene. This finding was verified by ectopic overexpression of LRRC4 or restoration of endogenous LRRC4 expression by treatment with the DNA demethylating agent 5-Aza-dC. Taken together, miR-182 and miR-381 may be a useful therapeutic target for treatment of glioma.	[Tang, Hailin; Wang, Zeyou; Liu, Xiaoping; Wu, Minghua; Li, Guiyuan] Cent S Univ, Canc Res Inst, Key Lab Carcinogenesis & Canc Invas, Minist Educ,Key Lab Carcinogenesis,Minist Hlth, Changsha, Hunan, Peoples R China; [Tang, Hailin; Liu, Xiaoping] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Qing; Wu, Minghua] Ctr Skull Base Surg & Neurooncol, Changsha, Hunan, Peoples R China	Central South University; State Key Lab Oncology South China; Sun Yat Sen University	Wu, MH (corresponding author), Cent S Univ, Canc Res Inst, Key Lab Carcinogenesis & Canc Invas, Minist Educ,Key Lab Carcinogenesis,Minist Hlth, Changsha, Hunan, Peoples R China.	wuminghua554@aliyun.com; ligy@xysm.net			National Natural Science Foundation of China [81272297, 81171932, 31100935]; Hunan Province Natural Sciences Foundations [11JJ1013]; Research Fund for the Doctoral Program of Higher Education of China [20110162110037]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Province Natural Sciences Foundations; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grants from National Natural Science Foundation of China (81272297, 81171932, 31100935) and Hunan Province Natural Sciences Foundations (11JJ1013); Research Fund for the Doctoral Program of Higher Education of China (20110162110037). There are no financial or other relationships that might lead to a conflict of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Drost J, 2010, NAT CELL BIOL, V12, P380, DOI 10.1038/ncb2038; Gao J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065138; Harquail J, 2012, CANCER BIOMARK, V11, P269, DOI 10.3233/CBM-120291; Hulleman E, 2005, ADV CANCER RES, V94, P1, DOI 10.1016/S0065-230X(05)94001-3; Liu HY, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-111; Mantovani F, 2010, CELL CYCLE, V9, P2777; Mihelich BL, 2011, J BIOL CHEM, V286, P44503, DOI 10.1074/jbc.M111.262915; Nagadia R, 2013, CELL ONCOL, V36, P1, DOI 10.1007/s13402-012-0122-4; Rossi S, 2013, ADV EXP MED BIOL, V774, P21, DOI 10.1007/978-94-007-5590-1_2; Tae S, 2011, NUCLEIC ACIDS RES, V39, P5424, DOI 10.1093/nar/gkr170; Tang H, 2013, CLIN CANC RES, V19, P5602; Tang H, 2013, CANC LETT; Tang HL, 2013, CURR CANCER DRUG TAR, V13, P221, DOI 10.2174/1568009611313020010; Tang HL, 2011, BRAIN RES, V1390, P21, DOI 10.1016/j.brainres.2011.03.034; Titolo D, 2008, J NEUROSCI, V28, P6473, DOI 10.1523/JNEUROSCI.0514-08.2008; Wang Jie-Ru, 2003, Ai Zheng, V22, P897; Weeraratne SD, 2012, ACTA NEUROPATHOL, V123, P539, DOI 10.1007/s00401-012-0969-5; Wu MH, 2008, J CELL BIOCHEM, V103, P245, DOI 10.1002/jcb.21400; Wu MH, 2008, J CELL PHYSIOL, V214, P65, DOI 10.1002/jcp.21163; Wu MH, 2007, ACTA BIOCH BIOPH SIN, V39, P731, DOI 10.1111/j.1745-7270.2007.00338.x; Wu MH, 2006, MOL BIOL CELL, V17, P3534, DOI 10.1091/mbc.E05-11-1082; Wu MH, 2009, CURR GENOMICS, V10, P216, DOI 10.2174/138920209788488481; Zhang LF, 2011, INT J MOL MED, V28, P381, DOI 10.3892/ijmm.2011.679; Zhang QH, 2005, FEBS LETT, V579, P3674, DOI 10.1016/j.febslet.2005.05.058; Zhang ZP, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-99; Zhou J, 2004, J CELL PHYSIOL, V200, P89, DOI 10.1002/jcp.20013; Zhou M, 2006, MOL CELL BIOCHEM, V292, P205, DOI 10.1007/s11010-006-9233-4	27	39	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84146	10.1371/journal.pone.0084146	http://dx.doi.org/10.1371/journal.pone.0084146			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404152	Green Submitted, Green Published, gold			2022-12-27	WOS:000329460800031
J	Baruch-Mordo, S; Wilson, KR; Lewis, DL; Broderick, J; Mao, JS; Breck, SW				Baruch-Mordo, Sharon; Wilson, Kenneth R.; Lewis, David L.; Broderick, John; Mao, Julie S.; Breck, Stewart W.			Stochasticity in Natural Forage Production Affects Use of Urban Areas by Black Bears: Implications to Management of Human-Bear Conflicts	PLOS ONE			English	Article							URSUS-AMERICANUS; COLLAR PERFORMANCE; ACTIVITY PATTERNS; NATIONAL-PARK; POPULATION; SURVIVAL; ECOLOGY; URBANIZATION; SELECTION; HABITUATION	The rapid expansion of global urban development is increasing opportunities for wildlife to forage and become dependent on anthropogenic resources. Wildlife using urban areas are often perceived dichotomously as urban or not, with some individuals removed in the belief that dependency on anthropogenic resources is irreversible and can lead to increased human-wildlife conflict. For American black bears (Ursus americanus), little is known about the degree of bear urbanization and its ecological mechanisms to guide the management of human-bear conflicts. Using 6 years of GPS location and activity data from bears in Aspen, Colorado, USA, we evaluated the degree of bear urbanization and the factors that best explained its variations. We estimated space use, activity patterns, survival, and reproduction and modeled their relationship with ecological covariates related to bear characteristics and natural food availability. Space use and activity patterns were dependent on natural food availability (good or poor food years), where bears used higher human density areas and became more nocturnal in poor food years. Patterns were reversible, i.e., individuals using urban areas in poor food years used wildland areas in subsequent good food years. While reproductive output was similar across years, survival was lower in poor food years when bears used urban areas to a greater extent. Our findings suggest that bear use of urban areas is reversible and fluctuates with the availability of natural food resources, and that removal of urban individuals in times of food failures has the potential to negatively affect bear populations. Given that under current predictions urbanization is expected to increase by 11% across American black bear range, and that natural food failure years are expected to increase in frequency with global climate change, alternative methods of reducing urban human-bear conflict are required if the goal is to prevent urban areas from becoming population sinks.	[Baruch-Mordo, Sharon; Wilson, Kenneth R.; Lewis, David L.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Baruch-Mordo, Sharon; Wilson, Kenneth R.] Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA; [Broderick, John] Colorado Pk & Wildlife, Terr Programs, Ft Collins, CO USA; [Mao, Julie S.] Colorado Pk & Wildlife, Terr Programs, Glenwood Springs, CO USA; [Breck, Stewart W.] Wildlife Serv, USDA, Anim & Plant Hlth Inspect Serv, Natl Wildlife Res Ctr, Ft Collins, CO USA	Colorado State University; Colorado State University; United States Department of Agriculture (USDA)	Baruch-Mordo, S (corresponding author), Nature Conservancy, Dev Design, Ft Collins, CO USA.	sbaruch-mordo@tnc.org	Breck, Stewart/GWC-5825-2022; Wilson, Kenneth R./P-8692-2019		United States Department of Agriculture - National Wildlife Research Center; city of Aspen [5353530]; Aspen Field Biology Lab; Jack H. Berryman Institute; Rocky Mountain Goats Foundation; Colorado Chapter of The Wildlife Society	United States Department of Agriculture - National Wildlife Research Center; city of Aspen; Aspen Field Biology Lab; Jack H. Berryman Institute; Rocky Mountain Goats Foundation; Colorado Chapter of The Wildlife Society	This study was funded by the United States Department of Agriculture - National Wildlife Research Center (SWB) (http://www.aphis.usda.gov/wildlife_damage/nwrc/). Additional funds awarded by the city of Aspen to KRW (CSU account no. 5353530). Fellowship and scholarship support given to SBM by Aspen Field Biology Lab, Jack H. Berryman Institute, Rocky Mountain Goats Foundation, and the Colorado Chapter of The Wildlife Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson WG, 2003, ECOLOGY, V84, P2476, DOI 10.1890/01-0707; [Anonymous], 2001, RESOLVING HUMAN WILD; Baker PJ, 2008, MAMMAL REV, V38, P123, DOI 10.1111/j.1365-2907.2008.00122.x; Baker PJ, 2007, MAMMAL REV, V37, P297, DOI 10.1111/j.1365-2907.2007.00102.x; Baldwin Roger A., 2009, Human-Wildlife Conflicts, V3, P271; Baruch-Mordo S, 2013, BIOL CONSERV, V160, P263, DOI 10.1016/j.biocon.2013.02.002; Baruch-Mordo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015681; Beck T.D.I., 1991, TECHNICAL PUBLICATIO, V39; Beckmann JP, 2004, WEST N AM NATURALIST, V64, P269; Beckmann JP, 2003, J ZOOL, V261, P207, DOI 10.1017/S0952836903004126; Beckmann JP, 2003, J MAMMAL, V84, P594, DOI 10.1644/1545-1542(2003)084<0594:UBBTTI>2.0.CO;2; Beckmann JP, 2008, HUMAN WILDLIFE CONFL, V2, P1698; Bierwagen BG, 2010, P NATL ACAD SCI USA, V107, P20887, DOI 10.1073/pnas.1002096107; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Carter J, 2001, HORTSCIENCE, V36, P1027, DOI 10.21273/HORTSCI.36.6.1027; Colorado State Demography Office, 2011, POP TOT COL MUN; D'Eon RG, 2005, J APPL ECOL, V42, P383, DOI 10.1111/j.1365-2664.2005.01010.x; Davis H, 2006, URSUS, V17, P41, DOI 10.2192/1537-6176(2006)17[41:IOPOSS]2.0.CO;2; DeStefano S, 2003, FRONT ECOL ENVIRON, V1, P95, DOI 10.1890/1540-9295(2003)001[0095:ETEOSW]2.0.CO;2; Duong T, 2003, J NONPARAMETR STAT, V15, P17, DOI 10.1080/10485250306039; Duong T, 2010, KS KERNEL SMOOTHING; Evans KL, 2011, GLOBAL CHANGE BIOL, V17, P32, DOI 10.1111/j.1365-2486.2010.02247.x; Fall MW, 2002, INT BIODETER BIODEGR, V49, P87, DOI 10.1016/S0964-8305(01)00107-X; Freedman AH, 2003, ECOL MODEL, V167, P47, DOI 10.1016/S0304-3800(03)00171-6; Gehrt SD., 2010, URBAN CARNIVORES ECO; Gilbert B.K., 1989, BEAR PEOPLE CONFLICT, P1; Gitzen RA, 2006, J WILDLIFE MANAGE, V70, P1334, DOI 10.2193/0022-541X(2006)70[1334:BSFFAO]2.0.CO;2; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Grinder MI, 2001, J WILDLIFE MANAGE, V65, P887, DOI 10.2307/3803038; Harveson PM, 2007, BIOL CONSERV, V134, P321, DOI 10.1016/j.biocon.2006.07.022; Hebblewhite M, 2003, BIOL CONSERV, V112, P415, DOI 10.1016/S0006-3207(02)00341-5; Hellgren EC, 2005, BIOL CONSERV, V122, P131, DOI 10.1016/j.biocon.2004.07.007; Herrero S, 2005, WILDLIFE SOC B, V33, P362, DOI 10.2193/0091-7648(2005)33[362:FTFBBH]2.0.CO;2; Hostetler JA, 2009, BIOL CONSERV, V142, P2456, DOI 10.1016/j.biocon.2009.05.029; Hristienko H, 2007, URSUS, V18, P72, DOI 10.2192/1537-6176(2007)18[72:GITSCA]2.0.CO;2; Jerzak Leszek, 2001, P403; JOHNSON PS, 2002, ECOLOGY SILVICULTURE; Kasbohm JW, 1996, J WILDLIFE MANAGE, V60, P408, DOI 10.2307/3802243; Kilpatrick HJ, 2000, WILDLIFE SOC B, V28, P1023; Kozakai C, 2011, J WILDLIFE MANAGE, V75, P867, DOI 10.1002/jwmg.122; Lee DJ, 2005, J WILDLIFE MANAGE, V69, P1641, DOI 10.2193/0022-541X(2005)69[1641:YASBBS]2.0.CO;2; Lewis JS, 2007, J APPL ECOL, V44, P663, DOI 10.1111/j.1365-2664.2007.01286.x; Lyons AJ, 2005, URSUS, V16, P255, DOI 10.2192/1537-6176(2005)016[0255:APOUAB]2.0.CO;2; Manfredo M., 2008, WHO CARES WILDLIFE S, Vfirst, DOI [10.1007/978-0-387-77040-6, DOI 10.1007/978-0-387-77040-6]; Marzluff J. M., 2008, URBAN ECOLOGY INT PE; Marzluff John M., 2001, P19; MATTSON DJ, 1992, J WILDLIFE MANAGE, V56, P432, DOI 10.2307/3808855; MCCULLOUGH D R, 1982, Wildlife Society Bulletin, V10, P27; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Messmer Terry A., 2009, Human-Wildlife Conflicts, V3, P10; Mitchell MS, 2009, URSUS, V20, P77, DOI 10.2192/1537-6176-20.2.77; Munro RHM, 2006, J MAMMAL, V87, P1112, DOI 10.1644/05-MAMM-A-410R3.1; NEILSON RP, 1980, AM J BOT, V67, P426, DOI 10.2307/2442353; Nelson RA, 1983, BEARS THEIR BIOL MAN, V5, P284, DOI [DOI 10.2307/3872551, 10.2307/3872551]; Oka T, 2004, J WILDLIFE MANAGE, V68, P979, DOI 10.2193/0022-541X(2004)068[0979:RBCIBP]2.0.CO;2; OLSON AR, 1983, CAN J PLANT SCI, V63, P461, DOI 10.4141/cjps83-053; Pinheiro J, 2010, NLME LINEAR NONLINEA; R Development Core Team R, 2009, R LANG ENV STAT COMP; Robertson BA, 2013, TRENDS ECOL EVOL, V28, P552, DOI 10.1016/j.tree.2013.04.004; Rodewald AD, 2008, ECOLOGY, V89, P515, DOI 10.1890/07-0358.1; Rolando A, 2003, REV ECOL-TERRE VIE, V58, P337; Rutz C, 2006, ARDEA, V94, P185; Ryan CW, 2007, URSUS, V18, P46, DOI 10.2192/1537-6176(2007)18[46:IOMPOB]2.0.CO;2; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Schrage MW, 1998, URSUS-SERIES, V10, P49; Shochat E, 2006, TRENDS ECOL EVOL, V21, P186, DOI 10.1016/j.tree.2005.11.019; Shochat E, 2004, OIKOS, V106, P622, DOI 10.1111/j.0030-1299.2004.13159.x; Smith MD, 2011, J ECOL, V99, P656, DOI 10.1111/j.1365-2745.2011.01798.x; SORK VL, 1993, ECOLOGY, V74, P528, DOI 10.2307/1939313; Spencer RD, 2007, URSUS, V18, P217, DOI 10.2192/1537-6176(2007)18[217:HARTHB]2.0.CO;2; STPIERRE RG, 1989, CAN J BOT, V67, P726, DOI 10.1139/b89-097; STPIERRE RG, 1990, CAN FIELD NAT, V104, P379; United Nat ions Populat ion Division, 2008, WORLD URB PROSP 2007; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Waite TA, 2007, ECOHEALTH, V4, P278, DOI 10.1007/s10393-007-0112-6; Walter J, 2013, ENVIRON EXP BOT, V94, P3, DOI 10.1016/j.envexpbot.2012.02.009; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; WILLEY CH, 1974, J WILDLIFE MANAGE, V38, P97, DOI 10.2307/3800203; Woodroffe R., 2005, CONSERV BIOL	79	91	94	2	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85122	10.1371/journal.pone.0085122	http://dx.doi.org/10.1371/journal.pone.0085122			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416350	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500218
J	Blanco, F; Barberia, I; Matute, H				Blanco, Fernando; Barberia, Itxaso; Matute, Helena			The Lack of Side Effects of an Ineffective Treatment Facilitates the Development of a Belief in Its Effectiveness	PLOS ONE			English	Article							CAUSAL JUDGMENT; CONTINGENCY; SUPERSTITION; COVARIATION; INFORMATION; ILLUSION; CUE	Some alternative medicines enjoy widespread use, and in certain situations are preferred over conventional, validated treatments in spite of the fact that they fail to prove effective when tested scientifically. We propose that the causal illusion, a basic cognitive bias, underlies the belief in the effectiveness of bogus treatments. Therefore, the variables that modulate the former might affect the latter. For example, it is well known that the illusion is boosted when a potential cause occurs with high probability. In this study, we examined the effect of this variable in a fictitious medical scenario. First, we showed that people used a fictitious medicine (i.e., a potential cause of remission) more often when they thought it caused no side effects. Second, the more often they used the medicine, the more likely they were to develop an illusory belief in its effectiveness, despite the fact that it was actually useless. This behavior may be parallel to actual pseudomedicine usage; that because a treatment is thought to be harmless, it is used with high frequency, hence the overestimation of its effectiveness in treating diseases with a high rate of spontaneous relief. This study helps shed light on the motivations spurring the widespread preference of pseudomedicines over scientific medicines. This is a valuable first step toward the development of scientifically validated strategies to counteract the impact of pseudomedicine on society.	[Blanco, Fernando; Barberia, Itxaso; Matute, Helena] Univ Deusto, Dept Fundamentos & Metodos Psicol, Bilbao, Spain	University of Deusto	Blanco, F (corresponding author), Univ Deusto, Dept Fundamentos & Metodos Psicol, Bilbao, Spain.	fernandoblanco@deusto.es	Blanco, Fernando/E-8941-2010; BARBERIA, ITXASO/L-8477-2014; Matute, Helena/A-8256-2011	Blanco, Fernando/0000-0003-1283-8313; BARBERIA, ITXASO/0000-0003-3045-2289; Matute, Helena/0000-0001-7221-1366	Direccion General de Investigacion of the Spanish Government [PSI2011-26965]; Departamento de Educacion, Universidades e Investigacion of the Basque Government [IT363-10]	Direccion General de Investigacion of the Spanish Government; Departamento de Educacion, Universidades e Investigacion of the Basque Government	Support for this research was provided by Direccion General de Investigacion of the Spanish Government (Grant PSI2011-26965) and Departamento de Educacion, Universidades e Investigacion of the Basque Government (Grant IT363-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN LG, 1983, LEARN MOTIV, V14, P381, DOI 10.1016/0023-9690(83)90024-3; Barberia I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071303; Blanco F, 2013, LEARN BEHAV, V41, P333, DOI 10.3758/s13420-013-0108-8; Blanco F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046203; Blanco F, 2011, Q J EXP PSYCHOL, V64, P1290, DOI 10.1080/17470218.2011.552727; Buehner MJ, 2003, J EXP PSYCHOL LEARN, V29, P1119, DOI 10.1037/0278-7393.29.6.1119; Frankel MS, 1999, WORKSH CONV AM ASS A; Freckelton I, 2012, J LAW MED, V19, P454; Hannah SD, 2009, CAN J EXP PSYCHOL, V63, P59, DOI 10.1037/a0013403; Hayes A. F., 2012, PROCESS VERSATILE CO; KAO SF, 1993, J EXP PSYCHOL LEARN, V19, P1363, DOI 10.1037/0278-7393.19.6.1363; Killeen PR, 2013, LEARN BEHAV, V41, P1, DOI 10.3758/s13420-012-0095-1; Matute H, 1996, PSYCHOL SCI, V7, P289, DOI 10.1111/j.1467-9280.1996.tb00376.x; Matute H, 2011, BRIT J PSYCHOL, V102, P392, DOI 10.1348/000712610X532210; Perales JC, 2007, PSYCHON B REV, V14, P577, DOI 10.3758/BF03196807; Rescorla, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Shang AJ, 2005, LANCET, V366, P726, DOI 10.1016/S0140-6736(05)67177-2; SKINNER BF, 1948, J EXP PSYCHOL, V38, P168, DOI 10.1037//0096-3445.121.3.273; STADDON JER, 1971, PSYCHOL REV, V78, P3, DOI 10.1037/h0030305; WASSERMAN EA, 1990, PSYCHOL LEARN MOTIV, V26, P27, DOI DOI 10.1016/S0079-7421(08)60051-1; White PA, 2004, MEM COGNITION, V32, P353, DOI 10.3758/BF03195830; Yarritu I, 2014, EXP PSYCHOL, V61, P38, DOI 10.1027/1618-3169/a000225	22	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84084	10.1371/journal.pone.0084084	http://dx.doi.org/10.1371/journal.pone.0084084			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291WL	24416194	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500095
J	Guadayol, O; Silbiger, NJ; Donahue, MJ; Thomas, FIM				Guadayol, Oscar; Silbiger, Nyssa J.; Donahue, Megan J.; Thomas, Florence I. M.			Patterns in Temporal Variability of Temperature, Oxygen and pH along an Environmental Gradient in a Coral Reef	PLOS ONE			English	Article							OCEAN ACIDIFICATION; STORM RUNOFF; KANEOHE BAY; PHYTOPLANKTON; TURBULENCE; PATCHINESS; DYNAMICS; PLANKTON; IMPACTS; SCALE	Spatial and temporal environmental variability are important drivers of ecological processes at all scales. As new tools allow the in situ exploration of individual responses to fluctuations, ecologically meaningful ways of characterizing environmental variability at organism scales are needed. We investigated the fine-scale spatial heterogeneity of high-frequency temporal variability in temperature, dissolved oxygen concentration, and pH experienced by benthic organisms in a shallow coastal coral reef. We used a spatio-temporal sampling design, consisting of 21 short-term time-series located along a reef flat-to-reef slope transect, coupled to a long-term station monitoring water column changes. Spectral analyses revealed sharp gradients in variance decomposed by frequency, as well as differences between physically-driven and biologically-reactive parameters. These results highlight the importance of environmental variance at organismal scales and present a new sampling scheme for exploring this variability in situ.	[Guadayol, Oscar; Silbiger, Nyssa J.; Donahue, Megan J.; Thomas, Florence I. M.] Univ Hawaii Manoa, Sch Ocean & Earth Sci & Technol, Hawaii Inst Marine Biol, Kaneohe, HI USA; [Silbiger, Nyssa J.] Univ Hawaii Manoa, Dept Biol, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Guadayol, O (corresponding author), Univ Hull, Sch Biol Biomed & Environm Sci, Kingston Upon Hull, Yorks, England.	oscar@guadayol.cat	Guadayol, Òscar/N-2940-2013; Donahue, Megan/Q-3528-2017	Guadayol, Òscar/0000-0001-9552-1041; Silbiger, Nyssa/0000-0003-4916-3217; Thomas, Florence/0000-0003-4347-6474; Donahue, Megan/0000-0002-7529-001X	National Oceanic and Atmospheric Administration (NOAA) Office of National Marine Sanctuaries-HIMB partnership (MOA) [2009-039/7932]; National Oceanic and Atmospheric Administration [R/EL-33]; University of Hawaii Sea Grant College Program, SOEST from NOAA Office of Sea Grant, Department of Commerce [NA09OAR4170060]; NOAA [NA12NOS4290140]	National Oceanic and Atmospheric Administration (NOAA) Office of National Marine Sanctuaries-HIMB partnership (MOA); National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); University of Hawaii Sea Grant College Program, SOEST from NOAA Office of Sea Grant, Department of Commerce; NOAA(National Oceanic Atmospheric Admin (NOAA) - USA)	Funding for this project came from National Oceanic and Atmospheric Administration (NOAA) Office of National Marine Sanctuaries-HIMB partnership (MOA #2009-039/7932). This paper is also funded in part by a grant/cooperative agreement from the National Oceanic and Atmospheric Administration, Project R/EL-33, which is sponsored by the University of Hawaii Sea Grant College Program, SOEST, under Institutional Grant No. NA09OAR4170060 from NOAA Office of Sea Grant, Department of Commerce. The views expressed herein are those of the author(s) and do not necessarily reflect the views of NOAA or any of its subagencies. UNIHI-SEAGRANT-JC-12-24. NJS was supported by NOAA Dr. Nancy Foster Scholarship Award No. NA12NOS4290140. This is HIMB contribution #1574 and SOEST contribution #9042. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barshis DJ, 2010, MOL ECOL, V19, P1705, DOI 10.1111/j.1365-294X.2010.04574.x; BATCHELOR GK, 1959, J FLUID MECH, V5, P113, DOI 10.1017/S002211205900009X; Bathen KH, 1968, 14 HAW I MAR BIOL; Benedetti-Cecchi L, 2003, ECOLOGY, V84, P2335, DOI 10.1890/02-8011; Bindoff NL, 2007, CLIMATE CHANGE 2007, P235; Boudreau B.P., 2001, BENTHIC BOUNDARY LAY; Chatfield C., 2003, ANAL TIME SERIES INT, V6, DOI 10.4324/9780203491683; De Carlo EH, 2007, APPL GEOCHEM, V22, P1777, DOI 10.1016/j.apgeochem.2007.03.034; Denny MW, 2004, ECOL MONOGR, V74, P513, DOI 10.1890/03-4043; Dickey TD, 2003, J MARINE SYST, V40, P5, DOI 10.1016/S0924-7963(03)00011-3; Dickson A.G., 2007, GUIDE BEST PRACTICES; Dove S, 2006, LIMNOL OCEANOGR, V51, P1149, DOI 10.4319/lo.2006.51.2.1149; Drupp P, 2011, AQUAT GEOCHEM, V17, P473, DOI 10.1007/s10498-010-9115-y; Duarte CM, 2013, ESTUAR COAST, V36, P221, DOI 10.1007/s12237-013-9594-3; Edmunds PJ, 2008, MAR ECOL PROG SER, V361, P307, DOI 10.3354/meps07556; Falciatore A, 2000, SCIENCE, V288, P2363, DOI 10.1126/science.288.5475.2363; Franks PJS, 2005, MAR ECOL PROG SER, V294, P295, DOI 10.3354/meps294295; Gagliano M, 2010, MAR BIOL, V157, P1849, DOI 10.1007/s00227-010-1456-y; Gorospe Kelvin D., 2011, Journal of Marine Biology, V2011, P1; Helmuth B, 2010, J EXP BIOL, V213, P995, DOI 10.1242/jeb.038463; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Jimenez IM, 2012, MAR BIOL, V159, P1773, DOI 10.1007/s00227-012-1968-8; Joint I, 2011, ISME J, V5, P1, DOI 10.1038/ismej.2010.79; Jokiel PL, 2008, CORAL REEFS, V27, P473, DOI 10.1007/s00338-008-0380-9; Kelly MW, 2013, FUNCT ECOL, V27, P980, DOI 10.1111/j.1365-2435.2012.02061.x; Koehl MAR, 2010, INTEGR COMP BIOL, V50, P539, DOI 10.1093/icb/icq101; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Lewis ER, 1998, ESS-DIVE, DOI 10.15485/1464255; Litchman E, 2000, FRESHWATER BIOL, V44, P223, DOI 10.1046/j.1365-2427.2000.00559.x; Lowe RJ, 2009, J PHYS OCEANOGR, V39, P873, DOI 10.1175/2008JPO3958.1; Lowe RJ, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005081; LUMLEY JL, 1983, J PHYS OCEANOGR, V13, P2000, DOI 10.1175/1520-0485(1983)013<2000:KOTCBA>2.0.CO;2; Mayfield AB, 2012, J EXP BIOL, V215, P4183, DOI 10.1242/jeb.071688; McCabe RM, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC006023; Middelboe AL, 2007, MAR ECOL PROG SER, V338, P107, DOI 10.3354/meps338107; Miner BG, 2004, ECOL LETT, V7, P794, DOI 10.1111/j.1461-0248.2004.00637.x; Niehaus AC, 2012, J EXP BIOL, V215, P694, DOI 10.1242/jeb.058032; Oliver TA, 2011, CORAL REEFS, V30, P429, DOI 10.1007/s00338-011-0721-y; Ostrander CE, 2008, ESTUAR COAST, V31, P192, DOI 10.1007/s12237-007-9001-z; Peters F, 2000, MAR ECOL PROG SER, V205, P291, DOI 10.3354/meps205291; Pincebourde S, 2012, ECOL LETT, V15, P680, DOI 10.1111/j.1461-0248.2012.01785.x; Pinheiro J, 2020, R PACKAGE VERSION 31; PLATT T, 1972, DEEP-SEA RES, V19, P183, DOI 10.1016/0011-7471(72)90029-0; POWELL TM, 1994, PHILOS T R SOC B, V343, P11, DOI 10.1098/rstb.1994.0002; Prairie J.C., 2012, LIMNOL OCEANOGR FLUI, V2, P121, DOI DOI 10.1215/21573689-1964713; Price NN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043843; Provoost P, 2010, BIOGEOSCIENCES, V7, P3869, DOI 10.5194/bg-7-3869-2010; Ringuet S, 2005, ESTUARIES, V28, P327, DOI 10.1007/BF02693916; Sanford E, 2011, ANNU REV MAR SCI, V3, P509, DOI 10.1146/annurev-marine-120709-142756; Searle SR., 1992, VARIANCE COMPONENTS; Shaw EC, 2013, GEOPHYS RES LETT, V40, P4685, DOI 10.1002/grl.50883; Shaw EC, 2013, GLOBAL CHANGE BIOL, V19, P1632, DOI 10.1111/gcb.12154; SMITH SV, 1981, PAC SCI, V35, P279; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Song B, 2007, J PHYCOL, V43, P542, DOI 10.1111/j.1529-8817.2007.00352.x; STEELE JH, 1985, NATURE, V313, P355, DOI 10.1038/313355a0; Team RDC, 2005, R LANG ENV STAT COMP; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; WING SR, 1993, MAR BIOL, V116, P519, DOI 10.1007/BF00350069; Wootton JT, 2008, P NATL ACAD SCI USA, V105, P18848, DOI 10.1073/pnas.0810079105; Yamazaki H, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024103; YSI Incorporated, 2011, 6 SER MULT WAT QUAL	63	66	66	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85213	10.1371/journal.pone.0085213	http://dx.doi.org/10.1371/journal.pone.0085213			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416364	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500227
J	Parra, EL; Ramos, V; Sanabria, O; Moreno, J				Parra, Eliana L.; Ramos, Viviana; Sanabria, Olga; Moreno, Jaime			Serotype and Genotype Distribution among Invasive Streptococcus pneumoniae Isolates in Colombia, 2005-2010	PLOS ONE			English	Article							PNEUMOCOCCAL DISEASE; UNITED-STATES; 19A; CLONES; EPIDEMIOLOGY; VACCINATION; DISCOVERY; CARRIAGE; PORTUGAL; SEPSIS	In Colombia, a laboratory-based surveillance of invasive Streptococcus pneumoniae isolates as part of SIREVA II PAHO has been conducted since 1994. This study describes the serotype distribution, antimicrobial resistance, and genetic relationships of pneumococcal isolates recovered in Colombia from 2005 to 2010. In this study, demographic data of invasive S. pneumoniae isolates were analyzed, and antimicrobial susceptibility patterns were determined. Pulse field gel electrophoresis (n = 629) and multilocus sequence typing (n = 10) were used to determine genetic relationship of isolates with minimal inhibitory concentration to penicillin >= 0.125 mg/mL. A total of 1775 isolates of S. pneumoniae were obtained. Fifteen serotypes accounted for 80.7% of isolates. Serotype 14 (23.1%) was the most frequent in the general population. Penicillin resistance was 30.7% in meningitis and 9.0% in non-meningitis. Clones Spain(6B)ST90, Spain(9V)ST156, Spain(23F)ST81, and Colombia(23F)ST338 were associated to isolates. Additionally, serotype 6A isolates were associated with ST460 and ST473, and 19A isolates with ST276, ST320, and ST1118. In conclusion, the surveillance program provided updated information of trends in serotype distribution, antimicrobial resistance and the circulation of clones in invasive pneumococcal diseases. These results could be helpful to understand the epidemiology of S. pneumoniae in Colombia, and provide a baseline to measure the impact of vaccine introduction.	[Parra, Eliana L.; Ramos, Viviana; Sanabria, Olga; Moreno, Jaime] Inst Nacl Salud, Microbiol Grp, Bogota, Colombia	Instituto Nacional de Salud (Colombia)	Moreno, J (corresponding author), Inst Nacl Salud, Microbiol Grp, Bogota, Colombia.	jmoreno@ins.gov.co		Parra Barrera, Eliana L./0000-0002-2745-7997				Aanensen DM, 2005, NUCLEIC ACIDS RES, V33, pW728, DOI 10.1093/nar/gki415; Agudelo Clara Inés, 2006, Biomédica, V26, P234; Aguiar SI, 2010, J CLIN MICROBIOL, V48, P101, DOI 10.1128/JCM.00665-09; [Anonymous], 2012, INF REG SIREVA 2; Baek JY, 2011, DIAGN MICR INFEC DIS, V69, P370, DOI 10.1016/j.diagmicrobio.2010.10.019; Brueggemann AB, 2007, PLOS PATHOG, V3, P1628, DOI 10.1371/journal.ppat.0030168; Calix JJ, 2012, J BIOL CHEM, V287, P27885, DOI 10.1074/jbc.M112.380451; Calix JJ, 2010, J INFECT DIS, V202, P29, DOI 10.1086/653123; Carvalho MD, 2009, J CLIN MICROBIOL, V47, P554, DOI 10.1128/JCM.01919-08; Castaneda E, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-124; Clinical and Laboratory Standards Institute, 2010, M100S21 CLSI; Constenla D, 2007, BURDEN PNEUMOCOCAL D; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Gherardi G, 2012, ANTIMICROB AGENTS CH, V56, P4965, DOI 10.1128/AAC.00830-12; Grall N, 2011, EUR J CLIN MICROBIOL, V30, P1511, DOI 10.1007/s10096-011-1251-9; Hausdorff WP, 2005, LANCET INFECT DIS, V5, P83, DOI 10.1016/S1473-3099(05)01280-6; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608; Henriques-Normark B, 2008, NAT REV MICROBIOL, V6, P827, DOI 10.1038/nrmicro2011; Hiller NL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028850; Horacio AN, 2012, VACCINE, V30, P218, DOI 10.1016/j.vaccine.2011.11.022; Hsieh YC, 2009, CLIN MICROBIOL INFEC, V15, P991, DOI 10.1111/j.1469-0691.2009.02743.x; Johnson HL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000348; Ko KS, 2013, J CLIN MICROBIOL, V51, P3395, DOI 10.1128/JCM.01645-13; Leal J, 2012, PEDIATR INFECT DIS J, V31, pE169, DOI 10.1097/INF.0b013e3182624a40; Lynch JP, 2010, CURR OPIN PULM MED, V16, P217, DOI 10.1097/MCP.0b013e3283385653; Mahjoub-Messai F, 2009, J CLIN MICROBIOL, V47, P837, DOI 10.1128/JCM.01547-08; Ministerio de Salud y Proteccion Social, JORN VAC LAS AM 2012; Munoz-Almagro C, 2011, J INFECTION, V63, P151, DOI 10.1016/j.jinf.2011.06.002; Oliver MB, 2013, J BIOL CHEM, V288, P25976, DOI 10.1074/jbc.M113.480152; Parra EL, 2013, VACCINE, V31, P4033, DOI 10.1016/j.vaccine.2013.04.074; Pillai DR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-642; Pletz MWR, 2004, ANTIMICROB AGENTS CH, V48, P3491, DOI 10.1128/AAC.48.9.3491-3497.2004; Reinert RR, 2009, CLIN MICROBIOL INFEC, V15, P7, DOI 10.1111/j.1469-0691.2009.02724.x; Reinert RR, 2010, VACCINE, V28, P4249, DOI 10.1016/j.vaccine.2010.04.020; Reinert RR, 2005, J CLIN MICROBIOL, V43, P1294, DOI 10.1128/JCM.43.3.1294-1300.2005; Rolo D, 2011, J ANTIMICROB CHEMOTH, V66, P1712, DOI 10.1093/jac/dkr193; Sa-Leao R, 2000, J INFECT DIS, V182, P1153, DOI 10.1086/315813; Schaaf B, 2007, EUR RESPIR J, V30, P517, DOI 10.1183/09031936.00021007; Scott JAG, 1996, CLIN INFECT DIS, V22, P973, DOI 10.1093/clinids/22.6.973; Serrano I, 2005, J CLIN MICROBIOL, V43, P1706, DOI 10.1128/JCM.43.4.1706-1715.2005; Shin J, 2011, J ANTIMICROB CHEMOTH, V66, P1001, DOI 10.1093/jac/dkr048; Sjostrom K, 2007, P NATL ACAD SCI USA, V104, P12907, DOI 10.1073/pnas.0705589104; Tan TQ, 2012, CLIN MICROBIOL REV, V25, P409, DOI 10.1128/CMR.00018-12; Vela MC, 2001, MICROB DRUG RESIST, V7, P153, DOI 10.1089/10766290152045020; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Weisfelt M, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-149	46	16	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84993	10.1371/journal.pone.0084993	http://dx.doi.org/10.1371/journal.pone.0084993			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416330	gold, Green Published, Green Submitted			2022-12-27	WOS:000329862500203
J	Roth, T; Plattner, M; Amrhein, V				Roth, Tobias; Plattner, Matthias; Amrhein, Valentin			Plants, Birds and Butterflies: Short-Term Responses of Species Communities to Climate Warming Vary by Taxon and with Altitude	PLOS ONE			English	Article							RANGE SHIFTS; PINUS-CEMBRA; DIVERSITY; BIODIVERSITY; HOMOGENIZATION; TEMPERATURES; INDICATORS; MOUNTAINS; ELEVATION; RICHNESS	As a consequence of climate warming, species usually shift their distribution towards higher latitudes or altitudes. Yet, it is unclear how different taxonomic groups may respond to climate warming over larger altitudinal ranges. Here, we used data from the national biodiversity monitoring program of Switzerland, collected over an altitudinal range of 2500 m. Within the short period of eight years (2003-2010), we found significant shifts in communities of vascular plants, butterflies and birds. At low altitudes, communities of all species groups changed towards warm-dwelling species, corresponding to an average uphill shift of 8 m, 38 m and 42 m in plant, butterfly and bird communities, respectively. However, rates of community changes decreased with altitude in plants and butterflies, while bird communities changed towards warm-dwelling species at all altitudes. We found no decrease in community variation with respect to temperature niches of species, suggesting that climate warming has not led to more homogenous communities. The different community changes depending on altitude could not be explained by different changes of air temperatures, since during the 16 years between 1995 and 2010, summer temperatures in Switzerland rose by about 0.07 degrees C per year at all altitudes. We discuss that land-use changes or increased disturbances may have prevented alpine plant and butterfly communities from changing towards warm-dwelling species. However, the findings are also consistent with the hypothesis that unlike birds, many alpine plant species in a warming climate could find suitable habitats within just a few metres, due to the highly varied surface of alpine landscapes. Our results may thus support the idea that for plants and butterflies and on a short temporal scale, alpine landscapes are safer places than lowlands in a warming world.	[Roth, Tobias; Plattner, Matthias] Hintermann & Weber AG, Reinach, Switzerland; [Roth, Tobias; Amrhein, Valentin] Univ Basel, Inst Zool, CH-4051 Basel, Switzerland; [Roth, Tobias; Amrhein, Valentin] Res Stn Petite Camargue Alsacienne, St Louis, France	University of Basel	Roth, T (corresponding author), Hintermann & Weber AG, Reinach, Switzerland.	roth@hintermannweber.ch	Amrhein, Valentin/ABD-6432-2021; Roth, Tobias/H-7927-2019	Roth, Tobias/0000-0001-9742-8297	Swiss Federal Office for the Environment; Swiss Association Pro Petite Camargue Alsacienne	Swiss Federal Office for the Environment; Swiss Association Pro Petite Camargue Alsacienne	Financial support was provided by the Swiss Federal Office for the Environment and the Swiss Association Pro Petite Camargue Alsacienne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archaux F, 2004, IBIS, V146, P138, DOI 10.1111/j.1474-919X.2004.00246.x; Begert M, 2005, INT J CLIMATOL, V25, P65, DOI 10.1002/joc.1118; Bertrand R, 2011, NATURE, V479, P517, DOI 10.1038/nature10548; Callaway RM, 2002, NATURE, V417, P844, DOI 10.1038/nature00812; Cannone N, 2007, FRONT ECOL ENVIRON, V5, P360, DOI 10.1890/1540-9295(2007)5[360:UIOCCO]2.0.CO;2; Cantarel AAM, 2013, J VEG SCI, V24, P113, DOI 10.1111/j.1654-1103.2012.01452.x; Ceppi P, 2012, INT J CLIMATOL, V32, P203, DOI 10.1002/joc.2260; Chamberlain D, 2012, IBIS, V154, P205, DOI 10.1111/j.1474-919X.2011.01196.x; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Clavero M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018581; Couvet D, 2011, CR BIOL, V334, P370, DOI 10.1016/j.crvi.2011.02.007; Crimmins SM, 2011, SCIENCE, V331, P324, DOI 10.1126/science.1199040; Davey CM, 2012, GLOBAL ECOL BIOGEOGR, V21, P568, DOI 10.1111/j.1466-8238.2011.00693.x; Devictor V, 2008, P ROY SOC B-BIOL SCI, V275, P2743, DOI 10.1098/rspb.2008.0878; Devictor V, 2012, NAT CLIM CHANGE, V2, P121, DOI 10.1038/NCLIMATE1347; Engler R, 2011, GLOBAL CHANGE BIOL, V17, P2330, DOI 10.1111/j.1365-2486.2010.02393.x; Feeley KJ, 2011, J BIOGEOGR, V38, P783, DOI 10.1111/j.1365-2699.2010.02444.x; Franzen M, 2012, BIODIVERS CONSERV, V21, P517, DOI 10.1007/s10531-011-0197-7; Gottfried M, 2012, NAT CLIM CHANGE, V2, P111, DOI [10.1038/nclimate1329, 10.1038/NCLIMATE1329]; Graham EA, 2012, ARCT ANTARCT ALP RES, V44, P288, DOI 10.1657/1938-4246-44.3.288; Grime JP, 2000, SCIENCE, V289, P762, DOI 10.1126/science.289.5480.762; Gusewell S, 2012, ECOL INDIC, V20, P134, DOI 10.1016/j.ecolind.2012.02.011; Hagemeijer W., 1997, EBCC ATLAS EUROPEAN; Hanewinkel M, 2013, NAT CLIM CHANGE, V3, P203, DOI [10.1038/nclimate1687, 10.1038/NCLIMATE1687]; Hanspach J, ECOGRAPHY; HATTENSCHWILER S, 1995, J VEG SCI, V6, P357, DOI 10.2307/3236235; Hintermann U., 2000, SCHRIFTENREIHE LANDS, V62, P47; Ibanez I, 2013, ECOL EVOL, V3, P170, DOI 10.1002/ece3.433; Kampichler C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035272; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Korner C, 2003, ALPINE PLANT LIFE FU, DOI DOI 10.1007/978-3-030-59538-8; Korner C., 2005, ADV GLOB CHANGE RES, P367; Landolt E., 2010, FLORA INDICATIVA; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Lenoir J, 2013, GLOBAL CHANGE BIOL, V19, P1470, DOI 10.1111/gcb.12129; Lenoir J, 2010, ECOGRAPHY, V33, P295, DOI 10.1111/j.1600-0587.2010.06279.x; Lindenmayer DB, 2009, TRENDS ECOL EVOL, V24, P482, DOI 10.1016/j.tree.2009.03.005; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Maggini R, 2011, ECOL MODEL, V222, P21, DOI 10.1016/j.ecolmodel.2010.09.010; Magurran AE, 2010, TRENDS ECOL EVOL, V25, P574, DOI 10.1016/j.tree.2010.06.016; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pauli H, 2012, SCIENCE, V336, P353, DOI 10.1126/science.1219033; Paulsen J, 2001, J VEG SCI, V12, P817, DOI 10.2307/3236869; Pellissier L, 2013, ECOGRAPHY, V36, P541, DOI 10.1111/j.1600-0587.2012.07716.x; Pinheiro J., 2011, NLME LINEAR NONLINEA; PLATT JR, 1964, SCIENCE, V146, P347, DOI 10.1126/science.146.3642.347; Quintero I, 2013, GLOBAL ECOL BIOGEOGR, V22, P422, DOI 10.1111/geb.12001; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Roth T, 2008, J APPL ECOL, V45, P987, DOI 10.1111/j.1365-2664.2007.01435.x; Scherrer D, 2011, J BIOGEOGR, V38, P406, DOI 10.1111/j.1365-2699.2010.02407.x; Scherrer D, 2010, GLOBAL CHANGE BIOL, V16, P2602, DOI 10.1111/j.1365-2486.2009.02122.x; Schuepp M, 1980, BEOBACHTUNGSNETZE SC; Schweiger O, ZOOKEYS IN PRESS; Schweiger O, 2008, ECOLOGY, V89, P3472, DOI 10.1890/07-1748.1; Settele J, 2008, CLIMATIC RISK ATLAS; Sinclair SJ, 2010, ECOL SOC, V15, DOI 10.5751/ES-03089-150108; van Strien AJ, 2012, ECOL INDIC, V14, P202, DOI 10.1016/j.ecolind.2011.07.007; Vetaas OR, 2002, J BIOGEOGR, V29, P545, DOI 10.1046/j.1365-2699.2002.00694.x; Vittoz P, 2008, ARCT ANTARCT ALP RES, V40, P225, DOI 10.1657/1523-0430(06-010)[VITTOZ]2.0.CO;2; Walther GR, 2005, J VEG SCI, V16, P541, DOI 10.1111/j.1654-1103.2005.tb02394.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4; Zuur Alain F., 2009, P1	64	64	67	5	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e82490	10.1371/journal.pone.0082490	http://dx.doi.org/10.1371/journal.pone.0082490			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416144	gold, Green Submitted, Green Published			2022-12-27	WOS:000329862500017
J	Vall, O; Gomez-Culebras, M; Puig, C; Rodriguez-Carrasco, E; Baltazar, AG; Canchucaja, L; Joya, X; Garcia-Algar, O				Vall, Oriol; Gomez-Culebras, Mario; Puig, Carme; Rodriguez-Carrasco, Ernesto; Gomez Baltazar, Arelis; Canchucaja, Lizzeth; Joya, Xavier; Garcia-Algar, Oscar			Prenatal and Postnatal Exposure to DDT by Breast Milk Analysis in Canary Islands	PLOS ONE			English	Article							PERSISTENT ORGANOCHLORINE COMPOUNDS; ADIPOSE-TISSUE; PESTICIDE-RESIDUES; BIRTH-WEIGHT; INADVERTENT EXPOSURE; RISK-ASSESSMENT; SPAIN; WOMEN; SERUM; FOOD	Introduction: The use of p,p'-dichlorodiphenyltrichloroethane (DDT) has been banned since the late 1970s due to its toxicity. However, its long half-life makes it persistent in the environment and, consequently, almost everyone has DDT residues in the body. Human milk constitutes an ideal non-conventional matrix to investigate environmental chronic exposure to organochlorine compounds (OCs) residues. The study aimed to identify potential population risk factors of exposure to DDT due to the proximity to countries where it is still used. Methods: Seventy-two consecutive lactating women were prospectively included in Tenerife, Canary Islands (Spain). A validated questionnaire was used to obtain socioeconomic, demographics data, and daily habits during pregnancy. DDT levels in breast milk were measured by gas chromatography with-electron capture detector (GC-ECD). Anthropometrics measurements in newborns were obtained. Results: Thirty-four out of 72 (47.2%) of the analysed milk samples presented detectable levels of DDT (mean: 0.92 ng/g), ranging between 0.08 to 16.96 ng/g. The socio-demographic variables did not significantly differ between detectable DDT and non-detectable DDT groups. We found positive association between DDT levels and vegetables (OR (95% CI): 1.23 (1.01-1.50)) and poultry meat (OR (95% CI): 2.05 (1.16-3.60)) consumption, and also between the presence of DDT in breast milk and gestational age (OR (95% CI): 0.59 (0.40-0.90)). Conclusions: DDT is present in breast milk of women at the time of delivery. Residual levels and the spread from countries still using DDT explain DDT detection from vegetables and from animal origin food. The presence of this compound in breast milk represents a pre- and postnatal exposure hazard for foetuses and infants due to chronic bioaccumulation and poor elimination, with possible deleterious effects on health. This data should be used to raise awareness of the risks of OCs exposure and to help establish health policies in order to avoid its use worldwide and thus, to prevent its propagation.	[Vall, Oriol; Puig, Carme; Gomez Baltazar, Arelis; Canchucaja, Lizzeth; Joya, Xavier; Garcia-Algar, Oscar] Inst Hosp Mar Invest Mediques IMIM, URIE, Barcelona, Spain; [Vall, Oriol; Puig, Carme; Joya, Xavier; Garcia-Algar, Oscar] Inst Salud Carlos III, Red Salud Maternoinfantil & Desarrollo SAMID, Madrid, Spain; [Vall, Oriol; Gomez Baltazar, Arelis; Canchucaja, Lizzeth; Garcia-Algar, Oscar] Univ Autonoma Barcelona, Dept Pediat Obstet Ginecol & Med Prevent, E-08193 Barcelona, Spain; [Gomez-Culebras, Mario; Rodriguez-Carrasco, Ernesto] Univ Tenerife, Hosp Candelaria, Dept Cirugia Pediat, Santa Cruz De Tenerife, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Instituto de Salud Carlos III; Autonomous University of Barcelona	Garcia-Algar, O (corresponding author), Inst Hosp Mar Invest Mediques IMIM, URIE, Barcelona, Spain.	90458@parcdesalutmar.cat		GARCIA-ALGAR, OSCAR/0000-0001-5708-4362				AHLBORG UG, 1992, EUR J PHARM-ENVIRON, V228, P179, DOI 10.1016/0926-6917(92)90029-C; AHLBORG UG, 1995, CRIT REV TOXICOL, V25, P463, DOI 10.3109/10408449509017924; Akkina JE, 2004, J TOXICOL ENV HEAL A, V67, P1407, DOI 10.1080/15287390490483845; ALAWI MA, 1992, ARCH ENVIRON CON TOX, V23, P235, DOI 10.1007/BF00212281; Algar OG, 2004, INDOOR AIR, V14, P298, DOI 10.1111/j.1600-0668.2004.00256.x; Allen RH, 1997, ENVIRON HEALTH PERSP, V105, P679, DOI 10.2307/3433389; Arrebola JP, 2012, ENVIRON INT, V38, P54, DOI 10.1016/j.envint.2011.08.006; Botella B, 2004, ENVIRON RES, V96, P34, DOI 10.1016/j.envres.2003.10.001; Bouwman H, 2012, ENVIRON POLLUT, V170, P63, DOI 10.1016/j.envpol.2012.06.009; Burke ER, 2003, B ENVIRON CONTAM TOX, V71, P148, DOI 10.1007/s00128-003-0142-x; Cok I, 2012, ENVIRON INT, V40, P63, DOI 10.1016/j.envint.2011.11.012; CORRIGAN PJ, 1990, AUST VET J, V67, P56, DOI 10.1111/j.1751-0813.1990.tb07695.x; Covaci A, 2002, ENVIRON RES, V88, P210, DOI 10.1006/enrs.2002.4334; Cruz S, 2003, SCI TOTAL ENVIRON, V317, P23, DOI 10.1016/S0048-9697(03)00334-6; Diaz-Diaz R, 2001, ENVIRON TOXICOL CHEM, V20, P1958, DOI [10.1002/etc.5620200914, 10.1897/1551-5028(2001)020&lt;1958:ATPFPL&gt;2.0.CO;2]; Ennaceur S, 2008, ENVIRON RES, V108, P86, DOI 10.1016/j.envres.2008.05.005; Farhang L, 2005, AM J EPIDEMIOL, V162, P717, DOI 10.1093/aje/kwi276; Ferrer A., 2003, Anales Sis San Navarra, V26, P155, DOI 10.4321/s1137-66272003000200009; Fontcuberta M, 2008, SCI TOTAL ENVIRON, V389, P52, DOI 10.1016/j.scitotenv.2007.08.043; Gladen BC, 2003, ANN EPIDEMIOL, V13, P151, DOI 10.1016/S1047-2797(02)00268-5; Glynn AW, 2003, ENVIRON HEALTH PERSP, V111, P349, DOI 10.1289/ehp.5456; GOMEZCATALAN J, 1995, B ENVIRON CONTAM TOX, V54, P534, DOI 10.1007/BF00192596; GUITART R, 1990, B ENVIRON CONTAM TOX, V44, P555, DOI 10.1007/BF01700875; Harcz P, 2007, FOOD ADDIT CONTAM A, V24, P713, DOI 10.1080/02652030601185071; Jakszyn P, 2009, CHEMOSPHERE, V76, P1518, DOI 10.1016/j.chemosphere.2009.05.048; Jusko TA, 2006, EPIDEMIOLOGY, V17, P692, DOI 10.1097/01.ede.0000232226.06807.90; Kezios KL, 2013, REPROD TOXICOL, V35, P156, DOI 10.1016/j.reprotox.2012.10.013; Khanjani N, 2006, ENVIRON RES, V101, P373, DOI 10.1016/j.envres.2005.10.003; LaKind JS, 2004, TOXICOL APPL PHARM, V198, P184, DOI 10.1016/j.taap.2003.08.021; Majem LS, 2000, ARCH LATINOAM NUTR, V50, P7; Manosa S, 2003, ENVIRON POLLUT, V122, P351, DOI 10.1016/S0269-7491(02)00334-2; Minh NH, 2004, ENVIRON POLLUT, V129, P431, DOI 10.1016/j.envpol.2003.11.012; Olea N, 1999, TOXICOL IND HEALTH, V15, P151, DOI 10.1191/074823399678846682; Porta M, 2008, GAC SANIT, V22, P248, DOI 10.1157/13123971; Porta M, 2012, SCI TOTAL ENVIRON, V423, P151, DOI 10.1016/j.scitotenv.2012.02.001; Qu WY, 2010, SCI TOTAL ENVIRON, V408, P3133, DOI 10.1016/j.scitotenv.2010.04.023; Ribas-Fito N, 2006, AM J EPIDEMIOL, V164, P955, DOI 10.1093/aje/kwj299; Ridal JJ, 2001, ENVIRON TOXICOL CHEM, V20, P1312, DOI [10.1002/etc.5620200620, 10.1897/1551-5028(2001)020&lt;1312:EONLAP&gt;2.0.CO;2]; Rylander L, 1995, SCAND J WORK ENV HEA, V21, P419, DOI 10.5271/sjweh.57; RYLANDER L, 1995, SCAND J WORK ENV HEA, V21, P368, DOI 10.5271/sjweh.51; Saleh M, 1996, J ENVIRON SCI HEAL B, V31, P241, DOI 10.1080/03601239609372985; Schafer KS, 2002, J EPIDEMIOL COMMUN H, V56, P813, DOI 10.1136/jech.56.11.813; Schinas V, 2000, ARCH ENVIRON HEALTH, V55, P411, DOI 10.1080/00039890009604039; Smith D, 1999, INT J EPIDEMIOL, V28, P179, DOI 10.1093/ije/28.2.179; Tao S, 2009, ENVIRON POLLUT, V157, P497, DOI 10.1016/j.envpol.2008.09.005; UNEP, 2006, C PART STOCKH CONV I; WHO, 2003, HLTH RISKS PERS ORG; Windal I, 2009, SCI TOTAL ENVIRON, V407, P4430, DOI 10.1016/j.scitotenv.2008.11.063; Zumbado M, 2005, SCI TOTAL ENVIRON, V339, P49, DOI 10.1016/j.scitotenv.2004.07.022	49	5	6	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83831	10.1371/journal.pone.0083831	http://dx.doi.org/10.1371/journal.pone.0083831			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416174	gold, Green Published, Green Submitted			2022-12-27	WOS:000329862500077
J	Vashum, KP; McEvoy, M; Milton, AH; Islam, MR; Hancock, S; Attia, J				Vashum, Khanrin P.; McEvoy, Mark; Milton, Abul Hasnat; Islam, Md Rafiqul; Hancock, Stephen; Attia, John			Is Serum Zinc Associated with Pancreatic Beta Cell Function and Insulin Sensitivity in Pre-Diabetic and Normal Individuals? Findings from the Hunter Community Study	PLOS ONE			English	Article							DIABETES-MELLITUS; TRACE-ELEMENTS; RESISTANCE; COPPER; SUPPLEMENTATION; IRON; PATHOGENESIS; DISEASE; OBESITY; RISK	Aim: To determine if there is a difference in serum zinc concentration between normoglycaemic, pre-diabetic and type-2 diabetic groups and if this is associated with pancreatic beta cell function and insulin sensitivity in the former 2 groups. Method: Cross sectional study of a random sample of older community-dwelling men and women in Newcastle, New South Wales, Australia. Beta cell function, insulin sensitivity and insulin resistance were calculated for normoglycaemic and prediabetes participants using the Homeostasis Model Assessment (HOMA-2) calculator. Result: A total of 452 participants were recruited for this study. Approximately 33% (N = 149) had diabetes, 33% (N = 151) had prediabetes and 34% (N = 152) were normoglycaemic. Homeostasis Model Assessment (HOMA) parameters were found to be significantly different between normoglycaemic and prediabetes groups (p<0.001). In adjusted linear regression, higher serum zinc concentration was associated with increased insulin sensitivity (p = 0.01) in the prediabetic group. There was also a significant association between smoking and worse insulin sensitivity. Conclusion: Higher serum zinc concentration is associated with increased insulin sensitivity. Longitudinal studies are required to determine if low serum zinc concentration plays a role in progression from pre-diabetes to diabetes.	[Vashum, Khanrin P.; McEvoy, Mark; Milton, Abul Hasnat; Islam, Md Rafiqul; Hancock, Stephen; Attia, John] Univ Newcastle, Sch Med & Publ Hlth, CCEB, Newcastle, NSW 2300, Australia; [Vashum, Khanrin P.; McEvoy, Mark; Milton, Abul Hasnat; Islam, Md Rafiqul; Hancock, Stephen; Attia, John] Hunter Med Res Inst, Newcastle, NSW, Australia; [Islam, Md Rafiqul] Govt Bangladesh, Minist Hlth & Family Welf, Dhaka, Bangladesh	University of Newcastle; Hunter Medical Research Institute; University of Newcastle	Vashum, KP (corresponding author), Univ Newcastle, Sch Med & Publ Hlth, CCEB, Newcastle, NSW 2300, Australia.	Khanrin.vashum@newcastle.edu.au	Attia, John R/F-5376-2013	Attia, John R/0000-0001-9800-1308; Vashum-Johnston, Khanrin/0000-0003-0433-4000; McEvoy, Mark/0000-0002-5505-5557	University of Newcastle; Vincent Fairfax Family Foundation; Lions District Diabetes foundation, Australia	University of Newcastle; Vincent Fairfax Family Foundation; Lions District Diabetes foundation, Australia	The University of Newcastle and Vincent Fairfax Family Foundation funded the Hunter Community study and this study was funded by Lions District Diabetes foundation, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2006, BIOCHEM BIOPH RES CO, V351, P165, DOI 10.1016/j.bbrc.2006.10.014; [Anonymous], 1978, MAIL TELEPHONE SURVE; Beletate V, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005525.pub2; Bergman BC, 2012, DIABETES, V61, P3156, DOI 10.2337/db12-0418; Chausmer AB, 1998, J AM COLL NUTR, V17, P109, DOI 10.1080/07315724.1998.10718735; Chen H, 2012, BIOL TRACE ELEM RES, V147, P67, DOI 10.1007/s12011-011-9306-4; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; Dhingra U, 2009, J HEALTH POPUL NUTR, V27, P632; Ekmekcioglu C, 2001, BIOL TRACE ELEM RES, V79, P205, DOI 10.1385/BTER:79:3:205; Engelgau MM, 2000, DIABETES CARE, V23, P1563, DOI 10.2337/diacare.23.10.1563; Ferrannini E, 2004, DIABETES, V53, pS26, DOI 10.2337/diabetes.53.suppl_3.S26; Ferrannini E, 1997, J CLIN INVEST, V100, P1166, DOI 10.1172/JCI119628; Forrer R, 2001, BIOL TRACE ELEM RES, V80, P77, DOI 10.1385/BTER:80:1:77; Hashemipour M, 2009, HORM-INT J ENDOCRINO, V8, P279, DOI 10.14310/horm.2002.1244; Health N, 2009, AUSTR GUIDELINES RED; Islam MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061776; Jayawardena R, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-13; Kazi TG, 2008, BIOL TRACE ELEM RES, V122, P1, DOI 10.1007/s12011-007-8062-y; Lee JH, 2012, ANN LAB MED, V32, P190, DOI 10.3343/alm.2012.32.3.190; Marreiro Dilina N., 2004, Arq Bras Endocrinol Metab, V48, P234, DOI 10.1590/S0004-27302004000200005; McEvoy M, 2010, INT J EPIDEMIOL, V39, P1452, DOI 10.1093/ije/dyp343; Meyer JA, 2009, METALLOMICS, V1, P32, DOI 10.1039/b817203j; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; Noormagi A, 2010, BIOCHEM J, V430, P511, DOI 10.1042/BJ20100627; Nriagu J, 2010, ENCY ENV HLTH, P789; Ognjanovic S, 2012, INT J OBES LOND; Olivares M, 2007, NUTRITION, V23, P292, DOI 10.1016/j.nut.2007.01.006; Rahim A, 2011, J PAK MED ASSOC, V61, P853; SCHUHMACHER M, 1994, SCI TOTAL ENVIRON, V148, P67, DOI 10.1016/0048-9697(94)90376-X; Simon SF, 2001, EXP BIOL MED, V226, P43, DOI 10.1177/153537020122600107; Singh RB, 1998, J AM COLL NUTR, V17, P564, DOI 10.1080/07315724.1998.10718804; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Sun Q, 2009, DIABETES CARE, V32, P629, DOI 10.2337/dc08-1913; Tallman DL, 1999, CAN J PHYSIOL PHARM, V77, P919, DOI 10.1139/cjpp-77-12-919; Trirogoff ML, 2007, AM J CLIN NUTR, V86, P1642, DOI 10.1093/ajcn/86.5.1642; Twigg SM, 2007, MED J AUSTRALIA, V186, P461, DOI 10.5694/j.1326-5377.2007.tb00998.x; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wessells KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050568; WHO, 2012, DIAB FACT SHEET 312; Wiernsperger N, 2010, WIERNSPERGER RAPIN D, V2; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Zargar AH, 1998, POSTGRAD MED J, V74, P665, DOI 10.1136/pgmj.74.877.665; Zheng Y, 2008, HEMOGLOBIN, V32, P135, DOI 10.1080/03630260701727077	43	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83944	10.1371/journal.pone.0083944	http://dx.doi.org/10.1371/journal.pone.0083944			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416185	gold, Green Published			2022-12-27	WOS:000329862500087
J	Zwiener, I; Frisch, B; Binder, H				Zwiener, Isabella; Frisch, Barbara; Binder, Harald			Transforming RNA-Seq Data to Improve the Performance of Prognostic Gene Signatures	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; VARIABLE SELECTION; SURVIVAL; REGRESSION; SHRINKAGE; NORMALIZATION	Gene expression measurements have successfully been used for building prognostic signatures, i.e for identifying a short list of important genes that can predict patient outcome. Mostly microarray measurements have been considered, and there is little advice available for building multivariable risk prediction models from RNA-Seq data. We specifically consider penalized regression techniques, such as the lasso and componentwise boosting, which can simultaneously consider all measurements and provide both, multivariable regression models for prediction and automated variable selection. However, they might be affected by the typical skewness, mean-variance-dependency or extreme values of RNA-Seq covariates and therefore could benefit from transformations of the latter. In an analytical part, we highlight preferential selection of covariates with large variances, which is problematic due to the mean-variance dependency of RNA-Seq data. In a simulation study, we compare different transformations of RNA-Seq data for potentially improving detection of important genes. Specifically, we consider standardization, the log transformation, a variance-stabilizing transformation, the Box-Cox transformation, and rank-based transformations. In addition, the prediction performance for real data from patients with kidney cancer and acute myeloid leukemia is considered. We show that signature size, identification performance, and prediction performance critically depend on the choice of a suitable transformation. Rank-based transformations perform well in all scenarios and can even outperform complex variance-stabilizing approaches. Generally, the results illustrate that the distribution and potential transformations of RNA-Seq data need to be considered as a critical step when building risk prediction models by penalized regression techniques.	[Zwiener, Isabella] Univ Med Ctr Mainz, CTH, Mainz, Germany; [Zwiener, Isabella; Frisch, Barbara; Binder, Harald] Univ Med Ctr Mainz, IMBEI, Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Zwiener, I (corresponding author), Univ Med Ctr Mainz, CTH, Mainz, Germany.	zwieneri@uni-mainz.de	Binder, Harald/C-7413-2009	Binder, Harald/0000-0002-5666-8662	Federal Ministry of Education and Research [BMBF 01EO1003]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The project was supported by the Federal Ministry of Education and Research (BMBF 01EO1003). The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Beasley TM, 2009, BEHAV GENET, V39, P580, DOI 10.1007/s10519-009-9281-0; Binder H, 2013, STAT MED, V32, P1778, DOI 10.1002/sim.5490; Binder H, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-14; Binder H, 2011, BIOMETRICAL J, V53, P170, DOI 10.1002/bimj.201000152; Boulesteix AL, 2011, BIOMETRICAL J, V53, P673, DOI 10.1002/bimj.201000189; Bovelstad HM, 2007, BIOINFORMATICS, V23, P2080, DOI 10.1093/bioinformatics/btm305; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Bullinger L, 2008, BLOOD, V111, P4490, DOI 10.1182/blood-2007-09-115055; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Gerds TA, 2007, BIOMETRICS, V63, P1283, DOI 10.1111/j.1541-0420.2007.00832.x; Goeman JJ, 2010, BIOMETRICAL J, V52, P70, DOI 10.1002/bimj.200900028; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Li J, 2011, COMPUT MATH METHOD M, V2011, DOI 10.1155/2011/527610; Li J, 2012, BIOSTATISTICS, V13, P523, DOI 10.1093/biostatistics/kxr031; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mooney M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061088; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Oshlack A, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-14; Quinn EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058815; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; SAKIA RM, 1992, J ROY STAT SOC D-STA, V41, P169, DOI 10.2307/2348250; Soneson C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-91; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Tibshirani R, 1997, STAT MED, V16, P385, DOI 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tutz G, 2007, COMPUT STAT DATA AN, V51, P6044, DOI 10.1016/j.csda.2006.11.041; Tutz G, 2006, BIOMETRICS, V62, P961, DOI 10.1111/j.1541-0420.2006.00578.x; Van De Wiel MA, 2013, BIOSTATISTICS, V14, P113, DOI 10.1093/biostatistics/kxs031; van Houwelingen HC, 2006, STAT MED, V25, P3201, DOI 10.1002/sim.2353; van Wieringen WN, 2009, COMPUT STAT DATA AN, V53, P1590, DOI 10.1016/j.csda.2008.05.021; VERWEIJ PJM, 1993, STAT MED, V12, P2305, DOI 10.1002/sim.4780122407; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu H, 2013, BIOSTATISTICS, V14, P232, DOI 10.1093/biostatistics/kxs033; Zytnicki M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025988	38	87	87	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85150	10.1371/journal.pone.0085150	http://dx.doi.org/10.1371/journal.pone.0085150			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416353	Green Published, gold			2022-12-27	WOS:000329862500221
J	Gossmann, TI; Waxman, D; Eyre-Walker, A				Gossmann, Toni I.; Waxman, David; Eyre-Walker, Adam			Fluctuating Selection Models and Mcdonald-Kreitman Type Analyses	PLOS ONE			English	Article							ADAPTIVE PROTEIN EVOLUTION; NATURAL-SELECTION; POPULATION-SIZE; FREQUENCY; REVEAL; DRIFT	It is likely that the strength of selection acting upon a mutation varies through time due to changes in the environment. However, most population genetic theory assumes that the strength of selection remains constant. Here we investigate the consequences of fluctuating selection pressures on the quantification of adaptive evolution using McDonald-Kreitman (MK) style approaches. In agreement with previous work, we show that fluctuating selection can generate evidence of adaptive evolution even when the expected strength of selection on a mutation is zero. However, we also find that the mutations, which contribute to both polymorphism and divergence tend, on average, to be positively selected during their lifetime, under fluctuating selection models. This is because mutations that fluctuate, by chance, to positive selected values, tend to reach higher frequencies in the population than those that fluctuate towards negative values. Hence the evidence of positive adaptive evolution detected under a fluctuating selection model by MK type approaches is genuine since fixed mutations tend to be advantageous on average during their lifetime. Never-the-less we show that methods tend to underestimate the rate of adaptive evolution when selection fluctuates.	[Gossmann, Toni I.; Eyre-Walker, Adam] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England; [Gossmann, Toni I.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Waxman, David] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China	University of Sussex; University of Sheffield; Fudan University	Eyre-Walker, A (corresponding author), Univ Sussex, Sch Life Sci, Brighton, E Sussex, England.	a.c.eyre-walker@sussex.ac.uk	Eyre-Walker, Adam/G-6216-2011; Gossmann, Toni/H-6579-2013	Eyre-Walker, Adam/0000-0001-5527-8729; Gossmann, Toni/0000-0001-6609-4116				Bell G, 2010, PHILOS T R SOC B, V365, P87, DOI 10.1098/rstb.2009.0150; Bierne N, 2004, MOL BIOL EVOL, V21, P1350, DOI 10.1093/molbev/msh134; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Charlesworth J, 2006, MOL BIOL EVOL, V23, P1348, DOI 10.1093/molbev/msk025; Eyre-Walker A, 2009, MOL BIOL EVOL, V26, P2097, DOI 10.1093/molbev/msp119; Fay JC, 2001, GENETICS, V158, P1227; FISHER RA, 1947, HEREDITY, V1, P143, DOI 10.1038/hdy.1947.11; Gillespie J, 1991, CAUSES MOL EVOLUTION, V2; GILLESPIE JH, 1973, GENET RES, V21, P115, DOI 10.1017/S001667230001329X; Gossmann TI, 2010, MOL BIOL EVOL, V27, P1822, DOI 10.1093/molbev/msq079; Huerta-Sanchez E, 2008, GENETICS, V178, P325, DOI 10.1534/genetics.107.073361; JENSEN L, 1973, GENET RES, V21, P215, DOI 10.1017/S0016672300013409; KARLIN S, 1974, THEOR POPUL BIOL, V6, P383, DOI 10.1016/0040-5809(74)90017-3; KIMURA M, 1954, GENETICS, V39, P280; LYNCH M, 1987, GENETICS, V115, P657; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; MUELLER LD, 1985, GENETICS, V111, P517; O'Hara RB, 2005, P ROY SOC B-BIOL SCI, V272, P211, DOI 10.1098/rspb.2004.2929; Schneider A, 2011, GENETICS, V189, P1427, DOI 10.1534/genetics.111.131730; Slotte T, 2010, MOL BIOL EVOL, V27, P1813, DOI 10.1093/molbev/msq062; Smith NGC, 2002, NATURE, V415, P1022, DOI 10.1038/4151022a; Strasburg JL, 2011, MOL BIOL EVOL, V28, P1569, DOI 10.1093/molbev/msq270; TAKAHATA N, 1975, P NATL ACAD SCI USA, V72, P4541, DOI 10.1073/pnas.72.11.4541; Waxman D, 2011, GENETICS, V188, P907, DOI 10.1534/genetics.111.129288; Zhang LQ, 2005, MOL BIOL EVOL, V22, P2504, DOI 10.1093/molbev/msi240	26	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84540	10.1371/journal.pone.0084540	http://dx.doi.org/10.1371/journal.pone.0084540			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409303	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000329463500027
J	Liao, JQ; Qian, F; Tchabo, N; Mhawech-Fauceglia, P; Beck, A; Qian, ZK; Wang, XH; Huss, WJ; Lele, SB; Morrison, CD; Odunsi, K				Liao, Jianqun; Qian, Feng; Tchabo, Nana; Mhawech-Fauceglia, Paulette; Beck, Amy; Qian, Zikun; Wang, Xinhui; Huss, Wendy J.; Lele, Shashikant B.; Morrison, Carl D.; Odunsi, Kunle			Ovarian Cancer Spheroid Cells with Stem Cell-Like Properties Contribute to Tumor Generation, Metastasis and Chemotherapy Resistance through Hypoxia-Resistant Metabolism	PLOS ONE			English	Article							CARCINOMA ASCITES SPHEROIDS; IN-VITRO MODEL; PROSTATE-CANCER; PROSPECTIVE IDENTIFICATION; INITIATING CELLS; PROGENITOR CELLS; MASS ISOTOPOMER; GENE-EXPRESSION; INVASION; GROWTH	Cells with sphere forming capacity, spheroid cells, are present in the malignant ascites of patients with epithelial ovarian cancer (EOC) and represent a significant impediment to efficacious treatment due to their putative role in progression, metastasis and chemotherapy resistance. The exact mechanisms that underlie EOC metastasis and drug resistance are not clear. Understanding the biology of sphere forming cells may contribute to the identification of novel therapeutic opportunities for metastatic EOC. Here we generated spheroid cells from human ovarian cancer cell lines and primary ovarian cancer. Xenoengraftment of as few as 2000 dissociated spheroid cells into immune-deficient mice allowed full recapitulation of the original tumor, whereas > 10(5) parent tumor cells remained non-tumorigenic. The spheroid cells were found to be enriched for cells with cancer stem cell-like characteristics such as upregulation of stem cell genes, self-renewal, high proliferative and differentiation potential, and high aldehyde dehydrogenase (ALDH) activity. Furthermore, spheroid cells were more aggressive in growth, migration, invasion, scratch recovery, clonogenic survival, anchorage-independent growth, and more resistant to chemotherapy in vitro. C-13-glucose metabolic studies revealed that spheroid cells route glucose predominantly to anaerobic glycolysis and pentose cycle to the detriment of re-routing glucose for anabolic purposes. These metabolic properties of sphere forming cells appear to confer increased resistance to apoptosis and contribute to more aggressive tumor growth. Collectively, we demonstrated that spheroid cells with cancer stem cell-like characteristics contributed to tumor generation, progression and chemotherapy resistance. This study provides insight into the relationship between tumor dissemination and metabolic attributes of human cancer stem cells and has clinical implications for cancer therapy.	[Liao, Jianqun; Lele, Shashikant B.; Odunsi, Kunle] Roswell Pk Canc Inst, Dept Gynecol Oncol, Buffalo, NY 14263 USA; [Qian, Feng; Odunsi, Kunle] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA; [Qian, Feng; Beck, Amy; Wang, Xinhui; Odunsi, Kunle] Roswell Pk Canc Inst, Ctr Immunotherapy, Buffalo, NY 14263 USA; [Liao, Jianqun] Roswell Pk Canc Inst, Dept Surg Oncol, Buffalo, NY 14263 USA; [Huss, Wendy J.] Roswell Pk Canc Inst, Dept Urol Oncol, Buffalo, NY 14263 USA; [Huss, Wendy J.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA; [Mhawech-Fauceglia, Paulette; Morrison, Carl D.] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA; [Wang, Xinhui] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Surg Oncol, Boston, MA USA; [Tchabo, Nana] Womens Canc Ctr, Atlant Hlth Syst Morristown Overlook Med Ctr, Morristown, NJ USA; Womens Canc Ctr, Atlant Hlth Syst Morristown Overlook Med Ctr, Summit, NJ USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Atlantic Health System; Atlantic Health System	Odunsi, K (corresponding author), Roswell Pk Canc Inst, Dept Gynecol Oncol, Buffalo, NY 14263 USA.	kunle.odunsi@roswellpark.org			Cancer Research Institute Ovarian Cancer; Cancer Vaccine Collaborative Grant of the Cancer Research Institute; Ludwig Institute for Cancer Research; Anna-Maria Kellen Clinical Investigator Award of the Cancer Research Institute; Roswell Park Cancer Institute Alliance Foundation [NIH P30 CA016056, NIH R01CA158318-01A1]; RPCI-UPCI Ovarian Cancer [SPORE P50CA159981-01A1]; NATIONAL CANCER INSTITUTE [P50CA159981, R01CA158318, P30CA016056] Funding Source: NIH RePORTER	Cancer Research Institute Ovarian Cancer; Cancer Vaccine Collaborative Grant of the Cancer Research Institute; Ludwig Institute for Cancer Research; Anna-Maria Kellen Clinical Investigator Award of the Cancer Research Institute; Roswell Park Cancer Institute Alliance Foundation; RPCI-UPCI Ovarian Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by Cancer Research Institute Ovarian Cancer Working Group Grant, Cancer Vaccine Collaborative Grant of the Cancer Research Institute and Ludwig Institute for Cancer Research, Anna-Maria Kellen Clinical Investigator Award of the Cancer Research Institute (to KO), Roswell Park Cancer Institute Alliance Foundation, NIH P30 CA016056; NIH R01CA158318-01A1 and RPCI-UPCI Ovarian Cancer SPORE P50CA159981-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaberg-Jessen C, 2013, INT J CLIN EXP PATHO, V6, P546; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; ALLEN HJ, 1987, EXP CELL BIOL, V55, P194; Armstrong Deborah, 2010, Clin Adv Hematol Oncol, V8, P675; Bapat SA, 2005, CANCER RES, V65, P3025, DOI 10.1158/0008-5472.CAN-04-3931; Bertozzi CC, 2006, IN VITRO CELL DEV-AN, V42, P58; Boros LG, 2002, DRUG DISCOV TODAY, V7, P364, DOI 10.1016/S1359-6446(02)02179-7; Boros LG, 2001, PANCREAS, V23, P141, DOI 10.1097/00006676-200108000-00004; Boros LG, 1998, MED HYPOTHESES, V50, P55, DOI 10.1016/S0306-9877(98)90178-5; Burleson KM, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-6; Burleson KM, 2004, CLIN EXP METASTAS, V21, P685, DOI 10.1007/s10585-004-5768-5; Burleson KM, 2004, GYNECOL ONCOL, V93, P170, DOI 10.1016/j.ygyno.2003.12.034; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Carpentino JE, 2009, CANCER RES, V69, P8208, DOI 10.1158/0008-5472.CAN-09-1132; Charafe-Jauffret E., 2013, CANC RES; Chen CT, 2010, BBA-GEN SUBJECTS, V1800, P257, DOI 10.1016/j.bbagen.2009.09.001; Chiaradonna F, 2012, BIOTECHNOL ADV, V30, P30, DOI 10.1016/j.biotechadv.2011.07.006; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Colombo N, 2006, CRIT REV ONCOL HEMAT, V60, P159, DOI 10.1016/j.critrevonc.2006.03.004; CROUCH SPM, 1993, J IMMUNOL METHODS, V160, P81, DOI 10.1016/0022-1759(93)90011-U; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Hill RP, 2007, JNCI-J NATL CANCER I, V99, P1435, DOI 10.1093/jnci/djm136; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kasho VN, 1996, ALIMENT PHARM THERAP, V10, P985, DOI 10.1046/j.1365-2036.1996.99271000.x; KATZ J, 1989, J BIOL CHEM, V264, P12994; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kondoh H, 2008, EXP CELL RES, V314, P1923, DOI 10.1016/j.yexcr.2008.03.007; L'Esperance S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-99; Lee WNP, 1998, AM J PHYSIOL-ENDOC M, V274, pE843, DOI 10.1152/ajpendo.1998.274.5.E843; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; LIU PP, 2013, CELL DEATH DIFFER; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Luca AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059689; Lyssiotis CA, 2012, CELL DEATH DIS, V3, DOI [10.1038/cddis.2012.41, 10.1038/cddis.2012.75]; Mohle R, 2007, SEMIN HEMATOL, V44, P193, DOI 10.1053/j.seminhematol.2007.04.006; Nakano A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027222; Naora H, 2005, NAT REV CANCER, V5, P355, DOI 10.1038/nrc1611; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Pejovic T, 2009, TRANSL ONCOL, V2, P341, DOI 10.1593/tlo.09199; Prigione A, 2010, STEM CELLS, V28, P721, DOI 10.1002/stem.404; Puiffe ML, 2007, NEOPLASIA, V9, P820, DOI 10.1593/neo.07472; Raamsdonk LM, 2001, NAT BIOTECHNOL, V19, P45, DOI 10.1038/83496; Shepherd TG, 2006, NAT PROTOC, V1, P2643, DOI 10.1038/nprot.2006.328; Shield Kristy, 2007, J Carcinog, V6, P11, DOI 10.1186/1477-3163-6-11; Shield K, 2009, GYNECOL ONCOL, V113, P143, DOI 10.1016/j.ygyno.2008.11.032; van den Hoogen C, 2010, CANCER RES, V70, P5163, DOI 10.1158/0008-5472.CAN-09-3806; Vang S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058226; Vizan P, 2005, CANCER RES, V65, P5512, DOI 10.1158/0008-5472.CAN-05-0074; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Yuan SQ, 2013, STEM CELLS, V31, P23, DOI 10.1002/stem.1273; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364; Zhou YF, 2011, J BIOL CHEM, V286, P32843, DOI 10.1074/jbc.M111.260935; Zietarska M, 2007, MOL CARCINOGEN, V46, P872, DOI 10.1002/mc.20315	59	262	268	9	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84941	10.1371/journal.pone.0084941	http://dx.doi.org/10.1371/journal.pone.0084941			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409314	Green Published, Green Submitted, gold			2022-12-27	WOS:000329463500038
J	Reischl, S; Li, LX; Walkinshaw, G; Flippin, LA; Marti, HH; Kunze, R				Reischl, Stefan; Li, Lexiao; Walkinshaw, Gail; Flippin, Lee A.; Marti, Hugo H.; Kunze, Reiner			Inhibition of HIF prolyl-4-hydroxylases by FG-4497 Reduces Brain Tissue Injury and Edema Formation during Ischemic Stroke	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; ENDOTHELIAL GROWTH-FACTOR; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; PROLYL HYDROXYLASES; ALZHEIMERS-DISEASE; VASCULAR LEAKAGE; NERVOUS-SYSTEM; MOUSE-BRAIN; VEGF; NEUROPROTECTION	Ischemic stroke results in disruption of the blood-brain barrier (BBB), edema formation and neuronal cell loss. Some neuroprotective factors such as vascular endothelial growth factor (VEGF) favor edema formation, while others such as erythropoietin (Epo) can mitigate it. Both factors are controlled by hypoxia inducible transcription factors (HIF) and the activity of prolyl hydroxylase domain proteins (PHD). We hypothesize that activation of the adaptive hypoxic response by inhibition of PHD results in neuroprotection and prevention of vascular leakage. Mice, subjected to cerebral ischemia, were pre- or post-treated with the novel PHD inhibitor FG-4497. Inhibition of PHD activity resulted in HIF-1 alpha stabilization, increased expression of VEGF and Epo, improved outcome from ischemic stroke and reduced edema formation by maintaining BBB integrity. Additional in vitro studies using brain endothelial cells and primary astrocytes confirmed that FG-4497 induces the HIF signaling pathway, leading to increased VEGF and Epo expression. In an in vitro ischemia model, using combined oxygen and glucose deprivation, FG-4497 promoted the survival of neurons. Furthermore, FG-4497 prevented the ischemia-induced rearrangement and gap formation of the tight junction proteins zonula occludens 1 and occludin, both in cultured endothelial cells and in infarcted brain tissue in vivo. These results indicate that FG-4497 has the potential to prevent cerebral ischemic damage by neuroprotection and prevention of vascular leakage.	[Reischl, Stefan; Li, Lexiao; Marti, Hugo H.; Kunze, Reiner] Heidelberg Univ, Inst Physiol & Pathophysiol, Heidelberg, Germany; [Walkinshaw, Gail; Flippin, Lee A.] FibroGen Inc, San Francisco, CA USA	Ruprecht Karls University Heidelberg; FibroGen	Kunze, R (corresponding author), Heidelberg Univ, Inst Physiol & Pathophysiol, Heidelberg, Germany.	reiner.kunze@physiologie.uni-heidelberg.de	Kunze, Reiner/K-8048-2019; Li, Lexiao/AAD-9166-2022; Li, Lexiao/GNP-5634-2022; Li, Lexiao/GQQ-6558-2022	Kunze, Reiner/0000-0002-8428-1027; Li, Lexiao/0000-0002-3693-5452; Reischl, Stefan/0000-0001-7341-4296; Marti, Hugo/0000-0002-8456-334X	Else Kroner-Fresenius-Stiftung [2012_A171]; B. Braun-Stiftung; Friedrich Fischer Nachlass (University of Heidelberg)	Else Kroner-Fresenius-Stiftung; B. Braun-Stiftung; Friedrich Fischer Nachlass (University of Heidelberg)	This work was supported by grants from Else Kroner-Fresenius-Stiftung (2012_A171; RK, HHM), B. Braun-Stiftung (HHM, RK) and Friedrich Fischer Nachlass (University of Heidelberg; RK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonetti DA, 1999, J BIOL CHEM, V274, P23463, DOI 10.1074/jbc.274.33.23463; Baranova O, 2007, J NEUROSCI, V27, P6320, DOI 10.1523/JNEUROSCI.0449-07.2007; Bauer AT, 2010, J CEREBR BLOOD F MET, V30, P837, DOI 10.1038/jcbfm.2009.248; Bernaudin M, 2000, GLIA, V30, P271, DOI 10.1002/(SICI)1098-1136(200005)30:3<271::AID-GLIA6>3.3.CO;2-8; Bernaudin M, 1999, J CEREBR BLOOD F MET, V19, P643, DOI 10.1097/00004647-199906000-00007; Chen RL, 2012, J PHYSIOL-LONDON, V590, P4079, DOI 10.1113/jphysiol.2012.232884; DAVIS JB, 1994, BRAIN RES, V652, P169, DOI 10.1016/0006-8993(94)90334-4; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Erez N, 2004, FEBS LETT, V567, P311, DOI 10.1016/j.febslet.2004.05.003; Esser S, 1998, J CELL SCI, V111, P1853; Fischer S, 1999, AM J PHYSIOL-CELL PH, V276, pC812; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Greenberg DA, 2013, CELL MOL LIFE SCI, V70, P1753, DOI 10.1007/s00018-013-1282-8; Helton R, 2005, J NEUROSCI, V25, P4099, DOI 10.1523/JNEUROSCI.4555-04.2005; Henze AT, 2010, CANCER RES, V70, P357, DOI 10.1158/0008-5472.CAN-09-1876; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Karuppagounder SS, 2012, J CEREBR BLOOD F MET, V32, P1347, DOI 10.1038/jcbfm.2012.28; Kaur C, 2008, CURR NEUROVASC RES, V5, P71, DOI 10.2174/156720208783565645; Kunze R, 2012, STROKE, V43, P2748, DOI 10.1161/STROKEAHA.112.669598; Li Y, 2007, NEUROCHEM RES, V32, P2132, DOI 10.1007/s11064-007-9387-9; Liu K, 2013, J MOL NEUROSCI, V49, P369, DOI 10.1007/s12031-012-9883-5; Martinez-Estrada OM, 2003, EUR J NEUROSCI, V18, P2538, DOI 10.1046/j.1460-9568.2003.02987.x; Milosevic J, 2009, NEUROTOX RES, V15, P367, DOI 10.1007/s12640-009-9043-z; MONTESANO R, 1990, CELL, V62, P435, DOI 10.1016/0092-8674(90)90009-4; Myllyharju J, 2013, BIOL CHEM, V394, P435, DOI 10.1515/hsz-2012-0328; Nagel S, 2011, J CEREBR BLOOD F MET, V31, P132, DOI 10.1038/jcbfm.2010.60; Ogle ME, 2012, NEUROBIOL DIS, V45, P733, DOI 10.1016/j.nbd.2011.10.020; Rabie T, 2008, PHYSIOLOGY, V23, P263, DOI 10.1152/physiol.00016.2008; Rabie T, 2011, INT J DEV NEUROSCI, V29, P655, DOI 10.1016/j.ijdevneu.2011.06.003; Rosenstein JM, 2010, ORGANOGENESIS, V6, P107, DOI 10.4161/org.6.2.11687; Sagare AP, 2013, J ALZHEIMERS DIS, V33, pS87, DOI 10.3233/JAD-2012-129037; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Schneider C, 2009, BRAIN RES, V1280, P43, DOI 10.1016/j.brainres.2009.05.023; Schoch HJ, 2002, BRAIN, V125, P2549, DOI 10.1093/brain/awf257; Siddiq A, 2005, J BIOL CHEM, V280, P41732, DOI 10.1074/jbc.M504963200; Siddiq A, 2007, NEUROCHEM RES, V32, P931, DOI 10.1007/s11064-006-9268-7; Sun FY, 2005, J NEUROSCI RES, V79, P180, DOI 10.1002/jnr.20321; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Valable S, 2005, J CEREBR BLOOD F MET, V25, P1491, DOI 10.1038/sj.jcbfm.9600148; Wang YM, 2005, BRAIN, V128, P52, DOI 10.1093/brain/awh325; Yan JQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027798; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zhao YX, 2011, J CEREBR BLOOD F MET, V31, P1412, DOI 10.1038/jcbfm.2010.230; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001	45	83	89	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84767	10.1371/journal.pone.0084767	http://dx.doi.org/10.1371/journal.pone.0084767			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409307	Green Published, Green Submitted, gold			2022-12-27	WOS:000329463500031
J	Gupta, A; Miegueu, P; Lapointe, M; Poirier, P; Martin, J; Bastien, M; Tiwari, S; Cianflone, K				Gupta, Abhishek; Miegueu, Pierre; Lapointe, Marc; Poirier, Paul; Martin, Julie; Bastien, Marjorie; Tiwari, Sunita; Cianflone, Katherine			Acute Post-Bariatric Surgery Increase in Orexin Levels Associates with Preferential Lipid Profile Improvement	PLOS ONE			English	Article							WEIGHT-LOSS; A LEVELS; PLASMA; OBESITY; LEPTIN; INSULIN; GLUCOSE; SLEEP; HYPOTHALAMUS; NEUROPEPTIDE	Context: Orexin is a recently identified neuropeptide hormone. Objectives: Acute and long-term post-bariatric changes in Orexin and relationship to post-operative metabolic outcomes. Design and Participants: Men and women undergoing biliopancreatic diversion with duodenal switch bariatric surgery (n = 76, BMI >= 35 kg/m(2)) were evaluated for body composition and plasma parameters at baseline, acutely (1 and 5 days) and long-term (6 and 12 months) post-surgery. Setting: University Hospital Centre, Canada. Interventions and Main Outcome Measures: Groups were subdivided based on acute (average 1 and 5 day) changes in Orexin prior to weight loss: (i). 10% Orexin decrease (n = 33, OrexinDEC) and (ii). 10% Orexin increase (n = 20, OrexinINC), to evaluate impact on long-term changes. Results: Both groups had comparable preoperative Orexin levels, BMI, age, sex distribution, diabetes and lipid lowering medication, plasma glucose and lipid parameters except for apolipoproteinB (p < 0.007). Orexin increase was rapid and maintained throughout one year, while OrexinDEC subjects remained significantly lower throughout. Over 12 months, changes in BMI, fat mass, and % fat mass were comparable. Fasting glucose and insulin increased immediately 1-day post-operatively, decreasing rapidly (5-day) and declining thereafter with the OrexinINC group remaining lower than the OrexinDEC group throughout (p = 0.001). Similarly, plasma cholesterol, triglyceride, LDL-C and HDL-C decreased at 1-day, increased slightly (5-day), except HDL-C, then decreased over 1 year, with greater decreases in OrexinINC group relative to OrexinDEC group. Conclusion: Rapid postoperative increases in plasma Orexin are associated with better improvement of glucose and lipid profiles following bariatric surgery.	[Gupta, Abhishek; Miegueu, Pierre; Lapointe, Marc; Poirier, Paul; Martin, Julie; Bastien, Marjorie; Cianflone, Katherine] Univ Laval, Ctr Rech, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Gupta, Abhishek; Tiwari, Sunita] King Georges Med Univ, Dept Physiol, Lucknow, Uttar Pradesh, India; [Poirier, Paul; Martin, Julie; Bastien, Marjorie] Univ Laval, Fac Pharm, Quebec City, PQ, Canada	Laval University; King George's Medical University; Laval University	Cianflone, K (corresponding author), Univ Laval, Ctr Rech, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada.	katherine.cianflone@criucpq.ulaval.ca		Lapointe, Marc/0000-0003-0461-2576	CIHR [77532]; Canadian Institutes for Health Research (CIHR); Obesity Network; CIHR Training Program in Obesity/Healthy Body Weight Research; Centre de Recherche de l'Institut de Cardiologie et de Pneumologie de Quebec(CRIUCPQ)	CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Obesity Network; CIHR Training Program in Obesity/Healthy Body Weight Research(Canadian Institutes of Health Research (CIHR)); Centre de Recherche de l'Institut de Cardiologie et de Pneumologie de Quebec(CRIUCPQ)	This study was supported by a grant from CIHR (#77532 to KC). K. Cianflone holds a Canada Research Chair in Adipose Tissue. PP is a senior clinical researcher of the Fonds de recherche du Quebec - Sante (FRQS). AG is supported by a Postdoctoral HOPE-scholarship from the Canadian Institutes for Health Research (CIHR). PM was supported by a training scholarship (Obesity Network). JM received a scholarship from the CIHR Training Program in Obesity/Healthy Body Weight Research and from the Centre de Recherche de l'Institut de Cardiologie et de Pneumologie de Quebec(CRIUCPQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam JA, 2002, INT J OBESITY, V26, P274, DOI 10.1038/sj.ijo.0801868; Adeghate E, 2012, VITAM HORM, V89, P111, DOI 10.1016/B978-0-12-394623-2.00007-X; Baranowska B, 2005, NEUROENDOCRINOL LETT, V26, P293; Brolin RE, 2002, JAMA-J AM MED ASSOC, V288, P2793, DOI 10.1001/jama.288.22.2793; Bronsky J, 2007, PHYSIOL RES, V56, P89, DOI 10.33549/physiolres.930860; Buchwald H, 2009, AM J MED, V122, P248, DOI 10.1016/j.amjmed.2008.09.041; Cai XJ, 1999, DIABETES, V48, P2132, DOI 10.2337/diabetes.48.11.2132; Campfield LA, 1999, BEST PRACT RES CL EN, V13, P13, DOI 10.1053/beem.1999.0004; Cummings David E., 2004, Journal of Clinical Endocrinology & Metabolism, V89, P2608, DOI 10.1210/jc.2004-0433; Cussons AJ, 2006, ATHEROSCLEROSIS, V185, P227, DOI 10.1016/j.atherosclerosis.2005.10.007; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; de Lecea L, 1999, CELL MOL LIFE SCI, V56, P473, DOI 10.1007/s000180050446; Digby JE, 2006, J ENDOCRINOL, V191, P129, DOI 10.1677/joe.1.06886; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Ganjavi H, 2007, J NEUROPSYCH CLIN N, V19, P413, DOI 10.1176/appi.neuropsych.19.4.413; Hara J, 2005, NEUROSCI LETT, V380, P239, DOI 10.1016/j.neulet.2005.01.046; Haynes AC, 1999, PEPTIDES, V20, P1099, DOI 10.1016/S0196-9781(99)00105-9; Higuchi S, 2002, NEUROSCI LETT, V318, P61, DOI 10.1016/S0304-3940(01)02476-4; Igarashi N, 2003, CHEST, V124, P1381, DOI 10.1378/chest.124.4.1381; Kirchgessner AL, 1999, NEURON, V24, P941, DOI 10.1016/S0896-6273(00)81041-7; Komaki G, 2001, EUR J ENDOCRINOL, V144, P645, DOI 10.1530/eje.0.1440645; Kotz C, 2012, ANN NY ACAD SCI, V1264, P72, DOI 10.1111/j.1749-6632.2012.06585.x; Martin J, 2013, CAN J CARDIOL; Naheed A, 2008, DIAGN MICR INFEC DIS, V61, P381, DOI 10.1016/j.diagmicrobio.2008.03.018; Nambu T, 1999, BRAIN RES, V827, P243, DOI 10.1016/S0006-8993(99)01336-0; O'Brien PE, 2006, OBES SURG, V16, P1032, DOI 10.1381/096089206778026316; Perello M, 2010, BIOL PSYCHIAT, V67, P880, DOI 10.1016/j.biopsych.2009.10.030; Poirier P, 2011, CIRCULATION, V123, P1683, DOI 10.1161/CIR.0b013e3182149099; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Schernthaner G, 2008, DIABETES CARE, V31, pS297, DOI 10.2337/dc08-s270; Shen J, 2008, NEUROSCI LETT, V444, P166, DOI 10.1016/j.neulet.2008.08.031; Shiuchi T, 2009, CELL METAB, V10, P466, DOI 10.1016/j.cmet.2009.09.013; Skrzypski M, 2011, DIABETOLOGIA, V54, P1841, DOI 10.1007/s00125-011-2152-2; Sutcliffe JG, 2002, NAT REV NEUROSCI, V3, P339, DOI 10.1038/nrn808; Tsujino N, 2009, PHARMACOL REV, V61, P162, DOI 10.1124/pr.109.001321; Tsuneki H, 2008, DIABETOLOGIA, V51, P657, DOI 10.1007/s00125-008-0929-8; Tsuneki H, 2010, ACTA PHYSIOL, V198, P335, DOI 10.1111/j.1748-1716.2009.02008.x; Voisin T, 2003, CELL MOL LIFE SCI, V60, P72, DOI 10.1007/s000180300005; Wilson BD, 1999, ENDOCRINOLOGY, V140, P2387, DOI 10.1210/en.140.5.2387; Zhu LY, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/754847	40	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84803	10.1371/journal.pone.0084803	http://dx.doi.org/10.1371/journal.pone.0084803			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400115	gold, Green Published, Green Submitted			2022-12-27	WOS:000329462700049
J	Haddick, PCG; Tom, I; Luis, E; Quinones, G; Wranik, BJ; Ramani, SR; Stephan, JP; Tessier-Lavigne, M; Gonzalez, LC				Haddick, Patrick C. G.; Tom, Irene; Luis, Elizabeth; Quinones, Gabriel; Wranik, Bernd J.; Ramani, Sree R.; Stephan, Jean-Philippe; Tessier-Lavigne, Marc; Gonzalez, Lino C.			Defining the Ligand Specificity of the Deleted in Colorectal Cancer (DCC) Receptor	PLOS ONE			English	Article							COMMISSURAL AXON GUIDANCE; NETRIN RECEPTOR; CBLN FAMILY; SIGNALING PATHWAYS; NERVOUS-SYSTEM; PROTEINS; CUES; MIDLINE; UNC5; IDENTIFICATION	The growth and guidance of many axons in the developing nervous system require Netrin-mediated activation of Deleted in Colorectal Cancer (DCC) and other still unknown signaling cues. Commissural axon guidance defects are more severe in DCC mutant mice than Netrin-1 mutant mice, suggesting additional DCC activating signals besides Netrin-1 are involved in proper axon growth. Here we report that interaction screens on extracellular protein microarrays representing over 1,000 proteins uniquely identified Cerebellin 4 (CBLN4), a member of the C1q-tumor necrosis factor (TNF) family, and Netrin-1 as extracellular DCC-binding partners. Immunofluorescence and radio-ligand binding studies demonstrate that Netrin-1 competes with CBLN4 binding at an overlapping site within the membrane-proximal fibronectin domains (FN) 4-6 of DCC and binds with similar to 5-fold higher affinity. CBLN4 also binds to the DCC homolog, Neogenin-1 (NEO1), but with a lower affinity compared to DCC. CBLN4-null mice did not show a defect in commissural axons of the developing spinal cord but did display a transient increase in the number of wandering axons in the brachial plexus, consistent with a role in axon guidance. Overall, the data solidifies CBLN4 as a bona fide DCC ligand and strengthens its implication in axon guidance.	[Haddick, Patrick C. G.; Tessier-Lavigne, Marc] Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA; [Tom, Irene; Luis, Elizabeth; Quinones, Gabriel; Wranik, Bernd J.; Ramani, Sree R.; Stephan, Jean-Philippe; Gonzalez, Lino C.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Gonzalez, LC (corresponding author), Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA.	gonzalez.lino@gene.com			Genentech, a member of the Roche group	Genentech, a member of the Roche group	All funding for this research was provided by Genentech, a member of the Roche group. The funder did have roles in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Ahmed G, 2011, J NEUROSCI, V31, P14018, DOI 10.1523/JNEUROSCI.0943-11.2011; Bai G, 2011, CELL, V144, P106, DOI 10.1016/j.cell.2010.11.053; Bonanomi D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001735; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Chedotal A, 2011, CURR OPIN NEUROBIOL, V21, P68, DOI 10.1016/j.conb.2010.07.008; Chen Q, 2012, J CELL SCI; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; De Vries M, 2008, J NEUROCHEM, V106, P1483, DOI 10.1111/j.1471-4159.2008.05485.x; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Engelkamp D, 2002, MECH DEVELOP, V118, P191, DOI 10.1016/S0925-4773(02)00248-4; Evans TA, 2010, CURR OPIN NEUROBIOL, V20, P79, DOI 10.1016/j.conb.2009.12.006; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Geisbrecht BV, 2003, J BIOL CHEM, V278, P32561, DOI 10.1074/jbc.M302943200; Gonzalez LC, 2012, METHODS, V57, P448, DOI 10.1016/j.ymeth.2012.06.004; Gu WXW, 2010, DEV DYNAM, V239, P2246, DOI 10.1002/dvdy.22357; Jaworski A, 2010, J NEUROSCI, V30, P9445, DOI 10.1523/JNEUROSCI.6290-09.2010; Joo JY, 2011, BIOCHEM BIOPH RES CO, V406, P627, DOI 10.1016/j.bbrc.2011.02.108; Karaulanov E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005742; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Kruger RP, 2004, J NEUROSCI, V24, P10826, DOI 10.1523/JNEUROSCI.3715-04.2004; Lobito AA, 2011, J BIOL CHEM, V286, P18969, DOI 10.1074/jbc.M111.224626; Matsuda K, 2011, EUR J NEUROSCI, V33, P1447, DOI 10.1111/j.1460-9568.2011.07638.x; Matsuda K, 2010, SCIENCE, V328, P363, DOI 10.1126/science.1185152; Miura E, 2006, EUR J NEUROSCI, V24, P750, DOI 10.1111/j.1460-9568.2006.04950.x; MUNSON PJ, 1983, SCIENCE, V220, P979, DOI 10.1126/science.6302842; Nawabi H, 2011, CELL MOL LIFE SCI, V68, P2539, DOI 10.1007/s00018-011-0691-9; Ramani SR, 2012, ANAL BIOCHEM, V420, P127, DOI 10.1016/j.ab.2011.09.017; Rong YQ, 2012, J NEUROCHEM, V120, P528, DOI 10.1111/j.1471-4159.2011.07604.x; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Sollner C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r99; Sun KLW, 2011, DEVELOPMENT, V138, P2153, DOI 10.1242/dev.044529; Sun Y, 2012, ANAL BIOCHEM, V424, P45, DOI 10.1016/j.ab.2012.01.034; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tom Irene, 2013, Curr Protoc Protein Sci, VChapter 27, DOI 10.1002/0471140864.ps2703s72; Wei P, 2012, J NEUROCHEM, V121, P717, DOI 10.1111/j.1471-4159.2012.07648.x; Yamagishi S, 2011, EMBO J, V30, P2920, DOI 10.1038/emboj.2011.189; Yang L, 2009, SCIENCE, V324, P944, DOI 10.1126/science.1171320; Yuzaki M, 2008, CELL MOL LIFE SCI, V65, P1698, DOI 10.1007/s00018-008-7550-3; Zhang SB, 2010, NEUROSCI RES, V66, P53, DOI 10.1016/j.neures.2009.09.1710; Zou YM, 2007, CURR OPIN NEUROBIOL, V17, P22, DOI 10.1016/j.conb.2007.01.006	41	38	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84823	10.1371/journal.pone.0084823	http://dx.doi.org/10.1371/journal.pone.0084823			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400119	gold, Green Published, Green Submitted			2022-12-27	WOS:000329462700053
J	Coustham, V; Vlad, D; Deremetz, A; Gy, I; Cubillos, FA; Kerdaffrec, E; Loudet, O; Bouche, N				Coustham, Vincent; Vlad, Daniela; Deremetz, Aurelie; Gy, Isabelle; Cubillos, Francisco A.; Kerdaffrec, Envel; Loudet, Olivier; Bouche, Nicolas			SHOOT GROWTH1 Maintains Arabidopsis Epigenomes by Regulating IBM1	PLOS ONE			English	Article							DNA METHYLATION; JMJC DOMAIN; HISTONE DEMETHYLASE; THALIANA; MUTANTS; METHYLTRANSFERASE; HETEROCHROMATIN; BINDING; PROTEIN; PATTERNS	Maintaining correct DNA and histone methylation patterns is essential for the development of all eukaryotes. In Arabidopsis, we identified SHOOT GROWTH1 (SG1), a novel protein involved in the control of gene methylation. SG1 contains both a Bromo-Adjacent Homology (BAH) domain found in several chromatin regulators and an RNA-Recognition Motif (RRM). The sg1 mutations are associated with drastic pleiotropic phenotypes. The mutants degenerate after few generations and are similar to mutants of the histone demethylase INCREASE IN BONSAI METHYLATION1 (IBM1). A methylome analysis of sg1 mutants revealed a large number of gene bodies hypermethylated in the cytosine CHG context, associated with an increase in di-methylation of lysine 9 on histone H3 tail (H3K9me2), an epigenetic mark normally found in silenced transposons. The sg1 phenotype is suppressed by mutations in genes encoding the DNA methyltransferase CHROMOMETHYLASE3 (CMT3) or the histone methyltransferase KRYPTONITE (KYP), indicating that SG1 functions antagonistically to CMT3 or KYP. We further show that the IBM1 transcript is not correctly processed in sg1, and that the functional IBM1 transcript complements sg1. Altogether, our results suggest a function for SG1 in the maintenance of genome integrity by regulating IBM1.	[Coustham, Vincent; Vlad, Daniela; Deremetz, Aurelie; Gy, Isabelle; Cubillos, Francisco A.; Kerdaffrec, Envel; Loudet, Olivier; Bouche, Nicolas] INRA, UMR1318, Inst Jean Pierre Bourgin, RD10, F-78026 Versailles, France; [Coustham, Vincent; Vlad, Daniela; Deremetz, Aurelie; Gy, Isabelle; Cubillos, Francisco A.; Kerdaffrec, Envel; Loudet, Olivier; Bouche, Nicolas] AgroParisTech, Inst Jean Pierre Bourgin, RD10, Versailles, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Loudet, O (corresponding author), INRA, UMR1318, Inst Jean Pierre Bourgin, RD10, F-78026 Versailles, France.	Olivier.Loudet@versailles.inra.fr; Nicolas.Bouche@versailles.inra.fr	Coustham, Vincent/C-1836-2014; Coustham, Vincent/GON-4976-2022; Loudet, Olivier/K-8266-2012; Loudet, Olivier/CAF-7559-2022; Cubillos, Francisco/G-5195-2019	Coustham, Vincent/0000-0002-5399-2723; Coustham, Vincent/0000-0002-5399-2723; Loudet, Olivier/0000-0003-3717-0137; Kerdaffrec, Envel/0000-0001-8667-6850; Bouche, Nicolas/0000-0002-3800-2613; Cubillos, Francisco/0000-0003-3022-469X	BAP INRA division; Marie Curie European Reintegration Grant [FP7-PERG08-GA-2010-277068]; ANR [11-JSV7-0013]; European Commission ['AGRON-OMICS'/LSHG-CT-2006-037704, 'ARABRAS'/ANR-06-ERAPG-003-01]; European Commission Framework Programme 7, ERC Starting Grant ['DECODE'/ERC-2009-StG-243359]	BAP INRA division; Marie Curie European Reintegration Grant(European Commission); ANR(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre); European Commission Framework Programme 7, ERC Starting Grant	VC was supported by the BAP INRA division and a Marie Curie European Reintegration Grant (FP7-PERG08-GA-2010-277068) to NB and OL. The authors acknowledge funding from ANR (Project 11-JSV7-0013) to NB. DV was supported by funding from the European Commission Framework Programme 6, Integrated Project 'AGRON-OMICS'/LSHG-CT-2006-037704 to OL. EK was supported by funding from ANR grant 'ARABRAS'/ANR-06-ERAPG-003-01 to OL. FC was supported by funding from the European Commission Framework Programme 7, ERC Starting Grant 'DECODE'/ERC-2009-StG-243359 to OL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agorio A, 2007, PLANT CELL, V19, P3778, DOI 10.1105/tpc.107.054494; Angel A, 2011, NATURE, V476, P105, DOI 10.1038/nature10241; Du JM, 2012, CELL, V151, P167, DOI 10.1016/j.cell.2012.07.034; Ebbs ML, 2006, PLANT CELL, V18, P1166, DOI 10.1105/tpc.106.041400; Fan D, 2012, NUCLEIC ACIDS RES, V40, P8905, DOI 10.1093/nar/gks647; Huff JT, 2012, CURR OPIN GENET DEV, V22, P132, DOI 10.1016/j.gde.2012.01.007; Inagaki S, 2010, EMBO J, V29, P3496, DOI 10.1038/emboj.2010.227; Johnson LM, 2007, CURR BIOL, V17, P379, DOI 10.1016/j.cub.2007.01.009; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kankel MW, 2003, GENETICS, V163, P1109; Kuo AJ, 2012, NATURE, V484, P115, DOI 10.1038/nature10956; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu XC, 2012, PLANT PHYSIOL, V158, P119, DOI 10.1104/pp.111.184275; Loudet O, 2005, THEOR APPL GENET, V110, P742, DOI 10.1007/s00122-004-1900-9; Mathieu O, 2005, EMBO J, V24, P2783, DOI 10.1038/sj.emboj.7600743; Miura A, 2009, EMBO J, V28, P1078, DOI 10.1038/emboj.2009.59; Rigal M, 2012, EMBO J, V31, P2981, DOI 10.1038/emboj.2012.141; Sasaki T, 2012, PLANT J, V70, P750, DOI 10.1111/j.1365-313X.2012.04911.x; Saze H, 2008, SCIENCE, V319, P462, DOI 10.1126/science.1150987; Saze H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3301; Schiex T., 2001, LNCS, P111, DOI [10.1007/3-540-45727-5_10, DOI 10.1007/3-540-45727-5_10]; Simon M, 2008, GENETICS, V178, P2253, DOI 10.1534/genetics.107.083899; Stroud H, 2013, CELL, V152, P352, DOI 10.1016/j.cell.2012.10.054; Vlad D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000945; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Wang XG, 2013, P NATL ACAD SCI USA, V110, P15467, DOI 10.1073/pnas.1315399110; Zemach A, 2013, CELL, V153, P193, DOI 10.1016/j.cell.2013.02.033	29	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84687	10.1371/journal.pone.0084687	http://dx.doi.org/10.1371/journal.pone.0084687			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404182	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460800061
J	Nunes, ERD; Zukurov, JP; Maricato, JT; Sucupira, MCA; Diaz, RS; Janini, LMR				De Morais Nunes, Edsel Renata; Zukurov, Jean Paulo; Maricato, Juliana Terzi; Araripe Sucupira, Maria Cecilia; Diaz, Ricardo Sobhie; Ramos Janini, Luiz Mario			Analysis of HIV-1 Protease Gene Reveals Frequent Multiple Infections Followed by Recombination among Drug Treated Individuals Living in Sao Paulo and Santos, Brazil	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DUAL INFECTIONS; SUBTYPE-C; GENOME SEQUENCES; RAKAI DISTRICT; SEX WORKERS; VIRAL LOAD; SUPERINFECTION; IDENTIFICATION; EPIDEMIC	The present study investigated the prevalence of HIV-1 multiple infections in a population composed by 47 patients under HAART failure and enrolled at the National DST/AIDS, Program, Ministry of Health, Brazil. Detection of multiple infections was done using a previously published RFLP assay for the HIV-1 protease gene, which is able of distinguishing between infections caused by a single or multiple HIV-1 subtypes. Samples with multiple infections were cloned, and sequence data submitted to phylogenetic analysis. We were able to identify 17 HIV-1 multiple infections out of 47 samples. Multiple infections were mostly composed by a mixture of recombinant viruses (94%), with only one case in which protease gene pure subtypes B and F were recovered. This is the first study that reports the prevalence of multiple infections and intersubtype recombinants in a population undergoing HAART in Brazil. Based on the data there was a steep increase of multiple infections after the introduction of the combined antiretroviral therapy in Brazil. Cases of multiple infections may be associated with HIV-1 genetic diversity through recombination allowing for the generation of viruses showing a combination of resistance mutations.	[De Morais Nunes, Edsel Renata; Zukurov, Jean Paulo; Araripe Sucupira, Maria Cecilia; Diaz, Ricardo Sobhie; Ramos Janini, Luiz Mario] Univ Fed Sao Paulo, Dept Med, Sao Paulo, Brazil; [Maricato, Juliana Terzi; Ramos Janini, Luiz Mario] Univ Fed Sao Paulo, Dept Microbiol Immunol & Parasitol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Nunes, ERD (corresponding author), Univ Fed Sao Paulo, Dept Med, Sao Paulo, Brazil.	edselmorais@gmail.com	Maricato, Juliana/F-1608-2012; Araripe Sucupira, Maria Cecilia/K-1931-2012	Janini, Luiz Mario/0000-0002-6186-6284; Araripe Sucupira, Maria Cecilia/0000-0002-1114-5382	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Foundation for the Support of Research in the State of Sao Paulo) [2009/10915-0, 2009/11216-9]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Foundation for the Support of Research in the State of Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Foundation for the Support of Research in the State of Sao Paulo; grant numbers 2009/10915-0 and 2009/11216-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreani G, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-392; ARTENSTEIN AW, 1995, J INFECT DIS, V171, P805, DOI 10.1093/infdis/171.4.805; Becker-Pergola G, 2000, AIDS RES HUM RETROV, V16, P1099, DOI 10.1089/088922200414938; Blackard JT, 2002, CLIN INFECT DIS, V34, P1108, DOI 10.1086/339547; Brenner B, 2004, AIDS, V18, P1653, DOI 10.1097/01.aids.0000131377.28694.04; Buonaguro L, 2007, J VIROL, V81, P10209, DOI 10.1128/JVI.00872-07; Campbell MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005690; Chakraborty B, 2004, AIDS, V18, P132, DOI 10.1097/01.aids.0000096893.73209.0e; Chohan B, 2005, J VIROL, V79, P10701, DOI 10.1128/JVI.79.16.10701-10708.2005; Clerc O, 2010, J CLIN VIROL, V47, P376, DOI 10.1016/j.jcv.2010.01.013; De Sa DJ, 2005, AIDS RES HUM RETROV, V21, P145, DOI 10.1089/aid.2005.21.145; De Sa DJ, 2006, AIDS RES HUM RETROV, V22, P1; de Sa DJ, 2009, AIDS RES HUM RETROV, V25, P925, DOI 10.1089/aid.2009.0073; DIAZ RS, 1995, J VIROL, V69, P3273, DOI 10.1128/JVI.69.6.3273-3281.1995; Dowling WE, 2002, AIDS, V16, P1809, DOI 10.1097/00002030-200209060-00015; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fang GW, 2004, AIDS, V18, P153, DOI 10.1097/00002030-200401230-00003; Fonjungo PN, 2002, J CLIN MICROBIOL, V40, P837, DOI 10.1128/JCM.40.3.837-845.2002; Fung ICH, 2010, MATH BIOSCI, V224, P1, DOI 10.1016/j.mbs.2009.11.007; Gale CV, 2006, AIDS RES HUM RETROV, V22, P985, DOI 10.1089/aid.2006.22.985; Gerhardt M, 2005, J VIROL, V79, P8249, DOI 10.1128/JVI.79.13.8249-8261.2005; Gottlieb GS, 2004, LANCET, V363, P619, DOI 10.1016/S0140-6736(04)15596-7; Grobler J, 2004, J INFECT DIS, V190, P1355, DOI 10.1086/423940; Guimaraes ML, 2008, AIDS, V22, P433, DOI 10.1097/QAD.0b013e3282f47ad0; Guimaraes ML, 2010, INFECT GENET EVOL, V10, P1094, DOI 10.1016/j.meegid.2010.07.001; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harris ME, 2002, AIDS RES HUM RETROV, V18, P1281, DOI 10.1089/088922202320886325; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Herbinger KH, 2006, AIDS RES HUM RETROV, V22, P599, DOI 10.1089/aid.2006.22.599; Hoelscher M, 2002, AIDS, V16, P2055, DOI 10.1097/00002030-200210180-00011; Hu DJ, 2005, AIDS, V19, P303; Janini LM, 1998, J INFECT DIS, V177, P227, DOI 10.1086/517360; Janini LM, 1996, VIRUS GENES, V13, P69, DOI 10.1007/BF00576981; JANINI LMR, 1995, 2 NAT C HUM RETR REL; Jost S, 2002, NEW ENGL J MED, V347, P731, DOI 10.1056/NEJMoa020263; Jurriaans S, 2008, JAIDS-J ACQ IMM DEF, V47, P69, DOI 10.1097/QAI.0b013e3181582d6f; Kiwanuka N, 2010, JAIDS-J ACQ IMM DEF, V54, P180, DOI 10.1097/QAI.0b013e3181c98fc0; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Manigart O, 2004, AIDS, V18, P1645, DOI 10.1097/01.aids.0000131333.30548.db; Masciotra S, 2000, AIDS RES HUM RETROV, V16, P1007, DOI 10.1089/08892220050058425; NDEMBI N, 2011, J ACQ IMMUN DEF SYND, V57, P2; Nkengasong JN, 2000, J ACQ IMMUN DEF SYND, V23, P430; Osmanov S, 2002, J ACQ IMMUN DEF SYND, V29, P184, DOI 10.1097/00042560-200202010-00013; Pando MA, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-58; Peeters M, 2000, AIDS, V14, pS129; Piantadosi A, 2007, PLOS PATHOG, V3, P1745, DOI 10.1371/journal.ppat.0030177; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Powell RLR, 2009, JAIDS-J ACQ IMM DEF, V50, P84, DOI 10.1097/QAI.0b013e31818d5a40; Ramos A, 1999, EMERG INFECT DIS, V5, P65, DOI 10.3201/eid0501.990108; Ramos A, 2002, J VIROL, V76, P7444, DOI 10.1128/JVI.76.15.7444-7452.2002; Sa DJ, 2003, J CLIN VIROL, V28, P186, DOI 10.1016/S1386-6532(03)00007-6; SAMPATHKUMAR R, 2012, ADV VIROL, V2012, P1; Sanabani SS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-74; Santos AF, 2006, AIDS, V20, P2011; Smith DM, 2006, VIROLOGY, V355, P1, DOI 10.1016/j.virol.2006.08.009; Smith DM, 2005, AIDS, V19, P1251, DOI 10.1097/01.aids.0000180095.12276.ac; Smith DM, 2005, J INFECT DIS, V192, P438, DOI 10.1086/431682; Smith DM, 2004, JAMA-J AM MED ASSOC, V292, P1177, DOI 10.1001/jama.292.10.1177; Ssemwanga D, 2011, VIROLOGY, V411, P113, DOI 10.1016/j.virol.2010.12.025; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tebit DM, 2011, LANCET INFECT DIS, V11, P45, DOI 10.1016/S1473-3099(10)70186-9; Templeton AR, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-54; Thomson MM, 2004, AIDS RES HUM RETROV, V20, P1126, DOI 10.1089/aid.2004.20.1126; UNAIDS, 2013, REP GLOB AIDS EP; van der Kuyl AC, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-67; van der Kuyl AC, 2011, AIDS RES HUM RETROV, V27, P429, DOI 10.1089/aid.2010.0175; VANDERKUYL AC, 2005, NEW ENGL J MED, V352, P24; Vijay NNV, 2008, J GEN VIROL, V89, P1467, DOI 10.1099/vir.0.83668-0; Yerly S, 2004, AIDS, V18, P1413, DOI 10.1097/01.aids.0000131330.28762.0c; 2013, HIV SEQ DAT	72	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84066	10.1371/journal.pone.0084066	http://dx.doi.org/10.1371/journal.pone.0084066			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404149	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460800028
J	Stoll, S; Kail, J; Lorenz, AW; Sundermann, A; Haase, P				Stoll, Stefan; Kail, Jochem; Lorenz, Armin W.; Sundermann, Andrea; Haase, Peter			The Importance of the Regional Species Pool, Ecological Species Traits and Local Habitat Conditions for the Colonization of Restored River Reaches by Fish	PLOS ONE			English	Article							HYDROMORPHOLOGICAL RESTORATION; STREAM HABITAT; LAND-USE; DIVERSITY; RECOVERY; REHABILITATION; FRAGMENTATION; HETEROGENEITY; COMMUNITIES; ASSEMBLAGES	It is commonly assumed that the colonization of restored river reaches by fish depends on the regional species pools; however, quantifications of the relationship between the composition of the regional species pool and restoration outcome are lacking. We analyzed data from 18 German river restoration projects and adjacent river reaches constituting the regional species pools of the restored reaches. We found that the ability of statistical models to describe the fish assemblages established in the restored reaches was greater when these models were based on 'biotic' variables relating to the regional species pool and the ecological traits of species rather than on 'abiotic' variables relating to the hydromorphological habitat structure of the restored habitats and descriptors of the restoration projects. For species presence in restored reaches, 'biotic' variables explained 34% of variability, with the occurrence rate of a species in the regional species pool being the most important variable, while 'abiotic' variables explained only the negligible amount of 2% of variability. For fish density in restored reaches, about twice the amount of variability was explained by 'biotic' (38%) compared to 'abiotic' (21%) variables, with species density in the regional species pool being most important. These results indicate that the colonization of restored river reaches by fish is largely determined by the assemblages in the surrounding species pool. Knowledge of species presence and abundance in the regional species pool can be used to estimate the likelihood of fish species becoming established in restored reaches.	[Stoll, Stefan; Sundermann, Andrea; Haase, Peter] Senckenberg Res Inst, Dept River Ecol & Conservat, Gelnhausen, Germany; [Stoll, Stefan; Sundermann, Andrea; Haase, Peter] Nat Hist Museum, Gelnhausen, Germany; [Stoll, Stefan; Haase, Peter] Biodivers & Climate Res Ctr, Frankfurt, Germany; [Kail, Jochem] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Biol & Ecol Fishes, Berlin, Germany; [Kail, Jochem; Lorenz, Armin W.] Univ Duisburg Essen, Dept Aquat Ecol, Essen, Germany	Senckenberg Gesellschaft fur Naturforschung (SGN); Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); University of Duisburg Essen	Stoll, S (corresponding author), Senckenberg Res Inst, Dept River Ecol & Conservat, Gelnhausen, Germany.	stefan.stoll@senckenberg.de	Stoll, Stefan/D-5278-2011; Haase, Peter/A-5644-2011; Sundermann, Andrea/A-2938-2009	Stoll, Stefan/0000-0002-3656-417X; Sundermann, Andrea/0000-0003-2304-1967	Deutsche Bundesstiftung Umwelt [FK 25032-33/2]; Hesse's Ministry of Environment [FK III 2-79i 02]; Hesse's Ministry of Higher Education, Research, and the Arts (BiK-F: Biodiversitat und Klima Forschungszentrum)	Deutsche Bundesstiftung Umwelt; Hesse's Ministry of Environment; Hesse's Ministry of Higher Education, Research, and the Arts (BiK-F: Biodiversitat und Klima Forschungszentrum)	This study was financially supported by Deutsche Bundesstiftung Umwelt (FK 25032-33/2), Hesse's Ministry of Environment (FK III 2-79i 02), and the research funding program 'LOEWE - Landes-Offensive zur Entwicklung Wissenschaftlich-oekonomischer Exzellenz' of Hesse's Ministry of Higher Education, Research, and the Arts (BiK-F: Biodiversitat und Klima Forschungszentrum). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese B, 2009, FRESHWATER BIOL, V54, P1444, DOI 10.1111/j.1365-2427.2009.02194.x; Allan JD, 2004, ANNU REV ECOL EVOL S, V35, P257, DOI 10.1146/annurev.ecolsys.35.120202.110122; [Anonymous], [No title captured]; Araki H, 2010, AQUACULTURE, V308, pS2, DOI 10.1016/j.aquaculture.2010.05.036; Bernhardt ES, 2011, ECOL APPL, V21, P1926, DOI 10.1890/10-1574.1; Clewell A, 1997, RESTOR ECOL, V5, P350, DOI 10.1046/j.1526-100X.1997.00548.x; COPP GH, 1989, ENVIRON BIOL FISH, V26, P1, DOI 10.1007/BF00002472; COPP GH, 1992, ENVIRON BIOL FISH, V33, P181, DOI 10.1007/BF00002563; CORNELL HV, 1992, J ANIM ECOL, V61, P1, DOI 10.2307/5503; DETENBECK NE, 1992, ENVIRON MANAGE, V16, P33, DOI 10.1007/BF02393907; Donaldson JA, 2013, FRESHWATER BIOL, V58, P1038, DOI 10.1111/fwb.12107; Dussling U, 2009, HDB FIBS; Dussling U, 2004, VERBUNDPROJEKT ERFOR; Fagan WF, 2002, ECOLOGY, V83, P3243, DOI 10.2307/3072074; GORE JA, 1990, ENVIRON MANAGE, V14, P737, DOI 10.1007/BF02394722; Gotelli NJ, 1999, EVOL ECOL RES, V1, P835; Grenouillet G., 2006, FISH INDICATOR DATAB; Haase P, 2013, HYDROBIOLOGIA, V704, P475, DOI 10.1007/s10750-012-1255-1; Hamilton J. B., 1989, PRACTICAL APPROACHES, P149; Hanski I, 1999, METAPOPULATION ECOLO; Huxel GR, 1999, RESTOR ECOL, V7, P309, DOI 10.1046/j.1526-100X.1999.72024.x; Jahnig SC, 2011, ECOL APPL, V21, P2007, DOI 10.1890/10-0618.1; Jahnig SC, 2013, HYDROBIOLOGIA, V712, P89, DOI 10.1007/s10750-012-1264-0; Kail J, 2007, J APPL ECOL, V44, P1145, DOI 10.1111/j.1365-2664.2007.01401.x; Kail J, 2009, RIVER RES APPL, V25, P537, DOI 10.1002/rra.1238; Kamp U, 2007, ENVIRON MONIT ASSESS, V127, P209, DOI 10.1007/s10661-006-9274-x; KONDOLF GM, 1995, RESTOR ECOL, V3, P133, DOI 10.1111/j.1526-100X.1995.tb00086.x; Kottelat M., 2007, HDB EUROPEAN FRESHWA, P646; Kucera-Hirzinger V, 2009, AQUAT SCI, V71, P94, DOI 10.1007/s00027-008-8110-5; Lake PS, 2007, FRESHWATER BIOL, V52, P597, DOI 10.1111/j.1365-2427.2006.01709.x; Leavy TR, 2009, N AM J FISH MANAGE, V29, P72, DOI 10.1577/M07-040.1; Lepori F, 2005, ECOL APPL, V15, P2060, DOI 10.1890/04-1372; Lorenz AW, 2013, HYDROBIOLOGIA, V704, P489, DOI 10.1007/s10750-012-1326-3; Lorenz AW, ECOLOGICAL ENG; Louca V, 2009, ECOL FRESHW FISH, V18, P60, DOI 10.1111/j.1600-0633.2008.00323.x; Neumann RM, 2002, ECOL FRESHW FISH, V11, P240, DOI 10.1034/j.1600-0633.2002.00016.x; Palmer MA, 1997, RESTOR ECOL, V5, P291, DOI 10.1046/j.1526-100X.1997.00543.x; Palmer MA, 2010, FRESHWATER BIOL, V55, P205, DOI 10.1111/j.1365-2427.2009.02372.x; POFF NL, 1995, ECOLOGY, V76, P606, DOI 10.2307/1941217; Poff NL, 1997, J N AM BENTHOL SOC, V16, P391, DOI 10.2307/1468026; Pretty JL, 2003, J APPL ECOL, V40, P251, DOI 10.1046/j.1365-2664.2003.00808.x; R Development Core Team, 2011, LANG ENV STAT COMP; Radinger J., 2013, FISH FISH, P1; Rahel FJ, 2002, ANNU REV ECOL SYST, V33, P291, DOI 10.1146/annurev.ecolsys.33.010802.150429; Reynolds James B., 1996, P221; Ricciardi A, 2009, TRENDS ECOL EVOL, V24, P248, DOI 10.1016/j.tree.2008.12.006; Roni P, 2008, N AM J FISH MANAGE, V28, P856, DOI 10.1577/M06-169.1; SCHLOSSER IJ, 1995, ECOLOGY, V76, P908, DOI 10.2307/1939356; Starrs D, 2011, FISHERIES MANAG ECOL, V18, P360, DOI 10.1111/j.1365-2400.2011.00788.x; Stoll S, 2008, J FISH BIOL, V72, P1001, DOI 10.1111/j.1095-8649.2007.01780.x; Stoll S, 2013, FRESHWATER BIOL, V58, P664, DOI 10.1111/fwb.12068; Sundermann A, 2011, ECOL APPL, V21, P1962, DOI 10.1890/10-0607.1; Sundermann A, 2011, FRESHWATER BIOL, V56, P1689, DOI 10.1111/j.1365-2427.2011.02599.x; Templeton CN, 2004, BEHAV ECOL, V15, P673, DOI 10.1093/beheco/arh065; Vitt P, 2009, TRENDS ECOL EVOL, V24, P473, DOI 10.1016/j.tree.2009.05.007; Wang LZ, 2001, ENVIRON MANAGE, V28, P255, DOI 10.1007/s0026702409; Weber C, 2009, RIVER RES APPL, V25, P687, DOI 10.1002/rra.1176; Willis SC, 2005, OECOLOGIA, V142, P284, DOI 10.1007/s00442-004-1723-z	58	52	52	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84741	10.1371/journal.pone.0084741	http://dx.doi.org/10.1371/journal.pone.0084741			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404187	Green Published, Green Submitted, gold			2022-12-27	WOS:000329460800066
J	Killer, SC; Blannin, AK; Jeukendrup, AE				Killer, Sophie C.; Blannin, Andrew K.; Jeukendrup, Asker E.			No Evidence of Dehydration with Moderate Daily Coffee Intake: A Counterbalanced Cross-Over Study in a Free-Living Population	PLOS ONE			English	Article							EXERCISE PERFORMANCE; CAFFEINE; HYDRATION; FLUID; WATER; BEVERAGES; INGESTION	It is often suggested that coffee causes dehydration and its consumption should be avoided or significantly reduced to maintain fluid balance. The aim of this study was to directly compare the effects of coffee consumption against water ingestion across a range of validated hydration assessment techniques. In a counterbalanced cross-over design, 50 male coffee drinkers (habitually consuming 3-6 cups per day) participated in two trials, each lasting three consecutive days. In addition to controlled physical activity, food and fluid intake, participants consumed either 4x200 mL of coffee containing 4 mg/kg caffeine (C) or water (W). Total body water (TBW) was calculated pre- and post-trial via ingestion of Deuterium Oxide. Urinary and haematological hydration markers were recorded daily in addition to nude body mass measurement (BM). Plasma was analysed for caffeine to confirm compliance. There were no significant changes in TBW from beginning to end of either trial and no differences between trials (51.5+/-1.4 vs. 51.4+/-1.3 kg, for C and W, respectively). No differences were observed between trials across any haematological markers or in 24 h urine volume (2409+/-660 vs. 2428+/-669 mL, for C and W, respectively), USG, osmolality or creatinine. Mean urinary Na+ excretion was higher in C than W (p = 0.02). No significant differences in BM were found between conditions, although a small progressive daily fall was observed within both trials (0.4+/-0.5 kg; p<0.05). Our data show that there were no significant differences across a wide range of haematological and urinary markers of hydration status between trials. These data suggest that coffee, when consumed in moderation by caffeine habituated males provides similar hydrating qualities to water.	[Killer, Sophie C.; Blannin, Andrew K.; Jeukendrup, Asker E.] Univ Birmingham, Sch Sport & Exercise Sci, Birmingham, W Midlands, England	University of Birmingham	Blannin, AK (corresponding author), Univ Birmingham, Sch Sport & Exercise Sci, Birmingham, W Midlands, England.	A.K.Blannin@bham.ac.uk			Institute for Scientific Information on Coffee (ISIC)	Institute for Scientific Information on Coffee (ISIC)	Funding for this study was provided by the Institute for Scientific Information on Coffee (ISIC). ISIC is a non-profit organisation, devoted to the study and disclosure of science related to coffee and health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostoni C, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1459; Armstrong LE, 2005, INT J SPORT NUTR EXE, V15, P252, DOI 10.1123/ijsnem.15.3.252; Bellisle F, 2010, EUR J CLIN NUTR, V64, P350, DOI 10.1038/ejcn.2010.4; Bird ET, 2005, NEUROUROL URODYNAM, V24, P611, DOI 10.1002/nau.20179; Currell K, 2008, APPL PHYSIOL NUTR ME, V33, P1067, DOI 10.1139/H08-084; Debry G, 1994, COFFEE HLTH; DODD SL, 1993, SPORTS MED, V15, P14, DOI 10.2165/00007256-199315010-00003; DORFMAN LJ, 1970, CLIN PHARMACOL THER, V11, P869; EDDY NATHAN B., 1928, JOUR PHARMACOL & EXP THERAPEUT, V33, P167; FISHER SM, 1986, INT J SPORTS MED, V7, P276, DOI 10.1055/s-2008-1025774; Fredholm B B, 1984, Prog Clin Biol Res, V158, P303; Graham TE, 1998, J APPL PHYSIOL, V85, P883, DOI 10.1152/jappl.1998.85.3.883; Grandjean AC, 2000, J AM COLL NUTR, V19, P591, DOI 10.1080/07315724.2000.10718956; Hodgson AB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059561, 10.1371/journal.pone.0079556]; IOM (Institute of medicine), 2004, DIET REF INT WAT POT; Jequier E, 2010, EUR J CLIN NUTR, V64, P115, DOI 10.1038/ejcn.2009.111; Kleiner SM, 1999, J AM DIET ASSOC, V99, P200, DOI 10.1016/S0002-8223(99)00048-6; Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203; Lote CJ., 2012, PRINCIPLES RENAL PHY, DOI [10.1007/978-1-4614-3785-7, DOI 10.1007/978-1-4614-3785-7]; Metabolic Solutions Inc, 2009, MEAS TOT BOD WAT EXT; NeuhauserBerthold M, 1997, ANN NUTR METAB, V41, P29, DOI 10.1159/000177975; NUSSBERGER J, 1990, J CARDIOVASC PHARM, V15, P685, DOI 10.1097/00005344-199005000-00001; Osswald Hartmut, 2011, Handb Exp Pharmacol, P391, DOI 10.1007/978-3-642-13443-2_15; PASSMORE AP, 1987, CLIN SCI, V72, P749, DOI 10.1042/cs0720749; Perrier Erica, 2013, Br J Nutr, V109, P1678, DOI 10.1017/S0007114512003601; Riesenhuber A, 2006, AMINO ACIDS, V31, P81, DOI 10.1007/s00726-006-0363-5; ROBERTSON D, 1981, J CLIN INVEST, V67, P1111, DOI 10.1172/JCI110124; Ruxton CH, 2011, BRIT J NUTR, V106, P588, DOI 10.1017/S0007114511000456; Silva A, 2013, APPL PHYSL NUTR META; The Fairtrade Foundation, 2012, FAIRTR COFF REP; WaterAid, 2012, HYDR TIPS WATERAID 2; Wemple RD, 1997, INT J SPORTS MED, V18, P40, DOI 10.1055/s-2007-972593	32	34	35	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84154	10.1371/journal.pone.0084154	http://dx.doi.org/10.1371/journal.pone.0084154			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416202	Green Published, Green Submitted, gold			2022-12-27	WOS:000329866300019
J	Wang, SY; Teng, QY; Jia, L; Sun, XY; Wu, YP; Zhou, JY				Wang, Sanying; Teng, Qiaoyang; Jia, Lu; Sun, Xiaoyuan; Wu, Yongping; Zhou, Jiyong			Infectious Bursal Disease Virus Influences the Transcription of Chicken gamma(c) and gamma(c) Family Cytokines during Infection	PLOS ONE			English	Article							IN-VITRO EXPRESSION; T-CELLS; CHAIN; INTERLEUKIN-2; PROLIFERATION; ANTIBODY	Infectious bursal disease virus (IBDV) infection causes immunodeficiency in chickens. To understand cell-mediated immunity during IBDV infection, this study perform a detailed analysis of chicken gamma(c) chain (chCD132) and gamma(c) family cytokines, including interleukins 2, 4, 7, 9, and 15. The mouse anti-chCD132 monoclonal antibody (mAb) was first generated by the E.coli-expressed gamma(c) protein. Immunofluorescence assay further showed that gamma(c) was a protein located with the anti-chCD132 mAb on the surface of chicken's splenic mononuclear cells. Real-time quantitative RT-PCR revealed that the chCD132 mRNA transcript was persistently downregulated in embryo fibroblasts, spleen and thymus of chickens infected with IBDV. Correspondingly during IBDV infection, the transcription of five gamma(c) family cytokines was downregulated in the thymus and presented an imbalance in the spleen. Fluorescence-activated cell sorting analyses also indicated that the percentage of CD132(+)CD8(+) T cells linearly decreased in the bursa of IBDV-infected chickens. These results confirmed that IBDV infection disturbed the in vivo balance of CD132 and gamma(c) family cytokine expression and that IBDV-induced immunodeficiency involved cellular networks related to the gamma(c) family.	[Wang, Sanying; Teng, Qiaoyang; Jia, Lu; Sun, Xiaoyuan; Zhou, Jiyong] Zhejiang Univ, Key Lab Anim Virol, Minist Agr, Hangzhou 310003, Zhejiang, Peoples R China; [Zhou, Jiyong] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China; [Wu, Yongping] Zhejiang A&F Univ, Coll Anim Sci & Technol, Linan, Zhejiang, Peoples R China	Ministry of Agriculture & Rural Affairs; Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Zhejiang A&F University	Wu, YP (corresponding author), Zhejiang A&F Univ, Coll Anim Sci & Technol, Linan, Zhejiang, Peoples R China.	wypzxd2002@163.com; jyzhou@zju.edu.cn			NSFC [31001075]; National Science and Technology Support Program [2010BAD04B01-10]; Key Scientific and Technological Innovation Team of Zhejiang Province [2010R50031]; China Agriculture Research System [CARS-41-K11]; Chinese Universities Scientific Fund; Zhejiang AF University [2012FR021, 2012FR061]; Zhejiang Provincial Natural Science Foundation [LQ12C17001]	NSFC(National Natural Science Foundation of China (NSFC)); National Science and Technology Support Program; Key Scientific and Technological Innovation Team of Zhejiang Province; China Agriculture Research System; Chinese Universities Scientific Fund; Zhejiang AF University; Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	This work was funded by NSFC (31001075), National Science and Technology Support Program (grant number 2010BAD04B01-10), Key Scientific and Technological Innovation Team of Zhejiang Province (2010R50031), China Agriculture Research System (CARS-41-K11) and Chinese Universities Scientific Fund, Zhejiang A&F University Talent Starting Program (2012FR021, 2012FR061), and Zhejiang Provincial Natural Science Foundation (grant number LQ12C17001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorosi S, 2009, J IMMUNOL, V182, P3304, DOI 10.4049/jimmunol.0802400; ARMITAGE RJ, 1995, J IMMUNOL, V154, P483; Crawley AM, 2010, EUR J IMMUNOL, V40, P1396, DOI 10.1002/eji.200940093; D'Souza WN, 2003, J IMMUNOL, V171, P5727, DOI 10.4049/jimmunol.171.11.5727; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Gu JY, 2010, DEV COMP IMMUNOL, V34, P258, DOI 10.1016/j.dci.2009.10.003; Juffroy O, 2010, J VIROL, V84, P96, DOI 10.1128/JVI.01475-09; Leonard WJ, 2001, NAT REV IMMUNOL, V1, P200, DOI 10.1038/35105066; Liu HW, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-364; Marino JH, 2010, HUM IMMUNOL, V71, P329, DOI 10.1016/j.humimm.2010.01.009; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Shi LX, 2009, VIRUS GENES, V39, P46, DOI 10.1007/s11262-008-0313-2; Sun JC, 2009, J IMMUNOL, V183, P2911, DOI 10.4049/jimmunol.0901872; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Tanimura N, 1998, J COMP PATHOL, V118, P15, DOI 10.1016/S0021-9975(98)80024-8; Teng QY, 2006, FEBS LETT, V580, P4274, DOI 10.1016/j.febslet.2006.06.044; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616; Wang YZ, 2009, MOL IMMUNOL, V46, P1964, DOI 10.1016/j.molimm.2009.03.011; Wu YP, 2012, PROTEOMICS, V12, P1844, DOI 10.1002/pmic.201100479; Wu YP, 2009, ARCH VIROL, V154, P1873, DOI 10.1007/s00705-009-0524-4; Zheng XJ, 2008, MOL CELL PROTEOMICS, V7, P612, DOI 10.1074/mcp.M700396-MCP200; Zheng XJ, 2006, DNA CELL BIOL, V25, P646, DOI 10.1089/dna.2006.25.646; Zhou JY, 2006, J GEN VIROL, V87, P1823, DOI 10.1099/vir.0.81800-0; Zhou JY, 2005, MOL IMMUNOL, V42, P589, DOI 10.1016/j.molimm.2004.09.014	25	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84503	10.1371/journal.pone.0084503	http://dx.doi.org/10.1371/journal.pone.0084503			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416239	gold, Green Submitted, Green Published			2022-12-27	WOS:000329866300026
J	Apri, M; de Gee, M; van Mourik, S; Molenaar, J				Apri, Mochamad; de Gee, Maarten; van Mourik, Simon; Molenaar, Jaap			Identifying Optimal Models to Represent Biochemical Systems	PLOS ONE			English	Article							PARAMETER-ESTIMATION; OPTIMIZATION; REDUCTION; DISCRIMINATION; MECHANISMS; NETWORKS; PATHWAYS; RECEPTOR; DESIGNS	Biochemical systems involving a high number of components with intricate interactions often lead to complex models containing a large number of parameters. Although a large model could describe in detail the mechanisms that underlie the system, its very large size may hinder us in understanding the key elements of the system. Also in terms of parameter identification, large models are often problematic. Therefore, a reduced model may be preferred to represent the system. Yet, in order to efficaciously replace the large model, the reduced model should have the same ability as the large model to produce reliable predictions for a broad set of testable experimental conditions. We present a novel method to extract an "optimal" reduced model from a large model to represent biochemical systems by combining a reduction method and a model discrimination method. The former assures that the reduced model contains only those components that are important to produce the dynamics observed in given experiments, whereas the latter ensures that the reduced model gives a good prediction for any feasible experimental conditions that are relevant to answer questions at hand. These two techniques are applied iteratively. The method reveals the biological core of a model mathematically, indicating the processes that are likely to be responsible for certain behavior. We demonstrate the algorithm on two realistic model examples. We show that in both cases the core is substantially smaller than the full model.	[Apri, Mochamad; de Gee, Maarten; van Mourik, Simon; Molenaar, Jaap] Wageningen Univ, NL-6700 AP Wageningen, Netherlands; [Apri, Mochamad; de Gee, Maarten; van Mourik, Simon; Molenaar, Jaap] Netherlands Consortium Syst Biol, Amsterdam, Netherlands; [Apri, Mochamad] Bandung Inst Technol, Ind & Financial Math Grp, Bandung, Indonesia	Wageningen University & Research; Institute Technology of Bandung	Apri, M (corresponding author), Wageningen Univ, NL-6700 AP Wageningen, Netherlands.	m.apri@math.itb.ac.id	van Mourik, Simon/D-9006-2013	Apri, Mochamad/0000-0001-7057-4323				Apri M, 2012, J THEOR BIOL, V304, P16, DOI 10.1016/j.jtbi.2012.03.019; ATKINSON AC, 1981, J ECONOMETRICS, V16, P15, DOI 10.1016/0304-4076(81)90072-5; Balsa-Canto E, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-26; Dano S, 2006, FEBS J, V273, P4862, DOI 10.1111/j.1742-4658.2006.05485.x; Dokoumetzidis A, 2009, IET SYST BIOL, V3, P40, DOI 10.1049/iet-syb:20070055; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Kholodenko BN, 1999, J BIOL CHEM, V274, P30169, DOI 10.1074/jbc.274.42.30169; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kooi BW, 2002, ECOL MODEL, V157, P69, DOI 10.1016/S0304-3800(02)00217-X; Krizek BA, 2005, NAT REV GENET, V6, P688, DOI 10.1038/nrg1675; Lillacci G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000696; Lopez-Fidalgo J, 2008, J STAT PLAN INFER, V138, P3797, DOI 10.1016/j.jspi.2008.01.014; Mendes P, 1998, BIOINFORMATICS, V14, P869, DOI 10.1093/bioinformatics/14.10.869; Moles CG, 2003, GENOME RES, V13, P2467, DOI 10.1101/gr.1262503; Orton RJ, 2005, BIOCHEM J, V392, P249, DOI 10.1042/BJ20050908; Radulescu O, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-86; Roussel MR, 2001, CHAOS, V11, P196, DOI 10.1063/1.1349891; Skanda D, 2010, BIOINFORMATICS, V26, P939, DOI 10.1093/bioinformatics/btq074; Smets I, 2002, BIOTECHNOL BIOENG, V80, P195, DOI 10.1002/bit.10359; SRINIVAS M, 1994, COMPUTER, V27, P17, DOI 10.1109/2.294849; Surovtsova I, 2009, BIOINFORMATICS, V25, P2816, DOI 10.1093/bioinformatics/btp451; TOMLIN AS, 1995, IND ENG CHEM RES, V34, P3749, DOI 10.1021/ie00038a010; TURANYI T, 1990, J MATH CHEM, V5, P203, DOI 10.1007/BF01166355; Ucinski D, 2005, J R STAT SOC B, V67, P3, DOI 10.1111/j.1467-9868.2005.00485.x; van Mourik S, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-101; Walter E, 1997, IDENTIFICATION PARAM	26	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83664	10.1371/journal.pone.0083664	http://dx.doi.org/10.1371/journal.pone.0083664			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416170	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500064
J	Cui, Y; Shooshtari, S; Forget, EL; Clara, I; Cheung, KF				Cui, Yang; Shooshtari, Shahin; Forget, Evelyn L.; Clara, Ian; Cheung, Kwong F.			Smoking during Pregnancy: Findings from the 2009-2010 Canadian Community Health Survey	PLOS ONE			English	Article							MATERNAL SMOKING; PREVALENCE; PREDICTORS; WOMEN; CARE	Objectives: Smoking during pregnancy may cause many health problems for pregnant women and their newborns. However, there is a paucity of research that has examined the predictors of smoking during pregnancy in Canada. This study used data from the 2009-2010 Canadian Community Health Survey (CCHS) to estimate the prevalence of smoking during pregnancy and examine the demographic, socioeconomic, health-related and behavioral determinants of this behavior. Methods and Findings: The data were obtained from the 2009-2010 CCHS master data file. Weighted estimates of the prevalence were calculated. Multivariable logistic regression was used to determine demographic, socioeconomic, health related and behavioral characteristics associated with smoking behavior during pregnancy. Women living in the Northern Territories had a high rate of smoking during pregnancy (59.3%). The prevalence of smoking during pregnancy was also high among women under 25 years old, of low socioeconomic status, who reported not having a regular medical doctor, being fair to poor in self-perceived health, having at least one chronic disease, having at least one mental illness, being heavy smokers, and being regular alcohol drinkers. Results from multivariable logistic regression revealed that the odds of smoking during pregnancy were decreased with increasing age (odds ratio [OR], 0.95; 95% confidence interval [CI], 0.91-0.99), having a regular family doctor [OR, 0.24; 95% CI, 0.11-0.52], having highest level of family income [OR, 0.09; 95% CI, 0.03-0.29]. Mothers who reported poor or fair self-perceived health [OR, 2.13; 95% CI, 0.96-4.71] and those who had at least one mental illness [OR, 1.81; 95% CI, 1.00-3.28] had greater odds of smoking during pregnancy. Conclusions: There are a number of demographic, socio-economic, health-related and behavioral characteristics that should be considered in developing and implementing effective population health promotional strategies to prevent smoking during pregnancy, promoting health and well-being of pregnant women and their newborns.	[Cui, Yang; Shooshtari, Shahin; Forget, Evelyn L.; Clara, Ian] Univ Manitoba, Dept Community Hlth Sci, Fac Med, Winnipeg, MB R3T 2N2, Canada; [Cheung, Kwong F.] Univ Manitoba, Fac Nursing, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba	Cui, Y (corresponding author), Univ Manitoba, Dept Community Hlth Sci, Fac Med, Winnipeg, MB R3T 2N2, Canada.	umcui@myumanitoba.ca		Shooshtari, Shahin/0000-0001-5247-2403				Al-Sahab B, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-24; Alberta Health, 2011, ALB REPR HLTH PREGN; Alverson CJ, 2011, PEDIATRICS, V127, pE647, DOI 10.1542/peds.2010-1399; [Anonymous], 2003, WOM HLTH SURV REP; British Columbia Perinatal Database Registry, 2006, ANN REP 2006; Connor SK, 1999, CAN J PUBLIC HEALTH, V90, P352, DOI 10.1007/BF03404527; FISCHER PJ, 1991, AM PSYCHOL, V46, P1115, DOI 10.1037/0003-066X.46.11.1115; Haustein KO, 1999, INT J CLIN PHARM TH, V37, P417; Health Canada, 2010, 1 NAT IN AB HLTH; Heaman MI, 2005, BIRTH-ISS PERINAT C, V32, P299, DOI 10.1111/j.0730-7659.2005.00387.x; Kahende JW, 2009, INT J ENV RES PUB HE, V6, P1095, DOI 10.3390/ijerph6031095; Lawrence D, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-285; Leonard S, 2001, PHARMACOL BIOCHEM BE, V70, P561, DOI 10.1016/S0091-3057(01)00677-3; Millar Wayne J, 2004, Health Rep, V15, P53; Muhajarine N, 1997, CAN J PUBLIC HEALTH, V88, P375, DOI 10.1007/BF03403909; Nagahawatte NT, 2008, ANN NY ACAD SCI, V1136, P80, DOI 10.1196/annals.1425.016; OSTER G, 1988, AM J PREV MED, V4, P216, DOI 10.1016/S0749-3797(18)31176-0; Public Health Agency of Canada, 2007, TOB US; Schneider S, 2008, EUR J CONTRACEP REPR, V13, P138, DOI 10.1080/13625180802027993; Statistics Canada, 2010, CAN HLTH MEAS SURV C; Statistics Canada, 2011, CAN COMM HLTH SURV C	21	46	46	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84640	10.1371/journal.pone.0084640	http://dx.doi.org/10.1371/journal.pone.0084640			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291WL	24416257	gold, Green Submitted, Green Published			2022-12-27	WOS:000329862500145
J	Li, H; Liu, YS; Gong, PH; Zhang, CS; Ye, JP				Li, Han; Liu, Yashu; Gong, Pinghua; Zhang, Changshui; Ye, Jieping		Alzheimers Dis Neuroimaging Initia	Hierarchical Interactions Model for Predicting Mild Cognitive Impairment (MCI) to Alzheimer's Disease (AD) Conversion	PLOS ONE			English	Article							VARIABLE SELECTION; IMAGING GENETICS; BIOMARKERS; REGRESSION	Identifying patients with Mild Cognitive Impairment (MCI) who are likely to convert to dementia has recently attracted increasing attention in Alzheimer's disease (AD) research. An accurate prediction of conversion from MCI to AD can aid clinicians to initiate treatments at early stage and monitor their effectiveness. However, existing prediction systems based on the original biosignatures are not satisfactory. In this paper, we propose to fit the prediction models using pairwise biosignature interactions, thus capturing higher-order relationship among biosignatures. Specifically, we employ hierarchical constraints and sparsity regularization to prune the high-dimensional input features. Based on the significant biosignatures and underlying interactions identified, we build classifiers to predict the conversion probability based on the selected features. We further analyze the underlying interaction effects of different biosignatures based on the so-called stable expectation scores. We have used 293 MCI subjects from Alzheimer's Disease Neuroimaging Initiative (ADNI) database that have MRI measurements at the baseline to evaluate the effectiveness of the proposed method. Our proposed method achieves better classification performance than state-of-the-art methods. Moreover, we discover several significant interactions predictive of MCI-to-AD conversion. These results shed light on improving the prediction performance using interaction features.	[Li, Han; Gong, Pinghua; Zhang, Changshui] Tsinghua Univ, Dept Automat, State Key Lab Intelligent Technol & Syst, Tsinghua Natl Lab Informat Sci & Technol TNList, Beijing 100084, Peoples R China; [Liu, Yashu; Ye, Jieping] Arizona State Univ, Biodesign Inst, Ctr Evolutionary Med & Informat, Tempe, AZ USA	Tsinghua University; Arizona State University; Arizona State University-Tempe	Zhang, CS (corresponding author), Tsinghua Univ, Dept Automat, State Key Lab Intelligent Technol & Syst, Tsinghua Natl Lab Informat Sci & Technol TNList, Beijing 100084, Peoples R China.	zcs@mail.tsinghua.edu.cn			973 Program [2013CB329503]; NSFC [91120301, 61075004, 61021063]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; NATIONAL INSTITUTE ON AGING [U01AG024904] Funding Source: NIH RePORTER	973 Program(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors' research was supported by 973 Program (2013CB329503) and NSFC (Grant No. 91120301, No. 61075004 and No. 61021063). Data collection and sharing for our project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ANDI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; Janssen Alzheimer Immunotherapy Research \& Development, LLC.; Johnson \& Johnson Pharmaceutical Research \& Development LLC.; Medpace, Inc.; Merck \& Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Association A.s., 2010, ALZHEIMERS DEMENT, P158, DOI [10.1016/j.jalz.2010.01.009, DOI 10.1016/J.JALZ.2010.01.009]; Bien J, 2012, ARXIV12055050; Boyd Stephen, 2010, Foundations and Trends in Machine Learning, V3, P1, DOI 10.1561/2200000016; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chipman H, 1996, CAN J STAT, V24, P17, DOI 10.2307/3315687; Choi NH, 2010, J AM STAT ASSOC, V105, P354, DOI 10.1198/jasa.2010.tm08281; COX DR, 1984, INT STAT REV, V52, P1, DOI 10.2307/1403235; Davatzikos C, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.023; Devanand DP, 2007, NEUROLOGY, V68, P828, DOI 10.1212/01.wnl.0000256697.20968.d7; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Fennema-Notestine C, 2009, HUM BRAIN MAPP, V30, P3238, DOI 10.1002/hbm.20744; Llano DA, 2011, ALZ DIS ASSOC DIS, V25, P73, DOI 10.1097/WAD.0b013e3181f5b8d8; Meinshausen N, 2010, J R STAT SOC B, V72, P417, DOI 10.1111/j.1467-9868.2010.00740.x; NELDER JA, 1977, J ROY STAT SOC A STA, V140, P48, DOI 10.2307/2344517; Nemirovski A, 2005, LECT NOTES; Nesterov Y, 2004, INTRO LECT CONVEX OP; Oommen T, 2008, MATH GEOSCI, V40, P409, DOI 10.1007/s11004-008-9156-6; PEIXOTO JL, 1987, AM STAT, V41, P311, DOI 10.2307/2684752; Petersen RC, 2003, NAT REV DRUG DISCOV, V2, P646, DOI 10.1038/nrd1155; Radchenko P, 2010, J AM STAT ASSOC, V105, P1541, DOI 10.1198/jasa.2010.tm10130; Tian XM, 2012, ACM T MULTIM COMPUT, V8, DOI 10.1145/2240136.2240139; Vapnik V. N., 2000, NATURE STAT LEARNING, DOI DOI 10.1007/978-1-4757-3264-1_1; Wang H., 2012, P ADV NEUR INF PROC, P1277; Wang H, 2012, BIOINFORMATICS, V28, pI127, DOI 10.1093/bioinformatics/bts228; Wang H, 2012, BIOINFORMATICS, V28, P229, DOI 10.1093/bioinformatics/btr649; Ye JP, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-46; Zhao Peng, 2006, 703 UC BERK DEP STAT; Zhou TY, 2013, IEEE T IMAGE PROCESS, V22, P244, DOI 10.1109/TIP.2012.2202678; Zhou TY, 2011, DATA MIN KNOWL DISC, V22, P340, DOI 10.1007/s10618-010-0182-x	29	41	44	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e82450	10.1371/journal.pone.0082450	http://dx.doi.org/10.1371/journal.pone.0082450			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416143	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500016
J	Liu, YH; Wang, LJ; Huang, KM; Wang, WW; Nie, XL; Jiang, Y; Li, PP; Liu, SS; Xu, P; Tang, HZ				Liu, Yanghui; Wang, Lijuan; Huang, Kaiming; Wang, Weiwei; Nie, Xueling; Jiang, Yi; Li, Pengpeng; Liu, Shanshan; Xu, Ping; Tang, Hongzhi			Physiological and Biochemical Characterization of a Novel Nicotine-Degrading Bacterium Pseudomonas geniculata N1	PLOS ONE			English	Article							STRAIN S16; DEGRADATION; PUTIDA; WASTE; BIODEGRADATION; HYDROXYLASE; CATABOLISM; GENE	Management of solid wastes with high nicotine content, such as those accumulated during tobacco manufacturing, poses a major challenge, which can be addressed by using bacteria such as Pseudomonas and Arthrobacter. In this study, a new species of Pseudomonas geniculata, namely strain N1, which is capable of efficiently degrading nicotine, was isolated and identified. The optimal growth conditions for strain N1 are a temperature of 30 degrees C, and a pH 6.5, at a rotation rate of 120 rpm min(-1) with 1 g l(-1) nicotine as the sole source of carbon and nitrogen. Myosmine, cotinine, 6-hydroxynicotine, 6-hydroxy- N-methylmyosmine, and 6-hydroxy-pseudooxynicotine were detected as the five intermediates through gas chromatography-mass and liquid chromatography-mass analyses. The identified metabolites were different from those generated by Pseudomonas putida strains. The analysis also highlighted the bacterial metabolic diversity in relation to nicotine degradation by different Pseudomonas strains.	[Liu, Yanghui; Wang, Lijuan; Huang, Kaiming; Wang, Weiwei; Nie, Xueling; Jiang, Yi; Li, Pengpeng; Xu, Ping; Tang, Hongzhi] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Liu, Yanghui; Wang, Lijuan; Huang, Kaiming; Wang, Weiwei; Nie, Xueling; Jiang, Yi; Li, Pengpeng; Xu, Ping; Tang, Hongzhi] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Liu, Shanshan] Shanghai Jiao Tong Univ, Sch Environm Sci & Engn, Shanghai 200030, Peoples R China; [Liu, Shanshan] Shanghai Nucl Engn Res & Design Inst, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Tang, HZ (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	tanghongzhi@sjtu.edu.cn			Chinese National Natural Science Foundation [31270154, 31230002, 31121064]; National Basic Research Program of China [2013CB733901]; "Shanghai Rising-Star Program'' [13QA1401700]; "Chen Xing'' project from Shanghai Jiaotong University	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); "Shanghai Rising-Star Program''; "Chen Xing'' project from Shanghai Jiaotong University	This work was supported in part by grants from the Chinese National Natural Science Foundation (31270154, 31230002, and 31121064), and from the National Basic Research Program of China (2013CB733901). We also acknowledge the "Shanghai Rising-Star Program'' (13QA1401700) and the "Chen Xing'' project from Shanghai Jiaotong University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandsch R, 2006, APPL MICROBIOL BIOT, V69, P493, DOI 10.1007/s00253-005-0226-0; Chen CM, 2008, INT BIODETER BIODEGR, V62, P226, DOI 10.1016/j.ibiod.2008.01.012; Civilini M, 1997, WASTE MANAGE RES, V15, P349, DOI 10.1177/0734242X9701500403; Cobzaru C, 2011, RES MICROBIOL, V162, P285, DOI 10.1016/j.resmic.2011.01.001; Eberhardt Hans-Jochen, 1995, Beitraege zur Tabakforschung International, V16, P119; FRANK HA, 1962, J BACTERIOL, V84, P68, DOI 10.1128/JB.84.1.68-71.1962; Ganas P, 2008, ARCH MICROBIOL, V189, P511, DOI 10.1007/s00203-007-0340-8; Henningfield JE, 1998, TOB CONTROL, V7, P281, DOI 10.1136/tc.7.3.281; Holmstedt B, 1988, ICSU S SERIES, V9; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lei LP, 2009, ANN MICROBIOL, V59, P247, DOI 10.1007/BF03178324; Li HJ, 2010, APPL MICROBIOL BIOT, V86, P11, DOI 10.1007/s00253-009-2427-4; Novotny TE, 1999, TOB CONTROL, V8, P75, DOI 10.1136/tc.8.1.75; Ruan AD, 2005, RES MICROBIOL, V156, P700, DOI 10.1016/j.resmic.2005.02.010; Tang HZ, 2008, APPL ENVIRON MICROB, V74, P1567, DOI 10.1128/AEM.02529-07; Tang HZ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003923; Tang HZ, 2012, J BACTERIOL, V194, P3553, DOI 10.1128/JB.00625-12; Tang HZ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00377; Tang HZ, 2011, J BIOL CHEM, V286, P39179, DOI 10.1074/jbc.M111.283929; Tang HZ, 2009, APPL ENVIRON MICROB, V75, P772, DOI 10.1128/AEM.02300-08; WADA E, 1953, SCIENCE, V117, P152, DOI 10.1126/science.117.3033.152; Wang HH, 2012, J APPL MICROBIOL, V112, P258, DOI 10.1111/j.1365-2672.2011.05208.x; Wang SN, 2007, MICROBIOL-SGM, V153, P1556, DOI 10.1099/mic.0.2006/005223-0; Wang SN, 2012, APPL MICROBIOL BIOT, V95, P1567, DOI 10.1007/s00253-012-4007-2; Wang SN, 2004, BIOTECHNOL LETT, V26, P1493, DOI 10.1023/B:BILE.0000044450.16235.65; Yuan YJ, 2005, INT BIODETER BIODEGR, V56, P45, DOI 10.1016/j.ibiod.2005.04.002	26	5	8	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84399	10.1371/journal.pone.0084399	http://dx.doi.org/10.1371/journal.pone.0084399			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416227	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500124
J	Rauch, DA; Harding, JC; Ratner, L				Rauch, Daniel A.; Harding, John C.; Ratner, Lee			IL-15 Deficient Tax Mice Reveal a Role for IL-1 alpha in Tumor Immunity	PLOS ONE			English	Article							T-CELL LEUKEMIA; VIRUS TYPE-I; NATURAL-KILLER; STERILE INFLAMMATION; ANTI-CD40 ANTIBODY; FIBROSARCOMA CELLS; INTERLEUKIN 15; MYELOID CELLS; COLON-CANCER; EXPRESSION	IL-15 is recognized as a promising candidate for tumor immunotherapy and has been described as both a promoter of cancer and a promoter of anti-cancer immunity. IL-15 was discovered in cells transformed by HTLV-1, the etiologic agent of adult T cell leukemia/lymphoma (ATL) and the human retrovirus that carries the Tax oncogene. We have developed the TAX-LUC mouse model of ATL in which Tax expression drives both malignant transformation and luciferase expression, enabling non-invasive imaging of tumorigenesis in real time. To identify the role of IL-15 in spontaneous development of lymphoma in vivo, an IL-15(-/-) TAX-LUC strain was developed and examined. The absence of IL-15 resulted in aggressive tumor growth and accelerated mortality and demonstrated that IL-15 was not required for Tax-mediated lymphoma but was essential for anti-tumor immunity. Further analysis revealed a unique transcriptional profile in tumor cells that arise in the absence of IL-15 that included a significant increase in the expression of IL-1 alpha and IL-1 alpha-regulated cytokines. Moreover, anti-IL-1 alpha antibodies and an IL-1 receptor antagonist (Anakinra) were used to interrogate the potential of IL-1 alpha targeted therapies in this model. Taken together, these findings identify IL-15 and IL-1 alpha as therapeutic targets in lymphoma.	[Rauch, Daniel A.; Harding, John C.; Ratner, Lee] Washington Univ, Sch Med, Dept Med, Div Mol Oncol, St Louis, MO 63110 USA	Washington University (WUSTL)	Ratner, L (corresponding author), Washington Univ, Sch Med, Dept Med, Div Mol Oncol, St Louis, MO 63110 USA.	lratner@dom.wustl.edu		Ratner, Lee/0000-0003-2744-7294	PHS [CA94056, CA10073, CA63417]; NATIONAL CANCER INSTITUTE [P50CA094056, R01CA063417] Funding Source: NIH RePORTER	PHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	PHS grants CA94056, CA10073, and CA63417. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apte RN, 2000, ADV EXP MED BIOL, V479, P277; Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; Azimi N, 1998, P NATL ACAD SCI USA, V95, P2452, DOI 10.1073/pnas.95.5.2452; Bamford RN, 1996, P NATL ACAD SCI USA, V93, P2897, DOI 10.1073/pnas.93.7.2897; Ben-Sasson SZ, 2011, CYTOKINE, V56, P122, DOI 10.1016/j.cyto.2011.07.006; BURTON JD, 1994, P NATL ACAD SCI USA, V91, P4935, DOI 10.1073/pnas.91.11.4935; Buryskova M, 2004, J BIOL CHEM, V279, P4017, DOI 10.1074/jbc.M306342200; Cohen I, 2010, P NATL ACAD SCI USA, V107, P2574, DOI 10.1073/pnas.0915018107; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dvorkin T, 2006, J LEUKOCYTE BIOL, V80, P96, DOI 10.1189/jlb.0905509; Elaraj DM, 2006, CLIN CANCER RES, V12, P1088, DOI 10.1158/1078-0432.CCR-05-1603; Elkabets M, 2009, J IMMUNOL, V182, P4874, DOI 10.4049/jimmunol.0803916; Gao L, 2005, BLOOD, V106, P4294, DOI 10.1182/blood-2005-04-1730; Gillgrass A, 2011, EXPERT REV CLIN IMMU, V7, P367, DOI [10.1586/ECI.10.102, 10.1586/eci.10.102]; Goon PKC, 2004, J INFECT DIS, V189, P2294, DOI 10.1086/420832; GROSSMAN WJ, 1995, P NATL ACAD SCI USA, V92, P1057, DOI 10.1073/pnas.92.4.1057; Hodge DL, 2009, CANCER RES, V69, P3986, DOI 10.1158/0008-5472.CAN-08-3735; Hong DS, 2011, MOL CANCER THER, V10, DOI [10.1158/1535-7163.TARG-11-A211, DOI 10.1158/1535-7163.TARG-11-A211]; Jakobisiak M, 2011, CYTOKINE GROWTH F R, V22, P99, DOI 10.1016/j.cytogfr.2011.04.001; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Kuniyasu H, 2003, CLIN CANCER RES, V9, P4802; Kurihara K, 2005, INT J CANCER, V114, P257, DOI 10.1002/ijc.20737; Luedke E, 2012, SURGERY, V152, P431, DOI 10.1016/j.surg.2012.05.035; Marhaba R, 2008, INT J CANCER, V123, P134, DOI 10.1002/ijc.23503; Mishra A, 2012, CANCER CELL, V22, P645, DOI 10.1016/j.ccr.2012.09.009; Moga E, 2011, EXP HEMATOL, V39, P1064, DOI 10.1016/j.exphem.2011.08.006; Mori N, 1996, BLOOD, V87, P3410, DOI 10.1182/blood.V87.8.3410.bloodjournal8783410; Nakayama Y, 2011, J MED MICROBIOL, V60, P1750, DOI 10.1099/jmm.0.033456-0; Nazarenko I, 2008, NEOPLASIA, V10, P549, DOI 10.1593/neo.08286; Pique C, 1996, J VIROL, V70, P4919, DOI 10.1128/JVI.70.8.4919-4926.1996; Portis T, 2001, BLOOD, V98, P1200, DOI 10.1182/blood.V98.4.1200; Rauch D, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-116; Rauch D, 2009, BLOOD, V113, P1493, DOI 10.1182/blood-2008-07-166462; Rider P, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00290; Rider P, 2011, J IMMUNOL, V187, P4835, DOI 10.4049/jimmunol.1102048; Roberti MP, 2012, BREAST CANCER RES TR, V136, P659, DOI 10.1007/s10549-012-2287-y; Rowan Aileen G, 2012, Leuk Res Treatment, V2012, P391953, DOI 10.1155/2012/391953; Sagawa K, 1996, MICROBIOL IMMUNOL, V40, P373, DOI 10.1111/j.1348-0421.1996.tb01082.x; Saijo S, 2002, ARTHRITIS RHEUM-US, V46, P533, DOI 10.1002/art.10172; Sato N, 2011, BLOOD, V117, P4032, DOI 10.1182/blood-2010-09-307504; Shah MV, 2008, BLOOD, V112, P770, DOI 10.1182/blood-2007-11-121871; Song XP, 2005, J IMMUNOL, V175, P8200, DOI 10.4049/jimmunol.175.12.8200; Song XP, 2003, J IMMUNOL, V171, P6448, DOI 10.4049/jimmunol.171.12.6448; Takeda S, 2004, INT J CANCER, V109, P559, DOI 10.1002/ijc.20007; Trentin L, 1996, BLOOD, V87, P3327, DOI 10.1182/blood.V87.8.3327.bloodjournal8783327; WANO Y, 1987, J CLIN INVEST, V80, P911, DOI 10.1172/JCI113152; Weiss JM, 2009, P NATL ACAD SCI USA, V106, P19455, DOI 10.1073/pnas.0909474106; Werman A, 2004, P NATL ACAD SCI USA, V101, P2434, DOI 10.1073/pnas.0308705101; Zhang ML, 2012, J IMMUNOL, V188, P6156, DOI 10.4049/jimmunol.1102604; Zhang ML, 2009, P NATL ACAD SCI USA, V106, P7513, DOI 10.1073/pnas.0902637106	50	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85028	10.1371/journal.pone.0085028	http://dx.doi.org/10.1371/journal.pone.0085028			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416335	Green Published, gold			2022-12-27	WOS:000329862500206
J	Liu, X; Huang, Y; Yang, DH; Li, XH; Liang, JK; Lin, L; Zhang, M; Zhong, KB; Liang, B; Li, JL				Liu, Xiao; Huang, Yu; Yang, Dinghua; Li, Xianghong; Liang, Jiankun; Lin, Liang; Zhang, Meng; Zhong, Kebo; Liang, Bo; Li, Jialu			Overexpression of TRIM24 Is Associated with the Onset and Progress of Human Hepatocellular Carcinoma	PLOS ONE			English	Article							ACTIVATION FUNCTION AF-2; CYCLIN D1; TIF1 ALPHA; TRANSCRIPTION; TIF1-ALPHA; EPITHELIA; RECEPTORS; MEDIATOR; PROTEIN; CANCER	The survival and colonization of tumor cells at new locations involve a variety of complex genetic, epigenetic, and microenvironmental factors. TRIM24 was originally named transcription intermediary factor 1-alpha (TIF1a), which was associated with cellular proliferation and was an oncogene in tumor development. Here we provide the first evidence of the expression profile and clinicopathological significance of TRIM24 in patients with hepatocellular carcinoma (HCC). Immunohistochemistry was employed to determine the expression level of TRIM24 in HCC tissues and noncancerous liver tissues. Elevated TRIM24 level was found in 61.4% HCC samples (51/83) correlating with AFP (P = 0.036), poor differentiation (P = 0.004), intrahepatic metastasis (P = 0.004), recurrence (P = 0.000006), and shorter tumor-free survival time (P = 0.002). Small interfering RNA induced down-regulation of TRIM24 promoted apoptosis in HCC cell line HepG2. Moreover, western blotting analysis revealed that knockdown of TRIM24 increased the protein levels of p53, Bax, and Caspase-8, and decreased Bcl-2, Survivin, Cyclin D1, and CDK4. Depletion of TRIM24 decreased Snail, Slug, b-catenin, and Vimentin, and increased Ecadherin expression, which suggested the involvement of TRIM24 in EMT. These results indicated that TRIM24 plays an important role in the pathogenesis of human HCC.	[Liu, Xiao; Huang, Yu; Yang, Dinghua; Li, Xianghong; Liang, Jiankun; Lin, Liang; Zhang, Meng; Zhong, Kebo; Liang, Bo; Li, Jialu] Southern Med Univ, Nanfang Hosp, Dept Hepatobiliary Surg, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Yang, DH (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Hepatobiliary Surg, Guangzhou, Guangdong, Peoples R China.	dhyang5810@yahoo.com	li, jia/GVT-7587-2022		Guangdong Natural Science Foundation [10151051501000120]	Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This work was supported by Guangdong Natural Science Foundation, NUM: 10151051501000120 (URL:http://gdsf.gdstc.gov.cn/Index.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allton K, 2009, P NATL ACAD SCI USA, V106, P11612, DOI 10.1073/pnas.0813177106; Belloni E, 2005, GENE CHROMOSOME CANC, V42, P320, DOI 10.1002/gcc.20144; Chambon M, 2011, AM J PATHOL, V178, P1461, DOI 10.1016/j.ajpath.2010.12.026; GREENBURG G, 1982, J CELL BIOL, V95, P333, DOI 10.1083/jcb.95.1.333; Herquel B, 2011, P NATL ACAD SCI USA, V108, P8212, DOI 10.1073/pnas.1101544108; Jain AK, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001268; Jain AK, 2009, CELL CYCLE, V8, P3668, DOI 10.4161/cc.8.22.9979; Katzenellenbogen BS, 1996, BIOL REPROD, V54, P287, DOI 10.1095/biolreprod54.2.287; Keum JS, 1999, BRIT J CANCER, V81, P127, DOI 10.1038/sj.bjc.6690661; Khetchoumian K, 2007, NAT GENET, V39, P1500, DOI 10.1038/ng.2007.15; Khetchoumian K, 2008, CELL CYCLE, V7, P3647, DOI 10.4161/cc.7.23.7123; Klugbauer S, 1999, ONCOGENE, V18, P4388, DOI 10.1038/sj.onc.1202824; Knudsen KE, 2006, ONCOGENE, V25, P1620, DOI 10.1038/sj.onc.1209371; Le Douarin B, 1998, J STEROID BIOCHEM, V65, P43, DOI 10.1016/S0960-0760(97)00175-1; LeDouarin B, 1997, BIOCHEM SOC T, V25, P605, DOI 10.1042/bst0250605; LEDOUARIN B, 1995, EMBO J, V14, P2020, DOI 10.1002/j.1460-2075.1995.tb07194.x; LeDouarin B, 1996, EMBO J, V15, P6701, DOI 10.1002/j.1460-2075.1996.tb01060.x; Li HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037657; Mann CD, 2007, EUR J CANCER, V43, P979, DOI 10.1016/j.ejca.2007.01.004; Marrero JA, 2006, CURR OPIN GASTROEN, V22, P248, DOI 10.1097/01.mog.0000218961.86182.8c; Motola-Kuba Daniel, 2006, Ann Hepatol, V5, P16; Ratschiller D, 2003, J CLIN ONCOL, V21, P2085, DOI 10.1200/JCO.2003.03.103; Roy PG, 2006, BREAST, V15, P718, DOI 10.1016/j.breast.2006.02.005; Sumie S, 2008, ANN SURG ONCOL, V15, P1375, DOI 10.1245/s10434-008-9846-9; Tsai WW, 2010, NATURE, V468, P927, DOI 10.1038/nature09542; Zhong S, 1999, NAT GENET, V23, P287, DOI 10.1038/15463; Zimmerman MA, 2008, ARCH SURG-CHICAGO, V143, P182, DOI 10.1001/archsurg.2007.39	27	42	45	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e85462	10.1371/journal.pone.0085462	http://dx.doi.org/10.1371/journal.pone.0085462			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409330	Green Submitted, Green Published, gold			2022-12-27	WOS:000329463500054
J	Zhang, ZL; Nix, CA; Ercan, UK; Gerstenhaber, JA; Joshi, SG; Zhong, YH				Zhang, Zhiling; Nix, Camilla A.; Ercan, Utku K.; Gerstenhaber, Jonathan A.; Joshi, Suresh G.; Zhong, Yinghui			Calcium Binding-Mediated Sustained Release of Minocycline from Hydrophilic Multilayer Coatings Targeting Infection and Inflammation	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; RESISTANT STAPHYLOCOCCUS-AUREUS; BIOMEDICAL APPLICATIONS; NITRIC-OXIDE; PH; BIOCOMPATIBILITY; TETRACYCLINES; ANTIBODIES; SURFACES; BIOFILMS	Infection and inflammation are common complications that seriously affect the functionality and longevity of implanted medical implants. Systemic administration of antibiotics and anti-inflammatory drugs often cannot achieve sufficient local concentration to be effective, and elicits serious side effects. Local delivery of therapeutics from drug-eluting coatings presents a promising solution. However, hydrophobic and thick coatings are commonly used to ensure sufficient drug loading and sustained release, which may limit tissue integration and tissue device communications. A calcium-mediated drug delivery mechanism was developed and characterized in this study. This novel mechanism allows controlled, sustained release of minocycline, an effective antibiotic and anti-inflammatory drug, from nanoscale thin hydrophilic polyelectrolyte multilayers for over 35 days at physiologically relevant concentrations. pH-responsive minocycline release was observed as the chelation between minocycline and Ca2+ is less stable at acidic pH, enabling 'smart' drug delivery in response to infection and/or inflammation-induced tissue acidosis. The release kinetics of minocycline can be controlled by varying initial loading, Ca2+ concentration, and Ca2+ incorporation into different layers, enabling facile development of implant coatings with versatile release kinetics. This drug delivery platform can potentially be used for releasing any drug that has high Ca2+ binding affinity, enabling its use in a variety of biomedical applications.	[Zhang, Zhiling; Nix, Camilla A.; Ercan, Utku K.; Gerstenhaber, Jonathan A.; Zhong, Yinghui] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA; [Joshi, Suresh G.] Drexel Univ, Coll Med, Surg Infect Program, Dept Surg, Philadelphia, PA 19104 USA; [Joshi, Suresh G.] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA	Drexel University; Drexel University; Drexel University	Zhong, YH (corresponding author), Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA.	yz348@drexel.edu	Ercan, Utku Kürşat/A-1658-2012; Ercan, Utku Kursat/AAX-1924-2020; Joshi, Suresh G./AAT-1354-2021	Ercan, Utku Kürşat/0000-0002-9762-2265; Joshi, Suresh G./0000-0002-7838-4898; Gerstenhaber, Jonathan/0000-0002-8162-7977	Drexel University	Drexel University	This work was supported by the startup fund from Drexel University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin AR, 1996, P NATL ACAD SCI USA, V93, P14014, DOI 10.1073/pnas.93.24.14014; Anderson JM, 1999, J CONTROL RELEASE, V57, P107, DOI 10.1016/S0168-3659(98)00178-3; Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81; Bernier C, 2001, ANN DERMATOL VENER, V128, P627; Bhatia S, 2010, STEREOT FUNCT NEUROS, V88, P147, DOI 10.1159/000303528; BJARNASON I, 1993, GASTROENTEROLOGY, V104, P1832, DOI 10.1016/0016-5085(93)90667-2; Boudou T, 2010, ADV MATER, V22, P441, DOI 10.1002/adma.200901327; Burke SE, 2004, MACROMOLECULES, V37, P5375, DOI 10.1021/ma049445o; Carlotti B, 2012, PHYS CHEM CHEM PHYS, V14, P823, DOI 10.1039/c1cp22703c; Chuang HF, 2008, BIOMACROMOLECULES, V9, P1660, DOI 10.1021/bm800185h; Coleman JW, 2001, INT IMMUNOPHARMACOL, V1, P1397, DOI 10.1016/S1567-5769(01)00086-8; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Dejugnat C., 2006, FUNCTIONAL COATINGS, P67; Del Pace S, 2010, INTERN EMERG MED, V5, P121, DOI 10.1007/s11739-010-0350-4; Dunston CR, 2011, PROTEOMICS, V11, P42, DOI 10.1002/pmic.201000273; Ercan UK, 2013, PLASMA PROCESS POLYM, V10, P544, DOI 10.1002/ppap.201200104; Gupta AK, 2004, J NEUROTRAUM, V21, P678, DOI 10.1089/0897715041269722; Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b; Hezi-Yamit A, 2009, J BIOMED MATER RES A, V90A, P133, DOI 10.1002/jbm.a.32057; Huster D, 1998, BIOPHYS J, V75, P909, DOI 10.1016/S0006-3495(98)77579-4; Jin LH, 2007, BIOPHYS CHEM, V128, P185, DOI 10.1016/j.bpc.2007.04.005; Johnson MD, 2007, J NEUROSCI METH, V160, P276, DOI 10.1016/j.jneumeth.2006.09.023; Joshi SG, 2010, AM J INFECT CONTROL, V38, P293, DOI 10.1016/j.ajic.2009.11.002; Le Nga N, 2011, J Diabetes Sci Technol, V5, P605; LIEDBERG H, 1989, SCAND J UROL NEPHROL, P2; Lu Y, 2009, BIOMATERIALS, V30, P4143, DOI 10.1016/j.biomaterials.2009.04.030; Maragakis LL, 2008, CLIN INFECT DIS, V46, P1254, DOI 10.1086/529198; Menkin V, 1937, AM J PATHOL, V13, P25; Nieman GF, 2001, CURR MED CHEM, V8, P317, DOI 10.2174/0929867013373570; Novak MT, 2010, ANAL BIOANAL CHEM, V398, P1695, DOI 10.1007/s00216-010-4097-6; Onuki Yoshinori, 2008, J Diabetes Sci Technol, V2, P1003; Page J, 2000, ARCH INTERN MED, V160, P777, DOI 10.1001/archinte.160.6.777; Pautke C, 2011, ORAL ONCOL, V47, P425, DOI 10.1016/j.oraloncology.2011.03.022; PIRSON Y, 1986, AM J KIDNEY DIS, V8, P338, DOI 10.1016/S0272-6386(86)80108-1; Poelstra KA, 2002, J BIOMED MATER RES, V60, P206, DOI 10.1002/jbm.10069; Reis CP, 2008, J PHARM SCI-US, V97, P5290, DOI 10.1002/jps.21347; Satpute MG, 2011, AM J INFECT CONTROL, V39, pE21, DOI 10.1016/j.ajic.2010.10.034; Schwartz AB, 2004, ANNU REV NEUROSCI, V27, P487, DOI 10.1146/annurev.neuro.27.070203.144233; Shukla A, 2011, J CONTROL RELEASE, V155, P159, DOI 10.1016/j.jconrel.2011.06.011; Shukla A, 2010, SMALL, V6, P2392, DOI 10.1002/smll.201001150; Soliman GM, 2010, MACROMOL BIOSCI, V10, P278, DOI 10.1002/mabi.200900259; Telang NV, 2010, AM J INFECT CONTROL, V38, P165, DOI 10.1016/j.ajic.2009.07.007; Tendeloo HJC, 1936, J BIOL CHEM, V113, P333; THE TH, 1970, IMMUNOLOGY, V18, P865; Wu P, 2006, BIOMATERIALS, V27, P2450, DOI 10.1016/j.biomaterials.2005.11.031; Zhong YH, 2008, J R SOC INTERFACE, V5, P957, DOI 10.1098/rsif.2008.0071; Zimmerli W, 2011, SEMIN IMMUNOPATHOL, V33, P295, DOI 10.1007/s00281-011-0275-7	47	13	13	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84360	10.1371/journal.pone.0084360	http://dx.doi.org/10.1371/journal.pone.0084360			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409292	gold, Green Published, Green Submitted			2022-12-27	WOS:000329463500016
J	Alves, FHF; Crestani, CC; Resstel, LBM; Correa, FMA				Alves, Fernando H. F.; Crestani, Carlos C.; Resstel, Leonardo B. M.; Correa, Fernando M. A.			Both alpha(1)- and alpha(2)-adrenoceptors in the Insular Cortex Are Involved in the Cardiovascular Responses to Acute Restraint Stress in Rats	PLOS ONE			English	Article							FREELY MOVING CATS; COERULEUS NEURONAL-ACTIVITY; MEDIAL PREFRONTAL CORTEX; NEUROENDOCRINE RESPONSES; LOCUS-COERULEUS; BED NUCLEUS; PHYSIOLOGICAL MANIPULATIONS; PARAVENTRICULAR NUCLEUS; SYMPATHETIC RESPONSES; BEHAVIORAL-RESPONSES	The insular cortex (IC) is a limbic structure involved in cardiovascular responses observed during aversive threats. However, the specific neurotransmitter mediating IC control of cardiovascular adjustments to stress is yet unknown. Therefore, in the present study we investigated the role of local IC adrenoceptors in the cardiovascular responses elicited by acute restraint stress in rats. Bilateral microinjection of different doses (0.3, 5, 10 and 15 nmol/100 nl) of the selective alpha(1)-adrenoceptor antagonist WB4101 into the IC reduced both the arterial pressure and heart rate increases elicited by restraint stress. However, local IC treatment with different doses (0.3, 5, 10 and 15 nmol/100 nl) of the selective alpha(2)-adrenoceptor antagonist RX821002 reduced restraint-evoked tachycardia without affecting the pressor response. The present findings are the first direct evidence showing the involvement of IC adrenoceptors in cardiovascular adjustments observed during aversive threats. Our findings indicate that IC noradrenergic neurotransmission acting through activation of both alpha(1)- and alpha(2)-adrenoceptors has a facilitatory influence on pressor response to acute restraint stress. Moreover, IC alpha(1)-adrenoceptors also play a facilitatory role on restraint-evoked tachycardiac response.	[Alves, Fernando H. F.; Resstel, Leonardo B. M.; Correa, Fernando M. A.] Univ Sao Paulo, Dept Pharmacol, Sch Med Ribeirao Preto, BR-14049 Ribeirao Preto, SP, Brazil; [Crestani, Carlos C.] Univ Estudual Paulista UNESP, Dept Nat Act Principles & Toxicol, Sch Pharmaceut Sci Araraquara, Araraquara, SP, Brazil	Universidade de Sao Paulo	Alves, FHF (corresponding author), Univ Sao Paulo, Dept Pharmacol, Sch Med Ribeirao Preto, BR-14049 Ribeirao Preto, SP, Brazil.	fer_farmacia@yahoo.com.br	Correa, Fernando/D-1614-2012; Crestani, Carlos C/E-4161-2012; Resstel, Leonardo/C-6100-2012	Correa, Fernando/0000-0003-4067-9524; Crestani, Carlos C/0000-0002-1942-858X; 	FAPESP [2010/09462-9]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Financial agency: FAPESP - Grant number 2010/09462-9, URL - www.fapesp.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE ED, 1987, J NEUROSCI, V7, P2837; Alves FHF, 2013, EUR J NEUROSCI, V38, P2300, DOI 10.1111/ejn.12210; Alves FHF, 2011, AUTON NEUROSCI-BASIC, V160, P90, DOI 10.1016/j.autneu.2010.11.002; Alves FHF, 2010, BRAIN RES, V1333, P57, DOI 10.1016/j.brainres.2010.03.077; Alves FHF, 2009, BRAIN RES, V1295, P119, DOI 10.1016/j.brainres.2009.08.013; Alves FHF, 2009, AUTON NEUROSCI-BASIC, V147, P56, DOI 10.1016/j.autneu.2008.12.015; BARRON BA, 1989, J AUTONOM NERV SYST, V28, P179, DOI 10.1016/0165-1838(89)90090-8; Baudrie V, 1997, J AUTON PHARMACOL, V17, P303, DOI 10.1046/j.1365-2680.1997.00465.x; Busnardo C, 2010, AUTON NEUROSCI-BASIC, V158, P51, DOI 10.1016/j.autneu.2010.06.003; BUTCHER KS, 1995, AM J PHYSIOL-REG I, V268, pR214, DOI 10.1152/ajpregu.1995.268.1.R214; Campeau S, 1997, J NEUROENDOCRINOL, V9, P577; Carrive P, 2002, AUTON NEUROSCI-BASIC, V98, P90, DOI 10.1016/S1566-0702(02)00039-5; Carrive P, 2006, CLIN EXP PHARMACOL P, V33, P1251, DOI 10.1111/j.1440-1681.2006.04519.x; Cecchi M, 2002, NEUROSCIENCE, V112, P13, DOI 10.1016/S0306-4522(02)00062-3; Cecchi M, 2002, NEUROPHARMACOLOGY, V43, P1139, DOI 10.1016/S0028-3908(02)00292-7; CECHETTO DF, 1992, AM J PHYSIOL, V263, pR544, DOI 10.1152/ajpregu.1992.263.3.R544; Crestani CC, 2008, BRIT J PHARMACOL, V153, P583, DOI 10.1038/sj.bjp.0707591; Crestani CC, 2009, STRESS, V12, P268, DOI 10.1080/10253890802331477; Crestani CC, 2010, STRESS, V13, P61, DOI 10.3109/10253890902927950; Dampney RAL, 2008, AUTON NEUROSCI-BASIC, V142, P3, DOI 10.1016/j.autneu.2008.07.005; Daubert DL, 2012, J PHYSIOL-LONDON, V590, P4881, DOI 10.1113/jphysiol.2012.232314; Deolindo MV, 2013, EUR J NEUROSCI, V38, P2374, DOI 10.1111/ejn.12246; Fornari RV, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00010; Hatton DC, 1997, AM J PHYSIOL-REG I, V272, pR1588, DOI 10.1152/ajpregu.1997.272.5.R1588; Irvine RJ, 1997, J PHARMACOL TOXICOL, V38, P157, DOI 10.1016/S1056-8719(97)00081-6; IWATA J, 1988, BEHAV NEUROSCI, V102, P66, DOI 10.1037/0735-7044.102.1.66; Joels M, 2009, NAT REV NEUROSCI, V10, P459, DOI 10.1038/nrn2632; KRETTEK JE, 1977, J COMP NEUROL, V171, P157, DOI 10.1002/cne.901710204; KRETZ R, 1984, J NEUROSCI METH, V11, P129, DOI 10.1016/0165-0270(84)90030-X; KRIEMAN MJ, 1992, NEUROPHARMACOLOGY, V31, P33, DOI 10.1016/0028-3908(92)90157-K; LEONARD CM, 1969, BRAIN RES, V12, P321, DOI 10.1016/0006-8993(69)90003-1; Lomber SG, 1999, J NEUROSCI METH, V86, P109, DOI 10.1016/S0165-0270(98)00160-5; Ma S, 2005, J NEUROENDOCRINOL, V17, P761, DOI 10.1111/j.1365-2826.2005.01372.x; Mayorov DN, 2002, AUTON NEUROSCI-BASIC, V98, P20, DOI 10.1016/S1566-0702(02)00024-3; McDougall SJ, 2000, HYPERTENSION, V35, P126, DOI 10.1161/01.HYP.35.1.126; MORILAK DA, 1987, BRAIN RES, V422, P24, DOI 10.1016/0006-8993(87)90536-1; MORILAK DA, 1987, BRAIN RES, V422, P32, DOI 10.1016/0006-8993(87)90537-3; MORRISON JH, 1978, J COMP NEUROL, V181, P17, DOI 10.1002/cne.901810103; MORRISON JH, 1979, SCIENCE, V205, P313, DOI 10.1126/science.451605; Morrison SF, 2001, AM J PHYSIOL-REG I, V281, pR683, DOI 10.1152/ajpregu.2001.281.3.R683; Nagai M, 2010, J AM SOC HYPERTENS, V4, P174, DOI 10.1016/j.jash.2010.05.001; Nosaka S, 1996, JPN J PHYSIOL, V46, P271, DOI 10.2170/jjphysiol.46.271; Oppenheimer SM, 1996, CLIN AUTON RES, V6, P131, DOI 10.1007/BF02281899; PAGE ME, 1992, NEUROSCIENCE, V51, P555, DOI 10.1016/0306-4522(92)90295-D; Pardon MC, 2002, NEUROSCIENCE, V115, P229, DOI 10.1016/S0306-4522(02)00364-0; Resstel LBM, 2006, AUTON NEUROSCI-BASIC, V126, P130, DOI 10.1016/j.autneu.2006.02.022; SAAD MAA, 1989, J AUTONOM NERV SYST, V27, P165, DOI 10.1016/0165-1838(89)90098-2; Saleh TM, 1998, AM J PHYSIOL-REG I, V274, pR1417, DOI 10.1152/ajpregu.1998.274.5.R1417; SANDKUHLER J, 1987, EXP BRAIN RES, V68, P168; SARA SJ, 1991, PROG BRAIN RES, V88, P571; SCHENBERG LC, 1993, BRAIN RES, V621, P50, DOI 10.1016/0006-8993(93)90296-Y; Tavares RF, 2006, NEUROSCIENCE, V143, P231, DOI 10.1016/j.neuroscience.2006.07.030; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P1; VALENTINO RJ, 1993, ANN NY ACAD SCI, V697, P173, DOI 10.1111/j.1749-6632.1993.tb49931.x; Verberne AJM, 1998, PROG NEUROBIOL, V54, P149, DOI 10.1016/S0301-0082(97)00056-7; Zhang ZH, 1998, BRAIN RES, V813, P73, DOI 10.1016/S0006-8993(98)00996-2	56	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e83900	10.1371/journal.pone.0083900	http://dx.doi.org/10.1371/journal.pone.0083900			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404141	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460800020
J	Bai, YT; Xu, ZG; Zhang, J; Mao, DQ; Luo, C; He, YY; Liang, GD; Lu, B; Bisesi, MS; Sun, QH; Xu, XY; Yang, WZ; Liu, QY				Bai, Yuntao; Xu, Zhiguang; Zhang, Jing; Mao, Deqiang; Luo, Chao; He, Yuanyuan; Liang, Guodong; Lu, Bo; Bisesi, Michael S.; Sun, Qinghua; Xu, Xinyi; Yang, Weizhong; Liu, Qiyong			Regional Impact of Climate on Japanese Encephalitis in Areas Located near the Three Gorges Dam	PLOS ONE			English	Article							RESERVOIR AREA; SCHISTOSOMIASIS TRANSMISSION; MAINLAND CHINA; ANDHRA-PRADESH; MOLECULAR CHARACTERIZATION; WEATHER VARIABLES; KURNOOL DISTRICT; SOUTHEAST-ASIA; YANGTZE-RIVER; VIRUS	Background: In this study, we aim to identify key climatic factors that are associated with the transmission of Japanese encephalitis virus in areas located near the Three Gorges Dam, between 1997 and 2008. Methods: We identified three geographical regions of Chongqing, based on their distance from the Three Gorges Dam. Collectively, the three regions consisted of 12 districts from which study information was collected. Zero-Inflated Poisson Regression models were run to identify key climatic factors of the transmission of Japanese encephalitis virus for both the whole study area and for each individual region; linear regression models were conducted to examine the fluctuation of climatic variables over time during the construction of the Three Gorges Dam. Results: Between 1997 and 2008, the incidence of Japanese encephalitis decreased throughout the entire city of Chongqing, with noticeable variations taking place in 2000, 2001 and 2006. The eastern region, which is closest to the Three Gorges Dam, suffered the highest incidence of Japanese encephalitis, while the western region experienced the lowest incidence. Linear regression models revealed that there were seasonal fluctuations of climatic variables during this period. Zero-Inflated Poisson Regression models indicated a significant positive association between temperature (with a lag of 1 and 3 months) and Japanese encephalitis incidence, and a significant negative association between rainfall (with a lag of 0 and 4 months) and Japanese encephalitis incidence. Conclusion: The spatial and temporal trends of Japanese encephalitis incidence that occurred in the City of Chongqing were associated with temperature and rainfall. Seasonal fluctuations of climatic variables during this period were also observed. Additional studies that focus on long-term data collection are needed to validate the findings of this study and to further explore the effects of the Three Gorges Dam on Japanese encephalitis and other related diseases.	[Bai, Yuntao; Bisesi, Michael S.; Sun, Qinghua] Ohio State Univ, Coll Publ Hlth, Div Environm Hlth Sci, Columbus, OH 43210 USA; [Xu, Zhiguang; Xu, Xinyi] Ohio State Univ, Dept Stat, Columbus, OH 43210 USA; [Zhang, Jing; Yang, Weizhong; Liu, Qiyong] Chinese Ctr Dis Control & Prevent, Key Lab Surveillance & Early Warning Infect Dis, Beijing, Peoples R China; [Mao, Deqiang] Chongqing Ctr Dis Control & Prevent, Chongqing, Peoples R China; [Luo, Chao] Wanzhou Dist Control Dis Prevent & Control, Chongqing, Peoples R China; [He, Yuanyuan] Yichang Ctr Dis Control & Prevent, Yichang, Hubei Province, Peoples R China; [Liang, Guodong] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Lu, Bo] Ohio State Univ, Coll Publ Hlth, Div Biostat, Columbus, OH 43210 USA; [Liu, Qiyong] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Dept Vector Biol & Control, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; University System of Ohio; Ohio State University; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Xu, XY (corresponding author), Ohio State Univ, Dept Stat, Columbus, OH 43210 USA.	xinyi@stat.osu.edu; yangwz@chinacdc.cn; liuqiyong@icdc.cn	Bai, Yuntao/S-8408-2016; Yang, Wei/HIA-0360-2022		Ohio State University Office of International Affairs Gateway Research Seed Grant; National Science Foundation [DMS-12-09194]; Division Of Mathematical Sciences [1209194] Funding Source: National Science Foundation	Ohio State University Office of International Affairs Gateway Research Seed Grant; National Science Foundation(National Science Foundation (NSF)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported in part by The Ohio State University Office of International Affairs Gateway Research Seed Grant (2011) to Qinghua Sun, and in part by the National Science Foundation under award number DMS-12-09194. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi P, 2003, VECTOR-BORNE ZOONOT, V3, P111, DOI 10.1089/153036603768395807; Bi P, 2007, J INFECTION, V55, P551, DOI 10.1016/j.jinf.2007.07.004; BUESCHER EL, 1959, AM J TROP MED HYG, V8, P678, DOI 10.4269/ajtmh.1959.8.678; Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233; Chai C, 2009, SCI TOTAL ENVIRON, V407, P4687, DOI 10.1016/j.scitotenv.2009.05.011; Dutta Kallol, 2011, Infectious Disorders - Drug Targets, V11, P300; Gao XY, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000624; Ghosh D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000437; Gray DJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001588; Hanna JN, 1996, MED J AUSTRALIA, V165, P256, DOI 10.5694/j.1326-5377.1996.tb124960.x; Henrich TJ, 2003, MICROBES INFECT, V5, P603, DOI 10.1016/S1286-4579(03)00100-X; Hills SL, 2009, EMERG INFECT DIS, V15, P1333, DOI 10.3201/eid1508.090149; Hu Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052687; Huang Liuqin, 2011, Weishengwu Xuebao, V51, P83; Impoinvil DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022192; Lin HL, 2012, INT J PUBLIC HEALTH, V57, P289, DOI 10.1007/s00038-011-0236-x; Mackenzie JS, 2001, EMERG INFECT DIS, V7, P497, DOI 10.3201/eid0707.017703; Miller RH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001678; MOGI M, 1983, AM J TROP MED HYG, V32, P170, DOI 10.4269/ajtmh.1983.32.170; Murty US, 2010, J VECTOR DIS, V47, P26; Nga PT, 2004, J GEN VIROL, V85, P1625, DOI 10.1099/vir.0.79797-0; REISEN W K, 1976, Southeast Asian Journal of Tropical Medicine and Public Health, V7, P61; Richards EE, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-32; RODRIGUES FM, 1981, T ROY SOC TROP MED H, V75, P258, DOI 10.1016/0035-9203(81)90330-8; Sabchareon A, 1998, ANN TROP PAEDIATR, V18, pS67, DOI 10.1080/02724936.1998.11747983; Sarkar A, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-368; Sleigh AC, 2001, LANCET, V357, P570, DOI 10.1016/S0140-6736(00)04072-1; Teng M, 2012, VIRUS GENES; Thongtan T, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/890586; Tian LW, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-110; Tiwari S, 2012, BRAZ J INFECT DIS, V16, P564, DOI 10.1016/j.bjid.2012.10.004; Upadhyayula SM, 2012, ASIAN PAC J TROP MED, V5, P337, DOI 10.1016/S1995-7645(12)60054-6; van den Hurk AF, 2009, ANNU REV ENTOMOL, V54, P17, DOI 10.1146/annurev.ento.54.110807.090510; Wang HY, 2009, JPN J INFECT DIS, V62, P331; Wang JX, 2009, CHEMOSPHERE, V75, P1119, DOI 10.1016/j.chemosphere.2009.01.016; Wang Y M, 1985, Zhonghua Yi Xue Za Zhi, V65, P648; Xu LJ, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-101; Xu X J, 1999, Southeast Asian J Trop Med Public Health, V30, P549; Xu XB, 2011, SCI TOTAL ENVIRON, V409, P4656, DOI 10.1016/j.scitotenv.2011.08.004; Zeng H, 2011, ACTA TROP, V120, P238, DOI 10.1016/j.actatropica.2011.09.003; Zhang Ding-lin, 2008, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V22, P95; Zhang Hui-juan, 2007, Zhonghua Yufang Yixue Zazhi, V41, P138; Zhang L, 2012, BIOMED ENVIRON SCI, V25, P297, DOI 10.3967/0895-3988.2012.03.007; Zhang Sheng, 2008, Huanjing Kexue, V29, P7; Zhang Sheng, 2007, Huanjing Kexue, V28, P500; Zheng H, 2013, J VET SCI, V14, P27, DOI 10.4142/jvs.2013.14.1.27; Zheng YY, 2012, REV MED VIROL, V22, P301, DOI 10.1002/rmv.1710; Zhou GJ, 2011, ENVIRON MONIT ASSESS, V176, P125, DOI 10.1007/s10661-010-1571-8; Zhu R, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-43; Zhu Ze-rong, 2011, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V25, P258	50	16	16	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84326	10.1371/journal.pone.0084326	http://dx.doi.org/10.1371/journal.pone.0084326			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404159	Green Submitted, gold, Green Published			2022-12-27	WOS:000329460800038
J	Benites, F; Simon, S; Sapozhnikova, E				Benites, Fernando; Simon, Svenja; Sapozhnikova, Elena			Mining Rare Associations between Biological Ontologies	PLOS ONE			English	Article							GENE-EXPRESSION; G-PROTEIN; RULES; RECEPTOR; SYSTEM	The constantly increasing volume and complexity of available biological data requires new methods for their management and analysis. An important challenge is the integration of information from different sources in order to discover possible hidden relations between already known data. In this paper we introduce a data mining approach which relates biological ontologies by mining cross and intra-ontology pairwise generalized association rules. Its advantage is sensitivity to rare associations, for these are important for biologists. We propose a new class of interestingness measures designed for hierarchically organized rules. These measures allow one to select the most important rules and to take into account rare cases. They favor rules with an actual interestingness value that exceeds the expected value. The latter is calculated taking into account the parent rule. We demonstrate this approach by applying it to the analysis of data from Gene Ontology and GPCR databases. Our objective is to discover interesting relations between two different ontologies or parts of a single ontology. The association rules that are thus discovered can provide the user with new knowledge about underlying biological processes or help improve annotation consistency. The obtained results show that produced rules represent meaningful and quite reliable associations.	[Benites, Fernando; Simon, Svenja; Sapozhnikova, Elena] Univ Konstanz, Dept Comp & Informat Sci, Constance, Germany	University of Konstanz	Benites, F (corresponding author), Univ Konstanz, Dept Comp & Informat Sci, Constance, Germany.	Fernando.Benites@Uni-Konstanz.de		Benites, Fernando/0000-0003-1153-182X	German Research Foundation (Deutsche Forschungsgemeinschaft (DFG))	German Research Foundation (Deutsche Forschungsgemeinschaft (DFG))(German Research Foundation (DFG))	The project is supported by the German Research Foundation (Deutsche Forschungsgemeinschaft (DFG)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R., 1993, SIGMOD Record, V22, P207, DOI 10.1145/170036.170072; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; An Li, 2009, IEEE Int Conf Bioinform Biomed Workshops, V2009, P254, DOI 10.1109/BIBMW.2009.5332104; Artamonova II, 2005, BIOINFORMATICS, V21, P49, DOI 10.1093/bioinformatics/bti1206; Artamonova II, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-261; Becquet C, 2002, GENOME BIOL, V3; Benites F, 2013, P INT C BIOINF MOD M; Benites F, 2012, LEARNING DIFFERENT C, P18; Berzal F., 2002, Intelligent Data Analysis, V6, P221; Bodenreider O, 2005, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2005, P91; BRADLEY SA, 1987, BIOCHEM J, V248, P495, DOI 10.1042/bj2480495; Brijs T., 2000, INT J INFORM THEORIE, V10, P370; Brin S., 1997, SIGMOD Record, V26, P255, DOI [10.1145/253262.253327, 10.1145/253262.253325]; Carmona-Saez P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-54; Creighton C, 2003, BIOINFORMATICS, V19, P79, DOI 10.1093/bioinformatics/19.1.79; Dafas PA, 2007, CURR BIOINFORM, V2, P157, DOI 10.2174/157489307781662114; Doan A.H., 2002, P 11 INT C WORLD WID, P662, DOI [10.1145/511446.511532, DOI 10.1145/511446.511532]; Faria D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040519; Flor PJ, 1997, NEUROPHARMACOLOGY, V36, P153, DOI 10.1016/S0028-3908(96)00176-1; Hackenberg M., 2008, BIOINFORMATICS; Jiawei Han, 1995, VLDB '95. Proceedings of the 21st International Conference on Very Large Data Bases, P420; Joyce AR, 2006, NAT REV MOL CELL BIO, V7, P198, DOI 10.1038/nrm1857; Karpinets TV, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks403; Lallich S., 2007, STUDIES COMPUTATIONA, P251, DOI DOI 10.1007/978-3-540-44918-8_; MacDonald NJ, 2010, BIOINFORMATICS, V26, P1834, DOI 10.1093/bioinformatics/btq305; Maedche A, 2000, FRONT ARTIF INTEL AP, V54, P321; Manda P, 2013, J BIOMED INFORM, V46, P849, DOI 10.1016/j.jbi.2013.06.012; Manda P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047411; Paulheim H, 2012, P 2 INT C WEB INT MI, P31, DOI [10.1145/2254129.2254168, DOI 10.1145/2254129.2254168.URL]; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; Rodriguez A, 2005, J AM SOC INF SCI TEC, V56, P493, DOI 10.1002/asi.20138; Shivakumar BL, 2012, INT J COMPUTER SCI I, V2, P542; Silla CN, 2011, INTELL DATA ANAL, V15, P979, DOI 10.3233/IDA-2011-0505; Srikant R., 1995, VLDB '95. Proceedings of the 21st International Conference on Very Large Data Bases, P407; Surana A, 2010, 16 INT C MAN DAT COM; Tamura M, 2008, BIOINFORMATICS, V24, P1523, DOI 10.1093/bioinformatics/btn210; Tan PN, 2004, INFORM SYST, V29, P293, DOI 10.1016/S0306-4379(03)00072-3; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Troyanskaya OG, 2003, P NATL ACAD SCI USA, V100, P8348, DOI 10.1073/pnas.0832373100; Tseng VS, 2009, INFORM SYST FRONT, V11, P433, DOI 10.1007/s10796-009-9156-1; van Hemert J, 2007, LECT NOTES COMPUT SC, V4414, P66; Vroling B, 2011, NUCLEIC ACIDS RES, V39, pD309, DOI 10.1093/nar/gkq1009; Weiss G.M., 2004, SIGKDD EXPLOR NEWSL, V6, P7, DOI [10.1145/1007730.1007734, DOI 10.1145/1007730.1007734]; Wu TY, 2010, DATA MIN KNOWL DISC, V21, P371, DOI 10.1007/s10618-009-0161-2	44	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84475	10.1371/journal.pone.0084475	http://dx.doi.org/10.1371/journal.pone.0084475			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404165	Green Published, Green Submitted, gold			2022-12-27	WOS:000329460800044
J	Fedigan, LM; Melin, AD; Addicott, JF; Kawamura, S				Fedigan, Linda M.; Melin, Amanda D.; Addicott, John F.; Kawamura, Shoji			The Heterozygote Superiority Hypothesis for Polymorphic Color Vision Is Not Supported by Long-Term Fitness Data from Wild Neotropical Monkeys	PLOS ONE			English	Article							WHITE-FACED CAPUCHINS; MARMOSETS CALLITHRIX-GEOFFROYI; CEBUS-CAPUCINUS; REPRODUCTIVE SUCCESS; TRICHROMATIC VISION; FORAGING ADVANTAGE; MALE DISPERSAL; OPSIN ALLELES; PRIMATE; EVOLUTION	The leading explanatory model for the widespread occurrence of color vision polymorphism in Neotropical primates is the heterozygote superiority hypothesis, which postulates that trichromatic individuals have a fitness advantage over other phenotypes because red-green chromatic discrimination is useful for foraging, social signaling, or predator detection. Alternative explanatory models predict that dichromatic and trichromatic phenotypes are each suited to distinct tasks. To conclusively evaluate these models, one must determine whether proposed visual advantages translate into differential fitness of trichromatic and dichromatic individuals. We tested whether color vision phenotype is a significant predictor of female fitness in a population of wild capuchins, using long-term (26 years) survival and fertility data. We found no advantage to trichromats over dichromats for three fitness measures (fertility rates, offspring survival and maternal survival). This finding suggests that a selective mechanism other than heterozygote advantage is operating to maintain the color vision polymorphism. We propose that attention be directed to field testing the alternative mechanisms of balancing selection proposed to explain opsin polymorphism: niche-divergence, frequency-dependence and mutual benefit of association. This is the first in-depth, long-term study examining the effects of color vision variation on survival and reproductive success in a naturally-occurring population of primates.	[Fedigan, Linda M.] Univ Calgary, Dept Anthropol, Calgary, AB T2N 1N4, Canada; [Melin, Amanda D.] Washington Univ, Dept Anthropol, St Louis, MO 63130 USA; [Addicott, John F.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Kawamura, Shoji] Univ Tokyo, Dept Integrated Biosci, Kashiwa, Chiba, Japan	University of Calgary; Washington University (WUSTL); University of Calgary; University of Tokyo	Fedigan, LM (corresponding author), Univ Calgary, Dept Anthropol, Calgary, AB T2N 1N4, Canada.	fedigan@ucalgary.ca		Melin, Amanda/0000-0002-0612-2514	Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs Program; Wenner-Gren Foundation; Leakey Foundation; Japan Society for the Promotion of Science [A22247036]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs Program(Canada Research Chairs); Wenner-Gren Foundation; Leakey Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Funding was provided by the Natural Sciences and Engineering Research Council of Canada (LMF, ADM, JFA) http://www.nserc-crsng.gc.ca, The Canada Research Chairs Program (LMF) http://www.chairs-chaires.gc.ca/, the Wenner-Gren and Leakey Foundations (ADM) http://www.wennergren.org/, http://leakeyfoundation.org, and a Grant-in-Aid for Scientific Research (A22247036) from the Japan Society for the Promotion of Science (SK) http://www.jsps.go.jp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradley BJ, 2011, EVOL ANTHROPOL, V20, P104, DOI 10.1002/evan.20306; Brown D., 1988, REPROD SUCCESS, P439; Caine NG, 2010, BIOL LETTERS, V6, P36, DOI 10.1098/rsbl.2009.0591; Caine NG, 2002, EAT OR BE EATEN, P58, DOI 10.1017/CBO9780511610233.005; Caine NG, 2000, P ROY SOC B-BIOL SCI, V267, P439, DOI 10.1098/rspb.2000.1019; Changizi MA, 2006, BIOL LETT-UK, V2, P217, DOI 10.1098/rsbl.2006.0440; Clutton-Brock T.H., 1988, P325; Cropp S, 2002, J MOL EVOL, V54, P734, DOI 10.1007/s0023901-0073-2; DEEB SS, 1992, AM J HUM GENET, V51, P687; Dominy NJ, 2001, NATURE, V410, P363, DOI 10.1038/35066567; Fedigan Linda M., 2012, P165; Fedigan LM, 2008, AM J PHYS ANTHROPOL, V137, P82, DOI 10.1002/ajpa.20848; Fedigan LM, 2011, AM J PHYS ANTHROPOL, V144, P317, DOI 10.1002/ajpa.21414; Fedigan LM, 2004, BEHAVIOUR, V141, P755, DOI 10.1163/1568539042245178; Fedigan LM, 2003, INT J PRIMATOL, V24, P723, DOI 10.1023/A:1024620620454; Freitag FB, 2012, J OPT SOC AM A, V29, pA216, DOI 10.1364/JOSAA.29.00A216; HARTL DL, 2007, PRINCIPLES POPULATIO, P4; Hiramatsu C, 2005, AM J PRIMATOL, V67, P447, DOI 10.1002/ajp.20199; Hiramatsu C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003356; Hiramatsu C, 2009, ANIM BEHAV, V77, P1421, DOI 10.1016/j.anbehav.2009.02.012; Hiwatashi T, 2010, MOL BIOL EVOL, V27, P453, DOI 10.1093/molbev/msp262; Jack KM, 2004, ANIM BEHAV, V67, P771, DOI 10.1016/j.anbehav.2003.06.015; Jack KM, 2004, ANIM BEHAV, V67, P761, DOI 10.1016/j.anbehav.2003.04.015; Jack KM, 2009, BEHAVIOUR, V146, P437; Jacobs GH, 2009, PHILOS T R SOC B, V364, P2957, DOI 10.1098/rstb.2009.0039; Jones JH, 2010, J ANIM ECOL, V79, P1262, DOI 10.1111/j.1365-2656.2010.01687.x; Kamilar JM, 2013, AM J PRIMATOL, V75, P740, DOI 10.1002/ajp.22099; Kawamura Shoji, 2012, P93; Melin AD, 2014, INT J PRIMATOL, V35, P258, DOI 10.1007/s10764-013-9730-8; Melin AD, 2013, VISION RES, V86, P87, DOI 10.1016/j.visres.2013.04.013; Melin A. D., 2012, EVOLUTIONARY BIOL ME, P225, DOI [DOI 10.1007/978-3-642-30425-5_13, 10.1007/978-3-642-30425-5_13]; Melin AD, 2008, BEHAV ECOL SOCIOBIOL, V62, P659, DOI 10.1007/s00265-007-0490-3; Melin AD, 2007, ANIM BEHAV, V73, P205, DOI 10.1016/j.anbehav.2006.07.003; Melin AD, 2010, CURR ZOOL, V56, P300, DOI 10.1093/czoolo/56.3.300; Melin AD, 2009, INT J PRIMATOL, V30, P753, DOI 10.1007/s10764-009-9383-9; MOLLON JD, 1989, J EXP BIOL, V146, P21; MOLLON JD, 1984, PROC R SOC SER B-BIO, V222, P373, DOI 10.1098/rspb.1984.0071; Montague MJ, 2014, INT J PRIMATOL, V35, P169, DOI 10.1007/s10764-013-9723-7; MORGAN MJ, 1992, P ROY SOC B-BIOL SCI, V248, P291, DOI 10.1098/rspb.1992.0074; Osorio D, 2004, AM NAT, V164, P696, DOI 10.1086/425332; Pusey Anne, 2012, P343; R Core Team, 2012, R LANG ENV STAT COMP; Regan BC, 2001, PHILOS T R SOC B, V356, P229, DOI 10.1098/rstb.2000.0773; Riba-Hernandez P, 2007, J EXP BIOL, V207, P2465; Rowe MP, 2004, VISUAL NEUROSCI, V21, P217, DOI 10.1017/S0952523804213104; Saito A, 2005, AM J PRIMATOL, V67, P471, DOI 10.1002/ajp.20201; Saito A, 2005, AM J PRIMATOL, V67, P425, DOI 10.1002/ajp.20197; Sharpe L.T., 1999, COLOR VISION GENES P, P3; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Smith AC, 2003, AM J PRIMATOL, V61, P145, DOI 10.1002/ajp.10117; Smith AC, 2012, ANIM BEHAV, V83, P479, DOI 10.1016/j.anbehav.2011.11.023; STRIER KB, 2004, PRIMATOLOGIA BRASIL, V8, P53; Sumner P, 2000, J EXP BIOL, V203, P1987; Sumner P, 2003, AM J PRIMATOL, V59, P67, DOI 10.1002/ajp.10066; Surridge AK, 2005, AM J PRIMATOL, V67, P463, DOI 10.1002/ajp.20200; Surridge AK, 2005, BIOL LETTERS, V1, P465, DOI 10.1098/rsbl.2005.0367; Surridge AK, 2003, TRENDS ECOL EVOL, V18, P198, DOI 10.1016/S0169-5347(03)00012-0; Surridge AK, 2002, MOL ECOL, V11, P2157, DOI 10.1046/j.1365-294X.2002.01597.x; Therneau T, 2012, PACKAGE SURVIVAL ANA; Vogel ER, 2007, BEHAV ECOL, V18, P292, DOI 10.1093/beheco/arl082; Yamashita N, 2005, BEHAV ECOL SOCIOBIOL, V58, P618, DOI 10.1007/s00265-005-0936-4	61	17	17	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84872	10.1371/journal.pone.0084872	http://dx.doi.org/10.1371/journal.pone.0084872			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404195	Green Submitted, gold, Green Published			2022-12-27	WOS:000329460800074
J	Shao, XH; Tian, L; Xu, WJ; Zhang, Z; Wang, CL; Qi, CJ; Ni, ZH; Mou, S				Shao, Xinghua; Tian, Lei; Xu, Weijia; Zhang, Zhen; Wang, Chunlin; Qi, Chaojun; Ni, Zhaohui; Mou, Shan			Diagnostic Value of Urinary Kidney Injury Molecule 1 for Acute Kidney Injury: A Meta-Analysis	PLOS ONE			English	Article							ACID-BINDING PROTEIN; BIOMARKERS; KIM-1; STRATIFICATION; SERUM; AKI; PERFORMANCE; CREATININE; OUTCOMES; QUALITY	Background: Urinary Kidney Injury Molecule 1 (KIM-1) is a proximal tubular injury biomarker for early detection of acute kidney injury (AKI), with variable performance characteristics depending on clinical and population settings. Methods: Meta-analysis was performed to assess the diagnostic value of urinary KIM-1 in AKI. Relevant studies were searched from MEDLINE, EMBASE, Pubmed, Elsevier Science Direct, Scopus, Web of Science, Google Scholar and Cochrane Library. Meta-analysis methods were used to pool sensitivity and specificity and to construct summary receiver operating characteristic (SROC) curves. Results: A total of 2979 patients from 11 eligible studies were enrolled in the analysis. Five prospective cohorts, two cross-sectional and four case-control studies were identified for meta-analysis. The estimated sensitivity of urinary KIM-1 for the diagnosis of AKI was 74.0% (95% CI, 61.0%-84.0%), and specificity was 86.0% (95% CI, 74.0%-93.0%). The SROC analysis showed an area under the curve of 0.86(0.83-0.89). Subgroup analysis suggested that population settings and detection time were the key factors affecting the efficiency of KIM-1 for AKI diagnosis. Limitation: Various population settings, different definition of AKI and Serum creatinine level used as the standard might have influence on AKI diagnosis. The relatively small number of studies and heterogeneity between them also affected the evaluation. Conclusion: Urinary KIM-1 may be a promising biomarker for early detection of AKI with considerable predictive value, especially for cardiac surgery patients, and its potential value needs to be validated in large studies and across a broader scope of clinical settings.	[Shao, Xinghua; Tian, Lei; Xu, Weijia; Zhang, Zhen; Wang, Chunlin; Qi, Chaojun; Ni, Zhaohui; Mou, Shan] Shanghai Jiao Tong Univ, Sch Med, Dept Nephrol, Mol Cell Lab Kidney Dis,Ren Ji Hosp, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Mou, S (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Nephrol, Mol Cell Lab Kidney Dis,Ren Ji Hosp, Shanghai 200030, Peoples R China.	shan_mou@126.com	shao, xinghua/GVU-8320-2022	mou, shan/0000-0003-4160-1681	National Basic Research Program of China 973 Program [2012CB517600, 2012CB517602]; National Natural Science Foundation of China [81102700, 81373865]; National "Twelfth Five-Year" Plan for Science & Technology Support [2011BAI10B00]; Science and Technology Commission of Shanghai Municipality, China [10JC1410100, 12401906400, 13401906100]; Shanghai Health Bureau [ZXSNXD-CC-ZDYJ002]; Funding scheme for training young teachers in Colleges and Universities in Shanghai	National Basic Research Program of China 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National "Twelfth Five-Year" Plan for Science & Technology Support; Science and Technology Commission of Shanghai Municipality, China(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Health Bureau; Funding scheme for training young teachers in Colleges and Universities in Shanghai	This study was supported in part by the National Basic Research Program of China 973 Program No. 2012CB517600 (No. 2012CB517602). The study was also sponsored by the National Natural Science Foundation of China (81102700 and 81373865), National "Twelfth Five-Year" Plan for Science & Technology Support No. 2011BAI10B00 and by grants 10JC1410100, 12401906400 and 13401906100 from the Science and Technology Commission of Shanghai Municipality, China. Program ZXSNXD-CC-ZDYJ002 from the Shanghai Health Bureau and Funding scheme for training young teachers in Colleges and Universities in Shanghai were also included. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiyanti Sri S, 2012, Acta Med Indones, V44, P246; Barrera-Chimal J, 2013, KIDNEY INT, V83, P93, DOI 10.1038/ki.2012.352; Bhavsar NA, 2012, AM J KIDNEY DIS, V60, P233, DOI 10.1053/j.ajkd.2012.02.336; Bonventre JV, 2008, SCAND J CLIN LAB INV, V68, P78, DOI 10.1080/00365510802145059; Coca SG, 2008, KIDNEY INT, V73, P1008, DOI 10.1038/sj.ki.5002729; Deville Walter L, 2002, BMC Med Res Methodol, V2, P9, DOI 10.1186/1471-2288-2-9; Edelstein CL, 2008, ADV CHRONIC KIDNEY D, V15, P222, DOI 10.1053/j.ackd.2008.04.003; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; El Naggar GF, 2012, LIFE SCI J, V9, P3937; Endre ZH, 2011, KIDNEY INT, V79, P1119, DOI 10.1038/ki.2010.555; Ferguson MA, 2010, KIDNEY INT, V77, P708, DOI 10.1038/ki.2009.422; Genc G, 2013, AM J PERINAT, V30, P245, DOI 10.1055/s-0032-1323587; Han WK, 2008, KIDNEY INT, V73, P863, DOI 10.1038/sj.ki.5002715; Han WK, 2002, KIDNEY INT, V62, P237, DOI 10.1046/j.1523-1755.2002.00433.x; Han WK, 2009, CLIN J AM SOC NEPHRO, V4, P873, DOI 10.2215/CJN.04810908; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huang Yun, 2011, Inflammation & Allergy Drug Targets, V10, P260; Ichimura T, 1998, J BIOL CHEM, V273, P4135, DOI 10.1074/jbc.273.7.4135; Lattanzio MR, 2009, J AM OSTEOPATH ASSOC, V109, P13; Li PKT, 2013, NAT REV NEPHROL, V9, P133, DOI 10.1038/nrneph.2013.20; Liang XL, 2010, BIOMARKERS, V15, P332, DOI 10.3109/13547501003706558; Liangos O, 2009, BIOMARKERS, V14, P423, DOI 10.1080/13547500903067744; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Nickolas TL, 2012, J AM COLL CARDIOL, V59, P246, DOI 10.1016/j.jacc.2011.10.854; Parikh CR, 2013, CLIN J AM SOC NEPHRO, V8, P1079, DOI 10.2215/CJN.10971012; PERRONE RD, 1992, CLIN CHEM, V38, P1933; Ronco C, 2007, INT J ARTIF ORGANS, V30, P373, DOI 10.1177/039139880703000503; Sarafidis K, 2012, PEDIATR NEPHROL, V27, P1575, DOI 10.1007/s00467-012-2162-4; Slocum JL, 2012, TRANSL RES, V159, P277, DOI 10.1016/j.trsl.2012.01.014; Sprenkle P, 2013, ARCH ESP UROL, V66, P99; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Vaidya VS, 2008, CTS-CLIN TRANSL SCI, V1, P200, DOI 10.1111/j.1752-8062.2008.00053.x; Waanders F, 2010, J PATHOL, V220, P7, DOI 10.1002/path.2642; Webb S, 2007, ANAESTH INTENS CARE, V35, P843, DOI 10.1177/0310057X0703500601; Whiting P, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8250; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31	37	121	131	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84131	10.1371/journal.pone.0084131	http://dx.doi.org/10.1371/journal.pone.0084131			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404151	gold, Green Published, Green Submitted			2022-12-27	WOS:000329460800030
J	Witz, N; Zhou, JW; Hess, RF				Witz, Nirel; Zhou, Jiawei; Hess, Robert F.			Similar Mechanisms Underlie the Detection of Horizontal and Vertical Disparity Corrugations	PLOS ONE			English	Article							ORIENTATION CHANNELS; SENSITIVITY; SUMMATION; THRESHOLD	Our aim was to compare sensitivity for horizontal and vertical disparity corrugations and to resolve whether these stimuli are processed by similar or radically different underlying mechanisms. We measure global disparity sensitivity as a function of carrier spatial frequency for equi-detectable carriers and found a similar optimal carrier relationship for vertical and horizontal stimuli. Sensitivity as a function of corrugation spatial frequency for stimuli of comparable spatial summation and composed of optimal, equi-detectable narrowband carriers did not significantly differ for vertical and horizontal stimuli. A small anisotropy was revealed when fixed, high contrast broadband carriers were used. In a separate discrimination-at-threshold experiment, multiple mechanisms of similar tuning were revealed to underlie the detection of both vertical and horizontal disparity corrugations. We conclude that the processing of the horizontal and vertical disparity corrugations occurs along similar lines.	[Witz, Nirel; Zhou, Jiawei; Hess, Robert F.] McGill Univ, Dept Ophthalmol, McGill Vis Res, Montreal, PQ H3A 2T5, Canada	McGill University	Hess, RF (corresponding author), McGill Univ, Dept Ophthalmol, McGill Vis Res, Montreal, PQ H3A 2T5, Canada.	robert.hess@mcgill.ca	Zhou, Jiawei/AGN-8024-2022	Zhou, Jiawei/0000-0003-4220-344X	NSERC [46528]	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by an NSERC grant(http://www.nserc-crsng.gc.ca/index_eng.asp) to RFH (#46528). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradshaw MF, 1999, VISION RES, V39, P3049, DOI 10.1016/S0042-6989(99)00015-2; Chen CC, 2006, VISION RES, V46, P2691, DOI 10.1016/j.visres.2006.02.009; Ellemberg D, 2006, VISION RES, V46, P2798, DOI 10.1016/j.visres.2006.01.028; Garcia-Perez MA, 1998, VISION RES, V38, P1861, DOI 10.1016/S0042-6989(97)00340-4; Hess RF, 1999, VISION RES, V39; Hibbard PB, 2002, J EXP PSYCHOL HUMAN, V28, P469, DOI 10.1037//0096-1523.28.2.469; HOWELL ER, 1978, VISION RES, V18, P369, DOI 10.1016/0042-6989(78)90045-7; Lee B, 1997, VISION RES, V37, P1769, DOI 10.1016/S0042-6989(96)00274-X; Pulliam K., 1982, VISUAL SIMULATION IM, VII, DOI [10.1117/12.932660, DOI 10.1117/12.932660]; ROBSON JG, 1981, VISION RES, V21, P409, DOI 10.1016/0042-6989(81)90169-3; SCHUMER R, 1979, VISION RES, V19, P1303, DOI 10.1016/0042-6989(79)90202-5; Serrano-Pedraza I, 2010, J VISION, V10, DOI 10.1167/10.12.10; THOMAS JP, 1979, J OPT SOC AM, V69, P652, DOI 10.1364/JOSA.69.000652; TYLER CW, 1975, VISION RES, V15, P583, DOI 10.1016/0042-6989(75)90306-5; Tyler CW, 2001, VISION RES, V41, P2235, DOI 10.1016/S0042-6989(00)00261-3; van der Willigen RF, 2010, J VISION, V10, DOI 10.1167/10.1.10; WATSON AB, 1981, VISION RES, V21, P1115, DOI 10.1016/0042-6989(81)90014-6; Witz N, 2013, VISION RES, V87, P10, DOI 10.1016/j.visres.2013.05.003	18	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84846	10.1371/journal.pone.0084846	http://dx.doi.org/10.1371/journal.pone.0084846			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404193	gold, Green Published, Green Submitted			2022-12-27	WOS:000329460800072
J	Gramatica, R; Di Matteo, T; Giorgetti, S; Barbiani, M; Bevec, D; Aste, T				Gramatica, Ruggero; Di Matteo, T.; Giorgetti, Stefano; Barbiani, Massimo; Bevec, Dorian; Aste, Tomaso			Graph Theory Enables Drug Repurposing - How a Mathematical Model Can Drive the Discovery of Hidden Mechanisms of Action	PLOS ONE			English	Article							KNOWLEDGE; INFORMATION; PHOSPHORYLATION; INHIBITION; EXPRESSION; ONTOLOGIES; APOPTOSIS; DISEASE; BIOLOGY; MEDLINE	We introduce a methodology to efficiently exploit natural-language expressed biomedical knowledge for repurposing existing drugs towards diseases for which they were not initially intended. Leveraging on developments in Computational Linguistics and Graph Theory, a methodology is defined to build a graph representation of knowledge, which is automatically analysed to discover hidden relations between any drug and any disease: these relations are specific paths among the biomedical entities of the graph, representing possible Modes of Action for any given pharmacological compound. We propose a measure for the likeliness of these paths based on a stochastic process on the graph. This measure depends on the abundance of indirect paths between a peptide and a disease, rather than solely on the strength of the shortest path connecting them. We provide real-world examples, showing how the method successfully retrieves known pathophysiological Mode of Action and finds new ones by meaningfully selecting and aggregating contributions from known bio-molecular interactions. Applications of this methodology are presented, and prove the efficacy of the method for selecting drugs as treatment options for rare diseases.	[Gramatica, Ruggero; Di Matteo, T.] Kings Coll London, Dept Math, London WC2R 2LS, England; [Gramatica, Ruggero; Giorgetti, Stefano; Barbiani, Massimo; Bevec, Dorian] Therametrics AG, Stans, Switzerland; [Aste, Tomaso] UCL, Dept Comp Sci, London, England	University of London; King's College London; University of London; University College London	Aste, T (corresponding author), Kings Coll London, Dept Math, London WC2R 2LS, England.	t.aste@ucl.ac.uk	Aste, Tomaso/ABA-8973-2020; DiMatteo, Tiziana/AGZ-7196-2022; Aste, Tomaso/E-9961-2010	Aste, Tomaso/0000-0002-4219-0215; Aste, Tomaso/0000-0002-4219-0215; Di Matteo, Tiziana/0000-0002-5913-3268; Giorgetti, Stefano/0000-0001-5424-9723	COST [TD1210]	COST(European Cooperation in Science and Technology (COST))	Tiziana Di Matteo and Ruggero Gramatica gratefully acknowledge support of this work by COST TD1210 project.	Ananiadou S., 2006, TEXT MINING BIOL BIO; Andronis C, 2011, BRIEF BIOINFORM, V12, P357, DOI 10.1093/bib/bbr005; Beuret L, 2007, J BIOL CHEM, V282, P14140, DOI 10.1074/jbc.M611563200; Blaschke C, 1999, Proc Int Conf Intell Syst Mol Biol, P60; Buchdunger E, 1996, CANCER RES, V56, P100; Caldarelli G., 2007, SCALE FREE NETWORKS; Cancino GI, 2008, BRAIN, V131, P2425, DOI 10.1093/brain/awn125; Chen X, 2012, MOL BIOSYST, V8, P1970, DOI 10.1039/c2mb00002d; Cohen KB, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040020; De Saussure F., 2011, COURSE GEN LINGUISTI; Dzeroski S., 2007, COMPUTATIONAL DISCOV; Eishi Y, 2002, J CLIN MICROBIOL, V40, P198, DOI 10.1128/JCM.40.1.198-204.2002; Erhardt RAA, 2006, DRUG DISCOV TODAY, V11, P315, DOI 10.1016/j.drudis.2006.02.011; Ertmer A, 2004, J BIOL CHEM, V279, P41918, DOI 10.1074/jbc.M405652200; Firth J.R., 1957, STUDIES LINGUISTIC A; Frijters R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000943; Goni J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058070; Gonzalez-Rey E, 2007, NAT REV IMMUNOL, V7, P52, DOI 10.1038/nri1984; Gruber TR, 1995, INT J HUM-COMPUT ST, V43, P907, DOI 10.1006/ijhc.1995.1081; Hristovski D, 2005, INT J MED INFORM, V74, P289, DOI 10.1016/j.ijmedinf.2004.04.024; Hunter L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-78; Jensen LJ, 2006, NAT REV GENET, V7, P119, DOI 10.1038/nrg1768; Jesionek-Kupnicka D, 2001, ACTA NEUROBIOL EXP, V61, P13; Jin W, 2007, LECT NOTES COMPUT SC, V4426, P555; Jurafsky D, 2002, SPEECH LANGUAGE PROC; Klein M, 2001, COMBINING RELATING O; Lekka E., 2012, DRUG DISCOVERY TODAY, V8, P103, DOI DOI 10.1016/J.DDSTR.2011.06.005; Lesk A.M., 2005, INTRO BIOINFORMATICS; Li YJ, 2010, BIOINFORMATICS, V26, P1219, DOI 10.1093/bioinformatics/btq108; Loging W, 2012, DRUG DISCOV TODAY TH, V8, P109; Luo B, 2006, WORLD J GASTROENTERO, V12, P1842, DOI 10.3748/wjg.v12.i12.1842; Maedche A, 2001, IEEE INTELL SYST APP, V16, P72, DOI 10.1109/5254.920602; Manning C.D., 1999, FDN STAT NATURAL LAN; Marandi Y, 2012, FOLIA NEUROPATHOL, V50, P46; Muller-Quernheim J, 1998, EUR RESPIR J, V12, P716, DOI 10.1183/09031936.98.12030716; Nakayama T, 2005, ENDOCR J, V52, P11, DOI 10.1507/endocrj.52.11; Narayanaswamy M, 2005, BIOINFORMATICS, V21, pI319, DOI 10.1093/bioinformatics/bti1011; Navigli R, 2009, ACM COMPUT SURV, V41, DOI 10.1145/1459352.1459355; Newman M., 2011, STRUCTURE DYNAMICS N; Oda K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S3-S5; Prasse A, 2010, AM J RESP CRIT CARE, V182, P540, DOI 10.1164/rccm.200909-1451OC; Rebholz-Schuhmann D, 2012, NAT REV GENET, V13, P829, DOI 10.1038/nrg3337; Rzhetsky A, 2008, CELL, V134, P9, DOI 10.1016/j.cell.2008.06.029; Sahlgren M, 2008, ITAL J LINGUIST, V20, P33; Saric Jasmin, 2005, In Silico Biology, V5, P21; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Schlatterer SD, 2011, J MOL NEUROSCI, V45, P445, DOI 10.1007/s12031-011-9588-1; Srinivasan P, 2004, BIOINFORMATICS, V20, P290, DOI 10.1093/bioinformatics/bth914; SWANSON DR, 1986, PERSPECT BIOL MED, V30, P7; SWANSON DR, 1993, LIBR TRENDS, V41, P606; Swanson DR, 1997, ARTIF INTELL, V91, P183, DOI 10.1016/S0004-3702(97)00008-8; Wild DJ, 2012, DRUG DISCOV TODAY, V17, P469, DOI 10.1016/j.drudis.2011.12.019; Yetisgen-Yildiz M, 2006, J BIOMED INFORM, V39, P600, DOI 10.1016/j.jbi.2005.11.010; Yuan X, 2006, BIOINFORMATICS, V22, P1668, DOI 10.1093/bioinformatics/btl159; Zhou HJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.041908; Zweigenbaum P, 2007, BRIEF BIOINFORM, V8, P358, DOI 10.1093/bib/bbm045	56	21	21	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84912	10.1371/journal.pone.0084912	http://dx.doi.org/10.1371/journal.pone.0084912			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416311	Green Submitted, Green Published, gold			2022-12-27	WOS:000329866300041
J	Wieling, M; Nerbonne, J; Bloem, J; Gooskens, C; Heeringa, W; Baayen, RH				Wieling, Martijn; Nerbonne, John; Bloem, Jelke; Gooskens, Charlotte; Heeringa, Wilbert; Baayen, R. Harald			A Cognitively Grounded Measure of Pronunciation Distance	PLOS ONE			English	Article								In this study we develop pronunciation distances based on naive discriminative learning (NDL). Measures of pronunciation distance are used in several subfields of linguistics, including psycholinguistics, dialectology and typology. In contrast to the commonly used Levenshtein algorithm, NDL is grounded in cognitive theory of competitive reinforcement learning and is able to generate asymmetrical pronunciation distances. In a first study, we validated the NDL-based pronunciation distances by comparing them to a large set of native-likeness ratings given by native American English speakers when presented with accented English speech. In a second study, the NDL-based pronunciation distances were validated on the basis of perceptual dialect distances of Norwegian speakers. Results indicated that the NDL-based pronunciation distances matched perceptual distances reasonably well with correlations ranging between 0.7 and 0.8. While the correlations were comparable to those obtained using the Levenshtein distance, the NDL-based approach is more flexible as it is also able to incorporate acoustic information other than sound segments.	[Wieling, Martijn; Baayen, R. Harald] Univ Tubingen, Dept Quantitat Linguist, Tubingen, Germany; [Nerbonne, John; Gooskens, Charlotte; Heeringa, Wilbert] Univ Groningen, Ctr Language & Cognit Groningen, Groningen, Netherlands; [Bloem, Jelke] Univ Amsterdam, Amsterdam Ctr Language & Commun, Amsterdam, Netherlands; [Baayen, R. Harald] Univ Alberta, Dept Linguist, Edmonton, AB, Canada	Eberhard Karls University of Tubingen; University of Groningen; University of Amsterdam; University of Alberta	Wieling, M (corresponding author), Univ Tubingen, Dept Quantitat Linguist, Tubingen, Germany.	wieling@gmail.com	Wieling, Martijn/AAA-2462-2019; Nerbonne, John/Y-8741-2019	Wieling, Martijn/0000-0003-0434-1526; Baayen, Harald/0000-0003-3178-3944; Bloem, Jelke/0000-0003-2221-0554; Gooskens, Charlotte/0000-0002-0958-3682	Netherlands Organisation for Scientific Research; Alexander von Humboldt Foundation	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	This work has been funded by the Netherlands Organisation for Scientific Research and the Alexander von Humboldt Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baayen RH, 2011, PSYCHOL REV, V118, P438, DOI 10.1037/a0023851; Bakker D, 2009, LINGUIST TYPOL, V13, P169, DOI DOI 10.1515/LITY.2009.009; Beijering K., 2008, LINGUISTICS NETHERLA, V15, P13; Brants T., 2009, WEB 1T 5 GRAM 10 EUR; Danks D, 2003, J MATH PSYCHOL, V47, P109, DOI 10.1016/S0022-2496(02)00016-0; Gooskens C., 2004, LANG VAR CHANGE, V16, P189, DOI [10.1017/S0954394504163023, DOI 10.1017/S0954394504163023]; Heeringa W, 2003, COMPUT HUMANITIES, V37, P257, DOI 10.1023/A:1025067132504; Heeringa W., 2006, LINGUISTIC DISTANCES, P51; HEERINGA WJ, 2004, THESIS RIJKSUNIVERSI; Kessler B, 1995, SEVENTH CONFERENCE OF THE EUROPEAN CHAPTER OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, P60; Labov William, 2010, PRINCIPLES LINGUISTI, V3; LEVENSHT.VI, 1965, DOKL AKAD NAUK SSSR+, V163, P845; Nerbonne J, 2009, HANDB SPRACH KOMMUN, V1, P550; Nerbonne John, 1997, COMPUTATIONAL PHONOL; Ramscar M, 2013, LANGUAGE IN PRESS; Ramscar M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022501; Ramscar M, 2010, COGNITIVE SCI, V34, P909, DOI 10.1111/j.1551-6709.2009.01092.x; Rescorla, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Sanders NC, 2009, J QUANT LINGUIST, V16, P96, DOI 10.1080/09296170802514138; Siegel S, 1996, PSYCHON B REV, V3, P314, DOI 10.3758/BF03210755; Valls E, 2013, LIT LINGUIST COMPUT, V28, P119, DOI 10.1093/llc/fqs052; Weinberger S.H., 2011, CORPUS BASED STUDIES, P265; Wichmann S, 2010, PHYSICA A, V389, P3632, DOI 10.1016/j.physa.2010.05.011; Wieling M., 2007, TAAL TONGVAL, V59, P84; Wieling M, 2007, P RANLP WORKSH COMP, P71; Wieling M, 2012, J PHONETICS, V40, P307, DOI 10.1016/j.wocn.2011.12.004; Wieling M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023613; Wieling Martijn, 2009, LANGUAGE TECHNOLOGY, P26	28	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e75734	10.1371/journal.pone.0075734	http://dx.doi.org/10.1371/journal.pone.0075734			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	291XP	24416119	gold, Green Published, Green Submitted			2022-12-27	WOS:000329866300002
J	Callisaya, ML; Beare, R; Phan, TG; Chen, J; Srikanth, VK				Callisaya, Michele L.; Beare, Richard; Phan, Thanh G.; Chen, Jian; Srikanth, Velandai K.			Global and Regional Associations of Smaller Cerebral Gray and White Matter Volumes with Gait in Older People	PLOS ONE			English	Article							BRAIN; RISK; POPULATION; PARAMETERS; DISORDERS; VELOCITY; ATROPHY; HUMANS; AGE	Background: Gait impairments increase with advancing age and can lead to falls and loss of independence. Brain atrophy also occurs in older age and may contribute to gait decline. We aimed to investigate global and regional relationships of cerebral gray and white matter volumes with gait speed, and its determinants step length and cadence, in older people. Methods: In a population-based study, participants aged >60 years without Parkinson's disease or brain infarcts underwent magnetic resonance imaging and gait measurements using a computerized walkway. Linear regression was used to study associations of total gray and white matter volumes with gait, adjusting for each other, age, sex, height and white matter hyperintensity volume. Other covariates considered in analyses included weight and vascular disease history. Voxel-based morphometry was used to study regional relationships of gray and white matter with gait. Results: There were 305 participants, mean age 71.4 (6.9) years, 54% male, mean gait speed 1.16 (0.22) m/s. Smaller total gray matter volume was independently associated with poorer gait speed (p = 0.001) and step length (p<0.001), but not cadence. Smaller volumes of cortical and subcortical gray matter in bilateral regions important for motor control, vision, perception and memory were independently associated with slower gait speed and shorter steps. No global or regional associations were observed between white matter volume and gait independent of gray matter volume, white matter hyperintensity volume and other covariates. Conclusion: Smaller gray matter volume in bilaterally distributed brain networks serving motor control was associated with slower gait speed and step length, but not cadence.	[Callisaya, Michele L.; Beare, Richard; Phan, Thanh G.; Chen, Jian; Srikanth, Velandai K.] Monash Univ, Dept Med, Southern Clin Sch, Stroke & Ageing Res Grp, Clayton, Vic, Australia; [Callisaya, Michele L.; Srikanth, Velandai K.] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas, Australia	Monash University; University of Tasmania	Callisaya, ML (corresponding author), Monash Univ, Dept Med, Southern Clin Sch, Stroke & Ageing Res Grp, Clayton, Vic, Australia.	michele.callisaya@monash.edu	Callisaya, Michele/I-2333-2013	Callisaya, Michele/0000-0003-2122-1622; Beare, Richard/0000-0002-7530-5664; Srikanth, Velandai/0000-0002-8442-8981; Chen, Jian/0000-0002-0684-0866	National Health and Medical Research Council (NHMRC) [403000, 491109]; NHMRC/National Heart Foundation [606544]; NHMRC [1034483]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC/National Heart Foundation(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by National Health and Medical Research Council (NHMRC) Grants 403000 and 491109. VS is funded by an NHMRC/National Heart Foundation Career Development Award (606544). MC is funded by an NHMRC Early Career Fellowship (1034483). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Yahya E, 2011, NEUROSCI BIOBEHAV R, V35, P715, DOI 10.1016/j.neubiorev.2010.08.008; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Baezner H, 2008, NEUROLOGY, V70, P935, DOI 10.1212/01.wnl.0000305959.46197.e6; Beare R, 2009, NEUROIMAGE, V47, P199, DOI 10.1016/j.neuroimage.2009.03.055; Callisaya ML, 2008, J GERONTOL A-BIOL, V63, P165, DOI 10.1093/gerona/63.2.165; Callisaya ML, 2009, AGE AGEING, V38, P290, DOI 10.1093/ageing/afp017; Cesari M, 2011, JAMA-J AM MED ASSOC, V305, P93, DOI 10.1001/jama.2010.1970; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166, DOI 10.1093/gerona/61.11.1166; de Laat KF, 2012, NEUROIMAGE, V59, P1478, DOI 10.1016/j.neuroimage.2011.08.005; de Laat KF, 2011, BRAIN, V134, P73, DOI 10.1093/brain/awq343; de Laat KF, 2010, STROKE, V41, P1652, DOI 10.1161/STROKEAHA.110.583229; Dietz V, 2003, CLIN NEUROPHYSIOL, V114, P1379, DOI 10.1016/S1388-2457(03)00120-2; Fjell AM, 2010, CEREB CORTEX, V20, P2069, DOI 10.1093/cercor/bhp279; Galluzzi S, 2008, NEUROL SCI, V29, pS296, DOI 10.1007/s10072-008-1002-6; Hampel H, 2008, ALZHEIMERS DEMENT, V4, P38, DOI 10.1016/j.jalz.2007.08.006; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Hollman JH, 2011, GAIT POSTURE, V34, P111, DOI 10.1016/j.gaitpost.2011.03.024; Holtzer R, 2006, NEUROPSYCHOLOGY, V20, P215, DOI 10.1037/0894-4105.20.2.215; Ikram MA, 2008, NEUROBIOL AGING, V29, P882, DOI 10.1016/j.neurobiolaging.2006.12.012; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; la Fougere C, 2010, NEUROIMAGE, V50, P1589, DOI 10.1016/j.neuroimage.2009.12.060; LAWTON MP, 1969, GERONTOLOGIST, V9, P9, DOI 10.1093/geront/9.1.9; Leritz EC, 2011, NEUROIMAGE, V54, P2659, DOI 10.1016/j.neuroimage.2010.10.050; Lord SR, 1996, AGE AGEING, V25, P292, DOI 10.1093/ageing/25.4.292; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; Martin KL, 2013, J GERONTOL A-BIOL, V68, P726, DOI 10.1093/gerona/gls224; Meyer JS, 1998, EUR NEUROL, V39, P7, DOI 10.1159/000052064; Mitchell GF, 2008, J APPL PHYSIOL, V105, P1652, DOI 10.1152/japplphysiol.90549.2008; Montero-Odasso M, 2005, J GERONTOL A-BIOL, V60, P1304, DOI 10.1093/gerona/60.10.1304; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Raji CA, 2009, NEUROLOGY, V73, P1899, DOI 10.1212/WNL.0b013e3181c3f293; Rosano C, 2006, NEUROEPIDEMIOLOGY, V26, P52, DOI 10.1159/000089240; Rosano C, 2007, J GERONTOL A-BIOL, V62, P1048, DOI 10.1093/gerona/62.9.1048; Rosano C, 2012, AGE AGEING, V41, P58, DOI 10.1093/ageing/afr113; Rosano C, 2008, J GERONTOL A-BIOL, V63, P1380, DOI 10.1093/gerona/63.12.1380; Rosano C, 2010, NEUROBIOL AGING, V31, P1197, DOI 10.1016/j.neurobiolaging.2008.08.004; Seidler RD, 2010, NEUROSCI BIOBEHAV R, V34, P721, DOI 10.1016/j.neubiorev.2009.10.005; Srikanth V., 2010, AGING HLTH, V6, P123, DOI DOI 10.2217/AHE.09.79; Srikanth V, 2009, STROKE, V40, P175, DOI 10.1161/STROKEAHA.108.524355; Statistics ABo, 2005, POP AG SEX TASM DAT; Verghese J, 2007, J NEUROL NEUROSUR PS, V78, P929, DOI 10.1136/jnnp.2006.106914; Wang CH, 2008, J NEURAL TRANSM, V115, P1149, DOI 10.1007/s00702-008-0058-z; Webster KE, 2005, GAIT POSTURE, V22, P317, DOI 10.1016/j.gaitpost.2004.10.005	45	40	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84909	10.1371/journal.pone.0084909	http://dx.doi.org/10.1371/journal.pone.0084909			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416309	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500188
J	Hoffman, MD; Krishnan, E				Hoffman, Martin D.; Krishnan, Eswar			Health and Exercise-Related Medical Issues among 1,212 Ultramarathon Runners: Baseline Findings from the Ultrarunners Longitudinal TRAcking (ULTRA) Study	PLOS ONE			English	Article							STRESS-FRACTURES; 161-KM ULTRAMARATHON; RUNNING INJURIES; HYPONATREMIA; PREVALENCE; PERFORMANCE; STATES; RACE	Regular exercise is associated with substantial health benefits; however, little is known about the health impact of extreme levels of exercise. This study examined the prevalence of chronic diseases, health-care utilization, and risk factors for exercise-related injuries among ultramarathon runners. Retrospective, self-reported enrollment data from an ongoing longitudinal observational study of 1,212 active ultramarathon runners were analyzed. The most prevalent chronic medical conditions were allergies/hay fever (25.1%) and exercise-induced asthma (13.0%), but there was a low prevalence of serious medical issues including cancers (4.5%), coronary artery disease (0.7%), seizure disorders (0.7%), diabetes (0.7%), and human immunodeficiency virus (HIV) infection (0.2%). In the year preceding enrollment, most (64.6%) reported an exercise-related injury that resulted in lost training days (median of 14 days), but little nonattendance of work or school due to illness, injury, or exercise-related medical conditions (medians of 0 days for each). The knee was the most common area of exercise-related injury. Prior year incidence of stress fractures was 5.5% with most (44.5%) involving the foot. Ultramarathon runners who sustained exercise-related injuries were younger (p<0.001) and less experienced (p<0.01) than those without injury. Stress fractures were more common (p<0.01) among women than men. We conclude that, compared with the general population, ultramarathon runners appear healthier and report fewer missed work or school days due to illness or injury. Ultramarathon runners have a higher prevalence of asthma and allergies than the general population, and the prevalence of serious medical issues was nontrivial and should be recognized by those providing medical care to these individuals. Ultramarathon runners, compared with shorter distance runners, have a similar annual incidence of exercise-related injuries but higher proportion of stress fractures involving the foot, and it is the younger and less experienced ultramarathoners who appear most at risk for injury.	[Hoffman, Martin D.] Northern Calif Hlth Care Syst, Dept Vet Affairs, Dept Phys Med & Rehabil, Sacramento, CA USA; [Hoffman, Martin D.] Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA; [Krishnan, Eswar] Stanford Univ, Sch Med, Dept Med, Palo Alto, CA 94304 USA	University of California System; University of California Davis; Stanford University	Hoffman, MD (corresponding author), Northern Calif Hlth Care Syst, Dept Vet Affairs, Dept Phys Med & Rehabil, Sacramento, CA USA.	martin.hoffman@va.gov	krishnan, Eswar/AAY-1269-2020	Hoffman, Martin/0000-0001-8819-5989	Western States Endurance Run Foundation	Western States Endurance Run Foundation	This material is the result of work supported with resources and the use of facilities at the VA Northern California Health Care System. The work was also partially supported by the Western States Endurance Run Foundation. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, ULTRARUNNING     MAR, V2013, P25; Bennell KL, 1996, AM J SPORT MED, V24, P211, DOI 10.1177/036354659602400217; BOVENS AMP, 1989, INT J SPORTS MED, V10, pS186, DOI 10.1055/s-2007-1024970; Brubaker C E, 1974, J Sports Med, V2, P189; Bruckner P, 1996, CLIN J SPORT MED, V6, P85, DOI 10.1097/00042752-199604000-00004; Bruso JR, 2010, WILD ENVIRON MED, V21, P303, DOI 10.1016/j.wem.2010.06.012; Eijkemans M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050775; Elers J, 2011, EXPERT REV RESP MED, V5, P343, DOI [10.1586/ERS.11.28, 10.1586/ers.11.28]; FRIZZELL RT, 1986, JAMA-J AM MED ASSOC, V255, P772, DOI 10.1001/jama.255.6.772; Graham SM, 2012, CLIN J SPORT MED, V22, P462, DOI 10.1097/JSM.0b013e3182694734; Hoffman MD, 2013, MED SCI SPORT EXER, V45, P784, DOI 10.1249/MSS.0b013e31827985a8; Hoffman MD, 2012, RES SPORTS MED, V20, P59, DOI 10.1080/15438627.2012.634707; Hoffman MD, 2011, INT J SPORT PHYSIOL, V6, P25, DOI 10.1123/ijspp.6.1.25; Hoffman MD, 2010, INT J HIST SPORT, V27, P1877, DOI 10.1080/09523367.2010.494385; Hoffman MD, 2013, J PHYS ACT IN PRESS; Hoffman MD, 2013, J STRENGTH COND RES; HOLTZHAUSEN LM, 1994, MED SCI SPORT EXER, V26, P1095; James S L, 1978, Am J Sports Med, V6, P40, DOI 10.1177/036354657800600202; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Khodaee M, 2012, CURR SPORT MED REP, V11, P290, DOI 10.1249/JSR.0b013e318272c34b; Krabak BJ, 2013, CURR SPORT MED REP, V12, P183, DOI 10.1249/JSR.0b013e3182913c98; Krabak BJ, 2011, MED SCI SPORT EXER, V43, P2314, DOI 10.1249/MSS.0b013e318221bfe3; Lang G., 1984, ULTRARUNNING, V3, P14; LYSHOLM J, 1987, AM J SPORT MED, V15, P168, DOI 10.1177/036354658701500213; MACERA CA, 1989, ARCH INTERN MED, V149, P2565, DOI 10.1001/archinte.149.11.2565; MATHESON GO, 1987, AM J SPORT MED, V15, P46, DOI 10.1177/036354658701500107; MCBRYDE AM, 1985, CLIN SPORT MED, V4, P737; Millet GY, 2012, J APPL PHYSIOL, V113, P507, DOI 10.1152/japplphysiol.00016.2012; RAUCH TM, 1988, J SPORT MED PHYS FIT, V28, P237; Robson-Ansley P, 2012, MED SCI SPORT EXER, V44, P999, DOI 10.1249/MSS.0b013e318243253d; SANDELL RC, 1988, PHYSICIAN SPORTSMED, V16, P86, DOI 10.1080/00913847.1988.11709598; Thompson W, 1983, ULTRARUNNING, V3, P22; Thorpe KE, 2007, HEALTH AFFAIR, V26, pW678, DOI 10.1377/hlthaff.26.6.w678; U.S. Department of Health and Human Services, 2012, VITAL HLTH STAT SERI, V10; van Gent RN, 2007, BRIT J SPORT MED, V41, P469, DOI 10.1136/bjsm.2006.033548; Scheer BV, 2011, CLIN J SPORT MED, V21, P444, DOI 10.1097/JSM.0b013e318225b0df; WALTER SD, 1989, ARCH INTERN MED, V149, P2561, DOI 10.1001/archinte.149.11.2561	37	73	75	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83867	10.1371/journal.pone.0083867	http://dx.doi.org/10.1371/journal.pone.0083867			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416176	gold, Green Submitted, Green Published			2022-12-27	WOS:000329862500079
J	Nagao, C; Nagano, N; Mizuguchi, K				Nagao, Chioko; Nagano, Nozomi; Mizuguchi, Kenji			Prediction of Detailed Enzyme Functions and Identification of Specificity Determining Residues by Random Forests	PLOS ONE			English	Article							HYDROLASE FOLD ENZYMES; AMINO-ACID-RESIDUES; ACTIVE-SITE GORGE; CRYSTAL-STRUCTURE; PROTEIN FUNCTION; MYCOBACTERIUM-TUBERCULOSIS; TRYPTOPHAN BIOSYNTHESIS; CATALYTIC DOMAIN; LIGAND-BINDING; SEQUENCE	Determining enzyme functions is essential for a thorough understanding of cellular processes. Although many prediction methods have been developed, it remains a significant challenge to predict enzyme functions at the fourth-digit level of the Enzyme Commission numbers. Functional specificity of enzymes often changes drastically by mutations of a small number of residues and therefore, information about these critical residues can potentially help discriminate detailed functions. However, because these residues must be identified by mutagenesis experiments, the available information is limited, and the lack of experimentally verified specificity determining residues (SDRs) has hindered the development of detailed function prediction methods and computational identification of SDRs. Here we present a novel method for predicting enzyme functions by random forests, EFPrf, along with a set of putative SDRs, the random forests derived SDRs (rf-SDRs). EFPrf consists of a set of binary predictors for enzymes in each CATH superfamily and the rf-SDRs are the residue positions corresponding to the most highly contributing attributes obtained from each predictor. EFPrf showed a precision of 0.98 and a recall of 0.89 in a cross-validated benchmark assessment. The rf-SDRs included many residues, whose importance for specificity had been validated experimentally. The analysis of the rf-SDRs revealed both a general tendency that functionally diverged superfamilies tend to include more active site residues in their rf-SDRs than in less diverged superfamilies, and superfamily-specific conservation patterns of each functional residue. EFPrf and the rf-SDRs will be an effective tool for annotating enzyme functions and for understanding how enzyme functions have diverged within each superfamily.	[Nagao, Chioko; Mizuguchi, Kenji] Natl Inst Biomed Innovat, Osaka, Japan; [Nagano, Nozomi] AIST, Computat Biol Res Ctr, Koto Ku, Tokyo, Japan	National Institute of Health Sciences - Japan; National Institute of Advanced Industrial Science & Technology (AIST)	Nagao, C (corresponding author), Natl Inst Biomed Innovat, Osaka, Japan.	chio@nibio.go.jp; kenji@nibio.go.jp	Nagano, Nozomi/A-5717-2017; Mizuguchi, Kenji/GVS-5857-2022	Nagano, Nozomi/0000-0002-2779-685X; Mizuguchi, Kenji/0000-0003-3021-7078	New Energy and Industrial Technology Development Organization (NEDO) of Japan [07C46056a]; Ministry of Education, Culture, Sports, Science, and Technology [25430186, 25293079]; Ministry of Health, Labor, and Welfare; Japan Society for the Promotion of Science (JSPS) [238048, 248047]	New Energy and Industrial Technology Development Organization (NEDO) of Japan(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by the Industrial Technology Research Grant Program in 2007 (grant number 07C46056a) from New Energy and Industrial Technology Development Organization (NEDO) of Japan, Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (grant numbers 25430186 and 25293079) and from the Ministry of Health, Labor, and Welfare to K.M., and also by Grant-in-Aid for Publication of Scientific Research Results (grant numbers 238048 and 248047) from Japan Society for the Promotion of Science (JSPS) to N.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addou S, 2009, J MOL BIOL, V387, P416, DOI 10.1016/j.jmb.2008.12.045; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Arakaki AK, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-107; Bannert C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-589; Bashton M, 2008, NUCLEIC ACIDS RES, V36, pD618, DOI 10.1093/nar/gkm611; BELAICH A, 1992, J BACTERIOL, V174, P4677, DOI 10.1128/JB.174.14.4677-4682.1992; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; BORTOLIGERMAN I, 1995, J MOL BIOL, V246, P82, DOI 10.1006/jmbi.1994.0068; Bourne Y, 2003, EMBO J, V22, P1, DOI 10.1093/emboj/cdg005; Bray T, 2009, J MOL BIOL, V386, P1423, DOI 10.1016/j.jmb.2008.11.057; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cai CZ, 2004, PROTEINS, V55, P66, DOI 10.1002/prot.20045; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Capra JA, 2008, BIOINFORMATICS, V24, P1473, DOI 10.1093/bioinformatics/btn214; Charnock SJ, 1997, J BIOL CHEM, V272, P2942, DOI 10.1074/jbc.272.5.2942; Chen XW, 2005, BIOINFORMATICS, V21, P4394, DOI 10.1093/bioinformatics/bti721; Claudel-Renard C, 2003, NUCLEIC ACIDS RES, V31, P6633, DOI 10.1093/nar/gkg847; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Dobson Paul D, 2003, J Mol Biol, V330, P771; DOMINGUEZ R, 1995, NAT STRUCT BIOL, V2, P569, DOI 10.1038/nsb0795-569; Dominguez R, 1996, J MOL BIOL, V257, P1042, DOI 10.1006/jmbi.1996.0222; Dondoshansky I, 2002, BLASTCLUST; DUCROS V, 1995, STRUCTURE, V3, P939, DOI 10.1016/S0969-2126(01)00228-3; Due AV, 2011, P NATL ACAD SCI USA, V108, P3554, DOI 10.1073/pnas.1015996108; Erdin S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S3-S6; Erskine PT, 1999, BIOCHEMISTRY-US, V38, P4266, DOI 10.1021/bi982137w; Fujimoto Z, 2003, J BIOL CHEM, V278, P20313, DOI 10.1074/jbc.M302292200; George RA, 2005, P NATL ACAD SCI USA, V102, P12299, DOI 10.1073/pnas.0504833102; Greenblatt HM, 2004, J AM CHEM SOC, V126, P15405, DOI 10.1021/ja0466154; GRIBSKOV M, 1990, METHOD ENZYMOL, V183, P146; Gutteridge A, 2005, TRENDS BIOCHEM SCI, V30, P622, DOI 10.1016/j.tibs.2005.09.006; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; HAREL M, 1993, P NATL ACAD SCI USA, V90, P9031, DOI 10.1073/pnas.90.19.9031; Harel M, 2000, PROTEIN SCI, V9, P1063, DOI 10.1110/ps.9.6.1063; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Henn-Sax M, 2002, BIOCHEMISTRY-US, V41, P12032, DOI 10.1021/bi026092h; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; Hulo N, 2008, NUCLEIC ACIDS RES, V36, pD245, DOI 10.1093/nar/gkm977; Kalinina OV, 2004, NUCLEIC ACIDS RES, V32, pW424, DOI 10.1093/nar/gkh391; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; Kristensen DM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-17; Kumar C, 2012, EURASIP J BIOINFORM, DOI [10.1186/1687-4153-2012, 10.1186/1687-4153-2012-1]; Kumar N, 2012, BIOINFORMATICS, V28, P2687, DOI 10.1093/bioinformatics/bts510; Lang D, 2000, SCIENCE, V289, P1546, DOI 10.1126/science.289.5484.1546; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Lee BJ, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-27; Lees J, 2010, NUCLEIC ACIDS RES, V38, pD296, DOI 10.1093/nar/gkp987; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; List F, 2011, CHEMBIOCHEM, V12, P1487, DOI 10.1002/cbic.201100082; Mertz RW, JANUS PREDICTION RAN; Nagano N, 2005, NUCLEIC ACIDS RES, V33, pD407, DOI 10.1093/nar/gki080; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Nagano N, 2001, PROTEIN ENG, V14, P845, DOI 10.1093/protein/14.11.845; Nagao C, 2012, PROTEINS, V80, P2426, DOI 10.1002/prot.24127; Nagao C, 2010, PROTEINS, V78, P2369, DOI 10.1002/prot.22750; Nakanishi T, 2005, BIOCHEMISTRY-US, V44, P1136, DOI 10.1021/bi0484522; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; NAVAS J, 1992, BIOCHEM BIOPH RES CO, V189, P807, DOI 10.1016/0006-291X(92)92274-2; Noda-Garcia L, 2013, MOL BIOL EVOL, V30, P2024, DOI 10.1093/molbev/mst115; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Porter CT, 2004, NUCLEIC ACIDS RES, V32, pD129, DOI 10.1093/nar/gkh028; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; R Core Team, 2021, R LANGUAGE ENV STAT; Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/NMETH.2340, 10.1038/nmeth.2340]; Redfern OC, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000485; Reisinger B, 2012, PROTEIN ENG DES SEL, V25, P751, DOI 10.1093/protein/gzs080; Rost B, 2003, CELL MOL LIFE SCI, V60, P2637, DOI 10.1007/s00018-003-3114-8; Sharma V, 1998, STRUCTURE, V6, P1587, DOI 10.1016/S0969-2126(98)00156-7; Shen HB, 2007, BIOCHEM BIOPH RES CO, V364, P53, DOI 10.1016/j.bbrc.2007.09.098; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; Svetnik V, 2003, J CHEM INF COMP SCI, V43, P1947, DOI 10.1021/ci034160g; Syed Umar, 2009, V541, P373, DOI 10.1007/978-1-59745-243-4_17; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tian WD, 2004, NUCLEIC ACIDS RES, V32, P6226, DOI 10.1093/nar/gkh956; Tian WD, 2003, J MOL BIOL, V333, P863, DOI 10.1016/j.jmb.2003.08.057; Todd AE, 2001, J MOL BIOL, V307, P1113, DOI 10.1006/jmbi.2001.4513; VELLOM DC, 1993, BIOCHEMISTRY-US, V32, P12, DOI 10.1021/bi00052a003; Voet D VJ, 1990, BIOCHEMISTRY; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wass MN, 2008, BIOINFORMATICS, V24, P798, DOI 10.1093/bioinformatics/btn037; Wass MN, 2012, NUCLEIC ACIDS RES, V40, pW466, DOI 10.1093/nar/gks489; Webb E. C., 1992, Enzyme nomenclature 1992. Recommendations of the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology on the Nomenclature and Classification of Enzymes.; Zolotnitsky G, 2004, P NATL ACAD SCI USA, V101, P11275, DOI 10.1073/pnas.0404311101	87	24	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84623	10.1371/journal.pone.0084623	http://dx.doi.org/10.1371/journal.pone.0084623			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416252	Green Submitted, gold, Green Published			2022-12-27	WOS:000329862500141
J	Poor, EE; Jakes, A; Loucks, C; Suitor, M				Poor, Erin E.; Jakes, Andrew; Loucks, Colby; Suitor, Mike			Modeling Fence Location and Density at a Regional Scale for Use in Wildlife Management	PLOS ONE			English	Article							WILDEBEEST; MAMMALS; SITE; DEER	Barbed and woven wire fences, common structures across western North America, act as impediments to wildlife movements. In particular, fencing influences pronghorn (Antilocapra americana) daily and seasonal movements, as well as modifying habitat selection. Because of fencing's impacts to pronghorn and other wildlife, it is a potentially important factor in both wildlife movement and habitat selection models. At this time, no geospatial fencing data is available at regional scales. Consequently, we constructed a regional fence model using a series of land tenure assumptions for the Hi-Line region of northern Montana - an area consisting of 13 counties over 103,400 km(2). Randomized 3.2 km long transects (n = 738) on both paved and unpaved roads were driven to collect information on habitat, fence densities and fence type. Using GIS, we constructed a fence location and a density model incorporating ownership, size, neighboring parcels, township boundaries and roads. Local knowledge of land ownership and land use assisted in improving the final models. We predict there is greater than 263,300 km of fencing in the Hi-Line region, with a maximum density of 6.8 km of fencing per km(2) and mean density of 2.4 km of fencing per km(2). Using field data to assess model accuracy, Cohen's Kappa was measured at 0.40. On-the-ground fence modification or removal could be prioritized by identifying high fence densities in critical wildlife areas such as pronghorn migratory pathways or sage grouse lekking habitat. Such novel fence data can assist wildlife and land managers to assess effects of anthropogenic features to wildlife at various scales; which in turn may help conserve declining grassland species and overall ecological functionality.	[Poor, Erin E.] Virginia Tech, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA; [Poor, Erin E.; Loucks, Colby] World Wildlife Fund, Conservat Sci Program, Washington, DC 20037 USA; [Jakes, Andrew; Suitor, Mike] Univ Calgary, Fac Environm Design, Calgary, AB T2N 1N4, Canada	Virginia Polytechnic Institute & State University; World Wildlife Fund; University of Calgary	Poor, EE (corresponding author), Virginia Tech, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA.	erinpoor@vt.edu		Poor, Erin/0000-0002-8799-3193	Kathryn Fuller Science for Nature Fund; Alberta Conservation Association [030-00-40-106-4000]; U.S. Bureau of Land Management [090-50778]; Montana Fish, Wildlife Parks [080018]; Saskatchewan Ministry of Environment [08FW111]; University of Calgary	Kathryn Fuller Science for Nature Fund; Alberta Conservation Association; U.S. Bureau of Land Management; Montana Fish, Wildlife Parks; Saskatchewan Ministry of Environment; University of Calgary	The work was supported by: Kathryn Fuller Science for Nature Fund, (no grant number) (http://worldwildlife.org/initiatives/fuller-science-for-nature-fund); Alberta Conservation Association, 030-00-40-106-4000 (http://www.ab-conservation.com/); U.S. Bureau of Land Management, 090-50778 (http://www.blm.gov/wo/st/en.html); Montana Fish, Wildlife & Parks, Cooperative Agreement 080018 (http://fwp.mt.gov/); Saskatchewan Ministry of Environment, Permit 08FW111 (http://www.environment.gov.sk.ca/); University of Calgary, (no grant number) (http://www.ucalgary.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baines D, 1997, J APPL ECOL, V34, P941, DOI 10.2307/2405284; BENSHAHAR R, 1993, J TROP ECOL, V9, P249, DOI 10.1017/S0266467400007252; Berger J, 2004, CONSERV BIOL, V18, P320, DOI 10.1111/j.1523-1739.2004.00548.x; Berger J, 2008, PLOS BIOL, V6, P1365, DOI 10.1371/journal.pbio.0060165; Berry H. H., 1997, Madoqua, V20, P137; Bolger DT, 2007, ECOL LETT, V10, P1; Boone Randall B., 2004, African Journal of Range & Forage Science, V21, P147, DOI 10.2989/10220110409485847; Congalton R. G., 1981, THESIS VIRGINIA POLY; Estes R, 1967, ZOOL TIERPSHYCH, V26, P284; Harrington JL, 2006, WILDLIFE SOC B, V34, P1295, DOI 10.2193/0091-7648(2006)34[1295:COUBAM]2.0.CO;2; Harris Grant, 2009, Endangered Species Research, V7, P55, DOI 10.3354/esr00173; Hayter EW, 1939, AGR HIST, V13, P189; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kie JG, 2002, ECOLOGY, V83, P530, DOI 10.1890/0012-9658(2002)083[0530:LHADSE]2.0.CO;2; Knick ST, 2011, STUD AVIAN BIOL, P203; Laliberte AS, 2004, BIOSCIENCE, V54, P123, DOI 10.1641/0006-3568(2004)054[0123:RCONAC]2.0.CO;2; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Moss R, 2001, BIOL CONSERV, V101, P255, DOI 10.1016/S0006-3207(01)00066-0; Nakazawa M, 2013, FUNCTIONS MED STAT B; Ockenfels RA, 1994, 13 AR GAM FISH DEP; Sawyer H, 2013, J APPL ECOL, V50, P68, DOI 10.1111/1365-2664.12013; Schaefer JA, 2000, LANDSCAPE ECOL, V15, P731, DOI 10.1023/A:1008160408257; Sheldon DP, 2005, PRONGHORN MOVEMENT D; SPINAGE C A, 1992, Oryx, V26, P147; Stevens BS, 2012, J WILDLIFE MANAGE, V76, P1370, DOI 10.1002/jwmg.397; Thirgood S, 2004, ANIM CONSERV, V7, P113, DOI 10.1017/S1367943004001404; Tufford W, 1960, MONTANA, V10, P62; WHYTE IJ, 1988, S AFR J WILDL RES, V18, P78; Williamson D., 1985, Parks, V10, P5	29	14	14	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83912	10.1371/journal.pone.0083912	http://dx.doi.org/10.1371/journal.pone.0083912			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416180	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500083
J	Xu, KD; Huang, XH; Wu, MM; Wang, Y; Chang, YX; Liu, K; Zhang, J; Zhang, Y; Zhang, FL; Yi, LM; Li, TT; Wang, RY; Tan, GX; Li, CW				Xu, Kedong; Huang, Xiaohui; Wu, Manman; Wang, Yan; Chang, Yunxia; Liu, Kun; Zhang, Ju; Zhang, Yi; Zhang, Fuli; Yi, Liming; Li, Tingting; Wang, Ruiyue; Tan, Guangxuan; Li, Chengwei			A Rapid, Highly Efficient and Economical Method of Agrobacterium-Mediated In planta Transient Transformation in Living Onion Epidermis	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; GENE-EXPRESSION; FLUORESCENCE COMPLEMENTATION; SUBCELLULAR-LOCALIZATION; PARTICLE BOMBARDMENT; PROTOPLAST SYSTEM; LEAF PROTOPLASTS; ARABIDOPSIS; OPTIMIZATION; TISSUES	Transient transformation is simpler, more efficient and economical in analyzing protein subcellular localization than stable transformation. Fluorescent fusion proteins were often used in transient transformation to follow the in vivo behavior of proteins. Onion epidermis, which has large, living and transparent cells in a monolayer, is suitable to visualize fluorescent fusion proteins. The often used transient transformation methods included particle bombardment, protoplast transfection and Agrobacterium-mediated transformation. Particle bombardment in onion epidermis was successfully established, however, it was expensive, biolistic equipment dependent and with low transformation efficiency. We developed a highly efficient in planta transient transformation method in onion epidermis by using a special agroinfiltration method, which could be fulfilled within 5 days from the pretreatment of onion bulb to the best time-point for analyzing gene expression. The transformation conditions were optimized to achieve 43.87% transformation efficiency in living onion epidermis. The developed method has advantages in cost, time-consuming, equipment dependency and transformation efficiency in contrast with those methods of particle bombardment in onion epidermal cells, protoplast transfection and Agrobacterium-mediated transient transformation in leaf epidermal cells of other plants. It will facilitate the analysis of protein subcellular localization on a large scale.	[Xu, Kedong; Wang, Yan; Liu, Kun; Zhang, Ju; Zhang, Yi; Zhang, Fuli; Tan, Guangxuan; Li, Chengwei] Zhoukou Normal Univ, Key Lab Plant Genet & Mol Breeding, Zhoukou, Peoples R China; [Huang, Xiaohui; Wu, Manman; Chang, Yunxia; Yi, Liming; Li, Tingting; Wang, Ruiyue] Zhoukou Normal Univ, Dept Life Sci, Zhoukou, Peoples R China; [Wang, Yan] Henan Agr Univ, Coll Life Sci, Zhengzhou, Peoples R China	Zhoukou Normal University; Zhoukou Normal University; Henan Agricultural University	Li, CW (corresponding author), Zhoukou Normal Univ, Key Lab Plant Genet & Mol Breeding, Zhoukou, Peoples R China.	lichengweiwau@hotmail.com		Wang, Yan/0000-0003-3262-9930	National Natural Science Foundation of China [31071807, 31272168]; Plan for Scientific Innovation Talent of Henan Province [124100510021]; Doctoral Scientific Research Starting Foundation of Zhoukou Normal University [zksybscx201108]; Scientific Research and Innovation Fund Projects of Zhoukou Normal University [zksykycx201306]; Science and Technology Research Major Projects of Department of Education of Henan Province [13B210270]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Plan for Scientific Innovation Talent of Henan Province; Doctoral Scientific Research Starting Foundation of Zhoukou Normal University; Scientific Research and Innovation Fund Projects of Zhoukou Normal University; Science and Technology Research Major Projects of Department of Education of Henan Province	The research was supported by National Natural Science Foundation of China (31071807, 31272168) (http://www.nsfc.gov.cn), Plan for Scientific Innovation Talent of Henan Province (124100510021) (http://www.hnkjt.gov.cn), Doctoral Scientific Research Starting Foundation of Zhoukou Normal University (zksybscx201108)(http://www.zknu.edu.cn), Scientific Research and Innovation Fund Projects of Zhoukou Normal University (zksykycx201306)(http://www.zknu.edu.cn) and the Science and Technology Research Major Projects of Department of Education of Henan Province (13B210270)(http://www.haedu.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL S, 1994, PLANT J, V5, P421, DOI 10.1111/j.1365-313X.1994.00421.x; Amoah BK, 2001, J EXP BOT, V52, P1135, DOI 10.1093/jexbot/52.358.1135; Baum K, 1997, PLANT J, V12, P463, DOI 10.1046/j.1365-313X.1997.12020463.x; Bhaskar PB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005812; Blachutzik JO, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-28; Blanvillain R, 2009, PLANT J, V57, P654, DOI 10.1111/j.1365-313X.2008.03717.x; Chen SB, 2006, MOL PLANT PATHOL, V7, P417, DOI 10.1111/j.1364-3703.2006.00346.x; Chen XL, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-9; Eady CC, 1996, PLANT CELL REP, V15, P958, DOI 10.1007/BF00231596; HAMILTON DA, 1992, PLANT MOL BIOL, V18, P211, DOI 10.1007/BF00034950; Han DG, 2013, PLANT MOL BIOL REP, V31, P802, DOI 10.1007/s11105-012-0551-2; Hollender CA, 2010, JOVE-J VIS EXP, V40, P1963, DOI DOI 10.3791/1963; Hosein FN, 2012, J AM SOC HORTIC SCI, V137, P263, DOI 10.21273/JASHS.137.4.263; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Keller ERJ, 1996, THEOR APPL GENET, V92, P417, DOI 10.1007/BF00223688; Lee LY, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-24; Li JF, 2009, PLANT METHODS, V5, DOI [10.1186/1746-4811-5-6, 10.1371/journal.pcbi.1000450]; LI YH, 1994, PLANT CELL REP, V13, P661, DOI 10.1007/BF00231619; LIU CN, 1992, PLANT MOL BIOL, V20, P1071, DOI 10.1007/BF00028894; Liu QL, 2011, BIOTECHNOL LETT, V33, P2073, DOI 10.1007/s10529-011-0659-8; Liu QL, 2010, MOL BIOL REP, V37, P1137, DOI 10.1007/s11033-009-9886-7; Manavella PA, 2009, NAT PROTOC, V4, P1699, DOI 10.1038/nprot.2009.178; Marion J, 2008, PLANT J, V56, P169, DOI 10.1111/j.1365-313X.2008.03596.x; McLusky SR, 1999, PLANT J, V17, P523, DOI 10.1046/j.1365-313X.1999.00403.x; Mitra J, 2012, J FOOD SCI TECH MYS, V49, P267, DOI 10.1007/s13197-011-0369-1; Noel LD, 2007, PLANT CELL, V19, P4061, DOI 10.1105/tpc.107.051896; OHLROGGE JB, 1979, P NATL ACAD SCI USA, V76, P1194, DOI 10.1073/pnas.76.3.1194; OPARKA KJ, 1994, NEW PHYTOL, V126, P571, DOI 10.1111/j.1469-8137.1994.tb02952.x; Orzaez D, 2006, PLANT PHYSIOL, V140, P3, DOI 10.1104/pp.105.068221; Pommerrenig B, 2013, PLANT J, V73, P392, DOI 10.1111/tpj.12037; Rasco-Gaunt S, 1999, PLANT CELL REP, V19, P118, DOI 10.1007/s002990050721; REGGIARDO MI, 1991, PLANT SCI, V75, P237, DOI 10.1016/0168-9452(91)90239-5; Santarem ER, 1998, PLANT CELL REP, V17, P752, DOI 10.1007/s002990050478; Shah H, 2001, J MOL BIOL, V309, P641, DOI 10.1006/jmbi.2001.4706; Sidorov VA, 1999, PLANT J, V19, P209, DOI 10.1046/j.1365-313X.1999.00508.x; Song SY, 2012, ENVIRON EXP BOT, V80, P1, DOI 10.1016/j.envexpbot.2012.02.001; Takata N, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-30; Trick HN, 1998, PLANT CELL REP, V17, P482, DOI 10.1007/s002990050429; Tsai AYL, 2012, PLANT J, V69, P809, DOI 10.1111/j.1365-313X.2011.04832.x; Tsuda K, 2012, PLANT J, V69, P713, DOI 10.1111/j.1365-313X.2011.04819.x; Ueki S, 2009, NAT PROTOC, V4, P71, DOI 10.1038/nprot.2008.217; Wang GL, 2002, GENE ENG PLANT, P734; WANG YC, 1988, PLANT MOL BIOL, V11, P433, DOI 10.1007/BF00039024; Wroblewski T, 2005, PLANT BIOTECHNOL J, V3, P259, DOI 10.1111/j.1467-7652.2005.00123.x; Xu KD, 2011, AFR J BIOTECHNOL, V10, P4011; Yang KY, 2001, P NATL ACAD SCI USA, V98, P741, DOI 10.1073/pnas.98.2.741; Ye GN, 1999, PLANT J, V19, P249, DOI 10.1046/j.1365-313X.1999.00520.x; Zhang G, 2003, PLANT CELL REP, V21, P860, DOI 10.1007/s00299-003-0585-x; Zhang HC, 2013, PLANT CELL REP, V32, P611, DOI 10.1007/s00299-013-1394-5; Zhang Y, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-30; Zhou C, 2013, PLANT MOL BIOL REP, V31, P783, DOI 10.1007/s11105-012-0545-0	51	92	110	4	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83556	10.1371/journal.pone.0083556	http://dx.doi.org/10.1371/journal.pone.0083556			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416168	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500056
J	Hasmats, J; Green, H; Orear, C; Validire, P; Huss, M; Kaller, M; Lundeberg, J				Hasmats, Johanna; Green, Henrik; Orear, Cedric; Validire, Pierre; Huss, Mikael; Kaller, Max; Lundeberg, Joakim			Assessment of Whole Genome Amplification for Sequence Capture and Massively Parallel Sequencing	PLOS ONE			English	Article							EXOME CAPTURE; AMPLIFIED DNA; MUTATION; CANCER; METAGENOMES; DISCOVERY; VIRUSES; SAMPLES; TUMOR	Exome sequence capture and massively parallel sequencing can be combined to achieve inexpensive and rapid global analyses of the functional sections of the genome. The difficulties of working with relatively small quantities of genetic material, as may be necessary when sharing tumor biopsies between collaborators for instance, can be overcome using whole genome amplification. However, the potential drawbacks of using a whole genome amplification technology based on random primers in combination with sequence capture followed by massively parallel sequencing have not yet been examined in detail, especially in the context of mutation discovery in tumor material. In this work, we compare mutations detected in sequence data for unamplified DNA, whole genome amplified DNA, and RNA originating from the same tumor tissue samples from 16 patients diagnosed with non-small cell lung cancer. The results obtained provide a comprehensive overview of the merits of these techniques for mutation analysis. We evaluated the identified genetic variants, and found that most (74%) of them were observed in both the amplified and the unamplified sequence data. Eighty-nine percent of the variations found by WGA were shared with unamplified DNA. We demonstrate a strategy for avoiding allelic bias by including RNA-sequencing information.	[Hasmats, Johanna; Green, Henrik; Kaller, Max; Lundeberg, Joakim] Royal Inst Technol, Div Gene Technol, Sch Biotechnol, Sci Life Lab, Stockholm, Sweden; [Green, Henrik] Natl Board Forens Med, Dept Forens Genet & Forens Toxicol, Linkoping, Sweden; [Green, Henrik] Linkoping Univ, Dept Hlth & Med Sci, Linkoping, Sweden; [Orear, Cedric] Inst Gustave Roussy, Genom Unit, Villejuif, France; [Validire, Pierre] Inst Mutualiste Montsouris, Dept Pathol, Paris, France; [Huss, Mikael] Stockholm Univ, Dept Biochem & Biophys, Sci Life Lab, S-10691 Stockholm, Sweden	Royal Institute of Technology; Swedish National Board of Forensic Medicine; Linkoping University; UNICANCER; Gustave Roussy; Institute Mutualiste Montsouris; UDICE-French Research Universities; Universite Paris Cite; Stockholm University	Green, H (corresponding author), Royal Inst Technol, Div Gene Technol, Sch Biotechnol, Sci Life Lab, Stockholm, Sweden.	henrik.green@rmv.se	Green, Henrik/D-1401-2012	Green, Henrik/0000-0002-8015-5728; Huss, Mikael/0000-0003-0839-2451	European Commission [CHEMORES LSHC-CT-2007-037665]; Swedish Cancer Society; Swedish Cancer Foundation; Swedish Research Council; Fondkistan; Stiftelsen Sigurd och Elsa Goljes Minne; Markus Borgstroms stiftelse	European Commission(European CommissionEuropean Commission Joint Research Centre); Swedish Cancer Society(Swedish Cancer Society); Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Fondkistan; Stiftelsen Sigurd och Elsa Goljes Minne; Markus Borgstroms stiftelse	This work was financially supported by grants from the European Commission (CHEMORES LSHC-CT-2007-037665), the Swedish Cancer Society, the Swedish Cancer Foundation, the Swedish Research Council, Fondkistan, Stiftelsen Sigurd och Elsa Goljes Minne and Markus Borgstroms stiftelse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agilent, 2012, SURESELECT TARG ENR; Asan, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r95; Chang H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021097; Chepelev I, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp507; Cirulli ET, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r57; Duhaime MB, 2012, VIROLOGY, V434, P181, DOI 10.1016/j.virol.2012.09.036; Duhaime MB, 2012, ENVIRON MICROBIOL, V14, P2526, DOI 10.1111/j.1462-2920.2012.02791.x; Forster M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks836; Hannemann J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026362; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Illumina, 2012, TRUS EX ENR KIT DAT; Indap AR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-468; Jiang T, 2011, SCI CHINA LIFE SCI, V54, P945, DOI 10.1007/s11427-011-4232-4; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Lee JC, 2012, MED SCI LAW; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Murphy SJ, 2013, GASTROENTEROLOGY, V145, P1098, DOI 10.1053/j.gastro.2013.07.049; Murphy SJ, 2012, DNA RES, V19, P395, DOI 10.1093/dnares/dss021; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nimblegen, 2011, SEQCAP EZ HUM EX LIB; Parla JS, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r97; Silander Kaisa, 2008, V439, P1, DOI 10.1007/978-1-59745-188-8_1; Siu WK, 2012, DIAGN MOL PATHOL, V21, P184, DOI 10.1097/PDM.0b013e31825554d0; Solonenko SA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-320; Stahl PL, 2012, ANNU REV BIOCHEM, V81, P359, DOI 10.1146/annurev-biochem-060410-094158; Sulonen AM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r94; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025; Yilmaz S, 2010, NAT METHODS, V7, P943, DOI 10.1038/nmeth1210-943	28	9	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84785	10.1371/journal.pone.0084785	http://dx.doi.org/10.1371/journal.pone.0084785			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409309	Green Submitted, gold, Green Published			2022-12-27	WOS:000329463500033
J	Campagnolo, L; Costanza, G; Francesconi, A; Arcuri, G; Moscatelli, I; Orlandi, A				Campagnolo, Luisa; Costanza, Gaetana; Francesconi, Arianna; Arcuri, Gaetano; Moscatelli, Ilana; Orlandi, Augusto			Sortilin Expression Is Essential for Pro-Nerve Growth Factor-Induced Apoptosis of Rat Vascular Smooth Muscle Cells	PLOS ONE			English	Article							PHENOTYPIC HETEROGENEITY INFLUENCES; MARKER EXPRESSION; IN-VITRO; ATHEROSCLEROSIS; NEUROTROPHIN; PROLIFERATION; NGF; SUSCEPTIBILITY; MECHANISMS; SURVIVAL	Background: Sortilin, a member of the Vps10p-domain receptor family, has been demonstrated a key regulator in mediating cellular response to pro-neurotrophins. In the present study, we investigated the role of sortilin in the apoptotic pathway of vascular smooth muscle cells. Methods and Principal Findings: Immunohistochemistry revealed that sortilin was barely detectable in human and rat normal young vessels, while its expression was increased in human fibroatheromatous plaques. Sortilin immunodetection was also marked in the neointima of the rat aorta fifteen days after ballooning. In vitro, rat aortic intimal cells expressed higher sortilin levels than normal media SMCs; sortilin was distributed in the cytoplasm and in correspondence of the cell membrane. After 48 h, pro-nerve growth factor (proNGF) induced the strong dose-dependent increase of intimal cell apoptosis and the accumulation of sortilin protein. ProNGF was a more potent apoptotic inducer than equimolar or even higher concentration of NGF, whereas brain derived neutrotrophic factor was ineffective. Targeted interfering RNA-mediated sortilin reduction counteracted proNGF-induced apoptosis without affecting p75(NTR) expression. ProNGF-induced apoptosis was associated to NF-kappa B down-regulation and bax increase. Inhibition of NF-kappa B activity increased intimal cell apoptosis that did not further increase with the addition of proNGF. Conclusions: Our results indicate that sortilin expression characterizes human atheromatous lesions and rat aortic post-injury neointima, and suggest that sortilin represents an important regulator of proNGF-induced SMC apoptosis and arterial remodeling.	[Campagnolo, Luisa; Costanza, Gaetana; Francesconi, Arianna; Arcuri, Gaetano; Moscatelli, Ilana; Orlandi, Augusto] Univ Roma Tor Vergata, Dept Biomed & Prevent, Inst Pathol Anat, Rome, Italy; [Moscatelli, Ilana] Lund Univ, Dept Mol Med & Gene Therapy, Lund Stem Cell Ctr, Lund, Sweden	University of Rome Tor Vergata; Lund University	Orlandi, A (corresponding author), Univ Roma Tor Vergata, Dept Biomed & Prevent, Inst Pathol Anat, Rome, Italy.	orlandi@uniroma2.it	Campagnolo, Luisa/K-3520-2018; Orlandi, Augusto/AHE-8753-2022; Costanza, Gaetana (Tania)/GXV-4686-2022; costanza, gaetana/J-5171-2018	Campagnolo, Luisa/0000-0003-3928-0276; costanza, gaetana/0000-0002-1115-4270; orlandi, augusto/0000-0001-7202-5854	AIFA [MRAR08L007]	AIFA	This work has been partially funded by a grant from AIFA (2008, MRAR08L007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	BENNETT MR, 1994, CIRC RES, V74, P525, DOI 10.1161/01.RES.74.3.525; BENNETT MR, 1995, J CLIN INVEST, V95, P2266, DOI 10.1172/JCI117917; BOCHATONPIALLAT ML, 1995, AM J PATHOL, V146, P1059; Bono F, 1997, FEBS LETT, V416, P243, DOI 10.1016/S0014-5793(97)01215-5; Boyle K, 2005, NEUROBIOL DIS, V20, P412, DOI 10.1016/j.nbd.2005.03.022; CLOWES AW, 1983, LAB INVEST, V49, P327; CLOWES AW, 1983, LAB INVEST, V49, P208; DONOVAN MJ, 1995, AM J PATHOL, V147, P309; Erl W, 1999, CIRC RES, V84, P668, DOI 10.1161/01.RES.84.6.668; Ferlosio A, 2012, ATHEROSCLEROSIS, V224, P51, DOI 10.1016/j.atherosclerosis.2012.07.016; Hao HY, 2003, ARTERIOSCL THROM VAS, V23, P1510, DOI 10.1161/01.ATV.0000090130.85752.ED; Hermans-Borgmeyer I, 1999, MOL BRAIN RES, V65, P216, DOI 10.1016/S0169-328X(99)00022-4; HEYMACH JV, 1995, J BIOL CHEM, V270, P12297, DOI 10.1074/jbc.270.20.12297; ISNER JM, 1995, CIRCULATION, V91, P2703, DOI 10.1161/01.CIR.91.11.2703; KOCHER O, 1984, LAB INVEST, V50, P645; KOLBECK R, 1994, EUR J BIOCHEM, V225, P995, DOI 10.1111/j.1432-1033.1994.0995b.x; Kraemer R, 1999, ARTERIOSCL THROM VAS, V19, P1041, DOI 10.1161/01.ATV.19.4.1041; Kraemer R, 2002, CIRC RES, V91, P494, DOI 10.1161/01.RES.0000035245.83233.2A; Lee FS, 2001, CURR OPIN NEUROBIOL, V11, P281, DOI 10.1016/S0959-4388(00)00209-9; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Orlandi A, 2005, EXP CELL RES, V311, P317, DOI 10.1016/j.yexcr.2005.10.008; ORLANDI A, 1994, EXP CELL RES, V214, P528, DOI 10.1006/excr.1994.1290; Orlandi A, 2001, ARTERIOSCL THROM VAS, V21, P1118, DOI 10.1161/hq0701.092144; ORLANDI A, 1994, ARTERIOSCLER THROMB, V14, P982, DOI 10.1161/01.ATV.14.6.982; Orlandi A, 2007, J BIOL CHEM, V282, P4932, DOI 10.1074/jbc.M606148200; Orlandi A, 2010, CARDIOVASC RES, V85, P214, DOI 10.1093/cvr/cvp288; Orlandi A, 2008, CELL CYCLE, V7, P3889, DOI 10.4161/cc.7.24.7323; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Perlman H, 1997, CIRCULATION, V95, P981; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; SCARISBRICK IA, 1993, J NEUROSCI, V13, P875; SCHWARTZ SM, 1995, CIRC RES, V77, P445, DOI 10.1161/01.RES.77.3.445; Shanahan CM, 1998, ARTERIOSCL THROM VAS, V18, P333, DOI 10.1161/01.ATV.18.3.333; Teng KK, 2010, DEV NEUROBIOL, V70, P350, DOI 10.1002/dneu.20768; Urban D, 2013, J BIOCHEM, V153, P197, DOI 10.1093/jb/mvs137; Wang SY, 2000, AM J PATHOL, V157, P1247, DOI 10.1016/S0002-9440(10)64640-8; Wu M, 1996, EMBO J, V15, P4682, DOI 10.1002/j.1460-2075.1996.tb00845.x	41	30	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84969	10.1371/journal.pone.0084969	http://dx.doi.org/10.1371/journal.pone.0084969			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404198	gold, Green Published, Green Submitted			2022-12-27	WOS:000329460800077
J	Gajjar, K; Ahmadzai, AA; Valasoulis, G; Trevisan, J; Founta, C; Nasioutziki, M; Loufopoulos, A; Kyrgiou, M; Stasinou, SM; Karakitsos, P; Paraskevaidis, E; Da Gama-Rose, B; Martin-Hirsch, PL; Martin, FL				Gajjar, Ketan; Ahmadzai, Abdullah A.; Valasoulis, George; Trevisan, Julio; Founta, Christina; Nasioutziki, Maria; Loufopoulos, Aristotelis; Kyrgiou, Maria; Stasinou, Sofia Melina; Karakitsos, Petros; Paraskevaidis, Evangelos; Da Gama-Rose, Bianca; Martin-Hirsch, Pierre L.; Martin, Francis L.			Histology Verification Demonstrates That Biospectroscopy Analysis of Cervical Cytology Identifies Underlying Disease More Accurately than Conventional Screening: Removing the Confounder of Discordance	PLOS ONE			English	Article							TRANSFORM INFRARED-SPECTROSCOPY; RAMAN-SPECTROSCOPY; MULTIVARIATE-ANALYSIS; INTRAEPITHELIAL NEOPLASIA; COMPUTATIONAL ANALYSIS; DISCRIMINANT-ANALYSIS; SQUAMOUS EPITHELIUM; DIAGNOSTIC-APPROACH; STRUCTURAL-CHANGES; FTIR SPECTROSCOPY	Background: Subjective visual assessment of cervical cytology is flawed, and this can manifest itself by inter- and intra-observer variability resulting ultimately in the degree of discordance in the grading categorisation of samples in screening vs. representative histology. Biospectroscopy methods have been suggested as sensor-based tools that can deliver objective assessments of cytology. However, studies to date have been apparently flawed by a corresponding lack of diagnostic efficiency when samples have previously been classed using cytology screening. This raises the question as to whether categorisation of cervical cytology based on imperfect conventional screening reduces the diagnostic accuracy of biospectroscopy approaches; are these latter methods more accurate and diagnose underlying disease? The purpose of this study was to compare the objective accuracy of infrared (IR) spectroscopy of cervical cytology samples using conventional cytology vs. histology-based categorisation. Methods: Within a typical clinical setting, a total of n = 322 liquid-based cytology samples were collected immediately before biopsy. Of these, it was possible to acquire subsequent histology for n = 154. Cytology samples were categorised according to conventional screening methods and subsequently interrogated employing attenuated total reflection Fourier-transform IR (ATR-FTIR) spectroscopy. IR spectra were pre-processed and analysed using linear discriminant analysis. Dunn's test was applied to identify the differences in spectra. Within the diagnostic categories, histology allowed us to determine the comparative efficiency of conventional screening vs. biospectroscopy to correctly identify either true atypia or underlying disease. Results: Conventional cytology-based screening results in poor sensitivity and specificity. IR spectra derived from cervical cytology do not appear to discriminate in a diagnostic fashion when categories were based on conventional screening. Scores plots of IR spectra exhibit marked crossover of spectral points between different cytological categories. Although, significant differences between spectral bands in different categories are noted, crossover samples point to the potential for poor specificity and hampers the development of biospectroscopy as a diagnostic tool. However, when histology-based categories are used to conduct analyses, the scores plot of IR spectra exhibit markedly better segregation. Conclusions: Histology demonstrates that ATR-FTIR spectroscopy of liquid-based cytology identifies the presence of underlying atypia or disease missed in conventional cytology screening. This study points to an urgent need for a future biospectroscopy study where categories are based on such histology. It will allow for the validation of this approach as a screening tool.	[Gajjar, Ketan; Ahmadzai, Abdullah A.; Trevisan, Julio; Martin, Francis L.] Univ Lancaster, Lancaster Environm Ctr, Ctr Biophoton, Lancaster, England; [Gajjar, Ketan; Founta, Christina; Da Gama-Rose, Bianca; Martin-Hirsch, Pierre L.] Lancashire Teaching Hosp NHS Fdn Trust, Dept Obstet & Gynaecol, Preston, Lancs, England; [Valasoulis, George; Founta, Christina; Stasinou, Sofia Melina; Paraskevaidis, Evangelos] Univ Hosp Ioannina, Dept Obstet & Gynaecol, Ioannina, Greece; [Nasioutziki, Maria; Loufopoulos, Aristotelis] Aristotle Univ Thessaloniki, Hippokrat Hosp Thessaloniki, Dept Obstet & Gynaecol 2, GR-54006 Thessaloniki, Greece; [Kyrgiou, Maria; Stasinou, Sofia Melina] Imperial Healthcare NHS Trust, Queen Charlottes & Chelsea Hammersmith Hosp, London, England; [Kyrgiou, Maria] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England; [Karakitsos, Petros] Univ Athens, Attikon Hosp, Dept Cytopathol, Athens, Greece	Lancaster University; University Hospital Ioannina; Aristotle University of Thessaloniki; Imperial College London; National & Kapodistrian University of Athens; University Hospital Attikon	Gajjar, K (corresponding author), Univ Lancaster, Lancaster Environm Ctr, Ctr Biophoton, Lancaster, England.	gajjarkb@gmail.com; f.martin@lancaster.ac.uk	NASIOUTZIKI, MARIA/HDM-7116-2022; Valasoulis, George/AAR-2795-2021; Paraskevaidis, Evangelos/ABH-4990-2020; Martin, Francis L/J-4585-2019	Valasoulis, George/0000-0003-4444-3711; Martin, Francis L/0000-0001-8562-4944	EPSRC [EP/K023349/1]; Engineering and Physical Sciences Research Council [EP/K023349/1] Funding Source: researchfish; Natural Environment Research Council [ceh010010] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding from EPSRC (grant number EP/K023349/1) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apgar BS, 2003, AM FAM PHYSICIAN, V68, P1992; Arbyn M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1284; Baker MJ, 2008, BRIT J CANCER, V99, P1859, DOI 10.1038/sj.bjc.6604753; Baldwin P, 2003, NAT REV CANCER, V3, P217, DOI 10.1038/nrc1010; Castanon A, 2012, CYTOPATHOLOGY, V23, P13, DOI 10.1111/j.1365-2303.2011.00948.x; Castle PE, 2011, LANCET ONCOL, V12, P880, DOI 10.1016/S1470-2045(11)70188-7; Chiriboga L, 1998, BIOSPECTROSCOPY, V4, P55, DOI 10.1002/(SICI)1520-6343(1998)4:1<55::AID-BSPY6>3.0.CO;2-R; Cuzick J, 2006, INT J CANCER, V119, P1095, DOI 10.1002/ijc.21955; Daniel W. W., 1990, APPL NONPARAMETRIC S, V2nd; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Duraipandian S, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.6.067007; El-Tawil SG, 2008, PATHOLOGY, V40, P600, DOI 10.1080/00313020802320622; FAHEY MT, 1995, AM J EPIDEMIOL, V141, P680, DOI 10.1093/oxfordjournals.aje.a117485; Gajjar K, 2013, ANALYST, V138, P3917, DOI 10.1039/c3an36654e; Gajjar K, 2013, ANAL METHODS-UK, V5, P89, DOI 10.1039/c2ay25544h; ISMAIL SM, 1989, BRIT MED J, V298, P707, DOI 10.1136/bmj.298.6675.707; Kanter EM, 2009, J BIOPHOTONICS, V2, P81, DOI 10.1002/jbio.200910001; Kelly JG, 2011, J PROTEOME RES, V10, P1437, DOI 10.1021/pr101067u; Kelly JG, 2010, ANAL BIOANAL CHEM, V398, P2191, DOI 10.1007/s00216-010-4179-5; Kelly JG, 2010, CLIN CHIM ACTA, V411, P1027, DOI 10.1016/j.cca.2010.03.029; Kitchener HC, 2009, LANCET ONCOL, V10, P672, DOI 10.1016/S1470-2045(09)70156-1; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; Kyrgiou M, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5847; Llabjani V, 2010, ENVIRON SCI TECHNOL, V44, P3992, DOI 10.1021/es100206f; Llabjani V, 2009, ENVIRON SCI TECHNOL, V43, P3356, DOI 10.1021/es8036127; Mahadevan-Jansen A, 1998, PHOTOCHEM PHOTOBIOL, V68, P427, DOI 10.1562/0031-8655(1998)068<0427:DOAFOP>2.3.CO;2; Mahadevan-Jansen A, 1998, PHOTOCHEM PHOTOBIOL, V68, P123, DOI 10.1111/j.1751-1097.1998.tb03262.x; Martin FL, 2007, J COMPUT BIOL, V14, P1176, DOI 10.1089/cmb.2007.0057; Martin FL, 2010, NAT PROTOC, V5, P1748, DOI 10.1038/nprot.2010.133; Mayrand M, 2007, NEW ENGL J MED, V357, P1579, DOI 10.1056/NEJMoa071430; McCrory D C, 1999, Evid Rep Technol Assess (Summ), P1; Mitchell M F, 1996, J Natl Cancer Inst Monogr, P17; Mohlenhoff B, 2005, BIOPHYS J, V88, P3635, DOI 10.1529/biophysj.104.057950; Nanda K, 2000, ANN INTERN MED, V132, P810, DOI 10.7326/0003-4819-132-10-200005160-00009; Njoroge Erick, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P5338; Paraskevaidis E, 2007, BJOG-INT J OBSTET GY, V114, P3, DOI 10.1111/j.1471-0528.2006.01178.x; Price GJ, 2003, HUM PATHOL, V34, P1193, DOI 10.1016/S0046-8177(03)00421-0; Purandare NC, 2013, BIOANALYSIS, V5, P2697, DOI [10.4155/BIO.13.233, 10.4155/bio.13.233]; Purandare NC, 2013, ANALYST, V138, P3909, DOI 10.1039/c3an36527a; Sauvaget C, 2011, INT J GYNECOL OBSTET, V113, P14, DOI 10.1016/j.ijgo.2010.10.012; Sindhuphak R, 2003, GYNECOL ONCOL, V90, P10, DOI 10.1016/S0090-8258(03)00196-3; Stoler MH, 2001, JAMA-J AM MED ASSOC, V285, P1500, DOI 10.1001/jama.285.11.1500; Taylor SE, 2011, BRIT J CANCER, V104, P790, DOI 10.1038/sj.bjc.6606094; Trevisan J, 2013, BIOINFORMATICS, V29, P1095, DOI 10.1093/bioinformatics/btt084; Trevisan J, 2012, ANALYST, V137, P3202, DOI 10.1039/c2an16300d; Wachsmann-Hogiu S, 2009, CURR OPIN BIOTECH, V20, P63, DOI 10.1016/j.copbio.2009.02.006; Walsh MJ, 2007, BIOCHEM BIOPH RES CO, V352, P213, DOI 10.1016/j.bbrc.2006.11.005; Walsh MJ, 2008, BIOMARK INSIGHTS, V3, P179; Wong PTT, 2002, BIOPOLYMERS, V67, P376, DOI 10.1002/bip.10166; WONG PTT, 1991, P NATL ACAD SCI USA, V88, P10988, DOI 10.1073/pnas.88.24.10988; Wood BR, 2004, GYNECOL ONCOL, V93, P59, DOI 10.1016/j.ygyno.2003.12.028; Wood BR, 1998, BIOSPECTROSCOPY, V4, P75, DOI 10.1002/(SICI)1520-6343(1998)4:2<75::AID-BSPY1>3.0.CO;2-R; Wright TC, 2012, BEST PRACT RES CL OB, V26, P197, DOI 10.1016/j.bpobgyn.2011.11.004; Yazdi HM, 1996, ACTA CYTOL, V40, P664	54	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e82416	10.1371/journal.pone.0082416	http://dx.doi.org/10.1371/journal.pone.0082416			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404130	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000329460800009
J	Jers, C; Michalak, M; Larsen, DM; Kepp, KP; Li, HY; Guo, Y; Kirpekar, F; Meyer, AS; Mikkelsen, JD				Jers, Carsten; Michalak, Malwina; Larsen, Dorte M.; Kepp, Kasper P.; Li, Haiying; Guo, Yao; Kirpekar, Finn; Meyer, Anne S.; Mikkelsen, Jorn D.			Rational Design of a New Trypanosoma rangeli Trans-Sialidase for Efficient Sialylation of Glycans	PLOS ONE			English	Article							CATALYTIC MECHANISM; LIQUID WATER; CRUZI; OLIGOSACCHARIDES; ACID; EXPRESSION; ENZYME; ASSAY	This paper reports rational engineering of Trypanosoma rangeli sialidase to develop an effective enzyme for a potentially important type of reactivity: production of sialylated prebiotic glycans. The Trypanosoma cruzi trans-sialidase and the homologous T. rangeli sialidase has previously been used to investigate the structural requirements for trans-sialidase activity. We observed that the T. cruzi trans-sialidase has a seven-amino-acid motif (197-203) at the border of the substrate binding cleft. The motif differs substantially in chemical properties and substitution probability from the homologous sialidase, and we hypothesised that this motif is important for trans-sialidase activity. The 197-203 motif is strongly positively charged with a marked change in hydrogen bond donor capacity as compared to the sialidase. To investigate the role of this motif, we expressed and characterised a T. rangeli sialidase mutant, Tr13. Conditions for efficient trans-sialylation were determined, and Tr13's acceptor specificity demonstrated promiscuity with respect to the acceptor molecule enabling sialylation of glycans containing terminal galactose and glucose and even monomers of glucose and fucose. Sialic acid is important in association with human milk oligosaccharides, and Tr13 was shown to sialylate a number of established and potential prebiotics. Initial evaluation of prebiotic potential using pure cultures demonstrated, albeit not selectively, growth of Bifidobacteria. Since the 197-203 motif stands out in the native trans-sialidase, is markedly different from the wild-type sialidase compared to previous mutants, and is shown here to confer efficient and broad trans-sialidase activity, we suggest that this motif can serve as a framework for future optimization of trans-sialylation towards prebiotic production.	[Jers, Carsten; Michalak, Malwina; Larsen, Dorte M.; Guo, Yao; Meyer, Anne S.; Mikkelsen, Jorn D.] Tech Univ Denmark, Dept Chem & Biochem Engn, Ctr BioProc Engn, DK-2800 Lyngby, Denmark; [Kepp, Kasper P.] Tech Univ Denmark, Dept Chem, DK-2800 Lyngby, Denmark; [Li, Haiying; Kirpekar, Finn] Southern Univ Denmark, Dept Biochem & Mol Biol, Odense, Denmark	Technical University of Denmark; Technical University of Denmark; University of Southern Denmark	Mikkelsen, JD (corresponding author), Tech Univ Denmark, Dept Chem & Biochem Engn, Ctr BioProc Engn, DK-2800 Lyngby, Denmark.	jdm@kt.dtu.dk	Meyer, Anne S/AAN-2157-2020; Kepp, Kasper P./AAA-4626-2021; Kepp, Kasper Planeta/G-1748-2013	Meyer, Anne S/0000-0001-8910-9931; Kepp, Kasper P./0000-0002-6754-7348; Kepp, Kasper Planeta/0000-0002-6754-7348; Kirpekar, Finn/0000-0003-1901-2266	Strategic Research Council in Denmark [09-067134]	Strategic Research Council in Denmark	This work was supported by the Strategic Research Council in Denmark, http://fivu.dk; The project number is 09-067134, The title is:"Enzymatic production of human milk oligosaccharides". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaya MF, 2004, STRUCTURE, V12, P775, DOI 10.1016/j.str.2004.02.036; Buschiazzo A, 2000, EMBO J, V19, P16, DOI 10.1093/emboj/19.1.16; Buschiazzo A, 2002, MOL CELL, V10, P757, DOI 10.1016/S1097-2765(02)00680-9; Chen X, 2010, ACS CHEM BIOL, V5, P163, DOI 10.1021/cb900266r; Damager I, 2008, BIOCHEMISTRY-US, V47, P3507, DOI 10.1021/bi7024832; DENNY PC, 1983, CLIN CHIM ACTA, V131, P333, DOI 10.1016/0009-8981(83)90103-1; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; HUMMER G, 1995, J PHYS CHEM-US, V99, P14188, DOI 10.1021/j100038a062; Koliwer-Brandl H, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-39; Kuhne TD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2459; Kunz C, 1996, J CHROMATOGR B, V685, P211, DOI 10.1016/S0378-4347(96)00181-8; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Makelainen H, 2010, BENEF MICROBES, V1, P139, DOI 10.3920/BM2009.0029; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Michalak M, 2012, ENZYME MICROB TECH, V50, P121, DOI 10.1016/j.enzmictec.2011.11.001; Montagna G, 2002, EUR J BIOCHEM, V269, P2941, DOI 10.1046/j.1432-1033.2002.02968.x; Onumpai C, 2011, APPL ENVIRON MICROB, V77, P5747, DOI 10.1128/AEM.00179-11; Paris G, 2005, J MOL BIOL, V345, P923, DOI 10.1016/j.jmb.2004.09.031; Paris G, 2001, GLYCOBIOLOGY, V11, P305, DOI 10.1093/glycob/11.4.305; Pereira MEA, 1996, INFECT IMMUN, V64, P3884, DOI 10.1128/IAI.64.9.3884-3892.1996; Ribeirao M, 1997, GLYCOBIOLOGY, V7, P1237, DOI 10.1093/glycob/7.8.1237; SAITO T, 1992, J DAIRY SCI, V75, P1768, DOI 10.3168/jds.S0022-0302(92)77936-3; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHENKMAN S, 1991, CELL, V65, P1117, DOI 10.1016/0092-8674(91)90008-M; Schmidt D, 2000, J ORG CHEM, V65, P8518, DOI 10.1021/jo000871r; Schrader S, 2003, ANAL BIOCHEM, V322, P139, DOI 10.1016/j.ab.2003.07.016; SCUDDER P, 1993, J BIOL CHEM, V268, P9886; Silva IR, 2011, ENZYME MICROB TECH, V49, P160, DOI 10.1016/j.enzmictec.2011.04.015; Singh S, 2000, CHEM COMMUN, P1013, DOI 10.1039/b002302g; SKOZA L, 1976, BIOCHEM J, V159, P457, DOI 10.1042/bj1590457; Smith JD, 2004, SCIENCE, V306, P851, DOI 10.1126/science.1102560; Walters DM, 1999, J BACTERIOL, V181, P4526, DOI 10.1128/JB.181.15.4526-4532.1999; Yu ZT, 2013, GLYCOBIOLOGY, V23, P169, DOI 10.1093/glycob/cws138	33	24	24	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e83902	10.1371/journal.pone.0083902	http://dx.doi.org/10.1371/journal.pone.0083902			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404142	gold, Green Published, Green Submitted			2022-12-27	WOS:000329460800021
J	Klein, JD; Sano, D; Sen, M; Myers, JN; Grandis, JR; Kim, S				Klein, Jonah D.; Sano, Daisuke; Sen, Malabika; Myers, Jeffrey N.; Grandis, Jennifer R.; Kim, Seungwon			STAT3 Oligonucleotide Inhibits Tumor Angiogenesis in Preclinical Models of Squamous Cell Carcinoma	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CONSTITUTIVE ACTIVATION; DECOY OLIGONUCLEOTIDE; NECK-CANCER; IN-VIVO; IMMUNODEFICIENT MICE; SIGNALING PATHWAY; HEAD; THERAPY; TRANSDUCER	Purpose: Signal transducer and activator of transcription 3 (STAT3) has shown to play a critical role in head and neck squamous cell carcinoma (HNSCC) and we have recently completed clinical trials of STAT3 decoy oligonucleotide in patients with recurrent or metastatic HNSCC. However, there is limited understanding of the role of STAT3 in modulating other aspects of tumorigenesis such as angiogenesis. In this study, we aimed to examine the effects of STAT3 decoy oligonucleotide on tumor angiogenesis. Experimental Design: A STAT3 decoy oligonucleotide and small interfering RNA (siRNA) were used to inhibit STAT3 in endothelial cells in vitro and in vivo. The biochemical effects of STAT3 inhibition were examined in conjunction with the consequences on proliferation, migration, apoptotic staining, and tubule formation. Additionally, we assessed the effects of STAT3 inhibition on tumor angiogenesis using murine xenograft models. Results: STAT3 decoy oligonucleotide decreased proliferation, induces apoptosis, decreased migration, and decreased tubule formation of endothelial cells in vitro. The STAT3 decoy oligonucleotide also inhibited tumor angiogenesis in murine tumor xenografts. Lastly, our data suggest that the antiangiogenic effects of STAT3 decoy oligonucleotide were mediated through the inhibition of both STAT3 and STAT1. Conclusions: The STAT3 decoy oligonucleotide was found to be an effective antiangiogenic agent, which is likely to contribute to the overall antitumor effects of this agent in solid tumors. Taken together with the previously demonstrated antitumor activity of this agent, STAT3 decoy oligonucleotide represents a promising single agent approach to targeting both the tumor and vascular compartments in various malignancies.	[Klein, Jonah D.; Sen, Malabika; Grandis, Jennifer R.; Kim, Seungwon] Univ Pittsburgh, Sch Med, Dept Otolaryngol, Pittsburgh, PA 15260 USA; [Sano, Daisuke] Yokohama City Univ, Grad Sch Med, Dept Biol & Funct Head & Neck, Yokohama, Kanagawa 232, Japan; [Myers, Jeffrey N.] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX USA; [Grandis, Jennifer R.; Kim, Seungwon] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yokohama City University; University of Texas System; UTMD Anderson Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kim, S (corresponding author), Univ Pittsburgh, Sch Med, Dept Otolaryngol, Pittsburgh, PA 15260 USA.	kimsw2@upmc.edu	Sano, Daisuke/R-6591-2018	Sano, Daisuke/0000-0002-7686-4724	NIH [K08 DE019201]; American College of Surgeons/Triological Society Clinician Scientist Career Development Grant; NATIONAL CANCER INSTITUTE [P50CA097190] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K08DE019201, R01DE023685] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American College of Surgeons/Triological Society Clinician Scientist Career Development Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was funded by the NIH grant K08 DE019201 and American College of Surgeons/Triological Society Clinician Scientist Career Development Grant. The funders have no role in study design, data collection and analysis, decision to publish, or prepartion of the manuscript.	Bartoli M, 2000, J BIOL CHEM, V275, P33189, DOI 10.1074/jbc.C000318200; Bartoli M, 2003, FASEB J, V17, P1562, DOI 10.1096/fj.02-1084fje; Battle TE, 2006, CANCER RES, V66, P3649, DOI 10.1158/0008-5472.CAN-05-3612; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; Cohen EEW, 2009, LANCET ONCOL, V10, P247, DOI 10.1016/S1470-2045(09)70002-6; Duan WX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057941; Duffy SA, 2008, CANCER-AM CANCER SOC, V113, P750, DOI 10.1002/cncr.23615; Grandis JR, 2000, P NATL ACAD SCI USA, V97, P4227, DOI 10.1073/pnas.97.8.4227; Gu JH, 2008, J NEURO-ONCOL, V89, P9, DOI 10.1007/s11060-008-9590-9; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Huang SY, 2002, ONCOGENE, V21, P2504, DOI 10.1038/sj.onc.1205341; Kano A, 2003, J EXP MED, V198, P1517, DOI 10.1084/jem.20030077; Leeman RJ, 2006, EXPERT OPIN BIOL TH, V6, P231, DOI 10.1517/14712598.6.3.231; Leong PL, 2003, P NATL ACAD SCI USA, V100, P4138, DOI 10.1073/pnas.0534764100; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Lui VWY, 2007, MOL PHARMACOL, V71, P1435, DOI 10.1124/mol.106.032284; Ni CW, 2004, AM J PHYSIOL-CELL PH, V287, pC771, DOI 10.1152/ajpcell.00532.2003; Nielsen M, 1997, P NATL ACAD SCI USA, V94, P6764, DOI 10.1073/pnas.94.13.6764; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Nor JE, 2001, LAB INVEST, V81, P453, DOI 10.1038/labinvest.3780253; Polverini PJ, 2003, METH MOLEC MED, V78, P161; Sano D, 2007, ONCOL REP, V17, P289; Schaefer LK, 2002, ONCOGENE, V21, P2058, DOI 10.1038/sj.onc.1205263; Sen M, 2010, AM ASS CANC RES ANN; Sen M, 2010, DEV STAT3 DECOY SYST; Sen M, 2012, CANCER DISCOV, V2, P694, DOI 10.1158/2159-8290.CD-12-0191; Sen M, 2009, CANCER CHEMOTH PHARM, V63, P983, DOI 10.1007/s00280-008-0823-6; Sriuranpong V, 2003, CANCER RES, V63, P2948; Sun XX, 2008, CANCER LETT, V262, P201, DOI 10.1016/j.canlet.2007.12.009; Sun ZK, 2006, IMMUNOBIOLOGY, V211, P199, DOI 10.1016/j.imbio.2005.11.004; Van Tubergen E, 2011, CANCER; Xi SC, 2005, ONCOGENE, V24, P970, DOI 10.1038/sj.onc.1208316; Yahata Y, 2003, J BIOL CHEM, V278, P40026, DOI 10.1074/jbc.M301866200; Yigitbasi OG, 2004, CANCER RES, V64, P7977, DOI 10.1158/0008-5472.CAN-04-1477; Zhang XL, 2010, CANCER GENET CYTOGEN, V197, P46, DOI 10.1016/j.cancergencyto.2009.10.004; Zhang XL, 2007, ONCOL REP, V17, P1377	36	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e81819	10.1371/journal.pone.0081819	http://dx.doi.org/10.1371/journal.pone.0081819			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404126	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000329460800005
J	Benedetti, A; Platt, R; Atherton, J				Benedetti, Andrea; Platt, Robert; Atherton, Juli			Generalized Linear Mixed Models for Binary Data: Are Matching Results from Penalized Quasi-Likelihood and Numerical Integration Less Biased?	PLOS ONE			English	Article							REGRESSION-MODELS; MULTILEVEL MODELS; RESPONSES	Background: Over time, adaptive Gaussian Hermite quadrature (QUAD) has become the preferred method for estimating generalized linear mixed models with binary outcomes. However, penalized quasi-likelihood (PQL) is still used frequently. In this work, we systematically evaluated whether matching results from PQL and QUAD indicate less bias in estimated regression coefficients and variance parameters via simulation. Methods: We performed a simulation study in which we varied the size of the data set, probability of the outcome, variance of the random effect, number of clusters and number of subjects per cluster, etc. We estimated bias in the regression coefficients, odds ratios and variance parameters as estimated via PQL and QUAD. We ascertained if similarity of estimated regression coefficients, odds ratios and variance parameters predicted less bias. Results: Overall, we found that the absolute percent bias of the odds ratio estimated via PQL or QUAD increased as the PQL- and QUAD-estimated odds ratios became more discrepant, though results varied markedly depending on the characteristics of the dataset Conclusions: Given how markedly results varied depending on data set characteristics, specifying a rule above which indicated biased results proved impossible. This work suggests that comparing results from generalized linear mixed models estimated via PQL and QUAD is a worthwhile exercise for regression coefficients and variance components obtained via QUAD, in situations where PQL is known to give reasonable results.	[Benedetti, Andrea; Platt, Robert] McGill Univ, Dept Med, Montreal, PQ, Canada; [Benedetti, Andrea] McGill Univ, Dept Epidemiol Biostat Occupat Hlth, Montreal, PQ, Canada; [Benedetti, Andrea] Montreal Chest Inst, Resp Epidemiol & Clin Res Unit, Montreal, PQ, Canada; [Platt, Robert] McGill Univ, Dept Pediat, Montreal, PQ H3A 2T5, Canada; [Atherton, Juli] Univ Quebec, Dept Math, Montreal, PQ H3C 3P8, Canada	McGill University; McGill University; McGill University; McGill University; University of Quebec; University of Quebec Montreal	Benedetti, A (corresponding author), McGill Univ, Dept Med, Montreal, PQ, Canada.	andrea.benedetti@mcgill.ca		Platt, Robert/0000-0002-5981-8443				Austin PC, 2010, INT J BIOSTAT, V6; Breslow N, 2003, UW WORKING PAPER SER, V192; Breslow N, 1995, BIOMETRIKA, V82, P91; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Callens M, 2005, J STAT COMPUT SIM, V75, P1003, DOI 10.1080/00949650412331321070; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; Geraci M, 2014, STAT COMPUT, V24, P461, DOI 10.1007/s11222-013-9381-9; Goldstein H, 1996, J ROY STAT SOC A STA, V159, P505, DOI 10.2307/2983328; HEDEKER D, 1994, J CONSULT CLIN PSYCH, V62, P757, DOI 10.1037/0022-006X.62.4.757; JANG JY, 1993, INT ARCH OCC ENV HEA, V65, pS219, DOI 10.1007/BF00381345; Jang W, 2009, COMMUN STAT-SIMUL C, V38, P692, DOI 10.1080/03610910802627055; Moineddin R, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-34; Molenberghs G., 2005, MODELS DISCRETE LONG; NEUHAUS JM, 1991, INT STAT REV, V59, P25, DOI 10.2307/1403572; Ng ESW, 2006, STAT MODEL, V6, P23, DOI 10.1191/1471082X06st106oa; Pinheiro J. C., 1995, J COMPUTATIONAL GRAP, V4, P12, DOI [DOI 10.2307/1390625, 10.1080/10618600.1995.10474663, DOI 10.1080/10618600.1995.10474663]; R Development Core Team, 2012, R LANG ENV STAT COMP; RODRIGUEZ G, 1995, J ROY STAT SOC A STA, V158, P73, DOI 10.2307/2983404; SAS/STAT, 2011, VERS 9 2 WIND	20	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84601	10.1371/journal.pone.0084601	http://dx.doi.org/10.1371/journal.pone.0084601			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416249	gold, Green Published, Green Accepted			2022-12-27	WOS:000329866300029
J	Ganapathy, A; Pandey, N; Srisailapathy, CRS; Jalvi, R; Malhotra, V; Venkatappa, M; Chatterjee, A; Sharma, M; Santhanam, R; Chadha, S; Ramesh, A; Agarwal, AK; Rangasayee, RR; Anand, A				Ganapathy, Aparna; Pandey, Nishtha; Srisailapathy, C. R. Srikumari; Jalvi, Rajeev; Malhotra, Vikas; Venkatappa, Mohan; Chatterjee, Arunima; Sharma, Meenakshi; Santhanam, Rekha; Chadha, Shelly; Ramesh, Arabandi; Agarwal, Arun K.; Rangasayee, Raghunath R.; Anand, Anuranjan			Non-Syndromic Hearing Impairment in India: High Allelic Heterogeneity among Mutations in TMPRSS3, TMC1, USHIC, CDH23 and TMIE	PLOS ONE			English	Article							USHER-SYNDROME; GENE; DEAFNESS; FAMILIES; PROTEIN; IDENTIFICATION; FREQUENCIES; VARIANTS	Mutations in the autosomal genes TMPRSS3, TMC1, USHIC, CDH23 and TMIE are known to cause hereditary hearing loss. To study the contribution of these genes to autosomal recessive, non-syndromic hearing loss (ARNSHL) in India, we examined 374 families with the disorder to identify potential mutations. We found four mutations in TMPRSS3, eight in TMC1, ten in USHIC, eight in CDH23 and three in TMIE. Of the 33 potentially pathogenic variants identified in these genes, 23 were new and the remaining have been previously reported. Collectively, mutations in these five genes contribute to about one-tenth of ARNSHL among the families examined. New mutations detected in this study extend the allelic heterogeneity of the genes and provide several additional variants for structure-function correlation studies. These findings have implications for early DNA-based detection of deafness and genetic counseling of affected families in the Indian subcontinent.	[Ganapathy, Aparna; Pandey, Nishtha; Venkatappa, Mohan; Chatterjee, Arunima; Sharma, Meenakshi; Santhanam, Rekha; Anand, Anuranjan] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Bangalore 560012, Karnataka, India; [Srisailapathy, C. R. Srikumari; Ramesh, Arabandi] Dr ALM Post Grad Inst Basic Med Sci, Dept Genet, Madras, Tamil Nadu, India; [Jalvi, Rajeev; Rangasayee, Raghunath R.] Ali Yavar Jung Natl Inst Hearing Handicapped, Dept Audiol, Bombay, Maharashtra, India; [Malhotra, Vikas; Chadha, Shelly; Agarwal, Arun K.] Maulana Azad Med Coll, Dept ENT, New Delhi, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore; Maulana Azad Medical College	Anand, A (corresponding author), Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Bangalore 560012, Karnataka, India.	anand@jncasr.ac.in	Chadha, Shelly/AAS-8147-2021; Santhanam, Rekha/AAU-3964-2021	Chadha, Shelly/0000-0001-5789-7259; 	Department of Biotechnology, New Delhi [BT/PR4449/Med/12/172/2003]; JNCASR, Bangalore; Council of Scientific and Industrial Research, New Delhi	Department of Biotechnology, New Delhi(Department of Biotechnology (DBT) India); JNCASR, Bangalore; Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	Funds for this work were provided by Department of Biotechnology, New Delhi (BT/PR4449/Med/12/172/2003) and JNCASR, Bangalore. AG and NP received research fellowships from Council of Scientific and Industrial Research, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahmed ZM, 2002, HUM GENET, V110, P527, DOI 10.1007/s00439-002-0732-4; Ahmed Zubair M, 2004, BMC Med Genet, V5, P24, DOI 10.1186/1471-2350-5-24; Astuto LM, 2002, AM J HUM GENET, V71, P262, DOI 10.1086/341558; Ben Said M, 2010, GENET TEST MOL BIOMA, V14, P307, DOI 10.1089/gtmb.2009.0174; Ben-Yosef T, 2001, J MED GENET, V38, P396, DOI 10.1136/jmg.38.6.396; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Blaydon DC, 2003, CLIN GENET, V63, P303, DOI 10.1034/j.1399-0004.2003.00058.x; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; Ceroni A, 2001, NUCLEIC ACIDS RES, V34, pW177; Davoudi-Dehaghani E, 2013, INT J PEDIATR OTORHI, V77, P821, DOI 10.1016/j.ijporl.2013.02.021; Duman D, 2011, GENET TEST MOL BIOMA, V15, P29, DOI 10.1089/gtmb.2010.0120; Guipponi M, 2008, FRONT BIOSCI-LANDMRK, V13, P1557, DOI 10.2741/2780; Hebsgaard SM, 1994, NUCLEIC ACIDS RES, V24, P3439; Herter S, 2005, BIOCHEM J, V390, P125, DOI 10.1042/BJ20041955; Kalay E, 2005, Hum Mutat, V26, P591, DOI 10.1002/humu.9384; Kitajiri SI, 2007, CLIN GENET, V72, P546, DOI 10.1111/j.1399-0004.2007.00895.x; Kurima K, 2002, NAT GENET, V30, P277, DOI 10.1038/ng842; Lee JW, 2013, GENE; LEE K, 2012, CLIN GENET, V82, P82, DOI DOI 10.1111/J.2044-8279.2010.02016.X; Masmoudi S, 2001, HUM MUTAT, V18, P101, DOI 10.1002/humu.1159; Miyagawa M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040366; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; Naz S, 2002, AM J HUM GENET, V71, P632, DOI 10.1086/342193; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; Ouyang XM, 2002, HUM GENET, V111, P26, DOI 10.1007/s00439-002-0736-0; Ramshankar M, 2008, EUR J HUM GENET, V10, P502; Rozen S, 2000, Methods Mol Biol, V132, P365; Sambrook J., 2001, MOL CLONING LAB MANU; Santos Regie Lyn P, 2005, Hum Mutat, V26, P396, DOI 10.1002/humu.9374; Santos RLP, 2006, J MOL MED, V84, P226, DOI 10.1007/s00109-005-0015-3; Scott HS, 2001, NAT GENET, V27, P59, DOI 10.1038/83768; Sirmaci A, 2009, INT J PEDIATR OTORHI, V73, P699, DOI 10.1016/j.ijporl.2009.01.005; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Wagatsuma M, 2007, CLIN GENET, V72, P339, DOI 10.1111/j.1399-0004.2007.00833.x; Wagner EJ, 2001, MOL CELL BIOL, V21, P3281, DOI 10.1128/MCB.21.10.3281-3288.2001; Wattenhofer M, 2005, HUM GENET, V117, P528, DOI 10.1007/s00439-005-1332-x; Wattenhofer M, 2002, J MOL MED-JMM, V80, P124, DOI 10.1007/s00109-001-0310-6; Weil D, 2003, HUM MOL GENET, V12, P463, DOI 10.1093/hmg/ddg051; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Yan D, 2008, FRONT BIOSCI-LANDMRK, V13, P4972, DOI 10.2741/3056; Yang JJ, 2010, INT J PEDIATR OTORHI, V74, P489, DOI 10.1016/j.ijporl.2010.02.001	45	43	46	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84773	10.1371/journal.pone.0084773	http://dx.doi.org/10.1371/journal.pone.0084773			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416283	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000329862500166
J	Ito, M; Kim, YG; Tsuji, H; Takahashi, T; Kiwaki, M; Nomoto, K; Danbara, H; Okada, N				Ito, Masahiro; Kim, Yun-Gi; Tsuji, Hirokazu; Takahashi, Takuya; Kiwaki, Mayumi; Nomoto, Koji; Danbara, Hirofumi; Okada, Nobuhiko			Transposon Mutagenesis of Probiotic Lactobacillus casei Identifies asnH, an Asparagine Synthetase Gene Involved in Its Immune-Activating Capacity	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-2; NF-KAPPA-B; LEWIS LUNG-CARCINOMA; ANTI-TUMOR ACTIVITY; ESCHERICHIA-COLI; PEPTIDOGLYCAN STRUCTURE; BLADDER-CANCER; STRAIN SHIROTA; CELL ACTIVITY; MICE	Lactobacillus casei ATCC 27139 enhances host innate immunity, and the J1 phage-resistant mutants of this strain lose the activity. A transposon insertion mutant library of L. casei ATCC 27139 was constructed, and nine J1 phage-resistant mutants out of them were obtained. Cloning and sequencing analyses identified three independent genes that were disrupted by insertion of the transposon element: asnH, encoding asparagine synthetase, and dnaJ and dnaK, encoding the molecular chaperones DnaJ and DnaK, respectively. Using an in vivo mouse model of Listeria infection, only asnH mutant showed deficiency in their ability to enhance host innate immunity, and complementation of the mutation by introduction of the wild-type asnH in the mutant strain recovered the immuno-augmenting activity. AsnH protein exhibited asparagine synthetase activity when the lysozyme-treated cell wall extracts of L. casei ATCC 27139 was added as substrate. The asnH mutants lost the thick and rigid peptidoglycan features that are characteristic to the wild-type cells, indicating that AsnH of L. casei is involved in peptidoglycan biosynthesis. These results indicate that asnH is required for the construction of the peptidoglycan composition involved in the immune-activating capacity of L. casei ATCC 27139.	[Ito, Masahiro; Kim, Yun-Gi; Danbara, Hirofumi; Okada, Nobuhiko] Kitasato Univ, Sch Pharm, Dept Microbiol, Minato Ku, Tokyo, Japan; [Tsuji, Hirokazu; Takahashi, Takuya; Kiwaki, Mayumi; Nomoto, Koji] Yakult Cent Inst Microbiol Res, Kunitachi, Tokyo 186, Japan	Kitasato University; Yakult Honsha Company, Limited	Okada, N (corresponding author), Kitasato Univ, Sch Pharm, Dept Microbiol, Minato Ku, Tokyo, Japan.	okadan@pharm.kitasato-u.ac.jp		Hirokazu, Tsuji/0000-0003-2856-6447	Japanese Ministry of Education, Culture, Sports, Science, and Technology [23790485]; Kitasato University Research Grant for Young Researchers	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kitasato University Research Grant for Young Researchers	This study was supported in part by a Grant-in-Aid for Young Scientists B (23790485 to MI) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology. This work was also funded in part by a Kitasato University Research Grant for Young Researchers (2012 to MI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANG D, 1991, J BIOL CHEM, V266, P24233; ASO Y, 1995, EUR UROL, V27, P104, DOI 10.1159/000475138; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BillotKlein D, 1997, J BACTERIOL, V179, P6208, DOI 10.1128/jb.179.19.6208-6212.1997; BOEHLEIN SK, 1994, J BIOL CHEM, V269, P26789; BYEON WH, 1984, J BACTERIOL, V158, P543, DOI 10.1128/JB.158.2.543-550.1984; Capra ML, 2006, J APPL MICROBIOL, V100, P334, DOI 10.1111/j.1365-2672.2005.02767.x; Courtin P, 2006, J BACTERIOL, V188, P5293, DOI 10.1128/JB.00285-06; Faure E, 2001, J IMMUNOL, V166, P2018, DOI 10.4049/jimmunol.166.3.2018; Fernandez EM, 2011, GUT, V60, P1050, DOI [10.1136/gut.2010.232918, 10.1136/gut.2010.232918corr1]; HASHIMOTO S, 1987, CANCER IMMUNOL IMMUN, V24, P1; Hirasawa T, 2000, J BACTERIOL, V182, P2696, DOI 10.1128/JB.182.10.2696-2701.2000; Hughes CA, 1997, PLANT MOL BIOL, V33, P301, DOI 10.1023/A:1005784202450; HUMBERT R, 1980, J BACTERIOL, V142, P212, DOI 10.1128/JB.142.1.212-220.1980; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Ito M, 2010, J APPL MICROBIOL, V109, P657, DOI 10.1111/j.1365-2672.2010.04690.x; KATO I, 1981, GANN, V72, P517; Kim YG, 2006, MICROBES INFECT, V8, P994, DOI 10.1016/j.micinf.2005.10.019; Kurt-Jones EA, 2002, BLOOD, V100, P1860, DOI 10.1182/blood.V100.5.1860.h81702001860_1860_1868; Larsen TM, 1999, BIOCHEMISTRY-US, V38, P16146, DOI 10.1021/bi9915768; Liu Y, 2001, INFECT IMMUN, V69, P2788, DOI 10.1128/IAI.69.5.2788-2796.2001; Matsuguchi T, 2000, BLOOD, V95, P1378, DOI 10.1182/blood.V95.4.1378.004k08_1378_1385; MATSUZAKI T, 1987, CANCER IMMUNOL IMMUN, V24, P99; Matsuzaki T, 1996, MED MICROBIOL IMMUN, V185, P157; MATSUZAKI T, 1987, CANCER IMMUNOL IMMUN, V25, P100; MATSUZAKI T, 1985, CANCER IMMUNOL IMMUN, V20, P18; MEI B, 1989, J BIOL CHEM, V264, P16613; MIAKE S, 1985, INFECT IMMUN, V48, P480, DOI 10.1128/IAI.48.2.480-485.1985; Miller MT, 2001, NAT STRUCT BIOL, V8, P684, DOI 10.1038/90394; Mitani Y, 2005, J BACTERIOL, V187, P2582, DOI 10.1128/JB.187.8.2582-2591.2005; NOMOTO K, 1985, J CLIN LAB IMMUNOL, V17, P91; OHASHI T, 1989, Biotherapy (Dordrecht), V1, P89, DOI 10.1007/BF02170139; Ohashi Y, 2002, UROL INT, V68, P273, DOI 10.1159/000058450; Reid G, 2003, CLIN MICROBIOL REV, V16, P658, DOI 10.1128/CMR.16.4.658-672.2003; Ren H, 2006, ANTIMICROB AGENTS CH, V50, P250, DOI 10.1128/AAC.50.1.250-255.2006; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Shida K, 2008, TRENDS IMMUNOL, V29, P565, DOI 10.1016/j.it.2008.07.011; Shimizu-Kadota M, 2000, GENE, V249, P127, DOI 10.1016/S0378-1119(00)00154-2; Smelt MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063099; Takeda K, 2006, CLIN EXP IMMUNOL, V146, P109, DOI 10.1111/j.1365-2249.2006.03165.x; Takeda K, 2007, J NUTR, V137, p791S, DOI 10.1093/jn/137.3.791S; Veiga P, 2009, J BACTERIOL, V191, P3752, DOI 10.1128/JB.00126-09; YOKOKURA T, 1977, J GEN MICROBIOL, V100, P139, DOI 10.1099/00221287-100-1-139; YOKOKURA T, 1986, INFECT IMMUN, V52, P156, DOI 10.1128/IAI.52.1.156-160.1986; Yoshimura A, 1999, J IMMUNOL, V163, P1; Zalkin H, 1993, Adv Enzymol Relat Areas Mol Biol, V66, P203	47	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83876	10.1371/journal.pone.0083876	http://dx.doi.org/10.1371/journal.pone.0083876			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416179	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500082
J	Laugel-Haushalter, V; Paschaki, M; Marangoni, P; Pilgram, C; Langer, A; Kuntz, T; Demassue, J; Morkmued, S; Choquet, P; Constantinesco, A; Bornert, F; Schmittbuhl, M; Pannetier, S; Viriot, L; Hanauer, A; Dolle, P; Bloch-Zupan, A				Laugel-Haushalter, Virginie; Paschaki, Marie; Marangoni, Pauline; Pilgram, Coralie; Langer, Arnaud; Kuntz, Thibaut; Demassue, Julie; Morkmued, Supawich; Choquet, Philippe; Constantinesco, Andre; Bornert, Fabien; Schmittbuhl, Matthieu; Pannetier, Solange; Viriot, Laurent; Hanauer, Andre; Dolle, Pascal; Bloch-Zupan, Agnes			RSK2 Is a Modulator of Craniofacial Development	PLOS ONE			English	Article							COFFIN-LOWRY-SYNDROME; RIBOSOMAL S6 KINASE; KAPPA-B-ALPHA; TOOTH DEVELOPMENT; RETINOIC ACID; IN-VITRO; TABBY/EDA MICE; SPROUTY GENES; MOUSE MOLAR; MORPHOGENESIS	Background: The RSK2 gene is responsible for Coffin-Lowry syndrome, an X-linked dominant genetic disorder causing mental retardation, skeletal growth delays, with craniofacial and digital abnormalities typically associated with this syndrome. Craniofacial and dental anomalies encountered in this rare disease have been poorly characterized. Methodology/Principal Findings: We examined, using X-Ray microtomographic analysis, the variable craniofacial dysmorphism and dental anomalies present in Rsk2 knockout mice, a model of Coffin-Lowry syndrome, as well as in triple Rsk1,2,3 knockout mutants. We report Rsk mutation produces surpernumerary teeth midline/mesial to the first molar. This highly penetrant phenotype recapitulates more ancestral tooth structures lost with evolution. Most likely this leads to a reduction of the maxillary diastema. Abnormalities of molar shape were generally restricted to the mesial part of both upper and lower first molars (M1). Expression analysis of the four Rsk genes (Rsk1, 2, 3 and 4) was performed at various stages of odontogenesis in wild-type (WT) mice. Rsk2 is expressed in the mesenchymal, neural crest-derived compartment, correlating with proliferative areas of the developing teeth. This is consistent with RSK2 functioning in cell cycle control and growth regulation, functions potentially responsible for severe dental phenotypes. To uncover molecular pathways involved in the etiology of these defects, we performed a comparative transcriptomic (DNA microarray) analysis of mandibular wild-type versus Rsk2-/Y molars. We further demonstrated a misregulation of several critical genes, using a Rsk2 shRNA knock-down strategy in molar tooth germs cultured in vitro. Conclusions: This study reveals RSK2 regulates craniofacial development including tooth development and patterning via novel transcriptional targets.	[Laugel-Haushalter, Virginie; Paschaki, Marie; Morkmued, Supawich; Pannetier, Solange; Hanauer, Andre; Dolle, Pascal; Bloch-Zupan, Agnes] Univ Strasbourg, INSERM, CNRS,U964, Inst Genet & Mol & Cellular Biol IGBMC,UMR 7104, Illkirch Graffenstaden, France; [Marangoni, Pauline; Viriot, Laurent] Univ Lyon 1, Ecole Normale Super Lyon, CNRS,UMR 5242,CNRS, Team Evodevo Vertebrate Dentit,Inst Genom Fonct L, F-69365 Lyon, France; [Pilgram, Coralie; Langer, Arnaud; Kuntz, Thibaut; Demassue, Julie; Morkmued, Supawich; Bornert, Fabien; Schmittbuhl, Matthieu; Bloch-Zupan, Agnes] Univ Strasbourg, Fac Dent, Strasbourg, France; [Choquet, Philippe; Constantinesco, Andre] HUS, Preclin Imaging Lab UF6237, Strasbourg, France; [Choquet, Philippe; Constantinesco, Andre] Univ Strasbourg, CNRS, ICube, Strasbourg, France; [Schmittbuhl, Matthieu; Bloch-Zupan, Agnes] HUS, Reference Ctr Orodental Manifestat Rare Dis, Strasbourg, France; [Bornert, Fabien; Schmittbuhl, Matthieu] Univ Strasbourg, INSERM, U1121, Strasbourg, France; [Morkmued, Supawich] Khon Kaen Univ, Fac Dent, Khon Kaen, Thailand	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Khon Kaen University	Bloch-Zupan, A (corresponding author), Univ Strasbourg, INSERM, CNRS,U964, Inst Genet & Mol & Cellular Biol IGBMC,UMR 7104, Illkirch Graffenstaden, France.	agnes.bloch-zupan@unistra.fr	Dolle, Pascal/A-8037-2010; CHOQUET, Philippe/H-5868-2019; Morkmued, Supawich/AAP-1112-2021; Bloch-Zupan, Agnes/N-7822-2016	Dolle, Pascal/0000-0002-9294-9090; CHOQUET, Philippe/0000-0003-0514-0726; Bloch-Zupan, Agnes/0000-0002-6511-2615; Viriot, Laurent/0000-0003-2092-588X; Paschaki, Marie/0000-0002-9490-8997	University of Strasbourg, the Hopitaux Universitaires de Strasbourg (API); IFRO (Institut Francais pour la Recherche Odontologique); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (INSERM); European Regional Development Fund (ERDF) of the European Union; Ministere Francais de la Recherche; Agence Nationale de la Recherche	University of Strasbourg, the Hopitaux Universitaires de Strasbourg (API); IFRO (Institut Francais pour la Recherche Odontologique); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); European Regional Development Fund (ERDF) of the European Union; Ministere Francais de la Recherche(Ministry of Research, France); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by grants (to AB-Z) from the University of Strasbourg, the Hopitaux Universitaires de Strasbourg (API, 2009-2012, "Development of the oral cavity: from gene to clinical phenotype in Human''), IFRO (Institut Francais pour la Recherche Odontologique), by institutional funds from the Centre National de la Recherche Scientifique (CNRS) and Institut National de la Sante et de la Recherche Medicale (INSERM). This project, A27 "Orodental manifestations of rare diseases'', selected by the Offensive Sciences of the Trinational Metropolitan Area Upper Rhine (TMR), is co-financed by the European Regional Development Fund (ERDF) of the European Union, in the framework of the INTERREG IV Upper Rhine programme. VL-H was the recipient of a PhD fellowship from the Ministere Francais de la Recherche. MP was supported by a grant from the Agence Nationale de la Recherche (to PD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg T, 2004, J HISTOCHEM CYTOCHEM, V52, P131, DOI 10.1177/002215540405200113; BLOCHZUPAN A, 1994, DIFFERENTIATION, V57, P195, DOI 10.1046/j.1432-0436.1994.5730195.x; BlochZupan A, 2012, ELSEV INSIGHT, P1; BLOCHZUPAN A, 1994, ARCH ORAL BIOL, V39, P891, DOI 10.1016/0003-9969(94)90021-3; Boran T, 2005, J DENT RES, V84, P228, DOI 10.1177/154405910508400304; Charles C, 2011, DEVELOPMENT, V138, P4063, DOI 10.1242/dev.069195; Charles C, 2009, ANAT REC, V292, P299, DOI 10.1002/ar.20804; Cho YY, 2005, CANCER RES, V65, P3596, DOI 10.1158/0008-5472.CAN-04-3935; Chotteau-Lelievre Anne, 2006, Methods Mol Biol, V326, P61; Coin R, 1999, INT J DEV BIOL, V43, P261; Courtois G, 2003, J CLIN INVEST, V112, P1108, DOI 10.1172/JCI200318714; Day P, 2000, J DENT CHILD, V67, P148; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fleischmannova J, 2008, EUR J ORAL SCI, V116, P1, DOI 10.1111/j.1600-0722.2007.00504.x; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Ghoda L, 1997, J BIOL CHEM, V272, P21281, DOI 10.1074/jbc.272.34.21281; Guimiot F, 2004, GENE EXPR PATTERNS, V4, P111, DOI 10.1016/j.modgep.2003.06.001; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hanauer A, 2002, J MED GENET, V39, P705, DOI 10.1136/jmg.39.10.705; Hauge C, 2006, J CELL SCI, V119, P3021, DOI 10.1242/jcs.02950; Igari K, 2006, INT J PAEDIATR DENT, V16, P213, DOI 10.1111/j.1365-263X.2006.00698.x; Ji Q, 2002, NATURE, V416, P816, DOI 10.1038/416816a; Kassai Y, 2005, SCIENCE, V309, P2067, DOI 10.1126/science.1116848; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; Klein OD, 2006, DEV CELL, V11, P181, DOI 10.1016/j.devcel.2006.05.014; Kohn M, 2003, GENE EXPR PATTERNS, V3, P173, DOI 10.1016/S1567-133X(03)00004-8; Kristenova P, 2002, Orthod Craniofac Res, V5, P205, DOI 10.1034/j.1600-0544.2002.02225.x; Lagronova-Churava S, 2013, J EXP ZOOL PART B, V320B, P307, DOI 10.1002/jez.b.22502; Laugel-Haushalter Virginie, 2013, BMC Res Notes, V6, P113, DOI 10.1186/1756-0500-6-113; Lesot H, 1998, EUR J ORAL SCI, V106, P64, DOI 10.1111/j.1600-0722.1998.tb02155.x; Lesot H, 2003, Bull Group Int Rech Sci Stomatol Odontol, V45, P1; Liu Z, 2012, ONCOGENE; MARK MP, 1991, DIFFERENTIATION, V48, P89, DOI 10.1111/j.1432-0436.1991.tb00247.x; MARK MP, 1992, INT J DEV BIOL, V36, P517; MITSIADIS TA, 1995, INT J DEV BIOL, V39, P195; Murashima-Suginami A, 2008, BIOCHEM BIOPH RES CO, V369, P1012, DOI 10.1016/j.bbrc.2008.02.135; Mustonen T, 2003, DEV BIOL, V259, P123, DOI 10.1016/S0012-1606(03)00157-X; Ohazama A, 2010, P NATL ACAD SCI USA, V107, P92, DOI 10.1073/pnas.0907236107; Ohazama A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004092; Ohazama A, 2009, DEVELOPMENT, V136, P897, DOI 10.1242/dev.027979; Peterka M, 2000, J CRAN GENET DEV BIO, V20, P35; Peterkova R, 2005, ARCH ORAL BIOL, V50, P219, DOI 10.1016/j.archoralbio.2004.10.020; Peterkova R, 2002, Orthod Craniofac Res, V5, P215, DOI 10.1034/j.1600-0544.2002.02226.x; Peterkova R, 2003, ANN NY ACAD SCI, V1010, P453, DOI 10.1196/annals.1299.083; Pispa J, 2003, GENE EXPR PATTERNS, V3, P675, DOI 10.1016/S1567-133X(03)00092-9; Poirier R, 2007, BEHAV GENET, V37, P31, DOI 10.1007/s10519-006-9116-1; Porntaveetus T, 2011, EUR J ORTHOD; RICHTSMEIER JT, 1995, CLEFT PALATE-CRAN J, V32, P217, DOI 10.1597/1545-1569(1995)032<0217:PRAVOT>2.3.CO;2; Richtsmeier JT, 2000, DEV DYNAM, V217, P137, DOI 10.1002/(SICI)1097-0177(200002)217:2<137::AID-DVDY1>3.0.CO;2-N; Romeo Y, 2012, BIOCHEM J, V441, P553, DOI 10.1042/BJ20110289; Schneider A, 2011, J NEUROCHEM, V119, P447, DOI 10.1111/j.1471-4159.2011.07423.x; Schouten GJ, 1997, EMBO J, V16, P3133, DOI 10.1093/emboj/16.11.3133; Tan Y, 1999, J BIOL CHEM, V274, P34859, DOI 10.1074/jbc.274.49.34859; Temtamy S A, 1975, Birth Defects Orig Artic Ser, V11, P133; TEMTAMY SA, 1975, J PEDIATR-US, V86, P724, DOI 10.1016/S0022-3476(75)80357-X; Tucker AS, 2004, DEV BIOL, V268, P185, DOI 10.1016/j.ydbio.2003.12.019; Tummers M, 2009, J EXP ZOOL PART B, V312B, P309, DOI 10.1002/jez.b.21280; Viriot L, 2000, INT J DEV BIOL, V44, P233; Viriot L, 2002, CONNECT TISSUE RES, V43, P129, DOI 10.1080/03008200290001168; Viriot L, 1997, INT J DEV BIOL, V41, P679; Wan XY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009118; Wise GE, 2011, EUR J ORAL SCI, V119, P333, DOI 10.1111/j.1600-0722.2011.00854.x; Wright TJ, 2004, DEV BIOL, V269, P264, DOI 10.1016/j.ydbio.2004.02.003; Xiao W, 2008, ONCOGENE, V27, P1536, DOI 10.1038/sj.onc.1210786; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Zeniou M, 2002, HUM MOL GENET, V11, P2929, DOI 10.1093/hmg/11.23.2929; Zhang M, 2001, J BIOL CHEM, V276, P44083, DOI 10.1074/jbc.M105748200	68	18	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84343	10.1371/journal.pone.0084343	http://dx.doi.org/10.1371/journal.pone.0084343			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416220	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500117
J	Lee, SH; Lee, SM; Goo, JM; Kim, KG; Kim, YJ; Park, CM				Lee, Sang Hwan; Lee, Sang Min; Goo, Jin Mo; Kim, Kwang-Gi; Kim, Young Jae; Park, Chang Min			Usefulness of Texture Analysis in Differentiating Transient from Persistent Part-solid Nodules(PSNs): A Retrospective Study	PLOS ONE			English	Article							GROUND-GLASS OPACITY; SUBSOLID PULMONARY NODULES; THIN-SECTION CT; LUNG-CANCER; MANAGEMENT; BIOMARKER; KURTOSIS; SKEWNESS	Background: Early discrimination between transient and persistent par-solid ground-glass nodules (PSNs) at CT is essential for patient management. The objective of our study was to retrospectively investigate the value of texture analysis in differentiating pulmonary transient and persistent PSNs in addition to clinical and CT features. Methods: This retrospective study was performed with IRB approval and a waiver of the requirement for patients' informed consent. From January 2007 to October 2009, we identified 77 individuals (39 men and 38 women; mean age, 55 years) with 86 PSNs on thin-section chest CT. Thirty-nine PSNs in 31 individuals were transient and 47 PSNs in 46 patients were persistent. The clinical, CT, and texture features of PSNs were evaluated. To investigate the additional value of texture analysis in differentiating transient from persistent PSNs, logistic regression analysis and C-statistics were performed. Results: Between transient and persistent PSNs, there were significant differences in age, gender, smoking history, and eosinophil count among the clinical features. As for thin-section CT features, there were significant differences in lesion size, solid portion size, and lesion multiplicity. In terms of texture features, there were significant differences in mean attenuation, skewness of whole PSN, attenuation ratio of whole PSN to inner solid portion, and 5-, 10-, 25-, 50-percentile CT numbers of whole PSN. Multivariate analysis revealed eosinophilia, lesion size, lesion multiplicity, mean attenuation of whole PSN, skewness of whole PSN, and 5-percentile CT number were significant independent predictors of transient PSNs. (P < 0.05) C-statistics revealed that texture analysis incorporating clinical and CT features (AUC, 92.9%) showed significantly higher differentiating performance of transient from persistent PSNs compared with the clinical and CT features alone (AUC, 79.0%). (P = 0.004) Conclusion: Texture analysis of PSNs in addition to clinical and CT features analysis has the potential to improve the differentiation of transient from persistent PSNs.	[Lee, Sang Hwan; Lee, Sang Min; Goo, Jin Mo; Park, Chang Min] Seoul Natl Univ, Dept Radiol, Coll Med, Seoul, South Korea; [Lee, Sang Hwan; Lee, Sang Min; Goo, Jin Mo; Park, Chang Min] Seoul Natl Univ, Inst Radiat Med, Med Res Ctr, Seoul, South Korea; [Goo, Jin Mo; Park, Chang Min] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea; [Kim, Kwang-Gi; Kim, Young Jae] Natl Canc Ctr, Dept Biomed Engn, Div Basic & Appl Sci, Gyeonggi Do, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); National Cancer Center - Korea (NCC)	Park, CM (corresponding author), Seoul Natl Univ, Dept Radiol, Coll Med, Seoul, South Korea.	cmpark@radiol.snu.ac.kr			Korean Society of Radiology	Korean Society of Radiology	This study was supported by a Bayer-Schering Radiological Research Fund of the Korean Society of Radiology from 2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asamura H, 2010, PRINCIPLES PRACTICE; Baek HJ, 2012, RADIOLOGY, V264, P834, DOI 10.1148/radiol.12112120; Godoy MCB, 2009, RADIOLOGY, V253, P606, DOI 10.1148/radiol.2533090179; Goh V, 2011, RADIOLOGY, V261, P165, DOI 10.1148/radiol.11110264; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Henschke CI, 2002, AM J ROENTGENOL, V178, P1053, DOI 10.2214/ajr.178.5.1781053; Kim HY, 2008, J COMPUT ASSIST TOMO, V32, P101, DOI 10.1097/RCT.0b013e31806535e5; Lee SM, 2012, EUR RADIOL, V22, P1556, DOI 10.1007/s00330-012-2395-4; Lee SM, 2010, RADIOLOGY, V255, P242, DOI 10.1148/radiol.09090547; Lee SM, 2013, RADIOLOGY; MARDIA KV, 1970, BIOMETRIKA, V57, P519, DOI 10.1093/biomet/57.3.519; Moon WK, 2010, AM J ROENTGENOL, V195, P1460, DOI 10.2214/AJR.09.3140; Naidich DP, 2013, RADIOLOGY, V266, P304, DOI 10.1148/radiol.12120628; Nakata M, 2002, CHEST, V121, P1464, DOI 10.1378/chest.121.5.1464; Ng F, 2013, RADIOLOGY, V266, P177, DOI 10.1148/radiol.12120254; Oh JY, 2007, LUNG CANCER, V55, P67, DOI 10.1016/j.lungcan.2006.09.009; Park CM, 2007, RADIOGRAPHICS, V27, P391, DOI 10.1148/rg.272065061	18	43	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85167	10.1371/journal.pone.0085167	http://dx.doi.org/10.1371/journal.pone.0085167			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416357	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500223
J	Lin, WH; Yeh, TK; Jiaang, WT; Yen, KJ; Chen, CH; Huang, CT; Yen, SC; Hsieh, SY; Chou, LH; Chen, CP; Chiu, CH; Kao, LC; Chao, YS; Chen, CT; Hsu, JTA				Lin, Wen-Hsing; Yeh, Teng-Kuang; Jiaang, Weir-Torn; Yen, Kuei-Jung; Chen, Chun-Hwa; Huang, Chin-Ting; Yen, Shih-Chieh; Hsieh, Shu-Yi; Chou, Ling-Hui; Chen, Ching-Ping; Chiu, Chun-Hsien; Kao, Li-Chun; Chao, Yu-Sheng; Chen, Chiung-Tong; Hsu, John T. -A.			Evaluation of the Antitumor Effects of BPR1J-340, a Potent and Selective FLT3 Inhibitor, Alone or in Combination with an HDAC Inhibitor, Vorinostat, in AML Cancer	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; HISTONE DEACETYLASE INHIBITOR; INTERNAL TANDEM DUPLICATION; ACUTE MYELOGENOUS LEUKEMIA; TYROSINE KINASE INHIBITOR; ACTIVATING MUTATION; APOPTOSIS INDUCTION; IN-VITRO; CELLS; PKC412	Overexpression or/and activating mutation of FLT3 kinase play a major driving role in the pathogenesis of acute myeloid leukemia (AML). Hence, pharmacologic inhibitors of FLT3 are of therapeutic potential for AML treatment. In this study, BPR1J-340 was identified as a novel potent FLT3 inhibitor by biochemical kinase activity (IC50 approximately 25 nM) and cellular proliferation (GC(50) approximately 5 nM) assays. BPR1J-340 inhibited the phosphorylation of FLT3 and STAT5 and triggered apoptosis in FLT3-ITD+ AML cells. The pharmacokinetic parameters of BPR1J-340 in rats were determined. BPR1J-340 also demonstrated pronounced tumor growth inhibition and regression in FLT3-ITD+ AML murine xenograft models. The combination treatment of the HDAC inhibitor vorinostat (SAHA) with BPR1J-340 synergistically induced apoptosis via Mcl-1 down-regulation in MOLM-13 AML cells, indicating that the combination of selective FLT3 kinase inhibitors and HDAC inhibitors could exhibit clinical benefit in AML therapy. Our results suggest that BPR1J-340 may be further developed in the preclinical and clinical studies as therapeutics in AML treatments.	[Lin, Wen-Hsing; Yeh, Teng-Kuang; Jiaang, Weir-Torn; Yen, Kuei-Jung; Chen, Chun-Hwa; Huang, Chin-Ting; Yen, Shih-Chieh; Hsieh, Shu-Yi; Chou, Ling-Hui; Chen, Ching-Ping; Chiu, Chun-Hsien; Kao, Li-Chun; Chao, Yu-Sheng; Chen, Chiung-Tong; Hsu, John T. -A.] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Zhunan, Taiwan; [Hsu, John T. -A.] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan	National Health Research Institutes - Taiwan; National Yang Ming Chiao Tung University	Chen, CT (corresponding author), Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Zhunan, Taiwan.	ctchen@nhri.org.tw; tsuanhsu@nhri.org.tw	Hsieh, Shu Yi/GLV-4929-2022; Hsu, John Tsu-An/C-1199-2010; Chen, Chiung-Tong/D-2075-2010; Hsieh, Shu Yi/AAT-9884-2021; Jiaang, Weir-Torn/D-2072-2010; Chao, Yu-Sheng/D-2074-2010	Hsieh, Shu Yi/0000-0003-0962-1236; 	National Health Research Institutes; National Science Council of Taiwan [NSC 100-2325-B-400-002-]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	The National Health Research Institutes and National Science Council of Taiwan (NSC 100-2325-B-400-002-) financially supported this study.	Al-Yacoub N, 2012, J INVEST DERMATOL, V132, P2263, DOI 10.1038/jid.2012.125; Bali P, 2004, CLIN CANCER RES, V10, P4991, DOI 10.1158/1078-0432.CCR-04-0210; Buchwald M, 2010, LEUKEMIA, V24, P1412, DOI 10.1038/leu.2010.114; Chu SH, 2009, DRUG RESIST UPDATE, V12, P8, DOI 10.1016/j.drup.2008.12.001; Coumar MS, 2008, BIOORG MED CHEM LETT, V18, P1623, DOI 10.1016/j.bmcl.2008.01.068; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; George P, 2005, BLOOD, V105, P1768, DOI 10.1182/blood-2004-09-3413; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Grundler R, 2003, BLOOD, V102, P646, DOI 10.1182/blood-2002-11-3441; Hart S, 2011, BLOOD CANCER J, V1, DOI 10.1038/bcj.2011.43; Kasper S, 2012, BLOOD CANCER J, V2, DOI 10.1038/bcj.2012.5; Kindler T, 2010, BLOOD, V116, P5089, DOI 10.1182/blood-2010-04-261867; Kiyoi H, 2005, INT J HEMATOL, V82, P85, DOI 10.1532/IJH97.05066; Kiyoi H, 1998, LEUKEMIA, V12, P1333, DOI 10.1038/sj.leu.2401130; Knapper S, 2006, BLOOD, V108, P3262, DOI 10.1182/blood-2006-04-015560; Kosugi H, 1999, LEUKEMIA, V13, P1316, DOI 10.1038/sj.leu.2401508; Lagadec C, 2009, ONCOGENE, V28, P1960, DOI 10.1038/onc.2009.61; Levis M, 2004, BLOOD, V104, P1145, DOI 10.1182/blood-2004-01-0388; Lin WH, 2012, BRIT J CANCER, V106, P475, DOI 10.1038/bjc.2011.564; Lin WH, 2013, BIOORGAN MED CHEM, V21, P2856, DOI 10.1016/j.bmc.2013.03.083; Lin WH, 2011, BIOORGAN MED CHEM, V19, P4173, DOI 10.1016/j.bmc.2011.06.016; Liu DP, 2007, ONCOL REP, V18, P673; Lowenberg B, 1999, NEW ENGL J MED, V341, P1051, DOI 10.1056/NEJM199909303411407; Markovic A, 2005, INT J BIOCHEM CELL B, V37, P1168, DOI 10.1016/j.biocel.2004.12.005; Mollgard L, 2008, CANCER CHEMOTH PHARM, V62, P439, DOI 10.1007/s00280-007-0623-4; Nakagawara A, 2001, CANCER LETT, V169, P107, DOI 10.1016/S0304-3835(01)00530-4; Nakao M, 1996, LEUKEMIA, V10, P1911; Nishioka C, 2008, LEUKEMIA RES, V32, P1382, DOI 10.1016/j.leukres.2008.02.018; Odgerel T, 2008, ONCOGENE, V27, P3102, DOI 10.1038/sj.onc.1210980; Pallis M, 2003, LEUKEMIA RES, V27, P803, DOI 10.1016/S0145-2126(03)00012-2; Pietschmann K, 2012, MOL CANCER THER, V11, P2373, DOI 10.1158/1535-7163.MCT-12-0129; Schaefer EW, 2009, HAEMATOL-HEMATOL J, V94, P1375, DOI 10.3324/haematol.2009.009217; Scheijen B, 2002, ONCOGENE, V21, P3314, DOI 10.1038/sj.onc.1205317; Shankar DB, 2007, BLOOD, V109, P3400, DOI 10.1182/blood-2006-06-029579; Shiotsu Y, 2009, BLOOD, V114, P1607, DOI 10.1182/blood-2009-01-199307; Shipley JL, 2009, EXP HEMATOL, V37, P649, DOI 10.1016/j.exphem.2009.04.002; Stirewalt DL, 2003, NAT REV CANCER, V3, P650, DOI 10.1038/nrc1169; Stone RM, 2012, LEUKEMIA, V26, P2061, DOI 10.1038/leu.2012.115; Stone RM, 2005, BLOOD, V105, P54, DOI 10.1182/blood-2004-03-0891; Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326; Weeraratna AT, 2000, PROSTATE, V45, P140, DOI 10.1002/1097-0045(20001001)45:2<140::AID-PROS8>3.0.CO;2-#; Wei Y, 2010, CLIN CANCER RES, V16, P3923, DOI 10.1158/1078-0432.CCR-10-0032; Weisberg E, 2002, CANCER CELL, V1, P433, DOI 10.1016/S1535-6108(02)00069-7; Weng CJ, 2005, J BIOL CHEM, V280, P10491, DOI 10.1074/jbc.M412819200; Wiernik Peter H, 2010, Clin Adv Hematol Oncol, V8, P429; Wiernik PH, 2010, CLIN ADV HEMATOL ONC, V8, P444; Yamamoto Y, 2001, BLOOD, V97, P2434, DOI 10.1182/blood.V97.8.2434; Yanada M, 2005, LEUKEMIA, V19, P1345, DOI 10.1038/sj.leu.2403838; Yee KWH, 2002, BLOOD, V100, P2941, DOI 10.1182/blood-2002-02-0531; Zhou JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019798	50	11	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83160	10.1371/journal.pone.0083160	http://dx.doi.org/10.1371/journal.pone.0083160			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416160	gold, Green Published, Green Submitted			2022-12-27	WOS:000329862500033
J	Mirzada, F; Schimberg, AS; Engelaer, FM; Bijwaard, GE; van Bodegom, D; Westendorp, RGJ; van Poppel, FWA				Mirzada, Fereshta; Schimberg, Anouk S.; Engelaer, Frouke M.; Bijwaard, Govert E.; van Bodegom, David; Westendorp, Rudi G. J.; van Poppel, Frans W. A.			Arts and Ageing; Life Expectancy of Historical Artists in the Low Countries	PLOS ONE			English	Article							ECONOMIC-DEVELOPMENT; LIVE LONGER; HEALTH; MUSIC; MORTALITY; WOMEN; NETHERLANDS; THERAPY; DISEASE; PEOPLE	Practising arts has been linked to lowering stress, anxiety and blood pressure. These mechanisms are all known to affect the ageing process. Therefore, we examine the relation between long-term involvement in arts and life expectancy at age 50 (LE50), in a cohort of 12,159 male acoustic, literary and visual artists, who were born between 1700 and 1899 in the Low Countries. We compared the life expectancy at age 50 of the various artists with the elite and middle class of that time. In the birth cohorts before 1850, acoustic (LE50:14.5-19.5) and literary artists (LE50:17.8-20.8) had a similar life expectancy at age 50 compared to the elite (LE50:18.0-19.0). Only visual artists (LE50:15.5-17.1) had a lower life expectancy at age 50 compared to the elite at that time. For the most recent birth cohorts from 1850 through 1899, the comparison between artists and the elite reversed and acoustic and literary artist had a lower life expectancy at age 50, while visual artists enjoyed a similar life expectancy at age 50. Although artists belonged to the middle socioeconomic class and lived predominantly in urban areas with poor living conditions, they had a life expectancy similar to the elite population. This is in line with observed favourable effects of practicing arts on health in the short-term. From our historical analysis, we hypothesize several mechanisms through which artistic creativity could influence the ageing process and life expectancy. These hypotheses, however, should be formally tested before any definite conclusions on effects of arts on ageing can be drawn.	[Mirzada, Fereshta; Schimberg, Anouk S.; Engelaer, Frouke M.; van Bodegom, David; Westendorp, Rudi G. J.] Leyden Acad Vital & Ageing, Leiden, Netherlands; [Engelaer, Frouke M.; van Bodegom, David; Westendorp, Rudi G. J.] Leiden Univ Med Ctr, Leiden, Netherlands; [Bijwaard, Govert E.; van Poppel, Frans W. A.] Netherlands Interdisciplinary Demog Inst NIDI, The Hague, Netherlands; [van Poppel, Frans W. A.] Univ Utrecht, Dept Sociol, Utrecht, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Royal Netherlands Academy of Arts & Sciences; Netherlands Interdisciplinary Demographic Institute (NIDI-KNAW); Utrecht University	Engelaer, FM (corresponding author), Leyden Acad Vital & Ageing, Leiden, Netherlands.	engelaer@leydenacademy.nl	Schimberg, Anouk S/S-5663-2017; Bijwaard, Govert E/K-6151-2012	Bijwaard, Govert E/0000-0002-6458-1647; van Bodegom, David/0000-0002-5691-8342				Antrim DK, 1944, MUSIC Q, V30, P409; Bengtsson T, 2011, EXPLOR ECON HIST, V48, P343, DOI 10.1016/j.eeh.2011.05.004; Bernardi L, 2006, HEART, V92, P445, DOI 10.1136/hrt.2005.064600; Bernatzky G, 2004, NEUROSCI LETT, V361, P4, DOI 10.1016/j.neulet.2003.12.022; Birchenall JA, 2007, WORLD DEV, V35, P543, DOI 10.1016/j.worlddev.2006.06.003; Bongaarts J, 2005, DEMOGRAPHY, V42, P23, DOI 10.1353/dem.2005.0003; Brodzinski E, 2009, HEALTH CARE ANAL, V17, P277, DOI 10.1007/s10728-009-0128-x; Cameron C., 2005, MICROECONOMETRICS US, P1056; Carrieri MP, 2005, INT J EPIDEMIOL, V34, P1435, DOI 10.1093/ije/dyi211; Centraal Bureau voor de Statistiek (CBS), 2007, LEV NAAR INK GEM 200; Chida Y, 2008, PSYCHOSOM MED, V70, P741, DOI 10.1097/PSY.0b013e31818105ba; Cohen Gene., 2009, ARTS HEALTH, V1, P48, DOI [DOI 10.1080/17533010802528033, 10.1080/17533010802528033]; Cohen GD, 2006, GENERATIONS, V30, P7; Collie K, 2006, J HEALTH PSYCHOL, V11, P761, DOI 10.1177/1359105306066632; Danner DD, 2001, J PERS SOC PSYCHOL, V80, P804, DOI 10.1037/0022-3514.80.5.804; Davidson KW, 2010, EUR HEART J, V31, P1065, DOI 10.1093/eurheartj/ehp603; Diener E, 2011, APPL PSYCHOL-HLTH WE, V3, P1, DOI 10.1111/j.1758-0854.2010.01045.x; Dobson R, 2007, BRIT MED J, V335, P1233, DOI 10.1136/bmj.39423.603391.DB; Esterling BA, 1999, CLIN PSYCHOL REV, V19, P79, DOI 10.1016/S0272-7358(98)00015-4; Gavrilov L.A., 1991, BIOL LIFE SPAN QUANT; Gompertz B., 1825, PHILOS T ROYAL SOC L, V115, P515, DOI [DOI 10.1098/RSTL.1825.0026, 10.1098/rstl.1825.0026]; Haines MR, 2004, SOC SCI HIST, V28, P249, DOI 10.1215/01455532-28-2-249; Heligman L., 1980, J I ACTUAR, V107, P49, DOI [DOI 10.1017/S0020268100040257, 10.1017/S0020268100040257]; Hoogenboom A, 1993, STAND KUNSTENAARS, P97; Howell R., 2007, HEALTH PSYCHOL REV, V1, P83, DOI [DOI 10.1080/17437190701492486, 10.1080/17437190701492486]; Kelly CG, 2012, J HOLIST NURS, V30, P48, DOI 10.1177/0898010111423418; Kuhn D, 2002, J MUSIC THER, V39, P30, DOI 10.1093/jmt/39.1.30; Lenart A, 2012, SCANDINAVIAN ACTUARI, P1, DOI 1080/03461238.2012.687697; Makin S, 2012, CHRONIC ILLN, V8, P64, DOI 10.1177/1742395311422613; Mammarella N, 2007, AGING CLIN EXP RES, V19, P394; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Merz CNB, 2002, BEHAV MED, V27, P141, DOI 10.1080/08964280209596039; Misic P, 2010, EUR PSYCHIAT, V25; Nanda U, 2011, J PSYCHIATR MENT HLT, V18, P386, DOI 10.1111/j.1365-2850.2010.01682.x; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; Patston LLM, 2007, LATERALITY, V12, P262, DOI 10.1080/13576500701251981; Pennebaker JW, 1997, PSYCHOL SCI, V8, P162, DOI 10.1111/j.1467-9280.1997.tb00403.x; Perenboom RJM, 2004, SOC INDIC RES, V65, P227, DOI 10.1023/A:1025822024481; Petrie KJ, 2004, PSYCHOSOM MED, V66, P272, DOI 10.1097/01.psy.0000116782.49850.d3; Redelmeier DA, 2001, ANN INTERN MED, V134, P955, DOI 10.7326/0003-4819-134-10-200105150-00009; Reynolds F, 2003, DISABIL REHABIL, V25, P785, DOI 10.1080/0963828031000093486; Rosenkranz K, 2007, J NEUROSCI, V27, P5200, DOI 10.1523/JNEUROSCI.0836-07.2007; Salmen Walter, 1983, SOCIAL STATUS PROFES; Schenk N, 2011, EXPLOR ECON HIST, V48, P401, DOI 10.1016/j.eeh.2011.05.010; Steptoe A, 2009, NEUROSCI BIOBEHAV R, V33, P63, DOI 10.1016/j.neubiorev.2008.04.010; Stolwijk C, 1998, UIT SCHILDERSWERELD, P250; Sylvestre MP, 2006, ANN INTERN MED, V145, P361, DOI 10.7326/0003-4819-145-5-200609050-00009; Teng XF, 2007, P ANN INT IEEE EMBS, P4649, DOI 10.1109/IEMBS.2007.4353376; van Bodegom David, 2013, Evolution Medicine and Public Health, P37, DOI 10.1093/emph/eot002; Van Lente D, 1996, DRUKPERSEN PAPIERMAC, P246; van Poppel F, 2013, POP STUD-J DEMOG, V67, P275, DOI 10.1080/00324728.2013.765955	51	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e82721	10.1371/journal.pone.0082721	http://dx.doi.org/10.1371/journal.pone.0082721			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	291WL	24416148	gold, Green Published, Green Submitted			2022-12-27	WOS:000329862500020
J	Scholz, F; Badgley, BD; Sadowsky, MJ; Kaplan, DH				Scholz, Felix; Badgley, Brian D.; Sadowsky, Michael J.; Kaplan, Daniel H.			Immune Mediated Shaping of Microflora Community Composition Depends on Barrier Site	PLOS ONE			English	Article							SEGMENTED FILAMENTOUS BACTERIA; T-CELL DEVELOPMENT; INTESTINAL MICROBIOTA; GUT MICROBIOME; DEFICIENT MICE; INDIGENOUS CLOSTRIDIUM; SKIN MICROBIOME; RARE BIOSPHERE; INFLAMMATION; OBESITY	Barrier surfaces, such as the intestinal lining and the skin, are colonized by a diverse community of commensal microorganisms. Although commensal microorganisms clearly impact the host immune system, whether the immune system also shapes the commensal community is poorly understood. We used 16S rDNA deep sequencing to test whether mice with specific immune defects have an altered commensal microflora. Initially, skin swabs were obtained from wild-type and Langerhans Cell (LC) deficient mice. Despite the intimate contacts that LC make with the upper epidermis, no significant differences were observed in microbial community composition. Similarly, the skin of MyD88/TRIF-/-, Rag1(-/-) and heterozygous littermate controls showed no alteration in their commensal communities. Next we examined mouth swabs and feces. We did not find a difference in the MyD88/TRIF-/- mice. However, we did observe a significant shift in the microbial composition in the feces and mouths of Rag1(-/-) mice. Thus, we conclude that the adaptive immune system modulates the microbial composition at mucosal surfaces in the steady-state but LC, adaptive immunity, and MyD88-dependent innate responses do not affect the skin microbiome revealing a major distinction between barrier sites.	[Scholz, Felix; Kaplan, Daniel H.] Univ Minnesota, Dept Dermatol, Ctr Immunol, Minneapolis, MN 55455 USA; [Badgley, Brian D.; Sadowsky, Michael J.] Univ Minnesota, Inst Biotechnol, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Kaplan, DH (corresponding author), Univ Minnesota, Dept Dermatol, Ctr Immunol, Minneapolis, MN 55455 USA.	dankaplan@umn.edu	Kaplan, Daniel H/N-2779-2013; Sadowsky, Michael/J-2507-2016	Kaplan, Daniel H/0000-0002-7851-7320; Sadowsky, Michael/0000-0001-8779-2781	National Institute of Health NIDCR [T32DE07288]; NIAMS [AR056632]; University of Minnesota; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007288] Funding Source: NIH RePORTER	National Institute of Health NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); University of Minnesota(University of Minnesota System); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was funded by the National Institute of Health NIDCR (T32DE07288, FS), NIAMS (AR056632, DHK), and a seed development grant from the University of Minnesota. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Chiba Tsutomu, 2011, Gastroenterology, V141, P1114, DOI 10.1053/j.gastro.2011.07.013; Chodaczek G, 2012, NAT IMMUNOL, V13, P272, DOI 10.1038/ni.2240; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cummings JH, 1997, NUTRITION, V13, P476, DOI 10.1016/S0899-9007(97)00114-7; Dave M, 2012, TRANSL RES, V160, P246, DOI 10.1016/j.trsl.2012.05.003; Dimitriu PA, 2013, ENV MICROBIOL REP, V5, P200, DOI 10.1111/j.1758-2229.2012.00393.x; Doss M, 2010, J LEUKOCYTE BIOL, V87, P79, DOI 10.1189/jlb.0609382; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Flores GE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044563; Fritz JH, 2012, NATURE, V481, P199, DOI 10.1038/nature10698; Gallo RL, 2011, J INVEST DERMATOL, V131, P1974, DOI 10.1038/jid.2011.182; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Garrett WS, 2009, CYTOKINE, V48, P144, DOI 10.1016/j.cyto.2009.07.007; Gorbachev AV, 2004, J IMMUNOL, V172, P2286, DOI 10.4049/jimmunol.172.4.2286; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Grice EA, 2010, P NATL ACAD SCI USA, V107, P14799, DOI 10.1073/pnas.1004204107; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hamilton MJ, 2013, GUT MICROBES, V4, P125, DOI 10.4161/gmic.23571; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hildebrand F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r4; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Huse SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034242; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Kaplan DH, 2005, IMMUNITY, V23, P611, DOI 10.1016/j.immuni.2005.10.008; Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111; Kubo A, 2009, J EXP MED, V206, P2937, DOI 10.1084/jem.20091527; Lai YP, 2010, J INVEST DERMATOL, V130, P2211, DOI 10.1038/jid.2010.123; Lai YP, 2009, NAT MED, V15, P1377, DOI 10.1038/nm.2062; Lozupone CA, 2013, GENOME RES, V23, P1704, DOI 10.1101/gr.151803.112; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; Marchesi JR, 2011, ENVIRON MICROBIOL, V13, P3088, DOI 10.1111/j.1462-2920.2011.02574.x; Marchesi JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020447; Morgan XC, 2013, TRENDS GENET, V29, P51, DOI 10.1016/j.tig.2012.09.005; Nagano Y, 2012, CURR OPIN IMMUNOL, V24, P392, DOI 10.1016/j.coi.2012.05.007; Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152; Parks BW, 2013, CELL METAB, V17, P141, DOI 10.1016/j.cmet.2012.12.007; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Scharschmidt TC, 2009, J INVEST DERMATOL, V129, P2435, DOI 10.1038/jid.2009.104; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Sonnenberg GF, 2010, ADV IMMUNOL, V107, P1, DOI [10.1016/S0065-2776(10)07008-2, 10.1016/B978-0-12-381300-8.00001-0]; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Talham GL, 1999, INFECT IMMUN, V67, P1992; Thompson CL, 2013, MUCOSAL IMMUNOL, V6, P200, DOI 10.1038/mi.2012.91; Tortola L, 2012, J CLIN INVEST, V122, P3965, DOI 10.1172/JCI63451; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Ubeda C, 2012, J EXP MED, V209, P1445, DOI 10.1084/jem.20120504; Wade WG, 2013, PHARMACOL RES, V69, P137, DOI 10.1016/j.phrs.2012.11.006; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352	59	24	24	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84019	10.1371/journal.pone.0084019	http://dx.doi.org/10.1371/journal.pone.0084019			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416190	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500090
J	Yun, HC; Fugate, WH; Murray, CK; Cropper, TL; Lott, L; McDonald, JM				Yun, Heather C.; Fugate, William H.; Murray, Clinton K.; Cropper, Thomas L.; Lott, Lisa; McDonald, J. Matthew			Pandemic Influenza Virus 2009 H1N1 and Adenovirus in a High Risk Population of Young Adults: Epidemiology, Comparison of Clinical Presentations, and Coinfection	PLOS ONE			English	Article							REAL-TIME PCR; RESPIRATORY-DISEASE; UNITED-STATES; US MILITARY; INFECTIONS; ILLNESS; ASSAY; SAMPLES	Background: In 2009, pandemic H1N1 influenza virus (2009 H1N1) emerged worldwide, causing morbidity and mortality that disproportionately affected young adults. Upper respiratory infection (URI), largely due to adenovirus, is an endemic cause of morbidity in military training. Whether clinical presentations differ or excess morbidity results from coinfection is unclear. Methods: The Center for Advanced Molecular Detection evaluates epidemiology and rapid diagnostics of respiratory pathogens in trainees with URI. From May 1, 2009, to November 30, 2009, demographic, clinical, and PCR data from throat and nasal specimens for adenovirus and 2009 H1N1 were prospectively collected. Results: 375 trainees with URI enrolled and were tested for both adenovirus and 2009 H1N1 by PCR (median age 20; 89% male). Adenovirus PCR was positive in 72% (96% serotype E-4) and 2009 H1N1 in 20%. Males were more likely to have adenovirus and females more likely to have 2009 H1N1 (p = 0.047). Subjects with 2009 H1N1 presented an average of 1 week earlier in training, had shorter illness duration before enrollment, less sore throat, diarrhea, and fewer abnormal findings on throat exam. Coryza and cough were more common with 2009 H1N1 compared to adenovirus. Subjects with 2009 H1N1 were less likely to have adenovirus than those without, despite persistently high frequencies of adenovirus detections during peak 2009 H1N1 weeks (15% vs. 83%, p < 0.01). Coinfection with adenovirus and 2009 H1N1 was rare (4%). Rates of hospitalization and pneumonia did not differ between the adenovirus, 2009 H1N1, or coinfected groups. Conclusion: Military trainees with 2009 H1N1 vs. adenovirus have differing clinical presentations, and males are more likely to have adenovirus. Despite high frequencies of adenovirus infection, coinfection with adenovirus and 2009 H1N1 is rare and apparently does not result in increased morbidity.	[Yun, Heather C.; Murray, Clinton K.] San Antonio Mil Med Ctr, Joint Base San Antonio F, TX USA; [Fugate, William H.; Lott, Lisa; McDonald, J. Matthew] Joint Base San Antonio Lackland, Ctr Adv Mol Detect, Joint Base San Antonio L, TX USA; [Cropper, Thomas L.] Trainee Hlth Surveillance, Joint Base San Antonio L, TX USA; [Yun, Heather C.; Murray, Clinton K.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA	San Antonio Military Medical Center; Uniformed Services University of the Health Sciences - USA	Yun, HC (corresponding author), San Antonio Mil Med Ctr, Joint Base San Antonio F, TX USA.	heather.c.yun.mil@mail.mil			Center for Advanced Molecular Detection	Center for Advanced Molecular Detection	The funding source of the Center for Advanced Molecular Detection's work, including this study, originates with the United States Air Force. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, FEBR RESP ILLN FRI S; [Anonymous], 2009, CDC 38 MILL DOS H1N1; [Anonymous], 2009, CDC PROT REALT RTPCR; Baccala GP, 2008, J CLIN VIROL, V43, P407, DOI 10.1016/j.jcv.2008.08.010; Butler D, 2010, NATURE, V464, P1112, DOI 10.1038/4641112a; Camargo C, 2012, BRAZ J INFECT DIS, V16, P180, DOI [10.1016/S1413-8670(12)70302-1, 10.1590/S1413-86702012000200013]; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P37; Coiras MT, 2003, J MED VIROL, V69, P132, DOI 10.1002/jmv.10255; DUDDING BA, 1973, AM J EPIDEMIOL, V97, P187, DOI 10.1093/oxfordjournals.aje.a121499; Esper FP, 2011, J INFECTION, V63, P260, DOI 10.1016/j.jinf.2011.04.004; Fendrick AM, 2003, ARCH INTERN MED, V163, P487, DOI 10.1001/archinte.163.4.487; Gray GC, 2000, CLIN INFECT DIS, V31, P663, DOI 10.1086/313999; Gray GC, 1999, EMERG INFECT DIS, V5, P379, DOI 10.3201/eid0503.990308; Gray GC, 2007, CLIN INFECT DIS, V45, P1120, DOI 10.1086/522188; Greer RM, 2009, J CLIN VIROL, V45, P10, DOI 10.1016/j.jcv.2009.03.008; Heim A, 2003, J MED VIROL, V70, P228, DOI 10.1002/jmv.10382; Kistler A, 2007, J INFECT DIS, V196, P817, DOI 10.1086/520816; Metzgar D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007081; Potter RN, 2012, EMERG INFECT DIS, V18, P507, DOI 10.3201/eid1803.111238; Pretorius MA, 2012, J INFECT DIS, V206, pS159, DOI 10.1093/infdis/jis538; Russell KL, 2006, J INFECT DIS, V194, P877, DOI 10.1086/507426; Sanchez JL, 2001, J MED VIROL, V65, P710, DOI 10.1002/jmv.2095; Schnepf N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023514; Tanner H, 2012, EUR J CLIN MICROBIOL, V31, P3001, DOI 10.1007/s10096-012-1653-3; Tate JE, 2009, J INFECT DIS, V199, P1419, DOI 10.1086/598520; Viboud C, 2010, PLOS CURR, V2; Walter EA, 2000, MIL MED, V165, P941, DOI 10.1093/milmed/165.12.941	27	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85094	10.1371/journal.pone.0085094	http://dx.doi.org/10.1371/journal.pone.0085094			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416345	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500214
J	Bruge, F; Tiano, L; Astolfi, P; Emanuelli, M; Damiani, E				Bruge, Francesca; Tiano, Luca; Astolfi, Paola; Emanuelli, Monica; Damiani, Elisabetta			Prevention of UVA-Induced Oxidative Damage in Human Dermal Fibroblasts by New UV Filters, Assessed Using a Novel In Vitro Experimental System	PLOS ONE			English	Article							HUMAN SKIN FIBROBLASTS; LIPID-PEROXIDATION; PHOTOSTABILITY; MATRIX; ABSORPTION; SUNSCREENS; EFFICACY; METALLOPROTEINASES; PHOTOPROTECTION; RADIATION	Background: UVA rays present in sunlight are able to reach the dermal skin layer generating reactive oxygen species (ROS) responsible for oxidative damage, alterations in gene expression, DNA damage, leading to cell inflammation, photoageing/-carcinogenesis. Sunscreens contain UV filters as active ingredients that absorb/reflect/dissipate UV radiation: their efficiency depends on their spectral profile and photostability which should then be reflected in biological protection of underlying skin. Methods: A set of new UV filters was synthesized, and the most photostable one was compared to BMDBM, a widely used UVA filter. Cultured human dermal fibroblasts were exposed to UVA radiation which was filtered by a base cream containing or not UV filters placed above cell culture wells. The endpoints measured were: cell viability (MTT assay), ROS generation (DCFH-DA assay), mitochondrial function (JC-1 assay), DNA integrity (Comet assay) and gene expression (MMP-1, COL1A1) by RT-qPCR. Results: The new UV filter resulted more efficient than BMDBM in preserving cell viability, mitochondrial functionality and oxidative DNA damage, despite similar inhibition levels of intracellular ROS. Moreover, expression of genes involved in dermal photoageing were positively affected by the filtering action of the tested molecules. Conclusions: The experimental model proposed was able to validate the efficacy of the new UV filter, taking into account important cellular events related to UV-induced intracellular oxidative stress, often underestimated in the assessments of these compounds. General Significance: The model may be used to compare the actual biological protection of commercial sunscreens and suncare products aside from their SPF and UVA-PF values.	[Bruge, Francesca; Tiano, Luca; Emanuelli, Monica] Univ Politecn Marche, Dipartimento Sci Clin Specialist & Odontostomatol, Ancona, Italy; [Astolfi, Paola] Univ Politecn Marche, Dipartimento Sci Ingn Mat Ambiente & Urbanist, Ancona, Italy; [Damiani, Elisabetta] Univ Politecn Marche, Dipartimento Sci Vita & Ambiente, Ancona, Italy	Marche Polytechnic University; Marche Polytechnic University; Marche Polytechnic University	Damiani, E (corresponding author), Univ Politecn Marche, Dipartimento Sci Clin Specialist & Odontostomatol, Ancona, Italy.	e.damiani@univpm.it	Astolfi, Paola/C-5953-2008; Tiano, Luca/ABC-2341-2020	Astolfi, Paola/0000-0003-3226-082X; Tiano, Luca/0000-0002-7519-7106; Damiani, Elisabetta/0000-0002-7885-1783	Universita Politecnica delle Marche	Universita Politecnica delle Marche	Funding was provided by the Universita Politecnica delle Marche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti A, 2011, TETRAHEDRON, V67, P6889, DOI 10.1016/j.tet.2011.06.094; Andrae I, 1997, J PHOTOCH PHOTOBIO B, V37, P147, DOI 10.1016/S1011-1344(96)07330-7; BATTISTONI P, 1983, J HETEROCYCLIC CHEM, V20, P451, DOI 10.1002/jhet.5570200235; Behbahani H, 2006, J NEUROSCI RES, V84, P891, DOI 10.1002/jnr.20990; Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340; Bonda C.A., 2005, SUNSCREENS REGULATIO, P321; Bruge F, 2011, J BIOTECHNOL, V156, P153, DOI 10.1016/j.jbiotec.2011.09.018; Buechner N, 2008, EXP GERONTOL, V43, P633, DOI 10.1016/j.exger.2008.04.009; Cantrell A, 2001, J PHOTOCH PHOTOBIO B, V64, P117, DOI 10.1016/S1011-1344(01)00226-3; COLIPA, 2006, COLIPA GUID INT SUN; Collins AR, 1996, ENVIRON HEALTH PERSP, V104, P465, DOI 10.2307/3432805; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Couteau C, 2007, PHARMAZIE, V62, P449, DOI 10.1691/ph.2007.6.6247; Damiani E, 1999, FREE RADICAL BIO MED, V26, P809, DOI 10.1016/S0891-5849(98)00292-5; Damiani E, 2006, J PHOTOCH PHOTOBIO B, V82, P204, DOI 10.1016/j.jphotobiol.2005.03.011; Damiani E, 2006, FREE RADICAL RES, V40, P485, DOI 10.1080/10715760600590065; Damiani E, 2007, J PHOTOCH PHOTOBIO B, V87, P95, DOI 10.1016/j.jphotobiol.2007.03.003; Damiani E, 2010, FREE RADICAL RES, V44, P304, DOI 10.3109/10715760903486065; Diffey BL, 1997, EUR J DERMATOL, V7, P226; Fligiel SEG, 2003, J INVEST DERMATOL, V120, P842, DOI 10.1046/j.1523-1747.2003.12148.x; Goslinski T, 2002, J MED CHEM, V45, P5052, DOI 10.1021/jm020827z; Hempel SL, 1999, FREE RADICAL BIO MED, V27, P146, DOI 10.1016/S0891-5849(99)00061-1; Jean C, 2011, PHOTODERMATOL PHOTO, V27, P318, DOI 10.1111/j.1600-0781.2011.00627.x; Karsenty G, 1995, Int Rev Immunol, V12, P177, DOI 10.3109/08830189509056711; Lejeune F, 2008, PHOTODERMATOL PHOTO, V24, P249, DOI 10.1111/j.1600-0781.2008.00370.x; Lhiaubet-Vallet V, 2010, PHOTOCH PHOTOBIO SCI, V9, P552, DOI 10.1039/b9pp00158a; Maines M.D., 1998, CURRENT PROTOCOLS TO; Marrot L, 2004, BRIT J DERMATOL, V151, P1234, DOI 10.1111/j.1365-2133.2004.06173.x; Masek T, 2005, ANAL BIOCHEM, V336, P46, DOI 10.1016/j.ab.2004.09.010; MATRISIAN LM, 1990, TRENDS GENET, V6, P121, DOI 10.1016/0168-9525(90)90126-Q; Palm MD, 2007, DERMATOL THER, V20, P360, DOI 10.1111/j.1529-8019.2007.00150.x; Pelizzo Maria, 2012, ISRN Dermatol, V2012, P352135, DOI 10.5402/2012/352135; Pescia AC, 2012, INT J PHARMACEUT, V427, P217, DOI 10.1016/j.ijpharm.2012.02.001; Polte T, 2004, FREE RADICAL BIO MED, V36, P1566, DOI 10.1016/j.freeradbiomed.2004.04.003; Puglia C, 2012, J PHARM SCI-US, V101, P301, DOI 10.1002/jps.22741; ROSCHER NM, 1994, J PHOTOCH PHOTOBIO A, V80, P417, DOI 10.1016/1010-6030(94)01043-9; Routaboul C, 1999, EUR J DERMATOL, V9, P95; SABITHA G, 1987, SYNTHETIC COMMUN, V17, P341, DOI 10.1080/00397918708077315; Sarasin A, 1999, MUTAT RES-FUND MOL M, V428, P5, DOI 10.1016/S1383-5742(99)00025-3; Sayre RM, 2005, PHOTOCHEM PHOTOBIOL, V81, P452, DOI 10.1562/2004-02-12-RA-083.1; Scharffetter-Kochanek K, 1997, BIOL CHEM, V378, P1247; SCHWACK W, 1995, J PHOTOCH PHOTOBIO B, V28, P229, DOI 10.1016/1011-1344(95)07118-L; Seite S, 1998, J PHOTOCH PHOTOBIO B, V44, P69, DOI 10.1016/S1011-1344(98)00122-5; Tarras-Wahlberg N, 1999, J INVEST DERMATOL, V113, P547, DOI 10.1046/j.1523-1747.1999.00721.x; Tiano L, 2010, FREE RADICAL BIO MED, V49, P408, DOI 10.1016/j.freeradbiomed.2010.04.032; Venditti E, 2008, FREE RADICAL BIO MED, V45, P345, DOI 10.1016/j.freeradbiomed.2008.04.025; Vielhaber G, 2006, PHOTOCH PHOTOBIO SCI, V5, P275, DOI 10.1039/b516702g; VILE GF, 1995, FREE RADICAL BIO MED, V18, P721, DOI 10.1016/0891-5849(94)00192-M; Wendel V., 2001, SOFW-J, V127, P12; Wondrak GT, 2003, J INVEST DERMATOL, V121, P578, DOI 10.1046/j.1523-1747.2003.12414.x	50	24	27	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e83401	10.1371/journal.pone.0083401	http://dx.doi.org/10.1371/journal.pone.0083401			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409282	gold, Green Published, Green Submitted			2022-12-27	WOS:000329463500006
J	Fuchs, S; Behrends, V; Bundy, JG; Crisanti, A; Nolan, T				Fuchs, Silke; Behrends, Volker; Bundy, Jacob G.; Crisanti, Andrea; Nolan, Tony			Phenylalanine Metabolism Regulates Reproduction and Parasite Melanization in the Malaria Mosquito	PLOS ONE			English	Article							ANOPHELES-GAMBIAE; EGG DEVELOPMENT; AEDES-AEGYPTI; MELANOTIC ENCAPSULATION; DOPA DECARBOXYLASE; GENES; INFUSION; HYDROXYLASE; OCTOPAMINE; CULICIDAE	The blood meal of the female malaria mosquito is a pre-requisite to egg production and also represents the transmission route for the malaria parasite. The proper and rapid assimilation of proteins and nutrients in the blood meal creates a significant metabolic challenge for the mosquito. To better understand this process we generated a global profile of metabolite changes in response to blood meal of Anopheles gambiae, using Gas Chromatography-Mass Spectrometry (GCMS). To disrupt a key pathway of amino acid metabolism we silenced the gene phenylalanine hydroxylase (PAH) involved in the conversion of the amino acid phenylalanine into tyrosine. We observed increased levels of phenylalanine and the potentially toxic metabolites phenylpyruvate and phenyllactate as well as a reduction in the amount of tyrosine available for melanin synthesis. This in turn resulted in a significant impairment of the melanotic encapsulation response against the rodent malaria parasite Plasmodium berghei. Furthermore silencing of PAH resulted in a significant impairment of mosquito fertility associated with reduction of laid eggs, retarded vitellogenesis and impaired melanisation of the chorion. Carbidopa, an inhibitor of the downstream enzyme DOPA decarboxylase that coverts DOPA into dopamine, produced similar effects on egg melanization and hatching rate suggesting that egg chorion maturation is mainly regulated via dopamine. This study sheds new light on the role of amino acid metabolism in regulating reproduction and immunity.	[Fuchs, Silke; Crisanti, Andrea; Nolan, Tony] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England; [Behrends, Volker; Bundy, Jacob G.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England	Imperial College London; Imperial College London	Nolan, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England.	t.nolan@imperial.ac.uk	Nolan, Tony/I-4925-2012; Bundy, Jacob G/C-2131-2008	Nolan, Tony/0000-0002-2982-8333; Bundy, Jacob G/0000-0002-1164-8465; Behrends, Volker/0000-0003-4855-5497; Crisanti, Andrea/0000-0002-2406-4426	European Community [242095]; INFRAVEC; Foundation for the National Institutes of Health through the Vector-Based Control of Transmission: Discovery Research (VCTR) program of the Grand Challenges in Global Health initiative	European Community(European Commission); INFRAVEC; Foundation for the National Institutes of Health through the Vector-Based Control of Transmission: Discovery Research (VCTR) program of the Grand Challenges in Global Health initiative	Funded by grants from European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement Nu 242095 and INFRAVEC and the Foundation for the National Institutes of Health through the Vector-Based Control of Transmission: Discovery Research (VCTR) program of the Grand Challenges in Global Health initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashida M., 1990, P239; Attardo GM, 2006, J EXP BIOL, V209, P3071, DOI 10.1242/jeb.02349; Baton LA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-257; Behrends V, 2011, ANAL BIOCHEM, V415, P206, DOI 10.1016/j.ab.2011.04.009; BEIER JC, 1990, J AM MOSQUITO CONTR, V6, P105; BILLINGSLEY PF, 1991, J MED ENTOMOL, V28, P865, DOI 10.1093/jmedent/28.6.865; Blandin S, 2002, EMBO REP, V3, P852, DOI 10.1093/embo-reports/kvf180; Christensen BM, 2005, TRENDS PARASITOL, V21, P192, DOI 10.1016/j.pt.2005.02.007; Clements A. N., 1992, BIOL MOSQUITOES, V1; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; Dana AN, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-5; DIMOND J. B., 1956, CANADIAN ENT, V88, P57; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; FERDIG MT, 1993, AM J TROP MED HYG, V49, P756, DOI 10.4269/ajtmh.1993.49.756; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Fukumitsu Y, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-92; Gazit V, 2003, BEHAV BRAIN RES, V143, P1, DOI 10.1016/S0166-4328(03)00075-5; Gonzalez-Santoyo I, 2012, ENTOMOL EXP APPL, V142, P1, DOI 10.1111/j.1570-7458.2011.01187.x; Hansen IA, 2005, J BIOL CHEM, V280, P20565, DOI 10.1074/jbc.M500712200; Hansen IA, 2004, P NATL ACAD SCI USA, V101, P10626, DOI 10.1073/pnas.0403460101; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUFTON SE, 1995, BIOCHEM J, V311, P353, DOI 10.1042/bj3110353; Infanger LC, 2004, INSECT BIOCHEM MOLEC, V34, P1329, DOI 10.1016/j.ibmb.2004.09.004; Isoe J, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.0101; Johnson JK, 2003, INSECT BIOCHEM MOLEC, V33, P345, DOI 10.1016/S0965-1748(02)00257-6; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kind T, 2009, ANAL CHEM, V81, P10038, DOI 10.1021/ac9019522; Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008; LEA AO, 1956, SCIENCE, V123, P890, DOI 10.1126/science.123.3203.890; LI JY, 1994, INSECT BIOCHEM MOLEC, V24, P1043, DOI 10.1016/0965-1748(94)90142-2; LI JY, 1994, COMP BIOCHEM PHYS A, V109, P835, DOI 10.1016/0300-9629(94)90231-3; LI JY, 1993, INSECT BIOCHEM MOLEC, V23, P739, DOI 10.1016/0965-1748(93)90048-W; Marinotti O, 2005, INSECT MOL BIOL, V14, P365, DOI 10.1111/j.1365-2583.2005.00567.x; Paskewitz SM, 2008, COMP BIOCHEM PHYS B, V150, P403, DOI 10.1016/j.cbpb.2008.04.010; PORTER CC, 1962, BIOCHEM PHARMACOL, V11, P1067, DOI 10.1016/0006-2952(62)90166-1; Richman AM, 1996, INSECT MOL BIOL, V5, P203, DOI 10.1111/j.1365-2583.1996.tb00055.x; Riehle MA, 2002, SCIENCE, V298, P172, DOI 10.1126/science.1076827; Rodriguez-Andres J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002977; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; Rogers DW, 2008, P NATL ACAD SCI USA, V105, P19390, DOI 10.1073/pnas.0809723105; Scheiner R, 2002, BEHAV BRAIN RES, V136, P545, DOI 10.1016/S0166-4328(02)00205-X; SINDEN RE, 1996, MOL BIOL INSECT DIS, P67; Thailayil J, 2011, P NATL ACAD SCI USA, V108, P13677, DOI 10.1073/pnas.1104738108; Turner EH, 2006, PHARMACOL THERAPEUT, V109, P325, DOI 10.1016/j.pharmthera.2005.06.004; Uchida K, 1998, J INSECT PHYSIOL, V44, P525, DOI 10.1016/S0022-1910(98)00033-X; Uchida K, 2001, J MED ENTOMOL, V38, P572, DOI 10.1603/0022-2585-38.4.572; UCHIDA K, 1992, J INSECT PHYSIOL, V38, P953, DOI 10.1016/0022-1910(92)90003-V; van't Hof AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010889; Williams Robin A, 2008, Clin Biochem Rev, V29, P31; Yassine H, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003029	50	40	45	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84865	10.1371/journal.pone.0084865	http://dx.doi.org/10.1371/journal.pone.0084865			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409310	Green Submitted, Green Published, gold			2022-12-27	WOS:000329463500034
J	Gan, SW; Surya, W; Vararattanavech, A; Torres, J				Gan, Siok Wan; Surya, Wahyu; Vararattanavech, Ardcharaporn; Torres, Jaume			Two Different Conformations in Hepatitis C Virus p7 Protein Account for Proton Transport and Dye Release	PLOS ONE			English	Article							ION-CHANNEL; SECONDARY STRUCTURE; TOPOLOGY; DETERMINANTS; FORMS; MODEL; POLYPEPTIDE; MUTATIONS; PEPTIDES; SINGLE	The p7 protein from the hepatitis C virus (HCV) is a 63 amino acid long polypeptide that is essential for replication, and is involved in protein trafficking and proton transport. Therefore, p7 is a possible target for antivirals. The consensus model for the channel formed by p7 protein is a hexameric or heptameric oligomer of alpha-helical hairpin monomers, each having two transmembrane domains, TM1 and TM2, where the N-terminal TM1 would face the lumen of this channel. A reported high-throughput functional assay to search for p7 channel inhibitors is based on carboxyfluorescein (CF) release from liposomes after p7 addition. However, the rationale for the dual ability of p7 to serve as an ion or proton channel in the infected cell, and to permeabilize membranes to large molecules like CF is not clear. We have recreated both activities in vitro, examining the conformation present in these assays using infrared spectroscopy. Our results indicate that an alpha-helical form of p7, which can transport protons, is not able to elicit CF release. In contrast, membrane permeabilization to CF is observed when p7 contains a high percentage of beta-structure, or when using a C-terminal fragment of p7, encompassing TM2. We propose that the reported inhibitory effect of some small compounds, e. g., rimantadine, on both CF release and proton transport can be explained via binding to the membrane-inserted C-terminal half of p7, increasing its rigidity, in a similar way to the influenza A M2-rimantadine interaction.	[Gan, Siok Wan; Surya, Wahyu; Vararattanavech, Ardcharaporn; Torres, Jaume] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Torres, J (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore.	jtorres@ntu.edu.sg	Torres, Jaume/A-2179-2011; Torres, Jaume/AAJ-4510-2020	Torres, Jaume/0000-0002-1282-9727; Surya, Wahyu/0000-0001-9240-371X	National Research Foundation [NRF-CRP4-2008-02]; AcRF [RG 38/08]	National Research Foundation; AcRF	J.T. acknowledges the funding of the National Research Foundation grant NRF-CRP4-2008-02 and AcRF Tier 1 grant RG 38/08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARFMANN HA, 1977, BIOPOLYMERS, V16, P1815, DOI 10.1002/bip.1977.360160815; Boson B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002144; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Carrere-Kremer S, 2002, J VIROL, V76, P3720, DOI 10.1128/JVI.76.8.3720-3730.2002; Chew CF, 2009, BIOPHYS J, V96, pL10, DOI 10.1016/j.bpj.2008.10.004; Clarke D, 2006, J BIOL CHEM, V281, P37057, DOI 10.1074/jbc.M602434200; Cook G. A., 2010, BIOCHIM BIOPHYS ACTA, V1808, P1448; Cook GA, 2009, EUR BIOPHYS J, V39; Cook GA, 2011, BBA-BIOMEMBRANES, V1808, P554, DOI 10.1016/j.bbamem.2010.08.005; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; Foster TL, 2011, HEPATOLOGY, V54, P79, DOI 10.1002/hep.24371; Gan SW, 2012, J BIOL CHEM, V287, P24671, DOI 10.1074/jbc.M111.332791; Gentzsch J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003355; Gervais C, 2011, J BIOMOL SCREEN, V16, P363, DOI 10.1177/1087057110396215; Griffin S, 2005, J VIROL, V79, P15525, DOI 10.1128/JVI.79.24.15525-15536.2005; Griffin SDC, 2003, FEBS LETT, V535, P34, DOI 10.1016/S0014-5793(02)03851-6; Haqshenas G, 2007, VIROLOGY, V360, P17, DOI 10.1016/j.virol.2006.10.014; Hu J, 2007, PROTEIN SCI, V16, P2153, DOI 10.1110/ps.072996707; HUANG CH, 1971, J BIOL CHEM, V246, P2555; Isherwood BJ, 2005, J GEN VIROL, V86, P667, DOI 10.1099/vir.0.80737-0; Lambert C, 2001, J BIOL CHEM, V276, P22265, DOI 10.1074/jbc.M100956200; Li H, 2012, VIROLOGY, V423, P30, DOI 10.1016/j.virol.2011.11.011; LITMAN BJ, 1973, BIOCHEMISTRY-US, V12, P2545, DOI 10.1021/bi00737a028; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Luik P, 2009, P NATL ACAD SCI USA, V106, P12712, DOI 10.1073/pnas.0905966106; Lundin M, 2003, J VIROL, V77, P5428, DOI 10.1128/JVI.77.9.5428-5438.2003; McGinnes LW, 2003, J VIROL, V77, P1951, DOI 10.1128/JVI.77.3.1951-1963.2003; Montserret R, 2010, J BIOL CHEM, V285, P31446, DOI 10.1074/jbc.M110.122895; MUTTER M, 1985, BIOPOLYMERS, V24, P1057, DOI 10.1002/bip.360240610; OuYang B, 2013, NATURE, V498, P521, DOI 10.1038/nature12283; PARSEGIAN VA, 1979, P NATL ACAD SCI USA, V76, P2750, DOI 10.1073/pnas.76.6.2750; Parthasarathy K, 2008, PROTEIN SCI, V17, P930, DOI 10.1110/ps.073234208; Patargias G, 2006, J MED CHEM, V49, P648, DOI 10.1021/jm050721e; Pavlovic D, 2003, P NATL ACAD SCI USA, V100, P6104, DOI 10.1073/pnas.1031527100; Perez-Berna AJ, 2008, J BIOL CHEM, V283, P8089, DOI 10.1074/jbc.M709413200; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Premkumar A, 2004, FEBS LETT, V557, P99, DOI 10.1016/S0014-5793(03)01453-4; REYNOLDS JA, 1985, METHOD ENZYMOL, V117, P41; Sakai A, 2003, P NATL ACAD SCI USA, V100, P11646, DOI 10.1073/pnas.1834545100; Steinmann E, 2007, PLOS PATHOG, V3, P962, DOI 10.1371/journal.ppat.0030103; StGelais C, 2007, ANTIVIR RES, V76, P48, DOI 10.1016/j.antiviral.2007.05.001; StGelais C, 2009, J VIROL, V83, P7970, DOI 10.1128/JVI.00521-09; Tedbury P, 2011, J GEN VIROL, V92, P819, DOI 10.1099/vir.0.027441-0; Tokuriki N, 2009, TRENDS BIOCHEM SCI, V34, P53, DOI 10.1016/j.tibs.2008.10.009; Torres J, 2000, BIOPHYS J, V79, P3139, DOI 10.1016/S0006-3495(00)76547-7; Torres J, 2000, J MOL BIOL, V300, P677, DOI 10.1006/jmbi.2000.3885; Torres J, 2006, BIOPHYS J, V91, P938, DOI 10.1529/biophysj.105.080119; Whitfield T, 2011, MOL MEMBR BIOL, V28, P254, DOI 10.3109/09687688.2011.581253; Wozniak AL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001087; Yi MK, 2007, J VIROL, V81, P629, DOI 10.1128/JVI.01890-06	52	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e78494	10.1371/journal.pone.0078494	http://dx.doi.org/10.1371/journal.pone.0078494			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409277	gold, Green Published			2022-12-27	WOS:000329463500001
J	Pan, Y; Bhattarai, S; Modestou, M; Drack, AV; Chetkovich, DM; Baker, SA				Pan, Yuan; Bhattarai, Sajag; Modestou, Modestos; Drack, Arlene V.; Chetkovich, Dane M.; Baker, Sheila A.			TRIP8b Is Required for Maximal Expression of HCN1 in the Mouse Retina	PLOS ONE			English	Article							NUCLEOTIDE-GATED CHANNELS; ROD PHOTORECEPTORS; BIPOLAR CELLS; GANGLION-CELLS; ION CHANNELS; RAT RETINA; TRAFFICKING; LOCALIZATION; SUBUNIT; PROTEINS	Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are cation-selective channels present in retina, brain and heart. The activity of HCN channels contributes to signal integration, cell excitability and pacemaker activity. HCN1 channels expressed in photoreceptors participate in keeping light responses transient and are required for normal mesopic vision. The subcellular localization of HCN1 varies among cell types. In photoreceptors HCN1 is concentrated in the inner segments while in other retinal neurons, HCN1 is evenly distributed though the cell. This is in contrast to hippocampal neurons where HCN1 is concentrated in a subset of dendrites. A key regulator of HCN1 trafficking and activity is tetratricopeptide repeat-containing Rab8b interacting protein (TRIP8b). Multiple splice isoforms of TRIP8b are expressed throughout the brain and can differentially regulate the surface expression and activity of HCN1. The purpose of the present study was to determine which isoforms of TRIP8b are expressed in the retina and to test if loss of TRIP8b alters HCN1 expression or trafficking. We found that TRIP8b colocalizes with HCN1 in multiple retina neurons and all major splice isoforms of TRIP8b are expressed in the retina. Photoreceptors express three different isoforms. In TRIP8b knockout mice, the ability of HCN1 to traffic to the surface of retinal neurons is unaffected. However, there is a large decrease in the total amount of HCN1. We conclude that TRIP8b in the retina is needed to achieve maximal expression of HCN1.	[Pan, Yuan; Modestou, Modestos; Baker, Sheila A.] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA; [Bhattarai, Sajag; Drack, Arlene V.; Baker, Sheila A.] Univ Iowa, Dept Ophthalmol & Visual Sci, Carver Coll Med, Iowa City, IA 52242 USA; [Chetkovich, Dane M.] Northwestern Univ, Ken & Ruth Davee Dept Neurol & Clin Neurosci, Feinberg Sch Med, Chicago, IL 60611 USA; [Chetkovich, Dane M.] Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA	University of Iowa; University of Iowa; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Baker, SA (corresponding author), Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA.	sheila-baker@uiowa.edu	Chetkovich, Dane/AAV-5457-2021	Drack, Arlene/0000-0002-8195-8426; Baker, Sheila/0000-0002-0259-0652; Pan, Yuan/0000-0002-9465-8289	Research to Prevent Blindness; National Institutes of Health [NS059934, EY020542]; NATIONAL EYE INSTITUTE [R01EY020542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059934] Funding Source: NIH RePORTER	Research to Prevent Blindness(Research to Prevent Blindness (RPB)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by grants from Research to Prevent Blindness (A. V. D.) and the National Institutes of Health: NS059934 (D. M. C) and EY020542 (S. A. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050442; Barbuti A, 2012, J MOL CELL CARDIOL, V53, P187, DOI 10.1016/j.yjmcc.2012.05.013; Barrow AJ, 2009, J NEUROSCI, V29, P5841, DOI 10.1523/JNEUROSCI.5746-08.2009; BAYLOR DA, 1984, J PHYSIOL-LONDON, V354, P203, DOI 10.1113/jphysiol.1984.sp015372; Braun AP, 2009, CHANNELS, V3, P217, DOI 10.4161/chan.3.4.9620; Bucchi A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00240; Della Santina L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029812; Demontis GC, 2002, J PHYSIOL-LONDON, V542, P89, DOI 10.1113/jphysiol.2002.017640; Demontis GC, 2009, INVEST OPHTH VIS SCI, V50, P1948, DOI 10.1167/iovs.08-2659; Drack AV, 2012, INVEST OPHTH VIS SCI, V53, P100, DOI 10.1167/iovs.11-8544; Eldstrom J, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411002092; FAIN GL, 1978, NATURE, V272, P467, DOI 10.1038/272467a0; Fyk-Kolodziej B, 2007, J COMP NEUROL, V501, P891, DOI 10.1002/cne.21287; Gravante B, 2004, J BIOL CHEM, V279, P43847, DOI 10.1074/jbc.M401598200; Han Y, 2011, J BIOL CHEM, V286, P20823, DOI 10.1074/jbc.M111.236125; HESTRIN S, 1987, J PHYSIOL-LONDON, V390, P319, DOI 10.1113/jphysiol.1987.sp016703; Huang Z, 2012, J NEUROSCI, V32, P14835, DOI 10.1523/JNEUROSCI.1544-12.2012; Ivanova E, 2006, VISUAL NEUROSCI, V23, P143, DOI 10.1017/S0952523806232048; Kim IB, 2003, J COMP NEUROL, V467, P389, DOI 10.1002/cne.10957; Knop GC, 2008, EUR J NEUROSCI, V28, P2221, DOI 10.1111/j.1460-9568.2008.06512.x; Koizumi A, 2004, MOL VIS, V10, P328; Lewis AS, 2011, J NEUROSCI, V31, P7424, DOI 10.1523/JNEUROSCI.0936-11.2011; Lewis AS, 2011, MOL CELL NEUROSCI, V46, P357, DOI 10.1016/j.mcn.2010.11.007; Lewis AS, 2009, J NEUROSCI, V29, P6250, DOI 10.1523/JNEUROSCI.0856-09.2009; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; Muller F, 2003, EUR J NEUROSCI, V17, P2084, DOI 10.1046/j.1460-9568.2003.02634.x; Nakamura F, 2011, CELL ADHES MIGR, V5, P160, DOI 10.4161/cam.5.2.14401; Noam Y, 2011, CURR OPIN NEUROBIOL, V21, P873, DOI 10.1016/j.conb.2011.06.013; Nolan MF, 2003, CELL, V115, P551, DOI 10.1016/S0092-8674(03)00884-5; Oi H, 2008, VISUAL NEUROSCI, V25, P95, DOI 10.1017/S095252380808005X; Partida GJ, 2012, INVEST OPHTH VIS SCI, V53, P1696, DOI 10.1167/iovs.11-9307; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Piskorowski R, 2011, NEURON, V70, P495, DOI 10.1016/j.neuron.2011.03.023; Qu JH, 2004, J BIOL CHEM, V279, P43497, DOI 10.1074/jbc.M405018200; Ramakrishnan NA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.375832; Reiners J, 2005, MOL VIS, V11, P347; Sahly I, 2012, J CELL BIOL, V199, P381, DOI 10.1083/jcb.201202012; Santoro B, 2004, J NEUROSCI, V24, P10750, DOI 10.1523/JNEUROSCI.3300-04.2004; Santoro B, 1999, ANN NY ACAD SCI, V868, P741, DOI 10.1111/j.1749-6632.1999.tb11353.x; Santoro B, 2011, J NEUROSCI, V31, P4074, DOI 10.1523/JNEUROSCI.5707-10.2011; Santoro B, 2009, NEURON, V62, P802, DOI 10.1016/j.neuron.2009.05.009; Savelieva I, 2008, DRUG SAFETY, V31, P95, DOI 10.2165/00002018-200831020-00001; Seeliger MW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1540; Shin M, 2008, NEUROBIOL DIS, V32, P26, DOI 10.1016/j.nbd.2008.06.013; Stradleigh TW, 2011, J COMP NEUROL, V519, P2546, DOI 10.1002/cne.22638; Tanimoto N, 2012, ADV EXP MED BIOL, V723, P807, DOI 10.1007/978-1-4614-0631-0_103; Wahl-Schott C, 2009, CELL MOL LIFE SCI, V66, P470, DOI 10.1007/s00018-008-8525-0; Wilkars W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032181; Yi EY, 2010, J NEUROPHYSIOL, V103, P2532, DOI 10.1152/jn.00506.2009; Ying SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042756; Yu H, 2001, CIRC RES, V88, pE84, DOI 10.1161/hh1201.093511	51	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e85850	10.1371/journal.pone.0085850	http://dx.doi.org/10.1371/journal.pone.0085850			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409334	gold, Green Published, Green Submitted			2022-12-27	WOS:000329463500058
J	Alwan, NA; Cade, JE; Greenwood, DC; Deanfield, J; Lawlor, DA				Alwan, Nisreen A.; Cade, Janet E.; Greenwood, Darren C.; Deanfield, John; Lawlor, Debbie A.			Associations of Maternal Iron Intake and Hemoglobin in Pregnancy with Offspring Vascular Phenotypes and Adiposity at Age 10: Findings from the Avon Longitudinal Study of Parents and Children	PLOS ONE			English	Article							BLOOD-PRESSURE; FETAL; COPPER; DEFICIENCY; ANEMIA; RAT; POPULATION; ABSORPTION; CHILDHOOD; WEIGHT	Background: Iron deficiency is common during pregnancy. Experimental animal studies suggest that it increases cardiovascular risk in the offspring. Objective: To examine the relationship between maternal pregnancy dietary and supplement iron intake and hemoglobin, with offspring's arterial stiffness (measured by carotid-radial pulse wave velocity), endothelial function (measured by brachial artery flow mediated dilatation), blood pressure, and adiposity (measured by body mass index), test for mediation by cord ferritin, birth weight, gestational age, and child dietary iron intake, and for effect modification by maternal vitamin C intake and offspring sex. Design: Prospective data from 2958 mothers and children pairs at 10 years of age enrolled in an English birth cohort, the Avon Longitudinal Study for Parents and Children (ALSPAC), was analysed. Results: 2639 (89.2%) mothers reported dietary iron intake in pregnancy below the UK reference nutrient intake of 14.8 mg/day. 1328 (44.9%) reported taking iron supplements, and 129 (4.4%) were anemic by 18 weeks gestation. No associations were observed apart from maternal iron intake from supplements with offspring systolic blood pressure (20.8 mmHg, 99% CI 21.7 to 0, P = 0.01 in the sample with all relevant data observed, and 20.7 mmHg, 99% CI 21.3 to 0, P = 0.008 in the sample with missing data imputed). Conclusion: There was no evidence of association between maternal pregnancy dietary iron intake, or maternal hemoglobin concentration (which is less likely to be biased by subjective reporting) with offspring outcomes. There was a modest inverse association between maternal iron supplement intake during pregnancy with offspring systolic blood pressure at 10 years.	[Alwan, Nisreen A.; Cade, Janet E.] Univ Leeds, Sch Food Sci & Nutr, Nutr Epidemiol Grp, Leeds, W Yorkshire, England; [Greenwood, Darren C.] Univ Leeds, Leeds Inst Hlth Genet & Therapeut, Div Epidemiol & Biostat, Leeds, W Yorkshire, England; [Deanfield, John] UCL, Inst Cardiovasc Sci, Vasc Physiol Unit, London, England; [Lawlor, Debbie A.] Univ Bristol, Med Res Council Integrat Epidemiol Unit, Bristol, Avon, England; [Lawlor, Debbie A.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England	University of Leeds; University of Leeds; University of London; University College London; University of Bristol; University of Bristol	Alwan, NA (corresponding author), Univ Leeds, Sch Food Sci & Nutr, Nutr Epidemiol Grp, Leeds, W Yorkshire, England.	N.Alwan@leeds.ac.uk	Alwan, Nisreen A./AFP-0662-2022; Greenwood, Darren C/C-3220-2008; Cade, Janet E/G-4250-2016	Alwan, Nisreen A./0000-0002-4134-8463; Greenwood, Darren C/0000-0001-7035-3096; Cade, Janet E/0000-0003-3421-0121; Deanfield, John/0000-0001-8806-6052; Lawlor, Debbie A/0000-0002-6793-2262	British Heart Foundation; Wellcome Trust [WT87789]; UK Medical Research Council [MC_UU_12013/5]; MRC [MC_UU_12013/5] Funding Source: UKRI; Medical Research Council [MC_PC_15018, MC_UU_12013/5] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome Trust); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Core support for ALSPAC is provided by the UK Medical Research Council, the Wellcome Trust and the University of Bristol. Funding for the vascular measurements used in this study was obtained from the British Heart Foundation. NAA is funded by a Wellcome Trust research fellowship [WT87789] and DAL works in a Unit that receives funding from the UK Medical Research Council [grant number MC_UU_12013/5]. The study funders had no role in study design, analysis and interpretation of data, the writing of the article or the decision to submit for publication. The views expressed in this paper are those of the authors and not necessarily any of the funding agencies that have supported this work.	AGRAWAL RMD, 1983, ACTA PAEDIATR SCAND, V72, P545, DOI 10.1111/j.1651-2227.1983.tb09768.x; Allen LH, 2000, AM J CLIN NUTR, V71, p1280S, DOI 10.1093/ajcn/71.5.1280s; Alwan NA, 2011, HUM REPROD, V26, P911, DOI 10.1093/humrep/der005; [Anonymous], 2001, IRON DEFICIENCY ANAE; Baker PN, 2009, AM J CLIN NUTR, V89, P1114, DOI 10.3945/ajcn.2008.27097; Belfort MB, 2008, INT J EPIDEMIOL, V37, P301, DOI 10.1093/ije/dyn002; Bergel E, 2000, AM J EPIDEMIOL, V151, P594, DOI 10.1093/oxfordjournals.aje.a010247; Bergmann RL, 2002, EUR J OBSTET GYN R B, V102, P155, DOI 10.1016/S0301-2115(01)00609-1; Boyd A., 2012, INT J EPIDEMIOLOGY, DOI 10.1093/ije/dys064; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Brion MJA, 2008, AM J CLIN NUTR, V88, P1126, DOI 10.1093/ajcn/88.4.1126; Brion MJA, 2010, AM J CLIN NUTR, V91, P748, DOI 10.3945/ajcn.2009.28623; Collings R, 2013, AM J CLIN NUTR, V98, P65, DOI 10.3945/ajcn.112.050609; CROWE C, 1995, J PHYSIOL-LONDON, V488, P515, DOI 10.1113/jphysiol.1995.sp020986; Cruickshank JK, 2009, HYPERTENSION, V53, P602, DOI 10.1161/HYPERTENSIONAHA.108.128033; Donald AE, 2010, EUR HEART J, V31, P1502, DOI 10.1093/eurheartj/ehq062; Fraser A, 2012, INT J EPIDEMIOLOGY; FSA, 2003, NAT DIET NUTR SURV A, V3; Gambling L, 2004, P NUTR SOC, V63, P553, DOI 10.1079/PNS2004385; Gambling L, 2004, J NUTR BIOCHEM, V15, P366, DOI 10.1016/j.jnutbio.2003.12.009; Gambling L, 2003, J NUTR, V133, p1554S, DOI 10.1093/jn/133.5.1554S; Gambling L, 2003, J PHYSIOL-LONDON, V552, P603, DOI 10.1113/jphysiol.2003.051383; Gambling L, 2008, BIOCHEM SOC T, V36, P1258, DOI 10.1042/BST0361258; Gibney M, 2004, PUBLIC HLTH NUTR; GODFREY KM, 1994, BRIT J OBSTET GYNAEC, V101, P398, DOI 10.1111/j.1471-0528.1994.tb11911.x; Halcox JPJ, 2002, CIRCULATION, V106, P653, DOI 10.1161/01.CIR.0000025404.78001.D8; Halcox JPJ, 2009, CIRCULATION, V119, P1005, DOI 10.1161/CIRCULATIONAHA.108.765701; Holland B, 1991, ROYAL SOC CHEM; KANESHIGE E, 1981, OBSTET GYNECOL, V57, P238; Kelleher SL, 2006, J NUTR, V136, P1185; LAW CM, 1991, ARCH DIS CHILD, V66, P1291, DOI 10.1136/adc.66.11.1291; Lisle SJM, 2003, BRIT J NUTR, V90, P33, DOI 10.1079/BJN2003881; Lone FW, 2004, TROP MED INT HEALTH, V9, P486, DOI 10.1111/j.1365-3156.2004.01222.x; McArdle HJ, 2006, PLACENTA, V27, pS56, DOI 10.1016/j.placenta.2006.01.014; Milman N, 2006, ANN HEMATOL, V85, P559, DOI 10.1007/s00277-006-0108-2; Rogers I, 1998, EUR J CLIN NUTR, V52, P246, DOI 10.1038/sj.ejcn.1600543; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Scholl TO, 2005, AM J CLIN NUTR, V81, p1218S; Singla PN, 1996, ACTA PAEDIATR, V85, P1327, DOI 10.1111/j.1651-2227.1996.tb13919.x; TAMURA T, 2002, OBSTET GYNECOL SURV, V57, P493, DOI DOI 10.1097/00006254-200208000-00008; WHINCUP P, 1994, J HUM HYPERTENS, V8, P337; WHO, 2010, MICR DEF; Zhou LM, 1998, AM J EPIDEMIOL, V148, P998; Zimmermann MB, 2008, BRIT J NUTR, V99, pS2, DOI 10.1017/S000711450800679X	44	13	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84684	10.1371/journal.pone.0084684	http://dx.doi.org/10.1371/journal.pone.0084684			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400110	Green Published, gold, Green Accepted			2022-12-27	WOS:000329462700044
J	Jiang, CX; Zhang, LJ; Zou, C; Long, XJ; Liu, X; Zheng, HR; Liao, WQ; Diao, YJ				Jiang, Chunxiang; Zhang, Lijuan; Zou, Chao; Long, Xiaojing; Liu, Xin; Zheng, Hairong; Liao, Weiqi; Diao, Yanjun			Diurnal Microstructural Variations in Healthy Adult Brain Revealed by Diffusion Tensor Imaging	PLOS ONE			English	Article							WHITE-MATTER CHANGES; FRACTIONAL ANISOTROPY; WATER DIFFUSION; SLEEP; COEFFICIENT; VOLUME; MRI; ASYMMETRY; GRAY; FACE	Biorhythm is a fundamental property of human physiology. Changes in the extracellular space induced by cell swelling in response to the neural activity enable the in vivo characterization of cerebral microstructure by measuring the water diffusivity using diffusion tensor imaging (DTI). To study the diurnal microstructural alterations of human brain, fifteen right-handed healthy adult subjects were recruited for DTI studies in two repeated sessions (8: 30 AM and 8: 30 PM) within a 24-hour interval. Fractional anisotropy (FA), apparent diffusion coefficient (ADC), axial (lambda(//)) and radial diffusivity (lambda(perpendicular to)) were compared pixel by pixel between the sessions for each subject. Significant increased morning measurements in FA, ADC, lambda(//) and lambda(perpendicular to) were seen in a wide range of brain areas involving frontal, parietal, temporal and occipital lobes. Prominent evening dominant lambda(perpendicular to) (18.58%) was detected in the right inferior temporal and ventral fusiform gyri. AM-PM variation of lambda(perpendicular to) was substantially left side hemisphere dominant (p<0.05), while no hemispheric preference was observed for the same analysis for ADC (p = 0.77), lambda(//) (p = 0.08) or FA (p = 0.25). The percentage change of ADC, lambda(//), lambda(perpendicular to), and FA were 1.59%, 2.15%, 1.20% and 2.84%, respectively, for brain areas without diurnal diffusivity contrast. Microstructural variations may function as the substrates of the phasic neural activities in correspondence to the environment adaptation in a light-dark cycle. This research provided a baseline for researches in neuroscience, sleep medicine, psychological and psychiatric disorders, and necessitates that diurnal effect should be taken into account in following up studies using diffusion tensor quantities.	[Jiang, Chunxiang; Zhang, Lijuan; Zou, Chao; Long, Xiaojing; Liu, Xin; Zheng, Hairong; Liao, Weiqi; Diao, Yanjun] Chinese Acad Sci, Shenzhen Inst Adv Technol, Paul C Lauterbur Res Ctr Biomed Imaging, Shenzhen, Peoples R China	Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Zhang, LJ (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Paul C Lauterbur Res Ctr Biomed Imaging, Shenzhen, Peoples R China.	lj.zhang@siat.ac.cn		Liao, Weiqi/0000-0002-8605-3749	Basic Research Program of Shenzhen [JCYJ20120615124706404]	Basic Research Program of Shenzhen	This study was partially sponsored by Basic Research Program of Shenzhen (Grant number JCYJ20120615124706404). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW RD, 1994, NEUROSCIENCE, V62, P371, DOI 10.1016/0306-4522(94)90372-7; BACHYRITA P, 1993, NEUROREPORT, V4, P343, DOI 10.1097/00001756-199304000-00001; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Buchel C, 2004, CEREB CORTEX, V14, P945, DOI 10.1093/cercor/bhh055; Buckley DL, 1999, MAGNET RESON MED, V42, P603, DOI 10.1002/(SICI)1522-2594(199909)42:3<603::AID-MRM25>3.0.CO;2-Q; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Choe AS, 2012, NMR BIOMED, V25, P900, DOI 10.1002/nbm.1810; Clark CA, 2000, MAGN RESON MED, V43, P133, DOI 10.1002/(SICI)1522-2594(200001)43:1<133::AID-MRM16>3.0.CO;2-X; Darquie A, 2001, P NATL ACAD SCI USA, V98, P9391, DOI 10.1073/pnas.151125698; Ellis CM, 1999, NEUROLOGY, V53, P1051, DOI 10.1212/WNL.53.5.1051; Farrell JAD, 2007, J MAGN RESON IMAGING, V26, P756, DOI 10.1002/jmri.21053; Flint J, 2009, NEUROIMAGE, V46, P411, DOI 10.1016/j.neuroimage.2009.02.003; Grill-Spector K, 2006, NAT NEUROSCI, V9, P1177, DOI 10.1038/nn1745; Habib J, 2010, MAGN RESON MED, V63, P1098, DOI 10.1002/mrm.22232; HASEGAWA Y, 1994, J CEREBR BLOOD F MET, V14, P383, DOI 10.1038/jcbfm.1994.49; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; HOEHNBERLAGE M, 1995, J CEREBR BLOOD F MET, V15, P1002, DOI 10.1038/jcbfm.1995.126; Hsiao JH, 2013, J COGNITIVE NEUROSCI, V25, P998, DOI 10.1162/jocn_a_00377; Ivry R.B., 1998, 2 SIDES PERCEPTION; Jean-Louis Girardin, 2005, J Circadian Rhythms, V3, P13, DOI 10.1186/1740-3391-3-13; Johnson C.H., 1990, ATLAS PHASE RESPONSE; Karatsoreos IN, 2011, P NATL ACAD SCI USA, V108, P1657, DOI 10.1073/pnas.1018375108; Kolaj M, 2012, J NEUROPHYSIOL, V107, P1835, DOI 10.1152/jn.00974.2011; Kumar R, 2012, J NEUROSCI RES, V90, P346, DOI 10.1002/jnr.22757; Le Bihan D, 2006, P NATL ACAD SCI USA, V103, P8263, DOI 10.1073/pnas.0600644103; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Le Bihan D, 2007, PHYS MED BIOL, V52, pR57, DOI 10.1088/0031-9155/52/7/R02; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; Li F, 2011, RADIOLOGY, V260, P216, DOI 10.1148/radiol.11101971; Li J, 2009, AM J MED GENET B, V150B, P375, DOI 10.1002/ajmg.b.30825; Long X., 2012, HUMAN BRAIN MAPPING; Mandl RCW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003631; Medina D, 2006, NEUROBIOL AGING, V27, P663, DOI 10.1016/j.neurobiolaging.2005.03.026; MILLARCRAIG MW, 1978, LANCET, V1, P795; Miller KL, 2007, P NATL ACAD SCI USA, V104, P20967, DOI 10.1073/pnas.0707257105; Morillon B, 2010, P NATL ACAD SCI USA, V107, P18688, DOI 10.1073/pnas.1007189107; Morin LP, 2006, BRAIN RES REV, V51, P1, DOI 10.1016/j.brainresrev.2005.08.003; Mukherjee P, 2000, RADIOLOGY, V215, P211, DOI 10.1148/radiology.215.1.r00ap29211; Mukherjee P, 2002, AM J NEURORADIOL, V23, P1445; Neil J, 2002, NMR BIOMED, V15, P543, DOI 10.1002/nbm.784; Neil JJ, 1998, RADIOLOGY, V209, P57, DOI 10.1148/radiology.209.1.9769812; O'Donnell LJ, 2010, LECT NOTES COMPUT SC, V6362, P225; Piantoni G, 2013, J NEUROSCI, V33, P227, DOI 10.1523/JNEUROSCI.2030-12.2013; PIERPAOLI C, 2003, P 11 ANN M ISMRM; Rocklage M, 2009, SLEEP, V32, P1100, DOI 10.1093/sleep/32.8.1100; Sach M, 2004, BRAIN, V127, P340, DOI 10.1093/brain/awh041; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; SERGENT J, 1982, J EXP PSYCHOL HUMAN, V8, P253, DOI 10.1037/0096-1523.8.2.253; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; Sheth BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005496; Slotnick SD, 2006, NEUROPSYCHOLOGIA, V44, P2874, DOI 10.1016/j.neuropsychologia.2006.06.021; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Stadlbauer A, 2010, RADIOLOGY, V257, P846, DOI 10.1148/radiol.10100343; Sturm W, 1999, NEUROPSYCHOLOGIA, V37, P797, DOI 10.1016/S0028-3932(98)00141-9; Sykova E, 2004, NEUROSCIENCE, V129, P861, DOI 10.1016/j.neuroscience.2004.06.077; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; Tamnes CK, 2010, CEREB CORTEX, V20, P534, DOI 10.1093/cercor/bhp118; Taubert M, 2012, NEUROSCIENTIST, V18, P320, DOI 10.1177/1073858411419048; Theodosis DT, 2008, PHYSIOL REV, V88, P983, DOI 10.1152/physrev.00036.2007; Tievsky AL, 1999, AM J NEURORADIOL, V20, P1491; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009; Tomasi D, 2009, CEREB CORTEX, V19, P233, DOI 10.1093/cercor/bhn073; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; Weis S., 2000, NEUROIMAGE, V11, pS10, DOI [10.1016/S1053-8119(00)90945-5, DOI 10.1016/S1053-8119(00)90945-5]; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965	70	20	20	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84822	10.1371/journal.pone.0084822	http://dx.doi.org/10.1371/journal.pone.0084822			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400118	gold, Green Submitted, Green Published			2022-12-27	WOS:000329462700052
J	Gonzalez, E; Piva, M; Rodriguez-Suarez, E; Gil, D; Royo, F; Elortza, F; Falcon-Perez, JM; Vivanco, MD				Gonzalez, Esperanza; Piva, Marco; Rodriguez-Suarez, Eva; Gil, David; Royo, Felix; Elortza, Felix; Falcon-Perez, Juan M.; Vivanco, Maria Dm			Human Mammospheres Secrete Hormone-Regulated Active Extracellular Vesicles	PLOS ONE			English	Article							BREAST-CANCER; STEM-CELLS; HUMAN-MILK; EXOSOMES; GROWTH; TUMOR; MICROVESICLES; MEDIATE; HETEROGENEITY; PROTEINS	Breast cancer is a leading cause of cancer-associated death worldwide. One of the most important prognostic factors for survival is the early detection of the disease. Recent studies indicate that extracellular vesicles may provide diagnostic information for cancer management. We demonstrate the secretion of extracellular vesicles by primary breast epithelial cells enriched for stem/progenitor cells cultured as mammospheres, in non-adherent conditions. Using a proteomic approach we identified proteins contained in these vesicles whose expression is affected by hormonal changes in the cellular environment. In addition, we showed that these vesicles are capable of promoting changes in expression levels of genes involved in epithelial-mesenchymal transition and stem cell markers. Our findings suggest that secreted extracellular vesicles could represent potential diagnostic and/or prognostic markers for breast cancer and support a role for extracellular vesicles in cancer progression.	[Gonzalez, Esperanza; Royo, Felix; Falcon-Perez, Juan M.] Metabol CIBERehd, Derio, Spain; [Piva, Marco; Vivanco, Maria Dm] CIBERehd, Cell Biol & Stem Cells Unit, Derio, Spain; [Rodriguez-Suarez, Eva; Elortza, Felix] CIBERehd, ProteoRed ISCIII, Derio, Spain; [Gil, David] CIC BioGUNE, Derio, Spain; [Falcon-Perez, Juan M.] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIC bioGUNE; Basque Foundation for Science	Falcon-Perez, JM (corresponding author), Metabol CIBERehd, Derio, Spain.	jfalcon@cicbiogune.es; mdmvivanco@cicbiogune.es	Carton, David Gil/G-2404-2011; Elortza, Felix/D-5058-2011; Vivanco, Maria/G-2393-2011; Carton, David Gil/M-9332-2019; Piva, Marco/F-2748-2019; Elortza, Felix/ABG-4183-2020; González, Esperanza/AAK-4097-2020; Royo, Felix/ABE-8064-2021; Royo, Felix/A-7198-2015; Falcon-Perez, Juan M/F-5920-2011; González, Esperanza/H-5450-2015	Carton, David Gil/0000-0003-4241-1302; Vivanco, Maria/0000-0002-9540-247X; Carton, David Gil/0000-0003-4241-1302; González, Esperanza/0000-0002-3831-4596; Royo, Felix/0000-0001-9769-4165; Royo, Felix/0000-0001-9769-4165; González, Esperanza/0000-0002-3831-4596; Elortza, Felix/0000-0001-8839-5438; Piva, Marco/0000-0001-6906-6065; Falcon-Perez, Juan M/0000-0003-3133-0670	Foundation La Caixa; Foundation for Science and Technology of the Portuguese Ministry of Science; Institute of Health Carlos III [06/0621, 09/00526, PI081877]; program Ramon y Cajal; Department of Education of the Government of the Autonomous Community of the Basque Country; Department of Health of the Government of the Autonomous Community of the Basque Country; Department of Industry, Tourism and Trade (Etortek)	Foundation La Caixa(La Caixa Foundation); Foundation for Science and Technology of the Portuguese Ministry of Science; Institute of Health Carlos III(Instituto de Salud Carlos III); program Ramon y Cajal(Spanish Government); Department of Education of the Government of the Autonomous Community of the Basque Country; Department of Health of the Government of the Autonomous Community of the Basque Country; Department of Industry, Tourism and Trade (Etortek)	This work was supported by grants from: Foundation La Caixa (MP), Foundation for Science and Technology of the Portuguese Ministry of Science (BS), the Institute of Health Carlos III (06/0621 & 09/00526 to JMFP and PI081877 to MdMV), the program Ramon y Cajal (JMFP), the Departments of Education and Health of the Government of the Autonomous Community of the Basque Country (MdMV) and the Department of Industry, Tourism and Trade (Etortek). Centro de Investigacion Biomedica en Red en el Area tematica de Enfermedades Hepaticas y Digestivas (CIBERehd) is funded by the Institute of Health Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Alvi AJ, 2003, BREAST CANCER RES, V5, DOI 10.1186/bcr563; Antonyak MA, 2011, P NATL ACAD SCI USA, V108, P4852, DOI 10.1073/pnas.1017667108; Aozuka Y, 2004, CANCER LETT, V216, P35, DOI 10.1016/j.canlet.2004.06.050; Bocchinfuso WP, 2000, ENDOCRINOLOGY, V141, P2982, DOI 10.1210/en.141.8.2982; Cho JA, 2011, GYNECOL ONCOL, V123, P379, DOI 10.1016/j.ygyno.2011.08.005; Clayton H, 2004, EXP CELL RES, V297, P444, DOI 10.1016/j.yexcr.2004.03.029; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Conde-Vancells J, 2008, J PROTEOME RES, V7, P5157, DOI 10.1021/pr8004887; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Ensslin MA, 2007, P NATL ACAD SCI USA, V104, P2715, DOI 10.1073/pnas.0610296104; Ifergan I, 2005, CANCER RES, V65, P10952, DOI 10.1158/0008-5472.CAN-05-2021; Kato K, 2010, AM J PATHOL, V176, P381, DOI 10.2353/ajpath.2010.090056; Koumangoye RB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024234; LAROCCA D, 1991, CANCER RES, V51, P4994; Lonnerdal B, 2004, ADV EXP MED BIOL, V554, P11; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Marquez DC, 2006, MOL CELL ENDOCRINOL, V246, P91, DOI 10.1016/j.mce.2005.11.020; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; Mossuz P, 1998, LEUKEMIA RES, V22, P1063, DOI 10.1016/S0145-2126(98)00101-5; Muralidharan-Chari V, 2009, CURR BIOL, V19, P1875, DOI 10.1016/j.cub.2009.09.059; Neutzner M, 2007, CANCER RES, V67, P6777, DOI 10.1158/0008-5472.CAN-07-0165; O'Brien K, 2013, EUR J CANCER, V49, P1845, DOI 10.1016/j.ejca.2013.01.017; Ochieng J, 2009, EXP CELL RES, V315, P1875, DOI 10.1016/j.yexcr.2009.03.010; Palazzolo G, 2012, ANTICANCER RES, V32, P847; Park SY, 2010, CLIN CANCER RES, V16, P876, DOI 10.1158/1078-0432.CCR-09-1532; Pasquier J, 2012, J BIOL CHEM, V287, P7374, DOI 10.1074/jbc.M111.312157; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Perez I, 2009, HEAD NECK-J SCI SPEC, V31, P1335, DOI 10.1002/hed.21099; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Saitoh Y, 2006, BIOL PHARM BULL, V29, P709, DOI 10.1248/bpb.29.709; Seli E, 2001, FERTIL STERIL, V75, P1172, DOI 10.1016/S0015-0282(01)01779-4; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P589, DOI 10.1074/mcp.M500321-MCP200; Silvestre JS, 2005, NAT MED, V11, P499, DOI 10.1038/nm1233; Simoes B.M., 2010, BREAST CANC RES TREA; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Teranishi J, 2008, PROSTATE, V68, P1666, DOI 10.1002/pros.20835; Vivanco MD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001215; Yamaguchi H, 2009, CANCER RES, V69, P8594, DOI 10.1158/0008-5472.CAN-09-2305	42	11	11	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e83955	10.1371/journal.pone.0083955	http://dx.doi.org/10.1371/journal.pone.0083955			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404144	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460800023
J	Johns, N; Hatakeyama, S; Stephens, NA; Degen, M; Degen, S; Frieauff, W; Lambert, C; Ross, JA; Roubenoff, R; Glass, DJ; Jacobi, C; Fearon, KCH				Johns, Neil; Hatakeyama, Shinji; Stephens, Nathan A.; Degen, Martin; Degen, Simone; Frieauff, Wilfried; Lambert, Christian; Ross, James A.; Roubenoff, Ronenn; Glass, David J.; Jacobi, Carsten; Fearon, Kenneth C. H.			Clinical Classification of Cancer Cachexia: Phenotypic Correlates in Human Skeletal Muscle	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME PATHWAY; STEM-CELL FUNCTION; PROTEIN-SYNTHESIS; MYOSIN ISOFORMS; ATROPHY; MASS; DEGRADATION; ACTIVATION; EXPRESSION; GENE	Background: Cachexia affects the majority of patients with advanced cancer and is associated with a reduction in treatment tolerance, response to therapy, and duration of survival. One impediment towards the effective treatment of cachexia is a validated classification system. Methods: 41 patients with resectable upper gastrointestinal (GI) or pancreatic cancer underwent characterisation for cachexia based on weight-loss (WL) and/or low muscularity (LM). Four diagnostic criteria were used >5% WL,>10% WL, LM, and LM+>2% WL. All patients underwent biopsy of the rectus muscle. Analysis included immunohistochemistry for fibre size and type, protein and nucleic acid concentration, Western blots for markers of autophagy, SMAD signalling, and inflammation. Findings: Compared with non-cachectic cancer patients, patients with LM or LM+>2% WL, mean muscle fibre diameter was reduced by about 25% (p = 0.02 and p = 0.001 respectively). No significant difference in fibre diameter was observed if patients had WL alone. Regardless of classification, there was no difference in fibre number or proportion of fibre type across all myosin heavy chain isoforms. Mean muscle protein content was reduced and the ratio of RNA/DNA decreased in patients with either >5% WL or LM+>2% WL. Compared with non-cachectic patients, SMAD3 protein levels were increased in patients with >5% WL (p = 0.022) and with >10% WL, beclin (p = 0.05) and ATG5 (p = 0.01) protein levels were increased. There were no differences in phospho-NFkB or phospho-STAT3 levels across any of the groups. Conclusion: Muscle fibre size, biochemical composition and pathway phenotype can vary according to whether the diagnostic criteria for cachexia are based on weight loss alone, a measure of low muscularity alone or a combination of the two. For intervention trials where the primary end-point is a change in muscle mass or function, use of combined diagnostic criteria may allow identification of a more homogeneous patient cohort, reduce the sample size required and enhance the time scale within which trials can be conducted.	[Johns, Neil; Stephens, Nathan A.; Ross, James A.; Fearon, Kenneth C. H.] Univ Edinburgh, Dept Clin & Surg Sci, Edinburgh, Midlothian, Scotland; [Hatakeyama, Shinji; Degen, Martin; Degen, Simone; Frieauff, Wilfried; Lambert, Christian; Jacobi, Carsten] Novartis Pharma AG, Novartis Inst BioMed Res Basel, Basel, Switzerland; [Roubenoff, Ronenn; Glass, David J.] Novartis Inst Biomed Res, Cambridge, MA USA	University of Edinburgh; Novartis; Novartis	Fearon, KCH (corresponding author), Univ Edinburgh, Dept Clin & Surg Sci, Edinburgh, Midlothian, Scotland.	k.fearon@ed.ac.uk	Glass, David/AAI-3910-2021; Hatakeyama, Shinji/I-8873-2019; Glass, David/C-4782-2012	Hatakeyama, Shinji/0000-0002-0166-2773; Glass, David/0000-0001-6187-4164; Roubenoff, Ronenn/0000-0002-3959-3179; Degen, Martin/0000-0002-4356-3714	Royal College of Surgeons	Royal College of Surgeons	The authors' received a small grant from Royal College of Surgeons: http://www.rcsed.ac.uk/fellows-members/awards-and-grants/grants/small-research-grants.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2005, CANCER CELL, V8, P421, DOI 10.1016/j.ccr.2005.10.004; Acharyya S, 2004, J CLIN INVEST, V114, P370, DOI 10.1172/jci200420174; Allen DL, 2001, AM J PHYSIOL-CELL PH, V280, pC637, DOI 10.1152/ajpcell.2001.280.3.C637; Aulino P, 2010, BMC CANCER, V10, P363; BARACOS VE, 1995, AM J PHYSIOL-ENDOC M, V268, pE996, DOI 10.1152/ajpendo.1995.268.5.E996; Bassett DR, 2000, MED SCI SPORT EXER, V32, P70, DOI 10.1097/00005768-200001000-00012; Basu R, 2002, J Nutr Health Aging, V6, P336; Bhogal AS, 2006, ANTICANCER RES, V26, P4149; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Braun TP, 2011, J EXP MED, V208, P2449, DOI 10.1084/jem.20111020; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; D'Orlando C, 2013, MUSCLE NERVE; Diffee GM, 2002, AM J PHYSIOL-CELL PH, V283, pC1376, DOI 10.1152/ajpcell.00154.2002; DREXLER H, 1992, CIRCULATION, V85, P1751, DOI 10.1161/01.CIR.85.5.1751; Eley HL, 2008, BRIT J CANCER, V98, P443, DOI 10.1038/sj.bjc.6604150; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; Gallagher I. J., 2012, CLIN CANC RES; Glass DJ, 2010, CURR OPIN CLIN NUTR, V13, P225, DOI 10.1097/MCO.0b013e32833862df; GOLDBERG AL, 1969, J PHYSIOL-LONDON, V200, P655, DOI 10.1113/jphysiol.1969.sp008714; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Harrison BC, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-5; Joulia-Ekaza D, 2007, CURR OPIN PHARMACOL, V7, P310, DOI 10.1016/j.coph.2006.11.011; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kumar A, 2012, CURR OPIN CLIN NUTR, V15, P233, DOI 10.1097/MCO.0b013e328351c3fc; Langley B, 2002, J BIOL CHEM, V277, P49831, DOI 10.1074/jbc.M204291200; Lecker SH, 1999, J NUTR, V129, p227S, DOI 10.1093/jn/129.1.227S; LI JB, 1976, AM J PHYSIOL, V231, P441, DOI 10.1152/ajplegacy.1976.231.2.441; LOPES MN, 1989, BIOCHEM J, V264, P713, DOI 10.1042/bj2640713; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Mourtzakis M, 2008, APPL PHYSIOL NUTR ME, V33, P997, DOI 10.1139/H08-075; PERRY GS, 1995, EPIDEMIOLOGY, V6, P61, DOI 10.1097/00001648-199501000-00012; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI 10.1016/S1470-2045(08)70153-0; Ryan AS, 2011, STROKE, V42, P416, DOI 10.1161/STROKEAHA.110.602441; Samuels SE, 2001, AM J PHYSIOL-REG I, V281, pR133, DOI 10.1152/ajpregu.2001.281.1.R133; Sartori R, 2009, AM J PHYSIOL-CELL PH, V296, pC1248, DOI 10.1152/ajpcell.00104.2009; Schmitt TL, 2007, J MOL MED, V85, P647, DOI 10.1007/s00109-007-0177-2; SCIOTE JJ, 1994, J NEUROL SCI, V126, P15, DOI 10.1016/0022-510X(94)90089-2; She PX, 2011, AM J PHYSIOL-ENDOC M, V301, pE49, DOI 10.1152/ajpendo.00630.2010; Shen W, 2004, J APPL PHYSIOL, V97, P2333, DOI 10.1152/japplphysiol.00744.2004; SMERDU V, 1994, AM J PHYSIOL-CELL PH, V267, pC1723, DOI 10.1152/ajpcell.1994.267.6.C1723; SMITH KL, 1993, BRIT J CANCER, V67, P680, DOI 10.1038/bjc.1993.126; Stephens NA, 2012, CLIN NUTR; Stephens NA, 2010, GENOME MED, V2, DOI 10.1186/gm122; STUNKARD AJ, 1981, AM J CLIN NUTR, V34, P1593, DOI 10.1093/ajcn/34.8.1593; Tan BHL, 2009, CLIN CANCER RES, V15, P6973, DOI 10.1158/1078-0432.CCR-09-1525; Tiao G, 1997, AM J PHYSIOL-REG I, V272, pR849, DOI 10.1152/ajpregu.1997.272.3.R849; Weber MA, 2007, J MOL MED, V85, P887, DOI 10.1007/s00109-007-0220-3; Weber MA, 2009, ACTA ONCOL, V48, P116, DOI 10.1080/02841860802130001; Williams JP, 2012, AM J CLIN NUTR, V96, P1064, DOI 10.3945/ajcn.112.045708	52	56	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e83618	10.1371/journal.pone.0083618	http://dx.doi.org/10.1371/journal.pone.0083618			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404136	gold, Green Submitted, Green Published			2022-12-27	WOS:000329460800015
J	Kuijper, DPJ; Verwijmeren, M; Churski, M; Zbyryt, A; Schmidt, K; Jedrzejewska, B; Smit, C				Kuijper, Dries P. J.; Verwijmeren, Mart; Churski, Marcin; Zbyryt, Adam; Schmidt, Krzysztof; Jedrzejewska, Bogumila; Smit, Chris			What Cues Do Ungulates Use to Assess Predation Risk in Dense Temperate Forests?	PLOS ONE			English	Article							BIALOWIEZA PRIMEVAL FOREST; YELLOWSTONE-NATIONAL-PARK; MEDIATED TROPHIC CASCADE; TEMPORAL VARIATION; EURASIAN LYNX; RED DEER; ANTIPREDATOR RESPONSE; NORTHERN YELLOWSTONE; BEHAVIORAL-RESPONSES; WOLF REINTRODUCTION	Anti-predator responses by ungulates can be based on habitat features or on the near-imminent threat of predators. In dense forest, cues that ungulates use to assess predation risk likely differ from half-open landscapes, as scent relative to sight is predicted to be more important. We studied, in the Bialowieza Primeval Forest (Poland), whether perceived predation risk in red deer (Cervus elaphus) and wild boar (Sus scrofa) is related to habitat visibility or olfactory cues of a predator. We used camera traps in two different set-ups to record undisturbed ungulate behavior and fresh wolf (Canis lupus) scats as olfactory cue. Habitat visibility at fixed locations in deciduous old growth forest affected neither vigilance levels nor visitation rate and cumulative visitation time of both ungulate species. However, red deer showed a more than two-fold increase of vigilance level from 22% of the time present on control plots to 46% on experimental plots containing one wolf scat. Higher vigilance came at the expense of time spent foraging, which decreased from 32% to 12% while exposed to the wolf scat. These behavioral changes were most pronounced during the first week of the experiment but continuous monitoring of the plots suggested that they might last for several weeks. Wild boar did not show behavioral responses indicating higher perceived predation risk. Visitation rate and cumulative visitation time were not affected by the presence of a wolf scat in both ungulate species. The current study showed that perceived predation risk in red deer and wild boar is not related to habitat visibility in a dense forest ecosystem. However, olfactory cues of wolves affected foraging behavior of their preferred prey species red deer. We showed that odor of wolves in an ecologically equivalent dose is sufficient to create fine-scale risk factors for red deer.	[Kuijper, Dries P. J.; Churski, Marcin; Schmidt, Krzysztof; Jedrzejewska, Bogumila] Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland; [Verwijmeren, Mart] Univ Utrecht, Copernicus Inst, Dept Environm Sci, Utrecht, Netherlands; [Zbyryt, Adam] Polish Soc Bird Protect, Bialystok, Poland; [Smit, Chris] Univ Groningen, Ctr Evolutionary & Ecol Studies, Community & Conservat Ecol Grp, Groningen, Netherlands	Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences; Utrecht University; University of Groningen	Kuijper, DPJ (corresponding author), Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland.	dkuijper@ibs.bialowieza.pl	Churski, Marcin/Y-5361-2019; Schmidt, Krzysztof/L-6437-2013; smit, christian/B-9817-2008	Churski, Marcin/0000-0001-8727-0203; Kuijper, Dries/0000-0002-0324-5893; Verwijmeren, Mart/0000-0002-8051-0697; smit, christian/0000-0002-4044-9473; Zbyryt, Adam/0000-0003-1490-5700; Schmidt, Krzysztof/0000-0002-9043-291X	Marie Curie European Reintegration Grant under the 7th framework program [PERG06-GA-2009-256444]; National Science Center, Poland [2011/01/B/NZ8/04337, 2012/05/B/NZ8/01010]; Polish Ministry of Science and Higher Education [N309 137 335]; European Union [245737]	Marie Curie European Reintegration Grant under the 7th framework program; National Science Center, Poland(National Science Centre, Poland); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); European Union(European Commission)	Part of the work of DPJK was supported by a Marie Curie European Reintegration Grant under the 7th framework program (project PERG06-GA-2009-256444) and funding by the National Science Center, Poland (grants no.: 2011/01/B/NZ8/04337 and 2012/05/B/NZ8/01010). Additionally MC received funding by the Polish Ministry of Science and Higher Education (grants no.: N309 137 335). BJ and KS received funding from the European Union 7th Framework Programme under project Research Potential in Conservation and Sustainable Management of Biodiversity - BIOCONSUS (grant agreement no. 245737). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apfelbach R, 2005, NEUROSCI BIOBEHAV R, V29, P1123, DOI 10.1016/j.neubiorev.2005.05.005; Arnould C, 1998, J CHEM ECOL, V24, P559, DOI 10.1023/A:1022321104758; Atwood TC, 2009, J WILDLIFE MANAGE, V73, P876, DOI 10.2193/2008-325; Barja I, 2008, CAN J ZOOL, V86, P170, DOI 10.1139/Z07-129; Barja I, 2005, FOLIA ZOOL, V54, P21; Bernadzki E, 1998, J VEG SCI, V9, P229, DOI 10.2307/3237122; Beschta RL, 2013, ECOLOGY, V94, P1420, DOI 10.1890/11-0063.1; Beschta RL, 2010, RESTOR ECOL, V18, P380, DOI 10.1111/j.1526-100X.2008.00450.x; Beyer HL, 2007, ECOL APPL, V17, P1563, DOI 10.1890/06-1254.1; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; Creel S, 2005, ECOLOGY, V86, P3387, DOI 10.1890/05-0032; Creel S, 2005, ANIM BEHAV, V69, P1181, DOI 10.1016/j.anbehav.2004.07.022; Creel S, 2008, ANIM BEHAV, V76, P1139, DOI 10.1016/j.anbehav.2008.07.006; Creel S, 2008, TRENDS ECOL EVOL, V23, P194, DOI 10.1016/j.tree.2007.12.004; Creel S, 2009, ECOLOGY, V90, P2454, DOI 10.1890/08-2017.1; Falinski J.B., 1986, VEGETATION DYNAMICS; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; Halofsky J, 2008, FORESTRY, V81, P195, DOI 10.1093/forestry/cpm044; Halofsky JS, 2008, OECOLOGIA, V155, P869, DOI 10.1007/s00442-007-0956-z; Hopcraft JGC, 2005, J ANIM ECOL, V74, P559, DOI 10.1111/j.1365-2656.2005.00955.x; JEDRZEJEWSKA B, 1994, J APPL ECOL, V31, P664, DOI 10.2307/2404157; Jedrzejewska B, 1997, ACTA THERIOL, V42, P399; Jedrzejewska B., 1998, PREDATION VERTEBRATE; Jedrzejewski W, 2002, ECOLOGY, V83, P1341, DOI 10.2307/3071948; Jedrzejewski W, 2000, J MAMMAL, V81, P197, DOI 10.1644/1545-1542(2000)081&lt;0197:PSAPBW&gt;2.0.CO;2; Kamler JF, 2008, AM MIDL NAT, V159, P75, DOI 10.1674/0003-0031(2008)159[75:HRORDI]2.0.CO;2; Kauffman MJ, 2007, ECOL LETT, V10, P690, DOI 10.1111/j.1461-0248.2007.01059.x; Kauffman MJ, 2010, ECOLOGY, V91, P2742, DOI 10.1890/09-1949.1; Kluever BM, 2009, BEHAV PROCESS, V81, P85, DOI 10.1016/j.beproc.2009.02.004; Kuijper DPJ, 2013, ECOGRAPHY, V36, P1263, DOI 10.1111/j.1600-0587.2013.00266.x; Kuijper DPJ, 2009, FOREST ECOL MANAG, V258, P1528, DOI 10.1016/j.foreco.2009.07.010; Kuijper DPJ, 2010, J VEG SCI, V21, P1082, DOI 10.1111/j.1654-1103.2010.01217.x; Kuijper DPJ, 2010, J ECOL, V98, P888, DOI 10.1111/j.1365-2745.2010.01656.x; Kweczlich I., 2004, Sylwan, V148, P18; Laundre JW, 2001, CAN J ZOOL, V79, P1401, DOI 10.1139/cjz-79-8-1401; LEWIS MA, 1993, NATURE, V366, P738, DOI 10.1038/366738a0; Li CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023623; Liley S, 2008, BEHAV ECOL, V19, P245, DOI 10.1093/beheco/arm116; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; Mao JS, 2005, J WILDLIFE MANAGE, V69, P1691, DOI 10.2193/0022-541X(2005)69[1691:HSBEBA]2.0.CO;2; Mech DL, 1977, SCIENCE, V198, P320, DOI 10.1126/science.198.4314.320; MELCHIORS MA, 1985, J WILDLIFE MANAGE, V49, P358, DOI 10.2307/3801531; Michalczuk C., 2001, PHYTOCOENOSIS, V13; Okarma H, 1997, ACTA THERIOL, V42, P203, DOI 10.4098/AT.arch.97-22; Parsons MH, 2010, ETHOLOGY, V116, P972, DOI 10.1111/j.1439-0310.2010.01810.x; PETERS RP, 1975, AM SCI, V63, P628; Podgorski T, 2008, ACTA THERIOL, V53, P97, DOI 10.1007/BF03194243; Podgorski T, 2013, J MAMMAL, V94, P109, DOI 10.1644/12-MAMM-A-038.1; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Proffitt KM, 2009, J WILDLIFE MANAGE, V73, P345, DOI 10.2193/2008-210; Ripple WJ, 2006, FOREST ECOL MANAG, V230, P96, DOI 10.1016/j.foreco.2006.04.023; Ripple WJ, 2004, BIOSCIENCE, V54, P755, DOI 10.1641/0006-3568(2004)054[0755:WATEOF]2.0.CO;2; Ripple WJ, 2001, BIOL CONSERV, V102, P227, DOI 10.1016/S0006-3207(01)00107-0; Samojlik T, 2007, ACADEMIA, V4, P36; Schmidt K, 2009, ECOL RES, V24, P207, DOI 10.1007/s11284-008-0496-y; Schmitz OJ, 1997, ECOLOGY, V78, P1388, DOI 10.1890/0012-9658(1997)078[1388:BMTCEO]2.0.CO;2; Schmitz OJ, 2001, ECOLOGY, V82, P2072, DOI 10.1890/0012-9658(2001)082[2072:EOTPSO]2.0.CO;2; Shrader AM, 2008, J ARID ENVIRON, V72, P1811, DOI 10.1016/j.jaridenv.2008.05.004; SWIHART RK, 1991, J CHEM ECOL, V17, P767, DOI 10.1007/BF00994199; Thaker M, 2011, ECOLOGY, V92, P398, DOI 10.1890/10-0126.1; UNDERWOOD R, 1982, BEHAVIOUR, V79, P82; Valeix M, 2009, ECOLOGY, V90, P23, DOI 10.1890/08-0606.1; Valeix M, 2010, LANDSCAPE ECOL, V25, P337, DOI 10.1007/s10980-009-9425-x; Winnie JA, 2012, ECOLOGY, V93, P2600, DOI 10.1890/11-1990.1; Winnie J, 2007, ANIM BEHAV, V73, P215, DOI 10.1016/j.anbehav.2006.07.007; Zar JH., 1999, BIOSTAT ANAL; Zub K, 2003, BEHAVIOUR, V140, P635, DOI 10.1163/156853903322149478	68	76	79	2	163	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84607	10.1371/journal.pone.0084607	http://dx.doi.org/10.1371/journal.pone.0084607			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404177	gold, Green Published, Green Submitted			2022-12-27	WOS:000329460800056
J	Qian, YJ; Zhang, J; Jung, YS; Chen, XB				Qian, Yingjuan; Zhang, Jin; Jung, Yong-Sam; Chen, Xinbin			DEC1 Coordinates with HDAC8 to Differentially Regulate TAp73 and Delta Np73 Expression	PLOS ONE			English	Article							DAMAGE RESPONSE PATHWAY; P53 FAMILY; DNA-DAMAGE; TRANSCRIPTION FACTORS; PROXIMAL PROMOTER; PROTEIN STABILITY; CELL-SURVIVAL; FEEDBACK LOOP; TARGET GENES; C-TERMINUS	P73, a member of the p53 family, plays a critical role in neural development and tumorigenesis. Due to the usage of two different promoters, p73 is expressed as two major isoforms, TAp73 and Delta Np73, often with opposing functions. Here, we reported that transcriptional factor DEC1, a target of the p53 family, exerts a distinct control of TAp73 and Delta Np73 expression. In particular, we showed that DEC1 was able to increase TAp73 expression via transcriptional activation of the TAp73 promoter. By contrast, Np73 transcription was inhibited by DEC1 via transcriptional repression of the Delta Np73 promoter. To further explore the underlying mechanism, we showed that DEC1 was unable to increase TAp73 expression in the absence of HDAC8, suggesting that HDAC8 is required for DEC1 to enhance TAp73 expression. Furthermore, we found that DEC1 was able to interact with HDAC8 and recruit HDAC8 to the TAp73, but not the Delta Np73, promoter. Together, our data provide evidence that DEC1 and HDAC8 in differentially regulate TAp73 and Delta Np73 expression, suggesting that this regulation may lay a foundation for a therapeutic strategy to enhance the chemosensitivity of tumor cells.	[Qian, Yingjuan; Zhang, Jin; Jung, Yong-Sam; Chen, Xinbin] Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA	University of California System; University of California Davis	Chen, XB (corresponding author), Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA.	xbchen@ucdavis.edu			National Institutes of Health [RO1 CA081237]; NATIONAL CANCER INSTITUTE [R01CA081237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported in part by a National Institutes of Health grant (RO1 CA081237). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chakrabarti J, 2004, BRIT J CANCER, V91, P954, DOI 10.1038/sj.bjc.6602059; Chen XB, 2001, ONCOGENE, V20, P769, DOI 10.1038/sj.onc.1204149; Cui RT, 2005, J BIOL CHEM, V280, P39152, DOI 10.1074/jbc.M504655200; Dulloo I, 2010, P NATL ACAD SCI USA, V107, P4902, DOI 10.1073/pnas.0906782107; Fontemaggi G, 2002, J BIOL CHEM, V277, P43359, DOI 10.1074/jbc.M205573200; Goldschneider D, 2005, J CELL SCI, V118, P1245, DOI 10.1242/jcs.01704; Grob TJ, 2001, CELL DEATH DIFFER, V8, P1213, DOI 10.1038/sj.cdd.4400962; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; Harms KL, 2005, MOL CELL BIOL, V25, P2014, DOI 10.1128/MCB.25.5.2014-2030.2005; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Ivanov SV, 2007, ONCOGENE, V26, P802, DOI 10.1038/sj.onc.1209842; Ivanova AV, 2001, J BIOL CHEM, V276, P15306, DOI 10.1074/jbc.M010516200; Jung YS, 2008, J BIOL CHEM, V283, P1018, DOI 10.1074/jbc.M707722200; Kartasheva NN, 2002, ONCOGENE, V21, P4715, DOI 10.1038/sj.onc.1205584; Li Y, 2006, ONCOGENE, V25, P3296, DOI 10.1038/sj.onc.1209363; Li YX, 2003, J BIOL CHEM, V278, P16899, DOI 10.1074/jbc.M300596200; Li YX, 2002, BIOCHEM J, V367, P413, DOI 10.1042/BJ20020514; Liu G, 2005, J BIOL CHEM, V280, P20111, DOI 10.1074/jbc.M413889200; Liu G, 2004, MOL CELL BIOL, V24, P487, DOI 10.1128/MCB.24.2.487-501.2004; Liu G, 2003, J BIOL CHEM, V278, P17557, DOI 10.1074/jbc.M210696200; Murray-Zmijewski F, 2006, CELL DEATH DIFFER, V13, P962, DOI 10.1038/sj.cdd.4401914; Nakagawa T, 2002, MOL CELL BIOL, V22, P2575, DOI 10.1128/MCB.22.8.2575-2585.2002; Qian YJ, 2008, J BIOL CHEM, V283, P22410, DOI 10.1074/jbc.M800643200; Qian YJ, 2008, J BIOL CHEM, V283, P2896, DOI 10.1074/jbc.M708624200; Qian YJ, 2012, P NATL ACAD SCI USA, V109, P11300, DOI 10.1073/pnas.1203185109; Qian YJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.207241; Rufini A, 2012, GENE DEV, V26, P2009, DOI 10.1101/gad.197640.112; Rufini Alessandro, 2011, Genes Cancer, V2, P491, DOI 10.1177/1947601911408890; Sayan BS, 2010, P NATL ACAD SCI USA, V107, P12877, DOI 10.1073/pnas.0911828107; Shen M, 2002, J BIOL CHEM, V277, P50112, DOI 10.1074/jbc.M206771200; Tissir F, 2009, P NATL ACAD SCI USA, V106, P16871, DOI 10.1073/pnas.0903191106; Toh WH, 2004, J BIOL CHEM, V279, P44713, DOI 10.1074/jbc.M407672200; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; Wilhelm MT, 2010, GENE DEV, V24, P549, DOI 10.1101/gad.1873910; Yamada K, 2005, FRONT BIOSCI-LANDMRK, V10, P3151, DOI 10.2741/1772; Yan W, 2013, ONCOGENE, V32, P599, DOI 10.1038/onc.2012.81; Yan WS, 2012, MOL CELL BIOL, V32, P2336, DOI 10.1128/MCB.00215-12; Zawel L, 2002, P NATL ACAD SCI USA, V99, P2848, DOI 10.1073/pnas.261714999; Zhang J, 2013, J BIOL CHEM, V288, P7727, DOI 10.1074/jbc.M112.429522; Zheng XJ, 2001, FEBS LETT, V489, P4, DOI 10.1016/S0014-5793(00)02437-6	40	16	18	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84015	10.1371/journal.pone.0084015	http://dx.doi.org/10.1371/journal.pone.0084015			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404147	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460800026
J	Walker, GE; Ricotti, R; Roccio, M; Moia, S; Bellone, S; Prodam, F; Bona, G				Walker, Gillian E.; Ricotti, Roberta; Roccio, Marta; Moia, Stefania; Bellone, Simonetta; Prodam, Flavia; Bona, Gianni			Pediatric Obesity and Vitamin D Deficiency: A Proteomic Approach Identifies Multimeric Adiponectin as a Key Link between These Conditions	PLOS ONE			English	Article							MOLECULAR-WEIGHT ADIPONECTIN; VISCERAL ADIPOSITY INDEX; METABOLIC SYNDROME; D-RECEPTOR; CARDIOVASCULAR-DISEASE; DSBA-L; CARDIOMETABOLIC RISK; GLUCOSE-HOMEOSTASIS; INSULIN-RESISTANCE; 3T3-L1 CELLS	Key circulating molecules that link vitamin D (VD) to pediatric obesity and its co-morbidities remain unclear. Using a proteomic approach, our objective was to identify key molecules in obese children dichotomized according to 25OH-vitamin D (25OHD) levels. A total of 42 obese children (M/F = 18/24) were divided according to their 25OHD3 levels into 25OHD3 deficient (VDD; n = 18; 25OHD<15 ng/ml) or normal subjects (NVD; n = 24;>30 ng/ml). Plasma proteomic analyses by two dimensional (2D)-electrophoresis were performed at baseline in all subjects. VDD subjects underwent a 12mo treatment with 3000 IU vitamin D3 once a week to confirm the proteomic analyses. The proteomic analyses identified 53 "spots" that differed between VDD and NVD (p<0.05), amongst which adiponectin was identified. Adiponectin was selected for confirmational studies due to its tight association with obesity and diabetes mellitus. Western Immunoblot (WIB) analyses of 2D-gels demonstrated a downregulation of adiponectin in VDD subjects, which was confirmed in the plasma from VDD with respect to NVD subjects (p<0.035) and increased following 12mo vitamin D3 supplementation in VDD subjects (p<0.02). High molecular weight (HMW) adiponectin, a surrogate indicator of insulin sensitivity, was significantly lower in VDD subjects (p<0.02) and improved with vitamin D3 supplementation (p<0.042). A direct effect in vitro of 1 alpha, 25-(OH)2D3 on adipocyte adiponectin synthesis was demonstrated, with adiponectin and its multimeric forms upregulated, even at low pharmacological doses (10(-9) M) of 1 alpha, 25-(OH)2D3. This upregulation was paralleled by the adiponectin interactive protein, DsbA-L, suggesting that the VD regulation of adiponectin involves post-transciptional events. Using a proteomic approach, multimeric adiponectin has been identified as a key plasma protein that links VDD to pediatric obesity.	[Walker, Gillian E.; Roccio, Marta; Moia, Stefania] Univ Piemonte Orientale Amedeo Avogadro, Dept Hlth Sci, Lab Clin Pediat, Novara, Italy; [Bellone, Simonetta; Prodam, Flavia; Bona, Gianni] Univ Piemonte Orientale Amedeo Avogadro, Dept Hlth Sci, Div Pediat, Novara, Italy	University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro	Walker, GE (corresponding author), Univ Piemonte Orientale Amedeo Avogadro, Dept Hlth Sci, Lab Clin Pediat, Novara, Italy.	gillian.walker@med.unipmn.it	Bellone, Simonetta/K-2196-2016	Prodam, Flavia/0000-0001-9660-5335	Research Projects of National Interest(PRIN) [prot. 20082P8CCE]; Regione Piemonte Grant [prot. 2827]	Research Projects of National Interest(PRIN); Regione Piemonte Grant(Regione Piemonte)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Support for the research reported was provided by Research Projects of National Interest(PRIN) 2008 (prot. 20082P8CCE) and Regione Piemonte Grant (2008, prot. 2827).	Alvarez JA, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/351385; Amato MC, 2010, DIABETES CARE, V33, P920, DOI 10.2337/dc09-1825; Ashraf A, 2009, J CLIN ENDOCR METAB, V94, P3200, DOI 10.1210/jc.2009-0445; Belenchia AM, 2013, AM J CLIN NUTR, V97, P774, DOI 10.3945/ajcn.112.050013; Blumberg JM, 2006, J BIOL CHEM, V281, P11205, DOI 10.1074/jbc.M510343200; Breslavsky A., 2013, CLIN NUTR; BUFFINGTON C, 1993, OBES SURG, V3, P421, DOI 10.1381/096089293765559142; Cacciari E, 2006, J ENDOCRINOL INVEST, V29, P581, DOI 10.1007/BF03344156; de Roos B, 2008, J PROTEOME RES, V7, P2280, DOI 10.1021/pr700714x; Ford ES, 2005, DIABETES CARE, V28, P1228, DOI 10.2337/diacare.28.5.1228; Freedman DS, 2009, ARCH PEDIAT ADOL MED, V163, P805, DOI 10.1001/archpediatrics.2009.104; Gao D, 2013, INT J OBESITY, V37, P357, DOI 10.1038/ijo.2012.53; George PS, 2012, DIABETIC MED, V29, pE142, DOI 10.1111/j.1464-5491.2012.03672.x; Giulietti A, 2007, DIABETES RES CLIN PR, V77, P47, DOI 10.1016/j.diabres.2006.10.007; Gueugnon C, 2012, APPL PHYSIOL NUTR ME, V37, P672, DOI [10.1139/h2012-045, 10.1139/H2012-045]; Gupta GK, 2012, EXP MOL PATHOL, V93, P82, DOI 10.1016/j.yexmp.2012.04.006; Hillman JB, 2011, DISCOV MED, V11, P521; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Hypponen E, 2006, DIABETES CARE, V29, P2244, DOI 10.2337/dc06-0946; Kelly A, 2011, ARCH DIS CHILD, V96, P447, DOI 10.1136/adc.2010.187591; Kong J, 2006, AM J PHYSIOL-ENDOC M, V290, pE916, DOI 10.1152/ajpendo.00410.2005; Lara-Castro C, 2006, DIABETES, V55, P249, DOI 10.2337/diabetes.55.1.249; Lichtash CT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065954; Liu E, 2009, J NUTR, V139, P329, DOI 10.3945/jn.108.093831; Liu ML, 2010, BIOCHEM J, V425, P41, DOI 10.1042/BJ20091045; Liu M, 2008, P NATL ACAD SCI USA, V105, P18302, DOI 10.1073/pnas.0806341105; Lorente-Cebrian S, 2012, EUR J NUTR, V51, P335, DOI 10.1007/s00394-011-0218-z; Martini LA, 2006, NUTR REV, V64, P479, DOI 10.1111/j.1753-4887.2006.tb00180.x; Martos-Moreno GA, 2010, OBESITY, V18, P2288, DOI 10.1038/oby.2010.68; Meerza D, 2012, J DIABETES COMPLICAT, V26, P363, DOI 10.1016/j.jdiacomp.2012.05.013; Mischak H, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001249; Norman AW, 2006, ENDOCRINOLOGY, V147, P5542, DOI 10.1210/en.2006-0946; Oberbach A, 2011, J PROTEOME RES, V10, P4769, DOI 10.1021/pr2005555; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Petta S, 2012, ALIMENT PHARM THER, V35, P238, DOI 10.1111/j.1365-2036.2011.04929.x; Prodam F, 2011, EUROPEAN E J CLIN NU, V6, P109; Qi Y, 2004, NAT MED, V10, P524, DOI 10.1038/nm1029; Reis JP, 2009, PEDIATRICS, V124, pE371, DOI 10.1542/peds.2009-0213; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Sergeev Igor N., 2009, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V9, P153; Shetty S, 2009, TRENDS PHARMACOL SCI, V30, P234, DOI 10.1016/j.tips.2009.02.004; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Song Q, 2012, NUTR RES REV, V16, P1; Sun X, 2007, OBESITY, V15, P340, DOI 10.1038/oby.2007.540; TANNER JM, 1976, ARCH DIS CHILD, V51, P170, DOI 10.1136/adc.51.3.170; Thomas GN, 2012, DIABETES CARE, V35, P1158, DOI 10.2337/dc11-1714; Wagner CL, 2008, PEDIATRICS, V122, P1142, DOI 10.1542/peds.2008-1862; Walker GE, 2008, OBESITY, V16, P1983, DOI 10.1038/oby.2008.326; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Wang ZV, 2008, P NATL ACAD SCI USA, V105, P18077, DOI 10.1073/pnas.0810027105; Weisse K, 2013, ALLERGY, V68, P220, DOI 10.1111/all.12081; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Wu-Wong JR, 2009, BRIT J PHARMACOL, V158, P395, DOI 10.1111/j.1476-5381.2009.00171.x; Zhou LJ, 2010, DIABETES, V59, P2809, DOI 10.2337/db10-0412; Zhou P, 2011, J PEDIATR-US, V158, P930, DOI 10.1016/j.jpeds.2010.11.034; Zunigaa S, 2011, CLIN RES HEPATOL GAS, V35, P295, DOI 10.1016/j.clinre.2011.02.003	58	36	45	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e83685	10.1371/journal.pone.0083685	http://dx.doi.org/10.1371/journal.pone.0083685			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404137	Green Published, Green Submitted, gold			2022-12-27	WOS:000329460800016
J	Bentley, RA; Acerbi, A; Ormerod, P; Lampos, V				Bentley, R. Alexander; Acerbi, Alberto; Ormerod, Paul; Lampos, Vasileios			Books Average Previous Decade of Economic Misery	PLOS ONE			English	Article							CULTURAL-EVOLUTION; UNEMPLOYMENT; EMOTIONS; INTELLIGENCE; PERFORMANCE; DEMOGRAPHY; MORTALITY; TIME	For the 20th century since the Depression, we find a strong correlation between a 'literary misery index' derived from English language books and a moving average of the previous decade of the annual U. S. economic misery index, which is the sum of inflation and unemployment rates. We find a peak in the goodness of fit at 11 years for the moving average. The fit between the two misery indices holds when using different techniques to measure the literary misery index, and this fit is significantly better than other possible correlations with different emotion indices. To check the robustness of the results, we also analysed books written in German language and obtained very similar correlations with the German economic misery index. The results suggest that millions of books published every year average the authors' shared economic experiences over the past decade.	[Bentley, R. Alexander; Acerbi, Alberto] Univ Bristol, Dept Archaeol & Anthropol, Bristol, Avon, England; [Ormerod, Paul] Volterra Partners LLP, London, England; [Ormerod, Paul] Univ Durham, Dept Anthropol, Durham, England; [Lampos, Vasileios] Univ Sheffield, Dept Comp Sci, Sheffield S10 2TN, S Yorkshire, England	University of Bristol; Durham University; University of Sheffield	Bentley, RA (corresponding author), Univ Bristol, Dept Archaeol & Anthropol, Bristol, Avon, England.	r.a.bentley@bristol.ac.uk	Bentley, R Alexander/GWZ-8982-2022	Acerbi, Alberto/0000-0001-5827-8003; Lampos, Vasileios/0000-0001-8555-2063; Bentley, R. Alexander/0000-0001-9086-2197	Newton International Fellowship; TrendMiner project (EU-FP7-ICT) [287863]	Newton International Fellowship; TrendMiner project (EU-FP7-ICT)	A. Acerbi is supported by a Newton International Fellowship. V. Lampos acknowledges the support from the TrendMiner project (EU-FP7-ICT n.287863). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson E, 2008, ADMIN SCI QUART, V53, P719, DOI 10.2189/asqu.53.4.719; Acerbi A, 2013, PLOS ONE, V8; Acerbi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032541; [Anonymous], 2009, NATURE, DOI DOI 10.1038/nature07634; [Anonymous], 2011, SCIENCE, DOI [DOI 10.21055/0370-1069-2020-1-51-60, DOI 10.1016/j.jocs.2010.12.007]; Bagozzi RP, 1999, J ACAD MARKET SCI, V27, P184, DOI 10.1177/0092070399272005; Bakshy E, 2011, P WSDM11 HONG KONG; Bandelj N, 2009, THEOR SOC, V38, P347, DOI 10.1007/s11186-009-9088-2; Bechara A, 2005, GAME ECON BEHAV, V52, P336, DOI 10.1016/j.geb.2004.06.010; Bentley RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047966; Berezin M, 2009, THEOR SOC, V38, P335, DOI 10.1007/s11186-009-9084-6; Berger J, 2009, P NATL ACAD SCI USA, V106, P8146, DOI 10.1073/pnas.0812647106; Calvo RA, 2010, IEEE T AFFECT COMPUT, V1, P18, DOI 10.1109/T-AFFC.2010.1; CARROLL J, 1995, HUM NATURE-INT BIOS, V6, P119, DOI 10.1007/BF02734174; Choi HY, 2012, ECON REC, V88, P2, DOI 10.1111/j.1475-4932.2012.00809.x; COEN RM, 1973, REV ECON STAT, V55, P46, DOI 10.2307/1927993; DeWall CN, 2011, PSYCHOL AESTHET CREA, V5, P200, DOI 10.1037/a0023195; Dodds PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026752; Elder G.H., 1974, CHILDREN GREAT DEPRE; Ettredge M, 2005, COMMUN ACM, V48, P87, DOI 10.1145/1096000.1096010; Gao JB, 2012, J R SOC INTERFACE, V9, P1956, DOI 10.1098/rsif.2011.0846; Giguere G, 2013, P NATL ACAD IN PRESS, DOI [10.1073/pnas.1219674110, DOI 10.1073/PNAS.1219674110)]; Goel S, 2010, P NATL ACAD SCI USA, V107, P17486, DOI 10.1073/pnas.1005962107; Henrich J, 2004, AM ANTIQUITY, V69, P197, DOI 10.2307/4128416; Hughes JM, 2012, P NATL ACAD SCI USA, V109, P7682, DOI 10.1073/pnas.1115407109; Kivimaki M, 2000, BRIT MED J, V320, P971, DOI 10.1136/bmj.320.7240.971; Kivimaki M, 2003, AM J EPIDEMIOL, V158, P663, DOI 10.1093/aje/kwg185; Kline MA, 2010, P ROY SOC B-BIOL SCI, V277, P2559, DOI 10.1098/rspb.2010.0452; Kloumann IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029484; Lampos V., P 51 ANN M ASS COMP, P993; Lampos V, 2012, ACM T INTEL SYST TEC, V3, DOI 10.1145/2337542.2337557; Lansdall-Welfare T, 2013, P 21 INT C COMP WORL, P1221; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lieberman E, 2007, NATURE, V449, P713, DOI 10.1038/nature06137; Lin Y., 2012, P ACL 2012 SYSTEM DE, P169, DOI DOI 10.1007/978-1-4614-2311-9_8; Loewenstein G, 2000, AM ECON REV, V90, P426, DOI 10.1257/aer.90.2.426; Maddisson A, 2003, WORLD EC HIST STAT; MARSHALL L, 1957, AFRICA, V27, P1, DOI 10.2307/1156363; McKee-Ryan FM, 2005, J APPL PSYCHOL, V90, P53, DOI 10.1037/0021-9010.90.1.53; Mesoudi A, 2008, PHILOS T R SOC B, V363, P3489, DOI 10.1098/rstb.2008.0129; Michel JB, 2011, SCIENCE, V331, P176, DOI 10.1126/science.1199644; MILLER GA, 1995, COMMUN ACM, V38, P39, DOI 10.1145/219717.219748; Mitchell B. R., 2007, INT HIST STAT EUROPE; Mullins DA, 2013, J ECON BEHAV ORGAN, V90, pS141, DOI 10.1016/j.jebo.2012.12.017; Murphy GC, 1999, J OCCUP ORGAN PSYCH, V72, P83, DOI 10.1348/096317999166518; Oishi S, 2013, PERS SOC PSYCHOL B, V39, P559, DOI 10.1177/0146167213480042; Okun A.M., 1981, PRICES QUANTITIES MA; Olivola CY, 2009, P NATL ACAD SCI USA, V106, P22151, DOI 10.1073/pnas.0908980106; Ormerod P, 2013, APPL ECON, V45, P1519, DOI 10.1080/00036846.2011.628299; Paul KI, 2009, J VOCAT BEHAV, V74, P264, DOI 10.1016/j.jvb.2009.01.001; Pennebaker, 2011, SECRET LIFE PRONOUNS, DOI 10.1387/gogoa.17916; Pennebaker JW, 2007, LINGUISTIC INQUIRY W; Perc M, 2012, J R SOC INTERFACE, V9, P3323, DOI 10.1098/rsif.2012.0491; Petersen AM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00943; Pinker S, 2008, P NATL ACAD SCI USA, V105, P833, DOI 10.1073/pnas.0707192105; Pinker S, 2010, P NATL ACAD SCI USA, V107, P8993, DOI 10.1073/pnas.0914630107; PORTER MF, 1980, PROGRAM-AUTOM LIBR, V14, P130, DOI 10.1108/eb046814; Powell A, 2009, SCIENCE, V324, P1298, DOI 10.1126/science.1170165; Preis T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00350; Quoidbach J, 2013, SCIENCE, V339, P96, DOI 10.1126/science.1229294; ROMER C, 1986, J POLIT ECON, V94, P1, DOI 10.1086/261361; Saavedra S, 2011, P NATL ACAD SCI USA, V108, P5296, DOI 10.1073/pnas.1018462108; Stewart MJ, 2009, J POVERTY, V13, P173, DOI 10.1080/10875540902841762; Stewart N, 2006, COGNITIVE PSYCHOL, V53, P1, DOI 10.1016/j.cogpsych.2005.10.003; Strapparava C, 2004, P 4 INT C LANG RES E, P1413; Strapparava C, 2008, APPLIED COMPUTING 2008, VOLS 1-3, P1556; Sullivan D, 2009, Q J ECON, V124, P1265, DOI 10.1162/qjec.2009.124.3.1265; Sumner WG, 1959, STUDY SOCIOLOGICAL I; Turchin P., 2009, SECULAR CYCLES; Twenge JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040181; van Lenthe FJ, 2005, J EPIDEMIOL COMMUN H, V59, P231, DOI 10.1136/jech.2004.022574; Wolf M, 2008, DIAGNOSTICA, V54, P85, DOI 10.1026/0012-1924.54.2.85; Woolley AW, 2010, SCIENCE, V330, P686, DOI 10.1126/science.1193147	73	35	36	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83147	10.1371/journal.pone.0083147	http://dx.doi.org/10.1371/journal.pone.0083147			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291WL	24416159	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000329862500032
J	Craddock, TJA; Fritsch, P; Rice, MA; del Rosario, RM; Miller, DB; Fletcher, MA; Klimas, NG; Broderick, G				Craddock, Travis J. A.; Fritsch, Paul; Rice, Mark A., Jr.; del Rosario, Ryan M.; Miller, Diane B.; Fletcher, Mary Ann; Klimas, Nancy G.; Broderick, Gordon			A Role for Homeostatic Drive in the Perpetuation of Complex Chronic Illness: Gulf War Illness and Chronic Fatigue Syndrome	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; REGULATORY NETWORKS; IMMUNE-SYSTEM; HPA AXIS; GLUCOCORTICOID-RECEPTOR; GONADAL AXIS; PRIMARY-CARE; T-CELLS; STRESS	A key component in the body's stress response, the hypothalamic-pituitary-adrenal (HPA) axis orchestrates changes across a broad range of major biological systems. Its dysfunction has been associated with numerous chronic diseases including Gulf War Illness (GWI) and chronic fatigue syndrome (CFS). Though tightly coupled with other components of endocrine and immune function, few models of HPA function account for these interactions. Here we extend conventional models of HPA function by including feed-forward and feedback interaction with sex hormone regulation and immune response. We use this multi-axis model to explore the role of homeostatic regulation in perpetuating chronic conditions, specifically GWI and CFS. An important obstacle in building these models across regulatory systems remains the scarcity of detailed human in vivo kinetic data as its collection can present significant health risks to subjects. We circumvented this using a discrete logic representation based solely on literature of physiological and biochemical connectivity to provide a qualitative description of system behavior. This connectivity model linked molecular variables across the HPA axis, hypothalamic-pituitary-gonadal (HPG) axis in men and women, as well as a simple immune network. Inclusion of these interactions produced multiple alternate homeostatic states and sexually dimorphic responses. Experimental data for endocrine-immune markers measured in male GWI subjects showed the greatest alignment with predictions of a naturally occurring alternate steady state presenting with hypercortisolism, low testosterone and a shift towards a Th1 immune response. In female CFS subjects, expression of these markers aligned with an alternate homeostatic state displaying hypocortisolism, high estradiol, and a shift towards an anti-inflammatory Th2 activation. These results support a role for homeostatic drive in perpetuating dysfunctional cortisol levels through persistent interaction with the immune system and HPG axis. Though coarse, these models may nonetheless support the design of robust treatments that might exploit these regulatory regimes.	[Craddock, Travis J. A.; Broderick, Gordon] Nova SE Univ, Ctr Psychol Studies, Ft Lauderdale, FL 33314 USA; [Craddock, Travis J. A.] Nova SE Univ, Grad Sch Comp & Informat Sci, Ft Lauderdale, FL 33314 USA; [Craddock, Travis J. A.; Rice, Mark A., Jr.; del Rosario, Ryan M.; Klimas, Nancy G.; Broderick, Gordon] Nova SE Univ, Inst Neuroimmune Med, Ft Lauderdale, FL 33314 USA; [Fritsch, Paul; Broderick, Gordon] Univ Alberta, Dept Med, Fac Dent & Med, Edmonton, AB, Canada; [Miller, Diane B.] NIOSH, Ctr Dis Control & Prevent, Morgantown, WV USA; [Fletcher, Mary Ann] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA; [Klimas, Nancy G.] Nova SE Univ, Coll Osteopath Med, Ft Lauderdale, FL 33314 USA; [Broderick, Gordon] Nova SE Univ, Coll Pharm, Ft Lauderdale, FL 33314 USA	Nova Southeastern University; Nova Southeastern University; Nova Southeastern University; University of Alberta; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); University of Miami; Nova Southeastern University; Nova Southeastern University	Craddock, TJA (corresponding author), Nova SE Univ, Ctr Psychol Studies, Ft Lauderdale, FL 33314 USA.	tcraddock@nova.edu		Craddock, Travis/0000-0001-7244-6317	US Department of Defense Congressionally Directed Medical Research Program (CDMRP) [GW093042, GW080152]; National Institutes of Health [RES0008852]	US Department of Defense Congressionally Directed Medical Research Program (CDMRP); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding came from the US Department of Defense Congressionally Directed Medical Research Program (CDMRP) awards (http://cdmrp.army.mil/) GW093042 (Broderick - PI) and GW080152 (Klimas - PI) as well as the National Institutes of Health (NIH)(http://www.nih.gov/) R01 award RES0008852 (Klimas - PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gonzalez DA, 2010, IMMUNOL LETT, V133, P6, DOI 10.1016/j.imlet.2010.07.001; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Aschbacher K, 2012, BRAIN BEHAV IMMUN, V26, P1047, DOI 10.1016/j.bbi.2012.06.002; Aspler AL, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-44; Beacher FDCC, 2009, NEUROIMAGE, V47, P937, DOI 10.1016/j.neuroimage.2009.05.038; Ben-Zvi A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000273; Berczi I, 2003, NEUROIMMUNE BIOL, V3, P495; Boneva RS, 2011, J WOMENS HEALTH, V20, P21, DOI 10.1089/jwh.2009.1900; Brenu EW, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-81; Broderick G, 2006, PHARMACOGENOMICS, V7, P407, DOI 10.2217/14622416.7.3.407; Broderick G, 2012, METHODS MOL BIOL; Broderick G, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-191; Broderick G, 2011, BRAIN BEHAV IMMUN, V25, P302, DOI 10.1016/j.bbi.2010.10.011; Broderick G, 2010, BRAIN BEHAV IMMUN, V24, P1209, DOI 10.1016/j.bbi.2010.04.012; BROWN MB, 1975, BIOMETRICS, V31, P987, DOI 10.2307/2529826; Bush KA, 2012, CELL IMMUNOL, V275, P80, DOI 10.1016/j.cellimm.2012.02.014; Chrousos GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3143pe36; Cleare AJ, 2003, ENDOCR REV, V24, P236, DOI 10.1210/er.2002-0014; Collins JF, 2002, CONTROL CLIN TRIALS, V23, P333, DOI 10.1016/S0197-2456(02)00192-7; Crofford LJ, 2004, BRAIN BEHAV IMMUN, V18, P314, DOI 10.1016/j.bbi.2003.12.011; Cutolo M, 2004, ENCY ENDOCRINE DIS, V2, P755; Dallman MF, 2002, HORMONES BRAIN BEHAV, P571; Doyle P, 2006, PHILOS T R SOC B, V361, P571, DOI 10.1098/rstb.2006.1817; Elenkov IJ, 2004, ANN NY ACAD SCI, V1024, P138, DOI 10.1196/annals.1321.010; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Evengard B, 2005, PSYCHOL MED, V35, P1317, DOI 10.1017/S0033291705005052; Fletcher MA, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-76; Folcik VA, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-1; Foster SC, 2003, J NEUROIMMUNOL, V140, P78, DOI 10.1016/S0165-5728(03)00177-2; Frankenstein Z, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-32; Fuite J, 2008, GENOMICS, V92, P393, DOI 10.1016/j.ygeno.2008.08.008; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Fukuda K, 1998, JAMA-J AM MED ASSOC, V280, P981, DOI 10.1001/jama.280.11.981; Gagliardi L, 2010, MOL CELL ENDOCRINOL, V316, P24, DOI 10.1016/j.mce.2009.07.015; Gallagher AM, 2004, J ROY SOC MED, V97, P571, DOI 10.1258/jrsm.97.12.571; Gangestad SW, 2012, BIOL REV, V87, P856, DOI 10.1111/j.1469-185X.2012.00226.x; Gerritsen L, 2011, BIOL PSYCHIAT, V70, P373, DOI 10.1016/j.biopsych.2011.01.029; Gil-Bea FJ, 2010, J ALZHEIMERS DIS, V22, P829, DOI 10.3233/JAD-2010-100663; Golier JA, 2006, PSYCHONEUROENDOCRINO, V31, P1181, DOI 10.1016/j.psyneuen.2006.08.005; Golier JA, 2007, BIOL PSYCHIAT, V62, P1175, DOI 10.1016/j.biopsych.2007.04.027; Golier JA, 2009, PSYCHONEUROENDOCRINO, V34, P1338, DOI 10.1016/j.psyneuen.2009.04.004; Groeneweg FL, 2011, J ENDOCRINOL, V209, P153, DOI 10.1530/JOE-10-0472; Gupta S, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-8; Hernando H, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r3; Hiller-Sturmhofel S, 1998, ALCOHOL HEALTH RES W, V22, P153; Jason LA, 1999, ARCH INTERN MED, V159, P2129, DOI 10.1001/archinte.159.18.2129; Jerjes WK, 2006, J PSYCHOSOM RES, V60, P145, DOI 10.1016/j.jpsychores.2005.07.008; Kawashima K, 2003, LIFE SCI, V74, P675, DOI 10.1016/j.lfs.2003.09.037; KELLERWOOD ME, 1984, ENDOCR REV, V5, P1, DOI 10.1210/edrv-5-1-1; Kin NW, 2006, J LEUKOCYTE BIOL, V79, P1093, DOI 10.1189/jlb.1105625; Lelu K, 2011, J IMMUNOL, V187, P2386, DOI 10.4049/jimmunol.1101578; Liberman AC, 2009, FASEB J, V23, P1558, DOI 10.1096/fj.08-121236; Lindal E, 2002, NORD J PSYCHIAT, V56, P273, DOI 10.1080/08039480260242769; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Mehta D, 2012, NEUROPHARMACOLOGY, V62, P654, DOI 10.1016/j.neuropharm.2011.03.009; Mendoza L, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-13; Mikics E, 2004, PSYCHONEUROENDOCRINO, V29, P618, DOI 10.1016/S0306-4530(03)00090-8; Nacul LC, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-91; Nakamura T, 2010, CLIN VACCINE IMMUNOL, V17, P582, DOI 10.1128/CVI.00379-09; Natelson BH, 2005, CLIN DIAGN LAB IMMUN, V12, P52, DOI 10.1128/CDLI.12.1.52-55.2005; Papadopoulos AS, 2012, NAT REV ENDOCRINOL, V8, P22, DOI 10.1038/nrendo.2011.153; Pariante CM, 2008, TRENDS NEUROSCI, V31, P464, DOI 10.1016/j.tins.2008.06.006; Pinon R, 2001, BIOL HUMAN REPROD; Queen KJ, 2013, INT J CANCER, V132, P2076, DOI 10.1002/ijc.27893; Rankin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030978; Reeves WC, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-25; Reyes M, 2003, ARCH INTERN MED, V163, P1530, DOI 10.1001/archinte.163.13.1530; RIVIER C, 1991, BIOL REPROD, V45, P523, DOI 10.1095/biolreprod45.4.523; Schacterle RS, 2004, ARCH INTERN MED, V164, P401, DOI 10.1001/archinte.164.4.401; Silverman MN, 2005, VIRAL IMMUNOL, V18, P41, DOI 10.1089/vim.2005.18.41; Skowera A, 2004, J CLIN IMMUNOL, V24, P66, DOI 10.1023/B:JOCI.0000018065.64685.82; Tarin JJ, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-53; THOMAS R, 1995, B MATH BIOL, V57, P247, DOI 10.1007/BF02460618; THOMAS R, 1991, J THEOR BIOL, V153, P1, DOI 10.1016/S0022-5193(05)80350-9; Tilbrook AJ, 2000, REV REPROD, V5, P105, DOI 10.1530/ror.0.0050105; Torpy DJ, 2007, CLIN ENDOCRINOL, V67, P161, DOI 10.1111/j.1365-2265.2007.02890.x; Torpy DJ, 1996, BAILLIERE CLIN RHEUM, V10, P181; Van Den Eede F, 2007, NEUROPSYCHOBIOLOGY, V55, P112, DOI 10.1159/000104468; Vernon SD, 2006, PHARMACOGENOMICS, V7, P345, DOI 10.2217/14622416.7.3.345; Viau V, 2002, J NEUROENDOCRINOL, V14, P506, DOI 10.1046/j.1365-2826.2002.00798.x; Vinther F, 2011, J MATH BIOL, V63, P663, DOI 10.1007/s00285-010-0384-2; Walker JJ, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001341; Walker JJ, 2010, P ROY SOC B-BIOL SCI, V277, P1627, DOI 10.1098/rspb.2009.2148; Watanobe H, 2003, ENDOCRINOLOGY, V144, P4868, DOI 10.1210/en.2003-0644; Wheway J, 2005, J EXP MED, V202, P1527, DOI 10.1084/jem.20051971; Whistler T, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-12; Wolfram M, 2011, PSYCHONEUROENDOCRINO, V36, P905, DOI 10.1016/j.psyneuen.2010.12.006; Yehuda R, 2009, STRESS CONSEQUENCES, P125; Young E.A., 2007, SEX DIFFERENCES BRAI, P95; Young EA, 2009, UNDERSTANDING DEPRES, P193; Zen M, 2011, AUTOIMMUN REV, V10, P305, DOI 10.1016/j.autrev.2010.11.009	91	48	49	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84839	10.1371/journal.pone.0084839	http://dx.doi.org/10.1371/journal.pone.0084839			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416298	gold, Green Published, Green Submitted			2022-12-27	WOS:000329862500178
J	Finch, C; Al-Damluji, MS; Krause, PJ; Niccolai, L; Steeves, T; O'Keefe, CF; Diuk-Wasser, MA				Finch, Casey; Al-Damluji, Mohammed Salim; Krause, Peter J.; Niccolai, Linda; Steeves, Tanner; O'Keefe, Corrine Folsom; Diuk-Wasser, Maria A.			Integrated Assessment of Behavioral and Environmental Risk Factors for Lyme Disease Infection on Block Island, Rhode Island	PLOS ONE			English	Article							AMBLYOMMA-AMERICANUM ACARI; IXODES-DAMMINI ACARI; TICK-BORNE DISEASES; BORRELIA-BURGDORFERI; ERYTHEMA MIGRANS; IXODIDAE NYMPHS; UNITED-STATES; FOREST FRAGMENTATION; MODEL SELECTION; LEAF-LITTER	Peridomestic exposure to Borrelia burgdorferi-infected Ixodes scapularis nymphs is considered the dominant means of infection with black-legged tick-borne pathogens in the eastern United States. Population level studies have detected a positive association between the density of infected nymphs and Lyme disease incidence. At a finer spatial scale within endemic communities, studies have focused on individual level risk behaviors, without accounting for differences in peridomestic nymphal density. This study simultaneously assessed the influence of peridomestic tick exposure risk and human behavior risk factors for Lyme disease infection on Block Island, Rhode Island. Tick exposure risk on Block Island properties was estimated using remotely sensed landscape metrics that strongly correlated with tick density at the individual property level. Behavioral risk factors and Lyme disease serology were assessed using a longitudinal serosurvey study. Significant factors associated with Lyme disease positive serology included one or more self-reported previous Lyme disease episodes, wearing protective clothing during outdoor activities, the average number of hours spent daily in tick habitat, the subject's age and the density of shrub edges on the subject's property. The best fit multivariate model included previous Lyme diagnoses and age. The strength of this association with previous Lyme disease suggests that the same sector of the population tends to be repeatedly infected. The second best multivariate model included a combination of environmental and behavioral factors, namely hours spent in vegetation, subject's age, shrub edge density (increase risk) and wearing protective clothing (decrease risk). Our findings highlight the importance of concurrent evaluation of both environmental and behavioral factors to design interventions to reduce the risk of tick-borne infections.	[Finch, Casey; Al-Damluji, Mohammed Salim; Krause, Peter J.; Niccolai, Linda; Steeves, Tanner; O'Keefe, Corrine Folsom; Diuk-Wasser, Maria A.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA; [Al-Damluji, Mohammed Salim] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [O'Keefe, Corrine Folsom] Audubon Connecticut, Southbury, CT USA	Yale University; Yale University	Diuk-Wasser, MA (corresponding author), Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA.	maria.diuk@yale.edu			Environmental Protection Agency [EPA 835120]; National Institutes of Health [NIH 1RO3AI076856-01, NIH RO1AI042402-01]; Gordon and Llaura Gund Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042402, R03AI076856] Funding Source: NIH RePORTER	Environmental Protection Agency(United States Environmental Protection Agency); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gordon and Llaura Gund Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by the Environmental Protection Agency grant EPA 835120 (MAD), the National Institutes of Health grant NIH 1RO3AI076856-01 (MAD), The National Institutes of Health grant NIH RO1AI042402-01 (PJK), and the Gordon and Llaura Gund Foundation (PJK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AgueroRosenfeld ME, 1996, J CLIN MICROBIOL, V34, P1; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allan BF, 2003, CONSERV BIOL, V17, P267, DOI 10.1046/j.1523-1739.2003.01260.x; Bacon Rendi Murphree, 2008, Morbidity and Mortality Weekly Report, V57, P1; Beyer HL, 2011, GEOSPATIAL MODELLING; Branda JA, 2011, CLIN INFECT DIS, V53, P541, DOI 10.1093/cid/cir464; Brei B, 2009, VECTOR-BORNE ZOONOT, V9, P423, DOI 10.1089/vbz.2008.0150; Brownstein JS, 2005, OECOLOGIA, V146, P469, DOI 10.1007/s00442-005-0251-9; Centers for Disease Control and Prevention (CDC), 1995, MMWR MORB MORTAL WKL, V44, P590; Cliff A, 1973, SPATIAL AUTOCORRELAT; Cliff A. D., 1981, SPATIAL PROCESSES MO; Connally NP, 2006, J VECTOR ECOL, V31, P364, DOI 10.3376/1081-1710(2006)31[364:APEFAP]2.0.CO;2; Connally NP, 2009, AM J PREV MED, V37, P201, DOI 10.1016/j.amepre.2009.04.026; CURRAN KL, 1993, J MED ENTOMOL, V30, P107, DOI 10.1093/jmedent/30.1.107; Daltroy LH, 2007, HEALTH EDUC BEHAV, V34, P531, DOI 10.1177/1090198106294646; Daniels TJ, 2000, J MED ENTOMOL, V37, P357, DOI 10.1603/0022-2585(2000)037[0357:EPSADS]2.0.CO;2; DANIELS TJ, 1991, J MED ENTOMOL, V28, P537, DOI 10.1093/jmedent/28.4.537; Dister SW, 1997, AM J TROP MED HYG, V57, P687, DOI 10.4269/ajtmh.1997.57.687; Diuk-Wasser MA, 2012, AM J TROP MED HYG, V86, P320, DOI 10.4269/ajtmh.2012.11-0395; Durden LA., 1996, NYMPHS GENUS IXODES; Eisen RJ, 2006, AM J TROP MED HYG, V75, P669, DOI 10.4269/ajtmh.2006.75.669; Enser R, 2000, ECOLOGY BLOCK ISLAND, P183; FALCO RC, 1989, AM J PUBLIC HEALTH, V79, P12, DOI 10.2105/AJPH.79.1.12; FALCO RC, 1988, AM J EPIDEMIOL, V127, P826, DOI 10.1093/oxfordjournals.aje.a114865; Falco RC, 1999, AM J EPIDEMIOL, V149, P771, DOI 10.1093/oxfordjournals.aje.a009886; Gatewood AG, 2009, APPL ENVIRON MICROB, V75, P2476, DOI 10.1128/AEM.02633-08; Gould LH, 2008, VECTOR-BORNE ZOONOT, V8, P769, DOI 10.1089/vbz.2007.0221; HAMMERSBERGGREN S, 1994, J CLIN MICROBIOL, V32, P1519, DOI 10.1128/JCM.32.6.1519-1525.1994; Hayes EB, 2003, NEW ENGL J MED, V348, P2424, DOI 10.1056/NEJMra021397; HOSMER DW, 1989, APPL LOGISTIC REGRES; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Jackson LE, 2006, COMMUNITY ECOL, V7, P189, DOI 10.1556/ComEc.7.2006.2.6; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kitron U, 1997, AM J EPIDEMIOL, V145, P558, DOI 10.1093/oxfordjournals.aje.a009145; Klein JD, 1996, CLIN PEDIATR, V35, P359, DOI 10.1177/000992289603500705; Krause PJ, 2006, AM J TROP MED HYG, V75, P1090, DOI 10.4269/ajtmh.2006.75.1090; Krause PJ, 2003, AM J TROP MED HYG, V68, P431, DOI 10.4269/ajtmh.2003.68.431; Lillesand T., 1987, REMOTE SENSING IMAGE; McGarigal K., 2002, FRAGSTATS SPATIAL PA; Meek J I, 1996, J Public Health Manag Pract, V2, P61; Nigrovic LE, 2007, EPIDEMIOL INFECT, V135, P1, DOI 10.1017/S0950268806007096; Ostfeld R, 2000, CAN J ZOOL, V78, P2061, DOI 10.1139/cjz-78-12-2061; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Piesman J, 2008, ANNU REV ENTOMOL, V53, P323, DOI 10.1146/annurev.ento.53.103106.093429; Piesman J, 2012, J ENVIRON HEALTH, V74, P30; Rosenzweig C, 2000, ECOLOGY BLOCK ISLAND, P183; Schulze TL, 1997, J MED ENTOMOL, V34, P615, DOI 10.1093/jmedent/34.6.615; SCHULZE TL, 1995, J MED ENTOMOL, V32, P730, DOI 10.1093/jmedent/32.5.730; Schulze TL, 2001, J MED ENTOMOL, V38, P344, DOI 10.1603/0022-2585-38.2.344; Skogman BH, 2010, ARCH DIS CHILD, V95, P1013, DOI 10.1136/adc.2010.183624; STAFFORD KC, 1991, J MED ENTOMOL, V28, P32, DOI 10.1093/jmedent/28.1.32; Stafford KC, 1998, J CLIN MICROBIOL, V36, P1240, DOI 10.1128/JCM.36.5.1240-1244.1998; Stafford KC., 2004, TICK MANAGEMENT HDB; Talleklint-Eisen L, 2000, J MED ENTOMOL, V37, P484, DOI 10.1603/0022-2585(2000)037[0484:EODSFE]2.0.CO;2; Tsao JI, 2004, P NATL ACAD SCI USA, V101, P18159, DOI 10.1073/pnas.0405763102; Updike T., 2010, RADIOMETRIC USE WORL; Vazquez M, 2008, EMERG INFECT DIS, V14, P210, DOI 10.3201/eid1402.070725; Voordouw MJ, 2013, VECTOR-BORNE ZOONOT, V13, P203, DOI 10.1089/vbz.2012.1003; Young JD, 1998, NEW ENGL J MED, V338, P1629, DOI 10.1056/NEJM199805283382216	60	63	63	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84758	10.1371/journal.pone.0084758	http://dx.doi.org/10.1371/journal.pone.0084758			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416278	Green Submitted, gold, Green Published			2022-12-27	WOS:000329862500161
J	Hao, PP; Liu, YP; Yang, CY; Liang, T; Zhang, C; Song, J; Han, JK; Hou, GH				Hao, Pan-Pan; Liu, Yan-Ping; Yang, Chang-Ya; Liang, Ting; Zhang, Chao; Song, Jing; Han, Jian-Kui; Hou, Gui-Hua			Evaluation of I-131-Anti-Angiotensin II Type 1 Receptor Monoclonal Antibody as a Reporter for Hepatocellular Carcinoma	PLOS ONE			English	Article							5-LIPOXYGENASE ACTIVATING PROTEIN; ANXIETY-LIKE BEHAVIOR; ENDOCANNABINOID SYSTEM; CANNABINOID RECEPTOR; MICE; INHIBITOR; MK-886; MAZE	Background: Finding a specific agent is useful for early detection of tumor. Angiotensin II type 1 receptor (AT(1)R) was reported to be elevated in a variety of tumors and participate in tumor progression. The aim of our study was to evaluate whether I-131-anti-AT(1)R monoclonal antibody (mAb) is an efficient imaging reporter for the detection of hepatocellular carcinoma. Methodology/Principal Findings: AT(1)R mAb or isotype IgG was radioiodinated with I-131 and the radiochemical purity and stability of the two imaging agents and the affinity of I-131-anti-AT(1)R mAb against AT(1)R were measured. 3.7 MBq I-131-anti-AT(1)R mAb or isotype I-131-IgG was intravenously injected to mice with hepatocellular carcinoma through tail vein, and then the whole-body autoradiography and biodistribution of the two imaging agents and the pharmacokinetics of I-131-anti-AT(1)R mAb were studied. I-131-anti-AT(1)R mAb and I-131-IgG were successfully radioiodinated and both maintained more stable in serum than in saline. The I-131-anti-AT(1)R mAb group showed much clearer whole-body images for observing hepatocellular carcinoma than the I-131-IgG group. The biodistributions of the two imaging agents suggested that hepatocellular carcinoma tissue uptook more I-131-anti-AT(1)R mAb than other tissues (%ID/g = 1.82 +/- 0.40 and T/NT ratio = 7.67 +/- 0.64 at 48 h), whereas hepatocellular carcinoma tissue did not selectively uptake I-131-IgG (%ID/g = 0.42 +/- 0.06 and T/NT ratio = 1.33 +/- 0.08 at 48 h). The pharmacokinetics of I-131-anti-AT(1)R mAb was in accordance with the two-compartment model, with a rapid distribution phase and a slow decline phase. These results were further verified by real-time RT-PCR, immunohistochemistry staining and Western blot. Conclusions/Significance: I-131-anti-AT(1)R mAb may be a potential target for early detection of tumor.	[Hao, Pan-Pan; Liu, Yan-Ping; Yang, Chang-Ya; Liang, Ting; Zhang, Chao; Song, Jing; Hou, Gui-Hua] Shandong Univ, Key Lab Expt Teratol, Minist Educ, Jinan 250100, Peoples R China; [Hao, Pan-Pan; Liu, Yan-Ping; Yang, Chang-Ya; Liang, Ting; Zhang, Chao; Song, Jing; Hou, Gui-Hua] Shandong Univ, Inst Expt Nucl Med, Sch Med, Jinan 250100, Peoples R China; [Hao, Pan-Pan] Shandong Univ, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250100, Peoples R China; [Hao, Pan-Pan] Shandong Univ, Chinese Minist Hlth, Qilu Hosp, Jinan 250100, Peoples R China; [Han, Jian-Kui] Shandong Univ, Qilu Hosp, Dept Nucl Med, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University; Shandong University	Hou, GH (corresponding author), Shandong Univ, Key Lab Expt Teratol, Minist Educ, Jinan 250100, Peoples R China.	ghhou1@hotmail.com	liu, yan/HCI-5542-2022; liu, yan/HGV-1365-2022		National Natural Science Foundation of China [81071172]; Natural Science Foundation of Shandong Province [ZR2010CM025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This work was supported by grants from the National Natural Science Foundation of China (81071172, JK Han) and the Natural Science Foundation of Shandong Province (ZR2010CM025, GH Hou). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biserni A, 2008, MOL PHARMACOL, V73, P1434, DOI 10.1124/mol.107.042689; CRUZ APM, 1994, PHARMACOL BIOCHEM BE, V49, P171, DOI 10.1016/0091-3057(94)90472-3; Joshi YB, 2013, J PSYCHIATR RES, V47, P694, DOI 10.1016/j.jpsychires.2012.12.011; Joshi YB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029448; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Lourenco J, 2011, J NEUROSCI, V31, P3243, DOI 10.1523/JNEUROSCI.3512-10.2011; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Naidu PS, 2007, PSYCHOPHARMACOLOGY, V192, P61, DOI 10.1007/s00213-006-0689-4; Pamplona FA, 2012, P NATL ACAD SCI USA, V109, P21134, DOI 10.1073/pnas.1202906109; Patel S, 2006, J PHARMACOL EXP THER, V318, P304, DOI 10.1124/jpet.106.101287; Piomelli D, 2000, TRENDS PHARMACOL SCI, V21, P218, DOI 10.1016/S0165-6147(00)01482-6; Ruehle S, 2012, J PSYCHOPHARMACOL, V26, P23, DOI 10.1177/0269881111408958; Shryock N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061882; Singh VP, 2005, PHARMACOL BIOCHEM BE, V81, P433, DOI 10.1016/j.pbb.2005.03.015; Takahashi RN, 2005, NEUROSCI LETT, V380, P270, DOI 10.1016/j.neulet.2005.01.049; Uz T, 2002, RESTOR NEUROL NEUROS, V20, P15; Uz T, 2008, NEUROSCI LETT, V436, P269, DOI 10.1016/j.neulet.2008.03.041; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578	18	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85002	10.1371/journal.pone.0085002	http://dx.doi.org/10.1371/journal.pone.0085002			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416333	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500205
J	Hoffmann, D; Mussolin, C; Martin, R; Schiltz, C				Hoffmann, Danielle; Mussolin, Christophe; Martin, Romain; Schiltz, Christine			The Impact of Mathematical Proficiency on the Number-Space Association	PLOS ONE			English	Article							WORKING-MEMORY; INDIVIDUAL-DIFFERENCES; DEVELOPMENTAL DYSCALCULIA; MENTAL REPRESENTATION; NUMERICAL ESTIMATION; ARITHMETIC FACTS; FUNCTIONAL LOCUS; ANGULAR GYRUS; MATH ANXIETY; SNARC	A specific instance of the association between numerical and spatial representations is the SNARC (Spatial Numerical Association of Response Codes) effect. The SNARC effect describes the finding that during binary classification of numbers participants are faster to respond to small/large numbers with the left/right hand respectively. Even though it has been frequently replicated, important inter-individual variability has also been reported. Mathematical proficiency is an obvious candidate source for inter-individual variability in numerical judgments, but studies investigating its influence on the SNARC effect remain scarce. The present experiment included a total of 95 University students, divided into three groups differing significantly in their mathematical proficiency levels. Using group analyses, it appeared that the three groups differed significantly in the strength of their number-space associations in a parity judgment task. This result was further confirmed on an individual level, with higher levels in arithmetic leading to relatively weaker SNARC effects. To explain this negative relationship we propose accounts based on differences in access to qualitatively different numerical representations and also consider more domain general factors, with a focus on inhibition capacities.	[Hoffmann, Danielle; Martin, Romain; Schiltz, Christine] Univ Luxembourg, Walferdange, Luxembourg; [Mussolin, Christophe] Univ Libre Bruxelles, Brussels, Belgium	University of Luxembourg; Universite Libre de Bruxelles	Hoffmann, D (corresponding author), Univ Luxembourg, Walferdange, Luxembourg.	danielle.hoffmann@uni.lu	Hoffmann, Danielle/J-7197-2019	Hoffmann, Danielle/0000-0001-7039-5587; Schiltz, Christine/0000-0002-1055-3878	University of Luxembourg [F3R-EMA-PUL-09NSP2]; National Research Fund, Luxembourg [AFR PHD-09-160]	University of Luxembourg; National Research Fund, Luxembourg(Luxembourg National Research Fund)	This work was funded by the University of Luxembourg (F3R-EMA-PUL-09NSP2; www.uni.lu) and the National Research Fund (AFR PHD-09-160; www.fnr.lu), Luxembourg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JR, 1999, J EXP PSYCHOL GEN, V128, P186, DOI 10.1037/0096-3445.128.2.186; ASHCRAFT MH, 1994, COGNITION EMOTION, V8, P97, DOI 10.1080/02699939408408931; Ashcraft MH, 2002, CURR DIR PSYCHOL SCI, V11, P181, DOI 10.1111/1467-8721.00196; Ashcraft MH, 2001, J EXP PSYCHOL GEN, V130, P224, DOI 10.1037/0096-3445.130.2.224; Ashkenazi S, 2010, NEUROPSYCHOLOGIA, V48, P2861, DOI 10.1016/j.neuropsychologia.2010.05.028; Bachot J., 2005, PSYCHOL SCI, V47, P172, DOI DOI 10.1016/0010-0277(92)90049-N; Bonato M, 2007, J EXP PSYCHOL HUMAN, V33, P1410, DOI 10.1037/0096-1523.33.6.1410; Bonato M, 2009, J COGNITIVE NEUROSCI, V21, P745, DOI 10.1162/jocn.2009.21054; Booth JL, 2006, DEV PSYCHOL, V42, P189, DOI 10.1037/0012-1649.41.6.189; Booth JL, 2008, CHILD DEV, V79, P1016, DOI 10.1111/j.1467-8624.2008.01173.x; Bull R, 2013, J EXP PSYCHOL GEN, V142, P181, DOI 10.1037/a0028387; Butterworth B., 2005, HDB MATH COGNITION, V1st, P455; Casarotti M, 2007, COGNITION, V102, P101, DOI 10.1016/j.cognition.2006.09.001; Castronovo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033832; Censabella S, 2004, CAH PSYCHOL COGN, V22, P635; Chen Q, 2010, COGNITIVE PSYCHOL, V60, P218, DOI 10.1016/j.cogpsych.2010.01.001; Cipora K, 2013, Q J EXP PSYCHOL, V66, P1974, DOI 10.1080/17470218.2013.772215; Cutini S, 2014, CEREB CORTEX, V24, P444, DOI 10.1093/cercor/bhs321; de Hevia MD, 2008, NEUROSCI BIOBEHAV R, V32, P1361, DOI 10.1016/j.neubiorev.2008.05.015; De Smedt B, 2011, J EXP CHILD PSYCHOL, V108, P278, DOI 10.1016/j.jecp.2010.09.003; De Smedt B, 2009, J EXP CHILD PSYCHOL, V103, P469, DOI 10.1016/j.jecp.2009.01.010; De Visscher A, 2013, CORTEX, V49, P50, DOI 10.1016/j.cortex.2012.01.003; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; DEHAENE S, 1990, J EXP PSYCHOL HUMAN, V16, P626, DOI 10.1037/0096-1523.16.3.626; Dehaene S, 1997, NUMBER SENSE MIND CR; Delazer M, 2003, COGNITIVE BRAIN RES, V18, P76, DOI 10.1016/j.cogbrainres.2003.09.005; Della Sala S, 1999, NEUROPSYCHOLOGIA, V37, P1189, DOI 10.1016/S0028-3932(98)00159-6; Della Sala S, 1997, VISUAL PATTERN TEST; DeWind NK, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00068; Di Luca S, 2006, Q J EXP PSYCHOL, V59, P1648, DOI 10.1080/17470210500256839; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Faust M. W., 1996, MATH COGNITION, V2, P25, DOI DOI 10.1080/135467996387534; Fias W., 2005, HDB MATH COGNITION, P43; Fias W., 1996, MATH COGNITION, V2, P95, DOI [DOI 10.1080/135467996387552, 10.1080/135467996387552]; Fias W, 2011, ATTENTION PERFORM, P133, DOI 10.1016/B978-0-12-385948-8.00010-4; Fischer MH, 2008, CORTEX, V44, P386, DOI 10.1016/j.cortex.2007.08.004; Fischer MH, 2003, NAT NEUROSCI, V6, P555, DOI 10.1038/nn1066; FISCHER MH, 2005, PSYCHOL SCI, V47, P22; Fischer U, 2011, PSYCHON B REV, V18, P177, DOI 10.3758/s13423-010-0031-3; Galfano G, 2006, PSYCHON B REV, V13, P869, DOI 10.3758/BF03194011; Galton F., 1880, NATURE, V21, P252, DOI [10.1038/021252a0, DOI 10.1038/021252A0]; Geary DC, 2007, CHILD DEV, V78, P1343, DOI 10.1111/j.1467-8624.2007.01069.x; GEARY DC, 1993, PSYCHOL BULL, V114, P345, DOI 10.1037/0033-2909.114.2.345; Geary DC, 2004, J LEARN DISABIL-US, V37, P4, DOI 10.1177/00222194040370010201; Gevers W, 2006, EXP PSYCHOL, V53, P58, DOI 10.1027/1618-3169.53.1.58; Gevers W, 2006, J EXP PSYCHOL HUMAN, V32, P32, DOI 10.1037/0096-1523.32.1.32; Gevers W, 2005, EUR J COGN PSYCHOL, V17, P659, DOI 10.1080/09541440540000112; Gevers W, 2010, J EXP PSYCHOL GEN, V139, P180, DOI 10.1037/a0017688; Gilmore CK, 2010, COGNITION, V115, P394, DOI 10.1016/j.cognition.2010.02.002; Gobel SM, 2011, J CROSS CULT PSYCHOL, V42, P543, DOI 10.1177/0022022111406251; Grabner RH, 2007, NEUROIMAGE, V38, P346, DOI 10.1016/j.neuroimage.2007.07.041; Grabner RH, 2009, HUM BRAIN MAPP, V30, P2936, DOI 10.1002/hbm.20720; Grabner RH, 2009, NEUROPSYCHOLOGIA, V47, P604, DOI 10.1016/j.neuropsychologia.2008.10.013; Gut M, 2012, INT J PSYCHOPHYSIOL, V85, P7, DOI 10.1016/j.ijpsycho.2012.02.007; HASHER L, 1979, J EXP PSYCHOL GEN, V108, P356, DOI 10.1037/0096-3445.108.3.356; Herrera A, 2008, ACTA PSYCHOL, V128, P225, DOI 10.1016/j.actpsy.2008.01.002; Hoffmann D, IMPACT INHI IN PRESS; Hoffmann D, 2013, J EXP CHILD PSYCHOL, V116, P775, DOI 10.1016/j.jecp.2013.07.013; Holloway ID, 2009, J EXP CHILD PSYCHOL, V103, P17, DOI 10.1016/j.jecp.2008.04.001; Hubbard EM, 2005, NAT REV NEUROSCI, V6, P435, DOI 10.1038/nrn1684; Imbo I, 2012, J EXP CHILD PSYCHOL, V111, P671, DOI 10.1016/j.jecp.2011.09.002; Kadosh RC, 2007, TRENDS COGN SCI, V11, P177, DOI 10.1016/j.tics.2007.01.003; Keus IM, 2005, MEM COGNITION, V33, P681, DOI 10.3758/BF03195335; Keus IM, 2005, COGNITIVE BRAIN RES, V24, P48, DOI 10.1016/j.cogbrainres.2004.12.005; Knops A, 2009, SCIENCE, V324, P1583, DOI 10.1126/science.1171599; Koten JW, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00115; Landerl K, 2004, COGNITION, V93, P99, DOI 10.1016/j.cognition.2003.11.004; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; LORCH RF, 1990, J EXP PSYCHOL LEARN, V16, P149, DOI 10.1037/0278-7393.16.1.149; Mazzocco MMM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023749; Mejias S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00518; Mejias S, 2012, CHILD NEUROPSYCHOL, V18, P550, DOI 10.1080/09297049.2011.625355; Mejias S, 2012, LEARN INDIVID DIFFER, V22, P164, DOI 10.1016/j.lindif.2011.09.013; Mussolin C, 2012, TRENDS NEUROSCI EDUC, V1, P21, DOI 10.1016/j.tine.2012.09.003; Mussolin C, 2011, ACTA PSYCHOL, V138, P193, DOI 10.1016/j.actpsy.2011.06.004; Mussolin C, 2010, COGNITION, V115, P10, DOI 10.1016/j.cognition.2009.10.006; Nuerk HC, 2004, Q J EXP PSYCHOL-A, V57, P835, DOI 10.1080/02724980343000512; Nys J, 2013, TRENDS NEUROSCI EDUC, V2, P13, DOI 10.1016/j.tine.2013.01.001; Passolunghi MC, 2004, J EXP CHILD PSYCHOL, V88, P348, DOI 10.1016/j.jecp.2004.04.002; Piazza M, 2013, PSYCHOL SCI, V24, P1037, DOI 10.1177/0956797612464057; Pinhas M, 2012, J EXP PSYCHOL LEARN, V38, P1187, DOI 10.1037/a0027390; Pinhas M, 2012, BEHAV RES METHODS, V44, P788, DOI 10.3758/s13428-011-0172-y; Previtali P, 2010, EXP BRAIN RES, V201, P599, DOI 10.1007/s00221-009-2063-3; Proctor RW, 2006, PSYCHOL BULL, V132, P416, DOI 10.1037/0033-2909.132.3.416; Ren P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023553; RESTLE F, 1970, J EXP PSYCHOL, V83, P274, DOI 10.1037/h0028573; Ristic J, 2006, PSYCHON B REV, V13, P862, DOI 10.3758/BF03194010; Rousselle L, 2007, COGNITION, V102, P361, DOI 10.1016/j.cognition.2006.01.005; Rubinsten O, 2005, NEUROPSYCHOLOGY, V19, P641, DOI 10.1037/0894-4105.19.5.641; Rubinsten O, 2006, J EDUC PSYCHOL, V98, P854, DOI 10.1037/0022-0663.98.4.854; Santens S, 2008, COGNITION, V108, P263, DOI 10.1016/j.cognition.2008.01.002; Schneider M, 2009, J EDUC PSYCHOL, V101, P359, DOI 10.1037/a0013840; Schneider W., 2002, E PRIME USERS GUIDE; Schweiter M., 2005, Z NEUROPSYCHOL, V16, P105, DOI DOI 10.1024/1016-264X.16.2.105; Shaki S, 2009, PSYCHON B REV, V16, P328, DOI 10.3758/PBR.16.2.328; Shalev RS, 2001, J LEARN DISABIL-US, V34, P59, DOI 10.1177/002221940103400105; Siegler RS, 2004, CHILD DEV, V75, P428, DOI 10.1111/j.1467-8624.2004.00684.x; Tschentscher N, 2012, NEUROIMAGE, V59, P3139, DOI 10.1016/j.neuroimage.2011.11.037; Tzelgov J, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00302; van Dijck Jean-Philippe, 2011, Front Hum Neurosci, V5, P182, DOI 10.3389/fnhum.2011.00182; van Dijck JP, 2011, COGNITION, V119, P114, DOI 10.1016/j.cognition.2010.12.013; van Dijck JP, 2009, COGNITION, V113, P248, DOI 10.1016/j.cognition.2009.08.005; Wood G., 2008, PSYCHOL SCI Q, V50, P489; Wood G, 2010, COMMUNICATION; Wood G, 2008, CORTEX, V44, P353, DOI 10.1016/j.cortex.2008.01.002; Wood G, 2006, CORTEX, V42, P1069, DOI 10.1016/S0010-9452(08)70219-3; Wood G, 2006, CORTEX, V42, P1119, DOI 10.1016/S0010-9452(08)70223-5; ZBRODOFF NJ, 1995, MEM COGNITION, V23, P689, DOI 10.3758/BF03200922; Zhang HY, 2011, J HUAZHONG U SCI-MED, V31, P131, DOI 10.1007/s11596-011-0164-2	111	42	43	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85048	10.1371/journal.pone.0085048	http://dx.doi.org/10.1371/journal.pone.0085048			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291WL	24416338	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500208
J	Howbert, JJ; Patterson, EE; Stead, SM; Brinkmann, B; Vasoli, V; Crepeau, D; Vite, CH; Sturges, B; Ruedebusch, V; Mavoori, J; Leyde, K; Sheffield, WD; Litt, B; Worrell, GA				Howbert, J. Jeffry; Patterson, Edward E.; Stead, S. Matt; Brinkmann, Ben; Vasoli, Vincent; Crepeau, Daniel; Vite, Charles H.; Sturges, Beverly; Ruedebusch, Vanessa; Mavoori, Jaideep; Leyde, Kent; Sheffield, W. Douglas; Litt, Brian; Worrell, Gregory A.			Forecasting Seizures in Dogs with Naturally Occurring Epilepsy	PLOS ONE			English	Article							REFRACTORY IDIOPATHIC EPILEPSY; CEREBRAL-BLOOD-FLOW; PREICTAL STATE; ZONISAMIDE THERAPY; CANINE EPILEPSY; EEG; PREDICTION; ONSET; ELECTROENCEPHALOGRAPHY; PERSPECTIVE	Seizure forecasting has the potential to create new therapeutic strategies for epilepsy, such as providing patient warnings and delivering preemptive therapy. Progress on seizure forecasting, however, has been hindered by lack of sufficient data to rigorously evaluate the hypothesis that seizures are preceded by physiological changes, and are not simply random events. We investigated seizure forecasting in three dogs with naturally occurring focal epilepsy implanted with a device recording continuous intracranial EEG (iEEG). The iEEG spectral power in six frequency bands: delta (0.1-4 Hz), theta (4-8 Hz), alpha (8-12 Hz), beta (12-30 Hz), low-gamma (30-70 Hz), and high-gamma (70-180 Hz), were used as features. Logistic regression classifiers were trained to discriminate labeled pre-ictal and inter-ictal data segments using combinations of the band spectral power features. Performance was assessed on separate test data sets via 10-fold cross-validation. A total of 125 spontaneous seizures were detected in continuous iEEG recordings spanning 6.5 to 15 months from 3 dogs. When considering all seizures, the seizure forecasting algorithm performed significantly better than a Poisson-model chance predictor constrained to have the same time in warning for all 3 dogs over a range of total warning times. Seizure clusters were observed in all 3 dogs, and when the effect of seizure clusters was decreased by considering the subset of seizures separated by at least 4 hours, the forecasting performance remained better than chance for a subset of algorithm parameters. These results demonstrate that seizures in canine epilepsy are not randomly occurring events, and highlight the feasibility of long-term seizure forecasting using iEEG monitoring.	[Howbert, J. Jeffry; Ruedebusch, Vanessa; Mavoori, Jaideep; Leyde, Kent; Sheffield, W. Douglas] NeuroVista Corp, Seattle, WA USA; [Patterson, Edward E.] Univ Minnesota, Ctr Vet Med, St Paul, MN 55108 USA; [Stead, S. Matt; Brinkmann, Ben; Vasoli, Vincent; Crepeau, Daniel; Worrell, Gregory A.] Mayo Clin, Mayo Syst Electrophysiol Lab, Rochester, MN 55905 USA; [Vite, Charles H.] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA; [Sturges, Beverly] Univ Calif Davis, Sch Vet, Davis, CA 95616 USA; [Litt, Brian] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA	University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic; University of Pennsylvania; University of California System; University of California Davis; University of Pennsylvania	Worrell, GA (corresponding author), Mayo Clin, Mayo Syst Electrophysiol Lab, Rochester, MN 55905 USA.	Worrell.Gregory@mayo.edu		Brinkmann, Benjamin/0000-0002-2392-8608; Vasoli, Vincent/0000-0001-8004-748X	National Institute of Neurological Disorders and Stroke NIH [U01-NS073557, R01- NS630391, U24-NS063930]; Mayo Clinic; NeuroVista Inc.; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR002512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS073557, U24NS063930] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010939] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Mayo Clinic; NeuroVista Inc.; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	NeuroVista Inc. had a role in study design, analysis, decision to publish, and preparation of the manuscript. The National Institute of Neurological Disorders and Stroke NIH (U01-NS073557, R01- NS630391, U24-NS063930), Mayo Clinic, and NeuroVista Inc. supported this work. No additional external funding received for this study.	Adelson PD, 1999, EPILEPSIA, V40, P1484, DOI 10.1111/j.1528-1157.1999.tb02030.x; ALARCON G, 1995, ELECTROEN CLIN NEURO, V94, P326, DOI 10.1016/0013-4694(94)00286-T; Andrzejak RG, 2009, CLIN NEUROPHYSIOL, V120, P1465, DOI 10.1016/j.clinph.2009.05.019; Andrzejak RG, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.010901; Badawy RA, 2013, ANN NEUROL IN PRESS; Badawy R, 2009, BRAIN, V132, P1013, DOI 10.1093/brain/awp017; Baumgartner C, 1998, J NUCL MED, V39, P978; Berendt M, 1999, J VET INTERN MED, V13, P14, DOI 10.1892/0891-6640(1999)013&lt;0014:EASCID&gt;2.3.CO;2; Berendt M, 1999, ACTA NEUROL SCAND, V99, P276, DOI 10.1111/j.1600-0404.1999.tb00676.x; Chandler K, 2006, VET J, V172, P207, DOI 10.1016/j.tvjl.2005.07.001; Coles L, 2013, EPILEPSY BE IN PRESS; Cook MJ, 2013, LANCET NEUROL, V12, P563, DOI 10.1016/S1474-4422(13)70075-9; Davis KA, 2011, EPILEPSY RES, V96, P116, DOI 10.1016/j.eplepsyres.2011.05.011; Dewey CW, 2004, J AM ANIM HOSP ASSOC, V40, P285, DOI 10.5326/0400285; Dudek FE, 2011, EPILEPSY RES, V97, P324, DOI 10.1016/j.eplepsyres.2011.10.017; Durazzo TS, 2008, NEUROLOGY, V70, P1265, DOI 10.1212/01.wnl.0000308938.84918.3f; Eiger CE, 2013, LANCET NEUROL, V12, P531, DOI 10.1016/S1474-4422(13)70092-9; Engel J, 2007, EPILEPSY COMPREHENSI; Federico P, 2005, BRAIN, V128, P1811, DOI 10.1093/brain/awh533; Fisher RS, 2012, ANN NEUROL, V71, P157, DOI 10.1002/ana.22621; Fisher RS, 2000, EPILEPSY BEHAV, V1, pS9, DOI 10.1006/ebeh.2000.0107; Gardner AB, 2006, J MACH LEARN RES, V7, P1025; Gowers S, 1885, EPILEPSY OTHER CHRON; Haut SR, 2007, NEUROLOGY, V68, P262, DOI 10.1212/01.wnl.0000252352.26421.13; Haut SR, 2006, EPILEPSY BEHAV, V8, P50, DOI 10.1016/j.yebeh.2005.08.018; Haut SR, 2005, NEUROLOGY, V65, P1313, DOI 10.1212/01.wnl.0000180685.84547.7f; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Lee SA, 2000, EPILEPSIA, V41, P297, DOI 10.1111/j.1528-1157.2000.tb00159.x; Linehan J, 2011, TREATMENT EPILEPSY P, P165; Main I, 1999, NATURE DEBATES; Mormann F, 2007, BRAIN, V130, P314, DOI 10.1093/brain/awl241; Morrell MJ, 2011, NEUROLOGY, V77, P1295, DOI 10.1212/WNL.0b013e3182302056; Murray, 1994, GLOBAL COMP ASSESSME; Park Y, 2011, EPILEPSIA, V52, P1761, DOI 10.1111/j.1528-1167.2011.03138.x; Pellegrino FC, 2004, CLIN NEUROPHYSIOL, V115, P477, DOI 10.1016/S1388-2457(03)00347-X; Platt SR, 2006, VET REC, V159, P881; Potschka H, 2013, EPILEPSIA, V54, P571, DOI 10.1111/epi.12138; Schulze-Bonhage A., 2008, SEIZURE PREDICTION E, DOI [10.1002/9783527625192.ch1, DOI 10.1002/9783527625192.CH1]; Schulze-Bonhage A, 2010, EPILEPSY BEHAV, V18, P388, DOI 10.1016/j.yebeh.2010.05.008; Snyder DE, 2008, J NEURAL ENG, V5, P392, DOI 10.1088/1741-2560/5/4/004; Stacey W, 2011, EPILEPSY RES, V97, P243, DOI 10.1016/j.eplepsyres.2011.07.012; Volk HA, 2008, VET J, V176, P310, DOI 10.1016/j.tvjl.2007.03.002; von Klopmann T, 2007, J SMALL ANIM PRACT, V48, P134, DOI 10.1111/j.1748-5827.2006.00290.x; Warren CP, 2010, J NEUROPHYSIOL, V104, P3530, DOI 10.1152/jn.00368.2010; Weinand ME, 1997, J NEUROSURG, V86, P226, DOI 10.3171/jns.1997.86.2.0226; Worrell GA, 2012, PROG NEUROBIOL, V98, P265, DOI 10.1016/j.pneurobio.2012.02.006	46	90	91	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e81920	10.1371/journal.pone.0081920	http://dx.doi.org/10.1371/journal.pone.0081920			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416133	gold, Green Published, Green Submitted			2022-12-27	WOS:000329862500010
J	Sancataldo, G; Vetri, V; Fodera, V; Di Cara, G; Militello, V; Leone, M				Sancataldo, Giuseppe; Vetri, Valeria; Fodera, Vito; Di Cara, Gianluca; Militello, Valeria; Leone, Maurizio			Oxidation Enhances Human Serum Albumin Thermal Stability and Changes the Routes of Amyloid Fibril Formation	PLOS ONE			English	Article							METHIONINE RESIDUES; PROTEIN OXIDATION; AGGREGATION; BOVINE; FLUORESCENCE; OLIGOMERS; ANTIOXIDANTS; POLYMORPHISM; MEMBRANE; REVEALS	Oxidative damages are linked to several aging-related diseases and are among the chemical pathways determining protein degradation. Specifically, interplay of oxidative stress and protein aggregation is recognized to have a link to the loss of cellular function in pathologies like Alzheimer's and Parkinson's diseases. Interaction between protein and reactive oxygen species may indeed induce small changes in protein structure and lead to the inhibition/modification of protein aggregation process, potentially determining the formation of species with different inherent toxicity. Understanding the temperate relationship between these events can be of utmost importance in unraveling the molecular basis of neurodegeneration. In this work, we investigated the effect of hydrogen peroxide oxidation on Human Serum Albumin (HSA) structure, thermal stability and aggregation properties. In the selected conditions, HSA forms fibrillar aggregates, while the oxidized protein undergoes aggregation via new routes involving, in different extents, specific domains of the molecule. Minute variations due to oxidation of single residues affect HSA tertiary structure leading to protein compaction, increased thermal stability, and reduced association propensity.	[Sancataldo, Giuseppe; Vetri, Valeria; Militello, Valeria; Leone, Maurizio] Univ Palermo, Dipartimento Fis & Chim, Palermo, Italy; [Vetri, Valeria; Militello, Valeria; Leone, Maurizio] CNR, IBF Uo, Palermo, Italy; [Fodera, Vito] Univ Copenhagen, Dept Drug Design & Pharmacol, Copenhagen, Denmark; [Fodera, Vito] Univ Cambridge, Cavendish Lab, Dept Phys, Sect Biol & Soft Syst, Cambridge CB3 0HE, England; [Di Cara, Gianluca] Ctr Oncobiol Sperimentale, Palermo, Italy	University of Palermo; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Copenhagen; University of Cambridge	Vetri, V (corresponding author), Univ Palermo, Dipartimento Fis & Chim, Palermo, Italy.	valeria.vetri@unipa.it	Foderà, Vito/F-9029-2010; Fodera, Vito/C-1966-2014; Sancataldo, Giuseppe/AAK-5326-2020; Foderà, Vito/AAZ-9925-2020; Leone, Maurizio/F-2353-2010; Vetri, Valeria/F-2314-2010	Foderà, Vito/0000-0003-2855-0568; Foderà, Vito/0000-0003-2855-0568; Leone, Maurizio/0000-0002-0292-7657; Vetri, Valeria/0000-0002-2307-1165; militello, valeria/0000-0001-8022-8547; DI CARA, Gianluca/0000-0003-3928-7072; sancataldo, giuseppe/0000-0002-8661-5895	FP7 Marie-Curie Actions Intra European Fellowship (IEF) for Career Development [299385]	FP7 Marie-Curie Actions Intra European Fellowship (IEF) for Career Development	V.F. acknowledges support from the FP7 Marie-Curie Actions Intra European Fellowship (IEF) for Career Development 2012-2014, project nr. 299385 "FibCat'' (University of Copenhagen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; Bagatolli L A, 1996, J Fluoresc, V6, P33, DOI 10.1007/BF00726724; Barnham KJ, 2003, J BIOL CHEM, V278, P42959, DOI 10.1074/jbc.M305494200; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Beal MF, 2002, FREE RADICAL BIO MED, V32; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Binger KJ, 2008, BIOCHEMISTRY-US, V47, P10208, DOI 10.1021/bi8009339; Bismuto E, 1996, PROTEIN SCI, V5, P121; Bolognesi B, 2010, ACS CHEM BIOL, V5, P735, DOI 10.1021/cb1001203; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Bourdon E, 2005, FREE RADICAL RES, V39, P15, DOI 10.1080/10715760400024935; Bourdon E, 2001, ANTIOXID REDOX SIGN, V3, P293, DOI 10.1089/152308601300185241; Browne SE, 1999, BRAIN PATHOL, V9, P147; Carrotta R, 2011, J PHYS CHEM B, V115, P2691, DOI 10.1021/jp1042409; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; Chatani E, 2005, J MOL BIOL, V352, P941, DOI 10.1016/j.jmb.2005.07.043; Chen Y, 1998, BIOCHEMISTRY-US, V37, P9976, DOI 10.1021/bi980274n; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; DANIEL E, 1966, BIOCHEMISTRY-US, V5, P1893, DOI 10.1021/bi00870a016; Duda JE, 2000, AM J PATHOL, V157, P1439, DOI 10.1016/S0002-9440(10)64781-5; Dusa A, 2006, BIOCHEMISTRY-US, V45, P2752, DOI 10.1021/bi051426z; Duy C, 2006, BIOPHYS J, V90, P3704, DOI 10.1529/biophysj.105.078980; Eichner T, 2011, MOL CELL, V43, P8, DOI 10.1016/j.molcel.2011.05.012; FINCH JW, 1993, ARCH BIOCHEM BIOPHYS, V305, P595, DOI 10.1006/abbi.1993.1466; Fleming PJ, 2000, J MOL BIOL, V299, P487, DOI 10.1006/jmbi.2000.3750; Fodera V, 2008, J PHYS CHEM B, V112, P3853, DOI 10.1021/jp710131u; Fodera V, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.108105; Fodera V, 2012, J PHYS CHEM LETT, V3, P2803, DOI 10.1021/jz301375d; Fodera V, 2008, J PHYS CHEM B, V112, P15174, DOI 10.1021/jp805560c; Goswami N, 2010, J PHYS CHEM B, V114, P15236, DOI 10.1021/jp105943d; HALLIWELL B, 1988, BIOCHEM PHARMACOL, V37, P569, DOI 10.1016/0006-2952(88)90126-8; Heegaard NHH, 2005, BIOCHEMISTRY-US, V44, P4397, DOI 10.1021/bi047594t; Herczenik E, 2008, FASEB J, V22, P2115, DOI 10.1096/fj.07-099671; Holm NK, 2007, BBA-PROTEINS PROTEOM, V1774, P1128, DOI 10.1016/j.bbapap.2007.06.008; Hou LM, 2002, J BIOL CHEM, V277, P40173, DOI 10.1074/jbc.C200338200; Iwao Y, 2006, DRUG METAB PHARMACOK, V21, P140, DOI 10.2133/dmpk.21.140; Jahn TR, 2005, FEBS J, V272, P5962, DOI 10.1111/j.1742-4658.2005.05021.x; Juarez J, 2009, J PHYS CHEM B, V113, P12391, DOI 10.1021/jp904167e; Juarez J, 2009, J PHYS CHEM B, V113, P10521, DOI 10.1021/jp902224d; Juarez J, 2009, BIOPHYS J, V96, P2353, DOI 10.1016/j.bpj.2008.12.3901; Karve Tejaswita M, 2011, J Amino Acids, V2011, P207691, DOI 10.4061/2011/207691; KATCHALSKI E, 1957, J AM CHEM SOC, V79, P4096, DOI 10.1021/ja01572a034; Kay MS, 1996, NAT STRUCT BIOL, V3, P439, DOI 10.1038/nsb0596-439; Koudelka T, 2012, J AGR FOOD CHEM, V60, P4144, DOI 10.1021/jf205168t; Kuznetsova IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040845; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lasch P, 2001, J BIOL CHEM, V276, P9492, DOI 10.1074/jbc.M008528200; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Levine RL, 1999, MECH AGEING DEV, V107, P323, DOI 10.1016/S0047-6374(98)00152-3; Lindgren M, 2005, BIOPHYS J, V88, P4200, DOI 10.1529/biophysj.104.049700; Maleknia SD, 2006, FEBS J, V273, P5400, DOI 10.1111/j.1742-4658.2006.05532.x; Markesbery WR, 1999, BRAIN PATHOL, V9, P133; MEUCCI E, 1991, J BIOL CHEM, V266, P4692; Militello V, 2003, BIOPHYS CHEM, V105, P133, DOI 10.1016/S0301-4622(03)00153-4; Moriyama Y, 1996, J PROTEIN CHEM, V15, P265, DOI 10.1007/BF01887115; Pedersen JS, 2006, J MOL BIOL, V355, P501, DOI 10.1016/j.jmb.2005.09.100; Peters T., 1996, ALL ALBUMIN BIOCH GE; Ravi J, 2011, EUR BIOPHYS J BIOPHY, V40, P339, DOI 10.1007/s00249-010-0656-1; Robbins KJ, 2012, LANGMUIR, V28, P16490, DOI 10.1021/la303677t; Robbins KJ, 2011, J PHYS CHEM LETT, V2, P735, DOI 10.1021/jz200066b; Roche M, 2008, FEBS LETT, V582, P1783, DOI 10.1016/j.febslet.2008.04.057; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Scheinost J.C., 2010, PROTEIN MISFOLDING D, P615; Schmit JD, 2011, BIOPHYS J, V100, P450, DOI 10.1016/j.bpj.2010.11.041; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Shacter E, 2000, DRUG METAB REV, V32, P307, DOI 10.1081/DMR-100102336; SHECHTER Y, 1975, BIOCHEMISTRY-US, V14, P4497, DOI 10.1021/bi00691a025; SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540; Smith MI, 2012, COLLOID SURFACE B, V89, P216, DOI 10.1016/j.colsurfb.2011.09.018; Souillac PO, 2003, BIOCHEMISTRY-US, V42, P8094, DOI 10.1021/bi034652m; Squier TC, 2001, EXP GERONTOL, V36, P1539, DOI 10.1016/S0531-5565(01)00139-5; Stadtman E R, 1992, EXS, V62, P64; Stadtman ER, 2001, ANN NY ACAD SCI, V928, P22; STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053; Stadtman ER, 2005, BIOCHIM BIOPHYS ACTA, P1703; Stefani M, 2004, BBA-MOL BASIS DIS, V1739, P5, DOI 10.1016/j.bbadis.2004.08.004; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; Sun HY, 1999, BIOCHEMISTRY-US, V38, P105, DOI 10.1021/bi981295k; Taboada P, 2006, J PHYS CHEM B, V110, P20733, DOI 10.1021/jp064861r; Uversky VN, 2002, FEBS LETT, V517, P239, DOI 10.1016/S0014-5793(02)02638-8; Vetri V, 2005, BIOPHYS CHEM, V113, P83, DOI 10.1016/j.bpc.2004.07.042; Vetri V, 2007, EUR BIOPHYS J BIOPHY, V36, P717, DOI 10.1007/s00249-007-0196-5; Vetri V, 2007, BIOPHYS CHEM, V125, P184, DOI 10.1016/j.bpc.2006.07.012; Vetri V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068912; Vetri V, 2011, ARCH BIOCHEM BIOPHYS, V508, P13, DOI 10.1016/j.abb.2011.01.024; VOGT W, 1995, FREE RADICAL BIO MED, V18, P93, DOI 10.1016/0891-5849(94)00158-G; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Wong YQ, 2010, P NATL ACAD SCI USA, V107, P1977, DOI 10.1073/pnas.0910136107; Xie H, 2013, PNAS; Zolese G, 2000, PROTEINS, V40, P39, DOI 10.1002/(SICI)1097-0134(20000701)40:1<39::AID-PROT60>3.0.CO;2-N	90	48	48	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84552	10.1371/journal.pone.0084552	http://dx.doi.org/10.1371/journal.pone.0084552			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416244	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500136
J	van Rijn, S; Barendse, M; van Goozen, S; Swaab, H				van Rijn, Sophie; Barendse, Marjolein; van Goozen, Stephanie; Swaab, Hanna			Social Attention, Affective Arousal and Empathy in Men with Klinefelter Syndrome (47,XXY): Evidence from Eyetracking and Skin Conductance	PLOS ONE			English	Article							EMOTION REGULATION ABILITIES; MALE BRAIN THEORY; FACE RECOGNITION; CHILDREN; INTELLIGENCE; INDIVIDUALS; ALEXITHYMIA; FIXATION; DISORDER; QUALITY	Individuals with an extra X chromosome (Klinefelter syndrome) are at risk for problems in social functioning and have an increased vulnerability for autism traits. In the search for underlying mechanisms driving this increased risk, this study focused on social attention, affective arousal and empathy. Seventeen adults with XXY and 20 non-clinical controls participated in this study. Eyetracking was used to investigate social attention, as expressed in visual scanning patterns in response to the viewing of empathy evoking video clips. Skin conductance levels, reflecting affective arousal, were recorded continuously during the clips as well. Empathic skills, i.e. participants' understanding of own and others' emotions in response to the clips was also assessed. Results showed reduced empathic understanding, decreased visual fixation to the eye region, but increased affective arousal in individuals with Klinefelter syndrome. We conclude that individuals with XXY tend to avoid the eye region. Considering the increased affective arousal, we speculate that this attentional deployment strategy may not be sufficient to successfully downregulate affective hyper-responsivity. As increased affective arousal was related to reduced empathic ability, we hypothesize that own affective responses to social cues play an important role in difficulties in understanding the feelings and intentions of others. This knowledge may help in the identification of risk factors for psychopathology and targets for treatment.	[van Rijn, Sophie; Barendse, Marjolein; van Goozen, Stephanie; Swaab, Hanna] Leiden Univ, Leiden, Netherlands; [van Rijn, Sophie; Swaab, Hanna] Leiden Inst Brain & Cognit, Leiden, Netherlands; [van Goozen, Stephanie] Cardiff Univ, Sch Psychol, Cardiff CF10 3AX, S Glam, Wales	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Cardiff University	van Rijn, S (corresponding author), Leiden Univ, Leiden, Netherlands.	srijn@fsw.leidenuniv.nl	Swaab, Hanna/AAD-2555-2019	Swaab, Hanna/0000-0003-3697-060X; van rijn, sophie/0000-0002-9179-7515	Netherlands Organization for Scientific Research [016.095.060]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by a Veni grant (grant number 016.095.060 to SVR) from the Netherlands Organization for Scientific Research (www.NWO.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bal E, 2010, J AUTISM DEV DISORD, V40, P358, DOI 10.1007/s10803-009-0884-3; Baron-Cohen S, 2002, TRENDS COGN SCI, V6, P248, DOI 10.1016/S1364-6613(02)01904-6; Baron-Cohen S, 2010, PROG BRAIN RES, V186, P167, DOI 10.1016/B978-0-444-53630-3.00011-7; Bebko GM, 2011, EMOTION, V11, P732, DOI 10.1037/a0024009; Berthoz S, 2005, EUR PSYCHIAT, V20, P291, DOI 10.1016/j.eurpsy.2004.06.013; Bird G, 2006, HUMAN BRAIN MAPPING; Bird G, 2011, J AUTISM DEV DISORD, V41, P1556, DOI 10.1007/s10803-011-1183-3; Bird G, 2010, BRAIN, V133, P1515, DOI 10.1093/brain/awq060; Bishop DVM, 2011, ARCH DIS CHILD, V96, P954, DOI 10.1136/adc.2009.179747; Boada R, 2009, DEV DISABIL RES REV, V15, P284, DOI 10.1002/ddrr.83; Bojesen A, 2003, J CLIN ENDOCR METAB, V88, P622, DOI 10.1210/jc.2002-021491; Boone KB, 2001, J INT NEUROPSYCH SOC, V7, P446, DOI 10.1017/S1355617701744013; BOOTHBUTTERFIELD M, 1990, HUM COMMUN RES, V16, P451, DOI 10.1111/j.1468-2958.1990.tb00219.x; Boucsein W, 2012, ELECTRODERMAL ACTIVITY, SECOND EDITION, P1, DOI 10.1007/978-1-4614-1126-0; Braaten EB, 2000, J CONSULT CLIN PSYCH, V68, P313, DOI [10.1037/0022-006X.68.2.313, 10.1037//0022-006X.68.2.313]; Bruining H, 2009, PEDIATRICS, V123, pE865, DOI 10.1542/peds.2008-1954; Campbell JM, 1998, PSYCHOL ASSESSMENT, V10, P431, DOI 10.1037/1040-3590.10.4.431; Connelly M, 2007, J PSYCHOSOM RES, V62, P649, DOI 10.1016/j.jpsychores.2006.12.008; Corden B, 2008, NEUROPSYCHOLOGIA, V46, P137, DOI 10.1016/j.neuropsychologia.2007.08.005; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; Dawson ME, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P159, DOI 10.1017/cbo9780511546396.007; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; Eisenberg N, 2000, J PERS SOC PSYCHOL, V78, P136, DOI 10.1037//0022-3514.66.4.776; Fitzgerald M, 2006, J AUTISM DEV DISORD, V36, P573, DOI 10.1007/s10803-006-0096-z; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Fusar-Poli P, 2009, J CLIN NEUROSCI, V16, P981, DOI 10.1016/j.jocn.2008.09.022; Geschwind D., 2004, LEARN DISABIL RES PR, V19, P166, DOI [DOI 10.1111/J.1540-5826.2004.00100.X, 10.1111/j.1540-5826.2004.00100.x]; Gross JJ, 2002, PSYCHOPHYSIOLOGY, V39, P281, DOI 10.1017/S0048577201393198; Gross JJ, 2007, HDB EMOTION REGULATI, P3, DOI DOI 10.1080/00140130600971135; Gyurak A, 2011, COGNITION EMOTION, V25, P400, DOI 10.1080/02699931.2010.544160; Halberstadt AG, 2001, SOC DEV, V10, P79, DOI 10.1111/1467-9507.00150; HerreraGraf M, 1996, EDUC PSYCHOL MEAS, V56, P522, DOI 10.1177/0013164496056003014; Hill E, 2004, J AUTISM DEV DISORD, V34, P229, DOI 10.1023/B:JADD.0000022613.41399.14; Hirstein W, 2001, P ROY SOC B-BIOL SCI, V268, P1883, DOI 10.1098/rspb.2001.1724; Hooker C, 2002, PSYCHIAT RES, V112, P41, DOI 10.1016/S0165-1781(02)00177-4; Hubert BE, 2009, AUTISM, V13, P9, DOI 10.1177/1362361308091649; Itier RJ, 2009, NEUROSCI BIOBEHAV R, V33, P843, DOI 10.1016/j.neubiorev.2009.02.004; Jonsson P, 2003, BIOL PSYCHOL, V62, P157, DOI 10.1016/S0301-0511(02)00114-X; Joseph RM, 2008, J INT NEUROPSYCH SOC, V14, P947, DOI 10.1017/S1355617708081344; Kirchner JC, 2011, J AUTISM DEV DISORD, V41, P158, DOI 10.1007/s10803-010-1032-9; Klein JT, 2009, CURR BIOL, V19, pR958, DOI 10.1016/j.cub.2009.08.010; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Konstantareas MM, 2006, J AUTISM DEV DISORD, V36, P143, DOI 10.1007/s10803-005-0051-4; Kreibig SD, 2007, PSYCHOPHYSIOLOGY, V44, P787, DOI 10.1111/j.1469-8986.2007.00550.x; Lee NR, 2011, J INT NEUROPSYCH SOC, V17, P522, DOI 10.1017/S1355617711000312; Leggett V, 2010, DEV MED CHILD NEUROL, V52, P119, DOI 10.1111/j.1469-8749.2009.03545.x; Lopes PN, 2005, EMOTION, V5, P113, DOI 10.1037/1528-3542.5.1.113; Lopes PN, 2004, PERS SOC PSYCHOL B, V30, P1018, DOI 10.1177/0146167204264762; Lopes PN, 2003, PERS INDIV DIFFER, V35, P641, DOI 10.1016/S0191-8869(02)00242-8; Main K, 2012, DEV NEW EMPATHY PARA; Mazefsky CA, 2013, J AM ACAD CHILD PSY, V52, P679, DOI 10.1016/j.jaac.2013.05.006; Mestre JM, 2006, PSICOTHEMA, V18, P112; Myers D. G., 2004, THEORIES EMOTION; Pelphrey KA, 2002, J AUTISM DEV DISORD, V32, P249, DOI 10.1023/A:1016374617369; Pinkham AE, 2003, AM J PSYCHIAT, V160, P815, DOI 10.1176/appi.ajp.160.5.815; Pinkham AE, 2006, PSYCHIAT RES, V143, P167, DOI 10.1016/j.psychres.2005.09.005; Ratcliffe S, 1999, ARCH DIS CHILD, V80, P192, DOI 10.1136/adc.80.2.192; RATCLIFFE SG, 1991, BIRTH DEF, V26, P1; ROBINSON A, 1991, BIRTH DEF, V26, P59; Samson AC, 2012, EMOTION, V12, P659, DOI 10.1037/a0027975; Schyns PG, 2007, CURR BIOL, V17, P1580, DOI 10.1016/j.cub.2007.08.048; SIFNEOS PE, 1973, PSYCHOTHER PSYCHOSOM, V22, P255, DOI 10.1159/000286529; STEWART DA, 1991, BIRTH DEF, V26, P131; Sze JA, 2010, EMOTION, V10, P803, DOI 10.1037/a0020146; Tani P, 2004, NEUROPSYCHOBIOLOGY, V49, P64, DOI 10.1159/000076412; Tartaglia Nicole, 2010, Pediatr Endocrinol Rev, V8 Suppl 1, P151; van Rijn S, 2006, SCHIZOPHR RES, V84, P194, DOI 10.1016/j.schres.2006.02.020; van Rijn S, J AUTISM DE IN PRESS; van Rijn S, 2008, J AUTISM DEV DISORD, V38, P1634, DOI 10.1007/s10803-008-0542-1; van Rijn S, 2007, J INT NEUROPSYCH SOC, V13, P1065, DOI 10.1017/S1355617707071044; van 't Wout M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005581; Vinette C, 2004, COGNITIVE SCI, V28, P289, DOI 10.1016/j.cogsci.2004.01.002; Visootsak J, 2009, DEV DISABIL RES REV, V15, P328, DOI 10.1002/ddrr.76; Webb TL, 2012, PSYCHOL BULL, V138, P775, DOI 10.1037/a0027600; Wechsler D., 1997, WECHSLER ADULT INTEL; Wechsler D., 2005, WECHSLER ADULT INTEL; Zechner U, 2001, TRENDS GENET, V17, P697, DOI 10.1016/S0168-9525(01)02446-5	77	28	28	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84721	10.1371/journal.pone.0084721	http://dx.doi.org/10.1371/journal.pone.0084721			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291WL	24416272	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000329862500155
J	He, WY; Sun, XF; Liu, L; Li, M; Jin, H; Wang, WH				He, Wenyin; Sun, Xiaofang; Liu, Lian; Li, Man; Jin, Hua; Wang, Wei-Hua			The Prevalence of Chromosomal Deletions Relating to Developmental Delay and/or Intellectual Disability in Human Euploid Blastocysts	PLOS ONE			English	Article							PREIMPLANTATION GENETIC DIAGNOSIS; COMPARATIVE GENOMIC HYBRIDIZATION; INTRACYTOPLASMIC SPERM INJECTION; ADVANCED MATERNAL AGE; COPY NUMBER VARIATION; ARRAY CGH; OLIGONUCLEOTIDE MICROARRAYS; SINGLETON PREGNANCIES; ANEUPLOIDY; MICRODELETIONS	Chromosomal anomalies in human embryos produced by in vitro fertilization are very common, which include numerical (aneuploidy) and structural (deletion, duplication or others) anomalies. Our previous study indicated that chromosomal deletion(s) is the most common structural anomaly accounting for approximately 8% of euploid blastocysts. It is still unknown if these deletions in human euploid blastocysts have clinical significance. In this study, we analyzed 15 previously diagnosed euploid blastocysts that had chromosomal deletion(s) using Agilent oligonucleotide DNA microarray platform and localized the gene location in each deletion. Then, we used OMIM gene map and phenotype database to investigate if these deletions are related with some important genes that cause genetic diseases, especially developmental delay or intellectual disability. As results, we found that the detectable chromosomal deletion size with Agilent microarray is above 2.38 Mb, while the deletions observed in human blastocysts are between 11.6 to 103 Mb. With OMIM gene map and phenotype database information, we found that deletions can result in loss of 81-464 genes. Out of these genes, 34-149 genes are related with known genetic problems. Furthermore, we found that 5 out of 15 samples lost genes in the deleted region, which were related to developmental delay and/or intellectual disability. In conclusion, our data indicates that all human euploid blastocysts with chromosomal deletion(s) are abnormal and transfer of these embryos may cause birth defects and/or developmental and intellectual disabilities. Therefore, the embryos with chromosomal deletion revealed by DNA microarray should not be transferred to the patients, or further gene map and/or phenotype seeking is necessary before making a final decision.	[He, Wenyin; Sun, Xiaofang] Guangzhou Med Univ, Affiliated Hosp 3, Key Lab Major Obstet Dis Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Liu, Lian; Li, Man; Jin, Hua] Pacgenomics Inc, Village Med Ctr, Thousand Oaks, CA USA; [Wang, Wei-Hua] New Houston Hlth, Houston, TX USA; [Wang, Wei-Hua] Vivere Hlth, Franklin, TN USA	Guangzhou Medical University	Wang, WH (corresponding author), New Houston Hlth, Houston, TX USA.	wangweihua11@yahoo.com			Third Affiliated Hospital of Guangzhou Medical University; National Natural Science Foundation of China [81270745]	Third Affiliated Hospital of Guangzhou Medical University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from The Third Affiliated Hospital of Guangzhou Medical University and the National Natural Science Foundation of China (81270745). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfarawati S, 2011, HUM REPROD, V26, P1560, DOI 10.1093/humrep/der068; Apantaku O, 2008, J OBSTET GYNAECOL, V28, P398, DOI 10.1080/01443610802091792; Barrett MT, 2004, P NATL ACAD SCI USA, V101, P17765, DOI 10.1073/pnas.0407979101; Brennan C, 2004, CANCER RES, V64, P4744, DOI 10.1158/0008-5472.CAN-04-1241; Chiang T, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094367; Coe BP, 2007, GENOMICS, V89, P647, DOI 10.1016/j.ygeno.2006.12.012; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; De Neubourg D, 2006, HUM REPROD, V21, P1041, DOI 10.1093/humrep/dei424; Fernandez BA, 2010, J MED GENET, V47, P195, DOI 10.1136/jmg.2009.069369; Fiegler H, 2006, GENOME RES, V16, P1566, DOI 10.1101/gr.5630906; Forman EJ, 2012, FERTIL STERIL, V98, P644, DOI 10.1016/j.fertnstert.2012.04.028; Fujii M, 2010, FERTIL STERIL, V94, P2113, DOI 10.1016/j.fertnstert.2009.12.031; Geigl JB, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp526; Girardet A, 2008, FERTIL STERIL, V90, DOI 10.1016/j.fertnstert.2007.07.1305; Grayton HM, 2012, PROG NEUROBIOL, V99, P81, DOI 10.1016/j.pneurobio.2012.07.005; Gutierrez-Mateo C, 2011, FERTIL STERIL, V95, P953, DOI 10.1016/j.fertnstert.2010.09.010; Halliday J, 2007, BEST PRACT RES CL OB, V21, P67, DOI 10.1016/j.bpobgyn.2006.08.004; Harper JC, 2010, FERTIL STERIL, V94, P1173, DOI 10.1016/j.fertnstert.2010.04.064; Harper-Stromberg E, 2011, BIOINFORMATICS, V27, P1052; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hehir-Kwa JY, 2007, DNA RES, V14, P1, DOI 10.1093/dnares/dsm002; Heilstedt HA, 2003, CLIN GENET, V64, P310, DOI 10.1034/j.1399-0004.2003.00126.x; Hellani A, 2008, REPROD BIOMED ONLINE, V17, P841, DOI 10.1016/S1472-6483(10)60413-0; Jones KT, 2008, HUM REPROD UPDATE, V14, P143, DOI 10.1093/humupd/dmm043; Kaminsky EB, 2011, GENET MED, V13, P777, DOI 10.1097/GIM.0b013e31822c79f9; Koolen DA, 2008, J MED GENET, V45, P710, DOI 10.1136/jmg.2008.058701; Li XM, 2008, CURR GENOMICS, V9, P466, DOI 10.2174/138920208786241199; Liang LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061838; Liu JQ, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.103192; Liu PF, 2011, CELL, V146, P888, DOI 10.1016/j.cell.2011.07.042; Manning M, 2010, AM J HUM GENET, V86, P749; Miao YL, 2009, HUM REPROD UPDATE, V15, P573, DOI 10.1093/humupd/dmp014; Miller DT, 2010, GENET MED, V12, P742; Perry GH, 2008, AM J HUM GENET, V82, P685, DOI 10.1016/j.ajhg.2007.12.010; Pober BR, 2010, NEW ENGL J MED, V362, P2142; Pober BR, 2010, NEW ENGL J MED, V362, P239, DOI 10.1056/NEJMra0903074; Poongothai J, 2009, SINGAP MED J, V50, P336; Reddy UM, 2007, OBSTET GYNECOL, V109, P967, DOI 10.1097/01.AOG.0000259316.04136.30; Ren Z, 2009, FERTIL STERIL, V91, P359, DOI 10.1016/j.fertnstert.2007.11.044; Rius M, 2011, FERTIL STERIL, V95, P413, DOI 10.1016/j.fertnstert.2010.07.1051; Sagoo GS, 2009, GENET MED, V11, P139, DOI 10.1097/GIM.0b013e318194ee8f; Schoolcraft WB, 2010, FERTIL STERIL, V94, pS23, DOI 10.1016/j.fertnstert.2010.07.090; Shen XT, 2011, J ASSIST REPROD GEN, V28, P957, DOI 10.1007/s10815-011-9598-5; Shoukier M, 2013, CLIN GENET, V83, P53, DOI 10.1111/j.1399-0004.2012.01850.x; Song NH, 2005, CHINESE MED J-PEKING, V118, P1462; Stankiewicz P, 2007, CURR OPIN GENET DEV, V17, P182, DOI 10.1016/j.gde.2007.04.009; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Sykulski Maciej, 2013, J Clin Bioinforma, V3, P12, DOI 10.1186/2043-9113-3-12; Treff NR, 2010, FERTIL STERIL, V94, P2017, DOI 10.1016/j.fertnstert.2010.01.052; Vanneste Evelyne, 2012, Frontiers in Genetics, V3, P44, DOI 10.3389/fgene.2012.00044; Wang ZB, 2011, PHYSIOLOGY, V26, P314, DOI 10.1152/physiol.00020.2011; Wapner RJ, 2012, NEW ENGL J MED, V367, P2175, DOI 10.1056/NEJMoa1203382; Yang ZH, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-24	53	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e85207	10.1371/journal.pone.0085207	http://dx.doi.org/10.1371/journal.pone.0085207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409323	Green Published, Green Submitted, gold			2022-12-27	WOS:000329463500047
J	Li, HH; Huang, ZY; Ye, SP; Lu, CY; Cheng, PC; Chen, SH; Chen, CS				Li, Hsing-Hui; Huang, Zi-Yu; Ye, Shih-Png; Lu, Chi-Yu; Cheng, Pai-Chiao; Chen, Shu-Hwa; Chen, Chii-Shiarng			Membrane Labeling of Coral Gastrodermal Cells by Biotinylation: The Proteomic Identification of Surface Proteins Involving Cnidaria-Dinoflagellate Endosymbiosis	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; MOLECULAR CHAPERONES; ALGAL SYMBIONTS; ACTIN; GENE; ZOOXANTHELLAE; ENDOCYTOSIS; RESPONSES; ANEMONE; BINDING	The cellular and molecular-scale processes underlying the stability of coral-Symbiodinium endosymbioses remain unclear despite decades of investigation. As the coral gastroderm is the only tissue layer characterized by this unique symbiotic association, the membranes of these symbiotic gastrodermal cells (SGCs) may play important roles in the initiation and maintenance of the endosymbiosis. In order to elucidate the interactions between the endosymbiotic dinoflagellates and their coral hosts, a thorough characterization of SGC membranes is therefore required. Cell surface proteins of isolated SGCs were biotinylated herein by a cell impermeant agent, biotin-XX sulfosuccinimidyl ester. The in situ distribution of these biotinylated proteins was uncovered by both fluorescence and transmission electron microscopic imaging of proteins bound to Alexa Fluor (R) 488-conjugated streptavidin. The identity of these proteins was then determined by two-dimensional gel electrophoresis followed by liquid chromatography-tandem mass spectrometry. Nineteen (19) proteins were identified, and they are known to be involved in the molecular chaperone/stress response, cytoskeletal remodeling, and energy metabolism. These results not only reveal the molecular characters of the host SGC membrane, but also provide critical insight into understanding the possible role of host membranes in this ecologically important endosymbiotic association.	[Li, Hsing-Hui; Huang, Zi-Yu; Ye, Shih-Png; Chen, Chii-Shiarng] Natl Dong Hwa Univ, Grad Inst Marine Biotechnol, Pingtung, Taiwan; [Li, Hsing-Hui; Chen, Chii-Shiarng] Taiwan Coral Res Ctr, Natl Museum Marine Biol & Aquarium, Pingtung, Taiwan; [Lu, Chi-Yu] Kaohsiung Med Univ, Coll Med, Dept Biochem, Kaohsiung, Taiwan; [Cheng, Pai-Chiao] Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan 70101, Taiwan; [Chen, Shu-Hwa] Acad Sinica, Inst Informat Sci, Taipei, Taiwan; [Chen, Chii-Shiarng] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung 80424, Taiwan	National Dong Hwa University; National Museum of Marine Biology & Aquarium; Kaohsiung Medical University; National Cheng Kung University; Academia Sinica - Taiwan; National Sun Yat Sen University	Chen, CS (corresponding author), Natl Dong Hwa Univ, Grad Inst Marine Biotechnol, Pingtung, Taiwan.	cchen@nmmba.gov.tw			National Science Council of Taiwan (NSC) [101-2311-B-291-002-MY3]; National Museum of Marine Biology and Aquarium	National Science Council of Taiwan (NSC)(Ministry of Science and Technology, Taiwan); National Museum of Marine Biology and Aquarium	This work was supported by the National Science Council of Taiwan (NSC 101-2311-B-291-002-MY3 to C.-S. Chen) and intramural funds from the National Museum of Marine Biology and Aquarium (to H.-H. Li and C.-S. Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BANKS PR, 1995, BIOCONJUGATE CHEM, V6, P447, DOI 10.1021/bc00034a015; Birkeland CR, 1997, LIFE DEATH CORAL REE, P1; Chen CS, 2012, SCI CHINA LIFE SCI, V55, P599, DOI 10.1007/s11427-012-4345-4; Chen CS, 2005, PROTOPLASMA, V226, P175, DOI 10.1007/s00709-005-0116-4; Chen CS, 1997, BIOPHYS J, V72, P37, DOI 10.1016/S0006-3495(97)78645-4; Chi SL, 2006, ANN MED, V38, P429, DOI 10.1080/07853890600928698; Davy SK, 2012, MICROBIOL MOL BIOL R, V76, P229, DOI 10.1128/MMBR.05014-11; Dunn SR, 2007, BIOL BULL-US, V212, P250, DOI 10.2307/25066607; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; FITT WK, 1983, J CELL SCI, V64, P195; GRANIER F, 1988, ELECTROPHORESIS, V9, P712, DOI 10.1002/elps.1150091106; Habich C, 2005, J IMMUNOL, V174, P1298, DOI 10.4049/jimmunol.174.3.1298; HOHMAN TC, 1982, J CELL BIOL, V94, P56, DOI 10.1083/jcb.94.1.56; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kregel KC, 2002, J APPL PHYSIOL, V92, P2177, DOI 10.1152/japplphysiol.01267.2001; Lin KL, 2000, ZOOL STUD, V39, P172; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Michalak M, 1999, BIOCHEM J, V344, P281, DOI 10.1042/0264-6021:3440281; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; MUSCATINE L, 1975, T AM MICROSC SOC, V94, P450, DOI 10.2307/3225518; Nakamura M, 2002, ANAL BIOCHEM, V304, P231, DOI 10.1006/abio.2002.5595; Peng SE, 2010, PROTEOMICS, V10, P1002, DOI 10.1002/pmic.200900595; Pfaendtner J, 2010, P NATL ACAD SCI USA, V107, P7299, DOI 10.1073/pnas.0911675107; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Soltys BJ, 1997, CELL BIOL INT, V21, P315, DOI 10.1006/cbir.1997.0144; Stossel TP, 2006, J CELL SCI, V119, P3261, DOI 10.1242/jcs.02994; Tambutte S, 2011, J EXP MAR BIOL ECOL, V408, P58, DOI 10.1016/j.jembe.2011.07.026; TRENCH RK, 1993, ENDOCYTOBIOSIS CELL, V9, P135; VANDERMEULEN JH, 1972, MAR BIOL, V16, P185; Vassilakos A, 1998, BIOCHEMISTRY-US, V37, P3480, DOI 10.1021/bi972465g; Wakefield TS, 2001, BIOL BULL-US, V200, P127, DOI 10.2307/1543306; Weis VM, 2001, CORAL REEFS, V20, P301, DOI 10.1007/s003380100179; Weston AJ, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015487	35	6	6	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e85119	10.1371/journal.pone.0085119	http://dx.doi.org/10.1371/journal.pone.0085119			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409319	Green Submitted, Green Published, gold			2022-12-27	WOS:000329463500043
J	Mangrud, OM; Waalen, R; Gudlaugsson, E; Dalen, I; Tasdemir, I; Janssen, EAM; Baak, JPA				Mangrud, Ok Malfrid; Waalen, Rune; Gudlaugsson, Einar; Dalen, Ingvild; Tasdemir, Ilker; Janssen, Emiel A. M.; Baak, Jan P. A.			Reproducibility and Prognostic Value of WHO1973 and WHO2004 Grading Systems in TaT1 Urothelial Carcinoma of the Urinary Bladder	PLOS ONE			English	Article							ORGANIZATION INTERNATIONAL SOCIETY; UROLOGIC-PATHOLOGY CLASSIFICATION; NEOPLASMS; WHO/ISUP; RISK; PROGRESSION; CANCER; TUMORS	Background: European treatment guidelines of TaT1 urinary bladder urothelial carcinomas depend highly on stage and WHO1973-grade but grading reproducibility is wanting. The newer WHO2004 grading system is still debated and both systems are currently used. Aims: To compare reproducibility and prognostic value (of stage progression) of the WHO1973 and WHO2004. Methods: One hundred and ninety-three primary urothelial carcinomas were reviewed. Follow-up data were retrieved from the patient records. Kappa statistics and Harrell's C-index were used. Results: Median follow-up was 75 months (range 1-127). 17 patients (9%) progressed, 82% of these within and 18% after 60 months. The distribution of WHO73-grades 1, 2 and 3 was 23%, 51% and 26%, interobserver agreement for each individual grade was 66% (kappa = 0.68), while for grades 1&2 versus 3 89% (kappa = 0.68). Intraobserver reproducibility was 68-63% for WHO73 and 88-89% for WHO73 as 1&2 vs. 3. Progression free survival rates at 5 years were 95% (grade 1), 98% (grade 2) and 82% (grade 3) and 96% and 82% for grades 1&2 versus 3 (Hazard Ratio, HR, 5.4, p = 0.003). Using WHO2004, 62% were low grade and 38% high grade, inter-observer agreement 87% (kappa = 0.70), intraobserver reproducibility 93%, and progression free 5-year survival rates 97% and 85% (HR 6.6, p = 0.004). Positive and negative predictive values for stage progression within 5 years for the WHO73 (12 vs. 3) were 18% and 96%, and 15% and 97% for the WHO04. Using Harrell's C-index, none of the grading systems was prognostically superior. Conclusion: None of the grading systems is prognostically stronger than the others. Most importantly, inter-observer reproducibility and sensitivities for stage progression of both systems are low and need improvement for optimal treatment.	[Mangrud, Ok Malfrid; Gudlaugsson, Einar; Janssen, Emiel A. M.; Baak, Jan P. A.] Stavanger Univ Hosp, Dept Pathol, Stavanger, Norway; [Mangrud, Ok Malfrid; Gudlaugsson, Einar; Baak, Jan P. A.] Univ Bergen, Clin Inst 1, Bergen, Norway; [Waalen, Rune] Innlandet Hosp Trust, Dept Pathol, Lillehammer, Norway; [Dalen, Ingvild] Stavanger Univ Hosp, Dept Res, Stavanger, Norway; [Tasdemir, Ilker] Stavanger Univ Hosp, Dept Urol, Stavanger, Norway	Stavanger University Hospital; University of Bergen; Innlandet Hospital Trust; Stavanger University Hospital; Stavanger University Hospital	Baak, JPA (corresponding author), Stavanger Univ Hosp, Dept Pathol, Stavanger, Norway.	jpabaak47@yahoo.com	Janssen, Emiel A.M./AAM-2357-2020					[Anonymous], 2004, KIDNEY TUMORS CHILDR; Babjuk M, 2011, EUR UROL, V59, P997, DOI 10.1016/j.eururo.2011.03.017; Bol MGW, 2003, J UROLOGY, V169, P1291, DOI 10.1097/01.ju.0000055471.78783.ae; Chen ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047199; Cheng L, 1999, CANCER, V86, P2102, DOI 10.1002/(SICI)1097-0142(19991115)86:10<2102::AID-CNCR31>3.3.CO;2-L; Cheng L, 2012, HUM PATHOL, V43, P2097, DOI 10.1016/j.humpath.2012.01.008; Eble JN, 2004, PATHOLOGY GENETICS T; Engers R, 2007, WORLD J UROL, V25, P595, DOI 10.1007/s00345-007-0209-0; Epstein JI, 2003, CRIT REV ONCOL HEMAT, V47, P83, DOI 10.1016/S1040-8428(03)00073-8; Epstein JI, 1998, AM J SURG PATHOL, V22, P1435, DOI 10.1097/00000478-199812000-00001; Fujii Y, 2003, BJU INT, V92, P559, DOI 10.1046/j.1464-410X.2003.04415.x; Gudlaugsson E, 2012, HISTOPATHOLOGY, V61, P1134, DOI 10.1111/j.1365-2559.2012.04329.x; Haldorsen T, 2011, CANC NORWAY 2009; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; HOLMANG S, 1995, J UROLOGY, V153, P1823, DOI 10.1016/S0022-5347(01)67321-X; Larsson P, 2003, SCAND J UROL NEPHROL, V37, P195, DOI 10.1080/00365590310008037; MacLennan GT, 2007, EUR UROL, V51, P889, DOI 10.1016/j.eururo.2006.10.037; Mostofi FK, 1973, HISTOLOGICAL TYPING; Murphy WM, 2002, J UROLOGY, V168, P968, DOI 10.1016/S0022-5347(05)64553-3; Pan CC, 2010, AM J CLIN PATHOL, V133, P788, DOI 10.1309/AJCP12MRVVHTCKEJ; Samaratunga H, 2002, UROLOGY, V60, P315, DOI 10.1016/S0090-4295(02)01705-3; Sylvester RJ, 2006, EUR UROL, V49, P466, DOI 10.1016/j.eururo.2005.12.031; van Rhijn BWG, 2010, EUR UROL, V58, P433, DOI 10.1016/j.eururo.2010.05.043; Rhijn BWG, 2010, EUR UROL, V57, P1052, DOI 10.1016/j.eururo.2009.09.022; Yin H, 2004, AM J CLIN PATHOL, V121, P679, DOI 10.1039/0KATYHQBJD5XHQ8J; Yorukoglu K, 2003, VIRCHOWS ARCH, V443, P734, DOI 10.1007/s00428-003-0905-0	26	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e83192	10.1371/journal.pone.0083192	http://dx.doi.org/10.1371/journal.pone.0083192			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409280	Green Published, Green Submitted, gold			2022-12-27	WOS:000329463500004
J	Berg, RK; Rahbek, SH; Kofod-Olsen, E; Holm, CK; Melchjorsen, J; Jensen, DG; Hansen, AL; Jorgensen, LB; Ostergaard, L; Tolstrup, M; Larsen, CS; Paludan, SR; Jakobsen, MR; Mogensen, TH				Berg, Randi K.; Rahbek, Stine H.; Kofod-Olsen, Emil; Holm, Christian K.; Melchjorsen, Jesper; Jensen, David G.; Hansen, Anne Louise; Jorgensen, Louise B.; Ostergaard, Lars; Tolstrup, Martin; Larsen, Carsten S.; Paludan, Soren R.; Jakobsen, Martin R.; Mogensen, Trine H.			T Cells Detect Intracellular DNA but Fail to Induce Type I IFN Responses: Implications for Restriction of HIV Replication	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PLASMACYTOID DENDRITIC CELLS; INNATE IMMUNE RECOGNITION; SINGLE-STRANDED RNA; SAMHD1 RESTRICTS; INTERFERON-ALPHA; INFECTION; SENSOR; LYMPHOCYTES; RETROVIRUS	HIV infects key cell types of the immune system, most notably macrophages and CD4+ T cells. Whereas macrophages represent an important viral reservoir, activated CD4+ T cells are the most permissive cell types supporting high levels of viral replication. In recent years, it has been appreciated that the innate immune system plays an important role in controlling HIV replication, e. g. via interferon (IFN)-inducible restriction factors. Moreover, innate immune responses are involved in driving chronic immune activation and the pathogenesis of progressive immunodeficiency. Several pattern recognition receptors detecting HIV have been reported, including Toll-like receptor 7 and Retinoic-inducible gene-I, which detects viral RNA. Here we report that human primary T cells fail to induce strong IFN responses, despite the fact that this cell type does express key molecules involved in DNA signaling pathways. We demonstrate that the DNA sensor IFI16 migrates to sites of foreign DNA localization in the cytoplasm and recruits the signaling molecules stimulator of IFN genes and Tank-binding kinase, but this does not result in expression of IFN and IFN-stimulated genes. Importantly, we show that cytosolic DNA fails to affect HIV replication. However, exogenous treatment of activated T cells with type I IFN has the capacity to induce expression of IFN-stimulated genes and suppress HIV replication. Our data suggest the existence of an impaired DNA signaling machinery in T cells, which may prevent this cell type from activating cell-autonomous anti-HIV responses. This phenomenon could contribute to the high permissiveness of CD4+ T cells for HIV-1.	[Berg, Randi K.; Kofod-Olsen, Emil; Melchjorsen, Jesper; Jensen, David G.; Ostergaard, Lars; Tolstrup, Martin; Larsen, Carsten S.; Mogensen, Trine H.] Aarhus Univ, Hosp Skejby, Dept Infect Dis, Aarhus, Denmark; [Rahbek, Stine H.; Kofod-Olsen, Emil; Holm, Christian K.; Hansen, Anne Louise; Paludan, Soren R.; Jakobsen, Martin R.] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Rahbek, Stine H.; Holm, Christian K.; Paludan, Soren R.; Jakobsen, Martin R.; Mogensen, Trine H.] Aarhus Res Ctr Innate Immunol, Aarhus, Denmark; [Jorgensen, Louise B.] State Serum Inst, Dept Virol, Copenhagen, Denmark	Aarhus University; Aarhus University; Statens Serum Institut	Mogensen, TH (corresponding author), Aarhus Univ, Hosp Skejby, Dept Infect Dis, Aarhus, Denmark.	Trinmoge@rm.dk	Ostergaard, Lars/AAA-3020-2020	Ostergaard, Lars/0000-0003-2459-0511; Tolstrup, Martin/0000-0001-7020-5173; Mogensen, Trine Hyrup/0000-0002-1853-9704; Ostergaard, Lars/0000-0002-7619-605X; Hansen, Anne Louise/0000-0002-3741-8705; Holm, Christian/0000-0002-2655-3362; , Martin/0000-0001-8847-9201	Danish Medical Research Council [09-066031, 12-124330, 10-081986]; Kong Christian IX og Dronning Louises Jubilaeumslegat; Aase og Ejnar Danielsens Fond; Foundation for the Advancement of Medical Sciences; Faculty of Health Sciences, Aarhus University; Lundbeck Foundation [R83-2011-7598] Funding Source: researchfish	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Kong Christian IX og Dronning Louises Jubilaeumslegat; Aase og Ejnar Danielsens Fond; Foundation for the Advancement of Medical Sciences; Faculty of Health Sciences, Aarhus University; Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Danish Medical Research Council (grant numbers 09-066031 (THM), 12-124330 (SRP), and 10-081986 (MRJ)). In addition, the work was supported by Kong Christian IX og Dronning Louises Jubilaeumslegat, Aase og Ejnar Danielsens Fond and The Foundation for the Advancement of Medical Sciences. RKB is recipient of a PhD fellowship from the Faculty of Health Sciences, Aarhus University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter G, 2007, J IMMUNOL, V178, P7658, DOI 10.4049/jimmunol.178.12.7658; BACHELERIE F, 1991, NATURE, V350, P709, DOI 10.1038/350709a0; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Barblu L, 2012, J INFECT DIS, V206, P790, DOI 10.1093/infdis/jis384; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Berg RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029291; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Brichacek B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012831; Cameron PU, 2010, P NATL ACAD SCI USA, V107, P16934, DOI 10.1073/pnas.1002894107; Carter CA, 2008, ANNU REV MICROBIOL, V62, P425, DOI 10.1146/annurev.micro.62.081307.162758; Chen KY, 2006, J VIROL, V80, P7645, DOI 10.1128/JVI.00206-06; De Cock KM, 2012, AIDS, V26, P1205, DOI 10.1097/QAD.0b013e328354622a; Dobson-Belaire WN, 2010, CELL MICROBIOL, V12, P1703, DOI 10.1111/j.1462-5822.2010.01502.x; Doehle BP, 2009, J VIROL, V83, P10395, DOI 10.1128/JVI.00849-09; Doitsh G, 2010, CELL, V143, P789, DOI 10.1016/j.cell.2010.11.001; Equils O, 2001, J IMMUNOL, V166, P2342, DOI 10.4049/jimmunol.166.4.2342; Ferguson BJ, 2012, ELIFE, V1, DOI 10.7554/eLife.00047; Freed EO, 2007, FIELDS VIROLOGY; Funderburg N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001915; Ganesh L, 2003, NATURE, V426, P853, DOI 10.1038/nature02171; Gao D, 2013, SCIENCE; GAO WY, 1993, P NATL ACAD SCI USA, V90, P8925, DOI 10.1073/pnas.90.19.8925; Gougeon ML, 2012, EXP CELL RES, V318, P1260, DOI 10.1016/j.yexcr.2012.03.012; Gringhuis SI, 2010, NAT IMMUNOL, V11, P419, DOI 10.1038/ni.1858; Hayashi T, 2010, MICROBES INFECT, V12, P937, DOI 10.1016/j.micinf.2010.06.003; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Holm CK, 2009, J IMMUNOL, V183, P4422, DOI 10.4049/jimmunol.0804318; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Isegawa Y, 2007, ACTA VIROL, V51, P13; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Iwasaki A, 2012, IMMUNITY, V37, P389, DOI 10.1016/j.immuni.2012.08.011; Jakobsen MR, 2013, P NATL ACAD SCI US; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; LATHEY JL, 1994, VIROLOGY, V199, P98, DOI 10.1006/viro.1994.1101; Lepelley A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001284; Li MQ, 2012, NATURE, V491, P125, DOI 10.1038/nature11433; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Meier A, 2009, NAT MED, V15, P955, DOI 10.1038/nm.2004; Mogensen TH, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-54; Moriuchi H, 2000, J VIROL, V74, P6849, DOI 10.1128/JVI.74.15.6849-6855.2000; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; OBRIEN WA, 1994, J VIROL, V68, P1258, DOI 10.1128/JVI.68.2.1258-1263.1994; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; Pirhonen J, 1999, J IMMUNOL, V162, P7322; Ploquin MJY, 2012, AIDS, V26, P1269, DOI 10.1097/QAD.0b013e328353e46b; Ranjbar S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002620; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shen L, 2008, NAT MED, V14, P762, DOI 10.1038/nm1777; Solis M, 2011, J VIROL, V85, P1224, DOI 10.1128/JVI.01635-10; Sterjovski J, 2010, VIROLOGY, V404, P269, DOI 10.1016/j.virol.2010.05.006; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Vendrame D, 2009, J VIROL, V83, P10527, DOI 10.1128/JVI.01235-09; Wei W, 2003, HISTOCHEM CELL BIOL, V119, P45, DOI 10.1007/s00418-002-0485-0; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091	70	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84513	10.1371/journal.pone.0084513	http://dx.doi.org/10.1371/journal.pone.0084513			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404168	Green Published, Green Submitted, gold			2022-12-27	WOS:000329460800047
J	Labno, A; Warrier, A; Wang, S; Zhang, X				Labno, Anna; Warrier, Ajithkumar; Wang, Sheng; Zhang, Xiang			Local Plasticity of Dendritic Excitability Can Be Autonomous of Synaptic Plasticity and Regulated by Activity-Based Phosphorylation of Kv4.2	PLOS ONE			English	Article							TIMING-DEPENDENT PLASTICITY; LONG-TERM POTENTIATION; CA1 PYRAMIDAL NEURONS; POTASSIUM CHANNELS; K+ CHANNELS; KINASE-II; EXPRESSION; MEMORY; HIPPOCAMPUS; CURRENTS	While plasticity is typically associated with persistent modifications of synaptic strengths, recent studies indicated that modulations of dendritic excitability may form the other part of the engram and dynamically affect computational processing and output of neuronal circuits. However it remains unknown whether modulation of dendritic excitability is controlled by synaptic changes or whether it can be distinct from them. Here we report the first observation of the induction of a persistent plastic decrease in dendritic excitability decoupled from synaptic stimulation, which is localized and purely activity-based. In rats this local plasticity decrease is conferred by CamKII mediated phosphorylation of A-type potassium channels upon interaction of a back propagating action potential (bAP) with dendritic depolarization.	[Labno, Anna; Warrier, Ajithkumar; Wang, Sheng; Zhang, Xiang] Nanoscale Sci & Engn Ctr, Berkeley, CA USA; [Labno, Anna] Univ Calif Berkeley, Biophys Program, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Zhang, X (corresponding author), Nanoscale Sci & Engn Ctr, Berkeley, CA USA.	xiang@berkeley.edu	Zhang, Xiang/F-6905-2011	Zhang, Xiang/0000-0002-3272-894X	National Institutes of Health through the NIH Roadmap for Medical Research [PN2 EY018228]; National Science Foundation Nano-scale Science and Engineering Center (NSF-NSEC) for Scalable and Integrated NAnoManufacturing (SINAM) [CMMI-0751621]; NATIONAL EYE INSTITUTE [PN2EY018228] Funding Source: NIH RePORTER	National Institutes of Health through the NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Nano-scale Science and Engineering Center (NSF-NSEC) for Scalable and Integrated NAnoManufacturing (SINAM)(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work is supported by the National Institutes of Health through the NIH Roadmap for Medical Research (PN2 EY018228) and the National Science Foundation Nano-scale Science and Engineering Center (NSF-NSEC) for Scalable and Integrated NAnoManufacturing (SINAM) (Grant No. CMMI-0751621). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrasfalvy BK, 2008, J PHYSIOL-LONDON, V586, P3881, DOI 10.1113/jphysiol.2008.154336; Bernard C, 2004, SCIENCE, V305, P532, DOI 10.1126/science.1097065; Birnbaum SG, 2004, PHYSIOL REV, V84, P803, DOI 10.1152/physrev.00039.2003; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Castro PA, 2001, J NEUROSCI, V21, P6626, DOI 10.1523/JNEUROSCI.21-17-06626.2001; Chen XX, 2006, J NEUROSCI, V26, P12143, DOI 10.1523/JNEUROSCI.2667-06.2006; Chi XX, 2000, J NEUROPHYSIOL, V84, P2834, DOI 10.1152/jn.2000.84.6.2834; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; Debanne Dominique, 2010, Front Synaptic Neurosci, V2, P21, DOI 10.3389/fnsyn.2010.00021; Escoubas P, 2002, MOL PHARMACOL, V62, P48, DOI 10.1124/mol.62.1.48; Frick A, 2004, NAT NEUROSCI, V7, P126, DOI 10.1038/nn1178; Giovannini MG, 2001, J NEUROSCI, V21, P7053, DOI 10.1523/JNEUROSCI.21-18-07053.2001; Gollo LL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000402; Gross C, 2011, J NEUROSCI, V31, P5693, DOI 10.1523/JNEUROSCI.6661-10.2011; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Isaac JTR, 2009, J NEUROSCI, V29, P6840, DOI 10.1523/JNEUROSCI.0731-09.2009; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Karmarkar UR, 2002, J NEUROPHYSIOL, V88, P507, DOI 10.1152/jn.2002.88.1.507; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; KOCSIS E, 1991, J STRUCT BIOL, V107, P6, DOI 10.1016/1047-8477(91)90025-R; Lee HY, 2011, NEURON, V72, P630, DOI 10.1016/j.neuron.2011.09.033; Legenstein R, 2011, J NEUROSCI, V31, P10787, DOI 10.1523/JNEUROSCI.5684-10.2011; Lei ZG, 2008, J NEUROCHEM, V106, P182, DOI 10.1111/j.1471-4159.2008.05356.x; Li CY, 2004, NEURON, V41, P257, DOI 10.1016/S0896-6273(03)00847-X; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Mozzachiodi R, 2010, TRENDS NEUROSCI, V33, P17, DOI 10.1016/j.tins.2009.10.001; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nestor MW, 2012, HIPPOCAMPUS, V22, P969, DOI 10.1002/hipo.20899; Niehusmann P, 2010, J NEUROSCI, V30, P6225, DOI 10.1523/JNEUROSCI.6411-09.2010; Ribeiro MJ, 2005, LEARN MEMORY, V12, P538, DOI 10.1101/lm.8305; Rosenkranz JA, 2009, J PHYSIOL-LONDON, V587, P115, DOI 10.1113/jphysiol.2008.158816; Ruiz-Gomez A, 2007, J BIOL CHEM, V282, P1205, DOI 10.1074/jbc.M607166200; Schulz DJ, 2006, J EXP BIOL, V209, P4821, DOI 10.1242/jeb.02567; Sharma SK, 2004, LEARN MEMORY, V11, P373, DOI 10.1101/lm.81104; Sjostrom PJ, 2008, PHYSIOL REV, V88, P769, DOI 10.1152/physrev.00016.2007; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Truchet B, 2012, LEARN MEMORY, V19, P282, DOI 10.1101/lm.025411.111; TSAUR ML, 1992, NEURON, V8, P1055, DOI 10.1016/0896-6273(92)90127-Y; Turrigiano G, 2011, ANNU REV NEUROSCI, V34, P89, DOI 10.1146/annurev-neuro-060909-153238; Varga AW, 2004, J NEUROSCI, V24, P3643, DOI 10.1523/JNEUROSCI.0154-04.2004; Wang S, 2007, NANO LETT, V7, P3859, DOI 10.1021/nl072783t; Watanabe S, 2002, P NATL ACAD SCI USA, V99, P8366, DOI 10.1073/pnas.122210599; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; Yuan LL, 2006, PROG NEUROBIOL, V78, P374, DOI 10.1016/j.pneurobio.2006.03.003; Zarayskiy VV, 2005, TOXICON, V45, P431, DOI 10.1016/j.toxicon.2004.11.015; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhao CP, 2011, HIPPOCAMPUS, V21, P288, DOI 10.1002/hipo.20748; Zou BD, 2005, BRAIN RES, V1033, P78, DOI 10.1016/j.brainres.2004.11.023	52	8	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84086	10.1371/journal.pone.0084086	http://dx.doi.org/10.1371/journal.pone.0084086			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404150	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460800029
J	Oliveira, FTP; Hickey, C; McDonald, JJ				Oliveira, Flavio T. P.; Hickey, Clayton; McDonald, John J.			Proactive and Reactive Processes in the Medial Frontal Cortex: An Electrophysiological Study	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; ERROR-DETECTION; PREFRONTAL CORTEX; RESPONSE CONFLICT; ERP COMPONENTS; FUNCTIONAL-SIGNIFICANCE; INTEGRATIVE THEORY; NEURAL SYSTEM; INHIBITION; ATTENTION	The posterior medial frontal cortex (pMFC) is known to be involved in adaptive goal-directed behavior, but its specific function is not yet clear. Most theories have proposed that the pMFC monitors performance in a reactive manner only, but it is possible that the pMFC also contributes to performance monitoring in a proactive manner. To date, the evidence for proactive pMFC activity is equivocal. Here, we investigated pMFC activity before, during and after the performance of a challenging motor task. Participants navigated a cursor through narrow and wide mazes in randomly intermixed trials. On each trial, participants saw previews of the actual maze display prior to gaining control of the cursor. Event-related potentials (ERPs) to the preview displays were compared to ERPs elicited by no-go signals and errors. Compared to the wider maze, the preview display for the more challenging narrow maze elicited a medial-frontal negativity (MFN) similar to the ERP components elicited by no-go signals and errors. Like these known ERP components, the preview-elicited MFN appeared to be generated from a source in pMFC. This is consistent with the hypothesis that the pMFC participates in adaptive behavior whenever there is a need for increased effort to maintain successful task performance.	[Oliveira, Flavio T. P.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Oliveira, Flavio T. P.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Hickey, Clayton] Vrije Univ Amsterdam, Amsterdam, Netherlands; [McDonald, John J.] Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Vrije Universiteit Amsterdam; Simon Fraser University	Oliveira, FTP (corresponding author), Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA.	oflavio@gmail.com	McDonald, John/P-6966-2015; Hickey, Clayton/ABA-6126-2021	Hickey, Clayton/0000-0002-4162-5643	Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs program; Canada Foundation for Innovation; Canadian Institutes of Health Research; Netherlands Organization for Scientific Research VENI grant [016-125-283]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs program(Canada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Netherlands Organization for Scientific Research VENI grant	This work was supported by the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca), the Canada Research Chairs program (http://www.chairs-chaires.gc.ca), the Canada Foundation for Innovation (http://www.innovation.ca), and the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca). CH is supported by the Netherlands Organization for Scientific Research (http://www.nwo.nl) VENI grant 016-125-283. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts E, 2008, J NEUROSCI, V28, P4671, DOI 10.1523/JNEUROSCI.4400-07.2008; Alexander WH, 2011, NAT NEUROSCI, V14, P1338, DOI 10.1038/nn.2921; Allain S, 2004, NEUROSCI LETT, V372, P161, DOI 10.1016/j.neulet.2004.09.036; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Badgaiyan RD, 1998, NEUROIMAGE, V7, P255, DOI 10.1006/nimg.1998.0326; Baird A, 2006, BRAIN COGNITION, V60, P166, DOI 10.1016/j.bandc.2005.11.003; Botvinick M., 2004, COGNIT NEUROSCI ATTE, P91; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2009, COGN AFFECT BEHAV NE, V9, P16, DOI 10.3758/CABN.9.1.16; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Brown JW, 2007, COGN AFFECT BEHAV NE, V7, P266, DOI 10.3758/CABN.7.4.266; Brown JW, 2005, SCIENCE, V307, P1118, DOI 10.1126/science.1105783; Bunge SA, 2001, BRAIN, V124, P2074, DOI 10.1093/brain/124.10.2074; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; Bush G., 2004, COGNITIVE NEUROSCIEN, P207; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Cohen JD, 2007, PHILOS T R SOC B, V362, P933, DOI 10.1098/rstb.2007.2098; Cohen RA, 1999, J NEUROPSYCH CLIN N, V11, P444, DOI 10.1176/jnp.11.4.444; Cohen RA, 1999, NEUROLOGY, V53, P819, DOI 10.1212/WNL.53.4.819; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; Croxson PL, 2009, J NEUROSCI, V29, P4531, DOI 10.1523/JNEUROSCI.4515-08.2009; De Clercq W, 2006, IEEE T BIO-MED ENG, V53, P2583, DOI 10.1109/TBME.2006.879459; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Donkers FCL, 2004, BRAIN COGNITION, V56, P165, DOI 10.1016/j.bandc.2004.04.005; Falkenstein M, 2002, J PSYCHOPHYSIOL, V16, P167, DOI 10.1027//0269-8803.16.3.167; Falkenstein M, 1999, ACTA PSYCHOL, V101, P267, DOI 10.1016/S0001-6918(99)00008-6; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; Fellows LK, 2005, BRAIN, V128, P788, DOI 10.1093/brain/awh405; Garavan H, 2002, NEUROIMAGE, V17, P1820, DOI 10.1006/nimg.2002.1326; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gomez-Herrero G, 2006, 2006 7TH NORDIC SIGNAL PROCESSING SYMPOSIUM, P130; Grech R, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-25; Hadland KA, 2003, J NEUROPHYSIOL, V89, P1161, DOI 10.1152/jn.00634.2002; Hickey C, 2010, J NEUROSCI, V30, P11096, DOI 10.1523/JNEUROSCI.1026-10.2010; Hoechstetter K., 2010, BESA RES TUTORIAL; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Ide JS, 2013, J NEUROSCI, V33, P2039, DOI 10.1523/JNEUROSCI.2201-12.2013; Isoda M, 2007, NAT NEUROSCI, V10, P240, DOI 10.1038/nn1830; Johnston K, 2007, NEURON, V53, P453, DOI 10.1016/j.neuron.2006.12.023; Jueptner M, 1997, J NEUROPHYSIOL, V77, P1313, DOI 10.1152/jn.1997.77.3.1313; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kiehl KA, 2000, PSYCHOPHYSIOLOGY, V37, P216, DOI 10.1111/1469-8986.3720216; Klein TA, 2007, NEUROIMAGE, V34, P1774, DOI 10.1016/j.neuroimage.2006.11.014; Konishi S, 1999, BRAIN, V122, P981, DOI 10.1093/brain/122.5.981; Luck S. J., 2004, EVENT RELATED POTENT, P17, DOI [DOI 10.1371/JOURNAL.PCBI.0020012, 10.1371/journal.pcbi.0020012]; Luks TL, 2002, NEUROIMAGE, V17, P792, DOI 10.1006/nimg.2002.1210; Luu P, 2004, CLIN NEUROPHYSIOL, V115, P1821, DOI 10.1016/j.clinph.2004.03.031; Luu P, 2003, PSYCHOL SCI, V14, P47, DOI 10.1111/1467-9280.01417; Mathalon DH, 2003, BIOL PSYCHOL, V64, P119, DOI 10.1016/S0301-0511(03)00105-4; Mathalon DH, 2003, NEUROBIOL AGING, V24, P675, DOI 10.1016/S0197-4580(02)00154-9; Milham MP, 2003, NEUROIMAGE, V18, P483, DOI 10.1016/S1053-8119(02)00050-2; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Mulert C, 2005, INT J PSYCHOPHYSIOL, V56, P65, DOI 10.1016/j.ijpsycho.2004.10.002; Mulert C, 2008, NEUROIMAGE, V42, P158, DOI 10.1016/j.neuroimage.2008.04.236; Mulert C, 2007, NEUROPSYCHOLOGIA, V45, P2294, DOI 10.1016/j.neuropsychologia.2007.02.020; Naito E, 2000, J NEUROPHYSIOL, V83, P1701, DOI 10.1152/jn.2000.83.3.1701; Nieuwenhuis S, 2007, CEREB CORTEX, V17, P1570, DOI 10.1093/cercor/bhl068; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; O'Connell RG, 2007, EUR J NEUROSCI, V25, P2571, DOI 10.1111/j.1460-9568.2007.05477.x; Ochsner KN, 2001, NEUROPSYCHOLOGIA, V39, P219, DOI 10.1016/S0028-3932(00)00114-7; Oliveira FTP, 2007, J COGNITIVE NEUROSCI, V19, P1994, DOI 10.1162/jocn.2007.19.12.1994; Overbeek TJM, 2005, J PSYCHOPHYSIOL, V19, P319, DOI 10.1027/0269-8803.19.4.319; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; PAUS T, 1993, J NEUROPHYSIOL, V70, P453, DOI 10.1152/jn.1993.70.2.453; Quilodran R, 2008, NEURON, V57, P314, DOI 10.1016/j.neuron.2007.11.031; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rushworth MFS, 2008, ANN NY ACAD SCI, V1124, P181, DOI 10.1196/annals.1440.014; Rushworth MFS, 2007, CURR OPIN NEUROBIOL, V17, P220, DOI 10.1016/j.conb.2007.03.001; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Schweimer J, 2005, BEHAV NEUROSCI, V119, P1687, DOI 10.1037/0735-7044.119.6.1687; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Taylor PCJ, 2007, J NEUROSCI, V27, P11343, DOI 10.1523/JNEUROSCI.2877-07.2007; THALER D, 1995, EXP BRAIN RES, V102, P445; Ullsperger M, 2006, INT J PSYCHOPHYSIOL, V59, P59, DOI 10.1016/j.ijpsycho.2005.06.010; Van Essen DC, 2002, CURR OPIN NEUROBIOL, V12, P574, DOI 10.1016/S0959-4388(02)00361-6; van Veen V, 2002, J COGNITIVE NEUROSCI, V14, P593, DOI 10.1162/08989290260045837; Walton ME, 2006, NEURAL NETWORKS, V19, P1302, DOI 10.1016/j.neunet.2006.03.005; Walton ME, 2003, J NEUROSCI, V23, P6475; Walton ME, 2002, J NEUROSCI, V22, P10996; Weissman DH, 2005, CEREB CORTEX, V15, P229, DOI 10.1093/cercor/bhh125; Xue G, 2008, CEREB CORTEX, V18, P1923, DOI 10.1093/cercor/bhm220; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI 10.1037/0033-295x.111.4.931; Yeung N, 2009, J NEUROSCI, V29, P14506, DOI 10.1523/JNEUROSCI.3615-09.2009	90	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84351	10.1371/journal.pone.0084351	http://dx.doi.org/10.1371/journal.pone.0084351			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404160	Green Published, Green Submitted, gold			2022-12-27	WOS:000329460800039
J	Tian, F; Zhang, YJ; Li, Y; Xie, Y				Tian, Feng; Zhang, Ya Jie; Li, Yu; Xie, Ying			Celecoxib Ameliorates Non-Alcoholic Steatohepatitis in Type 2 Diabetic Rats via Suppression of the Non-Canonical Wnt Signaling Pathway Expression	PLOS ONE			English	Article							FATTY LIVER-DISEASE; NF-KAPPA-B; INSULIN-RESISTANCE; COLON-CANCER; PPAR-GAMMA; ACTIVATION; BETA; MICE; OBESITY; COX-2	Our aim was to test whether pharmacological inhibition of cycloxygenase-2 (COX-2) reverses non-alcoholic steatohepatitis (NASH) in type 2 diabetes mellitus (T2DM) rats via suppression of the non-canonical Wnt signaling pathway expression. Twenty-four male Sprague-Dawley rats were randomly distributed to two groups and were fed with a high fat and sucrose (HF-HS) diet or a normal chow diet, respectively. After four weeks, rats fed with a HF-HS diet were made diabetic with low-dose streptozotocin. At the 9th week the diabetic rats fed with a HF-HS diet or the non-diabetic rats fed with a normal chow diet were further divided into two subgroups treated with vehicle or celecoxib (a selective COX-2 inhibitor, 10 mg/Kg/day, gavage) for the last 4 weeks, respectively. At the end of the 12th week, rats were anesthetized. NASH was assessed by histology. Related cytokine expression was measured at both the protein and gene levels through immunohistochemistry (IHC), Western blot and real-time PCR. T2DM rats fed with a HF-HS diet developed steatohepatitis and insulin resistance associated with elevated serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), insulin levels and the nonalcoholic fatty liver disease (NAFLD) activity score (NAS). The expression of Wnt5a, JNK1, NF-kappa B p65, and COX-2 were all significantly increased in the T2DM-NASH group compared with the control and control-cele group. Hepatic injury was improved by celecoxib in T2DM-NASH-Cele group indicated by reduced serum ALT and AST levels and hepatic inflammation was reduced by celecoxib showed by histology and the NAFLD activity score (NAS). Serum related metabolic parameters, HOMA-IR and insulin sensitivity index were all improved by celecoxib. The expression of Wnt5a, JNK1, NF-kappa B p65, and COX-2 expression were all suppressed by celecoxib in T2DM-NASH-Cele group. The results of the present study indicated that celecoxib ameliorated NASH in T2DM rats via suppression of the non-canonical Wnt5a/JNK1 signaling pathway expression.	[Tian, Feng; Zhang, Ya Jie; Xie, Ying] China Med Univ, Shengjing Hosp, Dept Gastroenterol, Shenyang, Liaoning Provin, Peoples R China; [Li, Yu] Third Peoples Hosp Dalian City, Dept Gastroenterol, Dalian, Liaoning Provin, Peoples R China	China Medical University	Tian, F (corresponding author), China Med Univ, Shengjing Hosp, Dept Gastroenterol, Shenyang, Liaoning Provin, Peoples R China.	tianfeng@sj-hospital.org			Science and Technology Program of Liaoning Province [2010225034]	Science and Technology Program of Liaoning Province	The article was supported by Science and Technology Program of Liaoning Province(2010225034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiola M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008509; Behari J, 2010, AM J PATHOL, V176, P744, DOI 10.2353/ajpath.2010.090667; Benitah SA, 2003, MOL BIOL CELL, V14, P3041, DOI 10.1091/mbc.E03-01-0016; Boden G, 2005, DIABETES, V54, P3458, DOI 10.2337/diabetes.54.12.3458; Braunersreuther V, 2012, WORLD J GASTROENTERO, V18, P727, DOI 10.3748/wjg.v18.i8.727; Brunt EM, 2011, HEPATOLOGY, V53, P810, DOI 10.1002/hep.24127; Buchanan FG, 2006, CANCER CELL, V9, P6, DOI 10.1016/j.ccr.2005.12.029; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chatrath H, 2012, SEMIN LIVER DIS, V32, P22, DOI 10.1055/s-0032-1306423; Clark JM, 2006, J CLIN GASTROENTEROL, V40, pS5; Dela Pena A, 2005, GASTROENTEROLOGY, V129, P1663, DOI 10.1053/j.gastro.2005.09.004; Fukuda T, 2008, P NATL ACAD SCI USA, V105, P3047, DOI 10.1073/pnas.0712148105; Gustafson B, 2006, J BIOL CHEM, V281, P9507, DOI 10.1074/jbc.M512077200; Hsieh PS, 2009, OBESITY, V17, P1150, DOI 10.1038/oby.2008.674; Katoh M, 2009, INT J MOL MED, V23, P763, DOI 10.3892/ijmm_00000190; Kawai M, 2007, BIOCHEM BIOPH RES CO, V363, P276, DOI 10.1016/j.bbrc.2007.08.088; Kikuchi A, 2012, ACTA PHYSIOL, V204, P17, DOI 10.1111/j.1748-1716.2011.02294.x; Leclercq IA, 2004, J HEPATOL, V41, P926, DOI 10.1016/j.jhep.2004.08.010; Lehwald N, 2012, GASTROENTEROLOGY, V143, P754, DOI 10.1053/j.gastro.2012.05.048; Lo L, 2011, J HEPATOL, V55, P435, DOI 10.1016/j.jhep.2010.10.039; Lu SY, 2007, EXP BIOL MED, V232, P643; Morris EM, 2011, ANTIOXID REDOX SIGN, V15, P485, DOI 10.1089/ars.2010.3795; Musso G, 2010, OBES REV, V11, P430, DOI 10.1111/j.1467-789X.2009.00657.x; Nunez F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018562; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; Rivera Chantal A, 2008, Pathophysiology, V15, P109, DOI 10.1016/j.pathophys.2008.04.003; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Schulte DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032437; Sheth SG, 1997, ANN INTERN MED, V126, P137, DOI 10.7326/0003-4819-126-2-199701150-00008; Tuynman JB, 2008, CANCER RES, V68, P1213, DOI 10.1158/0008-5472.CAN-07-5172; Vaish V, 2010, TUMOR BIOL, V31, P427, DOI 10.1007/s13277-010-0051-7; Vandoros GP, 2006, J CANCER RES CLIN, V132, P76, DOI 10.1007/s00432-005-0042-z; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wu HT, 2010, HORM METAB RES, V42, P775, DOI 10.1055/s-0030-1261952; Yu J, 2006, HEPATOLOGY, V43, P826, DOI 10.1002/hep.21108; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620	37	27	30	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e83819	10.1371/journal.pone.0083819	http://dx.doi.org/10.1371/journal.pone.0083819			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404139	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460800018
J	Assefa, Z; Lavens, A; Steyaert, C; Stange, G; Martens, GA; Ling, ZD; Hellemans, K; Pipeleers, D				Assefa, Zerihun; Lavens, Astrid; Steyaert, Christophe; Stange, Geert; Martens, Geert A.; Ling, Zhidong; Hellemans, Karine; Pipeleers, Daniel			Glucose Regulates Rat Beta Cell Number through Age-Dependent Effects on Beta Cell Survival and Proliferation	PLOS ONE			English	Article							PANCREATIC B-CELLS; INSULIN-RESISTANCE; POTENTIAL ROLE; GROWTH-FACTORS; REPLICATION; CAPACITY; MICE; REGENERATION; GLUCOKINASE; SECRETION	Background: Glucose effects on beta cell survival and DNA-synthesis suggest a role as regulator of beta cell mass but data on beta cell numbers are lacking. We examined outcome of these influences on the number of beta cells isolated at different growth stages in their population. Methods: Beta cells from neonatal, young-adult and old rats were cultured serum-free for 15 days. Their number was counted by automated whole-well imaging distinguishing influences on cell survival and on proliferative activity. Results: Elevated glucose (10-20 versus 5 mmol/l) increased the number of living beta cells from 8-week rats to 30%, following a time-and concentration-dependent recruitment of quiescent cells into DNA-synthesis; a glucokinase-activator lowered the threshold but did not raise total numbers of glucose-recruitable cells. No glucose-induced increase occurred in beta cells from 40-week rats. Neonatal beta cells doubled in number at 5 mmol/l involving a larger activated fraction that did not increase at higher concentrations; however, their higher susceptibility to glucose toxicity at 20 mmol/l resulted in 20% lower living cell numbers than at start. None of the age groups exhibited a repetitively proliferating subpopulation. Conclusions: Chronically elevated glucose levels increased the number of beta cells from young-adult but not from old rats; they interfered with expansion of neonatal beta cells and reduced their number. These effects are attributed to age-dependent differences in basal and glucose-induced proliferative activity and in cellular susceptibility to glucose toxicity. They also reflect age-dependent variations in the functional heterogeneity of the rat beta cell population.	[Pipeleers, Daniel] Brussels Free Univ VUB, Diabet Res Ctr, Diabet Pathol & Therapy Unit, Brussels, Belgium; Brussels Free Univ VUB, Ctr Beta Cell Therapy, Brussels, Belgium	Vrije Universiteit Brussel; Vrije Universiteit Brussel	Pipeleers, D (corresponding author), Brussels Free Univ VUB, Diabet Res Ctr, Diabet Pathol & Therapy Unit, Brussels, Belgium.	daniel.pipeleers@vub.ac.be	Assefa, Zerihun/V-5641-2017; Martens, Geert/ABA-6297-2020; Hellemans, Karine/B-7573-2013; stange, geert m/C-1092-2009; Martens, Geert A./F-6920-2015	Assefa, Zerihun/0000-0001-7803-5228; Martens, Geert/0000-0003-1208-6289; Hellemans, Karine/0000-0001-9306-4369; stange, geert m/0000-0003-3148-1372; Martens, Geert A./0000-0003-1208-6289; Pipeleers, Daniel/0000-0002-6440-2485	Belgian Science Policy (Interuniversity Attraction Poles phase VI) [IAP P6/40]; Agency for Innovation by Science and Technology in Flanders (IWT) [SBO/040084]; Research Foundation Flanders (FWO) [G.0428.09N, G.0400.07N]; VUB Research Council [IOF742]; IWT PhD fellowship; IWT Innovation Mandate	Belgian Science Policy (Interuniversity Attraction Poles phase VI); Agency for Innovation by Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Research Foundation Flanders (FWO)(FWO); VUB Research Council; IWT PhD fellowship; IWT Innovation Mandate	This study was supported by grants from the Belgian Science Policy (Interuniversity Attraction Poles phase VI, IAP P6/40), the Agency for Innovation by Science and Technology in Flanders (IWT; SBO/040084), the Research Foundation Flanders (FWO; G.0428.09N, and G.0400.07N) and the VUB Research Council (IOF742). Z. A. is a recipient of an IWT Innovation Mandate and A. L. was supported by an IWT PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo-Mazzucato C, 2011, DIABETOLOGIA, V54, P583, DOI 10.1007/s00125-010-2026-z; Alonso LC, 2007, DIABETES, V56, P1792, DOI 10.2337/db06-1513; Assmann A, 2009, MOL CELL BIOL, V29, P3219, DOI 10.1128/MCB.01489-08; BONNERWEIR S, 1989, DIABETES, V38, P49, DOI 10.2337/diabetes.38.1.49; Bosco D, 2000, DIABETES, V49, P233, DOI 10.2337/diabetes.49.2.233; Brennand K, 2007, PLOS BIOL, V5, P1520, DOI 10.1371/journal.pbio.0050163; Chang AM, 2003, AM J PHYSIOL-ENDOC M, V284, pE7, DOI 10.1152/ajpendo.00366.2002; CHICK WL, 1973, DIABETES, V22, P687, DOI 10.2337/diab.22.9.687; Chintinne M, 2010, DIABETOLOGIA, V53, P2380, DOI 10.1007/s00125-010-1851-4; Dadon D, 2012, DIABETES OBES METAB, V14, P101, DOI 10.1111/j.1463-1326.2012.01646.x; Ferrer J, 2011, CELL METAB, V13, P357, DOI 10.1016/j.cmet.2011.03.014; Grimsby J, 2003, SCIENCE, V301, P370, DOI 10.1126/science.1084073; Gunasekaran U, 2012, CELL CYCLE, V11, P2431, DOI 10.4161/cc.20545; HEIMBERG H, 1993, EMBO J, V12, P2873, DOI 10.1002/j.1460-2075.1993.tb05949.x; Heit JJ, 2006, ANNU REV CELL DEV BI, V22, P311, DOI 10.1146/annurev.cellbio.22.010305.104425; Hellemans KH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007266; HELLERSTROM C, 1991, DIABETES, V40, P89, DOI 10.2337/diab.40.2.S89; Hija A, 2013, DIABETES IN PRESS; Hoorens A, 1996, J CLIN INVEST, V98, P1568, DOI 10.1172/JCI118950; Hugl SR, 1998, J BIOL CHEM, V273, P17771, DOI 10.1074/jbc.273.28.17771; Jermendy A, 2011, DIABETOLOGIA, V54, P594, DOI 10.1007/s00125-010-2036-x; JETTON TL, 1992, P NATL ACAD SCI USA, V89, P2619, DOI 10.1073/pnas.89.7.2619; KIEKENS R, 1992, J CLIN INVEST, V89, P117, DOI 10.1172/JCI115551; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Kwon G, 2006, J BIOL CHEM, V281, P3261, DOI 10.1074/jbc.M508821200; Kwon G, 2004, DIABETES, V53, pS225, DOI 10.2337/diabetes.53.suppl_3.S225; LING Z, 1994, DIABETOLOGIA, V37, P15; LING ZD, 1994, ENDOCRINOLOGY, V134, P2614, DOI 10.1210/en.134.6.2614; Liu YM, 2009, DIABETES OBES METAB, V11, P54, DOI 10.1111/j.1463-1326.2009.01107.x; Maedler K, 2001, DIABETES, V50, P1683, DOI 10.2337/diabetes.50.8.1683; Maedler K, 2006, DIABETES, V55, P2455, DOI 10.2337/db05-1586; Martens GA, 2005, J BIOL CHEM, V280, P20389, DOI 10.1074/jbc.M411869200; Martens GA, 2013, J MOL ENDOC IN PRESS; Martens GA, 2009, VITAM HORM, V80, P507, DOI 10.1016/S0083-6729(08)00617-1; Metukuri MR, 2012, DIABETES, V61, P2004, DOI 10.2337/db11-0802; Navarro-Tableros V, 2007, AM J PHYSIOL-ENDOC M, V292, pE1018, DOI 10.1152/ajpendo.00457.2006; Nielsen JH, 2001, DIABETES, V50, pS25, DOI 10.2337/diabetes.50.2007.S25; Parnaud G, 2008, DIABETOLOGIA, V51, P91, DOI 10.1007/s00125-007-0855-1; Parnaud G, 2009, MOL ENDOCRINOL, V23, P1264, DOI 10.1210/me.2009-0008; Perl S, 2010, J CLIN ENDOCR METAB, V95, pE234, DOI 10.1210/jc.2010-0932; PIPELEERS D, 1994, DIABETOLOGIA, V37, pS57, DOI 10.1007/BF00400827; PIPELEERS DG, 1985, ENDOCRINOLOGY, V117, P806, DOI 10.1210/endo-117-3-806; PIPELEERS DG, 1985, ENDOCRINOLOGY, V117, P824, DOI 10.1210/endo-117-3-824; Porat S, 2011, CELL METAB, V13, P440, DOI 10.1016/j.cmet.2011.02.012; Rankin MM, 2009, DIABETES, V58, P1365, DOI 10.2337/db08-1198; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; Salpeter SJ, 2010, DEVELOPMENT, V137, P3205, DOI 10.1242/dev.054304; Stolovich-Rain M, 2012, J BIOL CHEM, V287, P27407, DOI 10.1074/jbc.M112.350736; SWENNE I, 1983, DIABETES, V32, P14, DOI 10.2337/diabetes.32.1.14; SWENNE I, 1982, DIABETES, V31, P754, DOI 10.2337/diab.31.9.754; Terauchi Y, 2007, J CLIN INVEST, V117, P246, DOI 10.1172/JCI17645; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Tschen SI, 2009, DIABETES, V58, P1312, DOI 10.2337/db08-1651; Wei P, 2009, DIABETOLOGIA, V52, P2142, DOI 10.1007/s00125-009-1446-0; Weir GC, 2007, J CLIN INVEST, V117, P81, DOI 10.1172/JCI30862	56	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85174	10.1371/journal.pone.0085174	http://dx.doi.org/10.1371/journal.pone.0085174			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416358	gold, Green Published, Green Submitted			2022-12-27	WOS:000329866300053
J	Beijamini, F; Pereira, SIR; Cini, FA; Louzada, FM				Beijamini, Felipe; Ribeiro Pereira, Sofia Isabel; Cini, Felipe Augusto; Louzada, Fernando Mazzilli			After Being Challenged by a Video Game Problem, Sleep Increases the Chance to Solve It	PLOS ONE			English	Article							SLOW-WAVE SLEEP; LATE-NIGHT SLEEP; HUMAN HIPPOCAMPUS; MEMORY; REACTIVATION; EXPERIENCE; CREATIVITY; INSIGHT; NAP	In the past years many studies have demonstrated the role of sleep on memory consolidation. It is known that sleeping after learning a declarative or non-declarative task, is better than remaining awake. Furthermore, there are reports of a possible role for dreams in consolidation of declarative memories. Other studies have reported the effect of naps on memory consolidation. With similar protocols, another set of studies indicated that sleep has a role in creativity and problem-solving. Here we hypothesised that sleep can increase the likelihood of solving problems. After struggling to solve a video game problem, subjects who took a nap (n = 14) were almost twice as likely to solve it when compared to the wake control group (n = 15). It is interesting to note that, in the nap group 9 out 14 subjects engaged in slow-wave sleep (SWS) and all solved the problem. Surprisingly, we did not find a significant involvement of Rapid Eye Movement (REM) sleep in this task. Slow-wave sleep is believed to be crucial for the transfer of memory-related information to the neocortex and implement intentions. Sleep can benefit problem-solving through the generalisation of newly encoded information and abstraction of the gist. In conclusion, our results indicate that sleep, even a nap, can potentiate the solution of problems that involve logical reasoning. Thus, sleep's function seems to go beyond memory consolidation to include managing of everyday-life events.	[Beijamini, Felipe; Ribeiro Pereira, Sofia Isabel; Cini, Felipe Augusto; Louzada, Fernando Mazzilli] Univ Fed Parana, Dept Fisiol, Lab Cronobiol Humana, BR-80060000 Curitiba, Parana, Brazil	Universidade Federal do Parana	Beijamini, F (corresponding author), Univ Fed Parana, Dept Fisiol, Lab Cronobiol Humana, BR-80060000 Curitiba, Parana, Brazil.	beijamini@gmail.com	Beijamini, Felipe/B-5670-2015; Louzada, Fernando/N-9809-2016	Beijamini, Felipe/0000-0002-8632-2101; Louzada, Fernando/0000-0002-4982-8082; Cini, Felipe Augusto/0000-0002-7252-8854	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); CNPq Productivity Fellowship; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq Productivity Fellowship(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). FML is recipient of a CNPq Productivity Fellowship. FB and SIRP are supported by a doctorate fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alger SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012131; Antony JW, 2012, NAT NEUROSCI, V15, P1114, DOI 10.1038/nn.3152; Buckner RL, 2010, ANNU REV PSYCHOL, V61, P27, DOI 10.1146/annurev.psych.60.110707.163508; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Cai DJ, 2009, P NATL ACAD SCI USA, V106, P10130, DOI 10.1073/pnas.0900271106; Diekelmann S, 2013, SLEEP, V36, P149, DOI 10.5665/sleep.2322; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Diekelmann S, 2009, SLEEP MED REV, V13, P309, DOI 10.1016/j.smrv.2008.08.002; Drago V, 2011, SLEEP MED, V12, P361, DOI 10.1016/j.sleep.2010.11.009; Ellenbogen JM, 2007, P NATL ACAD SCI USA, V104, P7723, DOI 10.1073/pnas.0700094104; Fischer S, 2011, J SLEEP RES, V20, P267, DOI 10.1111/j.1365-2869.2010.00881.x; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Iber C., 2007, AASM MANUAL SCORING; Lau H, 2010, NEUROBIOL LEARN MEM, V93, P554, DOI 10.1016/j.nlm.2010.02.003; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Lewis PA, 2011, TRENDS COGN SCI, V15, P343, DOI 10.1016/j.tics.2011.06.004; Marshall U, 2007, TRENDS COGN SCI, V11, P442, DOI 10.1016/j.tics.2007.09.001; Mednick S, 2003, NAT NEUROSCI, V6, P697, DOI 10.1038/nn1078; Nieuwenhuis ILC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065046; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Ribeiro S, 2004, LEARN MEMORY, V11, P686, DOI 10.1101/lm.75604; Ritter SM, 2012, J SLEEP RES, V21, P643, DOI 10.1111/j.1365-2869.2012.01006.x; Rudoy JD, 2009, SCIENCE, V326, P1079, DOI 10.1126/science.1179013; Sio UN, 2013, MEM COGNITION, V41, P159, DOI 10.3758/s13421-012-0256-7; Stickgold R, 2013, NAT NEUROSCI, V16, P139, DOI 10.1038/nn.3303; Wagner U, 2004, NATURE, V427, P352, DOI 10.1038/nature02223; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Wamsley EJ, 2010, LEARN MEMORY, V17, P332, DOI 10.1101/lm.1828310; Wamsley EJ, 2010, CURR BIOL, V20, P850, DOI 10.1016/j.cub.2010.03.027; Wilhelm I, 2011, J NEUROSCI, V31, P1563, DOI 10.1523/JNEUROSCI.3575-10.2011; Yordanova J, 2008, LEARN MEMORY, V15, P508, DOI 10.1101/lm.897908; Yordanova J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009442; Yordanova J, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.040.2009	35	30	31	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84342	10.1371/journal.pone.0084342	http://dx.doi.org/10.1371/journal.pone.0084342			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291WL	24416219	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000329862500116
J	Cui, F; Arnstein, D; Thomas, RM; Maurits, NM; Keysers, C; Gazzola, V				Cui, Fang; Arnstein, Dan; Thomas, Rajat Mani; Maurits, Natasha M.; Keysers, Christian; Gazzola, Valeria			Functional Magnetic Resonance Imaging Connectivity Analyses Reveal Efference-Copy to Primary Somatosensory Area, BA2	PLOS ONE			English	Article							INFERIOR PARIETAL; INTERINDIVIDUAL VARIABILITY; CYTOARCHITECTONIC MAPS; MOTOR CONTROL; CORTEX; MOVEMENTS; BRAIN; SUPPRESSION; PERCEPTION; PREDICTION	Some theories of motor control suggest efference-copies of motor commands reach somatosensory cortices. Here we used functional magnetic resonance imaging to test these models. We varied the amount of efference-copy signal by making participants squeeze a soft material either actively or passively. We found electromyographical recordings, an efference-copy proxy, to predict activity in primary somatosensory regions, in particular Brodmann Area (BA) 2. Partial correlation analyses confirmed that brain activity in cortical structures associated with motor control (premotor and supplementary motor cortices, the parietal area PF and the cerebellum) predicts brain activity in BA2 without being entirely mediated by activity in early somatosensory (BA3b) cortex. Our study therefore provides valuable empirical evidence for efference-copy models of motor control, and shows that signals in BA2 can indeed reflect an input from motor cortices and suggests that we should interpret activations in BA2 as evidence for somatosensory-motor rather than somatosensory coding alone.	[Cui, Fang; Arnstein, Dan; Keysers, Christian; Gazzola, Valeria] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Groningen, Netherlands; [Cui, Fang; Arnstein, Dan; Keysers, Christian; Gazzola, Valeria] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Cui, Fang; Thomas, Rajat Mani; Keysers, Christian; Gazzola, Valeria] Netherlands Inst Neurosci, Amsterdam, Netherlands; [Maurits, Natasha M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands	University of Groningen; University of Groningen; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Groningen	Gazzola, V (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Groningen, Netherlands.	v.gazzola@nin.knaw.nl	Keysers, Christian/H-6251-2013	Keysers, Christian/0000-0002-2845-5467; Maurits, Natasha/0000-0001-6231-7044; Gazzola, Valeria/0000-0003-0324-0619	European Commission; Dutch science foundation; N.W.O; Fulbright scholarship; China Scholarship Council for State Scholarship Fund	European Commission(European CommissionEuropean Commission Joint Research Centre); Dutch science foundation(Netherlands Organization for Scientific Research (NWO)); N.W.O(Netherlands Organization for Scientific Research (NWO)); Fulbright scholarship; China Scholarship Council for State Scholarship Fund(China Scholarship Council)	The work was supported by a Marie Curie Excellence Grant of the European Commission and a VIDI grant of the Dutch science foundation to CK (N.W.O.), a VENI grant of N.W.O.to VG, Fulbright scholarship to DA and the China Scholarship Council for State Scholarship Fund to FC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew Z, 2008, J NEUROSCI, V28, P12268, DOI 10.1523/JNEUROSCI.2836-08.2008; Allen PJ, 2000, NEUROIMAGE, V12, P230, DOI 10.1006/nimg.2000.0599; Arnstein D, 2011, J NEUROSCI, V31, P14243, DOI 10.1523/JNEUROSCI.0963-11.2011; Banerjee O, 2006, CONVEX OPTIMIZATION; Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; Blakemore SJ, 1999, J COGNITIVE NEUROSCI, V11, P551, DOI 10.1162/089892999563607; Caspers S, 2008, BRAIN STRUCT FUNCT, V212, P481, DOI 10.1007/s00429-008-0195-z; Caspers S, 2006, NEUROIMAGE, V33, P430, DOI 10.1016/j.neuroimage.2006.06.054; Caspers S, 2010, NEUROIMAGE, V50, P1148, DOI 10.1016/j.neuroimage.2009.12.112; Christensen MS, 2007, NAT NEUROSCI, V10, P417, DOI 10.1038/nn1873; Desmurget M, 2009, SCIENCE, V324, P811, DOI 10.1126/science.1169896; Diedrichsen J, 2009, NEUROIMAGE, V46, P39, DOI 10.1016/j.neuroimage.2009.01.045; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eickhoff SB, 2006, NEUROIMAGE, V32, P570, DOI 10.1016/j.neuroimage.2006.04.204; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; Gazzola V, 2009, CEREB CORTEX, V19, P1239, DOI 10.1093/cercor/bhn181; Geyer S, 2000, NEUROIMAGE, V11, P684, DOI 10.1006/nimg.2000.0548; Geyer S, 1999, NEUROIMAGE, V10, P63, DOI 10.1006/nimg.1999.0440; Geyer S, 1996, NATURE, V382, P805, DOI 10.1038/382805a0; Geyer S, 2004, ADV ANATOMY EMBRYOLO, V174, pI; Grefkes C, 2001, NEUROIMAGE, V14, P617, DOI 10.1006/nimg.2001.0858; Haggard P, 2004, COGNITIVE BRAIN RES, V19, P52, DOI 10.1016/j.cogbrainres.2003.10.018; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; JONES EG, 1978, J COMP NEUROL, V181, P291, DOI 10.1002/cne.901810206; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Keysers C, 2010, NAT REV NEUROSCI, V11, P417, DOI 10.1038/nrn2833; Keysers C, 2009, CURR OPIN NEUROBIOL, V19, P666, DOI 10.1016/j.conb.2009.10.006; London BM, 2013, J NEUROPHYSIOL, V109, P1505, DOI 10.1152/jn.00372.2012; Marrelec G, 2006, NEUROIMAGE, V32, P228, DOI 10.1016/j.neuroimage.2005.12.057; Meinshausen N, 2006, ANN STAT, V34, P1436, DOI 10.1214/009053606000000281; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; MISTLIN AJ, 1990, EXP BRAIN RES, V82, P437; Myers LJ, 2003, J NEUROSCI METH, V124, P157, DOI 10.1016/S0165-0270(03)00004-9; Petreanu L, 2012, NATURE, V489, P299, DOI 10.1038/nature11321; Poldrack RA, 2006, TRENDS COGN SCI, V10, P59, DOI 10.1016/j.tics.2005.12.004; PONS TP, 1986, J COMP NEUROL, V248, P313, DOI 10.1002/cne.902480303; Ramnani N, 2012, CEREBELLUM, V11, P366, DOI 10.1007/s12311-011-0272-3; Rozzi S, 2006, CEREB CORTEX, V16, P1389, DOI 10.1093/cercor/bhj076; Schippers MB, 2011, NEUROIMAGE, V57, P22, DOI 10.1016/j.neuroimage.2011.02.008; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; van Duinen H, 2005, NEUROIMAGE, V27, P240, DOI 10.1016/j.neuroimage.2005.04.003; van Duinen H, 2008, HUM BRAIN MAPP, V29, P281, DOI 10.1002/hbm.20388; Van Rootselaar AF, 2007, HUM BRAIN MAPP, V28, P1117, DOI 10.1002/hbm.20336; Weber DJ, 2011, IEEE T NEUR SYS REH, V19, P501, DOI 10.1109/TNSRE.2011.2163145; Weiller C, 1996, NEUROIMAGE, V4, P105, DOI 10.1006/nimg.1996.0034; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8	49	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84367	10.1371/journal.pone.0084367	http://dx.doi.org/10.1371/journal.pone.0084367			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416222	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500119
J	de Boer, HJ; Ouarghidi, A; Martin, G; Abbad, A; Kool, A				de Boer, Hugo J.; Ouarghidi, Abderrahim; Martin, Gary; Abbad, Abdelaziz; Kool, Anneleen			DNA Barcoding Reveals Limited Accuracy of Identifications Based on Folk Taxonomy	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; MOLECULAR-IDENTIFICATION; RETICULATE EVOLUTION; SEQUENCE; PLANTS; GENUS; BIOGEOGRAPHY; SELECTION	Background: The trade of plant roots as traditional medicine is an important source of income for many people around the world. Destructive harvesting practices threaten the existence of some plant species. Harvesters of medicinal roots identify the collected species according to their own folk taxonomies, but once the dried or powdered roots enter the chain of commercialization, accurate identification becomes more challenging. Methodology: A survey of morphological diversity among four root products traded in the medina of Marrakech was conducted. Fifty-one root samples were selected for molecular identification using DNA barcoding using three markers, trnH-psbA, rpoC1, and ITS. Sequences were searched using BLAST against a tailored reference database of Moroccan medicinal plants and their closest relatives submitted to NCBI GenBank. Principal Findings: Combining psbA-trnH, rpoC1, and ITS allowed the majority of the market samples to be identified to species level. Few of the species level barcoding identifications matched the scientific names given in the literature, including the most authoritative and widely cited pharmacopeia. Conclusions/Significance: The four root complexes selected from the medicinal plant products traded in Marrakech all comprise more than one species, but not those previously asserted. The findings have major implications for the monitoring of trade in endangered plant species as morphology-based species identifications alone may not be accurate. As a result, trade in certain species may be overestimated, whereas the commercialization of other species may not be recorded at all.	[de Boer, Hugo J.] Uppsala Univ, Dept Organismal Biol, Evolutionary Biol Ctr, Uppsala, Sweden; [de Boer, Hugo J.] Nat Biodivers Ctr, Leiden, Netherlands; [de Boer, Hugo J.; Kool, Anneleen] Univ Oslo, Nat Hist Museum, Oslo, Norway; [Ouarghidi, Abderrahim; Abbad, Abdelaziz] Cadi Ayyad Univ, Fac Sci Semlalia, Marrakech, Morocco; [Ouarghidi, Abderrahim; Abbad, Abdelaziz] Global Div Fdn, Marrakech, Morocco	Uppsala University; Naturalis Biodiversity Center; University of Oslo; Cadi Ayyad University of Marrakech	Kool, A (corresponding author), Univ Oslo, Nat Hist Museum, Oslo, Norway.	anneleen.kool@nhm.uio.no	de Boer, Hugo Joris/AAS-7585-2020; de Boer, Hugo/B-5640-2015	de Boer, Hugo Joris/0000-0003-1985-7859; de Boer, Hugo/0000-0003-1985-7859	SRL-MENA grant from the Swedish Research Council; Sida; Formas	SRL-MENA grant from the Swedish Research Council(Swedish Research Council); Sida; Formas(Swedish Research Council Formas)	This study was funded through a SRL-MENA grant from the Swedish Research Council, Sida and Formas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ARNASON U, 1991, HEREDITAS, V115, P183, DOI 10.1111/j.1601-5223.1991.tb03554.x; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Barthelson RA, 2006, AM J BOT, V93, P566, DOI 10.3732/ajb.93.4.566; BELLAKHDAR J, 1991, J ETHNOPHARMACOL, V35, P123, DOI 10.1016/0378-8741(91)90064-K; Bellakhdar J, 1997, PHARM MEROCAINE TRAD; Bellakhdar J, 1982, HERB DRUGS HERBALIST; BERLIN B, 1992, ETHNOBIOLOGICAL CLAS; Bertolazzi P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S7; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Boulos L., 1983, Medicinal plants of North Africa.; Brysting AK, 2007, SYST BIOL, V56, P467, DOI 10.1080/10635150701424553; Caldeira RL, 1998, MEM I OSWALDO CRUZ, V93, P219, DOI 10.1590/S0074-02761998000700039; Chase MW, 2009, SCIENCE, V325, P682, DOI 10.1126/science.1176906; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Cho Y, 2004, P NATL ACAD SCI USA, V101, P17741, DOI 10.1073/pnas.0408302101; Cunningham AB, 1993, PEOPLE PLANTS WORKIN, V1, P1; DasGupa B, 2005, BIOINFORMATICS, V21, P3424, DOI 10.1093/bioinformatics/bti547; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Dondoshansky I, 2002, BLASTCLUST NCBI SOFT; El-Hilaly J, 2003, J ETHNOPHARMACOL, V86, P149, DOI 10.1016/S0378-8741(03)00012-6; Eurlings MCM, 2010, FORENSIC SCI INT, V197, P30, DOI 10.1016/j.forsciint.2009.12.017; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Fennane M., 1998, BOCCONEA, V8, P1; Fennane M, 2007, FLORE PRATIQUE MAROC, V2; Fennane M, 2005, FLORE VASCULAIRE MAR; Fennane M, 1999, TRAV I SCI RABAT, V1, P1; Ford CS, 2009, BOT J LINN SOC, V159, P1, DOI 10.1111/j.1095-8339.2008.00938.x; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; GarnockJones PJ, 1996, PLANT SYST EVOL, V202, P211, DOI 10.1007/BF00983383; Hanelt P, 2001, MANSFELDS ENCY AGR H, P1; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth PM, 2011, P NATL ACAD SCI USA, V108, P19451, DOI 10.1073/pnas.1116812108; Humphries CJ, 1979, B BRIT MUS NAT HIST, V7, P83; Ibn Tattou M, 2008, FLORE VASCULAIRE MAR, V2; IUCN Centre for Mediterranean Cooperation, 2005, GUID MED PLANTS N AF; Ize-Ludlow D, 2004, PEDIATRICS, V114, pE653, DOI 10.1542/peds.2004-0058; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; Kool A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039459; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; LINARES E, 1987, J ETHNOPHARMACOL, V19, P153, DOI 10.1016/0378-8741(87)90039-0; Little DP, 2007, CLADISTICS, V23, P1, DOI 10.1111/j.1096-0031.2006.00126.x; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Munch K, 2008, SYSTEMATIC BIOL; Munch K, 2008, PHILOS T R SOC B, V363, P3997, DOI 10.1098/rstb.2008.0169; Ouarghidi A, 2007, THESIS CADI AYYAD U; Ouarghidi A, 2012, ECON BOT, V66, P370, DOI 10.1007/s12231-012-9215-2; Rach J, 2008, P ROY SOC B-BIOL SCI, V275, P237, DOI 10.1098/rspb.2007.1290; RASMUSSEN U, 1981, PLANTA MED, V43, P336, DOI 10.1055/s-2007-971521; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; RBG-K, 2007, ROYAL BOT GARD KEW D; Sarkinen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043808; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; SANG T, 1995, P NATL ACAD SCI USA, V92, P6813, DOI 10.1073/pnas.92.15.6813; Sass C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001154; Smith MA, 2008, MOL ECOL RESOUR, V8, P235, DOI 10.1111/j.1471-8286.2007.01964.x; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; Staats M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028448; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Stull GW, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1200497; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Valdes B, 2002, CATALOGUE PLANTES VA, V2; Valdes B, 2002, CATALOGUE PLANTES VA, V1; van Velzen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030490; Vanhaecke D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032939; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; YOON CS, 1991, MYCOLOGIA, V83, P835, DOI 10.2307/3760446	70	37	37	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84291	10.1371/journal.pone.0084291	http://dx.doi.org/10.1371/journal.pone.0084291			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416210	gold, Green Published, Green Submitted			2022-12-27	WOS:000329862500108
J	Heuertz, M; Duminil, J; Dauby, G; Savolainen, V; Hardy, OJ				Heuertz, Myriam; Duminil, Jerome; Dauby, Gilles; Savolainen, Vincent; Hardy, Olivier J.			Comparative Phylogeography in Rainforest Trees from Lower Guinea, Africa	PLOS ONE			English	Article							SANTIRIA-TRIMERA BURSERACEAE; SPATIAL GENETIC-STRUCTURE; COMPUTER-PROGRAM; ENVIRONMENTAL-CHANGE; CHLOROPLAST DNA; SEED DISPERSAL; TROPICAL TREE; HISTORY; PATTERNS; DIVERSITY	Comparative phylogeography is an effective approach to assess the evolutionary history of biological communities. We used comparative phylogeography in fourteen tree taxa from Lower Guinea (Atlantic Equatorial Africa) to test for congruence with two simple evolutionary scenarios based on physio-climatic features 1) the W-E environmental gradient and 2) the N-S seasonal inversion, which determine climatic and seasonality differences in the region. We sequenced the trnC-ycf6 plastid DNA region using a dual sampling strategy: fourteen taxa with small sample sizes (dataset 1, mean n = 16/ taxon), to assess whether a strong general pattern of allele endemism and genetic differentiation emerged; and four taxonomically well-studied species with larger sample sizes (dataset 2, mean n = 109/species) to detect the presence of particular shared phylogeographic patterns. When grouping the samples into two alternative sets of two populations, W and E, vs. N and S, neither dataset exhibited a strong pattern of allelic endemism, suggesting that none of the considered regions consistently harboured older populations. Differentiation in dataset 1 was similarly strong between W and E as between N and S, with 3-5 significant F-ST tests out of 14 tests in each scenario. Coalescent simulations indicated that, given the power of the data, this result probably reflects idiosyncratic histories of the taxa, or a weak common differentiation pattern (possibly with population substructure) undetectable across taxa in dataset 1. Dataset 2 identified a common genetic break separating the northern and southern populations of Greenwayodendron suaveolens subsp. suaveolens var. suaveolens, Milicia excelsa, Symphonia globulifera and Trichoscypha acuminata in Lower Guinea, in agreement with differentiation across the N-S seasonal inversion. Our work suggests that currently recognized tree taxa or suspected species complexes can contain strongly differentiated genetic lineages, which could lead to misinterpretation of phylogeographic patterns. Therefore the evolutionary processes of such taxa require further study in African tropical rainforests.	[Heuertz, Myriam; Duminil, Jerome; Dauby, Gilles; Hardy, Olivier J.] Univ Libre Bruxelles, Fac Sci Evolutionary Biol & Ecol, Brussels, Belgium; [Heuertz, Myriam] INIA, Forest Res Ctr, Madrid, Spain; [Duminil, Jerome] Biovers Int, Forest Genet Resources Programme, Sub Reg Off Cent Afr, Yaounde, Cameroon; [Savolainen, Vincent] Univ London Imperial Coll Sci Technol & Med, London, England; [Savolainen, Vincent] Royal Bot Gardens Kew, Jodrell Lab, London, England	Universite Libre de Bruxelles; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Alliance; Bioversity International; Imperial College London; Royal Botanic Gardens, Kew	Heuertz, M (corresponding author), Univ Fribourg, Dept Biol, Unit Ecol & Evolut, CH-1700 Fribourg, Switzerland.	heuertzm@gmail.com	Duminil, Jérôme/I-2024-2017; Heuertz, Myriam/A-7831-2011; Dauby, Gilles/W-4427-2019	Heuertz, Myriam/0000-0002-6322-3645; Duminil, Jerome/0000-0002-2500-824X; Gilles, Dauby/0000-0002-9498-413X; Savolainen, Vincent/0000-0001-5350-9984	Spanish Ministry for Science and Innovation (Ramon y Cajal programme) [RYC2009-04537]; Ministry for Economy and Competitiveness (AFFLORA) [CGL2012, CGL2012-40129-C02-02]; Belgian Fund for Scientific Research (FRS-FNRS) [1.2.155.06F, FC66560-1.5.095.08F, 2.4.577.10.F, F. 4.519.10.F]; Intra-European Marie Curie fellowship	Spanish Ministry for Science and Innovation (Ramon y Cajal programme); Ministry for Economy and Competitiveness (AFFLORA); Belgian Fund for Scientific Research (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); Intra-European Marie Curie fellowship(European Commission)	Funding was obtained from the Spanish Ministry for Science and Innovation (Ramon y Cajal programme, RYC2009-04537) and Ministry for Economy and Competitiveness (AFFLORA project, CGL2012 CGL2012-40129-C02-02), from the Belgian Fund for Scientific Research (FRS-FNRS projects 1.2.155.06F, FC66560-1.5.095.08F, 2.4.577.10.F and F. 4.519.10.F) and from an Intra-European Marie Curie fellowship to MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguinagalde I, 2005, J BIOGEOGR, V32, P329, DOI 10.1111/j.1365-2699.2004.01178.x; Alvarez N, 2009, ECOL LETT, V12, P632, DOI 10.1111/j.1461-0248.2009.01312.x; Anhuf D, 2006, PALAEOGEOGR PALAEOCL, V239, P510, DOI 10.1016/j.palaeo.2006.01.017; BARTHLOTT W, 1996, ERDKUNDE, V50, P317, DOI [DOI 10.3112/ERDKUNDE.1996.04.03, 10.1007/s004250050096, DOI 10.1007/S004250050096]; Barthlott W, 2005, NOVA ACT LC, V92, P61; Bonnefille R., 2007, TROPICAL RAINFOREST, P117; Born C, 2011, MOL ECOL, V20, P131, DOI 10.1111/j.1365-294X.2010.04919.x; Breteler F. J., 2001, Adansonia (Paris), V23, P303; Breteler F. J., 2004, Adansonia (Paris), V26, P97; Budde KB, 2013, HEREDITY, V111, P66, DOI 10.1038/hdy.2013.21; Clark CJ, 2001, BIOTROPICA, V33, P606, DOI 10.1111/j.1744-7429.2001.tb00219.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Dainou K, 2010, MOL ECOL, V19, P4462, DOI 10.1111/j.1365-294X.2010.04831.x; Dauby G., 2010, Tropical Plant Biology, V3, P4, DOI 10.1007/s12042-010-9041-6; Davies AG, 1999, INT J PRIMATOL, V20, P327, DOI 10.1023/A:1020596503533; Debout GDG, 2011, HEREDITY, V106, P88, DOI 10.1038/hdy.2010.35; DEMESURE B, 1995, MOL ECOL, V4, P129, DOI 10.1111/j.1365-294X.1995.tb00201.x; Doyle J. J., 1987, PHYTOCHEM B, P11; Duminil J, 2010, MOL ECOL, V19, P5469, DOI 10.1111/j.1365-294X.2010.04917.x; Duminil J, 2007, AM NAT, V169, P662, DOI 10.1086/513490; Duminil J, 2012, MOL PHYLOGENET EVOL, V62, P275, DOI 10.1016/j.ympev.2011.09.020; Dupont L, 2011, QUATERNARY SCI REV, V30, P3589, DOI 10.1016/j.quascirev.2011.09.019; Duveiller G, 2008, REMOTE SENS ENVIRON, V112, P1969, DOI 10.1016/j.rse.2007.07.026; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Excoffier L, 2011, BIOINFORMATICS, V27, P1332, DOI 10.1093/bioinformatics/btr124; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Fine PVA, 2013, J BIOGEOGR, V40, P646, DOI 10.1111/j.1365-2699.2011.02645.x; Gartlan S, 1989, CONSERVATION ECOSYST; GAUTIERHION A, 1985, OECOLOGIA, V65, P324, DOI 10.1007/BF00378906; Gonmadje CF, 2011, BIODIVERS CONSERV, V20, P2627, DOI 10.1007/s10531-011-0095-z; Gonmadje CF, 2012, PLANT ECOL EVOL, V145, P152, DOI 10.5091/plecevo.2012.573; HAMILTON AC, 1991, CLIMATIC CHANGE, V19, P65, DOI 10.1007/BF00142215; Hardesty BD, 2003, PLANT ECOL, V164, P49, DOI 10.1023/A:1021251831806; Hardy OJ, 2003, MOL ECOL, V12, P1577, DOI 10.1046/j.1365-294X.2003.01835.x; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hardy OJ, 2013, CR GEOSCI, V345, P284, DOI 10.1016/j.crte.2013.05.001; Hickerson MJ, 2006, EVOLUTION, V60, P2435; Huntley B., 1983, ATLAS PRESENT POLLEN; Ibrahim KM, 1996, HEREDITY, V77, P282, DOI 10.1038/hdy.1996.142; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jaramillo-Correa JP, 2010, MOL ECOL, V19, P5452, DOI 10.1111/j.1365-294X.2010.04912.x; Jones FA, 2013, J BIOGEOGR, V40, P720, DOI 10.1111/jbi.12037; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kenfack David, 2011, Harvard Papers in Botany, V16, P171, DOI 10.3100/0.25.016.0201; Knowles LL, 2004, J EVOLUTION BIOL, V17, P1, DOI 10.1046/j.1420-9101.2003.00644.x; Koffi KG, 2011, AM J BOT, V98, P254, DOI 10.3732/ajb.1000220; Koffi KG, 2010, PLANT ECOL EVOL, V143, P160, DOI 10.5091/plecevo.2010.433; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Kuper W, 2010, ANN MISSOURI BOT GAR, V91, P525; Lee C, 2004, MOL PHYLOGENET EVOL, V31, P894, DOI 10.1016/j.ympev.2003.10.009; Lezine A-M, 2007, ENCY QUATERNARY SCI, V4, P2682; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Linder HP, 2001, J BIOGEOGR, V28, P169, DOI 10.1046/j.1365-2699.2001.00527.x; Lowe A. J., 2010, Tropical Plant Biology, V3, P50, DOI 10.1007/s12042-010-9045-2; Maley J, 1996, BIODIVERSITY OF AFRICAN PLANTS, P519; Maley J, 1998, REV PALAEOBOT PALYNO, V99, P157, DOI 10.1016/S0034-6667(97)00047-X; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; Mayaux P, 2005, PHILOS T R SOC B, V360, P373, DOI 10.1098/rstb.2004.1590; Mitani M, 1999, ECOL RES, V14, P371, DOI 10.1046/j.1440-1703.1999.00317.x; Muloko-Ntoutoume N, 2000, MOL ECOL, V9, P359, DOI 10.1046/j.1365-294X.2000.00859.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nei M., 1987, MOL EVOLUTIONARY GEN; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Petit RJ, 2006, ANNU REV ECOL EVOL S, V37, P187, DOI 10.1146/annurev.ecolsys.37.091305.110215; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Plana V, 2004, PHILOS T ROY SOC B, V359, P1585, DOI 10.1098/rstb.2004.1535; Pons O, 1996, GENETICS, V144, P1237; Qiu YX, 2011, MOL PHYLOGENET EVOL, V59, P225, DOI 10.1016/j.ympev.2011.01.012; Richards CL, 2007, J BIOGEOGR, V34, P1833, DOI 10.1111/j.1365-2699.2007.01814.x; Senterre B, 2005, RECHERCHES METHODOLO; Sosef MS, 2004, MEMOIRS CALIFORNIA A, V28, P308; Sosef MSM, 1996, BIODIVERSITY OF AFRICAN PLANTS, P602; Stevart T, 2004, B BIOL SOC WASH, P275; Tchouto MGP, 2009, SYST BIODIVERS, V7, P21, DOI 10.1017/S1477200008002892; Turchetto-Zolet AC, 2013, MOL ECOL, V22, P1193, DOI 10.1111/mec.12164; Vande Weghe JP, 2004, FORESTS CENTRAL AFRI; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WHITE F, 1979, Bulletin du Jardin Botanique National de Belgique, V49, P11, DOI 10.2307/3667815	81	33	33	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84307	10.1371/journal.pone.0084307	http://dx.doi.org/10.1371/journal.pone.0084307			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416215	gold, Green Published, Green Submitted			2022-12-27	WOS:000329862500113
J	Jacobsen, PE; Henriksen, TB; Haubek, D; Ostergaard, JR				Jacobsen, Pernille E.; Henriksen, Tine B.; Haubek, Dorte; Ostergaard, John R.			Prenatal Exposure to Antiepileptic Drugs and Dental Agenesis	PLOS ONE			English	Article							GENETIC-BASIS; PREGNANCY; HYPODONTIA; PREVALENCE; ANOMALIES; MALFORMATIONS; TEETH	Objective: The aim of the study was to investigate the association between prenatal exposure to AEDs and the risk of dental agenesis and to differentiate between the possible effects of the different drugs used. Methods: Data on 214 exposed and 255 unexposed children, aged 12-18 years, were extracted from the Prescription Database of the Central Denmark Region and North Denmark Region and the Danish Medical Birth Registry. The children's dental charts were examined for the presence of dental agenesis. Results: Overall, children exposed to AED in utero had an increased risk of developing dental agenesis, but as a group, the difference was not significant (OR = 1.7; [95% CI: 0.8-3.6]). The risk of developing dental agenesis was three-fold increased (OR = 3.1; [95% CI: 1.3-7.4]) in children exposed to valproate in mono-or in poly-therapy with other AEDs than carbamazepine or oxcarbazepine. The risk was further increased (OR = 11.2; [95% CI: 2.4-51.9]) in children exposed to valproate and carbamazepine or oxcarbazepine in combination. Conclusions: The present study shows that dental agenesis is a potential congenital abnormality that is related to prenatal exposure to valproate, and dental agenesis may be considered a sensitive marker for the teratogenicity of valproate.	[Jacobsen, Pernille E.; Haubek, Dorte] Aarhus Univ, Dept Dent, Sect Pediat Dent, Aarhus, Denmark; [Henriksen, Tine B.] Aarhus Univ Hosp, Dept Pediat, Perinatal Epidemiol Res Unit, DK-8000 Aarhus, Denmark; [Ostergaard, John R.] Aarhus Univ Hosp, Dept Pediat, Ctr Rare Dis, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Jacobsen, PE (corresponding author), Aarhus Univ, Dept Dent, Sect Pediat Dent, Aarhus, Denmark.	pej@odontologi.au.dk			Calcin Foundation from the Danish Dental Association; DOFT Foundation from the Association of Community Dental Service; Aarhus University Research Foundation	Calcin Foundation from the Danish Dental Association; DOFT Foundation from the Association of Community Dental Service; Aarhus University Research Foundation	The study was financially supported by the Calcin Foundation from the Danish Dental Association, the DOFT Foundation from the Association of Community Dental Service and the Aarhus University Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaluusua S, 2006, INT DENT J, V56, P323, DOI 10.1111/j.1875-595X.2006.tb00336.x; Andersen TF, 1999, DAN MED BULL, V46, P263; Bailleul-Forestier I, 2008, EUR J MED GENET, V51, P383, DOI 10.1016/j.ejmg.2008.05.003; BLAYNEY JR, 1967, J AM DENT ASSOC, V74, P233; Chuang CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043692; CLAYTONSMITH J, 1995, J MED GENET, V32, P724, DOI 10.1136/jmg.32.9.724; Dolk H, 2010, ADV EXP MED BIOL, V686, P349, DOI 10.1007/978-90-481-9485-8_20; Gaist D, 1997, DAN MED BULL, V44, P445; GEELEN JAG, 1979, CRC CR REV TOXICOL, V6, P351, DOI 10.3109/10408447909043651; Helm S, 1973, Community Dent Oral Epidemiol, V1, P3, DOI 10.1111/j.1600-0528.1973.tb01055.x; Hvas CL, 2000, BRIT J OBSTET GYNAEC, V107, P896, DOI 10.1111/j.1471-0528.2000.tb11089.x; Jacobsen PE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058213; Jernvall J, 2012, DEVELOPMENT, V139, P3487, DOI 10.1242/dev.085084; Jheon AH, 2013, WIRES DEV BIOL, V2, P165, DOI 10.1002/wdev.63; Kapdan A., 2012, EUROPEAN J DENT, V06, P178; KJAER I, 1994, EUR J ORTHODONT, V16, P371, DOI 10.1093/ejo/16.5.371; Kjaer I, 2012, INT J DENT, V2012, DOI 10.1155/2012/145749; Knudsen LB, 1998, DAN MED BULL, V45, P320; Knudsen P A, 1967, Tandlaegebladet, V71, P199; KNUDSEN PA, 1967, ACTA ODONTOL SCAND, V25, P267, DOI 10.3109/00016356709104023; Koo J, 2012, ORAL DIS, DOI [10.1111/odi.12061, DOI 10.1111/0DI.12061]; Kulkarni G, 2011, DENT HYPOTHESES, V2, P63; Lapter M, 1998, COLLEGIUM ANTROPOL, V22, P291; MAGNUSSON TE, 1984, ACTA ODONTOL SCAND, V42, P137, DOI 10.3109/00016358408993864; Marinelli A, 2012, ODONTOLOGY, V100, P22, DOI 10.1007/s10266-011-0021-6; Molgaard-Nielsen D, 2011, JAMA-J AM MED ASSOC, V305, P1996, DOI 10.1001/jama.2011.624; MULLER TP, 1970, J AM DENT ASSOC, V81, P101, DOI 10.14219/jada.archive.1970.0151; Nieminen P, 2009, J EXP ZOOL PART B, V312B, P320, DOI 10.1002/jez.b.21277; Nik-Hussein N N, 1996, J Clin Pediatr Dent, V21, P15; Orup H I Jr, 2003, Orthod Craniofac Res, V6, P2, DOI 10.1046/j.1439-0280.2003.2o212.x; Orup HI, 1998, J CRAN GENET DEV BIO, V18, P129; Pedersen LB, 2012, INT J PAEDIATR DENT, V22, P239, DOI 10.1111/j.1365-263X.2011.01199.x; Pennell PB, 2008, EPILEPSIA, V49, P43, DOI 10.1111/j.1528-1167.2008.01926.x; Polder BJ, 2004, COMMUNITY DENT ORAL, V32, P217, DOI 10.1111/j.1600-0528.2004.00158.x; Rolling S, 2009, INT J PAEDIATR DENT, V19, P172, DOI 10.1111/j.1365-263X.2008.00958.x; Sabers Anne, 2009, Ugeskr Laeger, V171, P221; Thesleff I, 2006, AM J MED GENET A, V140A, P2530, DOI 10.1002/ajmg.a.31360; Tomson T, 2012, LANCET NEUROL, V11, P803, DOI 10.1016/S1474-4422(12)70103-5; Townsend GC, 2005, AUST DENT J, V50, P95, DOI 10.1111/j.1834-7819.2005.tb00347.x; Vajda FJ, 2013, NEUROLOGY, V81, P999, DOI 10.1212/WNL.0b013e3182a43e81; Veiby G, 2009, EPILEPSIA, V50, P2130, DOI 10.1111/j.1528-1167.2009.02147.x; Wlodarczyk BJ, 2012, AM J MED GENET A, V158A, P2071, DOI 10.1002/ajmg.a.35438	42	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84420	10.1371/journal.pone.0084420	http://dx.doi.org/10.1371/journal.pone.0084420			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416231	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500126
J	Sabarinathan, R; Wenzel, A; Novotny, P; Tang, XJ; Kalari, KR; Gorodkin, J				Sabarinathan, Radhakrishnan; Wenzel, Anne; Novotny, Peter; Tang, Xiaojia; Kalari, Krishna R.; Gorodkin, Jan			Transcriptome-Wide Analysis of UTRs in Non-Small Cell Lung Cancer Reveals Cancer-Related Genes with SNV-Induced Changes on RNA Secondary Structure and miRNA Target Sites	PLOS ONE			English	Article							DISEASE-ASSOCIATED SNPS; SOMATIC MUTATIONS; MICRORNA FUNCTION; KRAS MUTATIONS; GENOME; EXPRESSION; DATABASE; IDENTIFICATION; POLYMORPHISMS; DETERMINANTS	Traditional mutation assessment methods generally focus on predicting disruptive changes in protein-coding regions rather than non-coding regulatory regions like untranslated regions (UTRs) of mRNAs. The UTRs, however, are known to have many sequence and structural motifs that can regulate translational and transcriptional efficiency and stability of mRNAs through interaction with RNA-binding proteins and other non-coding RNAs like microRNAs (miRNAs). In a recent study, transcriptomes of tumor cells harboring mutant and wild-type KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) genes in patients with non-small cell lung cancer (NSCLC) have been sequenced to identify single nucleotide variations (SNVs). About 40% of the total SNVs (73,717) identified were mapped to UTRs, but omitted in the previous analysis. To meet this obvious demand for analysis of the UTRs, we designed a comprehensive pipeline to predict the effect of SNVs on two major regulatory elements, secondary structure and miRNA target sites. Out of 29,290 SNVs in 6462 genes, we predict 472 SNVs (in 408 genes) affecting local RNA secondary structure, 490 SNVs (in 447 genes) affecting miRNA target sites and 48 that do both. Together these disruptive SNVs were present in 803 different genes, out of which 188 (23.4%) were previously known to be cancer-associated. Notably, this ratio is significantly higher (one-sided Fisher's exact test p-value = 0.032) than the ratio (20.8%) of known cancer-associated genes (n = 1347) in our initial data set (n = 6462). Network analysis shows that the genes harboring disruptive SNVs were involved in molecular mechanisms of cancer, and the signaling pathways of LPS-stimulated MAPK, IL-6, iNOS, EIF2 and mTOR. In conclusion, we have found hundreds of SNVs which are highly disruptive with respect to changes in the secondary structure and miRNA target sites within UTRs. These changes hold the potential to alter the expression of known cancer genes or genes linked to cancer-associated pathways.	[Sabarinathan, Radhakrishnan; Wenzel, Anne; Gorodkin, Jan] Univ Copenhagen, Sect Anim Genet Bioinformat & Breeding, IKVH, Ctr Noncoding RNA Technol & Hlth, Frederiksberg, Denmark; [Novotny, Peter] Univ Copenhagen, Dept Biol, Bioinformat Ctr, Copenhagen, Denmark; [Novotny, Peter] Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark; [Tang, Xiaojia; Kalari, Krishna R.] Mayo Clin, Dept Hlth Sci Res, Div Biostat & Bioinformat, Rochester, MN USA; [Kalari, Krishna R.] Mayo Clin, Dept Canc Biol, Ctr Comprehens Canc, Jacksonville, FL 32224 USA	University of Copenhagen; University of Copenhagen; University of Copenhagen; Mayo Clinic; Mayo Clinic	Gorodkin, J (corresponding author), Univ Copenhagen, Sect Anim Genet Bioinformat & Breeding, IKVH, Ctr Noncoding RNA Technol & Hlth, Frederiksberg, Denmark.	gorodkin@rth.dk	Jensen, Betina W/J-2207-2015	Tang, Xiaojia/0000-0003-2457-9953; Wenzel, Anne/0000-0001-6187-4156; Gorodkin, Jan/0000-0001-5823-4000; Kalari, Krishna/0000-0001-8944-8378; Sabarinathan, Radhakrishnan/0000-0001-8916-3954	Danish Center for Scientific Computing (DCSC, DeiC); Danish Council for Strategic Research (Programme Commission on Strategic Growth Technologies); Danish Council for Independent Research (Technology and Production Sciences)	Danish Center for Scientific Computing (DCSC, DeiC); Danish Council for Strategic Research (Programme Commission on Strategic Growth Technologies); Danish Council for Independent Research (Technology and Production Sciences)(Det Frie Forskningsrad (DFF))	Danish Center for Scientific Computing (DCSC, DeiC); Danish Council for Strategic Research (Programme Commission on Strategic Growth Technologies); Danish Council for Independent Research (Technology and Production Sciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassi C, 2009, TRENDS CELL BIOL, V19, P465, DOI 10.1016/j.tcb.2009.06.001; Aouacheria A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-2; Arikawa E, 2011, SABIOSCIENCES; Barenboim M, 2010, HUM MUTAT, V31, P1223, DOI 10.1002/humu.21349; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhattacharya A, 2013, NUCLEIC ACIDS RES, V41, pD977, DOI 10.1093/nar/gks1138; Bruno AE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-44; Chatterjee S, 2009, BIOL CELL, V101, P251, DOI 10.1042/BC20080104; Chen XS, 2012, NUCLEIC ACIDS RES, V40, P8862, DOI 10.1093/nar/gks684; Chepelev I, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp507; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Chin LJ, 2008, CANCER RES, V68, P8535, DOI 10.1158/0008-5472.CAN-08-2129; Croft L, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-90; Diwa A, 2000, GENE DEV, V14, P1249; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; Enright AJ, 2004, GENOME BIOL, V5; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; FONTANA W, 1993, BIOPOLYMERS, V33, P1389, DOI 10.1002/bip.360330909; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gochhait S, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1780; Gong J, 2012, HUM MUTAT, V33, P254, DOI 10.1002/humu.21641; Grover R, 2011, RNA BIOL, V8, P132, DOI 10.4161/rna.8.1.14260; Haas U, 2012, RNA BIOL, V9, P924, DOI 10.4161/rna.20497; Halvorsen M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001074; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Iliopoulos D, 2010, MOL CELL, V39, P761, DOI 10.1016/j.molcel.2010.08.013; Ingenuity Systems, 2005, IPA NETW GEN ALG; Jambhekar A, 2007, RNA, V13, P625, DOI 10.1261/rna.262607; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kalari KR, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00012; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kaye JA, 2009, NEURON, V61, P57, DOI 10.1016/j.neuron.2008.11.012; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Latreche L, 2009, NUCLEIC ACIDS RES, V37, P5868, DOI 10.1093/nar/gkp635; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Martin JS, 2012, RNA, V18, P77, DOI 10.1261/rna.029900.111; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Mestdagh P, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr646; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Mwenifumbo JC, 2013, NAT REV GENET, V14, P321, DOI 10.1038/nrg3445; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Nicoloso MS, 2010, CANCER RES, V70, P2789, DOI 10.1158/0008-5472.CAN-09-3541; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pesole G, 2000, Brief Bioinform, V1, P236, DOI 10.1093/bib/1.3.236; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Reveal B, 2010, DEV CELL, V18, P496, DOI 10.1016/j.devcel.2009.12.021; Riely Gregory J, 2009, Proc Am Thorac Soc, V6, P201, DOI 10.1513/pats.200809-107LC; Rollin J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004158; Ruepp A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r6; Sabarinathan R, 2013, NUCLEIC ACIDS RES, V41, pW475, DOI 10.1093/nar/gkt291; Sabarinathan R, 2013, HUM MUTAT, V34, P546, DOI 10.1002/humu.22273; Seemann SE, 2013, UNPUB; Teresi RE, 2007, AM J HUM GENET, V81, P756, DOI 10.1086/521051; Tsang JS, 2010, MOL CELL, V38, P140, DOI 10.1016/j.molcel.2010.03.007; Walczak R, 1996, RNA, V2, P367; Wang Y, 2013, EUR J CELL BIOL, V92, P123, DOI 10.1016/j.ejcb.2012.11.004; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Wenzel A, 2012, BIOINFORMATICS, V28, P2738, DOI 10.1093/bioinformatics/bts519; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Yao ZZ, 2006, BIOINFORMATICS, V22, P445, DOI 10.1093/bioinformatics/btk008; Zhu QQ, 2011, AM J HUM GENET, V88, P458, DOI 10.1016/j.ajhg.2011.03.008; Ziebarth JD, 2012, NUCLEIC ACIDS RES, V40, pD216, DOI 10.1093/nar/gkr1026	66	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e82699	10.1371/journal.pone.0082699	http://dx.doi.org/10.1371/journal.pone.0082699			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416147	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500019
J	Zou, JJ; Chen, SL; Tan, J; Lin, L; Zhao, YY; Xu, HM; Lin, S; Zhang, J; Fan, HW; Xie, HG				Zou, Jian-Jun; Chen, Shao-Liang; Tan, Jie; Lin, Ling; Zhao, Ying-Ying; Xu, Hai-Mei; Lin, Song; Zhang, Juan; Fan, Hong-Wei; Xie, Hong-Guang			Increased Risk for Developing Major Adverse Cardiovascular Events in Stented Chinese Patients Treated with Dual Antiplatelet Therapy after Concomitant Use of the Proton Pump Inhibitor	PLOS ONE			English	Article							TASK-FORCE; CLOPIDOGREL; OMEPRAZOLE; PHARMACOKINETICS; PHARMACODYNAMICS; OUTCOMES; LANSOPRAZOLE; PANTOPRAZOLE; RABEPRAZOLE; CROSSOVER	Background: Some clinical studies have demonstrated that the proton pump inhibitor (PPI) could decrease clopidogrel platelet response and increase major adverse cardiovascular events (MACE) in white or black subjects. However, that remains to be determined in Chinese patients. In this study, we sought to determine whether there could be an increased risk for developing MACE after concomitant use of dual antiplatelet therapy (DAT) and a PPI in Chinese patients treated with percutaneous coronary intervention (PCI) and stenting. Methods: This study was a 5-year, single-center, retrospective cohort analysis of eligible patients (n = 6188) who received DAT and a PPI concomitantly (defined as PPI users) before discharge and/or 12-month follow-up after discharge as compared with those who received DAT alone (also defined as non-PPI users, n = 1465). The incidence of recurrent MACE, such as myocardial infarction (MI), definite stent thromboses (ST), or cardiovascular death, was compared between the PPI users and non-users. Results: PPI users had a significantly higher incidence of the MACE than non-users (13.9% vs. 10.6%; adjusted HR: 1.33; 95% CI: 1.12 - 1.57, P = 0.007). Stratified analysis revealed that concurrent use of DAT and a PPI was associated with a significantly increased risk for developing ST compared with DAT alone (1% vs. 0.4%; adjusted HR: 2.66, 95% CI: 1.16 - 5.87, P = 0.012). However, there were no significant differences in the risk of MI, cardiovascular death and other adverse events, regardless of combination of clopidogrel and a PPI. Conclusions: The study further suggests that concomitant use of DAT and a PPI may be associated with an increased risk for developing MACE, in particular definite ST, in Chinese PCI patients after discharge as compared with use of DAT alone.	[Zou, Jian-Jun; Tan, Jie; Fan, Hong-Wei; Xie, Hong-Guang] Nanjing Med Univ, Nanjing Hosp 1, Gen Clin Res Ctr, Div Clin Pharmacol, Nanjing, Jiangsu, Peoples R China; [Chen, Shao-Liang; Lin, Ling; Zhao, Ying-Ying; Xu, Hai-Mei; Lin, Song; Zhang, Juan] Nanjing Med Univ, Nanjing Hosp 1, Div Cardiovasc Med, Dept Med, Nanjing, Jiangsu, Peoples R China; [Xie, Hong-Guang] Nanjing Med Univ, Nanjing Hosp 1, Cent Lab, Gen Clin Res Ctr, Nanjing, Jiangsu, Peoples R China; [Xie, Hong-Guang] Nanjing Med Univ, Sch Pharm, Dept Pharmacol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Chen, SL (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Div Cardiovasc Med, Dept Med, Nanjing, Jiangsu, Peoples R China.	chmengx126@gmail.com; hongg.xie@gmail.com			National Natural Science Foundation of China [30901380]; Nanjing Bureau of Health [QYK10142, QYK11168]; Nanjing Bureau of Science and Technology [201001098]; Jiangsu (Province) Natural Science Foundation [BK 2012525]; Ministry of Human Resource and Social Security, China [2012-258]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nanjing Bureau of Health; Nanjing Bureau of Science and Technology; Jiangsu (Province) Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Ministry of Human Resource and Social Security, China	This study was supported, in part, by a grant from the National Natural Science Foundation of China (No. 30901380) and a grant from Nanjing Bureau of Health (No. QYK10142, and QYK11168) (all to J-JZ), a grant from Nanjing Bureau of Science and Technology (No. 201001098, to S-LC), and grants from the Jiangsu (Province) Natural Science Foundation (No. BK 2012525) and the Ministry of Human Resource and Social Security, China (No. 2012-258) (both to H-GX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JL, 2011, CIRCULATION, V123, pE426, DOI 10.1161/CIR.0b013e318212bb8b; Angiolillo DJ, 2011, CLIN PHARMACOL THER, V89, P65, DOI 10.1038/clpt.2010.219; Bhatt DL, 2008, J AM COLL CARDIOL, V52, P1502, DOI 10.1016/j.jacc.2008.08.002; Bhatt DL, 2010, NEW ENGL J MED, V363, P1909, DOI 10.1056/NEJMoa1007964; Charlot M, 2010, ANN INTERN MED, V153, P378, DOI 10.7326/0003-4819-153-6-201009210-00005; Chen SL, 2011, J AM COLL CARDIOL, V57, P914, DOI 10.1016/j.jacc.2010.10.023; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Ferreiro JL, 2010, CIRC-CARDIOVASC INTE, V3, P436, DOI 10.1161/CIRCINTERVENTIONS.110.957829; Furuta T, 2010, BRIT J CLIN PHARMACO, V70, P383, DOI 10.1111/j.1365-2125.2010.03717.x; Gilard M, 2008, J AM COLL CARDIOL, V51, P256, DOI 10.1016/j.jacc.2007.06.064; Ho PM, 2009, JAMA-J AM MED ASSOC, V301, P937, DOI 10.1001/jama.2009.261; Huang CC, 2010, AM J CARDIOL, V105, P1705, DOI 10.1016/j.amjcard.2010.01.348; Kim KA, 2008, CLIN PHARMACOL THER, V84, P236, DOI 10.1038/clpt.2008.20; Li XQ, 2004, DRUG METAB DISPOS, V32, P821, DOI 10.1124/dmd.32.8.821; Lim PWY, 2005, J GASTROEN HEPATOL, V20, pS22, DOI 10.1111/j.1440-1746.2005.04167.x; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; O'Donoghue ML, 2009, LANCET, V374, P989, DOI 10.1016/S0140-6736(09)61525-7; Pezalla E, 2008, J AM COLL CARDIOL, V52, P1038, DOI 10.1016/j.jacc.2008.05.053; Pham CQD, 2006, ANN PHARMACOTHER, V40, P1261, DOI 10.1345/aph.1G703; Rassen JA, 2009, CIRCULATION, V120, P2322, DOI 10.1161/CIRCULATIONAHA.109.873497; Ray WA, 2010, ANN INTERN MED, V152, P337, DOI 10.7326/0003-4819-152-6-201003160-00003; Savi P, 2006, P NATL ACAD SCI USA, V103, P11069, DOI 10.1073/pnas.0510446103; Siller-Matula JM, 2009, AM HEART J, V157, P148, DOI 10.1016/j.ahj.2008.09.017; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Small DS, 2008, J CLIN PHARMACOL, V48, P475, DOI 10.1177/0091270008315310; Stockl KM, 2010, ARCH INTERN MED, V170, P704, DOI 10.1001/archinternmed.2010.34; Xie HG, 2001, ANNU REV PHARMACOL, V41, P815, DOI 10.1146/annurev.pharmtox.41.1.815; Xie HG, 2011, PHARMACOL THERAPEUT, V129, P267, DOI 10.1016/j.pharmthera.2010.10.001; Zuern CS, 2010, THROMB RES, V125, pE51, DOI 10.1016/j.thromres.2009.08.016	30	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84985	10.1371/journal.pone.0084985	http://dx.doi.org/10.1371/journal.pone.0084985			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416326	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500200
J	Ye, W; Shen, CH; Lin, YL; Chen, PJ; Xu, XM; Oelmuller, R; Yeh, KW; Lai, ZX				Ye, Wei; Shen, Chin-Hui; Lin, Yuling; Chen, Peng-Jen; Xu, Xuming; Oelmueller, Ralf; Yeh, Kai-Wun; Lai, Zhongxiong			Growth Promotion-Related miRNAs in Oncidium Orchid Roots Colonized by the Endophytic Fungus Piriformospora indica	PLOS ONE			English	Article							SMALL RNAS; TRANSCRIPTION FACTOR; ARABIDOPSIS ROOTS; GOWER RAMSEY; BOX GENES; ENDOPLASMIC-RETICULUM; MERISTEM FORMATION; INNATE IMMUNITY; PLANT-GROWTH; EXPRESSION	Piriformospora indica, an endophytic fungus of Sebacinales, colonizes the roots of a wide range of host plants and establishes various benefits for the plants. In this work, we describe miRNAs which are upregulated in Oncidium orchid roots after colonization by the fungus. Growth promotion and vigorous root development were observed in Oncidium hybrid orchid, while seedlings were colonized by P. indica. We performed a genome-wide expression profiling of small RNAs in Oncidium orchid roots either colonized or not-colonized by P. indica. After sequencing, 24,570,250 and 24744,141 clean reads were obtained from two libraries. 13,736 from 17,036,953 unique sequences showed homology to either 86 miRNA families described in 41 plant species, or to 46 potential novel miRNAs, or to 51 corresponding miRNA precursors. The predicted target genes of these miRNAs are mainly involved in auxin signal perception and transduction, transcription, development and plant defense. The expression analysis of miRNAs and target genes demonstrated the regulatory functions they may participate in. This study revealed that growth stimulation of the Oncidium orchid after colonization by P. indica includes an intricate network of miRNAs and their targets. The symbiotic function of P. indica on Oncidium orchid resembles previous findings on Chinese cabbage. This is the first study on growth regulation and development of Oncidium orchid by miRNAs induced by the symbiotic fungus P. indica.	[Ye, Wei; Lin, Yuling; Lai, Zhongxiong] Fujian Agr & Forestry Univ, Inst Hort Biotechnol, Fuzhou, Fujian, Peoples R China; [Shen, Chin-Hui; Chen, Peng-Jen; Yeh, Kai-Wun] Natl Taiwan Univ, Inst Plant Biol, Taipei 10764, Taiwan; [Ye, Wei; Xu, Xuming] Sanming Acad Agr Sci, Sanming, Fujian, Peoples R China; [Shen, Chin-Hui] Ind Technol Res Inst, Green Energy & Ecotechnol Syst Ctr, Ecol Mat Technol Dept, Tainan, Taiwan; [Oelmueller, Ralf] Univ Jena, Dept Gen Bot & Plant Physiol, Jena, Germany	Fujian Agriculture & Forestry University; National Taiwan University; Industrial Technology Research Institute - Taiwan; Friedrich Schiller University of Jena	Yeh, KW (corresponding author), Natl Taiwan Univ, Inst Plant Biol, Taipei 10764, Taiwan.	ykwbppp@ntu.edu.tw; laizx01@163.com	Ye, Wei/AAR-3837-2021	Ye, Wei/0000-0002-4647-6552	National Science Council [NSC -101-2324-B-002-023-CC2]; National Natural Science Foundation of China [31078717, 31272149, 31201614]; Doctoral Program of Higher Education of the Chinese Ministry of Education [20093515110005, 20123515120008]; Fujian Provincial Natural Science Foundation of China [2012J05042]; NSC, Taiwan; DAAD, Germany; Fujian Provincial Science and Technology Platform Construction Project [2008N2001]	National Science Council(Ministry of Science and Technology, Taiwan); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Program of Higher Education of the Chinese Ministry of Education; Fujian Provincial Natural Science Foundation of China; NSC, Taiwan(Ministry of Science and Technology, Taiwan); DAAD, Germany(Deutscher Akademischer Austausch Dienst (DAAD)); Fujian Provincial Science and Technology Platform Construction Project	The work is supported by the fund of National Science Council under the project NSC -101-2324-B-002-023-CC2 to Dr. Kai-Wun Yeh. This work was also funded by the National Natural Science Foundation of China (31078717, 31272149, and 31201614), the Doctoral Program of Higher Education of the Chinese Ministry of Education (20093515110005 and 20123515120008), and Fujian Provincial Natural Science Foundation of China (2012J05042). The authors are also grateful to the support of PPP project, 2013 from both NSC, Taiwan and DAAD, Germany. This work was also funded by the Fujian Provincial Science and Technology Platform Construction Project (2008N2001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany SE, 2008, J BIOL CHEM, V283, P15932, DOI 10.1074/jbc.M801406200; Alcantara S, 2006, ANN BOT-LONDON, V98, P1207, DOI 10.1093/aob/mcl202; An FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018937; Baltruschat H, 2008, NEW PHYTOL, V180, P501, DOI 10.1111/j.1469-8137.2008.02583.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Branscheid A, 2010, MOL PLANT MICROBE IN, V23, P915, DOI 10.1094/MPMI-23-7-0915; Cai XN, 2006, J EXP BOT, V57, P2563, DOI 10.1093/jxb/erl022; Camehl I, 2010, PLANT SIGNAL BEHAV, V5, P932, DOI 10.4161/psb.5.8.12036; Camehl I, 2010, NEW PHYTOL, V185, P1062, DOI 10.1111/j.1469-8137.2009.03149.x; Chang YY, 2011, PLANT CELL PHYSIOL, V52, P1532, DOI 10.1093/pcp/pcr101; Chang YY, 2009, PLANT CELL PHYSIOL, V50, P1425, DOI 10.1093/pcp/pcp087; Chen XM, 2012, CURR OPIN GENET DEV, V22, P361, DOI 10.1016/j.gde.2012.04.004; Chiou CY, 2008, BIOTECHNOL LETT, V30, P1861, DOI 10.1007/s10529-008-9767-5; Chiou CY, 2008, PLANT MOL BIOL, V66, P379, DOI 10.1007/s11103-007-9275-3; Chiou CY, 2010, PLANTA, V232, P937, DOI 10.1007/s00425-010-1222-x; Chugh S, 2009, SCI HORTIC-AMSTERDAM, V122, P507, DOI 10.1016/j.scienta.2009.07.016; Combier JP, 2006, GENE DEV, V20, P3084, DOI 10.1101/gad.402806; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Deshmukh S, 2006, P NATL ACAD SCI USA, V103, P18450, DOI 10.1073/pnas.0605697103; Devers EA, 2011, PLANT PHYSIOL, V156, P1990, DOI 10.1104/pp.111.172627; Dillies MA, 2013, BRIEF BIOINFORM, V14, P671, DOI 10.1093/bib/bbs046; Eitas TK, 2010, CURR OPIN PLANT BIOL, V13, P472, DOI 10.1016/j.pbi.2010.04.007; Elhiti M, 2009, PLANT SIGNAL BEHAV, V4, P86, DOI 10.4161/psb.4.2.7692; Ghildiyal M, 2010, RNA, V16, P43, DOI 10.1261/rna.1972910; Guilfoyle TJ, 1998, CELL MOL LIFE SCI, V54, P619, DOI 10.1007/s000180050190; Guleria Praveen, 2011, Genomics Proteomics & Bioinformatics, V9, P183, DOI 10.1016/S1672-0229(11)60022-3; Hajdarpasic A, 2012, BOSNIAN J BASIC MED, V12, P169, DOI 10.17305/bjbms.2012.2471; Hou CJ, 2009, PLANT CELL PHYSIOL, V50, P1544, DOI 10.1093/pcp/pcp099; Hu HY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002327; Jacobs S, 2011, PLANT PHYSIOL, V156, P726, DOI 10.1104/pp.111.176446; Khan G, 2011, PLANT MOL BIOL, V77, P1573; Khatabi B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035502; Khraiwesh B, 2012, BBA-GENE REGUL MECH, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Kidner CA, 2005, DEV BIOL, V280, P504, DOI 10.1016/j.ydbio.2005.01.031; Lee YC, 2011, MOL PLANT MICROBE IN, V24, P421, DOI 10.1094/MPMI-05-10-0110; Lelandais-Briere C, 2009, PLANT CELL, V21, P2780, DOI 10.1105/tpc.109.068130; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Li X, 2005, COMPUT BIOL CHEM, V29, P360, DOI 10.1016/j.compbiolchem.2005.08.005; Liau CH, 2003, TRANSGENIC RES, V12, P329, DOI 10.1023/A:1023343620729; Ling LZ, 2012, GENETICA, V140, P317, DOI 10.1007/s10709-012-9684-3; Liu XJ, 2012, PLANTA, V236, P401, DOI 10.1007/s00425-012-1616-z; Luo Mao, 2011, Yichuan, V33, P1203, DOI 10.3724/SP.J.1005.2011.01203; McCaig BC, 2005, PLANTA, V221, P619, DOI 10.1007/s00425-004-1472-6; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Nagpal P, 2005, DEVELOPMENT, V132, P4107, DOI 10.1242/dev.01955; Navarro L, 2008, CURR BIOL, V18, P650, DOI 10.1016/j.cub.2008.03.060; Peskan-Berghofer T, 2004, PHYSIOL PLANTARUM, V122, P465, DOI 10.1111/j.1399-3054.2004.00424.x; Phillips JR, 2007, FEBS LETT, V581, P3592, DOI 10.1016/j.febslet.2007.04.007; Qiang X, 2012, MOL PLANT PATHOL, V13, P508, DOI 10.1111/j.1364-3703.2011.00764.x; Qiang XY, 2012, PLANT CELL, V24, P794, DOI 10.1105/tpc.111.093260; Ramakrishna W, 2002, PLANT CELL, V14, P3213, DOI 10.1105/tpc.006338; Ramirez SR, 2007, NATURE, V448, P1042, DOI 10.1038/nature06039; RYDEN LG, 1993, J MOL EVOL, V36, P41, DOI 10.1007/BF02407305; Schafer P, 2009, PLANT J, V59, P461, DOI 10.1111/j.1365-313X.2009.03887.x; Schafer P, 2009, PLANT RELATIONSHIPS, V5, P99; Senthilkumar S, 2000, CURR SCI INDIA, V79, P1527; Sherameti I, 2005, J BIOL CHEM, V280, P26241, DOI 10.1074/jbc.M500447200; Simon SA, 2009, PLANT PHYSIOL, V151, P1002, DOI 10.1104/pp.109.144345; Singer RB, 2003, J PLANT RES, V116, P19, DOI 10.1007/s10265-002-0064-4; Sirrenberg A, 2007, PHYSIOL PLANTARUM, V131, P581, DOI 10.1111/j.1399-3054.2007.00983.x; Stein E, 2008, PLANT CELL PHYSIOL, V49, P1747, DOI 10.1093/pcp/pcn147; STONE JM, 1995, PLANT PHYSIOL, V108, P451, DOI 10.1104/pp.108.2.451; Subramanian S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-160; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Tan J, 2005, BIOTECHNOL LETT, V27, P1517, DOI 10.1007/s10529-005-1468-8; Tang S, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-28; Vadassery J, 2008, MOL PLANT MICROBE IN, V21, P1371, DOI 10.1094/MPMI-21-10-1371; Varma A, 1999, APPL ENVIRON MICROB, V65, P2741; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Waller F, 2005, P NATL ACAD SCI USA, V102, P13386, DOI 10.1073/pnas.0504423102; Wang CY, 2008, PLANTA, V227, P1063, DOI 10.1007/s00425-007-0681-1; Wang CY, 2011, BIOCHEM BIOPH RES CO, V409, P363, DOI 10.1016/j.bbrc.2011.04.123; Wang D, 2007, CURR BIOL, V17, P1784, DOI 10.1016/j.cub.2007.09.025; Xie ZX, 2003, CURR BIOL, V13, P784, DOI 10.1016/S0960-9822(03)00281-1; Xu GX, 2009, P NATL ACAD SCI USA, V106, P835, DOI 10.1073/pnas.0812043106; Xue LJ, 2009, NUCLEIC ACIDS RES, V37, P916, DOI 10.1093/nar/gkn998; Yadav V, 2010, J BIOL CHEM, V285, P26532, DOI 10.1074/jbc.M110.111021; You SJ, 2003, PLANTA, V217, P60, DOI 10.1007/s00425-002-0970-7; Yu DX, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016818, 10.1371/journal.pone.0016079]; Zhang JH, 2012, PLANTA, V236, P647, DOI 10.1007/s00425-012-1643-9; Zhang ZH, 2012, CURR OPIN PLANT BIOL, V15, P652, DOI 10.1016/j.pbi.2012.05.007; Zhou GK, 2007, PLANT CELL PHYSIOL, V48, P391, DOI 10.1093/pcp/pcm008; Zhou JH, 2012, MOL GENET GENOMICS, V287, P275, DOI 10.1007/s00438-012-0678-8; Zuccaro A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002290	88	36	44	0	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84920	10.1371/journal.pone.0084920	http://dx.doi.org/10.1371/journal.pone.0084920			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409313	Green Submitted, Green Published, gold			2022-12-27	WOS:000329463500037
J	Boyle, DL; Hammaker, D; Edgar, M; Zaiss, MM; Teufel, S; David, JP; Schett, G; Firestein, GS				Boyle, David L.; Hammaker, Deepa; Edgar, Meghan; Zaiss, Mario M.; Teufel, Stefan; David, Jean Pierre; Schett, Georg; Firestein, Gary S.			Differential Roles of MAPK Kinases MKK3 and MKK6 in Osteoclastogenesis and Bone Loss	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; TUMOR-NECROSIS-FACTOR; COLLAGEN-INDUCED ARTHRITIS; GENE-EXPRESSION; ESTROGEN DEFICIENCY; SIGNALING PATHWAY; P38 MAPK; FAS LIGAND; OSTEOPOROSIS; DESTRUCTION	Bone mass is maintained by osteoclasts that resorb bone and osteoblasts that promote matrix deposition and mineralization. Bone homeostasis is altered in chronic inflammation as well as in post-menopausal loss of estrogen, which favors osteoclast activity that leads to osteoporosis. The MAPK p38 alpha is a key regulator of bone loss and p38 inhibitors preserve bone mass by inhibiting osteoclastogenesis. p38 function is regulated by two upstream MAPK kinases, namely MKK3 and MKK6. The goal of this study was to assess the effect of MKK3- or MKK6-deficiency on osteoclastogenesis in vitro and on bone loss in ovariectomy-induced osteoporosis in mice. We demonstrated that MKK3 but not MKK6, regulates osteoclast differentiation from bone marrow cells in vitro. Expression of NFATc1, a master transcription factor in osteoclastogenesis, is decreased in cells lacking MKK3 but not MKK6. Expression of osteoclast-specific genes Cathepsin K, osteoclast-associated receptor and MMP9, was inhibited in MKK3-/- cells. The effect of MKK-deficiency on ovariectomy-induced bone loss was then evaluated in female WT, MKK3-/- and MKK6-/- mice by micro-CT analysis. Bone loss was partially inhibited in MKK3-/- as well as MKK6-/- mice, despite normal osteoclastogenesis in MKK6-/- cells. This correlated with the lower osteoclast numbers in the MKK-deficient ovariectomized mice. These studies suggest that MKK3 and MKK6 differentially regulate bone loss due to estrogen withdrawal. MKK3 directly mediates osteoclastogenesis while MKK6 likely contributes to pro-inflammatory cytokine production that promotes osteoclast formation.	[Boyle, David L.; Hammaker, Deepa; Edgar, Meghan; Firestein, Gary S.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Zaiss, Mario M.] Ecole Polytech Fed Lausanne, Global Hlth Inst, CH-1015 Lausanne, Switzerland; [Teufel, Stefan; David, Jean Pierre] Univ Med Ctr Hamburg Eppendorf, Inst Osteol & Biomech, Hamburg, Germany; [Schett, Georg] Univ Erlangen Nurnberg, Dept Internal Med 3, D-91054 Erlangen, Germany	University of California System; University of California San Diego; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Erlangen Nuremberg	Hammaker, D (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.	dhammaker@ucsd.edu		zaiss, mario/0000-0003-3844-1664	NIH [AI-070555, AI-067752]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070555, R01AI067752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047825] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported by the NIH grants AI-070555 and AI-067752. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armas LAG, 2012, ENDOCRIN METAB CLIN, V41, P475, DOI 10.1016/j.ecl.2012.04.006; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Bohm C, 2009, J IMMUNOL, V183, P5938, DOI 10.4049/jimmunol.0901026; Bolon B, 2001, MOL THER, V3, P197, DOI 10.1006/mthe.2001.0245; Boyle DL, 2003, ARTHRITIS RES THER, V5, pR352, DOI 10.1186/ar1004; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Caverzasio J, 2008, J BONE MINER RES, V23, P1389, DOI 10.1359/JBMR.080410; David JP, 2010, CURR DIR AUTOIMMUN, V11, P135, DOI 10.1159/000289202; Faienza MF, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/575936; Feng X, 2005, IUBMB LIFE, V57, P389, DOI 10.1080/15216540500137669; Greenblatt MB, 2010, J CLIN INVEST, V120, P2457, DOI 10.1172/JCI42285; Hammaker D, 2012, ARTHRITIS RHEUM-US, V64, P678, DOI 10.1002/art.33359; Hill RJ, 2008, J PHARMACOL EXP THER, V327, P610, DOI 10.1124/jpet.108.139006; Huang H, 2006, CELL DEATH DIFFER, V13, P1879, DOI 10.1038/sj.cdd.4401882; Huang H, 2006, BIOCHEM BIOPH RES CO, V351, P99, DOI 10.1016/j.bbrc.2006.10.011; Inoue T, 2006, P NATL ACAD SCI USA, V103, P5484, DOI 10.1073/pnas.0509188103; Inoue T, 2005, J IMMUNOL, V174, P4301, DOI 10.4049/jimmunol.174.7.4301; Khosla S, 2001, ENDOCRINOLOGY, V142, P5050, DOI 10.1210/en.142.12.5050; Khosla S, 2012, TRENDS ENDOCRIN MET, V23, P576, DOI 10.1016/j.tem.2012.03.008; Kim JH, 2009, J IMMUNOL, V183, P1862, DOI 10.4049/jimmunol.0803007; Kimble RB, 1996, J BIOL CHEM, V271, P28890, DOI 10.1074/jbc.271.46.28890; Krum SA, 2008, CELL CYCLE, V7, P1348, DOI 10.4161/cc.7.10.5892; Krum SA, 2008, EMBO J, V27, P535, DOI 10.1038/sj.emboj.7601984; MANOLAGAS SC, 1995, BONE, V17, pS63, DOI 10.1016/8756-3282(95)00180-L; Matsumoto M, 2000, FEBS LETT, V486, P23, DOI 10.1016/S0014-5793(00)02231-6; Matsumoto M, 2000, J BIOL CHEM, V275, P31155, DOI 10.1074/jbc.M001229200; Mbalaviele G, 2006, J PHARMACOL EXP THER, V317, P1044, DOI 10.1124/jpet.105.100362; Medicherla S, 2006, J PHARMACOL EXP THER, V318, P132, DOI 10.1124/jpet.105.098020; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; PASSERI G, 1993, ENDOCRINOLOGY, V133, P822, DOI 10.1210/en.133.2.822; Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087; Sharma SM, 2007, J BIOL CHEM, V282, P15921, DOI 10.1074/jbc.M609723200; Shibata T, 2002, J BONE MINER RES, V17, P622, DOI 10.1359/jbmr.2002.17.4.622; So H, 2003, J BIOL CHEM, V278, P24209, DOI 10.1074/jbc.M302940200; Srivastava S, 1998, J CLIN INVEST, V102, P1850, DOI 10.1172/JCI4561; Strait K, 2008, INT J MOL MED, V21, P521; Sundaram K, 2007, EXP CELL RES, V313, P168, DOI 10.1016/j.yexcr.2006.10.001; Tokuda H, 2004, J CELL BIOCHEM, V91, P1053, DOI 10.1002/jcb.20004; Troen BR, 2006, ANN NY ACAD SCI, V1068, P165, DOI 10.1196/annals.1346.018; Tyagi AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044552; Wei S, 2005, J CLIN INVEST, V115, P282, DOI 10.1172/JCI200523394; Yamashita T, 2008, BIOCHEM BIOPH RES CO, V365, P252, DOI 10.1016/j.bbrc.2007.10.169; Yoshizawa T, 2009, J IMMUNOL, V183, P1360, DOI 10.4049/jimmunol.0900483; Zwerina J, 2006, ARTHRITIS RHEUM-US, V54, P463, DOI 10.1002/art.21626	44	17	20	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84818	10.1371/journal.pone.0084818	http://dx.doi.org/10.1371/journal.pone.0084818			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400116	Green Published, Green Submitted, gold			2022-12-27	WOS:000329462700050
J	Ballesteros, CI; Galvao, BD; Maisonette, S; Landeira-Fernandez, J				Ballesteros, Carolina Irurita; Galvao, Bruno de Oliveira; Maisonette, Silvia; Landeira-Fernandez, J.			Effect of Dorsal and Ventral Hippocampal Lesions on Contextual Fear Conditioning and Unconditioned Defensive Behavior Induced by Electrical Stimulation of the Dorsal Periaqueductal Gray	PLOS ONE			English	Article							DIFFERENTIAL CONTRIBUTIONS; ENTORHINAL CORTEX; RATS; AMYGDALA; ANXIETY; PROJECTIONS; EXPRESSION; MIDLINE; NUCLEI; MAZE	The dorsal (DH) and ventral (VH) subregions of the hippocampus are involved in contextual fear conditioning. However, it is still unknown whether these two brain areas also play a role in defensive behavior induced by electrical stimulation of the dorsal periaqueductal gray (dPAG). In the present study, rats were implanted with electrodes into the dPAG to determine freezing and escape response thresholds after sham or bilateral electrolytic lesions of the DH or VH. The duration of freezing behavior that outlasted electrical stimulation of the dPAG was also measured. The next day, these animals were subjected to contextual fear conditioning using footshock as an unconditioned stimulus. Electrolytic lesions of the DH and VH impaired contextual fear conditioning. Only VH lesions disrupted conditioned freezing immediately after footshock and increased the thresholds of aversive freezing and escape responses to dPAG electrical stimulation. Neither DH nor VH lesions disrupted post-dPAG stimulation freezing. These results indicate that the VH but not DH plays an important role in aversively defensive behavior induced by dPAG electrical stimulation. Interpretations of these findings should be made with caution because of the fact that a non-fiber-sparing lesion method was employed.	[Ballesteros, Carolina Irurita; Galvao, Bruno de Oliveira; Maisonette, Silvia; Landeira-Fernandez, J.] Pontificia Univ Catolica Rio de Janeiro, Dept Psicol, Rio De Janeiro, RJ, Brazil		Landeira-Fernandez, J (corresponding author), Pontificia Univ Catolica Rio de Janeiro, Dept Psicol, Rio De Janeiro, RJ, Brazil.	landeira@puc-rio.br	Landeira-Fernandez, J./F-6818-2012	Landeira-Fernandez, J./0000-0002-8395-8008	Brazilian National Research Council (CNPq); CNPq	Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	SM and JLF were supported by grants from the Brazilian National Research Council (CNPq). BOG was supported by graduate student fellowships from CNPq, and CIB was an international student from Colombia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannerman DM, 2003, BEHAV BRAIN RES, V139, P197, DOI 10.1016/S0166-4328(02)00268-1; Bland BH, 1998, NEUROSCI BIOBEHAV R, V22, P259, DOI 10.1016/S0149-7634(97)00013-4; Brandao ML, 2008, BEHAV BRAIN RES, V188, P1, DOI 10.1016/j.bbr.2007.10.018; BRANDAO ML, 1982, PHARMACOL BIOCHEM BE, V16, P397, DOI 10.1016/0091-3057(82)90441-5; Carvalho MC, 2008, PEPTIDES, V29, P1191, DOI 10.1016/j.peptides.2008.02.014; Degroot A, 2002, BRAIN RES, V949, P60, DOI 10.1016/S0006-8993(02)02965-7; FANSELOW MS, 1980, PAVLOVIAN J BIOL SCI, V15, P177; Kenny PJ, 2000, NEUROPHARMACOLOGY, V39, P300, DOI 10.1016/S0028-3908(99)00114-8; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; KOHLER C, 1985, NEUROSCIENCE, V16, P85, DOI 10.1016/0306-4522(85)90049-1; Krout KE, 2002, J COMP NEUROL, V448, P53, DOI 10.1002/cne.10236; Landeira-Fernandez J, 1999, BEHAV NEUROSCI, V113, P1049; Lee I, 2004, HIPPOCAMPUS, V14, P301, DOI 10.1002/hipo.10177; Maren S, 1997, BEHAV BRAIN RES, V88, P261, DOI 10.1016/S0166-4328(97)00088-0; Maren S, 1997, NEUROBIOL LEARN MEM, V67, P142, DOI 10.1006/nlme.1996.3752; Martinez RCR, 2006, NEUROBIOL LEARN MEM, V85, P58, DOI 10.1016/j.nlm.2005.08.007; McEown K, 2009, BRAIN RES, V1251, P185, DOI 10.1016/j.brainres.2008.11.041; McHugh SB, 2004, BEHAV NEUROSCI, V118, P63, DOI 10.1037/0735-7044.118.1.63; Menard J, 2001, BRAIN RES, V888, P163, DOI 10.1016/S0006-8993(00)03046-8; Oliveira LC, 2004, NEUROREPORT, V15, P2281, DOI 10.1097/00001756-200410050-00028; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Pentkowski NS, 2006, EUR J NEUROSCI, V23, P2185, DOI 10.1111/j.1460-9568.2006.04754.x; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Richmond MA, 1999, BEHAV NEUROSCI, V113, P1189, DOI 10.1037/0735-7044.113.6.1189; Rogers JL, 2006, NEUROBIOL LEARN MEM, V86, P72, DOI 10.1016/j.nlm.2006.01.002; Ruiz-Martinez RC, 2006, NEUROBIOL LEARN MEM, V85, P58; RUTH RE, 1982, J COMP NEUROL, V209, P69, DOI 10.1002/cne.902090107; Spolidorio PCM, 2007, PSYCHOPHARMACOLOGY, V195, P183, DOI 10.1007/s00213-007-0890-0; Trivedi MA, 2004, NEUROBIOL LEARN MEM, V81, P172, DOI 10.1016/j.nlm.2004.02.005; Vertes RP, 2006, NEUROSCIENCE, V142, P1, DOI 10.1016/j.neuroscience.2006.06.027; Vianna DML, 2001, LEARN MEMORY, V8, P164, DOI 10.1101/lm.36101; WITTER MP, 1989, PROG NEUROBIOL, V33, P161, DOI 10.1016/0301-0082(89)90009-9; Yoon T, 2007, NEUROBIOL LEARN MEM, V87, P464, DOI 10.1016/j.nlm.2006.12.006	35	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e83342	10.1371/journal.pone.0083342	http://dx.doi.org/10.1371/journal.pone.0083342			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404134	Green Submitted, gold, Green Published			2022-12-27	WOS:000329460800013
J	Sheng, K; Fang, WD; Su, ML; Li, R; Zou, DZ; Han, Y; Wang, XF; Cheng, OM				Sheng, Ke; Fang, Weidong; Su, Meilan; Li, Rong; Zou, Dezhi; Han, Yu; Wang, Xuefeng; Cheng, Oumei			Altered Spontaneous Brain Activity in Patients with Parkinson's Disease Accompanied by Depressive Symptoms, as Revealed by Regional Homogeneity and Functional Connectivity in the Prefrontal-Limbic System	PLOS ONE			English	Article							RESTING-STATE; TREATMENT-RESISTANT; MOTOR CORTEX; RISK-FACTORS; EMOTION; ATTENTION; BIPOLAR; FLUCTUATIONS; PERCEPTION; INHIBITION	As patients with Parkinson's disease (PD) are at high risk for comorbid depression, it is hypothesized that these two diseases are sharing common pathogenic pathways. Using regional homogeneity (ReHo) and functional connectivity approaches, we characterized human regional brain activity at resting state to examine specific brain networks in patients with PD and those with PD and depression (PDD). This study comprised 41 PD human patients and 25 normal human subjects. The patients completed the Hamilton Depression Rating Scale and were further divided into two groups: patients with depressive symptoms and non-depressed PD patients (nD-PD). Compared with the non-depressed patients, those with depressive symptoms exhibited significantly increased regional activity in the left middle frontal gyrus and right inferior frontal gyrus, and decreased ReHo in the left amygdala and bilateral lingual gyrus. Brain network connectivity analysis revealed decreased functional connectivity within the prefrontal-limbic system and increased functional connectivity in the prefrontal cortex and lingual gyrus in PDD compared with the nD-PD group. In summary, the findings showed regional brain activity alterations and disruption of the mood regulation network in PDD patients. The pathogenesis of PDD may be attributed to abnormal neural activity in multiple brain regions.	[Sheng, Ke; Su, Meilan; Li, Rong; Zou, Dezhi; Han, Yu; Wang, Xuefeng; Cheng, Oumei] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China; [Fang, Weidong] Chongqing Med Univ, Affiliated Hosp 1, Dept Radiol, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Cheng, OM (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China.	chengoumei@gmail.com			National Natural Science Foundation of China [81100981]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry; Natural Science Foundation Project of Chongqing (CSTC) [2010BB5110]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Natural Science Foundation Project of Chongqing (CSTC)(Natural Science Foundation of ChongqingNatural Science Foundation Project of CQ CSTC)	This research was supported by the National Natural Science Foundation of China (No. 81100981), The Project Sponsored by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry, Natural Science Foundation Project of Chongqing (CSTC, 2010BB5110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2012, NAT REV NEUROL, V8, P35, DOI 10.1038/nrneurol.2011.189; Baudrexel S, 2011, NEUROIMAGE, V55, P1728, DOI 10.1016/j.neuroimage.2011.01.017; Benuzzi F, 2009, MAGN RESON IMAGING, V27, P1088, DOI 10.1016/j.mri.2009.05.037; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cant JS, 2007, CEREB CORTEX, V17, P713, DOI 10.1093/cercor/bhk022; Carballedo A, 2011, J AFFECT DISORDERS, V134, P272, DOI 10.1016/j.jad.2011.06.021; Cardoso EF, 2009, NEUROIMAGE, V47, P467, DOI 10.1016/j.neuroimage.2009.04.059; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; D'Andrea JNA, 2013, NEUROPSYCHOLOGIA, V51, P1195, DOI 10.1016/j.neuropsychologia.2013.04.003; Davidson RJ, 1999, TRENDS COGN SCI, V3, P11, DOI 10.1016/S1364-6613(98)01265-0; De Smet HJ, 2013, BRAIN LANG, V17, P00201; Desseilles M, 2009, J NEUROSCI, V29, P1395, DOI 10.1523/JNEUROSCI.3341-08.2009; Dichter GS, 2009, SOC COGN AFFECT NEUR, V4, P59, DOI 10.1093/scan/nsn037; Drevets WC, 1998, ANNU REV MED, V49, P341, DOI 10.1146/annurev.med.49.1.341; Ehrt U, 2006, INT J GERIATR PSYCH, V21, P252, DOI 10.1002/gps.1456; Feldmann A, 2008, MOVEMENT DISORD, V23, P42, DOI 10.1002/mds.21765; Fitzgerald PB, 2008, HUM BRAIN MAPP, V29, P683, DOI 10.1002/hbm.20426; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Gallagher DA, 2012, NEUROBIOL DIS, V46, P581, DOI 10.1016/j.nbd.2011.12.041; Gitelman DR, 1999, BRAIN, V122, P1093, DOI 10.1093/brain/122.6.1093; Gmitrowicz A, 1994, Psychiatr Pol, V28, P509; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Guo WB, 2012, PROG NEURO-PSYCHOPH, V37, P153, DOI 10.1016/j.pnpbp.2012.01.011; Guo WB, 2013, PROG NEURO-PSYCHOPH, V44, P51, DOI 10.1016/j.pnpbp.2013.01.010; HAMILTON M, 1967, BRIT J SOC CLIN PSYC, V6, P278; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Hu SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059426; Hummer TA, 2013, BIOL PSYCHIAT, V73, P136, DOI 10.1016/j.biopsych.2012.06.036; Kendall M.G., 1990, RANK CORRELATION MET, V5th; Kostic VS, 2010, NEUROLOGY, V75, P857, DOI 10.1212/WNL.0b013e3181f11c1d; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lieberman A, 2006, ACTA NEUROL SCAND, V113, P1, DOI 10.1111/j.1600-0404.2006.00536.x; Lindeman S, 2000, ACTA PSYCHIAT SCAND, V102, P178, DOI 10.1034/j.1600-0447.2000.102003178.x; Liu Y, 2008, NEUROPSYCHOLOGIA, V46, P1648, DOI 10.1016/j.neuropsychologia.2008.01.027; Machizawa MG, 2010, J NEUROPHYSIOL, V103, P1569, DOI 10.1152/jn.90937.2008; Matsui H, 2007, J NEUROL, V254, P1170, DOI 10.1007/s00415-006-0236-6; Meppelink AM, 2009, BRAIN, V132, P2980, DOI 10.1093/brain/awp223; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Murray JB, 1996, J PSYCHOL, V130, P659, DOI 10.1080/00223980.1996.9915039; Paakki JJ, 2010, BRAIN RES, V1321, P169, DOI 10.1016/j.brainres.2009.12.081; Pereira MG, 2010, COGN AFFECT BEHAV NE, V10, P94, DOI 10.3758/CABN.10.1.94; Perlman SB, 2012, BIPOLAR DISORD, V14, P162, DOI 10.1111/j.1399-5618.2012.00999.x; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Politis M, 2010, NEUROLOGY, V75, P1920, DOI 10.1212/WNL.0b013e3181feb2ab; Porro CA, 2003, NEUROSCIENTIST, V9, P354, DOI 10.1177/1073858403253660; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; RAJPUT DR, 1993, J NEUROL NEUROSUR PS, V56, P938, DOI 10.1136/jnnp.56.8.938; Remy P, 2005, BRAIN, V128, P1314, DOI 10.1093/brain/awh445; RING HA, 1994, BRIT J PSYCHIAT, V165, P333, DOI 10.1192/bjp.165.3.333; Rogers BP, 2007, MAGN RESON IMAGING, V25, P1347, DOI 10.1016/j.mri.2007.03.007; SANTAMARIA J, 1986, NEUROLOGY, V36, P1130, DOI 10.1212/WNL.36.8.1130; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Savitz J, 2009, NEUROSCI BIOBEHAV R, V33, P699, DOI 10.1016/j.neubiorev.2009.01.004; Schoevers RA, 2000, J AFFECT DISORDERS, V59, P127, DOI 10.1016/S0165-0327(99)00124-X; Shukla DK, 2010, NEUROSCI LETT, V476, P46, DOI 10.1016/j.neulet.2010.03.080; Simmons AN, 2011, HUM BRAIN MAPP, V32, P1836, DOI 10.1002/hbm.21154; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; STARKSTEIN SE, 1990, J NERV MENT DIS, V178, P27, DOI 10.1097/00005053-199001000-00005; Suslow T, 2012, PSYCHIAT RES, V3, P00245; Tao H, 2013, MOL PSYCHIATR, V18, P101, DOI 10.1038/mp.2011.127; Teasdale JD, 1999, AM J PSYCHIAT, V156, P209; Tessitore A, 2002, J NEUROSCI, V22, P9099, DOI 10.1523/jneurosci.22-20-09099.2002; Tessitore A, 2012, PARKINSONISM RELAT D, V18, P781, DOI 10.1016/j.parkreldis.2012.03.018; Timmann D, 2007, CEREBELLUM, V6, P159, DOI 10.1080/14734220701496448; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Vohn R, 2007, HUM BRAIN MAPP, V28, P1267, DOI 10.1002/hbm.20350; Wen XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063691; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Wu T, 2011, HUM BRAIN MAPP, V32, P1443, DOI 10.1002/hbm.21118; Wu T, 2009, NEUROSCI LETT, V460, P6, DOI 10.1016/j.neulet.2009.05.046; Wu T, 2009, HUM BRAIN MAPP, V30, P1502, DOI 10.1002/hbm.20622; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhu CZ, 2008, NEUROIMAGE, V40, P110, DOI 10.1016/j.neuroimage.2007.11.029; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008; Zuo XN, 2013, NEUROIMAGE, V65, P374, DOI 10.1016/j.neuroimage.2012.10.017	84	66	69	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84705	10.1371/journal.pone.0084705	http://dx.doi.org/10.1371/journal.pone.0084705			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404185	Green Published, Green Submitted, gold			2022-12-27	WOS:000329460800064
J	Riddle, A; Maire, J; Cai, V; Nguyen, T; Gong, X; Hansen, K; Grafe, MR; Hohimer, R; Back, SA				Riddle, Art; Maire, Jennifer; Cai, Victor; Thuan Nguyen; Gong, Xi; Hansen, Kelly; Grafe, Marjorie R.; Hohimer, Roger; Back, Stephen A.			Hemodynamic and Metabolic Correlates of Perinatal White Matter Injury Severity	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; MIDGESTATIONAL SHEEP FETUSES; IMMATURE FETAL SHEEP; CARBOHYDRATE-METABOLISM; ACUTE HYPOXEMIA; GLUCOSE-METABOLISM; BRAIN ISCHEMIA; LACTATE; HYPOGLYCEMIA; RESPONSES	Background and Purpose: Although the spectrum of perinatal white matter injury (WMI) in preterm infants is shifting from cystic encephalomalacia to milder forms of WMI, the factors that contribute to this changing spectrum are unclear. We hypothesized that the variability in WMI quantified by immunohistochemical markers of inflammation could be correlated with the severity of impaired blood oxygen, glucose and lactate. Methods: We employed a preterm fetal sheep model of in utero moderate hypoxemia and global severe but not complete cerebral ischemia that reproduces the spectrum of human WMI. Since there is small but measurable residual brain blood flow during occlusion, we sought to determine if the metabolic state of the residual arterial blood was associated with severity of WMI. Near the conclusion of hypoxia-ischemia, we recorded cephalic arterial blood pressure, blood oxygen, glucose and lactate levels. To define the spectrum of WMI, an ordinal WMI rating scale was compared against an unbiased quantitative image analysis protocol that provided continuous histo-pathological outcome measures for astrogliosis and microgliosis derived from the entire white matter. Results: A spectrum of WMI was observed that ranged from diffuse non-necrotic lesions to more severe injury that comprised discrete foci of microscopic or macroscopic necrosis. Residual arterial pressure, oxygen content and blood glucose displayed a significant inverse association with WMI and lactate concentrations were directly related. Elevated glucose levels were the most significantly associated with less severe WMI. Conclusions: Our results suggest that under conditions of hypoxemia and severe cephalic hypotension, WMI severity measured using unbiased immunohistochemical measurements correlated with several physiologic parameters, including glucose, which may be a useful marker of fetal response to hypoxia or provide protection against energy failure and more severe WMI.	[Riddle, Art; Maire, Jennifer; Cai, Victor; Gong, Xi; Hansen, Kelly; Back, Stephen A.] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA; [Thuan Nguyen] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR 97201 USA; [Grafe, Marjorie R.] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97201 USA; [Hohimer, Roger] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA; [Back, Stephen A.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Back, SA (corresponding author), Oregon Hlth & Sci Univ, Dept Pediat, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97201 USA.	backs@ohsu.edu			National Institutes of Health: National Institute of Neurological Disorders and Stroke [1RO1NS054044, R37NS045737-06S1/06S2, 1F30NS066704]; NICHD [P01HD03443]; American Heart Association; March of Dimes Birth Defects Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS066704, R37NS045737, R01NS054044] Funding Source: NIH RePORTER	National Institutes of Health: National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); American Heart Association(American Heart Association); March of Dimes Birth Defects Foundation(March of Dimes); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by the National Institutes of Health: National Institute of Neurological Disorders and Stroke awards: 1RO1NS054044, R37NS045737-06S1/06S2 to SAB and 1F30NS066704 to AR and NICHD award P01HD03443. Supported by a Grant in Aid from the American Heart Association (SAB) and the March of Dimes Birth Defects Foundation (SAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ABRAMS RM, 1984, AM J PHYSIOL, V246, pR608, DOI 10.1152/ajpregu.1984.246.4.R608; ASANO H, 1994, AM J OBSTET GYNECOL, V170, P939, DOI 10.1016/S0002-9378(94)70310-8; Back S, 2012, ACQUIRED BRAIN INJUR, P29; Back SA, 2012, NEUROTHERAPEUTICS, V9, P359, DOI 10.1007/s13311-012-0108-y; Barkovich AJ, 1998, AM J NEURORADIOL, V19, P523; Bax M, 2006, JAMA-J AM MED ASSOC, V296, P1602, DOI 10.1001/jama.296.13.1602; Bennet L, 1999, J PHYSIOL-LONDON, V517, P247, DOI 10.1111/j.1469-7793.1999.0247z.x; BISSONNETTE JM, 1984, J DEV PHYSIOL, V6, P275; BISSONNETTE JM, 1985, J DEV PHYSIOL, V7, P421; BISSONNETTE JM, 1991, EXP PHYSIOL, V76, P515, DOI 10.1113/expphysiol.1991.sp003517; BRISTOW J, 1983, J CLIN INVEST, V71, P1047, DOI 10.1172/JCI110855; Burns CM, 2008, PEDIATRICS, V122, P65, DOI 10.1542/peds.2007-2822; Buser JR, 2012, ANN NEUROL, V71, P93, DOI 10.1002/ana.22627; CALLAHAN DJ, 1990, PEDIATR RES, V27, P186, DOI 10.1203/00006450-199002000-00020; CHAO CR, 1989, J CEREBR BLOOD F MET, V9, P53, DOI 10.1038/jcbfm.1989.7; CHAO CR, 1989, AM J OBSTET GYNECOL, V161, P221, DOI 10.1016/0002-9378(89)90270-6; Fillenz M, 2005, NEUROCHEM INT, V47, P413, DOI 10.1016/j.neuint.2005.05.011; Fletcher AJW, 2003, J PHYSIOL-LONDON, V549, P271, DOI 10.1113/jphysiol.2002.036418; Fowden AL, 1998, J PHYSIOL-LONDON, V508, P937, DOI 10.1111/j.1469-7793.1998.937bp.x; GLEASON CA, 1989, AM J PHYSIOL, V256, pR1264, DOI 10.1152/ajpregu.1989.256.6.R1264; GLEASON CA, 1990, AM J PHYSIOL, V258, pH1064, DOI 10.1152/ajpheart.1990.258.4.H1064; Gunn AJ, 2009, CLIN PERINATOL, V36, P579, DOI 10.1016/j.clp.2009.06.007; HARPER AM, 1963, J NEUROL NEUROSUR PS, V26, P341, DOI 10.1136/jnnp.26.4.341; HERMANSEN MC, 1984, BRAIN RES, V324, P101, DOI 10.1016/0006-8993(84)90626-7; HOHIMER AR, 1989, AM J OBSTET GYNECOL, V161, P1344; HOOPER SB, 1995, AM J PHYSIOL-REG I, V268, pR303, DOI 10.1152/ajpregu.1995.268.2.R303; IWAMOTO HS, 1989, AM J PHYSIOL, V256, pH613, DOI 10.1152/ajpheart.1989.256.3.H613; JONES MD, 1979, SEMIN PERINATOL, V3, P121; JONES MD, 1975, AM J PHYSIOL, V229, P235; Lawn CJ, 2005, COCHRANE DB SYST REV, V2; LeBlanc MH, 1997, BIOL NEONATE, V72, P243; MANN LI, 1970, PEDIATR RES, V4, P46, DOI 10.1203/00006450-197001000-00005; McClure MM, 2008, J CEREBR BLOOD F MET, V28, P995, DOI 10.1038/sj.jcbfm.9600597; McQuillen PS, 2010, ANN NY ACAD SCI, V1184, P68, DOI 10.1111/j.1749-6632.2009.05116.x; MEDINA JM, 1985, BIOL NEONATE, V48, P237, DOI 10.1159/000242176; Ment LR, 2009, LANCET NEUROL, V8, P1042, DOI 10.1016/S1474-4422(09)70257-1; Muller T, 2002, J PHYSIOL-LONDON, V539, P957, DOI 10.1013/jphysiol.2001.012590; Nadeem M, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-10; Petersson KH, 2004, PEDIATR RES, V56, P621, DOI 10.1203/01.PDR.0000139415.96985.BF; Pierson CR, 2007, ACTA NEUROPATHOL, V114, P619, DOI 10.1007/s00401-007-0295-5; Powers MJ, 2007, AM J PHYSIOL-REG I, V292, pR1542, DOI 10.1152/ajpregu.00300.2006; RICHARDSON BS, 1985, AM J PHYSIOL, V248, pR72, DOI 10.1152/ajpregu.1985.248.1.R72; Riddle A, 2006, J NEUROSCI, V26, P3045, DOI 10.1523/JNEUROSCI.5200-05.2006; Riddle A, 2012, STROKE, V43, P178, DOI 10.1161/STROKEAHA.111.632265; Riddle A, 2011, ANN NEUROL, V70, P493, DOI 10.1002/ana.22501; RUDOLPH CD, 1989, J DEV PHYSIOL, V11, P219; Nguyen T, 2011, STAT MED, V30, P3403, DOI 10.1002/sim.4366; TING P, 1983, EXP NEUROL, V80, P227, DOI 10.1016/0014-4886(83)90019-5; Vannucci RC, 2000, SEMIN PERINATOL, V24, P107, DOI 10.1053/sp.2000.6361; VANNUCCI RC, 1978, ANN NEUROL, V4, P73, DOI 10.1002/ana.410040114; Volpe JJ, 2008, NEUROLOGY NEWBORN, P399; WAGNER KR, 1986, J CEREBR BLOOD F MET, V6, P425, DOI 10.1038/jcbfm.1986.75; Wong DST, 2013, AM J NEURORADIOL, V34, P1456, DOI 10.3174/ajnr.A3423	54	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82940	10.1371/journal.pone.0082940	http://dx.doi.org/10.1371/journal.pone.0082940			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24416093	Green Published, gold, Green Submitted			2022-12-27	WOS:000328730300114
J	Boyce, SE; Tirunagari, N; Niedziela-Majka, A; Perry, J; Wong, M; Kan, E; Lagpacan, L; Barauskas, O; Hung, M; Fenaux, M; Appleby, T; Watkins, WJ; Schmitz, U; Sakowicz, R				Boyce, Sarah E.; Tirunagari, Neeraj; Niedziela-Majka, Anita; Perry, Jason; Wong, Melanie; Kan, Elaine; Lagpacan, Leanna; Barauskas, Ona; Hung, Magdeleine; Fenaux, Martijn; Appleby, Todd; Watkins, William J.; Schmitz, Uli; Sakowicz, Roman			Structural and Regulatory Elements of HCV NS5B Polymerase - beta-Loop and C-Terminal Tail - Are Required for Activity of Allosteric Thumb Site II Inhibitors	PLOS ONE			English	Article							DEPENDENT RNA-POLYMERASE; CRYSTAL-STRUCTURE; VIRUS POLYMERASE; PRECLINICAL CHARACTERIZATION; DE-NOVO; MECHANISM; BINDING; COMPLEXES; SELECTION; STEPS	Elucidation of the mechanism of action of the HCV NS5B polymerase thumb site II inhibitors has presented a challenge. Current opinion holds that these allosteric inhibitors stabilize the closed, inactive enzyme conformation, but how this inhibition is accomplished mechanistically is not well understood. Here, using a panel of NS5B proteins with mutations in key regulatory motifs of NS5B - the C-terminal tail and beta-loop - in conjunction with a diverse set of NS5B allosteric inhibitors, we show that thumb site II inhibitors possess a distinct mechanism of action. A combination of enzyme activity studies and direct binding assays reveals that these inhibitors require both regulatory elements to maintain the polymerase inhibitory activity. Removal of either element has little impact on the binding affinity of thumb site II inhibitors, but significantly reduces their potency. NS5B in complex with a thumb site II inhibitor displays a characteristic melting profile that suggests stabilization not only of the thumb domain but also the whole polymerase. Successive truncations of the C-terminal tail and/or removal of the beta-loop lead to progressive destabilization of the protein. Furthermore, the thermal unfolding transitions characteristic for thumb site II inhibitor - NS5B complex are absent in the inhibitor - bound constructs in which interactions between C-terminal tail and beta-loop are abolished, pointing to the pivotal role of both regulatory elements in communication between domains. Taken together, a comprehensive picture of inhibition by compounds binding to thumb site II emerges: inhibitor binding provides stabilization of the entire polymerase in an inactive, closed conformation, propagated via coupled interactions between the C-terminal tail and beta-loop.	[Boyce, Sarah E.; Tirunagari, Neeraj; Niedziela-Majka, Anita; Perry, Jason; Wong, Melanie; Kan, Elaine; Lagpacan, Leanna; Barauskas, Ona; Hung, Magdeleine; Fenaux, Martijn; Appleby, Todd; Watkins, William J.; Schmitz, Uli; Sakowicz, Roman] Gilead Sci Inc, Foster City, CA 94404 USA	Gilead Sciences	Sakowicz, R (corresponding author), Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA.	roman.sakowicz@gilead.com						Adachi T, 2002, BBA-PROTEINS PROTEOM, V1601, P38, DOI 10.1016/S1570-9639(02)00433-8; Aghemo A, 2013, NEW HORIZONS HEPATIT; Ago H, 1999, STRUCTURE, V7, P1417, DOI 10.1016/S0969-2126(00)80031-3; Ando I, 2012, ANTIMICROB AGENTS CH, V56, P4250, DOI 10.1128/AAC.00312-12; Biswal BK, 2005, J BIOL CHEM, V280, P18202, DOI 10.1074/jbc.M413410200; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Caillet-Saguy C, 2011, J MOL BIOL, V414, P370, DOI 10.1016/j.jmb.2011.10.001; Chinnaswamy S, 2010, J VIROL, V84, P5923, DOI 10.1128/JVI.02446-09; Chinnaswamy S, 2008, J BIOL CHEM, V283, P20535, DOI 10.1074/jbc.M801490200; Davis BC, 2013, PROTEINS, V81, P40, DOI 10.1002/prot.24154; De Clercq E, 2005, J MED CHEM, V48, P1297, DOI 10.1021/jm040158k; Delang L, 2013, CURR TOP MICROBIOL, V369, P289, DOI 10.1007/978-3-642-27340-7_12; Dutartre H, 2005, J BIOL CHEM, V280, P6359, DOI 10.1074/jbc.M410191200; Ellis DA, 2009, BIOORG MED CHEM LETT, V19, P6047, DOI 10.1016/j.bmcl.2009.09.051; Fenaux M, 2013, ANTIMICROB AGENTS CH, V57, P804, DOI 10.1128/AAC.02052-12; Gong P, 2010, P NATL ACAD SCI USA, V107, P22505, DOI 10.1073/pnas.1007626107; Hang JQ, 2009, J BIOL CHEM, V284, P15517, DOI 10.1074/jbc.M808889200; Hong Z, 2001, VIROLOGY, V285, P6, DOI 10.1006/viro.2001.0948; Howe AYM, 2006, ANTIMICROB AGENTS CH, V50, P4103, DOI 10.1128/AAC.00365-06; Hung M, 2002, ANTIVIR RES, V56, P99, DOI 10.1016/S0166-3542(02)00101-8; Jin ZN, 2012, J BIOL CHEM, V287, P10674, DOI 10.1074/jbc.M111.325530; Johnson CM, 2013, ARCH BIOCHEM BIOPHYS, V531, P100, DOI 10.1016/j.abb.2012.09.008; Kong CC, 2008, THIOPHENE ANALOGUES; Le Pogam S, 2006, J VIROL, V80, P6146, DOI 10.1128/JVI.02628-05; Lea WA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036219; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Li H, 2009, J MED CHEM, V52, P1255, DOI 10.1021/jm8014537; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Liu YY, 2006, BIOCHEMISTRY-US, V45, P11312, DOI 10.1021/bi060511j; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lohmann V, 2013, CURR TOP MICROBIOL, V369, P167, DOI 10.1007/978-3-642-27340-7_7; Moradpour D, 2013, CURR TOP MICROBIOL, V369, P113, DOI 10.1007/978-3-642-27340-7_5; Mosley RT, 2012, J VIROL, V86, P6503, DOI 10.1128/JVI.00386-12; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; O'Farrell D, 2003, J MOL BIOL, V326, P1025, DOI 10.1016/S0022-2836(02)01439-0; Pouliot J, 2008, ANN M AM ASS STUD LI; Reich S, 2010, J BIOL CHEM, V285, P13685, DOI 10.1074/jbc.M109.082206; Ruebsam F, 2009, BIOORG MED CHEM LETT, V19, P6404, DOI 10.1016/j.bmcl.2009.09.045; Ruebsam F, 2009, BIOORG MED CHEM LETT, V19, P451, DOI 10.1016/j.bmcl.2008.11.048; Scrima N, 2012, J VIROL, V86, P7107, DOI 10.1128/JVI.00459-12; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shim JH, 2002, J VIROL, V76, P7030, DOI 10.1128/JVI.76.14.7030-7039.2002; SHRAKE A, 1990, J BIOL CHEM, V265, P5055; Sivaraja M, 2008, 15 INT S HEP C VIR R; Wang MT, 2003, J BIOL CHEM, V278, P9489, DOI 10.1074/jbc.M209397200; Weber PC, 2003, CURR OPIN STRUC BIOL, V13, P115, DOI 10.1016/S0959-440X(03)00003-4; Winquist J, 2013, ANTIVIR RES, V97, P356, DOI 10.1016/j.antiviral.2012.12.027; Yi GH, 2012, ANTIMICROB AGENTS CH, V56, P830, DOI 10.1128/AAC.05438-11; Zamyatkin DF, 2008, J BIOL CHEM, V283, P7705, DOI 10.1074/jbc.M709563200	49	22	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84808	10.1371/journal.pone.0084808	http://dx.doi.org/10.1371/journal.pone.0084808			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416288	Green Submitted, gold, Green Published			2022-12-27	WOS:000329866300037
J	Mendes, SO; dos Santos, M; Peterle, GT; Maia, LD; Stur, E; Agostini, LP; de Carvalho, MB; Tajara, EH; Louro, ID; Trivilin, LO; da Silva-Conforti, AMA				Mendes, Suzanny Oliveira; dos Santos, Marcelo; Peterle, Gabriela Tonini; Maia, Lucas de Lima; Stur, Elaine; Agostini, Lidiane Pignaton; de Carvalho, Marcos Brasilino; Tajara, Eloiza Helena; Louro, Iuri Drumond; Trivilin, Leonardo Oliveira; Alvares da Silva-Conforti, Adriana Madeira			HIF-1alpha Expression Profile in Intratumoral and Peritumoral Inflammatory Cells as a Prognostic Marker for Squamous Cell Carcinoma of the Oral Cavity	PLOS ONE			English	Article							SURVIVAL; TARGETS; HEAD	The HIF-1 transcriptional complex is responsible for controlling transcription of over 100 genes involved in cell hypoxia response. HIF-1alpha subunit is stabilized in hypoxia conditions, creating the HIF-1 nuclear transcription factor. In inflammatory cells, high HIF-1alpha expression induces lymphocytic immunosuppression, decreasing tumoral antigen recognition, which promotes tumor growth. The present work investigated the relationship between HIF-1alpha expression in lymphocytes populating the intratumoral and peritumoral region of 56 patients with oral cancer. Our data indicates a prognostic value for this expression. High HIF-1alpha expression in peritumoral inflammatory cells is significantly related to worse patient outcome, whereas high expression in the intratumoral lymphoid cells correlates with a better prognosis. A risk profile indicating the chance of disease relapse and death was designed based on HIF-1alpha expression in tumoral inflammatory cells, defining low, intermediate and high risks. This risk profile was able to determine that high HIF-1alpha expression in peritumoral cells correlates with worse prognosis, independently of intratumoral expression. Low HIF-1alpha in tumor margins and high expression in the tumor was considered a low risk profile, showing no cases of disease relapse and disease related death. Intermediate risk was associated with low expression in tumor and tumor margins. Our results suggest that HIF-1alpha expression in tumor and peritumoral inflammatory cells may play an important role as prognostic tumor marker.	[Mendes, Suzanny Oliveira; dos Santos, Marcelo; Peterle, Gabriela Tonini; Maia, Lucas de Lima; Stur, Elaine; Agostini, Lidiane Pignaton; Louro, Iuri Drumond; Trivilin, Leonardo Oliveira; Alvares da Silva-Conforti, Adriana Madeira] Univ Fed Espirito Santo, Programa Pos Grad Biotecnol Renorbio, Vitoria, ES, Brazil; [dos Santos, Marcelo] Univ Fed Rio Grande do Norte, Dept Med, Caico, RN, Brazil; [de Carvalho, Marcos Brasilino] Hosp Heliopolis, Lab Biol Mol, Sao Paulo, Brazil; [Tajara, Eloiza Helena] Fac Med Sao Jose do Rio Preto, Dept Biol Mol, Sao Paulo, Brazil	Universidade Federal do Espirito Santo; Universidade Federal do Rio Grande do Norte	da Silva-Conforti, AMA (corresponding author), Univ Fed Espirito Santo, Programa Pos Grad Biotecnol Renorbio, Vitoria, ES, Brazil.	adriana.biomol@gmail.com	Álvares-da-Silva, Adriana M/J-2912-2018; Louro, Iuri D/I-8641-2012; Tajara, Eloiza H/G-7586-2012; dos Santos, Marcelo/K-2582-2012; Tonini Peterle, Gabriela/GWU-6986-2022; Brasilino de Carvalho, Marcos/C-1869-2014	Álvares-da-Silva, Adriana M/0000-0002-8078-0304; Tajara, Eloiza H/0000-0002-2603-2057; dos Santos, Marcelo/0000-0001-7321-7479; Brasilino de Carvalho, Marcos/0000-0001-6854-2680; Louro, Iuri/0000-0001-5160-9615; STUR, ELAINE/0000-0001-5962-0050	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [04/12054-9]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Espirito Santo (FAPES) [54653363]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Espirito Santo (FAPES)	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; grant 04/12054-9), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do Estado do Espirito Santo (FAPES grant 54653363). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, GLOBOCAN 2008 V2 0 C; Bauman JE, 2012, CURR OPIN ONCOL, V24, P235, DOI 10.1097/CCO.0b013e3283517920; Binahmed A, 2007, ORAL ONCOL, V43, P780, DOI 10.1016/j.oraloncology.2006.10.001; Campos AHJFM, 2009, MOL CELL BIOCHEM, V321, P95, DOI 10.1007/s11010-008-9923-1; Curado MP, 2009, CURR OPIN ONCOL, V21, P194, DOI 10.1097/CCO.0b013e32832a68ca; Dehne N, 2009, EXP CELL RES, V315, P1791, DOI 10.1016/j.yexcr.2009.03.019; Deschler DG, 2008, POCKET GUIDE NECK DI; Dong M, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0355-0; Kaya AO, 2012, J BUON, V17, P663; Kim JH, 2012, ONCOL REP, V28, P1701, DOI 10.3892/or.2012.2012; Lim YC, 2008, ACTA OTO-LARYNGOL, V128, P1132, DOI 10.1080/00016480801901691; Macarthur M, 2004, AM J PHYSIOL-GASTR L, V286, pG515, DOI 10.1152/ajpgi.00475.2003; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mohammed ZMA, 2012, CANCER TREAT REV, V38, P943, DOI 10.1016/j.ctrv.2012.04.011; Palazon A, 2012, CANCER DISCOV, V2, P608, DOI 10.1158/2159-8290.CD-11-0314; SANTOS MD, 2012, PLOS ONE, V0007; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; Soini Y, 2000, BRIT J CANCER, V83, P880, DOI 10.1054/bjoc.2000.1384; Thiel M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000853; Tougeron D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061001; Yadav GS, 2013, ACTA CYTOL, V57, P75, DOI 10.1159/000342916	23	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84923	10.1371/journal.pone.0084923	http://dx.doi.org/10.1371/journal.pone.0084923			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416312	Green Submitted, Green Published, gold			2022-12-27	WOS:000329866300042
J	Messing, J; Thole, C; Niehues, M; Shevtsova, A; Glocker, E; Boren, T; Hensel, A				Messing, Jutta; Thoele, Christian; Niehues, Michael; Shevtsova, Anna; Glocker, Erik; Boren, Thomas; Hensel, Andreas			Antiadhesive Properties of Abelmoschus esculentus (Okra) Immature Fruit Extract against Helicobacter pylori Adhesion	PLOS ONE			English	Article							INHIBIT ADHESION; BINDING; INFECTION; LIPOPOLYSACCHARIDE; POLYSACCHARIDES; RECURRENCE; LAMININ; PROTEIN; MILK	Background: Traditional Asian and African medicine use immature okra fruits (Abelmoschus esculentus) as mucilaginous food to combat gastritis. Its effectiveness is due to polysaccharides that inhibit the adhesion of Helicobacter pylori to stomach tissue. The present study investigates the antiadhesive effect in mechanistic detail. Methodology: A standardized aqueous fresh extract (Okra FE) from immature okra fruits was used for a quantitative in vitro adhesion assay with FITC-labled H. pylori J99, 2 clinical isolates, AGS cells, and fluorescence-activated cell sorting. Bacterial adhesins affected by FE were pinpointed using a dot-blot overlay assay with immobilized Lewis(b), sialyl-Lewis(a), H-1, laminin, and fibronectin. I-125-radiolabeled Okra FE polymer served for binding studies to different H. pylori strains and interaction experiments with BabA and SabA. Iron nanoparticles with different coatings were used to investigate the influence of the charge-dependence of an interaction on the H. pylori surface. Principal findings: Okra FE dose-dependently (0.2 to 2 mg/mL) inhibited H. pylori binding to AGS cells. FE inhibited the adhesive binding of membrane proteins BabA, SabA, and HpA to its specific ligands. Radiolabeled compounds from FE bound non-specifically to different strains of H. pylori, as well as to BabA/SabA deficient mutants, indicating an interaction with a still-unknown membrane structure in the vicinity of the adhesins. The binding depended on the charge of the inhibitors. Okra FE did not lead to subsequent feedback regulation or increased expression of adhesins or virulence factors. Conclusion: Non-specific interactions between high molecular compounds from okra fruits and the H. pylori surface lead to strong antiadhesive effects.	[Messing, Jutta; Thoele, Christian; Niehues, Michael; Hensel, Andreas] Univ Munster, Inst Pharmaceut Biol & Phytochem, D-48149 Munster, Germany; [Shevtsova, Anna; Boren, Thomas] Umea Univ, Umea, Sweden; [Glocker, Erik] Univ Hosp Freiburg, Dept Med Microbiol & Hyg, Reference Ctr Helicobacter Pylori, Freiburg, Germany	University of Munster; Umea University; University of Freiburg	Hensel, A (corresponding author), Univ Munster, Inst Pharmaceut Biol & Phytochem, D-48149 Munster, Germany.	ahensel@uni-muenster.de			German Research Foundation, DFG (International Research Training Group 1549 Molecular and Cellular Glyco-Sciences MCGS, Munster Hyderabad); Vetenskapsradet/VR(M), Cancerfonden	German Research Foundation, DFG (International Research Training Group 1549 Molecular and Cellular Glyco-Sciences MCGS, Munster Hyderabad)(German Research Foundation (DFG)); Vetenskapsradet/VR(M), Cancerfonden	Financial support by the German Research Foundation, DFG (International Research Training Group 1549 Molecular and Cellular Glyco-Sciences MCGS, Munster Hyderabad), to AH, JM, and CT and from Vetenskapsradet/VR(M), Cancerfonden to TB is acknowledged, and was in part performed within the Umea Centre for Microbial Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Aspholm M, 2006, PLOS PATHOG, V2, P989, DOI 10.1371/journal.ppat.0020110; Aspholm-Hurtig M, 2004, SCIENCE, V305, P519, DOI 10.1126/science.1098801; Dubois A, 1999, GASTROENTEROLOGY, V116, P90, DOI 10.1016/S0016-5085(99)70232-5; Gisbert JP, 2005, AM J GASTROENTEROL, V100, P2083, DOI 10.1111/j.1572-0241.2005.50043.x; Gloaguen V, 2007, PLANTA MED, V73, P1402, DOI 10.1055/s-2007-990237; Hirmo S, 1998, FEMS IMMUNOL MED MIC, V20, P275, DOI 10.1111/j.1574-695X.1998.tb01137.x; HUNTER WM, 1962, NATURE, V194, P495, DOI 10.1038/194495a0; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; Khamri W, 2005, INFECT IMMUN, V73, P7677, DOI 10.1128/IAI.73.11.7677-7686.2005; Kunz C, 2000, ANNU REV NUTR, V20, P699, DOI 10.1146/annurev.nutr.20.1.699; Lengsfeld C, 2004, PLANTA MED, V70, P620, DOI 10.1055/s-2004-827184; Lengsfeld C, 2004, J AGR FOOD CHEM, V52, P1495, DOI 10.1021/jf030666n; Lengsfeld C, 2007, ANIM FEED SCI TECH, V135, P113, DOI 10.1016/j.anifeedsci.2006.11.017; Linden S, 2002, GASTROENTEROLOGY, V123, P1923, DOI 10.1053/gast.2002.37076; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; Mysore JV, 1999, GASTROENTEROLOGY, V117, P1316, DOI 10.1016/S0016-5085(99)70282-9; Niehues A., 2010, MOL NUTR FOOD RES, V54, P1; Niehues M, 2010, International Patent application, Patent No. [PCT/NL2010/050158, 2010050158]; Niv Y, 2008, WORLD J GASTROENTERO, V14, P1477, DOI 10.3748/wjg.14.1477; Odenbreit S, 2002, INT J MED MICROBIOL, V292, P247, DOI 10.1078/1438-4221-00204; Odenbreit S, 1999, MOL MICROBIOL, V31, P1537, DOI 10.1046/j.1365-2958.1999.01300.x; Parente F, 2003, HELICOBACTER, V8, P252, DOI 10.1046/j.1523-5378.2003.00152.x; Selgrad M, 2011, CURR OPIN GASTROEN, V27, P565, DOI 10.1097/MOG.0b013e32834bb818; Sengkhamparn N, 2009, CARBOHYD RES, V344, P1824, DOI 10.1016/j.carres.2008.10.012; Sengkhamparn N, 2009, CARBOHYD RES, V344, P1842, DOI 10.1016/j.carres.2008.11.022; Shmuely H, 2004, DIAGN MICR INFEC DIS, V50, P231, DOI 10.1016/j.diagmicrobio.2004.08.011; Simon PM, 1997, INFECT IMMUN, V65, P750, DOI 10.1128/IAI.65.2.750-757.1997; Stingl K, 2005, INT J MED MICROBIOL, V295, P307, DOI 10.1016/j.ijmm.2005.06.006; Sun HY, 2007, J BIOL CHEM, V282, P9973, DOI 10.1074/jbc.M610285200; VALKONEN KH, 1993, FEMS IMMUNOL MED MIC, V7, P29, DOI 10.1111/j.1574-695X.1993.tb00378.x; Valkonen KH, 1997, INFECT IMMUN, V65, P916, DOI 10.1128/IAI.65.3.916-923.1997; Van de Bovenkamp JHB, 2003, HELICOBACTER, V8, P521, DOI 10.1046/j.1523-5378.2003.00173.x; Wittschier N, 2007, PHYTOMEDICINE, V14, P285, DOI 10.1016/j.phymed.2006.12.008; Wittschier N, 2009, J ETHNOPHARMACOL, V125, P218, DOI 10.1016/j.jep.2009.07.009; Yamaoka Yoshio, 2008, P37	37	44	50	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84836	10.1371/journal.pone.0084836	http://dx.doi.org/10.1371/journal.pone.0084836			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416297	Green Published, Green Submitted, gold			2022-12-27	WOS:000329866300039
J	Adebajo, S; Obianwu, O; Eluwa, G; Vu, L; Oginni, A; Tun, W; Sheehy, M; Ahonsi, B; Bashorun, A; Idogho, O; Karlyn, A				Adebajo, Sylvia; Obianwu, Otibho; Eluwa, George; Vu, Lung; Oginni, Ayo; Tun, Waimar; Sheehy, Meredith; Ahonsi, Babatunde; Bashorun, Adebobola; Idogho, Omokhudu; Karlyn, Andrew			Comparison of Audio Computer Assisted Self-Interview and Face-To-Face Interview Methods in Eliciting HIV-Related Risks among Men Who Have Sex with Men and Men Who Inject Drugs in Nigeria	PLOS ONE			English	Article							BEHAVIOR; PREVALENCE; SAMPLE; MODES; BIAS	Introduction: Face-to-face (FTF) interviews are the most frequently used means of obtaining information on sexual and drug injecting behaviours from men who have sex with men (MSM) and men who inject drugs (MWID). However, accurate information on these behaviours may be difficult to elicit because of sociocultural hostility towards these populations and the criminalization associated with these behaviours. Audio computer assisted self-interview (ACASI) is an interviewing technique that may mitigate social desirability bias in this context. Methods: This study evaluated differences in the reporting of HIV-related risky behaviours by MSM and MWID using ACASI and FTF interviews. Between August and September 2010, 712 MSM and 328 MWID in Nigeria were randomized to either ACASI or FTF interview for completion of a behavioural survey that included questions on sensitive sexual and injecting risk behaviours. Data were analyzed separately for MSM and MWID. Logistic regression was run for each behaviour as a dependent variable to determine differences in reporting methods. Results: MSM interviewed via ACASI reported significantly higher risky behaviours with both women (multiple female sexual partners 51% vs. 43%, p = 0.04; had unprotected anal sex with women 72% vs. 57%, p = 0.05) and men (multiple male sex partners 70% vs. 54%, p <= 0.001) than through FTF. Additionally, they were more likely to self-identify as homosexual (AOR: 3.3, 95%CI: 2.4-4.6) and report drug use in the past 12 months (AOR: 40.0, 95%CI: 9.6-166.0). MWID interviewed with ACASI were more likely to report needle sharing (AOR: 3.3, 95%CI: 1.2-8.9) and re-use (AOR: 2.2, 95%CI: 1.2-3.9) in the past month and prior HIV testing (AOR: 1.6, 95%CI 1.02-2.5). Conclusion: The feasibility of using ACASI in studies and clinics targeting key populations in Nigeria must be explored to increase the likelihood of obtaining more accurate data on high risk behaviours to inform improved risk reduction strategies that reduce HIV transmission.	[Adebajo, Sylvia; Obianwu, Otibho; Eluwa, George; Oginni, Ayo; Ahonsi, Babatunde] Populat Council, Abuja, Nigeria; [Vu, Lung] PSI, Washington, DC USA; [Tun, Waimar] Populat Council, Washington, DC USA; [Sheehy, Meredith] Populat Council, New York, NY 10021 USA; [Bashorun, Adebobola] Fed Minist Hlth, Abuja, Nigeria; [Idogho, Omokhudu] Soc Family Hlth, Abuja, Nigeria; [Karlyn, Andrew] USAID, Washington, DC USA	Population Council; Population Council; United States Agency for International Development (USAID)	Adebajo, S (corresponding author), Populat Council, Abuja, Nigeria.	sadebajo@popcouncil.org			UK Department for International Development (DFID) through the Enhancing Nigeria's Response to HIV/AIDS (ENR) program	UK Department for International Development (DFID) through the Enhancing Nigeria's Response to HIV/AIDS (ENR) program	The study was funded by the UK Department for International Development (DFID) through the Enhancing Nigeria's Response to HIV/AIDS (ENR) program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Find out more about DFID at https://www.gov.uk/government/organisations/department-for-international-development.	Aday LA, 2006, DESIGNING CONDUCTING; Adebajo Sylvia B, 2012, Afr J Reprod Health, V16, P21; Allman D, 2007, CULT HEALTH SEX, V9, P153, DOI 10.1080/13691050601040480; Beyrer C, 2010, SEX TRANSM INFECT, V86, P323, DOI 10.1136/sti.2009.040162; Des Jarlais DC, 1999, LANCET, V353, P1657, DOI 10.1016/S0140-6736(98)07026-3; ENR, 2010, PREV STIS MSM IDUS V; FMOH, 2007, INT BIOL BEH SURV SU; FMOH, 2010, INT BIOL BEH SURV SU; Ghanem KG, 2005, SEX TRANSM INFECT, V81, P421, DOI 10.1136/sti.2004.013193; Gregson S, 2002, SEX TRANSM DIS, V29, P568, DOI 10.1097/00007435-200210000-00002; Hallman K, 2004, DISADVANTAGE UNSAFE; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Hewett PC, 2004, SEX TRANSM INFECT, V80, P43, DOI 10.1136/sti.2004.013250; Jaya, 2008, American Journal of Public Health, V98, P169, DOI 10.2105/AJPH.2006.099937; Johnson AM, 2001, AIDS, V15, P111, DOI 10.1097/00002030-200101050-00016; Kissinger P, 1999, AM J EPIDEMIOL, V149, P950, DOI 10.1093/oxfordjournals.aje.a009739; Kurth AE, 2004, SEX TRANSM DIS, V31, P719, DOI 10.1097/01.olq.0000145855.36181.13; Langhaug LF, 2011, SEX TRANSM INFECT, V87, P165, DOI 10.1136/sti.2009.037374; Mensch BS, 2003, DEMOGRAPHY, V40, P247, DOI 10.1353/dem.2003.0017; Merrigan M, 2011, SEX TRANSM INFECT, V87, P65, DOI 10.1136/sti.2008.034991; Saghaei M., 2004, RANDOM ALLOCATION SO; Salganik MJ, 2006, J URBAN HEALTH, V83, pI98, DOI 10.1007/s11524-006-9106-x; Sheehy M, 2013, AIDS CARE, V6, P6; Torrone EA, 2010, AIDS PATIENT CARE ST, V24, P551, DOI 10.1089/apc.2010.0087; Turner CF, 1998, SCIENCE, V280, P867, DOI 10.1126/science.280.5365.867; van der Elst EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005340; Vu L, 2013, AIDS BEHAV IN PRESS; Vu L, 2013, JAIDS-J ACQ IMM DEF, V63, P221, DOI 10.1097/QAI.0b013e31828a3e60; WHO, 2009, ENV HLTH RISKS INFL; Williams ML, 2000, AIDS EDUC PREV, V12, P199	30	34	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e81981	10.1371/journal.pone.0081981	http://dx.doi.org/10.1371/journal.pone.0081981			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291WL	24416134	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500011
J	Finucane, MM; Sharpton, TJ; Laurent, TJ; Pollard, KS				Finucane, Mariel M.; Sharpton, Thomas J.; Laurent, Timothy J.; Pollard, Katherine S.			A Taxonomic Signature of Obesity in the Microbiome? Getting to the Guts of the Matter	PLOS ONE			English	Article							ECOLOGY	Obesity is an important and intractable public health problem. In addition to the well-known risk factors of behavior, diet, and genetics, gut microbial communities were recently identified as another possible source of risk and a potential therapeutic target. However, human and animal-model studies have yielded conflicting results about the precise nature of associations between microbiome composition and obesity. In this paper, we use publicly available data from the Human Microbiome Project (HMP) and MetaHIT, both surveys of healthy adults that include obese individuals, plus two smaller studies that specifically examined lean versus obese adults. We find that inter-study variability in the taxonomic composition of stool microbiomes far exceeds differences between lean and obese individuals within studies. Our analyses further reveal a high degree of variability in stool microbiome composition and diversity across individuals. While we confirm the previously published small, but statistically significant, differences in phylum-level taxonomic composition between lean and obese individuals in several cohorts, we find no association between BMI and taxonomic composition of stool microbiomes in the larger HMP and MetaHIT datasets. We explore a range of different statistical techniques and show that this result is robust to the choice of methodology. Differences between studies are likely due to a combination of technical and clinical factors. We conclude that there is no simple taxonomic signature of obesity in the microbiota of the human gut.	[Finucane, Mariel M.; Sharpton, Thomas J.; Laurent, Timothy J.; Pollard, Katherine S.] J David Gladstone Inst, San Francisco, CA USA; [Pollard, Katherine S.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Pollard, Katherine S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Pollard, KS (corresponding author), J David Gladstone Inst, San Francisco, CA USA.	kpollard@gladstone.ucsf.edu		Sharpton, Thomas/0000-0002-5996-7764	National Science Foundation [DMS-1069303]; NIH Roadmap for Medical Research	National Science Foundation(National Science Foundation (NSF)); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Science Foundation (grant #DMS-1069303) and a gift from the San Simeon Fund. Funding support for the development of NIH Human Microbiome Project - Core Microbiome Sampling Protocol A (HMP-A) was provided by the NIH Roadmap for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchison J, 1986, STAT ANAL COMPOSITIO, DOI DOI 10.1007/978-94-009-4109-0; Angly FE, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks251; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Crawford PA, 2009, P NATL ACAD SCI USA, V106, P11276, DOI 10.1073/pnas.0902366106; Davidsen T, 2010, NUCLEIC ACIDS RES, V38, pD340, DOI 10.1093/nar/gkp912; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Douketis JD, 2005, INT J OBESITY, V29, P1153, DOI 10.1038/sj.ijo.0802982; Graessler J, 2012, PHARMACOGENOMICS J, V2012, P1; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Knights D, 2011, FEMS MICROBIOL REV, V35, P343, DOI 10.1111/j.1574-6976.2010.00251.x; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Ley RE, 2010, CURR OPIN GASTROEN, V26, P5, DOI 10.1097/MOG.0b013e328333d751; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lozupone CA, 2013, GENOME RES, V23, P1704, DOI 10.1101/gr.151803.112; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Sweeney TE, 2013, JAMA SURG, P1; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wu DY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002566; Zimmer C, 2010, NY TIMES, pD1	31	212	217	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84689	10.1371/journal.pone.0084689	http://dx.doi.org/10.1371/journal.pone.0084689			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416266	gold, Green Published			2022-12-27	WOS:000329862500149
J	Gao, Q; Ju, ZH; Zhang, Y; Huang, JM; Zhang, XJ; Qi, C; Li, JB; Zhong, JF; Li, GR; Wang, CF				Gao, Qing; Ju, Zhihua; Zhang, Yan; Huang, Jinming; Zhang, Xiaojian; Qi, Chao; Li, Jianbin; Zhong, Jifeng; Li, Guorong; Wang, Changfa			Association of TNP2 Gene Polymorphisms of the bta-miR-154 Target Site with the Semen Quality Traits of Chinese Holstein Bulls	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; SPERMATIDAL PROTEIN TP2; DAIRY-CATTLE; MICRORNAS; EXPRESSION; SEQUENCE; MOUSE; PRM1; IDENTIFICATION; LOCALIZATION	Transition protein 2 (TNP2) participates in removing nucleohistones and the initial condensation of spermatid nucleus during spermiogenesis. This study investigated the relationship between the variants of the bovine TNP2 gene and the semen quality traits of Chinese Holstein bulls. We detected three single nucleotide polymorphisms (SNPs) of the TNP2 gene in 392 Chinese Holstein bulls, namely, g.269 G>A (exon 1), g.480 C>T (intron 1), and g.1536 C>T (3'-UTR). Association analysis showed that the semen quality traits of the Chinese Holstein bulls was significantly affected by the three SNPs. The bulls with the haplotypic combinations H6H4, H6H6, and H6H8 had higher initial semen motility than those with the H7H8 and H8H4 haplotypic combinations (P<0.05). SNPs in the microRNA (miRNA) binding region of the TNP2 gene 3'-UTR may have contributed to the phenotypic differences. The phenotypic differences are caused by the altered expression of the miRNAs and their targets. Bioinformatics analysis predicted that the g.1536 C>T site in the TNP2 3'-UTR is located in the bta-miR-154 binding region. The quantitative real-time polymerase chain reaction results showed that the TNP2 mRNA relative expression in bulls with the CT and CC genotypes was significantly higher than those with the TT genotype (P<0.05) in the g.1536 C>T site. The luciferase assay also indicated that bta-miR-154 directly targets TNP2 in a murine Leydig cell tumor cell line. The SNP g.1536 C>T in the TNP2 3'-UTR, which altered the binding of TNP2 with bta-miR-154, was found to be associated with the semen quality traits of Chinese Holstein bulls.	[Gao, Qing; Ju, Zhihua; Zhang, Yan; Huang, Jinming; Zhang, Xiaojian; Qi, Chao; Li, Jianbin; Zhong, Jifeng; Wang, Changfa] Shandong Acad Agr Sci, Dairy Cattle Res Ctr, Jinan, Peoples R China; [Gao, Qing; Li, Guorong] Shandong Normal Univ, Coll Life Sci, Jinan, Peoples R China	Shandong Academy of Agricultural Sciences; Shandong Normal University	Li, GR (corresponding author), Shandong Normal Univ, Coll Life Sci, Jinan, Peoples R China.	liguorong66@hotmail.com		Li, Jianbin/0000-0002-9587-2666	National Science and Technology Pillar Program during the 12th Five-Year Plan of China [2011BAD19B02, 2011BAD19B04]; Modern Agro-industry Technology Research System [CARS-37]; State Major Project of Transgenic [2011ZX08007-004]; National Natural Science Foundation of China [31271328, 31371255]; Well-bred Program of Shandong Province [2012LZ10-06]; Key Scientific and Technological Project of Shandong Province [2009GG20002033]	National Science and Technology Pillar Program during the 12th Five-Year Plan of China; Modern Agro-industry Technology Research System; State Major Project of Transgenic; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Well-bred Program of Shandong Province; Key Scientific and Technological Project of Shandong Province	This work was partially supported by grants the National Science and Technology Pillar Program during the 12th Five-Year Plan of China (Grant no. 2011BAD19B02 and 2011BAD19B04), the Modern Agro-industry Technology Research System (Grant no. CARS-37), State Major Project of Transgenic (2011ZX08007-004), the National Natural Science Foundation of China (31271328 and 31371255), the Well-bred Program of Shandong Province (Grant no. 2012LZ10-06), and the Key Scientific and Technological Project of Shandong Province (Gran' no. 2009GG20002033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Carletti MZ, 2009, J ANIM SCI, V87, pE29, DOI 10.2527/jas.2008-1331; Chandra V, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S2; COLE KD, 1987, BIOCHEM BIOPH RES CO, V147, P437, DOI 10.1016/S0006-291X(87)80140-7; ENGEL W, 1992, CYTOGENET CELL GENET, V61, P158, DOI 10.1159/000133397; Fridel R, 1994, MAMM GENOME, V5, P523; Georges M, 2007, CURR OPIN GENET DEV, V17, P166, DOI 10.1016/j.gde.2007.04.005; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hou QL, 2012, DNA CELL BIOL, V31, P739, DOI 10.1089/dna.2011.1402; Huang JM, 2011, INT J BIOL SCI, V7, P1016, DOI 10.7150/ijbs.7.1016; KIERSZENBAUM AL, 1975, J CELL BIOL, V65, P258, DOI 10.1083/jcb.65.2.258; KLEENE KC, 1989, DEVELOPMENT, V106, P367; Kramer JA, 1998, COMP BIOCHEM PHYS C, V120, P467, DOI 10.1016/S0742-8413(98)10062-2; Kundu TK, 1996, BIOCHEMISTRY-US, V35, P15626, DOI 10.1021/bi961271i; Li LM, 2012, IMMUNOGENETICS, V64, P817, DOI 10.1007/s00251-012-0641-1; Liao Y, 2010, INT J BIOCHEM CELL B, V42, P1363, DOI 10.1016/j.biocel.2009.07.019; LUERSSEN H, 1990, GENOMICS, V8, P324, DOI 10.1016/0888-7543(90)90289-7; Meetei AR, 2000, J BIOL CHEM, V275, P38500, DOI 10.1074/jbc.M002734200; Meistrich M., 1989, HISTONES OTHER BASIC, P165; Meistrich ML, 1993, MOL BIOL MALE REPROD, P67; Nicoloso MS, 2010, CANCER RES, V70, P2789, DOI 10.1158/0008-5472.CAN-09-3541; Nott A, 2003, RNA, V9, P607, DOI 10.1261/rna.5250403; REBOIS RV, 1982, J CELL BIOL, V94, P70, DOI 10.1083/jcb.94.1.70; REINHART N, 1991, BIOL CHEM H-S, V372, P431, DOI 10.1515/bchm3.1991.372.1.431; Reshmi G, 2011, GENOMICS, V98, P189, DOI 10.1016/j.ygeno.2011.06.005; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Tseden K, 2007, MOL REPROD DEV, V74, P273, DOI 10.1002/mrd.20570; WYKES SM, 1995, DNA CELL BIOL, V14, P155, DOI 10.1089/dna.1995.14.155; Wykes SM, 2003, DNA SEQUENCE, V14, P359, DOI 10.1080/10425170310001599453; Yan NH, 2009, J ASSIST REPROD GEN, V26, P179, DOI 10.1007/s10815-009-9305-y; Zan LinSen, 2007, Scientia Agricultura Sinica, V40, P1498; Zhang CL, 2007, ANAL BIOCHEM, V365, P286, DOI 10.1016/j.ab.2007.03.023; Zhao Chun-Jiang, 2003, Yichuan, V25, P327; Zhao M, 2001, MOL CELL BIOL, V21, P7243, DOI 10.1128/MCB.21.21.7243-7255.2001	34	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84355	10.1371/journal.pone.0084355	http://dx.doi.org/10.1371/journal.pone.0084355			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416221	Green Submitted, gold, Green Published			2022-12-27	WOS:000329862500118
J	Jeong, JH; Kim, K; Lim, D; Jeong, K; Hong, Y; Nguyen, VH; Kim, TH; Ryu, S; Lim, JA; Kim, JI; Kim, GJ; Kim, SC; Min, JJ; Choy, HE				Jeong, Jae-Ho; Kim, Kwangsoo; Lim, Daejin; Jeong, Kwangjoon; Hong, Yeongjin; Nguyen, Vu H.; Kim, Tae-Hyoung; Ryu, Sangryeol; Lim, Jeong-A; Kim, Jae Il; Kim, Geun-Joong; Kim, Sun Chang; Min, Jung-Joon; Choy, Hyon E.			Anti-Tumoral Effect of the Mitochondrial Target Domain of Noxa Delivered by an Engineered Salmonella typhimurium	PLOS ONE			English	Article							ESCHERICHIA-COLI; PROTEIN TRANSDUCTION; STATIONARY-PHASE; BCL-2 FAMILY; CELL; BACTERIA; CANCER; LYSIS; GENE; INDUCTION	Bacterial cancer therapy relies on the fact that several bacterial species are capable of targeting tumor tissue and that bacteria can be genetically engineered to selectively deliver therapeutic proteins of interest to the targeted tumors. However, the challenge of bacterial cancer therapy is the release of the therapeutic proteins from the bacteria and entry of the proteins into tumor cells. This study employed an attenuated Salmonella typhimurium to selectively deliver the mitochondrial targeting domain of Noxa (MTD) as a potential therapeutic cargo protein, and examined its anti-cancer effect. To release MTD from the bacteria, a novel bacterial lysis system of phage origin was deployed. To facilitate the entry of MTD into the tumor cells, the MTD was fused to DS4.3, a novel cell-penetrating peptide (CPP) derived from a voltage-gated potassium channel (K(v)2.1). The gene encoding DS4.3-MTD and the phage lysis genes were placed under the control of P-BAD, a promoter activated by L-arabinose. We demonstrated that DS4.3-MTD chimeric molecules expressed by the Salmonellae were anti-tumoral in cultured tumor cells and in mice with CT26 colon carcinoma.	[Jeong, Jae-Ho; Kim, Kwangsoo; Lim, Daejin; Jeong, Kwangjoon; Hong, Yeongjin; Choy, Hyon E.] Chonnam Natl Univ, Dept Microbiol, Sch Med, Kwangju, South Korea; [Nguyen, Vu H.; Min, Jung-Joon] Chonnam Natl Univ, Dept Nucl Med, Sch Med, Kwangju, South Korea; [Kim, Tae-Hyoung] Chonnam Natl Univ, Dept Biochem, Sch Med, Kwangju, South Korea; [Ryu, Sangryeol; Lim, Jeong-A] Seoul Natl Univ, Dept Food & Anim Biotechnol, Seoul, South Korea; [Kim, Jae Il] Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju, South Korea; [Kim, Geun-Joong] Chonnam Natl Univ, Dept Biol Sci, Coll Nat Sci, Kwangju, South Korea; [Kim, Sun Chang] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea	Chonnam National University; Chonnam National University; Chonnam National University; Seoul National University (SNU); Gwangju Institute of Science & Technology (GIST); Chonnam National University; Korea Advanced Institute of Science & Technology (KAIST)	Min, JJ (corresponding author), Chonnam Natl Univ, Dept Nucl Med, Sch Med, Kwangju, South Korea.	jjmin@jnu.ac.kr; hyonchoy@jnu.ac.kr	Nguyen, Vu/HGV-1806-2022; Kim, Sun/GSN-4867-2022; Kim, Sun Chang/C-2026-2011	Jeong, Jae-Ho/0000-0002-5544-9572	Intelligent Synthetic Biology Center of the Global Frontier Project; Ministry of Education, Science, and Technology (MEST) [2011-0031958]; National Research Foundation of Korea (NRF) [2012-0006072]; Pioneer Research Center Program "Bacteriobot" through NFR; MEST [2012-0001031]; Agriculture Research Center program of the Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea; Next-Generation BioGreen 21 Program; the Rural Development Administration, Republic of Korea [PJ008158]	Intelligent Synthetic Biology Center of the Global Frontier Project; Ministry of Education, Science, and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Pioneer Research Center Program "Bacteriobot" through NFR; MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea); Agriculture Research Center program of the Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea; Next-Generation BioGreen 21 Program; the Rural Development Administration, Republic of Korea	This work was supported by the Intelligent Synthetic Biology Center of the Global Frontier Project funded by the Ministry of Education, Science, and Technology (MEST) (2011-0031958). JJM was supported by the National Research Foundation of Korea (NRF) (No. 2012-0006072). YH was supported by the Pioneer Research Center Program "Bacteriobot" through NFR funded by MEST (2012-0001031). SR was supported by the Agriculture Research Center program of the Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea. JIK was supported by grant from the Next-Generation BioGreen 21 Program (PJ008158); the Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; BLIGHT MA, 1994, TRENDS BIOTECHNOL, V12, P450, DOI 10.1016/0167-7799(94)90020-5; Borjesson SI, 2008, CELL BIOCHEM BIOPHYS, V52, P149, DOI 10.1007/s12013-008-9032-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Clairmont C, 2000, J INFECT DIS, V181, P1996, DOI 10.1086/315497; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis R., 1980, ADV BACTERIAL GENETI; Deshayes S, 2004, BIOCHEMISTRY-US, V43, P1449, DOI 10.1021/bi035682s; Dom G, 2003, NUCLEIC ACIDS RES, V31, P556, DOI 10.1093/nar/gkg160; Ehrhardt H, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.53; Forbes NS, 2010, NAT REV CANCER, V10, P784, DOI 10.1038/nrc2934; Gariepy J, 2001, TRENDS BIOTECHNOL, V19, P21, DOI 10.1016/S0167-7799(00)01520-1; GARRETT J, 1990, J BACTERIOL, V172, P7275, DOI 10.1128/jb.172.12.7275-7277.1990; GARRETT J, 1981, MOL GEN GENET, V182, P326, DOI 10.1007/BF00269678; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hill PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025409; Jain RK, 2001, P NATL ACAD SCI USA, V98, P14748, DOI 10.1073/pnas.261606598; Jain V, 2000, INFECT IMMUN, V68, P986, DOI 10.1128/IAI.68.2.986-989.2000; Jarvik T, 2010, J BACTERIOL, V192, P560, DOI 10.1128/JB.01233-09; Jiang SN, 2013, MOL THER; Kim K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060511; Krepkiy D, 2009, NATURE, V462, P473, DOI 10.1038/nature08542; Le UN, 2011, MOL THER, V19, P951, DOI 10.1038/mt.2011.25; Levesque AA, 2007, CARCINOGENESIS, V28, P13, DOI 10.1093/carcin/bgl214; Lindgren M, 2000, TRENDS PHARMACOL SCI, V21, P99, DOI 10.1016/S0165-6147(00)01447-4; MARATEA D, 1985, GENE, V40, P39, DOI 10.1016/0378-1119(85)90022-8; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; MENGINLECREULX D, 1993, J BACTERIOL, V175, P6150, DOI 10.1128/JB.175.19.6150-6157.1993; Miksch G, 1997, ARCH MICROBIOL, V167, P143, DOI 10.1007/s002030050427; Miller J.H., 1972, EXPT MOL GENETICS; Min JJ, 2008, NAT PROTOC, V3, P629, DOI 10.1038/nprot.2008.32; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; NAUTS H C, 1953, Acta Med Scand Suppl, V276, P1; Nguyen VH, 2010, CANCER RES, V70, P18, DOI 10.1158/0008-5472.CAN-09-3453; Park SY, 2011, J MICROBIOL METH, V86, P108, DOI 10.1016/j.mimet.2011.04.003; Pawelek JM, 1997, CANCER RES, V57, P4537; Petros AM, 2004, BBA-MOL CELL RES, V1644, P83, DOI 10.1016/j.bbamcr.2003.08.012; SARVAS M, 1971, J BACTERIOL, V105, P467, DOI 10.1128/JB.105.2.467-471.1971; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Seo YW, 2009, CANCER RES, V69, P8356, DOI 10.1158/0008-5472.CAN-09-0349; Seo YW, 2003, J BIOL CHEM, V278, P48292, DOI 10.1074/jbc.M308785200; Shokri A, 2003, APPL MICROBIOL BIOT, V60, P654, DOI 10.1007/s00253-002-1156-8; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Song MY, 2004, J BIOL CHEM, V279, P34183, DOI 10.1074/jbc.M313491200; STREILEIN JW, 1995, SCIENCE, V270, P1158, DOI 10.1126/science.270.5239.1158; Stritzker J, 2007, INT J MED MICROBIOL, V297, P151, DOI 10.1016/j.ijmm.2007.01.008; Suzuki S, 2009, CANCER SCI, V100, P759, DOI 10.1111/j.1349-7006.2009.01096.x; Thamm DH, 2005, CLIN CANCER RES, V11, P4827, DOI 10.1158/1078-0432.CCR-04-2510; Thomas SM, 2004, CANCER TREAT REV, V30, P255, DOI 10.1016/j.ctrv.2003.10.003; Toso JF, 2002, J CLIN ONCOL, V20, P142, DOI 10.1200/JCO.20.1.142; Wadia JS, 2002, CURR OPIN BIOTECH, V13, P52, DOI 10.1016/S0958-1669(02)00284-7; Westphal K, 2008, CANCER RES, V68, P2952, DOI 10.1158/0008-5472.CAN-07-2984; WU HC, 1971, J BACTERIOL, V105, P455, DOI 10.1128/JB.105.2.455-466.1971; YOUNG R, 1995, FEMS MICROBIOL REV, V17, P191, DOI 10.1016/0168-6445(94)00079-4; Yu YA, 2004, NAT BIOTECHNOL, V22, P313, DOI 10.1038/nbt937; Zhang L, 2011, CELL DEATH DIFFER, V18, P864, DOI 10.1038/cdd.2010.152	59	44	47	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e80050	10.1371/journal.pone.0080050	http://dx.doi.org/10.1371/journal.pone.0080050			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416126	gold, Green Published, Green Submitted			2022-12-27	WOS:000329862500006
J	McGowan, NE; Marks, NJ; McInnes, CJ; Deane, D; Maule, AG; Scantlebury, M				McGowan, Natasha E.; Marks, Nikki J.; McInnes, Colin J.; Deane, David; Maule, Aaron G.; Scantlebury, Michael			Effects of Parasitism and Morphology on Squirrelpox Virus Seroprevalence in Grey Squirrels (Sciurus carolinensis)	PLOS ONE			English	Article							RED SQUIRRELS; LANDSCAPE SCALE; SPLEEN SIZE; POXVIRUS; TESTOSTERONE; VULGARIS; DISEASE; DOMINANCE; DYNAMICS; DECLINE	Invasive species have been cited as major causes of population extinctions in several animal and plant classes worldwide. The North American grey squirrel (Sciurus carolinensis) has a major detrimental effect on native red squirrel (Sciurus vulgaris) populations across Britain and Ireland, in part because it can be a reservoir host for the deadly squirrelpox virus (SQPV). Whilst various researchers have investigated the epizootiology of SQPV disease in grey squirrels and have modelled the consequent effects on red squirrel populations, less work has examined morphological and physiological characteristics that might make individual grey squirrels more susceptible to contracting SQPV. The current study investigated the putative relationships between morphology, parasitism, and SQPV exposure in grey squirrels. We found geographical, sex, and morphological differences in SQPV seroprevalence. In particular, larger animals, those with wide zygomatic arch widths (ZAW), males with large testes, and individuals with concurrent nematode and/or coccidial infections had an increased seroprevalence of SQPV. In addition, males with larger spleens, particularly those with narrow ZAW, were more likely to be exposed to SQPV. Overall these results show that there is variation in SQPV seroprevalence in grey squirrels and that, consequently, certain individual, or populations of, grey squirrels might be more responsible for transmitting SQPV to native red squirrel populations.	[McGowan, Natasha E.; Marks, Nikki J.; Maule, Aaron G.; Scantlebury, Michael] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland; [McInnes, Colin J.; Deane, David] Moredun Res Inst, Edinburgh EH17 7JH, Midlothian, Scotland	Queens University Belfast; Moredun Research Institute	Scantlebury, M (corresponding author), Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland.	m.scantlebury@qub.ac.uk		Maule, Aaron/0000-0003-0862-2667; McInnes, Colin/0000-0002-1465-9901	Scottish Government	Scottish Government	The research was supported by Queen's University Belfast and by the Northern Ireland Forest Service, which provided the specimens. CJM and DD were funded by the Scottish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basekim CC, 2000, ABDOM IMAGING, V25, P322; Bell BD, 2004, BIOL CONSERV, V120, P189, DOI 10.1016/j.biocon.2004.02.011; Bertolino S, 2003, BIOL CONSERV, V109, P351, DOI 10.1016/S0006-3207(02)00161-1; Blaustein AR, 2012, PHILOS T R SOC B, V367, P1688, DOI 10.1098/rstb.2012.0011; BOAG B, 1988, J WILDLIFE DIS, V24, P450, DOI 10.7589/0090-3558-24.3.450; Boonstra R, 2008, GEN COMP ENDOCR, V158, P61, DOI 10.1016/j.ygcen.2008.05.004; BOOTS M, 1994, ECOL ENTOMOL, V19, P319, DOI 10.1111/j.1365-2311.1994.tb00248.x; Burbidge AA, 2002, J BIOGEOGR, V29, P465, DOI 10.1046/j.1365-2699.2002.00699.x; Cattadori IM, 2008, INT J PARASITOL, V38, P371, DOI 10.1016/j.ijpara.2007.08.004; Chandra R.K., 1977, NUTR IMMUNITY INFECT; Crawley MJ, 2005, STAT INTRO USING R; Creel S, 2001, TRENDS ECOL EVOL, V16, P491, DOI 10.1016/S0169-5347(01)02227-3; Crump JA, 2001, EMERG INFECT DIS, V7, P767; Denk AG, 2006, J ORNITHOL, V147, P436, DOI 10.1007/s10336-005-0031-7; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Gurnell J, 2006, BIOL CONSERV, V131, P287, DOI 10.1016/j.biocon.2006.04.009; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Hojesjo J, 2007, J FISH BIOL, V70, P257, DOI 10.1111/j.1095-8649.2006.01299.x; Hopkins GHE, 1971, NAT HIST, V5, P530; JOYNER LP, 1966, PARASITOLOGY, V56, P531, DOI 10.1017/S0031182000069018; Kenward RE, 1985, S BR ECOL SOC, V25, P319; Kirkpatrick A, 2010, NATURE ED KNOWLEDGE, V1, P13; Koprowski JL, 1996, J MAMMAL, V77, P1006, DOI 10.2307/1382781; Koprowski JL, 2007, RODENT SOC; Lo CM, 1998, INT J PARASITOL, V28, P1695, DOI 10.1016/S0020-7519(98)00140-4; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; McCurdy DG, 1998, OIKOS, V82, P303, DOI 10.2307/3546970; McInnes CJ, 2013, ANIM CONSERV, V16, P51, DOI 10.1111/j.1469-1795.2012.00570.x; McInnes CJ, 2006, J GEN VIROL, V87, P2115, DOI 10.1099/vir.0.81966-0; Morand S, 2000, CAN J ZOOL, V78, P1356, DOI 10.1139/cjz-78-8-1356; Obon E, 2011, VET REC, V168, P86, DOI 10.1136/vr.d204; Poole A, 2009, BIODIVERS CONSERV, V18, P3205, DOI 10.1007/s10531-009-9637-z; R Development Core Team R, 2009, R LANG ENV STAT COMP; Rettew JA, 2008, BIOL REPROD, V78, P432, DOI 10.1095/biolreprod.107.063545; Rolff J, 2002, P ROY SOC B-BIOL SCI, V269, P867, DOI 10.1098/rspb.2002.1959; Rushton SP, 1997, J APPL ECOL, V34, P1137, DOI 10.2307/2405227; Russell AF, 2004, EVOLUTION, V58, P1600; Scantlebury M, 2007, P ROY SOC B-BIOL SCI, V274, P2169, DOI 10.1098/rspb.2007.0690; Scantlebury M, 2010, J ZOOL, V282, P246, DOI 10.1111/j.1469-7998.2010.00734.x; Shutler D, 1999, CAN J ZOOL, V77, P351, DOI 10.1139/cjz-77-3-351; Speakman JR, 2005, J EXP BIOL, V208, P1717, DOI 10.1242/jeb.01556; THIERMANN AB, 1981, J WILDLIFE DIS, V17, P39, DOI 10.7589/0090-3558-17.1.39; Thomas K, 2003, J GEN VIROL, V84, P3337, DOI 10.1099/vir.0.19464-0; Tompkins DM, 2002, P ROY SOC B-BIOL SCI, V269, P529, DOI 10.1098/rspb.2001.1897; Vicente J, 2007, NATURWISSENSCHAFTEN, V94, P581, DOI 10.1007/s00114-007-0231-5; Wang LJ, 2008, WORLD J GASTROENTERO, V14, P5125, DOI 10.3748/wjg.14.5125; WAUTERS LA, 1995, OIKOS, V72, P402, DOI 10.2307/3546126; WEBLEY GE, 1983, MAMMAL REV, V13, P149, DOI 10.1111/j.1365-2907.1983.tb00275.x; WEBLEY GE, 1985, GEN COMP ENDOCR, V59, P15, DOI 10.1016/0016-6480(85)90414-9; WICKINGS EJ, 1992, PHYSIOL BEHAV, V52, P909, DOI 10.1016/0031-9384(92)90370-H; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569; YAN GY, 1995, AM NAT, V146, P795, DOI 10.1086/285825; [No title captured]; [No title captured]	54	3	3	5	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83106	10.1371/journal.pone.0083106	http://dx.doi.org/10.1371/journal.pone.0083106			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416155	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500028
J	Semmineh, NB; Xu, JZ; Boxerman, JL; Delaney, GW; Cleary, PW; Gore, JC; Quarles, CC				Semmineh, Natenael B.; Xu, Junzhong; Boxerman, Jerrold L.; Delaney, Gary W.; Cleary, Paul W.; Gore, John C.; Quarles, C. Chad			An Efficient Computational Approach to Characterize DSC-MRI Signals Arising from Three-Dimensional Heterogeneous Tissue Structures	PLOS ONE			English	Article							CEREBRAL BLOOD-VOLUME; BRAIN-TUMOR; CONTRAST AGENTS; GRADIENT-ECHO; MAGNETIC-SUSCEPTIBILITY; PERFUSION MEASUREMENTS; TRANSVERSE RELAXATION; FIELD INHOMOGENEITY; KINASE INHIBITOR; FRACTAL MODELS	The systematic investigation of susceptibility-induced contrast in MRI is important to better interpret the influence of microvascular and microcellular morphology on DSC-MRI derived perfusion data. Recently, a novel computational approach called the Finite Perturber Method (FPM), which enables the study of susceptibility-induced contrast in MRI arising from arbitrary microvascular morphologies in 3D has been developed. However, the FPM has lower efficiency in simulating water diffusion especially for complex tissues. In this work, an improved computational approach that combines the FPM with a matrix-based finite difference method (FDM), which we call the Finite Perturber the Finite Difference Method (FPFDM), has been developed in order to efficiently investigate the influence of vascular and extravascular morphological features on susceptibility-induced transverse relaxation. The current work provides a framework for better interpreting how DSC-MRI data depend on various phenomena, including contrast agent leakage in cancerous tissues and water diffusion rates. In addition, we illustrate using simulated and micro-CT extracted tissue structures the improved FPFDM along with its potential applications and limitations.	[Semmineh, Natenael B.; Xu, Junzhong; Gore, John C.; Quarles, C. Chad] Vanderbilt Univ, Inst Imaging Sci, Nashville, TN 37235 USA; [Semmineh, Natenael B.; Gore, John C.] Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA; [Xu, Junzhong; Gore, John C.; Quarles, C. Chad] Vanderbilt Univ, Dept Radiol & Radiol Sci, Nashville, TN 37235 USA; [Boxerman, Jerrold L.] Rhode Isl Hosp, Dept Diagnost Imaging, Providence, RI USA; [Boxerman, Jerrold L.] Brown Univ, Rhode Isl Hosp, Alpert Med Sch, Providence, RI 02903 USA; [Delaney, Gary W.; Cleary, Paul W.] CSIRO Math & Informat Sci, Clayton, Vic, Australia; [Gore, John C.; Quarles, C. Chad] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Quarles, C. Chad] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Vanderbilt University; Vanderbilt University	Quarles, CC (corresponding author), Vanderbilt Univ, Inst Imaging Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.	chad.quarles@vanderbilt.edu	Cleary, Paul W/E-3965-2010; Quarles, Chad/V-1168-2019; Boxerman, Jerrold/AAH-3471-2020; Delaney, Gary W/B-3728-2009; Xu, junzhong/E-6731-2010	Cleary, Paul W/0000-0002-6481-3284; Boxerman, Jerrold/0000-0002-0594-1542; Xu, junzhong/0000-0001-7895-4232	National Institutes of Health [NIH/NCI K99/R00 CA127599, NIH/NCI R01 CA158079, P30 CA068485, NCI U24 CA126588]; NATIONAL CANCER INSTITUTE [K99CA127599, P30CA068485, R01CA158079, U24CA126588] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the National Institutes of Health through NIH/NCI K99/R00 CA127599, NIH/NCI R01 CA158079, P30 CA068485, NCI U24 CA126588. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONEN HJ, 1994, RADIOLOGY, V191, P41, DOI 10.1148/radiology.191.1.8134596; Aronen HJ, 2000, CLIN CANCER RES, V6, P2189; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Beaumont M, 2009, J CEREBR BLOOD F MET, V29, P1714, DOI 10.1038/jcbfm.2009.86; Bjornerud A, 2011, J CEREBR BLOOD F MET, V31, P2041, DOI 10.1038/jcbfm.2011.52; BOXERMAN JL, 1995, MAGNET RESON MED, V34, P4, DOI 10.1002/mrm.1910340103; BOXERMAN JL, 1995, MAGNET RESON MED, V34, P555, DOI 10.1002/mrm.1910340412; Boxerman JL, 2013, AJNR AM J NEURORADIO; Brix G, 1999, RADIOLOGY, V210, P269, DOI 10.1148/radiology.210.1.r99ja46269; Bruening R, 1996, AM J NEURORADIOL, V17, P831; Christen T, 2012, MAGN RESON MED, V67, P1458, DOI 10.1002/mrm.23094; Delaney GW, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/34002; Donahue KM, 2000, MAGNET RESON MED, V43, P845, DOI 10.1002/1522-2594(200006)43:6<845::AID-MRM10>3.0.CO;2-J; FISEL CR, 1991, MAGNET RESON MED, V17, P336, DOI 10.1002/mrm.1910170206; Frohlich AF, 2005, MAGN RESON MED, V53, P564, DOI 10.1002/mrm.20394; Gabrys E, 2006, CHAOS SOLITON FRACT, V27, P1, DOI 10.1016/j.chaos.2005.02.009; Gabrys E, 2005, CHAOS SOLITON FRACT, V24, P707, DOI 10.1016/j.chaos.2004.09.087; Hall MG, 2009, IEEE T MED IMAGING, V28, P1354, DOI 10.1109/TMI.2009.2015756; Hwang SN, 2003, MAGNET RESON MED, V50, P373, DOI 10.1002/mrm.10536; Kamoun WS, 2009, J CLIN ONCOL, V27, P2542, DOI 10.1200/JCO.2008.19.9356; Karshafian R, 2003, PHYS MED BIOL, V48, P3225, DOI 10.1088/0031-9155/48/19/009; KENNAN RP, 1994, MAGNET RESON MED, V31, P9, DOI 10.1002/mrm.1910310103; Kiselev VG, 1999, MAGN RESON MED, V41, P499, DOI 10.1002/(SICI)1522-2594(199903)41:3<499::AID-MRM12>3.0.CO;2-O; Kiselev VG, 2001, MAGN RESON MED, V46, P1113, DOI 10.1002/mrm.1307; Kjolby BF, 2006, MAGN RESON MED, V56, P187, DOI 10.1002/mrm.20920; Klassen LM, 2007, BIOPHYS J, V92, P1014, DOI 10.1529/biophysj.106.087965; Lemasson B, 2010, RADIOLOGY, V257, P342, DOI 10.1148/radiol.10092343; MAEDA M, 1993, RADIOLOGY, V189, P233, DOI 10.1148/radiology.189.1.8372199; Mangla R, 2011, AM J NEURORADIOL, V32, P1004, DOI 10.3174/ajnr.A2441; Marques JP, 2005, CONCEPT MAGN RESON B, V25B, P65, DOI 10.1002/cmr.b.20034; Marty B, 2013, CONTRAST MEDIA MOL I, V8, P12, DOI 10.1002/cmmi.1489; MEIER P, 1954, J APPL PHYSIOL, V6, P731, DOI 10.1152/jappl.1954.6.12.731; Murray CD, 1926, P NATL ACAD SCI USA, V12, P207, DOI 10.1073/pnas.12.3.207; Newman GC, 2006, J CEREBR BLOOD F MET, V26, P760, DOI 10.1038/sj.jcbfm.9600242; OGAWA S, 1990, MAGNET RESON MED, V16, P9, DOI 10.1002/mrm.1910160103; Pannetier NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057636; Pathak AP, 2003, J MAGN RESON IMAGING, V18, P397, DOI 10.1002/jmri.10371; Pathak AP, 2008, NEUROIMAGE, V40, P1130, DOI 10.1016/j.neuroimage.2008.01.022; Paulson ES, 2008, RADIOLOGY, V249, P601, DOI 10.1148/radiol.2492071659; Pintaske J, 2006, INVEST RADIOL, V41, P213, DOI 10.1097/01.rli.0000197668.44926.f7; Quarles CC, 2009, PHYS MED BIOL, V54, P5749, DOI 10.1088/0031-9155/54/19/006; ROSEN BR, 1991, MAGNET RESON MED, V19, P285, DOI 10.1002/mrm.1910190216; ROSEN BR, 1990, MAGNET RESON MED, V14, P249, DOI 10.1002/mrm.1910140211; Rybaczuk Marek, 2002, Med Sci Monit, V8, pMT145; Salomir R, 2003, CONCEPT MAGN RESON B, V19B, P26, DOI 10.1002/cmr.b.10083; Schreiner W, 1996, J THEOR BIOL, V180, P161, DOI 10.1006/jtbi.1996.0092; Siegal T, 1997, J NEUROSURG, V86, P22, DOI 10.3171/jns.1997.86.1.0022; Simpson NE, 1999, MAGN RESON MED, V42, P42, DOI 10.1002/(SICI)1522-2594(199907)42:1<42::AID-MRM8>3.0.CO;2-Z; Sorensen AG, 2012, CANCER RES, V72, P402, DOI 10.1158/0008-5472.CAN-11-2464; Sourbron S, 2009, MAGN RESON MED, V62, P672, DOI 10.1002/mrm.22042; Sourbron S, 2013, MAGN RESON MED, V69, P1430, DOI 10.1002/mrm.24383; Stables LA, 1998, MAGNET RESON MED, V40, P432, DOI 10.1002/mrm.1910400314; Sugahara T, 2001, AM J NEURORADIOL, V22, P1306; Sugahara T, 2000, AM J NEURORADIOL, V21, P901; WEISSKOFF RM, 1994, MAGNET RESON MED, V31, P601, DOI 10.1002/mrm.1910310605; WEISSKOFF RM, 1992, MAGNET RESON MED, V24, P375, DOI 10.1002/mrm.1910240219; Xu JZ, 2007, PHYS MED BIOL, V52, pN111, DOI 10.1088/0031-9155/52/7/N01; YABLONSKIY DA, 1994, MAGNET RESON MED, V32, P749, DOI 10.1002/mrm.1910320610	58	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84764	10.1371/journal.pone.0084764	http://dx.doi.org/10.1371/journal.pone.0084764			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416281	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500164
J	Xiang, Q; Chen, L; Hou, SP; Fang, J; Zhou, Y; Bai, L; Liu, YJ; Kijlstra, A; Yang, PZ				Xiang, Qin; Chen, Lu; Hou, Shengping; Fang, Jing; Zhou, Yan; Bai, Lin; Liu, Yunjia; Kijlstra, Aize; Yang, Peizeng			TRAF5 and TRAF3IP2 Gene Polymorphisms Are Associated with Behcet's Disease and Vogt-Koyanagi-Harada Syndrome: A Case-Control Study	PLOS ONE			English	Article							CHINESE HAN POPULATION; SYSTEMIC-LUPUS-ERYTHEMATOSUS; GENOME-WIDE ASSOCIATION; CD4(+) T-CELLS; RHEUMATOID-ARTHRITIS; PSORIATIC-ARTHRITIS; CONFER RISK; KAPPA-B; SUSCEPTIBILITY; IL-17	Background: TRAF5 and TRAF3IP2 have been reported to be associated with several autoimmune diseases. Behcet's disease (BD) and Vogt-Koyanagi-Harada (VKH) syndrome are two autoimmune uveitis entities whereby both genetic and environmental factors are thought to be involved. Objective: The role of TRAF5 and TRAF3IP2 in BD and VKH has not yet been reported and was therefore the subject of this study. Methods: The study included 789 BD patients, 940 VKH patients and 1601 healthy unrelated individuals. Genotyping was performed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) or TaqMan (R) SNP Genotyping Assay. Real-Time PCR was used to detect mRNA expression from PBMCs obtained from healthy controls with (n = 22) or without (n = 79) stimulation. Levels of TNF-alpha, IL-6 and IL-8 in culture supernatants were measured by ELISA (n = 22). Results: Three SNPs (rs6540679, rs12569232, rs10863888) of TRAF5 and rs13210247 of TRAF3IP2 were significantly associated with Behcet's disease and VKH syndrome (corrected P values ranging from 9.45x10(-12) to 0.027). TRAF3IP2 rs33980500 and rs13190932 were not polymorphic in Han Chinese. Following stimulation by lipopolysaccharide (LPS), carriers of the GG genotype of rs6540679/ TRAF5 had a higher TRAF5 mRNA expression (p = 0.004) and an increased TNF-alpha (p = 0.0052) and IL-6 (p = 0.0014) level compared with AA and AG genotype carriers. Conclusion: This study provides evidence that TRAF5 and TRAF3IP2 genes are involved in the development of BD and VKH syndrome. Functional research suggested that TRAF5 gene polymorphisms may regulate TRAF5 expression and downstream inflammatory cytokines such as TNF-alpha and IL-6.	[Xiang, Qin; Chen, Lu; Hou, Shengping; Fang, Jing; Zhou, Yan; Bai, Lin; Liu, Yunjia; Yang, Peizeng] Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Ophthalmol, Chongqing, Peoples R China; [Xiang, Qin; Chen, Lu; Hou, Shengping; Fang, Jing; Zhou, Yan; Bai, Lin; Liu, Yunjia; Yang, Peizeng] Chongqing Med Univ, Affiliated Hosp 1, Chongqing Eye Inst, Chongqing, Peoples R China; [Kijlstra, Aize] Univ Eye Clin Maastricht, Maastricht, Netherlands	Chongqing Medical University; Chongqing Medical University; Maastricht University; Maastricht University Medical Centre (MUMC)	Yang, PZ (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Ophthalmol, Chongqing, Peoples R China.	peizengycmu@126.com	Lauschner, Flavia H/P-2457-2018		National Basic Research Program of China (973 Program) [2011CB510200]; Key Project of Natural Science Foundation [81130019]; Clinic Key Project of Ministry of Health, Basic Research Program of Chongqing, Research Fund for the Doctoral Program of Higher Education of China [20115503110002]; Research Fund for the Doctoral Program of Higher Education of China [20115503110002]; Chongqing Key Laboratory of Ophthalmology [CSTC,2008CA5003]; Key Project of Health Bureau of Chongqing [2012-1-003]; PAR-EU Scholars Program	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Key Project of Natural Science Foundation; Clinic Key Project of Ministry of Health, Basic Research Program of Chongqing, Research Fund for the Doctoral Program of Higher Education of China; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Chongqing Key Laboratory of Ophthalmology; Key Project of Health Bureau of Chongqing; PAR-EU Scholars Program	This work was supported by National Basic Research Program of China (973 Program) (2011CB510200), Key Project of Natural Science Foundation (81130019), Clinic Key Project of Ministry of Health, Basic Research Program of Chongqing, Research Fund for the Doctoral Program of Higher Education of China (20115503110002), Research Fund for the Doctoral Program of Higher Education of China (20115503110002), Chongqing Key Laboratory of Ophthalmology (CSTC,2008CA5003), Key Project of Health Bureau of Chongqing (2012-1-003) and Fund for PAR-EU Scholars Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergholdt R, 2012, DIABETES, V61, P954, DOI 10.2337/db11-1263; Billie Au PY, 2007, ADV EXP MED BIOL, V597, P32; Bulek K, 2011, NAT IMMUNOL, V12, P844, DOI 10.1038/ni.2080; Cerhan JR, 2008, CANCER EPIDEM BIOMAR, V17, P3161, DOI 10.1158/1055-9965.EPI-08-0536; Chen FL, 2012, RHEUMATOLOGY, V51, P47, DOI 10.1093/rheumatology/ker345; Chi W, 2008, INVEST OPHTH VIS SCI, V49, P3058, DOI 10.1167/iovs.07-1390; Chi W, 2007, J ALLERGY CLIN IMMUN, V119, P1218, DOI 10.1016/j.jaci.2007.01.010; Chu ML, 2011, INVEST OPHTH VIS SCI, V52, P7084, DOI 10.1167/iovs.11-7539; Ciccacci C, 2012, J CROHNS COLITIS; Ciccacci C, 2013, J CROHNS COLITIS, V7, P44, DOI 10.1016/j.crohns.2012.02.020; DAVIS JL, 1990, OPHTHALMOLOGY, V97, P1137; Dolcino M, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/198956; Doyle MS, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4071; Ellinghaus E, 2010, NAT GENET, V42, P991, DOI 10.1038/ng.689; Fang W, 2008, CURR EYE RES, V33, P517, DOI 10.1080/02713680802233968; Han TU, 2009, ARTHRITIS RHEUM-US, V60, P2577, DOI 10.1002/art.24759; Hou S, 2012, ARTHRITIS RHEUM; Hu K, 2012, INVEST OPHTH VIS SCI, V53, P538, DOI 10.1167/iovs.11-8440; Hu K, 2010, HUM IMMUNOL, V71, P723, DOI 10.1016/j.humimm.2010.04.007; Huffmeier U, 2010, NAT GENET, V42, P996, DOI 10.1038/ng.688; Hunter CA, 2007, NAT IMMUNOL, V8, P232, DOI 10.1038/ni0307-232; Ideguchi H, 2011, MEDICINE, V90, P125, DOI 10.1097/MD.0b013e318211bf28; Jiang ZX, 2010, ANN RHEUM DIS, V69, P1325, DOI 10.1136/ard.2009.119420; Jiang ZX, 2010, HUM IMMUNOL, V71, P414, DOI 10.1016/j.humimm.2010.01.026; Jorgensen TN, 2009, EPIGENETICS AUTOIMMU, P55; Keino H, 2007, BRIT J OPHTHALMOL, V91, P1573, DOI 10.1136/bjo.2007.124875; Kitamei H, 2006, J LEUKOCYTE BIOL, V79, P1193, DOI 10.1189/jlb.0805453; Kraus ZJ, 2009, P NATL ACAD SCI USA, V106, P17140, DOI 10.1073/pnas.0903786106; Li H, 2013, HUM GENET, V132, P293, DOI 10.1007/s00439-012-1250-7; Ma AI, 2012, NAT IMMUNOL, V13, P1034, DOI 10.1038/ni.2448; Meguro A, 2010, ANN RHEUM DIS, V69, P747, DOI 10.1136/ard.2009.108571; Namjou B, 2012, ARTHRITIS RHEUM-US, V64, P1960, DOI 10.1002/art.34361; Niccoli L, 2007, RHEUMATOLOGY, V46, P1161, DOI 10.1093/rheumatology/kem101; Nishimoto K, 2010, ANN RHEUM DIS, V69, P368, DOI 10.1136/ard.2008.104315; O'Rielly DD, 2011, NAT REV RHEUMATOL, V7, P718, DOI 10.1038/nrrheum.2011.169; OHNO S, 1981, T OPHTHAL SOC UK, V101, P335; Okada AA, 2012, ARCH OPHTHALMOL-CHIC, V130, P592, DOI 10.1001/archophthalmol.2011.2698; Perricone C, 2013, IMMUNOGENETICS, V65, P703, DOI 10.1007/s00251-013-0717-6; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Potter C, 2007, ANN RHEUM DIS, V66, P1322, DOI 10.1136/ard.2006.065706; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Rassi DM, 2008, ANN NY ACAD SCI, V1150, P282, DOI 10.1196/annals.1447.064; Read RW, 2001, AM J OPHTHALMOL, V131, P647, DOI 10.1016/S0002-9394(01)00925-4; Shu QM, 2010, HUM IMMUNOL, V71, P988, DOI 10.1016/j.humimm.2010.06.020; SILMAN AJ, 1990, LANCET, V335, P1078; Snell LM, 2011, IMMUNOL REV, V244, P197, DOI 10.1111/j.1600-065X.2011.01063.x; Sugita S, 2006, INVEST OPHTH VIS SCI, V47, P2547, DOI 10.1167/iovs.05-1547; Sun DX, 2011, NAT IMMUNOL, V12, P853, DOI 10.1038/ni.2081; Yang PZ, 2008, OPHTHALMOLOGY, V115, P312, DOI 10.1016/j.ophtha.2007.04.056; Yang PZ, 2007, OPHTHALMOLOGY, V114, P606, DOI 10.1016/j.ophtha.2006.07.040; Yang PZ, 2005, CURR EYE RES, V30, P943, DOI 10.1080/02713680500263606; Zhang DY, 2011, AM J NEPHROL, V34, P483, DOI 10.1159/000333006; Zhang Z, 2006, INT J RHEUM DIS, V9, P244; ZHAO M, 1991, ARCH OPHTHALMOL-CHIC, V109, P368, DOI 10.1001/archopht.1991.01080030070041; Zhou Q, 2012, ANN RHEUM DIS; Zirlik A, 2007, ARTERIOSCL THROM VAS, V27, P1101, DOI 10.1161/ATVBAHA.107.140566	56	16	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84214	10.1371/journal.pone.0084214	http://dx.doi.org/10.1371/journal.pone.0084214			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416204	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500103
J	Komatsu, S; Kamata, T; Imai, A; Ohara, T; Miyaji, K; Kobayashi, Y; Kodama, K				Komatsu, Sei; Kamata, Teruaki; Imai, Atsuko; Ohara, Tomoki; Miyaji, Kazuaki; Kobayashi, Yasuhiko; Kodama, Kazuhisa			Quantitative Analysis of Coronary Vessels with Optimized Intracoronary CT Number	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; INTRAVASCULAR ULTRASOUND; ARTERY-DISEASE; ANGIOGRAPHY; PLAQUE; SYSTEM; REPRODUCIBILITY; DETERMINANTS; ATTENUATION; CARDIOLOGY	Background: Variability in intracoronary computed tomography (CT) number may influence vessel quantification. We confirmed the feasibility of a novel method for measuring vessel diameter and area using coronary CT angiography (CCTA) with an optimized intracoronary CT number, 350 HU. Methods: We performed intravascular ultrasound (IVUS) imaging in 52 patients with significant stenosis detected by coronary CT angiography targeting 350 HU using a CT number-controlling system. We measured 0-to-0 HU distances in the cross-sectional coronary images of 32 patients. We analyzed the ratio of 0-to-0 HU distances in CT images to media-to-media distances in IVUS images (C: I ratio). The area of >= 0 HU for 103 representative points in the remaining 20 patients was compared to the area of the traced external elastic membrane (EEM) in IVUS images. Results: There was a strong correlation between 0-to-0 HU distance in CT images and media-to-media diameter in IVUS images (r = 0.97, p < 0.001). The C: I ratio was 1.1. EEM area was estimated by dividing the area of >= 0 HU by the square of C: I. There was also a strong correlation between the estimated EEM area and the EEM area in IVUS images (r = 0.95, p < 0.001). Conclusions: Media-to-media diameter and EEM area can be estimated by CCTA targeting the optimized intracoronary CT number when blood vessel borders are defined at 0 HU.	[Komatsu, Sei; Imai, Atsuko; Ohara, Tomoki; Kobayashi, Yasuhiko; Kodama, Kazuhisa] Amagasaki Cent Hosp, Ctr Cardiovasc, Amagasaki, Hyogo, Japan; [Kamata, Teruaki; Miyaji, Kazuaki] Amagasaki Cent Hosp, Dept Diagnost Imaging, Amagasaki, Hyogo, Japan; [Imai, Atsuko] Osaka Univ, Sch Med, Dept Cardiol, Osaka, Japan	Osaka University	Komatsu, S (corresponding author), Amagasaki Cent Hosp, Ctr Cardiovasc, Amagasaki, Hyogo, Japan.	plaquemap@yahoo.co.jp	Komatsu, Sei/AAQ-6467-2020					Abbara Suhny, 2009, J Cardiovasc Comput Tomogr, V3, P190, DOI 10.1016/j.jcct.2009.03.004; ALFONSO F, 1994, J AM COLL CARDIOL, V23, P879, DOI 10.1016/0735-1097(94)90632-7; Budoff MJ, 2006, CIRCULATION, V114, P1761, DOI 10.1161/CIRCULATIONAHA.106.178458; Cademartiri F, 2005, EUR RADIOL, V15, P1426, DOI 10.1007/s00330-005-2697-x; Fei XL, 2008, AM J ROENTGENOL, V191, P43, DOI 10.2214/AJR.07.2653; Herzog BA, 2009, INT J CARDIOVAS IMAG, V25, P625, DOI 10.1007/s10554-009-9460-3; Komatsu S, 2005, CIRC J, V69, P72, DOI 10.1253/circj.69.72; Komatsu S, 2013, J CARDIOL, V62, P82, DOI 10.1016/j.jjcc.2013.03.004; Komatsu S, 2013, J CARDIOL, V61, P155, DOI 10.1016/j.jjcc.2012.09.006; Komatsu S, 2011, CIRC J, V75, P1515, DOI 10.1253/circj.CJ-11-0252; Leber AW, 2006, J AM COLL CARDIOL, V47, P672, DOI 10.1016/j.jacc.2005.10.058; Marwan M, 2011, J COMPUT ASSIST TOMO, V35, P113, DOI 10.1097/RCT.0b013e3181f7cb30; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Pazhenkottil AP, 2010, INT J CARDIOVAS IMAG, V26, P591, DOI 10.1007/s10554-010-9594-3; Peters RJG, 1996, EUR HEART J, V17, P1593; Petranovic Milena, 2009, J Cardiovasc Comput Tomogr, V3, P24, DOI 10.1016/j.jcct.2008.12.005; Voros S, 2011, JACC-CARDIOVASC INTE, V4, P198, DOI 10.1016/j.jcin.2010.10.008	17	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e85312	10.1371/journal.pone.0085312	http://dx.doi.org/10.1371/journal.pone.0085312			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409326	gold, Green Published, Green Submitted			2022-12-27	WOS:000329463500050
J	Martinez, C; Ortiz, AM; Juarranz, Y; Lamana, A; Seoane, IV; Leceta, J; Garcia-Vicuna, R; Gomariz, RP; Gonzalez-Alvaro, I				Martinez, Carmen; Ortiz, Ana M.; Juarranz, Yasmina; Lamana, Amalia; Seoane, Iria V.; Leceta, Javier; Garcia-Vicuna, Rosario; Gomariz, Rosa P.; Gonzalez-Alvaro, Isidoro			Serum Levels of Vasoactive Intestinal Peptide as a Prognostic Marker in Early Arthritis	PLOS ONE			English	Article							T-CELL SUBSETS; RHEUMATOID-ARTHRITIS; VIP; MICE; AUTOIMMUNE; MODEL; PACAP; PHARMACOLOGY; ASSOCIATION; RECEPTORS	Objective: Suitable biomarkers are essential for the design of therapeutic strategies in personalized medicine. Vasoactive intestinal peptide (VIP) has demonstrated immunomodulatory properties in autoimmune murine and ex vivo human models. Our aim was to study serum levels of VIP during the follow-up of an early arthritis (EA) cohort and to analyze its value as a biomarker predicting severity and therapeutic requirements. Methods: Data from 91 patients on an EA register were analyzed (76% rheumatoid arthritis (RA), 24% undifferentiated arthritis, 73% women, and median age 54 years; median disease duration at entry, 5.4 months). We collected per protocol sociodemographic, clinical, and therapeutic data. VIP levels were determined by enzyme immunoassay in sera harvested from the 91 patients (353 visits; 3.9 visit/patient) and from 100 healthy controls. VIP values below the 25th percentile of those assessed in healthy population were considered low. To determine the effect of independent variables on VIP levels, we performed a longitudinal multivariate analysis nested by patient and visit. A multivariate ordered logistic regression was modeled to determine the effect of low VIP serum levels on disease activity at the end of follow-up. Results: VIP concentrations varied considerably across EA patients. Those fulfilling the criteria for RA had the lowest values in the whole sample, although no significant differences were observed compared with healthy donors. Disease activity, which was assessed using DAS28, inversely correlated with VIP levels. After a two-year follow-up, those patients with low baseline levels of VIP displayed higher disease activity and received more intensive treatment. Conclusion: Patients who are unable to up-regulate VIP seem to have a worse clinical course despite receiving more intense treatment. Therefore, measurement of VIP levels may be suitable as a prognostic biomarker.	[Martinez, Carmen] Univ Complutense Madrid, Fac Med, Dept Biol Celular, Madrid, Spain; [Ortiz, Ana M.; Lamana, Amalia; Garcia-Vicuna, Rosario; Gonzalez-Alvaro, Isidoro] Hosp Univ Princesa, Inst Invest Sanitaria Princesa, Serv Reumatol, Madrid, Spain; [Juarranz, Yasmina; Seoane, Iria V.; Leceta, Javier; Gomariz, Rosa P.] Univ Complutense Madrid, Fac Biol, Dept Biol Celular, E-28040 Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid	Martinez, C (corresponding author), Univ Complutense Madrid, Fac Med, Dept Biol Celular, Madrid, Spain.	cmmora@bio.ucm.es	Seoane, Iria/M-4236-2017; Martínez, Carmen/AAC-2077-2020; Juarranz, Yasmina/H-5545-2019; LAMANA, AMALIA/I-6971-2017; de VicuÃa, Rosario Garcia/ABD-7892-2020; Juarranz, Yasmina/H-7942-2016; Leceta, Javier/H-6940-2017	Seoane, Iria/0000-0002-3644-1444; Juarranz, Yasmina/0000-0001-5886-8273; LAMANA, AMALIA/0000-0001-8779-5034; de VicuÃa, Rosario Garcia/0000-0001-9096-3780; Juarranz, Yasmina/0000-0001-5886-8273; Leceta, Javier/0000-0003-4845-0046	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III [PI08/0025, PI11/00195, PI11/00505, PI12/0758]; RETICS [RD08/0075, RD12/0009]; EU; Comunidad de Madrid [S2010/BMD-2350]	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III(Instituto de Salud Carlos III); RETICS; EU(European Commission); Comunidad de Madrid(Comunidad de Madrid)	This work was supported by the Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III (PI08/0025, PI11/00195, PI11/00505, PI12/0758, RETICS RD08/0075, RD12/0009) and by FEDER funds from EU, S2010/BMD-2350 from Comunidad de Madrid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad C, 2003, GASTROENTEROLOGY, V124, P961, DOI 10.1053/gast.2003.50141; Abad C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036922; Abad C, 2011, CURR PHARM DESIGN, V17, P1025, DOI 10.2174/138161211795589364; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Carrion M, 2011, ARTHRITIS RHEUM-US, V63, P1626, DOI 10.1002/art.30294; Colwell CS, 2003, AM J PHYSIOL-REG I, V285, pR939, DOI 10.1152/ajpregu.00200.2003; Couvineau A, 2012, BRIT J PHARMACOL, V166, P42, DOI 10.1111/j.1476-5381.2011.01676.x; de Vries-Bouwstra JK, 2008, ARTHRITIS RHEUM-US, V58, P1293, DOI 10.1002/art.23439; Delgado M, 1999, J IMMUNOL, V162, P1200; Delgado M, 2001, NAT MED, V7, P563, DOI 10.1038/87887; Diez JJ, 2008, NEPHROL DIAL TRANSPL, V23, P1387, DOI 10.1093/ndt/gfm776; El-Sayed ZA, 2009, RHEUMATOLOGY, V48, P843, DOI 10.1093/rheumatology/kep134; ESTEVEVIVES J, 1993, J RHEUMATOL, V20, P2116; Gomariz RP, 2006, ANN NY ACAD SCI, V1070, P51, DOI 10.1196/annals.1317.031; Gonzalez-Alvaro I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029492; Gonzalez-Rey E, 2006, ARTHRITIS RHEUM-US, V54, P864, DOI 10.1002/art.21652; Gonzalez-Rey E, 2007, ANN RHEUM DIS, V66, P70, DOI 10.1136/ard.2007.078519; GOZES I, 1993, J MOL NEUROSCI, V4, P185, DOI 10.1007/BF02782501; Gutierrez-Canas I, 2008, BRAIN BEHAV IMMUN, V22, P312, DOI 10.1016/j.bbi.2007.09.007; Harmar AJ, 2012, BRIT J PHARMACOL, V166, P4, DOI 10.1111/j.1476-5381.2012.01871.x; Jiang W, 2012, CLIN BIOCHEM, V45, P1607, DOI 10.1016/j.clinbiochem.2012.08.020; Jimeno R, 2010, IMMUNOL CELL BIOL, V88, P734, DOI 10.1038/icb.2010.29; Juarranz MG, 2004, RHEUMATOLOGY, V43, P416, DOI 10.1093/rheumatology/keh061; Juarranz Y, 2005, ARTHRITIS RES THER, V7, pR1034, DOI 10.1186/ar1779; Pan W, 2001, BIOMETRICS, V57, P529, DOI 10.1111/j.0006-341X.2001.00529.x; Perez-Garcia S, 2011, J CELL PHYSIOL, V226, P3261, DOI 10.1002/jcp.22687; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Raza Karim, 2009, Best Pract Res Clin Rheumatol, V23, P25, DOI 10.1016/j.berh.2008.08.001; Schoels M, 2010, ANN RHEUM DIS, V69, P638, DOI 10.1136/ard.2009.123976; Smolen JS, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2418; Szema AM, 2006, AM J PHYSIOL-LUNG C, V291, pL880, DOI 10.1152/ajplung.00499.2005; Szodoray P, 2010, AUTOIMMUN REV, V9, P140, DOI 10.1016/j.autrev.2009.04.006	32	40	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e85248	10.1371/journal.pone.0085248	http://dx.doi.org/10.1371/journal.pone.0085248			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409325	Green Submitted, Green Published, gold			2022-12-27	WOS:000329463500049
J	Decaro, N; Pinto, P; Mari, V; Elia, G; Larocca, V; Camero, M; Terio, V; Losurdo, M; Martella, V; Buonavoglia, C				Decaro, Nicola; Pinto, Pierfrancesco; Mari, Viviana; Elia, Gabriella; Larocca, Vittorio; Camero, Michele; Terio, Valentina; Losurdo, Michele; Martella, Vito; Buonavoglia, Canio			Full-Genome Analysis of a Canine Pneumovirus Causing Acute Respiratory Disease in Dogs, Italy	PLOS ONE			English	Article							REAL-TIME PCR; PNEUMONIA VIRUS; CORONAVIRUS; RNA; INFECTION; QUANTITATION; EVOLUTION; SEQUENCE; HOMOLOG; MOUSE	An outbreak of canine infectious respiratory disease (CIRD) associated to canine pneumovirus (CnPnV) infection is reported. The outbreak occurred in a shelter of the Apulia region and involved 37 out of 350 dogs that displayed cough and/or nasal discharge with no evidence of fever. The full-genomic characterisation showed that the causative agent (strain Bari/100-12) was closely related to CnPnVs that have been recently isolated in the USA, as well as to murine pneumovirus, which is responsible for respiratory disease in mice. The present study represents a useful contribution to the knowledge of the pathogenic potential of CnPnV and its association with CIRD in dogs. Further studies will elucidate the pathogenicity and epidemiology of this novel pneumovirus, thus addressing the eventual need for specific vaccines.	[Decaro, Nicola; Pinto, Pierfrancesco; Mari, Viviana; Elia, Gabriella; Larocca, Vittorio; Camero, Michele; Terio, Valentina; Losurdo, Michele; Martella, Vito; Buonavoglia, Canio] Univ Bari, Dept Vet Med, Valenzano, Italy	Universita degli Studi di Bari Aldo Moro	Decaro, N (corresponding author), Univ Bari, Dept Vet Med, Valenzano, Italy.	nicola.decaro@uniba.it	Decaro, Nicola/ABB-1426-2021; Terio, Valentina/Z-1206-2018; Martella, Vito/K-3146-2016; Decaro, Nicola/K-2560-2018; Elia, Gabriella/K-5286-2018; Decaro, Nicola/AAB-8820-2019; Larocca, Vittorio/K-4058-2016	Terio, Valentina/0000-0002-8908-6749; Martella, Vito/0000-0002-5740-6947; Elia, Gabriella/0000-0001-7469-2175; Decaro, Nicola/0000-0001-6348-7969; Camero, Michele/0000-0003-0026-8325; Larocca, Vittorio/0000-0003-1679-5699	Italian Ministry of Health, Ricerca corrente [IZS VE 21/09 RC]	Italian Ministry of Health, Ricerca corrente(Ministry of Health, Italy)	This work was supported by grants from the Italian Ministry of Health, Ricerca corrente 2009, project IZS VE 21/09 RC "Definizione di una procedura validata per la selezione di cani per programmi di Interventi Assistiti dagli Animali (IAA)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker SD, 2007, LAB ANIM-UK, V41, P229, DOI 10.1258/002367707780378203; Bukh J, 2011, P NATL ACAD SCI USA, V108, P12563, DOI 10.1073/pnas.1107612108; Buonavoglia C, 2007, VET RES, V38, P355, DOI 10.1051/vetres:2006058; Chalker VJ, 2004, MICROBIOL-SGM, V150, P3491, DOI 10.1099/mic.0.26848-0; Decaro N, 2005, J VIROL METHODS, V130, P72, DOI 10.1016/j.jviromet.2005.06.005; Decaro N, 2004, J VIROL METHODS, V119, P145, DOI 10.1016/j.jviromet.2004.03.012; Decaro N, 2002, MICROBIOLOGICA, V25, P291; Decaro N, 2008, VET MICROBIOL, V132, P221, DOI 10.1016/j.vetmic.2008.06.007; Decaro N, 2008, J VIROL METHODS, V151, P167, DOI 10.1016/j.jviromet.2008.05.016; Decaro N, 2008, VET CLIN N AM-SMALL, V38, P799, DOI 10.1016/j.cvsm.2008.02.006; Decaro N, 2010, J VIROL METHODS, V169, P176, DOI 10.1016/j.jviromet.2010.07.021; Di Trani L, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-87; Dibben O, 2007, VIRUS RES, V130, P303, DOI 10.1016/j.virusres.2007.06.009; Dubovi EJ, 2010, VET CLIN N AM-SMALL, V40, P1063, DOI 10.1016/j.cvsm.2010.07.005; Elia G, 2006, J VIROL METHODS, V136, P171, DOI 10.1016/j.jviromet.2006.05.004; Ellis JA, 2012, JAVMA-J AM VET MED A, V240, P273, DOI 10.2460/javma.240.3.273; Erles K, 2004, J CLIN MICROBIOL, V42, P4524, DOI 10.1128/JCM.42.10.4524-4529.2004; Erles K, 2003, VIROLOGY, V310, P216, DOI 10.1016/S0042-6822(03)00160-0; Fauquet C.M., 1999, 8 INT COMM TAX VIR, P1730, DOI 10.1006/rwvi.1999.0277; Glineur SF, 2013, VIROLOGY, V443, P257, DOI 10.1016/j.virol.2013.05.011; Greenwood AG, 2002, VET REC, V150, P543, DOI 10.1136/vr.150.17.543; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hu RL, 2001, VET RES COMMUN, V25, P77, DOI 10.1023/A:1006417203856; KAPLAN C, 1980, J HYG-CAMBRIDGE, V84, P285, DOI 10.1017/S0022172400026784; Kapoor A, 2012, J GEN VIROL, V93, P341, DOI 10.1099/vir.0.036624-0; Kapoor A, 2011, P NATL ACAD SCI USA, V108, P11608, DOI 10.1073/pnas.1101794108; Krempl CD, 2005, VIRUS GENES, V30, P237, DOI 10.1007/s11262-004-5631-4; Leary TP, 2002, J CLIN MICROBIOL, V40, P1368, DOI 10.1128/JCM.40.4.1368-1375.2002; Martella V, 2008, VET CLIN N AM-SMALL, V38, P787, DOI 10.1016/j.cvsm.2008.02.007; Mitchell JA, 2013, J CLIN MICROBIOL, V51, P4112, DOI 10.1128/JCM.02312-13; Percopo CM, 2011, VIROLOGY, V416, P26, DOI 10.1016/j.virol.2011.04.010; Priestnall SL, 2010, CLIN VACCINE IMMUNOL, V17, P1790, DOI 10.1128/CVI.00188-10; Renshaw R, 2011, VET MICROBIOL, V150, P88, DOI 10.1016/j.vetmic.2011.01.013; Renshaw RW, 2010, EMERG INFECT DIS, V16, P993, DOI 10.3201/eid1606.091778; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Zenner L, 2000, LAB ANIM-UK, V34, P76, DOI 10.1258/002367700780577957; Zhao ZQ, 2011, VET J, V188, P337, DOI 10.1016/j.tvjl.2010.05.022	37	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e85220	10.1371/journal.pone.0085220	http://dx.doi.org/10.1371/journal.pone.0085220			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400129	Green Published, gold, Green Submitted			2022-12-27	WOS:000329462700063
J	Denkinger, CM; Pai, M; Dowdy, DW				Denkinger, Claudia M.; Pai, Madhukar; Dowdy, David W.			Do We Need to Detect Isoniazid Resistance in Addition to Rifampicin Resistance in Diagnostic Tests for Tuberculosis?	PLOS ONE			English	Article							SHORT-COURSE CHEMOTHERAPY; INITIAL-DRUG RESISTANCE; MULTIDRUG-RESISTANT; MYCOBACTERIUM-TUBERCULOSIS; TREATMENT OUTCOMES; ANTIRETROVIRAL THERAPY; PREVENTIVE THERAPY; INFECTION; RISK; TRANSMISSION	Background: Multidrug-resistant tuberculosis (MDR-TB) is resistant to both rifampicin (RIF) and isoniazid (INH). Whereas many TB diagnostics detect RIF-resistance, few detect INH-monoresistance, which is common and may increase risk of acquired MDR-TB. Whether inclusion of INH-resistance in a first-line rapid test for TB would have an important impact on MDR-TB rates remains uncertain. Methods: We developed a transmission model to evaluate three tests in a population similar to that of India: a rapid molecular test for TB, the same test plus RIF-resistance detection ("TB+RIF''), and detection of RIF and INH-resistance ("TB+RIF/INH''). Our primary outcome was the prevalence of INH-resistant and MDR-TB at ten years. Results: Compared to the TB test alone and assuming treatment of all diagnosed MDR cases, the TB+RIF test reduced the prevalence of MDR-TB among all TB cases from 5.5% to 3.8% (30.6% reduction, 95% uncertainty range, UR: 17-54%). Despite using liberal assumptions about the impact of INH-monoresistance on treatment outcomes and MDR-TB acquisition, expansion from TB+RIF to TB+RIF/INH lowered this prevalence only from 3.8% to 3.6% further (4% reduction, 95% UR: 3-7%) and INH-monoresistant TB from 15.8% to 15.1% (4% reduction, 95% UR: (-8)-19%). Conclusion: When added to a rapid test for TB plus RIF-resistance, detection of INH-resistance has minimal impact on transmission of TB, MDR-TB, and INH-monoresistant TB.	[Denkinger, Claudia M.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Denkinger, Claudia M.; Pai, Madhukar] McGill Univ, McGill Int TB Ctr, Montreal, PQ, Canada; [Denkinger, Claudia M.; Pai, Madhukar] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Pai, Madhukar] Montreal Chest Inst, Resp Epidemiol & Clin Res Unit, Montreal, PQ, Canada; [Dowdy, David W.] Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Dowdy, David W.] Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD USA	Harvard University; Beth Israel Deaconess Medical Center; McGill University; McGill University; McGill University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Dowdy, DW (corresponding author), Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	ddowdy@jhsph.edu	PAL, MRINAL/ABG-9676-2020; Pai, Madhukar/AAX-9901-2021	PAL, MRINAL/0000-0002-1032-272X; Pai, Madhukar/0000-0003-3667-4536	New Diagnostics working groups of the Stop TB Partnership; Bill and Melinda Gates Foundation [OPP1061487]; Canadian Institute of Health Research [MOP 123291]; US National Institutes of Health [1R21AI101152]; McGill University; American Society of Tropical Medicine and Hygiene; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101152] Funding Source: NIH RePORTER	New Diagnostics working groups of the Stop TB Partnership; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McGill University; American Society of Tropical Medicine and Hygiene; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Development and publication of this manuscript was made possible with financial support from the New Diagnostics working groups of the Stop TB Partnership, grants from the Bill and Melinda Gates Foundation (OPP1061487), and the Canadian Institute of Health Research (MOP 123291) to MP as well as a US National Institutes of Health grant (1R21AI101152) to DWD. CMD is supported by a Richard Tomlinson Fellowship at McGill University and a fellowship of the Burroughs-Wellcome Fund from the American Society of Tropical Medicine and Hygiene. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Andrews JR, 2007, J INFECT DIS, V196, pS482, DOI 10.1086/521121; Andrews JR, 2012, CLIN INFECT DIS, V54, P784, DOI 10.1093/cid/cir951; ANGEL JH, 1984, BRIT J DIS CHEST, V78, P330; Balcells ME, 2006, EMERG INFECT DIS, V12, P744; Bhargava A, 2011, HYPOTHESIS, V9, pe7; Billington OJ, 1999, ANTIMICROB AGENTS CH, V43, P1866, DOI 10.1128/AAC.43.8.1866; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Botha E, 2008, INT J TUBERC LUNG D, V12, P820; Cattamanchi A, 2009, CLIN INFECT DIS, V48, P179, DOI 10.1086/595689; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P661; Chang K, 2012, J INFECTION, V64, P580, DOI 10.1016/j.jinf.2012.02.012; Cohen T, 2006, P NATL ACAD SCI USA, V103, P7042, DOI 10.1073/pnas.0600349103; Cohen T, 2004, NAT MED, V10, P1117, DOI 10.1038/nm1110; Cohn DL, 1997, CLIN INFECT DIS, V24, pS121, DOI 10.1093/clinids/24.Supplement_1.S121; Coninx R, 1999, LANCET, V353, P969, DOI 10.1016/S0140-6736(98)08341-X; Dorman SE, 2009, AM J RESP CRIT CARE, V180, P273, DOI 10.1164/rccm.200901-0078OC; Dye C, 1998, LANCET, V352, P1886, DOI 10.1016/S0140-6736(98)03199-7; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; FEREBEE SH, 1970, BIBL TUBERC MED THOR, V17, P28; Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410; Girosi Federico, 2006, Nature, V444 Suppl 1, P3, DOI 10.1038/nature05441; GRZYBOWSKI S, 1978, Bulletin of the International Union Against Tuberculosis, V53, P70; *HONG KONG CHEST S, 1981, LANCET, V1, P171; Jacobson KR, 2011, CLIN INFECT DIS, V53, P369, DOI 10.1093/cid/cir406; Jenkins HE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022927; Khan MS, 2009, TROP MED INT HEALTH, V14, P1437, DOI 10.1111/j.1365-3156.2009.02406.x; Law S, 2013, EUR RESPIR J; Lew W, 2008, ANN INTERN MED, V149, P123, DOI 10.7326/0003-4819-149-2-200807150-00008; Ling DI, 2008, EUR RESPIR J, V32, P1165, DOI 10.1183/09031936.00061808; Menzies D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000150, 10.1371/journal.pmed.1000146]; Menzies NA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001347; MITCHISON DA, 1986, AM REV RESPIR DIS, V133, P423; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Niemz A, 2012, EXPERT REV MOL DIAGN, V12, P687, DOI [10.1586/ERM.12.71, 10.1586/erm.12.71]; Nikam C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051121; PARAMASIVAN CN, 1993, TUBERCLE LUNG DIS, V74, P23, DOI 10.1016/0962-8479(93)90064-5; Pennell WT, 2011, TECHNICAL CHALLENGES OF MULTIPOLLUTANT AIR QUALITY MANAGEMENT, P1, DOI 10.1007/978-94-007-0304-9_1; Pym AS, 2002, INFECT IMMUN, V70, P4955, DOI 10.1128/IAI.70.9.4955-4960.2002; Revised National Tuberculosis Control Program I, 2011, PERFORMANCE DATA ON; Seung KJ, 2004, CLIN INFECT DIS, V39, P1321, DOI 10.1086/425005; Smith SE, 2012, INT J TUBERC LUNG D, V16, P203, DOI 10.5588/ijtld.11.0445; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Styblo K, 1991, EPIDEMIOLOGY OF TUBE; SUTHERLAND I, 1982, TUBERCLE, V63, P255, DOI 10.1016/S0041-3879(82)80013-5; Van Leth F, 2008, B WORLD HEALTH ORGAN, V86, P20, DOI 10.2471/BLT.06.037804; van Soolingen D, 2000, J INFECT DIS, V182, P1788, DOI 10.1086/317598; Vandan N, 2009, PUBLIC HEALTH, V123, P484, DOI 10.1016/j.puhe.2009.05.004; Vynnycky E, 1997, EPIDEMIOL INFECT, V119, P183, DOI 10.1017/S0950268897007917; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2008, ANTI TUBERCULOSIS DR; World Health Organization, 2008, MOLECULAR LINE PROBE; World Health Organization, 2011, AUTOMATED REAL TIME; World Health Organization, 2011, RAPID IMPLEMENTATION; World Health Organization, 2012, WHO MONITORING OF XP	57	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84197	10.1371/journal.pone.0084197	http://dx.doi.org/10.1371/journal.pone.0084197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404155	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460800034
J	He, BJ; Soderlund, DM				He, Bingjun; Soderlund, David M.			Functional Expression of Rat Na(v)1.6 Voltage-Gated Sodium Channels in HEK293 Cells: Modulation by the Auxiliary beta 1 Subunit	PLOS ONE			English	Article							PURKINJE NEURONS; ALPHA-SUBUNIT; INACTIVATION; CURRENTS; BETA-1-SUBUNIT; COEXPRESSION; TEFLUTHRIN; LINE	The Na(v)1.6 voltage-gated sodium channel alpha subunit isoform is abundantly expressed in the adult rat brain. To assess the functional modulation of Na(v)1.6 channels by the auxiliary beta 1 subunit we expressed the rat Na(v)1.6 sodium channel alpha subunit by stable transformation in HEK293 cells either alone or in combination with the rat beta 1 subunit and assessed the properties of the reconstituted channels by recording sodium currents using the whole-cell patch clamp technique. Coexpression with the beta 1 subunit accelerated the inactivation of sodium currents and shifted the voltage dependence of channel activation and steady-state fast inactivation by approximately 5-7 mV in the direction of depolarization. By contrast the beta 1 subunit had no effect on the stability of sodium currents following repeated depolarizations at high frequencies. Our results define modulatory effects of the beta 1 subunit on the properties of rat Na(v)1.6-mediated sodium currents reconstituted in HEK293 cells that differ from effects measured previously in the Xenopus oocyte expression system. We also identify differences in the kinetic and gating properties of the rat Na(v)1.6 channel expressed in the absence of the beta 1 subunit compared to the properties of the orthologous mouse and human channels expressed in this system.	[He, Bingjun] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Soderlund, David M.] Cornell Univ, Dept Entomol, Geneva, NY 14456 USA	Nankai University; Cornell University	Soderlund, DM (corresponding author), Cornell Univ, Dept Entomol, Geneva, NY 14456 USA.	dms6@cornell.edu			National Institute of Environmental Health Sciences, National Institutes of Health [R01-ES013686, R01-014591]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013686] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported in part by grants (R01-ES013686 and R01-014591) from the National Institute of Environmental Health Sciences, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AULD VJ, 1988, NEURON, V1, P449, DOI 10.1016/0896-6273(88)90176-6; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; Brackenbury WJ, 2010, P NATL ACAD SCI USA, V107, P2283, DOI 10.1073/pnas.0909434107; Burbidge SA, 2002, MOL BRAIN RES, V103, P80, DOI 10.1016/S0169-328X(02)00188-2; BURGESS DL, 1995, NAT GENET, V10, P461, DOI 10.1038/ng0895-461; Caldwell JH, 2000, P NATL ACAD SCI USA, V97, P5616, DOI 10.1073/pnas.090034797; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Chen Y, 2008, MOL CELL NEUROSCI, V38, P607, DOI 10.1016/j.mcn.2008.05.009; Cummins TR, 2001, J NEUROSCI, V21, P5952, DOI 10.1523/JNEUROSCI.21-16-05952.2001; Dietrich PS, 1998, J NEUROCHEM, V70, P2262; Felts PA, 1997, MOL BRAIN RES, V45, P71, DOI 10.1016/S0169-328X(96)00241-0; Ferrera L, 2006, EXP BRAIN RES, V172, P139, DOI 10.1007/s00221-005-0323-4; Goldin AL, 2001, ANNU REV PHYSIOL, V63, P871, DOI 10.1146/annurev.physiol.63.1.871; Goldin AL., 2006, EXPRESSION ANAL RECO, P1; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; He BJ, 2011, TOXICOL APPL PHARM, V257, P377, DOI 10.1016/j.taap.2011.09.021; He BJ, 2010, NEUROSCI LETT, V469, P268, DOI 10.1016/j.neulet.2009.12.012; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; Khaliq ZM, 2003, J NEUROSCI, V23, P4899, DOI 10.1523/jneurosci.23-12-04899.2003; Laezza F, 2009, MOL CELL NEUROSCI, V42, P90, DOI 10.1016/j.mcn.2009.05.007; Moran O, 2003, NEUROSCI LETT, V336, P175, DOI 10.1016/S0304-3940(02)01284-3; Moran O, 2000, FEBS LETT, V473, P132, DOI 10.1016/S0014-5793(00)01518-0; Patino GA, 2010, NEUROSCI LETT, V486, P53, DOI 10.1016/j.neulet.2010.06.050; Qu Y, 2001, MOL CELL NEUROSCI, V18, P570, DOI 10.1006/mcne.2001.1039; Raman IM, 2001, BIOPHYS J, V80, P729, DOI 10.1016/S0006-3495(01)76052-3; Schaller KL, 2003, CEREBELLUM, V2, P2, DOI 10.1080/14734220309424; Shah BS, 2001, J PHYSIOL-LONDON, V534, P763, DOI 10.1111/j.1469-7793.2001.t01-1-00763.x; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Tan JG, 2011, PESTIC BIOCHEM PHYS, V101, P256, DOI 10.1016/j.pestbp.2011.10.003; Tan JG, 2011, BIOCHEM BIOPH RES CO, V407, P788, DOI 10.1016/j.bbrc.2011.03.101; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; Welch NC, 2008, NEUROPHARMACOLOGY, V55, P1165, DOI 10.1016/j.neuropharm.2008.07.015; Whitaker WRJ, 2000, J COMP NEUROL, V422, P123, DOI 10.1002/(SICI)1096-9861(20000619)422:1<123::AID-CNE8>3.0.CO;2-X; Whitaker WRJ, 2001, MOL BRAIN RES, V88, P37, DOI 10.1016/S0169-328X(00)00289-8; Yu FH, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-207; Zhao J, 2011, J NEUROPHYSIOL, V106, P608, DOI 10.1152/jn.00107.2011	37	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e85188	10.1371/journal.pone.0085188	http://dx.doi.org/10.1371/journal.pone.0085188			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404202	Green Published, Green Submitted, gold			2022-12-27	WOS:000329460800081
J	Pyka, M; Cheng, S				Pyka, Martin; Cheng, Sen			Pattern Association and Consolidation Emerges from Connectivity Properties between Cortex and Hippocampus	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; CA3 NMDA RECEPTORS; SPATIAL MAP; MEMORY; RAT; MODEL; SEQUENCES; REPLAY; CELLS; AXONS	The basic structure of the cortico-hippocampal system is highly conserved across mammalian species. Comparatively few hippocampal neurons can represent and address a multitude of cortical patterns, establish associations between cortical patterns and consolidate these associations in the cortex. In this study, we investigate how elementary anatomical properties in the cortex-hippocampus loop along with synaptic plasticity contribute to these functions. Specifically, we focus on the high degree of connectivity between cortex and hippocampus leading to converging and diverging forward and backward projections and heterogenous synaptic transmission delays that result from the detached location of the hippocampus and its multiple loops. We found that in a model incorporating these concepts, each cortical pattern can evoke a unique spatio-temporal spiking pattern in hippocampal neurons. This hippocampal response facilitates a reliable disambiguation of learned associations and a bridging of a time interval larger than the time window of spike-timing dependent plasticity in the cortex. Moreover, we found that repeated retrieval of a stored association leads to a compression of the interval between cue presentation and retrieval of the associated pattern from the cortex. Neither a high degree of connectivity nor heterogenous synaptic delays alone is sufficient for this behavior. We conclude that basic anatomical properties between cortex and hippocampus implement mechanisms for representing and consolidating temporal information. Since our model reveals the observed functions for a range of parameters, we suggest that these functions are robust to evolutionary changes consistent with the preserved function of the hippocampal loop across different species.	[Pyka, Martin; Cheng, Sen] Ruhr Univ Bochum, Mercator Res Grp Struct Memory, Bochum, Germany; [Pyka, Martin; Cheng, Sen] Ruhr Univ Bochum, Fac Psychol, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Pyka, M (corresponding author), Ruhr Univ Bochum, Mercator Res Grp Struct Memory, Univ Str 150, Bochum, Germany.	martin.pyka@gmx.de	Cheng, Sen/A-5722-2009	Cheng, Sen/0000-0002-6719-8029	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [SFB 874]; Stiftung Mercator	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); Stiftung Mercator	This work was supported by a grant (SFB 874, project B2) from the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) and a grant from the Stiftung Mercator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Azizi AH, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00161; Buhry L, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/203462; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Carasatorre M, 2016, NEUROLOGIA, V31, P543, DOI 10.1016/j.nrl.2012.12.005; Cheng S, 2013, FRONT NEURAL CIRCUIT, V7, P1; Cravens CJ, 2006, EUR J NEUROSCI, V24, P1771, DOI 10.1111/j.1460-9568.2006.05044.x; Csicsvari J, 2007, EUR J NEUROSCI, V26, P704, DOI 10.1111/j.1460-9568.2007.05684.x; Davidson TJ, 2009, NEURON, V63, P497, DOI 10.1016/j.neuron.2009.07.027; Day M, 2003, NATURE, V424, P205, DOI 10.1038/nature01769; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; DONOGHUE JP, 1982, J COMP NEUROL, V212, P76, DOI 10.1002/cne.902120106; Eichenbaum H, 2013, TRENDS COGN SCI, V17, P81, DOI 10.1016/j.tics.2012.12.007; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; GEORGOPOULOS AP, 1991, ANNU REV NEUROSCI, V14, P361, DOI 10.1146/annurev.ne.14.030191.002045; Goodhill GJ, 2005, NETWORK-COMP NEURAL, V16, P5, DOI 10.1080/09548980500254654; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Hornby G., 2001, P 3 ANN C GENETIC EV, P868; INSAUSTI R, 1993, HIPPOCAMPUS, V3, P19; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Izhikevich EM, 2007, CEREB CORTEX, V17, P2443, DOI 10.1093/cercor/bhl152; Izhikevich EM, 2006, NEURAL COMPUT, V18, P245, DOI 10.1162/089976606775093882; Kali S, 2004, NAT NEUROSCI, V7, P286, DOI 10.1038/nn1202; Lall S, 2001, ANN REV GENETICS; Lavenex P, 2000, HIPPOCAMPUS, V10, P420, DOI 10.1002/1098-1063(2000)10:4<420::AID-HIPO8>3.3.CO;2-X; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; LEGENDY CR, 1967, MATH BIOSCI, V1, P555, DOI DOI 10.1016/0025-5564(67)90003-X; Levy W, 1983, NEUROSCIENCE, V8; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; MacDonald CJ, 2011, NEURON, V71, P737, DOI 10.1016/j.neuron.2011.07.012; Manns JR, 2006, HIPPOCAMPUS, V16, P795, DOI 10.1002/hipo.20205; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; McNaughton BL, 1989, NEUROBIOLOGY SPATIAL; Meeks JP, 2005, J PHYSIOL-LONDON, V566, P425, DOI 10.1113/jphysiol.2005.089086; Meinhardt H, 2008, CURR TOP DEV BIOL, V81, P1, DOI 10.1016/S0070-2153(07)81001-5; Mortimer D, 2009, P NATL ACAD SCI USA, V106, P10296, DOI 10.1073/pnas.0900715106; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Ohno M, 2005, LEARN MEMORY, V12, P211, DOI 10.1101/lm.90205; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Palm G, 1982, STUDIES BRAIN FUNCTI; PETIT TL, 1989, EXP NEUROL, V105, P72, DOI 10.1016/0014-4886(89)90173-8; Ragozzino ME, 2001, NEUROSCI LETT, V308, P145, DOI 10.1016/S0304-3940(01)02020-1; Risi S, 2013, CONFRONTING CHALLENG; Roland P E, 1984, Hum Neurobiol, V2, P205; Rolls ET, 2010, BEHAV BRAIN RES, V215, P180, DOI 10.1016/j.bbr.2010.03.027; Rolls ET, 2006, REV NEUROSCIENCE, V17, P175; ROLLS ET, 1993, EXP BRAIN RES, V93, P299; Rosoff WJ, 2004, NAT NEUROSCI, V7, P678, DOI 10.1038/nn1259; Rubin J, 2001, PHYS REV LETT, V86, P364, DOI 10.1103/PhysRevLett.86.364; Sakamoto T, 2005, BRAIN RES, V1039, P130, DOI 10.1016/j.brainres.2005.01.068; Shu YS, 2007, J NEUROPHYSIOL, V97, P746, DOI 10.1152/jn.00922.2006; Soleng AF, 2003, HIPPOCAMPUS, V13, P953, DOI 10.1002/hipo.10141; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Squire LR, 2001, HIPPOCAMPUS, V11, P50, DOI 10.1002/1098-1063(2001)11:1<50::AID-HIPO1019>3.0.CO;2-G; Stanley KO, 2009, ARTIF LIFE, V15, P1; Staresina B, 2006, J NEUROSCIENCE; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; Stein B.E., 1993, COGNITIVE NEUROSCIEN, P2; Szatmary B, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000879; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; Tseng W, 2004, HIPPOCAMPUS, V14, P58, DOI 10.1002/hipo.10157; Tubridy S, 2011, CEREB CORTEX, V21, P272, DOI 10.1093/cercor/bhq092; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; van Strien NM, 2009, NAT REV NEUROSCI, V10, P272, DOI 10.1038/nrn2614; Waddington A, 2012, FRONT COMPUT NEUROSC, V6, P1, DOI 10.3389/fncom.2012.00088; Walton ME, 2002, J NEUROSCI, V22, P10996; Wharton C, 1998, TRENDS COGNITIVE SCI; Witter MP, 2000, ANN NY ACAD SCI, V911, P1; Witter MP, 2000, HIPPOCAMPUS, V10, P398; Yates PA, 2004, J NEUROBIOL, V59, P95, DOI 10.1002/neu.10341	75	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e85016	10.1371/journal.pone.0085016	http://dx.doi.org/10.1371/journal.pone.0085016			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404200	Green Submitted, Green Published, gold			2022-12-27	WOS:000329460800079
J	Tomaiuolo, G; Rusciano, G; Caserta, S; Carciati, A; Carnovale, V; Abete, P; Sasso, A; Guido, S				Tomaiuolo, Giovanna; Rusciano, Giulia; Caserta, Sergio; Carciati, Antonio; Carnovale, Vincenzo; Abete, Pasquale; Sasso, Antonio; Guido, Stefano			A New Method to Improve the Clinical Evaluation of Cystic Fibrosis Patients by Mucus Viscoelastic Properties	PLOS ONE			English	Article							SPUTUM; DYNAMICS; RHEOLOGY; DISEASE; TISSUE	In cystic fibrosis (CF) patients airways mucus shows an increased viscoelasticity due to the concentration of high molecular weight components. Such mucus thickening eventually leads to bacterial overgrowth and prevents mucus clearance. The altered rheological behavior of mucus results in chronic lung infection and inflammation, which causes most of the cases of morbidity and mortality, although the cystic fibrosis complications affect other organs as well. Here, we present a quantitative study on the correlation between cystic fibrosis mucus viscoelasticity and patients clinical status. In particular, a new diagnostic parameter based on the correlation between CF sputum viscoelastic properties and the severity of the disease, expressed in terms of FEV1 and bacterial colonization, was developed. By using principal component analysis, we show that the types of colonization and FEV1 classes are significantly correlated to the elastic modulus, and that the latter can be used for CF severity classification with a high predictive efficiency (88%). The data presented here show that the elastic modulus of airways mucus, given the high predictive efficiency, could be used as a new clinical parameter in the prognostic evaluation of cystic fibrosis.	[Tomaiuolo, Giovanna; Caserta, Sergio; Carciati, Antonio; Guido, Stefano] Univ Naples Federico II, Dipartimento Ingn Chim Mat & Prod Ind, Naples, Italy; [Tomaiuolo, Giovanna; Caserta, Sergio; Guido, Stefano] CEINGE Adv Biotechnol, Naples, Italy; [Rusciano, Giulia; Sasso, Antonio] Complesso Univ MS Angelo, Univ Naples Federico II, Dipartimento Fis, Naples, Italy; [Carnovale, Vincenzo; Abete, Pasquale] Univ Naples Federico II, Dipartimento Sci Med Traslaz, Unita Fibrosi Cist Adulto, Naples, Italy	University of Naples Federico II; CEINGE Biotecnologie Avanzate; University of Naples Federico II; University of Naples Federico II	Tomaiuolo, G (corresponding author), Univ Naples Federico II, Dipartimento Ingn Chim Mat & Prod Ind, Naples, Italy.	g.tomaiuolo@unina.it	Tomaiuolo, Giovanna/K-8312-2019; Caserta, Sergio/E-4602-2012; Abete, Pasquale/AAC-2455-2022; Guido, Stefano/B-9928-2011; Rusciano, Giulia/A-2079-2010	Caserta, Sergio/0000-0002-4400-0059; Abete, Pasquale/0000-0002-4585-5390; Guido, Stefano/0000-0002-9247-6852; Rusciano, Giulia/0000-0002-7152-5352; Sasso, Antonio/0000-0003-3591-3531; Tomaiuolo, Giovanna/0000-0003-3012-0356; Carnovale, Vincenzo/0000-0002-4246-6883	Italian Ministry of Research under PRIN program	Italian Ministry of Research under PRIN program	Financial support from the Italian Ministry of Research under PRIN 2008 program is gratefully acknowledged. http://prin.miur.it/index.php?pag=2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060448; Amato F, 2012, J MOL DIAGN, V14, P81, DOI 10.1016/j.jmoldx.2011.09.001; Caserta S, 2005, CHEM ENG SCI, V60, P1019, DOI 10.1016/j.ces.2004.09.076; Caserta S, 2012, LANGMUIR, V28, P16254, DOI 10.1021/la303232w; Caserta S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.137801; Celli J, 2005, BIOMACROMOLECULES, V6, P1329, DOI 10.1021/bm0493990; Cone RA, 2009, ADV DRUG DELIVER REV, V61, P75, DOI 10.1016/j.addr.2008.09.008; Davis P B, 2001, Pediatr Rev, V22, P257, DOI 10.1542/pir.22-8-257; Davis PB, 1996, AM J RESP CRIT CARE, V154, P1229, DOI 10.1164/ajrccm.154.5.8912731; DAVIS S S, 1969, Biorheology, V6, P11; Dawson M, 2003, J BIOL CHEM, V278, P50393, DOI 10.1074/jbc.M309026200; de Jong BWD, 2006, ANAL CHEM, V78, P7761, DOI 10.1021/ac061417b; Feng W, 1998, AM J RESP CRIT CARE, V157, P710, DOI 10.1164/ajrccm.157.3.9703059; GILLIGAN PH, 1991, CLIN MICROBIOL REV, V4, P35, DOI 10.1128/CMR.4.1.35-51.1991; Giordano S, 2013, J MOL DIAGN, V15, P331, DOI 10.1016/j.jmoldx.2013.01.001; Harrison F, 2007, MICROBIOL-SGM, V153, P917, DOI 10.1099/mic.0.2006/004077-0; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Jonas A, 2010, LANGMUIR, V26, P14223, DOI 10.1021/la101498h; King M, 1997, AM J RESP CRIT CARE, V156, P173, DOI 10.1164/ajrccm.156.1.9512074; KING M, 1977, J APPL PHYSIOL, V42, P797, DOI 10.1152/jappl.1977.42.6.797; Lai SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004294; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P86, DOI 10.1016/j.addr.2008.09.012; Livak-Dahl E, 2013, LAB CHIP, V13, P297, DOI 10.1039/c2lc41130j; Maiuri L, 2008, J IMMUNOL, V180, P7697, DOI 10.4049/jimmunol.180.11.7697; Minale M, 2010, LANGMUIR, V26, P126, DOI 10.1021/la902187a; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Serisier DJ, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-63; Sheppard M., 2002, CURR DIAGN PATHOL, V8, P50, DOI 10.1054/cdip.2001.0088; Stenbit AE, 2011, CURR OPIN PULM MED, V17, P442, DOI 10.1097/MCP.0b013e32834b8c04; Tomaiuolo G, 2012, CYTOM PART A, V81A, P1040, DOI 10.1002/cyto.a.22215; Tomaiuolo G, 2012, PHYS FLUIDS, V24, DOI 10.1063/1.4721811; Tomaiuolo G, 2011, MICROVASC RES, V82, P35, DOI 10.1016/j.mvr.2011.03.004; Tomaiuolo G, 2011, LAB CHIP, V11, P449, DOI [10.1039/c0lc00348d, 10.1039/c01c00348d]; Tomaiuolo R, 2011, CLIN CHEM LAB MED, V49, P1289, DOI 10.1515/CCLM.2011.637; Vandenginste B.G.M., 1998, HDB CHEMOMETRICS QUA; Vij N, 2013, AM J RESP CRIT CARE, V187, P120, DOI 10.1164/rccm.201211-2011ED; Voter KZ, 2008, CLIN REV ALLERG IMMU, V35, P100, DOI 10.1007/s12016-008-8078-x; Waters V, 2011, AM J RESP CRIT CARE, V183, P635, DOI 10.1164/rccm.201009-1392OC	38	31	33	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e82297	10.1371/journal.pone.0082297	http://dx.doi.org/10.1371/journal.pone.0082297			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404129	gold, Green Published, Green Submitted			2022-12-27	WOS:000329460800008
J	Fikru, R; Hagos, A; Roge, S; Reyna-Bello, A; Gonzatti, MI; Merga, B; Goddeeris, BM; Buscher, P				Fikru, Regassa; Hagos, Ashenafi; Roge, Stijn; Reyna-Bello, Armando; Isabel Gonzatti, Mary; Merga, Bekana; Goddeeris, Bruno Maria; Buscher, Philippe			A Proline Racemase Based PCR for Identification of Trypanosoma vivax in Cattle Blood	PLOS ONE			English	Article							SOUTH-AMERICA; TSETSE; AMPLIFICATION; DIAGNOSIS; REVEALS	A study was conducted to develop a Trypanosoma vivax (T. vivax) specific PCR based on the T. vivax proline racemase (TvPRAC) gene. Forward and reverse primers were designed that bind at 764-783 bp and 983-1002 bp of the gene. To assess its specificity, TvPRAC PCR was conducted on DNA extracted from different haemotropic pathogens: T. vivax from Nigeria, Ethiopia and Venezuela, T. congolense Savannah type, T. brucei brucei, T. evansi, T. equiperdum, T. theileri, Theileria parva, Anaplasma marginale, Babesia bovis and Babesia bigemina and from bovine, goat, mouse, camel and human blood. The analytical sensitivity of the TvPRAC PCR was compared with that of the ITS-1 PCR and the 18S PCR-RFLP on a dilution series of T. vivax DNA in water. The diagnostic performance of the three PCRs was compared on 411 Ethiopian bovine blood specimens collected in a former study. TvPRAC PCR proved to be fully specific for T. vivax, irrespective of its geographical origin. Its analytical sensitivity was lower than that of ITS-1 PCR. On these bovine specimens, TvPRAC PCR detected 8.3% T. vivax infections while ITS-1 PCR and 18S PCR-RFLP detected respectively 22.6 and 6.1% T. vivax infections. The study demonstrates that a proline racemase based PCR could be used, preferably in combination with ITS-1 PCR, as a species-specific diagnostic test for T. vivax infections worldwide.	[Fikru, Regassa; Hagos, Ashenafi; Merga, Bekana] Univ Addis Ababa, Coll Vet Med & Agr, Debre Zeit, Ethiopia; [Fikru, Regassa; Roge, Stijn; Buscher, Philippe] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Fikru, Regassa; Goddeeris, Bruno Maria] Katholieke Univ Leuven, Dept Biosyst, Fac Biosci Engn, Louvain, Belgium; [Reyna-Bello, Armando] Univ Ac Expt Simon Rodriguez, Grp Inmunobiol, Ctr Estudios Biomed & Vet, Caracas, Venezuela; [Isabel Gonzatti, Mary] Univ Simon Bolivar, Dept Biol Celular, Grp Bioquim & Inmunol Hemoparasitos, Caracas, Venezuela	Addis Ababa University; Institute of Tropical Medicine (ITM); KU Leuven; Simon Bolivar University	Fikru, R (corresponding author), Univ Addis Ababa, Coll Vet Med & Agr, Debre Zeit, Ethiopia.	fikruregassa@yahoo.com	caputo, carlo/N-3747-2014; Goddeeris, Bruno Maria/L-2440-2015; Reyna-Bello, Armando/G-1117-2019; Büscher, Philippe/B-9956-2012	Goddeeris, Bruno Maria/0000-0003-3729-7592; Reyna-Bello, Armando/0000-0003-0846-5745; Büscher, Philippe/0000-0002-1926-7472; Gonzatti, Mary Isabel/0000-0003-4266-2988	Belgian Directorate General for Development Cooperation	Belgian Directorate General for Development Cooperation	The PhD fellowship of Fikru Regassa was financed by the Belgian Directorate General for Development Cooperation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe G, 1996, REV MED VET-TOULOUSE, V147, P897; Adams ER, 2006, ACTA TROP, V100, P103, DOI 10.1016/j.actatropica.2006.10.002; Barrowman PR, 1976, J VET RES, V43, P55; Chamond N, 2009, MOL BIOCHEM PARASIT, V165, P170, DOI 10.1016/j.molbiopara.2009.02.002; Cortez AP, 2009, MOL CELL PROBE, V23, P44, DOI 10.1016/j.mcp.2008.11.003; Davila AMR, 2000, ANN NY ACAD SCI, V916, P199, DOI 10.1111/j.1749-6632.2000.tb05291.x; Deborggraeve S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000972; Delespaux V, 2008, TRENDS PARASITOL, V24, P236, DOI 10.1016/j.pt.2008.02.006; Desquesnes M, 2001, INT J PARASITOL, V31, P610, DOI 10.1016/S0020-7519(01)00161-8; DICKIN SK, 1989, MOL BIOCHEM PARASIT, V33, P135, DOI 10.1016/0166-6851(89)90027-3; Fikru R, 2012, VET PARASITOL, V190, P355, DOI 10.1016/j.vetpar.2012.07.010; Geysen D, 2003, VET PARASITOL, V110, P171, DOI 10.1016/S0304-4017(02)00313-8; Geysen D, 2000, THESIS BRUNEL U UK; Gibson W, 2007, INT J PARASITOL, V37, P829, DOI 10.1016/j.ijpara.2007.03.002; Gonzalez LE, 2005, EXP PARASITOL, V111, P126, DOI 10.1016/j.exppara.2005.05.008; Hamilton PB, 2008, INFECT GENET EVOL, V8, P26, DOI 10.1016/j.meegid.2007.09.003; Hoare C, 1972, TRYPANOSOMES MAMMALS; LEEFLANG P, 1976, INT J PARASITOL, V6, P413, DOI 10.1016/0020-7519(76)90027-8; Masake RA, 1997, EXP PARASITOL, V85, P193, DOI 10.1006/expr.1996.4124; MASIGA DK, 1992, INT J PARASITOL, V22, P909, DOI 10.1016/0020-7519(92)90047-O; Morlais I, 2001, ACTA TROP, V80, P207, DOI 10.1016/S0001-706X(01)00160-7; Nakayima J, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-217; Njiru ZK, 2005, PARASITOL RES, V95, P186, DOI 10.1007/s00436-004-1267-5; Oluwafemi RA, 2007, SCI RES ESSAYS, V2, P380; Silva RAMS, 1998, MEM I OSWALDO CRUZ, V93, P29, DOI 10.1590/S0074-02761998000100006; SONGA EB, 1988, ANN SOC BELG MED TR, V68, P233; Steverding D, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-3; Thumbi Samuel M, 2010, BMC Res Notes, V3, P6, DOI 10.1186/1756-0500-3-6; van Meirvenne N., 1975, Annales Soc belge Med trop, V55, P1; Ventura RM, 2001, EXP PARASITOL, V99, P37, DOI 10.1006/expr.2001.4641; Verloo D, 2000, VET PARASITOL, V89, P129, DOI 10.1016/S0304-4017(00)00191-6; Viera AJ, 2005, FAM MED, V37, P360	32	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84819	10.1371/journal.pone.0084819	http://dx.doi.org/10.1371/journal.pone.0084819			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416292	Green Submitted, gold, Green Published			2022-12-27	WOS:000329862500174
J	Ghosh, D; Dey, SK; Saha, C				Ghosh, Debjani; Dey, Subrata Kumar; Saha, Chabita			Mutation Induced Conformational Changes in Genomic DNA from Cancerous K562 Cells Influence Drug-DNA Binding Modes	PLOS ONE			English	Article							CALF-THYMUS DNA; RAMAN-SPECTROSCOPY; FREE-ENERGY; MOLECULAR-MECHANISM; MYELOID-LEUKEMIA; IONIC LIQUID; DAUNOMYCIN; INTERCALATION; COMPLEX; RECOGNITION	Normal human genomic DNA (N-DNA) and mutated DNA (M-DNA) from K562 leukemic cells show different thermodynamic properties and binding affinities on interaction with anticancer drugs; adriamycin (ADR) and daunomycin (DNM). Isothermal calorimetric thermograms representing titration of ADR/DNM with N-DNA and M-DNA on analysis best fitted with sequential model of four and three events respectively. From Raman spectroscopy it has been identified that M-DNA is partially transformed to A form owing to mutations and N-DNA on binding of drugs too undergoes transition to A form of DNA. A correlation of thermodynamic contribution and structural data reveal the presence of different binding events in drug and DNA interactions. These events are assumed to be representative of minor groove complexation, reorientation of the drug in the complex, DNA deformation to accommodate the drugs and finally intercalation. Dynamic light scattering and zeta potential data also support differences in structure and mode of binding of N and M DNA. This study highlights that mutations can manifest structural changes in DNA, which may influence the binding efficacy of the drugs. New generation of drugs can be designed which recognize the difference in DNA structure in the cancerous cells instead of their biochemical manifestation.	[Ghosh, Debjani; Dey, Subrata Kumar; Saha, Chabita] West Bengal Univ Technol, Sch Biotechnol & Biol Sci, Kolkata, India	Maulana Abul Kalam Azad University of Technology	Saha, C (corresponding author), West Bengal Univ Technol, Sch Biotechnol & Biol Sci, Kolkata, India.	k.chabita@gmail.com	Saha, chabita/AAW-5020-2021		Department of Science and Technology (DST), Government of India; Council of Scientific and Industrial Research (CSIR), India	Department of Science and Technology (DST), Government of India(Department of Science & Technology (India)); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	Dr. Chabita Saha is thankful to Department of Science and Technology (DST), Government of India, for the financial support. Ms. Debjani Ghosh is financially supported by Council of Scientific and Industrial Research (CSIR), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora A, 2008, J PHYS CHEM B, V112, P8151, DOI 10.1021/jp711608y; BENEVIDES JM, 1983, NUCLEIC ACIDS RES, V11, P5747, DOI 10.1093/nar/11.16.5747; Benevides JM, 2005, J RAMAN SPECTROSC, V36, P279, DOI 10.1002/jrs.1324; CHAIRES JB, 1990, BIOCHEMISTRY-US, V29, P6145, DOI 10.1021/bi00478a006; CHAIRES JB, 1987, BIOCHEMISTRY-US, V26, P8227, DOI 10.1021/bi00399a031; Chaires JB, 1996, BIOCHEMISTRY-US, V35, P2047, DOI 10.1021/bi952812r; CHAIRES JB, 1985, BIOCHEMISTRY-US, V24, P260, DOI 10.1021/bi00323a004; Comoglio PM, 2008, NAT REV DRUG DISCOV, V7, P504, DOI 10.1038/nrd2530; Couzin J, 2002, SCIENCE, V298, P522, DOI 10.1126/science.298.5593.522; Ding YH, 2010, J PHYS CHEM B, V114, P2033, DOI 10.1021/jp9104757; Dong J, 2000, BIOCHEMISTRY-US, V39, P13241, DOI 10.1021/bi001437m; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Frantz S, 2005, NATURE, V437, P942, DOI 10.1038/437942a; Frantz S, 2006, NAT REV DRUG DISCOV, V5, P91, DOI 10.1038/nrd1972; Ghosh D, 2013, J BIOMOL STRUCT DYN, V31, P331, DOI 10.1080/07391102.2012.698190; Ghosh D, 2012, DNA CELL BIOL, V31, P377, DOI 10.1089/dna.2011.1299; He YF, 2013, COLLOID SURFACE B, V101, P398, DOI 10.1016/j.colsurfb.2012.07.027; Kabiri M, 2012, MOLECULES, V17, P3114, DOI 10.3390/molecules17033114; KOPKA ML, 1985, P NATL ACAD SCI USA, V82, P1376, DOI 10.1073/pnas.82.5.1376; KRISHNAMOORTHY CR, 1986, BIOCHEMISTRY-US, V25, P5933, DOI 10.1021/bi00368a015; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li G, 2002, SCI CHINA SER C, V45, P397, DOI 10.1360/02yc9044; Ling JY, 2005, CHINESE CHEM LETT, V16, P71; MACGREGOR RB, 1987, BIOCHEMISTRY-US, V26, P4008, DOI 10.1021/bi00387a040; Mady MM, 2004, J DRUG TARGET, V12, P11, DOI 10.1080/10611860410001683059; Majumder P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026486; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Movileanu L, 1999, J RAMAN SPECTROSC, V30, P637, DOI 10.1002/(SICI)1097-4555(199908)30:8<637::AID-JRS431>3.0.CO;2-B; Mukherjee A, 2008, J AM CHEM SOC, V130, P9747, DOI 10.1021/ja8001666; NEAULT JF, 1995, J BIOMOL STRUCT DYN, V13, P387, DOI 10.1080/07391102.1995.10508847; Neault JF, 1996, J BIOL CHEM, V271, P8140, DOI 10.1074/jbc.271.14.8140; NISHIMURA Y, 1983, NUCLEIC ACIDS RES, V11, P1579, DOI 10.1093/nar/11.5.1579; Qu XG, 2001, P NATL ACAD SCI USA, V98, P14212, DOI 10.1073/pnas.241509698; QUIGLEY GJ, 1980, P NATL ACAD SCI-BIOL, V77, P7204, DOI 10.1073/pnas.77.12.7204; REMETA DP, 1993, BIOCHEMISTRY-US, V32, P5064, DOI 10.1021/bi00070a014; RIZZO V, 1989, BIOCHEMISTRY-US, V28, P274, DOI 10.1021/bi00427a038; Salvia MV, 2013, BIOPHYS CHEM, V179, P1, DOI 10.1016/j.bpc.2013.04.001; Serban D, 2002, BIOCHEMISTRY-US, V41, P847, DOI 10.1021/bi011004z; SKOROBOGATY A, 1988, FEBS LETT, V227, P103, DOI 10.1016/0014-5793(88)80877-9; Sordet Olivier, 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P271, DOI 10.2174/1568011033482378; TEWEY KM, 1984, SCIENCE, V226, P466, DOI 10.1126/science.6093249; WARTELL RM, 1982, P NATL ACAD SCI-BIOL, V79, P2549, DOI 10.1073/pnas.79.8.2549; Wilhelm M, 2012, J AM CHEM SOC, V134, P8588, DOI 10.1021/ja301649k; Yoshikawa Y, 1996, BIOPHYS CHEM, V61, P93, DOI 10.1016/S0301-4622(96)02184-9	44	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84880	10.1371/journal.pone.0084880	http://dx.doi.org/10.1371/journal.pone.0084880			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416304	gold, Green Submitted, Green Published			2022-12-27	WOS:000329862500183
J	Jaceldo-Siegl, K; Haddad, E; Oda, K; Fraser, GE; Sabate, J				Jaceldo-Siegl, Karen; Haddad, Ella; Oda, Keiji; Fraser, Gary E.; Sabate, Joan			Tree Nuts Are Inversely Associated with Metabolic Syndrome and Obesity: The Adventist Health Study-2	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; BODY-WEIGHT; CARDIOVASCULAR EVENTS; NUTRIENT INTAKE; CONSUMPTION; RISK; PEANUTS; NUTRITION; ALMONDS; ADULTS	Objective: To examine the relationships of nut consumption, metabolic syndrome (MetS), and obesity in the Adventist Health Study-2, a relatively healthy population with a wide range of nut intake. Research Design and Methods: Cross-sectional analysis was conducted on clinical, dietary, anthropometric, and demographic data of 803 adults. MetS was defined according to the American Heart Association and the National Heart, Lung, and Blood Institute diagnostic criteria. We assessed intake of total nuts, tree nuts and peanuts, and also classified subjects into low tree nut/low peanut (LT/LP), low tree/high peanut (LT/HP), high tree nut/high peanut (HT/HP), and high tree/low peanut (HT/LP) consumers. Odds ratios were estimated using multivariable logistic regression. Results: 32% of subjects had MetS. Compared to LT/LP consumers, obesity was lower in LT/HP (OR = 0.89; 95% CI = 0.53, 1.48), HT/HP (OR = 0.63; 95% CI = 0.40, 0.99) and HT/LP (OR = 0.54; 95% CI = 0.34, 0.88) consumers, p for trend = 0.006. For MetS, odds ratios (95% CI) were 0.77 (0.47, 1.28), 0.65 (0.42, 1.00) and 0.68 (0.43, 1.07), respectively (p for trend = 0.056). Frequency of nut intake (once/week) had significant inverse associations with MetS (3% less for tree nuts and 2% less for total nuts) and obesity (7% less for tree nuts and 3% less for total nuts). Conclusions: Tree nuts appear to have strong inverse association with obesity, and favorable though weaker association with MetS independent of demographic, lifestyle and dietary factors.	[Jaceldo-Siegl, Karen; Haddad, Ella; Sabate, Joan] Loma Linda Univ, Sch Publ Hlth, Dept Nutr, Loma Linda, CA 92350 USA; [Oda, Keiji; Fraser, Gary E.; Sabate, Joan] Loma Linda Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Loma Linda, CA 92350 USA; [Jaceldo-Siegl, Karen; Fraser, Gary E.] Loma Linda Univ, Sch Publ Hlth, Loma Linda, CA 92350 USA	Loma Linda University; Loma Linda University; Loma Linda University	Jaceldo-Siegl, K (corresponding author), Loma Linda Univ, Sch Publ Hlth, Dept Nutr, Loma Linda, CA 92350 USA.	kjaceldo@llu.edu	Oda, Keiji/Q-6822-2019	Oda, Keiji/0000-0001-7631-6085; Sabate, Joan/0000-0002-9063-9785	National Institutes of Health/National Cancer Institute [UO1CA152939]; International Tree Nut Council Nutrition Research and Education Foundation; NATIONAL CANCER INSTITUTE [U01CA152939] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); International Tree Nut Council Nutrition Research and Education Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors gratefully acknowledge support from the National Institutes of Health/National Cancer Institute (UO1CA152939), and a grant from The International Tree Nut Council Nutrition Research and Education Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert CM, 2002, ARCH INTERN MED, V162, P1382, DOI 10.1001/archinte.162.12.1382; Badman MK, 2005, SCIENCE, V307, P1909, DOI 10.1126/science.1109951; Bes-Rastrollo M, 2009, AM J CLIN NUTR, V89, P1913, DOI 10.3945/ajcn.2008.27276; Butler TL, 2008, INT J EPIDEMIOL, V37, P260, DOI 10.1093/ije/dym165; Casas-Agustench P, 2011, NUTR METAB CARDIOVAS, V21, P518, DOI 10.1016/j.numecd.2009.11.010; Cassady BA, 2009, AM J CLIN NUTR, V89, P794, DOI 10.3945/ajcn.2008.26669; Crichton GE, 2011, OBES REV, V12, pe190, DOI 10.1111/j.1467-789X.2010.00837.x; Deshmukh-Taskar PR, 2009, PUBLIC HEALTH NUTR, V12, P2493, DOI 10.1017/S1368980009991261; Ervin R Bethene, 2009, Natl Health Stat Report, P1; Fernandez-Montero A, 2012, PUBLIC HEALTH NUTR, V23, P1; Flores-Mateo G, 2013, AM J CLIN NUTR, V97, P1346, DOI 10.3945/ajcn.111.031484; Ford ES, 2008, DIABETES CARE, V31, P1898, DOI 10.2337/dc08-0423; FRASER GE, 1992, ARCH INTERN MED, V152, P1416, DOI 10.1001/archinte.152.7.1416; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hollis J, 2007, BRIT J NUTR, V98, P651, DOI 10.1017/S0007114507734608; Ibarrola-Jurado N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057367; Jaceldo-Siegl K, 2004, BRIT J NUTR, V92, P533, DOI 10.1079/BJN20041223; Jaceldo-Siegl K, 2011, PUBLIC HEALTH NUTR, V14, P1988, DOI 10.1017/S1368980011000735; Jaceldo-Siegl K, 2010, PUBLIC HEALTH NUTR, V13, P812, DOI 10.1017/S1368980009992072; Jenab M, 2006, BRIT J NUTR, V96, pS12, DOI 10.1017/BJN20061859; Kafonek SD, 1996, CLIN CHEM, V42, P2002; Kelly JH, 2006, BRIT J NUTR, V96, pS61, DOI 10.1017/BJN20061865; King JG, 2008, J NUTR, V138, p1736S, DOI 10.1093/jn/138.9.1736S; Kouki R, 2011, EUR J CLIN NUTR, V65, P368, DOI 10.1038/ejcn.2010.262; Kris-Etherton PN, 2008, J NUTR, V138, p1746S; Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159; Martinez-Gonzalez MA, 2011, NUTR METAB CARDIOVAS, V21, pS40, DOI 10.1016/j.numecd.2010.11.005; Mattes RD, 2008, J NUTR, V138, p1741S, DOI 10.1093/jn/138.9.1741S; Mattes RD, 2010, ASIA PAC J CLIN NUTR, V19, P137; McKeown NM, 2004, DIABETES CARE, V27, P538, DOI 10.2337/diacare.27.2.538; Novotny JA, 2012, AM J CLIN NUTR, V96, P296, DOI 10.3945/ajcn.112.035782; O'Neil CE, 2012, NUTR RES, V32, P185, DOI 10.1016/j.nutres.2012.01.005; O'Neil CE, 2011, J AM COLL NUTR, V30, P502, DOI 10.1080/07315724.2011.10719996; Organization WH, 2006, GLOB DAT BOD MASS IN; Pan A, 2013, J NUTR, V143, P512, DOI 10.3945/jn.112.172171; Rajaram S, 2006, BRIT J NUTR, V96, pS79, DOI 10.1017/BJN20061867; Sabate J, 2010, ARCH INTERN MED, V170, P821, DOI 10.1001/archinternmed.2010.79; Salas-Salvado J, 2008, ARCH INTERN MED, V168, P2449, DOI 10.1001/archinte.168.22.2449; Schmidt C, 2012, METAB SYNDR RELAT D, V10, P394, DOI 10.1089/met.2012.0048; Vadivel V, 2012, NUTRITION, V28, P1089, DOI 10.1016/j.nut.2012.01.004	42	34	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85133	10.1371/journal.pone.0085133	http://dx.doi.org/10.1371/journal.pone.0085133			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416351	gold, Green Published, Green Submitted			2022-12-27	WOS:000329862500219
J	Liu, RL; Jiang, Y; Li, Q; Hammond, SK				Liu, Ruiling; Jiang, Yuan; Li, Qiang; Hammond, S. Katharine			An Assessment of Health Risks and Mortality from Exposure to Secondhand Smoke in Chinese Restaurants and Bars	PLOS ONE			English	Article							LUNG-CANCER; TOBACCO-SMOKE; HEART-DISEASE; PASSIVE SMOKING; PUBLIC PLACES; WORKERS; PREVALENCE; BURDEN; EXCESS	Introduction: Smoking is generally not regulated in restaurants or bars in China, or the restrictions are not fully implemented if there are any, while the related hazard health effects are not recognized by the majority of the Chinese population. Objectives: This study aims to assess the excess health risks and mortality attributed to secondhand smoke (SHS) exposure in restaurants and bars for both servers and patrons to provide necessary evidence for advancing tobacco control in this microenvironment. Methods: Two approaches were used for the assessment. One is a continuous approach based on existing field measurements and Repace and Lowrey's dose-response model, and the other is a categorical approach based on exposure or not and epidemiological studies. Results: Based on the continuous approach, servers were estimated to have a lifetime excess risk (LER) of lung cancer death (LCD) of 730 to 1,831x10(-6) for working five days a week for 45 years in smoking restaurants and 1,862 to 8,136x10(-6) in smoking bars, and patrons could have a LER of LCD of 47 to 117x10(-6) due to visiting smoking restaurants for an average of 13 minutes a day for 60 years, and 119 to 522x10(-6) due to visiting smoking bars. The categorical approach estimated that SHS exposure in restaurants and bars alone caused 84 LCD and 57 ischemic heart disease (IHD) deaths among nonsmoking servers and 1,2419 LCDs and 1,689 IHD deaths among the nonsmoking patron population. Conclusions: SHS exposure in restaurants and bars alone can impose high lifetime excess risks of lung cancer death and ischemic heart disease deaths to both servers and patrons, and can cause a significant number of deaths each year in China. These health risks and deaths can be prevented by banning smoking in restaurants and bars and effectively implementing these smoking bans.	[Liu, Ruiling; Hammond, S. Katharine] Univ Calif Berkeley, Dept Environm Hlth Sci, Berkeley, CA 94720 USA; [Jiang, Yuan] Chinese Ctr Dis Control & Prevent, Natl Tobacco Control Off, Beijing, Peoples R China; [Li, Qiang] Univ Waterloo, Dept Psychol, Waterloo, ON N2L 3G1, Canada	University of California System; University of California Berkeley; Chinese Center for Disease Control & Prevention; University of Waterloo	Hammond, SK (corresponding author), Univ Calif Berkeley, Dept Environm Hlth Sci, Berkeley, CA 94720 USA.	hammondk@berkeley.edu			Flight Attendants Medical Research Institute	Flight Attendants Medical Research Institute	This research project was supported by Dr. William Cahan Distinguished Professor Award to SKH from the Flight Attendants Medical Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari B., 2008, Morbidity and Mortality Weekly Report, V57, P1226; [Anonymous], 2004, IARC MON, V83; [Anonymous], 1997, EXP FACT HDB; California Environmental Protection Agency Office of Environmental Health Hazard Assessment Office of Air Resources Board, 2005, PROP ID ENV TOB SMOK; Chen M, 1997, 1996 NATL PREVALENCE; Chinese Centers for Disease Control and Prevention, 2012, 2011 CHIN TOB CONTR; Crouch T, 1987, ENVIRON SCI TECHNOL, V21, P415; Cui X, 2009, J CARDIOVASCULAR PUL, V28, P50; El-Hougeiri N, 2002, INDOOR BUILT ENVIRON, V11, P83; Gan Q, 2008, J OCCUP ENVIRON MED, V50, P570, DOI 10.1097/JOM.0b013e3181638640; Gan Q, 2007, TOB CONTROL, V16, P417, DOI 10.1136/tc.2007.021477; Hammond SK, 1999, ENVIRON HEALTH PERSP, V107, P329, DOI 10.2307/3434425; Hammond SK, 1999, ENV TOBACCO SMOKE EX, P973; Hedley AJ, 2006, TOXICOL SCI, V90, P539, DOI 10.1093/toxsci/kfj110; Jamrozik K, 2005, BRIT MED J, V330, P812, DOI 10.1136/bmj.38370.496632.8F; Klepeis N., 1996, ANAL NATL HUMAN ACTI; Lee J, 2010, INT J HYG ENVIR HEAL, V213, P348, DOI 10.1016/j.ijheh.2010.05.007; Li Q, 2011, NEW ENGL J MED, V364, P2469, DOI 10.1056/NEJMc1102459; Liu H, 2011, PREVENTIVE MED TRIBU, V17, P210; Liu R, 2013, INT J HYGIE IN PRESS; Liu R, 2013, ASSESSMENT RISK ASTH; Liu R, 2013, INT J HYG ENV HLTH; Liu RL, 2011, TOB CONTROL, V20, P397, DOI 10.1136/tc.2009.033233; Lopez MJ, 2006, MED CLIN-BARCELONA, V126, P13; Lv J, 2011, TOB CONTROL, V20, P309, DOI 10.1136/tc.2010.040352; Ma GuanSheng, 2005, Acta Nutrimenta Sinica, V27, P272; [康纪明 KANG Jiming], 2007, [中华流行病学杂志, Chinese Journal of Epidemiology], V28, P738; National Bureau of Statistics Ministry of Labour and Social Security of China, 2005, CHIN LAB STAT YB 200; National Bureau of Statistics of China, 2009, B 3 NAT EC CENS KEY; National Bureau of Statistics of China, 2008, TIM ACT PATT CHIN PE; National Bureau of Statistics of China, 2005, B 1 NAT EC CENS KEY, V3; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; REPACE JL, 1985, ENVIRON INT, V11, P3, DOI 10.1016/0160-4120(85)90098-4; REPACE JL, 1985, NEW YORK STATE J MED, V85, P381; Siegel M, 2003, TOB CONTROL, V12, P333, DOI 10.1136/tc.12.3.333; Steenland K, 1999, ENVIRON HEALTH PERSP, V107, P859, DOI 10.2307/3434566; Stillman F, 2007, TOB CONTROL, V16, P229, DOI 10.1136/tc.2006.018333; Sugimura H, 2006, CHEST, V129, P1088, DOI 10.1378/chest.129.4.1088; USDHHS, 2006, HLTH CONS INV EXP TO; Weng X, 1986, J CARDIOVASCULAR PUL, V02, P44; Xiao L, 2010, BIOMED ENVIRON SCI, V23, P430, DOI 10.1016/S0895-3988(11)60003-2; Yang G, 2010, TOBACCO CONTROL FUTU; Yang GH, 1999, JAMA-J AM MED ASSOC, V282, P1247, DOI 10.1001/jama.282.13.1247; [杨功焕 Yang Gonghuan], 2005, [中华流行病学杂志, Chinese Journal of Epidemiology], V26, P77; Yang Y, 2008, CHINESE J HLTH ED, V24, p[657, 660]; Zheng PP, 2009, HEALTH POLICY, V89, P216, DOI 10.1016/j.healthpol.2008.06.002	46	8	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84811	10.1371/journal.pone.0084811	http://dx.doi.org/10.1371/journal.pone.0084811			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416289	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500171
J	Tian, YM; Huang, ZF; Wang, ZX; Yin, CX; Zhou, LL; Zhang, LX; Huang, KK; Zhou, HS; Jiang, XJ; Li, JM; Liao, LB; Yang, M; Meng, FY				Tian, Yiming; Huang, Zoufang; Wang, Zhixiang; Yin, Changxin; Zhou, Lanlan; Zhang, Lingxiu; Huang, Kaikai; Zhou, Hongsheng; Jiang, Xuejie; Li, Jinming; Liao, Libin; Yang, Mo; Meng, Fanyi			Identification of Novel Molecular Markers for Prognosis Estimation of Acute Myeloid Leukemia: Over-Expression of PDCD7, FIS1 and Ang2 May Indicate Poor Prognosis in Pretreatment Patients with Acute Myeloid Leukemia	PLOS ONE			English	Article							MITOCHONDRIAL DYNAMICS; GROWTH-FACTORS; ANGIOPOIETIN-2; CELLS; RECOMMENDATIONS; ANGIOGENESIS; DIAGNOSIS; OUTCOMES; FISSION; PROTEIN	Numerous factors impact on the prognosis of acute myeloid leukemia (AML), among which molecular genetic abnormalities are developed increasingly, however, accurate prediction for newly diagnosed AML patients remains unsatisfied. For further improving the prognosis evaluation system, we investigated the transcripts levels of PDCD7, FIS1, FAM3A, CA6, APP, KLRF1, ATCAY, GGT5 and Ang2 in 97 AML patients and 30 non-malignant controls, and validated using the published microarray data from 225 cytogenetically normal AML (CN-AML) patients treated according to the German AMLCG-1999 protocol. Real-time quantitative polymerase chain reaction and western blot were carried out, and clinical data were collected and analyzed. High Ang2 and FIS1 expression discriminated the CR rate of AML patients (62.5% versus 82.9% for Ang2, P = 0.011; 61.4% versus 82.2% for FIS1, P = 0.029). In CN-AML, patients with high FIS1 expression were more likely to be resistant to two courses of induction (P = 0.035). Overall survival (OS) and relapse-free survival (RFS) were shorter in CN-AML patients with high PDCD7 expression (P, < 000.01; P = 0.006), and PDCD7 was revealed to be an independent risk factor for OS in CN-AML (P = 0.004). In the analysis of published data from 225 CN-AML patients, PDCD7 remained independently predicting OS in CN-AML (P = 0.039). As a conclusion, Ang2 and FIS1 seem related to decreased CR rate of AML patients, and PDCD7 is associated with shorter OS and RFS in CN-AML. Hence, PDCD7, Ang2 and FIS1 may indicate a more aggressive form and poor prognosis of AML.	[Tian, Yiming; Huang, Zoufang; Wang, Zhixiang; Yin, Changxin; Zhou, Lanlan; Zhang, Lingxiu; Huang, Kaikai; Zhou, Hongsheng; Jiang, Xuejie; Liao, Libin; Yang, Mo; Meng, Fanyi] Southern Med Univ, Nanfang Hosp, Dept Hematol, Guangzhou, Guangdong, Peoples R China; [Li, Jinming] Southern Med Univ, Bioinformat Dept, Guangzhou, Guangdong, Peoples R China; [Yang, Mo] Univ Hong Kong, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China	Southern Medical University - China; Southern Medical University - China; University of Hong Kong	Meng, FY (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Hematol, Guangzhou, Guangdong, Peoples R China.	mengfu@medmail.com.cn			National Science Foundation of Guangdong Province, China [S20110100003807]	National Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province)	This work is supported by grants from the National Science Foundation of Guangdong Province, China ( S20110100003807), the funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benecke H, 2005, EMBO J, V24, P3057, DOI 10.1038/sj.emboj.7600765; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; Damm F, 2011, BLOOD, V117, P4561, DOI 10.1182/blood-2010-08-303479; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Estey E, 1996, LEUKEMIA, V10, P932; Hou HA, 2008, LEUKEMIA RES, V32, P904, DOI 10.1016/j.leukres.2007.08.010; Huang HH, 2010, IMMUNOL INVEST, V39, P587, DOI 10.3109/08820131003720702; Iwasawa R, 2011, EMBO J, V30, P556, DOI 10.1038/emboj.2010.346; Jaffe ES, 2001, WHO CLASSIFICATION T; Jiang XJ, 2012, CANCER LETT, V326, P135, DOI 10.1016/j.canlet.2012.07.030; Juliusson G, 2009, BLOOD, V113, P4179, DOI 10.1182/blood-2008-07-172007; Kaddour-Djebbar I, 2010, INT J ONCOL, V36, P1437, DOI 10.3892/ijo_00000629; Kuttruff S, 2009, BLOOD, V113, P358, DOI [10.1182/blood-2008-04-145615, 10.1182/blood-2008-03-145615]; Lin PN, 1997, J CLIN INVEST, V100, P2072, DOI 10.1172/JCI119740; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lobov IB, 2002, P NATL ACAD SCI USA, V99, P11205, DOI 10.1073/pnas.172161899; Loges S, 2005, J CLIN ONCOL, V23, P1109, DOI 10.1200/JCO.2005.05.058; Mai S, 2010, J CELL SCI, V123, P917, DOI 10.1242/jcs.059246; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Manczak M, 2010, J ALZHEIMERS DIS JAD, P20; O'Donnell MR, 2011, NATL COMPREHENSIVE C; O'Donnell MR, 2005, NATL COMPREHENSIVE C; Park EJ, 1999, NUCLEIC ACIDS RES, V27, P1524, DOI 10.1093/nar/27.6.1524; Rakovic A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016746; Reddy PH, 2011, BRAIN RES REV, V67, P103, DOI 10.1016/j.brainresrev.2010.11.004; Rizzuto R, 2009, BBA-BIOENERGETICS, V1787, P1342, DOI 10.1016/j.bbabio.2009.03.015; Sastre-Serra J, 2012, INT J BIOCHEM CELL B, V44, P1901, DOI 10.1016/j.biocel.2012.07.012; Schliemann C, 2007, LEUKEMIA, V21, P1901, DOI 10.1038/sj.leu.2404820; Schliemann C, 2006, HAEMATOLOGICA, V91, P1203; Shirendeb U, 2011, HUM MOL GENET, V20, P1438, DOI 10.1093/hmg/ddr024; Tang J, 2006, GUO JI SHU XUE JI XU, V29, P297; Tang Jia-ming, 2005, Zhonghua Xue Ye Xue Za Zhi, V26, P653; Turunen JJ, 2008, MOL CELL BIOL, V28, P3548, DOI 10.1128/MCB.01928-07; Visconti RP, 2002, P NATL ACAD SCI USA, V99, P8219, DOI 10.1073/pnas.122109599; Vitale M, 2001, EUR J IMMUNOL, V31, P233, DOI 10.1002/1521-4141(200101)31:1<233::AID-IMMU233>3.3.CO;2-W; Wang B, 2008, CELL, V133, P1080, DOI 10.1016/j.cell.2008.04.042; Wang W, 2009, NAN FANG YI KE DA XU, V29, P2259; Will CL, 2004, RNA, V10, P929, DOI 10.1261/rna.7320604	38	22	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84150	10.1371/journal.pone.0084150	http://dx.doi.org/10.1371/journal.pone.0084150			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416201	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500102
J	Tondeleir, D; Noelanders, R; Bakkali, K; Ampe, C				Tondeleir, Davina; Noelanders, Rivka; Bakkali, Karima; Ampe, Christophe			Beta-Actin Is Required for Proper Mouse Neural Crest Ontogeny	PLOS ONE			English	Article							CELL-CELL ADHESION; MESSENGER-RNA LOCALIZATION; N-CADHERIN; IN-VIVO; MESENCHYMAL PHENOTYPE; XENOPUS CADHERIN-11; EXPRESSION PATTERN; MIGRATION; APOPTOSIS; MOTILITY	The mouse genome consists of six functional actin genes of which the expression patterns are temporally and spatially regulated during development and in the adult organism. Deletion of beta-actin in mouse is lethal during embryonic development, although there is compensatory expression of other actin isoforms. This suggests different isoform specific functions and, more in particular, an important function for beta-actin during early mammalian development. We here report a role for beta-actin during neural crest ontogeny. Although beta-actin null neural crest cells show expression of neural crest markers, less cells delaminate and their migration arrests shortly after. These phenotypes were associated with elevated apoptosis levels in neural crest cells, whereas proliferation levels were unchanged. Specifically the pre-migratory neural crest cells displayed higher levels of apoptosis, suggesting increased apoptosis in the neural tube accounts for the decreased amount of migrating neural crest cells seen in the beta-actin null embryos. These cells additionally displayed a lack of membrane bound N-cadherin and dramatic decrease in cadherin-11 expression which was more pronounced in the pre-migratory neural crest population, potentially indicating linkage between the cadherin-11 expression and apoptosis. By inhibiting ROCK ex vivo, the knockout neural crest cells regained migratory capacity and cadherin-11 expression was upregulated. We conclude that the presence of beta-actin is vital for survival, specifically of pre-migratory neural crest cells, their proper emigration from the neural tube and their subsequent migration. Furthermore, the absence of beta-actin affects cadherin-11 and N-cadherin function, which could partly be alleviated by ROCK inhibition, situating the Rho-ROCK signaling in a feedback loop with cadherin-11.	[Tondeleir, Davina; Noelanders, Rivka; Bakkali, Karima; Ampe, Christophe] Univ Ghent, Dept Biochem, Fac Med & Hlth Sci, B-9000 Ghent, Belgium	Ghent University	Ampe, C (corresponding author), Univ Ghent, Dept Biochem, Fac Med & Hlth Sci, B-9000 Ghent, Belgium.	christophe.ampe@ugent.be		Christophe, Ampe/0000-0002-8554-3594	Queen Elisabeth Medical Foundation for neuroscience (QEMF, Belgium); Fund for Scientific Research Flanders (FWO, Belgium); CA [G.0441.10N]	Queen Elisabeth Medical Foundation for neuroscience (QEMF, Belgium); Fund for Scientific Research Flanders (FWO, Belgium)(FWO); CA	This work was supported by the Queen Elisabeth Medical Foundation for neuroscience (QEMF, Belgium) and by the Fund for Scientific Research Flanders (FWO, Belgium). DT is a pre doctoral fellow of this Fund and CA received a research grant G.0441.10N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2002, MOL BIOL CELL, Vxxxiv, P1548; Baranwal S, 2012, MOL BIOL CELL, V23, P3542, DOI 10.1091/mbc.E12-02-0162; Bergeron KF, 2013, CLIN GENET, V83, P15, DOI 10.1111/cge.12032; Berndt JD, 2008, DEV BIOL, V324, P236, DOI 10.1016/j.ydbio.2008.09.013; BOBER E, 1994, DEVELOPMENT, V120, P603; Bononi J, 2008, MECH DEVELOP, V125, P1033, DOI 10.1016/j.mod.2008.07.007; Borchers A, 2001, DEVELOPMENT, V128, P3049; Bunnell TM, 2011, MOL BIOL CELL, V22, P4047, DOI 10.1091/mbc.E11-06-0582; Chalpe AJ, 2010, CELL ADHES MIGR, V4, P431, DOI 10.4161/cam.4.3.12138; Cheever TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032970; Cheever TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017768; Clay MR, 2011, CURR OPIN NEUROBIOL, V21, P17, DOI 10.1016/j.conb.2010.09.013; Conway SJ, 1997, DEVELOPMENT, V124, P505; Dupin E, 2006, ADV EXP MED BIOL, P58996; Espada J, 2009, J CELL PHYSIOL, V219, P84, DOI 10.1002/jcp.21652; Gartner A, 2012, EMBO J, V31, P1893, DOI 10.1038/emboj.2012.41; Gammill LS, 2010, DEV BIOL, V344, P555, DOI 10.1016/j.ydbio.2010.04.009; Groysman M, 2008, NEURAL DEV, V327; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Haldin CE, 2010, INT J BIOCHEM CELL B, V42, P441, DOI 10.1016/j.biocel.2009.11.014; HATTA K, 1987, DEV BIOL, V120, P215, DOI 10.1016/0012-1606(87)90119-9; Hofer D, 1997, J CELL SCI, V110, P765; HOFFMANN I, 1995, DEV BIOL, V169, P337, DOI 10.1006/dbio.1995.1148; Hong E, 2006, DEVELOPMENT, V133, P3895, DOI 10.1242/dev.02560; Huang CF, 2010, CANCER RES, V70, P4580, DOI 10.1158/0008-5472.CAN-09-3016; Huang GY, 1998, J CELL BIOL, V143, P1725, DOI 10.1083/jcb.143.6.1725; Jiang M, 2011, CURR TOP DEV BIOL, P9477; Kalcheim C, 1999, NEURAL CREST, Vxxiii; Kashef J, 2009, GENE DEV, V23, P1393, DOI 10.1101/gad.519409; Kaur H, 2012, MOL CANCER RES, V10, P293, DOI 10.1158/1541-7786.MCR-11-0457; Kiener HP, 2009, ARTHRITIS RHEUM-US, V60, P1305, DOI 10.1002/art.24453; Kiener HP, 2006, MOL BIOL CELL, V17, P2366, DOI 10.1091/mbc.E05-08-0745; KIMURA Y, 1995, DEV BIOL, V169, P347, DOI 10.1006/dbio.1995.1149; KISLAUSKIS EH, 1994, J CELL BIOL, V127, P441, DOI 10.1083/jcb.127.2.441; Li Yong, 2011, Genes Cancer, V2, P880, DOI 10.1177/1947601911433129; Liu JP, 1998, DEVELOPMENT, V125, P5055; Makrigiannakis A, 1999, AM J PATHOL, V154, P1391, DOI 10.1016/S0002-9440(10)65393-X; Mayanil CS, 2013, DEV NEUROSCI; Mayor R, 2013, DEVELOPMENT, V140, P2247, DOI 10.1242/dev.091751; MCHUGH KM, 1991, DEV BIOL, V148, P442, DOI 10.1016/0012-1606(91)90263-3; McKeown SJ, 2013, DEV BIOL, V373, P244, DOI 10.1016/j.ydbio.2012.10.028; Micholt L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066170; Miyoshi T, 2006, DEV DYNAM, V235, P1941, DOI 10.1002/dvdy.20799; Monahan TS, 2007, J VASC SURG, V45, P581, DOI 10.1016/j.jvs.2006.12.016; MURPHY M, 1991, P NATL ACAD SCI USA, V88, P3498, DOI 10.1073/pnas.88.8.3498; Nagy A, 2003, MANIPULATING MOUSE E, VIX; NAKAGAWA S, 1995, DEVELOPMENT, V121, P1321; Nakagawa S, 1998, DEVELOPMENT, V125, P2963; Oda H, 1998, DEV BIOL, V203, P435, DOI 10.1006/dbio.1998.9047; Peckham M, 2001, J CELL SCI, V114, P1367; Phillips HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037685; Pla P, 2001, J CELL PHYSIOL, V189, P121, DOI 10.1002/jcp.10008; Pollard TD, 2001, NATURE, V409, P842, DOI 10.1038/35057029; Pollarolo G, 2011, NAT NEUROSCI, V14, P1525, DOI 10.1038/nn.2976; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Roskams AJI, 1998, NEUROSCIENCE, V83, P191, DOI 10.1016/S0306-4522(97)00344-8; RUBERTE E, 1991, DEVELOPMENT, V111, P45; Sato T, 2005, DEVELOPMENT, V132, P2355, DOI 10.1242/dev.01823; Schulte JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070962; Schulz A, 2004, ANN NEUROL, V56, P342, DOI 10.1002/ana.20187; Schwabe T, 2013, CELL, V154, P351, DOI 10.1016/j.cell.2013.06.011; Shestakova EA, 2001, P NATL ACAD SCI USA, V98, P7045, DOI 10.1073/pnas.121146098; Shmerling D, 2005, GENESIS, V42, P229, DOI 10.1002/gene.20135; SIMONNEAU L, 1995, CELL ADHES COMMUN, V3, P115, DOI 10.3109/15419069509081281; Southard-Smith EM, 1998, NAT GENET, V18, P60, DOI 10.1038/ng0198-60; Tamura D, 2008, INT J ONCOL, V33, P17; Taneyhill LA, 2013, PROG MOL BIOL TRANSL; Taneyhill LA, 2008, CELL ADHES MIGR, V2, P223, DOI 10.4161/cam.2.4.6835; Theveneau E, 2012, DEV BIOL, V366, P34, DOI 10.1016/j.ydbio.2011.12.041; Theveneau E, 2010, DEV CELL, V19, P39, DOI 10.1016/j.devcel.2010.06.012; Tondeleir D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067855; Tondeleir D, 2012, MOL CELL PROTEOMICS, V11, P255, DOI 10.1074/mcp.M111.015099; Tondeleir D, 2009, CELL MOTIL CYTOSKEL, V66, P798, DOI 10.1002/cm.20350; Trainor PA, 2010, AM J MED GENET A, V152A, P2984, DOI 10.1002/ajmg.a.33454; Vallin J, 1998, MECH DEVELOP, V75, P171, DOI 10.1016/S0925-4773(98)00099-9; Vallorosi CJ, 2000, J BIOL CHEM, V275, P3328, DOI 10.1074/jbc.275.5.3328; VANDEKERCKHOVE J, 1978, J MOL BIOL, V126, P783, DOI 10.1016/0022-2836(78)90020-7; Wheelock MJ, 2003, ANNU REV CELL DEV BI, P19207; Yao JQ, 2006, NAT NEUROSCI, V9, P1265, DOI 10.1038/nn1773	79	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e85608	10.1371/journal.pone.0085608	http://dx.doi.org/10.1371/journal.pone.0085608			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409333	gold, Green Published, Green Submitted			2022-12-27	WOS:000329463500057
J	Letheulle, J; Tattevin, P; Saunders, L; Kerjouan, M; Lena, H; Desrues, B; Le Tulzo, Y; Jouneau, S				Letheulle, Julien; Tattevin, Pierre; Saunders, Lauren; Kerjouan, Mallorie; Lena, Herve; Desrues, Benoit; Le Tulzo, Yves; Jouneau, Stephane			Iterative Thoracentesis as First-Line Treatment of Complicated Parapneumonic Effusion	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; PERCUTANEOUS CATHETER DRAINAGE; PLEURAL FLUID COLLECTIONS; THORACIC EMPYEMA; 10-YEAR EXPERIENCE; BACTERIAL EMPYEMA; MANAGEMENT; INFECTION; GUIDELINE; MORTALITY	Rationale: Optimal management of complicated parapneumonic effusions (CPPE) remains controversial. Objectives: to assess safety and efficacy of iterative therapeutic thoracentesis (ITTC), the first-line treatment of CPPE in Rennes University Hospital. Methods: Patients with CPPE were identified through our computerized database. We retrospectively studied all cases of CPPE initially managed with ITTC in our institution between 2001 and 2010. ITTC failure was defined by the need for additional treatment (i.e. surgery or percutaneous drainage), or death. Results: Seventy-nine consecutive patients were included. The success rate was 81% (n = 64). Only 3 patients (4%) were referred to thoracic surgery. The one-year survival rate was 88%. On multivariate analysis, microorganisms observed in pleural fluid after Gram staining and first thoracentesis volume >= 450 mL were associated with ITTC failure with adjusted odds-ratios of 7.65 [95% CI, 1.44-40.67] and 6.97 [95% CI, 1.86-26.07], respectively. The main complications of ITTC were iatrogenic pneumothorax (n = 5, 6%) and vasovagal reactions (n = 3, 4%). None of the pneumothoraces required chest tube drainage, and no hemothorax or re-expansion pulmonary edema was observed. Conclusions: Although not indicated in international recommendations, ITTC is safe and effective as first-line treatment of CPPE, with limited invasiveness.	[Letheulle, Julien; Kerjouan, Mallorie; Lena, Herve; Desrues, Benoit; Jouneau, Stephane] Univ Rennes 1, Pontchaillou Hosp, Dept Resp Med, Rennes, France; [Letheulle, Julien; Tattevin, Pierre; Le Tulzo, Yves] Univ Rennes 1, Pontchaillou Hosp, Infect Dis & Intens Care Unit, Rennes, France; [Tattevin, Pierre] Univ Rennes 1, INSERM, U835, Rennes, France; [Saunders, Lauren] Univ Rennes 1, Pontchaillou Hosp, Dept Med Informat, Rennes, France; [Le Tulzo, Yves] Univ Rennes 1, CIC INSERM 0203, Rennes, France; [Jouneau, Stephane] Univ Rennes 1, IRSET U1085, Rennes, France	CHU Rennes; Universite de Rennes; CHU Rennes; Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; CHU Rennes; Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Universite de Rennes	Jouneau, S (corresponding author), Univ Rennes 1, Pontchaillou Hosp, Dept Resp Med, Rennes, France.	Stephane.jouneau@chu-rennes.fr	Jouneau, Stephane/K-9956-2015	Desrues, Benoit/0000-0002-1748-1694				Ahmed RA, 2006, AM J MED, V119, P877, DOI 10.1016/j.amjmed.2006.03.042; ALFAGEME I, 1993, CHEST, V103, P839, DOI 10.1378/chest.103.3.839; BARTTER T, 1993, CHEST, V103, P1873, DOI 10.1378/chest.103.6.1873; BENFIELD GFA, 1981, BRIT J DIS CHEST, V75, P358, DOI 10.1016/0007-0971(81)90023-1; CHAM CW, 1993, THORAX, V48, P925, DOI 10.1136/thx.48.9.925; Chapman SJ, 2004, CURR OPIN PULM MED, V10, P299, DOI 10.1097/01.mcp.0000129755.79467.67; Chen KY, 2000, CHEST, V117, P1685, DOI 10.1378/chest.117.6.1685; Colicc GL, 2000, CHEST, V118, P1158, DOI 10.1378/chest.118.4.1158; COLLINS TR, 1987, CHEST, V91, P817, DOI 10.1378/chest.91.6.817; Colt HG, 1999, CHEST, V116, P134, DOI 10.1378/chest.116.1.134; CROUCH JD, 1987, AM REV RESPIR DIS, V136, P174, DOI 10.1164/ajrccm/136.1.174; Davies CWH, 1999, AM J RESP CRIT CARE, V160, P1682, DOI 10.1164/ajrccm.160.5.9903002; Davies HE, 2010, THORAX, V65, P41, DOI 10.1136/thx.2010.137000; Ferguson AD, 1996, QJM-MON J ASSOC PHYS, V89, P285; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; GROGAN DR, 1990, ARCH INTERN MED, V150, P873, DOI 10.1001/archinte.150.4.873; Hasley PB, 1996, ARCH INTERN MED, V156, P2206, DOI 10.1001/archinte.156.19.2206; Huang HC, 1999, CHEST, V115, P751, DOI 10.1378/chest.115.3.751; HUNNAM GR, 1988, CLIN RADIOL, V39, P121; Jones PW, 2003, CHEST, V123, P418, DOI 10.1378/chest.123.2.418; Keeling AN, 2008, CARDIOVASC INTER RAD, V31, P135, DOI 10.1007/s00270-007-9197-0; Koegelenberg CFN, 2008, RESPIRATION, V75, P241, DOI 10.1159/000117172; Lawrence DR, 1997, ANN THORAC SURG, V64, P1448, DOI 10.1016/S0003-4975(97)00917-X; LEMMER JH, 1985, J THORAC CARDIOV SUR, V90, P849; LIGHT RW, 1980, AM J MED, V69, P507, DOI 10.1016/0002-9343(80)90460-X; Luh SP, 2005, CHEST, V127, P1427, DOI 10.1378/chest.127.4.1427; MANDAL AK, 1987, J THORAC CARDIOV SUR, V94, P414; Maskell NA, 2005, NEW ENGL J MED, V352, P865, DOI 10.1056/NEJMoa042473; Maskell NA, 2006, AM J RESP CRIT CARE, V174, P817, DOI 10.1164/rccm.200601-074OC; MERRIAM MA, 1988, AM J ROENTGENOL, V151, P1113, DOI 10.2214/ajr.151.6.1113; MOULTON JS, 1995, CHEST, V108, P1252, DOI 10.1378/chest.108.5.1252; Rahman NM, 2011, NEW ENGL J MED, V365, P518, DOI 10.1056/NEJMoa1012740; Riquet M, 2003, PNEUMOLOGIE; Sahn SA, 2007, CLIN INFECT DIS, V45, P1480, DOI 10.1086/522996; SENEFF MG, 1986, CHEST, V90, P97, DOI 10.1378/chest.90.1.97; Shankar S, 2000, EUR RADIOL, V10, P495, DOI 10.1007/s003300050083; SILVERMAN SG, 1988, RADIOLOGY, V169, P5, DOI 10.1148/radiology.169.1.3047789; Simmers TA, 1999, THORAC CARDIOV SURG, V47, P77, DOI 10.1055/s-2007-1013115; STORM HKR, 1992, THORAX, V47, P821, DOI 10.1136/thx.47.10.821; ULMER JL, 1991, J THORAC IMAG, V6, P65, DOI 10.1097/00005382-199109000-00014; VIANNA NJ, 1971, J AMER MED ASSOC, V215, P69, DOI 10.1001/jama.215.1.69; Wait MA, 1997, CHEST, V111, P1548, DOI 10.1378/chest.111.6.1548; WEHR CJ, 1986, SOUTH MED J, V79, P171, DOI 10.1097/00007611-198602000-00009	43	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84788	10.1371/journal.pone.0084788	http://dx.doi.org/10.1371/journal.pone.0084788			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400113	Green Published, Green Submitted, gold			2022-12-27	WOS:000329462700047
J	Rotem, S; Cohen, O; Bar-Haim, E; Bar-On, L; Ehrlich, S; Shafferman, A				Rotem, Shahar; Cohen, Ofer; Bar-Haim, Erez; Bar-On, Liat; Ehrlich, Sharon; Shafferman, Avigdor			Protective Immunity against Lethal F. tularensis holarctica LVS Provided by Vaccination with Selected Novel CD8(+) T Cell Epitopes	PLOS ONE			English	Article							FRANCISELLA-TULARENSIS; TULAREMIA VACCINES; CONFERS PROTECTION; INFECTION; STRAIN; LIVE; PATHOGEN; CD4(+); GROWTH; MACROPHAGES	Recently we described an unbiased bacterial whole-genome immunoinformatic analysis aimed at selection of potential CTL epitopes located in "hotspots" of predicted MHC-I binders. Applying this approach to the proteome of the facultative intracellular pathogen Francisella tularensis resulted in identification of 170 novel CTL epitopes, several of which were shown to elicit highly robust T cell responses. Here we demonstrate that by DNA immunization using a short DNA fragment expressing six of the most prominent identified CTL epitopes a potent and specific CD8+ T cell responses is being induced, to all encoded epitopes, a response not observed in control mice immunized with the DNA vector alone Moreover, this CTL-specific mediated immune response prevented disease development, allowed for a rapid clearance of the bacterial infection and provided complete protection against lethal challenge (10LD(50)) with F. tularensis holarctica Live Vaccine Strain (LVS) (a total to 30 of 30 immunized mice survived the challenge while all control DNA vector immunized mice succumbed). Furthermore, and in accordance with these results, CD8 deficient mice could not be protected from lethal challenge after immunization with the CTL-polyepitope. Vaccination with the DNA poly-epitope construct could even protect mice (8/10) against the more demanding pulmonary lethal challenge of LVS. Our approach provides a proof-of-principle for selecting and generating a multi-epitpoe CD8 T cell-stimulating vaccine against a model intracellular bacterium.	[Rotem, Shahar; Cohen, Ofer; Bar-Haim, Erez; Bar-On, Liat; Ehrlich, Sharon; Shafferman, Avigdor] Israel Inst Biol Res, Dept Biochem & Mol Genet, IL-70450 Ness Ziona, Israel		Shafferman, A (corresponding author), Israel Inst Biol Res, Dept Biochem & Mol Genet, IL-70450 Ness Ziona, Israel.	avigdors@iibr.gov.il	Bar-Haim, Erez/AAA-6444-2020	Bar-Haim, Erez/0000-0003-3435-8599	Israel Institute for Biological Research [SB/5110-137]	Israel Institute for Biological Research	Israel Institute for Biological Research funds, grant number SB/5110-137. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTHONY LSD, 1991, INFECT IMMUN, V59, P3291, DOI 10.1128/IAI.59.9.3291-3296.1991; Bakshi CS, 2008, VACCINE, V26, P5276, DOI 10.1016/j.vaccine.2008.07.051; Bar-Haim E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000211; Barry EM, 2009, HUM VACCINES, V5, P832, DOI 10.4161/hv.10297; Bolger CE, 2005, J LEUKOCYTE BIOL, V77, P893, DOI 10.1189/jlb.1104637; Chen WX, 2003, VACCINE, V21, P3690, DOI 10.1016/S0264-410X(03)00386-4; Conlan JW, 2011, FUTURE MICROBIOL, V6, P391, DOI [10.2217/FMB.11.22, 10.2217/fmb.11.22]; Conlan JW, 2005, VACCINE, V23, P2477, DOI 10.1016/j.vaccine.2004.10.034; CONLAN JW, 1994, INFECT IMMUN, V62, P5603, DOI 10.1128/IAI.62.12.5603-5607.1994; Conlan W, 2010, CHALLENGE OF HIGHLY PATHOGENIC MICROORGANISMS: MECHANISMS OF VIRULENCE AND NOVEL MEDICAL COUNTERMEASURES, P213, DOI 10.1007/978-90-481-9054-6_23; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; EIGELSBACH H, 1961, J IMMUNOL, V87, P415; Elkins KL, 1996, INFECT IMMUN, V64, P3288, DOI 10.1128/IAI.64.8.3288-3293.1996; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; FORTIER AH, 1995, INFECT IMMUN, V63, P1478, DOI 10.1128/IAI.63.4.1478-1483.1995; FORTIER AH, 1991, INFECT IMMUN, V59, P2922, DOI 10.1128/IAI.59.9.2922-2928.1991; Gregory SH, 2009, VACCINE, V27, P5299, DOI 10.1016/j.vaccine.2009.06.101; Griffin KF, 2007, FEMS IMMUNOL MED MIC, V49, P315, DOI 10.1111/j.1574-695X.2007.00219.x; Grosfeld H, 2003, INFECT IMMUN, V71, P374, DOI 10.1128/IAI.71.1.374-383.2003; HARTY JT, 1992, J EXP MED, V175, P1531, DOI 10.1084/jem.175.6.1531; Lin JS, 2011, J IMMUNOL, V187, P897, DOI 10.4049/jimmunol.1100174; LIPFORD GB, 1994, IMMUNOL LETT, V40, P101, DOI 10.1016/0165-2478(94)90179-1; Mann BJ, 2009, EXPERT REV VACCINES, V8, P877, DOI [10.1586/erv.09.51, 10.1586/ERV.09.51]; McLendon MK, 2006, ANNU REV MICROBIOL, V60, P167, DOI 10.1146/annurev.micro.60.080805.142126; McMurry Julie A, 2007, Med Health R I, V90, P311; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Oyston PCF, 2009, VACCINE, V27, pD48, DOI 10.1016/j.vaccine.2009.07.090; Ozawa Y, 2009, AM J RESP CELL MOL, V41, P440, DOI 10.1165/rcmb.2008-0446OC; PAMER EG, 1991, NATURE, V353, P852, DOI 10.1038/353852a0; Pinchuk I, 2005, J IMMUNOL, V174, P5729, DOI 10.4049/jimmunol.174.9.5729; Rotem S, 2012, ANTIMICROB AGENTS CH, V56, P5406, DOI 10.1128/AAC.01104-12; Teixeira FM, 2006, CLIN VACCINE IMMUNOL, V13, P930, DOI 10.1128/CVI.00151-06; TIGERTT WD, 1962, BACTERIOL REV, V26, P354, DOI 10.1128/MMBR.26.3.354-373.1962; Titball RW, 2008, DRUG DISCOV TODAY, V13, P596, DOI 10.1016/j.drudis.2008.04.010; Versage JL, 2003, J CLIN MICROBIOL, V41, P5492, DOI 10.1128/JCM.41.12.5492-5499.2003; Wizel B, 2002, J IMMUNOL, V169, P2524, DOI 10.4049/jimmunol.169.5.2524; Wu TH, 2005, INFECT IMMUN, V73, P2644, DOI 10.1128/IAI.73.5.2644-2654.2005; Yee D, 1996, J IMMUNOL, V157, P5042; Yoshida A, 2001, VACCINE, V19, P4297, DOI 10.1016/S0264-410X(01)00146-3; Zhang Y, 2012, INFECT IMMUN, V80, P206, DOI 10.1128/IAI.05971-11; Zvi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036440; Zvi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020050	42	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e85215	10.1371/journal.pone.0085215	http://dx.doi.org/10.1371/journal.pone.0085215			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400128	Green Published, Green Submitted, gold			2022-12-27	WOS:000329462700062
J	Bendavid, E				Bendavid, Eran			Is Health Aid Reaching the Poor? Analysis of Household Data from Aid Recipient Countries	PLOS ONE			English	Article							DEVELOPMENT ASSISTANCE; SOCIOECONOMIC-STATUS; GLOBAL HEALTH; TUBERCULOSIS; MORTALITY; BURDEN; FUND	Objective: To determine the extent to which the narrowing of child mortality across wealth gradients has been related to foreign aid to the health sector in low-and middle-income countries. Methods: Mortality and wealth data on 989,901 under-5 children from 957,674 households in 49 aid recipient countries in Africa, Asia, South America, and the Caribbean between 1993 and 2012 were used in the analysis. Declines in under-5 mortality in the four poorest wealth quantiles were compared to the decline among the wealthiest at varying levels of health aid per capita using fixed effects multivariable regression models and controlling for maternal education, urbanization, and domestic spending on health among recipient countries. Results: Each additional dollar in total health aid per capita was associated with 5.7 fewer deaths per 10,000 child-years among children in the poorest relative to the wealthiest households (p<.001). This was also true when measured in percent declines (1.90% faster decline in under-5 mortality among the poorest compared with the wealthiest with each dollar in total health aid, p=0.008). The association was stronger when using health aid specifically for malaria than total health aid, 12.60% faster decline among the poorest compared with the wealthiest with each dollar in malaria aid, p=0.001. Conclusions: Foreign aid to the health sector is preferentially related to reductions in under-5 mortality among the poorest compared with the wealthiest. Health aid addressing malaria, which imposes a disproportionate burden among the poor, may explain the observed effect.	[Bendavid, Eran] Stanford Univ, Div Gen Med Disciplines, Stanford, CA 94305 USA; [Bendavid, Eran] Stanford Univ, Ctr Hlth Policy, Stanford, CA 94305 USA; [Bendavid, Eran] Stanford Univ, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Bendavid, E (corresponding author), Stanford Univ, Div Gen Med Disciplines, Stanford, CA 94305 USA.	ebd@stanford.edu			George Rosenkranz award	George Rosenkranz award	Financial support for this study was received from the George Rosenkranz award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akachi Y, 2012, J INFECT DIS, V205, pS284, DOI 10.1093/infdis/jis189; [Anonymous], 2008, DEMOGRAPHIC HLTH RES; [Anonymous], 2012, FIN GLOB HLTH 2012 E; Bendavid E, 2012, JAMA-J AM MED ASSOC, V307, P2060, DOI 10.1001/jama.2012.2001; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bradley DJ., 1991, DIS MORTALITY SUBSAH, P248; Cometto G, 2009, LANCET, V373, P1500, DOI 10.1016/S0140-6736(09)60835-7; Demombynes G, 2012, 6057 WORLD BANK; Easterly W, 2009, J ECON LIT, V47, P373, DOI 10.1257/jel.47.2.373; Farmer P.E, 2001, INFECT INEQUALITIES; Flaxman AD, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000328; Fortson JG, 2008, DEMOGRAPHY, V45, P303, DOI 10.1353/dem.0.0006; Garrett L, 2007, FOREIGN AFF, V86, P14; Glass RI, 2006, LANCET, V368, P323, DOI 10.1016/S0140-6736(06)68815-6; Grepin KA, 2012, HEALTH POLICY PLANN, V27, P527, DOI 10.1093/heapol/czr076; Gwatkin DR, 1999, LANCET, V354, P586, DOI 10.1016/S0140-6736(99)02108-X; Houweling Tanja AJ, 2003, Int J Equity Health, V2, P8, DOI 10.1186/1475-9276-2-8; Komatsu R, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-109; Korenromp EL, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-18; Lim SS, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001091; *MACR INT, 2009, IMP COLL EFF RED DIS; Mishra P, 2009, J HEALTH ECON, V28, P855, DOI 10.1016/j.jhealeco.2009.05.004; Mishra V, 2007, AIDS, V21, pS17, DOI 10.1097/01.aids.0000300532.51860.2a; MUDENDA D, 2009, LANCET, V373, P2137; Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3; Rutstein S.O., 2004, DHS WEALTH INDEX ORC; Sridhar D, 2008, LANCET, V372, P1185, DOI 10.1016/S0140-6736(08)61485-3; United Nations Development Program, 2003, HUM DEV REP 2003 MIL; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; *WORLD BANK, 1993, WORLD DEV REP 1993 I	30	9	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84025	10.1371/journal.pone.0084025	http://dx.doi.org/10.1371/journal.pone.0084025			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	286IH	24404148	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460800027
J	Hintzpeter, J; Stapelfeld, C; Loerz, C; Martin, HJ; Maser, E				Hintzpeter, Jan; Stapelfeld, Claudia; Loerz, Christine; Martin, Hans-Joerg; Maser, Edmund			Green Tea and One of Its Constituents, Epigallocatechine-3-gallate, Are Potent Inhibitors of Human 11 beta-hydroxysteroid Dehydrogenase Type 1	PLOS ONE			English	Article							METABOLIC SYNDROME; INSULIN-RESISTANCE; HYDROGEN-PEROXIDE; VISCERAL OBESITY; CELL-CULTURE; IN-VIVO; PREVENTION; MICE; REGULATOR; CHEMISTRY	The microsomal enzyme 11 beta-hydroxysteroid deydrogenase type 1 (11 beta-HSD1) catalyzes the interconversion of glucocorticoid receptor-inert cortisone to receptor-active cortisol, thereby acting as an intracellular switch for regulating the access of glucocorticoid hormones to the glucocorticoid receptor. There is strong evidence for an important aetiological role of 11 beta-HSD1 in various metabolic disorders including insulin resistance, diabetes type 2, hypertension, dyslipidemia and obesity. Hence, modulation of 11 beta-HSD1 activity with selective inhibitors is being pursued as a new therapeutic approach for the treatment of the metabolic syndrome. Since tea has been associated with health benefits for thousands of years, we sought to elucidate the active principle in tea with regard to diabetes type 2 prevention. Several teas and tea specific polyphenolic compounds were tested for their possible inhibition of cortisone reduction with human liver microsomes and purified human 11 beta-HSD1. Indeed we found that tea extracts inhibited 11 beta-HSD1 mediated cortisone reduction, where green tea exhibited the highest inhibitory potency with an IC50 value of 3.749 mg dried tea leaves per ml. Consequently, major polyphenolic compounds from green tea, in particular catechins were tested with the same systems. (2)Epigallocatechin gallate (EGCG) revealed the highest inhibition of 11 beta-HSD1 activity (reduction: IC50 = 57.99 mu M; oxidation: IC50 = 131.2 mu M). Detailed kinetic studies indicate a direct competition mode of EGCG, with substrate and/or cofactor binding. Inhibition constants of EGCG on cortisone reduction were Ki = 22.68 mu M for microsomes and Ki = 18.74 mu M for purified 11 beta-HSD1. In silicio docking studies support the view that EGCG binds directly to the active site of 11 beta-HSD1 by forming a hydrogen bond with Lys187 of the catalytic triade. Our study is the first to provide evidence that the health benefits of green tea and its polyphenolic compounds may be attributed to an inhibition of the cortisol producing enzyme 11 beta-HSD1.	[Hintzpeter, Jan; Stapelfeld, Claudia; Loerz, Christine; Martin, Hans-Joerg; Maser, Edmund] Univ Med Sch Schleswig Holstein, Inst Toxicol & Pharmacol Nat Scientists, Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital	Maser, E (corresponding author), Univ Med Sch Schleswig Holstein, Inst Toxicol & Pharmacol Nat Scientists, Campus Kiel, Kiel, Germany.	maser@toxi.uni-kiel.de	Maser, Edmund/B-1728-2010		German Federal Ministry of Education and Research [0315397A]; Deutsche Forschungsgemeinschaft [MA 1704/5-2]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Work on 11 beta-HSD1 in our laboratory is funded by the German Federal Ministry of Education and Research (0315397A) and the Deutsche Forschungsgemeinschaft (MA 1704/5-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balentine DA, 1997, CRIT REV FOOD SCI, V37, P693, DOI 10.1080/10408399709527797; Bhagwat S., 2011, USDA DATABASE FLAVON; Blum A, 2000, TOXICOLOGY, V144, P113, DOI 10.1016/S0300-483X(99)00197-3; Blum A, 2003, PROG NUCLEIC ACID RE, V75, P173, DOI 10.1016/S0079-6603(03)75006-5; Blum A, 2012, J STEROID BIOCHEM, V128, P51, DOI 10.1016/j.jsbmb.2011.09.003; Brown AL, 2009, BRIT J NUTR, V101, P886, DOI 10.1017/S0007114508047727; Cabrera C, 2006, J AM COLL NUTR, V25, P79, DOI 10.1080/07315724.2006.10719518; Chacko Sabu M, 2010, Chin Med, V5, P13, DOI 10.1186/1749-8546-5-13; Dringen R, 1998, BRAIN RES PROTOC, V2, P223, DOI 10.1016/S1385-299X(97)00047-0; Ge R, 2010, CURR MED CHEM, V17, P412, DOI 10.2174/092986710790226147; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Grove KA, 2010, J NUTR, V140, P446, DOI 10.3945/jn.109.115972; Halliwell B, 2008, ARCH BIOCHEM BIOPHYS, V476, P107, DOI 10.1016/j.abb.2008.01.028; Harbowy ME, 1997, CRIT REV PLANT SCI, V16, P415, DOI 10.1080/713608154; Hughes KA, 2012, DIABETES, V61, P1357, DOI 10.2337/db11-1345; Ihm SH, 2012, ATHEROSCLEROSIS, V224, P377, DOI 10.1016/j.atherosclerosis.2012.07.006; Ikeda I, 2008, ASIA PAC J CLIN NUTR, V17, P273; Kershaw EE, 2005, DIABETES, V54, P1023, DOI 10.2337/diabetes.54.4.1023; Kotelevtsev Y, 1997, P NATL ACAD SCI USA, V94, P14924, DOI 10.1073/pnas.94.26.14924; Leung L, 2009, BRIT J NUTR, V102, P1703, DOI 10.1017/S0007114509992054; Long LH, 2000, BIOCHEM BIOPH RES CO, V273, P50, DOI 10.1006/bbrc.2000.2895; Macfarlane, 2004, EMPIRE TEA; Maeda-Yamamoto M, 2013, CURR PHARM DES; Maser E, 2002, BIOCHEMISTRY-US, V41, P2459, DOI 10.1021/bi015803t; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Morton NM, 2008, FRONT HORM RES, V36, P146, DOI 10.1159/000115363; Morton NM, 2004, DIABETES, V53, P931, DOI 10.2337/diabetes.53.4.931; Morton NM, 2001, J BIOL CHEM, V276, P41293, DOI 10.1074/jbc.M103676200; Nakachi K, 2000, BIOFACTORS, V13, P49, DOI 10.1002/biof.5520130109; Paterson JM, 2004, P NATL ACAD SCI USA, V101, P7088, DOI 10.1073/pnas.0305524101; Sae-Tan S, 2011, PHARMACOL RES, V64, P146, DOI 10.1016/j.phrs.2010.12.013; Sang SM, 2011, PHARMACOL RES, V64, P87, DOI 10.1016/j.phrs.2011.02.007; SATO Y, 1989, TOHOKU J EXP MED, V157, P337, DOI 10.1620/tjem.157.337; Setiawan VW, 2001, INT J CANCER, V92, P600, DOI 10.1002/ijc.1231; Shen Yao, 2010, Comb Chem High Throughput Screen, V13, P885, DOI 10.2174/138620710793360239; Staab CA, 2010, J STEROID BIOCHEM, V119, P56, DOI 10.1016/j.jsbmb.2009.12.013; Sueoka N, 2001, ANN NY ACAD SCI, V928, P274; Suzuki Y, 2012, P JPN ACAD B-PHYS, V88, P88, DOI 10.2183/pjab.88.88; Szelenyi P, 2013, BIOFACTORS OXF ENGL, DOI [10.1002/biof.1095, DOI 10.1002/BI0F.1095]; Thielecke F, 2009, PHYTOCHEMISTRY, V70, P11, DOI 10.1016/j.phytochem.2008.11.011; Tomlinson JW, 2004, ENDOCR REV, V25, P831, DOI 10.1210/er.2003-0031; Wamil M, 2007, DRUG DISCOV TODAY, V12, P504, DOI 10.1016/j.drudis.2007.06.001; Weng ZQ, 2012, TOXICOL LETT, V214, P328, DOI 10.1016/j.toxlet.2012.09.011; White PC, 1997, ENDOCR REV, V18, P135, DOI 10.1210/er.18.1.135	44	34	37	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84468	10.1371/journal.pone.0084468	http://dx.doi.org/10.1371/journal.pone.0084468			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404164	gold, Green Published, Green Submitted			2022-12-27	WOS:000329460800043
J	Wain, LV; Odenthal-Hesse, L; Abujaber, R; Sayers, I; Beardsmore, C; Gaillard, EA; Chappell, S; Dogaru, CM; McKeever, T; Guetta-Baranes, T; Kalsheker, N; Kuehni, CE; Hall, IP; Tobin, MD; Hollox, EJ				Wain, Louise V.; Odenthal-Hesse, Linda; Abujaber, Razan; Sayers, Ian; Beardsmore, Caroline; Gaillard, Erol A.; Chappell, Sally; Dogaru, Cristian M.; McKeever, Tricia; Guetta-Baranes, Tamar; Kalsheker, Noor; Kuehni, Claudia E.; Hall, Ian P.; Tobin, Martin D.; Hollox, Edward J.			Copy Number Variation of the Beta-Defensin Genes in Europeans: No Supporting Evidence for Association with Lung Function, Chronic Obstructive Pulmonary Disease or Asthma	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; AIRWAY EPITHELIAL-CELLS; RESPIRATORY-TRACT; FLOW OBSTRUCTION; CROHNS-DISEASE; POPULATION; EXPRESSION; HEALTH; RISK; SUSCEPTIBILITY	Lung function measures are heritable, predict mortality and are relevant in diagnosis of chronic obstructive pulmonary disease (COPD). COPD and asthma are diseases of the airways with major public health impacts and each have a heritable component. Genome-wide association studies of SNPs have revealed novel genetic associations with both diseases but only account for a small proportion of the heritability. Complex copy number variation may account for some of the missing heritability. A well-characterised genomic region of complex copy number variation contains beta-defensin genes (DEFB103, DEFB104 and DEFB4), which have a role in the innate immune response. Previous studies have implicated these and related genes as being associated with asthma or COPD. We hypothesised that copy number variation of these genes may play a role in lung function in the general population and in COPD and asthma risk. We undertook copy number typing of this locus in 1149 adult and 689 children using a paralogue ratio test and investigated association with COPD, asthma and lung function. Replication of findings was assessed in a larger independent sample of COPD cases and smoking controls. We found evidence for an association of beta-defensin copy number with COPD in the adult cohort (OR = 1.4, 95% CI: 1.02-1.92, P = 0.039) but this finding, and findings from a previous study, were not replicated in a larger follow-up sample(OR = 0.89, 95% CI: 0.72-1.07, P = 0.217). No robust evidence of association with asthma in children was observed. We found no evidence for association between beta-defensin copy number and lung function in the general populations. Our findings suggest that previous reports of association of beta-defensin copy number with COPD should be viewed with caution. Suboptimal measurement of copy number can lead to spurious associations. Further beta-defensin copy number measurement in larger sample sizes of COPD cases and children with asthma are needed.	[Wain, Louise V.; Tobin, Martin D.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Odenthal-Hesse, Linda; Abujaber, Razan; Tobin, Martin D.; Hollox, Edward J.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Sayers, Ian; Hall, Ian P.] Univ Nottingham, Sch Med, Div Resp Med, Nottingham, England; [Beardsmore, Caroline; Gaillard, Erol A.] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Beardsmore, Caroline; Gaillard, Erol A.; Tobin, Martin D.] Glenfield Hosp, Inst Lung Hlth, NIHR, Leicester Resp Biomed Res Unit, Leicester, Leics, England; [Chappell, Sally; Guetta-Baranes, Tamar; Kalsheker, Noor] Univ Nottingham, Sch Life Sci, Nottingham NG7 2RD, England; [Dogaru, Cristian M.; Kuehni, Claudia E.] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [McKeever, Tricia] Univ Nottingham, Sch Community Hlth Sci, Nottingham NG7 2RD, England	University of Leicester; University of Leicester; University of Nottingham; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Nottingham; University of Bern; University of Nottingham	Wain, LV (corresponding author), Univ Leicester, Dept Hlth Sci, Leicester, Leics, England.	louisewain@le.ac.uk	Odenthal-Hesse, Linda/HCI-6463-2022; Dogaru, Cristian/N-6290-2015; Dogaru, Cristian/I-1861-2019	Dogaru, Cristian/0000-0002-0722-6147; Dogaru, Cristian/0000-0002-0722-6147; Hall, Ian/0000-0001-9933-3216; Sayers, Ian/0000-0001-5601-5410; Tobin, Martin/0000-0002-3596-7874; McKeever, Tricia/0000-0003-0914-0416; Kuehni, Claudia E./0000-0001-8957-2002; Gaillard, Erol/0000-0003-0996-8133; Odenthal-Hesse, Linda/0000-0002-5519-2375; Chappell, Sally/0000-0002-0841-6655; Wain, Louise/0000-0003-4951-1867; Hollox, Edward/0000-0002-0115-2298	Higher Education Innovation Fund (HEIF); Asthma UK [07/048]; British Lung Foundation; Swiss National Science Foundation [3200B0-122341]; Medical Research Council Senior Clinical Fellowship [G0902313]; National Institute for Health Research (NIHR); Medical Research Council [G1000861]; Medical Research Council [G0902313, G0801123] Funding Source: researchfish; MRC [G0902313, G1000861] Funding Source: UKRI	Higher Education Innovation Fund (HEIF); Asthma UK; British Lung Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Medical Research Council Senior Clinical Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	DNA extraction from LRC samples and PRT DEFB genotyping of LRC and Gedling samples was funded by a Higher Education Innovation Fund (HEIF) funded Impact Award to Louise V. Wain. The Nottingham Gedling cohort collection was funded by Asthma UK and the British Lung Foundation. Leicester Respiratory Cohort (LRC) was funded by Swiss National Science Foundation grant 3200B0-122341 and Asthma UK grant 07/048. Martin D. Tobin holds a Medical Research Council Senior Clinical Fellowship (G0902313). The research was part-funded by the National Institute for Health Research (NIHR). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. Ian Hall and Ian Sayers hold a Medical Research Council programme grant (G1000861). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Bakar S, 2009, P NATL ACAD SCI USA, V106, P853, DOI 10.1073/pnas.0809073106; Aldhous MC, 2010, HUM MOL GENET, V19, P4930, DOI 10.1093/hmg/ddq411; Andresen E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021898; Artigas MS, 2011, AM J RESP CRIT CARE, V184, P786, DOI 10.1164/rccm.201102-0192OC; ARTIGAS MS, 2011, NAT GENET, V43, P1082, DOI DOI 10.1038/NG.941; Bals R, 1998, J CLIN INVEST, V102, P874, DOI 10.1172/JCI2410; Bentley RW, 2010, AM J GASTROENTEROL, V105, P354, DOI 10.1038/ajg.2009.582; Braman SS, 2006, CHEST, V130, p4S, DOI 10.1378/chest.130.1_suppl.4S; BRITTON JR, 1995, AM J RESP CRIT CARE, V151, P1383, DOI 10.1164/ajrccm.151.5.7735589; Castaldi PJ, 2011, AM J RESP CELL MOL, V45, P1147, DOI 10.1165/rcmb.2011-0055OC; Chappell S, 2006, HUM MUTAT, V27, P103, DOI 10.1002/humu.20275; Cho MH, 2010, NAT GENET, V42, P200, DOI 10.1038/ng.535; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cookson William O C, 2011, Proc Am Thorac Soc, V8, P149, DOI 10.1513/pats.201101-003MS; Dogaru CM, 2012, AM J RESP CRIT CARE, V185, P874, DOI 10.1164/rccm.201108-1490OC; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Fode P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016768; *GOLD, 2006, GLOB STRAT DIAGN MAN; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Hankinson JL, 2003, CHEST, V124, P1805, DOI 10.1378/chest.124.5.1805; Hankinson JL, 2010, CHEST, V137, P138, DOI 10.1378/chest.09-0919; Hardwick RJ, 2012, J INFECT DIS, V206, P1012, DOI 10.1093/infdis/jis448; Hardwick RJ, 2011, HUM MUTAT, V32, P743, DOI 10.1002/humu.21491; Himes BE, 2009, AM J HUM GENET, V84, P581, DOI 10.1016/j.ajhg.2009.04.006; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Hollox EJ, 2010, AM J GASTROENTEROL, V105, P360, DOI 10.1038/ajg.2009.573; Hollox EJ, 2003, AM J HUM GENET, V73, P591, DOI 10.1086/378157; Ishimoto H, 2006, EUR RESPIR J, V27, P253, DOI 10.1183/09031936.06.00105904; Janssens W, 2010, AM J RESP CRIT CARE, V182, P163, DOI 10.1164/rccm.200905-0767OC; Kuehni CE, 2007, INT J EPIDEMIOL, V36, P977, DOI 10.1093/ije/dym090; Levy H, 2005, J ALLERGY CLIN IMMUN, V115, P252, DOI 10.1016/j.jaci.2004.11.013; Liao ZL, 2012, PEPTIDES, V38, P350, DOI 10.1016/j.peptides.2012.09.013; Lopez AD, 2006, EUR RESPIR J, V27, P397, DOI 10.1183/09031936.06.00025805; McKeever TM, 2002, AM J RESP CRIT CARE, V165, P1299, DOI 10.1164/rccm.2109030; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Moranta D, 2010, INFECT IMMUN, V78, P1135, DOI 10.1128/IAI.00940-09; Myers RA, 2012, J ALLERGY CLIN IMMUN, V130, P1294, DOI 10.1016/j.jaci.2012.07.054; Myint PK, 2005, EUR RESPIR J, V26, P494, DOI 10.1183/09031936.05.00023605; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Schunemann HJ, 2000, CHEST, V118, P656, DOI 10.1378/chest.118.3.656; Semple F, 2012, J INNATE IMMUN, V4, P337, DOI 10.1159/000336619; Silverman EK, 1998, AM J RESP CRIT CARE, V157, P1770, DOI 10.1164/ajrccm.157.6.9706014; STRACHAN DP, 1992, J EPIDEMIOL COMMUN H, V46, P66, DOI 10.1136/jech.46.1.66; STRIPPOLI MP, 2013, PEDIATRICS; Stuart PE, 2012, J INVEST DERMATOL, V132, P2407, DOI 10.1038/jid.2012.191; Tecle T, 2010, INNATE IMMUN-LONDON, V16, P151, DOI 10.1177/1753425910365734; Tsutsumi-Ishii Y, 2003, J IMMUNOL, V170, P4226, DOI 10.4049/jimmunol.170.8.4226; Wain LV, 2009, LANCET, V374, P340, DOI 10.1016/S0140-6736(09)60249-X; Wan YI, 2012, THORAX, V67, P762, DOI 10.1136/thoraxjnl-2011-201262; Wilk JB, 2012, AM J RESP CRIT CARE, V186, P622, DOI 10.1164/rccm.201202-0366OC; Yanagi S, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-130; Young RP, 2007, EUR RESPIR J, V30, P616, DOI 10.1183/09031936.00021707	53	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84192	10.1371/journal.pone.0084192	http://dx.doi.org/10.1371/journal.pone.0084192			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404154	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460800033
J	Wang, P; Wu, TH; Zhang, Y				Wang, Ping; Wu, Tun-Hua; Zhang, Yong			In Situ Investigation the Photolysis of the PAHs Adsorbed on Mangrove Leaf Surfaces by Synchronous Solid Surface Fluorimetry	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; FIBEROPTIC SENSOR; FLUORESCENCE; ANTHRACENE; PLANT; L.; PHOTOCHEMISTRY; NEEDLES; WATER; PHOTODEGRADATION	An established synchronous solid surface fluorimetry (S-SSF) was utilized for in situ study the photolysis processes of anthracene (An) and pyrene (Py) adsorbed on the leaf surfaces of Kandelia obovata seedlings (Ko) and Aegiceras corniculata (L.) Blanco seedlings (Ac). Experimental results demonstrated that the photolysis of An and Py adsorbed on the leaf surfaces of two mangrove species under the laboratory conditions, followed first-order kinetics with their photolysis rates in the order of Ac. Ko. In addition, with the same amount of substances, the photolysis rate of An adsorbed on the same mangrove leaf surfaces was much faster than the adsorbed Py. In order to investigate further, the photolysis processes of An and Py in water were also studied for comparison. And the photolysis of An and Py in water also followed first-order kinetics. Moreover, for the same initial amount, the photolysis rate of the PAH in water was faster than that adsorbed on the leaf surfaces of two mangrove species. Therefore, photochemical behaviors of PAHs were dependent not only on their molecular structures but also the physical-chemical properties of the substrates on which they are adsorbed.	[Wang, Ping] Wenzhou Med Univ, Sch Environm Sci & Publ Hlth, Wenzhou, Peoples R China; [Wu, Tun-Hua] Wenzhou Med Univ, Sch Informat & Engn, Wenzhou, Peoples R China; [Zhang, Yong] Xiamen Univ, Environm Sci Res Ctr, State Key Lab Marine Environm Sci, Xiamen, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Xiamen University	Zhang, Y (corresponding author), Xiamen Univ, Environm Sci Res Ctr, State Key Lab Marine Environm Sci, Xiamen, Peoples R China.	fruitful@xmu.edu.cn	Wang, Ping/I-8405-2019; 张, 勇/G-3426-2010; Wu, Tunhua/L-9511-2019		National Natural Science Foundation of China [21177102, 21075102, 21207103]; Public Benefit Project of Zhejiang Province [2012C31025]; Natural Science Foundation of Zhejiang Province [LY13H180012]; Scientific Research Fund of Zhejiang Provincial Education Department [Y201222932]; Project of Wenzhou Municipal Science and Technology [G20110004]; Science and Technology Innovation Action of College Student of Zhejiang Province [2013R413010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Benefit Project of Zhejiang Province; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Scientific Research Fund of Zhejiang Provincial Education Department; Project of Wenzhou Municipal Science and Technology; Science and Technology Innovation Action of College Student of Zhejiang Province	National Natural Science Foundation of China (21177102, 21075102 and 21207103), Public Benefit Project of Zhejiang Province (2012C31025), Natural Science Foundation of Zhejiang Province (LY13H180012), Scientific Research Fund of Zhejiang Provincial Education Department (Y201222932), Project of Wenzhou Municipal Science and Technology (G20110004) and Science and Technology Innovation Action of College Student of Zhejiang Province (2013R413010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augusto S, 2010, ENVIRON POLLUT, V158, P483, DOI 10.1016/j.envpol.2009.08.016; CHEN GZ, 1990, FLUORESCENCE ANAL; Chen L, 2011, J FLUORESC, V21, P765, DOI 10.1007/s10895-010-0769-z; Chen L, 2010, TALANTA, V83, P324, DOI 10.1016/j.talanta.2010.09.025; De Laender F, 2011, ENVIRON SCI TECHNOL, V45, P9024, DOI 10.1021/es202423f; Feilberg A, 2001, ENVIRON SCI TECHNOL, V35, P108, DOI 10.1021/es990834l; Fioressi S, 2003, J PHYS CHEM A, V107, P5968, DOI 10.1021/jp027305f; Fioressi S, 1999, POLYCYCL AROMAT COMP, V14, P285, DOI 10.1080/10406639908019134; Gao YZ, 2006, CHEMOSPHERE, V63, P1560, DOI 10.1016/j.chemosphere.2005.09.058; Gorshkov AG, 2008, J ANAL CHEM+, V63, P805, DOI 10.1134/S1061934808080169; HUANG XD, 1993, ENVIRON TOXICOL CHEM, V12, P1067, DOI 10.1002/etc.5620120613; Kahan TF, 2007, J PHYS CHEM A, V111, P1277, DOI 10.1021/jp066660t; Ke L, 2002, MAR POLLUT BULL, V45, P339, DOI 10.1016/S0025-326X(02)00117-0; Komp P, 2000, SCI TOTAL ENVIRON, V250, P63, DOI 10.1016/S0048-9697(00)00364-8; KORFMACHER WA, 1980, ENVIRON SCI TECHNOL, V14, P1094, DOI 10.1021/es60169a019; Lehto KM, 2000, J PHOTOCH PHOTOBIO A, V136, P53, DOI 10.1016/S1010-6030(00)00321-X; LI YQ, 1991, THESIS XIAMEN U XIAM; Mackay Donald, 1997, ILLUSTRATED HDB PHYS; Mallakin A, 2000, CHEMOSPHERE, V40, P1435, DOI 10.1016/S0045-6535(99)00331-8; NIESSNER R, 1991, ANAL CHIM ACTA, V255, P231, DOI 10.1016/0003-2670(91)80051-T; Niu JF, 2003, ENVIRON POLLUT, V123, P39, DOI 10.1016/S0269-7491(02)00362-7; Oyo-Ita OE, 2013, APPL GEOCHEM, V28, P212, DOI 10.1016/j.apgeochem.2012.09.011; Pagni Richard M., 2005, V2, P193, DOI 10.1007/b138184; PANNE U, 1993, SENSOR ACTUAT B-CHEM, V13, P288, DOI 10.1016/0925-4005(93)85383-L; Ramdine G, 2012, ECOTOX ENVIRON SAFE, V79, P80, DOI 10.1016/j.ecoenv.2011.12.005; Reyes CA, 2000, ENVIRON SCI TECHNOL, V34, P415, DOI 10.1021/es9905391; Reza D, 1995, J PHOTOCH PHOTOBIO A, V86, P231; Robert AY, 1986, ENVIRON SCI TECHNOL, V20, P86; Rogers KR, 1996, CHEMOSPHERE, V33, P1151, DOI 10.1016/0045-6535(96)00255-X; Schuler F, 1998, CHEMOSPHERE, V36, P21, DOI 10.1016/S0045-6535(97)00349-4; Tham YWF, 2007, B ENVIRON CONTAM TOX, V79, P670, DOI 10.1007/s00128-007-9309-1; Wang DG, 2005, ATMOS ENVIRON, V39, P4583, DOI 10.1016/j.atmosenv.2005.04.008; Wang P, 2008, TALANTA, V76, P1177, DOI 10.1016/j.talanta.2008.05.021; Wang P, 2012, MAR POLLUT BULL, V64, P1654, DOI 10.1016/j.marpolbul.2012.05.034; Wang P, 2012, J COASTAL RES, V28, P499, DOI 10.2112/JCOASTRES-D-11-00111.1; Wang Ping, 2010, Toxicological and Environmental Chemistry, V92, P1825, DOI 10.1080/02772248.2010.482833; Wang P, 2010, J COASTAL RES, V26, P549, DOI 10.2112/08-1148.1; Wang XT, 2013, SCI TOTAL ENVIRON, V447, P80, DOI 10.1016/j.scitotenv.2012.12.086; Wild E, 2005, ENVIRON SCI TECHNOL, V39, P3695, DOI 10.1021/es048136a; Wild E, 2004, ENVIRON SCI TECHNOL, V38, P4195, DOI 10.1021/es049915u; Worrall DR, 1997, J PHYS CHEM B, V101, P4709, DOI 10.1021/jp970133f; Wu NY, 2009, ENVIRON POLLUT, V157, P1613, DOI 10.1016/j.envpol.2008.12.022; Xiao X, 2015, ORAL LIT CONTINUUM C; Xu Z, 2004, THESIS DALIAN U TECH	44	15	17	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84296	10.1371/journal.pone.0084296	http://dx.doi.org/10.1371/journal.pone.0084296			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404158	gold, Green Published, Green Submitted			2022-12-27	WOS:000329460800037
J	Khoo, HE; Azlan, A; Ismail, A; Abas, F; Hamid, M				Khoo, Hock Eng; Azlan, Azrina; Ismail, Amin; Abas, Faridah; Hamid, Muhajir			Inhibition of Oxidative Stress and Lipid Peroxidation by Anthocyanins from Defatted Canarium odontophyllum Pericarp and Peel Using In Vitro Bioassays	PLOS ONE			English	Article							LOW-DENSITY LIPOPROTEINS; B SCAVENGER RECEPTOR; OXIDIZED LDL; PHENOLIC-COMPOUNDS; PPAR-GAMMA; ANTIOXIDANT CAPACITY; ENDOTHELIAL-CELLS; CD36; DABAI; ATHEROSCLEROSIS	Canarium odontophyllum, also known as CO, is a highly nutritious fruit. Defatted parts of CO fruit are potent sources of nutraceutical. This study aimed to determine oxidative stress and lipid peroxidation effects of defatted CO pericarp and peel extracts using in vitro bioassays. Cell cytotoxic effect of the CO pericarp and peel extracts were also evaluated using HUVEC and Chang liver cell lines. The crude extracts of defatted CO peel and pericarp showed cytoprotective effects in t-BHP and 40% methanol-induced cell death. The crude extracts also showed no toxic effect to Chang liver cell line. Using CD36 ELISA, NAD+ and LDL inhibition assays, inhibition of oxidative stress were found higher in the crude extract of defatted CO peel compared to the pericarp extract. Hemoglobin and LDL oxidation assays revealed both crude extracts had significantly reduced lipid peroxidation as compared to control. TBARS values among defatted CO pericarp, peel, and cyanidin-3-glucoside showed no significant differences for hemoglobin and LDL oxidation assays. The protective effects of defatted CO parts, especially its peel is related to the presence of high anthocyanin that potentially offers as a pharmaceutical ingredient for cardioprotection.	[Khoo, Hock Eng; Azlan, Azrina; Ismail, Amin] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Nutr & Dietet, Serdang, Malaysia; [Azlan, Azrina; Ismail, Amin] Univ Putra Malaysia, Lab Halal Sci Res, Halal Prod Res Inst, Serdang, Malaysia; [Abas, Faridah] Univ Putra Malaysia, Dept Food Sci, Fac Food Sci & Technol, Serdang, Malaysia; [Hamid, Muhajir] Univ Putra Malaysia, Dept Microbiol, Fac Biotechnol & Biomol Sci, Serdang, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia	Azlan, A (corresponding author), Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Nutr & Dietet, Serdang, Malaysia.	azrina@upm.edu.my	Abas, Faridah/B-9229-2015; Khoo, Hock Eng/F-4007-2011; bin Ismail, Amin/J-8725-2015	Abas, Faridah/0000-0002-8110-9424; Khoo, Hock Eng/0000-0002-7686-6092; bin Ismail, Amin/0000-0002-9427-2028; Hamid, Muhajir/0000-0002-2475-7628	Research Management Center, Universiti Putra Malaysia [04-02-10-0921RU, 9192600]	Research Management Center, Universiti Putra Malaysia	This study was funded by the Research University Grant Scheme (04-02-10-0921RU, 9192600) from Research Management Center, Universiti Putra Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azlan A, 2010, J FOOD COMPOS ANAL, V23, P772, DOI 10.1016/j.jfca.2010.03.026; Azlan A, 2009, J FOOD AGRIC ENVIRON, V7, P55; BLANK F, 1947, BOT REV, V13, P241, DOI 10.1007/BF02861798; Boullier A, 2001, ANN NY ACAD SCI, V947, P214; Buege J A, 1978, Methods Enzymol, V52, P302; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Calvo D, 1998, J LIPID RES, V39, P777; Chang YC, 2006, FOOD CHEM TOXICOL, V44, P1015, DOI 10.1016/j.fct.2005.12.006; Chew LY, 2011, J FOOD COMPOS ANAL, V24, P670, DOI 10.1016/j.jfca.2011.01.006; Chew LY, 2012, FOOD ANAL METHOD, V5, P126, DOI 10.1007/s12161-011-9217-1; Cominacini L, 2001, J BIOL CHEM, V276, P13750, DOI 10.1074/jbc.M010612200; DASHTI N, 1984, BIOCHIM BIOPHYS ACTA, V794, P373, DOI 10.1016/0005-2760(84)90003-1; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Feng JW, 2000, J LIPID RES, V41, P688; Gabius HJ, 2001, CANCER INVEST, V19, P114, DOI 10.1081/CNV-100000146; Galeano NF, 1998, J LIPID RES, V39, P1263; Geraets L, 2006, BIOCHEM PHARMACOL, V72, P902, DOI 10.1016/j.bcp.2006.06.023; Han JH, 1997, J BIOL CHEM, V272, P21654, DOI 10.1074/jbc.272.34.21654; Heo HJ, 2005, J AGR FOOD CHEM, V53, P1984, DOI 10.1021/jf048616l; Huang D, 2009, CARDIOVASC RES, V81, P98, DOI 10.1093/cvr/cvn264; Khoo H.E., 2012, POLYPHENOLS CHEM DIE, P133; Khoo HE, 2013, SAINS MALAYS, V42, P949; Khoo HE, 2012, MOLECULES, V17, P9754, DOI 10.3390/molecules17089754; Khoo HE, 2012, FOOD ANAL METHOD, V5, P339, DOI 10.1007/s12161-011-9250-0; Kita T, 2001, ANN NY ACAD SCI, V947, P199; Kong KW, 2010, FOOD CHEM, V123, P1142, DOI 10.1016/j.foodchem.2010.05.077; Lima CF, 2006, LIFE SCI, V79, P2056, DOI 10.1016/j.lfs.2006.06.042; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lyall KA, 2009, AM J PHYSIOL-REG I, V297, pR70, DOI 10.1152/ajpregu.90740.2008; Meyer AS, 1998, FOOD CHEM, V61, P71, DOI 10.1016/S0308-8146(97)00100-3; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; Rodriguez J, 2006, BBA-GEN SUBJECTS, V1760, P1333, DOI 10.1016/j.bbagen.2006.04.005; Rotich, 2011, J TOXICOLOGY ENV HLT, V3, P367, DOI 10.5897/JTEHS.9000008; Rubic T, 2004, BIOCHEM PHARMACOL, V67, P411, DOI 10.1016/j.bcp.2003.09.014; Tan PH, 2004, ATHEROSCLEROSIS, V173, P171, DOI 10.1016/j.atherosclerosis.2003.12.011; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Tsoukatos DC, 1997, ARTERIOSCL THROM VAS, V17, P3505, DOI 10.1161/01.ATV.17.12.3505; TSUDA T, 1994, J AGR FOOD CHEM, V42, P2407, DOI 10.1021/jf00047a009; Uchide N, 2009, INTERVIROLOGY, V52, P164, DOI 10.1159/000224644; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Visavadiya NP, 2009, FOOD CHEM TOXICOL, V47, P2507, DOI 10.1016/j.fct.2009.07.009; Wang L, 2010, J BIOMOL SCREEN, V15, P239, DOI 10.1177/1087057109359686; WITZTUM JL, 1994, LANCET, V344, P793, DOI 10.1016/S0140-6736(94)92346-9; Yi W, 2006, FOOD RES INT, V39, P628, DOI 10.1016/j.foodres.2006.01.001	46	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e81447	10.1371/journal.pone.0081447	http://dx.doi.org/10.1371/journal.pone.0081447			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416130	gold, Green Published, Green Submitted			2022-12-27	WOS:000329866300004
J	Shabnam, N; Pardha-Saradhi, P; Sharmila, P				Shabnam, Nisha; Pardha-Saradhi, P.; Sharmila, P.			Phenolics Impart Au3+-Stress Tolerance to Cowpea by Generating Nanoparticles	PLOS ONE			English	Article							GOLD NANOPARTICLES; ANTIOXIDANT ACTIVITY; AU NANOPARTICLES; IN-VITRO; PLANTS; METAL; DETOXIFICATION; PROLINE; SEED; PEROXIDATION	While evaluating impact of Au nanoparticles on seed germination and early seedling growth of cowpea, HAuCl4 was used as control. Seedlings of cowpea raised in HAuCl4, even at concentration as high as 1 mM, did not show any suppression in growth. Accordingly, Au3+, despite being a heavy metal, did not alter levels of stress markers (viz. proline and malondialdehyde) in cowpea. Interestingly, cowpea turned clear pale yellow HAuCl4 solutions colloidal purple during the course of seed germination and seedling growth. These purple colloidal suspensions showed Au-nanoparticle specific surface plasmon resonance band in absorption spectra. Transmission electron microscopic and powder X-ray diffraction investigations confirmed presence of crystalline Au-nanoparticles in these purple suspensions. Each germinating seed of cowpea released similar to 35 nmoles of GAE of phenolics and since phenolics promote generation of Au-nanoparticles, which are less/non toxic compared to Au3+, it was contemplated that potential of cowpea to withstand Au3+ is linked to phenolics. Of the different components of germinating seed of cowpea tested, seed coat possessed immense power to generate Au-nanoparticles, as it was the key source of phenolics. To establish role of phenolics in generation of Au-nanoparticles (i) seed coat and (ii) the incubation medium in which phenolics were released by germinating seeds, were tested for their efficacy to generate Au-nanoparticles. Interestingly, incubation of either of these components with Au3+ triggered increase in generation of Au-nanoparticles with concomitant decrease in phenolics. Accordingly, with increase in concentration of Au3+, a proportionate increase in generation of Au-nanoparticles and decrease in phenolics was recorded. In summary, our findings clearly established that cowpea possessed potential to withstand Au3+-stress as the phenolics released by seed coat of germinating seeds possess potential to reduce toxic Au3+ to form non/less toxic Au-nanoparticles. Our investigations also pave a novel, simple, green and economically viable protocol for generation of Au-nanoparticles.	[Shabnam, Nisha; Pardha-Saradhi, P.] Univ Delhi, Dept Environm Studies, Delhi 110007, India; [Sharmila, P.] Indian Inst Technol, Dept Chem, Delhi, India	University of Delhi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Sharmila, P (corresponding author), Indian Inst Technol, Dept Chem, Delhi, India.	sharmilaps91@gmail.com	Shabnam, Nisha/J-7470-2019	Shabnam, Nisha/0000-0002-1855-8497	University Grants Commission (Govt. of India); Department of Biotechnology (Govt. of India) under Bio-CARe Women Scientist Scheme	University Grants Commission (Govt. of India)(University Grants Commission, India); Department of Biotechnology (Govt. of India) under Bio-CARe Women Scientist Scheme	Financial assistance provided to (i) Nisha Shabnam by University Grants Commission (Govt. of India); and (ii) P. Sharmila by Department of Biotechnology (Govt. of India) under Bio-CARe Women Scientist Scheme is duly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2007, NAT PROTOC, V2, P875, DOI 10.1038/nprot.2007.102; Ainsworth SK, 1981, ARCH PATHOL LAB MED, V105, P73; Alia, 1997, J PHOTOCH PHOTOBIO B, V38, P253, DOI 10.1016/S1011-1344(96)07470-2; ALIA, 1995, PHYTOCHEMISTRY, V39, P45, DOI 10.1016/0031-9422(94)00919-K; ALIA, 1993, BIOCHEM BIOPH RES CO, V193, P54; ALIA, 1991, J PLANT PHYSIOL, V138, P554, DOI 10.1016/S0176-1617(11)80240-3; Anderson CWN, 1998, NATURE, V395, P553, DOI 10.1038/26875; Baba A.A., 2011, CHEM B, V1, P1; Bali R, 2010, IND ENG CHEM RES, V49, P12762, DOI 10.1021/ie101600m; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Beattie IR, 2011, METALLOMICS, V3, P628, DOI 10.1039/c1mt00044f; Bekkara F, 1998, PLANT SOIL, V203, P27, DOI 10.1023/A:1004365913726; Bringezu K, 1999, J PLANT PHYSIOL, V154, P536, DOI 10.1016/S0176-1617(99)80295-8; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; Danscher G, 2006, PROG HISTOCHEM CYTO, V41, P57, DOI 10.1016/j.proghi.2006.06.001; Duenas M, 2006, FOOD CHEM, V98, P95, DOI 10.1016/j.foodchem.2005.05.052; Duncan DB, 1955, BIOMETRICS, V39, P205; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Ishikawa S, 2002, BIORESOURCE TECHNOL, V81, P201, DOI 10.1016/S0960-8524(01)00134-1; Jung C, 2003, PLANT SOIL, V252, P301, DOI 10.1023/A:1024775803759; Klaus-Joerger T, 2001, TRENDS BIOTECHNOL, V19, P15, DOI 10.1016/S0167-7799(00)01514-6; Lavid N, 2001, PLANTA, V212, P323, DOI 10.1007/s004250000400; Lengke MF, 2005, GEOCHIM COSMOCHIM AC, V69, P3759, DOI 10.1016/j.gca.2005.03.012; Ma JF, 2001, TRENDS PLANT SCI, V6, P273, DOI 10.1016/S1360-1385(01)01961-6; Maestri E, 2010, ENVIRON EXP BOT, V68, P1, DOI 10.1016/j.envexpbot.2009.10.011; Michalak A, 2006, POL J ENVIRON STUD, V15, P523; Migocka M, 2011, J EXP BOT, V62, P4903, DOI 10.1093/jxb/err180; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; Nune SK, 2009, J MATER CHEM, V19, P2912, DOI 10.1039/b822015h; Pardha Saradhi P, 2008, HDB NEW TECHNOLOGIES, P577; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; SARADHI PP, 1995, BIOCHEM BIOPH RES CO, V209, P1, DOI 10.1006/bbrc.1995.1461; Shabnam N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071123; Sharma NC, 2007, ENVIRON SCI TECHNOL, V41, P5137, DOI 10.1021/es062929a; Siddhuraju P, 2007, FOOD CHEM, V101, P10, DOI 10.1016/j.foodchem.2006.01.004; Sivakumar P, 1998, BIOCHEM BIOPH RES CO, V252, P428, DOI 10.1006/bbrc.1998.9666; Syed S, 2012, HYDROMETALLURGY, V115, P30, DOI 10.1016/j.hydromet.2011.12.012; Wang WX, 2007, COLLOID SURFACE A, V301, P73, DOI 10.1016/j.colsurfa.2006.12.037; Wenzl P, 2001, PLANT PHYSIOL, V125, P1473, DOI 10.1104/pp.125.3.1473; Yamal G, 2013, PROCESS BIOCHEM, V48, P532, DOI 10.1016/j.procbio.2013.02.011	40	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85242	10.1371/journal.pone.0085242	http://dx.doi.org/10.1371/journal.pone.0085242			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416368	gold, Green Submitted, Green Published			2022-12-27	WOS:000329866300058
J	Zheng, N; Chai, Z; Fu, F; Jiang, FC; Wang, XL; Zhang, XY; Wang, Z; Li, X				Zheng, Nan; Chai, Zheng; Fu, Fang; Jiang, Fucheng; Wang, Xiangling; Zhang, Xueyun; Wang, Zhuo; Li, Xi			Identification of a Novel Haemophilus parasuis-Specific B Cell Epitope Using Monoclonal Antibody against the OppA Protein	PLOS ONE			English	Article							PEPTIDE LIBRARY; VIRUS; SWINE; INFECTION; DIAGNOSIS; SEROVARS; DISEASE; ANTIGEN; MICE; PCR	Monoclonal antibody (MAb) 1B3 against Haemophilus parasuis (H. parasuis) was generated by fusing SP2/0 murine myeloma cells and spleen cells from BALB/c mice immunized with the whole-bacterial-cell suspension of H. parasuis HS80 (serotype 5). The MAb 1B3 showed strong reactivity with 15 serotype reference strains of H. parasuis using Dot blot and Western blot analysis. Immunoprecipitation and protein spectral analysis indicated that MAb 1B3 recognized by Oligopeptide permease A (OppA) belongs to the ATP binding cassette transporter family. In addition, a linear B-cell epitope recognized by MAb 1B3 was identified by the screening of a phage-displayed 12-mer random peptide library. Sequence analysis showed that MAb 1B3 was recognized by phages-displaying peptides with the consensus motif KTPSEXR (X means variable amino acids). Its amino acid sequence matched (469)KTPAEAR(475) of H. parasuis OppA protein. A series of progressively truncated peptides were synthesized to define the minimal region that was required for MAb 1B3 binding. The epitope was highly conserved in OppA protein sequences from the isolated H. parasuis strains, which was confirmed by alignment analysis. Furthermore, the minimal linear epitope was highly specific among 75 different bacterial strains as shown in sequence alignments. These results indicated MAb 1B3 might be potentially used to develop serological diagnostic tools for H. parasuis.	[Zheng, Nan; Chai, Zheng; Fu, Fang; Jiang, Fucheng; Wang, Xiangling; Zhang, Xueyun; Wang, Zhuo; Li, Xi] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Li, X (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin, Peoples R China.	lx2005@126.com	Chai, Zheng/Q-5121-2019		Special Fund for Agro-scientific Research in the Public Interest [201203056]	Special Fund for Agro-scientific Research in the Public Interest	This study was supported by Special Fund for Agro-scientific Research in the Public Interest (201203056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackall PJ, 1997, VET MICROBIOL, V56, P125, DOI 10.1016/S0378-1135(96)01342-9; del Rio ML, 2006, RES VET SCI, V80, P55, DOI 10.1016/j.rvsc.2005.03.004; Del Rio ML, 2003, J CLIN MICROBIOL, V41, P880, DOI 10.1128/JCM.41.2.880-882.2003; Garmory HS, 2004, INFECT IMMUN, V72, P6757, DOI 10.1128/IAI.72.12.6757-6763.2004; Kaneko N, 2013, ANAL CHEM, V85, P3152, DOI 10.1021/ac303344h; KIELSTEIN P, 1992, J CLIN MICROBIOL, V30, P862, DOI 10.1128/JCM.30.4.862-865.1992; Kouzmitcheva GA, 2001, CLIN DIAGN LAB IMMUN, V8, P150, DOI 10.1128/CDLI.8.1.150-160.2001; Li XS, 2011, J VIROL METHODS, V176, P46, DOI 10.1016/j.jviromet.2011.05.034; Lin XA, 2010, CLIN VACCINE IMMUNOL, V17, P778, DOI 10.1128/CVI.00405-09; MacInnes JI, 1999, CAN J VET RES, V63, P83; Oliveira S, 2004, VET MICROBIOL, V99, P1, DOI 10.1016/j.vetmic.2003.12.001; Olvera A, 2007, VET J, V174, P522, DOI 10.1016/j.tvjl.2006.10.017; Peng WP, 2008, VIRUS RES, V135, P267, DOI 10.1016/j.virusres.2008.04.003; Rafiee M, 2000, AUST VET J, V78, P846, DOI 10.1111/j.1751-0813.2000.tb10507.x; RAPPGABRIELSON VJ, 1992, AM J VET RES, V53, P659; Sun EC, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-100; Tadjine M, 2004, MICROBIOL-SGM, V150, P3935, DOI 10.1099/mic.0.27443-0; Tanabe M, 2006, INFECT IMMUN, V74, P3687, DOI 10.1128/IAI.01837-05; Tian HB, 2011, CLIN VACCINE IMMUNOL, V18, P1695, DOI 10.1128/CVI.05223-11; Wang HW, 2011, VET MICROBIOL, V148, P189, DOI 10.1016/j.vetmic.2010.09.013; Wang WS, 2013, APPL MICROBIOL BIOT, V97, P5933, DOI 10.1007/s00253-013-4779-z; Xue M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049842; Yang M, 2011, INFECT IMMUN, V79, P846, DOI 10.1128/IAI.00314-10	23	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84516	10.1371/journal.pone.0084516	http://dx.doi.org/10.1371/journal.pone.0084516			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416241	Green Submitted, Green Published, gold			2022-12-27	WOS:000329866300027
J	McElgunn, CJ; Pereira, CR; Parham, NJ; Smythe, JE; Wigglesworth, MJ; Smielewska, A; Parmar, SA; Gandelman, OA; Brown, NM; Tisi, LC; Curran, MD				McElgunn, Cathal J.; Pereira, Clint R.; Parham, Nicholas J.; Smythe, James E.; Wigglesworth, Michael J.; Smielewska, Anna; Parmar, Surendra A.; Gandelman, Olga A.; Brown, Nicholas M.; Tisi, Laurence C.; Curran, Martin D.			A Low Complexity Rapid Molecular Method for Detection of Clostridium difficile in Stool	PLOS ONE			English	Article							REAL-TIME PCR; XPERT C.-DIFFICILE; BD GENEOHM CDIFF; TOXIN; CULTURE; DIAGNOSIS; FECES; COLONIZATION; TRANSMISSION; INHIBITION	Here we describe a method for the detection of Clostridium difficile from stool using a novel low-complexity and rapid extraction process called Heat Elution (HE). The HE method is two-step and takes just 10 minutes, no specialist instruments are required and there is minimal hands-on time. A test method using HE was developed in conjunction with Loop-mediated Isothermal Amplification (LAMP) combined with the real-time bioluminescent reporter system known as BART targeting the toxin B gene (tcdB). The HE-LAMP-BART method was evaluated in a pilot study on clinical fecal samples (tcdB(+), n = 111; tcdB(-), n = 107). The HE-LAMP-BART method showed 95.5% sensitivity and 100% specificity against a gold standard reference method using cytotoxigenic culture and also a silica-based robotic extraction followed by tcdB PCR to control for storage. From sample to result, the HE-LAMP-BART method typically took 50 minutes, whereas the PCR method took >2.5 hours. In a further study (tcdB(+), n = 47; tcdB(-), n = 28) HE-LAMP-BART was compared to an alternative commercially available LAMP-based method, Illumigene (Meridian Bioscience, OH), and yielded 87.2% sensitivity and 100% specificity for the HE-LAMP-BART method compared to 76.6% and 100%, respectively, for Illumigene against the reference method. A subset of 27 samples (tcdB(+), n = 25; tcdB(-), n = 2) were further compared between HE-LAMP-BART, Illumigene, GeneXpert (Cepheid, Sunnyvale, CA) and RIDA (R) QUICK C. difficile Toxin A/B lateral flow rapid test (R-Biopharm, Darmstadt, Germany) resulting in sensitivities of HE-LAMP-BART 92%, Illumigene 72% GeneXpert 96% and RIDAQuick 76% against the reference method. The HE-LAMP-BART method offers the advantages of molecular based approaches without the cost and complexity usually associated with molecular tests. Further, the rapid time-to-result and simple protocol means the method can be applied away from the centralized laboratory settings.	[McElgunn, Cathal J.; Pereira, Clint R.; Smythe, James E.; Wigglesworth, Michael J.; Gandelman, Olga A.; Tisi, Laurence C.] Lumora Ltd, Ely, Cambs, England; [Parham, Nicholas J.; Smielewska, Anna; Parmar, Surendra A.; Brown, Nicholas M.; Curran, Martin D.] Addenbrookes Hosp, Publ Hlth England, Clin Microbiol & Publ Hlth Lab, Cambridge, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; Public Health England; University of Cambridge	McElgunn, CJ (corresponding author), Lumora Ltd, Ely, Cambs, England.	c.mcelgunn@lumora.co.uk		Brown, Nicholas/0000-0002-6657-300X; Smielewska, Anna/0000-0002-6200-6876				Abu al-Soud W, 2001, J CLIN MICROBIOL, V39, P485, DOI 10.1128/JCM.39.2.485-493.2001; Abu Al-Soud W, 1998, APPL ENVIRON MICROB, V64, P3748; AKANE A, 1994, J FORENSIC SCI, V39, P362; Ananthakrishnan AN, 2011, NAT REV GASTRO HEPAT, V8, P17, DOI 10.1038/nrgastro.2010.190; Antunes A, 2010, METHODS MOL BIOL, V646, P93, DOI 10.1007/978-1-60327-365-7_7; Bartlett JG, 2006, ANN INTERN MED, V145, P758, DOI 10.7326/0003-4819-145-10-200611210-00008; Bartlett JG, 2010, ANN NY ACAD SCI, V1213, P62, DOI 10.1111/j.1749-6632.2010.05863.x; Bartlett JG, 2010, INFECT CONT HOSP EP, V31, pS35, DOI 10.1086/655999; Belanger SD, 2003, J CLIN MICROBIOL, V41, P730, DOI 10.1128/JCM.41.2.730-734.2003; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Bossuyt P., 2006, NAT REV MICROBIOL, V4, P20, DOI [DOI 10.1038/nrmicro1523, DOI 10.1038/nrmico1523]; Brouwer MSM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023014; Burns DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024894; de Jong E, 2012, EUR J CLIN MICROBIOL, V31, P2219, DOI 10.1007/s10096-012-1558-1; Dineen SS, 2007, MOL MICROBIOL, V66, P206, DOI 10.1111/j.1365-2958.2007.05906.x; Gandelman OA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014155; Health Protection Agency, 2013, VOL SURV CLOSTR DIFF; Health Protection Agency, 2012, ANN REPORT; Huang SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060059; Jones AM, 2013, J INFECTION, V66, P115, DOI 10.1016/j.jinf.2012.10.019; Kato H, 2001, J MED MICROBIOL, V50, P720, DOI 10.1099/0022-1317-50-8-720; Kiddle G, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-15; Knetsch CW, 2011, J CLIN MICROBIOL, V49, P227, DOI 10.1128/JCM.01743-10; Kozak K, 2011, J CLIN MICROBIOL, V49, P2383, DOI 10.1128/JCM.00523-11; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Kvach EJ, 2010, J CLIN MICROBIOL, V48, P109, DOI 10.1128/JCM.01630-09; Kyne L, 2000, NEW ENGL J MED, V342, P390, DOI 10.1056/NEJM200002103420604; Lalande V, 2011, J CLIN MICROBIOL, V49, P2714, DOI 10.1128/JCM.01835-10; Lantz PG, 1997, J MICROBIOL METH, V28, P159, DOI 10.1016/S0167-7012(97)00979-2; Lawson AJ, 1997, J APPL MICROBIOL, V83, P375, DOI 10.1046/j.1365-2672.1997.00240.x; Monteiro L, 1997, J CLIN MICROBIOL, V35, P995, DOI 10.1128/JCM.35.4.995-998.1997; Novak-Weekley SM, 2010, J CLIN MICROBIOL, V48, P889, DOI 10.1128/JCM.01801-09; Oikarinen S, 2009, J CLIN VIROL, V44, P211, DOI 10.1016/j.jcv.2008.12.017; Pancholi P, 2012, J CLIN MICROBIOL, V50, P1331, DOI 10.1128/JCM.06597-11; Planche TD, 2013, LANCET INFECT DIS, V13, P936, DOI 10.1016/S1473-3099(13)70200-7; Quinn CD, 2010, J CLIN MICROBIOL, V48, P603, DOI 10.1128/JCM.01614-09; Riggs MM, 2007, CLIN INFECT DIS, V45, P992, DOI 10.1086/521854; Rupnik M, 2010, METHODS MOL BIOL, V646, P67, DOI 10.1007/978-1-60327-365-7_5; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Ryan J, 2010, IRISH J MED SCI, V179, P245, DOI 10.1007/s11845-009-0361-1; Shim JK, 1998, LANCET, V351, P633, DOI 10.1016/S0140-6736(97)08062-8; Simor AE, 2002, INFECT CONT HOSP EP, V23, P696, DOI 10.1086/501997; Sloan LM, 2008, J CLIN MICROBIOL, V46, P1996, DOI 10.1128/JCM.00032-08; Spigaglia P, 2002, J CLIN MICROBIOL, V40, P3470, DOI 10.1128/JCM.40.9.3470-3475.2002; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Stanley JD, 2013, CURR PROB SURG, V50, P302, DOI 10.1067/j.cpsurg.2013.02.004; Tenover FC, 2010, J CLIN MICROBIOL, V48, P3719, DOI 10.1128/JCM.00427-10; Thornton CG, 2004, J MICROBIOL METH, V59, P43, DOI 10.1016/j.mimet.2004.06.001; TSAI YL, 1992, APPL ENVIRON MICROB, V58, P2292, DOI 10.1128/AEM.58.7.2292-2295.1992; Viala C, 2012, J MICROBIOL METH, V90, P83, DOI 10.1016/j.mimet.2012.04.017; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005	51	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83808	10.1371/journal.pone.0083808	http://dx.doi.org/10.1371/journal.pone.0083808			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416173	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500075
J	Park, YH; Shin, JA; Han, K; Yim, HW; Lee, WC; Park, YM				Park, Young-Hoon; Shin, Jeong Ah; Han, Kyungdo; Yim, Hyeon Woo; Lee, Won-Chul; Park, Yong-Moon			Gender Difference in the Association of Metabolic Syndrome and Its Components with Age-Related Cataract: The Korea National Health and Nutrition Examination Survey 2008-2010	PLOS ONE			English	Article							BEAVER DAM EYE; RETINAL MICROVASCULAR SIGNS; DISEASE RISK-FACTORS; BLUE MOUNTAINS EYE; BODY-MASS INDEX; LENS OPACITIES; CARDIOVASCULAR-DISEASE; DIABETIC CATARACT; ALDOSE REDUCTASE; 5-YEAR INCIDENCE	Purpose: To explore the relationship of the metabolic syndrome (MetS) and its components with age-related cataract in a representative Korean population. Methods: We analyzed the data from the Korea National Health and Nutrition Examination Surveys (2008-2010). A total of 11,076 adults (4,811 men and 6,265 women) aged 40 and over who completed ophthalmologic examination were evaluated. Cataract was defined as the presence of cortical, nuclear, anterior (sub) capsular or posterior subcapsular cataract, from slit-lamp examination or previous cataract surgery. MetS was defined according to the Joint Interim Statement proposed in 2009 from the International Diabetes Federation and the American Heart Association/National Heart, Lung, and Blood Institute. Results: The prevalence of cataract and MetS in this population was 39.4% (37.1% for men and 41.6% for women) and 38.5% (37.6% for men and 39.4% for women), respectively. Cataract prevalence tended to increase with the number of MetS components in both genders (both P < 0.001). After being controlled for confounders, however, MetS was significantly associated with cataract only in women (adjusted odds ratio (aOR), 1.24; 95% confidence interval (CI), 1.02-1.50]. Reduced HDL cholesterol, elevated fasting glucose, and elevated triglycerides were also significantly associated with cataract in women (aOR, 95% CI; 1.27 (1.07-1.50), 1.23 (1.01-1.50), and 1.26 (1.04-1.52), respectively). In the subgroup analysis for cataract subtype, MetS and reduced HDL cholesterol were significantly associated with nuclear cataract in women (aOR, 95% CI; 1.25 (1.07-1.55) and 1.25 (1.03-1.52), respectively). However, such associations were not found in men. Conclusions: Our results suggest that MetS and its components appear to be associated with age-related cataract only among Korean women, especially in nuclear cataract.	[Park, Young-Hoon; Shin, Jeong Ah] Catholic Univ Korea, Coll Med, Dept Ophthalmol & Visual Sci, Seoul, South Korea; [Han, Kyungdo] Catholic Univ Korea, Coll Med, Dept Biostat, Seoul, South Korea; [Han, Kyungdo; Yim, Hyeon Woo; Lee, Won-Chul; Park, Yong-Moon] Catholic Univ Korea, Coll Med, Dept Prevent Med, Seoul, South Korea; [Park, Yong-Moon] Univ S Carolina, Dept Epidemiol & Biostat, Arnold Sch Publ Hlth, Columbia, SC 29208 USA	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Park, YM (corresponding author), Catholic Univ Korea, Coll Med, Dept Prevent Med, Seoul, South Korea.	markYMpark@gmail.com	PARK, YONG-MOON ("MARK")/ABA-2765-2021	PARK, YONG-MOON ("MARK")/0000-0002-5879-6879	Catholic Medical Center Research Foundation	Catholic Medical Center Research Foundation	This work was financially supported by research grants from the Catholic Medical Center Research Foundation made in the program year of 2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham Alison G, 2006, Ophthalmol Clin North Am, V19, P415; Agarwal DP, 2002, ALCOHOL ALCOHOLISM, V37, P409, DOI 10.1093/alcalc/37.5.409; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Banos G., 2011, Cardiovascular & Hematological Agents in Medicinal Chemistry, V9, P137; Costa LA, 2004, DIABETIC MED, V21, P252, DOI 10.1111/j.1464-5491.2004.01124.x; Delcourt C, 2000, AM J EPIDEMIOL, V151, P497; Di Benedetto A, 1999, J DIABETES COMPLICAT, V13, P159, DOI 10.1016/S1056-8727(98)00023-3; Galeone C, 2010, ANN EPIDEMIOL, V20, P380, DOI 10.1016/j.annepidem.2010.01.009; Goodrich M E, 1999, Ophthalmic Epidemiol, V6, P279, DOI 10.1076/opep.6.4.279.4188; Hennis A, 2004, ARCH OPHTHALMOL-CHIC, V122, P525, DOI 10.1001/archopht.122.4.525; Hiller R, 1998, OPHTHALMOLOGY, V105, P1244, DOI 10.1016/S0161-6420(98)97029-4; Hiller R, 2003, OPHTHALMOLOGY, V110, P578, DOI 10.1016/S0161-6420(02)01762-1; Hodge WG, 1995, EPIDEMIOL REV, V17, P336, DOI 10.1093/oxfordjournals.epirev.a036197; Jacques PF, 2003, AM J CLIN NUTR, V78, P400, DOI 10.1093/ajcn/78.3.400; Kawasaki R, 2008, BRIT J OPHTHALMOL, V92, P161, DOI 10.1136/bjo.2007.127449; KINOSHITA JH, 1979, METABOLISM, V28, P462, DOI 10.1016/0026-0495(79)90057-X; Klein B E, 2001, Ophthalmic Epidemiol, V8, P251, DOI 10.1076/opep.8.4.251.1612; Klein BEK, 2007, AM J OPHTHALMOL, V144, P961, DOI 10.1016/j.ajo.2007.08.016; Klein BEK, 1998, AM J OPHTHALMOL, V126, P782, DOI 10.1016/S0002-9394(98)00280-3; Klein BEK, 1997, AM J OPHTHALMOL, V123, P338, DOI 10.1016/S0002-9394(14)70129-1; KLEIN BEK, 1995, AM J OPHTHALMOL, V119, P640, DOI 10.1016/S0002-9394(14)70223-5; KLIMOV AN, 1993, ATHEROSCLEROSIS, V100, P13, DOI 10.1016/0021-9150(93)90063-Z; LEE AYW, 1995, P NATL ACAD SCI USA, V92, P2780, DOI 10.1073/pnas.92.7.2780; Lee DH, 2013, DIABETES METAB J, V37, P132, DOI 10.4093/dmj.2013.37.2.132; Leske MC, 1999, OPHTHALMOLOGY, V106, P1893, DOI 10.1016/S0161-6420(99)90398-6; Lim LS, 2009, AM J EPIDEMIOL, V169, P1267, DOI 10.1093/aje/kwp045; Lindblad BE, 2008, OPHTHALMOLOGY, V115, P1687, DOI 10.1016/j.ophtha.2008.04.004; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meyer D, 2003, Cardiovasc J S Afr, V14, P60; Paunksnis A, 2007, EUR J OPHTHALMOL, V17, P605, DOI 10.1177/112067210701700420; Regitz-Zagrosek V, 2006, CLIN RES CARDIOL, V95, P136, DOI 10.1007/s00392-006-0351-5; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Rowe N G, 2000, Ophthalmic Epidemiol, V7, P103; Sabanayagam C, 2011, INVEST OPHTH VIS SCI, V52, P2397, DOI 10.1167/iovs.10-6373; Saxena S, 2004, OPHTHAL EPIDEMIOL, V11, P271, DOI 10.1080/09286580490510733; Schaumberg DA, 2001, ANN EPIDEMIOL, V11, P104, DOI 10.1016/S1047-2797(00)00178-2; Seah SKL, 2002, OPHTHALMOLOGY, V109, P2058, DOI 10.1016/S0161-6420(02)01221-6; STEVENS VJ, 1978, P NATL ACAD SCI USA, V75, P2918, DOI 10.1073/pnas.75.6.2918; Stitt AW, 2001, BRIT J OPHTHALMOL, V85, P746, DOI 10.1136/bjo.85.6.746; Tan GS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1354, DOI 10.1001/archophthalmol.2009.268; Tan JSL, 2008, OPHTHAL EPIDEMIOL, V15, P317, DOI 10.1080/09286580802105806; Tavani Alessandra, 1995, Annals of Epidemiology, V5, P234, DOI 10.1016/1047-2797(94)00111-6; Tsutsumi K, 1999, BIOL PHARM BULL, V22, P37, DOI 10.1248/bpb.22.37; VARMA SD, 1984, CURR EYE RES, V3, P35, DOI 10.3109/02713688408997186; von Eckardstein A, 2005, CURR OPIN CLIN NUTR, V8, P147, DOI 10.1097/00075197-200503000-00007; Weintraub JM, 2002, INT J OBESITY, V26, P1588, DOI 10.1038/sj.ijo.0802158; West S, 2007, OPHTHAL EPIDEMIOL, V14, P173, DOI 10.1080/09286580701423151; Wong TY, 2006, BRIT J OPHTHALMOL, V90, P506, DOI 10.1136/bjo.2005.083733; Wong TY, 2004, INVEST OPHTH VIS SCI, V45, P2949, DOI 10.1167/iovs.04-0069; Wu SY, 2000, INT OPHTHALMOL CLIN, V40, P71, DOI 10.1097/00004397-200010000-00006; Younan C, 2003, OPHTHALMIC EPIDEMIOL, V10, P227, DOI 10.1076/opep.10.4.227.15905	51	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85068	10.1371/journal.pone.0085068	http://dx.doi.org/10.1371/journal.pone.0085068			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416342	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500212
J	Kimura, T; Takahashi, M; Yan, K; Sakurai, H				Kimura, Toru; Takahashi, Michi; Yan, Kunimasa; Sakurai, Hiroyuki			Expression of SLC2A9 Isoforms in the Kidney and Their Localization in Polarized Epithelial Cells	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RENAL HYPOURICEMIA; DILEUCINE MOTIF; URATE EXCRETION; GLUT9; IDENTIFICATION	Background: Many genome-wide association studies pointed out that SLC2A9 gene, which encodes a voltage-driven urate transporter, SLC2A9/GLUT9 (a.k.a. URATv1), as one of the most influential genes for serum urate levels. SLC2A9 is reported to encode two splice variants: SLC2A9-S (512 amino acids) and SLC2A9-L (540 amino acids), only difference being at their N-termini. We investigated isoform-specific localization of SLC2A9 in the human kidney and role of N-terminal amino acids in differential sorting in vitro. Methodology/Principal Findings: Isoform specific antibodies against SLC2A9 were developed and human kidney sections were stained. SLC2A9-S was expressed in the apical side of the collecting duct while SLC2A9-L was expressed in the basolateral side of the proximal tubule. GFP fused SLC2A9s were expressed in MDCK cells and intracellular localization was observed. SLC2A9-S was expressed at both apical and basolateral membranes, whereas SLC2A9-L was expressed only at the basolateral membrane. Although SLC2A9-L has a putative di-leucine motif at 33th and 34th leucine, deletion of the motif or replacement of leucine did not affect its subcellular localization. When up to 16 amino acids were removed from the N-terminal of SLC2A9-S or when up to 25 amino acids were removed from the N-terminal of SLC2A9-L, there was no change in their sorting. Deletion of 20 amino acids from SLC2A9-S was not expressed in the cell. More than 30 amino acids deletion from SLC2A9-L resulted in expression at both apical and basolateral membranes as well as in the lysosome. When amino acids from 25th and 30th were changed to alanine in SLC2A9-L, expression pattern was the same as wild-type. Conclusions/Significance: SLC2A9-L was expressed in the basolateral membrane of kidney proximal tubules in humans and this isoform is likely to responsible for urate reabsorption. N-terminal amino acids unique to each isoform played an important role in protein stability and trafficking.	[Kimura, Toru; Takahashi, Michi; Sakurai, Hiroyuki] Kyorin Univ, Sch Med, Dept Pharmacol & Toxicol, Mitaka, Tokyo 181, Japan; [Yan, Kunimasa] Kyorin Univ, Sch Med, Dept Pediat, Mitaka, Tokyo 181, Japan	Kyorin University; Kyorin University	Sakurai, H (corresponding author), Kyorin Univ, Sch Med, Dept Pharmacol & Toxicol, Mitaka, Tokyo 181, Japan.	hsakurai@ks.kyorin-u.ac.jp			JSPS KAKENHI [21790819, 23791852]; Kanzawa Medical Research Foundation; Gout Research Foundation of Japan; Kyorin University School of Medicine; Grants-in-Aid for Scientific Research [23791852] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kanzawa Medical Research Foundation(Kanzawa Medical Research Foundation); Gout Research Foundation of Japan(Gout Research Foundation of Japan); Kyorin University School of Medicine; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by in whole or in part, by JSPS KAKENHI Grant Numbers 21790819 and 23791852, Kanzawa Medical Research Foundation, the Gout Research Foundation of Japan, and Kyorin University School of Medicine (Research Encouragement Award and Collaborative Project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzai N, 2008, J BIOL CHEM, V283, P26834, DOI 10.1074/jbc.C800156200; Augustin R, 2004, J BIOL CHEM, V279, P16229, DOI 10.1074/jbc.M312226200; Bibee KP, 2013, MOL CELL BIOCHEM, V376, P163, DOI 10.1007/s11010-013-1564-3; Carmosino M, 2008, MOL BIOL CELL, V19, P4341, DOI 10.1091/mbc.E08-05-0478; Caulfield MJ, 2008, PLOS MED, V5, P1509, DOI 10.1371/journal.pmed.0050197; Dinour D, 2012, NEPHROL DIAL TRANSPL, V27, P1035, DOI 10.1093/ndt/gfr419; Dinour D, 2010, J AM SOC NEPHROL, V21, P64, DOI 10.1681/ASN.2009040406; Enomoto A, 2002, NATURE, V417, P447, DOI 10.1038/nature742; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Kimura T, 2011, NUCLEOS NUCLEOT NUCL, V30, P1295, DOI 10.1080/15257770.2011.628354; Kottgen A, 2013, NAT GENET, V45, P145, DOI 10.1038/ng.2500; Kolz M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000504; Li S, 2007, PLOS GENET, V3, P2156, DOI 10.1371/journal.pgen.0030194; Lisinski I, 2001, BIOCHEM J, V358, P517, DOI 10.1042/0264-6021:3580517; Mangravite LM, 2003, AM J PHYSIOL-RENAL, V284, pF902, DOI 10.1152/ajprenal.00215.2002; Manolescu AR, 2007, MOL MEMBR BIOL, V24, P455, DOI 10.1080/09687680701298143; Matsuo H, 2008, AM J HUM GENET, V83, P744, DOI 10.1016/j.ajhg.2008.11.001; Phay JE, 2000, GENOMICS, V66, P217, DOI 10.1006/geno.2000.6195; Preitner F, 2009, P NATL ACAD SCI USA, V106, P15501, DOI 10.1073/pnas.0904411106; Regeer RR, 2004, AM J PHYSIOL-CELL PH, V287, pC365, DOI 10.1152/ajpcell.00502.2003; Schmidt U, 2006, J CELL SCI, V119, P2321, DOI 10.1242/jcs.02943; Stiburkova B, 2012, PEDIATR NEPHROL, V27, P1411, DOI 10.1007/s00467-012-2174-0; Stiburkova B, 2011, MOL GENET METAB, V102, P430, DOI 10.1016/j.ymgme.2010.12.016; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; Witkowska K, 2012, AM J PHYSIOL-RENAL, V303, pF527, DOI 10.1152/ajprenal.00134.2012; Zhao XY, 2003, J EXP MED, V197, P153, DOI 10.1084/jem.20021109	26	53	57	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84996	10.1371/journal.pone.0084996	http://dx.doi.org/10.1371/journal.pone.0084996			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409316	Green Submitted, gold, Green Published			2022-12-27	WOS:000329463500040
J	Sike, A; Nagy, E; Vedelek, B; Pusztai, D; Szeremy, P; Venetianer, A; Boros, IM				Sike, Adam; Nagy, Enikoe; Vedelek, Balazs; Pusztai, David; Szeremy, Peter; Venetianer, Aniko; Boros, Imre M.			mRNA Levels of Related Abcb Genes Change Opposite to Each Other upon Histone Deacetylase Inhibition in Drug-Resistant Rat Hepatoma Cells	PLOS ONE			English	Article							P-GLYCOPROTEIN GENE; MULTIDRUG-RESISTANCE; TRANSCRIPTIONAL REGULATION; MDR1 EXPRESSION; PROMOTER REGION; BREAST-CANCER; HUMAN GENOME; LINES; ACETYLATION; ACTIVATION	The multidrug-resistant phenotype of tumor cells is acquired via an increased capability of drug efflux by ABC transporters and causes serious problems in cancer treatment. With the aim to uncover whether changes induced by epigenetic mechanisms in the expression level of drug transporter genes correlates with changes in the drug resistance phenotypes of resistant cells, we studied the expression of drug transporters in rat hepatoma cell lines. We found that of the three major rat ABC transporter genes Abcb1a, Abcb1b and Abcc1 the activity of only Abcb1b increased significantly in colchicine-selected, drug-resistant cells. Increased transporter expression in drug-resistant cells results primarily from transcriptional activation. A change in histone modification at the regulatory regions of the chromosomally adjacent Abcb1a and Abcb1b genes differentially affects the levels of corresponding mRNAs. Transcriptional up-and down-regulation accompany an increase in acetylation levels of histone H3 lysine 9 at the promoter regions of Abcb1b and Abcb1a, respectively. Drug efflux activity, however, does not follow tightly the transcriptional activity of drug transporter genes in hepatoma cells. Our results point out the need for careful analysis of cause-and-effect relationships between changes in histone modification, drug transporter expression and drug resistance phenotypes.	[Sike, Adam; Nagy, Enikoe; Vedelek, Balazs; Pusztai, David; Boros, Imre M.] Univ Szeged, Dept Biochem & Mol Biol, Szeged, Hungary; [Boros, Imre M.] Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary; [Szeremy, Peter] SOLVO Biotechnol, Szeged, Hungary; [Venetianer, Aniko] Biol Res Ctr, Inst Genet, H-6701 Szeged, Hungary	Szeged University; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Academy of Sciences; Hungarian Biological Research Center	Boros, IM (corresponding author), Univ Szeged, Dept Biochem & Mol Biol, Szeged, Hungary.	borosi@bio.u-szeged.hu	Vedelek, Balázs/M-4274-2018	Vedelek, Balázs/0000-0001-6981-0026; Boros, Imre/0000-0001-8504-9687	European Union; Europian Social Fund [HURO/1101/173/2.2.1, TAMOP-4.2.2.A-11/1/KONV-2012-0035]; European Social Fund [TAMOP-4.2.2.A-11/1/KONV-2012-0035];  [TAMOP 4.2.4. A/2-11-1-2012-0001]	European Union(European Commission); Europian Social Fund; European Social Fund(European Social Fund (ESF)); 	This work was supported by the European Union and co-funded by the Europian Social Fund. Project numbers: HURO/1101/173/2.2.1; TAMOP-4.2.2.A-11/1/KONV-2012-0035. AS was supported by fellowships of TAMOP 4.2.4. A/2-11-1-2012-0001 "National Excellence Program - Elaborating and operating an inland student and researcher personal support system convergence program'' The project was subsidized by the European Union and co-financed by the European Social Fund and until 31st of May, 2013 from TAMOP-4.2.2/B-10/1-2010-0012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COHEN D, 1991, J BIOL CHEM, V266, P2239; CROOP JM, 1989, MOL CELL BIOL, V9, P1346, DOI 10.1128/MCB.9.3.1346; David GL, 2004, CANCER BIOL THER, V3, P540, DOI 10.4161/cbt.3.6.845; DEVAULT A, 1990, MOL CELL BIOL, V10, P1652, DOI 10.1128/MCB.10.4.1652; El-Khoury V, 2007, BRIT J CANCER, V97, P562, DOI 10.1038/sj.bjc.6603914; Eyal S, 2006, BRIT J PHARMACOL, V149, P250, DOI 10.1038/sj.bjp.0706830; FARDEL O, 1993, FEBS LETT, V327, P189, DOI 10.1016/0014-5793(93)80167-S; Fazlina N, 2008, Malays J Pathol, V30, P87; Gatti L, 2005, METH MOLEC MED, V111, P127; Hever-Szabo A, 1998, ANTICANCER RES, V18, P3045; HOLLO Z, 1994, BBA-BIOMEMBRANES, V1191, P384, DOI 10.1016/0005-2736(94)90190-2; HSU SIH, 1990, MOL CELL BIOL, V10, P3596, DOI 10.1128/MCB.10.7.3596; HSU SIH, 1989, J BIOL CHEM, V264, P12053; Jin SK, 1998, MOL CELL BIOL, V18, P4377, DOI 10.1128/MCB.18.7.4377; Katoh M, 2006, J PHARM SCI-US, V95, P2673, DOI 10.1002/jps.20686; Kim SN, 2009, MOL CANCER RES, V7, P735, DOI 10.1158/1541-7786.MCR-08-0296; Koch CM, 2007, GENOME RES, V17, P691, DOI 10.1101/gr.5704207; KOHNO K, 1994, J BIOL CHEM, V269, P20503; KUO MT, 1992, CELL GROWTH DIFFER, V3, P531; Liang GN, 2004, P NATL ACAD SCI USA, V101, P7357, DOI 10.1073/pnas.0401866101; Loeuillet C, 2007, PHARMACOGENET GENOM, V17, P951, DOI 10.1097/FPC.0b013e3282eff934; Ma XJ, 2009, DRUGS, V69, P1911, DOI 10.2165/11315680-000000000-00000; Mickley LA, 1997, J CLIN INVEST, V99, P1947, DOI 10.1172/JCI119362; Nishida H, 2006, CHROMOSOME RES, V14, P203, DOI 10.1007/s10577-006-1036-7; Pirity M, 1996, CYTOTECHNOLOGY, V19, P207, DOI 10.1007/BF00744214; Raguz S, 2008, INT J CANCER, V122, P1058, DOI 10.1002/ijc.23149; Rajagopal A, 2002, CANCER RES, V62, P391; Robey RW, 2006, CLIN CANCER RES, V12, P1547, DOI 10.1158/1078-0432.CCR-05-1423; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Sarkadi B, 2006, PHYSIOL REV, V86, P1179, DOI 10.1152/physrev.00037.2005; Schinkel AH, 1997, P NATL ACAD SCI USA, V94, P4028, DOI 10.1073/pnas.94.8.4028; SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7; Schwab D, 2003, J MED CHEM, V46, P1716, DOI 10.1021/jm021012t; Scotto KW, 2003, ONCOGENE, V22, P7496, DOI 10.1038/sj.onc.1206950; SHEN DW, 1986, SCIENCE, V232, P643, DOI 10.1126/science.3457471; SONG RD, 1995, J BIOL CHEM, V270, P25468, DOI 10.1074/jbc.270.43.25468; STEIN U, 1994, EUR J CANCER, V30A, P1541, DOI 10.1016/0959-8049(94)00287-F; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; TEETER LD, 1993, MOL CARCINOGEN, V8, P67, DOI 10.1002/mc.2940080202; Toth M, 2012, CANC SCI; UEDA K, 1987, J BIOL CHEM, V262, P17432; Yague E, 2003, J BIOL CHEM, V278, P10344, DOI 10.1074/jbc.M211093200; YANG CPH, 1990, J BIOL CHEM, V265, P10282; Yatouji S, 2007, INT J ONCOL, V30, P1003; ZHAO JY, 1993, ENDOCRINOLOGY, V133, P521, DOI 10.1210/en.133.2.521	45	5	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84915	10.1371/journal.pone.0084915	http://dx.doi.org/10.1371/journal.pone.0084915			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409311	gold, Green Submitted, Green Published			2022-12-27	WOS:000329463500035
J	Sripetchwandee, J; Pipatpiboon, N; Chattipakorn, N; Chattipakorn, S				Sripetchwandee, Jirapas; Pipatpiboon, Noppamas; Chattipakorn, Nipon; Chattipakorn, Siriporn			Combined Therapy of Iron Chelator and Antioxidant Completely Restores Brain Dysfunction Induced by Iron Toxicity	PLOS ONE			English	Article							RECOGNITION MEMORY IMPAIRMENT; INSULIN-RECEPTOR FUNCTION; INDUCED OXIDATIVE STRESS; SYNAPTIC PLASTICITY; MITOCHONDRIAL DYSFUNCTION; INFLAMMATION ALTERS; EXPERIMENTAL STROKE; LIPID-PEROXIDATION; N-ACETYLCYSTEINE; OVERLOAD	Background: Excessive iron accumulation leads to iron toxicity in the brain; however the underlying mechanism is unclear. We investigated the effects of iron overload induced by high iron-diet consumption on brain mitochondrial function, brain synaptic plasticity and learning and memory. Iron chelator (deferiprone) and antioxidant (n-acetyl cysteine) effects on iron-overload brains were also studied. Methodology: Male Wistar rats were fed either normal diet or high iron-diet consumption for 12 weeks, after which rats in each diet group were treated with vehicle or deferiprone (50 mg/kg) or n-acetyl cysteine (100 mg/kg) or both for another 4 weeks. High iron-diet consumption caused brain iron accumulation, brain mitochondrial dysfunction, impaired brain synaptic plasticity and cognition, blood-brain-barrier breakdown, and brain apoptosis. Although both iron chelator and antioxidant attenuated these deleterious effects, combined therapy provided more robust results. Conclusion: In conclusion, this is the first study demonstrating that combined iron chelator and anti-oxidant therapy completely restored brain function impaired by iron overload.	[Sripetchwandee, Jirapas; Pipatpiboon, Noppamas; Chattipakorn, Nipon; Chattipakorn, Siriporn] Chiang Mai Univ, Fac Med, Cardiac Electrophysiol Res & Training Ctr, Neurophysiol Unit,Dept Physiol, Chiang Mai 50000, Thailand; [Chattipakorn, Siriporn] Chiang Mai Univ, Fac Dent, Dept Oral Biol & Diagnost Sci, Chiang Mai 50000, Thailand	Chiang Mai University; Chiang Mai University	Chattipakorn, N (corresponding author), Chiang Mai Univ, Fac Med, Cardiac Electrophysiol Res & Training Ctr, Neurophysiol Unit,Dept Physiol, Chiang Mai 50000, Thailand.	scchattipakorn@gmail.com	Chattipakorn, Nipon/AAJ-4049-2021	Pipatpiboon, Noppamas/0000-0001-8600-7681; Sripetchwandee, Jirapas/0000-0002-4473-7018; Chattipakorn, Nipon/0000-0003-3026-718X	Thailand Research Fund TRF-BRG [TRF-RTA5580006]; Faculty of Medicine Chiang Mai University Endowment Fund; National Research Council of Thailand; Thailand Research Fund through the Royal Golden Jubilee Program [PHD/0248/2552]; Chiang Mai University Excellent Center Award	Thailand Research Fund TRF-BRG(Thailand Research Fund (TRF)); Faculty of Medicine Chiang Mai University Endowment Fund; National Research Council of Thailand(National Research Council of Thailand (NRCT)); Thailand Research Fund through the Royal Golden Jubilee Program; Chiang Mai University Excellent Center Award	This work was supported by grants from the Thailand Research Fund TRF-BRG (SC), TRF-RTA5580006 (NC), Faculty of Medicine Chiang Mai University Endowment Fund (NC), National Research Council of Thailand (SC), Thailand Research Fund through the Royal Golden Jubilee Program (PHD/0248/2552: JS and SC), and Chiang Mai University Excellent Center Award (NC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GJ, 2007, AM J HEMATOL, V82, P1128, DOI 10.1002/ajh.21075; Armstrong FD, 2005, ANN NY ACAD SCI, V1054, P283, DOI 10.1196/annals.1345.036; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Barichello T, 2012, EUR J CLIN MICROBIOL, V31, P2005, DOI 10.1007/s10096-011-1533-2; Barluzzi R, 2002, J NEUROIMMUNOL, V132, P140, DOI 10.1016/S0165-5728(02)00324-7; Bartfay W J, 2000, Biol Res Nurs, V2, P49, DOI 10.1177/109980040000200106; Benarroch EE, 2009, NEUROLOGY, V72, P1436, DOI 10.1212/WNL.0b013e3181a26b30; Boddaert N, 2007, BLOOD, V110, P401, DOI 10.1182/blood-2006-12-065433; Cassinerio E, 2012, ANN HEMATOL, V91, P1443, DOI 10.1007/s00277-012-1480-8; Ceci A, 2003, EXPERT OPIN PHARMACO, V4, P1763, DOI 10.1517/14656566.4.10.1763; Chelli B, 2001, BIOCHEM PHARMACOL, V61, P695, DOI 10.1016/S0006-2952(00)00588-8; Cheng J, 2011, EUR J PHARMACOL, V650, P184, DOI 10.1016/j.ejphar.2010.09.033; Citri A, 2008, NEUROPSYCHOPHARMACOL, V33, P18, DOI 10.1038/sj.npp.1301559; Combes V, 2012, TRENDS PARASITOL, V28, P311, DOI 10.1016/j.pt.2012.05.008; Connor JR, 1996, GLIA, V17, P83, DOI 10.1002/(SICI)1098-1136(199606)17:2<83::AID-GLIA1>3.0.CO;2-7; Crichton RR, 2002, J INORG BIOCHEM, V91, P9, DOI 10.1016/S0162-0134(02)00461-0; Darley-Usmar V, 2004, FREE RADICAL BIO MED, V37, P753, DOI 10.1016/j.freeradbiomed.2004.05.026; de Lima MNM, 2007, EUR J PHARMACOL, V570, P111, DOI 10.1016/j.ejphar.2007.06.002; de Lima MNM, 2005, EUR J NEUROSCI, V21, P2521, DOI 10.1111/j.1460-9568.2005.04083.x; DENENBERG VH, 1969, ANN NY ACAD SCI, V159, P852, DOI 10.1111/j.1749-6632.1969.tb12983.x; Denes A, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-164; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Fabian E, 2011, J ASTHMA, V48, P351, DOI 10.3109/02770903.2011.560319; Farr SA, 2003, J NEUROCHEM, V84, P1173, DOI 10.1046/j.1471-4159.2003.01580.x; Fredenburg AM, 1996, TOXICOLOGY, V108, P191, DOI 10.1016/0300-483X(95)03301-U; Fretham SJB, 2011, ADV NUTR, V2, P112, DOI 10.3945/an.110.000190; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Gao YG, 2013, J ETHNOPHARMACOL, V145, P254, DOI 10.1016/j.jep.2012.10.060; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hershko C, 2010, ANN NY ACAD SCI, V1202, P1, DOI 10.1111/j.1749-6632.2010.05544.x; Hidalgo C, 2007, IUBMB LIFE, V59, P280, DOI 10.1080/15216540701222906; Hider RC, 2011, METALLOMICS, V3, P239, DOI 10.1039/c0mt00087f; Hua Y, 2008, ACTA NEUROCHIR SUPPL, V105, P3; Jamuar SS, 2012, THER ADV HEMATOL, V3, P299, DOI 10.1177/2040620712450252; JANERO DR, 1989, LIPIDS, V24, P125, DOI 10.1007/BF02535249; Jomova K, 2011, CURR PHARM DESIGN, V17, P3460, DOI 10.2174/138161211798072463; Khanna AK, 2012, LAB INVEST, V92, P224, DOI 10.1038/labinvest.2011.146; Kontoghiorghes GJ, 2010, HEMOGLOBIN, V34, P227, DOI 10.3109/03630269.2010.483662; Koppenol WH, 2001, REDOX REP, V6, P229, DOI 10.1179/135100001101536373; Kulawiak B, 2008, EXP NEUROL, V212, P543, DOI 10.1016/j.expneurol.2008.05.004; Kumfu S, 2012, BIOMETALS, V25, P1167, DOI 10.1007/s10534-012-9579-x; Kumfu S, 2012, EUR J HAEMATOL, V88, P535, DOI 10.1111/j.1600-0609.2012.01779.x; Lekawanvijit S, 2009, CAN J CARDIOL, V25, P213, DOI 10.1016/S0828-282X(09)70064-9; Liang LP, 2008, J NEUROSCI, V28, P11550, DOI 10.1523/JNEUROSCI.3016-08.2008; Liu WL, 2009, J NEUROCHEM, V108, P811, DOI 10.1111/j.1471-4159.2008.05821.x; Lochhead JJ, 2010, J CEREBR BLOOD F MET, V30, P1625, DOI 10.1038/jcbfm.2010.29; Long JG, 2009, NEUROCHEM RES, V34, P786, DOI 10.1007/s11064-008-9882-7; Maaroufi K, 2011, NEUROSCIENCE, V186, P39, DOI 10.1016/j.neuroscience.2011.04.003; Maaroufi K, 2009, NEUROBIOL LEARN MEM, V92, P345, DOI 10.1016/j.nlm.2009.04.002; Mariani R, 2009, MEDITERR J HEMATOL I, V1, DOI [10.4084/MMID.2009.006, 10.4084/MJHID.2009.006]; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; McColl BW, 2008, J NEUROSCI, V28, P9451, DOI 10.1523/JNEUROSCI.2674-08.2008; McNeill Alisdair, 2011, Handb Clin Neurol, V100, P161, DOI 10.1016/B978-0-444-52014-2.00009-4; Mehta V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057573; Miura Y, 2010, CASE REP MED, V2010, DOI 10.1155/2010/675060; Monastero R, 2000, ACTA NEUROL SCAND, V102, P162, DOI 10.1034/j.1600-0404.2000.102003162.x; Munoz P, 2011, J BIOL CHEM, V286, P13382, DOI 10.1074/jbc.M110.213785; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Novalija E, 2003, ANESTHESIOLOGY, V98, P1155, DOI 10.1097/00000542-200305000-00018; Origa R, 2007, HAEMATOL-HEMATOL J, V92, P583, DOI 10.3324/haematol.10842; Ortiz GG, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/708659; Perez VP, 2010, CURR NEUROVASC RES, V7, P15, DOI 10.2174/156720210790820172; Pipatpiboon N, 2013, EUR J NEUROSCI, V37, P839, DOI 10.1111/ejn.12088; Pipatpiboon N, 2012, ENDOCRINOLOGY, V153, P329, DOI 10.1210/en.2011-1502; Ramm GA, 2005, SEMIN LIVER DIS, V25, P433, DOI 10.1055/s-2005-923315; Rebouche CJ, 2004, J BIOCHEM BIOPH METH, V58, P239, DOI 10.1016/j.jbbm.2003.11.003; Reddy PH, 2011, CURR ALZHEIMER RES, V8, P393; Reddy PS, 2011, J TRACE ELEM MED BIO, V25, P247, DOI 10.1016/j.jtemb.2011.08.145; Ruiz-Meana M, 2006, CARDIOVASC RES, V71, P715, DOI 10.1016/j.cardiores.2006.06.019; Sen T, 2006, NEUROCHEM INT, V49, P20, DOI 10.1016/j.neuint.2005.12.018; Spellberg B, 2009, ANTIMICROB AGENTS CH, V53, P3122, DOI 10.1128/AAC.00361-09; Sripetchwandee J, 2013, LIFE SCI, V92, P298, DOI 10.1016/j.lfs.2013.01.004; Stanford SC, 2007, J PSYCHOPHARMACOL, V21, P134, DOI 10.1177/0269881107073199; Tong V, 2005, TOXICOL SCI, V86, P436, DOI 10.1093/toxsci/kfi185; Urrutia P, 2013, J NEUROCHEM, V126, P541, DOI 10.1111/jnc.12244; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Vannuvel K, 2013, J CELL PHYSIOL, V228, P1802, DOI 10.1002/jcp.24360; Vatassery GT, 2004, BBA-MOL BASIS DIS, V1688, P265, DOI 10.1016/j.bbadis.2003.12.013; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Walker J M, 1994, Methods Mol Biol, V32, P5; WEISS G, 1994, J EXP MED, V180, P969, DOI 10.1084/jem.180.3.969; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; Won SM, 2011, EXP MOL MED, V43, P121, DOI 10.3858/emm.2011.43.2.020; YEHUDA S, 1986, PHARMACOL BIOCHEM BE, V25, P141, DOI 10.1016/0091-3057(86)90244-3; Yin F, 2012, ANTIOXID REDOX SIGNA; YOUDIM MBH, 1978, P NUTR SOC, V37, P173, DOI 10.1079/PNS19780022; Zagaar M, 2013, SLEEP, V36, P751, DOI 10.5665/sleep.2642; Zarember KA, 2009, ANTIMICROB AGENTS CH, V53, P2654, DOI 10.1128/AAC.01547-08; Zhu Y, 2012, MOL BIOL REP, V39, P3727, DOI 10.1007/s11033-011-1148-9	89	65	66	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e85115	10.1371/journal.pone.0085115	http://dx.doi.org/10.1371/journal.pone.0085115			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400127	Green Published, Green Submitted, gold			2022-12-27	WOS:000329462700061
J	Kauder, SE; Santell, L; Mai, E; Wright, LY; Luis, E; N'Diaye, EN; Lutman, J; Ratti, N; Sa, SM; Maun, HR; Stefanich, E; Gonzalez, LC; Graham, RR; Diehl, L; Faubion, WA; Keir, ME; Young, J; Chaudhuri, A; Lazarus, RA; Egen, JG				Kauder, Steven E.; Santell, Lydia; Mai, Elaine; Wright, Lilyan Y.; Luis, Elizabeth; N'Diaye, Elsa N.; Lutman, Jeff; Ratti, Navneet; Sa, Susan M.; Maun, Henry R.; Stefanich, Eric; Gonzalez, Lino C.; Graham, Robert R.; Diehl, Lauri; Faubion, William A., Jr.; Keir, Mary E.; Young, Judy; Chaudhuri, Amitabha; Lazarus, Robert A.; Egen, Jackson G.			Functional Consequences of the Macrophage Stimulating Protein 689C Inflammatory Bowel Disease Risk Allele	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; GENOME-WIDE ASSOCIATION; ULCERATIVE-COLITIS; BETA-CHAIN; PERITONEAL-MACROPHAGES; PROTEOLYTIC CLEAVAGE; CRYSTAL-STRUCTURE; IFN-GAMMA; RON; EXPRESSION	Background: Macrophage stimulating protein (MSP) is a serum growth factor that binds to and activates the receptor tyrosine kinase, Recepteur d'Origine Nantais (RON). A non-synonymous coding variant in MSP (689C) has been associated with genetic susceptibility to both Crohn's disease and ulcerative colitis, two major types of inflammatory bowel disease (IBD) characterized by chronic inflammation of the digestive tract. We investigated the consequences of this polymorphism for MSP-RON pathway activity and IBD pathogenesis. Methods: RON expression patterns were examined on mouse and human cells and tissues under normal and disease conditions to identify cell types regulated by MSP-RON. Recombinant MSP variants were tested for their ability to bind and stimulate RON and undergo proteolytic activation. MSP concentrations were quantified in the serum of individuals carrying the MSP 689R and 689C alleles. Results: In intestinal tissue, RON was primarily expressed by epithelial cells under normal and disease conditions. The 689C polymorphism had no impact on the ability of MSP to bind to or signal through RON. In a cohort of normal individuals and IBD patients, carriers of the 689C polymorphism had lower concentrations of MSP in their serum. Conclusions: By reducing the quantities of circulating MSP, the 689C polymorphism, or a variant in linkage disequilibrium with this polymorphism, may impact RON ligand availability and thus receptor activity. Given the known functions of RON in regulating wound healing and our analysis of RON expression patterns in human intestinal tissue, these data suggest that decreased RON activity may impact the efficiency of epithelial repair and thus underlie the increased IBD susceptibility associated with the MSP 689C allele.	[Kauder, Steven E.; N'Diaye, Elsa N.; Egen, Jackson G.] Genentech Inc, Discovery Immunol, San Francisco, CA 94080 USA; [Santell, Lydia; Maun, Henry R.; Lazarus, Robert A.] Genentech Inc, Early Discovery Biochem, San Francisco, CA 94080 USA; [Mai, Elaine; Young, Judy] Genentech Inc, Biochem & Cellular Pharmacol, San Francisco, CA 94080 USA; [Wright, Lilyan Y.; Keir, Mary E.] Genentech Inc, Immunol Tissue Growth & Repair Diagnost Discovery, San Francisco, CA 94080 USA; [Luis, Elizabeth; Gonzalez, Lino C.] Genentech Inc, Prot Chem, San Francisco, CA 94080 USA; [Lutman, Jeff; Stefanich, Eric] Genentech Inc, Pharmacokinet & Pharmacodynam, San Francisco, CA 94080 USA; [Ratti, Navneet; Sa, Susan M.; Diehl, Lauri] Genentech Inc, Pathol, San Francisco, CA 94080 USA; [Graham, Robert R.] Genentech Inc, Immunol Tissue Growth & Repair Human Genet, San Francisco, CA 94080 USA; [Chaudhuri, Amitabha] Genentech Inc, Mol Oncol, San Francisco, CA 94080 USA; [Faubion, William A., Jr.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Mayo Clinic	Egen, JG (corresponding author), Genentech Inc, Discovery Immunol, San Francisco, CA 94080 USA.	egen.jackson@gene.com	Gonzalez, Lino/E-4102-2012	Gonzalez, Lino/0000-0003-3817-6450; Egen, Jackson/0000-0003-2053-0837	Genentech, Inc.	Genentech, Inc.(Roche HoldingGenentech)	This work was supported by Genentech, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Anderson CA, 2009, GASTROENTEROLOGY, V136, P523, DOI 10.1053/j.gastro.2008.10.032; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Benight NM, 2012, EXPERT OPIN THER TAR, V16, P921, DOI 10.1517/14728222.2012.710200; Brunelleschi S, 2001, BRIT J PHARMACOL, V134, P1285, DOI 10.1038/sj.bjp.0704356; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carafoli F, 2005, FEBS J, V272, P5799, DOI 10.1111/j.1742-4658.2005.04968.x; Chao KLL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041912; Chaudhuri A, 2013, IMMUNOL CELL BIOL, V91, P451, DOI 10.1038/icb.2013.27; Chaudhuri A, 2011, J BIOL CHEM, V286, P32762, DOI 10.1074/jbc.M111.239384; Chen YQ, 1998, J IMMUNOL, V161, P4950; Correll Pamela H., 1997, Genes and Function, V1, P69; Danilkovitch A, 1999, EXP CELL RES, V248, P575, DOI 10.1006/excr.1999.4429; Danilkovitch A, 2000, MOL CELL BIOL, V20, P2218, DOI 10.1128/MCB.20.6.2218-2227.2000; Danilkovitch A, 1999, J BIOL CHEM, V274, P29937, DOI 10.1074/jbc.274.42.29937; DONATE LE, 1994, PROTEIN SCI, V3, P2378, DOI 10.1002/pro.5560031222; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; Faubion Jr WA, 2013, AM J GASTROENTEROL; Franke A, 2010, NAT GENET, V42, P292, DOI 10.1038/ng.553; Ganesan R, 2012, PROTEIN ENG DES SEL, V25, P127, DOI 10.1093/protein/gzr067; Ganesan R, 2011, MOL CANCER RES, V9, P1175, DOI 10.1158/1541-7786.MCR-11-0004; GAUDINO G, 1994, EMBO J, V13, P3524, DOI 10.1002/j.1460-2075.1994.tb06659.x; Gaudino G, 1995, ONCOGENE, V11, P2627; Gorlatova N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027269; Goyette P, 2008, MUCOSAL IMMUNOL, V1, P131, DOI 10.1038/mi.2007.15; Hauser F, 2012, GENES IMMUN, V13, P321, DOI 10.1038/gene.2011.88; IWAMA A, 1995, BLOOD, V86, P3394, DOI 10.1182/blood.V86.9.3394.bloodjournal8693394; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Jubb Adrian M, 2006, Methods Mol Biol, V326, P255; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Leonard EJ, 1996, J LEUKOCYTE BIOL, V60, P453, DOI 10.1002/jlb.60.4.453; LLC. Schrodinger, PYMOL MOL GRAPH SYST; Medico E, 1996, MOL BIOL CELL, V7, P495, DOI 10.1091/mbc.7.4.495; Melum E, 2011, NAT GENET, V43, P17, DOI 10.1038/ng.728; Montero-Julian FA, 1998, HYBRIDOMA, V17, P541, DOI 10.1089/hyb.1998.17.541; Morrison AC, 2004, J IMMUNOL, V172, P1825, DOI 10.4049/jimmunol.172.3.1825; Morrison AC, 2002, J IMMUNOL, V168, P853, DOI 10.4049/jimmunol.168.2.853; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Nanney LB, 1998, J INVEST DERMATOL, V111, P573, DOI 10.1046/j.1523-1747.1998.00332.x; Okino T, 2001, DIGEST DIS SCI, V46, P424, DOI 10.1023/A:1005673420464; Santoro MM, 2003, DEV CELL, V5, P257, DOI 10.1016/S1534-5807(03)00201-6; Sharda DR, 2011, J IMMUNOL, V187, P2181, DOI 10.4049/jimmunol.1003460; Srivastava B, 2012, SCAND J GASTROENTERO, V47, P820, DOI 10.3109/00365521.2012.682090; Stamos J, 2004, EMBO J, V23, P2325, DOI 10.1038/sj.emboj.7600243; Stuart WD, 2011, HEPATOLOGY, V53, P1618, DOI 10.1002/hep.24239; Wahl RC, 1997, J BIOL CHEM, V272, P15053, DOI 10.1074/jbc.272.24.15053; Waltz SE, 2001, J CLIN INVEST, V108, P567, DOI 10.1172/JCI11881; WANG MH, 1994, SCIENCE, V266, P117, DOI 10.1126/science.7939629; Wang MH, 1997, J BIOL CHEM, V272, P16999, DOI 10.1074/jbc.272.27.16999; Wang MH, 1996, J CLIN INVEST, V97, P720, DOI 10.1172/JCI118470; WANG MH, 1994, J BIOL CHEM, V269, P3436; Wilson CB, 2008, J IMMUNOL, V181, P2303, DOI 10.4049/jimmunol.181.4.2303; Yao HP, 2013, NAT REV CANCER, V13, P466, DOI 10.1038/nrc3545; YOSHIMURA T, 1993, J BIOL CHEM, V268, P15461	56	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e83958	10.1371/journal.pone.0083958	http://dx.doi.org/10.1371/journal.pone.0083958			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24409221	gold, Green Submitted, Green Published			2022-12-27	WOS:000328882000134
J	He, ZJ; Wang, XL; Wu, Y; Jia, J; Hu, YS; Yang, XJ; Li, JQ; Fan, MX; Zhang, L; Guo, JC; Leung, MCP				He, Zhijie; Wang, Xiaolou; Wu, Yi; Jia, Jie; Hu, Yongshan; Yang, Xiaojiao; Li, Jianqi; Fan, Mingxia; Zhang, Li; Guo, Jinchun; Leung, Mason C. P.			Treadmill Pre-Training Ameliorates Brain Edema in Ischemic Stroke via Down-Regulation of Aquaporin-4: An MRI Study in Rats	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; BARRIER DYSFUNCTION; TRANSGENIC MICE; GENE DELETION; BLOOD; EXPRESSION; INJURY; GLUTAMATE; ANGIOGENESIS; REPERFUSION	Objective: Treadmill pre-training can ameliorate blood brain barrier (BBB) dysfunction in ischemia-reperfusion injury, however, its role in ischemic brain edema remains unclear. This study assessed the neuroprotective effects induced by treadmill pre-training, particularly on brain edema in transient middle cerebral artery occluded model. Methods: Transient middle cerebral artery occlusion to induce stroke was performed on rats after 2 weeks of treadmill pre-training. Magnetic resonance imaging (MRI) was used to evaluate the dynamic impairment of cerebral edema after ischemia-reperfusion injury. In addition, measurements of wet and dry brain weight, Evans Blue assay and Garcia scores were performed to investigate the cerebral water content, BBB permeability and neurologic deficit, respectively. Moreover, during ischemia-reperfusion injury, the expression of Aquaporin 4 (AQP4) was detected using immunofluorescence and Western bloting analyses. Results: Treadmill pre-training improved the relative apparent diffusion coefficient (rADC) loss in the ipsilateral cortex and striatum at 1 hour and 2.5 hours after cerebral ischemia. In the treadmill pre-training group, T2W1 values of the ipsilateral cortex and striatum increased less at 7.5 hours, 1 day, and 2 days after stroke while the brain water content decreased at 2 days after ischemia. Regarding the BBB permeability, the semi-quantitative amount of contrast agent leakage of treadmill pre-training group significantly decreased. Less Evans Blue exudation was also observed in treadmill pre-training group at 2 days after stroke. In addition, treadmill pre-training mitigated the Garcia score deficits at 2 days after stroke. Immunofluorescence staining and Western blotting results showed a significant decrease in the expression of AQP4 after treadmill ischemia following pre-training. Conclusions: Treadmill pre-training may reduce cerebral edema and BBB dysfunction during cerebral ischemia/reperfusion injury via the down-regulation of AQP4.	[He, Zhijie; Wang, Xiaolou; Wu, Yi; Jia, Jie; Hu, Yongshan; Yang, Xiaojiao; Zhang, Li] Fudan Univ, Huashan Hosp, Dept Rehabil, Shanghai 200433, Peoples R China; [Li, Jianqi; Fan, Mingxia] E China Normal Univ, Dept Phys, Shanghai Key Lab Magnet Resonance, Shanghai 200062, Peoples R China; [Hu, Yongshan; Guo, Jinchun] Fudan Univ, Shanghai Med Coll, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Leung, Mason C. P.] Hong Kong Polytech Univ, Dept Rehabil Sci, Kowloon, Hong Kong, Peoples R China	Fudan University; East China Normal University; Fudan University; Hong Kong Polytechnic University	Jia, J (corresponding author), Fudan Univ, Huashan Hosp, Dept Rehabil, Shanghai 200433, Peoples R China.	shannonjj@126.com; jingchunguo@shmu.edu.cn			National Natural Science Foundation of China [81171855, 81171856, 81272169]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The present study is supported by the National Natural Science Foundation of China (grant NO. 81171855, 81171856 and 81272169). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JJ, 2008, NEUROCHEM INT, V52, P447, DOI 10.1016/j.neuint.2007.08.006; Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P2106, DOI 10.1073/pnas.0437946100; Aoki K, 2003, ACTA NEUROPATHOL, V106, P121, DOI 10.1007/s00401-003-0709-y; Badaut J, 2007, PEDIATR RES, V62, P248, DOI 10.1203/PDR.0b013e3180db291b; Baskaya MK, 2000, J NEUROSURG, V92, P448, DOI 10.3171/jns.2000.92.3.0448; Belayev L, 1996, BRAIN RES, V739, P88, DOI 10.1016/S0006-8993(96)00815-3; Bloch O, 2005, J NEUROCHEM, V95, P254, DOI 10.1111/j.1471-4159.2005.03362.x; Carmichael S Thomas, 2005, NeuroRx, V2, P396; Denes A, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-164; Ding YH, 2005, ACTA NEUROPATHOL, V109, P237, DOI 10.1007/s00401-004-0943-y; Francesca B, 2010, CURR NEUROPHARMACOL, V8, P92, DOI 10.2174/157015910791233132; Fryclenlund DS, 2006, P NATL ACAD SCI USA, V103, P13532, DOI 10.1073/pnas.0605796103; Furman CS, 2003, P NATL ACAD SCI USA, V100, P13609, DOI 10.1073/pnas.2235843100; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Guo M, 2008, NEUROSCIENCE, V151, P340, DOI 10.1016/j.neuroscience.2007.10.006; Guo M, 2008, J CEREBR BLOOD F MET, V28, P1422, DOI 10.1038/jcbfm.2008.29; Hoshi A, 2011, EXP NEUROL, V227, P89, DOI 10.1016/j.expneurol.2010.09.016; Huang CX, 2013, NEUROSCIENCE, V233, P139, DOI 10.1016/j.neuroscience.2012.12.046; Igarashi H, 2011, NEUROL SCI, V32, P113, DOI 10.1007/s10072-010-0431-1; Israeli D, 2011, INT J BIOL SCI, V7, P1; Jia J, 2010, EXP BRAIN RES, V204, P173, DOI 10.1007/s00221-010-2320-5; Jia J, 2009, LIFE SCI, V84, P505, DOI 10.1016/j.lfs.2009.01.015; Kahle KT, 2009, PHYSIOLOGY, V24, P257, DOI 10.1152/physiol.00015.2009; Laird MD, 2010, J NEUROCHEM, V113, P637, DOI 10.1111/j.1471-4159.2010.06630.x; Liu XQ, 2008, J CEREBR BLOOD F MET, V28, P1898, DOI 10.1038/jcbfm.2008.83; Liu YQ, 2002, PEDIATR RES, V51, P25, DOI 10.1203/00006450-200201000-00007; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Nielsen S, 1997, J NEUROSCI, V17, P171; Papadopoulos MC, 2007, PEDIATR NEPHROL, V22, P778, DOI 10.1007/s00467-006-0411-0; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Phillips MD, 1999, NEUROIMAG CLIN N AM, V9, P41; Pillai DR, 2009, J CEREBR BLOOD F MET, V29, P1846, DOI 10.1038/jcbfm.2009.106; Rash JE, 1998, P NATL ACAD SCI USA, V95, P11981, DOI 10.1073/pnas.95.20.11981; Saadoun S, 2009, NEUROSCIENCE, V161, P764, DOI 10.1016/j.neuroscience.2009.03.069; Stoll G, 2009, J CEREBR BLOOD F MET, V29, P331, DOI 10.1038/jcbfm.2008.129; Swain RA, 2003, NEUROSCIENCE, V117, P1037, DOI 10.1016/S0306-4522(02)00664-4; Tait MJ, 2008, TRENDS NEUROSCI, V31, P37, DOI 10.1016/j.tins.2007.11.003; Taniguchi M, 2000, MOL BRAIN RES, V78, P131, DOI 10.1016/S0169-328X(00)00084-X; Vajda Z, 2002, P NATL ACAD SCI USA, V99, P13131, DOI 10.1073/pnas.192457099; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Wang Che-Chuan, 2010, BMC Pharmacology, V10, P11, DOI 10.1186/1471-2210-10-11; Yang BX, 2008, J BIOL CHEM, V283, P15280, DOI 10.1074/jbc.M801425200; Zeng XN, 2007, MOL CELL NEUROSCI, V34, P34, DOI 10.1016/j.mcn.2006.09.008; Zhang F, 2010, MOLECULES, V15, P5246, DOI 10.3390/molecules15085246; Zhang F, 2010, INT J MOL SCI, V11, P2658, DOI 10.3390/ijms11072658; Zhang PY, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-43	47	30	33	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84602	10.1371/journal.pone.0084602	http://dx.doi.org/10.1371/journal.pone.0084602			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416250	Green Published, Green Submitted, gold			2022-12-27	WOS:000329866300030
J	Liu, YJ; Yan, BB; Huang, ZY; Guo, R; Wu, JX; Liu, X; Yao, KQ; Lv, FJ; Deng, HS				Liu, Yijun; Yan, Bingbing; Huang, Ziyang; Guo, Rui; Wu, Jingxing; Liu, Xun; Yao, Kaiqing; Lv, Fajin; Deng, Huisheng			Feasibility and Safety of Fiber Optic Micro-Imaging in Canine Peripheral Airways	PLOS ONE			English	Article							BRONCHOSCOPY; DUCTOSCOPY; DIAGNOSIS	Purpose: To assess the feasibility and safety of imaging canine peripheral airways (<1 mm) with an experimental micro-imaging fiber optic bronchoscope. Methods: Twenty healthy dogs were scoped with a micro-imaging fiber optic bronchoscope (0.8 mm outer diameter). Images at various levels of the bronchioles, mucosal color, and tracheal secretions were recorded. The apparatus was stopped once it was difficult to insert. CT imaging was performed simultaneously to monitor progression. The safety of the device was evaluated by monitoring heart rate (HR), respiratory rate (RR), mean artery pressure (MAP), peripheral oxygen saturation (SpO(2)) and arterial blood gases (partial pressure of arterial carbon-dioxide, PaCO2, partial pressure of arterial oxygen, PaO2, and blood pH). Results: (1) According to the CT scan, the micro-imaging fiber was able to access the peripheral airways (<1 mm) in canines. (2) There was no significant change in the values of HR, MAP, pH and PaCO2 during the procedure (P > 0.05). Comparing pre-manipulation and post-manipulation values, SpO(2) (F = 13.06, P < 0.05) and PaO2 (F = 3.01, P = 0.01) were decreased, whereas RR (F = 3.85, P < 0.05) was elevated during the manipulation. (3) Self-limited bleeding was observed in one dog; severe bleeding or other complications did not occur. Conclusion: Although the new apparatus had little effect on SpO(2), PaO2 and RR, it can probe into small peripheral airways (<1 mm), which may provide a new platform for the early diagnosis of bronchiolar diseases.	[Liu, Yijun; Yan, Bingbing; Huang, Ziyang; Liu, Xun; Deng, Huisheng] Chongqing Med Univ, Affiliated Hosp 1, Dept Geriatr, Chongqing, Peoples R China; [Guo, Rui] Chongqing Med Univ, Affiliated Hosp 1, Dept Crit Care Med, Chongqing, Peoples R China; [Yao, Kaiqing; Lv, Fajin] Chongqing Med Univ, Affiliated Hosp 1, Dept Radiol, Chongqing, Peoples R China; [Wu, Jingxing] Chongqing Med Univ, Affiliated Hosp 1, Dept Resp, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Deng, HS (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Geriatr, Chongqing, Peoples R China.	denghuisheng_2004@163.com			Chongqing Science & Technology Commission (CSTC) [2009ab5218]; National Nature Science Foundation of China [81201173]	Chongqing Science & Technology Commission (CSTC)(Natural Science Foundation Project of CQ CSTC); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Chongqing Science & Technology Commission (CSTC, 2009ab5218) and the National Nature Science Foundation of China (No, 81201173). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brims FJH, 2012, CLIN RESPIR J, V6, P144, DOI 10.1111/j.1752-699X.2011.00254.x; Chung Kian Fan, 2013, Cough, V9, P6, DOI 10.1186/1745-9974-9-6; Colby TV, 1998, AM J CLIN PATHOL, V109, P101; Eberhardt R, 2010, J THORAC ONCOL, V5, P1559, DOI 10.1097/JTO.0b013e3181e8b308; Kaneko M, 2010, JPN J CLIN ONCOL, V40, P838, DOI 10.1093/jjco/hyq136; Liu GY, 2008, BREAST CANCER RES TR, V108, P271, DOI 10.1007/s10549-007-9598-4; Lv JJ, 2013, RESP CARE, V58, P1637, DOI 10.4187/respcare.01982; Martin-Loeches I, 2012, MED INTENSIVA, V36, P644, DOI 10.1016/j.medin.2012.09.001; MEAD J, 1970, NEW ENGL J MED, V282, P1318, DOI 10.1056/NEJM197006042822311; Nair A, 2012, RADIOGRAPHICS, V32, pE201, DOI 10.1148/rg.325115133; O JH, 2007, J NUCL MED, V48, P15; Rice A, 2009, HISTOPATHOLOGY, V54, P117, DOI 10.1111/j.1365-2559.2008.03175.x; Rooney CP, 2002, RESPIRATION, V69, P63, DOI 10.1159/000049372; Ryu JH, 2006, CURR OPIN PULM MED, V12, P145, DOI 10.1097/01.mcp.0000208455.80725.2a; Ryu JH, 2003, AM J RESP CRIT CARE, V168, P1277, DOI 10.1164/rccm.200301-053SO; Simpson JS, 2009, CAN J SURG, V52, pE245; Sriram KB, 2011, FUTURE ONCOL, V7, P737, DOI [10.2217/fon.11.45, 10.2217/FON.11.45]; TANAKA M, 1988, CHEST, V93, P228, DOI 10.1378/chest.93.2.228	18	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84829	10.1371/journal.pone.0084829	http://dx.doi.org/10.1371/journal.pone.0084829			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416294	Green Published, gold, Green Submitted			2022-12-27	WOS:000329866300038
J	Zhang, LF; Zhang, YQ; Shi, XC; Zhang, Y; Deng, GH; Lalvani, A; Liu, XQ				Zhang, Lifan; Zhang, Yueqiu; Shi, Xiaochun; Zhang, Yao; Deng, Guohua; Lalvani, Ajit; Liu, Xiaoqing			Utility of T-Cell Interferon-gamma Release Assays for Diagnosing Tuberculous Serositis: A Prospective Study in Beijing, China	PLOS ONE			English	Article							LINKED IMMUNOSPOT ASSAY; PLEURAL TUBERCULOSIS; LATENT TUBERCULOSIS; ELISPOT ASSAY; PERICARDITIS; RESPONSES; DISEASE; FLUID; AREA	Background: Diagnosis of tuberculous serositis remains a challenge. The aim of this study was to evaluate the diagnostic efficiency of T-SPOT.TB on serous effusion mononuclear cells (SEMC) for diagnosing tuberculous serositis in a high TB burden area. Methods: The present prospective study enrolled patients with suspected tuberculous serositis in a tertiary referral hospital in Beijing, China, to investigate the diagnostic sensitivity, specificity, predictive value (PV), and likelihood ratio(LR) of these tests. Clinical assessment, T-SPOT.TB on SEMC, and T-SPOT.TB on PBMC were performed. Test results were compared with the final confirmed diagnosis. Results: Of the 187 participants, 74 (39.6%) were microbiologically or clinically diagnosed as tuberculous serositis and 93(49.7%) were ruled out. The remaining 20 (10.7%) patients were clinically indeterminate and excluded from the final analysis. Compared to that on PBMC, T-SPOT.TB on SEMC showed higher sensitivity (91.9% vs 73.0%, P = 0.002), specificity (87.1% vs. 73.1%, P = 0.017), PPV (85.0% vs. 68.4%, P = 0.013), NPV (93.1% vs. 77.3%, P = 0.003), LR+ (7.12 vs. 2.72) and LR- (0.09 vs. 0.37), respectively. The frequencies of spot forming cells (SFCs) for T-SPOT.TB on SEMC were 636 per million SEMC (IQR, 143-3443) in patients with tuberculous serositis, which were 4.6-fold (IQR, 1.3-14.3) higher than those of PBMC. By ROC curve analysis, a cut-off value of 56 SFCs per million SEMC for T-SPOT.TB on SEMC showed a sensitivity of 90.5% and specificity of 89.2% for the diagnosis of tuberculous serositis. Conclusions: T-SPOT.TB on SEMC could be an accurate diagnostic method for tuberculous serositis in TB endemic settings. And 56 SFCs per million SEMC might be the optimal cut-off value to diagnose tuberculous serositis.	[Zhang, Lifan; Zhang, Yueqiu; Shi, Xiaochun; Deng, Guohua; Liu, Xiaoqing] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Infect Dis, Beijing 100730, Peoples R China; [Zhang, Lifan; Zhang, Yueqiu; Shi, Xiaochun; Deng, Guohua; Liu, Xiaoqing] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhang, Lifan; Zhang, Yao; Liu, Xiaoqing] Int Clin Epidemiol Network, Peking Union Med Coll, Clin Epidemiol Unit, Beijing, Peoples R China; [Lalvani, Ajit] Univ London Imperial Coll Sci Technol & Med, Dept Resp Med, Natl Heart & Lung Inst, London, England	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Imperial College London	Liu, XQ (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Infect Dis, Beijing 100730, Peoples R China.	liuxqpumch@126.com		Lalvani, Ajit/0000-0002-2396-246X	Capital Medical Development Scientific Research Fund [2005-2030]; Applied Research of the Clinical Characteristics in Capital Project [Z111107058811105]	Capital Medical Development Scientific Research Fund; Applied Research of the Clinical Characteristics in Capital Project	This study was funded by grants from the Capital Medical Development Scientific Research Fund [2005-2030 to Xiaoqing Liu] and the Applied Research of the Clinical Characteristics in Capital Project [Z111107058811105 to Xiaoqing Liu]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adetifa IM, 2010, PLOS ONE, V5; Andersen P, 2007, TRENDS MOL MED, V13, P175, DOI 10.1016/j.molmed.2007.03.004; Ariga H, 2007, CLIN INFECT DIS, V45, P1559, DOI 10.1086/523591; Baba K, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-35; BARNES PF, 1993, INFECT IMMUN, V61, P3482, DOI 10.1128/IAI.61.8.3482-3489.1993; Bathoorn E, 2011, CLIN VACCINE IMMUNOL, V18, P874, DOI 10.1128/CVI.00031-11; Biglino A, 2008, INFECTION, V36, P601, DOI 10.1007/s15010-008-7402-y; Chee CBE, 2009, EUR J CLIN MICROBIOL, V28, P667, DOI 10.1007/s10096-008-0670-8; Chegou NN, 2008, RESPIRATION, V76, P131, DOI 10.1159/000128575; Dheda K, 2009, EUR RESPIR J, V34, P1118, DOI 10.1183/09031936.00005309; Huo Fei-Fei, 2009, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V31, P449; Janssens JP, 2007, EUR RESPIR J, V30, P722, DOI 10.1183/09031936.00028507; Jian-sheng H, 2000, CHINESE J TUBERCULOS, V23; Kobashi Y, 2010, SCAND J INFECT DIS, V42, P712, DOI 10.3109/00365541003705768; Lee LN, 2009, CLIN MICROBIOL INFEC, V15, P173, DOI 10.1111/j.1469-0691.2008.02655.x; Liao CH, 2009, J INFECTION, V59, P402, DOI 10.1016/j.jinf.2009.10.001; Ling DI, 2011, EUR RESPIR J, V38, P649, DOI 10.1183/09031936.00181610; Losi M, 2007, EUR RESPIR J, V30, P1173, DOI 10.1183/09031936.00067307; Macaskill P, 2002, STAT MED, V21, P2527, DOI 10.1002/sim.1227; MacHin D, 2008, SAMPLE SIZE TABLES C, V3rd; Peto HM, 2009, CLIN INFECT DIS, V49, P1350, DOI 10.1086/605559; Ruan SY, 2012, THORAX, V67, P822, DOI 10.1136/thoraxjnl-2011-201363; Sharma SK, 2004, INDIAN J MED RES, V120, P316; Souza MC, 2008, INFECT IMMUN, V76, P5686, DOI 10.1128/IAI.00133-08; TGGotFNTE Survey, 2012, CHINESE J ANTITUBERC, V34; Valdes L, 1996, CHEST, V109, P158, DOI 10.1378/chest.109.1.158; Wilkinson KA, 2005, CLIN INFECT DIS, V40, P184, DOI 10.1086/426139; Xi-rong W, 2012, CHINESE J EVIDENCE B, V07; Zhang Li-Fan, 2009, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V31, P438	29	15	23	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85030	10.1371/journal.pone.0085030	http://dx.doi.org/10.1371/journal.pone.0085030			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416336	Green Published, Green Submitted, gold			2022-12-27	WOS:000329866300048
J	Fu, RH; Harn, HJ; Liu, SP; Chen, CS; Chang, WL; Chen, YM; Huang, JE; Li, RJ; Tsai, SY; Hung, HS; Shyu, WC; Lin, SZ; Wang, YC				Fu, Ru-Huei; Harn, Horng-Jyh; Liu, Shih-Ping; Chen, Chang-Shi; Chang, Wen-Lin; Chen, Yue-Mi; Huang, Jing-En; Li, Rong-Jhu; Tsai, Sung-Yu; Hung, Huey-Shan; Shyu, Woei-Cherng; Lin, Shinn-Zong; Wang, Yu-Chi			n-Butylidenephthalide Protects against Dopaminergic Neuron Degeneration and alpha-Synuclein Accumulation in Caenorhabditis elegans Models of Parkinson's Disease	PLOS ONE			English	Article							LIGUSTICUM-CHUANXIONG; GENE-EXPRESSION; ANIMAL-MODELS; IN-VITRO; DYSFUNCTION; INHIBITION; APOPTOSIS; CELLS; NEUROINFLAMMATION; NEURODEGENERATION	Background: Parkinson's disease (PD) is the second most common degenerative disorder of the central nervous system that impairs motor skills and cognitive function. To date, the disease has no effective therapies. The identification of new drugs that provide benefit in arresting the decline seen in PD patients is the focus of much recent study. However, the lengthy time frame for the progression of neurodegeneration in PD increases both the time and cost of examining potential therapeutic compounds in mammalian models. An alternative is to first evaluate the efficacy of compounds in Caenorhabditis elegans models, which reduces examination time from months to days. n-Butylidenephthalide is the naturally-occurring component derived from the chloroform extract of Angelica sinensis. It has been shown to have antitumor and anti-inflammatory properties, but no reports have yet described the effects of n-butylidenephthalide on PD. The aim of this study was to assess the potential for n-butylidenephthalide to improve PD in C. elegans models. Methodology/Principal Findings: In the current study, we employed a pharmacological strain that expresses green fluorescent protein specifically in dopaminergic neurons (BZ555) and a transgenic strain that expresses human alpha-synuclein in muscle cells (OW13) to investigate the antiparkinsonian activities of n-butylidenephthalide. Our results demonstrate that in PD animal models, n-butylidenephthalide significantly attenuates dopaminergic neuron degeneration induced by 6-hydroxydopamine; reduces alpha-synuclein accumulation; recovers lipid content, food-sensing behavior, and dopamine levels; and prolongs life-span of 6-hydroxydopamine treatment, thus revealing its potential as a possible antiparkinsonian drug. n-Butylidenephthalide may exert its effects by blocking egl-1 expression to inhibit apoptosis pathways and by raising rpn-6 expression to enhance the activity of proteasomes. Conclusions/Significance: n-Butylidenephthalide may be one of the effective neuroprotective agents for PD.	[Fu, Ru-Huei; Chang, Wen-Lin; Chen, Yue-Mi; Huang, Jing-En; Li, Rong-Jhu; Tsai, Sung-Yu; Shyu, Woei-Cherng; Lin, Shinn-Zong] China Med Univ, Grad Inst Immunol, Taichung, Taiwan; [Fu, Ru-Huei; Liu, Shih-Ping; Hung, Huey-Shan; Shyu, Woei-Cherng; Lin, Shinn-Zong] China Med Univ Hosp, Ctr Neuropsychiat, Taichung, Taiwan; [Harn, Horng-Jyh] China Med Univ Hosp, Dept Pathol, Taichung, Taiwan; [Liu, Shih-Ping; Hung, Huey-Shan] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Chen, Chang-Shi] Natl Cheng Kung Univ, Dept Biochem & Mol Biol, Tainan 70101, Taiwan; [Lin, Shinn-Zong] China Med Univ, Beigang Hosp, Dept Neurosurg, Yunlin, Taiwan; [Lin, Shinn-Zong] China Med Univ, Tainan Municipal An Nan Hosp, Dept Neurosurg, Tainan, Taiwan; [Wang, Yu-Chi] Ind Technol Res Inst, Biomed Technol & Device Res Labs, Hsinchu, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; National Cheng Kung University; China Medical University Taiwan; China Medical University Taiwan; Industrial Technology Research Institute - Taiwan	Fu, RH (corresponding author), China Med Univ, Grad Inst Immunol, Taichung, Taiwan.	rhfu@mail.cmu.edu.tw; yuchiw@itri.org.tw	Lin, Shinn-Zong/AAX-2379-2020; Chen, Chang-Shi/B-9251-2009	Chen, Chang-Shi/0000-0002-8201-3635; Fu, Ru-Huei/0000-0001-9367-1759; Liu, Shih-Ping/0000-0002-5803-4460	National Science Council in Taiwan [101-2314-B-039-010-MY2]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH102-TD-B-111-004]; China Medical University [DMR-102-054]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); Taiwan Department of Health Clinical Trial and Research Center of Excellence; China Medical University(China Medical University)	This work was supported by the National Science Council in Taiwan (101-2314-B-039-010-MY2), the Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH102-TD-B-111-004) and China Medical University (DMR-102-054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad B, 2012, J BIOL CHEM, V287, P9193, DOI 10.1074/jbc.M111.325548; Asikainen S, 2010, J MOL NEUROSCI, V41, P210, DOI 10.1007/s12031-009-9325-1; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI [DOI 10.1126/SCIENCE.282.5396.2028, DOI 10.1126/science.282.5396.2028]; Benedetto A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001084; Berman AE, 2011, ANN NEUROL, V69, P509, DOI 10.1002/ana.22162; Binukumar BK, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-35; Blandini F, 2012, FEBS J, V279, P1156, DOI 10.1111/j.1742-4658.2012.08491.x; Bove J, 2012, NEUROSCIENCE, V211, P51, DOI 10.1016/j.neuroscience.2011.10.057; BRENNER S, 1974, GENETICS, V77, P71; Bussell R, 2004, BIOCHEMISTRY-US, V43, P4810, DOI 10.1021/bi036135+; Caldwell KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007227; Cao PX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009312; Castro EMC, 2010, J NEURAL TRANSM, V117, P599, DOI 10.1007/s00702-010-0397-4; Chan SSK, 2006, EUR J PHARMACOL, V537, P111, DOI 10.1016/j.ejphar.2006.03.015; Chan SSK, 2009, J ETHNOPHARMACOL, V122, P308, DOI 10.1016/j.jep.2009.01.002; Charriaut-Marlangue C, 2004, THERAPIE, V59, P185, DOI 10.2515/therapie:2004035; Chen YL, 2008, MOL PHARMACOL, V74, P1046, DOI 10.1124/mol.107.044800; Chiu SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033742; Clark J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012333; Coelho M, 2012, NAT REV NEUROL, V8, P435, DOI 10.1038/nrneurol.2012.126; Collins LM, 2012, NEUROPHARMACOLOGY, V62, P2154, DOI 10.1016/j.neuropharm.2012.01.028; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; De Jesus-Cortes H, 2012, P NATL ACAD SCI USA, V109, P17010, DOI 10.1073/pnas.1213956109; Du XX, 2012, NEUROSCI BULL, V28, P253, DOI 10.1007/s12264-012-1238-2; Etminan M, 2005, LANCET NEUROL, V4, P362, DOI 10.1016/S1474-4422(05)70097-1; Fu RH, 2013, NEUROPHARMACOLOGY, DOI [10.1016/j.neuropharm.2013.08.007, DOI 10.1016/J.NEUR0PHARM.2013.08.007]; Fu RH, 2011, BIOTECHNOL LETT, V33, P903, DOI 10.1007/s10529-011-0528-5; Fu RH, 2010, ACTA BIOMATER, V6, P3621, DOI 10.1016/j.actbio.2010.03.005; Hamamichi S, 2008, P NATL ACAD SCI USA, V105, P728, DOI 10.1073/pnas.0711018105; Hansen C, 2012, TRENDS MOL MED, V18, P248, DOI 10.1016/j.molmed.2012.03.002; Harrington AJ, 2012, J NEUROSCI, V32, P2142, DOI 10.1523/JNEUROSCI.2606-11.2012; Harrington AJ, 2011, METHODS, V53, P220, DOI 10.1016/j.ymeth.2010.12.036; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Hwang CK, 2012, BIOSCI BIOTECH BIOCH, V76, P536, DOI 10.1271/bbb.110842; Hyman BT, 2012, NAT REV NEUROSCI, V13, P395, DOI 10.1038/nrn3228; Jadiya P, 2011, BIOCHEM BIOPH RES CO, V413, P605, DOI 10.1016/j.bbrc.2011.09.010; Jadiya P, 2011, BIOCHEM BIOPH RES CO, V413, P306, DOI 10.1016/j.bbrc.2011.08.092; Jankovic J, 2012, CURR OPIN NEUROL, V25, P433, DOI 10.1097/WCO.0b013e3283542fc2; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Kamp F, 2010, EMBO J, V29, P3571, DOI 10.1038/emboj.2010.223; Karpinar DP, 2009, EMBO J, V28, P3256, DOI 10.1038/emboj.2009.257; Kim HG, 2012, BIOL PHARM BULL, V35, P1287, DOI 10.1248/bpb.b12-00127; Ko WC, 2002, PLANTA MED, V68, P1004, DOI 10.1055/s-2002-35671; Ko WC, 1998, J PHARM PHARMACOL, V50, P1365, DOI 10.1111/j.2042-7158.1998.tb03361.x; Ko WC, 1998, PLANTA MED, V64, P229, DOI 10.1055/s-2006-957415; KUMAR H, 2013, EVID-BASED COMPL ALT, V2013, DOI DOI 10.1155/2013/514095; Kuwahara T, 2006, J BIOL CHEM, V281, P334, DOI 10.1074/jbc.M504860200; Kuwahara T, 2008, HUM MOL GENET, V17, P2997, DOI 10.1093/hmg/ddn198; Kuwahara T, 2012, J BIOL CHEM, V287, P7098, DOI 10.1074/jbc.M111.237131; Lee JY, 2012, HUM MOL GENET, V21, P3215, DOI 10.1093/hmg/dds155; Liu ZH, 2011, HUM MOL GENET, V20, P3933, DOI 10.1093/hmg/ddr312; Locke CJ, 2008, NEUROSCI LETT, V439, P129, DOI 10.1016/j.neulet.2008.05.003; Lu JH, 2012, AUTOPHAGY, V8, P98, DOI 10.4161/auto.8.1.18313; Maccarrone M, 2011, BRIT J PHARMACOL, V163, P1379, DOI 10.1111/j.1476-5381.2011.01277.x; Martinez-Finley EJ, 2011, METALLOMICS, V3, P271, DOI 10.1039/c0mt00064g; MIMURA Y, 1995, BIOL PHARM BULL, V18, P1203; Nass R, 2002, P NATL ACAD SCI USA, V99, P3264, DOI 10.1073/pnas.042497999; Nedelsky NB, 2008, BBA-MOL BASIS DIS, V1782, P691, DOI 10.1016/j.bbadis.2008.10.002; Onishi Hiraku, 2005, Curr Drug Discov Technol, V2, P169, DOI 10.2174/1570163054866891; Pandey N, 2008, ACTA NEUROPATHOL, V115, P479, DOI 10.1007/s00401-007-0332-4; Pourkarimi E, 2012, CELL DEATH DIFFER, V19, P406, DOI 10.1038/cdd.2011.104; Ramassamy C, 2006, EUR J PHARMACOL, V545, P51, DOI 10.1016/j.ejphar.2006.06.025; Rogers J, 2007, INT REV NEUROBIOL, V82, P235, DOI 10.1016/S0074-7742(07)82012-5; Roodveldt C, 2009, EMBO J, V28, P3758, DOI 10.1038/emboj.2009.298; Ruan QM, 2010, NEUROBIOL DIS, V37, P330, DOI 10.1016/j.nbd.2009.10.011; Saw CLL, 2013, BIOPHARM DRUG DISPOS, V34, P303, DOI 10.1002/bdd.1846; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Schreiber MA, 2011, NEUROSCI LETT, V498, P99, DOI 10.1016/j.neulet.2011.04.071; Sebastiao AM, 2013, NEUROPHARMACOLOGY, V64, P97, DOI 10.1016/j.neuropharm.2012.06.053; Shvadchak VV, 2011, FEBS LETT, V585, P3513, DOI 10.1016/j.febslet.2011.10.006; Slone SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021720; Snyder H, 2003, J BIOL CHEM, V278, P11753, DOI 10.1074/jbc.M208641200; Tan Wen, 2011, Int J Nanomedicine, V6, P1773, DOI 10.2147/IJN.S22683; TENG CM, 1987, BIOCHIM BIOPHYS ACTA, V924, P375; Tsai NM, 2006, J NEUROCHEM, V99, P1251, DOI 10.1111/j.1471-4159.2006.04151.x; Tucci ML, 2011, METHODS MOL BIOL, V793, P129, DOI 10.1007/978-1-61779-328-8_9; Usenovic M, 2012, HUM MOL GENET, V21, P3785, DOI 10.1093/hmg/dds206; van der Goot AT, 2012, P NATL ACAD SCI USA, V109, P14912, DOI 10.1073/pnas.1203083109; van Ham TJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000027; van Ham TJ, 2010, CELL, V142, P601, DOI 10.1016/j.cell.2010.07.020; Vidal-Gadea Andres G., 2012, Communicative & Integrative Biology, V5, P440; Vilchez D, 2012, NATURE, V489, P263, DOI 10.1038/nature11315; Voisine C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000504; Wei CW, 2009, ACTA PHARMACOL SIN, V30, P1297, DOI 10.1038/aps.2009.124; Yacoubian TA, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.4; Yang XL, 2012, J ETHNOPHARMACOL, V141, P41, DOI 10.1016/j.jep.2012.01.025; Yao C, 2010, NEUROBIOL DIS, V40, P73, DOI 10.1016/j.nbd.2010.04.002; Yeh JC, 2011, ANGIOGENESIS, V14, P187, DOI 10.1007/s10456-011-9202-8; Yi LZ, 2009, J CHROMATOGR A, V1216, P1991, DOI 10.1016/j.chroma.2008.07.033; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Yu ZL, 2011, MOL BIOL CELL, V22, P911, DOI 10.1091/mbc.E10-08-0655; Zbarsky V, 2005, FREE RADICAL RES, V39, P1119, DOI 10.1080/10715760500233113; Zhang ZJ, 2011, INT J MOL MED, V27, P195, DOI 10.3892/ijmm.2010.571; Zheng MH, 2012, J NEUROSCI METH, V204, P234, DOI 10.1016/j.jneumeth.2011.11.015	96	52	55	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85305	10.1371/journal.pone.0085305	http://dx.doi.org/10.1371/journal.pone.0085305			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416384	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500236
J	Gettings, J; O'Neill, B; Chokshi, DA; Colbert, JA; Gill, P; Lebovic, G; Lexchin, J; Persaud, N				Gettings, Jennifer; O'Neill, Braden; Chokshi, Dave A.; Colbert, James A.; Gill, Peter; Lebovic, Gerald; Lexchin, Joel; Persaud, Navindra			Differences in the Volume of Pharmaceutical Advertisements between Print General Medical Journals	PLOS ONE			English	Article							REFERENCES; QUALITY; YES	Background: Pharmaceutical advertisements have been argued to provide revenue that medical journals require but they are intended to alter prescribing behaviour and they are known to include low quality information. We determined whether a difference exists in the current level of pharmaceutical advertising in print general medical journals, and we estimated the revenue generated from print pharmaceutical advertising. Methods: Six print general medical journals in Canada, the United States, and the United Kingdom were sampled between 2007 and 2012. The number of advertisements and other journal content in selected issues of the Canadian Medical Association Journal (CMAJ), Canadian Family Physician (CFP), Journal of the American Medical Association (JAMA), New England Journal of Medicine (NEJM), British Medical Journal (BMJ), and Lancet were determined. Revenue gained from pharmaceutical advertising was estimated using each journal's 2013 advertising price list. Findings: The two Canadian journals sampled (CMAJ, CFP) contained five times more advertisements than the two American journals (JAMA, NEJM), and two British journals (BMJ, Lancet) (p<0.0001). The estimated annual revenue from pharmaceutical advertisements ranged from 0.025 pound million (for Lancet) to 3.8 pound million (for JAMA). The cost savings due to revenue from pharmaceutical advertising to each individual subscriber ranged from 0.02 pound (for Lancet) to 3.56 pound (for CFP) per issue. Conclusion: The volume of pharmaceutical advertisements differs between general medical journals, with the two Canadian journals sampled containing the most advertisements. International and temporal variations suggest that there is an opportunity for all general medical journals to reduce the number of pharmaceutical advertisements, explore other sources of revenue, and increase transparency regarding sources of revenue.	[Gettings, Jennifer; Persaud, Navindra] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [O'Neill, Braden; Gill, Peter] Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England; [O'Neill, Braden] Univ Calgary, Fac Med, Calgary, AB, Canada; [Chokshi, Dave A.] US Dept Vet Affairs, Washington, DC USA; [Colbert, James A.] Brigham & Womens Hosp, Div Med Commun, Boston, MA 02115 USA; [Colbert, James A.] Newton Wellesley Hosp, Dept Med, Boston, MA USA; [Gill, Peter] Univ Alberta, Fac Med & Dent, Edmonton, AB, Canada; [Lebovic, Gerald] St Michaels Hosp, Appl Hlth Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Lebovic, Gerald] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Lexchin, Joel] York Univ, Sch Hlth Policy & Management, Toronto, ON M3J 2R7, Canada; [Lexchin, Joel] Univ Hlth Network, Emergency Dept, Toronto, ON, Canada; [Lexchin, Joel; Persaud, Navindra] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; [Persaud, Navindra] St Michaels Hosp, Dept Family & Community Med, Toronto, ON M5B 1W8, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Oxford; University of Calgary; US Department of Veterans Affairs; Harvard University; Brigham & Women's Hospital; Newton Wellesley Hospital; University of Alberta; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; York University - Canada; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Persaud, N (corresponding author), St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada.	nav.persaud@utoronto.ca		Lebovic, Gerald/0000-0003-3540-3339; Gettings, Jennifer/0000-0002-4576-3293; Chokshi, Dave/0000-0001-7467-4591				[Anonymous], 2013, CANADIAN MED ASS J; [Anonymous], 2013, BRIT MED J ADVERTISI; [Anonymous], 2013, J AM MED ASS; [Anonymous], 2013, NEW ENGLAND J MED; Becker A, 2011, CAN MED ASSOC J, V183, P544, DOI 10.1503/cmaj.100951; Cooper RJ, 2005, CAN MED ASSOC J, V172, P487, DOI 10.1503/cmaj.1031940; Dehaas D, 2010, CAN FAM PHYSICIAN, V56, P978; Drazen JM, 2012, NEW ENGL J MED, V363, P188; Fletcher RH, 2003, LANCET, V361, P10, DOI 10.1016/S0140-6736(03)12185-X; Gaddis GM, 2009, ACAD EMERG MED, V16, P978, DOI 10.1111/j.1553-2712.2009.00534.x; Handel AE, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4212; Lankinen KS, 2004, PHARMACOEPIDEM DR S, V13, P789, DOI 10.1002/pds.1017; LEXCHIN J, 1994, CAN MED ASSOC J, V151, P47; Lexchin J, 2009, CAN J EMERG MED, V11, P375; Othman N, 2012, BMC PUBLIC HEALTH, V10, P294; Petch Jeremy, 2012, Healthc Policy, V8, P30; Smith R, 2007, BRIT MED J, V335, P74, DOI 10.1136/bmj.39259.472998.AD; Spurling GK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000352; Villanueva P, 2003, LANCET, V361, P27, DOI 10.1016/S0140-6736(03)12118-6; WILKES MS, 1992, ANN INTERN MED, V116, P912, DOI 10.7326/0003-4819-116-11-912	20	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84790	10.1371/journal.pone.0084790	http://dx.doi.org/10.1371/journal.pone.0084790			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416286	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500169
J	Mesfin, YM; Hailemariam, D; Biadglign, S; Kibret, KT				Mesfin, Yonatan Moges; Hailemariam, Damen; Biadglign, Sibhatu; Kibret, Kelemu Tilahun			Association between HIV/AIDS and Multi-Drug Resistance Tuberculosis: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							DRUG-RESISTANCE; RISK-FACTORS; HIV-INFECTION; EPIDEMIOLOGY; SURVEILLANCE	Background: Human immunodeficiency virus (HIV), multi-drug resistant tuberculosis (MDR) is emerging as major challenge facing tuberculosis control programs worldwide particularly in Asia and Africa. Findings from different studies on associations of HIV co-infection and drug resistance among patients with TB have been contradictory (discordant). Some institution based studies found strongly increased risks for multi-drug resistant TB (MDR TB) among patients co-infected with TB and HIV, whereas other studies found no increased risk (it remains less clear in community based studies. The aim was to conduct a systematic review and meta-analysis of the association between multi-drug resistant tuberculosis and HIV infection. Methods and findings: Systematic review of the published literature of observational studies was conducted. Original studies were identified using databases of Medline/Pubmed, Google Scholar and HINARI. The descriptions of original studies were made using frequency and forest plot. Publication bias was assessed using Funnel plot graphically and Egger weighted and Begg rank regression tests statistically. Heterogeneity across studies was checked using Cochrane Q test statistic and I-2. Pool risk estimates of MDR-TB and sub-grouping analysis were computed to analyze associations with HIV. Random effects of the meta-analysis of all 24 observational studies showed that HIV is associated with a marginal increased risk of multi-drug resistant tuberculosis (estimated Pooled OR 1.24; 95%, 1.04-1.43). Subgroup analyses showed that effect estimates were higher (Pooled OR 2.28; 95%, 1.52-3.04) for primary multi-drug resistance tuberculosis and moderate association between HIV/AIDS and MDR-TB among population based studies and no significant association in institution settings. Conclusions: This study demonstrated that there is association between MDR-TB and HIV. Capacity for diagnosis of MDR-TB and initiating and scale up of antiretroviral treatment, and collaborations between HIV and TB control programs need to be considered and strengthened.	[Mesfin, Yonatan Moges] Haramaya Univ, Dept Publ Hlth, Coll Med & Hlth Sci, Harar, Ethiopia; [Hailemariam, Damen] Univ Addis Ababa, Sch Publ Hlth, Addis Ababa, Ethiopia; [Kibret, Kelemu Tilahun] Wollega Univ, Dept Publ Hlth, Coll Med & Hlth Sci, Nekemte, Ethiopia	Haramaya University; Addis Ababa University	Kibret, KT (corresponding author), Wollega Univ, Dept Publ Hlth, Coll Med & Hlth Sci, Nekemte, Ethiopia.	ktwu27@gmail.com	Kibret, Kelemu T/AAT-4813-2020	Kibret, Kelemu T/0000-0002-4357-4122; Biadgilign, Sibhatu/0000-0002-7582-5977	Addis Ababa University	Addis Ababa University	This article was funded by Addis Ababa University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron L, 2004, CLIN MICROBIOL INFEC, V10, P388, DOI 10.1111/j.1469-0691.2004.00758.x; Abdulhalik S, 2011, RISK FACTOR MD UNPUB; [Anonymous], 2010, WHOHTMTB3; [Anonymous], 2008, WHOHTMTB2008393; Beth T, 2008, CLIN INFECT DIS, V47; Brito RC, 2010, INT J TUBERC LUNG D, V14, P24; Campos PE, 2003, EMERG INFECT DIS, V9, P1571, DOI 10.3201/eid0912.020731; Casal M, 2005, MICROB DRUG RESIST, V11, P62, DOI 10.1089/mdr.2005.11.62; Catharina HH, 2007, NETHERLANDS EMERGING, V13, P776; Churchyard GJ, 2000, INT J TUBERC LUNG D, V4, P433; Conaty SJ, 2004, EPIDEMIOL INFECT, V132, P1099, DOI 10.1017/S0950268804002869; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Diande Souba, 2009, RISK FACTORS MULTIDR; Dubrovina I, 2008, INT J TUBERC LUNG D, V12, P756; Espinal MA, 2001, INT J TUBERC LUNG D, V5, P887; Faustini A, 2006, THORAX, V61, P158, DOI 10.1136/thx.2005.045963; Girardi E, 1996, SCAND J INFECT DIS, V28, P487, DOI 10.3109/00365549609037945; Granich RM, 2005, JAMA-J AM MED ASSOC, V293, P232; Jason RA, 2010, PLOS ONE, V5, DOI [10.1371/journal.-pone.0015735, DOI 10.1371/J0URNAL.-P0NE.0015735]; Joseph P, 2006, AIDS, V20, P415, DOI 10.1097/01.aids.0000206505.09159.9a; JOSHUA F, 2006, AM J MED HYG, V75, P1025; Kai K, 2009, ANN INTERN MED, V150, P766; Kawai V, 2006, AM J TROP MED HYG, V75, P1027, DOI 10.4269/ajtmh.2006.75.1027; Liu ZY, 1998, INT J EPIDEMIOL, V27, P121, DOI 10.1093/ije/27.1.121; Mac-Arthur A, 2001, INT J TUBERC LUNG D, V5, P894; Mdivani N, 2008, INT J INFECT DIS, V12, P635, DOI 10.1016/j.ijid.2008.03.012; POZNIAK A, 2003, CLIN TUBERCULOSIS, P278; Punnotok J, 2000, INT J TUBERC LUNG D, V4, P537; Quy HT, 2006, INT J TUBERC LUNG D, V10, P160; Raviglione M, 2001, INT J TUBERC LUNG D, V5, P213; Robert J, 2003, EUR RESPIR J, V22, P833, DOI 10.1183/09031936.03.00014103; Rothstein HR, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P1, DOI 10.1002/0470870168; Schwoebel V, 1998, BRIT MED J, V317, P630, DOI 10.1136/bmj.317.7159.630; Singh MM, 2004, INDIAN J TUBERC, V51, P1; Suchindran S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005561; Taylor JP, 1999, AM J EPIDEMIOL, V149, P359, DOI 10.1093/oxfordjournals.aje.a009821; van Soolingen D, 2001, J INTERN MED, V249, P1, DOI 10.1046/j.1365-2796.2001.00772.x; Villamor E, 2006, EUR J CLIN NUTR, V60, P163, DOI 10.1038/sj.ejcn.1602281; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665; WELTMAN AC, 1994, ARCH INTERN MED, V154, P2161, DOI 10.1001/archinte.154.19.2161; Weyer K, 2007, S AFRICA MED J, V97; World Health Organization, 2010, GLOB TUB CONTR EP ST; World Health Organization, 2011, GUID OPT FEED LOW BI, P16; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7; Yoshiyama T, 2001, INT J TUBERC LUNG D, V5, P32; Zignol M, 2012, B WORLD HEALTH ORGAN, V90, P111, DOI 10.2471/BLT.11.092585	46	87	91	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e82235	10.1371/journal.pone.0082235	http://dx.doi.org/10.1371/journal.pone.0082235			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416139	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500013
J	Scuteri, A; Donzelli, E; Rodriguez-Menendez, V; Ravasi, M; Monfrini, M; Bonandrini, B; Figliuzzi, M; Remuzzi, A; Tredici, G				Scuteri, Arianna; Donzelli, Elisabetta; Rodriguez-Menendez, Virginia; Ravasi, Maddalena; Monfrini, Marianna; Bonandrini, Barbara; Figliuzzi, Marina; Remuzzi, Andrea; Tredici, Giovanni			A Double Mechanism for the Mesenchymal Stem Cells' Positive Effect on Pancreatic Islets	PLOS ONE			English	Article							HUMAN BONE-MARROW; STROMAL CELLS; SURVIVAL; INSULIN; DIFFERENTIATION; TRANSPLANTATION; MOLECULES; THERAPY; EXPRESS; TISSUE	The clinical usability of pancreatic islet transplantation for the treatment of type I diabetes, despite some encouraging results, is currently hampered by the short lifespan of the transplanted tissue. In vivo studies have demonstrated that co-transplantation of Mesenchymal Stem Cells (MSCs) with transplanted pancreatic islets is more effective with respect to pancreatic islets alone in ensuring glycemia control in diabetic rats, but the molecular mechanisms of this action are still unclear. The aim of this study was to elucidate the molecular mechanisms of the positive effect of MSCs on pancreatic islet functionality by setting up direct, indirect and mixed co-cultures. MSCs were both able to prolong the survival of pancreatic islets, and to directly differentiate into an "insulin-releasing'' phenotype. Two distinct mechanisms mediated these effects: i) the survival increase was observed in pancreatic islets indirectly co-cultured with MSCs, probably mediated by the trophic factors released by MSCs; ii) MSCs in direct contact with pancreatic islets started to express Pdx1, a pivotal gene of insulin production, and then differentiated into insulin releasing cells. These results demonstrate that MSCs may be useful for potentiating pancreatic islets' functionality and feasibility.	[Scuteri, Arianna; Donzelli, Elisabetta; Rodriguez-Menendez, Virginia; Ravasi, Maddalena; Monfrini, Marianna; Tredici, Giovanni] Univ Milano Bicocca, Dipartimento Chirurg & Med Interdisciplinare, Monza, Italy; [Bonandrini, Barbara; Figliuzzi, Marina] IRCCS Ist Ric Farmacol Mario Negri, Dept Biomed Engn, Bergamo, Italy; [Remuzzi, Andrea] Univ Bergamo, Dept Ind Engn, Dalmine, BG, Italy	University of Milano-Bicocca; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Bergamo	Scuteri, A (corresponding author), Univ Milano Bicocca, Dipartimento Chirurg & Med Interdisciplinare, Monza, Italy.	arianna.scuteri@unimib.it	Scuteri, Arianna/L-4946-2016; Figliuzzi, Marina/ABB-6409-2020; Donzelli, Elisabetta/J-6837-2015; Remuzzi, Andrea/F-2409-2015	Scuteri, Arianna/0000-0003-0240-313X; Figliuzzi, Marina/0000-0002-3239-2585; Donzelli, Elisabetta/0000-0002-9495-4256; Remuzzi, Andrea/0000-0002-4301-8927	MIUR - FIRB Futuro in Ricerca [RBFR08VSVI_001]	MIUR - FIRB Futuro in Ricerca(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	This work was supported by MIUR - FIRB Futuro in Ricerca 2008 Prot. N<SUP>o</SUP> RBFR08VSVI_001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen LB, 2004, WORLD J GASTROENTERO, V10, P3016; Crigler L, 2006, EXP NEUROL, V198, P54, DOI 10.1016/j.expneurol.2005.10.029; Daoud JT, 2011, BIOMATERIALS, V32, P1536, DOI 10.1016/j.biomaterials.2010.10.036; Donzelli E, 2007, ARCH ORAL BIOL, V52, P64, DOI 10.1016/j.archoralbio.2006.07.007; Duprez IR, 2011, UPSALA J MED SCI, V116, P8, DOI 10.3109/03009734.2010.524320; Figliuzzi M, 2009, TRANSPL P, V41, P1797, DOI 10.1016/j.transproceed.2008.11.015; Fiorina P, 2011, ENDOCR REV, V32, P725, DOI 10.1210/er.2011-0008; Francese R, 2010, CLIN IMMUNOL, V136, P309, DOI 10.1016/j.clim.2010.04.010; Hou Y, 2009, DIABETES RES CLIN PR, V86, P11, DOI 10.1016/j.diabres.2009.07.010; Ito T, 2010, TRANSPLANTATION, V89, P1438, DOI 10.1097/TP.0b013e3181db09c4; Jung EJ, 2011, CYTOTHERAPY, V13, P19, DOI 10.3109/14653249.2010.518608; Jurewicz M, 2010, DIABETES, V59, P3139, DOI 10.2337/db10-0542; Karaoz E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.14; Karaoz E, 2011, J TISSUE ENG REGEN M, V5, P491, DOI 10.1002/term.342; Ludwig B, 2010, CURR DIABETES REP, V10, P506, DOI 10.1007/s11892-010-0146-y; Marappagounder D, 2013, CELL MOL BIOL LETT, V18, P75, DOI 10.2478/s11658-012-0040-5; Minguell JJ, 2001, EXP BIOL MED, V226, P507, DOI 10.1177/153537020122600603; Moriscot C, 2005, STEM CELLS, V23, P594, DOI 10.1634/stemcells.2004-0123; Park KS, 2010, TRANSPLANTATION, V89, P509, DOI 10.1097/TP.0b013e3181c7dc99; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Remuzzi A, 2009, DIABETOLOGIA, V52, P2653, DOI 10.1007/s00125-009-1537-y; Rezende LF, 2007, J ENDOCRINOL, V195, P157, DOI 10.1677/JOE-07-0016; Rossignol J, 2011, BEHAV BRAIN RES, V217, P369, DOI 10.1016/j.bbr.2010.11.006; Ryan EA, 2006, DIABETES OBES METAB, V8, P1, DOI 10.1111/j.1463-1326.2004.00460.x; Sakata N, 2010, TRANSPLANTATION, V89, P686, DOI 10.1097/TP.0b013e3181cb3e8d; Satija NK, 2009, J CELL MOL MED, V13, P4385, DOI 10.1111/j.1582-4934.2009.00857.x; Scuteri A, 2011, NEUROSCIENCE, V172, P12, DOI 10.1016/j.neuroscience.2010.10.065; Scuteri A, 2006, BRAIN RES, V1116, P75, DOI 10.1016/j.brainres.2006.07.127; Solari MG, 2009, J AUTOIMMUN, V32, P116, DOI 10.1016/j.jaut.2009.01.003; Wang QW, 2012, AM J STEM CELLS, V1, P128; Yuan HJ, 2012, MOL BIOL REP, V39, P7777, DOI 10.1007/s11033-012-1619-7; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496	32	41	41	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84309	10.1371/journal.pone.0084309	http://dx.doi.org/10.1371/journal.pone.0084309			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416216	Green Published, gold			2022-12-27	WOS:000329862500114
J	Sovada, MA; Igl, LD; Pietz, PJ; Bartos, AJ				Sovada, Marsha A.; Igl, Lawrence D.; Pietz, Pamela J.; Bartos, Alisa J.			Influence of Climate Change on Productivity of American White Pelicans, Pelecanus erythrorhynchos	PLOS ONE			English	Article							NATIONAL-WILDLIFE-REFUGE; LONG-TERM; TIGER SALAMANDERS; PRAIRIE WETLANDS; NORTH-DAKOTA; PHENOLOGY; YOUNG; CONSEQUENCES; MISMATCH; WEATHER	In the past decade, severe weather and West Nile virus were major causes of chick mortality at American white pelican (Pelecanus erythrorhynchos) colonies in the northern plains of North America. At one of these colonies, Chase Lake National Wildlife Refuge in North Dakota, spring arrival by pelicans has advanced approximately 16 days over a period of 44 years (1965-2008). We examined phenology patterns of pelicans and timing of inclement weather through the 44-year period, and evaluated the consequence of earlier breeding relative to weather-related chick mortality. We found severe weather patterns to be random through time, rather than concurrently shifting with the advanced arrival of pelicans. In recent years, if nest initiations had followed the phenology patterns of 1965 (i.e., nesting initiated 16 days later), fewer chicks likely would have died from weather-related causes. That is, there would be fewer chicks exposed to severe weather during a vulnerable transition period that occurs between the stage when chicks are being brooded by adults and the stage when chicks from multiple nests become part of a thermally protective creche.	[Sovada, Marsha A.; Igl, Lawrence D.; Pietz, Pamela J.; Bartos, Alisa J.] US Geol Survey, Northern Prairie Wildlife Res Ctr, Jamestown, ND USA	United States Department of the Interior; United States Geological Survey	Sovada, MA (corresponding author), US Geol Survey, Northern Prairie Wildlife Res Ctr, Jamestown, ND USA.	msovada@usgs.gov	Igl, Lawrence D./ABG-5135-2021	Igl, Lawrence D./0000-0003-0530-7266	US Geological Survey's Northern Prairie Wildlife Research Center, the North Dakota Game and Fish Department; South Dakota Game, Fish and Parks Department through State Wildlife Grant [T-27-R]	US Geological Survey's Northern Prairie Wildlife Research Center, the North Dakota Game and Fish Department; South Dakota Game, Fish and Parks Department through State Wildlife Grant	Funding for this study was provided by US Geological Survey's Northern Prairie Wildlife Research Center, the North Dakota Game and Fish Department; and the South Dakota Game, Fish and Parks Department through State Wildlife Grant T-27-R, Study 2427 (administered by the US Fish and Wildlife Service). The outside funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham CL, 1999, CONDOR, V101, P832, DOI 10.2307/1370071; BARTHOLOMEW GA, 1953, ECOLOGY, V34, P554, DOI 10.2307/1929727; Benoy GA, 2008, WETLANDS, V28, P464, DOI 10.1672/07-07.1; Bluemle JP, 1991, FACE N DAKOTA; Cotton PA, 2003, P NATL ACAD SCI USA, V100, P12219, DOI 10.1073/pnas.1930548100; Crick HQP, 2004, IBIS, V146, P48, DOI 10.1111/j.1474-919X.2004.00327.x; DEUTSCHMAN MR, 1988, CAN J FISH AQUAT SCI, V45, P691, DOI 10.1139/f88-083; DIEM KL, 1994, COLON WATERBIRD, V17, P130, DOI 10.2307/1521291; Drever MC, 2007, J ANIM ECOL, V76, P139, DOI 10.1111/j.1365-2656.2006.01183.x; Dunbar DL, 1982, BREEDING ECOLOGY MAN; Dunnell KL, 2011, AM J BOT, V98, P935, DOI 10.3732/ajb.1000363; EVANS RM, 1984, CAN J ZOOL, V62, P808, DOI 10.1139/z84-117; EVANS RM, 1985, CONDOR, V87, P252, DOI 10.2307/1366890; EVANS RM, 1984, CAN J ZOOL, V62, P814, DOI 10.1139/z84-118; EVANS RM, 1994, BEHAVIOUR, V129, P13, DOI 10.1163/156853994X00334; Gordo O, 2007, CLIM RES, V35, P37, DOI 10.3354/cr00713; Gordo O, 2006, GLOBAL CHANGE BIOL, V12, P1993, DOI 10.1111/j.1365-2486.2006.01178.x; Higgins K.F., 1980, Prairie Naturalist, V12, P89; Institute SAS, 2010, SAS ONLINEDOC 9 2; JOHNSON RF, 1978, WILSON BULL, V90, P346; Johnson WC, 2005, BIOSCIENCE, V55, P863, DOI 10.1641/0006-3568(2005)055[0863:VONPWT]2.0.CO;2; King DT, 2005, WATERBIRDS, V28, P48, DOI 10.1675/1524-4695(2005)28[48:RPSOTA]2.0.CO;2; Knopf F.L., 2004, BIRDS N AM, P1; Larson D.L., 1998, STATUS TRENDS NATION, V2, P450; LARSON DL, 1994, AM MIDL NAT, V131, P330, DOI 10.2307/2426259; Le Bohec C, 2005, ANIM BEHAV, V70, P527, DOI 10.1016/j.anbehav.2004.11.012; Lehikoinen A, 2009, OIKOS, V118, P829, DOI 10.1111/j.1600-0706.2008.17440.x; Lingle GR, 1977, FOOD HABITS SEXING A; Ludwig GX, 2006, P ROY SOC B-BIOL SCI, V273, P2009, DOI 10.1098/rspb.2006.3538; Madden EM, 2005, WATERBIRDS, V28, P23, DOI 10.1675/1524-4695(2005)28[23:HABEOT]2.0.CO;2; Murphy-Klassen HM, 2005, AUK, V122, P1130, DOI 10.1642/0004-8038(2005)122[1130:LTISAD]2.0.CO;2; Niemuth ND, 2010, WETLANDS, V30, P1053, DOI 10.1007/s13157-010-0111-1; POIANI KA, 1991, BIOSCIENCE, V41, P611, DOI 10.2307/1311698; POIANI KA, 1993, CLIMATIC CHANGE, V24, P213, DOI 10.1007/BF01091830; Saino N, 2011, P ROY SOC B-BIOL SCI, V278, P835, DOI 10.1098/rspb.2010.1778; SCHALLER GEORGE B., 1964, CONDOR, V66, P3, DOI 10.2307/1365232; Sekercioglu CH, 2012, BIOL CONSERV, V148, P1, DOI 10.1016/j.biocon.2011.10.019; SIDLE J G, 1984, Prairie Naturalist, V16, P131; Skagen SK, 2012, ECOL APPL, V22, P1131, DOI 10.1890/11-0291.1; Sovada MA, 2005, WATERBIRDS, V28, P27, DOI 10.1675/1524-4695(2005)28[27:HACSOT]2.0.CO;2; Sovada MA, 2013, 20135105 US DEP INT, P117; Sovada MA, 2008, BIOL CONSERV, V141, P1021, DOI 10.1016/j.biocon.2008.01.019; Strait LE, 1973, THESIS MICHIGAN TECH; Todhunter PE, 1993, P N DAK ACAD SCI, V47, P5; Tourenq C, 1995, COLON WATERBIRD, V18, P216, DOI 10.2307/1521484; Visser ME, 2005, P ROY SOC B-BIOL SCI, V272, P2561, DOI 10.1098/rspb.2005.3356; Woodhouse CA, 1998, B AM METEOROL SOC, V79, P2693, DOI 10.1175/1520-0477(1998)079<2693:YODVIT>2.0.CO;2	47	6	6	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83430	10.1371/journal.pone.0083430	http://dx.doi.org/10.1371/journal.pone.0083430			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416165	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500047
J	van Harmelen, AL; Hauber, K; Moor, BG; Spinhoven, P; Boon, AE; Crone, EA; Elzinga, BM				van Harmelen, Anne-Laura; Hauber, Kirsten; Moor, Bregtje Gunther; Spinhoven, Philip; Boon, Albert E.; Crone, Eveline A.; Elzinga, Bernet M.			Childhood Emotional Maltreatment Severity Is Associated with Dorsal Medial Prefrontal Cortex Responsivity to Social Exclusion in Young Adults	PLOS ONE			English	Article							GENERALIZED ANXIETY DISORDER; PEER REJECTION; SELF-ESTEEM; OSTRACISM; STRESS; ADOLESCENTS; DEPRESSION; BRAIN; ABUSE; RISK	Children who have experienced chronic parental rejection and exclusion during childhood, as is the case in childhood emotional maltreatment, may become especially sensitive to social exclusion. This study investigated the neural and emotional responses to social exclusion (with the Cyberball task) in young adults reporting childhood emotional maltreatment. Using functional magnetic resonance imaging, we investigated brain responses and self-reported distress to social exclusion in 46 young adult patients and healthy controls (mean age = 19.2 +/- 2.16) reporting low to extreme childhood emotional maltreatment. Consistent with prior studies, social exclusion was associated with activity in the ventral medial prefrontal cortex and posterior cingulate cortex. In addition, severity of childhood emotional maltreatment was positively associated with increased dorsal medial prefrontal cortex responsivity to social exclusion. The dorsal medial prefrontal cortex plays a crucial role in self-and other-referential processing, suggesting that the more individuals have been rejected and maltreated in childhood, the more self-and other-processing is elicited by social exclusion in adulthood. Negative self-referential thinking, in itself, enhances cognitive vulnerability for the development of psychiatric disorders. Therefore, our findings may underlie the emotional and behavioural difficulties that have been reported in adults reporting childhood emotional maltreatment.	[van Harmelen, Anne-Laura; Moor, Bregtje Gunther; Spinhoven, Philip; Crone, Eveline A.; Elzinga, Bernet M.] Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands; [van Harmelen, Anne-Laura; Moor, Bregtje Gunther; Spinhoven, Philip; Crone, Eveline A.; Elzinga, Bernet M.] Leiden Univ, Inst Psychol, Leiden, Netherlands; [van Harmelen, Anne-Laura] Univ Cambridge, Dept Dev Psychiat, Cambridge, England; [Hauber, Kirsten] Youth Mental Hlth Care Ctr, The Hague, Netherlands; [Spinhoven, Philip] Leiden Univ Med Ctr, Dept Psychiat, Leiden, Netherlands; [Boon, Albert E.] Ctr Orthopsychiat & Forens Youth Psychiat, Fjord Lucertis, Capelle Aan Den IJssel, Netherlands; [Boon, Albert E.] Curium Leiden Univ Med Ctr, Dept Child & Adolescent Psychiat, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; University of Cambridge; Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC)	van Harmelen, AL (corresponding author), Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands.	avanharmelen@gmail.com		van Harmelen, Anne-Laura/0000-0003-1108-2921; Crone, Eveline/0000-0002-7508-6078; Boon, Albert/0000-0001-8667-6930	VIDI grant [016N085N353]; Netherlands Wetenschaps Organisatie (NWO)	VIDI grant; Netherlands Wetenschaps Organisatie (NWO)	This work was supported by a VIDI grant (grant number 016N085N353) awarded by the Netherlands Wetenschaps Organisatie (NWO) to the principal investigator BME. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, MANUAL CHILD BEHAV C; APSAC APS on the A of C, 1995, GUID PSYCH EV SUSP P; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Arntz A., 1996, JEUGD TRAUMA VRAGENL; Beck AT, 2008, AM J PSYCHIAT, V165, P969, DOI 10.1176/appi.ajp.2008.08050721; Bernstein DP, 1998, CHILDHOOD TRAUMA QUE; Blair KS, 2012, BIOL PSYCHIAT, V72, P476, DOI 10.1016/j.biopsych.2012.04.013; Bolling DZ, 2011, DEV COGN NEUROS-NETH, V1, P280, DOI 10.1016/j.dcn.2011.02.002; Boyes ME, 2009, PERS INDIV DIFFER, V47, P396, DOI 10.1016/j.paid.2009.04.005; Brett M., 2002, 8 INT C FUNCT MAPP H, V16, P497; Burklund LJ, 2007, SOC NEUROSCI-UK, V2, P238, DOI 10.1080/17470910701391711; Cacioppo S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02027; Czeh B, 2007, NEUROPSYCHOPHARMACOL, V32, P1490, DOI 10.1038/sj.npp.1301275; Dannlowski U, 2012, BIOL PSYCHIAT, V71, P286, DOI 10.1016/j.biopsych.2011.10.021; DeWall CN, 2012, SOC COGN AFFECT NEUR, V7, P184, DOI 10.1093/scan/nsq107; DeWall CN, 2011, CURR DIR PSYCHOL SCI, V20, P256, DOI 10.1177/0963721411417545; Duijsens IJ, 1996, PERS INDIV DIFFER, V20, P171, DOI 10.1016/0191-8869(95)00161-1; Egeland B, 2009, CHILD ABUSE NEGLECT, V33, P22, DOI 10.1016/j.chiabu.2008.12.004; Eisenberger NI, 2007, BIOL PSYCHIAT, V61, P1100, DOI 10.1016/j.biopsych.2006.08.007; Eisenberger NI, 2012, NAT REV NEUROSCI, V13, P421, DOI 10.1038/nrn3231; Ellis BJ, 2011, DEV PSYCHOPATHOL, V23, P7, DOI 10.1017/S0954579410000611; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Etkin A, 2010, AM J PSYCHIAT, V167, P545, DOI 10.1176/appi.ajp.2009.09070931; First MB., 1997, USERS GUIDE STRUCTUR; Gilbert R, 2009, LANCET, V373, P68, DOI 10.1016/S0140-6736(08)61706-7; Grimm S, 2009, HUM BRAIN MAPP, V30, P2617, DOI 10.1002/hbm.20693; Hardt J, 2004, J CHILD PSYCHOL PSYC, V45, P260, DOI 10.1111/j.1469-7610.2004.00218.x; Hart H, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00052; Iffland B, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-49; Lemogne C, 2009, SOC COGN AFFECT NEUR, V4, P305, DOI 10.1093/scan/nsp008; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Lindquist KA, 2012, BEHAV BRAIN SCI, V35, P121, DOI 10.1017/S0140525X11000446; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Masten CL, 2011, DEV PSYCHOPATHOL, V23, P283, DOI 10.1017/S0954579410000799; Masten CL, 2010, SOC NEUROSCI-UK, V5, P496, DOI 10.1080/17470919.2010.490673; Masten CL, 2009, SOC COGN AFFECT NEUR, V4, P143, DOI 10.1093/scan/nsp007; McEwen BS, 2012, NEUROPHARMACOLOGY, V62, P3, DOI 10.1016/j.neuropharm.2011.07.014; Meyer ML, 2012, SOC COGN AFFECT NEUR; Moor BG, 2012, NEUROIMAGE, V59, P708, DOI 10.1016/j.neuroimage.2011.07.028; Moran JM, 2006, J COGNITIVE NEUROSCI, V18, P1586, DOI 10.1162/jocn.2006.18.9.1586; Onoda K, 2010, SOC COGN AFFECT NEUR, V5, P385, DOI 10.1093/scan/nsq002; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rosenbach C, 2011, VERHALTENSTHERAPIE, V21, P87, DOI 10.1159/000328839; Sanchez MM, 2007, MOL PSYCHIATR, V12, P895, DOI 10.1038/sj.mp.4002025; Sanchez MM, 2001, DEV PSYCHOPATHOL, V13, P419, DOI 10.1017/S0954579401003029; Sebastian C, 2010, BRAIN COGNITION, V72, P134, DOI 10.1016/j.bandc.2009.06.008; Sebastian CL, 2012, SOC COGN AFFECT NEUR, V7, P53, DOI 10.1093/scan/nsr023; Sebastian CL, 2011, NEUROIMAGE, V57, P686, DOI 10.1016/j.neuroimage.2010.09.063; Somerville LH, 2006, NAT NEUROSCI, V9, P1007, DOI 10.1038/nn1728; Somerville LH, 2010, CEREB CORTEX, V20, P3005, DOI 10.1093/cercor/bhq049; Spinhoven P, 2010, J AFFECT DISORDERS, V126, P103, DOI 10.1016/j.jad.2010.02.132; Spitzer RL, 1990, STRUCTURED CLIN INTE; Themanson JR, 2012, SOC COGN AFFECT NEUR, P1; Thombs BD, 2009, CHILD ABUSE NEGLECT, V33, P518, DOI 10.1016/j.chiabu.2009.03.001; Tomoda A, 2011, NEUROIMAGE, V54, pS280, DOI 10.1016/j.neuroimage.2010.05.027; Tonmyr L, 2011, CHILD ABUSE NEGLECT, V35, P767, DOI 10.1016/j.chiabu.2011.04.011; Trickett PK, 2009, CHILD ABUSE NEGLECT, V33, P27, DOI 10.1016/j.chiabu.2008.12.003; van Beest I, 2006, J PERS SOC PSYCHOL, V91, P918, DOI 10.1037/0022-3514.91.5.918; van der Meer L, 2010, NEUROSCI BIOBEHAV R, V34, P935, DOI 10.1016/j.neubiorev.2009.12.004; van Harmelen AL, 2011, EUR J PSYCHOTRAUMATO, V2, DOI 10.3402/ejpt.v2i0.7336; van Harmelen AL, 2010, BIOL PSYCHIAT, V68, P832, DOI 10.1016/j.biopsych.2010.06.011; van Harmelen AL, 2010, BEHAV RES THER, V48, P486, DOI 10.1016/j.brat.2010.02.003; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Weschler D., 1991, WECHSLER INTELLIGENC; Williams KD, 2000, J PERS SOC PSYCHOL, V79, P748, DOI 10.1037/0022-3514.79.5.748; Williams KD, 2006, BEHAV RES METHODS, V38, P174, DOI 10.3758/BF03192765; Yoshimura S, 2009, BRAIN COGNITION, V69, P218, DOI 10.1016/j.bandc.2008.07.010; Zadro L, 2004, J EXP SOC PSYCHOL, V40, P560, DOI 10.1016/j.jesp.2003.11.006	69	66	66	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85107	10.1371/journal.pone.0085107	http://dx.doi.org/10.1371/journal.pone.0085107			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291WL	24416347	Green Submitted, gold, Green Published			2022-12-27	WOS:000329862500216
J	Zhang, B; Chen, J; Cheng, ASL; Ko, BCB				Zhang, Bin; Chen, Juan; Cheng, Alfred S. L.; Ko, Ben C. B.			Depletion of Sirtuin 1 (SIRT1) Leads to Epigenetic Modifications of Telomerase (TERT) Gene in Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							MAMMALIAN SIRTUINS; SKELETAL-MUSCLE; DNA METHYLATION; PROSTATE-CANCER; MESSENGER-RNA; HTERT GENE; TRANSCRIPTION; MAINTENANCE; EXPRESSION; HETEROCHROMATIN	Sirtuin 1 (SIRT1) is a nicotinamide adenine dinucleotide (NAD)-dependent deacetylase that is implicated in plethora of biological processes, including metabolism, aging, stress response, and tumorigenesis. Telomerase (TERT) is essential for telomere maintenance. Activation of TERT is considered a crucial step in tumorigenesis, and therefore it is a potential therapeutic target against cancer. We have recently found that SIRT1 expression is highly elevated in hepatocellular carcinoma, and the depletion of SIRT1 leads to substantial reduction in TERT mRNA and protein expression. However, the underlying molecular mechanism of SIRT1-dependent TERT expression remains uncharacterized. Here, we elucidated if SIRT1 regulates TERT expression via transcriptional, epigenetic and post-transcriptional mechanisms. We report that depletion of SIRT1 does not lead to significant change in transcriptional activity and CpG methylation patterns of the TERT promoter, nor does it affect mRNA stability or 3'-UTR regulation of TERT. Intriguingly, depletion of SIRT1 is associated with substantial induction of acetylated histone H3-K9 and reduction of trimethyl H3-K9 at the TERT gene, which are known to be associated with gene activation. Our data revealed that SIRT1 regulates histone acetylation and methylation at the TERT promoter. We postulated that SIRT1 may regulate TERT expression via long-range interaction, or via yet unidentified histone modifications.	[Zhang, Bin] Chinese Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Zhang, Bin] Chinese Univ Hong Kong, Dept Cellular Pathol, Hong Kong, Hong Kong, Peoples R China; [Chen, Juan] Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Minist Educ, Affiliated Hosp 2, Chongqing, Peoples R China; [Cheng, Alfred S. L.] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Ko, Ben C. B.] Hong Kong Polytech Univ, Shenzhen Res Inst, Hong Kong, Hong Kong, Peoples R China; [Ko, Ben C. B.] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chongqing Medical University; Chinese University of Hong Kong; Hong Kong Polytechnic University; Hong Kong Polytechnic University	Ko, BCB (corresponding author), Hong Kong Polytech Univ, Shenzhen Res Inst, Hong Kong, Hong Kong, Peoples R China.	ben.ko@polyu.edu.hk	Ko, Chi-bun/ACH-7514-2022; Cheng, Alfred SL/C-3327-2014	Cheng, Alfred SL/0000-0003-2345-6951; Ko, Ben Chi Bun/0000-0003-2027-5899	Research Grant Council Grants; National Natural Science Foundation of China	Research Grant Council Grants; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Research Grant Council Grants and National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amat R, 2009, J BIOL CHEM, V284, P21872, DOI 10.1074/jbc.M109.022749; Byles V, 2012, ONCOGENE, V31, P4619, DOI 10.1038/onc.2011.612; Chen HC, 2012, ANN SURG ONCOL, V19, P2011, DOI 10.1245/s10434-011-2159-4; Chen J, 2011, CANCER RES, V71, P4138, DOI 10.1158/0008-5472.CAN-10-4274; Choi HN, 2011, ONCOL REP, V26, P503, DOI 10.3892/or.2011.1301; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dvir-Ginzberg M, 2008, J BIOL CHEM, V283, P36300, DOI 10.1074/jbc.M803196200; El Ramy R, 2009, CELL MOL LIFE SCI, V66, P3219, DOI 10.1007/s00018-009-0105-4; Emerald BS, 2007, J BIOL CHEM, V282, P680, DOI 10.1074/jbc.M600224200; Fang YJ, 2011, CANCER LETT, V306, P10, DOI 10.1016/j.canlet.2011.02.019; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Horikawa I, 1999, CANCER RES, V59, P826; Huffman DM, 2007, CANCER RES, V67, P6612, DOI 10.1158/0008-5472.CAN-07-0085; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Lopatina NG, 2003, BIOCHEM BIOPH RES CO, V306, P650, DOI 10.1016/S0006-291X(03)01033-7; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; MOREIRA AL, 1993, J EXP MED, V177, P1675, DOI 10.1084/jem.177.6.1675; O'Hagan HM, 2011, CANCER CELL, V20, P606, DOI 10.1016/j.ccr.2011.09.012; O'Hagan HM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000155; Osterhage JL, 2009, J BIOL CHEM, V284, P16061, DOI 10.1074/jbc.R900011200; Palacios JA, 2010, J CELL BIOL, V191, P1299, DOI 10.1083/jcb.201005160; Portmann S, 2013, MOL CANCER THER, V12, P499, DOI 10.1158/1535-7163.MCT-12-0700; Pruitt K, 2006, PLOS GENET, V2, P344, DOI 10.1371/journal.pgen.0020040; Renaud S, 2007, NUCLEIC ACIDS RES, V35, P1245, DOI 10.1093/nar/gkl1125; Renaud S, 2005, NUCLEIC ACIDS RES, V33, P6850, DOI 10.1093/nar/gki989; Tong EHY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008435; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Yuan J, 2009, CELL CYCLE, V8, P1747, DOI 10.4161/cc.8.11.8620; Zhang T, 2010, BBA-PROTEINS PROTEOM, V1804, P1666, DOI 10.1016/j.bbapap.2009.10.022; Zhu QJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001446; Zinn RL, 2007, CANCER RES, V67, P194, DOI 10.1158/0008-5472.CAN-06-3396	37	30	33	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84931	10.1371/journal.pone.0084931	http://dx.doi.org/10.1371/journal.pone.0084931			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416313	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500190
J	Zhu, WY; Schmehl, DR; Mullin, CA; Frazier, JL				Zhu, Wanyi; Schmehl, Daniel R.; Mullin, Christopher A.; Frazier, James L.			Four Common Pesticides, Their Mixtures and a Formulation Solvent in the Hive Environment Have High Oral Toxicity to Honey Bee Larvae	PLOS ONE			English	Article							APIS-MELLIFERA; RISK-ASSESSMENT; N-METHYL; INSECTICIDES; N-ETHYL-2-PYRROLIDONE; CHLOROTHALONIL; HYMENOPTERA; METABOLITES; MITICIDES; POLLEN	Recently, the widespread distribution of pesticides detected in the hive has raised serious concerns about pesticide exposure on honey bee (Apis mellifera L.) health. A larval rearing method was adapted to assess the chronic oral toxicity to honey bee larvae of the four most common pesticides detected in pollen and wax - fluvalinate, coumaphos, chlorothalonil, and chloropyrifos - tested alone and in all combinations. All pesticides at hive-residue levels triggered a significant increase in larval mortality compared to untreated larvae by over two fold, with a strong increase after 3 days of exposure. Among these four pesticides, honey bee larvae were most sensitive to chlorothalonil compared to adults. Synergistic toxicity was observed in the binary mixture of chlorothalonil with fluvalinate at the concentrations of 34 mg/L and 3 mg/L, respectively; whereas, when diluted by 10 fold, the interaction switched to antagonism. Chlorothalonil at 34 mg/L was also found to synergize the miticide coumaphos at 8 mg/L. The addition of coumaphos significantly reduced the toxicity of the fluvalinate and chlorothalonil mixture, the only significant non-additive effect in all tested ternary mixtures. We also tested the common 'inert' ingredient N-methyl-2-pyrrolidone at seven concentrations, and documented its high toxicity to larval bees. We have shown that chronic dietary exposure to a fungicide, pesticide mixtures, and a formulation solvent have the potential to impact honey bee populations, and warrants further investigation. We suggest that pesticide mixtures in pollen be evaluated by adding their toxicities together, until complete data on interactions can be accumulated.	[Zhu, Wanyi; Mullin, Christopher A.; Frazier, James L.] Penn State Univ, Dept Entomol, Ctr Pollinator Res, University Pk, PA 16802 USA; [Schmehl, Daniel R.] Univ Florida, Dept Entomol & Nematol, Honey Bee Res & Extens Lab, Gainesville, FL 32611 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; State University System of Florida; University of Florida	Zhu, WY (corresponding author), Penn State Univ, Dept Entomol, Ctr Pollinator Res, University Pk, PA 16802 USA.	wanyizhupsu@gmail.com		Schmehl, Daniel/0000-0003-1591-8722	North American Pollinator Protection Campaign (NAPPC); United States Department of Agriculture (USDA)-The National Institute of Food and Agriculture (NIFA)	North American Pollinator Protection Campaign (NAPPC); United States Department of Agriculture (USDA)-The National Institute of Food and Agriculture (NIFA)	Funding for this work was provided by the North American Pollinator Protection Campaign (NAPPC) and the United States Department of Agriculture (USDA)-The National Institute of Food and Agriculture (NIFA) Managed Pollinator Coordinated Agricultural Project (CAP) program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins E, 1981, 2883 U CAL DIV AGR; ATKINS EL, 1986, J APICULT RES, V25, P242, DOI 10.1080/00218839.1986.11100725; Aupinel P, 2007, PEST MANAG SCI, V63, P1090, DOI 10.1002/ps.1446; Babendreier D, 2004, APIDOLOGIE, V35, P293, DOI 10.1051/apido:2004016; Babendreier D, 2007, FEMS MICROBIOL ECOL, V59, P600, DOI 10.1111/j.1574-6941.2006.00249.x; Becher MA, 2010, ECOL MODEL, V221, P769, DOI 10.1016/j.ecolmodel.2009.11.016; Bonisch U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039817; Bogdanov S, 2006, APIDOLOGIE, V37, P1, DOI 10.1051/apido:2005043; Bonzini S, 2011, APIDOLOGIE, V42, P378, DOI 10.1007/s13592-011-0011-2; Caux PY, 1996, CRIT REV ENV SCI TEC, V26, P45, DOI 10.1080/10643389609388486; Chauzat MP, 2011, ENVIRON TOXICOL CHEM, V30, P103, DOI 10.1002/etc.361; Ciarlo TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040848; Cox C, 2006, ENVIRON HEALTH PERSP, V114, P1803, DOI 10.1289/ehp.9374; Crailsheim K, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.05; DAVIS AR, 1989, BEE WORLD, V70, P163, DOI 10.1080/0005772X.1989.11099013; DeGrandi-Hoffman G, 2009, AM BEE J, V149, P667; DeLorenzo ME, 2003, J ENVIRON SCI HEAL B, V38, P529, DOI 10.1081/PFC-120023511; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Donovan Y, 2006, REREGISTRATION ELIGI; EC, 2009, OFF J EU L 200, P1; Everich R, 2009, J ECON ENTOMOL, V102, P20, DOI 10.1603/029.102.0104; FIEDLER L, 1987, J APICULT RES, V26, P115, DOI 10.1080/00218839.1987.11100747; Health and Safety Executive, 1997, 7210 EH HLTH SAF EX; Hendriksma HP, 2012, APIDOLOGIE, V43, P549, DOI 10.1007/s13592-012-0123-3; Hendriksma HP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028174; Hendriksma HP, 2011, METHODS ECOL EVOL, V2, P509, DOI 10.1111/j.2041-210X.2011.00099.x; Hertzberg RC, 2002, SCI TOTAL ENVIRON, V288, P31, DOI 10.1016/S0048-9697(01)01113-5; Heylen K, 2011, APIDOLOGIE, V42, P103, DOI 10.1051/apido/2010043; Hung YM, 2005, TOXICOL IND HEALTH, V21, P137, DOI 10.1191/0748233705th217oa; Johnson RM, 2006, J ECON ENTOMOL, V99, P1046, DOI 10.1603/0022-0493-99.4.1046; Johnson RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054092; Johnson RM, 2011, AM BEE J, V151, P975; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Johnson RM, 2009, J ECON ENTOMOL, V102, P474, DOI 10.1603/029.102.0202; Jouyban A, 2010, J PHARM PHARM SCI, V13, P524, DOI 10.18433/J3P306; Kalbfleisch R.L, 2011, STAT ANAL FAILURE TI; Kudsk P, 2004, WEED RES, V44, P313, DOI 10.1111/j.1365-3180.2004.00405.x; Ladurner E, 2005, APIDOLOGIE, V36, P449, DOI 10.1051/apido:2005032; Lan CH, 2004, B ENVIRON CONTAM TOX, V73, P392, DOI 10.1007/s00128-004-0441-x; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; PILLING ED, 1995, PESTIC BIOCHEM PHYS, V51, P1, DOI 10.1006/pest.1995.1001; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; Saillenfait AM, 2007, J APPL TOXICOL, V27, P491, DOI 10.1002/jat.1237; Schindler BK, 2012, ANAL CHEM, V84, P3787, DOI 10.1021/ac300439w; Suchail S, 2001, ENVIRON TOXICOL CHEM, V20, P2482, DOI [10.1002/etc.5620201113, 10.1897/1551-5028(2001)020&lt;2482:DBAACT&gt;2.0.CO;2]; Tasei JN, 2001, APIDOLOGIE, V32, P527, DOI 10.1051/apido:2001102; Thompson Helen, 2003, Bulletin of Insectology, V56, P131; VANBUREN NWM, 1992, PHYSIOL ENTOMOL, V17, P288, DOI 10.1111/j.1365-3032.1992.tb01024.x; vanEngelsdorp D, 2010, J ECON ENTOMOL, V103, P1517, DOI 10.1603/EC09429; WARNE MSJ, 1995, ECOTOX ENVIRON SAFE, V31, P23, DOI 10.1006/eesa.1995.1039; Winston M.L., 1991, BIOL HONEY BEE; Wu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014720; Yu S., 2008, TOXICOLOGY BIOCH INS, DOI 10.1201/9781420059762	53	230	238	6	185	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e77547	10.1371/journal.pone.0077547	http://dx.doi.org/10.1371/journal.pone.0077547			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416121	gold, Green Published			2022-12-27	WOS:000329862500002
J	Maia, GH; Quesado, JL; Soares, JI; do Carmo, JM; Andrade, PA; Andrade, JP; Lukoyanov, NV				Maia, Gisela H.; Quesado, Jose L.; Soares, Joana I.; do Carmo, Joana M.; Andrade, Pedro A.; Andrade, Jose P.; Lukoyanov, Nikolai V.			Loss of Hippocampal Neurons after Kainate Treatment Correlates with Behavioral Deficits	PLOS ONE			English	Article							RETROSPLENIAL CORTEX LESIONS; SPONTANEOUS MOTOR SEIZURES; STATUS EPILEPTICUS; KAINIC ACID; FUNCTIONAL-CHANGES; RATS; MEMORY; EPILEPSY; MODEL; PILOCARPINE	Treating rats with kainic acid induces status epilepticus (SE) and leads to the development of behavioral deficits and spontaneous recurrent seizures later in life. However, in a subset of rats, kainic acid treatment does not induce overt behaviorally obvious acute SE. The goal of this study was to compare the neuroanatomical and behavioral changes induced by kainate in rats that developed convulsive SE to those who did not. Adult male Wistar rats were treated with kainic acid and tested behaviorally 5 months later. Rats that had experienced convulsive SE showed impaired performance on the spatial water maze and passive avoidance tasks, and on the context and tone retention tests following fear conditioning. In addition, they exhibited less anxiety-like behaviors than controls on the open-field and elevated plus-maze tests. Histologically, convulsive SE was associated with marked neuron loss in the hippocampal CA3 and CA1 fields, and in the dentate hilus. Rats that had not experienced convulsive SE after kainate treatment showed less severe, but significant impairments on the spatial water maze and passive avoidance tasks. These rats had fewer neurons than control rats in the dentate hilus, but not in the hippocampal CA3 and CA1 fields. Correlational analyses revealed significant relationships between spatial memory indices of rats and neuronal numbers in the dentate hilus and CA3 pyramidal field. These results show that a part of the animals that do not display intense behavioral seizures (convulsive SE) immediately after an epileptogenic treatment, later in life, they may still have noticeable structural and functional changes in the brain.	[Maia, Gisela H.; Quesado, Jose L.; Andrade, Jose P.; Lukoyanov, Nikolai V.] Univ Porto, Fac Med, Dept Anat, P-4100 Oporto, Portugal; [Maia, Gisela H.; Soares, Joana I.; Lukoyanov, Nikolai V.] Univ Porto, Inst Biol Mol & Celular, Neural Networks Grp, P-4100 Oporto, Portugal; [Maia, Gisela H.; Soares, Joana I.; do Carmo, Joana M.; Andrade, Pedro A.; Lukoyanov, Nikolai V.] Univ Porto, Programa Doutoral Neurociencias, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto	Lukoyanov, NV (corresponding author), Univ Porto, Fac Med, Dept Anat, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	luk@med.up.pt	Andrade, Pedro/N-8410-2018; Andrade, José Paulo/L-8036-2013; Lukoyanov, Nikolay/X-9360-2019; Lukoyanov, Nikolai/N-1235-2013; Soares, Joana Isabel/ABC-5544-2021	Andrade, Pedro/0000-0001-9118-8341; Andrade, José Paulo/0000-0003-2585-200X; Lukoyanov, Nikolay/0000-0002-5206-7819; Lukoyanov, Nikolai/0000-0002-5206-7819; Soares, Joana I./0000-0002-3549-6873; Maia, Gisela/0000-0002-3199-340X	FEDER Funds through the Programa Operacional Factores de Competitividade - COMPETE; National Funds through FCT - Fundacao para a Ciencia e a Tecnologia [FCOMP-01-0124-FEDER-015919, PTDC/SAU-NSC/115506/2009]; Strategic Project Centro de Morfologia Experimental (CME/FM/UP) [PEst-OE/SAU/UI0121/2011]	FEDER Funds through the Programa Operacional Factores de Competitividade - COMPETE; National Funds through FCT - Fundacao para a Ciencia e a Tecnologia; Strategic Project Centro de Morfologia Experimental (CME/FM/UP)	This work was supported by FEDER Funds through the Programa Operacional Factores de Competitividade - COMPETE and National Funds through FCT - Fundacao para a Ciencia e a Tecnologia within the scope of the Project FCOMP-01-0124-FEDER-015919 PTDC/SAU-NSC/115506/2009, Strategic Project Centro de Morfologia Experimental (CME/FM/UP) - 2011-2012, Project PEst-OE/SAU/UI0121/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggleton JP, 2010, EUR J NEUROSCI, V31, P2292, DOI 10.1111/j.1460-9568.2010.07251.x; Akaike K, 2001, BRAIN RES, V900, P65, DOI 10.1016/S0006-8993(01)02252-1; Aldenkamp AP, 1996, ACTA NEUROL SCAND, V93, P253; Alessio A, 2004, EPILEPSY BEHAV, V5, P22, DOI 10.1016/j.yebeh.2003.10.010; Amaral David G., 1995, P443; Bakker A, 2008, SCIENCE, V319, P1640, DOI 10.1126/science.1152882; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Barkas L, 2012, BRAIN, V135, P2358, DOI 10.1093/brain/aws176; BENARI Y, 1980, BRAIN RES, V191, P79, DOI 10.1016/0006-8993(80)90316-9; Bonilha L, 2007, HUM BRAIN MAPP, V28, P1376, DOI 10.1002/hbm.20373; Brandt C, 2006, NEUROPHARMACOLOGY, V51, P789, DOI 10.1016/j.neuropharm.2006.05.021; Buckmaster PS, 1997, J COMP NEUROL, V385, P385; Cardoso A, 2008, BRAIN RES, V1218, P206, DOI 10.1016/j.brainres.2008.04.074; Cardoso A, 2011, BEHAV BRAIN RES, V225, P538, DOI 10.1016/j.bbr.2011.07.057; Cavarsan CF, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00106; Chen SY, 2005, BRAIN RES, V1057, P141, DOI 10.1016/j.brainres.2005.07.058; Covolan L, 2000, EPILEPSY RES, V39, P133, DOI 10.1016/S0920-1211(99)00119-9; Furtak SC, 2007, HIPPOCAMPUS, V17, P709, DOI 10.1002/hipo.20314; GAARSKJAER FB, 1978, J COMP NEUROL, V178, P49, DOI 10.1002/cne.901780104; GAYOSO MJ, 1994, BRAIN RES, V653, P92, DOI 10.1016/0006-8993(94)90376-X; Gilby KL, 2005, EPILEPSIA, V46, P3, DOI 10.1111/j.1528-1167.2005.01001.x; Gilby KL, 2009, BEHAV NEUROSCI, V123, P337, DOI 10.1037/a0014730; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; Hattiangady B, 2011, AGING DIS, V2, P1; Hellier JL, 1998, EPILEPSY RES, V31, P73, DOI 10.1016/S0920-1211(98)00017-5; Hellier JL, 1999, EPILEPSY RES, V35, P47, DOI 10.1016/S0920-1211(98)00127-2; Herguido MJ, 1999, NEUROSCIENCE, V93, P71, DOI 10.1016/S0306-4522(99)00163-3; Hort J, 2000, BEHAV BRAIN RES, V112, P77, DOI 10.1016/S0166-4328(00)00163-7; Inostroza M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038959; Inostroza M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022372; Kemppainen EJS, 2006, EPILEPSIA, V47, P820, DOI 10.1111/j.1528-1167.2006.00542.x; Kubova H, 2013, NEUROSCIENCE, V235, P232, DOI 10.1016/j.neuroscience.2012.12.055; Langer M, 2011, EPILEPSY RES, V96, P207, DOI 10.1016/j.eplepsyres.2011.06.005; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Lukoyanov NV, 2006, BEHAV BRAIN RES, V173, P229, DOI 10.1016/j.bbr.2006.06.026; Lukoyanov NV, 2005, BEHAV BRAIN RES, V158, P175, DOI 10.1016/j.bbr.2004.08.023; Lynch M, 2000, EUR J NEUROSCI, V12, P2252, DOI 10.1046/j.1460-9568.2000.00117.x; MARGERISON JH, 1966, BRAIN, V89, P499, DOI 10.1093/brain/89.3.499; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MATHERN GW, 1995, J NEUROSCI, V15, P3990; McIntyre DC, 2007, EPILEPSIA, V48, P30, DOI 10.1111/j.1528-1167.2007.01398.x; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Muller CJ, 2009, EXP NEUROL, V219, P284, DOI 10.1016/j.expneurol.2009.05.035; O'Reilly RC, 2014, COGNITIVE SCI, V38, P1229, DOI 10.1111/j.1551-6709.2011.01214.x; Olton D.S., 1983, NEUROBIOLOGY HIPPOCA, P335; Paulsen O, 1998, TRENDS NEUROSCI, V21, P273, DOI 10.1016/S0166-2236(97)01205-8; Piazzini A, 2001, EPILEPSY BEHAV, V2, P481, DOI 10.1006/ebeh.2001.0247; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Sayin U, 2004, EPILEPSIA, V45, P1539, DOI 10.1111/j.0013-9580.2004.54903.x; SHAPIRO SS, 1968, J AM STAT ASSOC, V63, P1343, DOI 10.2307/2285889; SLOVITER RS, 1987, SCIENCE, V235, P73, DOI 10.1126/science.2879352; STAFSTROM CE, 1993, EPILEPSIA, V34, P420, DOI 10.1111/j.1528-1157.1993.tb02582.x; Suarez LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048128; SUTULA T, 1989, ANN NEUROL, V26, P321, DOI 10.1002/ana.410260303; Szyndler J, 2005, PHARMACOL BIOCHEM BE, V81, P15, DOI 10.1016/j.pbb.2005.01.020; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; Tuunanen J, 1999, NEUROSCIENCE, V94, P473, DOI 10.1016/S0306-4522(99)00251-1; Vazdarjanova A, 2004, J NEUROSCI, V24, P6489, DOI 10.1523/JNEUROSCI.0350-04.2004; Vogt KE, 1999, P NATL ACAD SCI USA, V96, P1118, DOI 10.1073/pnas.96.3.1118; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Williams PA, 2009, J NEUROSCI, V29, P2103, DOI 10.1523/JNEUROSCI.0980-08.2009	63	30	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84722	10.1371/journal.pone.0084722	http://dx.doi.org/10.1371/journal.pone.0084722			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409306	Green Submitted, Green Published, gold			2022-12-27	WOS:000329463500030
J	Stepanenko, OV; Stepanenko, OV; Staiano, M; Kuznetsova, IM; Turoverov, KK; D'Auria, S				Stepanenko, Olga V.; Stepanenko, Olesya V.; Staiano, Maria; Kuznetsova, Irina M.; Turoverov, Konstantin K.; D'Auria, Sabato			The Quaternary Structure of the Recombinant Bovine Odorant-Binding Protein Is Modulated by Chemical Denaturants	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; DOMAIN; MECHANISM; FLUORESCENCE; STABILITY; COMPLEX; ANTICALINS; REVEALS; POCKET; FORMS	A large group of odorant-binding proteins (OBPs) has attracted great scientific interest as promising building blocks in constructing optical biosensors for dangerous substances, such as toxic and explosive molecules. Native tissue-extracted bovine OBP (bOBP) has a unique dimer folding pattern that involves crossing the a-helical domain in each monomer over the other monomer's b-barrel. In contrast, recombinant bOBP maintaining the high level of stability inherent to native tissue bOBP is produced in a stable native-like state with a decreased tendency for dimerization and is a mixture of monomers and dimers in a buffered solution. This work is focused on the study of the quaternary structure and the folding-unfolding processes of the recombinant bOBP in the absence and in the presence of guanidine hydrochloride (GdnHCl). Our results show that the recombinant bOBP native dimer is only formed at elevated GdnHCl concentrations (1.5 M). This process requires re-organizing the protein structure by progressing through the formation of an intermediate state. The bOBP dimerization process appears to be irreversible and it occurs before the protein unfolds. Though the observed structural changes for recombinant bOBP at pre-denaturing GdnHCl concentrations show a local character and the overall protein structure is maintained, such changes should be considered where the protein is used as a sensitive element in a biosensor system.	[Stepanenko, Olga V.; Stepanenko, Olesya V.; Kuznetsova, Irina M.; Turoverov, Konstantin K.] Russian Acad Sci, Inst Cytol, Lab Struct Dynam Stabil & Folding Prot, St Petersburg 194064, Russia; [Staiano, Maria; D'Auria, Sabato] CNR, IBP, Lab Mol Sensing, I-80125 Naples, Italy; [Kuznetsova, Irina M.] St Petersburg State Polytech Univ, St Petersburg, Russia	Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); Peter the Great St. Petersburg Polytechnic University	Turoverov, KK (corresponding author), Russian Acad Sci, Inst Cytol, Lab Struct Dynam Stabil & Folding Prot, St Petersburg 194064, Russia.	kkt@incras.ru; s.dauria@ibp.cnr.it	Kuznetsova, Irina M./R-9844-2017; Stepanenko, Olga/S-3427-2017; STAIANO, MARIA/B-9584-2015; Stepanenko, Olesya V/S-3433-2017; d'auria, sabato/C-3565-2015; Turoverov, Konstantin/S-2079-2016	Kuznetsova, Irina M./0000-0002-3336-4834; STAIANO, MARIA/0000-0003-0223-1825; d'auria, sabato/0000-0001-9320-494X; Stepanenko, Olesya/0000-0003-3779-6711; Stepanenko, Olga/0000-0002-9145-3480; Turoverov, Konstantin/0000-0002-6977-1896	Program MCB RAS; RAS; CNR; RF	Program MCB RAS; RAS(Russian Academy of SciencesRegione Sardegna); CNR(Consiglio Nazionale delle Ricerche (CNR)); RF	This work was supported in part by the Program MCB RAS (Konstantin K. Turoverov), the Scholarships from the President of RF (Olga V. Stepanenko and Olesya V. Stepanenko), and the Program of Cooperation between RAS and CNR (Sabato D'Auria and Konstantin K. Turoverov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETT MJ, 1994, P NATL ACAD SCI USA, V91, P3127, DOI 10.1073/pnas.91.8.3127; BENNETT MJ, 1995, PROTEIN SCI, V4, P2455, DOI 10.1002/pro.5560041202; Blanchet MA, 1996, NAT STRUCT BIOL, V3, P934, DOI 10.1038/nsb1196-934; Bourne Y, 2000, STRUCT FOLD DES, V8, P841, DOI 10.1016/S0969-2126(00)00175-1; BOURNE Y, 1995, P NATL ACAD SCI USA, V92, P10232, DOI 10.1073/pnas.92.22.10232; Dutta S, 2009, MOL BIOTECHNOL, V42, P1, DOI 10.1007/s12033-008-9127-7; EFTINK MR, 1991, METHOD BIOCHEM ANAL, V35, P127; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; Gebauer M, 2012, METHOD ENZYMOL, V503, P157, DOI 10.1016/B978-0-12-396962-0.00007-0; Giordano A, 2004, J PROTEOME RES, V3, P613, DOI 10.1021/pr034132d; Golebiowski J, 2007, PROTEINS, V67, P448, DOI 10.1002/prot.21307; Hakansson M, 2002, CURR PROTEIN PEPT SC, V3, P629, DOI 10.2174/1389203023380459; Hsin Jen, 2008, Curr Protoc Bioinformatics, VChapter 5, DOI 10.1002/0471250953.bi0507s24; Ikematsu M, 2005, BIOCHEM BIOPH RES CO, V333, P1227, DOI 10.1016/j.bbrc.2005.06.031; Jahn TR, 2005, FEBS J, V272, P5962, DOI 10.1111/j.1742-4658.2005.05021.x; Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770; Korndorfer IP, 2003, J MOL BIOL, V330, P385, DOI 10.1016/S0022-2836(03)00573-4; Kuznetsova IM, 2005, J PROTEOME RES, V4, P417, DOI 10.1021/pr0498077; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Malevanets A, 2008, J MOL BIOL, V382, P223, DOI 10.1016/j.jmb.2008.06.025; Mazzini A, 2002, BBA-PROTEINS PROTEOM, V1599, P90, DOI 10.1016/S1570-9639(02)00404-1; Mazzini A, 2007, J STRUCT BIOL, V159, P82, DOI 10.1016/j.jsb.2007.02.007; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Onuchic JN, 2004, CURR OPIN STRUC BIOL, V14, P70, DOI 10.1016/j.sbi.2004.01.009; Pace C N, 1986, Methods Enzymol, V131, P266; PARKER CA, 1962, ANALYST, V87, P83, DOI 10.1039/an9628700083; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Ramoni R, 2002, BIOCHEM J, V365, P739, DOI 10.1042/BJ20011631; Ramoni R, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/39/395012; Sanders A, 2004, J MOL BIOL, V336, P165, DOI 10.1016/j.jmb.2003.12.011; Skerra A, 2008, FEBS J, V275, P2677, DOI 10.1111/j.1742-4658.2008.06439.x; Spinelli S, 1998, BIOCHEMISTRY-US, V37, P7913, DOI 10.1021/bi980179e; Staiano M, 2007, BIOCHEMISTRY-US, V46, P11120, DOI 10.1021/bi7008129; Staniforth RA, 2001, EMBO J, V20, P4774, DOI 10.1093/emboj/20.17.4774; Stepanenko OV, 2008, PROTEINS, V71, P35, DOI 10.1002/prot.21658; Stepanenko OV, 2013, INT REV CEL MOL BIO, V302, P221, DOI 10.1016/B978-0-12-407699-0.00004-2; Stepanenko OV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048809; Stepanenko OV, 2011, J PHYS CHEM B, V115, P9022, DOI 10.1021/jp204555h; Stepanenko OV, 2011, J PHYS CHEM B, V115, P2765, DOI 10.1021/jp1095486; Stepanenko OV, 2004, BIOCHEMISTRY-US, V43, P5296, DOI 10.1021/bi0359325; Sulatskaya Anna I, 2012, Methods Mol Biol, V895, P441, DOI 10.1007/978-1-61779-927-3_26; Tegoni M, 1996, NAT STRUCT BIOL, V3, P863, DOI 10.1038/nsb1096-863; Turoverov K K, 1998, Tsitologiia, V40, P806; TUROVEROV KK, 1985, BIOPHYS CHEM, V23, P79, DOI 10.1016/0301-4622(85)80066-1; Turoverov KK, 2003, J FLUORESC, V13, P41, DOI 10.1023/A:1022366816812; Turoverov KK, 2010, PROG BIOPHYS MOL BIO, V102, P73, DOI 10.1016/j.pbiomolbio.2010.01.003; UVERSKY VN, 2013, BIOPOLYMERS; van der Wel PCA, 2012, PRION, V6, P211, DOI 10.4161/pri.18987; Verkhusha VV, 2003, FEMS YEAST RES, V3, P105, DOI 10.1111/j.1567-1364.2003.tb00145.x; Vincent F, 2004, EUR J BIOCHEM, V271, P3832, DOI 10.1111/j.1432-1033.2004.04315.x; Wei Y, 2008, BBA-PROTEINS PROTEOM, V1784, P666, DOI 10.1016/j.bbapap.2008.01.012; Zerovnik E, 2010, BIOCHIMIE, V92, P1597, DOI 10.1016/j.biochi.2010.05.012	53	7	7	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e85169	10.1371/journal.pone.0085169	http://dx.doi.org/10.1371/journal.pone.0085169			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409322	Green Published, Green Submitted, gold			2022-12-27	WOS:000329463500046
J	Lei, NY; Jabaji, Z; Wang, JF; Joshi, VS; Brinkley, GJ; Khalil, H; Wang, FC; Jaroszewicz, A; Pellegrini, M; Li, LH; Lewis, M; Stelzner, M; Dunn, JCY; Martin, MG				Lei, Nan Ye; Jabaji, Ziyad; Wang, Jiafang; Joshi, Vaidehi S.; Brinkley, Garrett J.; Khalil, Hassan; Wang, Fengchao; Jaroszewicz, Artur; Pellegrini, Matteo; Li, Linheng; Lewis, Michael; Stelzner, Matthias; Dunn, James C. Y.; Martin, G. Martin			Intestinal Subepithelial Myofibroblasts Support the Growth of Intestinal Epithelial Stem Cells	PLOS ONE			English	Article							IN-VITRO; WNT/BETA-CATENIN; SELF-RENEWAL; LGR5; DIFFERENTIATION; TRANSPLANTATION; RECEPTORS	Intestinal epithelial stem cells (ISCs) are the focus of recent intense study. Current in vitro models rely on supplementation with the Wnt agonist R-spondin1 to support robust growth, ISC self-renewal, and differentiation. Intestinal subepithelial myofibroblasts (ISEMFs) are important supportive cells within the ISC niche. We hypothesized that co-culture with ISEMF enhances the growth of ISCs in vitro and allows for their successful in vivo implantation and engraftment. ISC-containing small intestinal crypts, FACS-sorted single ISCs, and ISEMFs were procured from C57BL/6 mice. Crypts and single ISCs were grown in vitro into enteroids, in the presence or absence of ISEMFs. ISEMFs enhanced the growth of intestinal epithelium in vitro in a proximity-dependent fashion, with co-cultures giving rise to larger enteroids than monocultures. Co-culture of ISCs with supportive ISEMFs relinquished the requirement of exogenous R-spondin1 to sustain long-term growth and differentiation of ISCs. Mono-and co-cultures were implanted subcutaneously in syngeneic mice. Co-culture with ISEMFs proved necessary for successful in vivo engraftment and proliferation of enteroids; implants without ISEMFs did not survive. ISEMF whole transcriptome sequencing and qPCR demonstrated high expression of specific R-spondins, well-described Wnt agonists that supports ISC growth. Specific non-supportive ISEMF populations had reduced expression of R-spondins. The addition of ISEMFs in intestinal epithelial culture therefore recapitulates a critical element of the intestinal stem cell niche and allows for its experimental interrogation and biodesign-driven manipulation.	[Lei, Nan Ye; Joshi, Vaidehi S.; Dunn, James C. Y.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA; [Lei, Nan Ye; Jabaji, Ziyad; Khalil, Hassan; Stelzner, Matthias; Dunn, James C. Y.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Los Angeles, CA 90095 USA; [Wang, Jiafang; Brinkley, Garrett J.; Martin, G. Martin] Univ Calif Los Angeles, Mattel Childrens Hosp, Dept Pediat, Div Gastroenterol & Nutr, Los Angeles, CA 90095 USA; [Wang, Jiafang; Brinkley, Garrett J.; Martin, G. Martin] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Wang, Fengchao; Li, Linheng] Stowers Inst Med Res, Kansas City, MO USA; [Jaroszewicz, Artur; Pellegrini, Matteo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA; [Li, Linheng] Univ Kansas, Med Ctr, Dept Pathol, Kansas City, KS 66103 USA; [Li, Linheng] Univ Kansas, Med Ctr, Lab Med, Kansas City, KS 66103 USA; [Lewis, Michael] Vet Affairs Greater Los Angeles Healthcare Syst, Dept Pathol, Los Angeles, CA USA; [Stelzner, Matthias] Vet Affairs Greater Los Angeles Healthcare Syst, Dept Surg, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Stowers Institute for Medical Research; University of California System; University of California Los Angeles; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Martin, MG (corresponding author), Univ Calif Los Angeles, Mattel Childrens Hosp, Dept Pediat, Div Gastroenterol & Nutr, Los Angeles, CA 90095 USA.	mmartin@mednet.ucla.edu	Martín, María/HDL-9512-2022; Khalil, Hassan A/AAM-7914-2021	Khalil, Hassan A/0000-0002-3835-1290; Pellegrini, Matteo/0000-0001-9355-9564; Li, Linheng/0000-0001-9963-430X; Brinkley, Garrett/0000-0003-2622-3416	National Institute of Diabetes and Digestive and Kidney Diseases U01 Intestinal Stem Cell Consortium [DK085535-01, DK085535-02S2, DK083762, DK083319]; California Institute for Regenerative Medicine [RT2-01985]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301, U01DK085507, R01DK083762, R01DK083319, U01DK085535] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases U01 Intestinal Stem Cell Consortium; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases U01 Intestinal Stem Cell Consortium (DK085535-01 and DK085535-02S2), DK083762, DK083319 and the California Institute for Regenerative Medicine (RT2-01985). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agopian VG, 2009, J GASTROINTEST SURG, V13, P971, DOI 10.1007/s11605-009-0806-x; Avansino JR, 2006, SURGERY, V140, P423, DOI 10.1016/j.surg.2006.03.012; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2012, CELL STEM CELL, V11, P452, DOI 10.1016/j.stem.2012.09.009; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chen DC, 2006, CELLS TISSUES ORGANS, V184, P154, DOI 10.1159/000099622; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Durand A, 2012, P NATL ACAD SCI USA, V109, P8965, DOI 10.1073/pnas.1201652109; Farin HF, 2012, GASTROENTEROLOGY, V143, P1518, DOI 10.1053/j.gastro.2012.08.031; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Fritsch C, 2002, J CLIN INVEST, V110, P1629, DOI 10.1172/200213588; Gracz A D, 2012, Methods Mol Biol, V879, P89, DOI 10.1007/978-1-61779-815-3_6; Jabaji Z, 2013, TISSUE ENG PART C-ME, V19, P961, DOI [10.1089/ten.tec.2012.0710, 10.1089/ten.TEC.2012.0710]; Kim KA, 2008, MOL BIOL CELL, V19, P2588, DOI 10.1091/mbc.E08-02-0187; Lahar N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026898; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Papapietro O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2816; Plateroti M, 1998, AM J PHYSIOL-GASTR L, V274, pG945, DOI 10.1152/ajpgi.1998.274.5.G945; Potten CS, 2009, CELL PROLIFERAT, V42, P731, DOI 10.1111/j.1365-2184.2009.00642.x; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC183, DOI 10.1152/ajpcell.1999.277.2.C183; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Wang F, 2013, GASTROENTEROLOGY, DOI [10.1053/j.gastro.2013.04.050, DOI 10.1053/J.GAS-TR0.2013.04.050]; Yen TH, 2006, STEM CELL REV, V2, P203, DOI 10.1007/s12015-006-0048-1; Yeung TM, 2011, CELL MOL LIFE SCI, V68, P2513, DOI 10.1007/s00018-011-0687-5	30	71	75	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84651	10.1371/journal.pone.0084651	http://dx.doi.org/10.1371/journal.pone.0084651			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400106	Green Published, Green Submitted, gold			2022-12-27	WOS:000329462700040
J	Michael, N; Bischof, HJ; Lowel, S				Michael, Neethu; Bischof, Hans-Joachim; Loewel, Siegrid			Flavoprotein Autofluorescence Imaging of Visual System Activity in Zebra Finches and Mice	PLOS ONE			English	Article							INTRINSIC SIGNAL; PLASTICITY; CORTEX; BRAIN; MOUSE; BIRDS; MECHANISMS; MAPS	Large-scale brain activity patterns can be visualized by optical imaging of intrinsic signals (OIS) based on activity-dependent changes in the blood oxygenation level. Another method, flavoprotein autofluorescence imaging (AFI), exploits the mitochondrial flavoprotein autofluorescence, which is enhanced during neuronal activity. In birds, topographic mapping of visual space has been shown in the visual wulst, the avian homologue of the mammalian visual cortex by using OIS. We here applied the AFI method to visualize topographic maps in the visual wulst because with OIS, which depends on blood flow changes, blood vessel artifacts often obscure brain activity maps. We then compared both techniques quantitatively in zebra finches and in C57Bl/6J mice using the same setup and stimulation conditions. In addition to experiments with craniotomized animals, we also examined mice with intact skull (in zebra finches, intact skull imaging is not feasible probably due to the skull construction). In craniotomized animals, retinotopic maps were obtained by both methods in both species. Using AFI, artifacts caused by blood vessels were generally reduced, the magnitude of neuronal activity significantly higher and the retinotopic map quality better than that obtained by OIS in both zebra finches and mice. In contrast, our measurements in non-craniotomized mice did not reveal any quantitative differences between the two methods. Our results thus suggest that AFI is the method of choice for investigations of visual processing in zebra finches. In mice, however, if researchers decide to use the advantages of imaging through the intact skull, they will not be able to exploit the higher signals obtainable by the AFI-method.	[Michael, Neethu; Loewel, Siegrid] Univ Gottingen, Bernstein Focus Neurotechnol & Johann Friedrich B, Syst Neurosci Grp, D-37073 Gottingen, Germany; [Bischof, Hans-Joachim] Univ Bielefeld, D-33615 Bielefeld, Germany	University of Gottingen; University of Bielefeld	Michael, N (corresponding author), Univ Gottingen, Bernstein Focus Neurotechnol & Johann Friedrich B, Syst Neurosci Grp, D-37073 Gottingen, Germany.	neethu.michael@biologie.uni-goettingen.de			Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF) [01GQ0810]; Deutsche Forschungsgemeinschaft (DFG) [BI 245/21-1, LO 442/8-1]	Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was funded by grants from the Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF, http://www.bmbf.de/), grant number 01GQ0810 (S. L) and the Deutsche Forschungsgemeinschaft (DFG) (http://www.dfg.de/index.jsp), grant numbers BI 245/21-1 and LO 442/8-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bischof H, 2012, ANIMALS SEE WORLD CO, P483; Bischof HJ, 1997, EUR J MORPHOL, V35, P246, DOI 10.1076/ejom.35.4.246.13080; BISCHOF HJ, 1981, BRAIN RES BULL, V7, P435, DOI 10.1016/0361-9230(81)90042-3; Cang JH, 2005, VISUAL NEUROSCI, V22, P685, DOI 10.1017/S0952523805225178; Cang JH, 2005, NEURON, V48, P797, DOI 10.1016/j.neuron.2005.09.015; CHANCE B, 1962, SCIENCE, V137, P499, DOI 10.1126/science.137.3529.499; Goetze B, 2010, NEUROIMAGE, V49, P1622, DOI 10.1016/j.neuroimage.2009.10.019; Greifzu F, 2011, P NATL ACAD SCI USA, V108, P15450, DOI 10.1073/pnas.1016458108; GRINVALD A, 1983, BIOPHYS J, V42, P195, DOI 10.1016/S0006-3495(83)84386-0; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; HARTWIG HG, 1979, J COMP PHYSIOL, V130, P277, DOI 10.1007/BF00614615; Heimel JA, 2007, EUR J NEUROSCI, V25, P795, DOI 10.1111/j.1460-9568.2007.05333.x; Husson TR, 2007, J NEUROSCI, V27, P8665, DOI 10.1523/JNEUROSCI.2156-07.2007; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; KARTEN HJ, 1969, ANN NY ACAD SCI, V167, P164, DOI 10.1111/j.1749-6632.1969.tb20442.x; Keary N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011912; KUNZ WS, 1993, BIOCHEM MED METAB B, V50, P103, DOI 10.1006/bmmb.1993.1051; Lehmann K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003120; Magistretti PJ, 1999, PHILOS T R SOC B, V354, P1155, DOI 10.1098/rstb.1999.0471; Medina L, 2000, TRENDS NEUROSCI, V23, P1, DOI 10.1016/S0166-2236(99)01486-1; Schurr A, 2006, J CEREBR BLOOD F MET, V26, P142, DOI 10.1038/sj.jcbfm.9600174; Shibuki K, 2003, J PHYSIOL-LONDON, V549, P919, DOI 10.1113/jphysiol.2003.040709; Shibuki K., 2009, IN VIVO OPTICAL IMAG; Shimizu T, 1999, BEHAV BRAIN RES, V98, P183, DOI 10.1016/S0166-4328(98)00083-7; Shuttleworth CW, 2003, J NEUROSCI, V23, P3196; Tohmi M, 2006, J NEUROSCI, V26, P11775, DOI 10.1523/JNEUROSCI.1643-06.2006; Vazquez Alberto L, 2010, Front Neuroenergetics, V2, P11, DOI 10.3389/fnene.2010.00011; Zapeda A, 2004, J NEUROSCI METH, V136, P1, DOI 10.1016/j.jneumeth.2004.02.025; Zeigler H. P., 1993, VISION BRAIN BEHAV B, P415	29	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e85225	10.1371/journal.pone.0085225	http://dx.doi.org/10.1371/journal.pone.0085225			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400130	Green Submitted, Green Published, gold			2022-12-27	WOS:000329462700064
J	Garcia, S; Krausz, S; Ambarus, CA; Fernandez, BM; Hartkamp, LM; van Es, IE; Hamann, J; Baeten, DL; Tak, PP; Reedquist, KA				Garcia, Samuel; Krausz, Sarah; Ambarus, Carmen A.; Fernandez, Beatriz Malvar; Hartkamp, Linda M.; van Es, Inge E.; Hamann, Jorg; Baeten, Dominique L.; Tak, Paul P.; Reedquist, Kris A.			Tie2 Signaling Cooperates with TNF to Promote the Pro-Inflammatory Activation of Human Macrophages Independently of Macrophage Functional Phenotype	PLOS ONE			English	Article							TIE2-EXPRESSING MONOCYTES; OVEREXPRESSING ANGIOPOIETIN-1; TISSUE MACROPHAGES; ENDOTHELIAL-CELLS; DISEASE-ACTIVITY; GENE-EXPRESSION; SYNOVIAL TISSUE; IN-VIVO; POLARIZATION; PHOSPHORYLATION	Angiopoietin (Ang) -1 and -2 and their receptor Tie2 play critical roles in regulating angiogenic processes during development, homeostasis, tumorigenesis, inflammation and tissue repair. Tie2 signaling is best characterized in endothelial cells, but a subset of human and murine circulating monocytes/macrophages essential to solid tumor formation express Tie2 and display immunosuppressive properties consistent with M2 macrophage polarization. However, we have recently shown that Tie2 is strongly activated in pro-inflammatory macrophages present in rheumatoid arthritis patient synovial tissue. Here we examined the relationship between Tie2 expression and function during human macrophage polarization. Tie2 expression was observed under all polarization conditions, but was highest in IFN-gamma and IL-10 -differentiated macrophages. While TNF enhanced expression of a common restricted set of genes involved in angiogenesis and inflammation in GM-CSF, IFN-gamma and IL-10 -differentiated macrophages, expression of multiple chemokines and cytokines, including CXCL3, CXCL5, CXCL8, IL6, and IL12B was further augmented in the presence of Ang-1 and Ang-2, via Tie2 activation of JAK/STAT signaling. Conditioned medium from macrophages stimulated with Ang-1 or Ang-2 in combination with TNF, sustained monocyte recruitment. Our findings suggest a general role for Tie2 in cooperatively promoting the inflammatory activation of macrophages, independently of polarization conditions.	[Garcia, Samuel; Krausz, Sarah; Ambarus, Carmen A.; Fernandez, Beatriz Malvar; Hartkamp, Linda M.; van Es, Inge E.; Hamann, Jorg; Baeten, Dominique L.; Reedquist, Kris A.] Univ Amsterdam, Dept Expt Immunol, Amsterdam, Netherlands; [Garcia, Samuel; Krausz, Sarah; Ambarus, Carmen A.; Fernandez, Beatriz Malvar; Hartkamp, Linda M.; van Es, Inge E.; Baeten, Dominique L.; Tak, Paul P.; Reedquist, Kris A.] Univ Amsterdam, Dept Clin Immunol & Rheumatol, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam	Reedquist, KA (corresponding author), Univ Amsterdam, Dept Expt Immunol, Amsterdam, Netherlands.	k.a.reedquist@amc.uva.nl	Garcia Perez, Samuel/I-4729-2015	Garcia Perez, Samuel/0000-0002-5902-2699; Hamann, Jorg/0000-0002-9448-1727	Dutch Arthritis Association [NR 04-1-301, NR 09-1-405]; Anxeles Alvarino postdoctoral program (I+D+I Xunta de Galicia); Anxeles Alvarino postdoctoral program (European Social Fund (ESF))	Dutch Arthritis Association; Anxeles Alvarino postdoctoral program (I+D+I Xunta de Galicia); Anxeles Alvarino postdoctoral program (European Social Fund (ESF))	This research was supported by Dutch Arthritis Association project grants (NR 04-1-301 and NR 09-1-405) to Dr. K. A. Reedquist. Dr. S. Garcia is supported by the Anxeles Alvarino postdoctoral program (I+D+I Xunta de Galicia and the European Social Fund (ESF)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2010, HYPERTENSION, V56, P477, DOI 10.1161/HYPERTENSIONAHA.110.155556; Ambarus CA, 2012, J IMMUNOL METHODS, V375, P196, DOI 10.1016/j.jim.2011.10.013; Ambarus CA, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3796; Ambarus CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035994; Baeten D, 2005, ARTHRITIS RES THER, V7, pR359, DOI 10.1186/ar1501; Chen JX, 2004, AM J PHYSIOL-HEART C, V287, pH187, DOI 10.1152/ajpheart.01058.2003; Coffelt SB, 2011, J IMMUNOL, V186, P4183, DOI 10.4049/jimmunol.1002802; Coffelt SB, 2010, CANCER RES, V70, P5270, DOI 10.1158/0008-5472.CAN-10-0012; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; Duluc D, 2007, BLOOD, V110, P4319, DOI 10.1182/blood-2007-02-072587; Duluc D, 2009, INT J CANCER, V125, P367, DOI 10.1002/ijc.24401; Felcht M, 2012, J CLIN INVEST, V122, P1991, DOI 10.1172/JCI58832; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714; Hamilton JA, 2009, ARTHRITIS RHEUM-US, V60, P1210, DOI 10.1002/art.24505; Haq R, 2002, J BIOL CHEM, V277, P17359, DOI 10.1074/jbc.M201842200; Haringman JJ, 2005, ANN RHEUM DIS, V64, P834, DOI 10.1136/ard.2004.029751; Hatfield K, 2009, BRIT J HAEMATOL, V144, P53, DOI 10.1111/j.1365-2141.2008.07411.x; Huang HH, 2010, NAT REV CANCER, V10, P575, DOI 10.1038/nrc2894; Kim S, 2009, CELL SIGNAL, V21, P892, DOI 10.1016/j.cellsig.2009.01.034; Koning N, 2010, J INNATE IMMUN, V2, P195, DOI 10.1159/000252803; Krausz S, 2012, ANN RHEUM DIS, V71, P1402, DOI 10.1136/annrheumdis-2011-200718; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murdoch C, 2007, J IMMUNOL, V178, P7405, DOI 10.4049/jimmunol.178.11.7405; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Pucci F, 2009, BLOOD, V114, P901, DOI 10.1182/blood-2009-01-200931; Roviezzo F, 2005, J PHARMACOL EXP THER, V314, P738, DOI 10.1124/jpet.105.086553; Saharinen P, 2008, NAT CELL BIOL, V10, P527, DOI 10.1038/ncb1715; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Suri C, 1998, SCIENCE, V282, P468, DOI 10.1126/science.282.5388.468; Tak PP, 1997, ARTHRITIS RHEUM, V40, P217, DOI 10.1002/art.1780400206; Tammela T, 2005, BLOOD, V105, P4642, DOI 10.1182/blood-2004-08-3327; Thomas M, 2009, ANGIOGENESIS, V12, P125, DOI 10.1007/s10456-009-9147-3; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; Vandooren B, 2009, ARTHRITIS RHEUM-US, V60, P966, DOI 10.1002/art.24406; Venneri MA, 2007, BLOOD, V109, P5276, DOI 10.1182/blood-2006-10-053504; Wierenga ATJ, 2003, EXP HEMATOL, V31, P398, DOI 10.1016/S0301-472X(03)00045-6; Winston LA, 1995, J BIOL CHEM, V270, P30837, DOI 10.1074/jbc.270.52.30837; Yuan HT, 2009, MOL CELL BIOL, V29, P2011, DOI 10.1128/MCB.01472-08; Zhang YG, 2004, CARCINOGENESIS, V25, P1165, DOI 10.1093/carcin/bgh115	44	33	33	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e82088	10.1371/journal.pone.0082088	http://dx.doi.org/10.1371/journal.pone.0082088			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404127	Green Submitted, gold, Green Published			2022-12-27	WOS:000329460800006
J	Marshall, SM; Kelley, KL; Davis, MA; Wilson, MD; McDaniel, AL; Lee, RG; Crooke, RM; Graham, MJ; Rudel, LL; Brown, JM; Temel, RE				Marshall, Stephanie M.; Kelley, Kathryn L.; Davis, Matthew A.; Wilson, Martha D.; McDaniel, Allison L.; Lee, Richard G.; Crooke, Rosanne M.; Graham, Mark J.; Rudel, Lawrence L.; Brown, J. Mark; Temel, Ryan E.			Reduction of VLDL Secretion Decreases Cholesterol Excretion in Niemann-Pick C1-Like 1 Hepatic Transgenic Mice	PLOS ONE			English	Article							LIVER-X-RECEPTOR; TRIGLYCERIDE TRANSFER PROTEIN; BILIARY STEROL SECRETION; ABSORPTION; ACTIVATION; TRANSPORT; INHIBITION; EFFLUX; LIPOPROTEIN; ABCA1	An effective way to reduce LDL cholesterol, the primary risk factor of atherosclerotic cardiovascular disease, is to increase cholesterol excretion from the body. Our group and others have recently found that cholesterol excretion can be facilitated by both hepatobiliary and transintestinal pathways. However, the lipoprotein that moves cholesterol through the plasma to the small intestine for transintestinal cholesterol efflux (TICE) is unknown. To test the hypothesis that hepatic very low-density lipoproteins (VLDL) support TICE, antisense oligonucleotides (ASO) were used to knockdown hepatic expression of microsomal triglyceride transfer protein (MTP), which is necessary for VLDL assembly. While maintained on a high cholesterol diet, Niemann-Pick C1-like 1 hepatic transgenic (L1Tg) mice, which predominantly excrete cholesterol via TICE, and wild type (WT) littermates were treated with control ASO or MTP ASO. In both WT and L1Tg mice, MTP ASO decreased VLDL triglyceride (TG) and cholesterol secretion. Regardless of treatment, L1Tg mice had reduced biliary cholesterol compared to WT mice. However, only L1Tg mice treated with MTP ASO had reduced fecal cholesterol excretion. Based upon these findings, we conclude that VLDL or a byproduct such as LDL can move cholesterol from the liver to the small intestine for TICE.	[Marshall, Stephanie M.; Kelley, Kathryn L.; Davis, Matthew A.; Wilson, Martha D.; McDaniel, Allison L.; Rudel, Lawrence L.; Brown, J. Mark; Temel, Ryan E.] Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol, Sect Lipid Sci, Winston Salem, NC 27103 USA; [Lee, Richard G.; Crooke, Rosanne M.; Graham, Mark J.] ISIS Pharmaceut, Antisense Drug Discovery, Cardiovasc Grp, Carlsbad, CA 92008 USA; [Marshall, Stephanie M.; Brown, J. Mark] Cleveland Clin Fdn, Dept Cellular & Mol Med, Lerner Res Inst, Cleveland, OH 44195 USA; [Temel, Ryan E.] Univ Kentucky, Saha Cardiovasc Res Ctr, Lexington, KY USA	Wake Forest University; Wake Forest Baptist Medical Center; Isis Pharmaceuticals Inc; Cleveland Clinic Foundation; University of Kentucky	Brown, JM (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol, Sect Lipid Sci, Winston Salem, NC 27103 USA.	brownm5@ccf.org; ryan.temel@uky.edu			National Heart, Lung, and Blood Institute of the NIH [P01-HL049373, K99/R00-HL096166, K99/R00-HL088528]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL049373, K99HL096166] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Heart, Lung, and Blood Institute of the NIH (http://www.nhlbi.nih.gov/) funded this work through the following awards: P01-HL049373 to L. L. R., K99/R00-HL096166 to J.M.B., and K99/R00-HL088528 to R. E. T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alger HM, 2010, J BIOL CHEM, V285, P14267, DOI 10.1074/jbc.M110.118422; Brufau G, 2011, ARTERIOSCL THROM VAS, V31, P1726, DOI 10.1161/ATVBAHA.108.181206; Bura KS, 2013, J LIPID RES, V54, P1567, DOI 10.1194/jlr.M034454; Cai SF, 2001, J LIPID RES, V42, P902; CHENG SH, 1959, P SOC EXP BIOL MED, V101, P223; Chung Soonkyu, 2010, J Biol Chem, V285, P12197, DOI 10.1074/jbc.M109.096933; Crooke ST, 2004, ANNU REV MED, V55, P61, DOI 10.1146/annurev.med.55.091902.104408; Davis HR, 2011, CURR OPIN LIPIDOL, V22, P467, DOI 10.1097/MOL.0b013e32834c7c28; Hussain MM, 2003, J LIPID RES, V44, P22, DOI 10.1194/jlr.R200014-JLR200; Khera AV, 2010, CURR ATHEROSCLER REP, V12, P73, DOI 10.1007/s11883-009-0080-0; Kruit JK, 2005, GASTROENTEROLOGY, V128, P147, DOI 10.1053/j.gastro.2004.10.006; Le May C, 2012, ARTERIOSCLER THROMB, V32, pA22; Lee RG, 2013, J LIPID RES, V54, P602, DOI 10.1194/jlr.M029215; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Millar JS, 2005, J LIPID RES, V46, P2023, DOI 10.1194/jlr.D500019-JLR200; Nijstad N, 2011, GASTROENTEROLOGY, V140, P1043, DOI 10.1053/j.gastro.2010.11.055; Plosch T, 2002, J BIOL CHEM, V277, P33870, DOI 10.1074/jbc.M206522200; Rayner KJ, 2011, NATURE, V478, P404, DOI 10.1038/nature10486; SIMMONDS WJ, 1967, J CLIN INVEST, V46, P874, DOI 10.1172/JCI105587; Temel RE, 2005, J LIPID RES, V46, P2423, DOI 10.1194/jlr.M500232-JLR200; Temel RE, 2007, J CLIN INVEST, V117, P1968, DOI 10.1172/JCI30060; Temel RE, 2012, CURR OPIN LIPIDOL, V23, P85, DOI 10.1097/MOL.0b013e3283508c21; Temel RE, 2010, CELL METAB, V12, P96, DOI 10.1016/j.cmet.2010.05.011; van der Veen JN, 2009, J BIOL CHEM, V284, P19211, DOI 10.1074/jbc.M109.014860; van der Velde AE, 2008, AM J PHYSIOL-GASTR L, V295, pG203, DOI 10.1152/ajpgi.90231.2008; Van der Velde AE, 2007, GASTROENTEROLOGY, V133, P967, DOI 10.1053/j.gastro.2007.06.019; Vrins CLJ, 2012, J LIPID RES, V53, P2017, DOI 10.1194/jlr.M022194; Vrins CLJ, 2009, J LIPID RES, V50, P2046, DOI 10.1194/jlr.M800579-JLR200	29	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84418	10.1371/journal.pone.0084418	http://dx.doi.org/10.1371/journal.pone.0084418			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404162	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460800041
J	Tang, L; van de Ven, AL; Guo, DM; Andasari, V; Cristini, V; Li, KC; Zhou, XB				Tang, Lei; van de Ven, Anne L.; Guo, Dongmin; Andasari, Vivi; Cristini, Vittorio; Li, King C.; Zhou, Xiaobo			Computational Modeling of 3D Tumor Growth and Angiogenesis for Chemotherapy Evaluation	PLOS ONE			English	Article							INTERSTITIAL FLUID PRESSURE; CELL-PROLIFERATION; NONLINEAR SIMULATION; MATHEMATICAL-MODEL; OXYGEN-CONSUMPTION; IN-VIVO; CANCER; TRANSPORT; DELIVERY; PHARMACOKINETICS	Solid tumors develop abnormally at spatial and temporal scales, giving rise to biophysical barriers that impact anti-tumor chemotherapy. This may increase the expenditure and time for conventional drug pharmacokinetic and pharmacodynamic studies. In order to facilitate drug discovery, we propose a mathematical model that couples three-dimensional tumor growth and angiogenesis to simulate tumor progression for chemotherapy evaluation. This application-oriented model incorporates complex dynamical processes including cell-and vascular-mediated interstitial pressure, mass transport, angiogenesis, cell proliferation, and vessel maturation to model tumor progression through multiple stages including tumor initiation, avascular growth, and transition from avascular to vascular growth. Compared to pure mechanistic models, the proposed empirical methods are not only easy to conduct but can provide realistic predictions and calculations. A series of computational simulations were conducted to demonstrate the advantages of the proposed comprehensive model. The computational simulation results suggest that solid tumor geometry is related to the interstitial pressure, such that tumors with high interstitial pressure are more likely to develop dendritic structures than those with low interstitial pressure.	[Tang, Lei] Methodist Hosp, Res Inst, Dept Translat Imaging, Houston, TX 77030 USA; [Guo, Dongmin; Andasari, Vivi; Li, King C.; Zhou, Xiaobo] Wake Forest Sch Med, Dept Radiol, Winston Salem, NC 27106 USA; [van de Ven, Anne L.] Northeastern Univ, Dept Phys, Boston, MA 02115 USA; [Cristini, Vittorio] Univ New Mexico, Dept Pathol, Canc Res & Treatment Ctr, Dept Chem & Nucl Engn, Albuquerque, NM 87131 USA; [Cristini, Vittorio] Univ New Mexico, Ctr Biomed Engn, Albuquerque, NM 87131 USA	The Methodist Hospital System; The Methodist Hospital - Houston; Wake Forest University; Northeastern University; University of New Mexico; University of New Mexico	Zhou, XB (corresponding author), Wake Forest Sch Med, Dept Radiol, Winston Salem, NC 27106 USA.	xizhou@wakehealth.edu	Cristini, Vittorio/N-3540-2013	Cristini, Vittorio/0000-0002-7909-4278; Li, King/0000-0002-6473-2687; van de Ven, Anne/0000-0002-0347-4004	National Institutes of Health [5R01EB009009-06, U01CA166886-01]; Radiology Pilot Grant from Wake Forest University Health Sciences; National Science Foundation [DMS - 1263742, CTO PSOC - 1U54CA143837, TCCN - 1U54CA151668, USC PSOC - 1U54CA143907, ICBP - 1U54CA149196, NSF SBIR 1315372]; Victor and Ruby Hansen Surface Professorship in Molecular Modeling of Cancer; NATIONAL CANCER INSTITUTE [U54CA143907, U01CA166886, U54CA151668, U54CA149196, U54CA143837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009009] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Radiology Pilot Grant from Wake Forest University Health Sciences; National Science Foundation(National Science Foundation (NSF)); Victor and Ruby Hansen Surface Professorship in Molecular Modeling of Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was partially supported by the National Institutes of Health grants 5R01EB009009-06 (KL), U01CA166886-01 and Radiology Pilot Grant from Wake Forest University Health Sciences (XZ), National Science Foundation Grant DMS - 1263742, CTO PSOC - 1U54CA143837, TCCN - 1U54CA151668, USC PSOC - 1U54CA143907, ICBP - 1U54CA149196, NSF SBIR 1315372, the Victor and Ruby Hansen Surface Professorship in Molecular Modeling of Cancer (VC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andasari V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033726; Anderson ARA, 1998, B MATH BIOL, V60, P857, DOI 10.1006/bulm.1998.0042; Araujo RP, 2004, B MATH BIOL, V66, P1039, DOI 10.1016/j.bulm.2003.11.002; Baish JW, 2011, P NATL ACAD SCI USA, V108, P1799, DOI 10.1073/pnas.1018154108; BAXTER LT, 1989, MICROVASC RES, V37, P77, DOI 10.1016/0026-2862(89)90074-5; BAXTER LT, 1990, MICROVASC RES, V40, P246, DOI 10.1016/0026-2862(90)90023-K; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; BOUCHER Y, 1992, CANCER RES, V52, P5110; BREM H, 1975, J EXP MED, V141, P427, DOI 10.1084/jem.141.2.427; Bresch D, 2010, SIAM J SCI COMPUT, V32, P2321, DOI 10.1137/070708895; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Chaplain MAJ, 2006, ANNU REV BIOMED ENG, V8, P233, DOI 10.1146/annurev.bioeng.8.061505.095807; Chen YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007033; Dingemanse J, 2007, CLIN PHARMACOKINET, V46, P713, DOI 10.2165/00003088-200746090-00001; DiResta GR, 2005, ANN BIOMED ENG, V33, P1270, DOI 10.1007/s10439-005-5732-9; Dormann Sabine, 2002, In Silico Biology, V2, P393; ENDRICH B, 1979, J NATL CANCER I, V62, P387; Folkman J, 1992, Semin Cancer Biol, V3, P65; Frieboes HB, 2007, NEUROIMAGE, V37, pS59, DOI 10.1016/j.neuroimage.2007.03.008; Ganapathy V, 2009, PHARMACOL THERAPEUT, V121, P29, DOI 10.1016/j.pharmthera.2008.09.005; Goh YMF, 2001, PHARM RES-DORDR, V18, P761, DOI 10.1023/A:1011076110317; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Hofmann M, 2006, NEOPLASIA, V8, P89, DOI 10.1593/neo.05469; HOLTHUIS J, 1990, SCIENCE, V247, P1454, DOI 10.1126/science.2321007; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jiang Y, 2005, BIOPHYS J, V89, P3884, DOI 10.1529/biophysj.105.060640; Kerbel RS, 2000, CARCINOGENESIS, V21, P505, DOI 10.1093/carcin/21.3.505; LANGER R, 1980, P NATL ACAD SCI-BIOL, V77, P4331, DOI 10.1073/pnas.77.7.4331; Luo JC, 1998, CANCER RES, V58, P2652; Macklin P, 2009, J MATH BIOL, V58, P765, DOI 10.1007/s00285-008-0216-9; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Milde F, 2008, BIOPHYS J, V95, P3146, DOI 10.1529/biophysj.107.124511; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Nathan SS, 2005, CLIN CANCER RES, V11, P2389, DOI 10.1158/1078-0432.CCR-04-2048; Olsen MM, 2013, PROCEDIA COMPUT SCI, V18, P1016, DOI 10.1016/j.procs.2013.05.267; Orsolic N, 2003, TOXICON, V41, P861, DOI 10.1016/S0041-0101(03)00045-X; Perfahl H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014790; Pries AR, 2010, NAT REV CANCER, V10, P587, DOI 10.1038/nrc2895; Ramis-Conde I, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/016008; Ribba B, 2006, J THEOR BIOL, V243, P532, DOI 10.1016/j.jtbi.2006.07.013; Sanga S, 2007, NEUROIMAGE, V37, pS120, DOI 10.1016/j.neuroimage.2007.05.043; Sanga S, 2006, EXPERT REV ANTICANC, V6, P1361, DOI 10.1586/14737140.6.10.1361; Sherratt JA, 2001, J MATH BIOL, V43, P291, DOI 10.1007/s002850100088; Shirinifard A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007190; Sinek J, 2004, BIOMED MICRODEVICES, V6, P297, DOI 10.1023/B:BMMD.0000048562.29657.64; Sinek JP, 2009, J MATH BIOL, V58, P485, DOI 10.1007/s00285-008-0214-y; Tanaka T, 1997, HEPATOLOGY, V26, P283, DOI 10.1002/hep.510260205; Tang L, 2012, ISRN BIOMATHEMATICS, V2012; Vakoc BJ, 2009, NAT MED, V15, P1219, DOI 10.1038/nm.1971; VAUPEL P, 1987, CANCER RES, V47, P3496; Wang CH, 1998, CHEM ENG SCI, V53, P3579, DOI 10.1016/S0009-2509(98)00173-0; Wang J, 2013, THEOR BIOL MED MODEL, V10, DOI 10.1186/1742-4682-10-41; Wiig H, 2010, FIBROGENESIS TISSUE, V3; Zheng X, 2005, B MATH BIOL, V67, P211, DOI 10.1016/j.bulm.2004.08.001	54	50	52	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e83962	10.1371/journal.pone.0083962	http://dx.doi.org/10.1371/journal.pone.0083962			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404145	gold, Green Published, Green Submitted			2022-12-27	WOS:000329460800024
J	Brew, BK; Marks, GB; Almqvist, C; Cistulli, PA; Webb, K; Marshall, NS				Brew, Bronwyn K.; Marks, Guy B.; Almqvist, Catarina; Cistulli, Peter A.; Webb, Karen; Marshall, Nathaniel S.			Breastfeeding and Snoring: A Birth Cohort Study	PLOS ONE			English	Article							DISORDERED BREATHING SYMPTOMS; NONNUTRITIVE SUCKING HABITS; OBSTRUCTIVE SLEEP-APNEA; RISK-FACTORS; PRESCHOOL-CHILDREN; POPULATION-SAMPLE; EARLY-CHILDHOOD; YOUNG-CHILDREN; PREVALENCE; GROWTH	Objective: To investigate the relationship between breastfeeding and snoring in childhood. Methods: In a cohort of children with a family history of asthma who were recruited antenatally we prospectively recorded data on infant feeding practices throughout the first year of life. Snoring status and witnessed sleep apnea were measured at age 8 years by parent-completed questionnaire. Associations were estimated by logistic regression with, and without, adjustment for sets of confounders designed to exclude biasing effects. Results: Habitual snoring was reported in 18.8% of the sample, and witnessed apnea in 2.7%. Any breastfeeding for longer than one month was associated with a reduced risk of habitual snoring at age 8 (adjusted OR 0.48, 95% CI 0.29 to 0.81) and duration of breastfeeding was inversely associated with the prevalence of habitual snoring (adjusted OR 0.79, 95% CI 0.62 to 1.00). Any breastfeeding for longer than 1 month was associated with a lower risk of witnessed sleep apnea (adjusted OR 0.17, 95% CI 0.04 to 0.71). The protective associations were not mediated by BMI, current asthma, atopy or rhinitis at age 8 years. Conclusions: Breastfeeding for longer than one month decreases the risk of habitual snoring and witnessed apneas in this cohort of children with a family history of asthma. The underlying mechanism remains unclear but the finding would be consistent with a beneficial effect of the breast in the mouth on oropharyngeal development with consequent protection against upper airway dysfunction causing sleep-disordered breathing.	[Brew, Bronwyn K.; Marks, Guy B.; Marshall, Nathaniel S.] Woolcock Inst Med Res, Sydney, NSW, Australia; [Brew, Bronwyn K.; Marks, Guy B.; Cistulli, Peter A.; Marshall, Nathaniel S.] Univ Sydney, Sch Med, Sydney, NSW 2006, Australia; [Almqvist, Catarina] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Almqvist, Catarina] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Lung & Allergy Unit, Stockholm, Sweden; [Cistulli, Peter A.] Royal N Shore Hosp, Dept Resp & Sleep Med, Sydney, NSW, Australia; [Webb, Karen] Univ Calif Berkeley, Atkins Ctr Weight & Hlth, Berkeley, CA 94720 USA; [Marshall, Nathaniel S.] Univ Sydney, Sch Nursing, Sydney, NSW 2006, Australia	University of Sydney; Woolcock Institute of Medical Research; University of Sydney; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Royal North Shore Hospital; University of Sydney; University of California System; University of California Berkeley; University of Sydney	Brew, BK (corresponding author), Woolcock Inst Med Res, Sydney, NSW, Australia.	bronwynbrew@woolcock.org.au	Brew, Bronwyn K/AAV-5289-2020; Marshall, Nathaniel S/H-7375-2019; Marks, Guy B./F-5058-2013	Brew, Bronwyn K/0000-0002-9885-8261; Marshall, Nathaniel S/0000-0002-9014-1397; Marks, Guy B./0000-0002-8976-8053	National Health and Medical Research Council (NHMRC) [1038533]; NHMRC [1003500, 402827]; CAPS study by NHMRC Project [570919]; NHMRC Centres for Research Excellence in Respiratory and Sleep medicine [264598]; Interdisciplinary Sleep Medicine [571421]; Swedish Research Council; Swedish Heart-Lung foundation; Stockholm County Council; Karolinska Institutet, Stockholm Sweden	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); CAPS study by NHMRC Project(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Centres for Research Excellence in Respiratory and Sleep medicine(National Health and Medical Research Council (NHMRC) of Australia); Interdisciplinary Sleep Medicine; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung foundation(Swedish Heart-Lung Foundation); Stockholm County Council(Stockholm County Council); Karolinska Institutet, Stockholm Sweden(Karolinska Institutet)	Bronwyn Brew is supported by a National Health and Medical Research Council (NHMRC) research scholarship (#1038533), Guy Marks by NHMRC Practitioner fellowships (#1003500 & 402827), and the CAPS study by NHMRC Project Grant #570919 and the ongoing support of the NHMRC Centres for Research Excellence in Respiratory and Sleep medicine (#264598) and Interdisciplinary Sleep Medicine (#571421). Catarina Almqvist was supported by the Swedish Research Council, the Swedish Heart-Lung foundation and the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet, Stockholm Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beebe DW, 2012, PEDIATRICS, V130, P382, DOI 10.1542/peds.2012-0045; Binns C W, 2006, Breastfeed Rev, V14, P5; Bixler EO, 2008, HYPERTENSION, V52, P841, DOI 10.1161/HYPERTENSIONAHA.108.116756; Bixler EO, 2009, SLEEP, V32, P731, DOI 10.1093/sleep/32.6.731; Bonuck K, 2006, INT J PEDIATR OTORHI, V70, P769, DOI 10.1016/j.ijporl.2005.11.012; Bonuck KA, 2011, SLEEP, V34, P875, DOI 10.5665/SLEEP.1118; Chervin RD, 2002, PEDIATRICS, V109, P449, DOI 10.1542/peds.109.3.449; Darendeliler MA, 2009, SLEEP MED DENT PRACT, P85; Diouf JS, 2010, INT ORTHOD, V8, P372, DOI 10.1016/j.ortho.2010.10.001; Gottlieb DJ, 2003, PEDIATRICS, V112, P870, DOI 10.1542/peds.112.4.870; Gozal D, 2001, PEDIATRICS, V107, P1394, DOI 10.1542/peds.107.6.1394; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Huynh NT, 2011, AM J ORTHOD DENTOFAC, V140, P762, DOI 10.1016/j.ajodo.2011.03.023; JEANS WD, 1981, BRIT J RADIOL, V54, P117, DOI 10.1259/0007-1285-54-638-117; Kuehni CE, 2008, EUR RESPIR J, V31, P326, DOI 10.1183/09031936.00088407; LABBOK MH, 1987, AM J PREV MED, V3, P227; Labiner-Wolfe J, 2008, PEDIATRICS, V122, pS63, DOI 10.1542/peds.2008-1315h; Li AM, 2010, CHEST, V138, P519, DOI 10.1378/chest.09-1926; Loofstrand-Tidestrom B, 1999, EUR J ORTHODONT, V21, P323, DOI 10.1093/ejo/21.4.323; Lumeng Julie C, 2008, Proc Am Thorac Soc, V5, P242, DOI 10.1513/pats.200708-135MG; Marcus CL, 2002, PEDIATRICS, V109, P704; Marks GB, 2006, J ALLERGY CLIN IMMUN, V118, P53, DOI 10.1016/j.jaci.2006.04.004; Marshall NS, 2007, PEDIATR PULM, V42, P584, DOI 10.1002/ppul.20606; Mihrshahi S, 2001, CONTROL CLIN TRIALS, V22, P333, DOI 10.1016/S0197-2456(01)00112-X; Montaldo L, 2011, INT J PAEDIATR DENT, V21, P68, DOI 10.1111/j.1365-263X.2010.01092.x; Montgomery-Downs HE, 2007, PEDIATRICS, V120, P1030, DOI 10.1542/peds.2007-0722; Montgomery-Downs HE, 2004, SLEEP, V27, P87, DOI 10.1093/sleep/27.1.87; Montgomery-Downs HE, 2003, CLIN PEDIATR, V42, P719, DOI 10.1177/000992280304200808; Palmer Brian, 2006, Breastfeed Rev, V14, P11; Pirila-Parkkinen K, 2009, EUR J ORTHODONT, V31, P160, DOI 10.1093/ejo/cjn061; Raynes-Greenow CH, 2012, SLEEP, V35, P1475, DOI 10.5665/sleep.2192; Sanchez-Molins M, 2010, EUR J PAEDIATR DENT, V11, P87; Shrier I, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-70; Toelle BG, 2010, J ALLERGY CLIN IMMUN, V126, P388, DOI 10.1016/j.jaci.2010.04.031; Vazquez-Nava F, 2006, ARCH DIS CHILD, V91, P836, DOI 10.1136/adc.2005.088484; Woolridge M W, 1986, Midwifery, V2, P164, DOI 10.1016/S0266-6138(86)80041-9	36	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84956	10.1371/journal.pone.0084956	http://dx.doi.org/10.1371/journal.pone.0084956			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416321	gold, Green Submitted, Green Published			2022-12-27	WOS:000329862500197
J	Frank-Fahle, BA; Yergeau, E; Greer, CW; Lantuit, H; Wagner, D				Frank-Fahle, Beatrice A.; Yergeau, Etienne; Greer, Charles W.; Lantuit, Hugues; Wagner, Dirk			Microbial Functional Potential and Community Composition in Permafrost-Affected Soils of the NW Canadian Arctic	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; METHANE-OXIDIZING BACTERIA; LENA DELTA; METHANOTROPHIC BACTERIA; CARBON TURNOVER; METHANOGENIC PATHWAYS; POLYGONAL TUNDRA; LAPTEV SEA; GEN. NOV.; DIVERSITY	Permafrost-affected soils are among the most obvious ecosystems in which current microbial controls on organic matter decomposition are changing as a result of global warming. Warmer conditions in polygonal tundra will lead to a deepening of the seasonal active layer, provoking changes in microbial processes and possibly resulting in exacerbated carbon degradation under increasing anoxic conditions. To identify current microbial assemblages in carbon rich, water saturated permafrost environments, four polygonal tundra sites were investigated on Herschel Island and the Yukon Coast, Western Canadian Arctic. Ion Torrent sequencing of bacterial and archaeal 16S rRNA amplicons revealed the presence of all major microbial soil groups and indicated a local, vertical heterogeneity of the polygonal tundra soil community with increasing depth. Microbial diversity was found to be highest in the surface layers, decreasing towards the permafrost table. Quantitative PCR analysis of functional genes involved in carbon and nitrogen-cycling revealed a high functional potential in the surface layers, decreasing with increasing active layer depth. We observed that soil properties driving microbial diversity and functional potential varied in each study site. These results highlight the small-scale heterogeneity of geomorphologically comparable sites, greatly restricting generalizations about the fate of permafrost-affected environments in a warming Arctic.	[Frank-Fahle, Beatrice A.; Lantuit, Hugues] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Unit Potsdam, Potsdam, Germany; [Yergeau, Etienne; Greer, Charles W.] Natl Res Council Canada, Montreal, PQ, Canada; [Lantuit, Hugues] Univ Potsdam, Potsdam, Germany; [Wagner, Dirk] GFZ German Ctr Geosci, Sect Geomicrobiol 4 5, Potsdam, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Potsdam; National Research Council Canada; University of Potsdam; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences	Wagner, D (corresponding author), GFZ German Ctr Geosci, Sect Geomicrobiol 4 5, Potsdam, Germany.	dirk.wagner@gfz-potsdam.de	Lantuit, Hugues/ABC-8692-2020; Yergeau, Etienne/B-5344-2008; Yergeau, Etienne/AAZ-6145-2020; Wagner, Dirk/C-3932-2012	Lantuit, Hugues/0000-0003-1497-6760; Yergeau, Etienne/0000-0002-7112-3425; Wagner, Dirk/0000-0001-5064-497X	"International Cooperation in Education and Research" program of the International Bureau of the German Federal Ministry of Education and Research (BMBF); German Environmental Foundation (DBU)	"International Cooperation in Education and Research" program of the International Bureau of the German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Environmental Foundation (DBU)	This study was funded by the "International Cooperation in Education and Research" program of the International Bureau of the German Federal Ministry of Education and Research (BMBF) and through a doctoral scholarship to Beatrice A. Frank-Fahle from the German Environmental Foundation (DBU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aislabie JM, 2006, SOIL BIOL BIOCHEM, V38, P3041, DOI 10.1016/j.soilbio.2006.02.018; Barbier BA, 2012, FEMS MICROBIOL ECOL, V82, P287, DOI 10.1111/j.1574-6941.2012.01332.x; Bell TH, 2013, ISME J, V7, P1200, DOI 10.1038/ismej.2013.1; Bischoff J, 2013, GLOBAL BIOGEOCHEM CY, V27, P305, DOI 10.1029/2011GB004238; Brauer SL, 2011, INT J SYST EVOL MICR, V61, P45, DOI 10.1099/ijs.0.021782-0; Burn CR, 2009, CAN J GEOPHYS RES, V114, P1; Cadillo-Quiroz H, 2009, INT J SYST EVOL MICR, V59, P928, DOI 10.1099/ijs.0.006890-0; CHANTON JP, 1995, GEOCHIM COSMOCHIM AC, V59, P3663, DOI 10.1016/0016-7037(95)00240-Z; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Conrad R, 2005, ORG GEOCHEM, V36, P739, DOI 10.1016/j.orggeochem.2004.09.006; CONRAD R, 1987, FEMS MICROBIOL ECOL, V45, P281, DOI 10.1016/0378-1097(87)90005-X; Dunfield PF, 2007, NATURE, V450, P879, DOI 10.1038/nature06411; EDMEADES DC, 1985, NEW ZEAL J EXP AGR, V13, P47, DOI 10.1080/03015521.1985.10426058; Fiedler S, 2004, SOIL SCI SOC AM J, V68, P1002, DOI 10.2136/sssaj2004.1002; Ganzert L, 2007, FEMS MICROBIOL ECOL, V59, P476, DOI 10.1111/j.1574-6941.2006.00205.x; Graef C, 2011, ENV MICROBIOL REP, V3, P466, DOI 10.1111/j.1758-2229.2010.00237.x; Graham DE, 2012, ISME J, V6, P709, DOI 10.1038/ismej.2011.163; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; Hartley IP, 2008, ECOL LETT, V11, P1092, DOI 10.1111/j.1461-0248.2008.01223.x; Hobbie SE, 2000, GLOBAL CHANGE BIOL, V6, P196, DOI 10.1046/j.1365-2486.2000.06021.x; Hoj L, 2005, FEMS MICROBIOL ECOL, V53, P89, DOI 10.1016/j.femsec.2005.01.004; Hoj L, 2008, ISME J, V2, P37, DOI 10.1038/ismej.2007.84; Kip N, 2010, NAT GEOSCI, V3, P617, DOI 10.1038/NGEO939; Knoblauch C, 2013, GLOBAL CHANGE BIOL, V19, P985; Knoblauch C, 2008, SOIL BIOL BIOCHEM, V40, P3004, DOI 10.1016/j.soilbio.2008.08.020; Koch K, 2009, ENVIRON MICROBIOL, V11, P657, DOI 10.1111/j.1462-2920.2008.01836.x; Kolb S, 2003, APPL ENVIRON MICROB, V69, P2423, DOI 10.1128/AEM.69.5.2423-2429.2003; Kotsyurbenko OR, 2005, FEMS MICROBIOL ECOL, V53, P3, DOI 10.1016/j.femsec.2004.12.009; Kuhry P, 2010, PERMAFROST PERIGLAC, V21, P208, DOI 10.1002/ppp.684; Lawton J. H., 1993, REDUNDANCY ECOSYSTEM, P255; Le Mer J, 2001, EUR J SOIL BIOL, V37, P25, DOI 10.1016/S1164-5563(01)01067-6; Le Roux X, 2008, ISME J, V2, P221, DOI 10.1038/ismej.2007.109; Lee CK, 2012, ISME J, V6, P1046, DOI 10.1038/ismej.2011.170; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Liebner S, 2009, MICROB ECOL, V57, P25, DOI 10.1007/s00248-008-9411-x; Liebner S, 2008, INT MICROBIOL, V11, P195, DOI 10.2436/20.1501.01.60; Liebner S, 2007, ENVIRON MICROBIOL, V9, P107, DOI 10.1111/j.1462-2920.2006.01120.x; Liebner S, 2011, J ECOL, V99, P914, DOI 10.1111/j.1365-2745.2011.01823.x; Luton PE, 2002, MICROBIOL-SGM, V148, P3521, DOI 10.1099/00221287-148-11-3521; Mackelprang R, 2011, NATURE, V480, P368, DOI 10.1038/nature10576; Martineau C, 2010, APPL ENVIRON MICROB, V76, P5773, DOI 10.1128/AEM.03094-09; Metje M, 2007, ENVIRON MICROBIOL, V9, P954, DOI 10.1111/j.1462-2920.2006.01217.x; Minke M, 2007, PEATLANDS INT, V1, P36; Morozova D, 2007, FEMS MICROBIOL ECOL, V61, P16, DOI 10.1111/j.1574-6941.2007.00316.x; Nicolaisen MH, 2002, J MICROBIOL METH, V50, P189, DOI 10.1016/S0167-7012(02)00026-X; Poly F, 2001, RES MICROBIOL, V152, P95, DOI 10.1016/S0923-2508(00)01172-4; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Rivkina E, 2007, FEMS MICROBIOL ECOL, V61, P1, DOI 10.1111/j.1574-6941.2007.00315.x; Schimel JP., 1996, LANDSCAPE FUNCTION D, P203, DOI [DOI 10.1007/978-3-662-01145-4_10, 10.1007/978-3-662-01145-4_10]; Shaver G. R., 1992, ARCTIC ECOSYSTEMS CH, P193; SHIVAJI S, 1992, INT J SYST BACTERIOL, V42, P102, DOI 10.1099/00207713-42-1-102; Soil Survey Staff, 1998, KEYS SOIL TAX; Steven B, 2008, ENVIRON MICROBIOL, V10, P3388, DOI 10.1111/j.1462-2920.2008.01746.x; Strom L, 2003, GLOBAL CHANGE BIOL, V9, P1185, DOI 10.1046/j.1365-2486.2003.00655.x; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; van Everdingen RO, 2005, MULTILANGUAGE GLOSSA; van Wijk MT, 2005, OECOLOGIA, V142, P421, DOI 10.1007/s00442-004-1733-x; Wagner D, 2005, ENVIRON MICROBIOL, V7, P1582, DOI 10.1111/j.1462-2920.2005.00849.x; Wagner D., 2009, SOIL BIOL, P219; Wagner D, 2007, GLOBAL CHANGE BIOL, V13, P1089, DOI 10.1111/j.1365-2486.2007.01331.x; Wagner D, 2013, INT J SYST EVOL MICR, V63, P2986, DOI 10.1099/ijs.0.046565-0; Wagner D, 2009, CAN J MICROBIOL, V55, P73, DOI 10.1139/W08-121; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weintraub MN, 2005, BIOSCIENCE, V55, P408, DOI 10.1641/0006-3568(2005)055[0408:NCATSO]2.0.CO;2; Whalen SC, 1992, GLOBAL BIOGEOCHEM CY, V6, P139, DOI 10.1029/92GB00430; WynnWilliams DD, 1996, BIODIVERS CONSERV, V5, P1271, DOI 10.1007/BF00051979; Yergeau E, 2012, APPL ENVIRON MICROB, V78, P7626, DOI 10.1128/AEM.02036-12; Yergeau E, 2010, ISME J, V4, P1206, DOI 10.1038/ismej.2010.41; Yergeau E, 2009, APPL ENVIRON MICROB, V75, P6258, DOI 10.1128/AEM.01029-09	71	62	63	6	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84761	10.1371/journal.pone.0084761	http://dx.doi.org/10.1371/journal.pone.0084761			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416279	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500162
J	Lian, IB; Wu, HDI; Chang, WT; Chao, DY				Lian, Ie-Bin; Wu, Hong-Dar Isaac; Chang, Wan-Tzu; Chao, Day-Yu			The Temporal Trend of Influenza-Associated Morbidity and the Impact of Early Appearance of Antigenic Drifted Strains in a Southeast Asian Country	PLOS ONE			English	Article							PROPENSITY SCORE; IMMUNE-RESPONSE; ELDERLY-PEOPLE; META-ANALYSIS; OLDER-ADULTS; VACCINATION; MORTALITY; VACCINES; TAIWAN; VIRUS	Globally, influenza infection is a major cause of morbidity and mortality in the elderly, who are suggested to be the major target group for trivalent influenza vaccine (TIV) vaccination by World Health Organization. In spite of an increasing trend in vaccine coverage rates in many countries, the effect of vaccination among the elderly in reducing hospitalization and mortality remains controversial. In this study, we conducted a historical cohort study to evaluate the temporal pattern of influenza-associated morbidity among persons older than 64 years over a decade. The temporal patterns of influenza-associated morbidity rates among the elderly older than 64 years indicated that Taiwan's elderly P&I outpatient visits have been decreasing since the beginning of the 1999-2000 influenza season; however, hospitalization has been increasing despite significant increases in vaccine coverage. The propensity score logistic regression model was implemented to evaluate the source of bias and it was found that the TIV-receiving group had a higher propensity score than the non-receiving group (P<0.0001). In order to investigate the major factors affecting the temporal pattern of influenza-associated morbidity, we then used the propensity score as a summary confounder in a multivariate Poisson regression model based on the trimmed data. Our final models suggested that the factors affected the temporal pattern of morbidity differently. The variables including co-morbidity, vaccination rate, influenza virus type A and B isolation rate were associated with increased outpatient visits and hospitalization (p<0.05). In contrast, variables including high propensity score, increased 1 degrees C in temperature, matching vaccine strains of type A/H1N1 and type B were associated with decreased outpatient visits and hospitalization (p<0.05). Finally, we assessed the impact of early appearance of antigenic-drifted strains and concluded that an excess influenza-associated morbidity substantial trends toward higher P&I hospitalization, but not outpatient visits, during the influenza season with early appearance of antigenic-drifted strains.	[Lian, Ie-Bin; Chang, Wan-Tzu] Natl Changhua Univ Educ, Grad Inst Stat & Informat Sci, Changhua, Taiwan; [Wu, Hong-Dar Isaac] Natl Chung Hsing Univ, Dept Appl Math, Taichung 40227, Taiwan; [Wu, Hong-Dar Isaac] Natl Chung Hsing Univ, Inst Stat, Taichung 40227, Taiwan; [Chao, Day-Yu] Natl Chung Hsing Univ, Coll Vet Med, Grad Inst Microbiol & Publ Hlth, Taichung 40227, Taiwan	National Changhua University of Education; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University	Chao, DY (corresponding author), Natl Chung Hsing Univ, Coll Vet Med, Grad Inst Microbiol & Publ Hlth, Taichung 40227, Taiwan.	dychao@nchu.edu.tw	Lian, Ie-Bin/AAE-3368-2021; Chao, Day-Yu/AFH-8360-2022	Chao, Day-Yu/0000-0001-7139-026X; Lian, Ie-bin/0000-0003-3992-6049				Baxter R, 2010, VACCINE, V28, P7267, DOI 10.1016/j.vaccine.2010.08.088; Baxter R, 2010, J INFECT DIS, V201, P186, DOI 10.1086/649568; Beckett CG, 2004, CLIN INFECT DIS, V39, P443, DOI 10.1086/422314; Beyer WEP, 1999, ARCH INTERN MED, V159, P182, DOI 10.1001/archinte.159.2.182; Blank PR, 2009, INFECTION, V37, P390, DOI 10.1007/s15010-009-8467-y; Brydak LB, 2003, J CLIN IMMUNOL, V23, P214, DOI 10.1023/A:1023314029788; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; Chan TC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011317; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; de Bruijn IA, 1999, J INFECT DIS, V179, P31, DOI 10.1086/314540; Dean AS, 2010, VACCINE, V28, P864, DOI 10.1016/j.vaccine.2009.03.024; Fiore AE, 2009, CURR TOP MICROBIOL, V333, P43, DOI 10.1007/978-3-540-92165-3_3; Fireman B, 2009, AM J EPIDEMIOL, V170, P650, DOI 10.1093/aje/kwp173; Gorina Y, 2008, AGING TRENDS, V8, P1; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Ho TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050337; Hurwitz ES, 2000, JAMA-J AM MED ASSOC, V284, P1677, DOI 10.1001/jama.284.13.1677; Jackson LA, 2006, INT J EPIDEMIOL, V35, P337, DOI 10.1093/ije/dyi274; Jefferson T, 2005, LANCET, V366, P1165, DOI 10.1016/S0140-6736(05)67339-4; Jefferson T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004876.pub3; Jian JW, 2008, J CLIN MICROBIOL, V46, P1426, DOI 10.1128/JCM.01560-07; Kim SA, 2011, J HEALTH POPUL NUTR, V29, P574; King JC, 2006, NEW ENGL J MED, V355, P2523, DOI 10.1056/NEJMoa055414; Kwong JC, 2008, PLOS MED, V5, P1440, DOI 10.1371/journal.pmed.0050211; Lang PO, 2012, CLIN INTERV AGING, V7, P55, DOI 10.2147/CIA.S25215; Li DJ, 2008, J CLIN MICROBIOL, V46, P399, DOI 10.1128/JCM.01549-07; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Loeb M, 2010, JAMA-J AM MED ASSOC, V303, P943, DOI 10.1001/jama.2010.250; Mangtani P, 2004, J INFECT DIS, V190, P1, DOI 10.1086/421274; Mannino S, 2012, AM J EPIDEMIOL, V176, P527, DOI 10.1093/aje/kws313; Michiels B, 2011, VACCINE, V29, P9159, DOI 10.1016/j.vaccine.2011.08.008; Nichol KL, 2007, NEW ENGL J MED, V357, P1373, DOI 10.1056/NEJMoa070844; Nicholson KG, 1999, EPIDEMIOL INFECT, V123, P103, DOI 10.1017/S095026889900271X; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; Rizzo C, 2006, VACCINE, V24, P6468, DOI 10.1016/j.vaccine.2006.06.052; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Russell CA, 2008, VACCINE, V26, pD31, DOI 10.1016/j.vaccine.2008.07.078; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Shih SR, 2005, J CLIN MICROBIOL, V43, P1651, DOI 10.1128/JCM.43.4.1651-1661.2005; Simonsen L, 2007, LANCET INFECT DIS, V7, P658, DOI 10.1016/S1473-3099(07)70236-0; Sturmer T, 2010, AM J EPIDEMIOL, V172, P843, DOI 10.1093/aje/kwq198; Talbot HK, 2012, VACCINE, V30, P3937, DOI 10.1016/j.vaccine.2012.03.071; Vu T, 2002, VACCINE, V20, P1831, DOI 10.1016/S0264-410X(02)00041-5; Wang SF, 2009, J MED VIROL, V81, P1457, DOI 10.1002/jmv.21531; Wen CP, 2008, ANN INTERN MED, V148, P258, DOI 10.7326/0003-4819-148-4-200802190-00004; Wu CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049343	47	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84239	10.1371/journal.pone.0084239	http://dx.doi.org/10.1371/journal.pone.0084239			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416205	gold, Green Submitted, Green Published			2022-12-27	WOS:000329862500104
J	Prior, A; Laursen, TM; Larsen, KK; Johnsen, SP; Christensen, J; Andersen, G; Vestergaard, M				Prior, Anders; Laursen, Thomas Munk; Larsen, Karen Kjaer; Johnsen, Soren Paaske; Christensen, Jakob; Andersen, Grethe; Vestergaard, Mogens			Post-Stroke Mortality, Stroke Severity, and Preadmission Antipsychotic Medicine Use - A Population-Based Cohort Study	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; ATTENUATES BRAIN-DAMAGE; ISCHEMIA IN-VIVO; TREATMENT STRATEGIES; RELATIVE RISK; SCHIZOPHRENIA; SURVIVAL; POLYPHARMACY; MEDICATIONS; OLANZAPINE	Background and Purpose: It has been suggested that antipsychotic medication may be neuroprotective and may reduce post-stroke mortality, but studies are few and ambiguous. We aimed to investigate the post-stroke effects of preadmission antipsychotic use. Methods: We conducted a nationwide, population-based cohort study of 81,143 persons admitted with stroke in Denmark from 2003-2010. Using Danish health care databases, we extracted data on preadmission use of antipsychotics and confounding factors. We examined the association between current, former, and never use of antipsychotics and stroke severity, length of hospital stay, and 30-day post-stroke mortality using logistic regression analysis, survival analysis, and propensity score matching. Results: Current users of antipsychotics had a higher risk of severe or very severe stroke on The Scandinavian Stroke Scale than never users of antipsychotics (adjusted odds ratios, 1.43; 95% CI, 1.29-1.58). Current users were less likely to be discharged from hospital within 30 days of admission than never users (probability of non-discharge, 27.0% vs. 21.9%). Antipsychotics was associated with an increased 30-day post-stroke mortality among current users (adjusted mortality rate ratios, 1.42; 95% CI, 1.29-1.55), but not among former users (adjusted mortality rate ratios, 1.05; 95% CI, 0.98-1.14). Conclusions: Preadmission use of antipsychotics was associated with a higher risk of severe stroke, a longer duration of hospital stay, and a higher post-stroke mortality, even after adjustment for known confounders. Antipsychotics play an important role in the treatment of many psychiatric conditions, but our findings do not support the hypothesis that they reduce stroke severity or post-stroke mortality.	[Prior, Anders; Larsen, Karen Kjaer; Vestergaard, Mogens] Aarhus Univ, Dept Publ Hlth, Res Unit Gen Practice, Aarhus, Denmark; [Prior, Anders; Larsen, Karen Kjaer; Vestergaard, Mogens] Aarhus Univ, Dept Publ Hlth, Sect Gen Practice, Aarhus, Denmark; [Laursen, Thomas Munk] Aarhus Univ, Natl Ctr Register Based Res, iPSYCH, Aarhus, Denmark; [Johnsen, Soren Paaske] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark; [Christensen, Jakob; Andersen, Grethe] Aarhus Univ Hosp, Dept Neurol, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Aarhus University; Aarhus University	Prior, A (corresponding author), Aarhus Univ, Dept Publ Hlth, Res Unit Gen Practice, Aarhus, Denmark.	anders.prior@alm.au.dk	Vestergaard, Mogens/M-9333-2014; Laursen, Thomas Munk/AFQ-8066-2022; Prior, Anders/P-8628-2014	Vestergaard, Mogens/0000-0001-8830-2174; Prior, Anders/0000-0003-4053-3701; Laursen, Thomas Munk/0000-0001-6934-1784; Christensen, Jakob/0000-0002-9385-6435; Andersen, Grethe/0000-0001-6807-2500	Danish Heart Association; Lundbeck Foundation; Lundbeck Foundation [R155-2012-11280, R155-2014-1724] Funding Source: researchfish	Danish Heart Association; Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden)	This study was funded by unrestricted grants from the Danish Heart Association (http://www.hjerteforeningen.dk/om_os/in_english/) and The Lundbeck Foundation (http://www.lundbeckfoundation.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen KK, 2011, STROKE, V42, P2806, DOI 10.1161/STROKEAHA.111.619049; Andersen P. K., 2012, STAT MODELS BASED CO; Andersen TF, 1999, DAN MED BULL, V46, P263; ASPLUND K, 1985, STROKE, V16, P885; Baandrup L, 2010, J CLIN PSYCHIAT, V71, P103, DOI 10.4088/JCP.08m04818yel; Bushe CJ, 2010, J PSYCHOPHARMACOL, V24, P17, DOI 10.1177/1359786810382468; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Doehner W, 2013, EUR HEART J, V34, P268, DOI 10.1093/eurheartj/ehs340; GLOBUS MYT, 1987, NEUROLOGY, V37, P1712, DOI 10.1212/WNL.37.11.1712; Goldstein LB, 1997, CURR OPIN NEUROL, V10, P52, DOI 10.1097/00019052-199702000-00011; Goldstein LB, 1990, NEUROREHABILITATION, V4, P137; Haberg A, 2006, NEUROCHEM INT, V48, P531, DOI 10.1016/j.neuint.2005.12.025; Hazell AS, 2007, NEUROCHEM INT, V50, P941, DOI 10.1016/j.neuint.2007.04.026; John M Eisenberg Center for Clinical Decisions and Communications Science, 2012, COMP EFFECTIVENESS R; Kam KY, 2012, PROG NEURO-PSYCHOPH, V39, P69, DOI 10.1016/j.pnpbp.2012.05.010; Kang JH, 2011, PSYCHOSOM MED, V73, P106, DOI 10.1097/PSY.0b013e3181fdc2c9; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Kisely S, 2009, BRIT J PSYCHIAT, V195, P545, DOI 10.1192/bjp.bp.109.067082; Leucht S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008016.pub2; LINDENSTROM E, 1991, CEREBROVASC DIS, V1, P103, DOI 10.1159/000108825; Maher AR, 2011, JAMA-J AM MED ASSOC, V306, P1359, DOI 10.1001/jama.2011.1360; Mainz J, 2004, INT J QUAL HEALTH C, V16, pI45, DOI 10.1093/intqhc/mzh031; Mittal V, 2011, AM J ALZHEIMERS DIS, V26, P10, DOI 10.1177/1533317510390351; Montout C, 2002, SCHIZOPHR RES, V57, P147, DOI 10.1016/S0920-9964(01)00325-5; Osborn DPJ, 2007, ARCH GEN PSYCHIAT, V64, P242, DOI 10.1001/archpsyc.64.2.242; Pedersen CB, 2006, DAN MED BULL, V53, P441; Rosthoj S, 2004, COMPUT METH PROG BIO, V74, P69, DOI 10.1016/S0169-2607(03)00069-5; Tiihonen J, 2012, ARCH GEN PSYCHIAT, V69, P476, DOI 10.1001/archgenpsychiatry.2011.1532; Tiihonen J, 2009, LANCET, V374, P620, DOI 10.1016/S0140-6736(09)60742-X; Tsai KY, 2012, SCHIZOPHR RES, V138, P41, DOI 10.1016/j.schres.2012.02.013; VANHASSELT P, 1973, NEUROPHARMACOLOGY, V12, P245, DOI 10.1016/0028-3908(73)90109-3; Vargo JM, 1996, BEHAV BRAIN RES, V72, P39; VARGO JM, 1989, BEHAV NEUROSCI, V103, P1017, DOI 10.1037/0735-7044.103.5.1017; Vemmos K, 2011, STROKE, V42, P30, DOI 10.1161/STROKEAHA.110.593434; World Health Organization and Alzheimers Disease International, 2012, DEM PUBL HLTH PRIOR; Yulug B, 2008, J NEUROPSYCH CLIN N, V20, P107, DOI 10.1176/jnp.2008.20.1.107a; Yulug B, 2006, BRAIN RES BULL, V69, P656, DOI 10.1016/j.brainresbull.2006.03.017; Yulug B, 2006, BRAIN RES BULL, V71, P296, DOI 10.1016/j.brainresbull.2006.09.018; Yulug B, 2009, BRAIN RES BULL, V80, P95, DOI 10.1016/j.brainresbull.2009.06.013	40	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84103	10.1371/journal.pone.0084103	http://dx.doi.org/10.1371/journal.pone.0084103			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416196	Green Published, gold			2022-12-27	WOS:000329862500097
J	Schmitt, AK; Danisik, M; Aydar, E; Sen, E; Ulusoy, I; Lovera, OM				Schmitt, Axel K.; Danisik, Martin; Aydar, Erkan; Sen, Erdal; Ulusoy, Inan; Lovera, Oscar M.			Identifying the Volcanic Eruption Depicted in a Neolithic Painting at Catalhoyuk, Central Anatolia, Turkey	PLOS ONE			English	Article							ZIRCON; DISEQUILIBRIUM; STRATOVOLCANO; EVOLUTION; BASIN; AGES	A mural excavated at the Neolithic Catalhoyuk site (Central Anatolia, Turkey) has been interpreted as the oldest known map. Dating to similar to 6600 BCE, it putatively depicts an explosive summit eruption of the Hasan Dagi twin-peaks volcano located similar to 130 km northeast of Catalhoyuk, and a birds-eye view of a town plan in the foreground. This interpretation, however, has remained controversial not least because independent evidence for a contemporaneous explosive volcanic eruption of Hasan Dagi has been lacking. Here, we document the presence of andesitic pumice veneer on the summit of Hasan Dagi, which we dated using (U-Th)/He zircon geochronology. The (U-Th)/He zircon eruption age of 8.97 +/- 0.64 ka (or 6960 +/- 640 BCE; uncertainties 2 sigma) overlaps closely with C-14 ages for cultural strata at Catalhoyuk, including level VII containing the "map'' mural. A second pumice sample from a surficial deposit near the base of Hasan Dagi records an older explosive eruption at 28.9 +/- 1.5 ka. U-Th zircon crystallization ages in both samples range from near-eruption to secular equilibrium (>80 ka). Collectively, our results reveal protracted intrusive activity at Hasan Dagi punctuated by explosive venting, and provide the first radiometric ages for a Holocene explosive eruption which was most likely witnessed by humans in the area. Geologic and geochronologic lines of evidence thus support previous interpretations that residents of Catalhoyuk artistically represented an explosive eruption of Hasan Dagi volcano. The magmatic longevity recorded by quasi-continuous zircon crystallization coupled with new evidence for late-Pleistocene and Holocene explosive eruptions implicates Hasan Dagi as a potential volcanic hazard.	[Schmitt, Axel K.; Lovera, Oscar M.] Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90024 USA; [Danisik, Martin] Univ Waikato, Hamilton, New Zealand; [Aydar, Erkan] ATERRA R&D, Ankara, Turkey; [Sen, Erdal; Ulusoy, Inan] Hacettepe Univ, Dept Geol Engn, Ankara, Turkey	University of California System; University of California Los Angeles; University of Waikato; Hacettepe University	Schmitt, AK (corresponding author), Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90024 USA.	axel@argon.ess.ucla.edu	Danisik, Martin/GQY-6103-2022; ULUSOY, İNAN/G-5968-2013; ŞEN, ERDAL/G-5964-2013	ULUSOY, İNAN/0000-0002-6343-9921; ŞEN, ERDAL/0000-0002-9172-9926; Schmitt, Axel/0000-0002-9029-4211; Danisik, Martin/0000-0002-0885-4938	NSF EAR [1029193]	NSF EAR(National Science Foundation (NSF))	Partial support for this study comes from NSF EAR 1029193 "Facility Support: The UCLA National Ion Microprobe''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aydar E, 1998, J VOLCANOL GEOTH RES, V85, P69, DOI 10.1016/S0377-0273(98)00050-X; Aydar E, 1998, J VOLCANOL GEOTH RES, V85, P129, DOI 10.1016/S0377-0273(98)00053-5; Aydar E, 2012, J VOLCANOL GEOTH RES, V213, P83, DOI 10.1016/j.jvolgeores.2011.11.005; Barber EJW, 2010, AM J ARCHAEOL, V114, P343; Carter T, 2011, ANATOL STUD, V61, P1, DOI 10.1017/S0066154600008759; Cessford C., 2005, CHANGING MAT CATALHO, P65; Claiborne LL, 2010, GEOLOGY, V38, P1011, DOI 10.1130/G31285.1; Clarke KC, 2013, CARTOGR J, V50, P136, DOI 10.1179/0008704113Z.00000000079; Danisik M, 2012, EARTH PLANET SC LETT, V349, P240, DOI 10.1016/j.epsl.2012.06.041; Deniel C, 1998, J VOLCANOL GEOTH RES, V87, P275, DOI 10.1016/S0377-0273(98)00097-3; Ercan T., 1990, JEOMORFOLOJI DERGISI, V18, P39; Farley KA, 2002, EARTH PLANET SC LETT, V201, P117, DOI 10.1016/S0012-821X(02)00659-3; Harris SL, 2000, ARCHAEOLOGY VOLCANIS; Hodder I, 2007, ANNU REV ANTHROPOL, V36, P105, DOI 10.1146/annurev.anthro.36.081406.094308; INNOCENTI F, 1975, GEOL MAG, V112, P349, DOI 10.1017/S0016756800046744; Kuzucuoglu C, 1998, J VOLCANOL GEOTH RES, V85, P153, DOI 10.1016/S0377-0273(98)00054-7; Meece S., 2006, ANATOL STUD, V56, P1; Mellaart J., 1967, CATAL HUYUK NEOLITHI; Mellaart J., 1964, ANATOL STUD, V14, P39, DOI [DOI 10.2307/3642466, 10.2307/3642466]; Mellaart J, 1964, ILLUSTRATED LONDON N, P194; NOTSU K, 1995, J VOLCANOL GEOTH RES, V64, P171, DOI 10.1016/0377-0273(94)00077-T; Pastre JF, 1998, QUATERNAIRE, V9, P169; Schmitt AK, 2011, ANNU REV EARTH PL SC, V39, P321, DOI 10.1146/annurev-earth-040610-133330; Schmitt AK, 2010, EARTH PLANET SC LETT, V295, P91, DOI 10.1016/j.epsl.2010.03.028; Sigurdsson H, 2000, VOLCANOES ART; Ulkekul C, 1999, OXFORD HDB ANCIENT A, P99; Zanchetta G, 2011, HOLOCENE, V21, P33, DOI 10.1177/0959683610377531	27	55	57	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84711	10.1371/journal.pone.0084711	http://dx.doi.org/10.1371/journal.pone.0084711			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	291WL	24416270	Green Published, gold			2022-12-27	WOS:000329862500153
J	Mason, H; Shoaibi, A; Ghandour, R; O'Flaherty, M; Capewell, S; Khatib, R; Jabr, S; Unal, B; Sozmen, K; Arfa, C; Aissi, W; Ben Romdhane, H; Fouad, F; Al-Ali, R; Husseini, A				Mason, Helen; Shoaibi, Azza; Ghandour, Rula; O'Flaherty, Martin; Capewell, Simon; Khatib, Rana; Jabr, Samer; Unal, Belgin; Soezmen, Kaan; Arfa, Chokri; Aissi, Wafa; Ben Romdhane, Habiba; Fouad, Fouad; Al-Ali, Radwan; Husseini, Abdullatif		MedCHAMPS Project Team	A Cost Effectiveness Analysis of Salt Reduction Policies to Reduce Coronary Heart Disease in Four Eastern Mediterranean Countries	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; BLOOD-PRESSURE; MORTALITY; HEALTH; INTERVENTIONS; LIFE; PREVENTION; STRATEGIES; ENGLAND	Background: Coronary Heart Disease (CHD) is rising in middle income countries. Population based strategies to reduce specific CHD risk factors have an important role to play in reducing overall CHD mortality. Reducing dietary salt consumption is a potentially cost-effective way to reduce CHD events. This paper presents an economic evaluation of population based salt reduction policies in Tunisia, Syria, Palestine and Turkey. Methods and Findings: Three policies to reduce dietary salt intake were evaluated: a health promotion campaign, labelling of food packaging and mandatory reformulation of salt content in processed food. These were evaluated separately and in combination. Estimates of the effectiveness of salt reduction on blood pressure were based on a literature review. The reduction in mortality was estimated using the IMPACT CHD model specific to that country. Cumulative population health effects were quantified as life years gained (LYG) over a 10 year time frame. The costs of each policy were estimated using evidence from comparable policies and expert opinion including public sector costs and costs to the food industry. Health care costs associated with CHDs were estimated using standardized unit costs. The total cost of implementing each policy was compared against the current baseline (no policy). All costs were calculated using 2010 PPP exchange rates. In all four countries most policies were cost saving compared with the baseline. The combination of all three policies (reducing salt consumption by 30%) resulted in estimated cost savings of $235,000,000 and 6455 LYG in Tunisia; $39,000,000 and 31674 LYG in Syria; $6,000,000 and 2682 LYG in Palestine and $1,3000,000,000 and 378439 LYG in Turkey. Conclusion: Decreasing dietary salt intake will reduce coronary heart disease deaths in the four countries. A comprehensive strategy of health education and food industry actions to label and reduce salt content would save both money and lives.	[Mason, Helen] Glasgow Caledonian Univ, Yunus Ctr Social Business & Hlth, Glasgow G4 0BA, Lanark, Scotland; [Shoaibi, Azza; Ghandour, Rula; Khatib, Rana; Husseini, Abdullatif] Birzeit Univ, Inst Community & Publ Hlth, Birzeit, Palestine, Israel; [O'Flaherty, Martin; Capewell, Simon] Univ Liverpool, Inst Psychol Hlth & Soc, Dept Publ Hlth & Policy, Liverpool L69 3BX, Merseyside, England; [Jabr, Samer] Minist Hlth, Dept Hlth Econ, Nablus, Palestine, Israel; [Unal, Belgin] Dokuz Eylul Univ, Fac Med, Dept Publ Hlth, Inciralti Izmir, Turkey; [Soezmen, Kaan] Prov Hlth Directorate Izmir, Narlidere Community Hlth Ctr, Izmir, Turkey; [Arfa, Chokri] Univ Carthage, INTES, Tunis, Tunisia; [Aissi, Wafa; Ben Romdhane, Habiba] Univ Tunis El Manar, Fac Med, Cardiovasc Dis Epidemiol & Prevent Res Lab, Tunis, Tunisia; [Fouad, Fouad; Al-Ali, Radwan] Syrian Ctr Tobacco Studies, Aleppo, Syria; [Husseini, Abdullatif] Qatar Univ, Dept Hlth Sci, Publ Hlth Program, Doha, Qatar	Glasgow Caledonian University; Birzeit University; University of Liverpool; Dokuz Eylul University; Universite de Carthage; Universite de Tunis-El-Manar; Faculte de Medecine de Tunis (FMT); Qatar University	Mason, H (corresponding author), Glasgow Caledonian Univ, Yunus Ctr Social Business & Hlth, Glasgow G4 0BA, Lanark, Scotland.	Helen.mason@gcu.ac.uk	Unal, Belgin/E-7064-2017; Rastam, M. Samer/N-6365-2017; Husseini, Abdullatif/E-8377-2015; Ghandour, Rula/AHE-4572-2022	Unal, Belgin/0000-0002-4354-8266; Rastam, M. Samer/0000-0002-4004-7773; Husseini, Abdullatif/0000-0001-8767-5956; Satman, Ilhan/0000-0001-8613-1797; Critchley, Julia/0000-0002-5248-4188; Bennett, Kathleen/0000-0002-2861-7665; Collins, Marissa/0000-0002-0896-6673; Ahmad, Balsam/0000-0002-9146-3806; Unwin, Nigel/0000-0002-1368-1648; Arik Tasyikan, Hale/0000-0003-4298-4952; O'Flaherty, Martin/0000-0001-8944-4131; Demiral, Yucel/0000-0002-4281-0218; Roglic, Gojka/0000-0003-0872-0689; Mason, Helen/0000-0002-9303-2794	European Community [223075]	European Community(European Commission)	The research leading to these results has received funding from the European Community' Seventh Framework Programme (FP7/2007-2013) under grant agreement no223075 - the MedCHAMPS project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Rmeileh NME, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001061; Appel LJ, 2012, ANN EPIDEMIOL, V22, P417, DOI 10.1016/j.annepidem.2012.04.003; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Bajekal M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001237; Capewell S, 2000, EUR HEART J, V21, P1833, DOI 10.1053/euhj.2000.2318; Cappuccio FP, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4995; Cobiac LJ, 2010, HEART, V96, P1920, DOI 10.1136/hrt.2010.199240; Daviglus ML, 2005, ARCH INTERN MED, V165, P1028, DOI 10.1001/archinte.165.9.1028; Edejer T, 2003, MAKING CHOICES HLTH; Fidan D, 2007, QJM-INT J MED, V100, P277, DOI 10.1093/qjmed/hcm020; Ford ES, 2011, ANNU REV PUBL HEALTH, V32, P5, DOI 10.1146/annurev-publhealth-031210-101211; He FJ, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004937, DOI 10.1002/14651858.CD004937]; Hooper L, 2004, COCHRANE DATABASE SY, DOI [DOI 10.1002/14651858.CD003656.PUB2, 10.1002/14651858.CD003656.pub2]; Lenoir-Wijnkoop I, 2012, BRIT J NUTR, V108, P1714, DOI 10.1017/S0007114512003704; Lenoir-Wijnkoop I, 2011, Br J Nutr, V105, P157, DOI 10.1017/S0007114510003041; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; MacIntyre K, 2000, CIRCULATION, V102, P1126, DOI 10.1161/01.CIR.102.10.1126; Mohan S, 2009, CAN MED ASSOC J, V181, P605, DOI 10.1503/cmaj.090361; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; PUSKA P, 1985, ANNU REV PUBL HEALTH, V6, P147, DOI 10.1146/annurev.pu.06.050185.001051; Rappange DR, 2008, PHARMACOECONOMICS, V26, P815, DOI 10.2165/00019053-200826100-00003; Rastam S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-754; Selmer RM, 2000, J EPIDEMIOL COMMUN H, V54, P697, DOI 10.1136/jech.54.9.697; Smith-Spangler CM, 2010, ANN INTERN MED, V152, P481, DOI 10.7326/0003-4819-152-8-201004200-00212; Unal B, 2005, AM J PUBLIC HEALTH, V95, P103, DOI 10.2105/AJPH.2003.029579; Wang GJ, 2011, J HYPERTENS, V29, P1693, DOI 10.1097/HJH.0b013e328349ba18; World Health Organisation, 2012, HIGH LEV M GEN ASS P; World Health Organization, 2012, WORLD HLTH STAT; World Health Organization (WHO), 2010, JOINT TECHN M HELD W; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	31	62	66	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84445	10.1371/journal.pone.0084445	http://dx.doi.org/10.1371/journal.pone.0084445			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	286JC	24409297	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000329463500021
J	Nozari, N; Woodard, K; Thompson-Schill, SL				Nozari, Nazbanou; Woodard, Kristina; Thompson-Schill, Sharon L.			Consequences of Cathodal Stimulation for Behavior: When Does It Help and When Does It Hurt Performance?	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; NONINVASIVE BRAIN-STIMULATION; HUMAN MOTOR CORTEX; PREFRONTAL CORTEX; ELECTRICAL-STIMULATION; ANTERIOR CINGULATE; STATE-DEPENDENCY; WORKING-MEMORY; POLARIZATION; EXCITABILITY	Cathodal Transcranial Direct Current Stimulation (C-tDCS) has been reported, across different studies, to facilitate or hinder performance, or simply to have no tangible effect on behavior. This discrepancy is most prominent when C-tDCS is used to alter a cognitive function, questioning the assumption that cathodal stimulation always compromises performance. In this study, we aimed to study the effect of two variables on performance in a simple cognitive task (letter Flanker), when C-tDCS was applied to the left prefrontal cortex (PFC): (1) the time of testing relative to stimulation (during or after), and (2) the nature of the cognitive activity during stimulation in case of post-tDCS testing. In three experiments, we had participants either perform the Flanker task during C-tDCS (Experiment 1), or after C-tDCS. When the Flanker task was administered after C-tDCS, we varied whether during stimulation subjects were engaged in activities that posed low (Experiment 2) or high (Experiment 3) demands on the PFC. Our findings show that the nature of the task during C-tDCS has a systematic influence on the outcome, while timing per se does not.	[Nozari, Nazbanou; Woodard, Kristina; Thompson-Schill, Sharon L.] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA	University of Pennsylvania	Nozari, N (corresponding author), Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA.	nozari@sas.upenn.edu		Woodard, Kristina/0000-0002-7848-3829	 [R01-DC009209]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009209] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grant number R01-DC009209 (http://grants.nih.gov/grants/oer.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SC, 2011, BRAIN STIMUL, V4, P84, DOI 10.1016/j.brs.2010.06.004; Antal A, 2004, J COGNITIVE NEUROSCI, V16, P521, DOI 10.1162/089892904323057263; Berryhill ME, 2010, NEUROSCI LETT, V479, P312, DOI 10.1016/j.neulet.2010.05.087; Bestmann S, 2008, EXP BRAIN RES, V191, P383, DOI 10.1007/s00221-008-1601-8; Bikson M, 2010, CLIN NEUROPHYSIOL, V121, P1976, DOI 10.1016/j.clinph.2010.05.020; BINDMAN LJ, 1962, NATURE, V196, P584, DOI 10.1038/196584a0; Cerruti C, 2009, J COGNITIVE NEUROSCI, V21, P1980, DOI 10.1162/jocn.2008.21143; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Chrysikou EG, 2013, COGN NEUROSCI-UK, V4, P81, DOI 10.1080/17588928.2013.768221; Chrysikou EG, 2011, RESTOR NEUROL NEUROS, V29, P375, DOI 10.3233/RNN-2011-0610; DaSilva AF, 2011, JOVE-J VIS EXP, DOI 10.3791/2744; Floel A, 2008, J COGNITIVE NEUROSCI, V20, P1415, DOI 10.1162/jocn.2008.20098; Frank E, 2012, J NEUROL, V259, P327, DOI 10.1007/s00415-011-6189-4; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Friederici AD, 2013, J COGNITIVE NEUROSCI, V25, P814, DOI 10.1162/jocn_a_00350; Gibson JJ, 1937, J EXP PSYCHOL, V20, P453, DOI 10.1037/h0059826; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Grosbras MH, 2003, EUR J NEUROSCI, V18, P3121, DOI 10.1111/j.1460-9568.2003.03055.x; Iyer MB, 2005, NEUROLOGY, V64, P872, DOI 10.1212/01.WNL.0000152986.07469.E9; Jacobson L, 2012, EXP BRAIN RES, V216, P1, DOI 10.1007/s00221-011-2891-9; January D, 2009, J COGNITIVE NEUROSCI, V21, P2434, DOI 10.1162/jocn.2008.21179; Karim AA, 2010, CEREB CORTEX, V20, P205, DOI 10.1093/cercor/bhp090; Kincses TZ, 2004, NEUROPSYCHOLOGIA, V42, P113, DOI 10.1016/S0028-3932(03)00124-6; Knoch D, 2008, CEREB CORTEX, V18, P1987, DOI 10.1093/cercor/bhm237; Kraft A, 2010, EXP BRAIN RES, V207, P283, DOI 10.1007/s00221-010-2453-6; Lang N, 2003, SUPPL CLIN NEUROPHYS, V56, P277; Lang N, 2004, BIOL PSYCHIAT, V56, P634, DOI 10.1016/j.biopsych.2004.07.017; Langguth B, 2008, BRAIN STIMUL, V1, P192, DOI 10.1016/j.brs.2008.06.003; Loui P, 2011, J COGNITIVE NEUROSCI, V23, P1015, DOI 10.1162/jocn.2010.21500; Lupyan G, 2012, COGNITION, V124, P36, DOI 10.1016/j.cognition.2012.04.002; Madhavan S, 2010, BRAIN STIMUL, V3, P42, DOI 10.1016/j.brs.2009.06.005; Milham MP, 2001, COGNITIVE BRAIN RES, V12, P467, DOI 10.1016/S0926-6410(01)00076-3; Miranda PC, 2006, CLIN NEUROPHYSIOL, V117, P1623, DOI 10.1016/j.clinph.2006.04.009; Monti A, 2008, J NEUROL NEUROSUR PS, V79, P451, DOI 10.1136/jnnp.2007.135277; Nitsche MA, 2007, J NEUROPHYSIOL, V97, P3109, DOI 10.1152/jn.01312.2006; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2003, CLIN NEUROPHYSIOL, V114, P600, DOI 10.1016/S1388-2457(02)00412-1; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Nozari N, 2013, NEUROPSYCHOLOGIA, V51, P2770, DOI 10.1016/j.neuropsychologia.2013.08.019; Peinemann A, 2004, CLIN NEUROPHYSIOL, V115, P1519, DOI 10.1016/j.clinph.2004.02.005; Priori A, 1998, NEUROREPORT, V9, P2257, DOI 10.1097/00001756-199807130-00020; PURPURA DP, 1965, J NEUROPHYSIOL, V28, P166, DOI 10.1152/jn.1965.28.1.166; Rogalewski A, 2004, EUR J NEUROSCI, V20, P313, DOI 10.1111/j.0953-816X.2004.03450.x; ROTH BJ, 1994, CRIT REV BIOMED ENG, V22, P253; Siebner HR, 2004, J NEUROSCI, V24, P3379, DOI 10.1523/JNEUROSCI.5316-03.2004; Silvanto J, 2008, BRAIN TOPOGR, V21, P1, DOI 10.1007/s10548-008-0067-0; Silvanto J, 2008, TRENDS COGN SCI, V12, P447, DOI 10.1016/j.tics.2008.09.004; Sloutsky VM, 2004, J EXP PSYCHOL GEN, V133, P166, DOI 10.1037/0096-3445.133.2.166; Sparing R, 2009, BRAIN, V132, P3011, DOI 10.1093/brain/awp154; Sparing R, 2008, NEUROPSYCHOLOGIA, V46, P261, DOI 10.1016/j.neuropsychologia.2007.07.009; Stone DB, 2009, NEUROREPORT, V20, P1115, DOI 10.1097/WNR.0b013e32832e9aa2; Topper R, 1998, EXP BRAIN RES, V121, P371, DOI 10.1007/s002210050471; Touge T, 2001, CLIN NEUROPHYSIOL, V112, P2138, DOI 10.1016/S1388-2457(01)00651-4; Tseng P, 2012, J NEUROSCI, V32, P10554, DOI 10.1523/JNEUROSCI.0362-12.2012; TULVING E, 1982, J EXP PSYCHOL LEARN, V8, P336, DOI 10.1037/0278-7393.8.4.336; Utz KS, 2010, NEUROPSYCHOLOGIA, V48, P2789, DOI 10.1016/j.neuropsychologia.2010.06.002; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; Vandermeeren Y, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-38; Vanneste S, 2011, EXP BRAIN RES, V210, P217, DOI 10.1007/s00221-011-2617-z; Walsh V, 2003, BRADFORD BOOKS, P1; Wassermann EM, 1996, ELECTROMYOGR MOTOR C, V101, P412; You DS, 2011, BRAIN LANG, V119, P1, DOI 10.1016/j.bandl.2011.05.002; Ziemann U, 2008, BRAIN STIMUL, V1, P60, DOI 10.1016/j.brs.2007.08.003	63	55	59	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84338	10.1371/journal.pone.0084338	http://dx.doi.org/10.1371/journal.pone.0084338			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409291	Green Submitted, Green Published, gold			2022-12-27	WOS:000329463500015
J	Takeuchi, H; Taki, Y; Sassa, Y; Hashizume, H; Sekiguchi, A; Fukushima, A; Kawashima, R				Takeuchi, Hikaru; Taki, Yasuyuki; Sassa, Yuko; Hashizume, Hiroshi; Sekiguchi, Atsushi; Fukushima, Ai; Kawashima, Ryuta			Regional Gray Matter Volume Is Associated with Empathizing and Systemizing in Young Adults	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; HIGH-FUNCTIONING AUTISM; MIRROR-NEURON SYSTEM; SPECTRUM QUOTIENT AQ; ASPERGER-SYNDROME; WHITE-MATTER; HUMAN BRAIN; INTERINDIVIDUAL DIFFERENCES; EMOTIONAL INTELLIGENCE; INDIVIDUAL-DIFFERENCES	Empathizing is defined as the drive to identify the mental states of others for predicting their behavior and responding with an appropriate emotion. Systemizing is defined as the drive to analyze a system in terms of the rules that govern the system in order to predict its behavior. Using voxel-based morphometry and questionnaires in a large sample of normal, right-handed young adults, we investigated the regional gray matter volume (rGMV) correlates of empathizing and systemizing and additionally those of the D score, which is the difference between systemizing and empathizing, to reveal the comprehensive picture of those correlates. Negative rGMV correlates of empathizing and positive rGMV correlates of the D score (formed by the negative correlation between rGMV and empathizing), were found primarily in nodes in the default mode network, mirror neuron system, dorsal anterior cingulate cortex, and the lateral part of the prefrontal cortex together with other areas. Positive rGMV correlates of systemizing and of the D score (formed by the positive correlation between rGMV and systemizing) were found primarily in nodes in the external attention system, middle cingulate cortex, and other regions. Negative rGMV correlates of systemizing were found in an area close to the left posterior insula and putamen. These findings reconcile some previously inconsistent findings, provide other new findings and suggest that these areas contribute to empathizing-systemizing. Furthermore, the negative/positive rGMV correlates of empathizing and positive/negative rGMV correlates of systemizing overlapped substantially. This may be in line with the notion that empathizing and systemizing compete neurally in the brain.	[Takeuchi, Hikaru; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Smart Ageing Int Res Ctr, Sendai, Miyagi 980, Japan; [Taki, Yasuyuki; Sassa, Yuko; Hashizume, Hiroshi; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Div Dev Cognit Neurosci, Sendai, Miyagi 980, Japan; [Sekiguchi, Atsushi; Fukushima, Ai; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Dept Funct Brain Imaging, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University	Takeuchi, H (corresponding author), Tohoku Univ, Inst Dev Aging & Canc, Smart Ageing Int Res Ctr, Sendai, Miyagi 980, Japan.	takehi@idac.tohoku.ac.jp	Takeuchi, Hikaru/D-1057-2011	Takeuchi, Hikaru/0000-0002-8022-9694	JST/RISTEX, JST/CREST	JST/RISTEX, JST/CREST(Core Research for Evolutional Science and Technology (CREST))	This study was supported by JST/RISTEX, JST/CREST (no particular numbers exist). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambery FZ, 2006, AUTISM, V10, P551, DOI 10.1177/1362361306068507; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Andrew J, 2008, PERS INDIV DIFFER, V44, P1203, DOI 10.1016/j.paid.2007.11.014; [Anonymous], 2001, Z DIFFERENTIELLE DIA, DOI [10.1024//0170-1789.22.1.70, DOI 10.1024//0170-1789.22.1.70]; Antonova E, 2005, BIOL PSYCHIAT, V58, P457, DOI 10.1016/j.biopsych.2005.04.036; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Auyeung B, 2009, BRIT J PSYCHOL, V100, P1, DOI 10.1348/000712608X311731; Aydin K, 2007, AM J NEURORADIOL, V28, P1859, DOI 10.3174/ajnr.A0696; Bachevalier J, 2006, NEUROSCI BIOBEHAV R, V30, P97, DOI 10.1016/j.neubiorev.2005.07.002; Banissy MJ, 2012, NEUROIMAGE, V62, P2034, DOI 10.1016/j.neuroimage.2012.05.081; Banissy MJ, 2012, NEUROIMAGE; Baron JC, 2001, NEUROIMAGE, V14, P298, DOI 10.1006/nimg.2001.0848; Baron-Cohen S, 2003, PHILOS T ROY SOC B, V358, P361, DOI 10.1098/rstb.2002.1206; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455; Baron-Cohen S, 2002, TRENDS COGN SCI, V6, P248, DOI 10.1016/S1364-6613(02)01904-6; Baron-Cohen S., 1995, MINDBLINDNESS ESSAY; Baron-Cohen S., 2003, ESSENTIAL DIFFERENCE; Baron-Cohen S, 2007, ESSENTIAL DIFFERENCE; Baron-Cohen S, 2009, PHILOS T R SOC B, V364, P1377, DOI 10.1098/rstb.2008.0337; Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Billington J, 2008, NEUROPSYCHOLOGIA, V46, P511, DOI 10.1016/j.neuropsychologia.2007.09.003; Billington J, 2007, LEARN INDIVID DIFFER, V17, P260, DOI 10.1016/j.lindif.2007.02.004; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Carlson JM, 2012, NEUROIMAGE, V59, P1713, DOI 10.1016/j.neuroimage.2011.09.040; Cattaneo L, 2009, ARCH NEUROL-CHICAGO, V66, P557, DOI 10.1001/archneurol.2009.41; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chakrabarti B, 2006, SOC NEUROSCI-UK, V1, P364, DOI 10.1080/17470910601041317; Chechik G, 1999, NEURAL COMPUT, V11, P2061, DOI 10.1162/089976699300016089; Cheng Y, 2009, NEUROSCIENCE, V158, P713, DOI 10.1016/j.neuroscience.2008.10.026; Christoff K, 2000, PSYCHOBIOLOGY, V28, P168; Cohen MS, 1996, BRAIN, V119, P89, DOI 10.1093/brain/119.1.89; Constantino JN, 2000, J DEV BEHAV PEDIATR, V21, P2, DOI 10.1097/00004703-200002000-00002; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Costa P.T., 1992, PSYCHOL ASSESSMENT R, V396; Davis M. H., 1980, JCAS CAT SEL DOC PSY, V75, P989; DeGutis J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058253; Doherty RW, 1997, J NONVERBAL BEHAV, V21, P131, DOI 10.1023/A:1024956003661; Duerden EG, 2012, AUTISM RES, V5, P49, DOI 10.1002/aur.235; Duncan J, 2000, SCIENCE, V289, P457, DOI 10.1126/science.289.5478.457; Egner T, 2011, NAT NEUROSCI, V14, P1219, DOI 10.1038/nn.2932; Fan Y, 2011, NEUROSCI BIOBEHAV R, V35, P903, DOI 10.1016/j.neubiorev.2010.10.009; Focquaert F, 2007, PERS INDIV DIFFER, V43, P619, DOI 10.1016/j.paid.2007.01.004; Fornito A, 2008, BIOL PSYCHIAT, V64, P758, DOI 10.1016/j.biopsych.2008.05.032; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Gaser C., 2007, VBM TOOLBOX SPM2 VBM; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Goldenfeld N, 2005, CLIN NEUROPSYCHIATR, V2, P338; Haier RJ, 2004, NEUROIMAGE, V23, P425, DOI 10.1016/j.neuroimage.2004.04.025; HALL JA, 1978, PSYCHOL BULL, V85, P845, DOI 10.1037/0033-2909.85.4.845; Haruno M, 2006, J NEUROPHYSIOL, V95, P948, DOI 10.1152/jn.00382.2005; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Hill EL, 2003, PHILOS T R SOC B, V358, P281, DOI 10.1098/rstb.2002.1209; Iacoboni M, 2006, NAT REV NEUROSCI, V7, P942, DOI 10.1038/nrn2024; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Kanai R, 2012, CURR BIOL, V22, P1975, DOI 10.1016/j.cub.2012.08.045; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Krill AL, 2008, PERS INDIV DIFFER, V45, P684, DOI 10.1016/j.paid.2008.07.016; Kroger JK, 2002, CEREB CORTEX, V12, P477, DOI 10.1093/cercor/12.5.477; Lai MC, 2012, NEUROIMAGE, V61, P1347, DOI 10.1016/j.neuroimage.2012.03.018; Laird AR, 2005, HUM BRAIN MAPP, V25, P6, DOI 10.1002/hbm.20129; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Liu MJ, 2011, RES AUTISM SPECT DIS, V5, P294, DOI 10.1016/j.rasd.2010.04.011; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; Masten CL, 2010, SOC NEUROSCI-UK, V5, P496, DOI 10.1080/17470919.2010.490673; MEHRABIAN A, 1972, J PERS, V40, P525, DOI 10.1111/j.1467-6494.1972.tb00078.x; Milligan K, 2007, CHILD DEV, V78, P622, DOI 10.1111/j.1467-8624.2007.01018.x; Montgomery JM, 2010, EDUC TRAIN AUTISM DE, V45, P566; Mutschler I, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00177; Nagai M, 2007, EUR PSYCHIAT, V22, P387, DOI 10.1016/j.eurpsy.2007.02.006; Nettle D, 2006, PERS INDIV DIFFER, V40, P375, DOI 10.1016/j.paid.2005.07.008; Nettle D, 2007, BRIT J PSYCHOL, V98, P237, DOI 10.1348/000712606X117612; Nickl-Jockschat T, 2012, HUM BRAIN MAPP, V33, P1470, DOI 10.1002/hbm.21299; Olson IR, 2006, BRAIN COGNITION, V60, P262, DOI 10.1016/j.bandc.2005.11.010; Owen AM, 2000, EXP BRAIN RES, V133, P33, DOI 10.1007/s002210000398; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Paulus MP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010096; Pelphrey KA, 2008, ANN NY ACAD SCI, V1145, P283, DOI 10.1196/annals.1416.007; Penton-Voak IS, 2007, PERS INDIV DIFFER, V43, P2229, DOI 10.1016/j.paid.2007.07.004; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Postuma RB, 2006, CEREB CORTEX, V16, P1508, DOI 10.1093/cercor/bhj088; Pujol J, 2002, NEUROIMAGE, V15, P847, DOI 10.1006/nimg.2001.1004; Rameson L.T., 2011, J COGNITIVE NEUROSCI, V8, P1; Rankin KP, 2006, BRAIN, V129, P2945, DOI 10.1093/brain/awl254; Raven J.C., 1998, ADV PROGR MATRICES; Redcay E, 2005, BIOL PSYCHIAT, V58, P1, DOI 10.1016/j.biopsych.2005.03.026; Rizzolatti G, 2005, RES PER NEUROSCI, P107, DOI 10.1007/3-540-29803-7_9; Sassa Y, 2012, NEUROIMAGE, V60, P2035, DOI 10.1016/j.neuroimage.2012.02.021; Schultheiss OC, 2008, SOC COGN AFFECT NEUR, V3, P333, DOI 10.1093/scan/nsn030; Shamay-Tsoory SG, 2003, J COGNITIVE NEUROSCI, V15, P324, DOI 10.1162/089892903321593063; Shamay-Tsoory SG, 2009, BRAIN, V132, P617, DOI 10.1093/brain/awn279; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Singer T, 2005, NAT NEUROSCI, V8, P845, DOI 10.1038/nn0705-845; Sinzig Judith, 2008, Child Adolesc Psychiatry Ment Health, V2, P4, DOI 10.1186/1753-2000-2-4; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; Stileman E, 2007, THESIS U EDINBURGH E; Strayer J, 2004, SOC DEV, V13, P1, DOI 10.1111/j.1467-9507.2004.00254.x; Takeuchi H, 2012, HUMAN BRAIN MAPPING; Takeuchi H, 2013, HUMAN BRAIN MAPPING; Takeuchi H, 2012, BRAIN STRUCTURE FUNC; Takeuchi H, 2013, BRAIN STRUCT FUNCT, V218, P1017, DOI 10.1007/s00429-012-0444-z; Takeuchi H, 2013, NEUROIMAGE, V77, P222, DOI 10.1016/j.neuroimage.2013.04.004; Takeuchi H, 2013, CORTEX, V49, P1148, DOI 10.1016/j.cortex.2013.01.014; Takeuchi H, 2012, NEUROIMAGE, V59, P2899, DOI 10.1016/j.neuroimage.2011.09.064; Takeuchi H, 2011, HUM BRAIN MAPP, V32, P1497, DOI 10.1002/hbm.21122; Takeuchi H, 2010, NEUROIMAGE, V51, P578, DOI 10.1016/j.neuroimage.2010.02.078; Takeuchi H, 2010, NEUROIMAGE, V51, P11, DOI 10.1016/j.neuroimage.2010.02.035; Taki Y, 2004, NEUROBIOL AGING, V25, P455, DOI 10.1016/j.neurobiolaging.2003.09.002; Tazaki M, 2007, REVISED MANUAL WHO Q, V26; Via E, 2011, ARCH GEN PSYCHIAT, V68, P409, DOI 10.1001/archgenpsychiatry.2011.27; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; von dem Hagen EAH, 2011, CEREB CORTEX, V21, P493, DOI 10.1093/cercor/bhq062; Wagner DD, 2011, CEREB CORTEX, V21, P2788, DOI 10.1093/cercor/bhr074; Wakabayashi A, 2007, J AUTISM DEV DISORD, V37, P1823, DOI 10.1007/s10803-006-0316-6; Wakabayashi A, 2006, PERS INDIV DIFFER, V41, P929, DOI 10.1016/j.paid.2006.03.017; Wakabayashi Akio, 2006, Shinrigaku Kenkyu, V77, P271; Wallace GL, 2012, J NEUROSCI, V32, P4856, DOI 10.1523/JNEUROSCI.6214-11.2012; Wheelwright S, 2006, BRAIN RES, V1079, P47, DOI 10.1016/j.brainres.2006.01.012; Wray S, 2007, P PPIG 19 ANN WORKSH; Yu KK, 2011, J PSYCHIATR NEUROSCI, V36, P412, DOI 10.1503/jpn.100138; Zaki J, 2009, P NATL ACAD SCI USA, V106, P11382, DOI 10.1073/pnas.0902666106; Zeki S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003556; Zhou YA, 2010, COGN NEURODYNAMICS, V4, P275, DOI 10.1007/s11571-010-9126-9; Zielinski BA, 2010, P NATL ACAD SCI USA, V107, P18191, DOI 10.1073/pnas.1003109107	129	29	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84782	10.1371/journal.pone.0084782	http://dx.doi.org/10.1371/journal.pone.0084782			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409308	Green Published, Green Submitted, gold			2022-12-27	WOS:000329463500032
J	Brugnano, JL; Panitch, A				Brugnano, Jamie L.; Panitch, Alyssa			Matrix Stiffness Affects Endocytic Uptake of MK2-Inhibitor Peptides	PLOS ONE			English	Article							NONVIRAL GENE DELIVERY; CELL-ADHESION; SUBSTRATE; INHIBITION; MECHANISM; MORPHOLOGY; MIGRATION; HYDROGELS	In this study, the role of substrate stiffness on the endocytic uptake of a cell-penetrating peptide was investigated. The cell-penetrating peptide, an inhibitor of mitogen-activated protein kinase activated protein kinase II (MK2), enters a primary mesothelial cell line predominantly through caveolae. Using tissue culture polystyrene and polyacrylamide gels of varying stiffness for cell culture, and flow cytometry quantification and enzyme-linked immunoassays (ELISA) for uptake assays, we showed that the amount of uptake of the peptide is increased on soft substrates. Further, peptide uptake per cell increased at lower cell density. The improved uptake seen on soft substrates in vitro better correlates with in vivo functional studies where 10-100 mM concentrations of the MK2 inhibitor cell penetrating peptide demonstrated functional activity in several disease models. Additional characterization showed actin polymerization did not affect uptake, while microtubule polymerization had a profound effect on uptake. This work demonstrates that cell culture substrate stiffness can play a role in endocytic uptake, and may be an important consideration to improve correlations between in vitro and in vivo drug efficacy.	[Brugnano, Jamie L.; Panitch, Alyssa] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Panitch, A (corresponding author), Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.	apanitch@purdue.edu			National Institutes of Health [R01HL106792]; National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106792] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by the National Institutes of Health grant R01HL106792. JLB was support by an National Science Foundation graduate research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brugnano J, 2013, J PEPT SCI, V19, P629, DOI 10.1002/psc.2541; Brugnano JL, 2011, J CONTROL RELEASE, V155, P128, DOI 10.1016/j.jconrel.2011.05.007; Calvet D, 2004, MACROMOLECULES, V37, P7762, DOI 10.1021/ma049072r; Dhaliwal A, 2010, ACTA BIOMATER, V6, P3436, DOI 10.1016/j.actbio.2010.03.038; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Ehrbar M, 2011, BIOPHYS J, V100, P284, DOI 10.1016/j.bpj.2010.11.082; Engler A. J., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P335; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Ferrari A, 2003, MOL THER, V8, P284, DOI 10.1016/S1525-0016(03)00122-9; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Genes NG, 2004, ARCH BIOCHEM BIOPHYS, V422, P161, DOI 10.1016/j.abb.2003.11.023; Gump JM, 2007, TRENDS MOL MED, V13, P443, DOI 10.1016/j.molmed.2007.08.002; Herce HD, 2007, P NATL ACAD SCI USA, V104, P20805, DOI 10.1073/pnas.0706574105; Kandow CE, 2007, METHOD CELL BIOL, V83, P29, DOI 10.1016/S0091-679X(07)83002-0; Kaplan IM, 2005, J CONTROL RELEASE, V102, P247, DOI 10.1016/j.jconrel.2004.10.018; Kavalukas SL, 2009, J AM COLL SURGEONS, V209, pS17, DOI 10.1016/j.jamcollsurg.2009.06.028; Kim A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051813; Kong HJ, 2005, NAT MATER, V4, P460, DOI 10.1038/nmat1392; Kong HJ, 2007, NANO LETT, V7, P161, DOI 10.1021/nl062485g; Kuhlman W, 2007, BIOMACROMOLECULES, V8, P3206, DOI 10.1021/bm070237o; Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605; Liu AP, 2009, BIOPHYS J, V97, P1038, DOI 10.1016/j.bpj.2009.06.003; Maheshwari G, 2000, J CELL SCI, V113, P1677; MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Muto A, 2012, VASC PHARMACOL, V56, P47, DOI 10.1016/j.vph.2011.07.008; Mutsaers SE, 2004, INT J BIOCHEM CELL B, V36, P9, DOI 10.1016/S1357-2725(03)00242-5; Palm-Apergi C, 2009, FASEB J, V23, P214, DOI 10.1096/fj.08-110254; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; Sacher R, 2008, CURR OPIN CELL BIOL, V20, P483, DOI 10.1016/j.ceb.2008.06.002; Sally ML, 2011, J CELL MOL MED, V15, P2095, DOI 10.1111/j.1582-4934.2010.01212.x; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Subramanian A, 2005, J BIOMED MATER RES A, V75A, P742, DOI 10.1002/jbm.a.30489; Tse J.R., 2010, CURR PROTOC CELL BIO, V10, pUnit, DOI [DOI 10.1002/0471143030.CB1016S47, 10.1002/0471143030.cb1016s47]; Vendeville A, 2004, MOL BIOL CELL, V15, P2347, DOI 10.1091/mbc.E03-12-0921; Vittal R, 2013, AM J RESP CELL MOL, V49, P47, DOI 10.1165/rcmb.2012-0389OC; Wang YL, 1998, METHOD ENZYMOL, V298, P489, DOI 10.1016/S0076-6879(98)98041-7; Ward BC, 2011, J SURG RES, V169, pE27, DOI 10.1016/j.jss.2011.01.043; Wells RG, 2008, HEPATOLOGY, V47, P1394, DOI 10.1002/hep.22193; Yandek LE, 2007, BIOPHYS J, V92, P2434, DOI 10.1529/biophysj.106.100198; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Yip CYY, 2009, ARTERIOSCL THROM VAS, V29, P936, DOI 10.1161/ATVBAHA.108.182394; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103	44	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84821	10.1371/journal.pone.0084821	http://dx.doi.org/10.1371/journal.pone.0084821			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400117	Green Published, gold, Green Submitted			2022-12-27	WOS:000329462700051
J	Li, B; Chen, SB; Li, PC; Luo, QM; Gong, H				Li, Bing; Chen, Shangbin; Li, Pengcheng; Luo, Qingming; Gong, Hui			Refractory Period Modulates the Spatiotemporal Evolution of Cortical Spreading Depression: A Computational Study	PLOS ONE			English	Article							INTRINSIC OPTICAL SIGNAL; EXTRACELLULAR GLUTAMATE; PROPAGATION VELOCITY; IN-VIVO; WAVES; MODEL; MIGRAINE; BRAIN	Cortical spreading depression (CSD) is a pathophysiological phenomenon, which underlies some neurological disorders, such as migraine and stroke, but its mechanisms are still not completely understood. One of the striking facts is that the spatiotemporal evolution of CSD wave is varying. Observations in experiments reveal that a CSD wave may propagate through the entire cortex, or just bypass some areas of the cortex. In this paper, we have applied a 2D reaction-diffusion equation with recovery term to study the spatiotemporal evolution of CSD. By modulating the recovery rate from CSD in the modeled cortex, CSD waves with different spatiotemporal evolutions, either bypassing some areas or propagating slowly in these areas, were present. Moreover, spiral CSD waves could also be induced in case of the transiently altered recovery rate, i.e. block release from the absolute refractory period. These results suggest that the refractory period contributes to the different propagation patterns of CSD, which may help to interpret the mechanisms of CSD propagation.	[Li, Bing; Chen, Shangbin; Li, Pengcheng; Luo, Qingming; Gong, Hui] Huazhong Univ Sci & Technol, Britton Chance Ctr Biomed Photon, Wuhan Natl Lab Optoelect, Wuhan 430074, Hubei, Peoples R China; [Li, Bing; Chen, Shangbin; Li, Pengcheng; Luo, Qingming; Gong, Hui] Huazhong Univ Sci & Technol, Dept Biomed Engn, MoE Key Lab Biomed Photon, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Chen, SB (corresponding author), Huazhong Univ Sci & Technol, Britton Chance Ctr Biomed Photon, Wuhan Natl Lab Optoelect, Wuhan 430074, Hubei, Peoples R China.	sbchen@mail.hust.edu.cn		Luo, Qingming/0000-0002-6725-9311; Li, Bing/0000-0001-8949-733X	National Natural Science Foundation of China [61371014]; National High-Tech Research and Development Program of China (863 Program) [2012AA020401]; Fundamental Research Funds for the Central Universities [HUST: 2013TS038]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (grant number 61371014), the National High-Tech Research and Development Program of China (863 Program: 2012AA020401), and the Fundamental Research Funds for the Central Universities, HUST: 2013TS038. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Back T, 1996, J CEREBR BLOOD F MET, V16, P202, DOI 10.1097/00004647-199603000-00004; Bennett MR, 2008, BIOPHYS J, V95, P5648, DOI 10.1529/biophysj.108.137190; Brand S, 1998, N-S ARCH PHARMACOL, V357, P419, DOI 10.1007/PL00005188; Buchheim K, 2002, EXP NEUROL, V175, P76, DOI 10.1006/exnr.2002.7893; Chang JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070469; Chapuisat G, 2008, PROG BIOPHYS MOL BIO, V97, P4, DOI 10.1016/j.pbiomolbio.2007.10.004; Chen SB, 2006, NEUROSCI LETT, V396, P132, DOI 10.1016/j.neulet.2005.11.025; Chen SB, 2007, P SPIE, V6445; Chen SB, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2203654; Dahlem MA, 1997, EXP BRAIN RES, V115, P319, DOI 10.1007/PL00005700; Dahlem YA, 2005, BRAIN RES, V1049, P15, DOI 10.1016/j.brainres.2005.04.059; Dronne MA, 2009, MATH COMPUT MODEL, V49, P2138, DOI 10.1016/j.mcm.2008.07.024; Eiselt M, 2004, BRAIN RES, V1028, P83, DOI 10.1016/j.brainres.2004.09.002; GARDNERMEDWIN AR, 1984, AN ACAD BRAS CIENC, V56, P423; GORELOVA NA, 1983, J NEUROBIOL, V14, P353, DOI 10.1002/neu.480140503; Gorji A, 2001, BRAIN RES REV, V38, P33, DOI 10.1016/S0165-0173(01)00081-9; Grenier E, 2008, PROG BIOPHYS MOL BIO, V97, P54, DOI 10.1016/j.pbiomolbio.2007.10.002; Huang XY, 2010, NEURON, V68, P978, DOI 10.1016/j.neuron.2010.11.007; James MF, 1999, J PHYSIOL-LONDON, V519, P415, DOI 10.1111/j.1469-7793.1999.0415m.x; Kager H, 2000, J NEUROPHYSIOL, V84, P495, DOI 10.1152/jn.2000.84.1.495; Kager H, 2002, J NEUROPHYSIOL, V88, P2700, DOI 10.1152/jn.00237.2002; Karatas H, 2013, SCIENCE, V339, P1092, DOI 10.1126/science.1231897; KOROLEVA V I, 1983, Neirofiziologiya, V15, P226; Koroleva V I, 2009, Neurosci Behav Physiol, V39, P87, DOI 10.1007/s11055-008-9096-0; Korolleva VI, 2007, ZH VYSSH NERV DEYAT+, V57, P729; KRAIG RP, 1978, NEUROSCIENCE, V3, P1045, DOI 10.1016/0306-4522(78)90122-7; Kumagai T, 2011, J CEREBR BLOOD F MET, V31, P580, DOI 10.1038/jcbfm.2010.128; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; LECHLEITER J, 1991, SCIENCE, V252, P123, DOI 10.1126/science.2011747; Li BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041629; Martins-Ferreira H, 2000, BRAIN RES REV, V32, P215, DOI 10.1016/S0165-0173(99)00083-1; MAYEVSKY A, 1991, J CEREBR BLOOD F MET, V11, P829, DOI 10.1038/jcbfm.1991.142; Mayevsky A, 2011, J INNOV OPT HEAL SCI, V4, P337, DOI 10.1142/S1793545811001654; Miura RM, 2007, EUR PHYS J-SPEC TOP, V147, P287, DOI 10.1140/epjst/e2007-00214-8; Miura RM, 2013, SCIENCE, V23; OBRENOVITCH TP, 1995, J NEUROPHYSIOL, V73, P2107, DOI 10.1152/jn.1995.73.5.2107; Obrenovitch TP, 1996, J CEREBR BLOOD F MET, V16, P923, DOI 10.1097/00004647-199609000-00016; REGGIA JA, 1994, J AM MED INFORM ASSN, P873; Revett K, 1998, J CEREBR BLOOD F MET, V18, P998, DOI 10.1097/00004647-199809000-00009; Shapiro BE, 2001, J COMPUT NEUROSCI, V10, P99, DOI 10.1023/A:1008924227961; SHIBATA M, 1975, J NEUROPHYSIOL, V38, P158, DOI 10.1152/jn.1975.38.1.158; Smith JM, 2006, BIOL REV, V81, P457, DOI 10.1017/S1464793106007081; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Sun XL, 2010, J INNOV OPT HEAL SCI, V3, P103, DOI 10.1142/S1793545810000915; Teixeira HZ, 2008, COMPUT BIOL CHEM, V32, P273, DOI 10.1016/j.compbiolchem.2008.03.011; Tuckwell HC, 2008, AIP CONF PROC, V1028, P46, DOI 10.1063/1.2965101; Weimer M, 2005, EXP BRAIN RES, V161, P201, DOI 10.1007/s00221-004-2060-5; Weimer MS, 2005, EXP BRAIN RES, V164, P185, DOI 10.1007/s00221-005-2241-x	48	0	1	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84609	10.1371/journal.pone.0084609	http://dx.doi.org/10.1371/journal.pone.0084609			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400104	gold, Green Published, Green Submitted			2022-12-27	WOS:000329462700038
J	Ryan, C; Ross, S; Davey, P; Duncan, EM; Francis, JJ; Fielding, S; Johnston, M; Ker, J; Lee, AJ; MacLeod, MJ; Maxwell, S; McKay, GA; McLay, JS; Webb, DJ; Bond, C				Ryan, Cristin; Ross, Sarah; Davey, Peter; Duncan, Eilidh M.; Francis, Jill J.; Fielding, Shona; Johnston, Marie; Ker, Jean; Lee, Amanda Jane; MacLeod, Mary Joan; Maxwell, Simon; McKay, Gerard A.; McLay, James S.; Webb, David J.; Bond, Christine			Prevalence and Causes of Prescribing Errors: The PRescribing Outcomes for Trainee Doctors Engaged in Clinical Training (PROTECT) Study	PLOS ONE			English	Article							IN-HOSPITAL INPATIENTS; MEDICAL-STUDENTS; JUNIOR DOCTORS; INTERVENTIONS	Objectives: Study objectives were to investigate the prevalence and causes of prescribing errors amongst foundation doctors (i.e. junior doctors in their first (F1) or second (F2) year of post-graduate training), describe their knowledge and experience of prescribing errors, and explore their self-efficacy (i.e. confidence) in prescribing. Method: A three-part mixed-methods design was used, comprising: prospective observational study; semi-structured interviews and cross-sectional survey. All doctors prescribing in eight purposively selected hospitals in Scotland participated. All foundation doctors throughout Scotland participated in the survey. The number of prescribing errors per patient, doctor, ward and hospital, perceived causes of errors and a measure of doctors' self-efficacy were established. Results: 4710 patient charts and 44,726 prescribed medicines were reviewed. There were 3364 errors, affecting 1700 (36.1%) charts (overall error rate: 7.5%; F1: 7.4%; F2: 8.6%; consultants: 6.3%). Higher error rates were associated with : teaching hospitals (p<0.001), surgical (p =<0.001) or mixed wards (0.008) rather than medical ward, higher patient turnover wards (p<0.001), a greater number of prescribed medicines (p<0.001) and the months December and June (p<0.001). One hundred errors were discussed in 40 interviews. Error causation was multi-factorial; work environment and team factors were particularly noted. Of 548 completed questionnaires (national response rate of 35.4%), 508 (92.7% of respondents) reported errors, most of which (328 (64.6%) did not reach the patient. Pressure from other staff, workload and interruptions were cited as the main causes of errors. Foundation year 2 doctors reported greater confidence than year 1 doctors in deciding the most appropriate medication regimen. Conclusions: Prescribing errors are frequent and of complex causation. Foundation doctors made more errors than other doctors, but undertook the majority of prescribing, making them a key target for intervention. Contributing causes included work environment, team, task, individual and patient factors. Further work is needed to develop and assess interventions that address these.	[Ryan, Cristin] Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland; [Ross, Sarah; MacLeod, Mary Joan; McLay, James S.] Univ Aberdeen, Sch Med & Dent, Aberdeen, Scotland; [Davey, Peter; Ker, Jean] Univ Dundee, Sch Med, Dundee, Scotland; [Duncan, Eilidh M.] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen, Scotland; [Francis, Jill J.] City Univ London, Hlth Serv Res & Management Div, London EC1V 0HB, England; [Fielding, Shona; Lee, Amanda Jane] Univ Aberdeen, Med Stat Team, Aberdeen, Scotland; [Johnston, Marie] Univ Aberdeen, Aberdeen, Scotland; [Maxwell, Simon] Univ Edinburgh, Clin Pharmacol Unit, Edinburgh, Midlothian, Scotland; [McKay, Gerard A.] Glasgow Royal Infirm, Dept Clin Pharmacol, Glasgow G4 0SF, Lanark, Scotland; [Webb, David J.] Univ Edinburgh, Royal Infirm Edinburgh, Clin Pharmacol Unit, Edinburgh, Midlothian, Scotland; [Bond, Christine] Univ Aberdeen, Ctr Acad Primary Care, Aberdeen, Scotland	Queens University Belfast; University of Aberdeen; University of Dundee; University of Aberdeen; City University London; University of Aberdeen; University of Aberdeen; University of Edinburgh; University of Glasgow; Royal Infirmary of Edinburgh; University of Edinburgh; University of Aberdeen	Bond, C (corresponding author), Univ Aberdeen, Ctr Acad Primary Care, Aberdeen, Scotland.	c.m.bond@abdn.ac.uk	Francis, Jill/AHE-6998-2022	Macleod, Mary Joan/0000-0003-2115-8184; Francis, Jill/0000-0001-5784-8895; Maxwell, Simon/0000-0002-3032-7237; Duncan, Eilidh/0000-0002-1009-9732; Ryan, Cristin/0000-0002-6037-4413	Scottish Chief Scientists Office; Chief Scientist Office [CZH/4/505, HSRU2] Funding Source: researchfish	Scottish Chief Scientists Office; Chief Scientist Office	This project was funded by the Scottish Chief Scientists Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, DEV EVALUATING COMPL; Bandura A, 1994, ENCY HUMAN BEHAV, DOI DOI 10.1002/9780470479216.CORPSY0836; Bandura A., 1986, SOCIAL FDN THOUGHT A; Coombes ID, 2008, MED J AUSTRALIA, V188, P89, DOI 10.5694/j.1326-5377.2008.tb01529.x; De Amici D, 2000, CONTROL CLIN TRIALS, V21, P103, DOI 10.1016/S0197-2456(99)00054-9; Dean B, 2000, QUAL HEALTH CARE, V9, P232, DOI 10.1136/qhc.9.4.232; Dean B, 2002, LANCET, V359, P1373, DOI 10.1016/S0140-6736(02)08350-2; Franklin BD, 2011, POSTGRAD MED J, V87, P739, DOI 10.1136/pgmj.2011.117879; Heaton A, 2008, BRIT J CLIN PHARMACO, V66, P128, DOI 10.1111/j.1365-2125.2008.03197.x; Lewis PJ, 2009, DRUG SAFETY, V32, P379, DOI 10.2165/00002018-200932050-00002; Marteau TM, 1989, PSYCHOL HEALTH, V3, P173; Mayo E, 1993, HUMAN PROBLEMS IND C, V3, P53; Michie S, 2008, APPL PSYCHOL-INT REV, V57, P660, DOI 10.1111/j.1464-0597.2008.00341.x; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-10; Reason J., 1990, HUMAN ERROR; Ross S, 2012, POSTGRAD MED J, DOI [10.1136/postgradmedj-2011-130602, DOI 10.1136/P0STGRADMEDJ-2011-130602]; Ross S, 2013, BMJ QUAL SAF, V22, P97, DOI 10.1136/bmjqs-2012-001175; Ross S, 2009, BRIT J CLIN PHARMACO, V67, P662, DOI 10.1111/j.1365-2125.2009.03395.x; Ross S, 2009, BRIT J CLIN PHARMACO, V67, P629, DOI 10.1111/j.1365-2125.2008.03330.x; Ryan C, 2013, BR J CLIN P IN PRESS; T Dornan, 2009, DEPTH INVESTIGATION; Tobaiqy M, 2007, BRIT J CLIN PHARMACO, V64, P363, DOI 10.1111/j.1365-2125.2007.02925.x; WYNNE G, 1987, BRIT MED J, V294, P1198, DOI 10.1136/bmj.294.6581.1198	23	104	107	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e79802	10.1371/journal.pone.0079802	http://dx.doi.org/10.1371/journal.pone.0079802			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404122	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000329460800001
J	Shakibaei, M; Buhrmann, C; Kraehe, P; Shayan, P; Lueders, C; Goel, A				Shakibaei, Mehdi; Buhrmann, Constanze; Kraehe, Patricia; Shayan, Parviz; Lueders, Cora; Goel, Ajay			Curcumin Chemosensitizes 5-Fluorouracil Resistant MMR-Deficient Human Colon Cancer Cells in High Density Cultures	PLOS ONE			English	Article							FACTOR-KAPPA-B; MISMATCH REPAIR DEFICIENCY; STEM-CELLS; DNA METHYLATION; TUMOR-CELLS; INHIBITION; GROWTH; EXPRESSION; PROLIFERATION; INFLAMMATION	Objective: Treatment of colorectal cancer (CRC) remains a clinical challenge, as more than 15% of patients are resistant to 5-Fluorouracil (5-FU)-based chemotherapeutic regimens, and tumor recurrence rates can be as high as 50-60%. Cancer stem cells (CSC) are capable of surviving conventional chemotherapies that permits regeneration of original tumors. Therefore, we investigated the effectiveness of 5-FU and plant polyphenol (curcumin) in context of DNA mismatch repair (MMR) status and CSC activity in 3D cultures of CRC cells. Methods: High density 3D cultures of CRC cell lines HCT116, HCT116+ch3 (complemented with chromosome 3) and their corresponding isogenic 5-FU-chemo-resistant derivative clones (HCT116R, HCT116+ch3R) were treated with 5-FU either without or with curcumin in time-and dose-dependent assays. Results: Pre-treatment with curcumin significantly enhanced the effect of 5-FU on HCT116R and HCR116+ch3R cells, in contrast to 5-FU alone as evidenced by increased disintegration of colonospheres, enhanced apoptosis and by inhibiting their growth. Curcumin and/or 5-FU strongly affected MMR-deficient CRC cells in high density cultures, however MMR-proficient CRC cells were more sensitive. These effects of curcumin in enhancing chemosensitivity to 5-FU were further supported by its ability to effectively suppress CSC pools as evidenced by decreased number of CSC marker positive cells, highlighting the suitability of this 3D culture model for evaluating CSC marker expression in a close to vivo setting. Conclusion: Our results illustrate novel and previously unrecognized effects of curcumin in enhancing chemosensitization to 5-FU-based chemotherapy on DNA MMR-deficient and their chemo-resistant counterparts by targeting the CSC sub-population. (246 words in abstract).	[Shakibaei, Mehdi; Buhrmann, Constanze; Kraehe, Patricia] Univ Munich, Inst Anat, Munich, Germany; [Shayan, Parviz] Investigating Inst Mol Biol Syst Transfer, Tehran, Iran; [Lueders, Cora] German Heart Inst Berlin, Dept Thorac & Cardiovasc Surg, Lab Tissue Engn, Berlin, Germany; [Goel, Ajay] Baylor Univ, Med Ctr, Gastrointestinal Canc Res Lab, Div Gastroenterol,Baylor Res Inst, Dallas, TX USA; [Goel, Ajay] Baylor Univ, Med Ctr, Charles A Sammons Canc Ctr, Dallas, TX USA	University of Munich; German Heart Center Berlin; Baylor Scott & White Health; Baylor University; Baylor University Medical Center; Baylor University; Baylor University Medical Center	Shakibaei, M (corresponding author), Univ Munich, Inst Anat, Munich, Germany.	mehdi.shakibaei@med.uni-muenchen.de; ajay.goel@baylorhealth.edu	Prof. Dr. Shakibaei, Mehdi/AAA-7004-2020	Prof. Dr. Shakibaei, Mehdi/0000-0002-6304-7506; Buhrmann, Constanze/0000-0002-0786-0463; Goel, Ajay/0000-0003-1396-6341				Abdul Khalek Feras J, 2010, Gastrointest Cancer Res, pS16; Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Ali S, 2010, CANCER RES, V70, P3606, DOI 10.1158/0008-5472.CAN-09-4598; Ali S, 2010, J CELL BIOCHEM, V110, P171, DOI 10.1002/jcb.22523; Bao B, 2012, CANCER RES, V72, P335, DOI 10.1158/0008-5472.CAN-11-2182; Bharti AC, 2002, BIOCHEM PHARMACOL, V64, P883, DOI 10.1016/S0006-2952(02)01154-1; Bharti AC, 2003, BLOOD, V101, P1053, DOI 10.1182/blood-2002-05-1320; Boman BM, 2008, J CLIN ONCOL, V26, P2795, DOI 10.1200/JCO.2008.17.7436; Borralho PM, 2007, BBA-MOL BASIS DIS, V1772, P40, DOI 10.1016/j.bbadis.2006.09.005; Buhrmann C, 2011, J BIOL CHEM, V286, P28556, DOI 10.1074/jbc.M111.256180; Chauhan DP, 2002, CURR PHARM DESIGN, V8, P1695, DOI 10.2174/1381612023394016; Chibaudel B, 2012, THER ADV MED ONCOL, V4, P75, DOI 10.1177/1758834011431592; Csaki C, 2008, BIOCHEM PHARMACOL, V75, P677, DOI 10.1016/j.bcp.2007.09.014; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dalerba P, 2007, CELL STEM CELL, V1, P241, DOI 10.1016/j.stem.2007.08.012; Dallas NA, 2009, CANCER RES, V69, P1951, DOI 10.1158/0008-5472.CAN-08-2023; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Dihlmann S, 2005, INT J CANCER, V113, P515, DOI 10.1002/ijc.20609; Drummond JT, 1996, J BIOL CHEM, V271, P19645, DOI 10.1074/jbc.271.33.19645; Du BY, 2006, CHEMOTHERAPY, V52, P23, DOI 10.1159/000090238; Duarte VM, 2010, MOL CANCER THER, V9, P2665, DOI 10.1158/1535-7163.MCT-10-0064; EDEN S, 1994, CURR OPIN GENET DEV, V4, P255, DOI 10.1016/S0959-437X(05)80052-8; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Fujita H, 2007, ONCOL REP, V18, P1129; Fukui K, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/260512; Gonzalez-Vallinas M, 2013, PHARM RES; Gupta SC, 2010, CANCER METAST REV, V29, P405, DOI 10.1007/s10555-010-9235-2; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hollenbach JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021808; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Jemal Ahmedin, 2009, V471, P3, DOI 10.1007/978-1-59745-416-2_1; Jiang ZH, 2010, MOL CANCER THER, V9, P558, DOI 10.1158/1535-7163.MCT-09-0627; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Kanwar SS, 2011, PHARM RES-DORDR, V28, P827, DOI 10.1007/s11095-010-0336-y; KOI M, 1994, CANCER RES, V54, P4308; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Lawson DA, 2007, J CLIN INVEST, V117, P2044, DOI 10.1172/JCI32810; Majumdar APN, 2009, NUTR CANCER, V61, P544, DOI 10.1080/01635580902752262; Patel BB, 2008, INT J CANCER, V122, P267, DOI 10.1002/ijc.23097; Polyak K, 2006, NAT MED, V12, P296, DOI 10.1038/nm1379; Sargent DJ, 2010, J CLIN ONCOL, V28, P3219, DOI 10.1200/JCO.2009.27.1825; Shakibaei M, 1997, CELL BIOL INT, V21, P115, DOI 10.1006/cbir.1996.0118; Shakibaei M, 1998, EXP CELL RES, V240, P95, DOI 10.1006/excr.1998.3933; Shakibaei M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057218; Shishodia S, 2007, CURR PROB CANCER, V31, P243, DOI 10.1016/j.currproblcancer.2007.04.001; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Stuelten CH, 2010, STEM CELLS, V28, P649, DOI 10.1002/stem.324; Sung MK, 2013, WORLD J GASTROENTERO, V19, P994, DOI 10.3748/wjg.v19.i7.994; Swindall Amanda F, 2013, Cancers (Basel), V5, P943, DOI 10.3390/cancers5030943; TATE PH, 1993, CURR OPIN GENET DEV, V3, P226, DOI 10.1016/0959-437X(93)90027-M; Todaro M, 2010, GASTROENTEROLOGY, V138, P2151, DOI 10.1053/j.gastro.2009.12.063; Vaish M, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-26; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Yu YJ, 2009, TRANSL ONCOL, V2, P321, DOI 10.1593/tlo.09193; Zhang N, 2008, MOLECULES, V13, P1551, DOI 10.3390/molecules13081551	57	82	85	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e85397	10.1371/journal.pone.0085397	http://dx.doi.org/10.1371/journal.pone.0085397			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404205	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000329460800084
J	Borengasser, SJ; Kang, P; Faske, J; Gomez-Acevedo, H; Blackburn, ML; Badger, TM; Shankar, K				Borengasser, Sarah J.; Kang, Ping; Faske, Jennifer; Gomez-Acevedo, Horacio; Blackburn, Michael L.; Badger, Thomas M.; Shankar, Kartik			High Fat Diet and In Utero Exposure to Maternal Obesity Disrupts Circadian Rhythm and Leads to Metabolic Programming of Liver in Rat Offspring	PLOS ONE			English	Article							HEPATIC GENE-EXPRESSION; BODY-MASS INDEX; INSULIN-RESISTANCE; PPAR-ALPHA; DEVELOPMENTAL ORIGINS; SENSITIVITY-ANALYSIS; CHRONIC ETHANOL; ANIMAL-MODELS; PREGNANT RATS; WEIGHT-GAIN	The risk of obesity in adulthood is subject to programming beginning at conception. In animal models, exposure to maternal obesity and high fat diets influences the risk of obesity in the offspring. Among other long-term changes, offspring from obese rats develop hyperinsulinemia, hepatic steatosis, and lipogenic gene expression in the liver at weaning. However, the precise underlying mechanisms leading to metabolic dysregulation in the offspring remains unclear. Using a rat model of overfeeding-induced obesity, we previously demonstrated that exposure to maternal obesity from preconception to birth, is sufficient to program increased obesity risk in the offspring. Offspring of obese rat dams gain greater body weight and fat mass when fed high fat diet (HFD) as compared to lean dam. Since, disruptions of diurnal circadian rhythm are known to detrimentally impact metabolically active tissues such as liver, we examined the hypothesis that maternal obesity leads to perturbations of core clock components and thus energy metabolism in offspring liver. Offspring from lean and obese dams were examined at post-natal day 35, following a short (2 wk) HFD challenge. Hepatic mRNA expression of circadian (CLOCK, BMAL1, REV-ERB alpha, CRY, PER) and metabolic (PPAR alpha, SIRT1) genes were strongly suppressed in offspring exposed to both maternal obesity and HFD. Using a mathematical model, we identified two distinct biological mechanisms that modulate PPAR alpha mRNA expression: i) decreased mRNA synthesis rates; and ii) increased non-specific mRNA degradation rate. Moreover, our findings demonstrate that changes in PPAR alpha transcription were associated with epigenomic alterations in H3K4me3 and H3K27me3 histone marks near the PPAR alpha transcription start site. Our findings indicated that offspring from obese rat dams have detrimental alternations to circadian machinery that may contribute to impaired liver metabolism in response to HFD, specifically via reduced PPAR alpha expression prior to obesity development.	[Borengasser, Sarah J.; Kang, Ping; Faske, Jennifer; Gomez-Acevedo, Horacio; Blackburn, Michael L.; Badger, Thomas M.; Shankar, Kartik] Arkansas Childrens Nutr Ctr, Little Rock, AR 72202 USA; [Borengasser, Sarah J.; Gomez-Acevedo, Horacio; Badger, Thomas M.; Shankar, Kartik] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Shankar, K (corresponding author), Arkansas Childrens Nutr Ctr, Little Rock, AR 72202 USA.	ShankarKartik@uams.edu	Gomez-Acevedo, Horacio/AAR-8783-2021	Gomez-Acevedo, Horacio/0000-0002-1570-1606; Borengasser, Sarah/0000-0002-9984-0178; Shankar, Kartik/0000-0002-7964-9026	National Institutes of Health [R01-DK084225]; USDA Agriculture Research Service CRIS [6251-51000-007-04S]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084225] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA Agriculture Research Service CRIS; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported by the National Institutes of Health-R01-DK084225 (K.S.) and USDA Agriculture Research Service CRIS 6251-51000-007-04S. The funding agencies had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aagaard-Tillery KM, 2008, J MOL ENDOCRINOL, V41, P91, DOI 10.1677/JME-08-0025; Ainge H, 2011, INT J OBESITY, V35, P325, DOI 10.1038/ijo.2010.149; Albrecht U, 2012, NEURON, V74, P246, DOI 10.1016/j.neuron.2012.04.006; Alfaradhi Maria Z., 2011, Frontiers in Genetics, V2, P27, DOI 10.3389/fgene.2011.00027; Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; BADGER TM, 1993, J PHARMACOL EXP THER, V264, P938; BADGER TM, 1993, J PHARMACOL EXP THER, V264, P438; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Baumgardner JN, 2008, AM J PHYSIOL-GASTR L, V294, pG27, DOI 10.1152/ajpgi.00296.2007; Bayol SA, 2008, J PHYSIOL-LONDON, V586, P3219, DOI 10.1113/jphysiol.2008.153817; Borengasser SJ, 2013, ENDOCRINOLOGY, V154, P4113, DOI 10.1210/en.2012-2255; Borengasser SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024068; Canaple L, 2006, MOL ENDOCRINOL, V20, P1715, DOI 10.1210/me.2006-0052; Catalano PM, 2009, AM J CLIN NUTR, V90, P1303, DOI 10.3945/ajcn.2008.27416; Catalano PM, 2009, DIABETES CARE, V32, P1076, DOI 10.2337/dc08-2077; Catalano PM, 2003, J CLIN ENDOCR METAB, V88, P3505, DOI 10.1210/jc.2003-031046; Coomans CP, 2013, FASEB J, V27, P1721, DOI 10.1096/fj.12-210898; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Deckelbaum RJ, 2001, OBES RES, V9, p239S, DOI 10.1038/oby.2001.125; Delezie J, 2011, ANN NY ACAD SCI, V1243, P30, DOI 10.1111/j.1749-6632.2011.06246.x; Etchegaray JP, 2006, J BIOL CHEM, V281, P21209, DOI 10.1074/jbc.M603722200; Feng D, 2012, MOL CELL, V47, P158, DOI 10.1016/j.molcel.2012.06.026; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Gallou-Kabani C, 2007, EPIGENETICS-US, V2, P137, DOI 10.4161/epi.2.3.4897; Haimovich G, 2013, BBA-GENE REGUL MECH, V1829, P643, DOI 10.1016/j.bbagrm.2013.01.004; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Heerwagen MJR, 2010, AM J PHYSIOL-REG I, V299, pR711, DOI 10.1152/ajpregu.00310.2010; Jaaskelainen A, 2011, INT J OBESITY, V35, P1289, DOI 10.1038/ijo.2011.150; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Korourian S, 1999, TOXICOL SCI, V47, P110, DOI 10.1093/toxsci/47.1.110; Kral JG, 2006, PEDIATRICS, V118, pE1644, DOI 10.1542/peds.2006-1379; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lawlor DA, 2007, AM J EPIDEMIOL, V165, P418, DOI 10.1093/aje/kwk030; Leloup JC, 2004, J THEOR BIOL, V230, P541, DOI 10.1016/j.jtbi.2004.04.040; Leloup JC, 2003, P NATL ACAD SCI USA, V100, P7051, DOI 10.1073/pnas.1132112100; Levin BE, 1998, AM J PHYSIOL-REG I, V275, pR1374, DOI 10.1152/ajpregu.1998.275.4.R1374; Li M, 2011, EXP DIABETES RES, DOI [10.1155/2011/592408, 10.4061/2011/179819]; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Lillycrop KA, 2008, BRIT J NUTR, V100, P278, DOI 10.1017/S0007114507894438; Lu Lu, 2011, Chinese Medical Sciences Journal, V26, P77; Maltepe E, 2010, J CLIN INVEST, V120, P1016, DOI 10.1172/JCI41211; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Masri S, 2012, ANN NY ACAD SCI, V1264, P103, DOI 10.1111/j.1749-6632.2012.06649.x; McCurdy CE, 2009, J CLIN INVEST, V119, P323, DOI 10.1172/JCI32661; Meissner A, 2010, NAT BIOTECHNOL, V28, P1079, DOI 10.1038/nbt.1684; Nathanielsz PW, 2007, OBSTET GYN CLIN N AM, V34, P201, DOI 10.1016/j.ogc.2007.03.006; O'Hagan HM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000155; O'Meara MM, 2012, CHROMOSOMA, V121, P221, DOI 10.1007/s00412-012-0361-1; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Oishi K, 2005, BIOCHEM J, V386, P575, DOI 10.1042/BJ20041150; Oishi K, 2008, NEUROREPORT, V19, P487, DOI 10.1097/WNR.0b013e3282f7968f; Olson CM, 2009, MATERN CHILD HLTH J, V13, P839, DOI 10.1007/s10995-008-0413-6; Reynolds RM, 2010, J CLIN ENDOCR METAB, V95, P5365, DOI 10.1210/jc.2010-0697; Reynolds RM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4539; Richards J, 2012, FASEB J, V26, P3602, DOI 10.1096/fj.12-203554; Saben J, 2013, AM J PHYSIOL-ENDOC M, V305, pE1, DOI 10.1152/ajpendo.00076.2013; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Schroeder AM, 2012, J PHYSIOL-LONDON, V590, P6213, DOI 10.1113/jphysiol.2012.233676; Shankar K, 2008, ENDOCRINOLOGY, V149, P1748, DOI 10.1210/en.2007-0903; Shankar K, 2008, AM J PHYSIOL-REG I, V294, pR528, DOI 10.1152/ajpregu.00316.2007; Shankar K, 2006, EXP BIOL MED, V231, P1379, DOI 10.1177/153537020623100812; Shankar K, 2010, ENDOCRINOLOGY, V151, P2577, DOI 10.1210/en.2010-0017; Shankar K, 2010, ENDOCRINOLOGY, V151, P153, DOI 10.1210/en.2009-0840; Shi SQ, 2013, CURR BIOL, V23, P372, DOI 10.1016/j.cub.2013.01.048; Singhal A, 2004, LANCET, V363, P1642, DOI 10.1016/S0140-6736(04)16210-7; Singhal R, 2008, CARCINOGENESIS, V29, P227, DOI 10.1093/carcin/bgm288; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Smith J, 2009, J CLIN ENDOCR METAB, V94, P4275, DOI 10.1210/jc.2009-0709; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Suter M, 2011, FASEB J, V25, P714, DOI 10.1096/fj.10-172080; Suter MA, 2012, FASEB J, V26, P5106, DOI 10.1096/fj.12-212878; Sutton GM, 2010, ENDOCRINOLOGY, V151, P1570, DOI 10.1210/en.2009-1133; Villamor E, 2006, LANCET, V368, P1164, DOI 10.1016/S0140-6736(06)69473-7; Whitaker RC, 2004, PEDIATRICS, V114, pE29, DOI 10.1542/peds.114.1.e29; Wolff G, 2012, MED SCI SPORT EXER, V44, P1663, DOI 10.1249/MSS.0b013e318255cf4c; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	82	69	73	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84209	10.1371/journal.pone.0084209	http://dx.doi.org/10.1371/journal.pone.0084209			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416203	gold, Green Submitted, Green Published			2022-12-27	WOS:000329866300020
J	Luo, L; Li, L				Luo, Le; Li, Li			Defining and Evaluating Classification Algorithm for High-Dimensional Data Based on Latent Topics	PLOS ONE			English	Article								Automatic text categorization is one of the key techniques in information retrieval and the data mining field. The classification is usually time-consuming when the training dataset is large and high-dimensional. Many methods have been proposed to solve this problem, but few can achieve satisfactory efficiency. In this paper, we present a method which combines the Latent Dirichlet Allocation (LDA) algorithm and the Support Vector Machine (SVM). LDA is first used to generate reduced dimensional representation of topics as feature in VSM. It is able to reduce features dramatically but keeps the necessary semantic information. The Support Vector Machine (SVM) is then employed to classify the data based on the generated features. We evaluate the algorithm on 20 Newsgroups and Reuters-21578 datasets, respectively. The experimental results show that the classification based on our proposed LDA+SVM model achieves high performance in terms of precision, recall and F1 measure. Further, it can achieve this within a much shorter time-frame. Our process improves greatly upon the previous work in this field and displays strong potential to achieve a streamlined classification process for a wide range of applications.	[Luo, Le; Li, Li] Southwest Univ, Fac Comp & Informat Sci, Chongqing, Peoples R China	Southwest University - China	Li, L (corresponding author), Southwest Univ, Fac Comp & Informat Sci, Chongqing, Peoples R China.	lily@swu.edu.cn			National Natural Science Foundation of China [61170192]; Natural Science Foundation Project of CQ [CSTC2012JJB40012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of CQ(Natural Science Foundation Project of CQ CSTC)	This work was supported by National Natural Science Foundation of China (No. 61170192) and Natural Science Foundation Project of CQ (No. CSTC2012JJB40012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellman R. E., 2003, DYNAMIC PROGRAMMING; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Cai J., 2007, P EMNLP CONLL; Christopher J., 2009, MACH LEARN, V2, P275; Debole F, 2005, J AM SOC INF SCI TEC, V56, P584, DOI 10.1002/asi.20147; Di Nunzio GM, 2004, LECT NOTES COMPUT SC, V2997, P112; Forman G, 2004, LECT NOTES ARTIF INT, V3202, P161; Forman G, 2003, J MACHINE LEARNING R, V3, P1533; Guo L., 2004, INT C CONTROL, P1; Hao PY, 2007, EXPERT SYST APPL, V33, P627, DOI 10.1016/j.eswa.2006.06.009; Heinrich G., 2009, PARAMETER ESTIMATION; Kazama J, 2005, MACH LEARN, V60, P159, DOI 10.1007/s10994-005-0911-3; Kim H, 2005, J MACH LEARN RES, V6, P37; Minh HQ, 2006, LECT NOTES ARTIF INT, V4005, P154, DOI 10.1007/11776420_14; Phan X., 2008, P 17 INT C WORLD WID, P91, DOI 10.1145/1367497.1367510; Schivinski Bruno, 2013, WORKING PAPER SERI A, V12, P2; Tang J., 2012, P 18 ACM SIGKDD INT, P1366, DOI DOI 10.1145/2339530.2339741; Tang J, 2011, MACH LEARN, V82, P211, DOI 10.1007/s10994-010-5212-9; YANG Y, 1997, CMUCS97127	20	11	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e82119	10.1371/journal.pone.0082119	http://dx.doi.org/10.1371/journal.pone.0082119			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416136	Green Submitted, Green Published, gold			2022-12-27	WOS:000329866300008
J	Walentowicz-Sadlecka, M; Sadlecki, P; Bodnar, M; Marszalek, A; Walentowicz, P; Sokup, A; Wilinska-Jankowska, A; Grabiec, M				Walentowicz-Sadlecka, Malgorzata; Sadlecki, Pawel; Bodnar, Magdalena; Marszalek, Andrzej; Walentowicz, Pawel; Sokup, Alina; Wilinska-Jankowska, Arnika; Grabiec, Marek			Stromal Derived Factor-1 (SDF-1) and Its Receptors CXCR4 and CXCR7 in Endometrial Cancer Patients	PLOS ONE			English	Article							TUMOR; CHEMOKINES; EXPRESSION; METASTASIS; CARCINOMA; SURVIVAL; CXCL12; AXIS	Purpose: One of the most important function of stromal derived factor-1 (SDF-1) and its receptors, is regulating the process of metastasis formation. The aim of our study was to investigate the correlation between SDF-1, CXCR4 and CXCR7 protein levels measured by immunohistochemistry with the clinicopathological features and the survival of endometrial cancer patients. Materials and Methods: 92 patients aged 37-84 (mean 65.1 +/- 9.5) were enrolled to our study between January 2000 and December 2007. After the diagnosis of endometrial cancer, all women underwent total abdominal hysterectomy, with bilateral salpingoophorectomy and pelvic lymph node dissection. In all patients clinical stage (according to FIGO classification), histologic grade, myometrial invasion, lymph node and distant metastases were determined. Furthermore, the survival time was assessed. Immunohistochemical analyses of SDF-1, CXCR4 and CXCR7 were performed on archive formalin fixed paraffin embedded tissue sections. Results: Statistically significant correlations (p < 0.01) were reported between SDF-1 and the clinical stage of disease, lymph node metastases, distant metastases, deep myometrial invasion (>= 50%), cervical involvement, involvement of adnexa. Statistically significant correlation (p < 0.01) was found between SDF-1 expression and the risk of the recurrence. Higher SDF-1 expression was associated with ahigher risk of recurrence (p = 0.0001). The results of CXCR4and CXCR7 expression didn't reveal any significant differences(p > 0.05) between the proteins expression in the primary tumor cells and the clinicopathological features. Moreover, the Kaplan-Meier analyses demonstrated a stepwise impairment of cancer overall survival (OS) with increasing SDF-1 expression. Conclusion: The important role of SDF-1 as a predictor of negative clinicopathological characteristics of atumor suggests that the expression of this stromal factor should be included in the panel of accessory pathomorphological tests and could be helpful in establishing a more accurate prognosis in endometrial cancer patients.	[Walentowicz-Sadlecka, Malgorzata; Sadlecki, Pawel; Walentowicz, Pawel; Grabiec, Marek] Nicolaus Copernicus Univ Torun, Ludwik Rydygier Coll Med Bydgoszcz, Dept Obstet & Gynecol, Bydgoszcz, Poland; [Bodnar, Magdalena; Marszalek, Andrzej] Nicolaus Copernicus Univ Torun, Ludwik Rydygier Coll Med Bydgoszcz, Dept Clin Pathol, Bydgoszcz, Poland; [Sokup, Alina] Nicolaus Copernicus Univ Torun, Ludwik Rydygier Coll Med Bydgoszcz, Dept Gastroenterol Angiol & Internal Dis, Bydgoszcz, Poland; [Wilinska-Jankowska, Arnika] Ludwik Rydygier Hosp Torun, Dept Physiotherapy, Torun, Poland	Nicolaus Copernicus University; Nicolaus Copernicus University; Nicolaus Copernicus University	Walentowicz-Sadlecka, M (corresponding author), Nicolaus Copernicus Univ Torun, Ludwik Rydygier Coll Med Bydgoszcz, Dept Obstet & Gynecol, Bydgoszcz, Poland.	walentowiczm@cm.umk.pl	Sadłecki, Paweł/I-5728-2014; Sokup, Alina/M-5222-2014; Sadlecki, Pawel/AAB-5046-2021; Bodnar, Magdalena/D-6131-2014; Sadlecki, Pawel/AAB-6993-2021	Sadłecki, Paweł/0000-0001-8355-2553; Sokup, Alina/0000-0002-7470-6706; Bodnar, Magdalena/0000-0003-3748-1058; Sadlecki, Pawel/0000-0001-8355-2553; Walentowicz, Pawel/0000-0002-7748-343X				Amant F, 2005, LANCET, V366, P491, DOI 10.1016/S0140-6736(05)67063-8; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Bakkum-Gamez JN, 2008, MAYO CLIN PROC, V83, P97, DOI 10.4065/83.1.97; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Campbell DJ, 2003, IMMUNOL REV, V195, P58, DOI 10.1034/j.1600-065X.2003.00067.x; Felix AS, 2012, INT J CANCER, V131, pE114, DOI 10.1002/ijc.27317; Gelmini S, 2009, CLIN EXP METASTAS, V26, P261, DOI 10.1007/s10585-009-9240-4; Ho TK, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/143209; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kajiyama H, 2008, INT J CANCER, V122, P91, DOI 10.1002/ijc.23083; Kodama J, 2007, ANN ONCOL, V18, P269, DOI 10.1093/annonc/mdl370; Lee E, 2013, PIGM CELL MELANOMA R, V26, P58, DOI 10.1111/pcmr.12024; Liu FF, 2009, HISTOPATHOLOGY, V54, P741, DOI 10.1111/j.1365-2559.2009.03289.x; Mantovani A, 2008, LANCET, V371, P771, DOI 10.1016/S0140-6736(08)60241-X; McLean MH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015366; Mizokami Y, 2004, INT J CANCER, V110, P652, DOI 10.1002/ijc.20183; REMMELE W, 1987, PATHOLOGE, V8, P138; Salomonnson E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051500; SHIROZU M, 1995, GENOMICS, V28, P495, DOI 10.1006/geno.1995.1180; Subramaniam KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068923; Sun QM, 2009, J BIOL CHEM, V284, P32066, DOI 10.1074/jbc.M109.057166; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Tsukamoto H, 2007, CLIN EXP METASTAS, V24, P423, DOI 10.1007/s10585-007-9079-5; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Wang SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069182; Wojcechowskyj JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024918; Zhang SW, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-62	31	22	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84629	10.1371/journal.pone.0084629	http://dx.doi.org/10.1371/journal.pone.0084629			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416254	Green Published, Green Submitted, gold			2022-12-27	WOS:000329866300031
J	Angus, AA; Agapakis, CM; Fong, S; Yerrapragada, S; Estrada-de los Santos, P; Yang, P; Song, N; Kano, S; Caballero-Mellado, J; de Faria, SM; Dakora, FD; Weinstock, G; Hirsch, AM				Angus, Annette A.; Agapakis, Christina M.; Fong, Stephanie; Yerrapragada, Shailaja; Estrada-de los Santos, Paulina; Yang, Paul; Song, Nannie; Kano, Stephanie; Caballero-Mellado, Jesus; de Faria, Sergio M.; Dakora, Felix D.; Weinstock, George; Hirsch, Ann M.			Plant-Associated Symbiotic Burkholderia Species Lack Hallmark Strategies Required in Mammalian Pathogenesis	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; QUORUM-SENSING SYSTEM; CAENORHABDITIS-ELEGANS; SECRETION SYSTEM; VI SECRETION; PSEUDOMALLEI; VIRULENCE; CEPACIA; INFECTION; NOV	Burkholderia is a diverse and dynamic genus, containing pathogenic species as well as species that form complex interactions with plants. Pathogenic strains, such as B. pseudomallei and B. mallei, can cause serious disease in mammals, while other Burkholderia strains are opportunistic pathogens, infecting humans or animals with a compromised immune system. Although some of the opportunistic Burkholderia pathogens are known to promote plant growth and even fix nitrogen, the risk of infection to infants, the elderly, and people who are immunocompromised has not only resulted in a restriction on their use, but has also limited the application of non-pathogenic, symbiotic species, several of which nodulate legume roots or have positive effects on plant growth. However, recent phylogenetic analyses have demonstrated that Burkholderia species separate into distinct lineages, suggesting the possibility for safe use of certain symbiotic species in agricultural contexts. A number of environmental strains that promote plant growth or degrade xenobiotics are also included in the symbiotic lineage. Many of these species have the potential to enhance agriculture in areas where fertilizers are not readily available and may serve in the future as inocula for crops growing in soils impacted by climate change. Here we address the pathogenic potential of several of the symbiotic Burkholderia strains using bioinformatics and functional tests. A series of infection experiments using Caenorhabditis elegans and HeLa cells, as well as genomic characterization of pathogenic loci, show that the risk of opportunistic infection by symbiotic strains such as B. tuberum is extremely low.	[Angus, Annette A.; Agapakis, Christina M.; Fong, Stephanie; Yang, Paul; Song, Nannie; Kano, Stephanie; Hirsch, Ann M.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90047 USA; [Hirsch, Ann M.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Yerrapragada, Shailaja] Baylor Coll Med, Houston, TX 77030 USA; [Estrada-de los Santos, Paulina] Inst Politecn Nacl, Dept Microbiol, Escuela Nacl Ciencias Biol, Mexico City 07738, DF, Mexico; [Caballero-Mellado, Jesus] Univ Nacl Autonoma Mexico, Genom Sci Ctr, Cuernavaca, Morelos, Mexico; [de Faria, Sergio M.] Embrapa Agrobiol, Rio De Janeiro, Brazil; [Dakora, Felix D.] Tshwane Univ Technol, Dept Chem, Pretoria, South Africa; [Weinstock, George] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Baylor College of Medicine; Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Tshwane University of Technology; Washington University (WUSTL)	Hirsch, AM (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90047 USA.	ahirsch@ucla.edu	de Faria, Sergio Miana/C-1405-2013; Weinstock, George M/C-6314-2013; de los Santos, Paulina Estrada/AAE-8582-2021; de los Santos, Paulina Estrada/S-1238-2018; Hirsch, Ann M/D-3562-2009; Dakora, Felix/AAI-4090-2020	Weinstock, George M/0000-0002-2997-4592; de los Santos, Paulina Estrada/0000-0003-2407-0284; de los Santos, Paulina Estrada/0000-0003-2407-0284; Hirsch, Ann M/0000-0002-9633-1538; Dakora, Felix/0000-0002-9070-6896; de Faria, Sergio/0000-0001-5066-046X	National Science Foundation (USA) [IOB-0537497]; Shanbrom Family Foundation; University of California Office of The President; L'Oreal USA For Women in Science Fellowship	National Science Foundation (USA)(National Science Foundation (NSF)); Shanbrom Family Foundation; University of California Office of The President(University of California System); L'Oreal USA For Women in Science Fellowship(L'Oreal Group)	This research was supported in part by a grant (IOB-0537497) from the National Science Foundation (USA) to GW and AMH and a Shanbrom Family Foundation grant to AMH. A University of California Office of The President, President's Postdoctoral Fellowship, supported AAA. CMA was supported by the L'Oreal USA For Women in Science Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus AA, 2013, PLANT SOIL, V369, P543, DOI 10.1007/s11104-013-1590-7; [Anonymous], 2003, FED REGISTER, V68, P35315; Araujo R, 2004, J CLIN MICROBIOL, V42, P4335, DOI 10.1128/JCM.42.9.4335-4337.2004; Backert S, 2006, CURR OPIN MICROBIOL, V9, P207, DOI 10.1016/j.mib.2006.02.008; Baldwin A, 2004, INFECT IMMUN, V72, P1537, DOI 10.1128/IAI.72.3.1537-1547.2004; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Berg G, 2005, ENVIRON MICROBIOL, V7, P1673, DOI 10.1111/j.1462-2920.2005.00891.x; Bhatt AS, 2013, NEW ENGL J MED, V369, P517, DOI 10.1056/NEJMoa1211115; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Bladergroen MR, 2003, MOL PLANT MICROBE IN, V16, P53, DOI 10.1094/MPMI.2003.16.1.53; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Caballero-Mellado J, 2004, INT J SYST EVOL MICR, V54, P1165, DOI 10.1099/ijs.0.02951-0; Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753; Chain PSG, 2006, P NATL ACAD SCI USA, V103, P15280, DOI 10.1073/pnas.0606924103; Chen CY, 2008, J HOSP INFECT, V68, P203, DOI 10.1016/j.jhin.2007.11.021; Chiarini L, 2006, TRENDS MICROBIOL, V14, P277, DOI 10.1016/j.tim.2006.04.006; Chua KL, 2003, INFECT IMMUN, V71, P1622, DOI 10.1128/IAI.71.4.1622-1629.2003; Coenye T, 2002, J CLIN MICROBIOL, V40, P2062, DOI 10.1128/JCM.40.6.2062-2069.2002; Cooper VS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007961; Cunha CD, 2012, J BACTERIOL, V194, P6675, DOI 10.1128/JB.01821-12; de los Santos-Villalobos S, 2012, WORLD J MICROB BIOT, V28, P2615, DOI 10.1007/s11274-012-1071-9; DeShazer D, 1997, J BACTERIOL, V179, P2116, DOI 10.1128/jb.179.7.2116-2125.1997; Essex-Lopresti AE, 2005, INFECT IMMUN, V73, P1260, DOI 10.1128/IAI.73.2.1260-1264.2005; Estrada-de los Santos P, 2013, CURR MICROBIOL, V67, P51, DOI 10.1007/s00284-013-0330-9; French CT, 2011, P NATL ACAD SCI USA, V108, P12095, DOI 10.1073/pnas.1107183108; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; Gyaneshwar P, 2002, PLANT SOIL, V245, P83, DOI 10.1023/A:1020663916259; Gyaneshwar P, 2011, MOL PLANT MICROBE IN, V24, P1276, DOI 10.1094/MPMI-06-11-0172; Haraga A, 2008, INFECT IMMUN, V76, P5402, DOI 10.1128/IAI.00626-08; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Holmes A, 1998, EMERG INFECT DIS, V4, P221, DOI 10.3201/eid0402.980209; Kaplan D, 2013, AM J BOT, V100, P1713, DOI 10.3732/ajb.1200615; Kuykendall LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034673; La Scola B, 2002, INT J SYST EVOL MICR, V52, P1773, DOI [10.1099/ijs.0.02149-0, 10.1099/00207713-52-5-1773]; Magalhaes Marcelo, 2002, J Cyst Fibros, V1, P292, DOI 10.1016/S1569-1993(02)00101-7; McCarter LL, 2004, J MOL MICROB BIOTECH, V7, P18, DOI 10.1159/000077866; Mitter B, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00120; Niu QH, 2010, P NATL ACAD SCI USA, V107, P16631, DOI 10.1073/pnas.1007276107; O'Sullivan LA, 2007, ENVIRON MICROBIOL, V9, P1017, DOI 10.1111/j.1462-2920.2006.01228.x; Onofre-Lemus J, 2009, APPL ENVIRON MICROB, V75, P6581, DOI 10.1128/AEM.01240-09; Paphitou NI, 2003, INFECTION, V31, P421, DOI 10.1007/s15010-003-3175-5; Payne GW, 2005, APPL ENVIRON MICROB, V71, P3917, DOI 10.1128/AEM.71.7.3917-3927.2005; Perin L, 2006, APPL ENVIRON MICROB, V72, P3103, DOI 10.1128/AEM.72.5.3103-3110.2006; Reckseidler-Zenteno SL, 2005, INFECT IMMUN, V73, P1106, DOI 10.1128/IAI.73.2.1106-1115.2005; Reinke SN, 2010, MOL GENET METAB, V100, P274, DOI 10.1016/j.ymgme.2010.03.013; Riesenfeld CS, 2004, ENVIRON MICROBIOL, V6, P981, DOI 10.1111/j.1462-2920.2004.00664.x; Roest HP, 1997, MOL PLANT MICROBE IN, V10, P938, DOI 10.1094/MPMI.1997.10.7.938; Sanchez PA, 2010, NAT GEOSCI, V3, P299, DOI 10.1038/ngeo853; Schmidt MA, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-98; Schwarz S, 2010, TRENDS MICROBIOL, V18, P531, DOI 10.1016/j.tim.2010.09.001; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Seo YS, 2011, J BACTERIOL, V193, P3149, DOI 10.1128/JB.00420-11; Stiernagle Theresa, 2006, WormBook, P1; Suarez-Moreno ZR, 2008, MICROBIOL-SGM, V154, P2048, DOI 10.1099/mic.0.2008/017780-0; Suarez-Moreno ZR, 2012, MICROB ECOL, V63, P249, DOI 10.1007/s00248-011-9929-1; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Torbeck Lynn, 2011, PDA J Pharm Sci Technol, V65, P535, DOI 10.5731/pdajpst.2011.00793; Ulrich RL, 2004, J MED MICROBIOL, V53, P1053, DOI 10.1099/jmm.0.45661-0; Urban TA, 2004, INFECT IMMUN, V72, P5126, DOI 10.1128/IAI.72.9.5126-5134.2004; Valade E, 2004, J BACTERIOL, V186, P2288, DOI 10.1128/JB.186.8.2288-2294.2004; Whitlock GC, 2007, FEMS MICROBIOL LETT, V277, P115, DOI 10.1111/j.1574-6968.2007.00949.x; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; YABUUCHI E, 1995, MICROBIOL IMMUNOL, V39, P897, DOI 10.1111/j.1348-0421.1995.tb03275.x; YABUUCHI E, 1992, MICROBIOL IMMUNOL, V36, P1251, DOI 10.1111/j.1348-0421.1992.tb02129.x; Zachow C, 2009, EUR J PLANT PATHOL, V125, P367, DOI 10.1007/s10658-009-9486-3; Zhang RF, 2009, MICROBIOL-SGM, V155, P4005, DOI 10.1099/mic.0.033043-0	67	76	81	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83779	10.1371/journal.pone.0083779	http://dx.doi.org/10.1371/journal.pone.0083779			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416172	Green Published, gold			2022-12-27	WOS:000329862500072
J	Driessen, TM; Zhao, CJ; Whittlinger, A; Williams, H; Gammie, SC				Driessen, Terri M.; Zhao, Changjiu; Whittlinger, Anna; Williams, Horecia; Gammie, Stephen C.			Endogenous CNS Expression of Neurotensin and Neurotensin Receptors Is Altered during the Postpartum Period in Outbred Mice	PLOS ONE			English	Article							HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; CENTRAL-NERVOUS-SYSTEM; MEDIAL PREOPTIC AREA; MATERNAL-BEHAVIOR; MESSENGER-RNA; GENE-EXPRESSION; LATERAL SEPTUM; NEUROMEDIN-N; BED NUCLEUS; RAT-BRAIN	Neurotensin (NT) is a neuropeptide identical in mice and humans that is produced and released in many CNS regions associated with maternal behavior. NT has been linked to aspects of maternal care and previous studies have indirectly suggested that endogenous NT signaling is altered in the postpartum period. In the present study, we directly examine whether NT and its receptors exhibit altered gene expression in maternal relative to virgin outbred mice using real time quantitative PCR (qPCR) across multiple brain regions. We also examine NT protein levels using anti-NT antibodies and immunohistochemistry in specific brain regions. In the medial preoptic area (MPOA), which is critical for maternal behaviors, mRNA of NT and NT receptor 3 (Sort1) were significantly up-regulated in postpartum mice compared to virgins. NT mRNA was also elevated in postpartum females in the bed nucleus of the stria terminalis dorsal. However, in the lateral septum, NT mRNA was down-regulated in postpartum females. In the paraventricular nucleus of the hypothalamus (PVN), Ntsr1 expression was down-regulated in postpartum females. Neurotensin receptor 2 (Ntsr2) expression was not altered in any brain region tested. In terms of protein expression, NT immunohistochemistry results indicated that NT labeling was elevated in the postpartum brain in the MPOA, lateral hypothalamus, and two subregions of PVN. Together, these findings indicate that endogenous changes occur in NT and its receptors across multiple brain regions, and these likely support the emergence of some maternal behaviors.	[Driessen, Terri M.; Zhao, Changjiu; Whittlinger, Anna; Gammie, Stephen C.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Williams, Horecia] Ft Valley State Univ, Dept Anim Sci, Ft Valley, GA USA; [Gammie, Stephen C.] Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University System of Georgia; Fort Valley State University; University of Wisconsin System; University of Wisconsin Madison	Driessen, TM (corresponding author), Univ Wisconsin, Dept Zool, Madison, WI 53706 USA.	tdriessen@wisc.edu	Zhao, Changjiu/M-8263-2014		National Science Foundation [IOS-0921706]	National Science Foundation(National Science Foundation (NSF))	This work was supported by a National Science Foundation grant IOS-0921706 to SCG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER MJ, 1989, P NATL ACAD SCI USA, V86, P5202, DOI 10.1073/pnas.86.13.5202; Alexander MJ, 1998, J COMP NEUROL, V402, P475; ALLEN GV, 1995, NEUROSCIENCE, V69, P533, DOI 10.1016/0306-4522(95)00261-G; Angelidou A, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-48; AXELSON JF, 1992, NEUROSCI LETT, V136, P5, DOI 10.1016/0304-3940(92)90634-J; BERK ML, 1981, NEUROSCIENCE, V6, P1601, DOI 10.1016/0306-4522(81)90227-X; Binder EB, 2001, PHARMACOL REV, V53, P453; Bonefeld BE, 2008, SYNAPSE, V62, P302, DOI 10.1002/syn.20496; Boudin H, 1996, J COMP NEUROL, V373, P76; BRIDGES RS, 1996, PARENTAL CARE EVOLUT; BROWN KJ, 1995, PHYSIOL BEHAV, V58, P1085, DOI 10.1016/0031-9384(95)02043-8; Byrnes EM, 2002, PHARMACOL BIOCHEM BE, V73, P869, DOI 10.1016/S0091-3057(02)00941-3; CARRAWAY R, 1973, J BIOL CHEM, V248, P6854; Chalon P, 1996, FEBS LETT, V386, P91, DOI 10.1016/0014-5793(96)00397-3; CONRAD LCA, 1976, J COMP NEUROL, V169, P185, DOI 10.1002/cne.901690205; Consiglio AR, 1996, PHYSIOL BEHAV, V59, P591, DOI 10.1016/0031-9384(95)02117-5; Cui H, 2005, J NEUROSCI, V25, P9497, DOI 10.1523/JNEUROSCI.2269-05.2005; Cullinan WE, 1996, J COMP NEUROL, V368, P88; D'Anna KL, 2006, J NEUROENDOCRINOL, V18, P553, DOI 10.1111/j.1365-2826.2006.01448.x; D'Anna KL, 2009, BEHAV NEUROSCI, V123, P356, DOI 10.1037/a0014987; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Dobner PR, 2006, PEPTIDES, V27, P2405, DOI 10.1016/j.peptides.2006.04.025; Dobner PR, 2005, CELL MOL LIFE SCI, V62, P1946, DOI 10.1007/s00018-005-5128-x; DOBNER PR, 1987, P NATL ACAD SCI USA, V84, P3516, DOI 10.1073/pnas.84.10.3516; Dobner PR, 2001, P NATL ACAD SCI USA, V98, P8048, DOI 10.1073/pnas.141042198; DUNN JD, 1987, BRAIN RES, V407, P327, DOI 10.1016/0006-8993(87)91111-5; Forray MI, 2004, BRAIN RES REV, V47, P145, DOI 10.1016/j.brainresrev.2004.07.011; Francis DD, 2000, J NEUROENDOCRINOL, V12, P1145, DOI 10.1046/j.1365-2826.2000.00599.x; Gammie SC, 2007, GENES BRAIN BEHAV, V6, P432, DOI 10.1111/j.1601-183X.2006.00271.x; Gammie SC, 2009, NEUROSCIENCE, V158, P1215, DOI 10.1016/j.neuroscience.2008.11.045; Gammie SC, 2005, MOL BRAIN RES, V139, P201, DOI 10.1016/j.molbrainres.2005.05.011; Gammie SC, 2004, BEHAV NEUROSCI, V118, P805, DOI 10.1037/0735-7044.118.4.805; Gammie SC, 2012, BRAIN RES, V1433, P47, DOI 10.1016/j.brainres.2011.11.017; Geerling JC, 2006, J COMP NEUROL, V494, P515, DOI 10.1002/cne.20808; Geisler S, 2006, EUR J NEUROSCI, V24, P116, DOI 10.1111/j.1460-9568.2006.04928.x; HERMAN JP, 1994, J NEUROENDOCRINOL, V6, P433, DOI 10.1111/j.1365-2826.1994.tb00604.x; Insel TR, 2010, NEURON, V65, P768, DOI 10.1016/j.neuron.2010.03.005; INSEL TR, 1992, ANN NY ACAD SCI, V652, P122, DOI 10.1111/j.1749-6632.1992.tb34350.x; INSEL TR, 1990, J NEUROENDOCRINOL, V2, P539, DOI 10.1111/j.1365-2826.1990.tb00445.x; INSEL TR, 1989, PHYSIOL BEHAV, V45, P1033, DOI 10.1016/0031-9384(89)90234-5; JENNES L, 1982, J COMP NEUROL, V210, P211, DOI 10.1002/cne.902100302; Johnstone LE, 2004, J NEUROENDOCRINOL, V16, P605, DOI 10.1111/j.1365-2826.2004.01208.x; Jurek B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037060; KALIVAS PW, 1993, BRAIN RES REV, V18, P75, DOI 10.1016/0165-0173(93)90008-N; KENDRICK KM, 1992, BRAIN RES, V569, P199, DOI 10.1016/0006-8993(92)90631-I; Kinkead B., 2006, CNS & Neurological Disorders-Drug Targets, V5, P205, DOI 10.2174/187152706776359655; KISLAUSKIS E, 1988, J BIOL CHEM, V263, P4963; KITABGI P, 1992, ANN NY ACAD SCI, V668, P30, DOI 10.1111/j.1749-6632.1992.tb27337.x; Kitabgi P, 2006, PEPTIDES, V27, P2515, DOI 10.1016/j.peptides.2005.12.017; Kitabgi P, 2006, PEPTIDES, V27, P2508, DOI 10.1016/j.peptides.2006.03.038; KOCH M, 1989, BRAIN RES, V489, P101, DOI 10.1016/0006-8993(89)90012-7; Lee G, 2009, BEHAV NEUROSCI, V123, P1169, DOI 10.1037/a0017535; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Levine JB, 2008, NEUROSCIENCE, V151, P589, DOI 10.1016/j.neuroscience.2007.10.014; Lonstein JS, 2002, NEUROSCI BIOBEHAV R, V26, P869, DOI 10.1016/S0149-7634(02)00087-8; Lonstein JS, 2000, NEUROENDOCRINOLOGY, V72, P91, DOI 10.1159/000054576; Maeno H, 2004, BRAIN RES, V998, P122, DOI 10.1016/j.brainres.2003.11.039; Maeno H, 1996, MOL BRAIN RES, V40, P97; Maharjan S, 2005, J NEUROCHEM, V93, P1502, DOI 10.1111/j.1471-4159.2005.03142.x; MARCONDES F. K., 2002, Braz. J. Biol., V62, P609, DOI 10.1590/S1519-69842002000400008; Mazella J, 1998, J BIOL CHEM, V273, P26273, DOI 10.1074/jbc.273.41.26273; Mazella J, 1996, J NEUROSCI, V16, P5613; Mazella J, 2006, PEPTIDES, V27, P2488, DOI 10.1016/j.peptides.2006.02.012; Miller SM, 2010, PHARMACOL BIOCHEM BE, V95, P457, DOI 10.1016/j.pbb.2010.03.007; MOOS F, 1989, EXP BRAIN RES, V76, P593, DOI 10.1007/BF00248916; Najimi M, 1998, J BIOL CHEM, V273, P21634, DOI 10.1074/jbc.273.34.21634; Nelissen K, 2010, J NEUROSCI METH, V187, P78, DOI 10.1016/j.jneumeth.2009.12.018; Nelson RJ, 1997, HORM BEHAV, V31, P188, DOI 10.1006/hbeh.1997.1381; NEMEROFF CB, 1977, BRAIN RES, V128, P485, DOI 10.1016/0006-8993(77)90173-1; NEMEROFF CB, 1986, PSYCHONEUROENDOCRINO, V11, P15, DOI 10.1016/0306-4530(86)90029-6; Neumann ID, 2008, J NEUROENDOCRINOL, V20, P858, DOI 10.1111/j.1365-2826.2008.01726.x; Nicot A, 1997, J NEUROENDOCRINOL, V9, P263, DOI 10.1046/j.1365-2826.1997.00581.x; Nielsen MS, 1999, J BIOL CHEM, V274, P8832, DOI 10.1074/jbc.274.13.8832; NIEUWENHUYS R, 1982, J COMP NEUROL, V206, P49, DOI 10.1002/cne.902060106; Numan M, 2005, BEHAV NEUROSCI, V119, P1588, DOI 10.1037/0735-7044.119.6.1588; NUMAN M, 1985, J COMP NEUROL, V237, P552, DOI 10.1002/cne.902370411; Numan M., 2003, HORM BR BEHAV; OCONNOR WT, 1992, BRAIN RES, V573, P209, DOI 10.1016/0006-8993(92)90765-2; Palanza P, 2001, PHYSIOL BEHAV, V73, P411, DOI 10.1016/S0031-9384(01)00494-2; Pawluski JL, 2010, J NEUROENDOCRINOL, V22, P248, DOI 10.1111/j.1365-2826.2010.01960.x; PETRAGLIA F, 1985, J ENDOCRINOL, V105, P239, DOI 10.1677/joe.0.1050239; Pettibone DJ, 2002, J PHARMACOL EXP THER, V300, P305, DOI 10.1124/jpet.300.1.305; Remaury A, 2002, BRAIN RES, V953, P63, DOI 10.1016/S0006-8993(02)03271-7; ROWE W, 1995, J NEUROENDOCRINOL, V7, P109, DOI 10.1111/j.1365-2826.1995.tb00673.x; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sarret P, 2003, J COMP NEUROL, V461, P483, DOI 10.1002/cne.10708; SAWCHENKO PE, 1983, J COMP NEUROL, V218, P121, DOI 10.1002/cne.902180202; Scotti MAL, 2011, HORM BEHAV, V60, P177, DOI 10.1016/j.yhbeh.2011.04.007; Scotti MAL, 2011, BEHAV NEUROSCI, V125, P434, DOI 10.1037/a0023184; Sheehan TP, 2004, BRAIN RES REV, V46, P71, DOI 10.1016/j.brainresrev.2004.04.009; SILVERMAN AJ, 1981, BRAIN RES BULL, V6, P47, DOI 10.1016/S0361-9230(81)80068-8; Slattery DA, 2008, J PHYSIOL-LONDON, V586, P377, DOI 10.1113/jphysiol.2007.145896; SORENSON CA, 1975, PHARMACOL BIOCHEM BE, V3, P331, DOI 10.1016/0091-3057(75)90039-8; Souaze F, 1997, J BIOL CHEM, V272, P10087; Souaze F, 2006, PEPTIDES, V27, P2493, DOI 10.1016/j.peptides.2006.04.029; Sun YJ, 2001, MOL BRAIN RES, V95, P167, DOI 10.1016/S0169-328X(01)00220-0; TANAKA K, 1990, NEURON, V4, P847, DOI 10.1016/0896-6273(90)90137-5; TRIBOLLET E, 1981, NEUROSCIENCE, V6, P1315, DOI 10.1016/0306-4522(81)90190-1; Tsuneoka Y, 2013, J COMP NEUROL, V521, P1633, DOI 10.1002/cne.23251; UHL GR, 1977, P NATL ACAD SCI USA, V74, P4059, DOI 10.1073/pnas.74.9.4059; WAKERLEY JB, 1990, J ENDOCRINOL, V125, P467, DOI 10.1677/joe.0.1250467; Walker N, 1998, MOL BRAIN RES, V57, P193, DOI 10.1016/S0169-328X(98)00074-6; Watters JJ, 1998, J NEUROSCI, V18, P6672; Young LJ, 1997, J NEUROENDOCRINOL, V9, P859, DOI 10.1046/j.1365-2826.1997.00654.x; Zhao CJ, 2012, BRAIN RES, V1470, P35, DOI 10.1016/j.brainres.2012.06.002; Zhao CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038602; Ziegler DR, 2002, INTEGR COMP BIOL, V42, P541, DOI 10.1093/icb/42.3.541	107	19	19	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83098	10.1371/journal.pone.0083098	http://dx.doi.org/10.1371/journal.pone.0083098			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416154	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500026
J	Garbett, NC; Merchant, ML; Helm, CW; Jenson, AB; Klein, JB; Chaires, JB				Garbett, Nichola C.; Merchant, Michael L.; Helm, C. William; Jenson, Alfred B.; Klein, Jon B.; Chaires, Jonathan B.			Detection of Cervical Cancer Biomarker Patterns in Blood Plasma and Urine by Differential Scanning Calorimetry and Mass Spectrometry	PLOS ONE			English	Article							SERUM PEPTIDOME PATTERNS; INTRAEPITHELIAL NEOPLASIA; HUMAN-PAPILLOMAVIRUS; DIAGNOSIS; PROTEOME; EXPRESSION; GUIDELINES; MANAGEMENT; SMEARS; TESTS	Improved methods for the accurate identification of both the presence and severity of cervical intraepithelial neoplasia (CIN) and extent of spread of invasive carcinomas of the cervix (IC) are needed. Differential scanning calorimetry (DSC) has recently been shown to detect specific changes in the thermal behavior of blood plasma proteins in several diseases. This methodology is being explored to provide a complementary approach for screening of cervical disease. The present study evaluated the utility of DSC in differentiating between healthy controls, increasing severity of CIN and early and advanced IC. Significant discrimination was apparent relative to the extent of disease with no clear effect of demographic factors such as age, ethnicity, smoking status and parity. Of most clinical relevance, there was strong differentiation of CIN from healthy controls and IC, and amongst patients with IC between FIGO Stage I and advanced cancer. The observed disease-specific changes in DSC profiles (thermograms) were hypothesized to reflect differential expression of disease biomarkers that subsequently bound to and affected the thermal behavior of the most abundant plasma proteins. The effect of interacting biomarkers can be inferred from the modulation of thermograms but cannot be directly identified by DSC. To investigate the nature of the proposed interactions, mass spectrometry (MS) analyses were employed. Quantitative assessment of the low molecular weight protein fragments of plasma and urine samples revealed a small list of peptides whose abundance was correlated with the extent of cervical disease, with the most striking plasma peptidome data supporting the interactome theory of peptide portioning to abundant plasma proteins. The combined DSC and MS approach in this study was successful in identifying unique biomarker signatures for cervical cancer and demonstrated the utility of DSC plasma profiles as a complementary diagnostic tool to evaluate cervical cancer health.	[Garbett, Nichola C.; Helm, C. William; Jenson, Alfred B.; Klein, Jon B.; Chaires, Jonathan B.] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [Garbett, Nichola C.; Merchant, Michael L.; Helm, C. William; Jenson, Alfred B.; Klein, Jon B.; Chaires, Jonathan B.] Univ Louisville, Dept Med, Louisville, KY 40292 USA; [Merchant, Michael L.; Klein, Jon B.] Univ Louisville, Ctr Environm Genom & Integrat Biol, Louisville, KY 40292 USA; [Helm, C. William] Univ Louisville, Div Gynecol Oncol, Louisville, KY 40292 USA; [Klein, Jon B.] Robley Rex Vet Affairs Med Ctr, Louisville, KY USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville	Garbett, NC (corresponding author), Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA.	nichola.garbett@louisville.edu	Merchant, Michael/F-7109-2013; Merchant, Michael/N-7444-2013	Chaires, Jonathan/0000-0001-5477-945X; Merchant, Michael/0000-0003-4128-4057	Office of Research and Development, Medical Research Service, Department of Veterans Affairs, the Department of Energy Office of Science Financial Assistance Program [DE-FG02-05ER6406]; NIEHS [P30ES014443]; National Cancer Institute [R44 CA103437]; Elsa. U. Pardee Foundation; NATIONAL CANCER INSTITUTE [R44CA103437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES014443] Funding Source: NIH RePORTER	Office of Research and Development, Medical Research Service, Department of Veterans Affairs, the Department of Energy Office of Science Financial Assistance Program; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Elsa. U. Pardee Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This material is based on work supported by the Office of Research and Development, Medical Research Service, Department of Veterans Affairs, the Department of Energy Office of Science Financial Assistance Program (DE-FG02-05ER6406 to MLM and JBK), and the NIEHS grant P30ES014443 (to MLM and JBK). This work was also supported by a subcontract awarded to JBC from National Cancer Institute grant R44 CA103437 and by a grant to JBC from the Elsa. U. Pardee Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2013, CANC FACTS FIG 2013; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Bulkmans NWJ, 2007, LANCET, V370, P1764, DOI 10.1016/S0140-6736(07)61450-0; Chagovetz AA, 2011, J NEURO-ONCOL, V105, P499, DOI 10.1007/s11060-011-0630-5; Chertov O, 2004, PROTEOMICS, V4, P1195, DOI 10.1002/pmic.200300677; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; del Pino M, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.05.046; Diamandis EP, 2006, J PROTEOME RES, V5, P2079, DOI 10.1021/pr060225u; Diamandis EP, 2006, CANCER RES, V66, P5540, DOI 10.1158/0008-5472.CAN-05-4503; Diamands EP, 2006, CLIN CHEM, V52, P771, DOI 10.1373/clinchem.2005.064972; FERENCZ A, 2011, SKIN CANC OVERVIEW I, DOI DOI 10.5772/25606.; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Garbett NC, 2008, BIOPHYS J, V94, P1377, DOI 10.1529/biophysj.107.119453; Garbett NC, 2007, SEMIN NEPHROL, V27, P621, DOI 10.1016/j.semnephrol.2007.09.004; Garbett NC, 2007, CLIN CHEM, V53, P2012, DOI 10.1373/clinchem.2007.091165; Garbett NC, 2009, EXP MOL PATHOL, V86, P186, DOI 10.1016/j.yexmp.2008.12.001; Massad LS, 2013, J LOW GENIT TRACT DI, V17, pS1, DOI 10.1097/LGT.0b013e318287d329; MCINDOE WA, 1984, OBSTET GYNECOL, V64, P451; Menschaert G, 2010, J PROTEOME RES, V9, P2051, DOI 10.1021/pr900929m; Merchant ML, 2009, J AM SOC NEPHROL, V20, P2065, DOI 10.1681/ASN.2008121233; Michnik A, 2010, J THERM ANAL CALORIM, V102, P57, DOI 10.1007/s10973-009-0602-6; Mitchell M F, 1996, J Natl Cancer Inst Monogr, P17; Moore GD, 2005, DIAGN CYTOPATHOL, V32, P82, DOI 10.1002/dc.20186; Murphy N, 2003, J CLIN PATHOL, V56, P56, DOI 10.1136/jcp.56.1.56; Naucler P, 2007, NEW ENGL J MED, V357, P1589, DOI 10.1056/NEJMoa073204; No JH, 2009, ANN NY ACAD SCI, V1171, P100, DOI 10.1111/j.1749-6632.2009.04898.x; Ronco G, 2010, LANCET ONCOL, V11, P249, DOI 10.1016/S1470-2045(09)70360-2; Saslow D, 2012, CA-CANCER J CLIN, V62, P147, DOI 10.3322/caac.21139; Smith C, 2009, NEPHROL DIAL TRANSPL, V24, P1422, DOI 10.1093/ndt/gfn676; Solomon D, 2001, J NATL CANCER I, V93, P293, DOI 10.1093/jnci/93.4.293; TEMPST P, 2009, Patent No. 20090208921; Todinova S, 2012, BBA-GEN SUBJECTS, V1820, P1879, DOI 10.1016/j.bbagen.2012.08.001; Todinova S, 2011, ANAL CHEM, V83, P7992, DOI 10.1021/ac202055m; Villanueva J, 2006, J CLIN INVEST, V116, P271, DOI 10.1172/JCI26022; Villanueva J, 2005, J PROTEOME RES, V4, P1060, DOI 10.1021/pr050034b; Villanueva J, 2004, ANAL CHEM, V76, P1560, DOI 10.1021/ac0352171; Villanueva J, 2008, MOL CELL PROTEOMICS, V7, P509, DOI 10.1074/mcp.M700397-MCP200; Villanueva J, 2007, NAT PROTOC, V2, P588, DOI 10.1038/nprot.2007.57; Villanueva J, 2006, MOL CELL PROTEOMICS, V5, P1840, DOI 10.1074/mcp.M600229-MCP200; Zapf I, 2011, THERMOCHIM ACTA, V524, P88, DOI 10.1016/j.tca.2011.06.019; Zhou M, 2004, ELECTROPHORESIS, V25, P1289, DOI 10.1002/elps.200405866	41	45	49	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84710	10.1371/journal.pone.0084710	http://dx.doi.org/10.1371/journal.pone.0084710			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416269	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500152
J	Michan, S; Juan, AM; Hurst, CG; Cui, ZH; Evans, LP; Hatton, CJ; Pei, DT; Ju, MH; Sinclair, DA; Smith, LEH; Chen, J				Michan, Shaday; Juan, Aimee M.; Hurst, Christian G.; Cui, Zhenghao; Evans, Lucy P.; Hatton, Colman J.; Pei, Dorothy T.; Ju, Meihua; Sinclair, David A.; Smith, Lois E. H.; Chen, Jing			Sirtuin1 Over-Expression Does Not Impact Retinal Vascular and Neuronal Degeneration in a Mouse Model of Oxygen-Induced Retinopathy	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; DIABETIC-RETINOPATHY; SIRT1 DEACETYLASE; PROLIFERATIVE RETINOPATHY; PATHOLOGICAL ANGIOGENESIS; DEPENDENT REGULATION; RESVERATROL; ACTIVATOR; SRT1720; MICE	Proliferative retinopathy is a leading cause of blindness, including retinopathy of prematurity (ROP) in children and diabetic retinopathy in adults. Retinopathy is characterized by an initial phase of vessel loss, leading to tissue ischemia and hypoxia, followed by sight threatening pathologic neovascularization in the second phase. Previously we found that Sirtuin1 (Sirt1), a metabolically dependent protein deacetylase, regulates vascular regeneration in a mouse model of oxygen-induced proliferative retinopathy (OIR), as neuronal depletion of Sirt1 in retina worsens retinopathy. In this study we assessed whether over-expression of Sirtuin1 in retinal neurons and vessels achieved by crossing Sirt1 over-expressing flox mice with Nestin-Cre mice or Tie2-Cre mice, respectively, may protect against retinopathy. We found that over-expression of Sirt1 in Nestin expressing retinal neurons does not impact vaso-obliteration or pathologic neovascularization in OIR, nor does it influence neuronal degeneration in OIR. Similarly, increased expression of Sirt1 in Tie2 expressing vascular endothelial cells and monocytes/macrophages does not protect retinal vessels in OIR. In addition to the genetic approaches, dietary supplement with Sirt1 activators, resveratrol or SRT1720, were fed to wild type mice with OIR. Neither treatment showed significant vaso-protective effects in retinopathy. Together these results indicate that although endogenous Sirt1 is important as a stress-induced protector in retinopathy, over-expression of Sirt1 or treatment with small molecule activators at the examined doses do not provide additional protection against retinopathy in mice. Further studies are needed to examine in depth whether increasing levels of Sirt1 may serve as a potential therapeutic approach to treat or prevent retinopathy.	[Juan, Aimee M.; Hurst, Christian G.; Cui, Zhenghao; Evans, Lucy P.; Hatton, Colman J.; Pei, Dorothy T.; Ju, Meihua; Smith, Lois E. H.; Chen, Jing] Harvard Univ, Sch Med, Dept Ophthalmol, Boston Childrens Hosp, Boston, MA 02114 USA; [Juan, Aimee M.; Chen, Jing] Harvard Univ, Sch Med, Manton Ctr Orphan Dis Res, Boston Childrens Hosp, Boston, MA USA; [Sinclair, David A.] Harvard Univ, Sch Med, Dept Genet, Paul F Glenn Labs Biol Mech Aging, Boston, MA USA; [Sinclair, David A.] Univ New S Wales, Dept Pharmacol, Kensington, NSW 2033, Australia	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; University of New South Wales Sydney	Chen, J (corresponding author), Harvard Univ, Sch Med, Dept Ophthalmol, Boston Childrens Hosp, Boston, MA 02114 USA.	jing.chen@childrens.harvard.edu		Juan, Aimee/0000-0002-0221-2280; Sinclair, David/0000-0002-9936-436X	Charles H. Hood Foundation; Boston Children's Hospital (BCH) Ophthalmology Foundation; BCH Manton Center for Orphan Disease Research; Blind Childrens Center; BrightFocus Foundation; Mass Lions Eye Research Fund Inc.; BCH Career Development Award; CONACyT [177819]; National Institutes of Health [EY017017, EY022275, PO1 HD18655]; V. Kann Rasmussen Foundation; RPB Senior Investigator Award; Alcon Research Institute Award; Lowy Medical Research Institute; Paul F. Glenn Foundation; NIH [RO1AG019719]; Juvenile Diabetes Research Foundation; United Mitochondrial Disease Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY017017, R01EY022275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019719] Funding Source: NIH RePORTER	Charles H. Hood Foundation; Boston Children's Hospital (BCH) Ophthalmology Foundation; BCH Manton Center for Orphan Disease Research; Blind Childrens Center; BrightFocus Foundation(BrightFocus Foundation); Mass Lions Eye Research Fund Inc.; BCH Career Development Award; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); V. Kann Rasmussen Foundation; RPB Senior Investigator Award; Alcon Research Institute Award; Lowy Medical Research Institute; Paul F. Glenn Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); United Mitochondrial Disease Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Charles H. Hood Foundation, Boston Children's Hospital (BCH) Ophthalmology Foundation, BCH Manton Center for Orphan Disease Research, Blind Childrens Center, BrightFocus Foundation, Mass Lions Eye Research Fund Inc., and BCH Career Development Award (to JC). SM is supported by CONACyT (177819). LEHS is supported by National Institutes of Health (EY017017, EY022275, PO1 HD18655), V. Kann Rasmussen Foundation, RPB Senior Investigator Award, Alcon Research Institute Award, and the Lowy Medical Research Institute. DAS is supported by the Paul F. Glenn Foundation, NIH (RO1AG019719), Juvenile Diabetes Research Foundation, and the United Mitochondrial Disease Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO LP, 1995, P NATL ACAD SCI USA, V92, P10457, DOI 10.1073/pnas.92.23.10457; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur JA, 2010, BBA-PROTEINS PROTEOM, V1804, P1626, DOI 10.1016/j.bbapap.2009.10.025; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chen B, 2009, SCIENCE, V323, P256, DOI 10.1126/science.1166226; Chen J, 2013, ANGIOGENESIS    0804, V4; Chen J, 2008, J CLIN INVEST, V118, P526, DOI [10.1172/JC133813, 10.1172/JCI33813]; Chen Jing, 2007, Angiogenesis, V10, P133, DOI 10.1007/s10456-007-9066-0; Chen J, 2011, CURR OPIN PEDIATR, V23, P173, DOI 10.1097/MOP.0b013e3283423f35; Chen J, 2011, CIRCULATION, V124, P1871, DOI 10.1161/CIRCULATIONAHA.111.040337; Chen J, 2009, INVEST OPHTH VIS SCI, V50, P1329, DOI 10.1167/iovs.08-2521; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; Donmez G, 2012, J NEUROSCI, V32, P124, DOI 10.1523/JNEUROSCI.3442-11.2012; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Fulton AB, 2009, PROG RETIN EYE RES, V28, P452, DOI 10.1016/j.preteyeres.2009.06.003; Guarani V, 2011, NATURE, V473, P234, DOI 10.1038/nature09917; Guarente L, 2011, NEW ENGL J MED, V364, P2235, DOI 10.1056/NEJMra1100831; Hua J, 2011, INVEST OPHTHALMOL VI; Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Ichikawa T, 2013, RESPIROLOGY, V18, P332, DOI 10.1111/j.1440-1843.2012.02284.x; Jiang ML, 2012, NAT MED, V18, P153, DOI 10.1038/nm.2558; Joyal JS, 2011, BLOOD, V117, P6024, DOI 10.1182/blood-2010-10-311589; Kadiyala CS, 2012, J BIOL CHEM; Khan AA, 2010, AM J PATHOL, V177, P481, DOI 10.2353/ajpath.2010.090836; Kim Woo Taek, 2010, Korean J Ophthalmol, V24, P108, DOI 10.3341/kjo.2010.24.2.108; King RE, 2005, CHEM-BIOL INTERACT, V151, P143, DOI 10.1016/j.cbi.2004.11.003; Kubota S, 2010, AM J PATHOL, V177, P1725, DOI 10.2353/ajpath.2010.100098; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Libert S, 2011, CELL, V147, P1459, DOI 10.1016/j.cell.2011.10.054; Michan S, 2013, CURR PHARM DES; Michan S, 2010, J NEUROSCI, V30, P9695, DOI 10.1523/JNEUROSCI.0027-10.2010; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Minor RK, 2011, SCI REP-UK, V1, DOI 10.1038/srep00070; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Potente M, 2007, GENE DEV, V21, P2644, DOI 10.1101/gad.435107; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sapieha P, 2012, BLOOD, V120, P2182, DOI 10.1182/blood-2012-04-396846; Shindler KS, 2010, J NEURO-OPHTHALMOL, V30, P328, DOI 10.1097/WNO.0b013e3181f7f833; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Smoliga JM, 2011, MOL NUTR FOOD RES, V55, P1129, DOI 10.1002/mnfr.201100143; Stahl A, 2009, ANGIOGENESIS, V12, P297, DOI 10.1007/s10456-009-9155-3; Stahl A, 2012, BLOOD; Stahl A, 2010, INVEST OPHTH VIS SCI, V51, P2813, DOI 10.1167/iovs.10-5176; Suzuki K, 2012, ONCOL REP, V27, P1726, DOI 10.3892/or.2012.1750; Watanabe D, 2005, NEW ENGL J MED, V353, P782, DOI 10.1056/NEJMoa041773; Wiejak J, 2013, BIOCHEM J, V454, P283, DOI 10.1042/BJ20130481	53	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85031	10.1371/journal.pone.0085031	http://dx.doi.org/10.1371/journal.pone.0085031			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416337	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500207
J	Feher, K; Lisec, J; Romisch-Margl, L; Selbig, J; Gierl, A; Piepho, HP; Nikoloski, Z; Willmitzer, L				Feher, Kristen; Lisec, Jan; Roemisch-Margl, Lilla; Selbig, Joachim; Gierl, Alfons; Piepho, Hans-Peter; Nikoloski, Zoran; Willmitzer, Lothar			Deducing Hybrid Performance from Parental Metabolic Profiles of Young Primary Roots of Maize by Using a Multivariate Diallel Approach	PLOS ONE			English	Article							VECTOR MACHINE REGRESSION; GENE-EXPRESSION; PREDICTION; HETEROSIS; CROSSES	Heterosis, the greater vigor of hybrids compared to their parents, has been exploited in maize breeding for more than 100 years to produce ever better performing elite hybrids of increased yield. Despite extensive research, the underlying mechanisms shaping the extent of heterosis are not well understood, rendering the process of selecting an optimal set of parental lines tedious. This study is based on a dataset consisting of 112 metabolite levels in young roots of four parental maize inbred lines and their corresponding twelve hybrids, along with the roots' biomass as a heterotic trait. Because the parental biomass is a poor predictor for hybrid biomass, we established a model framework to deduce the biomass of the hybrid from metabolite profiles of its parental lines. In the proposed framework, the hybrid metabolite levels are expressed relative to the parental levels by incorporating the standard concept of additivity/dominance, which we name the Combined Relative Level (CRL). Our modeling strategy includes a feature selection step on the parental levels which are demonstrated to be predictive of CRL across many hybrid metabolites. We demonstrate that these selected parental metabolites are further predictive of hybrid biomass. Our approach directly employs the diallel structure in a multivariate fashion, whereby we attempt to not only predict macroscopic phenotype (biomass), but also molecular phenotype (metabolite profiles). Therefore, our study provides the first steps for further investigations of the genetic determinants to metabolism and, ultimately, growth. Finally, our success on the small-scale experiments implies a valid strategy for large-scale experiments, where parental metabolite profiles may be used together with profiles of selected hybrids as a training set to predict biomass of all possible hybrids.	[Feher, Kristen; Lisec, Jan; Selbig, Joachim; Nikoloski, Zoran; Willmitzer, Lothar] Max Planck Inst Mol Plant Physiol, Potsdam, Germany; [Feher, Kristen; Selbig, Joachim] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Roemisch-Margl, Lilla; Gierl, Alfons] Tech Univ Munich, Dept Plants Genet, Freising Weihenstephan, Germany; [Piepho, Hans-Peter] Univ Hohenheim, Inst Crop Sci, Stuttgart, Germany	Max Planck Society; University of Potsdam; Technical University of Munich; University Hohenheim	Lisec, J (corresponding author), Max Planck Inst Mol Plant Physiol, Potsdam, Germany.	Lisec@mpimp-golm.mpg.de		Lisec, Jan/0000-0003-1220-2286; Piepho, Hans-Peter/0000-0001-7813-2992; Nikoloski, Zoran/0000-0003-2671-6763	Deutsche Forschungsgemeinschaft (DFG) [SPP 1149]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This project was supported by the Deutsche Forschungsgemeinschaft (DFG) grant "Heterosis in plants" (SPP 1149). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergmuller E, 2005, BIOINFORMATICS, V21, P1635, DOI DOI 10.1093/BI0INF0RMATICS/BTI236; Bernardo R, 1996, CROP SCI, V36, P50, DOI [10.2135/cropsci1996.0011183X003600040009x, 10.2135/cropsci1996.0011183X003600040007x]; Birchler JA, 2007, BBA-GENE STRUCT EXPR, V1769, P422, DOI 10.1016/j.bbaexp.2006.12.002; Boulesteix A.-L., 2004, STAT APPL GENET MOL, V3, P1075, DOI DOI 10.2202/1544-6115.1075; Boulesteix AL, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-85; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chen ZJ, 2013, NAT REV GENET, V14, P471, DOI 10.1038/nrg3503; Cilas C, 1998, EUPHYTICA, V104, P49, DOI 10.1023/A:1018635216182; Cuadros-Inostroza A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-428; Duvick DN, 2005, MAYDICA, V50, P193; Fernie AR, 2004, NAT REV MOL CELL BIO, V5, P763, DOI 10.1038/nrm1451; Frisch M, 2010, THEOR APPL GENET, V120, P441, DOI 10.1007/s00122-009-1204-1; Fu JJ, 2012, THEOR APPL GENET, V124, P825, DOI 10.1007/s00122-011-1747-9; Gartner T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005220; Giavalisco P, 2011, PLANT J, V68, P364, DOI 10.1111/j.1365-313X.2011.04682.x; Guo M, 2003, PLANT J, V36, P30, DOI 10.1046/j.1365-313X.2003.01852.x; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hochholdinger F, 2009, CURR OPIN PLANT BIOL, V12, P172, DOI 10.1016/j.pbi.2008.12.002; Hoecker N, 2006, THEOR APPL GENET, V112, P421, DOI 10.1007/s00122-005-0139-4; Hoecker N, 2008, GENETICS, V179, P1275, DOI 10.1534/genetics.108.088278; Lenarcic AB, 2012, GENETICS, V190, P413, DOI 10.1534/genetics.111.132563; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Lisec J, 2011, PLANT J, V68, P326, DOI 10.1111/j.1365-313X.2011.04689.x; Maenhout S, 2007, THEOR APPL GENET, V115, P1003, DOI 10.1007/s00122-007-0627-9; MCWILLIAM JR, 1965, AUST J BIOL SCI, V18, P569, DOI 10.1071/BI9650569; Melchinger AE, 1999, GENETICS AND EXPLOITATION OF HETEROSIS IN CROPS, P99; Meyer RC, 2007, P NATL ACAD SCI USA, V104, P4759, DOI 10.1073/pnas.0609709104; Mohring J, 2011, CROP SCI, V51, P470, DOI 10.2135/cropsci2010.05.0272; Paschold A, 2010, THEOR APPL GENET, V120, P383, DOI 10.1007/s00122-009-1082-6; Riedelsheimer C, 2012, NAT GENET, V44, P217, DOI 10.1038/ng.1033; Schrag TA, 2009, MAYDICA, V54, P353; Schrag TA, 2010, THEOR APPL GENET, V120, P451, DOI 10.1007/s00122-009-1208-x; Shull, 1914, Z INDUKT ABSTAMMUNGS, V12, P97, DOI DOI 10.1007/BF01837282; Slawski M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-439; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Steinfath M, 2010, THEOR APPL GENET, V120, P239, DOI 10.1007/s00122-009-1191-2; Sulpice R, 2010, PLANT CELL, V22, P2872, DOI 10.1105/tpc.110.076653; Technow F, 2012, THEOR APPL GENET, V125, P1181, DOI 10.1007/s00122-012-1905-8; Vuylsteke M, 2000, HEREDITY, V85, P208, DOI 10.1046/j.1365-2540.2000.00747.x; Yang WZ, 2012, GENETICS, V190, P1491, DOI 10.1534/genetics.111.131540; ZANONI U, 1989, CROP SCI, V29, P577, DOI 10.2135/cropsci1989.0011183X002900030005x	41	15	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e85435	10.1371/journal.pone.0085435	http://dx.doi.org/10.1371/journal.pone.0085435			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409329	Green Submitted, Green Published, gold			2022-12-27	WOS:000329463500053
J	Koci, J; Ramaseshadri, P; Bolognesi, R; Segers, G; Flannagan, R; Park, Y				Koci, Juraj; Ramaseshadri, Parthasarathy; Bolognesi, Renata; Segers, Gerrit; Flannagan, Ronald; Park, Yoonseong			Ultrastructural Changes Caused by Snf7 RNAi in Larval Enterocytes of Western Corn Rootworm (Diabrotica virgifera virgifera Le Conte)	PLOS ONE			English	Article							BETA-GALACTOSIDASE; ESCRT-II; MACHINERY; AUTOPHAGY; TRANSPORT	The high sensitivity to oral RNA interference (RNAi) of western corn rootworm (WCR, Diabrotica virgifera virgifera Le Conte) provides a novel tool for pest control. Previous studies have shown that RNAi of DvSnf7, an essential cellular component of endosomal sorting complex required for transport (ESCRT), caused deficiencies in protein de-ubiquitination and autophagy, leading to WCR death. Here we investigated the detailed mechanism leading to larval death by analyzing the ultrastructural changes in midgut enterocytes of WCR treated with double-stranded RNA (ds-DvSnf7). The progressive phases of pathological symptoms caused by DvSnf7-RNAi in enterocytes include: 1) the appearance of irregularly shaped macroautophagic complexes consisting of relatively large lysosomes and multi-lamellar bodies, indicative of failure in autolysosome formation; 2) cell sloughing and loss of apical microvilli, and eventually, 3) massive loss of cellular contents indicating loss of membrane integrity. These data suggest that the critical functions of Snf7 in insect midgut cells demonstrated by the ultrastructural changes in DvSnf7 larval enterocytes underlies the conserved essential function of the ESCRT pathway in autophagy and membrane stability in other organisms.	[Koci, Juraj; Park, Yoonseong] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA; [Ramaseshadri, Parthasarathy; Bolognesi, Renata; Segers, Gerrit; Flannagan, Ronald] Monsanto Co, Dept Biotechnol, Chesterfield, MO USA	Kansas State University; Monsanto	Park, Y (corresponding author), Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA.	ypark@ksu.edu	Koči, Juraj/C-3754-2014; Park, Yoonseong/J-5861-2013	Koči, Juraj/0000-0002-5560-806X; Park, Yoonseong/0000-0003-1191-7335	Monsanto Company	Monsanto Company	The scientists in Monsanto Company, the funder, were involved in study design, decision to publish, and preparation of the manuscript.	ALLEGRANZA A, 1989, CLIN NEUROPATHOL, V8, P266; ALROY J, 1985, SCIENCE, V229, P470, DOI 10.1126/science.3925555; Alves AP, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14122; AMANO N, 1983, ACTA NEUROPATHOL, V61, P283, DOI 10.1007/BF00691999; Babst M, 2002, DEV CELL, V3, P283, DOI 10.1016/S1534-5807(02)00219-8; Babst M, 2011, CURR OPIN CELL BIOL, V23, P452, DOI 10.1016/j.ceb.2011.04.008; Bachman PM, 2013, TRANSGENIC RES; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bolognesi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047534; Capalbo L, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120070; Chaudhari SS, 2011, P NATL ACAD SCI USA, V108, P17028, DOI 10.1073/pnas.1112288108; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gray ME, 2009, ANNU REV ENTOMOL, V54, P303, DOI 10.1146/annurev.ento.54.110807.090434; Lee JA, 2007, CURR BIOL, V17, P1561, DOI 10.1016/j.cub.2007.07.029; Menzies FM, 2011, CURR OPIN CELL BIOL, V23, P190, DOI 10.1016/j.ceb.2010.10.010; Ohshima T, 1997, P NATL ACAD SCI USA, V94, P2540, DOI 10.1073/pnas.94.6.2540; Piper RC, 2011, TRENDS CELL BIOL, V21, P647, DOI 10.1016/j.tcb.2011.08.007; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Ramaseshadri P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054270; Rangasamy M, 2012, PEST MANAG SCI, V68, P587, DOI 10.1002/ps.2301; Rusten TE, 2008, CELL CYCLE, V7, P1166, DOI 10.4161/cc.7.9.5784; Rusten TE, 2007, CURR BIOL, V17, P1817, DOI 10.1016/j.cub.2007.09.032; Rusten TE, 2012, NAT CELL BIOL, V14, P38, DOI 10.1038/ncb2381; Rusten TE, 2009, J CELL SCI, V122, P2179, DOI 10.1242/jcs.050021; Segers G, 2010, IN VITRO CELL DEV-AN, V46, pS69; Vaccari T, 2009, J CELL SCI, V122, P2413, DOI 10.1242/jcs.046391; Wong ASL, 2011, BBA-MOL BASIS DIS, V1812, P1490, DOI 10.1016/j.bbadis.2011.07.005; Yang J, 2010, J CELL SCI, V123, P861, DOI 10.1242/jcs.060475; Yu L, 2004, CELL CYCLE, V3, P1124	29	20	21	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e83985	10.1371/journal.pone.0083985	http://dx.doi.org/10.1371/journal.pone.0083985			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409288	Green Submitted, Green Published, gold			2022-12-27	WOS:000329463500012
J	Pinato, DJ; Stavraka, C; Flynn, MJ; Forster, MD; O'Cathail, SM; Seckl, MJ; Kristeleit, RS; Olmos, D; Turnbull, SJ; Blagden, SP				Pinato, David J.; Stavraka, Chara; Flynn, Michael J.; Forster, Martin D.; O'Cathail, Sean M.; Seckl, Michael J.; Kristeleit, Rebecca S.; Olmos, David; Turnbull, Samantha J.; Blagden, Sarah P.			An Inflammation Based Score Can Optimize the Selection of Patients with Advanced Cancer Considered for Early Phase Clinical Trials	PLOS ONE			English	Article							PROGNOSTIC-FACTORS; I TRIALS; SYSTEMIC INFLAMMATION; LYMPHOCYTE RATIO; SURVIVAL; PARTICIPANTS; EXPERIENCE; MORTALITY; CONTEXT; INDEX	Background: Adequate organ function and good performance status (PS) are common eligibility criteria for phase I trials. As inflammation is pathogenic and prognostic in cancer we investigated the prognostic performance of inflammation-based indices including the neutrophil (NLR) and platelet to lymphocyte ratio (PLR). Methods: We studied inflammatory scores in 118 unselected referrals. NLR normalization was recalculated at disease reassessment. Each variable was assessed for progression-free (PFS) and overall survival (OS) on uni- and multivariate analyses and tested for 90 days survival (90DS) prediction using receiving operator curves (ROC). Results: We included 118 patients with median OS 4.4 months, 23% PS>1. LDH >= 450 and NLR >= 5 were multivariate predictors of OS (p<0.001). NLR normalization predicted for longer OS (p<0.001) and PFS (p<0.05). PS and NLR ranked as most accurate predictors of both 90DS with area under ROC values of 0.66 and 0.64, and OS with c-score of 0.69 and 0.60. The combination of NLR+PS increased prognostic accuracy to 0.72. The NLR was externally validated in a cohort of 126 subjects. Conclusions: We identified the NLR as a validated and objective index to improve patient selection for experimental therapies, with its normalization following treatment predicting for a survival benefit of 7 months. Prospective validation of the NLR is warranted.	[Pinato, David J.; Stavraka, Chara] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Wellcome Trust McMichael Clin Res Facil, London, England; [Flynn, Michael J.; Forster, Martin D.; Kristeleit, Rebecca S.; Turnbull, Samantha J.; Blagden, Sarah P.] Univ Coll London Hosp, Univ Coll London Clin Res Facil, London, England; [O'Cathail, Sean M.; Seckl, Michael J.] Univ London Imperial Coll Sci Technol & Med, Dept Oncol, London, England; [Olmos, David] Royal Marsden Hosp, Sutton, Surrey, England; [Olmos, David] Inst Canc Res, Sutton, Surrey, England	Imperial College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; Imperial College London; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Blagden, SP (corresponding author), Univ Coll London Hosp, Univ Coll London Clin Res Facil, London, England.	s.blagden@imperial.ac.uk	Olmos, David/L-5664-2015; Blagden, Sarah Patricia/I-2096-2019; Pinato, David James/ABB-3719-2020; OCathail, Sean/GON-8094-2022; Stavraka, Chara/F-8385-2013	Pinato, David James/0000-0002-3529-0103; Olmos Hidalgo, David/0000-0002-7003-4826; O'Cathail, Sean Micheal/0000-0001-5574-9199; Stavraka, Chara/0000-0001-7623-299X	Wellcome Trust; Imperial Experimental Cancer Medicine Centre (ECMC); Cancer Research UK (CRUK); Imperial National Institute for Health Research (NIHR) Biomedical Research Centre (BRC); Ovarian Cancer Action [OCA10] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Imperial Experimental Cancer Medicine Centre (ECMC); Cancer Research UK (CRUK)(Cancer Research UK); Imperial National Institute for Health Research (NIHR) Biomedical Research Centre (BRC); Ovarian Cancer Action(Ovarian Cancer Action)	This work has been in part supported by grants from the Wellcome Trust (http://www.wellcome.ac.uk/), Imperial Experimental Cancer Medicine Centre (ECMC, http://www.ecmcnetwork.org.uk/network-centres/london-imperial/), Cancer Research UK (CRUK, http://www.cancerresearchuk.org/home/) and the Imperial National Institute for Health Research (NIHR) Biomedical Research Centre (BRC, http://imperialbrc.org/our-research/research-themes/cancer). UCL members of staff have received support from ECMC and BRC (http://www.ecmcnetwork.org.uk/network-centres/london-ucl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alison MR, 2011, RECENT RESULTS CANC, V185, P135, DOI 10.1007/978-3-642-03503-6_8; Aliustaoglu M, 2010, HEPATO-GASTROENTEROL, V57, P640; Arkenau HT, 2008, BRIT J CANCER, V98, P1029, DOI 10.1038/sj.bjc.6604218; Arkenau HT, 2008, EUR J CANCER, V44, P1536, DOI 10.1016/j.ejca.2008.04.017; Berasain C, 2009, ANN NY ACAD SCI, V1155, P206, DOI 10.1111/j.1749-6632.2009.03704.x; Blagden SP, 2003, BRIT J CANCER, V89, P1022, DOI 10.1038/sj.bjc.6601231; Chau NG, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-426; Chua W, 2011, BRIT J CANCER, V104, P1288, DOI 10.1038/bjc.2011.100; Chua W, 2012, SUPPORT CARE CANCER, V20, P1869, DOI 10.1007/s00520-011-1289-3; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Erdman SE, 2010, INT J CANCER, V127, P768, DOI 10.1002/ijc.25430; Esper Dema Halasa, 2005, Nutr Clin Pract, V20, P369, DOI 10.1177/0115426505020004369; Guthrie GJK, 2013, CRIT REV ONCOL HEMAT, V88, P218, DOI 10.1016/j.critrevonc.2013.03.010; Han C, 2003, BRIT J CANCER, V89, P1166, DOI 10.1038/sj.bjc.6601218; Harrell FE, 2010, RMS REGRESSION MODEL; Ho J, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-263; Italiano A, 2008, ANN ONCOL, V19, P787, DOI 10.1093/annonc/mdm548; Kao SCH, 2010, CLIN CANCER RES, V16, P5805, DOI 10.1158/1078-0432.CCR-10-2245; Karavasilis V, 2008, EUR J CANCER, V44, P978, DOI 10.1016/j.ejca.2008.02.040; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; McMillan DC, 2013, CANCER TREAT REV, V39, P534, DOI 10.1016/j.ctrv.2012.08.003; McMillan DC, 2009, CURR OPIN CLIN NUTR, V12, P223, DOI 10.1097/MCO.0b013e32832a7902; Moore MM, 2010, CLIN PHARMACOL THER, V87, P504, DOI 10.1038/clpt.2009.254; Murry DJ, 1998, INT J CANCER, V78, P48; Olmos D, 2012, J CLIN ONCOL, V30, P996, DOI 10.1200/JCO.2010.34.5074; Olmos D, 2012, EUR J CANCER, V48, P594, DOI 10.1016/j.ejca.2011.11.004; Parulekar WR, 2004, JNCI-J NATL CANCER I, V96, P990, DOI 10.1093/jnci/djh182; Penel N, 2008, INVEST NEW DRUG, V26, P53, DOI 10.1007/s10637-007-9088-x; Penel N, 2010, INVEST NEW DRUG, V28, P76, DOI 10.1007/s10637-009-9224-x; Penel N, 2009, J CLIN ONCOL, V27, pE105, DOI 10.1200/JCO.2009.24.1810; Pinato DJ, 2012, J HEPATOL, V57, P1013, DOI 10.1016/j.jhep.2012.06.022; Pinato DJ, 2012, TRANSL RES, V160, P146, DOI 10.1016/j.trsl.2012.01.011; Pinato DJ, 2012, J THORAC ONCOL, V7, P587, DOI 10.1097/JTO.0b013e31823f45c1; Ploquin A, 2012, CRIT REV ONCOL HEMAT; Proctor MJ, 2011, EUR J CANCER, V47, P2633, DOI 10.1016/j.ejca.2011.03.028; Ray-Coquard I, 2009, CANCER RES, V69, P5383, DOI 10.1158/0008-5472.CAN-08-3845; Rivory LP, 2002, BRIT J CANCER, V87, P277, DOI 10.1038/sj.bjc.6600448; Simon RM, 2011, BRIEF BIOINFORM, V12, P203, DOI 10.1093/bib/bbr001; Stavraka C, 2014, CANCER-AM CANCER SOC, V120, P262, DOI 10.1002/cncr.28381; Team RDC, 2010, R LANG ENV STAT COMP; Wheler J, 2009, CANCER, V115, P1091, DOI 10.1002/cncr.24018; Yamamoto N, 1999, INT J ONCOL, V15, P737	42	25	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e83279	10.1371/journal.pone.0083279	http://dx.doi.org/10.1371/journal.pone.0083279			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409281	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000329463500005
J	Menzies, AM; Haydu, LE; Carlino, MS; Azer, MWF; Carr, PJA; Kefford, RF; Long, GV				Menzies, Alexander M.; Haydu, Lauren E.; Carlino, Matteo S.; Azer, Mary W. F.; Carr, Peter J. A.; Kefford, Richard F.; Long, Georgina V.			Inter- and Intra-Patient Heterogeneity of Response and Progression to Targeted Therapy in Metastatic Melanoma	PLOS ONE			English	Article							BRAF-MUTANT; TUMOR MICROENVIRONMENT; MEK INHIBITION; VEMURAFENIB; DABRAFENIB	Background: MAPK inhibitors (MAPKi) are active in BRAF-mutant metastatic melanoma patients, but the extent of response and progression-free survival (PFS) is variable, and complete responses are rare. We sought to examine the patterns of response and progression in patients treated with targeted therapy. Methods: MAPKi-naive patients treated with combined dabrafenib and trametinib had all metastases >= 5 mm (lymph nodes >= 15 mm in short axis) visible on computed tomography measured at baseline and throughout treatment. Results: 24 patients had 135 measured metastases (median 4.5/patient, median diameter 16 mm). Time to best response (median 5.5 mo, range 1.7-20.1 mo), and the degree of best response (median -70%, range +9 to -100%) varied amongst patients. 17% of patients achieved complete response (CR), whereas 53% of metastases underwent CR, including 42% >= 10 mm. Metastases that underwent CR were smaller than non-CR metastases (median 11 vs 20 mm, P<0.001). PFS was variable among patients (median 8.2 mo, range 2.6-18.3 mo), and 50% of patients had disease progression in new metastases only. Only 1% (1/71) of CR-metastases subsequently progressed. Twelve-month overall survival was poorer in those with a more heterogeneous initial response to therapy than less heterogeneous (67% vs 93%, P=0.009). Conclusion: Melanoma response and progression with MAPKi displays marked inter-and intra-patient heterogeneity. Most metastases undergo complete response, yet only a small proportion of patients achieve an overall complete response. Similarly, disease progression often occurs only in a subset of the tumor burden, and often in new metastases alone. Clinical heterogeneity, likely reflecting molecular heterogeneity, remains a barrier to the effective treatment of melanoma patients.	[Menzies, Alexander M.; Haydu, Lauren E.; Carlino, Matteo S.; Kefford, Richard F.; Long, Georgina V.] Melanoma Inst Australia, Sydney, NSW, Australia; [Menzies, Alexander M.; Haydu, Lauren E.; Carlino, Matteo S.; Carr, Peter J. A.; Kefford, Richard F.; Long, Georgina V.] Univ Sydney, Sydney, NSW 2006, Australia; [Carlino, Matteo S.; Azer, Mary W. F.; Kefford, Richard F.] Westmead Hosp, Crown Princess Mary Canc Ctr, Sydney, NSW, Australia; [Carr, Peter J. A.] Westmead Hosp, Dept Radiol, Sydney, NSW, Australia; [Carlino, Matteo S.; Kefford, Richard F.] Westmead Inst Canc Res, Westmead, NSW, Australia	Melanoma Institute Australia; University of Sydney; University of Sydney; University of Sydney; University of Sydney	Menzies, AM (corresponding author), Melanoma Inst Australia, Sydney, NSW, Australia.	alexander.menzies@sydney.edu.au	Long, Georgina V/C-1771-2013; Carlino, Matteo/GRS-7198-2022	Long, Georgina V/0000-0001-8894-3545; Menzies, Alexander Maxwell/0000-0001-5183-7562; Kefford, Richard/0000-0001-9251-9229; Carlino, Matteo/0000-0002-7861-4104	National Health and Medical Research Council of Australia (NHMRC); Cancer Institute NSW; Australian Cancer Research Foundation; Melanoma Foundation of the University of Sydney; Melanoma Institute Australia; GlaxoSmithKline	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute NSW; Australian Cancer Research Foundation; Melanoma Foundation of the University of Sydney(University of Sydney); Melanoma Institute Australia; GlaxoSmithKline(GlaxoSmithKline)	This work was supported by Program Grants from the National Health and Medical Research Council of Australia (NHMRC), Cancer Institute NSW, Australian Cancer Research Foundation, the Melanoma Foundation of the University of Sydney and Melanoma Institute Australia. GlaxoSmithKline funded the clinical trial from which these data were obtained. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman A, 2013, CANCER IN PRESS; Ascierto PA, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-107; Azer MF, 2013, CANCER IN PRESS; Carlino MS, 2013, MOL CANCER THER, V12, P1332, DOI 10.1158/1535-7163.MCT-13-0011; Carlino MS, 2013, EUR J CANCER, V49, P395, DOI 10.1016/j.ejca.2012.08.018; Chan M, 2013, J CLIN ONCOLOGY, V31; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Frederick DT, 2013, CLIN CANCER RES, V19, P1225, DOI 10.1158/1078-0432.CCR-12-1630; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Katona TM, 2007, AM J SURG PATHOL, V31, P1029, DOI 10.1097/PAS.0b013e31802b3488; Kim KB, 2011, J CLIN ONCOLOGY, V29; Lin J, 2011, BRIT J CANCER, V104, P464, DOI 10.1038/sj.bjc.6606072; McArthur GA, 2012, J CLIN ONCOL, V30, P1628, DOI 10.1200/JCO.2011.39.1938; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Takata M, 2000, INT J CANCER, V85, P492, DOI 10.1002/(SICI)1097-0215(20000215)85:4<492::AID-IJC8>3.3.CO;2-R; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wilmott JS, 2012, MOL CANCER THER, V11, P2704, DOI 10.1158/1535-7163.MCT-12-0530; Wilmott JS, 2012, CLIN CANCER RES, V18, P1386, DOI 10.1158/1078-0432.CCR-11-2479; Yancovitz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029336	22	58	58	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e85004	10.1371/journal.pone.0085004	http://dx.doi.org/10.1371/journal.pone.0085004			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400126	Green Published, Green Submitted, gold			2022-12-27	WOS:000329462700060
J	Min, L; Chen, D; Qu, LK; Shou, CC				Min, Li; Chen, Duo; Qu, Like; Shou, Chengchao			Tumor Necrosis Factor-A Polymorphisms and Colorectal Cancer Risk: A Meta-Analysis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CYTOKINE GENE POLYMORPHISMS; TNF-ALPHA; INFLAMMATORY RESPONSE; COMMON POLYMORPHISMS; SUSCEPTIBILITY LOCUS; PROMOTER; METABOLISM; CARCINOMA; REGION	Background and Objectives: Tumor necrosis factor-alpha (TNF-a) was related to inflammation and involved in the development of colorectal cancer. Polymorphisms located in TNF-a promoter region, such as 308G/A and 238G/A, could affect the risk of various types of cancer by regulating TNF-a production. In this study, a meta-analysis was performed to investigate the association between common polymorphisms of TNF-a promoter region and colorectal cancer susceptibility. Methods: Searching of several databases was performed for all publications on the association between TNF-a polymorphisms and colorectal cancer. Summary odds ratios (ORs) with their 95% confidence intervals (95% CIs) were calculated using random-effects models. Stratified analyses based on ethnicity and control population source were also conducted. Results: Overall, TNF-a 308A polymorphism showed a significant association with increased risk of colorectal cancer in worldwide populations under homozygote comparison [AA vs. GG, OR (95% CI) = 1.46 (1.07-1.97)] other than heterozygote comparison [AG vs. GG, OR (95% CI) = 1.05 (0.93-1.19)]. TNF-a 238A was not associated with colorectal cancer risk under homozygote or heterozygote comparisons. In stratified analysis, significant association was observed only in Western populations [AA vs. GG, OR (95% CI) = 1.39 (1.01-1.91)] other than in Eastern populations under homozygote comparison. No significant difference was observed between population-based subgroup and hospital-based subgroup. Conclusions: TNF-a 308A was moderately associated with an increased risk of colorectal cancer in Western populations, and TNF-a 238A polymorphism was not significantly associated with colorectal cancer risk.	[Min, Li; Qu, Like; Shou, Chengchao] Peking Univ, Key Lab Carcinogenesis & Translat Res, Minist Educ, Dept Biochem,Canc Hosp & Inst, Beijing 100871, Peoples R China; [Min, Li; Qu, Like; Shou, Chengchao] Peking Univ, Key Lab Carcinogenesis & Translat Res, Minist Educ, Dept Mol Biol,Canc Hosp & Inst, Beijing 100871, Peoples R China; [Chen, Duo] Peking Univ, Key Lab Carcinogenesis & Translat Res, Minist Educ, Dept Epidemiol,Canc Hosp & Inst, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Shou, CC (corresponding author), Peking Univ, Key Lab Carcinogenesis & Translat Res, Minist Educ, Dept Biochem,Canc Hosp & Inst, Beijing 100871, Peoples R China.	scc@bjcancer.org	Min, Li/T-8107-2018; Min, Li/AAG-2088-2021	Min, Li/0000-0001-9595-5536; Min, Li/0000-0001-9595-5536	Doctoral Program of Higher Education of China [20110001110050]; National 973 Program of China [2009CB521805]	Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National 973 Program of China(National Basic Research Program of China)	This work was supported by the Doctoral Program of Higher Education of China (20110001110050) and National 973 Program of China (2009CB521805). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2012, BLOOD, V119, P651, DOI 10.1182/blood-2011-04-325225; Arem H, 2013, ANN EPIDEMIOL; Barton A, 2008, HUM MOL GENET, V17, P2274, DOI 10.1093/hmg/ddn128; Chen ZP, 2013, INT J COLORECTAL DIS, V28, P431, DOI 10.1007/s00384-012-1481-z; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Fei BY, 2005, CHIN J DIG, V25, P661; Figueiredo JC, 2011, CANCER EPIDEM BIOMAR, V20, P758, DOI 10.1158/1055-9965.EPI-10-0675; Garrity-Park M, 2012, INFLAMM BOWEL DIS, V18, P275, DOI 10.1002/ibd.21681; Garrity-Park MM, 2008, AM J GASTROENTEROL, V103, P407, DOI 10.1111/j.1572-0241.2007.01572.x; Gorouhi F, 2008, BRIT J CANCER, V98, P1443, DOI 10.1038/sj.bjc.6604277; Gunter MJ, 2006, CANCER EPIDEM BIOMAR, V15, P1126, DOI 10.1158/1055-9965.EPI-06-0042; Guo W, 2005, CHINESE MED J-PEKING, V118, P1870; Gupta R, 2008, ORAL ONCOL, V44, P455, DOI 10.1016/j.oraloncology.2007.06.003; Hellmig S, 2005, AM J GASTROENTEROL, V100, P2644, DOI 10.1111/j.1572-0241.2005.00338.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hong Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050856; Huizinga TWJ, 1997, J NEUROIMMUNOL, V72, P149, DOI 10.1016/S0165-5728(96)00182-8; Jang WH, 2001, CANCER LETT, V166, P41, DOI 10.1016/S0304-3835(01)00438-4; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Landi S, 2003, CANCER RES, V63, P3560; Li MQ, 2011, GENET TEST MOL BIOMA, V15, P743, DOI 10.1089/gtmb.2011.0068; Lindholm E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002546; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Macarthur M, 2005, CANCER EPIDEM BIOMAR, V14, P1613, DOI 10.1158/1055-9965.EPI-04-0878; Madani S, 2008, ACTA ONCOL, V47, P473, DOI 10.1080/02841860701491694; Nieminen U, 2013, INT J CANC; Park KS, 1998, MOL CELLS, V8, P246; Peng WJ, 2012, MOL BIOL REP, V39, P5187, DOI 10.1007/s11033-011-1315-z; Popa C, 2007, J LIPID RES, V48, P751, DOI 10.1194/jlr.R600021-JLR200; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Suchy J, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-112; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Theodoratou E, 2012, JNCI-J NATL CANCER I, V104, P1433, DOI 10.1093/jnci/djs369; Theodoropoulos G, 2006, WORLD J GASTROENTERO, V12, P5037, DOI 10.3748/wjg.v12.i31.5037; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Toth EK, 2007, INT J CANCER, V121, P1744, DOI 10.1002/ijc.22922; Tsilidis KK, 2009, CANCER CAUSE CONTROL, V20, P1739, DOI 10.1007/s10552-009-9427-7; Wang AZ, 2008, J TONGJI U, V29, P24; Wang DZ, 2013, ANNU REV MED, V64, P131, DOI 10.1146/annurev-med-112211-154330; Wang J, 2011, INT J IMMUNOGENET, V38, P311, DOI 10.1111/j.1744-313X.2011.01014.x; Waters JP, 2013, J PATHOL, V230, P132, DOI 10.1002/path.4187; Wu Guo-yang, 2008, Zhonghua Wei Chang Wai Ke Za Zhi, V11, P569; Yang Y, 2011, BREAST CANCER RES TR, V129, P513, DOI 10.1007/s10549-011-1494-2; Yang Y, 2011, J CANCER RES CLIN, V137, P947, DOI 10.1007/s00432-010-0959-8; Yehuda-Shnaidman E, 2012, OBES REV, V13, P1083, DOI 10.1111/j.1467-789X.2012.01024.x; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zhang HL, 2013, TUMOR BIOL, V34, P1659, DOI 10.1007/s13277-013-0699-x; Zhou P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022092	49	29	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e85187	10.1371/journal.pone.0085187	http://dx.doi.org/10.1371/journal.pone.0085187			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404201	Green Published, Green Submitted, gold			2022-12-27	WOS:000329460800080
J	Molet, M; Maicher, V; Peeters, C				Molet, Mathieu; Maicher, Vincent; Peeters, Christian			Bigger Helpers in the Ant Cataglyphis bombycina: Increased Worker Polymorphism or Novel Soldier Caste?	PLOS ONE			English	Article							MAJOR WORKERS; HYMENOPTERA; EVOLUTION; QUEENS; REPRODUCTIVES; SMALLER	Introduction: The mechanisms by which development favors or constrains the evolution of new phenotypes are incompletely understood. Polyphenic species may benefit from developmental plasticity not only regarding ecological advantages, but also potential for evolutionary diversification. For instance, the repeated evolution of novel castes in ants may have been facilitated by the existence of alternative queen and worker castes and their respective developmental programs. Material and Methods: Cataglyphis bombycina is exceptional in its genus because winged queens and size-polymorphic workers occur together with bigger individuals having saber-shaped mandibles. We measured seven body parts in more than 150 individuals to perform a morphometric analysis and assess the developmental origin of this novel phenotype. Results: Adults with saber-shaped mandibles differ from both workers and queens regarding the size of most body parts. Their relative growth rates are identical to workers for some pairs of body parts, and identical to queens for other pairs of body parts; critical sizes differ in all cases. Conclusions: Big individuals are a third caste, i.e. soldiers, not major workers. Novel traits such as elongated mandibles are combined with a mix of queen and worker growth rates. We also reveal the existence of a dimorphism in the queen caste (microgynes and macrogynes). We discuss how novel phenotypes can evolve more readily in the context of an existing polyphenism. Both morphological traits and growth rules from existing queen and worker castes can be recombined, hence mosaic phenotypes are more likely to be viable. In C. bombycina, such a mosaic phenotype appears to function both for defense (saber-shaped mandibles) and fat storage (big abdomen). Recycling of developmental programs may have contributed to the morphological diversity and ecological success of ants.	[Molet, Mathieu; Maicher, Vincent; Peeters, Christian] Univ Paris 06, UMR 7625, Lab Ecol & Evolut, Paris, France; [Molet, Mathieu; Maicher, Vincent; Peeters, Christian] CNRS, UMR 7625, Lab Ecol & Evolut, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Molet, M (corresponding author), Univ Paris 06, UMR 7625, Lab Ecol & Evolut, Paris, France.	mathieu.molet@upmc.fr	Peeters, Christian/G-2696-2013; Molet, Mathieu/ABB-3127-2020	Peeters, Christian/0000-0002-0964-0819; Molet, Mathieu/0000-0002-1247-8904	Agence Nationale de la Recherche [ANTEVO ANR-12-JSV7-0003-01]; Laboratoire Ecologie & Evolution UMR7625 (Universite Pierre et Marie Curie - Centre National de la Recherche Scientifique)	Agence Nationale de la Recherche(French National Research Agency (ANR)); Laboratoire Ecologie & Evolution UMR7625 (Universite Pierre et Marie Curie - Centre National de la Recherche Scientifique)	This work was funded by Agence Nationale de la Recherche (project ANTEVO ANR-12-JSV7-0003-01) and by Laboratoire Ecologie & Evolution UMR7625 (Universite Pierre et Marie Curie - Centre National de la Recherche Scientifique). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Bernard F., 1951, Bull Soc Hist nat Toulouse, V86, P88; Billick I, 2007, INSECT SOC, V54, P113, DOI 10.1007/s00040-007-0918-9; Cagniant Henri, 2009, ORSIS Organismes i Sistemes, V24, P41; Delye G., 1957, Insectes Sociaux Paris, V4, P77, DOI 10.1007/BF02224144; Gobin B, 2000, NATURWISSENSCHAFTEN, V87, P323, DOI 10.1007/s001140050731; GOTWALD WH, 1978, BIOTROPICA, V10, P161, DOI 10.2307/2387902; HASEGAWA E, 1993, BEHAV ECOL SOCIOBIOL, V33, P73; Heinze J, 1999, NATURWISSENSCHAFTEN, V86, P93, DOI 10.1007/s001140050579; Holldobler B., 1990, pi; Huang MH, 2011, INSECT SOC, V58, P539, DOI 10.1007/s00040-011-0176-8; Lachaud JP, 1999, OECOLOGIA, V120, P515, DOI 10.1007/s004420050885; Leniaud L, 2013, INSECT SOC, V60, P337, DOI 10.1007/s00040-013-0298-2; Lenoir Alain, 2010, Israel Journal of Entomology, V39, P1; Molet M, 2007, NATURWISSENSCHAFTEN, V94, P280, DOI 10.1007/s00114-006-0190-2; Molet M, 2012, AM NAT, V180, P328, DOI 10.1086/667368; Peeters C, 2001, ANNU REV ENTOMOL, V46, P601, DOI 10.1146/annurev.ento.46.1.601; Peeters C, 2013, EVOLUTION SOLDIER CA; Peeters C, 2012, MYRMECOL NEWS, V16, P75; PISARSKI B, 1965, B ACAD POL SCI BIOL, V13, P417; Powell S, 2008, FUNCT ECOL, V22, P902, DOI 10.1111/j.1365-2435.2008.01436.x; Ruppell O, 1999, INSECT SOC, V46, P6, DOI 10.1007/s000400050106; TSUJI K, 1990, APPL ENTOMOL ZOOL, V25, P283, DOI 10.1303/aez.25.283; Urbani CB, 1998, INSECT SOC, V45, P315, DOI 10.1007/s000400050091; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; WEHNER R, 1992, NATURE, V357, P586, DOI 10.1038/357586a0; WHEELER DE, 1991, AM NAT, V138, P1218, DOI 10.1086/285279; Wheeler Diana E., 1994, P245; Wilson E.O., 2003, PHEIDOLE NEW WORLD D, V1; WILSON EO, 1953, Q REV BIOL, V28, P136, DOI 10.1086/399512	30	25	25	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84929	10.1371/journal.pone.0084929	http://dx.doi.org/10.1371/journal.pone.0084929			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404196	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460800075
J	van Brunschot, SL; Bergervoet, JHW; Pagendam, DE; de Weerdt, M; Geering, ADW; Drenth, A; van der Vlugt, RAA				van Brunschot, Sharon L.; Bergervoet, Jan H. W.; Pagendam, Daniel E.; de Weerdt, Marjanne; Geering, Andrew D. W.; Drenth, Andre; van der Vlugt, Rene A. A.			Development of a Multiplexed Bead-Based Suspension Array for the Detection and Discrimination of Pospiviroid Plant Pathogens	PLOS ONE			English	Article							RT-PCR ASSAY; 1ST REPORT; GREENHOUSE TOMATOES; NATURAL INFECTION; VIROID DISEASE; POTATO; IDENTIFICATION; TRANSMISSION; TECHNOLOGY; STRAIN	Efficient and reliable diagnostic tools for the routine indexing and certification of clean propagating material are essential for the management of pospiviroid diseases in horticultural crops. This study describes the development of a true multiplexed diagnostic method for the detection and identification of all nine currently recognized pospiviroid species in one assay using Luminex bead-based suspension array technology. In addition, a new data-driven, statistical method is presented for establishing thresholds for positivity for individual assays within multiplexed arrays. When applied to the multiplexed array data generated in this study, the new method was shown to have better control of false positives and false negative results than two other commonly used approaches for setting thresholds. The 11-plex Luminex MagPlex-TAG pospiviroid array described here has a unique hierarchical assay design, incorporating a near-universal assay in addition to nine species-specific assays, and a co-amplified plant internal control assay for quality assurance purposes. All assays of the multiplexed array were shown to be 100% specific, sensitive and reproducible. The multiplexed array described herein is robust, easy to use, displays unambiguous results and has strong potential for use in routine pospiviroid indexing to improve disease management strategies.	[van Brunschot, Sharon L.; Geering, Andrew D. W.] Plant Biosecur Cooperat Res Ctr, Bruce, ACT, Australia; [van Brunschot, Sharon L.] Univ Queensland, Sch Agr & Food Sci, St Lucia, Qld, Australia; [Bergervoet, Jan H. W.; de Weerdt, Marjanne; van der Vlugt, Rene A. A.] Univ Wageningen & Res Ctr, Wageningen, Netherlands; [Pagendam, Daniel E.] Commonwealth Sci & Ind Res Org Math Informat & St, Dutton Pk, Qld, Australia; [Geering, Andrew D. W.; Drenth, Andre] Univ Queensland, Ctr Plant Sci, St Lucia, Qld, Australia	University of Queensland; Wageningen University & Research; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland	van der Vlugt, RAA (corresponding author), Univ Wageningen & Res Ctr, Wageningen, Netherlands.	rene.vandervlugt@wur.nl	van der Vlugt, Rene/D-3001-2017; Geering, Andrew/A-7912-2011; Pagendam, Daniel E/B-1683-2010; Drenth, Andre/A-4915-2008	van der Vlugt, Rene/0000-0001-9094-685X; Pagendam, Daniel E/0000-0002-8347-4767; Drenth, Andre/0000-0002-8510-1534; van Brunschot, Sharon/0000-0002-9634-9463	Interreg "Healthy Greenhouse"; Plant Biosecurity Cooperative Research Centre under the Australian Government's Cooperative Research Centres Program [CRC60070]	Interreg "Healthy Greenhouse"; Plant Biosecurity Cooperative Research Centre under the Australian Government's Cooperative Research Centres Program(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This study was supported by a grant from Interreg "Healthy Greenhouse" (www.gezondekas.eu). The authors would like to acknowledge the support of the Plant Biosecurity Cooperative Research Centre (Project No. CRC60070), established and supported under the Australian Government's Cooperative Research Centres Program (http://www.crcplantbiosecurity.com.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antignus Y, 2002, PHYTOPARASITICA, V30, P502, DOI 10.1007/BF02979755; Babady NE, 2011, J CLIN MICROBIOL, V49, P3777, DOI 10.1128/JCM.01135-11; Balada-Llasat JM, 2012, J CLIN MICROBIOL, V50, P492, DOI 10.1128/JCM.06375-11; Battaglia A, 2011, J FORENSIC SCI, V56, P760, DOI 10.1111/j.1556-4029.2011.01708.x; Bergervoet JHW, 2008, J VIROL METHODS, V149, P63, DOI 10.1016/j.jviromet.2008.01.020; Boonham N, 2004, J VIROL METHODS, V116, P139, DOI 10.1016/j.jviromet.2003.11.005; Bostan H, 2004, J VIROL METHODS, V116, P189, DOI 10.1016/j.jviromet.2003.11.014; Botermans M, 2013, J VIROL METHODS, V187, P43, DOI 10.1016/j.jviromet.2012.09.004; Diener TO, 1999, ARCH VIROL, P203; Dorak M.T., 2006, ADV METHODS SERIES, P93; Flores R, 2005, ANNU REV PHYTOPATHOL, V43, P117, DOI 10.1146/annurev.phyto.43.040204.140243; Foord AJ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/289295; Frey A, 1998, J IMMUNOL METHODS, V221, P35, DOI 10.1016/S0022-1759(98)00170-7; GALINDO J, 1982, PHYTOPATHOLOGY, V72, P49, DOI 10.1094/Phyto-72-49; Hailstones DL, 2003, AUSTRALAS PLANT PATH, V32, P317, DOI 10.1071/AP03005; KRAMER SM, 1983, J IMMUNOL METHODS, V60, P243, DOI 10.1016/0022-1759(83)90352-6; Landlinger C, 2009, J CLIN MICROBIOL, V47, P1063, DOI 10.1128/JCM.01558-08; Lebas BSM, 2005, AUSTRALAS PLANT PATH, V34, P129, DOI 10.1071/AP05002; Lin A, 2011, J MICROBIOL METH, V87, P105, DOI 10.1016/j.mimet.2011.07.019; Ling KS, 2010, PLANT DIS, V94, P1376, DOI 10.1094/PDIS-07-10-0516; Liu J, 2011, J CLIN VIROL, V50, P308, DOI 10.1016/j.jcv.2010.12.009; Mahony J, 2007, J CLIN MICROBIOL, V45, P2965, DOI 10.1128/JCM.02436-06; Matsushita Y, 2008, J GEN PLANT PATHOL, V74, P182, DOI 10.1007/s10327-008-0076-6; Monger W, 2010, J VIROL METHODS, V169, P207, DOI 10.1016/j.jviromet.2010.07.002; Owens R. A., 2012, VIRUS TAXONOMY, P1221; R_Development_Core_Team, 2011, R LANG ENV STAT COMP; Roenhorst J. W., 2005, Bulletin OEPP, V35, P133, DOI 10.1111/j.1365-2338.2005.00798.x; Shamloul AM, 1997, CAN J PLANT PATHOL, V19, P89, DOI 10.1080/07060669709500580; SINGH RP, 1993, CAN J PLANT PATHOL, V15, P134, DOI 10.1080/07060669309500813; Singh RP, 2009, EUR J PLANT PATHOL, V124, P691, DOI 10.1007/s10658-009-9440-4; Singh RP, 2009, EUR J PLANT PATHOL, V123, P111, DOI 10.1007/s10658-008-9344-8; Skelton A., 2009, NEW DIS REP, V19, P30; Steyer S, 2010, PLANT PATHOL, V59, P794, DOI 10.1111/j.1365-3059.2010.02261.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Verhoeven J. T. J., 2011, New Disease Reports, V23, P15, DOI 10.5197/j.2044-0588.2011.023.015; Verhoeven JTJ, 2007, PLANT DIS, V91, P1055, DOI 10.1094/PDIS-91-8-1055A; Verhoeven JTJ, 2011, ARCH VIROL, V156, P1433, DOI 10.1007/s00705-011-0975-2; Verhoeven JTJ, 2010, PLANT DIS, V94, P920, DOI 10.1094/PDIS-94-7-0920C; Verhoeven JTJ, 2010, ARCH VIROL, V155, P269, DOI 10.1007/s00705-009-0572-9; Verhoeven JTJ, 2010, PLANT PATHOL, V59, P3, DOI 10.1111/j.1365-3059.2009.02173.x; Verhoeven JTJ, 2009, VIRUS RES, V144, P209, DOI 10.1016/j.virusres.2009.05.002; Verhoeven JTJ, 1998, EUR J PLANT PATHOL, V104, P383, DOI 10.1023/A:1008688023649; Verhoeven JTJ, 2004, EUR J PLANT PATHOL, V110, P823, DOI 10.1007/s10658-004-2493-5; Wilson WJ, 2005, MOL CELL PROBE, V19, P137, DOI 10.1016/j.mcp.2004.10.005; Wu Y, 2011, J CLIN MICROBIOL, V49, P419, DOI 10.1128/JCM.01871-10	45	26	26	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84743	10.1371/journal.pone.0084743	http://dx.doi.org/10.1371/journal.pone.0084743			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404188	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000329460800067
J	Jardim-Perassi, BV; Arbab, AS; Ferreira, LC; Borin, TF; Varma, NRS; Iskander, ASM; Shankar, A; Ali, MM; Zuccari, DAPD				Jardim-Perassi, Bruna Victorasso; Arbab, Ali S.; Ferreira, Livia Carvalho; Borin, Thaiz Ferraz; Varma, Nadimpalli R. S.; Iskander, A. S. M.; Shankar, Adarsh; Ali, Meser M.; Pires de Campos Zuccari, Debora Aparecida			Effect of Melatonin on Tumor Growth and Angiogenesis in Xenograft Model of Breast Cancer	PLOS ONE			English	Article							STEM-CELLS; VASCULAR-PERMEABILITY; SIGNALING PATHWAYS; IN-VIVO; EXPRESSION; INHIBITION; PROLIFERATION; VEGF; RECRUITMENT; ACTIVATION	As neovascularization is essential for tumor growth and metastasis, controlling angiogenesis is a promising tactic in limiting cancer progression. Melatonin has been studied for their inhibitory properties on angiogenesis in cancer. We performed an in vivo study to evaluate the effects of melatonin treatment on angiogenesis in breast cancer. Cell viability was measured by MTT assay after melatonin treatment in triple-negative breast cancer cells (MDA-MB-231). After, cells were implanted in athymic nude mice and treated with melatonin or vehicle daily, administered intraperitoneally 1 hour before turning the room light off. Volume of the tumors was measured weekly with a digital caliper and at the end of treatments animals underwent single photon emission computed tomography (SPECT) with Technetium-99m tagged vascular endothelial growth factor (VEGF) C to detect in vivo angiogenesis. In addition, expression of pro-angiogenic/growth factors in the tumor extracts was evaluated by membrane antibody array and collected tumor tissues were analyzed with histochemical staining. Melatonin in vitro treatment (1 mM) decreased cell viability (p<0.05). The breast cancer xenografts nude mice treated with melatonin showed reduced tumor size and cell proliferation (Ki-67) compared to control animals after 21 days of treatment (p<0.05). Expression of VEGF receptor 2 decreased significantly in the treated animals compared to that of control when determined by immunohistochemistry (p<0.05) but the changes were not significant on SPECT (p>0.05) images. In addition, there was a decrease of micro-vessel density (Von Willebrand Factor) in melatonin treated mice (p<0.05). However, semiquantitative densitometry analysis of membrane array indicated increased expression of epidermal growth factor receptor and insulin-like growth factor 1 in treated tumors compared to vehicle treated tumors (p<0.05). In conclusion, melatonin treatment showed effectiveness in reducing tumor growth and cell proliferation, as well as in the inhibition of angiogenesis.	[Jardim-Perassi, Bruna Victorasso; Ferreira, Livia Carvalho] Univ Estadual Paulista, Dept Biol, Sao Paulo, Brazil; [Jardim-Perassi, Bruna Victorasso; Ferreira, Livia Carvalho; Borin, Thaiz Ferraz; Pires de Campos Zuccari, Debora Aparecida] Fac Med Sao Jose Rio Preto, Dept Mol Biol, Lab Invest Mol Canc, Sao Paulo, Brazil; [Arbab, Ali S.; Varma, Nadimpalli R. S.; Iskander, A. S. M.; Shankar, Adarsh; Ali, Meser M.] Henry Ford Hosp, Dept Radiol, Cellular & Mol Imaging Lab, Detroit, MI 48202 USA; [Borin, Thaiz Ferraz; Pires de Campos Zuccari, Debora Aparecida] Fac Med Sao Jose Rio Preto, Dept Mol Biol, Sao Paulo, Brazil	Universidade Estadual Paulista; Henry Ford Health System; Henry Ford Hospital	Zuccari, DAPD (corresponding author), Fac Med Sao Jose Rio Preto, Dept Mol Biol, Lab Invest Mol Canc, Sao Paulo, Brazil.	debora.zuccari@famerp.br	Jardim-Perassi, Bruna V/H-8633-2014; Borin, Thaiz Ferraz/E-8013-2012; de Campos Zuccari, Debora Aparecida Pires/M-3560-2014; Arbab, Ali/AAS-1933-2020	Borin, Thaiz Ferraz/0000-0003-1464-9823; de Campos Zuccari, Debora Aparecida Pires/0000-0002-0146-9041; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP/ Brazil [2011/01052-9, 2011/01054-1, 2012/05065-0]; NIH [R01CA160216, R01CA172048]; NATIONAL CANCER INSTITUTE [R01CA172048, R01CA160216] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP/ Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP/ Brazil (2011/01052-9, 2011/01054-1 and 2012/05065-0) and NIH (R01CA160216 and R01CA172048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS MJ, 1990, J NUCL MED, V31, P2022; Ali MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008727; Alvarez-Garcia V, 2013, J PINEAL RES, V54, P373, DOI 10.1111/jpi.12007; Alvarez-Garcia V, 2013, MICROVASC RES, V87, P25, DOI 10.1016/j.mvr.2013.02.008; Ambasta RK, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-26; Arbab AS, 2008, FASEB J, V22, P3234, DOI 10.1096/fj.07-105676; Arbab AS, 2012, HISTOL HISTOPATHOL, V27, P549, DOI 10.14670/HH-27.549; Backer MV, 2007, NAT MED, V13, P504, DOI 10.1038/nm1522; Bennett IC, 2000, BREAST, V9, P247, DOI 10.1054/brst.2000.0208; Blankenberg FG, 2006, EUR J NUCL MED MOL I, V33, P841, DOI 10.1007/s00259-006-0099-1; Blask DE, 1997, CANCER RES, V57, P1909; Carpini JD, 2010, ANGIOGENESIS, V13, P43, DOI 10.1007/s10456-010-9163-3; Cos S, 1998, CANCER RES, V58, P4383; Cos S, 2000, FRONT NEUROENDOCRIN, V21, P133, DOI 10.1006/frne.1999.0194; Cui PL, 2008, J PINEAL RES, V44, P107, DOI 10.1111/j.1600-079X.2007.00496.x; Cui PL, 2006, J PINEAL RES, V41, P358, DOI 10.1111/j.1600-079X.2006.00375.x; Cui PL, 2012, J PINEAL RES, V52, P236, DOI 10.1111/j.1600-079X.2011.00933.x; Dai M, 2008, J PINEAL RES, V44, P121, DOI 10.1111/j.1600-079X.2007.00498.x; Di Bella G, 2013, INT J MOL SCI, V14, P2410, DOI 10.3390/ijms14022410; Fic M, 2007, IN VIVO, V21, P513; Finley SD, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-193; Greenberg S, 2010, CANCER J, V16, P33, DOI 10.1097/PPO.0b013e3181d38514; HILL SM, 1992, CANCER LETT, V64, P249, DOI 10.1016/0304-3835(92)90050-6; Hill SM, 2011, J MAMMARY GLAND BIOL, V16, P235, DOI 10.1007/s10911-011-9222-4; Hill SM, 2009, INTEGR CANCER THER, V8, P337, DOI 10.1177/1534735409353332; Hilmi C, 2012, J NUCLEIC ACIDS, V2012, DOI 10.1155/2012/162692; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Institut Nacional do Cancer (INCA), 2010, EST INC MORT CANC BR; Instituto Nacional do Cancer (INCA), 2005, INC CANC BRAS; Jablonska K, 2013, J PINEAL RES, V54, P334, DOI 10.1111/jpi.12032; Janic B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009173; Jensen Mette Munk, 2008, BMC Med Imaging, V8, P16, DOI 10.1186/1471-2342-8-16; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; Johansson I, 2012, GENE CHROMOSOME CANC, V51, P375, DOI 10.1002/gcc.21922; Jung JH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/879746; Kallergi G, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2452; Kaur C, 2007, J PINEAL RES, V42, P338, DOI 10.1111/j.1600-079X.2007.00424.x; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kim KJ, 2013, J PINEAL RES, V54, P264, DOI 10.1111/j.1600-079X.2012.01030.x; Leman ES, 2001, BIOELECTROMAGNETICS, V22, P178, DOI 10.1002/bem.36; LEWY AJ, 1980, SCIENCE, V210, P1267, DOI 10.1126/science.7434030; LISSONI P, 1995, BRIT J CANCER, V71, P854, DOI 10.1038/bjc.1995.164; Lissoni P, 2001, NEUROENDOCRINOL LETT, V22, P45; Liu H, 2011, ANAT REC, V294, P781, DOI 10.1002/ar.21361; Luchetti F, 2010, FASEB J, V24, P3603, DOI 10.1096/fj.10-154450; Maganhin CC, 2008, REV ASSOC MED BRAS, V54, P267, DOI 10.1590/S0104-42302008000300022; Margheri M, 2012, EUR J PHARMACOL, V681, P34, DOI 10.1016/j.ejphar.2012.02.011; Mediavilla MD, 1999, LIFE SCI, V65, P415, DOI 10.1016/S0024-3205(99)00262-3; MIRUNALINI S, 2010, J APPL SCI RES, V6, P245; Norden AD, 2008, LANCET NEUROL, V7, P1152, DOI 10.1016/S1474-4422(08)70260-6; Oprea-Ilies G, 2013, BREAST CANCER RES TR, V137, P677, DOI 10.1007/s10549-012-2371-3; Park JW, 2009, J PINEAL RES, V46, P415, DOI 10.1111/j.1600-079X.2009.00678.x; Park SY, 2010, J PINEAL RES, V48, P178, DOI 10.1111/j.1600-079X.2009.00742.x; PLATE KH, 1993, CANCER RES, V53, P5822; Proietti S, 2013, CELL MOL LIFE SCI, V70, P2139, DOI 10.1007/s00018-012-1161-8; Rao GN, 2000, BREAST CANCER RES TR, V64, P287, DOI 10.1023/A:1026552405042; Romon R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-157; Sanchez-Barcelo EJ, 2005, J PINEAL RES, V38, P217, DOI 10.1111/j.1600-079X.2004.00207.x; Semenza GL, 2002, TRENDS MOL MED, V8, pS62, DOI 10.1016/S1471-4914(02)02317-1; Silverman MD, 2007, ARTHRITIS RHEUM-US, V56, P1817, DOI 10.1002/art.22706; Stefanini MO, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-77; Vordermark D, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-45; Walker RA, 1997, CANCER METAST REV, V16, P5, DOI 10.1023/A:1005740222307; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Yuan L, 2002, MOL CELL ENDOCRINOL, V192, P147, DOI 10.1016/S0303-7207(02)00029-1	66	117	120	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85311	10.1371/journal.pone.0085311	http://dx.doi.org/10.1371/journal.pone.0085311			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416386	Green Submitted, gold, Green Published			2022-12-27	WOS:000329866300068
J	Campbell, AH; Marzinelli, EM; Verges, A; Coleman, MA; Steinberg, PD				Campbell, Alexandra H.; Marzinelli, Ezequiel M.; Verges, Adriana; Coleman, Melinda A.; Steinberg, Peter D.			Towards Restoration of Missing Underwater Forests	PLOS ONE			English	Article							CLIMATE-CHANGE; REGIME SHIFTS; BIODIVERSITY; HABITAT; RESILIENCE; CONSEQUENCES; RECRUITMENT; POPULATIONS; PATTERNS; RECOVERY	Degradation of natural habitats due to urbanization is a major cause of biodiversity loss. Anthropogenic impacts can drive phase shifts from productive, complex ecosystems to less desirable, less diverse systems that provide fewer services. Macroalgae are the dominant habitat-forming organisms on temperate coastlines, providing habitat and food to entire communities. In recent decades, there has been a decline in macroalgal cover along some urbanised shorelines, leading to a shift from diverse algal forests to more simple turf algae or barren habitats. Phyllospora comosa, a major habitat forming macroalga in south-eastern Australia, has disappeared from the urban shores of Sydney. Its disappearance is coincident with heavy sewage outfall discharges along the metropolitan coast during 1970s and 1980s. Despite significant improvements in water-quality since that time, Phyllospora has not re-established. We experimentally transplanted adult Phyllospora into two rocky reefs in the Sydney metropolitan region to examine the model that Sydney is now suitable for the survival and recruitment of Phyllospora and thus assess the possibility of restoring Phyllospora back onto reefs where it was once abundant. Survival of transplanted individuals was high overall, but also spatially variable: at one site most individuals were grazed, while at the other site survival was similar to undisturbed algae and procedural controls. Transplanted algae reproduced and recruitment rates were higher than in natural populations at one experimental site, with high survival of new recruits after almost 18 months. Low supply and settlement success of propagules in the absence of adults and herbivory (in some places) emerge as three potential processes that may have been preventing natural re-establishment of this alga. Understanding of the processes and interactions that shape this system are necessary to provide ecologically sensible goals and the information needed to successfully restore these underwater forests.	[Campbell, Alexandra H.; Marzinelli, Ezequiel M.; Verges, Adriana; Steinberg, Peter D.] Sydney Inst Marine Sci, Mosman, NSW, Australia; [Campbell, Alexandra H.; Marzinelli, Ezequiel M.; Verges, Adriana; Steinberg, Peter D.] Univ New S Wales, Ctr Marine Bioinnovat, Sydney, NSW, Australia; [Campbell, Alexandra H.; Marzinelli, Ezequiel M.; Verges, Adriana; Steinberg, Peter D.] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Campbell, Alexandra H.; Marzinelli, Ezequiel M.; Verges, Adriana] Univ New S Wales, Evolut & Ecol Res Ctr, Sydney, NSW, Australia; [Coleman, Melinda A.] NSW Fisheries, Dept Primary Ind, Coffs Harbour, NSW, Australia; [Steinberg, Peter D.] Nanyang Technol Univ, Adv Environm Biotechnol Ctr, Singapore, Singapore	Sydney Institute of Marine Science; University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; NSW Department of Primary Industries; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Campbell, AH (corresponding author), Sydney Inst Marine Sci, Mosman, NSW, Australia.	alexandra.campbell@unsw.edu.au	Marzinelli, Ezequiel/AAH-2906-2019; Coleman, Melinda A/R-5563-2016; Verges, Adriana/B-8288-2013	Marzinelli, Ezequiel/0000-0002-3762-3389; Coleman, Melinda A/0000-0003-2623-633X; Verges, Adriana/0000-0002-3507-1234; Steinberg, Peter/0000-0002-1781-0726; Campbell, Alexandra/0000-0002-2322-2840	Australian Research Council [DP1096464]; UNSW	Australian Research Council(Australian Research Council); UNSW	This work was funded by an Australian Research Council Discovery project (DP1096464) awarded to PDS and MAC and a UNSW Early Career Researcher grant awarded to AHC, EMM and AV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; ANDERSON M. J., 2007, PERMANOVA PRIMER GUI; Andrew N., 1999, SO SEAS ECOLOGY AUST; Bishop MJ, 2010, OECOLOGIA, V163, P517, DOI 10.1007/s00442-009-1555-y; BODKIN JL, 1988, J EXP MAR BIOL ECOL, V117, P227, DOI 10.1016/0022-0981(88)90059-7; BURRIDGE TR, 1995, B ENVIRON CONTAM TOX, V55, P621; Campbell AH, 2011, GLOBAL CHANGE BIOL, V17, P2958, DOI 10.1111/j.1365-2486.2011.02456.x; Carney LT, 2005, MAR ECOL PROG SER, V302, P49, DOI 10.3354/meps302049; CHAPMAN ARO, 1995, PHYCOLOGIA, V34, P1, DOI 10.2216/i0031-8884-34-1-1.1; CHAPMAN MG, 1986, J EXP MAR BIOL ECOL, V103, P181, DOI 10.1016/0022-0981(86)90140-1; Chapman MG, 1997, FRONTIERS ECOLOGY BU; Coleman MA, 2008, J PHYCOL, V44, P897, DOI 10.1111/j.1529-8817.2008.00541.x; Coleman MA, 2009, MAR ECOL PROG SER, V381, P63, DOI 10.3354/meps07977; Connell SD, 2008, MAR ECOL PROG SER, V360, P63, DOI 10.3354/meps07526; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; DAYTON PK, 1985, ANNU REV ECOL SYST, V16, P215, DOI 10.1146/annurev.es.16.110185.001243; Edwards A.J., 2007, REEF RESTORATION CON; Ellis EC, 2011, PHILOS T R SOC A, V369, P1010, DOI 10.1098/rsta.2010.0331; Field CD, 1998, MAR POLLUT BULL, V37, P383; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Folke C, 2006, GLOBAL ENVIRON CHANG, V16, P253, DOI 10.1016/j.gloenvcha.2006.04.002; Galatowitsch S.M., 2012, ECOLOGICAL RESTORATI; Goodsell PJ, 2009, ECOL STUD-ANAL SYNTH, V206, P333, DOI 10.1007/978-3-540-92704-4_24; Gorman D, 2009, ECOL APPL, V19, P1114, DOI 10.1890/08-0831.1; Hernandez-Carmona G, 2005, BOT MAR, V43, P273; Hobbs RJ, 1996, RESTOR ECOL, V4, P93, DOI 10.1111/j.1526-100X.1996.tb00112.x; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; JANZEN DH, 1976, ANNU REV ECOL SYST, V7, P347, DOI 10.1146/annurev.es.07.110176.002023; Johnson LE, 1998, OECOLOGIA, V117, P517, DOI 10.1007/s004420050688; KENDRICK GA, 1995, J EXP MAR BIOL ECOL, V192, P273, DOI 10.1016/0022-0981(95)00076-4; KENNELLY SJ, 1987, MAR ECOL PROG SER, V40, P155, DOI 10.3354/meps040155; Kerswell AP, 2006, ECOLOGY, V87, P2479, DOI 10.1890/0012-9658(2006)87[2479:GBPOBM]2.0.CO;2; Konar B, 2003, ECOLOGY, V84, P174, DOI 10.1890/0012-9658(2003)084[0174:TSOBRB]2.0.CO;2; Lindenmayer DB, 2011, P NATL ACAD SCI USA, V108, P15887, DOI 10.1073/pnas.1110245108; Lorentsen SH, 2010, BIOL CONSERV, V143, P2054, DOI 10.1016/j.biocon.2010.05.013; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Lotze HK, 2011, TRENDS ECOL EVOL, V26, P595, DOI 10.1016/j.tree.2011.07.008; Marzinelli EM, 2014, J APPL PHYCOL, V26, P1089, DOI 10.1007/s10811-013-0158-5; Marzinelli EM, 2009, ECOLOGY, V90, P2948, DOI 10.1890/08-1893.1; Nielsen HD, 2008, AQUAT BIOL, V3, P121, DOI 10.3354/ab00069; O'Connor KC, 2010, J EXP MAR BIOL ECOL, V386, P1, DOI 10.1016/j.jembe.2010.01.016; Paine RT, 1998, ECOSYSTEMS, V1, P535, DOI 10.1007/s100219900049; Parker JD, 2006, SCIENCE, V311, P1459, DOI 10.1126/science.1121407; Scanes PR, 1995, MAR POLLUT BULL, V31, P343, DOI 10.1016/0025-326X(96)81926-6; Schiel DR, 1992, RESTORING NATIONAS M; Sheridan P, 2004, ESTUARIES, V27, P781, DOI 10.1007/BF02912040; Smale DA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2829; Spurgeon J.P.G., 2000, COLLECTED ESSAYS EC, P125; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Sydney-Water, 2007, SYDNEYS DEEPWATER OC; Taylor DI, 2010, ECOLOGY, V91, P201, DOI 10.1890/08-1512.1; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Toohey B, 2004, MAR BIOL, V144, P1019, DOI 10.1007/s00227-003-1267-5; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; UNDERWOOD AJ, 1991, AUST J ECOL, V16, P231, DOI 10.1111/j.1442-9993.1991.tb01050.x; van Treeck P, 1999, ESTUAR COAST SHELF S, V49, P75, DOI 10.1016/S0272-7714(99)80011-0; WAHL M, 1995, OECOLOGIA, V102, P329, DOI 10.1007/BF00329800; Wernberg T, 2005, AQUAT ECOL, V39, P419, DOI 10.1007/s10452-005-9009-z; Wernberg T, 2013, NAT CLIM CHANGE, V3, P78, DOI [10.1038/NCLIMATE1627, 10.1038/nclimate1627]; Wernberg T, 2011, CURR BIOL, V21, P1828, DOI 10.1016/j.cub.2011.09.028; Wernberg T, 2011, J EXP MAR BIOL ECOL, V400, P7, DOI 10.1016/j.jembe.2011.02.021; Womersley H.B.S., 1996, MARINE BENTHIC FLORA; WOMERSLEY H.B.S, 1987, MARINE BENTHIC FLO 2; Young CN, 2012, B MAR SCI, V88, P1075, DOI 10.5343/bms.2011.1143; Young TP, 2005, ECOL LETT, V8, P662, DOI 10.1111/j.1461-0248.2005.00764.x; Yu YQ, 2012, ECOL ENG, V44, P10, DOI 10.1016/j.ecoleng.2012.03.016; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	69	93	94	2	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84106	10.1371/journal.pone.0084106	http://dx.doi.org/10.1371/journal.pone.0084106			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416198	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500099
J	Cao, TT; Thompson, JE				Cao, Tingting; Thompson, Jonathan E.			Remote Sensing of Atmospheric Optical Depth Using a Smartphone Sun Photometer	PLOS ONE			English	Article							CELL-PHONE; SPECTROSCOPY; EXTINCTION; AERONET; NETWORK	In recent years, smart phones have been explored for making a variety of mobile measurements. Smart phones feature many advanced sensors such as cameras, GPS capability, and accelerometers within a handheld device that is portable, inexpensive, and consistently located with an end user. In this work, a smartphone was used as a sun photometer for the remote sensing of atmospheric optical depth. The top-of-the-atmosphere (TOA) irradiance was estimated through the construction of Langley plots on days when the sky was cloudless and clear. Changes in optical depth were monitored on a different day when clouds intermittently blocked the sun. The device demonstrated a measurement precision of 1.2% relative standard deviation for replicate photograph measurements (38 trials, 134 datum). However, when the accuracy of the method was assessed through using optical filters of known transmittance, a more substantial uncertainty was apparent in the data. Roughly 95% of replicate smart phone measured transmittances are expected to lie within +/- 11.6% of the true transmittance value. This uncertainty in transmission corresponds to an optical depth of approx. +/- 0.12-0.13 suggesting the smartphone sun photometer would be useful only in polluted areas that experience significant optical depths. The device can be used as a tool in the classroom to present how aerosols and gases effect atmospheric transmission. If improvements in measurement precision can be achieved, future work may allow monitoring networks to be developed in which citizen scientists submit acquired data from a variety of locations.	[Cao, Tingting; Thompson, Jonathan E.] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA	Texas Tech University System; Texas Tech University	Thompson, JE (corresponding author), Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA.	jon.thompson@ttu.edu	Thompson, Jonathan/M-9815-2019	Thompson, Jonathan/0000-0003-1550-2823	State of Texas/Texas Tech University	State of Texas/Texas Tech University	The authors would like to thank the State of Texas/Texas Tech University for financial support of this project through new investigator start-up funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov MD, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010543; ANGSTROM A, 1970, TELLUS, V22, P205; Delaney JL, 2011, ANAL CHEM, V83, P1300, DOI 10.1021/ac102392t; Dial KD, 2010, ANAL CHEM, V82, P7885, DOI 10.1021/ac100617j; Dubovik O, 2000, J GEOPHYS RES-ATMOS, V105, P9791, DOI 10.1029/2000JD900040; Halthore RN, 1997, J GEOPHYS RES-ATMOS, V102, P4343, DOI 10.1029/96JD03247; Holben BN, 1998, REMOTE SENS ENVIRON, V66, P1, DOI 10.1016/S0034-4257(98)00031-5; Ma LL, 2012, ANAL CHEM, V84, P5611, DOI 10.1021/ac3005814; Ma LL, 2011, AEOLIAN RES, V3, P235, DOI 10.1016/j.aeolia.2011.05.002; Madan A, 2010, P ACM UB 2010 COP DE; Perez-Ramirez D, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016450; Redmond H, 2011, PHYS CHEM CHEM PHYS, V13, P6872, DOI 10.1039/c0cp02270e; Redmond HE, 2010, AEOLIAN RES, V2, P5, DOI 10.1016/j.aeolia.2009.09.002; Scheeline A, 2010, APPL SPECTROSC, V64, p256A, DOI 10.1366/000370210792434378; Shaw G. E., 1973, Journal of Applied Meteorology, V12, P374, DOI 10.1175/1520-0450(1973)012<0374:IOAEUD>2.0.CO;2; SHAW GE, 1983, B AM METEOROL SOC, V64, P4, DOI 10.1175/1520-0477(1983)064<0004:SP>2.0.CO;2; Smith ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017150; Staehelin J, 1998, J GEOPHYS RES-ATMOS, V103, P5827, DOI 10.1029/97JD02402; Thompson JE, 2006, APPL OPTICS, V45, P2465, DOI 10.1364/AO.45.002465; Thompson JE, 2003, AEROSOL SCI TECH, V37, P221, DOI 10.1080/02786820300942; Thompson JE, 2002, ANAL CHEM, V74, P1962, DOI 10.1021/ac0110505; Thompson JE, 2008, OPT EXPRESS, V16, P2191, DOI 10.1364/OE.16.002191; Thompson JE, 2007, MEAS SCI TECHNOL, V18, P147, DOI 10.1088/0957-0233/18/1/018; Zhu HY, 2012, ANALYST, V137, P2541, DOI 10.1039/c2an35071h; Zhu HY, 2011, ANAL CHEM, V83, P6641, DOI 10.1021/ac201587a	25	11	12	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84119	10.1371/journal.pone.0084119	http://dx.doi.org/10.1371/journal.pone.0084119			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416199	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500100
J	Coall, DA; Hilbrand, S; Hertwig, R				Coall, David A.; Hilbrand, Sonja; Hertwig, Ralph			Predictors of Grandparental Investment Decisions in Contemporary Europe: Biological Relatedness and Beyond	PLOS ONE			English	Article							PREFERENTIAL INVESTMENT; EVOLUTIONARY-THEORY; CHILD-CARE; FAMILY; KIN; GRANDCHILDREN; ADOLESCENT; SOLICITUDE; CONTACT; GENDER	Across human cultures, grandparents make a valued contribution to the health of their families and communities. Moreover, evidence is gathering that grandparents have a positive impact on the development of grandchildren in contemporary industrialized societies. A broad range of factors that influence the likelihood grandparents will invest in their grandchildren has been explored by disciplines as diverse as sociology, economics, psychology and evolutionary biology. To progress toward an encompassing framework, this study will include biological relatedness between grandparents and grandchildren, a factor central to some discipline's theoretical frameworks (e. g., evolutionary biology), next to a wide range of other factors in an analysis of grandparental investment in contemporary Europe. This study draws on data collected in the Survey of Health, Ageing and Retirement in Europe from 11 European countries that included 22,967 grandparent-child dyads. Grandparents reported biological relatedness, and grandparental investment was measured as the frequency of informal childcare. Biological and non-biological grandparents differed significantly in a variety of individual, familial and area-level characteristics. Furthermore, many other economic, sociological, and psychological factors also influenced grandparental investment. When they were controlled, biological grandparents, relative to non-biological grandparents, were more likely to invest heavily, looking after their grandchildren almost daily or weekly. Paradoxically, however, they were also more likely to invest nothing at all. We discuss the methodological and theoretical implications of these findings across disciplines.	[Coall, David A.] Edith Cowan Univ, Sch Med Sci, Joondalup, WA, Australia; [Coall, David A.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Crawley, WA, Australia; [Hilbrand, Sonja] Univ Basel, Dept Psychol, Basel, Switzerland; [Hertwig, Ralph] Max Planck Inst Human Dev, Ctr Adapt Rat, Berlin, Germany	Edith Cowan University; University of Western Australia; University of Basel; Max Planck Society	Coall, DA (corresponding author), Edith Cowan Univ, Sch Med Sci, Joondalup, WA, Australia.	d.coall@ecu.edu.au	Hertwig, Ralph/B-3468-2015; Coall, David/AAR-4761-2020	Hertwig, Ralph/0000-0002-9908-9556; Coall, David/0000-0002-0488-2683	European Commission [QLK6-CT-2001-00360, SHARE-I3, RII-CT-2006-062193, CIT5-CT-2005-028857]; US National Institute on Ageing [U01 AG09740-13S2, P01 AG005842, P01 AG08291, P30 AG12815, Y1-AG-4553-01, OGHA 04-064]; Data collection in Austria (through the Austrian Science Foundation, FWF); Belgium (through the Belgian Science Policy Office); Switzerland (through BBW/OFES/UFES); US National Institute on Aging [R21 AG025169]; German-Israeli Foundation for Scientific Research and Development (GIF); National Insurance Institute of Israel; NATIONAL INSTITUTE ON AGING [P30AG012815, P01AG005842, P01AG008291, U01AG009740, R21AG025169] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); US National Institute on Ageing(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Data collection in Austria (through the Austrian Science Foundation, FWF)(Austrian Science Fund (FWF)); Belgium (through the Belgian Science Policy Office); Switzerland (through BBW/OFES/UFES); US National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); German-Israeli Foundation for Scientific Research and Development (GIF)(German-Israeli Foundation for Scientific Research and Development); National Insurance Institute of Israel; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study used release 2.0.1 of first wave data of SHARE 2004: The SHARE data collection has been primarily funded by the European Commission through the Fifth Framework Program (project QLK6-CT-2001-00360 in the thematic program Quality of Life). Additional funding came from the US National Institute on Ageing (U01 AG09740-13S2, P01 AG005842, P01 AG08291, P30 AG12815, Y1-AG-4553-01, and OGHA 04-064). Data collection in Austria (through the Austrian Science Foundation, FWF), Belgium (through the Belgian Science Policy Office), and Switzerland (through BBW/OFES/UFES) was nationally funded. SHARE data collection in Israel was funded by the US National Institute on Aging (R21 AG025169), the German-Israeli Foundation for Scientific Research and Development (GIF), and the National Insurance Institute of Israel. Further support by the European Commission through the Sixth Framework Program (projects SHARE-I3, RII-CT-2006-062193, and COMPARE, CIT5-CT-2005-028857) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDOUS J, 1995, J FAM ISSUES, V16, P104, DOI 10.1177/019251395016001006; Allen-Arave W, 2008, EVOL HUM BEHAV, V29, P305, DOI 10.1016/j.evolhumbehav.2008.03.002; Anderson KG, 2005, HUM NATURE-INT BIOS, V16, P1, DOI 10.1007/s12110-005-1005-4; Attar-Schwartz S, 2009, J FAM PSYCHOL, V23, P67, DOI 10.1037/a0014383; Beise J., 2005, GRANDMOTHERHOOD EVOL, P215; Bishop DI, 2009, EVOL PSYCHOL, V7, P66, DOI 10.1177/147470490900700109; Borsch-Supan A., 2005, SURVEY HLTH AGEING R; BRAY JH, 1990, FAM RELAT, V39, P414, DOI 10.2307/585221; Clutton-Brock T, 2009, NATURE, V462, P51, DOI 10.1038/nature08366; Coall DA, 2011, CURR DIR PSYCHOL SCI, V20, P93, DOI 10.1177/0963721411403269; Coall DA, 2010, BEHAV BRAIN SCI, V33, P1, DOI 10.1017/S0140525X09991105; Coall DA, 2009, AM J HUM BIOL, V21, P455, DOI 10.1002/ajhb.20894; DALY M, 1980, J MARRIAGE FAM, V42, P277, DOI 10.2307/351225; Danielsbacka M, 2012, EUR J AGEING, V9, P329, DOI 10.1007/s10433-012-0240-x; Danielsbacka M, 2011, EVOL PSYCHOL-US, V9, P3, DOI 10.1177/147470491100900102; de Souza EM, 2007, SOC SCI MED, V65, P1397, DOI 10.1016/j.socscimed.2007.05.022; Del Boca D, 2002, J POPUL ECON, V15, P549, DOI 10.1007/s001480100089; Drew LM, 2007, J FAM PSYCHOL, V21, P372, DOI 10.1037/0893-3200.21.3.372; Dubas JS, 2001, J FAM ISSUES, V22, P478, DOI 10.1177/019251301022004005; EGGEBEEN DJ, 1992, RES AGING, V14, P427, DOI 10.1177/0164027592144001; EISENBERG AR, 1988, SEX ROLES, V19, P205, DOI 10.1007/BF00290155; Euler HA, 1996, HUM NATURE-INT BIOS, V7, P39, DOI 10.1007/BF02733489; Friedman D, 2008, RATION SOC, V20, P31, DOI 10.1177/1043463107085436; Geary DC, 2000, PSYCHOL BULL, V126, P55, DOI 10.1037/0033-2909.126.1.55; Gibson MA, 2006, PLOS MED, V3, P476, DOI 10.1371/journal.pmed.0030087; Grundy E, 2006, AGEING SOC, V26, P707, DOI 10.1017/S0144686X06004934; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hank K, 2009, J FAM ISSUES, V30, P53, DOI 10.1177/0192513X08322627; Hill K., 1996, ACHE LIFE HIST ECOLO, DOI 10.4324/9781351329248; Hrdy S.B., 1999, MOTHER NATURE MATERN; Huber BR, 2007, CROSS-CULT RES, V41, P196, DOI 10.1177/1069397106298261; Ingold Tim, 2001, ALAS POOR DARWIN ARG; Ivey PK, 2000, CURR ANTHROPOL, V41, P856, DOI 10.1086/317414; Kaptijn R, 2013, J BIOSOC SCI, V45, P289, DOI 10.1017/S0021932012000612; Kaptijn R, 2010, HUM NATURE-INT BIOS, V21, P393, DOI 10.1007/s12110-010-9098-9; KENNEDY GE, 1990, GERONTOLOGIST, V30, P43, DOI 10.1093/geront/30.1.43; Laham SM, 2005, PERS SOC PSYCHOL B, V31, P63, DOI 10.1177/0146167204271318; Locatelli M., 2005, REV ECON HOUSEHOLD, V3, P453, DOI DOI 10.1007/S11150-005-4944-Y; Mangen D.J., 1988, MEASUREMENT INTERGEN; McNamee CB, 2011, DEMOGR RES, V24, P293, DOI 10.4054/DemRes.2011.24.13; Michalski RL, 2005, HUM NATURE-INT BIOS, V16, P293, DOI 10.1007/s12110-005-1012-5; MICHALSKI RL, 2005, HUM NATURE, V16, P292, DOI DOI 10.1007/S12110-005-1012-5; Nettle D, 2011, P ROY SOC B-BIOL SCI, V278, P1721, DOI 10.1098/rspb.2010.1726; OYSERMAN D, 1993, DEV PSYCHOL, V29, P564, DOI 10.1037/0012-1649.29.3.564; Patterson CJ, 1998, AM J ORTHOPSYCHIAT, V68, P390, DOI 10.1037/h0080348; Pollet TV, 2009, J BIOSOC SCI, V41, P355, DOI 10.1017/S0021932009003307; Population Reference Bureau, 2012, 2004 WORLD POP DAT S; Rossi AS., 1990, HUMAN BONDING PARENT; Ruiz SA, 2007, J SOC ISSUES, V63, P793, DOI 10.1111/j.1540-4560.2007.00537.x; Sear R, 2008, EVOL HUM BEHAV, V29, P1, DOI 10.1016/j.evolhumbehav.2007.10.001; Sear R, 2011, POPUL DEV REV, V37, P81, DOI 10.1111/j.1728-4457.2011.00379.x; SMITH MS, 1987, SOCIOBIOLOGY PSYCHOL, P225, DOI DOI 10.1037/0012-1649.23.1.49; Tejada-Vera B, 2010, NATL VITAL STAT REP, V58, P25; Tran US, 2009, BASIC APPL SOC PSYCH, V31, P295, DOI 10.1080/01973530903316773; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; TURKE PW, 1989, POPUL DEV REV, V15, P61, DOI 10.2307/1973405; Voland E, 2002, BEHAV ECOL SOCIOBIOL, V52, P435, DOI 10.1007/s00265-002-0539-2	57	43	43	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84082	10.1371/journal.pone.0084082	http://dx.doi.org/10.1371/journal.pone.0084082			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291WL	24416193	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500094
J	de Carvalho, LL; Maltarollo, VG; de Lima, EF; Weber, KC; Honorio, KM; da Silva, ABF				de Carvalho, Luciana L.; Maltarollo, Vinicius G.; de Lima, Emmanuela Ferreira; Weber, Karen C.; Honorio, Kathia M.; da Silva, Alberico B. F.			Molecular Features Related to HIV Integrase Inhibition Obtained from Structure- and Ligand-Based Approaches	PLOS ONE			English	Article							POTENT; RALTEGRAVIR; DISCOVERY; BINDING; DOMAIN	Among several biological targets to treat AIDS, HIV integrase is a promising enzyme that can be employed to develop new anti-HIV agents. The aim of this work is to propose a mechanistic interpretation of HIV-1 integrase inhibition and to rationalize the molecular features related to the binding affinity of studied ligands. A set of 79 HIV-1 integrase inhibitors and its relationship with biological activity are investigated employing 2D and 3D QSAR models, docking analysis and DFT studies. Analyses of docking poses and frontier molecular orbitals revealed important features on the main ligand-receptor interactions. 2D and 3D models presenting good internal consistency, predictive power and stability were obtained in all cases. Significant correlation coefficients (r(2) = 0.908 and q(2) = 0.643 for 2D model; r(2) = 0.904 and q(2) = 0.719 for 3D model) were obtained, indicating the potential of these models for untested compounds. The generated holograms and contribution maps revealed important molecular requirements to HIV-1 IN inhibition and several evidences for molecular modifications. The final models along with information resulting from molecular orbitals, 2D contribution and 3D contour maps should be useful in the design of new inhibitors with increased potency and selectivity within the chemical diversity of the data.	[de Carvalho, Luciana L.; da Silva, Alberico B. F.] Univ Sao Paulo, Inst Quim Sao Carlos, Sao Carlos, SP, Brazil; [Maltarollo, Vinicius G.; Honorio, Kathia M.] Univ Fed ABC, Ctr Ciencias Nat & Humanas, Santo Andre, Brazil; [de Lima, Emmanuela Ferreira; Honorio, Kathia M.] Univ Sao Paulo, Escola Artes Ciencias & Humanidades, Sao Paulo, Brazil; [Weber, Karen C.] Univ Fed Paraiba, Ctr Ciencias Exatas & Nat, BR-58059900 Joao Pessoa, Paraiba, Brazil	Universidade de Sao Paulo; Universidade Federal do ABC (UFABC); Universidade de Sao Paulo; Universidade Federal da Paraiba	Honorio, KM (corresponding author), Univ Fed ABC, Ctr Ciencias Nat & Humanas, Santo Andre, Brazil.	kmhonorio@usp.br; alberico@iqsc.usp.br	da Silva, Alberico Borges Ferreira/AAB-3642-2021; Honorio, Kathia/AAG-9844-2020; Honorio, Kathia M/D-4998-2012; da Silva, Albérico B. F./C-3274-2011; Maltarollo, Vinicius Gonçalves/AAV-6849-2021; Weber, Karen/AAC-2888-2020	da Silva, Alberico Borges Ferreira/0000-0003-2337-1042; Honorio, Kathia/0000-0002-6938-0676; Honorio, Kathia M/0000-0002-6938-0676; Maltarollo, Vinicius Gonçalves/0000-0001-9675-5907; Weber, Karen/0000-0003-4823-5290	CNPq; FAPESP; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This article was supported by CNPq, FAPESP and CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, SYBYL 8 1; BECKE AD, 1993, J CHEM PHYS, V98, P1372, DOI 10.1063/1.464304; CLARK M, 1989, J COMPUT CHEM, V10, P982, DOI 10.1002/jcc.540100804; CRAMER RD, 1988, J AM CHEM SOC, V110, P5959, DOI 10.1021/ja00226a005; De Clercq E, 2007, NAT REV DRUG DISCOV, V6, P1001, DOI 10.1038/nrd2424; DeLano Scientific LLC, 2006, PYMOL MOL GRAPH SYST; Di Francesco ME, 2008, BIOORG MED CHEM LETT, V18, P2709, DOI 10.1016/j.bmcl.2008.03.017; DITCHFIELD R, 1971, J CHEM PHYS, V54, P724, DOI 10.1063/1.1674902; Esposito D, 1998, EMBO J, V17, P5832, DOI 10.1093/emboj/17.19.5832; FDA notifications, 2009, AIDS ALERT, V24, P106; Frisch M. J., 2019, GAUSSIAN 16 REVISION; Gardelli C, 2007, J MED CHEM, V50, P4953, DOI 10.1021/jm0704705; Goldgur Y, 1999, P NATL ACAD SCI USA, V96, P13040, DOI 10.1073/pnas.96.23.13040; Goldgur Y, 1998, P NATL ACAD SCI USA, V95, P9150, DOI 10.1073/pnas.95.16.9150; Grinsztejn B, 2007, LANCET, V369, P1261, DOI 10.1016/S0140-6736(07)60597-2; Gupta P, 2011, MOL DIVERS, V15, P733, DOI 10.1007/s11030-011-9304-7; Gupta P, 2009, EUR J MED CHEM, V44, P4276, DOI 10.1016/j.ejmech.2009.07.010; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Heuer TS, 1997, BIOCHEMISTRY-US, V36, P10655, DOI 10.1021/bi970782h; Jilek BL, 2012, NAT MED, V18, P446, DOI 10.1038/nm.2649; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Lemmen C, 2000, J COMPUT AID MOL DES, V14, P215, DOI 10.1023/A:1008194019144; Pace P, 2007, J MED CHEM, V50, P2225, DOI 10.1021/jm070027u; Pommier Y, 2005, TRENDS PHARMACOL SCI, V26, P138, DOI 10.1016/j.tips.2005.01.008; Pommier Y, 2005, NAT REV DRUG DISCOV, V4, P236, DOI 10.1038/nrd1660; Quashie PK, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-34; Sharma H, 2012, J CHEM INF MODEL, V52, P515, DOI 10.1021/ci200485a; STEWART JJP, 1990, J COMPUT AID MOL DES, V4, P1, DOI 10.1007/BF00128336; Summa V, 2008, J MED CHEM, V51, P5843, DOI 10.1021/jm800245z; Summa V, 2006, J MED CHEM, V49, P6646, DOI 10.1021/jm060854f; UNAIDS, 2012, GLOBAL REPORT UNAIDS; Weber KC, 2010, CHEM BIOL DRUG DES, V76, P320, DOI 10.1111/j.1747-0285.2010.01016.x; WOLD S, 1984, SIAM J SCI STAT COMP, V5, P735, DOI 10.1137/0905052	34	7	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e81301	10.1371/journal.pone.0081301	http://dx.doi.org/10.1371/journal.pone.0081301			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416129	gold, Green Published, Green Submitted			2022-12-27	WOS:000329862500009
J	de Gouw, D; Hermans, PWM; Bootsma, HJ; Zomer, A; Heuvelman, K; Diavatopoulos, DA; Mooi, FR				de Gouw, Daan; Hermans, Peter W. M.; Bootsma, Hester J.; Zomer, Aldert; Heuvelman, Kees; Diavatopoulos, Dimitri A.; Mooi, Frits R.			Differentially Expressed Genes in Bordetella pertussis Strains Belonging to a Lineage Which Recently Spread Globally	PLOS ONE			English	Article							RESPIRATORY-TRACT; ESCHERICHIA-COLI; ENVIRONMENTAL-REGULATION; NEUTROPHIL RECRUITMENT; PHOSPHATE GROUPS; TOXIN; INFECTION; VIRULENCE; BRONCHISEPTICA; IDENTIFICATION	Pertussis is a highly contagious, acute respiratory disease in humans caused by the Gram-negative pathogen Bordetella pertussis. Pertussis has resurged in the face of intensive vaccination and this has coincided with the emergence of strains carrying a particular allele for the pertussis toxin promoter, ptxP3, which is associated with higher levels of pertussis toxin (Ptx) production. Within 10 to 20 years, ptxP3 strains have nearly completely replaced the previously dominant ptxP1 strains resulting in a worldwide selective sweep. In order to identify B. pertussis genes associated with the selective sweep, we compared the expression of genes in ptxP1 and ptxP3 strains that are under control of the Bordetella master virulence regulatory locus (bvgASR). The BvgAS proteins comprise a two component sensory transduction system which is regulated by temperature, nicotinic acid and sulfate. By increasing the sulfate concentration, it is possible to change the phase of B. pertussis from virulent to avirulent. Until recently, the only distinctive phenotype of ptxP3 strains was a higher Ptx production. Here we identify additional phenotypic differences between ptxP1 and ptxP3 strains which may have contributed to its global spread by comparing global transcriptional responses under sulfate-modulating conditions. We show that ptxP3 strains are less sensitive to sulfate-mediated gene suppression, resulting in an increased production of the vaccine antigens pertactin (Prn) and Ptx and a number of other virulence genes, including a type III secretion toxin, Vag8, a protein involved in complement resistance, and lpxE involved in lipid A modification. Furthermore, enhanced expression of the vaccine antigens Ptx and Prn by ptxP3 strains was confirmed at the protein level. Identification of genes differentially expressed between ptxP1 and ptxP3 strains may elucidate how B. pertussis has adapted to vaccination and allow the improvement of pertussis vaccines by identifying novel vaccine candidates.	[de Gouw, Daan; Hermans, Peter W. M.; Bootsma, Hester J.; Zomer, Aldert; Diavatopoulos, Dimitri A.; Mooi, Frits R.] Radboud Univ Nijmegen, Med Ctr, Lab Pediat Infect Dis, Dept Pediat, Nijmegen, Netherlands; [de Gouw, Daan; Hermans, Peter W. M.; Bootsma, Hester J.; Zomer, Aldert; Diavatopoulos, Dimitri A.; Mooi, Frits R.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Inst Infect Inflammat & Immun, Nijmegen, Netherlands; [Heuvelman, Kees; Mooi, Frits R.] Natl Inst Publ Hlth & Environm RIVM, Netherlands Ctr Infect Dis Control, Bilthoven, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Netherlands National Institute for Public Health & the Environment	Mooi, FR (corresponding author), Radboud Univ Nijmegen, Med Ctr, Lab Pediat Infect Dis, Dept Pediat, Nijmegen, Netherlands.	frits.mooi@rivm.nl	Diavatopoulos, Dimitri A/L-4269-2015; Hermans, Peter W.M./H-8042-2014; Mooi, prof.F.R./L-4528-2015	Diavatopoulos, Dimitri A/0000-0001-7065-7807; Zomer, Aldert/0000-0002-0758-5190	Netherlands Organization of Scientific Research (ZonMw) [125020001]	Netherlands Organization of Scientific Research (ZonMw)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development)	D.d.G. is supported by Grant 125020001 from the Netherlands Organization of Scientific Research (ZonMw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani A, 2011, VACCINE, V29, P3438, DOI 10.1016/j.vaccine.2011.02.070; Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675; Andreasen C, 2008, INFECT IMMUN, V76, P5139, DOI 10.1128/IAI.00895-08; Bart MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-627; Berbers GAM, 2009, HUM VACCINES, V5, P497, DOI 10.4161/hv.8112; Bisgard KM, 2004, PEDIATR INFECT DIS J, V23, P985, DOI 10.1097/01.inf.0000145263.37198.2b; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bottero D, 2012, J APPL MICROBIOL, V112, P1266, DOI 10.1111/j.1365-2672.2012.05299.x; Campbell P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035874; Carbonetti NH, 2004, INFECT IMMUN, V72, P3350, DOI 10.1128/IAI.72.6.3350-3358.2004; Carbonetti NH, 2007, INFECT IMMUN, V75, P1713, DOI 10.1128/IAI.01578-06; Carbonetti NH, 2010, FUTURE MICROBIOL, V5, P455, DOI 10.2217/FMB.09.133; Conyn van Spaendock MAE, 2012, 215121002 RIVM; Cotter PA, 1997, MOL MICROBIOL, V24, P671, DOI 10.1046/j.1365-2958.1997.3821741.x; Cullen TW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002454; Cummings CA, 2006, J BACTERIOL, V188, P1775, DOI 10.1128/JB.188.5.1775-1785.2006; de Gouw D, 2011, FEMS MICROBIOL REV, V35, P441, DOI 10.1111/j.1574-6976.2010.00257.x; de Greeff SC, 2010, CLIN INFECT DIS, V50, P1339, DOI 10.1086/652281; de Greeff SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014183; de Vries SPW, 2010, J BACTERIOL, V192, P3574, DOI 10.1128/JB.00121-10; Decker KB, 2012, MICROBIOL-SGM, V158, P1665, DOI 10.1099/mic.0.058941-0; Diavatopoulos DA, 2005, PLOS PATHOG, V1, P373, DOI 10.1371/journal.ooat.0010045; Han HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017797; Herrou J, 2010, P NATL ACAD SCI USA, V107, P17351, DOI 10.1073/pnas.1006267107; HOMMA JY, 1985, J BIOCHEM-TOKYO, V98, P395, DOI 10.1093/oxfordjournals.jbchem.a135294; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101; Kallonen T, 2012, CLIN MICROBIOL INFEC, V18, pE377, DOI 10.1111/j.1469-0691.2012.04000.x; Kallonen T, 2011, INFECT GENET EVOL, V11, P2034, DOI 10.1016/j.meegid.2011.09.012; King AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066150; King AJ, 2008, BMC GENOMICS, V9, P1, DOI 10.1186/1471-2164-9-311; Kirimanjeswara GS, 2005, J CLIN INVEST, V115, P3594, DOI 10.1172/JCI24609; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Kong QK, 2011, J IMMUNOL, V187, P412, DOI 10.4049/jimmunol.1100339; Kowalzik F, 2007, PEDIATR INFECT DIS J, V26, P238, DOI 10.1097/01.inf.0000256750.07118.ee; KREDICH NM, 1996, ESCHERICHIA COLI SAL, P514; Lamblin G, 2001, GLYCOCONJUGATE J, V18, P661, DOI 10.1023/A:1020867221861; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marr N, 2008, J BACTERIOL, V190, P4281, DOI 10.1128/JB.01875-07; Marr N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020585; Marr N, 2010, J INFECT DIS, V202, P1897, DOI 10.1086/657409; Marr N, 2010, INFECT IMMUN, V78, P2060, DOI 10.1128/IAI.01346-09; MELTON AR, 1989, J BACTERIOL, V171, P6206, DOI 10.1128/jb.171.11.6206-6212.1989; MELTON AR, 1993, INFECT IMMUN, V61, P807, DOI 10.1128/IAI.61.3.807-815.1993; MERKEL TJ, 1995, J BACTERIOL, V177, P2727, DOI 10.1128/jb.177.10.2727-2736.1995; Merkel TJ, 1998, INFECT IMMUN, V66, P4367; Mielcarek N, 1998, NAT BIOTECHNOL, V16, P454, DOI 10.1038/nbt0598-454; Mooi FR, 2010, INFECT GENET EVOL, V10, P36, DOI 10.1016/j.meegid.2009.10.007; Mooi FR, 2009, EMERG INFECT DIS, V15, P1206, DOI 10.3201/eid1508.081511; Nagamatsu K, 2009, J EXP MED, V206, P3073, DOI 10.1084/jem.20090494; Nasso M, 2009, J IMMUNOL, V183, P1892, DOI 10.4049/jimmunol.0901071; Neo YL, 2010, MICROBES INFECT, V12, P238, DOI 10.1016/j.micinf.2009.12.002; Octavia S, 2012, J INFECT DIS, V205, P1220, DOI 10.1093/infdis/jis178; Ohtsu I, 2010, J BIOL CHEM, V285, P17479, DOI 10.1074/jbc.M109.081356; Ouellet M, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-97; Panina EM, 2005, MOL MICROBIOL, V58, P267, DOI 10.1111/j.1365-2958.2005.04823.x; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Petersen RF, 2012, EMERG INFECT DIS, V18, P767, DOI 10.3201/eid1805.110812; PORTER JF, 1993, FEMS MICROBIOL LETT, V110, P33, DOI 10.1111/j.1574-6968.1993.tb06291.x; ROZMAN P, 1992, J CHROMATOGR-BIOMED, V574, P146, DOI 10.1016/0378-4347(92)80110-C; SCARLATO V, 1991, EMBO J, V10, P3971, DOI 10.1002/j.1460-2075.1991.tb04967.x; Schmidtke AJ, 2012, EMERG INFECT DIS, V18, P1248, DOI 10.3201/eid1808.120082; SIRKO A, 1990, J BACTERIOL, V172, P3351, DOI 10.1128/jb.172.6.3351-3357.1990; SPANGRUDE GJ, 1985, J IMMUNOL, V135, P4135; STAROS JV, 1986, ANAL BIOCHEM, V156, P220, DOI 10.1016/0003-2697(86)90176-4; Stockbauer KE, 2001, MOL MICROBIOL, V39, P65, DOI 10.1046/j.1365-2958.2001.02191.x; Stocks P, 1932, J HYG, V32, P582; Thalen M, 1999, J BIOTECHNOL, V75, P147, DOI 10.1016/S0168-1656(99)00155-8; van der Ploeg JR, 2001, ARCH MICROBIOL, V176, P1, DOI 10.1007/s002030100298; van Gageldonk PGM, 2008, J IMMUNOL METHODS, V335, P79, DOI 10.1016/j.jim.2008.02.018; van Gent M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046407; van Gent M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020340; Witt MA, 2012, CLIN INFECT DIS, V54, P1730, DOI 10.1093/cid/cis287; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zurita E, 2013, INFECT IMMUN, V81, P2371, DOI 10.1128/IAI.00336-13	77	49	52	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84523	10.1371/journal.pone.0084523	http://dx.doi.org/10.1371/journal.pone.0084523			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416242	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500134
J	Elshrif, MM; Cherry, EM				Elshrif, Mohamed M.; Cherry, Elizabeth M.			A Quantitative Comparison of the Behavior of Human Ventricular Cardiac Electrophysiology Models in Tissue	PLOS ONE			English	Article							ACTION-POTENTIAL DURATION; STEADY-STATE; RESTITUTION; FIBRILLATION; ALTERNANS; HEART; MYOCYTES; DISEASE; CELLS; MYOCARDIUM	Numerical integration of mathematical models of heart cell electrophysiology provides an important computational tool for studying cardiac arrhythmias, but the abundance of available models complicates selecting an appropriate model. We study the behavior of two recently published models of human ventricular action potentials, the Grandi-Pasqualini-Bers (GPB) and the O'Hara-Virag-Varro-Rudy (OVVR) models, and compare the results with four previously published models and with available experimental and clinical data. We find the shapes and durations of action potentials and calcium transients differ between the GPB and OVVR models, as do the magnitudes and rate- dependent properties of transmembrane currents and the calcium transient. Differences also occur in the steady- state and S1-S2 action potential duration and conduction velocity restitution curves, including a maximum conduction velocity for the OVVR model roughly half that of the GPB model and well below clinical values. Between single cells and tissue, both models exhibit differences in properties, including maximum upstroke velocity, action potential amplitude, and minimum diastolic interval. Compared to experimental data, action potential durations for the GPB and OVVR models agree fairly well (although OVVR epicardial action potentials are shorter), but maximum slopes of steady- state restitution curves are smaller. Although studies show alternans in normal hearts, it occurs only in the OVVR model, and only for a narrow range of cycle lengths. We find initiated spiral waves do not progress to sustained breakup for either model. The dominant spiral wave period of the GPB model falls within clinically relevant values for ventricular tachycardia (VT), but for the OVVR model, the dominant period is longer than periods associated with VT. Our results should facilitate choosing a model to match properties of interest in human cardiac tissue and to replicate arrhythmia behavior more closely. Furthermore, by indicating areas where existing models disagree, our findings suggest avenues for further experimental work.	[Elshrif, Mohamed M.] Rochester Inst Technol, B Thomas Golisano Coll Comp & Informat Sci, Rochester, NY 14623 USA; [Cherry, Elizabeth M.] Rochester Inst Technol, Sch Math Sci, Rochester, NY 14623 USA	Rochester Institute of Technology; Rochester Institute of Technology	Cherry, EM (corresponding author), Rochester Inst Technol, Sch Math Sci, Rochester, NY 14623 USA.	elizabeth.cherry@rit.edu			Libyan-North American Scholarship Program from the Ministry of Higher Education and Scientific Research in Libya; National Science Foundation [CMMI-1028261, OCI-1053575]; European Community's Seventh Framework Program [HEALTH-F2-2009-241526]; EUTrigTreat [HEALTH-F2-2009-241526]	Libyan-North American Scholarship Program from the Ministry of Higher Education and Scientific Research in Libya; National Science Foundation(National Science Foundation (NSF)); European Community's Seventh Framework Program(European Commission); EUTrigTreat	This study was supported by the Libyan-North American Scholarship Program from the Ministry of Higher Education and Scientific Research in Libya (M.M.E). This material is based upon work supported by the National Science Foundation under Grant Number CMMI-1028261 (E. M. C.) and the research leading to the results has received funding from the European Community's Seventh Framework Program FP7/20072013 under grant agreement No. HEALTH-F2-2009-241526, EUTrigTreat (E.M.C.). This work used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation grant number OCI-1053575. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernus O, 2002, AM J PHYSIOL-HEART C, V282, pH2296, DOI 10.1152/ajpheart.00731.2001; Bueno-Orovio A, 2008, J THEOR BIOL, V253, P544, DOI 10.1016/j.jtbi.2008.03.029; Bueno-Orovio A, 2006, SIAM J SCI COMPUT, V28, P886, DOI 10.1137/040607575; Bueno-Orovio A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052234; Cherry EM, 2008, PROG BIOPHYS MOL BIO, V98, P24, DOI 10.1016/j.pbiomolbio.2008.05.002; Cherry EM, 2008, J THEOR BIOL, V254, P674, DOI 10.1016/j.jtbi.2008.06.030; Cherry EM, 2007, AM J PHYSIOL-HEART C, V292, pH43, DOI 10.1152/ajpheart.00955.2006; Cherry EM, 2011, J THEOR BIOL, V285, P164, DOI 10.1016/j.jtbi.2011.06.039; Cherry EM, 2004, AM J PHYSIOL-HEART C, V286, pH2332, DOI 10.1152/ajpheart.00747.2003; Clayton RH, 2011, PROG BIOPHYS MOL BIO, V104, P22, DOI 10.1016/j.pbiomolbio.2010.05.008; Clayton RH, 1999, MED BIOL ENG COMPUT, V37, P354, DOI 10.1007/BF02513312; DROUIN E, 1995, J AM COLL CARDIOL, V26, P185, DOI 10.1016/0735-1097(95)00167-X; Fenton F, 1998, CHAOS, V8, P20, DOI 10.1063/1.166311; Fenton F.H., 2008, SCHOLARPEDIA, V3, P1868, DOI [10.4249/scholarpedia.1868, DOI 10.4249/SCHOLARPEDIA.1868]; Fenton FH, 2002, CHAOS, V12, P852, DOI 10.1063/1.1504242; Fink M, 2011, PROG BIOPHYS MOL BIO, V104, P2, DOI 10.1016/j.pbiomolbio.2010.03.002; FRANZ MR, 1988, J CLIN INVEST, V82, P972, DOI 10.1172/JCI113706; FRAZIER DW, 1989, J CLIN INVEST, V83, P1039, DOI 10.1172/JCI113945; Grandi E, 2010, J MOL CELL CARDIOL, V48, P112, DOI 10.1016/j.yjmcc.2009.09.019; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hund TJ, 2001, BIOPHYS J, V81, P3324, DOI 10.1016/S0006-3495(01)75965-6; Iyer V, 2004, BIOPHYS J, V87, P1507, DOI 10.1529/biophysj.104.043299; Janse MJ, 2011, HEART RHYTHM, V8, P934, DOI 10.1016/j.hrthm.2010.10.048; Jongsma HJ, 2000, CIRC RES, V86, P1193, DOI 10.1161/01.RES.86.12.1193; Koller ML, 2005, CIRCULATION, V112, P1542, DOI 10.1161/CIRCULATIONAHA.104.502831; Li GR, 1998, AM J PHYSIOL-HEART C, V275, pH369, DOI 10.1152/ajpheart.1998.275.2.H369; Nabauer M, 1996, CIRCULATION, V93, P168, DOI 10.1161/01.CIR.93.1.168; Nanthakumar K, 2004, HEART RHYTHM, V1, P14, DOI 10.1016/j.hrthm.2004.01.007; Nanthakumar K, 2007, AM J PHYSIOL-HEART C, V293, pH875, DOI 10.1152/ajpheart.01415.2006; Nash MP, 2006, EXP PHYSIOL, V91, P339, DOI 10.1113/expphysiol.2005.031070; Nattel S, 2011, HEART RHYTHM, V8, P1293, DOI 10.1016/j.hrthm.2011.06.002; Nygren A, 2001, PHILOS T ROY SOC A, V359, P1111, DOI 10.1098/rsta.2001.0819; O'Hara T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002061; Pak HN, 2004, J CARDIOVASC ELECTR, V15, P1357, DOI 10.1046/j.1540-8167.2004.03569.x; Pereon Y, 2000, AM J PHYSIOL-HEART C, V278, pH1908, DOI 10.1152/ajpheart.2000.278.6.H1908; Priebe L, 1998, CIRC RES, V82, P1206, DOI 10.1161/01.RES.82.11.1206; ROSENBAUM DS, 1994, NEW ENGL J MED, V330, P235, DOI 10.1056/NEJM199401273300402; RUSH S, 1978, IEEE T BIO-MED ENG, V25, P389, DOI 10.1109/TBME.1978.326270; SAKAKIBARA Y, 1993, AM J PHYSIOL, V265, pH1301, DOI 10.1152/ajpheart.1993.265.4.H1301; Taggart P, 2000, J MOL CELL CARDIOL, V32, P621, DOI 10.1006/jmcc.2000.1105; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; Ten Tusscher KHWJ, 2006, PROG BIOPHYS MOL BIO, V90, P326, DOI 10.1016/j.pbiomolbio.2005.05.015; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; Wilders R, 2007, MED BIOL ENG COMPUT, V45, P189, DOI 10.1007/s11517-006-0127-0; Wilson LD, 2011, HEART RHYTHM, V8, P930, DOI 10.1016/j.hrthm.2011.01.026; Yue AM, 2005, J AM COLL CARDIOL, V46, P1067, DOI 10.1016/j.jacc.2005.05.074	46	41	42	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84401	10.1371/journal.pone.0084401	http://dx.doi.org/10.1371/journal.pone.0084401			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416228	gold, Green Published, Green Submitted			2022-12-27	WOS:000329862500125
J	Hu, YJ; Tu, PC; Lin, CS; Guo, ST				Hu, Yuh-Jyh; Tu, Po-Chin; Lin, Chun-Sheng; Guo, Szu-Ting			Identification and Chronological Analysis of Genomic Signatures in Influenza A Viruses	PLOS ONE			English	Article							INTEGRAL MEMBRANE-PROTEIN; NS1 PROTEIN; POLYMERASE; BINDING; ORIGIN; SWINE; M1; M2; ADAPTATION; CRITERIA	An increase in the availability of data on the influenza A viruses (IAV) has enabled the identification of the potential determinants of IAV host specificity using computational approaches. In this study, we proposed an alternative approach, based on the adjusted Rand index (ARI), for the evaluation of genomic signatures of IAVs and their ability to distinguish hosts they infected. Our experiments showed that the host-specific signatures identified using the ARI were more characteristic of their hosts than those identified using previous measures. Our results provided updates on the host-specific genomic signatures in the internal proteins of the IAV based on the sequence data as of February 2013 in the National Center for Biotechnology Information (NCBI). Unlike other approaches for signature recognition, our approach considered not only the ability of signatures to distinguish hosts (according to the ARI), but also the chronological relationships among proteins. We identified novel signatures that could be mapped to known functional domains, and introduced a chronological analysis to investigate the changes in host-specific genomic signatures over time. Our chronological analytical approach provided results on the adaptive variability of signatures, which correlated with previous studies' findings, and indicated prospective adaptation trends that warrant further investigation.	[Hu, Yuh-Jyh; Lin, Chun-Sheng] Natl Chiao Tung Univ, Inst Biomed Engn, Hsinchu, Taiwan; [Hu, Yuh-Jyh; Tu, Po-Chin; Guo, Szu-Ting] Natl Chiao Tung Univ, Dept Comp Sci, Hsinchu, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Hu, YJ (corresponding author), Natl Chiao Tung Univ, Inst Biomed Engn, Hsinchu, Taiwan.	yhu@cs.nctu.edu.tw			National Science Council, Taiwan [NSC 102-2221-E-009-125]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was partially supported by National Science Council (www.nsc.gov.tw), Taiwan (NSC 102-2221-E-009-125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aragon T, 2000, MOL CELL BIOL, V20, P6259, DOI 10.1128/MCB.20.17.6259-6268.2000; Babon JAB, 2009, HUM IMMUNOL, V70, P711, DOI 10.1016/j.humimm.2009.06.004; Baudin F, 2001, VIROLOGY, V281, P102, DOI 10.1006/viro.2000.0804; Brown EG, 2001, P NATL ACAD SCI USA, V98, P6883, DOI 10.1073/pnas.111165798; Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921; Bussey KA, 2010, J VIROL, V84, P4395, DOI 10.1128/JVI.02642-09; Chen BJ, 2008, J VIROL, V82, P10059, DOI 10.1128/JVI.01184-08; Chen GW, 2006, EMERG INFECT DIS, V12, P1353, DOI 10.3201/eid1209.060276; Chen GW, 2009, EMERG INFECT DIS, V15, P1897, DOI 10.3201/eid1512.090845; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Deng YP, 1997, J IMMUNOL, V158, P1507; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finkelstein DB, 2007, J VIROL, V81, P10292, DOI 10.1128/JVI.00921-07; Forbes NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031839; Gabriel G, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1158; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gianfrani C, 2000, HUM IMMUNOL, V61, P438, DOI 10.1016/S0198-8859(00)00105-1; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Hudjetz B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002488; HULL JD, 1988, J CELL BIOL, V106, P1489, DOI 10.1083/jcb.106.5.1489; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; Kochs G, 2007, J VIROL, V81, P7011, DOI 10.1128/JVI.02581-06; LAMB RA, 1985, CELL, V40, P627, DOI 10.1016/0092-8674(85)90211-9; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Manz B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003279; Mehle A, 2008, CELL HOST MICROBE, V4, P111, DOI 10.1016/j.chom.2008.06.007; Mehle A, 2009, P NATL ACAD SCI USA, V106, P21312, DOI 10.1073/pnas.0911915106; MILLIGAN GW, 1986, MULTIVAR BEHAV RES, V21, P441, DOI 10.1207/s15327906mbr2104_5; Miotto O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009025; Naffakh N, 2008, ANNU REV MICROBIOL, V62, P403, DOI 10.1146/annurev.micro.62.081307.162746; NIETO A, 1994, J GEN VIROL, V75, P29, DOI 10.1099/0022-1317-75-1-29; PALESE P., 2007, FIELDS VIROLOGY, V2, P1647, DOI DOI 10.1371/JOURNAL.PPAT.1003019; Pan CE, 2010, PLOS ONE, V5, pA31, DOI 10.1371/journal.pone.0009549; Ping JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021740; Qian XY, 1995, RNA, V1, P948; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Reid AH, 2004, J VIROL, V78, P12462, DOI 10.1128/JVI.78.22.12462-12470.2004; SanzEzquerro JJ, 1996, J VIROL, V70, P1905, DOI 10.1128/JVI.70.3.1905-1911.1996; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; STRANDEN AM, 1993, VIROLOGY, V197, P642, DOI 10.1006/viro.1993.1639; Tamuri AU, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000564; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Thaa B, 2009, VIROLOGY, V383, P150, DOI 10.1016/j.virol.2008.10.001; Tian CL, 2003, PROTEIN SCI, V12, P2597, DOI 10.1110/ps.03168503; Yamada H, 2004, FEBS LETT, V578, P331, DOI 10.1016/j.febslet.2004.11.017; Zhou NN, 1999, J VIROL, V73, P8851, DOI 10.1128/JVI.73.10.8851-8856.1999	47	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84638	10.1371/journal.pone.0084638	http://dx.doi.org/10.1371/journal.pone.0084638			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416256	gold, Green Published, Green Submitted			2022-12-27	WOS:000329862500144
J	Jung, SK; Aleman-Meza, B; Riepe, C; Zhong, WW				Jung, Sang-Kyu; Aleman-Meza, Boanerges; Riepe, Celeste; Zhong, Weiwei			QuantWorm: A Comprehensive Software Package for Caenorhabditis elegans Phenotypic Assays	PLOS ONE			English	Article							EGG-LAYING BEHAVIOR; C-ELEGANS; PLC-BETA; G(Q)ALPHA; CELASTROL; PATHWAY; SYSTEM; G(O)ALPHA; DRUG	Phenotypic assays are crucial in genetics; however, traditional methods that rely on human observation are unsuitable for quantitative, large-scale experiments. Furthermore, there is an increasing need for comprehensive analyses of multiple phenotypes to provide multidimensional information. Here we developed an automated, high-throughput computer imaging system for quantifying multiple Caenorhabditis elegans phenotypes. Our imaging system is composed of a microscope equipped with a digital camera and a motorized stage connected to a computer running the QuantWorm software package. Currently, the software package contains one data acquisition module and four image analysis programs: WormLifespan, WormLocomotion, WormLength, and WormEgg. The data acquisition module collects images and videos. The WormLifespan software counts the number of moving worms by using two time-lapse images; the WormLocomotion software computes the velocity of moving worms; the WormLength software measures worm body size; and the WormEgg software counts the number of eggs. To evaluate the performance of our software, we compared the results of our software with manual measurements. We then demonstrated the application of the QuantWorm software in a drug assay and a genetic assay. Overall, the QuantWorm software provided accurate measurements at a high speed. Software source code, executable programs, and sample images are available at www.quantworm.org. Our software package has several advantages over current imaging systems for C. elegans. It is an all-in-one package for quantifying multiple phenotypes. The QuantWorm software is written in Java and its source code is freely available, so it does not require use of commercial software or libraries. It can be run on multiple platforms and easily customized to cope with new methods and requirements.	[Jung, Sang-Kyu; Aleman-Meza, Boanerges; Riepe, Celeste; Zhong, Weiwei] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA	Rice University	Zhong, WW (corresponding author), Rice Univ, Dept Biochem & Cell Biol, POB 1892, Houston, TX 77251 USA.	Weiwei.Zhong@rice.edu		Riepe, Celeste/0000-0001-8672-5392	National Institutes of Health [HG004724, DA018341]; Kinship foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R00HG004724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA018341] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kinship foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health grants HG004724 and DA018341 and by a Searle Scholar grant from the Kinship foundation to WZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison AC, 2001, PROG NEURO-PSYCHOPH, V25, P1341, DOI 10.1016/S0278-5846(01)00192-0; Bastiani C, 2006, HETEROTRIMERIC G PRO; Bastiani CA, 2003, GENETICS, V165, P1805; Bradley Derek, 2007, Journal of Graphics Tools, V12, P13; Brinker AM, 2007, PHYTOCHEMISTRY, V68, P732, DOI 10.1016/j.phytochem.2006.11.029; Ch'ng Q, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000283; Chase DL, 2001, CURR BIOL, V11, P222, DOI 10.1016/S0960-9822(01)00071-9; Daniels SA, 2000, GENETICS, V156, P123; Dong MQ, 2007, SCIENCE, V317, P660, DOI 10.1126/science.1139952; Feng ZY, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-115; Fujiwara M, 2002, NEURON, V36, P1091, DOI 10.1016/S0896-6273(02)01093-0; Gosai SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015460; Hajdu-Cronin YM, 1999, GENE DEV, V13, P1780, DOI 10.1101/gad.13.14.1780; He MF, 2009, J ETHNOPHARMACOL, V121, P61, DOI 10.1016/j.jep.2008.09.033; Hu S, 2011, GENETICS, V189, P137, DOI 10.1534/genetics.111.131227; Kawli T, 2010, P NATL ACAD SCI USA, V107, P13788, DOI 10.1073/pnas.0914715107; Kim DH, 2009, EUR J CLIN INVEST, V39, P819, DOI 10.1111/j.1365-2362.2009.02186.x; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; Lee J, 2004, J MOL BIOL, V344, P585, DOI 10.1016/j.jmb.2004.09.050; Mathew MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033483; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; Mohamed M, 2008, IEEE INT SYMP CIRC S, P1072, DOI 10.1109/ISCAS.2008.4541607; Moore BT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057142; Morck C, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-39; Perez-Mansilla B, 2009, ADV GENET, V65, P145, DOI 10.1016/S0065-2660(09)65004-5; Ramot D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002208; Sethi G, 2007, BLOOD, V109, P2727, DOI 10.1182/blood-2006-10-050807; Stiernagle T., 2006, WORMBOOK MAINTENANCE; Stroustrup N, 2013, NAT METHODS, V10, P665, DOI [10.1038/NMETH.2475, 10.1038/nmeth.2475]; Swierczek NA, 2011, NAT METHODS, V8, P592, DOI [10.1038/NMETH.1625, 10.1038/nmeth.1625]; Tsibidis GD, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-86; Wahlby C, 2012, NAT METHODS, V9, P714, DOI [10.1038/nmeth.1984, 10.1038/NMETH.1984]; Williams SL, 2007, GENE DEV, V21, P2731, DOI 10.1101/gad.1592007; Yu H, 2013, P NATL ACAD SCI US; Zhang S, 2012, CELL ISOLATION CULTU, P1	35	33	33	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84830	10.1371/journal.pone.0084830	http://dx.doi.org/10.1371/journal.pone.0084830			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416295	Green Published, gold			2022-12-27	WOS:000329862500176
J	Nielsen, A; Mansson, M; Bojer, MS; Gram, L; Larsen, TO; Novick, RP; Frees, D; Frokiaer, H; Ingmer, H				Nielsen, Anita; Mansson, Maria; Bojer, Martin S.; Gram, Lone; Larsen, Thomas O.; Novick, Richard P.; Frees, Dorte; Frokiaer, Hanne; Ingmer, Hanne			Solonamide B Inhibits Quorum Sensing and Reduces Staphylococcus aureus Mediated Killing of Human Neutrophils	PLOS ONE			English	Article							VIRULENCE GENE-EXPRESSION; ALPHA-HEMOLYSIN; ANTIBIOTIC-RESISTANCE; AUTOINDUCING PEPTIDES; FUTURE-PROSPECTS; AGR; INFECTIONS; STRAINS; DISEASE; TOXIN	Methicillin-resistant Staphylococcus aureus (MRSA) continues to be a serious human pathogen, and particularly the spread of community associated (CA)-MRSA strains such as USA300 is a concern, as these strains can cause severe infections in otherwise healthy adults. Recently, we reported that a cyclodepsipeptide termed Solonamide B isolated from the marine bacterium, Photobacterium halotolerans strongly reduces expression of RNAIII, the effector molecule of the agr quorum sensing system. Here we show that Solonamide B interferes with the binding of S. aureus autoinducing peptides (AIPs) to sensor histidine kinase, AgrC, of the agr two-component system. The hypervirulence of USA300 has been linked to increased expression of central virulence factors like a-hemolysin and the phenol soluble modulins (PSMs). Importantly, in strain USA300 Solonamide B dramatically reduced the activity of a-hemolysin and the transcription of psma encoding PSMs with an 80% reduction in toxicity of supernatants towards human neutrophils and rabbit erythrocytes. To our knowledge this is the first report of a compound produced naturally by a Gram-negative marine bacterium that interferes with agr and affects both RNAIII and AgrA controlled virulence gene expression in S. aureus.	[Nielsen, Anita; Bojer, Martin S.; Frees, Dorte; Frokiaer, Hanne; Ingmer, Hanne] Univ Copenhagen, Dept Vet Dis Biol, Fac Hlth & Med Sci, Copenhagen, Denmark; [Mansson, Maria; Gram, Lone; Larsen, Thomas O.] Tech Univ Denmark, Ctr Microbial Biotechnol, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Novick, Richard P.] NYU, Sch Med, Skirball Inst Biomol Med, New York, NY USA	University of Copenhagen; Technical University of Denmark; New York University	Ingmer, H (corresponding author), Univ Copenhagen, Dept Vet Dis Biol, Fac Hlth & Med Sci, Copenhagen, Denmark.	hi@sund.ku.dk		Frees, Dorte/0000-0003-4946-2890; Novick, richard/0000-0003-4418-7893; Gram, Lone/0000-0002-1076-5723; Frokiaer, Hanne/0000-0003-1472-9698; Bojer, Martin Saxtorph/0000-0002-8488-9593; Larsen, Thomas Ostenfeld/0000-0002-3362-5707; Ingmer, Hanne/0000-0002-8350-5631	Programme Committee for Food, Health and Welfare under the Danish Strategic Research Council	Programme Committee for Food, Health and Welfare under the Danish Strategic Research Council	This work was supported by funding from the Programme Committee for Food, Health and Welfare under the Danish Strategic Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Archer GL, 1998, CLIN INFECT DIS, V26, P1179, DOI 10.1086/520289; BERNHEIMER AW, 1963, J GEN MICROBIOL, V30, P455, DOI 10.1099/00221287-30-3-455; BHAKDI S, 1984, INFECT IMMUN, V46, P318, DOI 10.1128/IAI.46.2.318-323.1984; BHAKDI S, 1991, MICROBIOL REV, V55, P733, DOI 10.1128/MMBR.55.4.733-751.1991; Cegelski L, 2008, NAT REV MICROBIOL, V6, P17, DOI 10.1038/nrmicro1818; Chan PF, 1998, MICROBIOL-SGM, V144, P2469, DOI 10.1099/00221287-144-9-2469; Chan WC, 2004, J MED CHEM, V47, P4633, DOI 10.1021/jm0400754; Cheung GYC, 2011, INFECT IMMUN, V79, P1927, DOI 10.1128/IAI.00046-11; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; Deresinski S, 2006, DRUGS, V66, P1797, DOI 10.2165/00003495-200666140-00002; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; FIRON N, 1987, INFECT IMMUN, V55, P472, DOI 10.1128/IAI.55.2.472-476.1987; Fischetti V., 2006, GRAM POSITIVE PATHOG, V2nd; Geisinger E, 2009, P NATL ACAD SCI USA, V106, P1216, DOI 10.1073/pnas.0807760106; George EA, 2007, CHEMBIOCHEM, V8, P847, DOI 10.1002/cbic.200700023; Graves SF, 2010, J MOL MED, V88, P109, DOI 10.1007/s00109-009-0573-x; Hentzer M, 2003, EMBO J, V22, P3803, DOI 10.1093/emboj/cdg366; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Janeway JC, 2005, IMMUNO BIOL IMMUNE S; Jarraud S, 2000, J BACTERIOL, V182, P6517, DOI 10.1128/JB.182.22.6517-6522.2000; Jarry TM, 2008, CELL MICROBIOL, V10, P1801, DOI 10.1111/j.1462-5822.2008.01166.x; Jelsbak L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012752; Jensen RO, 2008, J MOL BIOL, V381, P300, DOI 10.1016/j.jmb.2008.06.018; Ji GY, 1995, P NATL ACAD SCI USA, V92, P12055, DOI 10.1073/pnas.92.26.12055; Ji GY, 1997, SCIENCE, V276, P2027, DOI 10.1126/science.276.5321.2027; Kazakova SV, 2005, NEW ENGL J MED, V352, P468, DOI 10.1056/NEJMoa042859; Krucke GW, 2009, AM J EMERG MED, V27, P344, DOI 10.1016/j.ajem.2008.03.046; Loughman JA, 2009, J INFECT DIS, V199, P294, DOI 10.1086/595982; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Lowy FD, 2007, NAT MED, V13, P1418, DOI 10.1038/nm1207-1418; Lyon GJ, 2000, P NATL ACAD SCI USA, V97, P13330, DOI 10.1073/pnas.97.24.13330; Lyon GJ, 2002, BIOCHEMISTRY-US, V41, P10095, DOI 10.1021/bi026049u; Mansson M, 2011, MAR DRUGS, V9, P2537, DOI 10.3390/md9122537; Mayville P, 1999, P NATL ACAD SCI USA, V96, P1218, DOI 10.1073/pnas.96.4.1218; Moran GJ, 2005, EMERG INFECT DIS, V11, P928; Nielsen A, 2010, ANTIMICROB AGENTS CH, V54, P509, DOI 10.1128/AAC.00940-09; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; NOVICK RP, 1967, J EXP MED, V125, P45, DOI 10.1084/jem.125.1.45; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Queck SY, 2008, MOL CELL, V32, P150, DOI 10.1016/j.molcel.2008.08.005; Ragle BE, 2009, INFECT IMMUN, V77, P2712, DOI 10.1128/IAI.00115-09; Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013; RECSEI P, 1986, MOL GEN GENET, V202, P58, DOI 10.1007/BF00330517; Sakoulas G, 2008, CLIN INFECT DIS, V46, pS360, DOI 10.1086/533592; Shoham M, 2011, FUTURE MED CHEM, V3, P775, DOI [10.4155/FMC.11.43, 10.4155/fmc.11.43]; THOMPSON RL, 1982, ANN INTERN MED, V97, P309, DOI 10.7326/0003-4819-97-3-309; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Werner G, 2008, FUTURE MICROBIOL, V3, P547, DOI 10.2217/17460913.3.5.547	52	66	67	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84992	10.1371/journal.pone.0084992	http://dx.doi.org/10.1371/journal.pone.0084992			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416329	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500202
J	Rauhamaki, V; Wolfram, J; Jokitalo, E; Hanski, I; Dahlhoff, EP				Rauhamaki, Virve; Wolfram, Joy; Jokitalo, Eija; Hanski, Ilkka; Dahlhoff, Elizabeth P.			Differences in the Aerobic Capacity of Flight Muscles between Butterfly Populations and Species with Dissimilar Flight Abilities	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; PHOSPHOGLUCOSE ISOMERASE PGI; RESPIRATORY-CHAIN ENZYMES; HONEYBEES APIS-MELLIFERA; DISPERSAL RATE; INSECT FLIGHT; EVOLUTIONARY DYNAMICS; FITNESS DIFFERENCES; ENERGY-METABOLISM; GENETIC-VARIATION	Habitat loss and climate change are rapidly converting natural habitats and thereby increasing the significance of dispersal capacity for vulnerable species. Flight is necessary for dispersal in many insects, and differences in dispersal capacity may reflect dissimilarities in flight muscle aerobic capacity. In a large metapopulation of the Glanville fritillary butterfly in the A land Islands in Finland, adults disperse frequently between small local populations. Individuals found in newly established populations have higher flight metabolic rates and field-measured dispersal distances than butterflies in old populations. To assess possible differences in flight muscle aerobic capacity among Glanville fritillary populations, enzyme activities and tissue concentrations of the mitochondrial protein Cytochrome-c Oxidase (CytOx) were measured and compared with four other species of Nymphalid butterflies. Flight muscle structure and mitochondrial density were also examined in the Glanville fritillary and a long-distance migrant, the red admiral. Glanville fritillaries from new populations had significantly higher aerobic capacities than individuals from old populations. Comparing the different species, strong-flying butterfly species had higher flight muscle CytOx content and enzymatic activity than short-distance fliers, and mitochondria were larger and more numerous in the flight muscle of the red admiral than the Glanville fritillary. These results suggest that superior dispersal capacity of butterflies in new populations of the Glanville fritillary is due in part to greater aerobic capacity, though this species has a low aerobic capacity in general when compared with known strong fliers. Low aerobic capacity may limit dispersal ability of the Glanville fritillary.	[Rauhamaki, Virve] Univ Helsinki, Inst Biotechnol, Struct Biol & Biophys Program, Helsinki Bioenerget Grp, Helsinki, Finland; [Wolfram, Joy; Hanski, Ilkka; Dahlhoff, Elizabeth P.] Univ Helsinki, Dept Biosci, Metapopulat Res Grp, Helsinki, Finland; [Jokitalo, Eija] Univ Helsinki, Inst Biotechnol, Electron Microscopy Unit, Helsinki, Finland; [Dahlhoff, Elizabeth P.] Santa Clara Univ, Dept Biol, Santa Clara, CA 95053 USA	University of Helsinki; University of Helsinki; University of Helsinki; Santa Clara University	Dahlhoff, EP (corresponding author), Univ Helsinki, Dept Biosci, Metapopulat Res Grp, Helsinki, Finland.	edahlhoff@scu.edu	Wolfram, Joy/I-1574-2019; Dahlhoff, Elizabeth/AAI-1636-2020; Jokitalo, Eija/C-8375-2009	Wolfram, Joy/0000-0003-0579-9897; Dahlhoff, Elizabeth/0000-0002-7019-5005; Jokitalo, Eija/0000-0002-4159-6934	European Research Council [232826]; Academy of Finland [131155, 38604, 44887]; Sigrid Juselius Foundation; Biocentrum Helsinki; Fulbright U.S. Scholar Program (Dahlhoff); Division Of Environmental Biology [0844406] Funding Source: National Science Foundation	European Research Council(European Research Council (ERC)European Commission); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Biocentrum Helsinki; Fulbright U.S. Scholar Program (Dahlhoff); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was supported by the European Research Council (AdG grant number 232826 to Hanski), Academy of Finland (Finnish CoE Programme, grant numbers 131155, 38604 and 44887 to Hanski), Sigrid Juselius Foundation and Biocentrum Helsinki, and the Fulbright U.S. Scholar Program (Dahlhoff). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnio H, 2011, BUTTERFLIES EUROPE P; Asher J, 2001, MILLENNIUM ATLAS BUT; Asher J, 2011, J INSECT CONSERV, V15, P291, DOI 10.1007/s10841-010-9346-7; Austin A, 2011, OIKOS, V120, P1357, DOI 10.1111/j.1600-0706.2010.18992.x; BARTHOLOMEW GA, 1978, J EXP BIOL, V76, P11; Billeter Regula, 2003, Bulletin of the Geobotanical Institute ETH, V69, P45; Brattstrom O, 2010, ECOL ENTOMOL, V35, P248, DOI 10.1111/j.1365-2311.2009.01163.x; Brower LP, 2006, INTEGR COMP BIOL, V46, P1123, DOI 10.1093/icb/icl029; BROWN W D, 1990, Journal of Research on the Lepidoptera, V29, P1; Chown S.L., 2004, INSECT PHYSL ECOLOGY, DOI DOI 10.1002/joc.5086; Dahlhoff EP, 2007, J BIOSCIENCES, V32, P477, DOI 10.1007/s12038-007-0047-7; Dahlhoff EP, 2000, P NATL ACAD SCI USA, V97, P10056, DOI 10.1073/pnas.160277697; Dudley R, 2000, ANNU REV PHYSIOL, V62, P135, DOI 10.1146/annurev.physiol.62.1.135; Eanes WF, 1999, ANNU REV ECOL SYST, V30, P301, DOI 10.1146/annurev.ecolsys.30.1.301; Gibbs M, 2010, OECOLOGIA, V163, P341, DOI 10.1007/s00442-010-1613-5; Guerra PA, 2009, BIOL LETTERS, V5, P229, DOI 10.1098/rsbl.2008.0570; Haag CR, 2005, P ROY SOC B-BIOL SCI, V272, P2449, DOI 10.1098/rspb.2005.3235; HANSKI I, 1994, ECOLOGY, V75, P747, DOI 10.2307/1941732; Hanski I, 2004, ECOL LETT, V7, P958, DOI 10.1111/j.1461-0248.2004.00654.x; Hanski I, 2002, OIKOS, V98, P87, DOI 10.1034/j.1600-0706.2002.980109.x; Hanski I., 1999, METAPOPULATION ECOLO; Hanski I, 2006, PLOS BIOL, V4, P719, DOI 10.1371/journal.pbio.0040129; Hanski I, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P290; Hanski I, 2011, ECOL LETT, V14, P1025, DOI 10.1111/j.1461-0248.2011.01671.x; Hanski IA, 2011, P NATL ACAD SCI USA, V108, P14397, DOI 10.1073/pnas.1110020108; Heidl SJ, 2013, EFFECTS LOCAL ENV GE; JOOS B, 1987, J EXP BIOL, V133, P317; Kallioniemi E, 2011, FUNCT ECOL, V25, P1032, DOI 10.1111/j.1365-2435.2011.01854.x; Karl I, 2008, OIKOS, V117, P778, DOI 10.1111/j.0030-1299.2008.16522.x; Karl I, 2010, POPUL ECOL, V52, P307, DOI 10.1007/s10144-009-0191-z; Karl I, 2009, ECOGRAPHY, V32, P488, DOI 10.1111/j.1600-0587.2008.05660.x; Keppel J., 1997, DATA ANAL RES DESIGN; Klemme I, 2009, J EVOLUTION BIOL, V22, P1944, DOI 10.1111/j.1420-9101.2009.01807.x; Marden JH, 2013, EVOLUTION, V67, P1105, DOI 10.1111/evo.12004; Marden JH, 2000, ANNU REV PHYSIOL, V62, P157, DOI 10.1146/annurev.physiol.62.1.157; Mikkola K, 2003, EUR J ENTOMOL, V100, P625, DOI 10.14411/eje.2003.091; Niitepold K, 2011, OECOLOGIA, V165, P847, DOI 10.1007/s00442-010-1886-8; Niitepold K, 2010, J EXP BIOL, V213, P1042, DOI 10.1242/jeb.034132; Niitepold K, 2009, ECOLOGY, V90, P2223, DOI 10.1890/08-1498.1; Niven JE, 2005, BIOL LETTERS, V1, P346, DOI 10.1098/rsbl.2005.0311; O'Brien DM, 1999, J EXP BIOL, V202, P441; OBRIEN J, 1991, PHYSIOL ZOOL, V64, P1509, DOI 10.1086/physzool.64.6.30158227; Orsini L, 2009, J EVOLUTION BIOL, V22, P367, DOI 10.1111/j.1420-9101.2008.01653.x; Ovaskainen O, 2008, P NATL ACAD SCI USA, V105, P19090, DOI 10.1073/pnas.0802066105; Pichaud N, 2010, J EXP BIOL, V213, P1665, DOI 10.1242/jeb.040261; Saastamoinen M, 2008, HEREDITY, V100, P39, DOI 10.1038/sj.hdy.6801056; Saastamoinen M, 2008, AM NAT, V171, pE701, DOI 10.1086/587531; Saastamoinen M, 2009, P ROY SOC B-BIOL SCI, V276, P1313, DOI 10.1098/rspb.2008.1464; Sacktor B, 1976, Biochem Soc Symp, P111; Shreeve TG, 2001, J INSECT CONSERV, V5, P145, DOI 10.1023/A:1017556113534; Sogl B, 2000, EUR J BIOCHEM, V267, P11, DOI 10.1046/j.1432-1327.2000.00936.x; Stefanescu C, 2001, ECOL ENTOMOL, V26, P525, DOI 10.1046/j.1365-2311.2001.00347.x; Suarez RK, 2011, J EXP BIOL, V214, P172, DOI 10.1242/jeb.047936; Suarez RK, 2005, J EXP BIOL, V208, P3573, DOI 10.1242/jeb.01775; Suarez RK, 2000, PHYSIOL BIOCHEM ZOOL, V73, P765, DOI 10.1086/318112; Suarez RK, 1999, J EXP ZOOL, V284, P1, DOI 10.1002/(SICI)1097-010X(19990615)284:1&lt;1::AID-JEZ1&gt;3.0.CO;2-P; Suarez RK, 2000, J EXP BIOL, V203, P905; Sutcliffe OL, 1996, CONSERV BIOL, V10, P1359, DOI 10.1046/j.1523-1739.1996.10051359.x; Sutcliffe OL, 1997, OECOLOGIA, V109, P235, DOI 10.1007/s004420050078; TAYLOR CR, 1987, ANNU REV PHYSIOL, V49, P135, DOI 10.1146/annurev.ph.49.030187.001031; Van Dyck S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013923; Vandewoestijne S, 1999, MOL ECOL, V8, P1539, DOI 10.1046/j.1365-294x.1999.00725.x; Vogt JT, 2000, J INSECT PHYSIOL, V46, P697, DOI 10.1016/S0022-1910(99)00158-4; Wang RJ, 2011, ECOL ENTOMOL, V36, P251, DOI 10.1111/j.1365-2311.2011.01267.x; Watt Ward B., 2003, P319; WATT WB, 1992, P NATL ACAD SCI USA, V89, P10608, DOI 10.1073/pnas.89.22.10608; WATT WB, 1977, GENETICS, V87, P177; Wheat CW, 2011, MOL ECOL, V20, P1813, DOI 10.1111/j.1365-294X.2011.05062.x; Wheat CW, 2010, CONSERV GENET, V11, P387, DOI 10.1007/s10592-009-0042-7; Wheat CW, 2006, MOL BIOL EVOL, V23, P499, DOI 10.1093/molbev/msj062; Wilson RJ, 2004, NATURE, V432, P393, DOI 10.1038/nature03031; Zera AJ, 1997, ANNU REV ENTOMOL, V42, P207, DOI 10.1146/annurev.ento.42.1.207; Zera AJ, 2007, ANNU REV ECOL EVOL S, V38, P793, DOI 10.1146/annurev.ecolsys.38.091206.095615; Zheng CZ, 2009, PHILOS T R SOC B, V364, P1519, DOI 10.1098/rstb.2009.0005	74	12	12	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e78069	10.1371/journal.pone.0078069	http://dx.doi.org/10.1371/journal.pone.0078069			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416122	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500003
J	Redmond, EM; Liu, WM; Hamm, K; Hatch, E; Cahill, PA; Morrow, D				Redmond, Eileen M.; Liu, Weimin; Hamm, Katie; Hatch, Ekaterina; Cahill, Paul A.; Morrow, David			Perivascular Delivery of Notch 1 siRNA Inhibits Injury-Induced Arterial Remodeling	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; IN-VITRO; GROWTH-FACTOR; EXPRESSION; APOPTOSIS; RESTENOSIS; PROLIFERATION; PATHWAY; INTIMA; ATHEROSCLEROSIS	Objectives: To determine the efficacy of perivascular delivery of Notch 1 siRNA in preventing injury-induced arterial remodeling. Methods and Results: Carotid artery ligation was performed to induce arterial remodeling. After 14 days, morphometric analysis confirmed increased vSMC growth and subsequent media thickening and neointimal formation. Laser capture microdissection, quantitative qRT-PCR and immunoblot analysis of medial tissue revealed a significant increase in Notch1 receptor and notch target gene, Hrt 1 and 2 expression in the injured vessels. Perivascular delivery of Notch 1 siRNA by pluronic gel inhibited the injury-induced increase in Notch 1 receptor and target gene expression when compared to scrambled siRNA controls while concomitantly reducing media thickening and neointimal formation to pre-injury, sham-operated levels. Selective Notch 1 knockdown also reversed the injury-induced inhibition of pro-apoptotic Bax expression while decreasing injury-induced anti-apoptotic Bcl-XL expression to sham-operated control levels. In parallel experiments, proliferative cyclin levels, as measured by PCNA expression, were reversed to sham-operated control levels following selective Notch 1 knockdown. Conclusion: These results suggest that injury-induced arterial remodeling can be successfully inhibited by localized perivascular delivery of Notch 1 siRNA.	[Redmond, Eileen M.; Liu, Weimin; Hamm, Katie; Hatch, Ekaterina; Morrow, David] Univ Rochester, Med Ctr, Dept Surg, Rochester, NY 14642 USA; [Cahill, Paul A.] Dublin City Univ, Vasc Hlth Res Ctr, Dublin 9, Ireland	University of Rochester; Dublin City University	Morrow, D (corresponding author), Univ Rochester, Med Ctr, Dept Surg, Rochester, NY 14642 USA.	david_morrow@urmc.rochester.edu	Cahill, Paul A/E-8061-2011	Cahill, Paul A/0000-0002-5385-6502; Redmond, Eileen M/0000-0001-8642-4418	National Institutes of Health [R00HL095650, R21AA020365]; Science Foundation Ireland [SFI-11/PI/1128]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL095650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA020365] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported in part by funds from the National Institutes of Health (R00HL095650 to D. M.) and (R21AA020365 TO E. R) and Science Foundation Ireland (SFI-11/PI/1128 to PAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acampora KB, 2010, ANN VASC SURG, V24, P116, DOI 10.1016/j.avsg.2009.07.019; Anderson LM, 2007, J CLIN INVEST, V117, P299, DOI 10.1172/JCI31288; Andres V, 1998, INT J MOL MED, V2, P81; Brown LA, 2000, MECH DEVELOP, V90, P237, DOI 10.1016/S0925-4773(99)00256-7; Dangas G, 2002, CIRCULATION, V105, P2586, DOI 10.1161/01.CIR.0000019122.00032.DF; Doi H, 2009, BIOCHEM BIOPH RES CO, V381, P654, DOI 10.1016/j.bbrc.2009.02.116; Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904; Goldie LC, 2008, ORGANOGENESIS, V4, P257, DOI [DOI 10.4161/ORG.4.4.7416, DOI 10.4161/org.4.4.7416]; Iso T, 2003, ARTERIOSCL THROM VAS, V23, P543, DOI 10.1161/01.ATV.0000060892.81529.8F; Korshunov VA, 2003, ARTERIOSCL THROM VAS, V23, P2185, DOI 10.1161/01.ATV.0000103120.06092.14; Korshunov VA, 2008, CURR OPIN HEMATOL, V15, P250, DOI 10.1097/MOH.0b013e3282f97d71; Leng Q, 2009, DRUG FUTURE, V34, P721, DOI 10.1358/dof.2009.034.09.1413267; Li YX, 2009, CIRCULATION, V119, P2686, DOI 10.1161/CIRCULATIONAHA.108.790485; Marx SO, 2011, CIRC-CARDIOVASC INTE, V4, P104, DOI 10.1161/CIRCINTERVENTIONS.110.957332; McGrath JC, 2005, EXP PHYSIOL, V90, P469, DOI 10.1113/expphysiol.2005.030130; Morrow D, 2005, ARTERIOSCL THROM VAS, V25, pE86; Morrow D, 2005, AM J PHYSIOL-CELL PH, V289, pC1188, DOI 10.1152/ajpcell.00198.2005; Morrow D, 2005, CIRC RES, V96, P567, DOI 10.1161/01.RES.0000159182.98874.43; Morrow D, 2010, ARTERIOSCL THROM VAS, V30, P2597, DOI 10.1161/ATVBAHA.110.215681; Morrow D, 2009, ARTERIOSCL THROM VAS, V29, P1112, DOI 10.1161/ATVBAHA.109.186890; Morrow D, 2008, CIRC RES, V103, P1370, DOI 10.1161/CIRCRESAHA.108.187534; Outtz HH, 2010, J IMMUNOL, V185, P4363, DOI 10.4049/jimmunol.1000720; Perumalsamy LR, 2010, P NATL ACAD SCI USA, V107, P6882, DOI 10.1073/pnas.0910060107; Pollman MJ, 1998, NAT MED, V4, P222, DOI 10.1038/nm0298-222; Redmond E, 2013, ATHEROSCLEROSIS THRO; Schwartz S M, 2000, Curr Atheroscler Rep, V2, P422, DOI 10.1007/s11883-000-0081-5; SCHWARTZ SM, 1995, CIRC RES, V77, P445, DOI 10.1161/01.RES.77.3.445; Smolock EM, 2012, CIRCULATION, V126, P2418, DOI 10.1161/CIRCULATIONAHA.112.125971; Sweeney C, 2004, FASEB J, V18, P1421, DOI 10.1096/fj.04-1700fje; Takeshita K, 2007, CIRC RES, V100, P70, DOI 10.1161/01.RES.0000254788.47304.6e; Wang WL, 2003, BIOCHEM BIOPH RES CO, V308, P596, DOI 10.1016/S0006-291X(03)01453-0; Wang WL, 2002, J BIOL CHEM, V277, P21723, DOI 10.1074/jbc.M202224200; Wang WL, 2002, J BIOL CHEM, V277, P23165, DOI 10.1074/jbc.M201409200; Ward MR, 2000, CIRCULATION, V102, P1186, DOI 10.1161/01.CIR.102.10.1186; Yang Cheng, 2001, Chinese Medical Sciences Journal, V16, P182	35	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84122	10.1371/journal.pone.0084122	http://dx.doi.org/10.1371/journal.pone.0084122			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416200	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500101
J	Shitikov, EA; Bespyatykh, JA; Ischenko, DS; Alexeev, DG; Karpova, IY; Kostryukova, ES; Isaeva, YD; Nosova, EY; Mokrousov, IV; Vyazovaya, AA; Narvskaya, OV; Vishnevsky, BI; Otten, TF; Zhuravlev, VY; Yablonsky, PK; Ilina, EN; Govorun, VM				Shitikov, Egor A.; Bespyatykh, Julia A.; Ischenko, Dmitry S.; Alexeev, Dmitry G.; Karpova, Irina Y.; Kostryukova, Elena S.; Isaeva, Yulia D.; Nosova, Elena Y.; Mokrousov, Igor V.; Vyazovaya, Anna A.; Narvskaya, Olga V.; Vishnevsky, Boris I.; Otten, Tatiana F.; Zhuravlev, Valery Y.; Yablonsky, Peter K.; Ilina, Elena N.; Govorun, Vadim M.			Unusual Large-Scale Chromosomal Rearrangements in Mycobacterium tuberculosis Beijing B0/W148 Cluster Isolates	PLOS ONE			English	Article							DRUG-RESISTANT TUBERCULOSIS; GENETIC DIVERSITY; GENOME ANALYSIS; STRAIN; EPIDEMIOLOGY; EVOLUTION; RUSSIA; FAMILY; DELETIONS; ALIGNMENT	The Mycobacterium tuberculosis (MTB) Beijing family isolates are geographically widespread, and there are examples of Beijing isolates that are hypervirulent and associated with drug resistance. One-fourth of Beijing genotype isolates found in Russia belong to the B0/W148 group. The aim of the present study was to investigate features of these endemic strains on a genomic level. Four Russian clinical isolates of this group were sequenced, and the data obtained was compared with published sequences of various MTB strain genomes, including genome of strain W-148 of the same B0/W148 group. The comparison of the W-148 and H37Rv genomes revealed two independent inversions of large segments of the chromosome. The same inversions were found in one of the studied strains after deep sequencing using both the fragment and mate-paired libraries. Additionally, inversions were confirmed by RFLP hybridization analysis. The discovered rearrangements were verified by PCR in all four newly sequenced strains in the study and in four additional strains of the same Beijing B0/W148 group. The other 32 MTB strains from different phylogenetic lineages were tested and revealed no inversions. We suggest that the initial largest inversion changed the orientation of the three megabase (Mb) segment of the chromosome, and the second one occurred in the previously inverted region and partly restored the orientation of the 2.1 Mb inner segment of the region. This is another remarkable example of genomic rearrangements in the MTB in addition to the recently published of large-scale duplications. The described cases suggest that large-scale genomic rearrangements in the currently circulating MTB isolates may occur more frequently than previously considered, and we hope that further studies will help to determine the exact mechanism of such events.	[Shitikov, Egor A.; Bespyatykh, Julia A.; Ischenko, Dmitry S.; Alexeev, Dmitry G.; Karpova, Irina Y.; Kostryukova, Elena S.; Ilina, Elena N.; Govorun, Vadim M.] Res Inst Phys Chem Med, Moscow, Russia; [Ischenko, Dmitry S.; Alexeev, Dmitry G.] Moscow Inst Phys & Technol, Dolgoprudnyi, Russia; [Isaeva, Yulia D.; Nosova, Elena Y.] Moscow Sci Pract Ctr Treatment TB Moscow Healthca, Moscow, Russia; [Mokrousov, Igor V.; Vyazovaya, Anna A.; Narvskaya, Olga V.] St Petersburg Pasteur Inst, St Petersburg, Russia; [Vishnevsky, Boris I.; Otten, Tatiana F.; Zhuravlev, Valery Y.; Yablonsky, Peter K.] Res Inst Phthisiopulmonol, St Petersburg, Russia	Lopukhin Federal Research & Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency; Moscow Institute of Physics & Technology; Saint-Petersburg Pasteur Institute; St. Petersburg State Research Institute of Phthisiopulmonology	Shitikov, EA (corresponding author), Res Inst Phys Chem Med, Moscow, Russia.	egorshtkv@gmail.com	Shitikov, Egor/AAJ-4171-2021; Alexeev, Dmitry/A-6167-2013; Kostryukova, Elena/D-8064-2014; Narvskaya, Olga/H-1770-2012; Ilina, Elena/ABI-1172-2020; Govorun, Vadim M/A-9043-2018; Zhuravlev, Viacheslav Y./H-1223-2017; Bespyatykh, Julia A/Q-8132-2016; Yablonskiy, Petr/T-8804-2017; Mokrousov, Igor/J-3640-2014; Ilina, Elena N/N-8190-2015; Mokrousov, Igor/Q-5941-2019; Shitikov, Egor/Q-2520-2017	Shitikov, Egor/0000-0002-4865-6004; Alexeev, Dmitry/0000-0003-0783-1176; Kostryukova, Elena/0000-0002-0457-6803; Narvskaya, Olga/0000-0002-0830-5808; Ilina, Elena/0000-0003-0130-5079; Bespyatykh, Julia A/0000-0002-4408-503X; Yablonskiy, Petr/0000-0003-4385-9643; Mokrousov, Igor/0000-0001-5924-0576; Ilina, Elena N/0000-0003-0130-5079; Mokrousov, Igor/0000-0001-5924-0576; Shitikov, Egor/0000-0002-4865-6004; Zhuravlev, Viacheslav/0000-0001-6906-6225	Ministry of Education and Science of the Russian Federation [16.522.11.2003]; European Commission (ORCHID project) [261378]	Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); European Commission (ORCHID project)(European Commission)	This work was partly supported by 16.522.11.2003 grant of the Ministry of Education and Science of the Russian Federation; and by the European Commission (ORCHID project, Grant Agreement No. 261378). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Brosch R, 1999, INFECT IMMUN, V67, P5768, DOI 10.1128/IAI.67.11.5768-5774.1999; Brosch R, 2000, YEAST, V17, P111, DOI 10.1002/1097-0061(20000630)17:2<111::AID-YEA17>3.0.CO;2-G; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Casali N, 2012, GENOME RES, V22, P735, DOI 10.1101/gr.128678.111; Coyne S, 2010, MICROBIOL-SGM, V156, P1448, DOI 10.1099/mic.0.033639-0; Cui LZ, 2012, P NATL ACAD SCI USA, V109, pE1647, DOI 10.1073/pnas.1204307109; DALE JW, 1995, EUR RESPIR J, V8, pS633; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Domenech P, 2010, J BACTERIOL, V192, P4562, DOI 10.1128/JB.00536-10; Dos Vultos T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001538; Eisen JA, 2000, GENOME BIOL, V1; Fang Z, 1999, J BACTERIOL, V181, P1014, DOI 10.1128/JB.181.3.1014-1020.1999; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Garcia-Betancur JC, 2012, INFECT GENET EVOL, V12, P819, DOI 10.1016/j.meegid.2011.09.024; Hsu CY, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00236; Ilina EN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056577; Ioerger TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007778; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kurepina NE, 2001, INT J TUBERC LUNG D, V5, pS41; Kurokawa S, 2013, MAR BIOTECHNOL, V15, P596, DOI 10.1007/s10126-013-9511-6; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lasunskaia E, 2010, MICROBES INFECT, V12, P467, DOI 10.1016/j.micinf.2010.02.008; Mokrousov I, 2013, CLIN MICROBIOL REV, V26, P342, DOI 10.1128/CMR.00087-12; Muttucumaru DGN, 2004, CURR ISSUES MOL BIOL, V6, P145; Nalbantoglu U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009007; Narvskaia O V, 1999, Probl Tuberk, P39; Narvskaya O, 2005, TRENDS IN DNA FINGERPRINTING RESEARCH, P111; Narvskaya O, 2002, EUR J CLIN MICROBIOL, V21, P596, DOI 10.1007/s10096-002-0775-4; Pardini M, 2009, TUBERCULOSIS, V89, P317, DOI 10.1016/j.tube.2009.04.002; Smirnov G B, 2010, Mol Gen Mikrobiol Virusol, P11; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Thomas JM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-21; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Wang XM, 2008, TUBERCULOSIS, V88, P399, DOI 10.1016/j.tube.2008.02.003; Weiner B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0026038	40	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84971	10.1371/journal.pone.0084971	http://dx.doi.org/10.1371/journal.pone.0084971			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416324	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500198
J	Vellichirammal, NN; Zera, AJ; Schilder, RJ; Wehrkamp, C; Riethoven, JJM; Brisson, JA				Vellichirammal, Neetha Nanoth; Zera, Anthony J.; Schilder, Rudolf J.; Wehrkamp, Cody; Riethoven, Jean-Jack M.; Brisson, Jennifer A.			De Novo Transcriptome Assembly from Fat Body and Flight Muscles Transcripts to Identify Morph-Specific Gene Expression Profiles in Gryllus firmus	PLOS ONE			English	Article							WING-POLYMORPHIC CRICKET; HISTORY TRADE-OFFS; HEMOLYMPH JH TITER; LIFE-HISTORY; INTERMEDIARY METABOLISM; RNA-SEQ; LIPID BIOSYNTHESIS; REPRODUCTION; DISPERSAL; CAPABILITY	Wing polymorphism is a powerful model for examining many aspects of adaptation. The wing dimorphic cricket species, Gryllus firmus, consists of a long-winged morph with functional flight muscles that is capable of flight, and two flightless morphs. One (obligately) flightless morph emerges as an adult with vestigial wings and vestigial flight muscles. The other (plastic) flightless morph emerges with fully-developed wings but later in adulthood histolyzes its flight muscles. Importantly both flightless morphs have substantially increased reproductive output relative to the flight-capable morph. Much is known about the physiological and biochemical differences between the morphs with respect to adaptations for flight versus reproduction. In contrast, little is known about the molecular genetic basis of these morph-specific adaptations. To address this issue, we assembled a de novo transcriptome of G. firmus using 141.5 million Illumina reads generated from flight muscles and fat body, two organs that play key roles in flight and reproduction. We used the resulting 34,411 transcripts as a reference transcriptome for differential gene expression analyses. A comparison of gene expression profiles from functional flight muscles in the flight-capable morph versus histolyzed flight muscles in the plastic flight incapable morph identified a suite of genes involved in respiration that were highly expressed in pink (functional) flight muscles and genes involved in proteolysis highly expressed in the white (histolyzed) flight muscles. A comparison of fat body transcripts from the obligately flightless versus the flight-capable morphs revealed differential expression of genes involved in triglyceride biosynthesis, lipid transport, immune function and reproduction. These data provide a valuable resource for future molecular genetics research in this and related species and provide insight on the role of gene expression in morph-specific adaptations for flight versus reproduction.	[Vellichirammal, Neetha Nanoth; Zera, Anthony J.; Wehrkamp, Cody; Riethoven, Jean-Jack M.; Brisson, Jennifer A.] Univ Nebraska, Sch Biol Sci, Lincoln, NE USA; [Riethoven, Jean-Jack M.] Univ Nebraska, Bioinformat Core Res Facil, Lincoln, NE USA; [Schilder, Rudolf J.] Penn State Univ, Dept Biol, State Coll, PA USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Brisson, JA (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.	jennifer.brisson@gmail.com	/M-7215-2019	Riethoven, Jean-Jack/0000-0002-2709-7880; Brisson, Jennifer/0000-0001-7000-0709; Nanoth Vellichirammal, Neetha/0000-0002-5740-7093	School of Biological Sciences, UNL; NSF [IOS-1121960]; Nebraska Research Initiative	School of Biological Sciences, UNL; NSF(National Science Foundation (NSF)); Nebraska Research Initiative	Financial support for this study was provided by start up funds to JAB from the School of Biological Sciences, UNL, and NSF grant IOS-1121960 to AJZ. Part of the bioinformatics analysis was performed by the Bioinformatics research core facility in the UNL Center for Biotechnology and was partially supported by funding from the Nebraska Research Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Badisco L, 2008, J MOL ENDOCRINOL, V40, P137, DOI 10.1677/JME-07-0161; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brisson JA, 2007, EVOL DEV, V9, P338, DOI 10.1111/j.1525-142X.2007.00170.x; Chen X, 2012, INSECT BIOCHEM MOLEC, V42, P665, DOI 10.1016/j.ibmb.2012.05.004; Coleman RA, 2000, ANNU REV NUTR, V20, P77, DOI 10.1146/annurev.nutr.20.1.77; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crawford JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014202; Crnokrak P, 2002, J EVOLUTION BIOL, V15, P388, DOI 10.1046/j.1420-9101.2002.00401.x; EDWARDS GA, 1955, Q J MICROSC SCI, V96, P151; Fitzhugh GH, 1997, J EXP BIOL, V200, P1473; FYRBERG C, 1994, BIOCHEM GENET, V32, P119, DOI 10.1007/BF00554420; Ghanim M, 2006, INSECT BIOCHEM MOLEC, V36, P857, DOI 10.1016/j.ibmb.2006.08.007; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guerra PA, 2011, BIOL REV, V86, P813, DOI 10.1111/j.1469-185X.2010.00172.x; Hardie J., 1985, COMPREHENSIVE INSECT, V8, P441; HARRISON RG, 1980, ANNU REV ECOL SYST, V11, P95, DOI 10.1146/annurev.es.11.110180.000523; Harshman LG, 2007, TRENDS ECOL EVOL, V22, P80, DOI 10.1016/j.tree.2006.10.008; Herranz R, 2004, GENE EXPR PATTERNS, V4, P183, DOI 10.1016/j.modgep.2003.09.008; Jiang CJ, 2012, EUR J ENTOMOL, V109, P579, DOI 10.14411/eje.2012.072; Kawasaki K, 1996, INSECT BIOCHEM MOLEC, V26, P355, DOI 10.1016/0965-1748(95)00101-8; Keeling CI, 2012, INSECT BIOCHEM MOLEC, V42, P525, DOI 10.1016/j.ibmb.2012.03.010; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maxova A, 2001, EUR J ENTOMOL, V98, P433, DOI 10.14411/eje.2001.063; Maxwell RA, 2002, J BIOL CHEM, V277, P21874, DOI 10.1074/jbc.M201510200; Miyata S, 2008, GENETICS, V178, P903, DOI 10.1534/genetics.107.083923; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; O'Neil ST, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-310; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; ROFF DA, 1986, EVOLUTION, V40, P1009, DOI 10.1111/j.1558-5646.1986.tb00568.x; Roff DA, 2007, PHYSIOL BIOCHEM ZOOL, V80, P358, DOI 10.1086/518012; Schilder RJ, 2011, MOL BIOL EVOL, V28, P3381, DOI 10.1093/molbev/msr171; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang YD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003102; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilson K, 2002, P NATL ACAD SCI USA, V99, P5471, DOI 10.1073/pnas.082461999; Wilson R, 1999, J IMMUNOL, V162, P1590; Zera A. J., 2009, Phenotypic plasticity of insects: mechanisms and consequences, P609; Zera AJ, 2005, INTEGR COMP BIOL, V45, P511, DOI 10.1093/icb/45.3.511; Zera AJ, 1999, J INSECT PHYSIOL, V45, P275, DOI 10.1016/S0022-1910(98)00123-1; Zera AJ, 1997, PHYSIOL ZOOL, V70, P519, DOI 10.1086/515865; Zera AJ, 1997, ANNU REV ENTOMOL, V42, P207, DOI 10.1146/annurev.ento.42.1.207; Zera AJ, 2004, PHYSIOL BIOCHEM ZOOL, V77, P255, DOI 10.1086/383500; Zera AJ, 2003, J INSECT PHYSIOL, V49, P933, DOI 10.1016/S0022-1910(03)00152-5; Zera AJ, 2003, EVOLUTION, V57, P586, DOI 10.1111/j.0014-3820.2003.tb01550.x; Zera AJ, 2001, J INSECT PHYSIOL, V47, P1147, DOI 10.1016/S0022-1910(01)00096-8; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006; Zera AJ, 2006, AM NAT, V167, P889, DOI 10.1086/503578; Zera AJ, 2011, MECHANISMS OF LIFE HISTORY EVOLUTION: THE GENETICS AND PHYSIOLOGY OF LIFE HISTORY TRAITS AND TRADE-OFFS, P311; Zera AJ, 2009, EXPERIMENTAL EVOLUTION: CONCEPTS, METHODS, AND APPLICATIONS OF SELECTION EXPERIMENTS, P217; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhao ZW, 2004, J INSECT PHYSIOL, V50, P965, DOI 10.1016/j.jinsphys.2004.07.008; Zhao ZW, 2004, J INSECT PHYSIOL, V50, P93, DOI 10.1016/j.jinsphys.2003.10.003; Zhao ZW, 2002, P NATL ACAD SCI USA, V99, P16829, DOI 10.1073/pnas.262533999	58	29	29	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e82129	10.1371/journal.pone.0082129	http://dx.doi.org/10.1371/journal.pone.0082129			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416137	gold, Green Published, Green Submitted			2022-12-27	WOS:000329862500012
J	Zhao, CH; Bu, XM; Wang, W; Ma, TX; Ma, HY				Zhao, Chenghai; Bu, Xianmin; Wang, Wei; Ma, Tingxian; Ma, Haiying			GEC-derived SFRP5 Inhibits Wnt5a-Induced Macrophage Chemotaxis and Activation	PLOS ONE			English	Article							CANCER-RELATED INFLAMMATION; GASTRIC EPITHELIAL-CELLS; HELICOBACTER-PYLORI; INDUCED INVASION; EXPRESSION; CHEMOATTRACTANT; WNT5A; CYCLOOXYGENASE-2; MIGRATION; ANGIOGENESIS	Aberrant macrophage infiltration and activation has been implicated in gastric inflammation and carcinogenesis. Overexpression of Wnt5a and downregulation of SFRP5, a Wnt5a antagonist, were both observed in gastric cancers recently. This study attempted to explore whether Wnt5a/SFRP5 axis was involved in macrophage chemotaxis and activation. It was found that both Wnt5a transfection and recombinant Wnt5a (rWnt5a) treatment upregulated CCL2 expression in macrophages, involving JNK and NF kappa B signals. Conditioned medium from Wnt5a-treated macrophages promoted macrophage chemotaxis mainly dependent on CCL2. SFRP5 from gastric epithelial cells (GECs) inhibited Wnt5a-induced CCL2 expression and macrophage chemotaxis. In addition, Wnt5a treatment stimulated macrophages to produce inflammatory cytokines and COX-2/PGE2, which was also suppressed by SFRP5 from GECs. These results demonstrate that Wnt5a induces macrophage chemotaxis and activation, which can be blocked by GEC-derived SFRP5, suggesting that Wnt5a overproduction and SFRP5 deficiency in gastric mucosa may together play an important role in gastric inflammation and carcinogenesis.	[Zhao, Chenghai; Wang, Wei; Ma, Tingxian; Ma, Haiying] China Med Univ, Dept Pathophysiol, Coll Basic Med Sci, Shenyang, Peoples R China; [Bu, Xianmin] China Med Univ, Shengjing Hosp, Dept Gen Surg, Shenyang, Peoples R China	China Medical University; China Medical University	Zhao, CH (corresponding author), China Med Univ, Dept Pathophysiol, Coll Basic Med Sci, Shenyang, Peoples R China.	zhaochenghai1@sina.com			National Natural Science Foundation of China [81370517]; Division of Science and Technology, Liaoning Province, China [20092125]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Division of Science and Technology, Liaoning Province, China	This work was supported by a grant from National Natural Science Foundation of China (81370517) and a grant from Division of Science and Technology, Liaoning Province, China (20092125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algra AM, 2012, LANCET ONCOL, V13, P518, DOI 10.1016/S1470-2045(12)70112-2; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Chang YJ, 2005, J IMMUNOL, V175, P8242, DOI 10.4049/jimmunol.175.12.8242; Chung HY, 2007, ANN NY ACAD SCI, V1095, P220, DOI 10.1196/annals.1397.026; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Futagami S, 2003, GUT, V52, P1257, DOI 10.1136/gut.52.9.1257; Isomoto H, 2004, AM J GASTROENTEROL, V99, P1063, DOI 10.1111/j.1572-0241.2004.30847.x; Kim J, 2010, J IMMUNOL, V185, P1274, DOI 10.4049/jimmunol.1000181; Kurayoshi M, 2006, CANCER RES, V66, P10439, DOI 10.1158/0008-5472.CAN-06-2359; Kuroda T, 2005, CLIN CANCER RES, V11, P7629, DOI 10.1158/1078-0432.CCR-05-0798; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Nanbara H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034434; Oshima H, 2011, GASTROENTEROLOGY, V140, P596, DOI 10.1053/j.gastro.2010.11.007; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; Pukrop T, 2006, P NATL ACAD SCI USA, V103, P5454, DOI 10.1073/pnas.0509703103; REINECKER HC, 1995, GASTROENTEROLOGY, V108, P40, DOI 10.1016/0016-5085(95)90006-3; Ripka S, 2007, CARCINOGENESIS, V28, P1178, DOI 10.1093/carcin/bgl255; Ristimaki A, 1997, CANCER RES, V57, P1276; Saukkonen K, 2001, CLIN CANCER RES, V7, P1923; Schumacher MA, 2012, GASTROENTEROLOGY, V142, P1150, DOI 10.1053/j.gastro.2012.01.029; Sen M, 2000, P NATL ACAD SCI USA, V97, P2791, DOI 10.1073/pnas.050574297; Seo JH, 2004, LAB INVEST, V84, P49, DOI 10.1038/labinvest.3700010; Sica A, 2008, CANCER LETT, V267, P204, DOI 10.1016/j.canlet.2008.03.028; Thiel A, 2011, CANCER METAST REV, V30, P387, DOI 10.1007/s10555-011-9312-1; THUN MJ, 1993, CANCER RES, V53, P1322; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Zhao CH, 2013, CARCINOGENESIS, V34, P146, DOI 10.1093/carcin/bgs309; Zhao CH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-419; Zhao CH, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-224	30	20	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85058	10.1371/journal.pone.0085058	http://dx.doi.org/10.1371/journal.pone.0085058			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416340	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500210
J	Zhou, PL; Ren, JZ; Han, XW; Wu, G; Zhang, WG; Ding, PX; Bi, YH				Zhou, Pengli; Ren, Jianzhuang; Han, Xinwei; Wu, Gang; Zhang, Wenguang; Ding, Pengxu; Bi, Yonghua			Initial Imaging Analysis of Budd-Chiari Syndrome in Henan Province of China: Most Cases Have Combined Inferior Vena Cava and Hepatic Veins Involvement	PLOS ONE			English	Article							CLINICAL-FEATURES; SURGICAL ANATOMY; SONOGRAPHY; MANAGEMENT; THROMBOSIS; SPECTRUM	Aim: To evaluate the type of venous involvement in Chinese Budd-Chiari syndrome (BCS) patients and the relative diagnostic accuracy of the different imaging modalities. Methods: Using digital subtraction angiography (DSA) as a reference standard, color Doppler ultrasound (CDUS), computed tomography angiography (CTA), and magnetic resonance angiography (MRA) were performed on 338 patients with BCS. We analyzed the course of the main and any accessory hepatic veins (HVs) and the inferior vena cava (IVC) to assess the etiology of obstructed segments and diagnostic accuracy of CDUS, CTA and MRA. Results: Among the 338 cases, there were 8 cases (2.4%) of isolated IVC membranous obstruction, 45 cases (13.3%) of isolated HV occlusion, and 285 cases (84.3%) with both IVC membranous obstruction and HV occlusion. Comparing with DSA, CDUS, CTA had a diagnostic accuracy of 89.3% and 80.2% in detecting BCS, and 83.4% of cases correctly correlated by MRA. Conclusion: In Henan Province, most patients with BCS have complex lesions combining IVC and HV involvement. The combination of CDUS and CTA or MRI is useful for diagnosis of BCS and guiding therapy.	[Zhou, Pengli; Ren, Jianzhuang; Han, Xinwei; Wu, Gang; Zhang, Wenguang; Ding, Pengxu; Bi, Yonghua] Zhengzhou Univ, Affiliated Hosp 1, Dept Intervent Radiol, Zhengzhou 450052, Henan Province, Peoples R China	Zhengzhou University	Han, XW (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Intervent Radiol, Zhengzhou 450052, Henan Province, Peoples R China.	hanxinwei2006@163.com	han, wei/ABG-2691-2021					Bargallo X, 2003, AM J ROENTGENOL, V181, P1641, DOI 10.2214/ajr.181.6.1811641; BOLONDI L, 1991, GASTROENTEROLOGY, V100, P1324; Buckley O, 2007, EUR RADIOL, V17, P2071, DOI 10.1007/s00330-006-0537-2; Chawla Y, 1999, J GASTROEN HEPATOL, V14, P904, DOI 10.1046/j.1440-1746.1999.01969.x; Cheng DL, 2013, J GASTROEN HEPATOL, V28, P1061, DOI 10.1111/jgh.12140; Deltenre P, 2001, GUT, V48, P264, DOI 10.1136/gut.48.2.264; Eapen CE, 2006, GUT, V55, P878, DOI 10.1136/gut.2005.071423; ELIAS H, 1952, AM J ANAT, V90, P59, DOI 10.1002/aja.1000900104; Erden A, 2007, EUR J RADIOL, V61, P44, DOI 10.1016/j.ejrad.2006.11.004; GOLDSMITH NA, 1957, SURG GYNECOL OBSTET, V105, P310; Janssen HLA, 2003, J HEPATOL, V38, P364, DOI 10.1016/S0168-8278(02)00434-8; Janssen HLA, 2000, BLOOD, V96, P2364; Kamath PS, 2006, LIVER TRANSPLANT, V12, pS21, DOI 10.1002/lt.20939; Khuroo MS, 2005, J GASTROEN HEPATOL, V20, P1494, DOI 10.1111/j.1440-1746.2005.03878.x; KIMURA C, 1964, Jpn Circ J, V28, P181; Maetani Y, 2002, AM J ROENTGENOL, V178, P869, DOI 10.2214/ajr.178.4.1780869; Mahmoud AEA, 1996, QJM-MON J ASSOC PHYS, V89, P37, DOI 10.1093/oxfordjournals.qjmed.a030135; Meng WCS, 2003, ANZ J SURG, V73, P407, DOI 10.1046/j.1445-2197.2003.t01-1-02633.x; MILLER WJ, 1993, ABDOM IMAGING, V18, P329, DOI 10.1007/BF00201775; Mukund A, 2011, WORLD J RADIOL, V3, P169, DOI 10.4329/wjr.v3.i7.169; Murad SD, 2004, HEPATOLOGY, V39, P500, DOI 10.1002/hep.20064; NAKAMURA S, 1981, SURG GYNECOL OBSTET, V152, P43; Noone TC, 2000, JMRI-J MAGN RESON IM, V11, P44, DOI 10.1002/(SICI)1522-2586(200001)11:1<44::AID-JMRI6>3.3.CO;2-F; OKUDA H, 1995, J HEPATOL, V22, P1, DOI 10.1016/0168-8278(95)80252-5; Okuda Kunio, 2002, Hepatobiliary Pancreat Dis Int, V1, P499; Pemmaraju Naveen, 2012, J Med Case Rep, V6, P102, DOI 10.1186/1752-1947-6-102; Plessier A, 2008, SEMIN LIVER DIS, V28, P259, DOI 10.1055/s-0028-1085094; Plessier A, 2012, J HEPATOL, V56, pS25, DOI 10.1016/S0168-8278(12)60004-X; Qiao T, 2005, SWISS MED WKLY, V135, P318; Rav-Acha M, 2004, Harefuah, V143, P372; Rav-Acha M, 2004, HAREFUAH, V143, P389; REES DC, 1995, LANCET, V346, P1133, DOI 10.1016/S0140-6736(95)91803-5; Sato Toshio J, 2002, J Hepatobiliary Pancreat Surg, V9, P55, DOI 10.1007/s005340200005; Singh V, 2000, J GASTROEN HEPATOL, V15, P550, DOI 10.1046/j.1440-1746.2000.02157.x; Smalberg JH, 2012, BLOOD, V120, P4921, DOI 10.1182/blood-2011-09-376517; Valla D, 1997, HEPATOLOGY, V25, P814, DOI 10.1002/hep.510250405; Wang ZG, 2005, ANZ J SURG, V75, P55, DOI 10.1111/j.1445-2197.2005.03135.x; Xue H, 2010, DIGEST DIS SCI, V55, P2659, DOI 10.1007/s10620-009-1087-7; YANAGA K, 1994, SURGERY, V115, P757	39	31	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85135	10.1371/journal.pone.0085135	http://dx.doi.org/10.1371/journal.pone.0085135			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416352	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500220
J	Garaizar, P; Vadillo, MA; Lopez-de-Ipina, D; Matute, H				Garaizar, Pablo; Vadillo, Miguel A.; Lopez-de-Ipina, Diego; Matute, Helena			Measuring Software Timing Errors in the Presentation of Visual Stimuli in Cognitive Neuroscience Experiments	PLOS ONE			English	Article							DISPLAY; ACCURACY	Because of the features provided by an abundance of specialized experimental software packages, personal computers have become prominent and powerful tools in cognitive research. Most of these programs have mechanisms to control the precision and accuracy with which visual stimuli are presented as well as the response times. However, external factors, often related to the technology used to display the visual information, can have a noticeable impact on the actual performance and may be easily overlooked by researchers. The aim of this study is to measure the precision and accuracy of the timing mechanisms of some of the most popular software packages used in a typical laboratory scenario in order to assess whether presentation times configured by researchers do not differ from measured times more than what is expected due to the hardware limitations. Despite the apparent precision and accuracy of the results, important issues related to timing setups in the presentation of visual stimuli were found, and they should be taken into account by researchers in their experiments.	[Garaizar, Pablo; Lopez-de-Ipina, Diego] Univ Deusto, DeustoTech, Deusto Inst Technol, Bilbao, Spain; [Vadillo, Miguel A.] UCL, London, England; [Matute, Helena] Univ Deusto, Fac Psychol & Educ, Bilbao, Spain	University of Deusto; University of London; University College London; University of Deusto	Garaizar, P (corresponding author), Univ Deusto, DeustoTech, Deusto Inst Technol, Bilbao, Spain.	garaizar@deusto.es	Garaizar, Pablo/A-9031-2011; López-de-Ipiña, Diego/A-9651-2012; Vadillo, Miguel A./A-8702-2011; Garaizar, Pablo/U-6469-2019; Matute, Helena/A-8256-2011	Garaizar, Pablo/0000-0001-8160-9130; López-de-Ipiña, Diego/0000-0001-8055-6823; Vadillo, Miguel A./0000-0001-8421-816X; Garaizar, Pablo/0000-0001-8160-9130; Matute, Helena/0000-0001-7221-1366	Direccion General de Investigacion of the Spanish Government [PSI2011-26965]; Basque Government [IT363-10]	Direccion General de Investigacion of the Spanish Government; Basque Government(Basque Government)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Support for this research was provided by Grant PSI2011-26965 from Direccion General de Investigacion of the Spanish Government and Grant IT363-10 from the Basque Government.	Castellano JA., 1992, HDB DISPLAY TECHNOLO; Cowan WB, 1995, HDB OPTICS, V1, P2721; Elze T, 2010, J NEUROSCI METH, V191, P171, DOI 10.1016/j.jneumeth.2010.06.018; Elze T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012792; Elze T, 2009, MED PHYS, V36, P4984, DOI 10.1118/1.3238154; FAZIO RH, 1986, J PERS SOC PSYCHOL, V50, P229, DOI 10.1037/0022-3514.50.2.229; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; Foster K, 2012, DMDX DISPLAY SOFTWAR; Lagroix HEP, 2012, ATTEN PERCEPT PSYCHO, V74, P1033, DOI 10.3758/s13414-012-0281-4; Mathot S, 2012, BEHAV RES METHODS, V44, P314, DOI 10.3758/s13428-011-0168-7; NEELY JH, 1977, J EXP PSYCHOL GEN, V106, P226, DOI 10.1037/0096-3445.106.3.226; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Plant RR, 2009, BEHAV RES METHODS, V41, P598, DOI 10.3758/BRM.41.3.598; Plant RR, 2004, BEHAV RES METH INS C, V36, P291, DOI 10.3758/BF03195575; RATCLIFF R, 1978, J VERB LEARN VERB BE, V17, P403, DOI 10.1016/S0022-5371(78)90238-4; Schmidt WC, 2001, BEHAV RES METH INS C, V33, P187, DOI 10.3758/BF03195365; Schneider W., 2002, E PRIME USERS GUIDE; Stewart N, 2006, BEHAV RES METHODS, V38, P142, DOI 10.3758/BF03192759; Wang P, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00085	19	30	30	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e85108	10.1371/journal.pone.0085108	http://dx.doi.org/10.1371/journal.pone.0085108			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409318	Green Published, gold, Green Submitted			2022-12-27	WOS:000329463500042
J	Gkouvatsos, K; Fillebeen, C; Daba, A; Wagner, J; Sebastiani, G; Pantopoulos, K				Gkouvatsos, Konstantinos; Fillebeen, Carine; Daba, Alina; Wagner, John; Sebastiani, Giada; Pantopoulos, Kostas			Iron-Dependent Regulation of Hepcidin in Hjv-/- Mice: Evidence That Hemojuvelin Is Dispensable for Sensing Body Iron Levels	PLOS ONE			English	Article							DIETARY IRON; OVERLOAD; MODEL; EXPRESSION; LIVER; SERUM	Hemojuvelin (Hjv) is a bone morphogenetic protein (BMP) co-receptor involved in the control of systemic iron homeostasis. Functional inactivation of Hjv leads to severe iron overload in humans and mice due to marked suppression of the ironregulatory hormone hepcidin. To investigate the role of Hjv in body iron sensing, Hjv-/- mice and isogenic wild type controls were placed on a moderately low, a standard or a high iron diet for four weeks. Hjv-/- mice developed systemic iron overload under all regimens. Transferrin (Tf) was highly saturated regardless of the dietary iron content, while liver iron deposition was proportional to it. Hepcidin mRNA expression responded to fluctuations in dietary iron intake, despite the absence of Hjv. Nevertheless, iron-dependent upregulation of hepcidin was more than an order of magnitude lower compared to that seen in wild type controls. Likewise, iron signaling via the BMP/ Smad pathway was preserved but substantially attenuated. These findings suggest that Hjv is not required for sensing of body iron levels and merely functions as an enhancer for iron signaling to hepcidin.	[Gkouvatsos, Konstantinos; Fillebeen, Carine; Daba, Alina; Wagner, John; Pantopoulos, Kostas] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Sebastiani, Giada] McGill Univ, Royal Victoria Hosp, Ctr Hlth, Div Gastroenterol, Montreal, PQ H3A 1A1, Canada; [Sebastiani, Giada; Pantopoulos, Kostas] McGill Univ, Dept Med, Montreal, PQ, Canada	Lady Davis Institute; McGill University; McGill University; Royal Victoria Hospital; McGill University	Pantopoulos, K (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada.	kostas.pantopoulos@mcgill.ca	Pantopoulos, Kostas/A-9668-2008	Pantopoulos, Kostas/0000-0002-2305-0057; Sebastiani, Giada/0000-0003-2655-8283	Canadian Institutes for Health Research (CIHR) [MOP-86515]; Fonds de la Recherche en Sante du Quebec (FRSQ); FRSQ	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); FRSQ(Fonds de la Recherche en Sante du Quebec)	This work was supported by a grant from the Canadian Institutes for Health Research (CIHR; MOP-86515). KG and AD are recipients of doctoral fellowships from the Fonds de la Recherche en Sante du Quebec (FRSQ). GS and KP hold Chercheur-Boursier and Chercheur National career awards, respectively, from the FRSQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Camus LM, 2007, J MOL EVOL, V65, P68, DOI 10.1007/s00239-006-0241-5; Chen W, 2011, BLOOD, V117, P6319, DOI 10.1182/blood-2010-12-327957; Chua ACG, 2011, HEPATOLOGY, V54, P16, DOI 10.1002/hep.24449; Corradini E, 2011, HEPATOLOGY, V54, P273, DOI 10.1002/hep.24359; Daba A, 2013, J MOL MED, V91, P95, DOI 10.1007/s00109-012-0937-5; Fleming RE, 2001, P NATL ACAD SCI USA, V98, P2707, DOI 10.1073/pnas.051630898; Fleming RE, 2012, NEW ENGL J MED, V366, P348, DOI 10.1056/NEJMra1004967; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Gkouvatsos K, 2011, HEPATOLOGY, V54, P1800, DOI 10.1002/hep.24547; Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Krijt J, 2007, BLOOD CELL MOL DIS, V39, P92, DOI 10.1016/j.bcmd.2007.02.004; Krijt J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037391; Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qiao B, 2012, CELL METAB, V15, P918, DOI 10.1016/j.cmet.2012.03.018; Ramos E, 2011, HEPATOLOGY, V53, P1333, DOI 10.1002/hep.24178; Sebastiani G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025138; Sebastiani G, 2011, METALLOMICS, V3, P971, DOI 10.1039/c1mt00082a; Theurl I, 2008, BLOOD, V111, P2392, DOI 10.1182/blood-2007-05-090019; Wang FD, 2007, NAT GENET, V39, P1025, DOI 10.1038/ng2059; Wessling-Resnick M, 2010, ANNU REV NUTR, V30, P105, DOI 10.1146/annurev.nutr.012809.104804; Zhang AS, 2010, J BIOL CHEM, V285, P16416, DOI 10.1074/jbc.M110.109488; Zhao NN, 2013, J CLIN INVEST, V123, P2337, DOI 10.1172/JCI67225	26	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e85530	10.1371/journal.pone.0085530	http://dx.doi.org/10.1371/journal.pone.0085530			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409331	Green Published, Green Submitted, gold			2022-12-27	WOS:000329463500055
J	Liu, F; Gore, AJ; Wilson, JL; Korc, M				Liu, Fang; Gore, A. Jesse; Wilson, Julie L.; Korc, Murray			DUSP1 Is a Novel Target for Enhancing Pancreatic Cancer Cell Sensitivity to Gemcitabine	PLOS ONE			English	Article							PROTEIN-KINASE PHOSPHATASE-1; MKP-1; INHIBITION; EXPRESSION; GROWTH; OVEREXPRESSION; RESISTANCE; BIOLOGY	Pancreatic ductal adenocarcinoma (PDAC) is a deadly cancer with a poor prognosis that is characterized by excessive mitogenic pathway activation and marked chemoresistance to a broad spectrum of chemotherapeutic drugs. Dual specificity protein phosphatase 1 (DUSP1) is a key negative regulator of mitogen activated protein kinases (MAPKs). Yet, DUSP1 is overexpressed in pancreatic cancer cells (PCCs) in PDAC where it paradoxically enhances colony formation in soft agar and promotes in vivo tumorigenicity. However, it is not known whether DUSP1 overexpression contributes to PDAC chemoresistance. Using BxPC3 and COLO-357 human PCCs, we show that gemcitabine activates c-JUN N-terminal kinase (JNK) and p38 mitogen activated protein kinase (p38 MAPK), key kinases in two major stress-activated signaling pathways. Gemcitabine-induced JNK and p38 MAPK activation mediates increased apoptosis, but also transcriptionally upregulates DUSP1, as evidenced by increased DUSP1 mRNA levels and RNA polymerase II loading at DUSP1 gene body. Conversely, shRNA-mediated inhibition of DUSP1 enhances JNK and p38 MAPK activation and gemcitabine chemosensitivity. Using doxycycline-inducible knockdown of DUSP1 in established orthotopic pancreatic tumors, we found that combining gemcitabine with DUSP1 inhibition improves animal survival, attenuates angiogenesis, and enhances apoptotic cell death, as compared with gemcitabine alone. Taken together, these results suggest that gemcitabine-mediated upregulation of DUSP1 contributes to a negative feedback loop that attenuates its beneficial actions on stress pathways and apoptosis, raising the possibility that targeting DUSP1 in PDAC may have the advantage of enhancing gemcitabine chemosensitivity while suppressing angiogenesis.	[Korc, Murray] Indiana Univ Sch Med, Dept Med, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46202 USA; Indiana Univ Sch Med, Dept Biochem, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46202 USA; Indiana Univ Sch Med, Dept Mol Biol, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46202 USA; Ctr Pancreat Canc Res, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Korc, M (corresponding author), Indiana Univ Sch Med, Dept Med, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46202 USA.	mkorc@iu.edu			National Cancer Institute (NCI) [CA-R37-075059]; National Institutes of Health; NATIONAL CANCER INSTITUTE [P30CA082709, R01CA075059, R37CA075059] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute (NCI) grant CA-R37-075059 to MK, awarded by the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold NB, 2007, CLIN CANCER RES, V13, P18, DOI 10.1158/1078-0432.CCR-06-0914; Bang YJ, 1998, BIOCHEM BIOPH RES CO, V250, P43, DOI 10.1006/bbrc.1998.9256; Bermudez O, 2010, AM J PHYSIOL-CELL PH, V299, pC189, DOI 10.1152/ajpcell.00347.2009; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Calvisi DF, 2008, CANCER RES, V68, P4192, DOI 10.1158/0008-5472.CAN-07-6157; Carriere C, 2011, GASTROENTEROLOGY, V141, P1091, DOI 10.1053/j.gastro.2011.05.041; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Casals-Casas C, 2009, EUR J IMMUNOL, V39, P1902, DOI 10.1002/eji.200839037; CHANG SC, 1990, J NUTR, V120, P1228, DOI 10.1093/jn/120.10.1228; Chu GC, 2007, J CELL BIOCHEM, V101, P887, DOI 10.1002/jcb.21209; Comalada M, 2012, EUR J IMMUNOL, V42, P1938, DOI 10.1002/eji.201242441; Denkert C, 2002, INT J CANCER, V102, P507, DOI 10.1002/ijc.10746; Fryer RA, 2011, ANTICANCER RES, V31, P3747; Gu DS, 2013, MOL CANCER THER, V12, P1038, DOI 10.1158/1535-7163.MCT-12-1030; Heinemann V, 2006, J CLIN ONCOL, V24, P3946, DOI 10.1200/JCO.2005.05.1490; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hung SW, 2012, CANCER LETT, V320, P138, DOI 10.1016/j.canlet.2012.03.007; Kleeff J, 1998, J BIOL CHEM, V273, P7495, DOI 10.1074/jbc.273.13.7495; Korc M, 2003, MOL CANCER, V2, P1; Laderoute KR, 1999, J BIOL CHEM, V274, P12890, DOI 10.1074/jbc.274.18.12890; Landry J, 2010, J SURG ONCOL, V101, P587, DOI 10.1002/jso.21527; Liao Q, 2003, GASTROENTEROLOGY, V124, P1830, DOI 10.1016/S0016-5085(03)00398-6; Liu F, 2012, MOL CANCER THER, V11, P2138, DOI 10.1158/1535-7163.MCT-12-0562; Liu YX, 2008, MOL CANCER RES, V6, P624, DOI 10.1158/1541-7786.MCR-07-2019; Loda M, 1996, AM J PATHOL, V149, P1553; Mahadevan D, 2007, MOL CANCER THER, V6, P1186, DOI 10.1158/1535-7163.MCT-06-0686; Moncho-Amor V, 2011, ONCOGENE, V30, P668, DOI 10.1038/onc.2010.449; MORGAN RT, 1980, INT J CANCER, V25, P591, DOI 10.1002/ijc.2910250507; Schild C, 2009, MOL CARCINOGEN, V48, P1149, DOI 10.1002/mc.20569; Schutte M, 1997, CANCER RES, V57, P3126; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Small GW, 2007, CANCER RES, V67, P4459, DOI 10.1158/0008-5472.CAN-06-2644; Srikanth S, 1999, MOL CELL BIOCHEM, V199, P169, DOI 10.1023/A:1006980326855; Vicent S, 2004, CLIN CANCER RES, V10, P3639, DOI 10.1158/1078-0432.CCR-03-0771; Von Hoff DD, 2011, J CLIN ONCOL, V29, P4548, DOI 10.1200/JCO.2011.36.5742; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang HY, 2003, CANCER LETT, V191, P229, DOI 10.1016/S0304-3835(02)00612-2; Wang JL, 2007, CANCER RES, V67, P6737, DOI 10.1158/0008-5472.CAN-06-4402; Wang J, 2009, CELL CYCLE, V8, P3191, DOI 10.4161/cc.8.19.9751; Wang ZW, 2011, NAT REV GASTRO HEPAT, V8, P27, DOI 10.1038/nrgastro.2010.188	41	70	70	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84982	10.1371/journal.pone.0084982	http://dx.doi.org/10.1371/journal.pone.0084982			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409315	Green Published, gold, Green Submitted			2022-12-27	WOS:000329463500039
J	Park, B; Kim, DS; Park, HJ				Park, Bumhee; Kim, Dae-Shik; Park, Hae-Jeong			Graph Independent Component Analysis Reveals Repertoires of Intrinsic Network Components in the Human Brain	PLOS ONE			English	Article							RESTING-STATE NETWORKS; HUMAN CEREBRAL-CORTEX; FUNCTIONAL CONNECTIVITY; ARCHITECTURE; MODEL; FMRI; MRI; PET	Does each cognitive task elicit a new cognitive network each time in the brain? Recent data suggest that pre-existing repertoires of a much smaller number of canonical network components are selectively and dynamically used to compute new cognitive tasks. To this end, we propose a novel method (graph-ICA) that seeks to extract these canonical network components from a limited number of resting state spontaneous networks. Graph-ICA decomposes a weighted mixture of source edge-sharing subnetworks with different weighted edges by applying an independent component analysis on cross-sectional brain networks represented as graphs. We evaluated the plausibility in our simulation study and identified 49 intrinsic subnetworks by applying it in the resting state fMRI data. Using the derived subnetwork repertories, we decomposed brain networks during specific tasks including motor activity, working memory exercises, and verb generation, and identified subnetworks associated with performance on these tasks. We also analyzed sex differences in utilization of subnetworks, which was useful in characterizing group networks. These results suggest that this method can effectively be utilized to identify task-specific as well as sex-specific functional subnetworks. Moreover, graph-ICA can provide more direct information on the edge weights among brain regions working together as a network, which cannot be directly obtained through voxel-level spatial ICA.	[Park, Bumhee; Park, Hae-Jeong] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul 120749, South Korea; [Park, Bumhee; Park, Hae-Jeong] Yonsei Univ, Coll Med, Dept Nucl Med, Seoul 120749, South Korea; [Park, Bumhee; Park, Hae-Jeong] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul 120749, South Korea; [Kim, Dae-Shik] Korea Adv Inst Sci & Technol, Dept Elect Engn, Taejon 305701, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Korea Advanced Institute of Science & Technology (KAIST)	Park, HJ (corresponding author), Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul 120749, South Korea.	parkhj@yuhs.ac	Kim, Dae-Shik/C-2071-2011	Park, Hae-Jeong/0000-0002-4633-0756	Original Technology Research Program for Brain Science through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [20100018839]	Original Technology Research Program for Brain Science through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Original Technology Research Program for Brain Science through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (20100018839 for HJP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Elseoud A, 2010, HUM BRAIN MAPP, V31, P1207, DOI 10.1002/hbm.20929; Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; Bashan A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1705; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Di X, 2012, BRAIN CONNECT, V2, P275, DOI 10.1089/brain.2012.0086; Evans TS, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016105; Ferrarini L, 2009, HUM BRAIN MAPP, V30, P2220, DOI 10.1002/hbm.20663; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Horwitz B, 1999, TRENDS COGN SCI, V3, P91, DOI 10.1016/S1364-6613(99)01282-6; Karunanayaka P, 2010, NEUROIMAGE, V51, P472, DOI 10.1016/j.neuroimage.2009.12.108; Laird AR, 2011, J COGNITIVE NEUROSCI, V23, P4022, DOI 10.1162/jocn_a_00077; Llinas R.R., 2001, I VORTEX NEURONS SEL; MacLean JN, 2005, NEURON, V48, P811, DOI 10.1016/j.neuron.2005.09.035; McIntosh AR, 2004, NEUROINFORMATICS, V2, P175, DOI 10.1385/NI:2:2:175; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Park B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074935; Park HJ, 2003, HUM BRAIN MAPP, V18, P284, DOI 10.1002/hbm.10085; Pinotsis DA, 2012, NEUROIMAGE, V59, P1261, DOI [10.1016/j.neuroimage.2011.08.020, 10.1016/j.neuroimage.2010.12.039]; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Tomasi D, 2012, HUM BRAIN MAPP, V33, P849, DOI 10.1002/hbm.21252; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Van Essen DC, 2007, NEUROIMAGE, V37, P1050, DOI 10.1016/j.neuroimage.2007.02.021; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Weissman-Fogel I, 2010, HUM BRAIN MAPP, V31, P1713, DOI 10.1002/hbm.20968; Xu L, 2009, HUM BRAIN MAPP, V30, P711, DOI 10.1002/hbm.20540; Yan XD, 2011, J NEUROSCI METH, V199, P108, DOI 10.1016/j.jneumeth.2011.05.001; Yang Z, 2008, HUM BRAIN MAPP, V29, P711, DOI 10.1002/hbm.20432; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Ystad M, 2010, NEUROIMAGE, V52, P379, DOI 10.1016/j.neuroimage.2010.03.062; Zhang ZY, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.062803; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080	48	16	18	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e82873	10.1371/journal.pone.0082873	http://dx.doi.org/10.1371/journal.pone.0082873			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409279	Green Published, gold, Green Submitted			2022-12-27	WOS:000329463500003
J	Chakravorty, R; Rawlinson, D; Zhang, A; Markham, J; Dowling, MR; Wellard, C; Zhou, JHS; Hodgkin, PD				Chakravorty, Rajib; Rawlinson, David; Zhang, Alan; Markham, John; Dowling, Mark R.; Wellard, Cameron; Zhou, Jie H. S.; Hodgkin, Philip D.			Labour-Efficient In Vitro Lymphocyte Population Tracking and Fate Prediction Using Automation and Manual Review	PLOS ONE			English	Review							CELL TRACKING; LINEAGE CONSTRUCTION; CHEMOTAXIS; SOFTWARE; MINIMUM	Interest in cell heterogeneity and differentiation has recently led to increased use of time-lapse microscopy. Previous studies have shown that cell fate may be determined well in advance of the event. We used a mixture of automation and manual review of time-lapse live cell imaging to track the positions, contours, divisions, deaths and lineage of 44 B-lymphocyte founders and their 631 progeny in vitro over a period of 108 hours. Using this data to train a Support Vector Machine classifier, we were retrospectively able to predict the fates of individual lymphocytes with more than 90% accuracy, using only time-lapse imaging captured prior to mitosis or death of 90% of all cells. The motivation for this paper is to explore the impact of labour-efficient assistive software tools that allow larger and more ambitious live-cell time-lapse microscopy studies. After training on this data, we show that machine learning methods can be used for realtime prediction of individual cell fates. These techniques could lead to realtime cell culture segregation for purposes such as phenotype screening. We were able to produce a large volume of data with less effort than previously reported, due to the image processing, computer vision, tracking and human-computer interaction tools used. We describe the workflow of the software-assisted experiments and the graphical interfaces that were needed. To validate our results we used our methods to reproduce a variety of published data about lymphocyte populations and behaviour. We also make all our data publicly available, including a large quantity of lymphocyte spatio-temporal dynamics and related lineage information.	[Chakravorty, Rajib; Rawlinson, David; Zhang, Alan; Markham, John] Univ Melbourne, Dept Elect & Elect Engn, Natl ICT Australia, Melbourne, Vic, Australia; [Dowling, Mark R.; Wellard, Cameron; Zhou, Jie H. S.; Hodgkin, Philip D.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Dowling, Mark R.; Wellard, Cameron; Zhou, Jie H. S.; Hodgkin, Philip D.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia	NICTA; University of Melbourne; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne	Chakravorty, R (corresponding author), Univ Melbourne, Dept Elect & Elect Engn, Natl ICT Australia, Melbourne, Vic, Australia.	rajib.chakravorty@nicta.com.au		Hodgkin, Philip/0000-0002-8604-1940; Zhou, Jie/0000-0002-9113-800X; Dowling, Mark/0000-0002-8056-5348; Rawlinson, David/0000-0001-9443-3840; Markham, John/0000-0002-5738-3861	Australian Government; Australian Research Council through the ICT Centre of Excellence program	Australian Government(Australian GovernmentCGIAR); Australian Research Council through the ICT Centre of Excellence program(Australian Research Council)	NICTA is funded by the Australian Government as represented by the Department of Broadband, Communications and the Digital Economy and the Australian Research Council through the ICT Centre of Excellence program. WEHI contribution to this work was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham AG, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-74; Al-Kofahi O, 2006, CELL CYCLE, V5, P327, DOI 10.4161/cc.5.3.2426; BARSHALOM Y, 1975, AUTOMATICA, V11, P451, DOI 10.1016/0005-1098(75)90021-7; BISE R, 2011, IEEE INT S BIOM IM; *BITPL, IM; Brown MR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000741; Bruce V, 2001, J EXP PSYCHOL-APPL, V7, P207, DOI 10.1037/1076-898X.7.3.207; BRUCE V, 1999, J EXPT PSYCHOL APPL, V5; CHALLA S, 2002, TARGET TRACKING BAYE, V1, P437; Cohen AR, 2010, NAT METHODS, V7, P213, DOI [10.1038/NMETH.1424, 10.1038/nmeth.1424]; COLLINS M, 2009, COMBINATORIAL CHEM H, V12; Debeir O, 2004, CYTOM PART A, V60A, P29, DOI 10.1002/cyto.a.20040; DOWNEY M, 2011, IEEE INT S BIOM IM N; Duffy KR, 2012, SCIENCE, V335, P338, DOI 10.1126/science.1213230; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; FENDLEY ME, 2009, THESIS WRIGHT STATE; Fortmann T. E., 1980, Proceedings of the 19th IEEE Conference on Decision & Control Including the Symposium on Adaptive Processes, P807; Halin C, 2005, ANNU REV CELL DEV BI, V21, P581, DOI 10.1146/annurev.cellbio.21.122303.133159; Hawkins ED, 2009, P NATL ACAD SCI USA, V106, P13457, DOI 10.1073/pnas.0905629106; Hawkins ED, 2007, NAT PROTOC, V2, P2057, DOI 10.1038/nprot.2007.297; Higgins JM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000288; *INSTR K, 2011, MAN CELL TRACK FIJ; Jin T, 2008, CYTOKINE, V44, P1, DOI 10.1016/j.cyto.2008.06.017; JULIUS MH, 1972, P NATL ACAD SCI USA, V69, P1934, DOI 10.1073/pnas.69.7.1934; Kachouie NN, 2007, IEEE T BIO-MED ENG, V54, P2011, DOI 10.1109/TBME.2007.895747; Kan A, 2011, J MICROSC-OXFORD, V244, P194, DOI 10.1111/j.1365-2818.2011.03529.x; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Li K, 2007, LECT NOTES COMPUT SC, V4792, P295; Markham JF, 2010, J R SOC INTERFACE, V7, P1049, DOI 10.1098/rsif.2009.0488; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; *MOL DEV, MET; MOLLER C, 2010, DRUG DISCOVERY TODAY, V15; MOOGK DR, 2009, THESIS WATERLOO; Musicki D, 2002, IEEE DECIS CONTR P, P2415, DOI 10.1109/CDC.2002.1184197; MUSICKI D, 1994, IEEE T AUTOMAT CONTR, V39, P1237, DOI 10.1109/9.293185; PAVLIDIS T, 1978, IEEE T SYST MAN CYB, V8, P66; *PERKINELMER, VOL; Rapoport DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027315; Rasband W., 2006, IMAGEJ; Rieger MA, 2009, SCIENCE, V325, P217, DOI 10.1126/science.1171461; Roerdink J. B. T. M., 2000, Fundamenta Informaticae, V41, P187; Sacan A, 2008, BIOINFORMATICS, V24, P1647, DOI 10.1093/bioinformatics/btn247; Scherf N, 2012, EXP HEMATOL, V40, P119, DOI 10.1016/j.exphem.2011.10.009; SCHROEDER T, 2011, NATURE METHODS, V8; Schroeder T, 2010, NAT METHODS, V7, P190, DOI 10.1038/nmeth0310-190; Sica GT, 2006, RADIOLOGY, V238, P780, DOI 10.1148/radiol.2383041109; Uppaluri S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002058; *WARW SYST BIOL CT, CELLTR; *WARW SYST BIOL CT, LIN; Witt CM, 2005, PLOS BIOL, V3, P1062, DOI 10.1371/journal.pbio.0030160; ZANELLA F, 2010, TRENDS BIOTECHNOLOGY, V28; Zhou J, 2007, LECT NOTES COMPUT SC, V4552, P1028; Zhou J, 2006, ISPRS J PHOTOGRAMM, V61, P108, DOI 10.1016/j.isprsjprs.2006.09.002; Zilman A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012775	54	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e83251	10.1371/journal.pone.0083251	http://dx.doi.org/10.1371/journal.pone.0083251			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404133	Green Published, gold			2022-12-27	WOS:000329460800012
J	Hosiner, D; Gerber, S; Lichtenberg-Frate, H; Glaser, W; Schuller, C; Klipp, E				Hosiner, Dagmar; Gerber, Susanne; Lichtenberg-Frate, Hella; Glaser, Walter; Schueller, Christoph; Klipp, Edda			Impact of Acute Metal Stress in Saccharomyces cerevisiae	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; GENE-EXPRESSION; TOXIC METALS; IN-VIVO; CADMIUM; TOLERANCE; ZINC; MICROARRAY; NICKEL; TRANSPORT	Although considered as essential cofactors for a variety of enzymatic reactions and for important structural and functional roles in cell metabolism, metals at high concentrations are potent toxic pollutants and pose complex biochemical problems for cells. We report results of single dose acute toxicity testing in the model organism S. cerevisiae. The effects of moderate toxic concentrations of 10 different human health relevant metals, Ag+, Al3+, As3+, Cd2+, Co2+, Hg2+, Mn2+, Ni2+, V3+, and Zn2+, following short-term exposure were analyzed by transcription profiling to provide the identification of early-on target genes or pathways. In contrast to common acute toxicity tests where defined endpoints are monitored we focused on the entire genomic response. We provide evidence that the induction of central elements of the oxidative stress response by the majority of investigated metals is the basic detoxification process against short-term metal exposure. General detoxification mechanisms also comprised the induction of genes coding for chaperones and those for chelation of metal ions via siderophores and amino acids. Hierarchical clustering, transcription factor analyses, and gene ontology data further revealed activation of genes involved in metal-specific protein catabolism along with repression of growth-related processes such as protein synthesis. Metal ion group specific differences in the expression responses with shared transcriptional regulators for both, up-regulation and repression were also observed. Additionally, some processes unique for individual metals were evident as well. In view of current concerns regarding environmental pollution our results may support ongoing attempts to develop methods to monitor potentially hazardous areas or liquids and to establish standardized tests using suitable eukaryotic a model organism.	[Hosiner, Dagmar; Schueller, Christoph] Univ Nat Resources & Life Sci BOKU, Dept Appl Genet & Cell Biol, Vienna, Austria; [Gerber, Susanne] Univ Svizzera Italiana, Fac Informat, Inst Computat Sci, AG Computat Time Series Anal, Lugano, Switzerland; [Gerber, Susanne; Klipp, Edda] Theoret Biophys Humboldt Univ Berlin, Berlin, Germany; [Lichtenberg-Frate, Hella] Univ Bonn, IZMB, AG Mol Bioenerget, Bonn, Germany; [Glaser, Walter] Med Univ Vienna, Inst Med Biochem, MFPL, Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; Universita della Svizzera Italiana; University of Bonn; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Klipp, E (corresponding author), Theoret Biophys Humboldt Univ Berlin, Berlin, Germany.	edda.klipp@rz.hu-berlin.de	Gerber, Susanne/I-6352-2018	Gerber, Susanne/0000-0001-9513-0729; Schuller, Christoph/0000-0002-1649-1217	German Ministry for Education and Research (BMBF) [FKZ 0315786A,B]; Swiss HP2C-initiative "Swiss Platform for High-Performance and High-Productivity Computing"; European Commission [201142]; Austrian science fund FWF [P23355]; Austrian Science Fund (FWF) [P 23355] Funding Source: researchfish	German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Swiss HP2C-initiative "Swiss Platform for High-Performance and High-Productivity Computing"; European Commission(European CommissionEuropean Commission Joint Research Centre); Austrian science fund FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the German Ministry for Education and Research (BMBF grant for the SysMO project Translucent2, FKZ 0315786A,B to EK and HLF), by the Swiss HP2C-initiative "Swiss Platform for High-Performance and High-Productivity Computing", the European Commission 7th Framework Programme: UNICELLSYS (Contract No. 201142, to EK) and the Austrian science fund FWF grant P23355 (to CS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas-Terki T, 2001, MOL CELL BIOL, V21, P7569, DOI 10.1128/MCB.21.22.7569-7575.2001; Akache B, 2002, J BIOL CHEM, V277, P21254, DOI 10.1074/jbc.M202566200; Ballatori N, 2002, ENVIRON HEALTH PERSP, V110, P689, DOI 10.1289/ehp.02110s5689; Belcastro M, 2005, J MASS SPECTROM, V40, P300, DOI 10.1002/jms.755; Beyersmann D, 2008, ARCH TOXICOL, V82, P493, DOI 10.1007/s00204-008-0313-y; Boeke J.D., 1991, MOL CELLULAR BIOL YE, V1, P193; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boorsma A, 2005, NUCLEIC ACIDS RES, V33, pW592, DOI 10.1093/nar/gki484; Bozhkov A, 2010, INDIAN J EXP BIOL, V48, P679; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Cao YR, 2012, WORLD J MICROB BIOT, V28, P1727, DOI 10.1007/s11274-011-0983-0; Chen CY, 2003, ARCH TOXICOL, V77, P123, DOI 10.1007/s00204-002-0427-6; Chen F, 2002, CRIT REV ONCOL HEMAT, V42, P105, DOI 10.1016/S1040-8428(01)00211-6; Chen HB, 2005, TOXICOL APPL PHARM, V206, P275, DOI 10.1016/j.taap.2004.11.011; Chrestensen CA, 2000, J BIOL CHEM, V275, P26556, DOI 10.1074/jbc.M004097200; Dandrea T, 2004, FREE RADICAL BIO MED, V36, P881, DOI 10.1016/j.freeradbiomed.2003.12.014; Dormer UH, 2000, J BIOL CHEM, V275, P32611, DOI 10.1074/jbc.M004167200; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ercal Nuran, 2001, Current Topics in Medicinal Chemistry, V1, P529, DOI 10.2174/1568026013394831; Ezaki B, 2005, J EXP BOT, V56, P2661, DOI 10.1093/jxb/eri259; Farcasanu IC, 2005, BIOSCI BIOTECH BIOCH, V69, P2343, DOI 10.1271/bbb.69.2343; Fauchon M, 2002, MOL CELL, V9, P713, DOI 10.1016/S1097-2765(02)00500-2; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hassinen VH, 2011, PLANT BIOLOGY, V13, P225, DOI 10.1111/j.1438-8677.2010.00398.x; Haugen AC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r95; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Hosiner D, 2009, MOL BIOL CELL, V20, P1048, DOI 10.1091/mbc.E08-04-0438; Jin YH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000053; Khanna S, 2011, TOXICOLOGY, V287, P46, DOI 10.1016/j.tox.2011.05.013; Kim S, 1998, P NATL ACAD SCI USA, V95, P12860, DOI 10.1073/pnas.95.22.12860; Larochelle M, 2006, MOL CELL BIOL, V26, P6690, DOI 10.1128/MCB.02450-05; Lee DH, 1996, MOL CELL BIOL, V16, P4773; Lempiainen H, 2009, MOL CELL, V33, P704, DOI 10.1016/j.molcel.2009.01.034; Lempiainen H, 2009, CURR OPIN CELL BIOL, V21, P855, DOI 10.1016/j.ceb.2009.09.002; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; MAGER WH, 1995, MICROBIOL REV, V59, P506, DOI 10.1128/MMBR.59.3.506-531.1995; Martin DE, 2004, CELL, V119, P969, DOI 10.1016/j.cell.2004.11.047; MCLACHLAN GJ, 2004, ANAL MICROARRAY GENE; Momose Y, 2001, ENVIRON TOXICOL CHEM, V20, P2353; Nadon R, 2002, TRENDS GENET, V18, P265, DOI 10.1016/S0168-9525(02)02665-3; Nathan DF, 1997, P NATL ACAD SCI USA, V94, P12949, DOI 10.1073/pnas.94.24.12949; Niazi JH, 2011, APPL BIOCHEM BIOTECH, V164, P1278, DOI 10.1007/s12010-011-9212-4; Nies DH, 1999, APPL MICROBIOL BIOT, V51, P730, DOI 10.1007/s002530051457; Pagani MA, 2007, MOL MICROBIOL, V65, P521, DOI 10.1111/j.1365-2958.2007.05807.x; Pearce DA, 1999, J BACTERIOL, V181, P4774, DOI 10.1128/JB.181.16.4774-4779.1999; Porwol T, 1998, EUR J BIOCHEM, V256, P16, DOI 10.1046/j.1432-1327.1998.2560016.x; Qiu JW, 2005, ARCH ENVIRON CON TOX, V48, P278, DOI 10.1007/s00244-004-0001-8; Rainbow PS, 2005, AQUAT TOXICOL, V72, P45, DOI 10.1016/j.aquatox.2004.11.016; Ralph DM, 2010, FREE RADICAL BIO MED, V49, P649, DOI 10.1016/j.freeradbiomed.2010.05.023; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; Richards KD, 1998, PLANT PHYSIOL, V116, P409, DOI 10.1104/pp.116.1.409; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rosen BP, 2002, COMP BIOCHEM PHYS A, V133, P689, DOI 10.1016/S1095-6433(02)00201-5; Ruotolo R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r67; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Saponja JA, 1996, J INORG BIOCHEM, V62, P253, DOI 10.1016/0162-0134(95)00159-X; Silver JD, 2009, BIOSTATISTICS, V10, P352, DOI 10.1093/biostatistics/kxn042; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Smyth GK., 2005, LIMMA LINEAR MODELS; Stadler JA, 2002, J BIOL CHEM, V277, P39649, DOI 10.1074/jbc.M203924200; Stohs S J, 1995, J Basic Clin Physiol Pharmacol, V6, P205; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; Tamas MJ, 2001, CURR GENET, V40, P2, DOI 10.1007/s002940100234; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Thorsen M, 2007, PHYSIOL GENOMICS, V30, P35, DOI 10.1152/physiolgenomics.00236.2006; Thorsen M, 2006, MOL BIOL CELL, V17, P4400, DOI 10.1091/mbc.E06-04-0315; Thorsen M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-105; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Vido K, 2001, J BIOL CHEM, V276, P8469, DOI 10.1074/jbc.M008708200; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Ward RJ, 2001, J INORG BIOCHEM, V87, P9, DOI 10.1016/S0162-0134(01)00308-7; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Wu LF, 2002, NAT GENET, V31, P255, DOI 10.1038/ng906; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Wysocki R, 2010, FEMS MICROBIOL REV, V34, P925, DOI 10.1111/j.1574-6976.2010.00217.x	79	59	60	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e83330	10.1371/journal.pone.0083330	http://dx.doi.org/10.1371/journal.pone.0083330			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416162	Green Published, gold, Green Submitted			2022-12-27	WOS:000329866300013
J	Huang, SF; Xie, Y; Yang, P; Chen, P; Zhang, LP				Huang, Shifeng; Xie, Yan; Yang, Ping; Chen, Pu; Zhang, Liping			HCV Core Protein-Induced Down-Regulation of microRNA-152 Promoted Aberrant Proliferation by Regulating Wnt1 in HepG2 Cells	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; HEPATOCELLULAR-CARCINOMA; UP-REGULATION; EXPRESSION; LIVER; HEPATOCARCINOGENESIS; CANCER; IDENTIFICATION; INFECTION; CIRCUIT	Background: Hepatitis C virus (HCV) has been reported to regulate cellular microRNAs (miRNAs). The HCV core protein is considered to be a potential oncoprotein in HCV-related hepatocellular carcinoma (HCV-HCC), but HCV core-regulated miRNAs are largely unknown. Our preliminary experiments revealed significant down-regulation of microRNA-152 (miR-152) by HCV core protein in HepG2 cells. Through target gene prediction softwares, Wnt1 was predicted to be a potential target of miR-152. The present study was initiated to investigate whether miR-152 is aberrantly regulated by the HCV core protein, and involved in the regulation of the aberrant proliferation of HCV-HCC cells. Methods: MiR-152 levels were examined by stem-loop real-time RT-PCR (SLqRT-PCR). Cell proliferation was analyzed by MTT and colony formation assay. Cell cycle analysis was performed by flow cytometry. Luciferase reporter assay was conducted to confirm miRNA-target association. Wnt1 expression was determined by real-time qPCR and Western blotting. Results: HCV core protein significantly suppressed miR-152 expression, and led to significant Wnt1 up-regulation with a concomitant aberrantly promoted proliferation. Moreover, we validated that miR-152 inhibition promoted, while miR-152 mimics inhibited cell proliferation. Using, qRT-PCR and western blot, Wnt1 was demonstrated to be regulated by miR-152. Luciferase activity assay showed that while miR-152 mimics significantly reduced the luciferase activity by 83.76% (P<0.0001), miR-152 inhibitor showed no effect on luciferase reporter. Most notably, salvage expression of miR-152 after Ad-HCV core infection for 24 h almost totally reversed the proliferation-promoting effect of the HCV core protein, and meanwhile, reduced the expression of both Wnt1 mRNA and protein to basal levels. Conclusion: These findings provide important evidence that the reduced miR-152 expression by HCV core protein can indirectly lose an inhibitory effect on Wnt1, which might, at least partially lead to cell proliferation of liver cancer cells. MiR-152 may have a therapeutic potential to suppress liver cancer proliferation.	[Huang, Shifeng; Xie, Yan; Yang, Ping; Chen, Pu; Zhang, Liping] Chongqing Med Univ, Affiliated Hosp 1, Dept Lab Med, Chongqing, Peoples R China	Chongqing Medical University	Zhang, LP (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Lab Med, Chongqing, Peoples R China.	liuzhangcq@yahoo.com		Huang, Shifeng/0000-0001-7641-8823	National Science Foundation of China [81071621, 30973378, 81101826, 81272545]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by combined grants from the National Science Foundation of China (No. 81071621, 30973378, 81101826 and 81272545; http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braconi C, 2010, CLIN CANCER RES, V16, P957, DOI 10.1158/1078-0432.CCR-09-2123; Braconi C, 2010, HEPATOLOGY, V51, P881, DOI 10.1002/hep.23381; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Deng YB, 2010, CANCER SCI, V101, P1501, DOI 10.1111/j.1349-7006.2010.01549.x; Fukutomi T, 2005, HEPATOLOGY, V41, P1096, DOI 10.1002/hep.20668; Hatziapostolou M, 2011, CELL, V147, P1233, DOI 10.1016/j.cell.2011.10.043; Hsu SH, 2012, J CLIN INVEST, V122, P2871, DOI 10.1172/JCI63539; Huang JF, 2010, HEPATOLOGY, V52, P60, DOI 10.1002/hep.23660; Lambert MP, 2011, J HEPATOL, V54, P705, DOI 10.1016/j.jhep.2010.07.027; Lee HH, 2009, CANCER EPIDEM BIOMAR, V18, P1562, DOI 10.1158/1055-9965.EPI-09-0039; Lee TH, 2006, J BIOMED SCI, V13, P27, DOI 10.1007/s11373-005-9030-1; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Peveling-Oberhag J, 2012, LEUKEMIA, V26, P1654, DOI 10.1038/leu.2012.29; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Sun BK, 2008, J AM ACAD DERMATOL, V59, P725, DOI 10.1016/j.jaad.2008.08.017; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Tsai WC, 2012, J CLIN INVEST, V122, P2884, DOI 10.1172/JCI63455; Tsuruta T, 2011, CANCER RES, V71, P6450, DOI 10.1158/0008-5472.CAN-11-0364; Vazquez-Del Mercado M, 2010, CLIN EXP RHEUMATOL, V28, P842; Xu Q, 2013, J MOL CELL BIOL, V5, P3, DOI 10.1093/jmcb/mjs049; Zeng B, 2012, FEBS LETT, V586, P3271, DOI 10.1016/j.febslet.2012.06.049; Zhang YL, 2012, HEPATOLOGY, V56, P1631, DOI 10.1002/hep.25849; Zheng F, 2012, GUT, V61, P278, DOI 10.1136/gut.2011.239145; Zhou X, 2012, ONCOL REP, V27, P447, DOI 10.3892/or.2011.1482	26	55	59	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e81730	10.1371/journal.pone.0081730	http://dx.doi.org/10.1371/journal.pone.0081730			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416131	Green Published, Green Submitted, gold			2022-12-27	WOS:000329866300005
J	van Bilsen, M; Daniels, A; Brouwers, O; Janssen, BJA; Derks, WJA; Brouns, AE; Munts, C; Schalkwijk, CG; van der Vusse, GJ; van Nieuwenhoven, FA				van Bilsen, Marc; Daniels, Anneleen; Brouwers, Olaf; Janssen, Ben J. A.; Derks, Wouter J. A.; Brouns, Agnieszka E.; Munts, Chantal; Schalkwijk, Casper G.; van der Vusse, Ger J.; van Nieuwenhoven, Frans A.			Hypertension Is a Conditional Factor for the Development of Cardiac Hypertrophy in Type 2 Diabetic Mice	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; DIASTOLIC DYSFUNCTION; CONTRACTILE DYSFUNCTION; CARDIOVASCULAR-DISEASE; MYOCARDIAL FIBROSIS; INSULIN-RESISTANCE; METABOLIC SYNDROME; GROWTH-FACTOR; DB/DB MICE; CARDIOMYOPATHY	Background: Type 2 diabetes is frequently associated with co-morbidities, including hypertension. Here we investigated if hypertension is a critical factor in myocardial remodeling and the development of cardiac dysfunction in type 2 diabetic db/db mice. Methods: Thereto, 14-wks-old male db/db mice and non-diabetic db/+ mice received vehicle or angiotensin II (AngII) for 4 wks to induce mild hypertension (n = 9-10 per group). Left ventricular (LV) function was assessed by serial echocardiography and during a dobutamine stress test. LV tissue was subjected to molecular and (immuno) histochemical analysis to assess effects on hypertrophy, fibrosis and inflammation. Results: Vehicle-treated diabetic mice neither displayed marked myocardial structural remodeling nor cardiac dysfunction. AngII-treatment did not affect body weight and fasting glucose levels, and induced a comparable increase in blood pressure in diabetic and control mice. Nonetheless, AngII-induced LV hypertrophy was significantly more pronounced in diabetic than in control mice as assessed by LV mass (increase +51% and +34%, respectively, p<0.01) and cardiomyocyte size (+53% and +31%, p<0.001). This was associated with enhanced LV mRNA expression of markers of hypertrophy and fibrosis and reduced activation of AMP-activated protein kinase (AMPK), while accumulation of Advanced Glycation End products (AGEs) and the expression levels of markers of inflammation were not altered. Moreover, AngII-treatment reduced LV fractional shortening and contractility in diabetic mice, but not in control mice. Conclusions: Collectively, the present findings indicate that type 2 diabetes in its early stage is not yet associated with adverse cardiac structural changes, but already renders the heart more susceptible to hypertension-induced hypertrophic remodeling.	[van Bilsen, Marc; Daniels, Anneleen; Munts, Chantal; van der Vusse, Ger J.; van Nieuwenhoven, Frans A.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Physiol, Maastricht, Netherlands; [Brouwers, Olaf; Schalkwijk, Casper G.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Internal Med, Maastricht, Netherlands; [Janssen, Ben J. A.; Brouns, Agnieszka E.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Pharmacol, Maastricht, Netherlands; [Derks, Wouter J. A.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Cardiol, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University; Maastricht University	van Bilsen, M (corresponding author), Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Physiol, Maastricht, Netherlands.	m.vanbilsen@maastrichtuniversity.nl	van Bilsen, Marc/E-8342-2016	Derks, Wouter/0000-0002-6508-0078; van Nieuwenhoven, Frans/0000-0002-5757-0069; Schalkwijk, Casper G/0000-0003-0190-2690	CARIM; EU-FP6 [LSHM-CT-2005-018833]	CARIM; EU-FP6(European Commission)	This work was supported by grants from CARIM and EU-FP6 (LSHM-CT-2005-018833, EUGeneHeart). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Jorge A, 2004, Diab Vasc Dis Res, V1, P89, DOI 10.3132/dvdr.2004.013; Aneja A, 2008, AM J MED, V121, P748, DOI 10.1016/j.amjmed.2008.03.046; Ares-Carrasco S, 2009, AM J PHYSIOL-HEART C, V297, pH2109, DOI 10.1152/ajpheart.00157.2009; Bagi Z, 2005, ARTERIOSCL THROM VAS, V25, P1610, DOI 10.1161/01.ATV.0000172688.26838.9f; Barouch LA, 2003, CIRCULATION, V108, P754, DOI 10.1161/01.CIR.0000083716.82622.FD; Bodiga VL, 2014, HEART FAIL REV, V19, P49, DOI 10.1007/s10741-013-9374-y; Bottero Virginie, 2003, Mol Diagn, V7, P187, DOI 10.2165/00066982-200307030-00008; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Brouwers O, 2011, J BIOL CHEM, V286, P1374, DOI 10.1074/jbc.M110.144097; Buchanan J, 2005, ENDOCRINOLOGY, V146, P5341, DOI 10.1210/en.2005-0938; Chan AYM, 2004, J BIOL CHEM, V279, P32771, DOI 10.1074/jbc.M403528200; Daniels A, 2010, ACTA PHYSIOL, V200, P11, DOI 10.1111/j.1748-1716.2010.02102.x; Daniels A, 2009, ACTA PHYSIOL, V195, P321, DOI 10.1111/j.1748-1716.2008.01936.x; Daniels A, 2012, EUR J HEART FAIL, V14, P193, DOI 10.1093/eurjhf/hfr166; Daugherty Alan, 2009, J Vis Exp, DOI 10.3791/1291; Falcao-Pires I, 2011, CIRCULATION, V124, P1151, DOI 10.1161/CIRCULATIONAHA.111.025270; Falcao-Pires I, 2011, BASIC RES CARDIOL, V106, P801, DOI 10.1007/s00395-011-0184-x; Fang ZY, 2004, ENDOCR REV, V25, P543, DOI 10.1210/er.2003-0012; FEIN FS, 1990, AM J PHYSIOL, V258, pH793, DOI 10.1152/ajpheart.1990.258.3.H793; Gonzalez-Quesada C, 2013, CIRC RES, V113, P1331, DOI 10.1161/CIRCRESAHA.113.302593; Hanssen NMJ, 2013, J CLIN ENDOCR METAB, V98, pE1369, DOI 10.1210/jc.2013-1068; Hermida N, 2013, CARDIOVASC RES, V99, P44, DOI 10.1093/cvr/cvt070; How OJ, 2006, DIABETES, V55, P466, DOI 10.2337/diabetes.55.02.06.db05-1164; Howard Barbara V, 2002, Circulation, V105, pe132, DOI 10.1161/01.CIR.0000013953.41667.09; Kaplan NM, 2006, LANCET, V367, P168, DOI 10.1016/S0140-6736(06)67965-8; Kelly DJ, 2007, AM J PHYSIOL-HEART C, V293, pH2860, DOI 10.1152/ajpheart.01167.2006; Nguyen Dung V, 2012, Front Endocrinol (Lausanne), V3, P170, DOI 10.3389/fendo.2012.00170; Park CW, 2009, DIABETES, V58, P2666, DOI 10.2337/db09-0136; Reyes M, 2006, AM J PHYSIOL-HEART C, V291, pH1659, DOI 10.1152/ajpheart.00609.2005; Romeo GR, 2012, ARTERIOSCL THROM VAS, V32, P1771, DOI 10.1161/ATVBAHA.111.241869; RUBLER S, 1972, AM J CARDIOL, V30, P595, DOI 10.1016/0002-9149(72)90595-4; Senador D, 2009, EXP PHYSIOL, V94, P648, DOI 10.1113/expphysiol.2008.046474; Shah AM, 2012, EUR J HEART FAIL, V14, P185, DOI 10.1093/eurjhf/hfr125; Smeets PJH, 2008, J BIOL CHEM, V283, P29109, DOI 10.1074/jbc.M802143200; Tikellis C, 2012, CLIN SCI, V123, P519, DOI 10.1042/CS20110668; Van den Bergh A, 2006, EUR J HEART FAIL, V8, P777, DOI 10.1016/j.ejheart.2006.03.001; Willemsen S, 2012, AM HEART J, V164, P742, DOI 10.1016/j.ahj.2012.07.027; Yue P, 2007, AM J PHYSIOL-HEART C, V292, pH2106, DOI 10.1152/ajpheart.00856.2006; Zhang P, 2008, HYPERTENSION, V52, P918, DOI 10.1161/HYPERTENSIONAHA.108.114702	39	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85078	10.1371/journal.pone.0085078	http://dx.doi.org/10.1371/journal.pone.0085078			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416343	gold, Green Submitted, Green Published			2022-12-27	WOS:000329866300049
J	Zauber, P; Bishop, T; Taylor, C; Sabbath-Solitare, M; Marotta, S; Tomlinson, I				Zauber, Peter; Bishop, Timothy; Taylor, Claire; Sabbath-Solitare, Marlene; Marotta, Stephen; Tomlinson, Ian			Colorectal Tumors from APC*I1307K Carriers Principally Harbor Somatic APC Mutations outside the A8 Tract	PLOS ONE			English	Article							POLYPOSIS-COLI GENE; ADENOMATOUS-POLYPOSIS; I1307K VARIANT; ASHKENAZI JEWS; GERMLINE; CANCER; POLYMORPHISMS; CARCINOMAS; NEOPLASIA; ALLELE	Purpose: APC*I1307K (c.3920T>A) is an inherited variant associated with colorectal tumour risk found almost exclusively in those of Ashkenazi Jewish ancestry. A single nucleotide substitution creates an oligo-adenine tract (A8) that appears to be inherently prone to further mis-pairing and slippage. The reported multiple tumor phenotype of carriers is not easily reconciled with molecular and population genetics data. We postulated that some c.3920T>A carriers with multiple adenomas have other unidentified APC germ line or somatic mutations. Methods: DNA from 82 colonic tumours and accompanying normal tissue collected from 29 carriers with multiple colorectal tumors was directly sequenced between codons 716 and 1604. We also assessed APC gene loss of heterozygosity. Results: One patient (3.4%) was found to have an additional APC germ line mutation. Twenty-five of the tumours showed no significant somatic molecular change, 36 showed one change, 20 showed two, and one tumour showed more than 2 changes. Our data suggest a correlation between advancing histology and fewer beta-catenin binding sites remaining in the mutant proteins. Conclusions: There were no other common germ line variants identified within the region of the APC gene examined, suggesting that any effect from this region on tumour production is attributable to the c.3920T>A allele. Our findings further suggest the only somatic genetic change clearly attributable to the c.3920T>A mutation is the c.3924_3925insA.	[Zauber, Peter] St Barnabas Hosp, Dept Med, Livingston, NJ 07039 USA; [Bishop, Timothy] Univ Leeds, Epidemiol & Biostat Sect, Leeds Inst Mol Med, Leeds, W Yorkshire, England; [Taylor, Claire] Univ Leeds, Canc Res UK Genom Facil, Leeds Inst Mol Med, Leeds, W Yorkshire, England; [Sabbath-Solitare, Marlene; Marotta, Stephen] St Barnabas Hosp, Dept Pathol, Livingston, NJ USA; [Tomlinson, Ian] Wellcome Trust Ctr Human Genet, Oxford, England	University of Leeds; University of Leeds; University of Oxford; Wellcome Centre for Human Genetics	Zauber, P (corresponding author), St Barnabas Hosp, Dept Med, Livingston, NJ 07039 USA.	pzauber@gmail.com		Bishop, Tim/0000-0002-8752-8785	Harvey Nussbaum Foundation of Saint Barnabas Medical Center; June Bleiwise Foundation; Cancer Research UK [C588/A10589]; Cancer Research UK [10589] Funding Source: researchfish	Harvey Nussbaum Foundation of Saint Barnabas Medical Center; June Bleiwise Foundation; Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This research was supported by the Harvey Nussbaum Foundation of Saint Barnabas Medical Center, the June Bleiwise Foundation and awards from Cancer Research UK (C588/A10589). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage P., 1971, STAT METHODS MED RES, V1; Azzopardi D, 2008, CANCER RES, V68, P358, DOI 10.1158/0008-5472.CAN-07-5733; Beroud C, 1996, NUCLEIC ACIDS RES, V24, P121, DOI 10.1093/nar/24.1.121; Cleary SP, 2008, DIS COLON RECTUM, V51, P1467, DOI 10.1007/s10350-008-9356-7; Crabtree M, 2003, ONCOGENE, V22, P4257, DOI 10.1038/sj.onc.1206471; Fidder HH, 2005, AM J GASTROENTEROL, V100, P1376, DOI 10.1111/j.1572-0241.2005.41580.x; Frayling IM, 1998, P NATL ACAD SCI USA, V95, P10722, DOI 10.1073/pnas.95.18.10722; Gryfe R, 1998, CANCER RES, V58, P4040; Kohler EM, 2009, HUM MOL GENET, V18, P213, DOI 10.1093/hmg/ddn338; Laken SJ, 1997, NAT GENET, V17, P79, DOI 10.1038/ng0997-79; Lamlum H, 2000, HUM MOL GENET, V9, P2215, DOI 10.1093/oxfordjournals.hmg.a018912; Lamlum H, 1999, NAT MED, V5, P1071, DOI 10.1038/12511; Liang J, 2013, AM J EPIDEMIOL, V177, P1169, DOI 10.1093/aje/kws382; NAKAMURA Y, 1992, TOHOKU J EXP MED, V168, P141, DOI 10.1620/tjem.168.141; Pollard P, 2009, GASTROENTEROLOGY, V136, P2204, DOI 10.1053/j.gastro.2009.02.058; Rennert G, 2005, DIS COLON RECTUM, V48, P2317, DOI 10.1007/s10350-005-0167-9; Shtoyerman-Chen R, 2001, GENET TEST, V5, P141, DOI 10.1089/109065701753145628; Sieber O, 2003, J PATHOL, V199, P137, DOI 10.1002/path.1272; SOLOMON E, 1987, NATURE, V328, P616, DOI 10.1038/328616a0; Thirlwell C, 2010, GASTROENTEROLOGY, V138, P1441, DOI 10.1053/j.gastro.2010.01.033; Zauber NP, 2005, CANCER-AM CANCER SOC, V104, P719, DOI 10.1002/cncr.21230; Zauber NP, 2003, J PATHOL, V199, P146, DOI 10.1002/path.1226	22	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84498	10.1371/journal.pone.0084498	http://dx.doi.org/10.1371/journal.pone.0084498			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416237	Green Published, gold, Green Submitted			2022-12-27	WOS:000329866300025
J	Carlisle, RE; Brimble, E; Werner, KE; Cruz, GL; Ask, K; Ingram, AJ; Dickhout, JG				Carlisle, Rachel E.; Brimble, Elise; Werner, Kaitlyn E.; Cruz, Gaile L.; Ask, Kjetil; Ingram, Alistair J.; Dickhout, Jeffrey G.			4-Phenylbutyrate Inhibits Tunicamycin-Induced Acute Kidney Injury via CHOP/GADD153 Repression	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; HISTONE DEACETYLASE INHIBITOR; ORAL SODIUM PHENYLBUTYRATE; PROGRAMMED CELL-DEATH; ER STRESS; CHEMICAL CHAPERONE; APOPTOSIS; CYTOTOXICITY; CONTRIBUTES	Different forms of acute kidney injury (AKI) have been associated with endoplasmic reticulum (ER) stress; these include AKI caused by acetaminophen, antibiotics, cisplatin, and radiocontrast. Tunicamycin (TM) is a nucleoside antibiotic known to induce ER stress and is a commonly used inducer of AKI. 4-phenylbutyrate (4-PBA) is an FDA approved substance used in children who suffer from urea cycle disorders. 4-PBA acts as an ER stress inhibitor by aiding in protein folding at the molecular level and preventing misfolded protein aggregation. The main objective of this study was to determine if 4-PBA could protect from AKI induced by ER stress, as typified by the TM-model, and what mechanism(s) of 4-PBA's action were responsible for protection. C57BL/6 mice were treated with saline, TM or TM plus 4-PBA. 4-PBA partially protected the anatomic segment most susceptible to damage, the outer medullary stripe, from TM-induced AKI. In vitro work showed that 4-PBA protected human proximal tubular cells from apoptosis and TM-induced CHOP expression, an ER stress inducible proapoptotic gene. Further, immunofluorescent staining in the animal model found similar protection by 4-PBA from CHOP nuclear translocation in the tubular epithelium of the medulla. This was accompanied by a reduction in apoptosis and GRP78 expression. CHOP-/- mice were protected from TM-induced AKI. The protective effects of 4-PBA extended to the ultrastructural integrity of proximal tubule cells in the outer medulla. When taken together, these results indicate that 4-PBA acts as an ER stress inhibitor, to partially protect the kidney from TM-induced AKI through the repression of ER stress-induced CHOP expression.	[Carlisle, Rachel E.; Brimble, Elise; Werner, Kaitlyn E.; Cruz, Gaile L.; Ingram, Alistair J.; Dickhout, Jeffrey G.] McMaster Univ, Dept Med, Div Nephrol, Hamilton, ON, Canada; [Carlisle, Rachel E.; Brimble, Elise; Werner, Kaitlyn E.; Cruz, Gaile L.; Ask, Kjetil; Ingram, Alistair J.; Dickhout, Jeffrey G.] St Josephs Healthcare Hamilton, Hamilton, ON, Canada; [Ask, Kjetil] McMaster Univ, Dept Med, Div Respirol, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Dickhout, JG (corresponding author), McMaster Univ, Dept Med, Div Nephrol, Hamilton, ON, Canada.	jdickhou@stjosham.on.ca	Dickhout, Jeffrey/R-2606-2019; Ask, Kjetil/AGE-0063-2022; Ask, Kjetil/B-6833-2015	Brimble, Elise/0000-0002-7238-7342; Carlisle, Rachel/0000-0002-4266-1953; Ask, Kjetil/0000-0002-0202-735X	Canadian Institutes of Health Research [OSO-115895]; St. Joseph's Healthcare Hamilton; McMaster University, Department of Medicine Internal Career Research Award; Father Sean O'Sullivan Research Studentship Award, St. Joseph's Healthcare Hamilton; Department of Medicine, Division of Nephrology, McMaster University	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); St. Joseph's Healthcare Hamilton; McMaster University, Department of Medicine Internal Career Research Award; Father Sean O'Sullivan Research Studentship Award, St. Joseph's Healthcare Hamilton; Department of Medicine, Division of Nephrology, McMaster University	This work was supported by a research grant from the Canadian Institutes of Health Research to Jeffrey G. Dickhout (OSO-115895). Financial support from St. Joseph's Healthcare Hamilton is acknowledged. Jeffrey G. Dickhout also acknowledges support from St. Joseph's Healthcare Hamilton and holds a McMaster University, Department of Medicine Internal Career Research Award. Rachel E. Carlisle has been supported by a studentship from a Father Sean O'Sullivan Research Studentship Award, St. Joseph's Healthcare Hamilton. Financial support from the Department of Medicine, Division of Nephrology, McMaster University is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basseri S, 2009, J LIPID RES, V50, P2486, DOI 10.1194/jlr.M900216-JLR200; Carducci MA, 1996, CLIN CANCER RES, V2, P379; Carlisle RE, 2012, AM J PHYSIOL-RENAL, V303, pF467, DOI 10.1152/ajprenal.00481.2011; COLLINS AF, 1995, BLOOD, V85, P43, DOI 10.1182/blood.V85.1.43.bloodjournal85143; de Almeida SF, 2007, J BIOL CHEM, V282, P27905, DOI 10.1074/jbc.M702672200; Dickhout JG, 2012, J BIOL CHEM, V287, P7603, DOI 10.1074/jbc.M111.304576; Dickhout JG, 2011, CIRC RES, V108, P629, DOI 10.1161/CIRCRESAHA.110.226803; Dickhout JG, 2011, FASEB J, V25, P576, DOI 10.1096/fj.10-159319; Dickhout JG, 2009, ANTIOXID REDOX SIGN, V11, P2341, DOI [10.1089/ars.2009.2705, 10.1089/ARS.2009.2705]; Dyer ES, 2002, INT J CANCER, V101, P496, DOI 10.1002/ijc.10609; Hosoi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040144; Hossain GS, 2003, J BIOL CHEM, V278, P30317, DOI 10.1074/jbc.M212897200; Huang LH, 2011, KIDNEY INT, V79, P613, DOI 10.1038/ki.2010.469; Lhotak S, 2012, AM J PHYSIOL-RENAL, V303, pF266, DOI 10.1152/ajprenal.00482.2011; Lichter-Konecki U, 2011, MOL GENET METAB, V103, P323, DOI 10.1016/j.ymgme.2011.04.013; Loffing J, 1999, AM J PHYSIOL-LUNG C, V277, pL700, DOI 10.1152/ajplung.1999.277.4.L700; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Miller AC, 2011, RADIAT ENVIRON BIOPH, V50, P585, DOI 10.1007/s00411-011-0384-7; Mimori S, 2013, BIOORG MED CHEM LETT, V23, P6015, DOI 10.1016/j.bmcl.2013.08.001; Mimori S, 2012, BIOL PHARM BULL, V35, P84, DOI 10.1248/bpb.35.84; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ota T, 2008, J CLIN INVEST, V118, P316, DOI 10.1172/JCI32752; Peyrou M, 2007, TOXICOL SCI, V99, P338, DOI 10.1093/toxsci/kfm105; Peyrou M, 2007, TOXICOL IN VITRO, V21, P878, DOI 10.1016/j.tiv.2007.03.001; Phuphanich S, 2005, NEURO-ONCOLOGY, V7, P177, DOI 10.1215/S1152851704000183; Prachasilchai W, 2008, EUR J PHARMACOL, V592, P138, DOI 10.1016/j.ejphar.2008.06.108; Prachasilchai W, 2009, J PHARMACOL SCI, V109, P311, DOI 10.1254/jphs.08272SC; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang FM, 2011, BIOCHEM J, V433, P245, DOI 10.1042/BJ20101293; Wang WJ, 2003, J CELL SCI, V116, P683, DOI 10.1242/jcs.00267; Woo CW, 2009, NAT CELL BIOL, V11, P1473, DOI 10.1038/ncb1996; Wu CT, 2010, TOXICOL SCI, V114, P295, DOI 10.1093/toxsci/kfq006; Xiao CT, 2011, DIABETES, V60, P918, DOI 10.2337/db10-1433; Yam GHT, 2007, INVEST OPHTH VIS SCI, V48, P1683, DOI 10.1167/iovs.06-0943; Yan K, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000013297.11876.5B; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	39	71	72	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84663	10.1371/journal.pone.0084663	http://dx.doi.org/10.1371/journal.pone.0084663			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416259	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500146
J	Gong, S; Sheng, P; Jin, H; He, H; Qi, EB; Chen, W; Dong, Y; Hou, LJ				Gong, Shun; Sheng, Ping; Jin, Hai; He, Hua; Qi, Enbo; Chen, Wen; Dong, Yan; Hou, Lijun			Effect of Methylphenidate in Patients with Cancer-Related Fatigue: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							DOUBLE-BLIND; PHASE-III; MANAGEMENT; DEPRESSION; LIFE	Background: Cancer-related fatigue (CRF) is a common symptom affecting patients with cancer. There are an increasing number of trials examining potential treatments for CRF. Methylphenidate represents one of the most researched drugs and an up-to-date assessment of the evidence for its use is needed. Trials of methylphenidate for CRF provided inconsistent results. This meta-analysis was aimed at assessing the effect and safety of methylphenidate on CRF. Methods: We comprehensively searched the Pubmed, EMBASE, PSYCHInfo and the Cochrane databases in order to identify published studies on the effect of methylphenidate on CRF. Primary outcomes included fatigue. Secondary outcomes included depression, cognition and adverse effects. Findings: A meta-analysis was conducted on five randomized controlled trials and 498 patients were enrolled. Despite a large placebo effect observed in the studies included, pooled data suggested therapeutic effect of methylphenidate on CRF. Subgroup Analyses showed that the efficacy of methylphenidate on CRF is getting better with prolonging treatment duration, with a MD of -3.70 (95% CI -7.03- -0.37, p = 0.03) for long-time group and a MD of -2.49 (95% CI -6.01-1.03, p = 0.17) for short-time group. In general, there was no impact of methylphenidate on depression and cognition associated with CRF. Adverse events were similar between methylphenidate and placebo groups except that more patients reported vertigo, anxiety, anorexia and nausea in methylphenidate group compared to placebo group. Conclusion: Existing trials of methylphenidate on CRF provided limited evidence for the use of methylphenidate to treat CRF. The absolute numbers still remain small, and further confirmation is needed before firm recommendations on their usage and safety can be made in the treatment of CRF.	[Gong, Shun; Sheng, Ping; Jin, Hai; He, Hua; Qi, Enbo; Chen, Wen; Dong, Yan; Hou, Lijun] Second Mil Med Univ, Changzheng Hosp, PLA Inst Neurosurg, Dept Neurosurg,Shanghai Inst Neurosurg, Shanghai, Peoples R China; [Sheng, Ping; Dong, Yan] Second Mil Med Univ, Changzheng Hosp, Neurosci Ctr, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Dong, Y (corresponding author), Second Mil Med Univ, Changzheng Hosp, PLA Inst Neurosurg, Dept Neurosurg,Shanghai Inst Neurosurg, Shanghai, Peoples R China.	dongyan2006@yahoo.com; lj_hou@hotmail.com			Natural Science Foundation from Science and Technology Commission of Shanghai Municipality [11ZR1448700]; Research Foundation for Returned Scholars from Ministry of Education of China	Natural Science Foundation from Science and Technology Commission of Shanghai Municipality; Research Foundation for Returned Scholars from Ministry of Education of China	Dr. Yan Dong is supported by Natural Science Foundation from Science and Technology Commission of Shanghai Municipality (11ZR1448700) and Research Foundation for Returned Scholars from Ministry of Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addington AM, 2001, PSYCHOL MED, V31, P1037, DOI 10.1017/S0033291701004214; Barnes EA, 2002, INT J GYNECOL CANCER, V12, P424, DOI 10.1046/j.1525-1438.2002.t01-1-01147.x; Bruera E, 2003, J CLIN ONCOL, V21, P4439, DOI 10.1200/JCO.2003.06.156; Bruera E, 2006, J CLIN ONCOL, V24, P2073, DOI 10.1200/JCO.2005.02.8506; BRUERA E, 1992, PAIN, V50, P75, DOI 10.1016/0304-3959(92)90114-Q; BRUERA E, 1992, PAIN, V48, P163, DOI 10.1016/0304-3959(92)90053-E; Butler JM, 2007, INT J RADIAT ONCOL, V69, P1496, DOI 10.1016/j.ijrobp.2007.05.076; Candy M, 2008, COCHRANE DB SYST REV; Cella D, 2001, J CLIN ONCOL, V19, P3385, DOI 10.1200/JCO.2001.19.14.3385; Conklin HM, 2009, PEDIATRICS, V124, P226, DOI 10.1542/peds.2008-1855; Cramp F, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006145.pub3; Cueva JF, 2012, INVEST NEW DRUG, V30, P688, DOI 10.1007/s10637-010-9539-7; Dewey A, 2010, INT J EVID-BASED HEA, V8, P106, DOI 10.1111/j.1744-1609.2010.00162.x; Dy SM, 2008, J CLIN ONCOL, V26, P3886, DOI 10.1200/JCO.2007.15.9525; Fleishman S, 2005, BREAST CANCER RES TR, V94, pS214; Gehring K, 2012, J NEURO-ONCOL, V107, P165, DOI 10.1007/s11060-011-0723-1; Godfrey J, 2009, J PSYCHOPHARMACOL, V23, P194, DOI 10.1177/0269881108089809; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Hwang SS, 2003, J PAIN SYMPTOM MANAG, V26, P604, DOI 10.1016/S0885-3924(03)00218-5; Jacobsen PB, 2003, SEMIN RADIAT ONCOL, V13, P372, DOI 10.1016/S1053-4296(03)00021-3; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jensen PS, 2009, EVID-BASED MENT HEAL, V12, P18, DOI 10.1136/ebmh.12.1.18; Johnson RL, 2010, PSYCHO-ONCOLOGY, V19, P955, DOI 10.1002/pon.1646; Lawrence D.P., 2004, J NATL CANC I MONOGR, V32, P40, DOI [DOI 10.1093/JNCIM0N0GRAPHS/LGH027, DOI 10.1093/JNCIMONOGRAPHS/LGH027]; Lower EE, 2009, J PAIN SYMPTOM MANAG, V38, P650, DOI 10.1016/j.jpainsymman.2009.03.011; Mendoza TR, 1999, CANCER-AM CANCER SOC, V85, P1186, DOI 10.1002/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N; Minton O, 2008, JNCI-J NATL CANCER I, V100, P1155, DOI 10.1093/jnci/djn250; Minton O, 2013, CANCER-AM CANCER SOC, V119, P2124, DOI 10.1002/cncr.28058; Minton O, 2011, J PAIN SYMPTOM MANAG, V41, P761, DOI 10.1016/j.jpainsymman.2010.06.020; Minton O, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006704.pub3; Mock V, 2000, ONCOLOGY-NY, V14, P151; Mock Victoria, 2007, J Natl Compr Canc Netw, V5, P1054; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moraska AR, 2010, J CLIN ONCOL, V28, P3673, DOI 10.1200/JCO.2010.28.1444; Peuckmann V, 2010, COCHRANE DB SYST REV, V10, P11; Roth AJ, 2010, CANCER-AM CANCER SOC, V116, P5102, DOI 10.1002/cncr.25424; Schwartz AL, 2002, ONCOL NURS FORUM, V29, P85; Simmler Linda D, 2013, BMC Res Notes, V6, P220, DOI 10.1186/1756-0500-6-220; Webster K, 1998, ONCOLOGY-NY, V12, P697; Wiley MD, 2009, NEUROPSYCHOPHARMACOL, V34, P1339, DOI 10.1038/npp.2008.188; Yellen SB, 1997, J PAIN SYMPTOM MANAG, V13, P63, DOI 10.1016/S0885-3924(96)00274-6; Yennurajalingam S, 2007, JAMA-J AM MED ASSOC, V297, P295, DOI 10.1001/jama.297.3.295; Yennurajalingam S, 2011, ONCOLOGIST, V16, P246, DOI 10.1634/theoncologist.2010-0214	43	62	65	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84391	10.1371/journal.pone.0084391	http://dx.doi.org/10.1371/journal.pone.0084391			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416225	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500122
J	Ino, K; Masuya, M; Tawara, I; Miyata, E; Oda, K; Nakamori, Y; Suzuki, K; Ohishi, K; Katayama, N				Ino, Kazuko; Masuya, Masahiro; Tawara, Isao; Miyata, Eri; Oda, Keiko; Nakamori, Yoshiki; Suzuki, Kei; Ohishi, Kohshi; Katayama, Naoyuki			Monocytes Infiltrate the Pancreas via the MCP-1/CCR2 Pathway and Differentiate into Stellate Cells	PLOS ONE			English	Article							CHEMOATTRACTANT PROTEIN-1 MCP-1; ANGIOTENSIN-II; BONE-MARROW; ENDOTHELIAL-CELLS; HEMATOPOIETIC ORIGIN; INFLAMMATORY SITES; GENE-EXPRESSION; FIBROSIS; MICE; MACROPHAGES	Recent studies have shown that monocytes possess pluripotent plasticity. We previously reported that monocytes could differentiate into hepatic stellate cells. Although stellate cells are also present in the pancreas, their origin remains unclear. An accumulation of enhanced green fluorescent protein (EGFP)(+) CD45(-) cells was observed in the pancreases and livers of chimeric mice, which were transplanted with a single hematopoietic stem cell isolated from EGFP-transgenic mice and treated with carbon tetrachloride (CCl4). Because the vast majority of EGFP(+) CD45(-) cells in the pancreas expressed stellate cell-associated antigens such as vimentin, desmin, glial fibrillary acidic protein, procollagen-I, and alpha-smooth muscle actin, they were characterized as pancreatic stellate cells (PaSCs). EGFP(+) PaSCs were also observed in CCl4-treated mice adoptively transferred with monocytes but not with other cell lineages isolated from EGFP-transgenic mice. The expression of monocyte chemoattractant protein-1 (MCP-1) and angiotensin II (Ang II) increased in the pancreas of CCl4-treated mice and their respective receptors, C-C chemokine receptor 2 (CCR2) and Ang II type 1 receptor (AT1R), were expressed on Ly6C high monocytes isolated from EGFP-transgenic mice. We examined the effect of an AT1R antagonist, irbesartan, which is also a CCR2 antagonist, on the migration of monocytes into the pancreas. Monocytes migrated toward MCP-1 but not Ang II in vitro. Irbesartan inhibited not only their in vitro chemotaxis but also in vivo migration of adoptively transferred monocytes from peripheral blood into the pancreas. Irbesartan treatment significantly reduced the numbers of EGFP(+) F4/80(+) CCR2(+) monocytic cells and EGFP(+) PaSCs in the pancreas of CCl4-treated chimeric mice receiving EGFP(+) bone marrow cells. A specific CCR2 antagonist RS504393 inhibited the occurrence of EGFP(+) PaSCs in injured mice. We propose that CCR2(+) monocytes migrate into the pancreas possibly via the MCP-1/CCR2 pathway and give rise to PaSCs.	[Ino, Kazuko; Masuya, Masahiro; Tawara, Isao; Miyata, Eri; Oda, Keiko; Nakamori, Yoshiki; Suzuki, Kei; Ohishi, Kohshi; Katayama, Naoyuki] Mie Univ, Dept Hematol & Oncol, Grad Sch Med, Tsu, Mie 514, Japan	Mie University	Masuya, M (corresponding author), Mie Univ, Dept Hematol & Oncol, Grad Sch Med, Tsu, Mie 514, Japan.	mmasuya@clin.medic.mie-u.ac.jp; n-kata@clin.medic.mie-u.ac.jp			Japan Society for the Promotion of Science [20591150, 21591200]; Mitsubishi Pharma Research Foundation; Dainippon-Sumitomo Pharmaceutical	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mitsubishi Pharma Research Foundation; Dainippon-Sumitomo Pharmaceutical(Johnson & Johnson)	This work was supported in part by Grants-in-Aid for Scientific Research (C) for 2008-2010 (to M. M., Grant 20591150) and 2009-2011 (to N.K., Grant 21591200) from the Japan Society for the Promotion of Science, and the Mitsubishi Pharma Research Foundation (to M. M.). M. M. has received research funding from Dainippon-Sumitomo Pharmaceutical within the past two years. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba S, 2004, J HEPATOL, V40, P255, DOI 10.1016/j.jhep.2003.10.012; Bielinski SJ, 2007, GENES IMMUN, V8, P684, DOI 10.1038/sj.gene.6364434; Bush E, 2000, HYPERTENSION, V36, P360, DOI 10.1161/01.HYP.36.3.360; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Chipitsyna G, 2007, ENDOCRINOLOGY, V148, P2198, DOI 10.1210/en.2006-1358; CUSHING SD, 1990, P NATL ACAD SCI USA, V87, P5134, DOI 10.1073/pnas.87.13.5134; DOI K, 1991, LAB ANIM, V25, P21, DOI 10.1258/002367791780808121; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Goecke H, 2000, SURGERY, V128, P806, DOI 10.1067/msy.2000.108613; Grady T, 1997, GASTROENTEROLOGY, V113, P1966, DOI 10.1016/S0016-5085(97)70017-9; Haudek SB, 2010, J MOL CELL CARDIOL, V49, P499, DOI 10.1016/j.yjmcc.2010.05.005; Heymann Felix, 2009, Inflammation & Allergy Drug Targets, V8, P307; Hodge DL, 2012, EUR J IMMUNOL, V42, P2644, DOI 10.1002/eji.201242408; Inoue Masanobu, 2002, Pancreas, V25, pe64, DOI 10.1097/00006676-200211000-00023; Ishibashi T, 2008, J GASTROENTEROL, V43, P79, DOI 10.1007/s00535-007-2126-9; Kanno K, 2005, DIGEST DIS SCI, V50, P942, DOI 10.1007/s10620-005-2669-7; Kintscher U, 2001, HYPERTENSION, V37, P587, DOI 10.1161/01.HYP.37.2.587; Kitagawa K, 2004, AM J PATHOL, V165, P237, DOI 10.1016/S0002-9440(10)63292-0; Leung PS, 2007, J PHYSIOL-LONDON, V580, P31, DOI 10.1113/jphysiol.2006.126193; Marrache F, 2008, GUT, V57, P1113, DOI 10.1136/gut.2007.143271; Marshall TG, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-1; Masuya M, 2003, BLOOD, V101, P2215, DOI 10.1182/blood-2002-04-1076; Masuya M, 2011, EXP HEMATOL, V39, P934, DOI 10.1016/j.exphem.2011.06.001; Mateo T, 2006, J IMMUNOL, V176, P5577, DOI 10.4049/jimmunol.176.9.5577; McIntosh LM, 2009, CLIN EXP IMMUNOL, V155, P295, DOI 10.1111/j.1365-2249.2008.03819.x; Medina A, 2009, WOUND REPAIR REGEN, V17, P268, DOI 10.1111/j.1524-475X.2009.00457.x; Miyata E, 2008, BLOOD, V111, P2427, DOI 10.1182/blood-2007-07-101261; Miyata N, 1999, AM J PHYSIOL-RENAL, V277, pF437, DOI 10.1152/ajprenal.1999.277.3.F437; Nagashio Y, 2004, AM J PHYSIOL-GASTR L, V287, pG170, DOI 10.1152/ajpgi.00005.2004; Naim Y, 2007, ARTERIOSCL THROM VAS, V27, P2370, DOI 10.1161/ATVBAHA.107.147009; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Omary MB, 2007, J CLIN INVEST, V117, P50, DOI 10.1172/JCI30082; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Pueyo ME, 1996, BRIT J PHARMACOL, V118, P79, DOI 10.1111/j.1476-5381.1996.tb15369.x; Rasini E, 2006, REGUL PEPTIDES, V134, P69, DOI 10.1016/j.regpep.2006.01.007; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Rodgers KE, 2000, STEM CELLS, V18, P287, DOI 10.1634/stemcells.18-4-287; ROLLINS BJ, 1988, P NATL ACAD SCI USA, V85, P3738, DOI 10.1073/pnas.85.11.3738; Ruiz-Ortega M, 1998, J IMMUNOL, V161, P430; Saurer L, 2000, GASTROENTEROLOGY, V118, P356, DOI 10.1016/S0016-5085(00)70218-6; Scarlett CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026088; Sharma M, 1998, AM J PHYSIOL-RENAL, V274, pF623; Si Y, 2010, J CLIN INVEST, V120, P1192, DOI 10.1172/JCI40310; SICA A, 1990, J IMMUNOL, V144, P3034; Sparmann G, 2010, CELL RES, V20, P288, DOI 10.1038/cr.2010.10; Suzuki Y, 2003, INT J BIOCHEM CELL B, V35, P881, DOI 10.1016/S1357-2725(02)00271-6; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; Takai S, 2011, J PHARMACOL SCI, V116, P309, DOI 10.1254/jphs.11053FP; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Vestergaard C, 2004, ACTA DERM-VENEREOL, V84, P353, DOI 10.1080/00015550410034444; Vig P, 2006, HEPATOLOGY, V43, P316, DOI 10.1002/hep.21018; Watanabe T, 2009, AM J PHYSIOL-GASTR L, V297, pG1138, DOI 10.1152/ajpgi.00123.2009; YOSHIMURA T, 1989, FEBS LETT, V244, P487, DOI 10.1016/0014-5793(89)80590-3	54	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84889	10.1371/journal.pone.0084889	http://dx.doi.org/10.1371/journal.pone.0084889			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416305	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500184
J	Kiechle, K; Bazarian, JJ; Merchant-Borna, K; Stoecklein, V; Rozen, E; Blyth, B; Huang, JH; Dayawansa, S; Kanz, K; Biberthaler, P				Kiechle, Karin; Bazarian, Jeffrey J.; Merchant-Borna, Kian; Stoecklein, Veit; Rozen, Eric; Blyth, Brian; Huang, Jason H.; Dayawansa, Samantha; Kanz, Karl; Biberthaler, Peter			Subject-Specific Increases in Serum S-100B Distinguish Sports-Related Concussion from Sports-Related Exertion	PLOS ONE			English	Article							NEURON-SPECIFIC ENOLASE; TRAUMATIC BRAIN-INJURY; MINOR HEAD-INJURY; HIGH-SCHOOL; BIOCHEMICAL MARKERS; COMPUTED-TOMOGRAPHY; S100 PROTEINS; ELITE PLAYERS; DAMAGE S-100B; EPIDEMIOLOGY	Background: The on-field diagnosis of sports-related concussion (SRC) is complicated by the lack of an accurate and objective marker of brain injury. Purpose: To compare subject-specific changes in the astroglial protein, S100B, before and after SRC among collegiate and semi-professional contact sport athletes, and compare these changes to differences in S100B before and after non-contact exertion. Study Design: Longitudinal cohort study. Methods: From 2009-2011, we performed a prospective study of athletes from Munich, Germany, and Rochester, New York, USA. Serum S100B was measured in all SRC athletes at pre-season baseline, within 3 hours of injury, and at days 2, 3 and 7 post-SRC. Among a subset of athletes, S100B was measured after non-contact exertion but before injury. All samples were collected identically and analyzed using an automated electrochemiluminescent assay to quantify serum S100B levels. Results: Forty-six athletes (30 Munich, 16 Rochester) underwent baseline testing. Thirty underwent additional post-exertion S100B testing. Twenty-two athletes (16 Rochester, 6 Munich) sustained a SRC, and 17 had S100B testing within 3 hours post-injury. The mean 3-hour post-SRC S100B was significantly higher than pre-season baseline (0.099+/-0.008 mu g/L vs. 0.058+/-0.006 mu g/L, p = 0.0002). Mean post-exertion S100B was not significantly different than the preseason baseline. S100B levels at post-injury days 2, 3 and 7 were significantly lower than the 3-hour level, and not different than baseline. Both the absolute change and proportional increase in S100B 3-hour post-injury were accurate discriminators of SRC from non-contact exertion without SRC (AUC 0.772 and 0.904, respectively). A 3-hour post-concussion S100B >0.122 mu g/L and a proportional S100B increase of >45.9% over baseline were both 96.7% specific for SRC. Conclusions: Relative and absolute increases in serum S100B can accurately distinguish SRC from sports-related exertion, and may be a useful adjunct to the diagnosis of SRC.	[Kiechle, Karin; Kanz, Karl] Univ Munich, Dept Trauma Surg, Klinikum Univ Munchen, Munich, Germany; [Bazarian, Jeffrey J.; Merchant-Borna, Kian; Blyth, Brian] Univ Rochester, Med Ctr, Dept Emergency Med, Rochester, NY 14642 USA; [Stoecklein, Veit] Univ Munich, Dept Neurosurg, Klinikum Univ Munchen, Munich, Germany; [Rozen, Eric] Univ Rochester, Dept Athlet & Recreat, Rochester, NY USA; [Huang, Jason H.; Dayawansa, Samantha] Univ Rochester, Med Ctr, Dept Neurosurg, Rochester, NY 14642 USA; [Biberthaler, Peter] Tech Univ Munich, Dept Trauma Surg, D-80290 Munich, Germany	University of Munich; University of Rochester; University of Munich; University of Rochester; University of Rochester; Technical University of Munich	Bazarian, JJ (corresponding author), Univ Rochester, Med Ctr, Dept Emergency Med, Rochester, NY 14642 USA.	jeff_bazarian@urmc.rochester.edu	Huang, Jason H/J-4739-2019	Huang, Jason H/0000-0002-4426-0168	National Institutes of Health [K24HD064754]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K24HD064754] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by National Institutes of Health grant K24HD064754. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazarian JJ, 2013, J NEUROTRAUM, V30, P1747, DOI 10.1089/neu.2013.2853; Ben Abdesselam O, 2003, CLIN CHEM, V49, P836, DOI 10.1373/49.5.836; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Bonham VL, 2010, NEW ENGL J MED, V363, P997, DOI 10.1056/NEJMp1007639; Cantu R., 2009, J ATHL TRAINING, V44, P434, DOI [DOI 10.4085/1062-6050-44.4.434, 10.4085/1062-6050-44.4.434]; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; FierceBiomarkers, 2012, A STARS I MICR SFC F; Hasselblatt M, 2004, NEUROLOGY, V62, P1634, DOI 10.1212/01.WNL.0000123092.97047.B1; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Otto M, 2000, INT J SPORTS MED, V21, P551, DOI 10.1055/s-2000-8480; Pham N, 2010, PLOS ONE, V5, DOI DOI 10.1371/ANN0TATI0N/BDCB41F2-A320-4401-A6AB-86E71738597E].PL0S; Prevention CCfDC, 2007, MMWR-MORBID MORTAL W, V56, P733; Rickels E, 2011, UNFALLCHIRURG, V114, P417, DOI 10.1007/s00113-010-1872-y; Rickels E, 2010, BRAIN INJURY, V24, P1491, DOI 10.3109/02699052.2010.498006; Stalnacke BM, 2006, BRIT J SPORT MED, V40, P313, DOI 10.1136/bjsm.2005.021584; Stalnacke BM, 2004, BRAIN INJURY, V18, P899, DOI 10.1080/02699050410001671865; Stalnacke BM, 2003, CLIN J SPORT MED, V13, P292; Tang W., 2012, APPL CATEGORICAL COU; Towend W, 2006, J NEUROTRAUM, V23, P149; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	29	45	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84977	10.1371/journal.pone.0084977	http://dx.doi.org/10.1371/journal.pone.0084977			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416325	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500199
J	Klenk, J; Rapp, K; Ulmer, H; Concin, H; Nagel, G				Klenk, Jochen; Rapp, Kilian; Ulmer, Hanno; Concin, Hans; Nagel, Gabriele			Changes of Body Mass Index in Relation to Mortality: Results of a Cohort of 42,099 Adults	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; WEIGHT CHANGE; PHYSICAL-ACTIVITY; HEART-DISEASE; KOREAN MEN; OBESITY; RISK; WOMEN; ASSOCIATION; HEALTH	Background: High Body-Mass-Index (BMI) is associated with increased all-cause mortality, but little is known about the effect of short-and long-term BMI change on mortality. The aim of the study was to determine how long-term weight change affects mortality. Methods and findings: Within a population-based prospective cohort of 42,099 Austrian men and women (mean age 43 years) with at least three BMI measurements we investigated the relationship of BMI at baseline and two subsequent BMI change intervals of five years each with all-cause mortality using Cox proportional Hazard models. During median follow-up of 12 years 4,119 deaths were identified. The lowest mortalities were found in persons with normal weight or overweight at baseline and stable BMI over 10 years. Weight gain (>= 0.10 kg/m(2)/year) during the first five years was associated with increased mortality in overweight and obese people. For weight gain during both time intervals mortality risk remained significantly increased only in overweight (Hazard Ratio (HR): 1.39 (95% confidence interval: 1.01; 1.92)) and obese women (1.85 (95% confidence interval: 1.18; 2.89)). Weight loss (< -0.10 kg/m(2)/year) increased all-cause mortality in men and women consistently. BMI change over time assessed using accepted World Health Organisation BMI categories showed no increased mortality risk for people who remained in the normal or overweight category for all three measurements. In contrast, HRs for stable obese men and women were 1.57 (95% CI: 1.31; 1.87) and 1.46 (95% CI: 1.25; 1.71) respectively. Conclusion: Our findings highlight the importance of weight stability and obesity avoidance in prevention strategy.	[Klenk, Jochen; Rapp, Kilian; Nagel, Gabriele] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany; [Klenk, Jochen; Rapp, Kilian] Robert Bosch Krankenhaus, Clin Geriatr Rehabil, Stuttgart, Germany; [Ulmer, Hanno] Med Univ Innsbruck, Dept Med Stat Informat & Hlth Econ, A-6020 Innsbruck, Austria; [Concin, Hans; Nagel, Gabriele] Agcy Prevent & Social Med, Bregenz, Austria	Ulm University; Bosch; Robert Bosch Krankenhaus; Medical University of Innsbruck	Nagel, G (corresponding author), Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany.	gabriele.nagel@uni-ulm.de	Ulmer, Hanno/S-6615-2019; Rapp, Kilian/AAJ-3370-2020; Klenk, Jochen/R-3614-2019; Nagel, Gabriele/C-3635-2012; vhmpp, aks/F-9756-2012; Klenk, Jochen/C-2164-2012	Ulmer, Hanno/0000-0001-5911-1002; Rapp, Kilian/0000-0003-1625-2571; Klenk, Jochen/0000-0002-5987-447X; Nagel, Gabriele/0000-0001-6185-8535; 	State of Vorarlberg, Austria	State of Vorarlberg, Austria	Members of the VHM&PP study group are Gunter Diem MD, Guntram Hinteregger MD, Karin Parschalk MD, Wolfgang Metzler MD, Elmar Stimpfl, Raphael Peter (Agency for Preventive-and Social Medicine, Bregenz, Austria) and Stephan K. Weiland dagger MD MSc (Institute of Epidemiology and Medical Biometry, Ulm University, Germany). We thank all physicians and participants in the Vorarlberg Health Monitoring and Prevention Programme (VHM&PP) for completing the study examinations and providing data. The VHM&PP is supported by the State of Vorarlberg, Austria. The VHM&PP is supported by the State of Vorarlberg, Austria. We thank Markus Wallner, Christian Bernhard, Andrea Kaufmann, and Gabriela Dur from the Vorarlberg State Government and Chad Logan from the Institute of Epidemiology and Medical Biometry.	[Anonymous], 2002, WEIGHT CONTR PHYS AC; Berentzen T, 2006, NUTR REV, V64, P502, DOI [10.1301/nr.2006.nov.502507, 10.1111/j.1753-4887.2006.tb00183.x]; BLAIR SN, 1993, ANN INTERN MED, V119, P749, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00024; Bosomworth NJ, 2012, CAN FAM PHYSICIAN, V58, P517; Botoseneanu A., 2012, Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, V67, P1075; Bray GA, 2004, J CLIN ENDOCR METAB, V89, P2583, DOI 10.1210/jc.2004-0535; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Cartwright MJ, 2007, EXP GERONTOL, V42, P463, DOI 10.1016/j.exger.2007.03.003; Corrada MM, 2006, AM J EPIDEMIOL, V163, P938, DOI 10.1093/aje/kwj114; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Droyvold WB, 2005, J INTERN MED, V257, P338, DOI 10.1111/j.1365-2796.2005.01458.x; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Flegal KM, 2011, AM J EPIDEMIOL, V173, P1, DOI 10.1093/aje/kwq341; Harrington M, 2009, NUTR RES REV, V22, P93, DOI 10.1017/S0954422409990035; He JH, 2009, INT J ENV RES PUB HE, V6, P3115, DOI 10.3390/ijerph6123115; Heitmann BL, 2009, OBESITY, V17, P136, DOI 10.1038/oby.2008.479; Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135; Jee SH, 2005, AM J EPIDEMIOL, V162, P42, DOI 10.1093/aje/kwi166; Klenk J, 2009, EUR J EPIDEMIOL, V24, P83, DOI 10.1007/s10654-009-9312-4; LEE IM, 1992, JAMA-J AM MED ASSOC, V268, P2045, DOI 10.1001/jama.268.15.2045; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; PETERS ETJ, 1995, INT J OBESITY, V19, P862; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Rapp K, 2005, BRIT J CANCER, V93, P1062, DOI 10.1038/sj.bjc.6602819; Rosengren A, 1999, EUR HEART J, V20, P269, DOI 10.1053/euhj.1998.1235; Stampfer M, 2005, PLOS MED, V2, P476, DOI 10.1371/journal.pmed.0020181; Statistik Austria, METH TOD; Stevens J, 2000, NUTR REV, V58, P129, DOI 10.1111/j.1753-4887.2000.tb01847.x; Travier N, 2009, PREV MED, V49, P365, DOI 10.1016/j.ypmed.2009.08.009; Ulmer H, 2003, EUR HEART J, V24, P1004, DOI 10.1016/S0195-668X(03)00170-2; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Yarnell JWG, 2000, J EPIDEMIOL COMMUN H, V54, P344, DOI 10.1136/jech.54.5.344; Yun KE, 2010, INT J EPIDEMIOL, V39, P520, DOI 10.1093/ije/dyp282	33	37	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84817	10.1371/journal.pone.0084817	http://dx.doi.org/10.1371/journal.pone.0084817			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416291	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500173
J	Li, LM; Menon, DK; Janowitz, T				Li, Lucia M.; Menon, David K.; Janowitz, Tobias			Cross-Sectional Analysis of Data from the US Clinical Trials Database Reveals Poor Translational Clinical Trial Effort for Traumatic Brain Injury, Compared with Stroke	PLOS ONE			English	Article							THERAPEUTIC HYPOTHERMIA; FOLLOW-UP; TBI; CLINICALTRIALS.GOV; REHABILITATION; THROMBOLYSIS; DISABILITY; MODERATE; OUTCOMES; ASPIRIN	Traumatic brain injury (TBI) is an important public health problem, comparable to stroke in incidence and prevalence. Few interventions have proven efficacy in TBI, and clinical trials are, therefore, necessary to advance management in TBI. We describe the current clinical trial landscape in traumatic brain injury and compare it with the trial efforts for stroke. For this, we analysed all stroke and TBI studies registered on the US Clinical Trials (www.clinicaltrials.gov) database over a 10-year period (01/01/2000 to 01/31/2013). This methodology has been previously used to analyse clinical trial efforts in other specialties. We describe the research profile in each area: total number of studies, total number of participants and change in number of research studies over time. We also analysed key study characteristics, such as enrolment number and scope of recruitment. We found a mismatch between relative public health burden and relative research effort in each disease. Despite TBI having comparable prevalence and higher incidence than stroke, it has around one fifth of the number of clinical trials and participant recruitment. Both stroke and TBI have experienced an increase in the number of studies over the examined time period, but the rate of growth for TBI is one third that for stroke. Small-scale (< 1000 participants per trial) and single centre studies form the majority of clinical trials in both stroke and TBI, with TBI having significantly fewer studies with international recruitment. We discuss the consequences of these findings and how the situation might be improved. A sustained research effort, entailing increased international collaboration and rethinking the methodology of running clinical trials, is required in order to improve outcomes after traumatic brain injury.	[Li, Lucia M.] Univ London Imperial Coll Sci Technol & Med, Div Med, London, England; [Menon, David K.] Cambridge Univ Hosp NHS Fdn Trust, Div Anaesthesia, Cambridge, England; [Janowitz, Tobias] Cambridge Univ Hosp NHS Fdn Trust, Dept Oncol, Cambridge, England	Imperial College London; University of Cambridge; University of Cambridge	Li, LM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Med, London, England.	lml34@doctors.org.uk		Li, Lucia/0000-0001-7339-4854	NIHR Fellowship; Neuroscience Theme of the NIHR Cambridge Biomedical Research Centre; NIHR; European Commission (TBIcare); Wellcome Trust Translational Medicine and Therapeutics programme; Medical Research Council [G0001354B, G0001354, G1000183B] Funding Source: researchfish; National Institute for Health Research [CL-2011-14-007, NF-SI-0512-10090, ACF-2012-21-012] Funding Source: researchfish	NIHR Fellowship; Neuroscience Theme of the NIHR Cambridge Biomedical Research Centre; NIHR(National Institute for Health Research (NIHR)); European Commission (TBIcare)(European Commission); Wellcome Trust Translational Medicine and Therapeutics programme; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	LML is supported by an NIHR Fellowship. DKM is supported by the Neuroscience Theme of the NIHR Cambridge Biomedical Research Centre and an NIHR Senior Investigator awards, and by Framework Program 7 funding from the European Commission (TBIcare). TJ is supported by the Wellcome Trust Translational Medicine and Therapeutics programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; Andrews PJD, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-8; [Anonymous], 2012, LANCET NEUROL, V11, P1, DOI 10.1016/S1474-4422(11)70292-7; [Anonymous], 2012, CANC RES UK REP ACC; [Anonymous], 2012, BRIT HEART FDN ANN R; Barthel FMS, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-21; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Califf RM, 2012, JAMA-J AM MED ASSOC, V307, P1838, DOI 10.1001/jama.2012.3424; Chan J, 2007, INT J REHABIL RES, V30, P137, DOI 10.1097/MRR.0b013e32813a2f11; Charles N, 2007, NEUROREHABILITATION, V22, P61; Chen ZM, 2000, STROKE, V31, P1240, DOI 10.1161/01.STR.31.6.1240; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P1400, DOI 10.1016/j.apmr.2007.08.006; Di Legge S, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/391538; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Finkelstein E., 2006, INCIDENCE EC BURDEN; Foundation BT, 2007, J NEUROTRAUM, P106; Georgiou AP, 2013, BRIT J ANAESTH, V110, P357, DOI 10.1093/bja/aes500; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Hacke Werner, 2008, N Engl J Med, V359, P1317, DOI 10.1056/NEJMoa0804656; Hammell CL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1683; Hawley CA, 2002, BRAIN INJURY, V16, P969, DOI 10.1080/02699050210147239; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Hirsch BR, 2013, JAMA INTERN MED, V173, P972, DOI 10.1001/jamainternmed.2013.627; Hoffmann B, 2002, ACT NEUR S, V79, P33; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Hoofien D, 2001, BRAIN INJURY, V15, P189; Janowitz T, 2011, PROTEIN ENG DES SEL, V24, P105, DOI 10.1093/protein/gzq090; Janowitz T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000330; Lecouturier Jan, 2008, BMC Med Ethics, V9, P9, DOI 10.1186/1472-6939-9-9; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76, DOI DOI 10.1097/00001199-199106000-00010; National Office of Statistics, 2011, DEATH REG SUMM TABL; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ross JS, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7292; Rothwell PM, 2012, LANCET NEUROL, V11, P2, DOI 10.1016/S1474-4422(11)70283-6; Royston P, 2003, STAT MED, V22, P2239, DOI 10.1002/sim.1430; Royston P, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-81; Sandercock P, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000029; Tagliaferri T, 2006, ACTA NEUROCHIR, P225; Tate CM, 2013, J NEUROTRAUMA; Union E, 2012, PROPOSAL REGULATION; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; von Wild KRH, 2008, ACT NEUR S, V101, P55; Wang YJ, 2013, NEW ENGL J MED, V369, P11, DOI 10.1056/NEJMoa1215340; Wardlaw JM, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000213; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Zarin DA, 2007, JAMA-J AM MED ASSOC, V297, P2112, DOI 10.1001/jama.297.19.2112; Zarin DA, 2011, NEW ENGL J MED, V364, P852, DOI 10.1056/NEJMsa1012065	60	15	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84336	10.1371/journal.pone.0084336	http://dx.doi.org/10.1371/journal.pone.0084336			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291WL	24416218	Green Published, Green Accepted, gold			2022-12-27	WOS:000329862500115
J	Liu, MJ; Bienfait, B; Sacher, O; Gasteiger, J; Siezen, RJ; Nauta, A; Geurts, JMW				Liu, Mengjin; Bienfait, Bruno; Sacher, Oliver; Gasteiger, Johann; Siezen, Roland J.; Nauta, Arjen; Geurts, Jan M. W.			Combining Chemoinformatics with Bioinformatics: In Silico Prediction of Bacterial Flavor-Forming Pathways by a Chemical Systems Biology Approach "Reverse Pathway Engineering''	PLOS ONE			English	Article							VOLATILE SULFUR-COMPOUNDS; LACTIC-ACID BACTERIA; L-LACTATE OXIDASE; ALPHA-KETO ACIDS; AMINO-ACIDS; METABOLISM; ENZYMES; CONVERSION; GENOMICS; RECONSTRUCTION	The incompleteness of genome-scale metabolic models is a major bottleneck for systems biology approaches, which are based on large numbers of metabolites as identified and quantified by metabolomics. Many of the revealed secondary metabolites and/or their derivatives, such as flavor compounds, are non-essential in metabolism, and many of their synthesis pathways are unknown. In this study, we describe a novel approach, Reverse Pathway Engineering (RPE), which combines chemoinformatics and bioinformatics analyses, to predict the "missing links'' between compounds of interest and their possible metabolic precursors by providing plausible chemical and/or enzymatic reactions. We demonstrate the added-value of the approach by using flavor-forming pathways in lactic acid bacteria (LAB) as an example. Established metabolic routes leading to the formation of flavor compounds from leucine were successfully replicated. Novel reactions involved in flavor formation, i.e. the conversion of alpha-hydroxy-isocaproate to 3-methylbutanoic acid and the synthesis of dimethyl sulfide, as well as the involved enzymes were successfully predicted. These new insights into the flavor-formation mechanisms in LAB can have a significant impact on improving the control of aroma formation in fermented food products. Since the input reaction databases and compounds are highly flexible, the RPE approach can be easily extended to a broad spectrum of applications, amongst others health/disease biomarker discovery as well as synthetic biology.	[Liu, Mengjin; Nauta, Arjen; Geurts, Jan M. W.] FrieslandCampina, Dept Nutr Sci, Amersfoort, Netherlands; [Liu, Mengjin; Siezen, Roland J.] Radboud Univ Nijmegen, Ctr Mol & Biomol Informat, NL-6525 ED Nijmegen, Netherlands; [Bienfait, Bruno; Sacher, Oliver; Gasteiger, Johann] Mol Networks GmbH, Erlangen, Germany; [Gasteiger, Johann] Univ Erlangen Nurnberg, Comp Chem Ctr, D-91054 Erlangen, Germany	Radboud University Nijmegen; University of Erlangen Nuremberg	Geurts, JMW (corresponding author), FrieslandCampina, Dept Nutr Sci, Amersfoort, Netherlands.	jan.geurts@frieslandcampina.com	Siezen, Roland J/P-5745-2015		Casimir program of the Ministry of Economic Affairs, The Netherlands [CSI4017]	Casimir program of the Ministry of Economic Affairs, The Netherlands	This work was supported by grant CSI4017 of the Casimir program of the Ministry of Economic Affairs, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardo Y, 2006, BIOTECHNOL ADV, V24, P238, DOI 10.1016/j.biotechadv.2005.11.005; Attieh J, 2002, PLANT MOL BIOL, V50, P511, DOI 10.1023/A:1019865829534; Bentley R, 2004, CHEMOSPHERE, V55, P291, DOI 10.1016/j.chemosphere.2003.12.017; Bonnarme P, 2004, FEMS MICROBIOL LETT, V236, P85, DOI 10.1016/j.femsle.2004.05.022; Breitling R, 2008, NAT REV MICROBIOL, V6, P156, DOI 10.1038/nrmicro1797; Chambellon E, 2009, J BACTERIOL, V191, P873, DOI 10.1128/JB.01114-08; COREY EJ, 1985, SCIENCE, V228, P408, DOI 10.1126/science.3838594; de la Plaza M, 2004, FEMS MICROBIOL LETT, V238, P367, DOI 10.1016/j.femsle.2004.07.057; Dunn WB, 2005, ANALYST, V130, P606, DOI 10.1039/b418288j; Durot M, 2009, FEMS MICROBIOL REV, V33, P164, DOI 10.1111/j.1574-6976.2008.00146.x; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Feist AM, 2009, NAT REV MICROBIOL, V7, P129, DOI 10.1038/nrmicro1949; Fernandez M, 2006, CRIT REV MICROBIOL, V32, P155, DOI 10.1080/10408410600880643; Furusawa C, 2013, ADV BIOCHEM ENG BIOT, V131, P1, DOI 10.1007/10_2012_137; Ganesan B, 2006, APPL ENVIRON MICROB, V72, P4264, DOI 10.1128/AEM.00448-06; GIEGEL DA, 1990, J BIOL CHEM, V265, P6626; Helinck S, 2004, APPL ENVIRON MICROB, V70, P3855, DOI 10.1128/AEM.70.7.3855-3861.2004; Holmes E, 2008, NATURE, V453, P396, DOI 10.1038/nature06882; Ihlenfeldt WD, 1995, ANGEW CHEM INT EDIT, V34, P2613; KADOTA H, 1972, ANNU REV MICROBIOL, V26, P127, DOI 10.1146/annurev.mi.26.100172.001015; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kastenmuller G, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r28; Kinross James M, 2008, Curr Gastroenterol Rep, V10, P396, DOI 10.1007/s11894-008-0075-y; Kumar A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-6; Landaud S, 2008, APPL MICROBIOL BIOT, V77, P1191, DOI 10.1007/s00253-007-1288-y; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Law J, 2009, J CHEM INF MODEL, V49, P593, DOI 10.1021/ci800228y; Lee JW, 2012, NAT CHEM BIOL, V8, P536, DOI [10.1038/NCHEMBIO.970, 10.1038/nchembio.970]; Liu M, 2008, APPL ENVIRON MICROB, V74, P4590, DOI 10.1128/AEM.00150-08; Mapelli V, 2008, TRENDS BIOTECHNOL, V26, P490, DOI 10.1016/j.tibtech.2008.05.008; Martin CH, 2009, CHEM BIOL, V16, P277, DOI 10.1016/j.chembiol.2009.01.010; Mashkina AV, 2000, KINET CATAL+, V41, P216, DOI 10.1007/BF02771423; Medema MH, 2012, NAT REV MICROBIOL, V10, P191, DOI 10.1038/nrmicro2717; Michal G, 1999, BIOCH PATHWAYS ATLAS; Morimoto Y, 1998, BIOCHIMIE, V80, P309, DOI 10.1016/S0300-9084(98)80072-2; Overbeek R, 2003, NUCLEIC ACIDS RES, V31, P164, DOI 10.1093/nar/gkg148; Pastink MI, 2008, INT DAIRY J, V18, P781, DOI 10.1016/j.idairyj.2007.07.006; Pettit RK, 2009, APPL MICROBIOL BIOT, V83, P19, DOI 10.1007/s00253-009-1916-9; Pfortner M., 2003, HDB CHEMOINFORMATICS, P1457; Ran NQ, 2007, J AM CHEM SOC, V129, P6130, DOI 10.1021/ja067330p; Ranganathan S, 2012, METAB ENG, V14, P687, DOI 10.1016/j.ymben.2012.08.008; Reitz M, 2004, ORG BIOMOL CHEM, V2, P3226, DOI 10.1039/b410949j; Rezzi S, 2007, J PROTEOME RES, V6, P4469, DOI 10.1021/pr070431h; Sacher O, 2009, J CHEM INF MODEL, V49, P1525, DOI 10.1021/ci800277f; Scheer M, 2011, NUCLEIC ACIDS RES, V39, pD670, DOI 10.1093/nar/gkq1089; Schulz S, 2007, NAT PROD REP, V24, P814, DOI 10.1039/b507392h; Simon GM, 2008, NAT CHEM BIOL, V4, P639, DOI 10.1038/nchembio1108-639; Sitzmann M, 2003, CHEMOINFORMATICS TXB, P567; Smit BA, 2004, J AGR FOOD CHEM, V52, P1263, DOI 10.1021/jf035147z; Smit G, 2005, FEMS MICROBIOL REV, V29, P591, DOI 10.1016/j.femsre.2005.04.002; Sztajer H, 1996, APPL MICROBIOL BIOT, V45, P600, DOI 10.1007/s002530050736; Takemori S, 1975, Methods Enzymol, V41, P329; Taylor BF, 1989, BIOGENIC SULFUR ENV; Teusink B, 2006, J BIOL CHEM, V281, P40041, DOI 10.1074/jbc.M606263200; van der Heijden RTJM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-83; Ward DE, 1999, J BACTERIOL, V181, P5433, DOI 10.1128/JB.181.17.5433-5442.1999; Weimer B, 1999, ANTON LEEUW INT J G, V76, P247, DOI 10.1023/A:1002050625344; Xu P, 1996, APPL BIOCHEM BIOTECH, V56, P277, DOI 10.1007/BF02786958; Yorita K, 1996, J BIOL CHEM, V271, P28300, DOI 10.1074/jbc.271.45.28300; Yvon M, 2000, APPL ENVIRON MICROB, V66, P571, DOI 10.1128/AEM.66.2.571-577.2000; Yvon M, 2006, AUST J DAIRY TECHNOL, V61, P88	61	33	35	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84769	10.1371/journal.pone.0084769	http://dx.doi.org/10.1371/journal.pone.0084769			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416282	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500165
J	Lund, K; Vase, L; Petersen, GL; Jensen, TS; Finnerup, NB				Lund, Karen; Vase, Lene; Petersen, Gitte L.; Jensen, Troels S.; Finnerup, Nanna B.			Randomised Controlled Trials May Underestimate Drug Effects: Balanced Placebo Trial Design	PLOS ONE			English	Article							NEUROPATHIC PAIN; CLINICAL-TRIALS; MEDICINE; ANTIDEPRESSANTS; EXPECTATION; ANALGESIA; MUSCLE	Background: It is an inherent assumption in randomised controlled trials that the drug effect can be estimated by subtracting the response during placebo from the response during active drug treatment. Objective: To test the assumption of additivity. The primary hypothesis was that the total treatment effect is smaller than the sum of the drug effect and the placebo effect. The secondary hypothesis was that non-additivity was most pronounced in participants with large placebo effects. Methods: We used a within-subject randomised blinded balanced placebo design and included 48 healthy volunteers (50% males), mean (SD) age 23.4 (6.2) years. Experimental pain was induced by injections of hypertonic saline into the masseter muscle. Participants received four injections with hypertonic saline along with lidocaine or matching placebo in randomised order: A: received hypertonic saline/told hypertonic saline; B: received hypertonic saline+lidocaine/told hypertonic saline; C: received hypertonic saline+placebo/told hypertonic saline+pain killer; D: received hypertonic saline+lidocaine/told hypertonic saline+pain killer. The primary outcome measure was the area under the curve (AUC, mm(2)) of pain intensity during injections. Results: There was a significant difference between the sum of the drug effect and the placebo effect (mean AUC 6279 mm(2) (95% CI, 4936-7622)) and the total treatment effect (mean AUC 5455 mm(2) (95% CI, 4585-6324)) (P = 0.049). This difference was larger for participants with large versus small placebo effects (P = 0.015), and the difference correlated significantly with the size of the placebo effect (r = 0.65, P = 0.006). Conclusion: Although this study examined placebo effects and not the whole placebo response as in randomised controlled trials, it does suggest that the additivity assumption may be incorrect, and that the estimated drug effects in randomised controlled trials may be underestimated, particularly in studies reporting large placebo responses. The implications for randomised controlled trials and systematic reviews need to be discussed.	[Lund, Karen; Jensen, Troels S.; Finnerup, Nanna B.] Aarhus Univ Hosp, Danish Pain Res Ctr, DK-8000 Aarhus, Denmark; [Vase, Lene; Petersen, Gitte L.] Aarhus Univ, Sch Business & Social Sci, Dept Psychol, Aarhus, Denmark	Aarhus University; Aarhus University	Lund, K (corresponding author), Aarhus Univ Hosp, Danish Pain Res Ctr, DK-8000 Aarhus, Denmark.	k.lund@ki.au.dk	Jensen, Troels Staehelin/A-3418-2009; Finnerup, Nanna Brix/ABA-8219-2020	Jensen, Troels Staehelin/0000-0002-3487-6380; Finnerup, Nanna Brix/0000-0001-5541-0240; Petersen, Gitte Laue/0000-0001-8317-4759; Vase, Lene/0000-0002-0379-2256	Innovative Medicines Initiative Joint Undertaking [115007]; European Union; EFPIA companies	Innovative Medicines Initiative Joint Undertaking; European Union(European Commission); EFPIA companies	The research leading to these results is part of the Europain Collaboration, which has received support from the Innovative Medicines Initiative Joint Undertaking, under grant agreement no 115007, the resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies' in kind contribution www.imi.europa.eu. The funding source had the possibility to comment on the design and the reporting of the study, but had no role in the collection, analysis, and interpretation of the data and the decision to submit for publication.	Amanzio M, 1999, J NEUROSCI, V19, P484, DOI 10.1523/JNEUROSCI.19-01-00484.1999; Bendixen KH, 2010, J OROFAC PAIN, V24, P398; Benedetti F, 2011, NEUROPSYCHOPHARMACOL, V36, P339, DOI 10.1038/npp.2010.81; Bridge JA, 2009, AM J PSYCHIAT, V166, P42, DOI 10.1176/appi.ajp.2008.08020247; Cepeda MS, 2012, PAIN MED, V13, P575, DOI 10.1111/j.1526-4637.2012.01340.x; Dworkin RH, 2012, PAIN, V153, P1148, DOI 10.1016/j.pain.2012.03.003; Eccles R, 2010, LUNG, V188, pS53, DOI 10.1007/s00408-009-9173-3; Enck P, 2013, NAT REV DRUG DISCOV, V12, P191, DOI 10.1038/nrd3923; Enck P, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-90; Enck P, 2011, PHILOS T R SOC B, V366, P1889, DOI 10.1098/rstb.2010.0384; Finnerup NB, 2010, PAIN, V150, P573, DOI 10.1016/j.pain.2010.06.019; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Fonnebo V, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-7; Fountoulakis KN, 2012, J PSYCHOPHARMACOL, V26, P744, DOI 10.1177/0269881111421969; Hammami MM, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-110; Horjales-Araujo E, 2013, EUR J PAIN, V17, P811, DOI 10.1002/j.1532-2149.2012.00253.x; Katz J, 2008, NEUROLOGY, V70, P263, DOI 10.1212/01.wnl.0000275528.01263.6c; Khan A, 2003, J NERV MENT DIS, V191, P211, DOI 10.1097/00005053-200304000-00001; Kirsch I, 2000, BIOL PSYCHIAT, V47, P733, DOI 10.1016/S0006-3223(00)00832-5; Kirsch I., 2002, PREV TREAT, V5, p23a, DOI [10.1037/1522-3736.5.1.523a, DOI 10.1037/1522-3736.5.1.523A]; Kirsch I, 2013, COMPLEMENT THER MED, V21, P102, DOI 10.1016/j.ctim.2012.12.003; Leuchter AF, 2002, AM J PSYCHIAT, V159, P122, DOI 10.1176/appi.ajp.159.1.122; Meissner K, 2011, PHILOS T R SOC B, V366, P1783, DOI 10.1098/rstb.2010.0414; Moerman DE, 2000, MED ANTHROPOL Q, V14, P51, DOI 10.1525/maq.2000.14.1.51; Moncrieff J., 2004, COCHRANE DB SYST REV, V1, P1, DOI DOI 10.1002/14651858.CD003012.PUB2; Mora MS, 2011, PHILOS T R SOC B, V366, P1879, DOI 10.1098/rstb.2010.0394; Petrovic P, 2010, PAIN, V150, P59, DOI 10.1016/j.pain.2010.03.011; Rief W, 2012, PAIN, V153, P2473, DOI 10.1016/j.pain.2012.09.007; ROHSENOW DJ, 1981, ADDICT BEHAV, V6, P107, DOI 10.1016/0306-4603(81)90003-4; ROSS S, 1962, PSYCHOL REP, V10, P383, DOI 10.2466/PR0.10.2.383-392; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Turner JA, 2002, PAIN, V99, P91, DOI 10.1016/S0304-3959(02)00060-X; van Die MD, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-41; Vase L, 2005, PAIN, V115, P338, DOI 10.1016/j.pain.2005.03.014; Vase L, 2002, PAIN, V99, P443, DOI 10.1016/S0304-3959(02)00205-1; Waring DR, 2008, INT J LAW PSYCHIAT, V31, P453, DOI 10.1016/j.ijlp.2008.09.001	36	43	43	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84104	10.1371/journal.pone.0084104	http://dx.doi.org/10.1371/journal.pone.0084104			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416197	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500098
J	MacIntosh, BJ; Crane, DE; Sage, MD; Rajab, AS; Donahue, MJ; McIlroy, WE; Middleton, LE				MacIntosh, Bradley J.; Crane, David E.; Sage, Michael D.; Rajab, A. Saeed; Donahue, Manus J.; McIlroy, William E.; Middleton, Laura E.			Impact of a Single Bout of Aerobic Exercise on Regional Brain Perfusion and Activation Responses in Healthy Young Adults	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; WHITE-MATTER; PHYSICAL-ACTIVITY; OLDER-ADULTS; FITNESS; STROKE; INTENSITY; HUMANS; TASK; METAANALYSIS	Purpose: Despite the generally accepted view that aerobic exercise can have positive effects on brain health, few studies have measured brain responses to exercise over a short time span. The purpose of this study was to examine the impact within one hour of a single bout of exercise on brain perfusion and neuronal activation. Methods: Healthy adults (n = 16; age range: 20-35 yrs) were scanned using Magnetic Resonance Imaging (MRI) before and after 20 minutes of exercise at 70% of their age-predicted maximal heart rate. Pseudo-continuous arterial spin labeling (pcASL) was used to measure absolute cerebral blood flow (CBF) prior to exercise (pre) and at 10 min (post-10) and 40 min (post-40) post-exercise. Blood oxygenation level dependent (BOLD) functional MRI (fMRI) was performed pre and postexercise to characterize activation differences related to a go/no-go reaction time task. Results: Compared to pre-exercise levels, grey matter CBF was 11% (+/- 9%) lower at post-10 (P < 0.0004) and not different at post-40 (P = 0.12), while global WM CBF was increased at both time points post-exercise (P < 0.0006). Regionally, the hippocampus and insula showed a decrease in perfusion in ROI-analysis at post-10 (P < 0.005, FDR corrected), whereas voxel-wise analysis identified elevated perfusion in the left medial postcentral gyrus at post-40 compared to pre (p(corrected) = 0.05). BOLD activations were consistent between sessions, however, the left parietal operculum showed reduced BOLD activation after exercise. Conclusion: This study provides preliminary evidence of regionalized brain effects associated with a single bout of aerobic exercise. The observed acute cerebrovascular responses may provide some insight into the brain's ability to change in relation to chronic interventions.	[MacIntosh, Bradley J.; Rajab, A. Saeed] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [MacIntosh, Bradley J.; Crane, David E.; Rajab, A. Saeed; McIlroy, William E.; Middleton, Laura E.] Sunnybrook Res Inst, Canadian Partnership Stroke Recovery, Toronto, ON, Canada; [Sage, Michael D.; McIlroy, William E.; Middleton, Laura E.] Univ Toronto, Toronto Rehabil Inst, Toronto, ON, Canada; [Sage, Michael D.] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON, Canada; [McIlroy, William E.; Middleton, Laura E.] Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada; [Donahue, Manus J.] Vanderbilt Univ, Dept Radiol, Nashville, TN 37235 USA	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; University of Toronto; University of Waterloo; Vanderbilt University	MacIntosh, BJ (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.	bmac@sri.utoronto.ca	Middleton, Laura/C-6024-2009; Middleton, Laura/ABG-8940-2021	Middleton, Laura/0000-0001-8624-3123; McIlroy, William/0000-0003-2319-1746; MacIntosh, Bradley/0000-0001-7300-2355	Heart and Stroke Foundation Centre for Stroke Recovery; Natural Sciences and Engineering Research Council of Canada (NSERC); Philips Healthcare	Heart and Stroke Foundation Centre for Stroke Recovery(Heart & Stroke Foundation of Canada); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Philips Healthcare	This study was supported by funding from the Heart and Stroke Foundation Centre for Stroke Recovery and the Natural Sciences and Engineering Research Council of Canada (NSERC). BJM has received funding support from Philips Healthcare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainslie PN, 2008, J PHYSIOL-LONDON, V586, P4005, DOI 10.1113/jphysiol.2008.158279; [Anonymous], 1984, J CARDIAC REHABIL; Borg G., 1998, BORGS PERCEIVED EXER; Brown AD, 2010, NEUROBIOL AGING, V31, P2047, DOI 10.1016/j.neurobiolaging.2008.11.002; Chang YK, 2012, BRAIN RES, V1453, P87, DOI 10.1016/j.brainres.2012.02.068; Chen TL, 2010, NEUROIMAGE, V53, P181, DOI 10.1016/j.neuroimage.2010.06.023; Christensen LOD, 2000, EXP BRAIN RES, V135, P66, DOI 10.1007/s002210000493; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166, DOI 10.1093/gerona/61.11.1166; Czurko A, 1999, EUR J NEUROSCI, V11, P344, DOI 10.1046/j.1460-9568.1999.00446.x; Dai W, 2008, STROKE, V39, P349, DOI 10.1161/STROKEAHA.107.495457; Davranche K, 2009, J SPORT EXERCISE PSY, V31, P628, DOI 10.1123/jsep.31.5.628; DECETY J, 1994, NATURE, V371, P600, DOI 10.1038/371600a0; Dishman RK, 2006, OBESITY, V14, P345, DOI 10.1038/oby.2006.46; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Eulenburg PZ, 2012, NEUROIMAGE, V60, P162, DOI 10.1016/j.neuroimage.2011.12.032; Fassbender C, 2004, COGNITIVE BRAIN RES, V20, P132, DOI 10.1016/j.cogbrainres.2004.02.007; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Hoschneider DP, 2007, BRAIN RES, V1184, P96, DOI 10.1016/j.brainres.2007.09.081; Ivey FM, 2011, STROKE, V42, P1994, DOI 10.1161/STROKEAHA.110.607879; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kamijo K, 2004, EUR J APPL PHYSIOL, V92, P305, DOI 10.1007/s00421-004-1097-2; Kamijo K, 2007, INT J PSYCHOPHYSIOL, V65, P114, DOI 10.1016/j.ijpsycho.2007.04.001; Lee CD, 2003, STROKE, V34, P2475, DOI 10.1161/01.STR.0000091843.02517.9D; MacDonald JR, 2002, J HUM HYPERTENS, V16, P225, DOI 10.1038/sj.jhh.1001377; MacIntosh B, 2007, HUM BRAIN MAPP, V28, P835, DOI 10.1002/hbm.20308; MacIntosh BJ, 2008, J CEREBR BLOOD F MET, V28, P1514, DOI 10.1038/jcbfm.2008.46; Mandell DM, 2008, STROKE, V39, P1993, DOI 10.1161/STROKEAHA.107.501692; Manly T, 2003, NEUROCASE, V9, P340, DOI 10.1076/neur.9.4.340.15553; Marks BL, 2011, BRIT J SPORT MED, V45, P1208, DOI 10.1136/bjsm.2009.068114; Martin RE, 2004, J NEUROPHYSIOL, V92, P2428, DOI 10.1152/jn.01144.2003; Middleton LE, 2013, NEUROSCI BIOBEHAV R, V37, P133, DOI 10.1016/j.neubiorev.2012.11.011; Molenberghs P, 2009, NEUROPSYCHOLOGIA, V47, P2866, DOI 10.1016/j.neuropsychologia.2009.06.012; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nybo L, 2002, J APPL PHYSIOL, V93, P58, DOI 10.1152/japplphysiol.00049.2002; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; Pescatello LS, 2004, J HYPERTENS, V22, P1881, DOI 10.1097/00004872-200410000-00009; Petruzzello SJ, 1997, PSYCHOPHYSIOLOGY, V34, P527, DOI 10.1111/j.1469-8986.1997.tb01739.x; Rhyu IJ, 2010, NEUROSCIENCE, V167, P1239, DOI 10.1016/j.neuroscience.2010.03.003; Rovio S, 2010, NEUROBIOL AGING, V31, P1927, DOI 10.1016/j.neurobiolaging.2008.10.007; Smith JC, 2010, J NEUROSCI METH, V191, P258, DOI 10.1016/j.jneumeth.2010.06.028; Stroth S, 2009, BRAIN RES, V1269, P114, DOI 10.1016/j.brainres.2009.02.073; Thomas AG, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00086; van Osch MJP, 2009, MAGN RESON MED, V62, P165, DOI 10.1002/mrm.22002; Williamson JW, 1997, J PHYSIOL-LONDON, V503, P277, DOI 10.1111/j.1469-7793.1997.277bh.x; Yung LM, 2009, SPORTS MED, V39, P45, DOI 10.2165/00007256-200939010-00004	47	66	67	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85163	10.1371/journal.pone.0085163	http://dx.doi.org/10.1371/journal.pone.0085163			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416356	Green Submitted, gold, Green Published			2022-12-27	WOS:000329862500222
J	Mulero-Pazmany, M; Stolper, R; van Essen, LD; Negro, JJ; Sassen, T				Mulero-Pazmany, Margarita; Stolper, Roel; van Essen, L. D.; Negro, Juan J.; Sassen, Tyrell			Remotely Piloted Aircraft Systems as a Rhinoceros Anti-Poaching Tool in Africa	PLOS ONE			English	Article							AERIAL VEHICLES	Over the last years there has been a massive increase in rhinoceros poaching incidents, with more than two individuals killed per day in South Africa in the first months of 2013. Immediate actions are needed to preserve current populations and the agents involved in their protection are demanding new technologies to increase their efficiency in the field. We assessed the use of remotely piloted aircraft systems (RPAS) to monitor for poaching activities. We performed 20 flights with 3 types of cameras: visual photo, HD video and thermal video, to test the ability of the systems to detect (a) rhinoceros, (b) people acting as poachers and (c) to do fence surveillance. The study area consisted of several large game farms in KwaZulu-Natal province, South Africa. The targets were better detected at the lowest altitudes, but to operate the plane safely and in a discreet way, altitudes between 100 and 180 m were the most convenient. Open areas facilitated target detection, while forest habitats complicated it. Detectability using visual cameras was higher at morning and midday, but the thermal camera provided the best images in the morning and at night. Considering not only the technical capabilities of the systems but also the poachers modus operandi and the current control methods, we propose RPAS usage as a tool for surveillance of sensitive areas, for supporting field anti-poaching operations, as a deterrent tool for poachers and as a complementary method for rhinoceros ecology research. Here, we demonstrate that low cost RPAS can be useful for rhinoceros stakeholders for field control procedures. There are, however, important practical limitations that should be considered for their successful and realistic integration in the anti-poaching battle.	[Mulero-Pazmany, Margarita; Negro, Juan J.] CSIC, Donana Biol Stn, Dept Evolutionary Ecol, E-41080 Seville, Spain; [Stolper, Roel; Sassen, Tyrell] CSIR, Dept Sensor Sci Technol, ZA-0001 Pretoria, South Africa; [van Essen, L. D.] Univ Pretoria, Ctr Wildlife Management, ZA-0002 Pretoria, South Africa	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Council for Scientific & Industrial Research (CSIR) - South Africa; University of Pretoria	Mulero-Pazmany, M (corresponding author), CSIC, Donana Biol Stn, Dept Evolutionary Ecol, E-41080 Seville, Spain.	muleromara@ebd.csic.es	Negro, Juan Jose/I-2653-2015; Mulero-Pazmany, Margarita/M-5596-2013	Negro, Juan Jose/0000-0002-8697-5647; Mulero-Pazmany, Margarita/0000-0002-0303-9360	European Commission [257649]; Donana Biological Station, CSIC; Centre for Wildlife Management (University of Pretoria); CSIR; Aeromab, (Andalusia Government, Project for Excellence) [P07-RNM-03246]	European Commission(European CommissionEuropean Commission Joint Research Centre); Donana Biological Station, CSIC; Centre for Wildlife Management (University of Pretoria); CSIR(Council of Scientific & Industrial Research (CSIR) - India); Aeromab, (Andalusia Government, Project for Excellence)	This study was conducted within the Projects: Aeromab, (Andalusia Government, Project for Excellence, 2007, P07-RNM-03246) and Planet (European Commission 7th FP Grant Agreement 257649) granted to Donana Biological Station, CSIC. Centre for Wildlife Management (University of Pretoria) and CSIR contributed to the study with their own funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chabot D, 2012, WATERBIRDS, V35, P170, DOI 10.1675/063.035.0119; Dublin HT, 2011, PACHYDERM, P1; Emslie R, 2013, 16 M C PART BANGK TH, V51, P1; Emslie R., 1999, STATUS SURVEY CONSER; Emslie R, 2012, CERATOTHERIUM SIMUM; Eustace M, 2012, BUS DAY         0120; Ferreira SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045989; Getzin S, 2012, METHODS ECOL EVOL, V3, P397, DOI 10.1111/j.2041-210X.2011.00158.x; Ingham LA, 2006, AERONAUT J, V110, P695, DOI 10.1017/S0001924000001561; Israel M, 2011, INT ARCH PHOTOGRAMM, V38-1, P51; Jones GP, 2006, WILDLIFE SOC B, V34, P750, DOI 10.2193/0091-7648(2006)34[750:AAOSUA]2.0.CO;2; Knight M, 2011, PACHYDERM, P7; Koh LP, 2012, TROP CONSERV SCI, V5, P121, DOI 10.1177/194008291200500202; Lever C, 2004, ORYX, V38, P13; Loon R, 1997, S AFR J SCI, V93, P237; Mamba A, 2009, REGULATION UNMANNED; Martin E, 2010, PACHYDERM, P48; Milledge SAH, 2007, PACHYDERM, P96; PVan Blyenburgh, 1999, UAVS CURRENT SITUATI; Rodriguez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050336; SACAA, 2008, INT POL CIV UNM AIRC; SAMAA, 2001, MAN PROC MOD AIRCR R; Sarda-Palomera F, 2012, IBIS, V154, P177, DOI 10.1111/j.1474-919X.2011.01177.x; Vermeulen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054700; Watts AC, 2010, J WILDLIFE MANAGE, V74, P1614, DOI 10.2193/2009-425; Wild S, 2013, BUSSINES DAY; WWF, 2013, GOOGL HELPS WWF STOP; Zenko M., 2013, REFORMING US DRONE S	28	141	144	2	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83873	10.1371/journal.pone.0083873	http://dx.doi.org/10.1371/journal.pone.0083873			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416177	Green Published, gold			2022-12-27	WOS:000329862500080
J	Pallet, N; Chauvet, S; Chasse, JF; Vincent, M; Avillach, P; Levi, C; Meas-Yedid, V; Olivo-Marin, JC; Nga-Matsogo, D; Beaune, P; Thervet, E; Karras, A				Pallet, Nicolas; Chauvet, Sophie; Chasse, Jean-Francois; Vincent, Marc; Avillach, Paul; Levi, Charlene; Meas-Yedid, Vannary; Olivo-Marin, Jean-Christophe; Nga-Matsogo, Diane; Beaune, Philippe; Thervet, Eric; Karras, Alexandre			Urinary Retinol Binding Protein Is a Marker of the Extent of Interstitial Kidney Fibrosis	PLOS ONE			English	Article							MOLECULAR-WEIGHT PROTEINS; OXFORD CLASSIFICATION; IMAGE-ANALYSIS; RENAL-DISEASE; NEPHROPATHY; TRANSPLANTATION; QUANTIFICATION; MECHANISMS; HISTOLOGY; SURVIVAL	Currently, a non-invasive method to estimate the degree of interstitial fibrosis (IF) in chronic kidney disease is not available in routine. The aim of our study was to evaluate the diagnostic performance of the measurement of urinary low molecular weight (LMW) protein concentrations as a method to determine the extent of IF. The urines specimen from 162 consecutive patients who underwent renal biopsy were used in the analysis. Numerical quantification software based on the colorimetric analysis of fibrous areas was used to assess the percentage IF. Total proteinuria, albuminuria, and the urinary levels of retinol binding protein (RBP), alpha1-microglobulin (alpha 1MG), beta 2-microglobulin (beta 2MG), transferrin, and IgG immunoglobulins were measured. There was a significant correlation between the degree of IF and the RBP/creatinine (creat) ratio (R2: 0.11, p<0.0001). IF was associated to a lesser extent with urinary beta 2MG and alpha 1MG; however, there was no association with total proteinuria or high molecular weight (HMW) proteinuria. The correlation between IF and RBP/creat remained significant after adjustment to the estimated glomerular filtration rate, age, body mass index, alpha 1MG, and beta 2MG. The specificity of the test for diagnosing a fibrosis score of >25% of the parenchyma was 95% when using a threshold of 20 mg/g creat. In conclusion, RBP appears to be a quantitative and non-invasive marker for the independent prediction of the extent of kidney IF. Because methods for the measurement of urinary RBP are available in most clinical chemistry departments, RBP measurement is appealing for implementation in the routine care of patients with chronic kidney disease.	[Pallet, Nicolas; Chasse, Jean-Francois; Vincent, Marc; Beaune, Philippe] Ctr Univ St Peres, INSERM, U775, Paris, France; [Pallet, Nicolas; Beaune, Philippe] Hop Europeen Georges Pompidou, AP HP, Serv Biochim, Paris, France; [Pallet, Nicolas; Chauvet, Sophie; Levi, Charlene; Nga-Matsogo, Diane; Thervet, Eric; Karras, Alexandre] Hop Europeen Georges Pompidou, AP HP, Serv Nephrol, Paris, France; [Meas-Yedid, Vannary; Olivo-Marin, Jean-Christophe] Inst Pasteur, Unite Anal Image Quantitat, Paris, France; [Avillach, Paul] Hop Europeen Georges Pompidou, AP HP, Dept Informat Med, Paris, France; [Pallet, Nicolas; Chasse, Jean-Francois; Avillach, Paul; Beaune, Philippe; Thervet, Eric] Univ Paris 05, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Pallet, N (corresponding author), Ctr Univ St Peres, INSERM, U775, Paris, France.	npallet@yahoo.fr	Olivo-Marin, Jean-Christophe/K-4428-2015	Olivo-Marin, Jean-Christophe/0000-0001-6796-0696; Beaune, Philippe/0000-0002-6569-9014; Pallet, Nicolas/0000-0002-8486-3596				Amer H, 2007, AM J TRANSPLANT, V7, P2748, DOI 10.1111/j.1600-6143.2007.02006.x; Amer H, 2013, AM J TRANSPLANT, V13, P676, DOI 10.1111/ajt.12044; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Cravedi P, 2012, NAT REV NEPHROL, V8, P301, DOI 10.1038/nrneph.2012.42; Dati F, 1996, EUR J CLIN CHEM CLIN, V34, P517; El Ghoul B, 2010, CLIN J AM SOC NEPHRO, V5, P205, DOI 10.2215/CJN.06610909; Farris AB, 2011, J AM SOC NEPHROL, V22, P176, DOI 10.1681/ASN.2009091005; Gressner A, 1995, PROTEINSTOFFWECHEL; Halimi JM, 2007, AM J TRANSPLANT, V7, P2775, DOI 10.1111/j.1600-6143.2007.02010.x; Hertig A, 2008, J AM SOC NEPHROL, V19, P1584, DOI 10.1681/ASN.2007101160; Iwasawa H, 2013, NEPHROLOGY, V18, P285, DOI 10.1111/nep.12039; Kirsztajn GM, 2002, NEPHRON, V90, P424; Levey AS, 1999, J AM SOC NEPHROL, V10, P2426; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Meas-Yedid V, 2011, TRANSPLANTATION, V92, P890, DOI 10.1097/TP.0b013e31822d879a; Mirkovic K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055887; PARVIAINEN MT, 1983, CLIN CHEM, V29, P853; Post AR, 2013, J BIOMED INFORM, V46, P410, DOI 10.1016/j.jbi.2013.01.005; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Servais A, 2007, TRANSPLANTATION, V84, P1595, DOI 10.1097/01.tp.0000295749.50525.bd; TOMLINSON PA, 1992, PEDIATR NEPHROL, V6, P565, DOI 10.1007/BF00866510; Twyman SJ, 2000, CLIN CHIM ACTA, V297, P155, DOI 10.1016/S0009-8981(00)00242-4; van den Brand JAJG, 2011, CLIN J AM SOC NEPHRO, V6, P2846, DOI 10.2215/CJN.04020411; Weiss RH, 2012, NAT REV NEPHROL, V8, P22, DOI 10.1038/nrneph.2011.152; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793	25	28	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84708	10.1371/journal.pone.0084708	http://dx.doi.org/10.1371/journal.pone.0084708			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416268	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500151
J	Rubsamen, D; Kunze, MM; Buderus, V; Brauss, TF; Bajer, MM; Brune, B; Schmid, T				Ruebsamen, Daniela; Kunze, Michael M.; Buderus, Victoria; Brauss, Thilo F.; Bajer, Magdalena M.; Bruene, Bernhard; Schmid, Tobias			Inflammatory Conditions Induce IRES-Dependent Translation of cyp24a1	PLOS ONE			English	Article							INTERNAL RIBOSOME ENTRY; MESSENGER-RNA TRANSLATION; SITE-MEDIATED TRANSLATION; CELL STRESS; CANCER; INITIATION; EXPRESSION; PROTEIN; MTOR; PHOSPHORYLATION	Rapid alterations in protein expression are commonly regulated by adjusting translation. In addition to cap-dependent translation, which is e. g. induced by pro-proliferative signaling via the mammalian target of rapamycin (mTOR)-kinase, alternative modes of translation, such as internal ribosome entry site (IRES)-dependent translation, are often enhanced under stress conditions, even if cap-dependent translation is attenuated. Common stress stimuli comprise nutrient deprivation, hypoxia, but also inflammatory signals supplied by infiltrating immune cells. Yet, the impact of inflammatory microenvironments on translation in tumor cells still remains largely elusive. In the present study, we aimed at identifying translationally deregulated targets in tumor cells under inflammatory conditions. Using polysome profiling and microarray analysis, we identified cyp24a1 (1,25-dihydroxyvitamin D-3 24-hydroxylase) to be translationally upregulated in breast tumor cells co-cultured with conditioned medium of activated monocyte-derived macrophages (CM). Using bicistronic reporter assays, we identified and validated an IRES within the 59 untranslated region (5'UTR) of cyp24a1, which enhances translation of cyp24a1 upon CM treatment. Furthermore, IRES-dependent translation of cyp24a1 by CM was sensitive to phosphatidylinositol-3-kinase (PI3K) inhibition, while constitutive activation of Akt sufficed to induce its IRES activity. Our data provide evidence that cyp24a1 expression is translationally regulated via an IRES element, which is responsive to an inflammatory environment. Considering the negative feedback impact of cyp24a1 on the vitamin D responses, the identification of a novel, translational mechanism of cyp24a1 regulation might open new possibilities to overcome the current limitations of vitamin D as tumor therapeutic option.	[Ruebsamen, Daniela; Kunze, Michael M.; Buderus, Victoria; Brauss, Thilo F.; Bajer, Magdalena M.; Bruene, Bernhard; Schmid, Tobias] Goethe Univ Frankfurt, Inst Biochem 1, D-60054 Frankfurt, Germany	Goethe University Frankfurt	Schmid, T (corresponding author), Goethe Univ Frankfurt, Inst Biochem 1, D-60054 Frankfurt, Germany.	T.Schmid@biochem.uni-frankfurt.de		Schmid, Tobias/0000-0002-1952-5259	DFG [SCHM2663, GRK1172]; LOEWE-Schwerpunkt OSF [III L 4-518/55.004 (2009)]; Hessian Ministry of Higher Education, Research and Arts	DFG(German Research Foundation (DFG)); LOEWE-Schwerpunkt OSF; Hessian Ministry of Higher Education, Research and Arts	This work was supported by the DFG (SCHM2663; GRK1172) and the LOEWE-Schwerpunkt OSF [III L 4-518/55.004 (2009)] funded by the Hessian Ministry of Higher Education, Research and Arts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averous J, 2008, ONCOGENE, V27, P1106, DOI 10.1038/sj.onc.1210715; Balla B, 2011, THYROID, V21, P459, DOI 10.1089/thy.2010.0420; Blagden SP, 2011, NAT REV CLIN ONCOL, V8, P280, DOI 10.1038/nrclinonc.2011.16; CHEN KS, 1995, BBA-GENE STRUCT EXPR, V1263, P1, DOI 10.1016/0167-4781(95)00060-T; Coldwell MJ, 2000, ONCOGENE, V19, P899, DOI 10.1038/sj.onc.1203407; Dhamija S, 2011, J BIOL CHEM, V286, P33279, DOI 10.1074/jbc.M111.264754; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hobaus J, 2013, INT J CANC; Holcik M, 2004, CURR CANCER DRUG TAR, V4, P299, DOI 10.2174/1568009043333005; Horvath E, 2012, ANTICANCER RES, V32, P4791; Horvath HC, 2010, J HISTOCHEM CYTOCHEM, V58, P277, DOI 10.1369/jhc.2009.954339; Kobayashi N, 2003, BLOOD, V102, P3186, DOI 10.1182/blood-2003-02-0567; Konno Y, 2009, MOL PHARMACOL, V75, P265, DOI 10.1124/mol.108.051904; Lang KJD, 2002, MOL BIOL CELL, V13, P1792, DOI 10.1091/mbc.02-02-0017; Lewis SM, 2005, CELL DEATH DIFFER, V12, P547, DOI 10.1038/sj.cdd.4401602; Lopes N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-483; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Moreau A, 2007, BIOCHEM BIOPH RES CO, V360, P76, DOI 10.1016/j.bbrc.2007.06.003; Novakovic B, 2009, J BIOL CHEM, V284, P14838, DOI 10.1074/jbc.M809542200; Pascussi JM, 2005, J CLIN INVEST, V115, P177, DOI 10.1172/JCI200521867; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Petz M, 2012, NUCLEIC ACIDS RES, V40, P9738, DOI 10.1093/nar/gks760; Rubsamen D, 2012, RNA, V18, P1910, DOI 10.1261/rna.033019.112; Schmid T, 2008, CANCER RES, V68, P1254, DOI 10.1158/0008-5472.CAN-07-1719; Schmid T, 2011, CARCINOGENESIS, V32, P1427, DOI 10.1093/carcin/bgr131; Schuster I, 2011, BBA-PROTEINS PROTEOM, V1814, P186, DOI 10.1016/j.bbapap.2010.06.022; Sherrill KW, 2004, J BIOL CHEM, V279, P29066, DOI 10.1074/jbc.M402727200; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spriggs KA, 2005, BIOCHEM SOC T, V33, P1483, DOI 10.1042/BST0331483; Spriggs KA, 2008, BIOL CELL, V100, P27, DOI 10.1042/BC20070098; Svitkin YV, 2005, MOL CELL BIOL, V25, P10556, DOI 10.1128/MCB.25.23.10556-10565.2005; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; van der Velden AW, 1999, INT J BIOCHEM CELL B, V31, P87, DOI 10.1016/S1357-2725(98)00134-4; Van Eden ME, 2004, RNA, V10, P720, DOI 10.1261/rna.5225204; Yasuda M, 2010, MOL CARCINOGEN, V49, P837, DOI 10.1002/mc.20660	38	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85314	10.1371/journal.pone.0085314	http://dx.doi.org/10.1371/journal.pone.0085314			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416388	gold, Green Submitted, Green Published			2022-12-27	WOS:000329862500237
J	Al-Salahi, OSA; Ji, D; Majid, AMSA; Kit-Lam, C; Abdullah, WZ; Zaki, A; Din, SKKJ; Yusoff, NM; Majid, ASA				Al-Salahi, Omar Saeed Ali; Ji, Dan; Majid, Amin Malik Shah Abdul; Kit-Lam, Chan; Abdullah, Wan Zaidah; Zaki, Abdelhamid; Din, Shah Kamal Khan Jamal; Yusoff, Narazah Mohd; Majid, Aman Shah Abdul			Anti-Tumor Activity of Eurycoma longifolia Root Extracts against K-562 Cell Line: In Vitro and In Vivo Study	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; CYCLE ARREST; DNA-DAMAGE; GROWTH ARREST; CYTOCHROME-C; CANCER-CELLS; ANTIPROLIFERATIVE ACTIVITY; PLASMODIUM-FALCIPARUM; SIGNALING PATHWAYS; INDUCED APOPTOSIS	Eurycoma longifolia Jack has been widely used in traditional medicine for its antimalarial, aphrodisiac, anti-diabetic, antimicrobial and anti-pyretic activities. Its anticancer activity has also been recently reported on different solid tumors, however no anti-leukemic activity of this plant has been reported. Thus the present study assesses the in vitro and in vivo anti-proliferative and apoptotic potentials of E. longifolia on K-562 leukemic cell line. The K-562 cells (purchased from ATCC) were isolated from patients with chronic myelocytic leukemia (CML) were treated with the various fractions (TAF273, F3 and F4) of E. longifolia root methanolic extract at various concentrations and time intervals and the anti-proliferative activity assessed by MTS assay. Flow cytometry was used to assess the apoptosis and cell cycle arrest. Nude mice injected subcutaneously with 10(7) K-562 cells were used to study the anti-leukemic activity of TAF273 in vivo. TAF273, F3 and F4 showed various degrees of growth inhibition with IC50 values of 19, 55 and 62 mu g/ml, respectively. TAF273 induced apoptosis in a dose and time dependent manner. TAF273 arrested cell cycle at G1and S phases. Intraperitoneal administration of TAF273 (50 mg/kg) resulted in a significant growth inhibition of subcutaneous tumor in TAF273-treated mice compared with the control mice (P = 0.024). TAF273 shows potent anti-proliferative activity in vitro and in vivo models of CML and therefore, justifies further efforts to define more clearly the potential benefits of using TAF273 as a novel therapeutic strategy for CML management.	[Al-Salahi, Omar Saeed Ali; Zaki, Abdelhamid; Yusoff, Narazah Mohd; Majid, Aman Shah Abdul] Univ Sains Malaysia, AMDI, Kepala Batas, Pulau Pinang, Malaysia; [Ji, Dan] Third Mil Med Univ, Southwest Hosp, Southwest Eye Hosp, Key Lab Visual Damage & Regenerat & Restorat Chon, Chongqing, Peoples R China; [Majid, Amin Malik Shah Abdul; Kit-Lam, Chan] Univ Sains Malaysia, Sch Pharmaceut Sci, George Town, Malaysia; [Abdullah, Wan Zaidah] USM, Sch Med Sci, Dept Haematol, Kubang Kerian, Kelantan, Malaysia; [Zaki, Abdelhamid] Cairo Univ, Natl Res Ctr, Therapeut Chem Dept, Cairo, Egypt; [Din, Shah Kamal Khan Jamal] Hosp Sultanah Bhiyah, OMF Surg, Alor Setar, Kedah, Malaysia	Universiti Sains Malaysia; Army Medical University; Universiti Sains Malaysia; Universiti Sains Malaysia; Egyptian Knowledge Bank (EKB); Cairo University; National Research Centre (NRC)	Yusoff, NM (corresponding author), Univ Sains Malaysia, AMDI, Kepala Batas, Pulau Pinang, Malaysia.	narazah@amdi.usm.edu.my; amanshah75@gmail.com	Abdullah, Wan Zaidah/K-9935-2017; Majid, Aman Shah Abdul/I-3809-2012; Abdullah, Wan Zaidah/E-3526-2012; Mohd Yusoff, Narazah/I-3203-2017	Abdullah, Wan Zaidah/0000-0002-4008-6772; Majid, Aman Shah Abdul/0000-0001-9679-122X; Abdullah, Wan Zaidah/0000-0002-4008-6772; Abdul Majid, Amin Malik Shah/0000-0001-7499-2258; Mohd Yusoff, Narazah/0000-0001-6801-2508				AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; Baran Y, 2007, J BIOL CHEM, V282, P10922, DOI 10.1074/jbc.M610157200; Bunch RT, 1997, CELL GROWTH DIFFER, V8, P779; Chan KL, 2004, J ETHNOPHARMACOL, V92, P223, DOI 10.1016/j.jep.2004.02.025; De Feudis P, 2000, NEOPLASIA, V2, P202, DOI 10.1038/sj.neo.7900086; Druker BJ, 2002, TRENDS MOL MED, V8, pS14, DOI 10.1016/S1471-4914(02)02305-5; Eshkoor SA, 2008, ARCH MED RES, V39, P668, DOI 10.1016/j.arcmed.2008.06.003; Gao L, 2006, CHINESE MED J-PEKING, V119, P911, DOI 10.1097/00029330-200606010-00006; Gupta M, 2006, J BIOL CHEM, V281, P17552, DOI 10.1074/jbc.M600950200; Gupta MK, 2003, WORLD J GASTROENTERO, V9, P1144, DOI 10.3748/wjg.v9.i6.1144; Han ZY, 1999, MOL CELL BIOL, V19, P1381; Jabbour E, 2009, BLOOD, V114, P2037, DOI 10.1182/blood-2009-01-197715; Janumyan YM, 2003, EMBO J, V22, P5459, DOI 10.1093/emboj/cdg533; Jin SQ, 2003, ONCOGENE, V22, P8536, DOI 10.1038/sj.onc.1206907; Jiwajinda S, 2002, J ETHNOPHARMACOL, V82, P55, DOI 10.1016/S0378-8741(02)00160-5; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Katz AJ, 2005, STEM CELLS, V23, P412, DOI 10.1634/stemcells.2004-0021; Kaur M, 2009, J NUTR, V139, p1806S, DOI 10.3945/jn.109.106864; KELLOFF GJ, 1993, J CELL BIOCHEM, P2; Kelman Z, 1997, ONCOGENE, V14, P629, DOI 10.1038/sj.onc.1200886; Kim DW, 2009, INT J HEMATOL, V89, P664, DOI 10.1007/s12185-009-0326-1; Li F, 1997, J BIOL CHEM, V272, P30299, DOI 10.1074/jbc.272.48.30299; Liang YY, 2005, CELL SIGNAL, V17, P243, DOI 10.1016/j.cellsig.2004.07.006; Lim TH, 2005, ANN ACAD MED SINGAP, V34, P533; LIN D, 1992, P NATL ACAD SCI USA, V89, P9210, DOI 10.1073/pnas.89.19.9210; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; Linke SP, 1996, GENE DEV, V10, P934, DOI 10.1101/gad.10.8.934; Low BS, 2013, J ETHNOPHARMACOL, V149, P201, DOI 10.1016/j.jep.2013.06.023; Low B, 2011, NAT PROD COMMUN, V6, P337; Low BS, 2005, PLANTA MED, V71, P803, DOI 10.1055/s-2005-871259; Mahfudh N., 2008, CANC MOL, V4, P109; Moroy T, 2004, INT J BIOCHEM CELL B, V36, P1424, DOI 10.1016/S1357-2725(03)00432-1; Mullan PB, 2001, ONCOGENE, V20, P6123, DOI 10.1038/sj.onc.1204712; O'Brien S, 2009, J NATL COMPR CANC NE, V7, P984, DOI 10.6004/jnccn.2009.0065; Payne SR, 2008, MOL CELL BIOL, V28, P258, DOI 10.1128/MCB.01536-07; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Purwantinings Hussin AH, 2009, INT J PHARM PHARM SC, V3, P343; Quentmeier H, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-6; Shi L, 2010, BIOCHEM BIOPH RES CO, V396, P224, DOI 10.1016/j.bbrc.2010.04.068; Siafakas AR, 2009, INT J BIOCHEM CELL B, V41, P986, DOI 10.1016/j.biocel.2008.06.018; Suh Y, 2009, CARCINOGENESIS, V30, P300, DOI 10.1093/carcin/bgn269; Tee TT, 2007, ANTICANCER RES, V27, P3425; Teh CH, 2009, ACTA CRYSTALLOGR E, V65, pO898, DOI 10.1107/S1600536809010502; Tsurimoto T., 1999, FRONT BIOSCI, V4, P849; Ueda JY, 2002, BIOL PHARM BULL, V25, P753, DOI 10.1248/bpb.25.753; von Bueren AO, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-19; Wang F, 2009, BMB REP, V42, P725, DOI 10.5483/BMBRep.2009.42.11.725; Weiss RS, 2003, MOL CELL BIOL, V23, P791, DOI 10.1128/MCB.23.3.791-803.2003; Wernsdorfer WH, 2009, WIEN KLIN WOCHENSCHR, V121, P23, DOI 10.1007/s00508-009-1230-7; Wong PF, 2012, PHYTOMEDICINE, V19, P138, DOI 10.1016/j.phymed.2011.07.001; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Zakaria Y, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-16; Zhuang HQ, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-12	53	16	19	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e83818	10.1371/journal.pone.0083818	http://dx.doi.org/10.1371/journal.pone.0083818			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409284	gold, Green Published, Green Submitted			2022-12-27	WOS:000329463500008
J	Bansal, V; Dorn, C; Grunert, M; Klaassen, S; Hetzer, R; Berger, F; Sperling, SR				Bansal, Vikas; Dorn, Cornelia; Grunert, Marcel; Klaassen, Sabine; Hetzer, Roland; Berger, Felix; Sperling, Silke R.			Outlier-Based Identification of Copy Number Variations Using Targeted Resequencing in a Small Cohort of Patients with Tetralogy of Fallot	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; 22Q11.2 DELETION SYNDROME; AORTIC-VALVE; GENOME; DEFECTS; DUPLICATION; PREVALENCE; MUTATIONS; PHENOTYPE; FREQUENCY	Copy number variations (CNVs) are one of the main sources of variability in the human genome. Many CNVs are associated with various diseases including cardiovascular disease. In addition to hybridization-based methods, next-generation sequencing (NGS) technologies are increasingly used for CNV discovery. However, respective computational methods applicable to NGS data are still limited. We developed a novel CNV calling method based on outlier detection applicable to small cohorts, which is of particular interest for the discovery of individual CNVs within families, de novo CNVs in trios and/or small cohorts of specific phenotypes like rare diseases. Approximately 7,000 rare diseases are currently known, which collectively affect similar to 6% of the population. For our method, we applied the Dixon's Q test to detect outliers and used a Hidden Markov Model for their assessment. The method can be used for data obtained by exome and targeted resequencing. We evaluated our outlier-based method in comparison to the CNV calling tool CoNIFER using eight HapMap exome samples and subsequently applied both methods to targeted resequencing data of patients with Tetralogy of Fallot (TOF), the most common cyanotic congenital heart disease. In both the HapMap samples and the TOF cases, our method is superior to CoNIFER, such that it identifies more true positive CNVs. Called CNVs in TOF cases were validated by qPCR and HapMap CNVs were confirmed with available array-CGH data. In the TOF patients, we found four copy number gains affecting three genes, of which two are important regulators of heart development (NOTCH1, ISL1) and one is located in a region associated with cardiac malformations (PRODH at 22q11). In summary, we present a novel CNV calling method based on outlier detection, which will be of particular interest for the analysis of de novo or individual CNVs in trios or cohorts up to 30 individuals, respectively.	[Bansal, Vikas; Dorn, Cornelia; Grunert, Marcel; Sperling, Silke R.] Charite, Expt & Clin Res Ctr, Dept Cardiovasc Genet, D-13353 Berlin, Germany; [Bansal, Vikas; Dorn, Cornelia; Grunert, Marcel; Klaassen, Sabine; Sperling, Silke R.] Max Delbruck Ctr MDC Mol Med, Berlin, Germany; [Bansal, Vikas] Free Univ Berlin, Dept Math & Comp Sci, Berlin, Germany; [Dorn, Cornelia; Sperling, Silke R.] Free Univ Berlin, Dept Biol Chem & Pharm, Berlin, Germany; [Klaassen, Sabine] Natl Register Congenital Heart Defects, Berlin, Germany; [Klaassen, Sabine] Charite, Expt & Clin Res Ctr, D-13353 Berlin, Germany; [Klaassen, Sabine; Berger, Felix] Charite, Dept Pediat Cardiol, D-13353 Berlin, Germany; [Hetzer, Roland] German Heart Inst, Dept Cardiac Surg, Berlin, Germany; [Berger, Felix] German Heart Inst, Dept Pediat Cardiol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Heart Center Berlin; German Heart Center Berlin	Sperling, SR (corresponding author), Charite, Expt & Clin Res Ctr, Dept Cardiovasc Genet, D-13353 Berlin, Germany.	silke.sperling@charite.de		Klaassen, Sabine/0000-0001-5925-9912; Berger, Felix/0000-0001-7881-1557; Bansal, Vikas/0000-0002-0944-7226; Grunert, Marcel/0000-0002-2375-6404; Rickert-Sperling, Silke/0000-0002-7135-3298	European Community [2009-223463, People-2011-ITN-289600]; Studienstiftung des Deutschen Volkes; German Research Foundation [574157]; Competence Network for Congenital Heart Defects; Federal Ministry of Education and Research (BMBF) [FKZ 01GI0601]; MRC [G0700929] Funding Source: UKRI; Medical Research Council [G0700929] Funding Source: researchfish	European Community(European Commission); Studienstiftung des Deutschen Volkes; German Research Foundation(German Research Foundation (DFG)); Competence Network for Congenital Heart Defects; Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the European Community's Seventh Framework Programme contracts ("CardioGeNet") 2009-223463 and ("CardioNet") People-2011-ITN-289600 (all to SRS), a Marie Curie PhD fellowship to VB, a PhD scholarship to CD by the Studienstiftung des Deutschen Volkes, and the German Research Foundation (Heisenberg professorship and grant 574157 to SRS). This work was also supported by the Competence Network for Congenital Heart Defects funded by the Federal Ministry of Education and Research (BMBF), support code FKZ 01GI0601. The funders had no role in study design, data collection and analysis.	Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Amarasinghe KC, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S2-S2; Apitz C, 2009, SCIENCEDIRECT COM LA; Baum LE, 1970, MAXIMIZATION TECHNIQ, DOI DOI 10.2307/2239727; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cuturilo G, 2011, EUR J PEDIATR, V170, P1465, DOI 10.1007/s00431-011-1533-3; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; Dixon WJ, 1950, ANAL EXTREME VALUES, DOI DOI 10.2307/2236602; Erdogan F, 2008, J MED GENET, V45, P704, DOI 10.1136/jmg.2008.058776; Fahed AC, 2013, CIRC RES, V112, P707, DOI 10.1161/CIRCRESAHA.112.300853; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; FERENCZ C, 1985, AM J EPIDEMIOL, V121, P31, DOI 10.1093/oxfordjournals.aje.a113979; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Fromer M, 2012, AM J HUM GENET, V91, P597, DOI 10.1016/j.ajhg.2012.08.005; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; Goldmuntz E, 1998, J AM COLL CARDIOL, V32, P492, DOI 10.1016/S0735-1097(98)00259-9; Greenway SC, 2009, NAT GENET, V41, P931, DOI 10.1038/ng.415; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Humphreys G, 2012, B WORLD HEALTH ORGAN, V90, P406, DOI 10.2471/BLT.12.020612; Kaynak B, 2003, CIRCULATION, V107, P2467, DOI 10.1161/01.CIR.0000066694.21510.E2; Krumm N, 2012, GENOME RES, V22, P1525, DOI 10.1101/gr.138115.112; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2012, BIOINFORMATICS, V28, P1307, DOI 10.1093/bioinformatics/bts146; Luo C, 2012, AM J MED GENET A, V158A, P1918, DOI 10.1002/ajmg.a.35471; Luo H, 2012, EUR J MED GENET, V55, P646, DOI 10.1016/j.ejmg.2012.07.006; Mohamed SA, 2006, BIOCHEM BIOPH RES CO, V345, P1460, DOI 10.1016/j.bbrc.2006.05.046; Momma K, 2010, AM J CARDIOL, V105, P1617, DOI 10.1016/j.amjcard.2010.01.333; NORA JJ, 1968, CIRCULATION, V38, P604, DOI 10.1161/01.CIR.38.3.604; Plagnol V, 2012, BIOINFORMATICS, V28, P2747, DOI 10.1093/bioinformatics/bts526; Reller MD, 2008, J PEDIATR-US, V153, P807, DOI 10.1016/j.jpeds.2008.05.059; Rorabacher DB, 1991, STAT TREATMENT REJEC, DOI DOI 10.1021/AC00002A010; Schlesinger J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001313; Shi YH, 2013, BIOINFORMATICS, V29, P1461, DOI 10.1093/bioinformatics/btt151; Silversides CK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002843; Soemedi R, 2012, AM J HUM GENET, V91, P489, DOI 10.1016/j.ajhg.2012.08.003; Thienpont B, 2007, EUR HEART J, V28, P2778, DOI 10.1093/eurheartj/ehl560; Toenjes M, 2008, MOL BIOSYST, V4, P589, DOI 10.1039/b800207j; Viterbi A, 1967, ERROR BOUNDS CONVOLU	40	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e85375	10.1371/journal.pone.0085375	http://dx.doi.org/10.1371/journal.pone.0085375			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400131	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000329462700065
J	Gao, JL; Weaver, SR; Dai, JM; Jia, YN; Liu, XD; Jin, KZ; Fu, H				Gao, Junling; Weaver, Scott R.; Dai, Junming; Jia, Yingnan; Liu, Xingdi; Jin, Kezhi; Fu, Hua			Workplace Social Capital and Mental Health among Chinese Employees: A Multi-Level, Cross-Sectional Study	PLOS ONE			English	Article							FINNISH PUBLIC-SECTOR; SELF-RATED HEALTH; POLITICAL-ECONOMY; ASSOCIATION; WORK; DEPRESSION; RESOURCE; SMOKING; STRESS; WOMEN	Background: Whereas the majority of previous research on social capital and health has been on residential neighborhoods and communities, the evidence remains sparse on workplace social capital. To address this gap in the literature, we examined the association between workplace social capital and health status among Chinese employees in a large, multi-level, cross-sectional study. Methods: By employing a two-stage stratified random sampling procedure, 2,796 employees were identified from 35 workplaces in Shanghai during March to November 2012. Workplace social capital was assessed using a validated and psychometrically tested eight-item measure, and the Chinese language version of the WHO-Five Well-Being Index (WHO-5) was used to assess mental health. Control variables included sex, age, marital status, education level, occupation status, smoking status, physical activity, and job stress. Multilevel logistic regression analysis was conducted to explore whether individual-and workplace-level social capital was associated with mental health status. Results: In total, 34.9% of workers reported poor mental health (WHO-5,13). After controlling for individual-level socio-demographic and lifestyle variables, compared to workers with the highest quartile of personal social capital, workers with the third, second, and lowest quartiles exhibited 1.39 to 3.54 times greater odds of poor mental health, 1.39 (95% CI: 1.10-1.75), 1.85 (95% CI: 1.38-2.46) and 3.54 (95% CI: 2.73-4.59), respectively. Corresponding odds ratios for workplace-level social capital were 0.95 (95% CI: 0.61-1.49), 1.14 (95% CI: 0.72-1.81) and 1.63 (95% CI: 1.05-2.53) for the third, second, and lowest quartiles, respectively. Conclusions: Higher workplace social capital is associated with lower odds of poor mental health among Chinese employees. Promoting social capital at the workplace may contribute to enhancing employees' mental health in China.	[Gao, Junling; Dai, Junming; Jia, Yingnan; Liu, Xingdi; Jin, Kezhi; Fu, Hua] Fudan Univ, Sch Publ Hlth, Key Lab Publ Hlth Safety, Minist Educ, Shanghai 200433, Peoples R China; [Weaver, Scott R.] Georgia State Univ, Sch Publ Hlth, Atlanta, GA 30303 USA	Fudan University; University System of Georgia; Georgia State University	Fu, H (corresponding author), Fudan Univ, Sch Publ Hlth, Key Lab Publ Hlth Safety, Minist Educ, Shanghai 200433, Peoples R China.	hfu@fudan.edu.cn	gao, junling/L-7465-2019		Humanity and Social Science Youth Foundation of Ministry of Education of China [13YJCZH043]; National Institute of Minority Health and Health Disparities of the National Institutes of Health [1P20MD004806]	Humanity and Social Science Youth Foundation of Ministry of Education of China; National Institute of Minority Health and Health Disparities of the National Institutes of Health	This work was funded by Humanity and Social Science Youth Foundation of Ministry of Education of China (Grant No: 13YJCZH043) and partially supported by the National Institute of Minority Health and Health Disparities of the National Institutes of Health (Grant No: 1P20MD004806). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum FE, 2003, J EPIDEMIOL COMMUN H, V57, P320, DOI 10.1136/jech.57.5.320; Berkman L., 2000, SOCIAL EPIDEMIOLOGY; Chen DR, 2008, HEALTH CARE MANAGE R, V33, P40, DOI 10.1097/01.HMR.0000304488.57404.64; Coleman J., 1994, FDN SOCIAL THEORY; Cutrona CE, 2000, J PERS SOC PSYCHOL, V79, P1088, DOI 10.1037/0022-3514.79.6.1088; De Silva MJ, 2005, J EPIDEMIOL COMMUN H, V59, P619, DOI 10.1136/jech.2004.029678; Gao J, 2012, CHINESE J HLTH ED, V28, P806, DOI DOI 10.16168/J.CNKI.ISSN.1002; Hamano T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013214; Helen H, 2005, PROMOTING MENTAL HLT; Henkel V, 2003, BRIT MED J, V326, P200, DOI 10.1136/bmj.326.7382.200; IPAQ Research Committee, 2005, GUID DAT PROC AN INT; Jung J, 2012, J OCCUP ENVIRON MED, V54, P23, DOI 10.1097/JOM.0b013e318237a1b6; Kawachi I, 2004, INT J EPIDEMIOL, V33, P682, DOI 10.1093/ije/dyh177; Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458; Kawachi I, 1999, ANN NY ACAD SCI, V896, P120, DOI 10.1111/j.1749-6632.1999.tb08110.x; Kouvonen A, 2008, ADDICTION, V103, P1857, DOI 10.1111/j.1360-0443.2008.02315.x; Kouvonen A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-251; Kouvonen A, 2008, AM J EPIDEMIOL, V167, P1143, DOI 10.1093/aje/kwn067; Lindstrom M, 2006, SOC SCI MED, V62, P280, DOI 10.1016/j.socscimed.2005.06.005; Liukkonen V, 2004, SOC SCI MED, V59, P2447, DOI 10.1016/j.socscimed.2004.04.013; Lochner K, 1999, HEALTH PLACE, V5, P259, DOI 10.1016/S1353-8292(99)00016-7; Macfarlane DJ, 2007, J SCI MED SPORT, V10, P45, DOI 10.1016/j.jsams.2006.05.003; Murayama H, 2012, J EPIDEMIOL, V22, P179, DOI 10.2188/jea.JE20110128; Nyqvist F, 2013, AGING MENT HEALTH, V17, P394, DOI 10.1080/13607863.2012.742490; Poortinga W, 2006, SOC SCI MED, V62, P292, DOI 10.1016/j.socscimed.2005.06.008; Putman R.D., 2000, BOWLING ALONE COLLAP; Roosa MW, 2003, AM J COMMUN PSYCHOL, V31, P55, DOI 10.1023/A:1023070519597; Sapp AL, 2010, J OCCUP ENVIRON MED, V52, P740, DOI 10.1097/JOM.0b013e3181e80842; Subramanian SV, 2002, J URBAN HEALTH, V79, pS21, DOI 10.1093/jurban/79.suppl_1.S21; Sundquist K, 2007, HEALTH PLACE, V13, P324, DOI 10.1016/j.healthplace.2006.02.002; Suzuki E, 2009, J EPIDEMIOL COMMUN H, V63, P692, DOI 10.1136/jech.2008.082453; Suzuki E, 2010, SOC SCI MED, V70, P1367, DOI 10.1016/j.socscimed.2010.01.014; Szreter S, 2004, INT J EPIDEMIOL, V33, P650, DOI 10.1093/ije/dyh013; Wang J.C, 2008, MULTILEVEL MODELS ME; WHO Collaborating Centre in Mental Health, CHIN VERS WHO 5 WELL	35	49	56	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e85005	10.1371/journal.pone.0085005	http://dx.doi.org/10.1371/journal.pone.0085005			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	286IH	24404199	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460800078
J	Nsubuga, RN; White, RG; Mayanja, BN; Shafer, LA				Nsubuga, Rebecca N.; White, Richard G.; Mayanja, Billy N.; Shafer, Leigh Anne			Estimation of the HIV Basic Reproduction Number in Rural South West Uganda: 1991-2008	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; ANTIRETROVIRAL THERAPY; TRANSMISSION; RATIO; SURVIVAL; SPREAD; MODELS; COHORT	Background: The basic reproduction number, R-0, is one of the many measures of the epidemic potential of an infection in a population. We estimate HIV R-0 over 18 years in a rural population in Uganda, examine method-specific differences in estimated R-0, and estimate behavioural changes that would reduce R-0 below one. Methods: Data on HIV natural history and infectiousness were collated from literature. Data on new sexual partner count were available from a rural clinical cohort in Uganda over 1991-2008. R-0 was estimated using six methods. Behavioural changes required to reduce R-0 below one were calculated. Results: Reported number of new partners per year was 0 to 16 (women) and 0 to 80 (men). When proportionate sexual mixing was assumed, the different methods yielded comparable R-0 estimates. Assuming totally assortative mixing led to increased R-0 estimates in the high sexual activity class while all estimates in the low-activity class were below one. Using the "effective" partner change rate introduced by Anderson and colleagues resulted in R-0 estimates all above one except in the lowest sexual activity class. R-0 could be reduced below one if: (a) medium risk individuals reduce their partner acquisition rate by 70% and higher risk individuals reduce their partner acquisition rate by 93%, or (b) higher risk individuals reduce the partner acquisition rate by 95%. Conclusions: The estimated R-0 depended strongly on the method used. Ignoring variation in sexual activity leads to an underestimation of R-0. Relying on behaviour change alone to eradicate HIV may require unrealistically large reductions in risk behaviour, even though for a small proportion of the population. To control HIV, complementary prevention strategies such as male circumcision and HIV treatment services need rapid scale up.	[Nsubuga, Rebecca N.; Mayanja, Billy N.] Uganda Virus Res Inst, MRC, Uganda Res Unit AIDS, Entebbe, Uganda; [White, Richard G.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Shafer, Leigh Anne] Univ Manitoba, Hlth Sci Ctr, Winnipeg, MB, Canada	Uganda Virus Research Institute; University of London; London School of Hygiene & Tropical Medicine; University of Manitoba; Children's Hospital Research Institute of Manitoba	Nsubuga, RN (corresponding author), Uganda Virus Res Inst, MRC, Uganda Res Unit AIDS, Entebbe, Uganda.	rebecca.nsubuga@mrcuganda.org	Mayanja, Billy/AAL-5087-2021; White, Richard G/D-5407-2009	White, Richard G/0000-0003-4410-6635	Medical Research Council, UK [G0501499, G0802414, MR/J005088/1]; Bill and Melinda Gates Foundation (Consortium to Respond Effectively to the AIDS/TB Epidemic) [19790.01]; Bill and Melinda Gates Foundation (TB Modelling and Analysis Consortium) [21675]; Medical Research Council [G0501499, MC_U950080928, MR/J005088/1, G0802414] Funding Source: researchfish; MRC [G0501499, G0802414, MR/J005088/1, MC_U950080928] Funding Source: UKRI	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bill and Melinda Gates Foundation (Consortium to Respond Effectively to the AIDS/TB Epidemic); Bill and Melinda Gates Foundation (TB Modelling and Analysis Consortium); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was part of a programme of research funded by the Medical Research Council, UK, (G0501499). RGW is funded the Medical Research Council (UK) (Methodology Research Fellowship: G0802414 and grant MR/J005088/1) and the Bill and Melinda Gates Foundation (Consortium to Respond Effectively to the AIDS/TB Epidemic: 19790.01, and the TB Modelling and Analysis Consortium: 21675). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	ANDERSON R M, 1986, IMA Journal of Mathematics Applied in Medicine and Biology, V3, P229; ANDERSON R M, 1991; ANDERSON RM, 1988, NATURE, V333, P514, DOI 10.1038/333514a0; DIEKMANN O, 1991, MATH BIOSCI, V107, P325, DOI 10.1016/0025-5564(91)90012-8; DIEKMANN O, 1990, J MATH BIOL, V28, P365; DIETZ K, 1993, MATH BIOSCI, V117, P35, DOI 10.1016/0025-5564(93)90016-4; Dietz K, 1993, Stat Methods Med Res, V2, P23, DOI 10.1177/096228029300200103; Garnett GP, 1996, SEX TRANSM DIS, V23, P248, DOI 10.1097/00007435-199605000-00015; GUPTA S, 1989, AIDS, V3, P807, DOI 10.1097/00002030-198912000-00005; Hyman JM, 2000, MATH BIOSCI, V167, P65, DOI 10.1016/S0025-5564(00)00025-0; JACQUEZ JA, 1991, MATH BIOSCI, V107, P161, DOI 10.1016/0025-5564(91)90003-2; Kazooba P, 2012, TROP MED INT HEALTH, V17, pe49, DOI 10.1111/j.1365-3156.2012.02942.x; Leynaert B, 1998, AM J EPIDEMIOL, V148, P88, DOI 10.1093/oxfordjournals.aje.a009564; MAY RM, 1987, NATURE, V326, P137, DOI 10.1038/326137a0; Morgan D, 1997, AIDS, V11, P633, DOI 10.1097/00002030-199705000-00011; Morgan D, 2000, SEX TRANSM INFECT, V76, P193, DOI 10.1136/sti.76.3.193; Ngom P, 2004, INDEPTH MOD LIF TABL; SEELEY J, 1991, AIDS Care, V3, P207, DOI 10.1080/09540129108253064; Todd J, 2007, AIDS, V21, pS55, DOI 10.1097/01.aids.0000299411.75269.e8; Van der Paal L, 2007, AIDS, V21, pS21, DOI 10.1097/01.aids.0000299407.52399.05; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411	21	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e83778	10.1371/journal.pone.0083778	http://dx.doi.org/10.1371/journal.pone.0083778			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404138	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000329460800017
J	Deschamps, P; Munsters, N; Kenemans, L; Schutter, D; Matthys, W				Deschamps, Peter; Munsters, Nicolette; Kenemans, Leon; Schutter, Dennis; Matthys, Walter			Facial Mimicry in 6-7 Year Old Children with Disruptive Behavior Disorder and ADHD	PLOS ONE			English	Article							OPPOSITIONAL DEFIANT DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT-HYPERACTIVITY DISORDER; CONDUCT DISORDER; GENDER-DIFFERENCES; FILM CLIPS; EXPRESSIONS; EMPATHY; BOYS; RECOGNITION	Background: Impairments in facial mimicry are considered a proxy for deficits in affective empathy and have been demonstrated in 10 year old children and in adolescents with disruptive behavior disorder (DBD). However, it is not known whether these impairments are already present at an earlier age. Emotional deficits have also been shown in children with attention-deficit/hyperactivity disorder (ADHD). Aims: To examine facial mimicry in younger, 6-7 year old children with DBD and with ADHD. Methods: Electromyographic (EMG) activity in response to emotional facial expressions was recorded in 47 children with DBD, 18 children with ADHD and 35 healthy developing children. Results: All groups displayed significant facial mimicry to the emotional expressions of other children. No group differences between children with DBD, children with ADHD and healthy developing children were found. In addition, no differences in facial mimicry were found between the clinical group (i.e., all children with a diagnosis) and the typically developing group in an analysis with ADHD symptoms as a covariate, and no differences were found between the clinical children and the typically developing children with DBD symptoms as a covariate. Conclusion: Facial mimicry in children with DBD and ADHD throughout the first primary school years was unimpaired, in line with studies on empathy using other paradigms.	[Deschamps, Peter; Matthys, Walter] Univ Med Ctr Utrecht, Dept Psychiat, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Munsters, Nicolette; Kenemans, Leon; Schutter, Dennis] Univ Utrecht, Dept Expt Psychol, Helmholtz Res Inst, Utrecht, Netherlands; [Matthys, Walter] Univ Utrecht, Dept Child & Adolescent Studies, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University	Deschamps, P (corresponding author), Univ Med Ctr Utrecht, Dept Psychiat, Brain Ctr Rudolf Magnus, Utrecht, Netherlands.	p.k.h.deschamps@umcutrecht.nl			Netherlands Organization for Scientific Research (NWO) [VIDI 452-07-012]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	Dennis J.L.G Schutter was supported by an Innovational Research Grant (VIDI 452-07-012) from the Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T.M., 2001, MANUAL ASEBA SCH AGE; Braaten EB, 2000, J CONSULT CLIN PSYCH, V68, P313, DOI [10.1037/0022-006X.68.2.313, 10.1037//0022-006X.68.2.313]; Dadds MR, 2006, BRIT J PSYCHIAT, V189, P280, DOI 10.1192/bjp.bp.105.018150; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; de Wied M, 2006, J PSYCHIAT RES, V40, P112, DOI 10.1016/j.jpsychires.2005.08.003; de Wied M, 2012, J ABNORM CHILD PSYCH, V40, P211, DOI 10.1007/s10802-011-9557-8; De Wied M, 2009, PSYCHOPHYSIOLOGY, V46, P996, DOI 10.1111/j.1469-8986.2009.00851.x; Deschamps PKH, 2012, INT J PSYCHOPHYSIOL, V85, P195, DOI 10.1016/j.ijpsycho.2012.05.004; Dimberg U, 2000, PSYCHOPHYSIOLOGY, V37, P693, DOI 10.1111/1469-8986.3750693; DIMBERG U, 1990, BIOL PSYCHOL, V30, P151, DOI 10.1016/0301-0511(90)90024-Q; Dyck MJ, 2001, EUR CHILD ADOLES PSY, V10, P105, DOI 10.1007/s007870170033; EISENBERG N, 1987, PSYCHOL BULL, V101, P91, DOI 10.1037/0033-2909.101.1.91; Eisenberg N, 2010, SOC ISS POLICY REV, V4, P143, DOI 10.1111/j.1751-2409.2010.01020.x; FESHBACH ND, 1968, CHILD DEV, V39, P133, DOI 10.2307/1127365; Frick P. J, 1999, HDB DISRUPTIVE BEHAV, P507, DOI DOI 10.1007/978-1-4615-4881-2_24; FRIDLUND AJ, 1986, PSYCHOPHYSIOLOGY, V23, P567, DOI 10.1111/j.1469-8986.1986.tb00676.x; Gill KL, 2003, DEV PSYCHOPATHOL, V15, P55, DOI 10.1017/S095457940300004X; Hofelich AJ, 2012, COGNITION EMOTION, V26, P119, DOI 10.1080/02699931.2011.559192; Kort W., 2005, WISC 3 NL WECHSLER I; LAHEY BB, 1995, J ABNORM PSYCHOL, V104, P83, DOI 10.1037/0021-843X.104.1.83; Larsen JT, 2009, PSYCHOPHYSIOLOGY, V46, P831, DOI 10.1111/j.1469-8986.2009.00820.x; Martel MM, 2010, PSYCHOL ASSESSMENT, V22, P816, DOI 10.1037/a0020975; Marton I, 2009, J ABNORM CHILD PSYCH, V37, P107, DOI 10.1007/s10802-008-9262-4; Matthys W, 2013, DEV PSYCHOPATHOL, V25, P193, DOI 10.1017/S0954579412000272; Matthys W, 2012, CLIN CHILD FAM PSYCH, V15, P234, DOI 10.1007/s10567-012-0118-7; MILLER PA, 1988, PSYCHOL BULL, V103, P324, DOI 10.1037/0033-2909.103.3.324; Newman JP, 2010, BIOL PSYCHIAT, V67, P66, DOI 10.1016/j.biopsych.2009.07.035; Nock MK, 2007, J CHILD PSYCHOL PSYC, V48, P703, DOI 10.1111/j.1469-7610.2007.01733.x; Pelc K, 2006, PEDIATR NEUROL, V35, P93, DOI 10.1016/j.pediatrneurol.2006.01.014; Rowe R, 2010, J ABNORM PSYCHOL, V119, P726, DOI 10.1037/a0020798; Sattler J., 1992, ASSESSMENT CHILDREN; Shaffer D, 2000, J AM ACAD CHILD PSY, V39, P28, DOI 10.1097/00004583-200001000-00014; Sinzig J, 2008, EUR CHILD ADOLES PSY, V17, P63, DOI 10.1007/s00787-007-0637-9; Sonnby-Borgstrom M, 2008, SCAND J PSYCHOL, V49, P111, DOI 10.1111/j.1467-9450.2008.00626.x; Sterba S, 2007, J CHILD PSYCHOL PSYC, V48, P1005, DOI 10.1111/j.1469-7610.2007.01770.x; Stringaris A, 2009, J CHILD PSYCHOL PSYC, V50, P216, DOI 10.1111/j.1469-7610.2008.01989.x; Stringaris A, 2009, J AM ACAD CHILD PSY, V48, P404, DOI 10.1097/CHI.0b013e3181984f30; Williams LM, 2008, BIOL PSYCHIAT, V63, P917, DOI 10.1016/j.biopsych.2007.11.022; Yuill N, 2007, EUR CHILD ADOLES PSY, V16, P398, DOI 10.1007/s00787-007-0612-5	39	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84965	10.1371/journal.pone.0084965	http://dx.doi.org/10.1371/journal.pone.0084965			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291XP	24416323	Green Published, Green Submitted, gold			2022-12-27	WOS:000329866300045
J	Katan, M; Moon, YP; Paik, MC; Wolfert, RL; Sacco, RL; Elkind, MSV				Katan, Mira; Moon, Yeseon P.; Paik, Myunghee C.; Wolfert, Robert L.; Sacco, Ralph L.; Elkind, Mitchell S. V.			Lipoprotein-Associated Phospholipase A2 Is Associated with Atherosclerotic Stroke Risk: The Northern Manhattan Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; ISCHEMIC-STROKE; CEREBRAL INFARCTION; RECURRENT STROKE; A(2) ACTIVITY; DISEASE; RACE; COHORT; SEX; ETHNICITY	Background: Lipoprotein-associated phospholipase A2 (LpPLA2) levels are associated with stroke, though whether this extends to all populations and stroke subtypes is unknown. Methods: Serum samples from stroke-free community participants in the Northern Manhattan Study were assayed for LpPLA2 mass and activity. Participants were followed annually for stroke. Cox-proportional-hazard models were fitted to estimate hazard-ratios and 95% confidence intervals (HR, 95% CI) for the association of LpPLA2 levels with ischemic stroke (IS), after adjusting for demographic and medical risk factors. Results: Serum samples were available in 1946 participants, of whom 151 (7.8%) experienced a first IS during median followup 11 years. Mean age was 69 (SD 10), 35.6% were men, 20% non-Hispanic Whites, 22% non-Hispanic Blacks, and 55% Hispanics. LpPLA2 mass and activity levels were not associated with overall IS risk. LpPLA2 mass but not activity levels were associated with strokes due to large artery atherosclerosis (LAA; adjusted HR per SD 1.55, 95% CI 1.17-2.04). There was a dose-response relationship with LAA (compared to first quartile, 2nd quartile HR = 1.43, 95% CI 0.23-8.64; 3rd quartile HR = 4.47, 95% CI 0.93-21.54; 4th quartile HR = 5.07, 95% CI 1.07-24.06). The associations between LpPLA2-mass and LAA-stroke risk differed by race-ethnicity (p = 0.01); LpPLA2-mass was associated with increased risk of LAA among non-Hispanic Whites (adjusted HR per SD 1.44, 95% CI 0.98-2.11), but not other race-ethnic groups. Conclusion: LpPLA2-mass levels were associated with risk of atherosclerotic stroke among non-Hispanic White participants, but not in other race-ethnic groups in the cohort. Further study is needed to confirm these race-ethnic differences and the reasons for them.	[Katan, Mira; Moon, Yeseon P.; Elkind, Mitchell S. V.] Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; [Katan, Mira] Univ Zurich Hosp, Dept Neurol, Zurich, Switzerland; [Paik, Myunghee C.] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA; [Wolfert, Robert L.] diaDexus Inc, San Francisco, CA USA; [Sacco, Ralph L.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Sacco, Ralph L.] Univ Miami, Miller Sch Med, Dept Epidemiol, Miami, FL 33136 USA; [Sacco, Ralph L.] Univ Miami, Miller Sch Med, Dept Human Genet, Miami, FL 33136 USA; [Elkind, Mitchell S. V.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	Columbia University; University of Zurich; University Zurich Hospital; Columbia University; University of Miami; University of Miami; University of Miami; Columbia University	Katan, M (corresponding author), Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA.	mira.katan@usz.ch	Sacco, Ralph/Y-9278-2019	Katan, Mira/0000-0002-9265-8066	National Institutes of Health/National Institute of Neurological Disorders and Stroke [R37 NS 29993, R01 NS 48134]; Swiss National Science Foundation [PBZHP3-130982]; Fondation Leduqc; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048134, R37NS029993] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fondation Leduqc; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health/National Institute of Neurological Disorders and Stroke (R37 NS 29993 [RLS/MSVE] and R01 NS 48134 [MSVE]) and the Swiss National Science Foundation (PBZHP3-130982 [MK] as well as the Fondation Leduqc [MK]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; [Anonymous], 1995, LANCET, V346, P1647; Ballantyne CM, 2005, ARCH INTERN MED, V165, P2479, DOI 10.1001/archinte.165.21.2479; Bang OY, 2008, NEUROLOGY, V70, P841, DOI 10.1212/01.wnl.0000294323.48661.a9; Brilakis ES, 2008, ATHEROSCLEROSIS, V199, P110, DOI 10.1016/j.atherosclerosis.2007.10.010; CAPLAN LR, 1986, STROKE, V17, P648, DOI 10.1161/01.STR.17.4.648; Cook NR, 2012, CLIN CHEM, V58, P1352, DOI 10.1373/clinchem.2012.188870; De Silva DA, 2007, STROKE, V38, P2592, DOI 10.1161/STROKEAHA.107.484584; Delgado P, 2012, CEREBROVASC DIS, V33, P150, DOI 10.1159/000334193; Elkind MSV, 2006, ARCH INTERN MED, V166, P2073, DOI 10.1001/archinte.166.19.2073; Elkind MSV, 2009, CEREBROVASC DIS, V27, P42, DOI 10.1159/000172633; Elkind MSV, 2005, NEUROLOGY, V64, P2121, DOI 10.1212/01.WNL.0000165989.12122.49; Gan R, 1997, NEUROLOGY, V48, P1204, DOI 10.1212/WNL.48.5.1204; Gentry E M, 1985, Am J Prev Med, V1, P9; Gorelick PB, 2008, AM J CARDIOL, V101, p34F, DOI 10.1016/j.amjcard.2008.04.017; Mannheim D, 2008, STROKE, V39, P1448, DOI 10.1161/STROKEAHA.107.503193; Markus HS, 2007, CIRCULATION, V116, P2157, DOI 10.1161/CIRCULATIONAHA.107.699785; Oei HHS, 2005, CIRCULATION, V111, P570, DOI 10.1161/01.CIR.0000154553.12214.CD; Oliver LK, 2011, CLIN BIOCHEM, V44, P1247, DOI 10.1016/j.clinbiochem.2011.07.005; Persson M, 2008, ATHEROSCLEROSIS, V200, P191, DOI 10.1016/j.atherosclerosis.2007.12.001; Petty GW, 1999, STROKE, V30, P2513, DOI 10.1161/01.STR.30.12.2513; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Sacco RL, 2004, STROKE, V35, P2263, DOI 10.1161/01.STR.0000142374.33919.92; SACCO RL, 1995, STROKE, V26, P14, DOI 10.1161/01.STR.26.1.14; Serruys PW, 2008, CIRCULATION, V118, P1172, DOI 10.1161/CIRCULATIONAHA.108.771899; Thompson A, 2010, LANCET, V375, P1536, DOI 10.1016/S0140-6736(10)60319-4; *WHO, 1983, WHOMNC821; Wilensky RL, 2008, NAT MED, V14, P1059, DOI 10.1038/nm.1870; Willey JZ, 2009, ARCH NEUROL-CHICAGO, V66, P1400, DOI 10.1001/archneurol.2009.210; Wityk RJ, 1996, STROKE, V27, P1974, DOI 10.1161/01.STR.27.11.1974; Wong KS, 1998, NEUROLOGY, V50, P812, DOI 10.1212/WNL.50.3.812	31	42	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e83393	10.1371/journal.pone.0083393	http://dx.doi.org/10.1371/journal.pone.0083393			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416164	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000329866300014
J	Hahn, E; Vollath, A; Ta, TTM; Hahn, C; Kuehl, LK; Dettling, M; Neuhaus, AH				Hahn, Eric; Vollath, Andrea; Ta, Tam T. M.; Hahn, Constanze; Kuehl, Linn K.; Dettling, Michael; Neuhaus, Andres H.			Assessing Long-Term Test-Retest Reliability of the CPT-IP in Schizophrenia	PLOS ONE			English	Article							CONTINUOUS PERFORMANCE-TEST; SUSTAINED ATTENTION DEFICITS; IDENTICAL PAIRS VERSION; 1ST EPISODE; SCHIZOTYPY; IMPAIRMENT; VALIDATION; STABILITY; PRECISION; PANSS	Background: The Continuous Performance Test-Identical Pairs version (CPT-IP) is a well-established measure of sustained attention, and its more challenging versions are particularly suited to detect subtle processing deficits in patients with schizophrenia. However, while there are few longitudinal samples for the CPT-IP, no study has addressed stability for more than two month in patients with schizophrenia. Assessing long-term test-retest reliability of the CPT-IP would facilitate the ability of clinicians to draw conclusions from studies involving interventions as long term cognitive or pharmacological treatments. The present study assessed 12 month test-retest reliability for the two most challenging versions of CPT-IP (4-digit and shapes) in a matched sample of clinically stable schizophrenia outpatients and healthy controls. Methods: Fifty clinically stable schizophrenia outpatients and 50 healthy controls were assessed with the CPT-IP for the 4-digit and shape conditions. From these, 40 patients and 47 controls were reassessed with an average interval of 12.3 months between test sessions. Test-retest reliability was analyzed with Pearson correlations and results were compared with previous data involving healthy controls and short-term studies in patients with schizophrenia. Results: Especially d' and hit rate discriminated well between patients with schizophrenia and healthy controls for both CPT-IP conditions and at both test sessions. Healthy controls demonstrated sufficient long term test-retest correlations of d', hit rate and reaction time for both the 4-digit and shape conditions. However, in schizophrenia patients, long-term reliability correlations were at best moderate for d' and hit rate only. Conclusions: The current study provides further evidence that d' and hit rate yield consistent cross-sectional discrimination sensitivity. At best moderate long-term test-retest reliability of d' in schizophrenia outpatients may be not sufficient for practical use of this measure in long term clinical trials.	[Hahn, Eric; Vollath, Andrea; Ta, Tam T. M.; Kuehl, Linn K.; Dettling, Michael; Neuhaus, Andres H.] Charite, Dept Psychiat & Psychotherapy, D-13353 Berlin, Germany; [Hahn, Constanze] Ruhr Univ Bochum, Dept Biopsychol, Bochum, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruhr University Bochum	Hahn, E (corresponding author), Charite, Dept Psychiat & Psychotherapy, Campus Benjamin Franklin, D-13353 Berlin, Germany.	eric.hahn@charite.de	Neuhaus, Andres H./H-4500-2019	Neuhaus, Andres H./0000-0003-2644-610X; Hahn, Eric/0000-0002-3782-1983; Ta, Thi Minh Tam/0000-0002-9252-3161				Altman DG., 1999, PRACTICAL STAT MED R; Andreasen NC, 2010, BIOL PSYCHIAT, V67, P255, DOI 10.1016/j.biopsych.2009.08.040; Barch DM, 2010, SCHIZOPHRENIA BULL, V36, P43, DOI 10.1093/schbul/sbp139; Barnett JH, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-16; Bergida H, 2006, J ABNORM PSYCHOL, V115, P545, DOI 10.1037/0021-843X.115.3.545; Chen WJ, 2000, AM J MED GENET, V97, P52, DOI 10.1002/(SICI)1096-8628(200021)97:1<52::AID-AJMG7>3.0.CO;2-6; Cicchetti DV, 1999, J CLIN EXP NEUROPSYC, V21, P567, DOI 10.1076/jcen.21.4.567.886; Cicchetti DV, 2001, J CLIN EXP NEUROPSYC, V23, P695, DOI 10.1076/jcen.23.5.695.1249; CORNBLATT BA, 1988, PSYCHIAT RES, V26, P223, DOI 10.1016/0165-1781(88)90076-5; CORNBLATT BA, 1989, PSYCHIAT RES, V29, P65, DOI 10.1016/0165-1781(89)90188-1; Cornblatt BA, 2001, AM J MED GENET, V105, P11, DOI 10.1002/1096-8628(20010108)105:1<11::AID-AJMG1045>3.3.CO;2-7; CORNBLATT BA, 1994, SCHIZOPHRENIA BULL, V20, P248; FRANKE P, 1994, PSYCHIAT RES, V54, P259, DOI 10.1016/0165-1781(94)90020-5; Gooding DC, 2006, SCHIZOPHR RES, V82, P27, DOI 10.1016/j.schres.2005.11.015; Green MF, 2004, SCHIZOPHR RES, V72, P41, DOI 10.1016/j.schres.2004.09.009; Kahn PV, 2012, SCHIZOPHR RES, V142, P153, DOI 10.1016/j.schres.2012.09.009; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Keefe RSE, 2011, SCHIZOPHR RES, V125, P161, DOI 10.1016/j.schres.2010.09.015; Kumar CTS, 2010, SCHIZOPHR RES, V124, P152, DOI 10.1016/j.schres.2010.07.006; Kurtz MM, 2001, SCHIZOPHR RES, V48, P307, DOI 10.1016/S0920-9964(00)00060-8; Leucht S, 2005, SCHIZOPHR RES, V79, P231, DOI 10.1016/j.schres.2005.04.008; Rodriguez-Sanchez JM, 2013, SCHIZOPHR RES, V150, P121, DOI 10.1016/j.schres.2013.06.042; Miles AA, 2014, SCHIZOPHR RES, V152, P435, DOI 10.1016/j.schres.2013.09.006; Nuechterlein KH, 2008, AM J PSYCHIAT, V165, P203, DOI 10.1176/appi.ajp.2007.07010042; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pietrzak RH, 2009, HUM PSYCHOPHARM CLIN, V24, P113, DOI 10.1002/hup.998; Roalf DR, 2013, SCHIZOPHRENIA BULL, V39, P1008, DOI 10.1093/schbul/sbs078; Roitman SEL, 1997, AM J PSYCHIAT, V154, P655; Salgado-Pineda P, 2003, NEUROIMAGE, V19, P365, DOI 10.1016/S1053-8119(03)00094-6; Shamsi S, 2011, SCHIZOPHR RES, V126, P257, DOI 10.1016/j.schres.2010.08.007; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Tandon R, 2013, SCHIZOPHR RES, V150, P3, DOI 10.1016/j.schres.2013.05.028; Thaden E, 2006, SCHIZOPHR RES, V81, P157, DOI 10.1016/j.schres.2005.09.015	34	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84780	10.1371/journal.pone.0084780	http://dx.doi.org/10.1371/journal.pone.0084780			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291WL	24416285	Green Submitted, gold, Green Published			2022-12-27	WOS:000329862500168
J	Hannagan, T; Ziegler, JC; Dufau, S; Fagot, J; Grainger, J				Hannagan, Thomas; Ziegler, Johannes C.; Dufau, Stephane; Fagot, Joel; Grainger, Jonathan			Deep Learning of Orthographic Representations in Baboons	PLOS ONE			English	Article							WORD RECOGNITION; FORM; ARCHITECTURE; DYSLEXIA; NETWORK; CODE	What is the origin of our ability to learn orthographic knowledge? We use deep convolutional networks to emulate the primate's ventral visual stream and explore the recent finding that baboons can be trained to discriminate English words from nonwords [1]. The networks were exposed to the exact same sequence of stimuli and reinforcement signals as the baboons in the experiment, and learned to map real visual inputs (pixels) of letter strings onto binary word/nonword responses. We show that the networks' highest levels of representations were indeed sensitive to letter combinations as postulated in our previous research. The model also captured the key empirical findings, such as generalization to novel words, along with some intriguing inter-individual differences. The present work shows the merits of deep learning networks that can simulate the whole processing chain all the way from the visual input to the response while allowing researchers to analyze the complex representations that emerge during the learning process.	[Hannagan, Thomas] Aix Marseille Univ, Lab Psychol Cognit, Marseille, France; CNRS, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS)	Hannagan, T (corresponding author), Aix Marseille Univ, Lab Psychol Cognit, Marseille, France.	thom.hannagan@gmail.com	Dufau, Stephane/B-6349-2008; Grainger, Jonathan/C-9299-2009; Ziegler, Johannes/C-2234-2008	Dufau, Stephane/0000-0002-2692-2084; fagot, joel/0000-0002-9824-9685; Ziegler, Johannes/0000-0002-2061-5729	European Research Council (ERC) [230313]; French government [ANR-11-IDEX-0001-02]	European Research Council (ERC)(European Research Council (ERC)European Commission); French government	This research was supported by a grant from the European Research Council (ERC grant 230313) to Jonathan Grainger. It was carried out within the Labex BLRI (ANR-11-LABX-0036) and has benefited from support from the French government, managed by the French National Agency for Research (ANR), Investments of the Future A*MIDEX (ANR-11-IDEX-0001-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bains W, 2012, SCIENCE, V337, DOI 10.1126/science.1224508; Bergstra J., 2011, P NIPS BIGLEARNING W; Binder JR, 2006, NEUROIMAGE, V33, P739, DOI 10.1016/j.neuroimage.2006.06.053; Blaizot X, 2000, J CEREBR BLOOD F MET, V20, P213, DOI 10.1097/00004647-200002000-00001; Brincat SL, 2006, NEURON, V49, P17, DOI 10.1016/j.neuron.2005.11.026; Ciresan D., 2012, IEEE C COMP VIS PATT; Cohen G, 2000, EXPLORING COGNITION; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; Dehaene S, 2005, TRENDS COGN SCI, V9, P335, DOI 10.1016/j.tics.2005.05.004; Di Bono MG, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00635; Erhan D., 2010, 1355 U MONTR; Farabet C., 2013, IEEE T PATTERN ANAL; Frost R, 2013, PSYCHOL SCI, V24, P1868, DOI 10.1177/0956797613482145; FUKUSHIMA K, 1980, BIOL CYBERN, V36, P193, DOI 10.1007/BF00344251; Grainger J, 2003, MENTAL LEXICON: SOME WORDS TO TALK ABOUT WORDS, P1; Grainger J, 2008, LANG COGNITIVE PROC, V23, P1, DOI 10.1080/01690960701578013; Grainger J, 2012, SCIENCE, V336, P245, DOI 10.1126/science.1218152; Hannagan T, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003250; Hannagan T, 2012, COGNITIVE SCI, V36, P575, DOI 10.1111/j.1551-6709.2012.01236.x; Hannagan T, 2011, NEURAL COMPUT, V23, P251, DOI 10.1162/NECO_a_00064; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Leveille J, 2013, NEURAL COMPUT, V25, P1261, DOI 10.1162/NECO_a_00435; Mechler F, 2002, VISION RES, V42, P1017, DOI 10.1016/S0042-6989(02)00025-1; MOZER MC, 1987, ATTENTION PERFORM, P83; Mutch J, 2008, INT J COMPUT VISION, V80, P45, DOI 10.1007/s11263-007-0118-0; Pegado F, 2011, NEUROIMAGE, V55, P742, DOI 10.1016/j.neuroimage.2010.11.043; Perea M, 2004, J MEM LANG, V51, P231, DOI 10.1016/j.jml.2004.05.005; PLAUT DC, 1993, COGNITIVE NEUROPSYCH, V10, P377, DOI 10.1080/02643299308253469; Rauschecker AM, 2012, P NATL ACAD SCI USA, V109, pE1568, DOI 10.1073/pnas.1121304109; Serre T, 2007, P NATL ACAD SCI USA, V104, P6424, DOI 10.1073/pnas.0700622104; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; Stoianov I, 2012, NAT NEUROSCI, V15, P194, DOI 10.1038/nn.2996; Thomas MSC, 2012, BRAIN COGNITION, V78, P38, DOI 10.1016/j.bandc.2011.10.003; VANESSEN DC, 1994, NEURON, V13, P1, DOI 10.1016/0896-6273(94)90455-3; Vinckier F, 2007, NEURON, V55, P143, DOI 10.1016/j.neuron.2007.05.031; Whitney C, 1999, Prog Brain Res, V121, P143; Ziegler JC, 2005, PSYCHOL BULL, V131, P3, DOI 10.1037/0033-2909.131.1.3; Ziegler JC, PHILOS T B IN PRESS; Ziegler JC, 2013, PSYCHOL SCI, V24, P1609, DOI 10.1177/0956797612474322	40	18	18	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84843	10.1371/journal.pone.0084843	http://dx.doi.org/10.1371/journal.pone.0084843			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416300	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500180
J	Penny, D; Chevance, JB; Tang, D; De Greef, S				Penny, Dan; Chevance, Jean-Baptiste; Tang, David; De Greef, Stephane			The Environmental Impact of Cambodia's Ancient City of Mahendraparvata (Phnom Kulen)	PLOS ONE			English	Article							WATER MANAGEMENT; LAND-USE; ANGKOR; CARBONATE; SEDIMENTS; IGNITION; POLLEN	The Khmer kingdom, whose capital was at Angkor from the 9th to the 14th -15th century, was founded in 802 by king Jayavarman II in a city called Mahandraparvata, on Phnom Kulen. Virtually nothing more is known of Mahandraparvata from the epigraphic sources, but systematic archaeological survey and excavation have identified an array of cultural features that point to a more extensive and enduring settlement than the historical record indicates. Recent remote sensing data have revolutionized our view, revealing the remains of a city with a complex and spatially extensive network of urban infrastructure. Here, we present a record of vegetation change and soil erosion from within that urban network, dating from the 8th century CE. Our findings indicate approximately 400 years of intensive land use, punctuated by discrete periods of intense erosion beginning in the mid 9th century and ending in the late 11th century. A marked change in water management practices is apparent from the 12th century CE, with implications for water supply to Angkor itself. This is the first indication that settlement on Mahendraparvata was not only extensive, but also intensive and enduring, with a marked environmental impact.	[Penny, Dan; Tang, David] Univ Sydney, Sch Geosci, Sydney, NSW 2006, Australia; [Chevance, Jean-Baptiste; De Greef, Stephane] Archaeol & Dev Fdn, London, England	University of Sydney	Penny, D (corresponding author), Univ Sydney, Sch Geosci, Sydney, NSW 2006, Australia.	dan.penny@sydney.edu.au		Penny, Dan/0000-0002-7905-0339	Australian Research Council [DP0558130]; Mohamed S. Farsi Foundation; AINSE Award [ALNGRA11031]	Australian Research Council(Australian Research Council); Mohamed S. Farsi Foundation; AINSE Award	The research is funded by the Australian Research Council (DP0558130) (http://www.arc.gov.au) and the Mohamed S. Farsi Foundation (http://www. themsff.org). Radiocarbon analyses were funded by AINSE Award ALNGRA11031 (http://www.ainse.edu.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, ENV MAGNETIC SUSCEPT; [Anonymous], 1998, SOC EC POLITICS PREA; Aymonier E, 1901, CAMBODGE 2 PROVINCES, V2; Boulbet J, 1973, ARTS ASIATIQUES, V27; Boulbet J, 1979, PHNOM KULEN REGION C; Buckley BM, 2010, P NATL ACAD SCI USA, V107, P6748, DOI 10.1073/pnas.0910827107; Carbonnel JP, 1972, QUATERNAIRE CAMBODGI; Chevance JB, 2013, UNEARTHING SE ASIAS, V1, P257; Chevance JB, 2005, U PARIS 3 SORBORNNE; Chevance JB, 2011, THESIS UFR ORIENT MO; Coedes G, 1943, B EC FR EXTR ORIENT, V43, P56; Color Munsell, 1975, MUNSELL SOIL COLOR C; Dan P, 2007, NUCL INSTRUM METH B, V259, P388, DOI 10.1016/j.nimb.2007.02.095; de Lajonquiere EEL, 1902, INVENTAIRE DESCRIPTI, V1; de Lajonquiere EEL, 1911, INVENTAIRE DESCRIPTI, V3; DEAN WE, 1974, J SEDIMENT PETROL, V44, P242; Desbat A., 2008, PROGRAMME CERANGKOR; Ea D, 2010, ANLONG THOM CULTURAL; Ea D, 2008, INTERPRETING SE ASIA, P275; Evans D, 2007, P NATL ACAD SCI USA, V104, P14277, DOI 10.1073/pnas.0702525104; Evans DH, 2013, P NATL ACAD SCI USA, V110, P12595, DOI 10.1073/pnas.1306539110; Fletcher R., 2003, UDAYA, V4, P107; Fletcher R, 2008, ANTIQUITY, V82, P658, DOI 10.1017/S0003598X00097295; Gaughan AE, 2009, APPL GEOGR, V29, P212, DOI 10.1016/j.apgeog.2008.09.007; Glew Jr, 2002, DEV PALEOENVIRON RES, V1, P73; Groslier Bernard-Philippe, 1979, B ECOLE FRANCAISE EX, V66, P161, DOI DOI 10.3406/BEFEO.1979.4014; Hansen E, 1969, CAMBODGE CONSERVATIO, P1; Heiri O, 2001, J PALEOLIMNOL, V25, P101, DOI 10.1023/A:1008119611481; Higham CFW, 2001, ANGKOR UDAYA, V2, P109; Iversen J, 1989, J BIOGEOGR; Juggins S, 2007, C2 VERSION 1 5 USER; Kummu M, 2009, J ENVIRON MANAGE, V90, P1413, DOI 10.1016/j.jenvman.2008.08.007; Lefferts L, 2008, SELECTED PAPERS 10 I, P286; Lustig E, 2001, THESIS U SYDNEY; Maxwell AL, 2001, QUATERNARY RES, V56, P390, DOI 10.1006/qres.2001.2271; Miksic J, 2009, ARI WORKING PAPERS, V16, P1; Penny D, 2005, J ARCHAEOL SCI, V32, P69, DOI 10.1016/j.jas.2004.07.002; Penny D., 2005, B ECOLE FRANCAISE EX, V92, P497; Penny D, 2006, ANTIQUITY, V80, P599, DOI 10.1017/S0003598X00094060; Phon D, 2000, DICT PLANTS USED CAM; Pottier C., 2009, ASEANIE, V24, P61; Pottier C, 1999, CARTE ARCHEOLOGIQUE; Pottier C, 2002, UDAYA, V2, P117; Pottier C., 2004, UDAYA J KHMER STUD, V5, P167; Reimer PJ, 2004, RADIOCARBON, V46, P1029, DOI 10.1017/S0033822200032999; Rollet B, 1972, VEGETATION CAMBODGE; Stern P, 1938, B EC FR EXTR ORIENT, V38, P111; STOCKMARR J, 1971, Pollen et Spores, V13, P615; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Stuiver M, 2010, CALIB 6 0 PROGRAM; Tabata Y., 2008, J SE ASIAN ARCHAEOLO, V28, P61; Theilade I, 2011, NORD J BOT, V29, P71, DOI 10.1111/j.1756-1051.2010.01003.x; Uchida E, 2007, J ARCHAEOL SCI, V34, P924, DOI 10.1016/j.jas.2006.09.015; van Huissteden J, 1999, CLUSTER 3 0 FACULTY; VANLIERE WJ, 1980, WORLD ARCHAEOL, V11, P265, DOI 10.1080/00438243.1980.9979766; Wentworth CK, 1922, J GEOL, V30, P377, DOI 10.1086/622910	56	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84252	10.1371/journal.pone.0084252	http://dx.doi.org/10.1371/journal.pone.0084252			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	291WL	24416206	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500105
J	Rowe, RK; Striz, M; Bachstetter, AD; Van Eldik, LJ; Donohue, KD; O'Hara, BF; Lifshitz, J				Rowe, Rachel K.; Striz, Martin; Bachstetter, Adam D.; Van Eldik, Linda J.; Donohue, Kevin D.; O'Hara, Bruce F.; Lifshitz, Jonathan			Diffuse Brain Injury Induces Acute Post-Traumatic Sleep	PLOS ONE			English	Article							CYTOKINES; WAKE; INTERLEUKIN-1-BETA; PATHOPHYSIOLOGY; ACTIVATION; DISORDERS	Objective: Clinical observations report excessive sleepiness immediately following traumatic brain injury (TBI); however, there is a lack of experimental evidence to support or refute the benefit of sleep following a brain injury. The aim of this study is to investigate acute post-traumatic sleep. Methods: Sham, mild or moderate diffuse TBI was induced by midline fluid percussion injury (mFPI) in male C57BL/6J mice at 9: 00 or 21: 00 to evaluate injury-induced sleep behavior at sleep and wake onset, respectively. Sleep profiles were measured post-injury using a non-invasive, piezoelectric cage system. In separate cohorts of mice, inflammatory cytokines in the neocortex were quantified by immunoassay, and microglial activation was visualized by immunohistochemistry. Results: Immediately after diffuse TBI, quantitative measures of sleep were characterized by a significant increase in sleep (>50%) for the first 6 hours post-injury, resulting from increases in sleep bout length, compared to sham. Acute post-traumatic sleep increased significantly independent of injury severity and time of injury (9: 00 vs 21: 00). The pro-inflammatory cytokine IL-1 beta increased in brain-injured mice compared to sham over the first 9 hours post-injury. Iba-1 positive microglia were evident in brain-injured cortex at 6 hours post-injury. Conclusion: Post-traumatic sleep occurs for up to 6 hours after diffuse brain injury in the mouse regardless of injury severity or time of day. The temporal profile of secondary injury cascades may be driving the significant increase in post-traumatic sleep and contribute to the natural course of recovery through cellular repair.	[Rowe, Rachel K.; Lifshitz, Jonathan] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Rowe, Rachel K.; Lifshitz, Jonathan] Univ Arizona, Dept Child Hlth, Coll Med Phoenix, Phoenix, AZ USA; [Lifshitz, Jonathan] Phoenix Veteran Affairs Healthcare Syst, Phoenix, AZ USA; [Rowe, Rachel K.; Van Eldik, Linda J.; Lifshitz, Jonathan] Univ Kentucky, Coll Med, Dept Anat & Neurobiol, Lexington, KY USA; [Striz, Martin; O'Hara, Bruce F.] Univ Kentucky, Dept Biol, Coll Arts & Sci, Lexington, KY USA; [Donohue, Kevin D.] Univ Kentucky, Dept Elect & Comp Engn, Coll Engn, Lexington, KY USA; [Lifshitz, Jonathan] Univ Kentucky, Coll Med, Dept Phys Med & Rehabil, Lexington, KY USA; [Rowe, Rachel K.; Van Eldik, Linda J.; O'Hara, Bruce F.; Lifshitz, Jonathan] Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr SCoBIRC, Lexington, KY USA; [Bachstetter, Adam D.; Van Eldik, Linda J.] Univ Kentucky, Coll Med, Sanders Brown Ctr Aging, Lexington, KY 40536 USA	Barrow Neurological Institute; Phoenix Children's Hospital; University of Arizona; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	Lifshitz, J (corresponding author), Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA.	jlifshitz@email.arizona.edu		Bachstetter, Adam/0000-0003-4646-6757; Rowe, Rachel/0000-0002-9034-3159	National Institutes of Health (NIH) [R21 NS072611, R01 NS065052, R01 NS064247, KSCHIRT 10-5A, F32 AG037280]; National Institute of Neurological Disorders and Stroke (NINDS); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065052, R21NS072611, R01NS064247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG037280] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Support provided by National Institutes of Health (NIH) grants R21 NS072611 (JL/BFO), R01 NS065052 (JL), R01 NS064247 (LVE), KSCHIRT 10-5A, F32 AG037280 (ADB). RKR was supported by a Research Supplement to Promote Diversity by the National Institute of Neurological Disorders and Stroke (NINDS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albensi BC, 2003, BRAIN INJURY, V17, P653, DOI 10.1080/0269905031000107142; Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; Arciniegas, 2000, Curr Treat Options Neurol, V2, P169; Bachstetter AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-79; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2012, NEUROMOL MED, V14, P205, DOI 10.1007/s12017-012-8178-x; Boone DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046204; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Chikahisa Sachiko, 2011, Front Neurol, V2, P87, DOI 10.3389/fneur.2011.00087; Chokroverty S, 2010, INDIAN J MED RES, V131, P126; Curry Parichat, 2011, Int J Crit Illn Inj Sci, V1, P27, DOI 10.4103/2229-5151.79279; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; Donohue KD, 2008, BIOMED ENG ONLINE, V7, DOI 10.1186/1475-925X-7-14; Dworak M, 2010, J NEUROSCI, V30, P9007, DOI 10.1523/JNEUROSCI.1423-10.2010; FAN L, 1995, MOL BRAIN RES, V30, P125; Fang JD, 1998, AM J PHYSIOL-REG I, V274, pR655, DOI 10.1152/ajpregu.1998.274.3.R655; Flores AE, 2007, IEEE T BIO-MED ENG, V54, P225, DOI 10.1109/TBME.2006.886938; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Gentleman D, 1999, BRIT MED BULL, V55, P910, DOI 10.1258/0007142991902718; Hall KD, 2010, BRAIN RES, V1323, P161, DOI 10.1016/j.brainres.2010.01.067; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hosseini AH, 2009, MED SCI SPORT EXER, V41, P1687, DOI 10.1249/MSS.0b013e31819fcd1b; Huber R, 2000, BRAIN RES, V857, P8, DOI 10.1016/S0006-8993(99)02248-9; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Krueger JM, 2007, SLEEP MED CLIN, V2, P161, DOI 10.1016/j.jsmc.2007.03.003; Krueger JM, 2008, CURR PHARM DESIGN, V14, P3408, DOI 10.2174/138161208786549281; KRUEGER JM, 1995, INT ARCH ALLERGY IMM, V106, P97, DOI 10.1159/000236827; Krueger JM, 2001, ANN NY ACAD SCI, V933, P211; Lifshitz J, 2008, ANIMAL MODELS ACUTE; Lifshitz J, 2007, J NEUROPATH EXP NEUR, V66, P218, DOI 10.1097/01.jnen.0000248558.75950.4d; Lifshitz J, 2012, BRAIN STRUCT FUNCT, V217, P49, DOI 10.1007/s00429-011-0323-z; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McCoy JG, 2011, NEUROBIOL LEARN MEM, V96, P564, DOI 10.1016/j.nlm.2011.07.004; McNamara KCS, 2010, J NEUROTRAUM, V27, P695, DOI 10.1089/neu.2009.1237; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wisor JP, 2011, SLEEP, V34, P261, DOI 10.1093/sleep/34.3.261; Yasuda T, 2005, SLEEP, V28, P177, DOI 10.1093/sleep/28.2.177; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	48	49	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e82507	10.1371/journal.pone.0082507	http://dx.doi.org/10.1371/journal.pone.0082507			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416145	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500018
J	Schut, AGT; Wardell-Johnson, GW; Yates, CJ; Keppel, G; Baran, I; Franklin, SE; Hopper, SD; Van Niel, KP; Mucina, L; Byrne, M				Schut, Antonius G. T.; Wardell-Johnson, Grant W.; Yates, Colin J.; Keppel, Gunnar; Baran, Ireneusz; Franklin, Steven E.; Hopper, Stephen D.; Van Niel, Kimberley P.; Mucina, Ladislav; Byrne, Margaret			Rapid Characterisation of Vegetation Structure to Predict Refugia and Climate Change Impacts across a Global Biodiversity Hotspot	PLOS ONE			English	Article							CONSERVATION; FOREST; AUSTRALIA; FUTURE; FIRE; DISTRIBUTIONS; ADAPTATION; ECOSYSTEMS; INSELBERGS; EVOLUTION	Identification of refugia is an increasingly important adaptation strategy in conservation planning under rapid anthropogenic climate change. Granite outcrops (GOs) provide extraordinary diversity, including a wide range of taxa, vegetation types and habitats in the Southwest Australian Floristic Region (SWAFR). However, poor characterization of GOs limits the capacity of conservation planning for refugia under climate change. A novel means for the rapid identification of potential refugia is presented, based on the assessment of local-scale environment and vegetation structure in a wider region. This approach was tested on GOs across the SWAFR. Airborne discrete return Light Detection And Ranging (LiDAR) data and Red Green and Blue (RGB) imagery were acquired. Vertical vegetation profiles were used to derive 54 structural classes. Structural vegetation types were described in three areas for supervised classification of a further 13 GOs across the region. Habitat descriptions based on 494 vegetation plots on and around these GOs were used to quantify relationships between environmental variables, ground cover and canopy height. The vegetation surrounding GOs is strongly related to structural vegetation types (Kappa = 0.8) and to its spatial context. Water gaining sites around GOs are characterized by taller and denser vegetation in all areas. The strong relationship between rainfall, soil-depth, and vegetation structure (R 2 of 0.8-0.9) allowed comparisons of vegetation structure between current and future climate. Significant shifts in vegetation structural types were predicted and mapped for future climates. Water gaining areas below granite outcrops were identified as important putative refugia. A reduction in rainfall may be offset by the occurrence of deeper soil elsewhere on the outcrop. However, climate change interactions with fire and water table declines may render our conclusions conservative. The LiDAR-based mapping approach presented enables the integration of site-based biotic assessment with structural vegetation types for the rapid delineation and prioritization of key refugia.	[Schut, Antonius G. T.] Curtin Univ, Dept Spatial Sci, Bentley, WA, Australia; [Schut, Antonius G. T.; Wardell-Johnson, Grant W.] Curtin Univ, Curtin Inst Biodivers & Climate, Bentley, WA, Australia; [Yates, Colin J.; Byrne, Margaret] Dept Pk & Wildlife, Div Sci, Bentley, WA, Australia; [Keppel, Gunnar] Univ S Australia, Sch Nat & Built Environm, Adelaide, SA 5001, Australia; [Keppel, Gunnar] Univ S Australia, Barbara Hardy Inst, Adelaide, SA 5001, Australia; [Baran, Ireneusz] AAM Pty Ltd, Perth, WA, Australia; [Franklin, Steven E.] Trent Univ, Peterborough, ON K9J 7B8, Canada; [Hopper, Stephen D.] Univ Western Australia, Ctr Excellence Nat Resource Management, Albany, WA, Australia; [Van Niel, Kimberley P.] Univ Western Australia, Sch Earth & Environm, Crawley, WA, Australia; [Mucina, Ladislav] Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia	Curtin University; Curtin University; University of South Australia; University of South Australia; Trent University; University of Western Australia; University of Western Australia; University of Western Australia	Schut, AGT (corresponding author), Curtin Univ, Dept Spatial Sci, Bentley, WA, Australia.	tom.schut@wur.nl	Mucina, Ladislav/M-8875-2019; Mucina, Ladislav/B-6278-2012; Mucina, Ladislav/A-6275-2019; Byrne, Margaret/H-8198-2015; Keppel, Gunnar/B-3364-2015; Hopper, Stephen D/G-4222-2012; Mucina, Laco/H-5490-2014; Keppel, Gunnar/F-3767-2013	Mucina, Ladislav/0000-0003-0317-8886; Mucina, Ladislav/0000-0003-0317-8886; Mucina, Ladislav/0000-0003-0317-8886; Byrne, Margaret/0000-0002-7197-5409; Hopper, Stephen D/0000-0002-0364-2856; Mucina, Laco/0000-0003-0317-8886; Keppel, Gunnar/0000-0001-7092-6149; Franklin, Steven/0000-0003-1886-9153; Schut, Antonius/0000-0002-7512-728X	ARC, Curtin University [LP0990914]	ARC, Curtin University(Australian Research Council)	The paper was supported by ARC Linkage Grant LP0990914, a Targeted Fellowship at Curtin University to G. W. Wardell-Johnson, and in-kind support from AAM Pty. The funders had no role in study design and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, Climate change in Australia; Ashcroft MB, 2013, AGR FOREST METEOROL, V176, P77, DOI 10.1016/j.agrformet.2013.03.008; Ashcroft MB, 2012, GLOBAL CHANGE BIOL, V18, P1866, DOI 10.1111/j.1365-2486.2012.02661.x; Austin MP, 2011, J BIOGEOGR, V38, P1, DOI 10.1111/j.1365-2699.2010.02416.x; Bates BC, 2008, CLIMATIC CHANGE, V89, P339, DOI 10.1007/s10584-007-9390-9; Beard J.S., 1990, PLANT LIFE W AUSTR; Bergen KM, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000883; Bettenay E, 1963, J DEP AGR WA, V4, P216; Bindon P.R., 1997, J ROYAL SOC W AUSTR, V80, P173; Bond WJ, 2005, NEW PHYTOL, V165, P525, DOI 10.1111/j.1469-8137.2004.01252.x; Bradstock RA, 2010, GLOBAL ECOL BIOGEOGR, V19, P145, DOI 10.1111/j.1466-8238.2009.00512.x; Brouwers N, 2013, LANDSCAPE ECOL, V28, P69, DOI 10.1007/s10980-012-9815-3; Burke A, 2003, DIVERS DISTRIB, V9, P375, DOI 10.1046/j.1472-4642.2003.00035.x; Burke A, 2002, J ARID ENVIRON, V50, P219, DOI 10.1006/jare.2001.0907; Burrows ND, 2013, AUST J BOT, V61, P81, DOI 10.1071/BT12240; Cowling RM, 1996, TRENDS ECOL EVOL, V11, P362, DOI 10.1016/0169-5347(96)10044-6; Croton JT, 2005, SALINITY LAND USE IM; CSIRO BOM, 2007, CLIM CHANG AUSTR OBS; Fernie N, 1930, J I ENG, V2, P198; Fitzpatrick MC, 2008, GLOBAL CHANGE BIOL, V14, P1337, DOI 10.1111/j.1365-2486.2008.01559.x; Ford KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065008; Franklin J, 2013, GLOBAL CHANGE BIOL, V19, P473, DOI 10.1111/gcb.12051; Fried JS, 2004, CLIMATIC CHANGE, V64, P169, DOI 10.1023/B:CLIM.0000024667.89579.ed; Game ET, 2011, GLOBAL CHANGE BIOL, V17, P3150, DOI 10.1111/j.1365-2486.2011.02457.x; Goetz S, 2007, REMOTE SENS ENVIRON, V108, P254, DOI 10.1016/j.rse.2006.11.016; Golbraikh A, 2002, J MOL GRAPH MODEL, V20, P269, DOI 10.1016/S1093-3263(01)00123-1; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HOPKINS AJM, 1981, AUST J ECOL, V6, P177, DOI 10.1111/j.1442-9993.1981.tb01288.x; Hopper S. D., 1997, Journal of the Royal Society of Western Australia, V80, P141; Hopper S. D., 2000, Journal of the Royal Society of Western Australia, V83, P173; Hopper SD, 2004, ANNU REV ECOL EVOL S, V35, P623, DOI 10.1146/annurev.ecolsys.35.112202.130201; Hopper SD, 2009, PLANT SOIL, V322, P49, DOI 10.1007/s11104-009-0068-0; Hughes JD, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050797; Jaskierniak D, 2011, REMOTE SENS ENVIRON, V115, P573, DOI 10.1016/j.rse.2010.10.003; Keppel G, 2012, GLOBAL CHANGE BIOL, V18, P2389, DOI 10.1111/j.1365-2486.2012.02729.x; Keppel G, 2012, GLOBAL ECOL BIOGEOGR, V21, P393, DOI 10.1111/j.1466-8238.2011.00686.x; Klausmeyer KR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006392; Klein C, 2009, ECOL APPL, V19, P206, DOI 10.1890/07-1684.1; Korhonen L, 2011, REMOTE SENS ENVIRON, V115, P1065, DOI 10.1016/j.rse.2010.12.011; Laing I.A.F., 1997, J ROYAL SOC W AUSTR, V80, P181; Lambers H, 2010, PLANT SOIL, V334, P11, DOI 10.1007/s11104-010-0444-9; Loarie SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002502; Macfarlane C, 2010, FOREST ECOL MANAG, V260, P96, DOI 10.1016/j.foreco.2010.04.005; Mallet C, 2009, ISPRS J PHOTOGRAMM, V64, P1, DOI 10.1016/j.isprsjprs.2008.09.007; Matusick G, 2013, EUR J FOREST RES, V132, P497, DOI 10.1007/s10342-013-0690-5; Michael Damian R., 2010, Ecological Management & Restoration, V11, P43, DOI 10.1111/j.1442-8903.2010.00512.x; Mignaut T, 2010, PLANT ECOL EVOL, V143, P128, DOI 10.5091/plecevo.2010.404; Miura N, 2010, REMOTE SENS ENVIRON, V114, P1069, DOI 10.1016/j.rse.2009.12.017; Morsdorf F, 2010, REMOTE SENS ENVIRON, V114, P1403, DOI 10.1016/j.rse.2010.01.023; Mucina L., 2006, VEGETATION S AFRICA, P801; Mucina L, 2011, PLANT SOIL, V341, P1, DOI 10.1007/s11104-011-0734-x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Orians GH, 2007, BIOL REV, V82, P393, DOI 10.1111/j.1469-185X.2007.00017.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pate J. S., 1984, KWONGAN PLANT LIFE S; Pearce K.B., 2007, CLIMATE CHANGE AUSTR; Penuelas J, 2003, GLOBAL CHANGE BIOL, V9, P131, DOI 10.1046/j.1365-2486.2003.00566.x; Petrone KC, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043102; Pinder A. M., 2000, Journal of the Royal Society of Western Australia, V83, P149; Poot P, 2013, PLANT SOIL, V364, P409, DOI 10.1007/s11104-012-1452-8; Poot P, 2012, ANN BOT-LONDON, V110, P291, DOI 10.1093/aob/mcr322; Porembski S., 1997, Journal of the Royal Society of Western Australia, V80, P193; Reed AJ, 2012, FUTURE STREAMFLOWS N; Reitberger J, 2009, ISPRS J PHOTOGRAMM, V64, P561, DOI 10.1016/j.isprsjprs.2009.04.002; Reside A. E., 2013, CLIMATE CHANGE REFUG; Richards J.A., 2006, REMOTE SENSING DIGIT; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Rundel Philip W., 2001, P145; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sander J, 2012, PLANT BIOSYST, V146, P451, DOI 10.1080/11263504.2012.656726; Schimper AFW., 1903, PLANT GEOGRAPHY PHYS; Schofield NJ, 1989, JARRAH FOREST, P179; Schut AGT, CANOPY PROFILING VEG; Simonson WD, 2013, ECOL INDIC, V24, P636, DOI 10.1016/j.ecolind.2012.08.024; Simonson WD, 2012, CONSERV BIOL, V26, P840, DOI 10.1111/j.1523-1739.2012.01869.x; Specht RL., 1970, AUSTR ENV, P44; Sun D, 1997, AUST J BOT, V45, P929, DOI 10.1071/BT96121; Twidale C. R., 1997, SPECIAL PUBLICATIONS, V120, P13; Verboom WH, 2003, PLANT SOIL, V248, P321, DOI 10.1023/A:1022358014629; Wardell-Johnson G., 1996, Journal of the Royal Society of Western Australia, V79, P249; Wardell-Johnson Grant W., 2011, Pacific Conservation Biology, V17, P220; Withers P. C., 1997, Journal of the Royal Society of Western Australia, V80, P159; Wulder MA, 2012, REMOTE SENS ENVIRON, V121, P196, DOI 10.1016/j.rse.2012.02.001; Wulder MA, 2008, FOREST CHRON, V84, P807, DOI 10.5558/tfc84807-6; Yates CJ, 2003, J VEG SCI, V14, P185, DOI 10.1111/j.1654-1103.2003.tb02143.x; Yates CJ, 2010, DIVERS DISTRIB, V16, P187, DOI 10.1111/j.1472-4642.2009.00623.x	86	49	53	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e82778	10.1371/journal.pone.0082778	http://dx.doi.org/10.1371/journal.pone.0082778			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416149	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000329862500021
J	Gartner, S; Gunesch, A; Knyazeva, T; Wolf, P; Hogel, B; Eiermann, W; Ullrich, A; Knyazev, P; Ataseven, B				Gaertner, Silvia; Gunesch, Angela; Knyazeva, Tatiana; Wolf, Petra; Hoegel, Bernhard; Eiermann, Wolfgang; Ullrich, Axel; Knyazev, Pjotr; Ataseven, Beyhan			PTK 7 Is a Transforming Gene and Prognostic Marker for Breast Cancer and Nodal Metastasis Involvement	PLOS ONE			English	Article							TYROSINE KINASE FAMILY; EXPRESSION SIGNATURE; EPITHELIAL-CELLS; MIGRATION; MOLECULE; DEFINES; RNA	Protein Tyrosin Kinase 7 (PTK7) is upregulated in several human cancers; however, its clinical implication in breast cancer (BC) and lymph node (LN) is still unclear. In order to investigate the function of PTK7 in mediating BC cell motility and invasivity, PTK7 expression in BC cell lines was determined. PTK7 signaling in highly invasive breast cancer cells was inhibited by a dominant-negative PTK7 mutant, an antibody against the extracellular domain of PTK7, and siRNA knockdown of PTK7. This resulted in decreased motility and invasivity of BC cells. We further examined PTK7 expression in BC and LN tissue of 128 BC patients by RT-PCR and its correlation with BC related genes like HER2, HER3, PAI1, MMP1, K19, and CD44. Expression profiling in BC cell lines and primary tumors showed association of PTK7 with ER/PR/HER2-negative (TNBC-triple negative BC) cancer. Oncomine data analysis confirmed this observation and classified PTK7 in a cluster with genes associated with agressive behavior of primary BC. Furthermore PTK7 expression was significantly different with respect to tumor size (ANOVA, p = 0.033) in BC and nodal involvement (ANOVA, p = 0.007) in LN. PTK7 expression in metastatic LN was related to shorter DFS (Cox Regression, p = 0.041). Our observations confirmed the transforming potential of PTK7, as well as its involvement in motility and invasivity of BC cells. PTK7 is highly expressed in TNBC cell lines. It represents a novel prognostic marker for BC patients and has potential therapeutic significance.	[Gaertner, Silvia; Gunesch, Angela; Knyazeva, Tatiana; Ullrich, Axel; Knyazev, Pjotr] Max Planck Inst Biochem, Dept Mol Biol, Martinsried, Germany; [Ataseven, Beyhan] Red Cross Hosp, Dept Gynecol & Obstet, Munich, Germany; [Ataseven, Beyhan] Kliniken Essen Mitte Evangel Huyssens Stiftung, Dept Gynecol & Gynecol Oncol, Essen, Germany; [Hoegel, Bernhard] Red Cross Hosp, Dept Pathol, Munich, Germany; [Wolf, Petra] Tech Univ, Klinikum Rechts Isar, Inst Med Stat & Epidemiol, Munich, Germany; [Eiermann, Wolfgang] Interdisziplinares Onkolog Zentrum, Dept Gynecol & Gynecol Oncol, Munich, Germany	Max Planck Society; Kliniken Essen-Mitte; Technical University of Munich	Knyazev, P (corresponding author), Max Planck Inst Biochem, Dept Mol Biol, Martinsried, Germany.	knzayev@biochem.mpg.de; ataseven@gmx.net			Max-Planck-Society	Max-Planck-Society(Max Planck Society)	The work was funded by the Max-Planck-Society www.mpg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bundred NJ, 2001, CANCER TREAT REV, V27, P137, DOI 10.1053/ctrv.2000.0207; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Easty DJ, 1997, INT J CANCER, V71, P1061, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1061::AID-IJC24>3.0.CO;2-F; Ellsworth RE, 2009, CLIN EXP METASTAS, V26, P205, DOI 10.1007/s10585-008-9232-9; Endoh H, 2004, J CLIN ONCOL, V22, P811, DOI 10.1200/JCO.2004.04.109; Ferlay SH, 2010, IARC CANCERBASE; Gobble RM, 2011, CANCER RES, V71, P2697, DOI 10.1158/0008-5472.CAN-10-3588; Golubkov VS, 2012, J BIOL CHEM; Gorringe KL, 2005, GENE CHROMOSOME CANC, V42, P247, DOI 10.1002/gcc.20136; Jechlinger M, 2006, J CLIN INVEST, V116, P1561, DOI 10.1172/JCI24652; Jung JW, 2002, BBA-GENE STRUCT EXPR, V1579, P153, DOI 10.1016/S0167-4781(02)00536-5; Kousidou OC, 2004, ANTICANCER RES, V24, P4025; Lin Y, 2012, J SURG ONCOL; MOSSIE K, 1995, ONCOGENE, V11, P2179; Na HW, 2012, J BIOL CHEM, V287, P25001, DOI 10.1074/jbc.M112.348904; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Park SK, 1996, J BIOCHEM, V119, P235; Peradziryi H, 2012, ARCH BIOCH BIOPHYS; Prebet T, 2010, BLOOD, V116, P2315, DOI 10.1182/blood-2010-01-262352; Puppo F, 2011, EMBO REP, V12, P43, DOI 10.1038/embor.2010.185; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Shin WS, 2008, BIOCHEM BIOPH RES CO, V371, P793, DOI 10.1016/j.bbrc.2008.04.168; Shnitsar I, 2008, DEVELOPMENT, V135, P4015, DOI 10.1242/dev.023556; SOULE HD, 1990, CANCER RES, V50, P6075; Speers C, 2009, CLIN CANCER RES, V15, P6327, DOI 10.1158/1078-0432.CCR-09-1107; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Vuoriluoto K, 2011, ONCOGENE, V30, P1436, DOI 10.1038/onc.2010.509; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zelinski DP, 2001, CANCER RES, V61, P2301	32	38	39	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84472	10.1371/journal.pone.0084472	http://dx.doi.org/10.1371/journal.pone.0084472			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409301	Green Published, gold, Green Submitted			2022-12-27	WOS:000329463500025
J	Shivapurkar, N; Weiner, LM; Marshall, JL; Madhavan, S; Mays, AD; Juhl, H; Wellstein, A				Shivapurkar, Narayan; Weiner, Louis M.; Marshall, John L.; Madhavan, Subha; Mays, Anne Deslattes; Juhl, Hartmut; Wellstein, Anton			Recurrence of Early Stage Colon Cancer Predicted by Expression Pattern of Circulating microRNAs	PLOS ONE			English	Article							COLORECTAL-CANCER; PLASMA MICRORNAS; BIOMARKERS; CELLS; SERUM; TUMORS; ADENOCARCINOMA; SIGNATURE; DIAGNOSIS; SURVIVAL	Systemic treatment of patients with early-stage cancers attempts to eradicate occult metastatic disease to prevent recurrence and increased morbidity. However, prediction of recurrence from an analysis of the primary tumor is limited because disseminated cancer cells only represent a small subset of the primary lesion. Here we analyze the expression of circulating microRNAs (miRs) in serum obtained pre-surgically from patients with early stage colorectal cancers. Groups of five patients with and without disease recurrence were used to identify an informative panel of circulating miRs using quantitative PCR of genome-wide miR expression as well as a set of published candidate miRs. A panel of six informative miRs (miR-15a, mir-103, miR-148a, miR-320a, miR-451, miR-596) was derived from this analysis and evaluated in a separate validation set of thirty patients. Hierarchical clustering of the expression levels of these six circulating miRs and Kaplan-Meier analysis showed that the risk of disease recurrence of early stage colon cancer can be predicted by this panel of miRs that are measurable in the circulation at the time of diagnosis (P = 0.0026; Hazard Ratio 5.4; 95% CI of 1.9 to 15).	[Shivapurkar, Narayan; Weiner, Louis M.; Marshall, John L.; Madhavan, Subha; Mays, Anne Deslattes; Juhl, Hartmut; Wellstein, Anton] Georgetown Univ, Lombardi Canc Ctr, Washington, DC 20007 USA; [Juhl, Hartmut] Indivumed GmbH, Hamburg, Germany	Georgetown University	Shivapurkar, N (corresponding author), Georgetown Univ, Lombardi Canc Ctr, Washington, DC 20007 USA.	nms35@georgetown.edu; wellstea@georgetown.edu		Deslattes Mays, Anne/0000-0001-7951-3439; Wellstein, Anton/0000-0002-0570-4950	NIH [CA108440, P30 CA051008, HHSN2612200800001E]; Lombardi Cancer Center; Ruesch Center; NATIONAL CANCER INSTITUTE [R01CA108440, T32CA009686, R01CA050633, R01CA071508, P30CA051008] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL068686] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lombardi Cancer Center; Ruesch Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The study was supported in part by NIH grants CA108440 (AW), P30 CA051008 (LW), HHSN2612200800001E (SM), the Lombardi Cancer Center (NS) and the Ruesch Center (NS, JLM, SM, and AW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwar SL, 2013, INT J CANCER, V133, P660, DOI 10.1002/ijc.28068; Aslam MI, 2009, BRIT J SURG, V96, P702, DOI 10.1002/bjs.6628; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Brase JC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-306; Buchholz M, 2005, CLIN CANCER RES, V11, P8048, DOI 10.1158/1078-0432.CCR-05-1274; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cheng HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017745; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Costa FF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025114; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Dickinson BA, 2013, EUR J HEART FAIL, V15, P650, DOI 10.1093/eurjhf/hft018; Gibby KA, 2009, P NATL ACAD SCI USA, V106, P8585, DOI 10.1073/pnas.0810952106; Guay C, 2013, NAT REV ENDOCRINOL, V9, P513, DOI 10.1038/nrendo.2013.86; Gunderson LL, 2010, J CLIN ONCOL, V28, P264, DOI 10.1200/JCO.2009.24.0952; Henry NL, 2012, MOL ONCOL, V6, P140, DOI 10.1016/j.molonc.2012.01.010; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Jamieson NB, 2012, CLIN CANCER RES, V18, P534, DOI 10.1158/1078-0432.CCR-11-0679; Ortega FJ, 2013, CLIN CHEM, V59, P781, DOI 10.1373/clinchem.2012.195776; Keller A, 2011, NAT METHODS, V8, P841, DOI [10.1038/nmeth.1682, 10.1038/NMETH.1682]; Kerr DJ, 2013, NAT REV CLIN ON 0611, P1; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; LaConti JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020687; Liao YL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012976; Lodes MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006229; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma RM, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-38; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Musumeci M, 2011, ONCOGENE, V30, P4231, DOI 10.1038/onc.2011.140; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Ng EKO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053141; Okada H, 2010, INT J BIOCHEM CELL B, V42, P1256, DOI 10.1016/j.biocel.2010.02.002; Palma J, 2012, NUCLEIC ACIDS RES, V40, P9125, DOI 10.1093/nar/gks656; Pigati L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013515; Poste G, 2012, CLIN CANCER RES, V18, P1515, DOI 10.1158/1078-0432.CCR-11-2206; Poste G, 2011, NATURE, V469, P156, DOI 10.1038/469156a; Redis RS, 2012, PHARMACOL THERAPEUT, V136, P169, DOI 10.1016/j.pharmthera.2012.08.003; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Schepeler T, 2008, CANCER RES, V68, P6416, DOI 10.1158/0008-5472.CAN-07-6110; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Spinetti G, 2013, CIRC RES, V112, DOI 10.1161/CIRCRESAHA.111.300418; Su TH, 2013, P NATL ACAD SCI USA, V110, P7844, DOI 10.1073/pnas.1306138110; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Visone R, 2009, AM J PATHOL, V174, P1131, DOI 10.2353/ajpath.2009.080794; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645; Wang K, 2010, NUCLEIC ACIDS RES, V38, P7248, DOI 10.1093/nar/gkq601; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Wulfken LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025787; Zhang Y, 2010, CLIN CHEM, V56, P1830, DOI 10.1373/clinchem.2010.147850	55	50	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84686	10.1371/journal.pone.0084686	http://dx.doi.org/10.1371/journal.pone.0084686			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400111	Green Published, gold, Green Submitted			2022-12-27	WOS:000329462700045
J	O'Hara, L; York, JP; Zhang, PM; Smith, LB				O'Hara, Laura; York, Jean Philippe; Zhang, Pumin; Smith, Lee B.			Targeting of GFP-Cre to the Mouse Cyp11a1 Locus Both Drives Cre Recombinase Expression in Steroidogenic Cells and Permits Generation of Cyp11a1 Knock Out Mice	PLOS ONE			English	Article							DEFICIENCY SYNDROMES; DISRUPTION; ENZYMES; BRAIN; OVARY	To permit conditional gene targeting of floxed alleles in steroidogenic cell-types we have generated a transgenic mouse line that expresses Cre Recombinase under the regulation of the endogenous Cytochrome P450 side chain cleavage enzyme (Cyp11a1) promoter. Mice Carrying the Cyp11a1-GC (GFP-Cre) allele express Cre Recombinase in fetal adrenal and testis, and adrenal cortex, testicular Leydig cells (and a small proportion of Sertoli cells), theca cells of the ovary, and the hindbrain in postnatal life. Circulating testosterone concentration is unchanged in Cyp11(+/GC) males, suggesting steroidogenesis is unaffected by loss of one allele of Cyp11a1, mice are grossly normal, and Cre Recombinase functions to recombine floxed alleles of both a YFP reporter gene and the Androgen Receptor (AR) in steroidogenic cells of the testis, ovary, adrenal and hindbrain. Additionally, when bred to homozygosity (Cyp11a1(GC/GC)), knock-in of GFP-Cre to the endogenous Cyp11a1 locus results in a novel mouse model lacking endogenous Cyp11a1 (P450-SCC) function. This unique dual-purpose model has utility both for those wishing to conditionally target genes within steroidogenic cell types and for studies requiring mice lacking endogenous steroid hormone production.	[O'Hara, Laura; Smith, Lee B.] Univ Edinburgh, MRC, Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland; [York, Jean Philippe; Zhang, Pumin] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA	University of Edinburgh; Baylor College of Medicine	Smith, LB (corresponding author), Univ Edinburgh, MRC, Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland.	lee.smith@ed.ac.uk		O'Hara, Laura/0000-0001-7790-9261; Smith, Lee/0000-0002-4103-3074	UK Medical Research Council [G1100354/1]; National Institute of Diabetes and Digestive and Kidney Diseases [DK070214]; NATIONAL CANCER INSTITUTE [R01CA122623, R01CA116097] Funding Source: NIH RePORTER; Medical Research Council [G1002033, G1100354] Funding Source: researchfish; MRC [G1100354, G1002033] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded by a UK Medical Research Council Programme Grant award (G1100354/1) to LBS, and by a U01 grant from National Institute of Diabetes and Digestive and Kidney Diseases (DK070214) to PZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bridges PJ, 2008, GENESIS, V46, P499, DOI 10.1002/dvg.20428; Buaas FW, 2012, DEVELOPMENT, V139, P4561, DOI 10.1242/dev.087247; Chiang YF, 2011, J CELL PHYSIOL, V226, P1998, DOI 10.1002/jcp.22534; Chung BC, 2002, ENDOCR RES, V28, P575, DOI 10.1081/ERC-120016842; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; Hu MC, 2002, MOL ENDOCRINOL, V16, P1943, DOI 10.1210/me.2002-0055; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Nagy Andras, 2009, V530, P365, DOI 10.1007/978-1-59745-471-1_19; Nebert DW, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0431; O'Hara Laura, 2012, BMC Res Notes, V5, P16, DOI 10.1186/1756-0500-5-16; O'Hara L, 2011, ENDOCRINOLOGY, V152, P718, DOI 10.1210/en.2010-0928; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; Pelletier G, 2010, PROG BRAIN RES, V181, P193, DOI 10.1016/S0079-6123(08)81011-4; Smith L, 2011, REPRODUCTION, V141, P151, DOI 10.1530/REP-10-0404; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tsutsui K, 1999, COMP BIOCHEM PHYS C, V124, P121, DOI 10.1016/S0742-8413(99)00065-1; Welsh M, 2009, FASEB J, V23, P4218, DOI 10.1096/fj.09-138347; Wu HS, 2007, GENESIS, V45, P59, DOI 10.1002/dvg.20266; Zhang PM, 2002, NAT GENET, V30, P31, DOI 10.1038/ng797	19	25	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84541	10.1371/journal.pone.0084541	http://dx.doi.org/10.1371/journal.pone.0084541			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404170	gold, Green Published, Green Submitted			2022-12-27	WOS:000329460800049
J	Wang, YQ; Luo, QQ; Li, YP; Deng, SL; Wei, SY; Li, XL				Wang, Yingqiang; Luo, Qianqian; Li, Youping; Deng, Shaolin; Wei, Shiyou; Li, Xianglian			Radiofrequency Ablation versus Hepatic Resection for Small Hepatocellular Carcinomas: A Meta-Analysis of Randomized and Nonrandomized Controlled Trials	PLOS ONE			English	Article							ADJUSTED LIFE-YEARS; SURGICAL RESECTION; SYSTEMATIC ANALYSIS; GLOBAL BURDEN; SURVIVAL; THERAPY; HEPATECTOMY; PROGNOSIS; OUTCOMES; SURGERY	Objectives: To evaluate the efficacy and safety of radiofrequency ablation (RFA) versus hepatic resection (HR) for early hepatocellular carcinoma (HCC) meeting the Milan criteria. Methods: A meta-analysis was conducted, and PubMed, Web of Science, the Cochrane Library, CBM, CNKI and VIP databases were systematically searched through November 2012 for randomized and nonrandomized controlled trials (RCTs and NRCTs). The Cochrane Collaboration's tool and modified MINORS score were applied to assess the quality of RCTs and NRCTs, respectively. The GRADE approach was employed to evaluate the strength of evidence. Results: Three RCTs and twenty-five NRCTs were included. Among 11,873 patients involved, 6,094 patients were treated with RFA, and 5,779 with HR. The pooled results of RCTs demonstrated no significant difference between groups for 1- and 3-year overall survival (OS), recurrence-free survival (RFS) and disease-free survival (DFS) (p>0.05). The 5-year OS (Relative Risk, RR 0.72, 95% CI 0.60 to 0.88) and RFS (RR 0.56, 95% CI 0.40 to 0.78) were lower with RFA than with HR. The 3- and 5-year recurrences with RFA were higher than with HR (RR 1.48, 95% CI 1.14 to 1.94, and RR 1.52, 95% CI 1.18 to 1.97, respectively), but 1-year recurrence and in-hospital mortality showed no significant differences between groups (p>0.05). The complication rate (RR 0.18, 95% CI 0.06 to 0.53) was lower and hospital stays (Mean difference -8.77, 95% CI -210.36 to 27.18) were shorter with RFA than with HR. The pooled results of NRCTs showed that the RFA group had lower 1-, 3- and 5-year OS, RFS and DFS, and higher recurrence than the HR group (p<0.05). But for patients with very early stage HCC, RFA was comparable to HR for OS and recurrence. Conclusion: The effectiveness of RFA is comparable to HR, with fewer complications but higher recurrence, especially for very early HCC patients.	[Wang, Yingqiang; Li, Youping; Li, Xianglian] Sichuan Univ, West China Hosp, Chinese Cochrane Ctr, Chengdu 610064, Peoples R China; [Wang, Yingqiang] 363 Hosp, Dept Med Adm, Chengdu, Peoples R China; [Luo, Qianqian] West China Hosp, Natl Chengdu Ctr Safety Evaluat Drugs, Chengdu, Peoples R China; [Deng, Shaolin; Wei, Shiyou] Sichuan Univ, West China Hosp, West China Med Sch, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University	Li, YP (corresponding author), Sichuan Univ, West China Hosp, Chinese Cochrane Ctr, Chengdu 610064, Peoples R China.	yzmylab@hotmail.com	Wang, Yingqiang/J-6654-2019		National Technology Support Program [2011BAI14B01]	National Technology Support Program	This work was funded by National Technology Support Program (2011BAI14B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Hilal M, 2008, J GASTROINTEST SURG, V12, P1521, DOI 10.1007/s11605-008-0553-4; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Bu XY, 2009, CHIN ARCH GEN SURG E, V3, P127; Chen MS, 2006, ANN SURG, V243, P321, DOI 10.1097/01.sla.0000201480.65519.b8; Cho Chang Min, 2005, Korean J Hepatol, V11, P59; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Feng K, 2012, J HEPATOL, V57, P794, DOI 10.1016/j.jhep.2012.05.007; [付京 FU Jing], 2011, [吉林大学学报. 医学版, Journal of Jilin Univeristy. Medicine edition], V37, P733; [高文 GAO Wen], 2007, [中国医学影像技术, Chinese Journal of Medical Imaging Technology], V23, P254; Gravante G, 2011, J GASTROINTEST SURG, V15, P378, DOI 10.1007/s11605-010-1377-6; Guglielmi A, 2008, J GASTROINTEST SURG, V12, P192, DOI 10.1007/s11605-007-0392-8; Guo WX, 2010, WORLD J SURG, V34, P2671, DOI 10.1007/s00268-010-0732-9; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; Hasegawa K, 2008, J HEPATOL, V49, P589, DOI 10.1016/j.jhep.2008.05.018; Higgins JP, 2011, CONCHRANE HDB SYSTMA; Hiraoka A, 2008, HEPATO-GASTROENTEROL, V55, P2171; Hong SN, 2005, J CLIN GASTROENTEROL, V39, P247, DOI 10.1097/01.mcg.0000152746.72149.31; Huang JW, 2011, J GASTROINTEST SURG, V15, P311, DOI 10.1007/s11605-010-1372-y; Huang JW, 2010, ANN SURG, V252, P903, DOI 10.1097/SLA.0b013e3181efc656; Hung HH, 2011, CLIN GASTROENTEROL H, V9, P79, DOI 10.1016/j.cgh.2010.08.018; Ikeda K, 2011, LIVER INT, V31, P692, DOI 10.1111/j.1478-3231.2011.02480.x; Kobayashi M, 2009, CANCER-AM CANCER SOC, V115, P571, DOI 10.1002/cncr.24031; Kong WT, 2011, J CLIN ONCOL, V10, P399; Li L, 2012, J GASTROEN HEPATOL, V27, P51, DOI 10.1111/j.1440-1746.2011.06947.x; Liu H, 2011, PRACITICAL CLIN MED, V12, P16; Liu JG, 2010, WORLD J GASTROENTERO, V16, P3450, DOI 10.3748/wjg.v16.i27.3450; Lupo L, 2007, HPB (Oxford), V9, P429, DOI 10.1080/13651820701713758; Minami Y, 2011, INT J HEPATOL, V2011, DOI 10.4061/2011/104685; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Montorsi M, 2005, J GASTROINTEST SURG, V9, P62, DOI 10.1016/j.gassur.2004.10.003; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nishikawa H, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-143; Park SK, 2013, KOREAN J INTERN MED, V28, P428, DOI 10.3904/kjim.2013.28.4.428; Peng ZW, 2012, RADIOLOGY, V262, P1022, DOI 10.1148/radiol.11110817; Santambrogio R, 2009, ANN SURG ONCOL, V16, P3289, DOI 10.1245/s10434-009-0678-z; Slim K, 2003, ANZ J SURG, V73, P712, DOI 10.1046/j.1445-2197.2003.02748.x; Soerjomataram I, 2012, LANCET, V380, P1840, DOI 10.1016/S0140-6736(12)60919-2; Takahashi S, 2007, ONCOLOGY-BASEL, V72, P98, DOI 10.1159/000111714; The Food and Drug Administration (FDA), 2021, FOOD SCI BIOTECHNOL; Ueno S, 2009, J HEPATO-BILIARY-PAN, V16, P359, DOI 10.1007/s00534-009-0069-7; Vivarelli M, 2004, ANN SURG, V240, P102, DOI 10.1097/01.sla.0000129672.51886.44; Wang JH, 2012, J HEPATOL, V56, P412, DOI 10.1016/j.jhep.2011.05.020; Wang YQ, 2013, J EVID BASE IN PRESS; Xie XQ, 2010, INT J TECHNOL ASSESS, V26, P390, DOI 10.1017/S0266462310001029; Xu G, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-163; Zhou T, 2007, J HEPATOBILIARY SURG, V15, P424; Zytoon AA, 2007, JPN J CLIN ONCOL, V37, P658, DOI 10.1093/jjco/hym086	50	69	80	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84484	10.1371/journal.pone.0084484	http://dx.doi.org/10.1371/journal.pone.0084484			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404166	Green Submitted, Green Published, gold			2022-12-27	WOS:000329460800045
J	Trimbos, KB; Doorenweerd, C; Kraaijeveld, K; Musters, CJM; Groen, NM; de Knijff, P; Piersma, T; de Snoo, GR				Trimbos, Krijn B.; Doorenweerd, Camiel; Kraaijeveld, Ken; Musters, C. J. M.; Groen, Niko M.; de Knijff, Peter; Piersma, Theunis; de Snoo, Geert R.			Patterns in Nuclear and Mitochondrial DNA Reveal Historical and Recent Isolation in the Black-Tailed Godwit (Limosa limosa)	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; STATISTICAL TESTS; SOFTWARE; DIFFERENTIATION; PHYLOGEOGRAPHY; DEMOGRAPHY; NEUTRALITY	On the basis of morphological differences, three subspecies of Black-tailed Godwit (Limosa limosa) have been recognized (L. l. limosa, L. l. islandica and L. l. melanuroides). In previous studies mitochondrial DNA (mtDNA) sequence data showed minimal genetic divergence between the three subspecies and an absence of sub-structuring within L. l. limosa. Here, population genetic structure and phylogeographic patterns have been analyzed using COI, HVR1 and HVR2 mtDNA sequence data as well as 12 microsatellite loci (nuDNA). The nuDNA data suggest genetic differentiation between L. l. limosa from Sweden and The Netherlands, between L. l. limosa and L. l. islandica, but not between L. l. limosa and L. l. melanuroides. However, the mtDNA data were not consistent with the nuDNA pattern. mtDNA did support a split between L. l. melanuroides and L. l. limosa/L. l. islandica and also demonstrated two L. l. limosa haplotype clusters that were not geographically isolated. This genetic structure can be explained by a scenario of isolation of L. l. melanuroides from L. l. limosa in Beringia during the Last Glacial Maximum. During the Pleistocene separation of L. l. islandica from L. l. limosa occurred, followed by colonization of Iceland by the L. l. islandica during the Holocene. Within L. l. limosa founder events, followed by population expansion, took place during the Holocene also. According to the patterns observed in both markers together and their geographic separation, we propose that the three traditional subspecies indeed represent three separate genetic units.	[Trimbos, Krijn B.; Musters, C. J. M.; de Snoo, Geert R.] Leiden Univ, Inst Environm Sci CML, Dept Conservat Biol, Leiden, Netherlands; [Doorenweerd, Camiel] Netherlands Ctr Biodivers, Dept Terr Zool, Leiden, Netherlands; [Kraaijeveld, Ken; de Knijff, Peter] Leiden Univ, Dept Human Genet, Leiden Genome Technol Ctr, Med Ctr, NL-2300 RA Leiden, Netherlands; [Groen, Niko M.; Piersma, Theunis] Univ Groningen, Dept Anim Ecol, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands; [Piersma, Theunis] NIOZ Royal Netherlands Inst Sea Res, Dept Marine Ecol, Den Burg, Texel, Netherlands	Leiden University; Leiden University - Excl LUMC; Naturalis Biodiversity Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Trimbos, KB (corresponding author), Leiden Univ, Inst Environm Sci CML, Dept Conservat Biol, Leiden, Netherlands.	trimbos@cml.leidenuniv.nl	Doorenweerd, Camiel/AAO-4314-2020; Piersma, Theunis/D-1871-2012; Musters, Cornelis/K-7828-2013; de Knijff, Peter/Y-2519-2018	Doorenweerd, Camiel/0000-0002-0418-4439; de Knijff, Peter/0000-0002-0899-771X; Piersma, Theunis/0000-0001-9668-466X; Trimbos, Krijn Baptist/0000-0001-5280-6434; Musters, C.J.M./0000-0003-1321-6786				Adams J. M., 1997, GLOBAL LAND ENV LAST; Beintema A. J., 1995, ECOLOGISCHE ATLAS NE; BirdLife International, 2009, SPEC FACTSH LIM LIM; Birdlife International I., 2004, BIRDS EUR POP EST TR; Buehler DM, 2005, CONDOR, V107, P497, DOI 10.1650/0010-5422(2005)107[0497:PDTAHD]2.0.CO;2; Chao A, 2008, BIOMETRICS, V64, P1178, DOI 10.1111/j.1541-0420.2008.01010.x; Cramp S., 1982, BIRDS W PALEARCTIC, V3; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Edwards S, 2009, MOL ECOL, V18, P2930, DOI 10.1111/j.1365-294X.2009.04270.x; Elbourne R, 2011, THESIS DEP ECOLOGY E; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Gill Jennifer A., 2007, Wader Study Group Bulletin, V114, P43; Glaubitz JC, 2004, MOL ECOL NOTES, V4, P309, DOI 10.1111/j.1471-8286.2004.00597.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Haverschmidt F., 1963, BLACK TAILED GODWIT; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hoglund J, 2009, J ORNITHOL, V150, P45, DOI 10.1007/s10336-008-0316-8; Jones KL, 2005, MOL ECOL, V14, P2645, DOI 10.1111/j.1365-294X.2005.02622.x; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kerr KCR, 2007, MOL ECOL NOTES, V7, P535, DOI 10.1111/j.1471-8286.2006.01670.x; Kleijn D, 2010, IBIS, V152, P475, DOI 10.1111/j.1474-919X.2010.01025.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liebers D, 2004, P ROY SOC B-BIOL SCI, V271, P893, DOI 10.1098/rspb.2004.2679; Liebers D, 2001, MOL ECOL, V10, P2447, DOI 10.1046/j.0962-1083.2001.01370.x; Lopes RJ, 2013, J ORNITHOL, V154, P35, DOI 10.1007/s10336-012-0865-8; Mantooth SJ, 2011, GEOGR COMPASS, V5, P1, DOI 10.1111/j.1749-8198.2009.00297.x; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; MOORE WS, 1995, EVOLUTION, V49, P718, DOI 10.1111/j.1558-5646.1995.tb02308.x; Mulder T, 1972, NEDERLAND AANTALLEN; Ottvall R, 2005, CONSERV GENET, V6, P321, DOI 10.1007/s10592-005-4973-3; Paton T, 2002, P ROY SOC B-BIOL SCI, V269, P839, DOI 10.1098/rspb.2002.1961; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Qiagen, 2003, DNEASY TISS HDB PROT, P18; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Richardson DS, 2001, MOL ECOL, V10, P2263, DOI 10.1046/j.0962-1083.2001.01355.x; Ronka A, 2008, CONSERV GENET, V9, P29, DOI 10.1007/s10592-007-9299-x; Roselaar C.S., 1991, Dutch Birding, V13, P128; Rubinoff D, 2005, SYST BIOL, V54, P952, DOI 10.1080/10635150500234674; Rubinoff D, 2006, J HERED, V97, P581, DOI 10.1093/jhered/esl036; Ruokonen M, 2002, MOL PHYLOGENET EVOL, V23, P422, DOI 10.1016/S1055-7903(02)00021-0; Schekkerman H, 2008, J APPL ECOL, V45, P1067, DOI 10.1111/j.1365-2664.2008.01506.x; Schindel DE, 2011, ZOOKEYS, P87, DOI 10.3897/zookeys.152.2473; Schmitt T, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-11; Schwartz MK, 2009, CONSERV GENET, V10, P441, DOI 10.1007/s10592-008-9622-1; TAJIMA F, 1989, GENETICS, V123, P585; Thomas GH, 2004, BMC EVOL BIOL, V28, P1471; Trimbos KB, 2011, CONSERV GENET, V12, P629, DOI 10.1007/s10592-010-0167-8; Trimbos KB, 2009, J ORNITHOL, V150, P915, DOI 10.1007/s10336-009-0422-2; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Verkuil YI, 2009, MOL ECOL RESOUR, V9, P1415, DOI 10.1111/j.1755-0998.2009.02685.x; Wahlund S, 1928, HEREDITAS, V11, P65, DOI 10.1111/j.1601-5223.1928.tb02483.x; Wenink PW, 1996, AUK, V113, P744, DOI 10.2307/4088854; Wilson John James, 2011, BMC Ecology, V11, P18, DOI 10.1186/1472-6785-11-18; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x; Zwarts L., 2009, LIVING EDGE WETLANDS	61	12	13	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e83949	10.1371/journal.pone.0083949	http://dx.doi.org/10.1371/journal.pone.0083949			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416186	Green Published, Green Submitted, gold			2022-12-27	WOS:000329866300017
J	Hamady, LL; Natanson, LJ; Skomal, GB; Thorrold, SR				Hamady, Li Ling; Natanson, Lisa J.; Skomal, Gregory B.; Thorrold, Simon R.			Vertebral Bomb Radiocarbon Suggests Extreme Longevity in White Sharks	PLOS ONE			English	Article							CARCHARODON-CARCHARIAS; AGE-DETERMINATION; PELAGIC SHARKS; ORANGE ROUGHY; LAMNA-NASUS; VALIDATION; GROWTH; POPULATIONS; CHRONOLOGIES; CONSERVATION	Conservation and management efforts for white sharks (Carcharodon carcharias) remain hampered by a lack of basic demographic information including age and growth rates. Sharks are typically aged by counting growth bands sequentially deposited in their vertebrae, but the assumption of annual deposition of these band pairs requires testing. We compared radiocarbon (Delta C-14) values in vertebrae from four female and four male white sharks from the northwestern Atlantic Ocean (NWA) with reference chronologies documenting the marine uptake of C-14 produced by atmospheric testing of thermonuclear devices to generate the first radiocarbon age estimates for adult white sharks. Age estimates were up to 40 years old for the largest female (fork length [FL]: 526 cm) and 73 years old for the largest male (FL: 493 cm). Our results dramatically extend the maximum age and longevity of white sharks compared to earlier studies, hint at possible sexual dimorphism in growth rates, and raise concerns that white shark populations are considerably more sensitive to human-induced mortality than previously thought.	[Hamady, Li Ling; Thorrold, Simon R.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Hamady, Li Ling] MIT, Woods Hole Oceanog Inst, Joint Program Oceanog Appl Ocean Sci & Engn, Cambridge, MA 02139 USA; [Natanson, Lisa J.] NOAA, Natl Marine Fisheries Serv, Apex Predators Program, Narragansett, RI 02882 USA; [Skomal, Gregory B.] Massachusetts Div Marine Fisheries, New Bedford, MA USA	Woods Hole Oceanographic Institution; Massachusetts Institute of Technology (MIT); Woods Hole Oceanographic Institution; National Oceanic Atmospheric Admin (NOAA) - USA; Massachusetts Division of Marine Fisheries	Hamady, LL (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.	liling@whoi.edu	Thorrold, Simon R/B-7565-2012	Thorrold, Simon R/0000-0002-1533-7517; Hamady, Li Ling/0000-0003-3380-6150	National Science Foundation [OCE 0825148]; National Science Foundation Graduate Research Fellowship Program	National Science Foundation(National Science Foundation (NSF)); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF))	This study was funded by the National Science Foundation (OCE 0825148 was awarded to SRT) and LLH was supported by the National Science Foundation Graduate Research Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose S. H., 1993, PREHISTORIC HUMAN BO, P1; Andrews AH, 2013, CAN J FISH AQUAT SCI, V70, P1131, DOI 10.1139/cjfas-2012-0537; Andrews AH, 2011, FISH B-NOAA, V109, P454; Andrews AH, 2009, CAN J FISH AQUAT SCI, V66, P1130, DOI 10.1139/F09-059; Ardizzone D, 2006, ENVIRON BIOL FISH, V77, P355, DOI 10.1007/s10641-006-9106-4; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Bonfil R, 2005, SCIENCE, V310, P100, DOI 10.1126/science.1114898; Burgess GH, 2005, FISHERIES, V30, P30; Cailliet G.M., 1985, Memoirs of the Southern California Academy of Sciences, V9, P49; Cailliet GM, 2004, CRC MAR BIOL SER, P399; Campana SE, 2001, J FISH BIOL, V59, P197, DOI [10.1111/j.1095-8649.2001.tb00127.x, 10.1006/jfbi.2001.1668]; Campana SE, 2002, CAN J FISH AQUAT SCI, V59, P450, DOI 10.1139/F02-027; Campana SE, 2008, CAN J FISH AQUAT SCI, V65, P733, DOI 10.1139/F08-012; CITES, 2004, PROP INCL CARCH CARC; CMS, 2007, UNEP CMS REC 8 16 MI, V2005; Compagno LJV, 2001, FAO SPECIES CATALOGU, V2, P100; Cortes E, 2002, CONSERV BIOL, V16, P1048, DOI 10.1046/j.1523-1739.2002.00423.x; Domeier Michael L., 2012, P133; DRUFFEL EM, 1978, GEOPHYS RES LETT, V5, P913, DOI 10.1029/GL005i011p00913; Dulvy NK, 2008, AQUAT CONSERV, V18, P459, DOI 10.1002/aqc.975; Estrada JA, 2006, ECOLOGY, V87, P829, DOI 10.1890/0012-9658(2006)87[829:UOIAOV]2.0.CO;2; FENTON GE, 1991, MAR BIOL, V109, P197, DOI 10.1007/BF01319387; Francis MP, 2007, MAR FRESHWATER RES, V58, P10, DOI 10.1071/MF06069; Francis MP, 1996, GREAT WHITE SHARKS, P157, DOI 10.1016/B978-012415031-7/50016-1; Goldman KJ, 2012, CRC MAR BIOL SER, P423; IUCN, 2013, IUCN RED LIST THREAT, V1; Kalish J.M., 2001, USE BOMB RADIOCARBON, P116; KALISH JM, 1993, EARTH PLANET SC LETT, V114, P549, DOI 10.1016/0012-821X(93)90082-K; Kerr LA, 2006, ENVIRON BIOL FISH, V77, P337, DOI 10.1007/s10641-006-9125-1; Kim SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045068; Kneebone J, 2008, MAR BIOL, V154, P423, DOI 10.1007/s00227-008-0934-y; McMahon KW, 2013, OCEANOGR MAR BIOL, V51, P327; McMahon KW, 2013, LIMNOL OCEANOGR, V58, P697, DOI 10.4319/lo.2013.58.2.0697; Michener R.H., 1994, P138; Mollet HF, 1996, GREAT WHITE SHARKS, P91, DOI 10.1016/B978-012415031-7/50011-2; Natanson LJ, 2014, ENVIRON BIOL FISH, V97, P881, DOI 10.1007/s10641-013-0189-4; Natanson LJ, 2002, FISH B-NOAA, V100, P266; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; Passerotti MS, 2010, FISH B-NOAA, V108, P346; Rogers PJ, 2013, MAR FRESHWATER RES, V64, P20, DOI 10.1071/MF11234; Smith SE, 1998, MAR FRESHWATER RES, V49, P663, DOI 10.1071/MF97135; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Tanaka S, 2011, MAR FRESHWATER RES, V62, P548, DOI 10.1071/MF10130; Thorrold SR, 1997, GEOCHIM COSMOCHIM AC, V61, P2909, DOI 10.1016/S0016-7037(97)00141-5; Tieszen Larry L., 1993, MOL ARCHAEOLOGY PREH, P121, DOI DOI 10.1007/978-3-662-02894-0_5; TUROSS N, 1988, GEOCHIM COSMOCHIM AC, V52, P929, DOI 10.1016/0016-7037(88)90364-X; Weng KC, 2007, MAR BIOL, V152, P877, DOI 10.1007/s00227-007-0739-4; Wintner SP, 1999, FISH B-NOAA, V97, P153	48	63	65	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84006	10.1371/journal.pone.0084006	http://dx.doi.org/10.1371/journal.pone.0084006			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416189	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500089
J	Jang, MS; Goo, E; An, JH; Kim, J; Hwang, I				Jang, Moon Sun; Goo, Eunhye; An, Jae Hyung; Kim, Jinwoo; Hwang, Ingyu			Quorum Sensing Controls Flagellar Morphogenesis in Burkholderia glumae	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; BIOFILM FORMATION; VIBRIO-CHOLERAE; MOTILITY; FLHF; BACTERIA; POLAR; GENE; PROTEIN; SYSTEM	Burkholderia glumae is a motile plant pathogenic bacterium that has multiple polar flagella and one LuxR/LuxI-type quorum sensing (QS) system, TofR/TofI. A QS-dependent transcriptional regulator, QsmR, activates flagellar master regulator flhDC genes. FlhDC subsequently activates flagellar gene expression in B. glumae at 37 degrees C. Here, we confirm that the interplay between QS and temperature is critical for normal polar flagellar morphogenesis in B. glumae. In the wild-type bacterium, flagellar gene expression and flagellar number were greater at 28 degrees C compared to 37 degrees C. The QS-dependent flhC gene was significantly expressed at 28 degrees C in two QS-defective (tofI::Omega and qsmR::Omega) mutants. Thus, flagella were present in both tofI::Omega and qsmR::Omega mutants at 28 degrees C, but were absent at 37 degrees C. Most tofI::Omega and qsmR::Omega mutant cells possessed polar or nonpolar flagella at 28 degrees C. Nonpolarly flagellated cells processing flagella around cell surface of both tofI::Omega and qsmR::Omega mutants exhibited tumbling and spinning movements. The flhF gene encoding GTPase involved in regulating the correct placement of flagella in other bacteria was expressed in QS mutants in a FlhDC-dependent manner at 28 degrees C. However, FlhF was mislocalized in QS mutants, and was associated with nonpolar flagellar formation in QS mutants at 28 degrees C. These results indicate that QS-independent expression of flagellar genes at 28 degrees C allows flagellar biogenesis, but is not sufficient for normal polar flagellar morphogenesis in B. glumae. Our findings demonstrate that QS functions together with temperature to control flagellar morphogenesis in B. glumae.	[Jang, Moon Sun; Goo, Eunhye; An, Jae Hyung; Hwang, Ingyu] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Kim, Jinwoo] Gyeongsang Natl Univ, Div Appl Life Sci, Jinju, South Korea; [Kim, Jinwoo] Gyeongsang Natl Univ, Inst Agr & Life Sci, Jinju, South Korea	Seoul National University (SNU); Gyeongsang National University; Gyeongsang National University	Hwang, I (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.	ingyu@snu.ac.kr	Kim, Jinwoo/AAP-8786-2020; Goo, Eunhye/ERO-2624-2022	Kim, Jinwoo/0000-0003-1104-8088; 	Creative Research Initiatives Program of the National Research Foundation of Korea [2010-0018280]	Creative Research Initiatives Program of the National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the Creative Research Initiatives Program (2010-0018280) of the National Research Foundation of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge P, 2002, CURR OPIN MICROBIOL, V5, P160, DOI 10.1016/S1369-5274(02)00302-8; Atkinson S, 2006, J BACTERIOL, V188, P1451, DOI 10.1128/JB.188.4.1451-1461.2006; Balaban M, 2009, J BACTERIOL, V191, P6602, DOI 10.1128/JB.00884-09; Bange G, 2011, NAT STRUCT MOL BIOL, V18, P1376, DOI 10.1038/nsmb.2141; CARPENTER PB, 1992, MOL MICROBIOL, V6, P2705, DOI 10.1111/j.1365-2958.1992.tb01447.x; Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887; Choi KH, 2006, NAT PROTOC, V1, P162, DOI 10.1038/nprot.2006.25; Correa NE, 2005, J BACTERIOL, V187, P6324, DOI 10.1128/JB.187.18.6324-6332.2005; Dasgupta N, 2003, MOL MICROBIOL, V50, P809, DOI 10.1046/j.1365-2958.2003.03740.x; Fujii M, 2008, J MOL BIOL, V379, P273, DOI 10.1016/j.jmb.2008.04.012; Fuqua C, 2001, ANNU REV GENET, V35, P439, DOI 10.1146/annurev.genet.35.102401.090913; Goo E, 2012, P NATL ACAD SCI USA, V109, P19775, DOI 10.1073/pnas.1218092109; Goo E, 2010, J PROTEOME RES, V9, P3184, DOI 10.1021/pr100045n; Haya S, 2011, APPL ENVIRON MICROB, V77, P2799, DOI 10.1128/AEM.00286-11; Henke JM, 2004, J BACTERIOL, V186, P3794, DOI 10.1128/JB.186.12.3794-3805.2004; Hoang HH, 2008, J BACTERIOL, V190, P861, DOI 10.1128/JB.01310-07; Hussain MBBM, 2008, J BACTERIOL, V190, P1045, DOI 10.1128/JB.01472-07; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kim J, 2004, MOL MICROBIOL, V54, P921, DOI 10.1111/j.1365-2958.2004.04338.x; Kim J, 2007, MOL MICROBIOL, V64, P165, DOI 10.1111/j.1365-2958.2007.05646.x; Kim J, 2010, PLANT PATHOLOGY J, V26, P271, DOI 10.5423/PPJ.2010.26.3.271; Kirkpatrick CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006809; Koster DA, 2012, J MOL BIOL, V424, P180, DOI 10.1016/j.jmb.2012.09.005; Kusumoto A, 2008, MICROBIOL-SGM, V154, P1390, DOI 10.1099/mic.0.2007/012641-0; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Matsuda I., 1988, ANN PHYTOPATHOL SOC, V54, P378, DOI DOI 10.3186/JJPHYTOPATH.54.378; McCarter LL, 2006, CURR OPIN MICROBIOL, V9, P180, DOI 10.1016/j.mib.2006.02.001; McCarter LL, 2004, J MOL MICROB BIOTECH, V7, P18, DOI 10.1159/000077866; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Murray TS, 2006, J BACTERIOL, V188, P6995, DOI 10.1128/JB.00790-06; OKINO H, 1989, J BACTERIOL, V171, P2075, DOI 10.1128/jb.171.4.2075-2082.1989; Pandza S, 2000, MOL MICROBIOL, V36, P414, DOI 10.1046/j.1365-2958.2000.01859.x; Rader BA, 2007, J BACTERIOL, V189, P6109, DOI 10.1128/JB.00246-07; Smith RS, 2003, CURR OPIN MICROBIOL, V6, P56, DOI 10.1016/S1369-5274(03)00008-0; Smith TG, 2009, ADV APPL MICROBIOL, V67, P257, DOI 10.1016/S0065-2164(08)01008-3; Soutourina OA, 2003, FEMS MICROBIOL REV, V27, P505, DOI 10.1016/S0168-6445(03)00064-0; Soutourina OA, 2001, APPL ENVIRON MICROB, V67, P3852, DOI 10.1128/AEM.67.9.3852-3859.2001; Sperandio V, 2002, MOL MICROBIOL, V43, P809, DOI 10.1046/j.1365-2958.2002.02803.x; Tsushima Seiya, 1996, Annals of the Phytopathological Society of Japan, V62, P108, DOI 10.3186/jjphytopath.62.108; Waters CA, 2008, J BACTERIOL, V190, P2527, DOI 10.1128/JB.01756-07; Zan JD, 2012, MOL MICROBIOL, V85, P916, DOI 10.1111/j.1365-2958.2012.08149.x	41	23	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84831	10.1371/journal.pone.0084831	http://dx.doi.org/10.1371/journal.pone.0084831			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416296	Green Submitted, gold, Green Published			2022-12-27	WOS:000329862500177
J	Tang, LL; Cheng, CP; Wan, KY; Li, RH; Wang, DZ; Tao, Y; Pan, JF; Xie, J; Chen, F				Tang, Leilei; Cheng, Chuanpeng; Wan, Kaiyuan; Li, Ruhai; Wang, Daozhong; Tao, Yong; Pan, Junfeng; Xie, Juan; Chen, Fang			Impact of Fertilizing Pattern on the Biodiversity of a Weed Community and Wheat Growth	PLOS ONE			English	Article							WINTER-WHEAT; SPECIES-DIVERSITY; ORGANIC AGRICULTURE; OILSEED RAPE; MANAGEMENT; COMPETITION; CONSERVATION; VEGETATION; FIELDS; CROPS	Weeding and fertilization are important farming practices. Integrated weed management should protect or improve the biodiversity of farmland weed communities for a better ecological environment with not only increased crop yield, but also reduced use of herbicides. This study hypothesized that appropriate fertilization would benefit both crop growth and the biodiversity of farmland weed communities. To study the effects of different fertilizing patterns on the biodiversity of a farmland weed community and their adaptive mechanisms, indices of species diversity and responses of weed species and wheat were investigated in a 17-year field trial with a winter wheat-soybean rotation. This long term field trial includes six fertilizing treatments with different N, P and K application rates. The results indicated that wheat and the four prevalent weed species (Galium aparine, Vicia sativa, Veronica persica and Geranium carolinianum) showed different responses to fertilizer treatment in terms of density, plant height, shoot biomass, and nutrient accumulations. Each individual weed population exhibited its own adaptive mechanisms, such as increased internode length for growth advantages and increased light interception. The PK treatment had higher density, shoot biomass, Shannon-Wiener and Pielou Indices of weed community than N plus P fertilizer treatments. The N1/2PK treatment showed the same weed species number as the PK treatment. It also showed higher Shannon-Wiener and Pielou Indices of the weed community, although it had a lower wheat yield than the NPK treatment. The negative effects of the N1/2PK treatment on wheat yield could be balanced by the simultaneous positive effects on weed communities, which are intermediate in terms of the effects on wheat and weeds.	[Tang, Leilei; Cheng, Chuanpeng; Wan, Kaiyuan; Tao, Yong; Pan, Junfeng; Xie, Juan; Chen, Fang] Chinese Acad Sci, Key Lab Aquat Bot & Watershed Ecol, Wuhan Bot Garden, Wuhan, Peoples R China; [Tang, Leilei] Hainan Modern Agr Inspect & Testing Precaut & Con, Agr Dept Hainan Prov, Haikou, Peoples R China; [Wan, Kaiyuan] Chinese Acad Sci, Ecol Restorat ECORES Lab, Chengdu Inst Biol, Chengdu, Peoples R China; [Li, Ruhai] Hubei Acad Agr Sci, Inst Plant Protect & Soil Sci, Wuhan, Peoples R China; [Wang, Daozhong] Anhui Acad Agr Sci, Inst Soil & Fertilizer Sci, Hefei, Peoples R China; [Chen, Fang] China Program Int Plant Nutr Inst IPNI, Wuhan, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Hubei Academy of Agricultural Sciences; Anhui Academy of Agricultural Sciences	Wan, KY (corresponding author), Chinese Acad Sci, Key Lab Aquat Bot & Watershed Ecol, Wuhan Bot Garden, Wuhan, Peoples R China.	kaiyuanwan@126.com; fchen@ipni.ac.cn			China Program of International Plant Nutrition Institute [IPNI-HB-34]; Opening Project of Hubei Key Laboratory of Wetland Evolution & Ecological Restoration	China Program of International Plant Nutrition Institute; Opening Project of Hubei Key Laboratory of Wetland Evolution & Ecological Restoration	This work was supported by the China Program of International Plant Nutrition Institute (IPNI-HB-34) and the Opening Project of Hubei Key Laboratory of Wetland Evolution & Ecological Restoration(2011-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri MA, 1999, AGR ECOSYST ENVIRON, V74, P19, DOI 10.1016/S0167-8809(99)00028-6; Angonin C, 1996, WEED RES, V36, P175, DOI 10.1111/j.1365-3180.1996.tb01813.x; [Anonymous], [No title captured]; Bengtsson J, 2005, J APPL ECOL, V42, P261, DOI 10.1111/j.1365-2664.2005.01005.x; Blackshaw RE, 2005, CROP PROT, V24, P971, DOI 10.1016/j.cropro.2005.01.021; Blackshaw RE, 2002, WEED SCI, V50, P634, DOI 10.1614/0043-1745(2002)050[0634:FAMANU]2.0.CO;2; Blackshaw RE, 2009, WEED BIOL MANAG, V9, P46, DOI 10.1111/j.1445-6664.2008.00317.x; Derksen DA, 1996, PHYTOPROTECTION, V77, P29, DOI 10.7202/706098ar; DITOMASO JM, 1995, WEED SCI, V43, P491, DOI 10.1017/S0043174500081522; Forcella F, 2000, FIELD CROP RES, V67, P123, DOI 10.1016/S0378-4290(00)00088-5; Fried G, 2009, BIOL CONSERV, V142, P238, DOI 10.1016/j.biocon.2008.09.029; Fried G, 2008, AGR ECOSYST ENVIRON, V128, P68, DOI 10.1016/j.agee.2008.05.003; GOLDBERG DE, 1990, ECOLOGY, V71, P213, DOI 10.2307/1940261; Hanzlik K, 2011, AGR ECOSYST ENVIRON, V141, P323, DOI 10.1016/j.agee.2011.03.010; Kleijn D, 1997, BIOL CONSERV, V81, P57, DOI 10.1016/S0006-3207(96)00153-X; Lamberti-Raverot B, 2012, J EXP BOT, V63, P6115, DOI 10.1093/jxb/ers268; Li Ruhai, 2008, Shengwu Duoyangxing, V16, P118, DOI 10.3724/SP.J.1003.2008.07339; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; MAHN E-G, 1988, P71; MARSH SP, 2006, INT ASS AGR EC ITS S; Marshall EJP, 2003, WEED RES, V43, P77, DOI 10.1046/j.1365-3180.2003.00326.x; Murphy CE, 2006, EUPHYTICA, V148, P61, DOI 10.1007/s10681-006-5941-9; Nie J, 2009, WEED SCI, V57, P256, DOI 10.1614/WS-08-106.1; Ochoa-Hueso R, 2010, PLANT ECOL, V210, P263, DOI 10.1007/s11258-010-9755-4; Odero DC, 2011, WEED SCI, V59, P310, DOI 10.1614/WS-D-10-00082.1; Pal RW, 2013, PLANT BIOSYST, V147, P343, DOI 10.1080/11263504.2012.753485; Pinke G, 2012, APPL VEG SCI, V15, P136, DOI 10.1111/j.1654-109X.2011.01158.x; Poggio SL, 2005, AGR ECOSYST ENVIRON, V109, P48, DOI 10.1016/j.agee.2005.02.019; PYSEK P, 1991, J VEG SCI, V2, P237, DOI 10.2307/3235956; Rassam G, 2011, WEED BIOL MANAG, V11, P83, DOI 10.1111/j.1445-6664.2011.00407.x; Silc U, 2009, WEED RES, V49, P602, DOI 10.1111/j.1365-3180.2009.00726.x; Storkey J, 2007, AGR ECOSYST ENVIRON, V122, P173, DOI 10.1016/j.agee.2006.12.031; Tang LL, 2014, J PLANT ECOL, V7, P39, DOI 10.1093/jpe/rtt018; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; Tilman David, 1993, P13; van Elsen T, 2000, AGR ECOSYST ENVIRON, V77, P101, DOI 10.1016/S0167-8809(99)00096-1; Vollmann J, 2010, EUR J AGRON, V32, P243, DOI 10.1016/j.eja.2010.01.001; Yin LC, 2005, AGR ECOSYST ENVIRON, V107, P181, DOI 10.1016/j.agee.2004.11.003; Yin LC, 2006, CROP PROT, V25, P910, DOI 10.1016/j.cropro.2005.11.013; Yoshida S., 1976, LAB MANUAL PHYSL STU, P61	41	29	35	3	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84370	10.1371/journal.pone.0084370	http://dx.doi.org/10.1371/journal.pone.0084370			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416223	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500120
J	Wang, LX; Liu, X; Liang, M; Tan, FL; Liang, WY; Chen, YY; Lin, YX; Huang, L; Xing, JH; Chen, W				Wang, Lingxia; Liu, Xiao; Liang, Meng; Tan, Fanglin; Liang, Wenyu; Chen, Yiyong; Lin, Yongxiang; Huang, Li; Xing, Jianhong; Chen, Wei			Proteomic Analysis of Salt-Responsive Proteins in the Leaves of Mangrove Kandelia candel during Short-Term Stress	PLOS ONE			English	Article							EXPRESSED SEQUENCE TAGS; NACL STRESS; SUPEROXIDE-DISMUTASE; DEHYDROASCORBATE REDUCTASE; GLUTATHIONE-REDUCTASE; MOLECULAR CHAPERONES; GEL-ELECTROPHORESIS; HYDROGEN-PEROXIDE; SEEDLING ROOTS; BURMA MANGROVE	Salt stress is a major abiotic stress that limits crop productivity in many regions of the world. A comparative proteomic approach to identify salt stress-responsive proteins and to understand the molecular mechanisms was carried out in the woody halophyte Kandelia candel. Four-leaf-old K. candel seedlings were exposed to 150 (control), 300, 450, and 600 mM NaCl for 3 days. Proteins extracted from the leaves of K. candel seedlings were separated by two-dimensional gel electrophoresis (2-DE). More than 900 protein spots were detected on each gel, and 53 differentially expressed protein spots were located with at least two-fold differences in abundance on 2-DE maps, of which 48 were identified by matrix-assisted laser desorption ionization time-of-flight/time-of-flight mass spectrometry (MALDI-TOF-TOF/MS). The results showed that K. candel could withstand up to 450 mM NaCl stress by up-regulating proteins that are mainly involved in photosynthesis, respiration and energy metabolism, Na+ compartmentalization, protein folding and assembly, and signal transduction. Physiological data, including superoxide dismutase (SOD) and dehydroascorbate reductase (DHAR) activities, hydrogen peroxide (H2O2) and superoxide anion radicals (O-2(-)) contents, as well as Na+ content and K+/Na+ ratios all correlated well with our proteomic results. This study provides new global insights into woody halophyte salt stress responses. Identification of differentially expressed proteins promotes better understanding of the molecular basis for salt stress reduction in K. candel.	[Wang, Lingxia; Chen, Wei] Fujian Agr & Forestry Univ, Minist Educ Genet Breeding & Multiple Utilizat Cr, Key Lab, Fuzhou, Fujian, Peoples R China; [Wang, Lingxia; Liu, Xiao; Liang, Meng; Chen, Yiyong; Lin, Yongxiang; Xing, Jianhong; Chen, Wei] Fujian Agr & Forestry Univ, Sch Life Sci, Fuzhou, Fujian, Peoples R China; [Tan, Fanglin; Huang, Li] Fujian Acad Forestry, Fuzhou, Fujian, Peoples R China; [Liang, Wenyu] Ningxia Univ, Sch Life Sci, Yinchuan, Ningxia, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Ningxia University	Chen, W (corresponding author), Fujian Agr & Forestry Univ, Minist Educ Genet Breeding & Multiple Utilizat Cr, Key Lab, Fuzhou, Fujian, Peoples R China.	weichen909@163.com	Xing, Jianhong/AAK-1568-2020; xing, jianhong/AAI-2254-2020	Xing, Jianhong/0000-0001-8220-8005; 	National Natural Science Grant of China [31070542]; Provincial Natural Science Grant of Fujian, China [2010J01067]	National Natural Science Grant of China(National Natural Science Foundation of China (NSFC)); Provincial Natural Science Grant of Fujian, China	This work was supported by the National Natural Science Grant of China (Award no. 31070542) and the Provincial Natural Science Grant of Fujian, China (Award no. 2010J01067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi FM, 2004, PROTEOMICS, V4, P2072, DOI 10.1002/pmic.200300741; Abogadallah GM, 2010, PLANT SIGNAL BEHAV, V5, P369, DOI 10.4161/psb.5.4.10873; Agarwal GK, 2002, PROTEOMICS, V2, P947, DOI 10.1002/1615-9861(200208)2:8<947::AID-PROT947>3.0.CO;2-J; AITKEN A, 1995, TRENDS BIOCHEM SCI, V20, P95, DOI 10.1016/S0968-0004(00)88971-9; Allakhverdiev SI, 1999, P NATL ACAD SCI USA, V96, P5862, DOI 10.1073/pnas.96.10.5862; Askari H, 2006, PROTEOMICS, V6, P2542, DOI 10.1002/pmic.200500328; Bandehagh A, 2011, PROTEOMICS, V11, P1965, DOI 10.1002/pmic.201000564; Batelli G, 2007, MOL CELL BIOL, V27, P7781, DOI 10.1128/MCB.00430-07; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAKMAK I, 1992, PLANT PHYSIOL, V98, P1222, DOI 10.1104/pp.98.4.1222; Camoni L, 1998, FEBS LETT, V430, P381, DOI 10.1016/S0014-5793(98)00696-6; Chen FG, 2011, J PROTEOME RES, V10, P3944, DOI 10.1021/pr200535r; CHUANG FS, 1973, MIKROCHIM ACTA, P523, DOI 10.1007/BF01217998; Dasgupta N, 2011, TREES-STRUCT FUNCT, V26, P377; Du CX, 2010, PHYTOCHEMISTRY, V71, P1450, DOI 10.1016/j.phytochem.2010.05.020; Eltayeb AE, 2006, PHYSIOL PLANTARUM, V127, P57, DOI 10.1111/j.1399-3054.2006.00624.x; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fatehi F, 2012, MOL BIOL REP, V39, P6387, DOI 10.1007/s11033-012-1460-z; Finnie C, 1999, PLANT MOL BIOL, V40, P545, DOI 10.1023/A:1006211014713; GOSSETT DR, 1994, CROP SCI, V34, P706, DOI 10.2135/cropsci1994.0011183X003400030020x; Gruber CW, 2006, TRENDS BIOCHEM SCI, V31, P455, DOI 10.1016/j.tibs.2006.06.001; Guo GF, 2012, J PROTEOMICS, V75, P1867, DOI 10.1016/j.jprot.2011.12.032; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hoper D, 2006, PROTEOMICS, V6, P1550, DOI 10.1002/pmic.200500197; Hotta M, 2000, PLANT CELL PHYSL S, V41, P79; Huang GJ, 2008, BOT STUD, V49, P1; Huang GY, 2012, TREES-STRUCT FUNCT, V26, P1537, DOI 10.1007/s00468-012-0727-2; Huang W, 2003, BIOL PLANTARUM, V47, P501, DOI 10.1023/B:BIOP.0000041053.39549.2a; HYLAND K, 1983, ANAL BIOCHEM, V135, P280, DOI 10.1016/0003-2697(83)90684-X; Jiang Y, 2007, J EXP BOT, V58, P3591, DOI 10.1093/jxb/erm207; Jithesh MN, 2006, PLANT CELL REP, V25, P865, DOI 10.1007/s00299-006-0127-4; Johnson S, 2001, TRENDS CELL BIOL, V11, P122, DOI 10.1016/S0962-8924(01)01926-2; Katz A, 2007, MOL CELL PROTEOMICS, V6, P1459, DOI 10.1074/mcp.M700002-MCP200; Kim DW, 2005, ELECTROPHORESIS, V26, P4521, DOI 10.1002/elps.200500334; Komatsu S, 2009, AMINO ACIDS, V36, P115, DOI 10.1007/s00726-008-0039-4; Kosova K, 2011, J PROTEOMICS, V74, P1301, DOI 10.1016/j.jprot.2011.02.006; Liang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036499; Liang WY, 2012, J PROTEOMICS, V75, P5604, DOI 10.1016/j.jprot.2012.07.041; Liu H, 2010, PLANTA, V231, P847, DOI 10.1007/s00425-009-1093-1; Ma HY, 2012, J PROTEOMICS, V75, P1529, DOI 10.1016/j.jprot.2011.11.026; Mandhania S, 2006, BIOL PLANTARUM, V50, P227, DOI 10.1007/s10535-006-0011-7; Maserti BE, 2011, J PLANT PHYSIOL, V168, P392, DOI 10.1016/j.jplph.2010.07.026; Mehta PA, 2005, THEOR APPL GENET, V110, P416, DOI 10.1007/s00122-004-1801-y; Meloni DA, 2003, ENVIRON EXP BOT, V49, P69, DOI 10.1016/S0098-8472(02)00058-8; Miyama M, 2008, PLANT MOL BIOL, V68, P119, DOI 10.1007/s11103-008-9356-y; Miyama M, 2006, PLANT SCI, V171, P234, DOI 10.1016/j.plantsci.2006.03.015; Munns R, 2006, J EXP BOT, V57, P1025, DOI 10.1093/jxb/erj100; Ndimba BK, 2005, PROTEOMICS, V5, P4185, DOI 10.1002/pmic.200401282; Palmgren MG, 1998, ADV BOT RES, V28, P1; Pang QY, 2010, J PROTEOME RES, V9, P2584, DOI 10.1021/pr100034f; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; Parida AK, 2004, TREES-STRUCT FUNCT, V18, P167, DOI 10.1007/s00468-003-0293-8; Parida AK, 2003, PHOTOSYNTHETICA, V41, P191, DOI 10.1023/B:PHOT.0000011951.37231.69; Parida AK, 2010, TREES-STRUCT FUNCT, V24, P199, DOI 10.1007/s00468-010-0417-x; PATTERSON BD, 1984, ANAL BIOCHEM, V139, P487, DOI 10.1016/0003-2697(84)90039-3; Persson S, 2003, PLANT PHYSIOL, V133, P1385, DOI 10.1104/pp.103.024943; Rasoulnia A, 2011, MOL BIOL REP, V38, P5055, DOI 10.1007/s11033-010-0651-8; Rospert S, 1996, EMBO J, V15, P764, DOI 10.1002/j.1460-2075.1996.tb00412.x; Santiago LS, 2000, INT J PLANT SCI, V161, P99, DOI 10.1086/314236; Saravanan RS, 2004, PROTEOMICS, V4, P2522, DOI 10.1002/pmic.200300789; Sarhadi E, 2012, PLANT PHYSIOL BIOCH, V58, P280, DOI 10.1016/j.plaphy.2012.07.013; Song Y, 2011, J PROTEOMICS, V74, P1045, DOI 10.1016/j.jprot.2011.03.009; Sugihara K, 2000, PLANT CELL PHYSIOL, V41, P1279, DOI 10.1093/pcp/pcd061; Swami AK, 2011, ENVIRON EXP BOT, V71, P321, DOI 10.1016/j.envexpbot.2010.12.017; Tada Y, 2009, PLANT CELL PHYSIOL, V50, P439, DOI 10.1093/pcp/pcp002; Takemura T, 2000, AQUAT BOT, V68, P15, DOI 10.1016/S0304-3770(00)00106-6; Tanaka Y, 2000, PLANT CELL PHYSL, V41, ps27; Tuteja N, 2007, METHOD ENZYMOL, V428, P419, DOI 10.1016/S0076-6879(07)28024-3; Wan XY, 2008, MOL CELL PROTEOMICS, V7, P1469, DOI 10.1074/mcp.M700488-MCP200; Wang A. G., 1990, PLANT PHYSL COMMUN, V6, P55, DOI DOI 10.1021/ja00874a010; Wang WF, 1996, J MOL EVOL, V43, P384; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Wang XC, 2013, MOL CELL PROTEOMICS, V12, P2174, DOI 10.1074/mcp.M112.022475; Wang XC, 2009, J PROTEOME RES, V8, P3331, DOI 10.1021/pr801083a; Weng ZX, 2013, TREES-STRUCT FUNCT, P1; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Wong YY, 2007, AQUAT BOT, V86, P117, DOI 10.1016/j.aquabot.2006.09.009; Yan SP, 2005, PROTEOMICS, V5, P235, DOI 10.1002/pmic.200400853; You XR, 2012, J PROTEOMICS, V75, P1099, DOI 10.1016/j.jprot.2011.10.023; Yu JJ, 2013, INT J MOL SCI, V14, P1740, DOI 10.3390/ijms14011740; Zhang JL, 2013, PHOTOSYNTH RES, V115, P1, DOI 10.1007/s11120-013-9813-6; Zhang Q, 2011, J PROTEOME RES, V10, P46, DOI 10.1021/pr101052y; Zhao Q, 2013, J PROTEOMICS, V82, P230, DOI 10.1016/j.jprot.2013.01.024; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0; Zhu Z, 2012, TREE PHYSIOL, V32, P1378, DOI 10.1093/treephys/tps097	85	54	61	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83141	10.1371/journal.pone.0083141	http://dx.doi.org/10.1371/journal.pone.0083141			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416157	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500030
J	Kawakami, T; He, J; Morita, H; Yokoyama, K; Kaji, H; Tanaka, C; Suemori, S; Tohyama, K; Tohyama, Y				Kawakami, Tatsumi; He, Jinsong; Morita, Hiroyuki; Yokoyama, Kunio; Kaji, Hiroaki; Tanaka, Chisato; Suemori, Shin-ichiro; Tohyama, Kaoru; Tohyama, Yumi			Rab27a Is Essential for the Formation of Neutrophil Extracellular Traps (NETs) in Neutrophil-Like Differentiated HL60 Cells	PLOS ONE			English	Article							NETTING NEUTROPHILS; MYELOPEROXIDASE; EXOCYTOSIS; MATURATION; IMMUNITY	Neutrophils play a crucial role in host defence. In response to a variety of inflammatory stimulation, they form neutrophil extracellular traps (NETs). NETs are extracellular structures composed of chromatin fibers decorated with antimicrobial proteins and developing studies indicate that NETs contribute to extracellular microbial killing. While the intracellular signaling pathways that regulate NET formation remain largely unknown, there is growing evidence that generation of reactive oxygen species (ROS) is a key event for NET formation. The Rab family small GTPase Rab27a is an important component of the secretory machinery of azurophilic granules in neutrophils. However, the precise mechanism of NET formation and whether or not Rab27a contributes to this process are unknown. Using neutrophil-like differentiated HL60 cells, we show here that Rab27a plays an essential role in both phorbol myristate acetate (PMA)- and Candida albicans-induced NET formation by regulating ROS production. Rab27a-knockdown inhibited ROS-positive phagosome formation during complement-mediated phagocytosis. To investigate the role of Rab27a in neutrophil function in detail, both primary human neutrophils and neutrophil-like differentiated HL60 cells were treated with PMA, and NET formation process was assessed by measurement of release of histone H3 into the medium, citrullination of the arginine in position 3 of histone H4 and chase of the nuclear change of the living cells in the co-existence of both cell-permeable and -impermeable nuclear indicators. PMA-induced NET formation occured sequentially in both neutrophil-like differentiated HL60 cells and primary neutrophils, and Rab27a-knockdown clearly inhibited NET formation in association with reduced ROS production. We also found that serum-treated Candida albicans triggers NET formation in a ROS-dependent manner, and that Rab27a-knockdown inhibits this process as well. Our findings demonstrate that Rab27a plays an important role in NET formation induced by both Candida albicans infection and PMA treatment by regulating ROS production.	[Kawakami, Tatsumi; He, Jinsong; Morita, Hiroyuki; Yokoyama, Kunio; Kaji, Hiroaki; Tanaka, Chisato; Tohyama, Yumi] Himeji Dokkyo Univ, Fac Pharmaceut Sci, Div Biochem, Himeji, Hyogo, Japan; [Yokoyama, Kunio] Kobe Univ, Grad Sch Med, Div Gastroenterol Surg, Kobe, Hyogo 657, Japan; [Suemori, Shin-ichiro; Tohyama, Kaoru] Kawasaki Med Sch, Dept Lab Med, Kurashiki, Okayama, Japan	Himeji Dokkyo University; Kobe University; Kawasaki Medical School	Tohyama, Y (corresponding author), Himeji Dokkyo Univ, Fac Pharmaceut Sci, Div Biochem, Himeji, Hyogo, Japan.	ytohyama@himeji-du.ac.jp			KAKENHI; Japan Society for the Promotion of Sciences; Grants-in-Aid for Scientific Research [23590374] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by KAKENHI; a Grant-in-Aid for Scientific Research (C) from Japan Society for the Promotion of Sciences (to Y.T. and K. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abdallah DSA, 2012, INFECT IMMUN, V80, P768, DOI 10.1128/IAI.05730-11; Akong-Moore K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042984; Berkowitz JKM, 2001, J BIOL CHEM, V276, P18855, DOI 10.1074/jbc.M011167200; Bianchi M, 2009, BLOOD, V114, P2619, DOI 10.1182/blood-2009-05-221606; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2012, J CELL BIOL, V198, P773, DOI 10.1083/jcb.201203170; Catz SD, 2013, J LEUKOCYTE BIOL, V94, P613, DOI 10.1189/jlb.1112600; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Hakkim A, 2011, NAT CHEM BIOL, V7, P75, DOI 10.1038/NCHEMBIO.496; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Jancic C, 2007, NAT CELL BIOL, V9, P367, DOI 10.1038/ncb1552; Jerke U, 2013, J BIOL CHEM, V288, P12910, DOI 10.1074/jbc.M112.434613; Johnson JL, 2010, TRAFFIC, V11, P533, DOI 10.1111/j.1600-0854.2009.01029.x; Kahlenberg JM, 2013, J IMMUNOL, V190, P1217, DOI 10.4049/jimmunol.1202388; Kaplan MJ, 2012, J IMMUNOL, V189, P2689, DOI 10.4049/jimmunol.1201719; Keshari RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048111; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Kurihara R, 2006, J BIOL CHEM, V281, P12908, DOI 10.1074/jbc.M510871200; Kuroda TS, 2004, NAT CELL BIOL, V6, P1195, DOI 10.1038/ncb1197; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; McInturff AM, 2012, BLOOD, V120, P3118, DOI 10.1182/blood-2012-01-405993; Menager MM, 2007, NAT IMMUNOL, V8, P257, DOI 10.1038/ni1431; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; Metzler KD, 2011, BLOOD, V117, P953, DOI 10.1182/blood-2010-06-290171; Monfregola J, 2012, J BIOL CHEM, V287, P44603, DOI 10.1074/jbc.M112.414029; Munafo DB, 2007, BIOCHEM J, V402, P229, DOI 10.1042/BJ20060950; Munafo DB, 2009, J INNATE IMMUN, V1, P527, DOI 10.1159/000235860; Nordenfelt P, 2011, J LEUKOCYTE BIOL, V90, P271, DOI 10.1189/jlb.0810457; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Pang L, 2013, J IMMUNOL, V190, P6488, DOI 10.4049/jimmunol.1203215; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Pilsczek FH, 2010, J IMMUNOL, V185, P7413, DOI 10.4049/jimmunol.1000675; Saitoh T, 2012, CELL HOST MICROBE, V12, P109, DOI 10.1016/j.chom.2012.05.015; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; Shi YH, 2006, BLOOD, V107, P4554, DOI 10.1182/blood-2005-09-3616; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x; Villanueva E, 2011, J IMMUNOL, V187, P538, DOI 10.4049/jimmunol.1100450; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; Yokoyama K, 2011, J BIOL CHEM, V286, P5375, DOI 10.1074/jbc.M110.171702	40	28	31	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84704	10.1371/journal.pone.0084704	http://dx.doi.org/10.1371/journal.pone.0084704			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404184	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460800063
J	Nagao, T; Kurosu, T; Umezawa, Y; Nogami, A; Oshikawa, G; Tohda, S; Yamamoto, M; Miura, O				Nagao, Toshikage; Kurosu, Tetsuya; Umezawa, Yoshihiro; Nogami, Ayako; Oshikawa, Gaku; Tohda, Shuji; Yamamoto, Masahide; Miura, Osamu			Proliferation and Survival Signaling from Both Jak2-V617F and Lyn Involving GSK3 and mTOR/p70S6K/4EBP1 in PVTL-1 Cell Line Newly Established from Acute Myeloid Leukemia Transformed from Polycythemia Vera	PLOS ONE			English	Article							TYROSINE KINASE JAK2; ESSENTIAL THROMBOCYTHEMIA; ERYTHROPOIETIN RECEPTOR; THERAPEUTIC TARGET; MUTATION; ACTIVATION; RESISTANT; APOPTOSIS; BCR/ABL; STAT5	The gain of function mutation JAK2-V617F is very frequently found in myeloproliferative neoplasms (MPNs) and is strongly implicated in pathogenesis of these and other hematological malignancies. Here we report establishment of a new leukemia cell line, PVTL-1, homozygous for JAK2-V617F from a 73-year-old female patient with acute myeloid leukemia (AML) transformed from MPN. PVTL-1 is positive for CD7, CD13, CD33, CD34, CD117, HLA-DR, and MPO, and has complex karyotypic abnormalities, 44, XX,-5q,-7,-8, add(11)(p11.2), add(11)(q23), 216,+ 21,222,+ mar1. Sequence analysis of JAK2 revealed only the mutated allele coding for Jak2-V617F. Proliferation of PVTL-1 was inhibited and apoptosis was induced by the pan-Jak inhibitor Jak inhibitor-1 (JakI-1) or dasatinib, which inhibits the Src family kinases as well as BCR/ABL. Consistently, the Src family kinase Lyn was constitutively activated with phosphorylation of Y396 in the activation loop, which was inhibited by dasatinib but not by JakI-1. Further analyses with JakI-1 and dasatinib indicated that Jak2-V617F phosphorylated STAT5 and SHP2 while Lyn phosphorylated SHP1, SHP2, Gab-2, c-Cbl, and CrkL to induce the SHP2/Gab2 and c-Cbl/CrkL complex formation. In addition, JakI-1 and dasatinib inactivated the mTOR/p70S6K/4EBP1 pathway and reduced the inhibitory phosphorylation of GSK3 in PVTL-1 cells, which correlated with their effects on proliferation and survival of these cells. Furthermore, inhibition of GSK3 by its inhibitor SB216763 mitigated apoptosis induced by dasatinib but not by JakI-1. Together, these data suggest that apoptosis may be suppressed in PVTL-1 cells through inactivation of GSK3 by Lyn as well as Jak2-V617F and additionally through activation of STAT5 by Jak2-V617F. It is also speculated that activation of the mTOR/p70S6K/4EBP1 pathway may mediate proliferation signaling from Jak2-V617F and Lyn. PVTL-1 cells may provide a valuable model system to elucidate the molecular mechanisms involved in evolution of Jak2-V617F-expressing MPN to AML and to develop novel therapies against this intractable condition.	[Nagao, Toshikage; Kurosu, Tetsuya; Umezawa, Yoshihiro; Nogami, Ayako; Oshikawa, Gaku; Yamamoto, Masahide; Miura, Osamu] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Hematol, Tokyo, Japan; [Tohda, Shuji] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Lab Med, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Miura, O (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Hematol, Tokyo, Japan.	miura.hema@tmd.ac.jp		Miura, Osamu/0000-0002-0981-3054; Umezawa, Yoshihiro/0000-0003-1027-1552; Yamamoto, Masahide/0000-0002-3142-8806	Ministry of Education, Culture, Sports, Science and Technology of Japan [21591194, 24591384, 22591030, 24790966]; Grants-in-Aid for Scientific Research [24790966] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from Ministry of Education, Culture, Sports, Science and Technology of Japan (grant numbers 21591194, 24591384, 22591030, and 24790966). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Arai A, 2001, J BIOL CHEM, V276, P33282, DOI 10.1074/jbc.M102924200; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bogani C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054826; Chapuis N, 2010, LEUKEMIA, V24, P1686, DOI 10.1038/leu.2010.170; Chiara F, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00016; Chin H, 1997, BLOOD, V89, P4327, DOI 10.1182/blood.V89.12.4327; Chin H, 1998, BLOOD, V91, P3734; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Contri A, 2005, J CLIN INVEST, V115, P369, DOI 10.1172/JC1200522094; Dos Santos C, 2008, BLOOD, V111, P2269, DOI 10.1182/blood-2007-04-082099; Ihle JN, 2007, CURR OPIN GENET DEV, V17, P8, DOI 10.1016/j.gde.2006.12.009; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; Ingley E, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-21; Klucher KM, 1998, BLOOD, V91, P3927, DOI 10.1182/blood.V91.10.3927.3927_3927_3934; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kurosu T, 2009, CANCER RES, V69, P3927, DOI 10.1158/0008-5472.CAN-08-2978; LaFave LM, 2012, TRENDS PHARMACOL SCI, V33, P574, DOI 10.1016/j.tips.2012.08.005; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; MIURA O, 1994, J BIOL CHEM, V269, P614; Nagao T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027397; Okamoto M, 2007, LEUKEMIA, V21, P403, DOI 10.1038/sj.leu.2404547; Quentmeier H, 2006, LEUKEMIA, V20, P471, DOI 10.1038/sj.leu.2404081; Quintas-Cardama A, 2013, LEUKEMIA RES, V37, P465, DOI 10.1016/j.leukres.2012.12.006; Samanta AK, 2009, ONCOGENE, V28, P1669, DOI 10.1038/onc.2009.7; Shami PJ, 2012, LEUKEMIA, V26, P214, DOI 10.1038/leu.2011.217; Takeda Y, 2011, BRIT J HAEMATOL, V153, P589, DOI 10.1111/j.1365-2141.2011.08663.x; Tamburini J, 2009, BLOOD, V114, P1618, DOI 10.1182/blood-2008-10-184515; Tefferi A, 2012, AM J HEMATOL, V87, P285, DOI 10.1002/ajh.23135; Theocharides A, 2007, BLOOD, V110, P375, DOI 10.1182/blood-2006-12-062125; Wu J, 2008, J NATL CANCER I, V100, P926, DOI 10.1093/jnci/djn188; Wu N, 2013, INT J ONCOL, V42, P419, DOI 10.3892/ijo.2012.1729	31	21	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84746	10.1371/journal.pone.0084746	http://dx.doi.org/10.1371/journal.pone.0084746			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404189	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460800068
J	Yan, X; Lin, JT; Talabattula, VAN; Mussmann, C; Yang, F; Wree, A; Rolfs, A; Luo, JK				Yan, Xin; Lin, Juntang; Talabattula, Venkata Ajay Narendra; Mussmann, Carolin; Yang, Fan; Wree, Andreas; Rolfs, Arndt; Luo, Jiankai			ADAM10 Negatively Regulates Neuronal Differentiation during Spinal Cord Development	PLOS ONE			English	Article							NERVOUS-SYSTEM DEVELOPMENT; NEURAL PROGENITOR CELLS; SONIC HEDGEHOG; MOTOR-NEURONS; N-CADHERIN; NOTCH; EXPRESSION; NEUROGENESIS; CLEAVAGE; FAMILY	Members of the ADAM (a disintegrin and metalloprotease) family are involved in embryogenesis and tissue formation via their proteolytic function, cell-cell and cell-matrix interactions. ADAM10 is expressed temporally and spatially in the developing chicken spinal cord, but its function remains elusive. In the present study, we address this question by electroporating ADAM10 specific morpholino antisense oligonucleotides (ADAM10-mo) or dominant-negative ADAM10 (dn-ADAM10) plasmid into the developing chicken spinal cord as well as by in vitro cell culture investigation. Our results show that downregulation of ADAM10 drives precocious differentiation of neural progenitor cells and radial glial cells, resulting in an increase of neurons in the developing spinal cord, even in the prospective ventricular zone. Remarkably, overexpression of the dn-ADAM10 plasmid mutated in the metalloprotease domain (dn-ADAM10-me) mimics the phenotype as found by the ADAM10-mo transfection. Furthermore, in vitro experiments on cultured cells demonstrate that downregulation of ADAM10 decreases the amount of the cleaved intracellular part of Notch1 receptor and its target, and increases the number of beta III-tubulin-positive cells during neural progenitor cell differentiation. Taken together, our data suggest that ADAM10 negatively regulates neuronal differentiation, possibly via its proteolytic effect on the Notch signaling during development of the spinal cord.	[Yan, Xin; Talabattula, Venkata Ajay Narendra; Mussmann, Carolin; Yang, Fan; Rolfs, Arndt; Luo, Jiankai] Univ Rostock, Sch Med, Albrecht Kossel Inst Neuroregenerat, D-18055 Rostock, Germany; [Lin, Juntang] Xinxiang Med Univ, Key Lab Med Tissue Regenerat Henan Prov, Xinxiang, Peoples R China; [Lin, Juntang] Univ Jena, Sch Med, Inst Anat 1, Jena, Germany; [Wree, Andreas] Univ Rostock, Sch Med, Inst Anat, D-18055 Rostock, Germany	University of Rostock; Xinxiang Medical University; Friedrich Schiller University of Jena; University of Rostock	Luo, JK (corresponding author), Univ Rostock, Sch Med, Albrecht Kossel Inst Neuroregenerat, D-18055 Rostock, Germany.	jiankai.luo@uni-rostock.de	Yan, Xin/AAF-9039-2019	Yan, Xin/0000-0002-9135-7915	German Research Foundation [DFG LU 1455/1-1]	German Research Foundation(German Research Foundation (DFG))	This work was supported by a grant from the German Research Foundation (DFG LU 1455/1-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfandari D, 2009, SEMIN CELL DEV BIOL, V20, P153, DOI 10.1016/j.semcdb.2008.09.006; Appel B, 2001, BMC Dev Biol, V1, P13, DOI 10.1186/1471-213X-1-13; Bai G, 2007, DEV CELL, V13, P283, DOI 10.1016/j.devcel.2007.05.014; Briscoe J, 2008, PHILOS T R SOC B, V363, P57, DOI 10.1098/rstb.2006.2012; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Cayuso J, 2006, DEVELOPMENT, V133, P517, DOI 10.1242/dev.02228; Chen YYY, 2007, J NEUROSCI, V27, P8448, DOI 10.1523/JNEUROSCI.1841-07.2007; Christian LM, 2012, FLY, V6, P30, DOI 10.4161/fly.18823; COFFMAN CR, 1993, CELL, V73, P659, DOI 10.1016/0092-8674(93)90247-N; Del Barrio MG, 2007, DEVELOPMENT, V134, P3427, DOI 10.1242/dev.005868; Donato R, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-36; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Fior R, 2005, DEV BIOL, V281, P318, DOI 10.1016/j.ydbio.2005.03.017; Giese AK, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-94; Hall RJ, 2003, DEV BIOL, V256, P146, DOI 10.1016/S0012-1606(02)00133-1; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hatakeyama J, 2006, DEV NEUROSCI-BASEL, V28, P92, DOI 10.1159/000090756; Hubner R, 2010, BIOCHEM BIOPH RES CO, V400, P358, DOI 10.1016/j.bbrc.2010.08.066; Jarriault S, 2005, DEV BIOL, V287, P1, DOI 10.1016/j.ydbio.2005.08.014; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; Kageyama R, 1997, CURR OPIN GENET DEV, V7, P659, DOI 10.1016/S0959-437X(97)80014-7; Kaltezioti V, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000565; Kimura J, 2004, DEV GROWTH DIFFER, V46, P219; Kos R, 2003, DEV DYNAM, V226, P470, DOI 10.1002/dvdy.10254; Kubo F, 2009, DEVELOPMENT, V136, P1823, DOI 10.1242/dev.029272; Kuhn TB, 2003, METHOD CELL BIOL, V71, P67, DOI 10.1016/S0091-679X(03)01005-7; Lieber T, 2002, GENE DEV, V16, P209, DOI 10.1101/gad.942302; Lin J, 2008, NEUROSCIENCE, V157, P360, DOI 10.1016/j.neuroscience.2008.08.053; Lin JT, 2010, DEV DYNAM, V239, P1246, DOI 10.1002/dvdy.22272; Liu AM, 2005, NAT REV NEUROSCI, V6, P945, DOI 10.1038/nrn1805; Luo J, 2006, NEUROSCIENCE, V142, P1133, DOI 10.1016/j.neuroscience.2006.07.038; Luo J, 2007, DEV DYNAM, V236, P2331, DOI 10.1002/dvdy.21248; Luo JK, 2009, NEUROREPORT, V20, P365, DOI 10.1097/WNR.0b013e3283243fe4; Luo JK, 2005, DEV DYNAM, V233, P1470, DOI 10.1002/dvdy.20454; Malinverno M, 2010, J NEUROSCI, V30, P16343, DOI 10.1523/JNEUROSCI.1984-10.2010; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Marigo V, 1996, DEV BIOL, V180, P273, DOI 10.1006/dbio.1996.0300; Murthy A, 2012, IMMUNITY, V36, P105, DOI 10.1016/j.immuni.2012.01.005; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; Peng CY, 2007, NEURON, V53, P813, DOI 10.1016/j.neuron.2007.02.019; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Schweitzer R, 2000, MECH DEVELOP, V98, P171, DOI 10.1016/S0925-4773(00)00458-5; Skaggs K, 2011, DEVELOPMENT, V138, P3199, DOI 10.1242/dev.057281; Ulloa F, 2007, CELL CYCLE, V6, P2640, DOI 10.4161/cc.6.21.4822; van Tetering G, 2009, J BIOL CHEM, V284, P31018, DOI 10.1074/jbc.M109.006775; Varnum-Finney B, 2008, BLOOD, V111, P2615, DOI 10.1182/blood-2007-03-079855; Yan X, 2011, DEV GROWTH DIFFER, V53, P726, DOI 10.1111/j.1440-169X.2011.01282.x; Yan X, 2011, DEV GROWTH DIFFER, V53, P333, DOI 10.1111/j.1440-169X.2010.01238.x; Yang P, 2006, PROG NEUROBIOL, V79, P73, DOI 10.1016/j.pneurobio.2006.05.001; Yang XD, 2006, DEV NEUROSCI-BASEL, V28, P102, DOI 10.1159/000090757; Yavari R, 1998, HUM MOL GENET, V7, P1161, DOI 10.1093/hmg/7.7.1161; Zolkiewska A, 2008, CELL MOL LIFE SCI, V65, P2056, DOI 10.1007/s00018-008-7586-4	55	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84617	10.1371/journal.pone.0084617	http://dx.doi.org/10.1371/journal.pone.0084617			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404179	Green Submitted, gold, Green Published			2022-12-27	WOS:000329460800058
J	Zhang, NN; Liu, YT; Ma, L; Wang, L; Hao, XZ; Yuan, Z; Lin, DM; Li, D; Zhou, YJ; Lin, H; Han, XH; Sun, Y; Shi, YK				Zhang, Ning-Ning; Liu, Yu-Tao; Ma, Li; Wang, Lin; Hao, Xue-Zhi; Yuan, Zheng; Lin, Dong-Mei; Li, Dan; Zhou, Yu-Jie; Lin, Hua; Han, Xiao-Hong; Sun, Yan; Shi, Yuankai			The Molecular Detection and Clinical Significance of ALK Rearrangement in Selected Advanced Non-Small Cell Lung Cancer: ALK Expression Provides Insights into ALK Targeted Therapy	PLOS ONE			English	Article							EML4-ALK FUSION GENE; INTERNATIONAL-ASSOCIATION; TYROSINE KINASE; EGFR MUTATION; ADENOCARCINOMA; CRIZOTINIB; SURVIVAL; INHIBITOR; CLASSIFICATION; FEATURES	Background: This study aimed to elucidate clinical significance of anaplastic lymphoma kinase (ALK) rearrangement in selected advanced non-small cell lung cancer (NSCLC), to compare the application of different ALK detection methods, and especially evaluate a possible association between ALK expression and clinical outcomes in crizotinib-treated patients. Methods: ALK status was assessed by fluorescent in situ hybridization (FISH), immunohistochemistry (IHC) and quantitative RT-PCR (qRT-PCR) in 173 selected advanced NSCLC patients. Clinicopathologic data, genotype status and survival outcomes were analyzed. Moreover, the association of ALK expression with clinical outcomes was evaluated in ALK FISH-positive crizotinib-treated patients including two patients with concurrent epidermal growth factor receptor (EGFR) mutation. Results: The positivity detection rate of ALK rearrangement by FISH, IHC and qRT-PCR was 35.5% (59/166), 35.7% (61/171), and 27.9% (34/122), respectively. ALK rearrangement was observed predominantly in young patients, never or light smokers, and adenocarcinomas, especially with signet ring cell features and poor differentiation. Median progression-free survival (PFS) of crizotinib-treated patients was 7.6 months. The overall survival (OS) of these patients was longer compared with that of crizotinib-naive or wild-type cohorts, but there was no significant difference in OS compared with patients with EGFR mutation. ALK expression did not associate with PFS; but, when ALK expression was analyzed as a dichotomous variable, moderate and strong ALK expression had a decreased risk of death (P = 0.026). The two patients with concomitant EGFR and ALK alterations showed difference in ALK expression, response to EGFR and ALK inhibitors, and overall survival. Conclusions: Selective enrichment according to clinicopathologic features in NSCLC patients could highly improve the positivity detection rate of ALK rearrangement for ALK-targeted therapy. IHC could provide more clues for clinical trial design and therapeutic strategies for ALK-positive NSCLC patients including patients with double genetic aberration of ALK and EGFR.	[Zhang, Ning-Ning; Liu, Yu-Tao; Ma, Li; Wang, Lin; Hao, Xue-Zhi; Li, Dan; Zhou, Yu-Jie; Han, Xiao-Hong; Sun, Yan; Shi, Yuankai] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Med Oncol, Beijing 100730, Peoples R China; [Zhang, Ning-Ning; Liu, Yu-Tao; Ma, Li; Wang, Lin; Hao, Xue-Zhi; Yuan, Zheng; Lin, Dong-Mei; Li, Dan; Zhou, Yu-Jie; Lin, Hua; Han, Xiao-Hong; Sun, Yan; Shi, Yuankai] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhang, Ning-Ning; Liu, Yu-Tao; Ma, Li; Wang, Lin; Hao, Xue-Zhi; Li, Dan; Zhou, Yu-Jie; Han, Xiao-Hong; Sun, Yan; Shi, Yuankai] Beijing Key Lab Clin Study Anticanc Mol Targeted, Beijing, Peoples R China; [Yuan, Zheng; Lin, Dong-Mei] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Pathol, Beijing 100730, Peoples R China; [Lin, Hua] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Med Record, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS	Shi, YK (corresponding author), Chinese Acad Med Sci, Canc Inst & Hosp, Dept Med Oncol, Beijing 100730, Peoples R China.	syuankaipumc@126.com	Zhou, Yu/HHN-3071-2022; han, xiao/HDN-9782-2022		Research Special Fund for Public Welfare Industry of Health [200902002-1]; National Science and Technology Major Project [2008ZX09312, 2012ZX09303012]; National High Technology Research and Development Program of China [2011AA02A110]; Beijing Municipal Science and Technology Commission [Z121107005112005, Z121102009212055]; Special Funds for Central Health Authority [B2009B124]; Cancer Institute and Hospital of Chinese Academy of Medical Sciences [LC2012A18]	Research Special Fund for Public Welfare Industry of Health; National Science and Technology Major Project; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); Special Funds for Central Health Authority; Cancer Institute and Hospital of Chinese Academy of Medical Sciences	Funding: This study was supported in part by grants from the Research Special Fund for Public Welfare Industry of Health (200902002-1), National Science and Technology Major Project (2008ZX09312, 2012ZX09303012), National High Technology Research and Development Program of China (2011AA02A110), Beijing Municipal Science and Technology Commission (Z121107005112005, Z121102009212055), Special Funds for Central Health Authority (B2009B124) and Major Research Program of Cancer Institute and Hospital of Chinese Academy of Medical Sciences (LC2012A18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beasley MB, 2005, SEMIN ROENTGENOL, V40, P90, DOI 10.1053/j.ro.2005.01.001; Camidge DR, 2011, J THORAC ONCOL, V6, P774, DOI 10.1097/JTO.0b013e31820cf053; Camidge DR, 2010, CLIN CANCER RES, V16, P5581, DOI 10.1158/1078-0432.CCR-10-0851; Gandhi L, 2012, CLIN CANCER RES, V18, P3737, DOI 10.1158/1078-0432.CCR-11-2393; Kim H, 2011, J THORAC ONCOL, V6, P1359, DOI 10.1097/JTO.0b013e31821cfc73; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Kuo YW, 2010, J THORAC ONCOL, V5, P2039, DOI 10.1097/JTO.0b013e3181f43274; Lee CK, 2013, JNCI-J NATL CANCER I, V105, P595, DOI 10.1093/jnci/djt072; Lee JO, 2011, J THORAC ONCOL, V6, P1474, DOI 10.1097/JTO.0b013e3182208fc2; Lee JK, 2012, CANCER-AM CANCER SOC, V118, P3579, DOI 10.1002/cncr.26668; Lindeman NI, 2013, J THORAC ONCOL, V8, P823, DOI 10.1097/JTO.0b013e318290868f; Marchetti A, 2013, J THORAC ONCOL, V8, P352, DOI 10.1097/JTO.0b013e31827d5280; Martelli MP, 2009, AM J PATHOL, V174, P661, DOI 10.2353/ajpath.2009.080755; McLeer-Florin A, 2012, J THORAC ONCOL, V7, P348, DOI 10.1097/JTO.0b013e3182381535; Miyanaga A, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-262; Orenstein JM, 2011, NEW ENGL J MED, V364, P777, DOI 10.1056/NEJMc1013325; Ou SHI, 2012, ONCOLOGIST, V17, P1351, DOI 10.1634/theoncologist.2012-0311; Park HS, 2012, LUNG CANCER, V77, P288, DOI 10.1016/j.lungcan.2012.03.004; Popat S, 2011, J THORAC ONCOL, V6, P1962, DOI 10.1097/JTO.0b013e31822eec5e; Ren SX, 2012, CANCER-AM CANCER SOC, V118, P5588, DOI 10.1002/cncr.27603; Rodig SJ, 2009, CLIN CANCER RES, V15, P5216, DOI 10.1158/1078-0432.CCR-09-0802; Seto T, 2013, LANCET ONCOL, V14, P590, DOI 10.1016/S1470-2045(13)70142-6; Shaw AT, 2011, LANCET ONCOL, V12, P1004, DOI 10.1016/S1470-2045(11)70232-7; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Sun JM, 2012, J THORAC ONCOL, V7, pE36, DOI 10.1097/JTO.0b013e318274694e; Takahashi T, 2010, ANN SURG ONCOL, V17, P889, DOI 10.1245/s10434-009-0808-7; Thunnissen E, 2012, VIRCHOWS ARCH, V461, P245, DOI 10.1007/s00428-012-1281-4; Tiseo M, 2011, LUNG CANCER, V71, P241, DOI 10.1016/j.lungcan.2010.11.014; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Wallander ML, 2012, ARCH PATHOL LAB MED, V136, P796, DOI 10.5858/arpa.2011-0321-OA; Wang ZJ, 2012, ONCOLOGY-BASEL, V83, P248, DOI 10.1159/000341381; Wong DWS, 2009, CANCER-AM CANCER SOC, V115, P1723, DOI 10.1002/cncr.24181; Wu SG, 2012, J THORAC ONCOL, V7, P98, DOI 10.1097/JTO.0b013e3182370e30; Yang P, 2012, J THORAC ONCOL, V7, P90, DOI 10.1097/JTO.0b013e31823c5c32; Yi ES, 2011, J THORAC ONCOL, V6, P459, DOI 10.1097/JTO.0b013e318209edb9; Zhang XC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-188	37	13	23	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84501	10.1371/journal.pone.0084501	http://dx.doi.org/10.1371/journal.pone.0084501			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404167	gold, Green Submitted, Green Published			2022-12-27	WOS:000329460800046
J	Escudero, M; Martin-Bravo, S; Mayrose, I; Fernandez-Mazuecos, M; Fiz-Palacios, O; Hipp, AL; Pimentel, M; Jimenez-Mejias, P; Valcarcel, V; Vargas, P; Luceno, M				Escudero, Marcial; Martin-Bravo, Santiago; Mayrose, Itay; Fernandez-Mazuecos, Mario; Fiz-Palacios, Omar; Hipp, Andrew L.; Pimentel, Manuel; Jimenez-Mejias, Pedro; Valcarcel, Virginia; Vargas, Pablo; Luceno, Modesto			Karyotypic Changes through Dysploidy Persist Longer over Evolutionary Time than Polyploid Changes	PLOS ONE			English	Article							CHROMOSOME-NUMBER; CAREX CYPERACEAE; SEQUENCE DATA; GENOME SIZE; PLANTS; ANGIOSPERMS; SUCCESS; PHYLOGENETICS; EXTINCTION; ANEUPLOIDY	Chromosome evolution has been demonstrated to have profound effects on diversification rates and speciation in angiosperms. While polyploidy has predated some major radiations in plants, it has also been related to decreased diversification rates. There has been comparatively little attention to the evolutionary role of gains and losses of single chromosomes, which may or not entail changes in the DNA content (then called aneuploidy or dysploidy, respectively). In this study we investigate the role of chromosome number transitions and of possible associated genome size changes in angiosperm evolution. We model the tempo and mode of chromosome number evolution and its possible correlation with patterns of cladogenesis in 15 angiosperm clades. Inferred polyploid transitions are distributed more frequently towards recent times than single chromosome gains and losses. This is likely because the latter events do not entail changes in DNA content and are probably due to fission or fusion events (dysploidy), as revealed by an analysis of the relationship between genome size and chromosome number. Our results support the general pattern that recently originated polyploids fail to persist, and suggest that dysploidy may have comparatively longer-term persistence than polyploidy. Changes in chromosome number associated with dysploidy were typically observed across the phylogenies based on a chi-square analysis, consistent with these changes being neutral with respect to diversification.	[Escudero, Marcial; Martin-Bravo, Santiago; Jimenez-Mejias, Pedro; Luceno, Modesto] Pablo de Olavide Univ, Seville, Spain; [Escudero, Marcial; Hipp, Andrew L.] Morton Arboretum, Herbarium, Lisle, IL USA; [Escudero, Marcial; Hipp, Andrew L.] Field Museum, Chicago, IL USA; [Mayrose, Itay] Tel Aviv Univ, IL-69978 Tel Aviv, Israel; [Fernandez-Mazuecos, Mario; Jimenez-Mejias, Pedro; Vargas, Pablo] Real Jardin Bot CSIC, Madrid, Spain; [Fiz-Palacios, Omar] Uppsala Univ, Uppsala, Sweden; [Pimentel, Manuel] Univ A Coruna, La Coruna, Spain; [Valcarcel, Virginia] Univ Autonoma Madrid, Madrid, Spain	Universidad Pablo de Olavide; Field Museum of Natural History (Chicago); Tel Aviv University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid; Uppsala University; Universidade da Coruna; Autonomous University of Madrid	Martin-Bravo, S (corresponding author), Pablo de Olavide Univ, Seville, Spain.	smarbra@upo.es	Lirio, Antonio Marcial Escudero/H-2099-2015; Valcárcel, Virginia/L-1795-2014; Luceño, Modesto/H-2753-2015; Fernández-Mazuecos, Mario/F-9699-2011; Martín-Bravo, Santiago/I-3554-2017; Jiménez-Mejías, Pedro/H-7274-2015	Lirio, Antonio Marcial Escudero/0000-0002-2541-5427; Valcárcel, Virginia/0000-0001-7509-5284; Luceño, Modesto/0000-0002-4321-2121; Fernández-Mazuecos, Mario/0000-0003-4027-6477; Martín-Bravo, Santiago/0000-0003-0626-0770; Jiménez-Mejías, Pedro/0000-0003-2815-4477; Pimentel, Manuel/0000-0003-4452-6584; Mayrose, Itay/0000-0002-8460-1502	Spanish Ministry of Economy and Competitivity [CGL2009-09972, CGL2012-38744]; MEC-Fulbright fellowship [FU2009-0946]; MEC Marie Curie (Project HoloChromEvol) fellowship	Spanish Ministry of Economy and Competitivity(Spanish Government); MEC-Fulbright fellowship(Spanish Government); MEC Marie Curie (Project HoloChromEvol) fellowship	This work was supported by the Spanish Ministry of Economy and Competitivity (Project CGL2009-09972 and CGL2012-38744) to M. Luceno (PI), S. Martin-Bravo, M. Escudero, and P. Jimenez-Mejias; by MEC-Fulbright (FU2009-0946); and Marie Curie (Project HoloChromEvol) fellowships to M. Escudero. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Brochmann C, 2004, BIOL J LINN SOC, V82, P521, DOI 10.1111/j.1095-8312.2004.00337.x; Chung KS, 2011, AM J BOT, V98, P122, DOI 10.3732/ajb.1000046; Church SA, 2003, MOL PHYLOGENET EVOL, V27, P223, DOI 10.1016/S1055-7903(02)00446-3; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; De Bodt S, 2005, TRENDS ECOL EVOL, V20, P591, DOI 10.1016/j.tree.2005.07.008; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fawcett J.A., 2010, TRENDS ECOL EVOL, V2, P13, DOI DOI 10.4081/EB.2010.E3; Fawcett JA, 2009, P NATL ACAD SCI USA, V106, P5737, DOI 10.1073/pnas.0900906106; Givnish TJ, 1999, MOL PHYLOGENET EVOL, V12, P360, DOI 10.1006/mpev.1999.0601; Grant V., 1981, PLANT SPECIATION; Guerra M, 2008, CYTOGENET GENOME RES, V120, P339, DOI 10.1159/000121083; Hegarty M, 2007, CURR BIOL, V17, pR927, DOI 10.1016/j.cub.2007.08.060; Hegarty MJ, 2008, CURR BIOL, V18, pR435, DOI 10.1016/j.cub.2008.03.043; Hipp AL, 2009, BOT REV, V75, P96, DOI 10.1007/s12229-008-9022-8; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; LEE KH, 1993, EUPHYTICA, V72, P15; Leitch IJ, 2004, BIOL J LINN SOC, V82, P651, DOI 10.1111/j.1095-8312.2004.00349.x; LEVIN DA, 1983, AM NAT, V122, P1, DOI 10.1086/284115; Lipnerova I, 2013, ANN BOT-LONDON, V111, P79, DOI 10.1093/aob/mcs239; Mayrose I, 2011, SCIENCE, V333, P1257, DOI 10.1126/science.1207205; Mayrose I, 2010, SYST BIOL, V59, P132, DOI 10.1093/sysbio/syp083; Otto SP, 2007, CELL, V131, P452, DOI 10.1016/j.cell.2007.10.022; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; R Development Core Team, 2012, R LANG ENV STAT COMP; RAY PM, 1957, AM J BOT, V44, P529, DOI 10.2307/2438922; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Schubert I, 2011, TRENDS GENET, V27, P207, DOI 10.1016/j.tig.2011.03.004; Soltis DE, 2001, AM J BOT, V88, P883, DOI 10.2307/2657040; Soltis DE, 2009, P NATL ACAD SCI USA, V106, P5455, DOI 10.1073/pnas.0901994106; Soltis DE, 2009, AM J BOT, V96, P336, DOI 10.3732/ajb.0800079; Soltis PS, 2000, P NATL ACAD SCI USA, V97, P7051, DOI 10.1073/pnas.97.13.7051; SOLTIS PS, 1993, NEW ZEAL J BOT, V31, P203, DOI 10.1080/0028825X.1993.10419497; STEBBINS G. L., 1971, Chromosomal evolution in higher plants.; STEBBINS GL, 1984, BOT HELV, V94, P1; Van de Peer Y, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-113; Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600; VICKERY RK, 1995, GREAT BASIN NAT, V55, P174; Wagner W. H. Jun., 1970, Taxon, P146; Wood TE, 2009, P NATL ACAD SCI USA, V106, P13875, DOI 10.1073/pnas.0811575106	41	59	61	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85266	10.1371/journal.pone.0085266	http://dx.doi.org/10.1371/journal.pone.0085266			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416374	Green Published, gold, Green Submitted			2022-12-27	WOS:000329866300061
J	Liebal, K; Vaish, A; Haun, D; Tomasello, M				Liebal, Katja; Vaish, Amrisha; Haun, Daniel; Tomasello, Michael			Does Sympathy Motivate Prosocial Behaviour in Great Apes?	PLOS ONE			English	Article							CHIMPANZEES HELP; YOUNG-CHILDREN; FOOD; ALTRUISM; EMPATHY; HARASSMENT	Prosocial behaviours such as helping, comforting, or sharing are central to human social life. Because they emerge early in ontogeny, it has been proposed that humans are prosocial by nature and that from early on empathy and sympathy motivate such behaviours. The emerging question is whether humans share these abilities to feel with and for someone with our closest relatives, the great apes. Although several studies demonstrated that great apes help others, little is known about their underlying motivations. This study addresses this issue and investigates whether four species of great apes (Pongo pygmaeus, Gorilla gorilla, Pan troglodytes, Pan paniscus) help a conspecific more after observing the conspecific being harmed (a human experimenter steals the conspecific's food) compared to a condition where no harming occurred. Results showed that in regard to the occurrence of prosocial behaviours, only orangutans, but not the African great apes, help others when help is needed, contrasting prior findings on chimpanzees. However, with the exception of one population of orangutans that helped significantly more after a conspecific was harmed than when no harm occurred, prosocial behaviour in great apes was not motivated by concern for others.	[Liebal, Katja] Free Univ Berlin, Excellence Cluster Languages Emot, Dept Educ & Psychol, Berlin, Germany; [Liebal, Katja] Univ Portsmouth, Dept Psychol, Portsmouth, Hants, England; [Liebal, Katja; Vaish, Amrisha; Haun, Daniel; Tomasello, Michael] Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Leipzig, Germany	Free University of Berlin; University of Portsmouth; Max Planck Society	Liebal, K (corresponding author), Free Univ Berlin, Excellence Cluster Languages Emot, Dept Educ & Psychol, Berlin, Germany.	katja.liebal@fu-berlin.de	Liebal, Katja/AAQ-7910-2020	Liebal, Katja/0000-0003-2447-8327	Volkswagen Foundation; Fritz Thyssen Foundation	Volkswagen Foundation(Volkswagen); Fritz Thyssen Foundation	DFG)/Excellence Cluster3Languages of Emotion2 (EXC 302). Amrisha Vaish was supported by a Dilthey Fellowship provided by the Volkswagen Foundation and the Fritz Thyssen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman D.G., 1991, PRACTICAL STATISTIC; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Bates D., 2010, LME4 LINEAR MIXED EF; Batson C. D., 1998, HDB SOCIAL PSYCHOL, V2, P282, DOI DOI 10.1002/0471264385.WEI0519; Batson CD., 1991, ALTRUISM QUESTION SO; Benenson JF, 2007, EVOL HUM BEHAV, V28, P168, DOI 10.1016/j.evolhumbehav.2006.10.003; Burkart JM, 2007, P NATL ACAD SCI USA, V104, P19762, DOI 10.1073/pnas.0710310104; Cronin KA, 2012, ANIM BEHAV, V84, P1085, DOI 10.1016/j.anbehav.2012.08.009; Dawkins Richard, 1976, SELFISH GENE; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; DEWAAL FBM, 1979, BEHAV ECOL SOCIOBIOL, V5, P55, DOI 10.1007/BF00302695; Dobson AJ., 2008, INTRO GEN LINEAR MOD, DOI 10.1201/9780367807849; Eisenberg N, 2006, HANDBOOK OF MORAL DEVELOPMENT, P517; EISENBERG N, 1987, PSYCHOL BULL, V101, P91, DOI 10.1037/0033-2909.101.1.91; Gilby IC, 2006, ANIM BEHAV, V71, P953, DOI 10.1016/j.anbehav.2005.09.009; Hare B, 2010, CURR BIOL, V20, pR230, DOI 10.1016/j.cub.2009.12.038; Hepach R, 2013, INFANCY, V18, P67, DOI 10.1111/j.1532-7078.2012.00130.x; Hobson JA, 2009, DEVELOPMENTAL SCI, V12, P249, DOI 10.1111/j.1467-7687.2008.00762.x; Hoffman M. L., 2001, EMPATHY MORAL DEV IM; Jensen K, 2006, P ROY SOC B-BIOL SCI, V273, P1013, DOI 10.1098/rspb.2005.3417; Koski SE, 2010, EUR J DEV PSYCHOL, V7, P38, DOI 10.1080/17405620902986991; Lakshminarayanan VR, 2008, CURR BIOL, V18, pR999, DOI 10.1016/j.cub.2008.08.057; Li YY, 2013, PSYCHOL SCI, V24, P1686, DOI 10.1177/0956797613479975; Liszkowski U, 2006, J COGN DEV, V7, P173, DOI 10.1207/s15327647jcd0702_2; Massen JJM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009734; Melis AP, 2011, P ROY SOC B-BIOL SCI, V278, P1405, DOI 10.1098/rspb.2010.1735; OCONNELL SM, 1995, PRIMATES, V36, P397, DOI 10.1007/BF02382862; Pele M, 2009, J COMP PSYCHOL, V123, P375, DOI 10.1037/a0017253; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; *R COR DEV TEAM, 2012, R LANG ENV STAT COMP; Rochat P, 2009, J CROSS CULT PSYCHOL, V40, P416, DOI 10.1177/0022022109332844; SAGI A, 1976, DEV PSYCHOL, V12, P175, DOI 10.1037/0012-1649.12.2.175; Silk JB, 2005, NATURE, V437, P1357, DOI 10.1038/nature04243; Silk JB., 2012, OXFORD HDB EVOLUTION, P115; Stevens JR, 2004, P ROY SOC B-BIOL SCI, V271, P451, DOI 10.1098/rspb.2003.2625; Tomasello M, 2009, WHY WE COOPERATE, P1; Vaish A, 2009, DEV PSYCHOL, V45, P534, DOI 10.1037/a0014322; Vonk J, 2008, ANIM BEHAV, V75, P1757, DOI 10.1016/j.anbehav.2007.09.036; Warneken F, 2006, CHILD DEV, V77, P640, DOI 10.1111/j.1467-8624.2006.00895.x; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448; Warneken F, 2007, PLOS BIOL, V5, P1414, DOI 10.1371/journal.pbio.0050184; Warneken F, 2013, COGNITION, V126, P101, DOI 10.1016/j.cognition.2012.09.011; Warneken F, 2009, TRENDS COGN SCI, V13, P397, DOI 10.1016/j.tics.2009.06.008; Warneken F, 2009, BRIT J PSYCHOL, V100, P455, DOI 10.1348/000712608X379061; Yamamoto S, 2012, SOC JUSTICE RES, V25, P233, DOI 10.1007/s11211-012-0160-0; Yamamoto S, 2012, P NATL ACAD SCI USA, V109, P3588, DOI 10.1073/pnas.1108517109; Yamamoto S, 2010, ANIM BEHAV, V79, P595, DOI 10.1016/j.anbehav.2009.11.034; Yamamoto S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007416; ZAHNWAXLER C, 1992, DEV PSYCHOL, V28, P126, DOI 10.1037/0012-1649.28.1.126	49	33	33	6	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84299	10.1371/journal.pone.0084299	http://dx.doi.org/10.1371/journal.pone.0084299			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416212	gold, Green Published, Green Submitted			2022-12-27	WOS:000329862500110
J	Meyer, CG; O'Malley, JM; Papastamatiou, YP; Dale, JJ; Hutchinson, MR; Anderson, JM; Royer, MA; Holland, KN				Meyer, Carl G.; O'Malley, Joseph M.; Papastamatiou, Yannis P.; Dale, Jonathan J.; Hutchinson, Melanie R.; Anderson, James M.; Royer, Mark A.; Holland, Kim N.			Growth and Maximum Size of Tiger Sharks (Galeocerdo cuvier) in Hawaii	PLOS ONE			English	Article							WESTERN NORTH-ATLANTIC; GULF-OF-MEXICO; INDIVIDUAL VARIABILITY; SOUTHWESTERN AUSTRALIA; CARCHARHINUS-OBSCURUS; REPRODUCTIVE-BIOLOGY; MOVEMENT PATTERNS; MARINE PREDATOR; DUSKY SHARKS; CATCH RATES	Tiger sharks (Galecerdo cuvier) are apex predators characterized by their broad diet, large size and rapid growth. Tiger shark maximum size is typically between 380 & 450 cm Total Length (TL), with a few individuals reaching 550 cm TL, but the maximum size of tiger sharks in Hawaii waters remains uncertain. A previous study suggested tiger sharks grow rather slowly in Hawaii compared to other regions, but this may have been an artifact of the method used to estimate growth (unvalidated vertebral ring counts) compounded by small sample size and narrow size range. Since 1993, the University of Hawaii has conducted a research program aimed at elucidating tiger shark biology, and to date 420 tiger sharks have been tagged and 50 recaptured. All recaptures were from Hawaii except a single shark recaptured off Isla Jacques Cousteau (24 degrees 13'17 '' N 109 degrees 52'14 '' W), in the southern Gulf of California (minimum distance between tag and recapture sites = approximately 5,000 km), after 366 days at liberty (DAL). We used these empirical mark-recapture data to estimate growth rates and maximum size for tiger sharks in Hawaii. We found that tiger sharks in Hawaii grow twice as fast as previously thought, on average reaching 340 cm TL by age 5, and attaining a maximum size of 403 cm TL. Our model indicates the fastest growing individuals attain 400 cm TL by age 5, and the largest reach a maximum size of 444 cm TL. The largest shark captured during our study was 464 cm TL but individuals >450 cm TL were extremely rare (0.005% of sharks captured). We conclude that tiger shark growth rates and maximum sizes in Hawaii are generally consistent with those in other regions, and hypothesize that a broad diet may help them to achieve this rapid growth by maximizing prey consumption rates.	[Meyer, Carl G.; Hutchinson, Melanie R.; Anderson, James M.; Royer, Mark A.; Holland, Kim N.] Univ Hawaii Manoa, Hawaii Inst Marine Biol, Honolulu, HI 96822 USA; [O'Malley, Joseph M.] Natl Marine Fisheries Serv, Pacific Isl Fisheries Sci Ctr, Honolulu, HI USA; [Papastamatiou, Yannis P.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Papastamatiou, Yannis P.] Univ St Andrews, Sch Biol, Scottish Oceans Inst, St Andrews, Fife, Scotland; [Dale, Jonathan J.] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA	University of Hawaii System; University of Hawaii Manoa; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; State University System of Florida; University of Florida; University of St Andrews; Stanford University	Meyer, CG (corresponding author), Univ Hawaii Manoa, Hawaii Inst Marine Biol, Honolulu, HI 96822 USA.	carlm@hawaii.edu	Holland, Kim/ABH-1490-2021	Anderson, James/0000-0002-4900-5916	National Oceanic and Atmospheric Administration (National Marine Sanctuaries Program); University of Hawaii Sea Grant; State of Hawaii (Department of Land and Natural Resources)	National Oceanic and Atmospheric Administration (National Marine Sanctuaries Program); University of Hawaii Sea Grant; State of Hawaii (Department of Land and Natural Resources)	The authors are grateful to National Oceanic and Atmospheric Administration (National Marine Sanctuaries Program), University of Hawaii Sea Grant and the State of Hawaii (Department of Land and Natural Resources) for providing funding to support a variety of shark research projects that collectively made this study possible. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso AS, 2012, J FISH BIOL, V81, P2080, DOI 10.1111/j.1095-8649.2012.03455.x; Bass AJ, 1975, OCEANOGR RES INT DUR, V38, P100; Beerkircher L.R., 2002, MAR FISH REV, V64, P40, DOI DOI 10.1037/0003-066x.59.1.29; BRANSTETTER S, 1987, FISH B-NOAA, V85, P269; BRANSTETTER S, 1981, CONTRIB MAR SCI, V24, P13; Branstetter S, 1981, CONTRIB MAR SCI, V24, P213; Cailliet GM, 2004, CRC MAR BIOL SER, P399; Carlson JK, 1999, COPEIA, P684; DeCrosta MA, 1984, P 2 S RES INV NW HAW, V2, P75; Ebert DA., 2013, FAO SPEC CAT FISH PU, V7, P523; Fitzpatrick R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051927; Fourmanoir P., 1961, Memoires de l'Institut Scientifique de Madagascar, V4F, P1; Francis MP, 1998, NEW ZEAL J MAR FRESH, V32, P427, DOI 10.1080/00288330.1998.9516835; Francis R.I.C.C., 1988, New Zealand Journal of Marine and Freshwater Research, V22, P42; FRANCIS RICC, 1988, CAN J FISH AQUAT SCI, V45, P936, DOI 10.1139/f88-115; GULLAND J. A., 1959, JOUR CONSEIL PERM INTERNATL EXPLOR MER, V25, P47; Hammerschlag N, 2012, FUNCT ECOL, V26, P567, DOI 10.1111/j.1365-2435.2012.01973.x; Heithaus MR, 2001, ENVIRON BIOL FISH, V61, P25, DOI 10.1023/A:1011021210685; Holland KN, 1999, MAR BIOL, V134, P665, DOI 10.1007/s002270050582; Holmes BJ, 2012, FISH RES, V129, P38, DOI 10.1016/j.fishres.2012.06.005; Hussey NE, 2009, MAR FRESHWATER RES, V60, P571, DOI 10.1071/MF08280; Kneebone J, 2008, MAR BIOL, V154, P423, DOI 10.1007/s00227-008-0934-y; Kohler NE, 2001, ENVIRON BIOL FISH, V60, P191, DOI 10.1023/A:1007679303082; Lowe CG, 1996, ENVIRON BIOL FISH, V47, P203, DOI 10.1007/BF00005044; McGarvey R, 1999, MAR FRESHWATER RES, V50, P333, DOI 10.1071/MF97172; Meyer CG, 2010, MAR BIOL, V157, P1857, DOI 10.1007/s00227-010-1457-x; Meyer CG, 2009, ENVIRON CONSERV, V36, P104, DOI 10.1017/S0376892909990038; Natanson LJ, 2006, ENVIRON BIOL FISH, V77, P367, DOI 10.1007/s10641-006-9127-z; Natanson LJ, 1999, FISH B-NOAA, V97, P944; Natanson LJ, 2002, COL VOL SCI PAP ICCA, V54, P1261; Papastamatiou YP, 2013, ECOLOGY, V94, P2595, DOI 10.1890/12-2014.1; Papastamatiou YP, 2010, MAR FRESHWATER RES, V61, P1366, DOI 10.1071/MF10056; Romine JG, 2006, ENVIRON BIOL FISH, V77, P229, DOI 10.1007/s10641-006-9113-5; SAINSBURY KJ, 1980, CAN J FISH AQUAT SCI, V37, P241, DOI 10.1139/f80-031; SIMPFENDORFER C, 1992, AUST J MAR FRESH RES, V43, P33, DOI 10.1071/MF9920033; Simpfendorfer CA, 2008, J FISH BIOL, V72, P711, DOI 10.1111/j.1095-8649.2007.01764.x; Simpfendorfer CA, 2000, FISH B-NOAA, V98, P811; Simpfendorfer CA, 2000, ENVIRON BIOL FISH, V58, P335, DOI 10.1023/A:1007624828001; Simpfendorfer CA, 2001, ENVIRON BIOL FISH, V61, P37, DOI 10.1023/A:1011021710183; Skomal GB, 2003, FISH B-NOAA, V101, P627; Smith EB, 1997, CAN J FISH AQUAT SCI, V54, P2025, DOI 10.1139/f97-110; STEVENS JD, 1984, AUST J MAR FRESH RES, V35, P573, DOI 10.1071/MF9840573; STEVENS JD, 1991, AUST J MAR FRESH RES, V42, P151; TYLER JA, 1994, REV FISH BIOL FISHER, V4, P91, DOI 10.1007/BF00043262; Wearmouth VJ, 2008, ADV MAR BIOL, V54, P107, DOI 10.1016/S0065-2881(08)00002-3; Welsford DC, 2005, FISH B-NOAA, V103, P697; Whitney NM, 2007, MAR BIOL, V151, P63, DOI 10.1007/s00227-006-0476-0; Wintner SP, 2000, MAR FRESHWATER RES, V51, P43, DOI 10.1071/MF99077; Wirsing AJ, 2006, MAR BIOL, V149, P961, DOI 10.1007/s00227-006-0278-4	49	27	27	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84799	10.1371/journal.pone.0084799	http://dx.doi.org/10.1371/journal.pone.0084799			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416287	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500170
J	Elgendi, M; Eskofier, B; Dokos, S; Abbott, D				Elgendi, Mohamed; Eskofier, Bjoern; Dokos, Socrates; Abbott, Derek			Revisiting QRS Detection Methodologies for Portable, Wearable, Battery-Operated, and Wireless ECG Systems	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; HIGH-SPEED ANALYSIS; DETECTION ALGORITHM; WAVELET TRANSFORM; PATTERN-RECOGNITION; ATRIAL-FIBRILLATION; CARDIAC-ARRHYTHMIA; DATA-COMPRESSION; TIME; FILTER	Cardiovascular diseases are the number one cause of death worldwide. Currently, portable battery-operated systems such as mobile phones with wireless ECG sensors have the potential to be used in continuous cardiac function assessment that can be easily integrated into daily life. These portable point-of-care diagnostic systems can therefore help unveil and treat cardiovascular diseases. The basis for ECG analysis is a robust detection of the prominent QRS complex, as well as other ECG signal characteristics. However, it is not clear from the literature which ECG analysis algorithms are suited for an implementation on a mobile device. We investigate current QRS detection algorithms based on three assessment criteria: 1) robustness to noise, 2) parameter choice, and 3) numerical efficiency, in order to target a universal fast-robust detector. Furthermore, existing QRS detection algorithms may provide an acceptable solution only on small segments of ECG signals, within a certain amplitude range, or amid particular types of arrhythmia and/or noise. These issues are discussed in the context of a comparison with the most conventional algorithms, followed by future recommendations for developing reliable QRS detection schemes suitable for implementation on battery-operated mobile devices.	[Elgendi, Mohamed] Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada; [Eskofier, Bjoern] Univ Erlangen Nurnberg, Pattern Recognit Lab, Bavaria, Germany; [Dokos, Socrates] Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW, Australia; [Abbott, Derek] Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia	University of Alberta; University of Erlangen Nuremberg; University of New South Wales Sydney; University of Adelaide	Elgendi, M (corresponding author), Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada.	moe.elgendi@gmail.com	Eskofier, Bjoern/ABF-1284-2021; Abbott, Derek/E-8352-2011; Elgendi, Mohamed/I-8596-2016	Eskofier, Bjoern/0000-0002-0417-0336; Abbott, Derek/0000-0002-0945-2674; Elgendi, Mohamed/0000-0003-1831-0202; Dokos, Socrates/0000-0002-7399-2712				Abbaspour S., 1995, P IEEE 17 ANN C ENG, P887, DOI DOI 10.1109/IEMBS.1995.579254; Afonso VX, 1999, IEEE T BIO-MED ENG, V46, P192, DOI 10.1109/10.740882; Afonso VX, 1997, P IEEE EMBS, V18, P1037, DOI 10.1109/IEMBS.1996.652698; AHLSTROM ML, 1983, IEEE T BIO-MED ENG, V30, P651, DOI 10.1109/TBME.1983.325067; Ahmed SM, 2000, MED ENG PHYS, V22, P39, DOI 10.1016/S1350-4533(00)00010-2; Alesanco A, 2003, COMPUT CARDIOL, V30, P593, DOI 10.1109/CIC.2003.1291225; Alwan A, 2011, GLOBAL STATUS REPORT ON NONCOMMUNICABLE DISEASES 2010, P9; Arafat MA, 2009, INT CONF ACOUST SPEE, P461, DOI 10.1109/ICASSP.2009.4959620; Arzeno NM, 2008, IEEE T BIO-MED ENG, V55, P478, DOI 10.1109/TBME.2007.912658; Arzeno Natalia M, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P1788; Ayat M, 2009, IEEE ENG MED BIO, P416, DOI 10.1109/IEMBS.2009.5332617; Baig MM, 2013, MED BIOL ENG COMPUT, V51, P485, DOI 10.1007/s11517-012-1021-6; Balda R. A., 1977, Proceedings of the IFIP TC 4 working conference on trends in computer-processed electrocardiograms, P197; Bashour CA, 2004, CHEST, V126, p831S, DOI 10.1378/chest.126.4_MeetingAbstracts.831S-a; BELFORTE G, 1979, IEEE T BIO-MED ENG, V26, P125, DOI 10.1109/TBME.1979.326470; Benitez D, 2001, COMPUT BIOL MED, V31, P399, DOI 10.1016/S0010-4825(01)00009-9; Benitez DS, 2000, COMPUT CARDIOL, V27, P379, DOI 10.1109/CIC.2000.898536; Bloom DE, 2011, GLOBAL EC BURDEN NON, DOI DOI 10.1192/BJP.184.5.393; BORJESSON PO, 1982, IEEE T BIO-MED ENG, V29, P341, DOI 10.1109/TBME.1982.324901; Bothe HH, 1997, NEUROFUZZY METHODEN; Burrus C.S., 1997, INTRO WAVELETS WAVEL; Chen HC, 2003, COMPUT CARDIOL, V30, P585; Chen SW, 2006, COMPUT METH PROG BIO, V82, P187, DOI 10.1016/j.cmpb.2005.11.012; Cheng WT, 1998, P ANN INT IEEE EMBS, V20, P143, DOI 10.1109/IEMBS.1998.745850; Chiarugi F, 2007, COMPUT CARDIOL, V34, P157, DOI 10.1109/CIC.2007.4745445; Chouakri SA, 2011, APPL MATH COMPUT, V217, P9508, DOI 10.1016/j.amc.2011.03.001; Chouhan VS, 2008, INT J COMPUT SCI NET, V8, P155; CHRISTOV II, 1992, MED BIOL ENG COMPUT, V30, P253, DOI 10.1007/BF02446141; Christov II, 2004, BIOMED ENG ONLINE, V3, DOI 10.1186/1475-925X-3-28; CHU CHH, 1989, IEEE T BIO-MED ENG, V36, P262, DOI 10.1109/10.16474; CIACCIO EJ, 1993, IEEE ENG MED BIOL, V12, P106, DOI 10.1109/51.248173; Clifford G, 2006, ADV METHODS TOOLS EC; Coast A, 1989, ENG MED BIOL SOC 198, P34; Coast D. A., 1993, ICASSP-93. 1993 IEEE International Conference on Acoustics, Speech, and Signal Processing (Cat. No.92CH3252-4), P67, DOI 10.1109/ICASSP.1993.319056; COAST DA, 1990, IEEE T BIO-MED ENG, V37, P826, DOI 10.1109/10.58593; Damerval C, 2005, IEEE SIGNAL PROC LET, V12, P701, DOI 10.1109/LSP.2005.855548; de Chazal P, 2004, IEEE T BIO-MED ENG, V51, P1196, DOI 10.1109/TBME.2004.827359; Di Virgilio V, 1995, P 17 IEEE ANN C ENG, V2, P1051, DOI [10.1109/IEMBS.1995.579466, DOI 10.1109/IEMBS.1995.579466]; Dilaveris PE, 1998, AM HEART J, V135, P733, DOI 10.1016/S0002-8703(98)70030-4; Dinh HAN, 2001, P ANN INT IEEE EMBS, V23, P1883, DOI [10.1109/IEMBS.2001.1020593, 10.1007/BF03178366]; DOBBS S E, 1984, Journal of Clinical Engineering, V9, P197; Dokur Z, 2001, COMPUT METH PROG BIO, V66, P167, DOI 10.1016/S0169-2607(00)00133-4; Dokur Z, 1997, MED ENG PHYS, V19, P738, DOI 10.1016/S1350-4533(97)00029-5; DONOHO DL, 1995, IEEE T INFORM THEORY, V41, P613, DOI 10.1109/18.382009; Doyle Tim L A, 2004, Int J Med Sci, V1, P11; EBENEZER D, 1993, J BIOMED ENG, V15, P132, DOI 10.1016/0141-5425(93)90042-W; Elgendi M., 2009, INT J HYBRID INF TEC, V2, P65; Elgendi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073557; Elgendi M, 2010, BIOSIGNALS 2010: PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON BIO-INSPIRED SYSTEMS AND SIGNAL PROCESSING, P428; Elgendi M, 2009, 2009 35TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE, P78; Elgendi M, 2008, CSA 2008: INTERNATIONAL SYMPOSIUM ON COMPUTER SCIENCE AND ITS APPLICATIONS, PROCEEDINGS, P153, DOI 10.1109/CSA.2008.16; Engelse W. A. H., 1979, Computers in Cardiology, P37; Eskofier B, 2008, P 4 RUSS BAV C BIOM, P48; FANCOTT T, 1980, IEEE T BIO-MED ENG, V27, P685, DOI 10.1109/TBME.1980.326593; Fard PJM, 2008, INT J CARDIOL, V124, P250, DOI 10.1016/j.ijcard.2006.11.236; Fei Zhang, 2009, 2009 IEEE Biomedical Circuits and Systems Conference (BioCAS), P225, DOI 10.1109/BIOCAS.2009.5372042; FRADEN J, 1980, MED BIOL ENG COMPUT, V18, P125, DOI 10.1007/BF02443287; FRIESEN GM, 1990, IEEE T BIO-MED ENG, V37, P85, DOI 10.1109/10.43620; Garcia-Berdones C, 1997, LECT NOTES COMPUT SC, V1240, P1260, DOI 10.1007/BFb0032586; Ghaffarl A, 2008, COMPUT ELECTR ENG, V34, P81, DOI 10.1016/j.compeleceng.2007.10.005; Goss J, 2008, PROJECTION AUSTR HLT; Goutas A., 2005, ITBM RBM, V26, P127; Gradl S, 2012, IEEE ENG MED BIO, P2452, DOI 10.1109/EMBC.2012.6346460; Gustafson D, 1977, R1044 CS DRAP LAB; Hamilton PS, 1988, P ANN INT C IEEE ENG, V1, P14; Hayn D, 2011, COMPUT CARDIOL CONF, V38, P353; Hii PC, 2011, SENSORS-BASEL, V11, P6799, DOI 10.3390/s110706799; HOLSINGE.WP, 1971, IEEE T BIO-MED ENG, VBM18, P212, DOI 10.1109/TBME.1971.4502834; Hongyan X., 2008, P 2 INT C BIO BIOM E, P693; HU YH, 1993, J ELECTROCARDIOL, V26, P66, DOI 10.1088/0022-3727/26/1/011; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Jasemian Y, 2005, J TELEMED TELECARE, V11, P256, DOI 10.1258/1357633054471911; Jurik AD, 2008, COMPUTER, V41, P96, DOI 10.1109/MC.2008.133; Kadambe S, 1999, IEEE T BIO-MED ENG, V46, P838, DOI 10.1109/10.771194; Kaplan D. T., 1990, COMPUT CARDIOL, P503; Keselbrener L, 1997, MED ENG PHYS, V19, P481, DOI 10.1016/S1350-4533(97)00013-1; Kim H, 2010, IEEE T INF TECHNOL B, V14, P93, DOI 10.1109/TITB.2009.2031638; Kohler B. U., 2003, PROGR BIOMED RES, V8, P138; Krasteva VT., 2006, ELECTROTECHNIQUES EL, V9, DOI DOI 10.1.1.535.6847; Krimi S, 2008, P 2008 3 INT C INF C, P1; LAGUNA P, 1990, IEEE T BIO-MED ENG, V37, P420, DOI 10.1109/10.52350; Lee J, 1997, P IEEE EMBS, V18, P1396, DOI 10.1109/IEMBS.1996.647473; Lee RG, 2007, IEEE T INF TECHNOL B, V11, P507, DOI 10.1109/TITB.2006.888701; LESKI J, 1992, P IEEE EMBS, V14, P555; LI CW, 1995, IEEE T BIO-MED ENG, V42, P21, DOI 10.1109/10.362922; LIGTENBERG A, 1983, COMPUT BIOMED RES, V16, P273, DOI 10.1016/0010-4809(83)90027-7; Lin CC, 2008, COMPUTERS IN CARDIOLOGY 2008, VOLS 1 AND 2, P477, DOI 10.1109/CIC.2008.4749082; Lin MD, 2011, J SIGNAL PROCESS SYS, V62, P205, DOI 10.1007/s11265-008-0329-9; Lu Y, 2011, IEEE MULTIMEDIA, V18, P4, DOI 10.1109/MMUL.2011.33; Lu YS, 2008, INT CONF BIOMED, P315, DOI 10.1109/BMEI.2008.77; MALLAT S, 1992, IEEE T INFORM THEORY, V38, P617, DOI 10.1109/18.119727; Martin-Clemente R, 2011, IEEE T BIO-MED ENG, V58, P227, DOI 10.1109/TBME.2010.2059703; Martinez JP, 2004, IEEE T BIO-MED ENG, V51, P570, DOI 10.1109/TBME.2003.821031; Menard A., 1981, IEEE 1981 IECI Proceedings. "Applications of Mini and Microcomputers", P64; Messer SR, 2001, MICROELECTR J, V32, P931, DOI 10.1016/S0026-2692(01)00095-7; Moody GA, 2001, IEEE ENG MED BIOL, V20, P45, DOI 10.1109/51.932724; Moraes JCTB, 2002, COMPUT CARDIOL, V29, P205, DOI 10.1109/CIC.2002.1166743; MORIZETMAHOUDEAUX P, 1981, MED BIOL ENG COMPUT, V19, P497, DOI 10.1007/BF02441319; Munoz Ramos O, 2013, LECT NOTES ELECT ENG, V152, P327; NYGARDS ME, 1979, COMPUT BIOMED RES, V12, P181, DOI 10.1016/0010-4809(79)90015-6; NYGARDS ME, 1983, MED BIOL ENG COMPUT, V21, P538, DOI 10.1007/BF02442378; OKADA M, 1979, IEEE T BIO-MED ENG, V26, P700, DOI 10.1109/TBME.1979.326461; Oresko J, 2010, THESIS U PITTSBURG; Oukhellou L, 2006, P IEEE INT C AC SPEE, V3, pIII; PAN J, 1985, IEEE T BIO-MED ENG, V32, P230, DOI 10.1109/TBME.1985.325532; Paoletti M, 2006, COMPUT METH PROG BIO, V82, P20, DOI 10.1016/j.cmpb.2006.01.005; Rao KD, 1997, IETE J RES, V43, P345, DOI 10.1080/03772063.1997.11416001; Rasid MFA, 2005, IEEE T INF TECHNOL B, V9, P35, DOI 10.1109/TITB.2004.840070; Ruha A, 1997, IEEE T BIO-MED ENG, V44, P159, DOI 10.1109/10.554762; Sameni R, 2007, IEEE T BIO-MED ENG, V54, P2172, DOI 10.1109/TBME.2007.897817; Scholz UJ, 1997, PHYSIOL BEHAV, V62, P1037, DOI 10.1016/S0031-9384(97)00234-5; Scully CG, 2012, IEEE T BIO-MED ENG, V59, P303, DOI 10.1109/TBME.2011.2163157; Sharma LN, 2013, SIGNAL IMAGE VIDEO P, V7, P235, DOI 10.1007/s11760-011-0227-7; Shouldice RB, 2004, SLEEP, V27, P784, DOI 10.1093/sleep/27.4.784; Shyu LY, 2004, IEEE T BIO-MED ENG, V51, P1269, DOI 10.1109/TBME.2004.824131; Silva I, 2011, COMPUT CARDIOL CONF, V38, P273; Solar Hector, 2012, Impact Analysis of Solutions for Chronic Disease Prevention and Management. Proceedings 10th International Conference on Smart Homes and Health Telematics (ICOST 2012), P140, DOI 10.1007/978-3-642-30779-9_18; Srnmo L, 1982, P IEEE COMP CARD, P201; Strang G, 1997, WAVELETS FILTER BANK; Strintzis M, 1992, NEURAL NETW WORLD, V3, P313; Sufi F, 2007, P ANN INT IEEE EMBS, P3697, DOI 10.1109/IEMBS.2007.4353134; Sun Ying, 1992, Biomedical Instrumentation and Technology, V26, P477; SUPPAPPOLA S, 1994, IEEE T BIO-MED ENG, V41, P397, DOI 10.1109/10.284971; Szilagyi L., 1999, Proceedings of the First Joint BMES/EMBS Conference. 1999 IEEE Engineering in Medicine and Biology 21st Annual Conference and the 1999 Annual Fall Meeting of the Biomedical Engineering Society (Cat. No.99CH37015), DOI 10.1109/IEMBS.1999.802340; Szilagyi SM, 2000, P ANN INT IEEE EMBS, V22, P1267, DOI 10.1109/IEMBS.2000.897966; Tang JT, 2008, ICNC 2008: FOURTH INTERNATIONAL CONFERENCE ON NATURAL COMPUTATION, VOL 5, PROCEEDINGS, P624, DOI 10.1109/ICNC.2008.337; THAKOR NV, 1984, IEEE T BIO-MED ENG, V31, P702, DOI 10.1109/TBME.1984.325393; THAKOR NV, 1991, IEEE T BIO-MED ENG, V38, P785, DOI 10.1109/10.83591; Thong T, 2004, IEEE T BIO-MED ENG, V51, P561, DOI 10.1109/TBME.2003.821030; TRAHANIAS P, 1990, IEEE T PATTERN ANAL, V12, P648, DOI 10.1109/34.56207; TRAHANIAS PE, 1993, IEEE T BIO-MED ENG, V40, P201, DOI 10.1109/10.212060; Trinder J, 2001, J SLEEP RES, V10, P253, DOI 10.1046/j.1365-2869.2001.00263.x; Tsipouras MG, 2002, COMPUT CARDIOL, V29, P485, DOI 10.1109/CIC.2002.1166815; Ulusar UD, 2009, IEEE ENG MED BIO, P4666, DOI 10.1109/IEMBS.2009.5334180; Vai MI, 2004, IEEE T BIO-MED ENG, V51, P1407, DOI 10.1109/TBME.2004.827937; Vijaya G, 1998, J MED ENG TECHNOL, V22, P160, DOI 10.3109/03091909809032534; Wen C, 2008, MEASUREMENT, V41, P463, DOI 10.1016/j.measurement.2006.12.006; WIDROW B, 1975, P IEEE, V63, P1692, DOI 10.1109/PROC.1975.10036; Xu XM, 2005, P ANN INT IEEE EMBS, P7281; XUE QZ, 1992, IEEE T BIO-MED ENG, V39, P317, DOI 10.1109/10.126604; Yongli C, 2005, P 27 ANN INT C ENG M, P4654; Zapanta L, 2004, P ANN INT IEEE EMBS, V26, P3889; Zhang CF, 2012, IEEE J EM SEL TOP C, V2, P52, DOI 10.1109/JETCAS.2012.2187706; Zhang F, 2007, P ANN INT IEEE EMBS, P3196, DOI 10.1109/IEMBS.2007.4353009; Zhang F, 2007, 2007 IEEE BIOMEDICAL CIRCUITS AND SYSTEMS CONFERENCE, P211, DOI 10.1109/BIOCAS.2007.4463346; Zhang F, 2009, IEEE INT SYMP CIRC S, P1473; Zheng HB, 2008, 2008 10TH IEEE INTERNATIONAL CONFERENCE ON E-HEALTH NETWORKING, APPLICATIONS AND SERVICES, P169, DOI 10.1109/HEALTH.2008.4600130; Zheng X, 2008, ISISE 2008: INTERNATIONAL SYMPOSIUM ON INFORMATION SCIENCE AND ENGINEERING, VOL 2, P502, DOI 10.1109/ISISE.2008.61; Zhou Hai-Ying, 2008, 2008 9th International Conference on Signal Processing (ICSP 2008), P2150, DOI 10.1109/ICOSP.2008.4697572; Zhou SK, 1988, ANN INT C IEEE ENG M; Zidelmal Z, 2012, COMPUT METH PROG BIO, V107, P490, DOI 10.1016/j.cmpb.2011.12.004	151	145	152	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84018	10.1371/journal.pone.0084018	http://dx.doi.org/10.1371/journal.pone.0084018			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409290	Green Published, Green Submitted, gold			2022-12-27	WOS:000329463500014
J	Gonzalez-Santoyo, I; Gonzalez-Tokman, DM; Munguia-Steyer, RE; Cordoba-Aguilar, A				Gonzalez-Santoyo, Isaac; Gonzalez-Tokman, Daniel M.; Munguia-Steyer, Roberto E.; Cordoba-Aguilar, Alex			A Mismatch between the Perceived Fighting Signal and Fighting Ability Reveals Survival and Physiological Costs for Bearers	PLOS ONE			English	Article							ALTERNATIVE MATING TACTICS; AMERICAN RUBYSPOT; BODY-SIZE; SEXUAL SELECTION; COMPETITION; EXPRESSION; ORNAMENT; MALES; TRAIT; COLORATION	Signals of fighting indicate an animal's intention to attack and so they serve to prevent costly aggressive encounters. However, according to theory, a signal that is different in design (i.e. a novel signal) but that fails to inform fighting intentions will result in negative fitness consequences for the bearer. In the present study we used males of the territorial damselfly Hetaerina americana, which have a red wing spot during territory defense that has evolved as a signal of fighting ability. By producing a novel signal (covering the red spot with blue ink) in territory owners, we investigated: a) the behavioral responses by conspecific males; b) survival cost and c) three physiological mediators of impaired survival: muscular fat reserves, muscle mass and immune ability. We predicted that males with the novel signal would be attacked more often by conspecifics as the former would fail to convey fighting ability and intentions adequately. This will result in lower survival and physiological condition for the novel signal bearers. We found that, compared to control males (males whose red spot was not changed), experimental males had reduced survival, were less able to hold a territory, and had a reduced muscle mass. It seems that spot modified males were not able to effectively communicate their territory tenancy, which may explain why they lost their defended sites. Our results provide support for theoretical models that a novel signal that fails to informing fighting ability may lead to a fitness cost for bearers.	[Gonzalez-Santoyo, Isaac; Gonzalez-Tokman, Daniel M.; Munguia-Steyer, Roberto E.; Cordoba-Aguilar, Alex] Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol & Evolutiva, Ciudad Univ, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Cordoba-Aguilar, A (corresponding author), Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol & Evolutiva, Ciudad Univ, Mexico City 04510, DF, Mexico.	acordoba@ecologia.unam.mx	Gonzalez-Tokman, Daniel/Q-6833-2018; Munguía-Steyer, Roberto/U-3935-2019	Gonzalez-Tokman, Daniel/0000-0001-7251-5773; Munguía-Steyer, Roberto/0000-0002-2951-4684; G-Santoyo, Isaac/0000-0002-1484-9836	PAPIIT-UNAM grant [IN-222312-3]	PAPIIT-UNAM grant	Financial support came from a PAPIIT-UNAM grant (IN-222312-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez HA, 2013, BIOL J LINN SOC, V108, P521, DOI 10.1111/j.1095-8312.2012.02031.x; Anderson CN, 2010, P ROY SOC B-BIOL SCI, V277, P3669, DOI 10.1098/rspb.2010.0935; [Anonymous], 2003, ANIMAL SIGNALS; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Clark CJ, 2012, ANIM BEHAV, V84, P269, DOI 10.1016/j.anbehav.2012.04.012; Contreras-Garduno J, 2007, J INSECT PHYSIOL, V53, P612, DOI 10.1016/j.jinsphys.2007.03.003; Contreras-Garduno J, 2006, J ETHOL, V24, P165, DOI 10.1007/s10164-005-0177-z; Contreras-Garduno J, 2008, BEHAV ECOL, V19, P724, DOI 10.1093/beheco/arn026; Contreras-Garduno J, 2007, ETHOLOGY, V113, P944, DOI 10.1111/j.1439-0310.2007.01402.x; Cook RD, 1982, RESIDUALS INFLUENCE; Cordoba-Aguilar A, 2009, ECOL ENTOMOL, V34, P228, DOI 10.1111/j.1365-2311.2008.01061.x; Cordoba-Aguilar A., 1995, ODONATOLOGICA, V24, P442; Cordoba-Aguilar Alejandro, 1993, Brenesia, V39-40, P181; Cordoba-Aguilar A, 2009, BEHAV ECOL SOCIOBIOL, V63, P751, DOI 10.1007/s00265-009-0709-6; Crawley M.J., 2007, R BOOK; Dijkstra PD, 2010, EVOLUTION, V64, P2797, DOI 10.1111/j.1558-5646.2010.01046.x; Gonzalez-Santoyo I, 2010, BEHAVIOUR, V147, P1285, DOI 10.1163/000579510X516777; Gonzalez-Santoyo I, 2012, ENTOMOL EXP APPL, V142, P1, DOI 10.1111/j.1570-7458.2011.01187.x; Gonzalez-Tokman D, 2011, ANIM BEHAV, V81, P1185, DOI 10.1016/j.anbehav.2011.02.027; Gonzalez-Tokman DM, 2012, EVOLUTION, V66, P3294, DOI 10.1111/j.1558-5646.2012.01678.x; Grether GF, 1997, P ROY SOC B-BIOL SCI, V264, P207, DOI 10.1098/rspb.1997.0029; Grether GF, 1996, EVOLUTION, V50, P1939, DOI 10.1111/j.1558-5646.1996.tb03581.x; Grether GF, 1996, EVOLUTION, V50, P1949, DOI 10.1111/j.1558-5646.1996.tb03582.x; Jimenez-Cortes JG, 2012, J INSECT PHYSIOL, V58, P318, DOI 10.1016/j.jinsphys.2011.11.004; Hegyi G, 2011, BEHAV ECOL SOCIOBIOL, V65, P1647, DOI 10.1007/s00265-011-1175-5; HILL GE, 1999, P INT ORN C, V22, P1654; Horridge A, 2009, J EXP BIOL, V212, P2721, DOI 10.1242/jeb.030916; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; KAISER MJ, 1990, J EXP MAR BIOL ECOL, V140, P121, DOI 10.1016/0022-0981(90)90086-R; Kiere LM, 2009, J AVIAN BIOL, V40, P605, DOI 10.1111/j.1600-048X.2009.04718.x; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Mappes J, 1997, BEHAV ECOL, V8, P174, DOI 10.1093/beheco/8.2.174; Munguia-Steyer R, 2010, J EVOLUTION BIOL, V23, P175, DOI 10.1111/j.1420-9101.2009.01894.x; Olson VA, 1998, TRENDS ECOL EVOL, V13, P510, DOI 10.1016/S0169-5347(98)01484-0; Olsson M, 2007, MOL ECOL, V16, P5307, DOI 10.1111/j.1365-294X.2007.03578.x; Plaistow S, 1996, P ROY SOC B-BIOL SCI, V263, P1233, DOI 10.1098/rspb.1996.0181; Prokopova M, 2010, BIOL J LINN SOC, V100, P890, DOI 10.1111/j.1095-8312.2010.01463.x; Pryke SR, 2009, ANIM BEHAV, V78, P393, DOI 10.1016/j.anbehav.2009.05.013; Pryke SR, 2001, ANIM BEHAV, V62, P695, DOI 10.1006/anbe.2001.1804; Pryke SR, 2001, EVOLUTION, V55, P1452; Raihani G, 2008, ANIM BEHAV, V75, P1851, DOI 10.1016/j.anbehav.2007.11.002; Searcy W.N.S, 2005, EVOLUTION ANIMAL COM; Serrano-Meneses MA, 2007, ANIM BEHAV, V73, P987, DOI 10.1016/j.anbehav.2006.08.012; Setchell JM, 2005, ETHOLOGY, V111, P25, DOI 10.1111/j.1439-0310.2004.01054.x; SMITH JM, 1988, PHILOS T ROY SOC B, V319, P557, DOI 10.1098/rstb.1988.0065; Svensson EI, 2007, AM NAT, V170, P101, DOI 10.1086/518181; Taborsky M, 2008, ALTERNATIVE REPRODUCTIVE TACTICS: AN INTEGRATIVE APPROACH, P1, DOI 10.1017/CBO9780511542602.002; Tibbetts EA, 2004, NATURE, V432, P218, DOI 10.1038/nature02949; Toivanen T, 2009, CAN J ZOOL, V87, P684, DOI 10.1139/Z09-055; Viljugrein H, 1997, P ROY SOC B-BIOL SCI, V264, P815, DOI 10.1098/rspb.1997.0114; WAAGE JK, 1988, ANIM BEHAV, V36, P586, DOI 10.1016/S0003-3472(88)80030-7; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Williams B. K., 2002, ANAL MANAGEMENT ANIM	53	12	12	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84571	10.1371/journal.pone.0084571	http://dx.doi.org/10.1371/journal.pone.0084571			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409304	Green Submitted, Green Published, gold			2022-12-27	WOS:000329463500028
J	Kim, YS; Jung, SH; Jung, DH; Choi, SJ; Lee, YR; Kim, JS				Kim, Young Sook; Jung, Seung-Hyun; Jung, Dong Ho; Choi, So-Jin; Lee, Yu-Ri; Kim, Jin Sook			Gas6 Stimulates Angiogenesis of Human Retinal Endothelial Cells and of Zebrafish Embryos via ERK1/2 Signaling	PLOS ONE			English	Article							GROWTH ARREST; DIABETIC-RETINOPATHY; ANTI-VEGF; GENE 6; AXL; RECEPTOR; PROLIFERATION; CARCINOMA; MIGRATION; PATHWAY	Aim: To determine if growth arrest-specific 6 (Gas6) plays an important role in the regulation of angiogenesis in human retinal microvascular endothelial cells (HRMECs) and in vessel development of zebrafish. Methods: Proliferation, wound-healing cell migration, and tube formation were measured in HRMECs treated with recombinant human Gas6 (rhGas6). Sprague-Dawley rat aortas in Matrigels were treated with rhGas6, and microvessel sprouting emanating from arterial rings was analyzed. Transgenic zebrafish embryos (flk:GFP) were microinjected with rhGas6 at 50 hours post-fertilization (hpf), and ectopic sprouting of subintestinal vessels (SIVs) was observed under a confocal microscope. Morpholino oligonucleotides (MOs) were microinjected to knockdown gas6 in zebrafish embryos, and intersegmental vessel impairment was observed. The effect of the extracellular signal-regulated kinase (ERK1/2) inhibitor on the migration of HRMECs and on vessel development in zebrafish embryos was tested. Results: rhGas6 stimulated proliferation, migration, and tube formation in HRMECs in a dose-dependent manner. In rat aortas, rhGas6 induced vessel outgrowth, and the sprouting length was longer than that of controls. The rhGas6-microinjected zebrafish embryos had significantly increased vessel outgrowth in the SIVs. Recombinant human vascular endothelial growth factor (rhVEGF) served as a positive control. Knockdown of gas6 inhibited angiogenesis in the developing vessels of zebrafish. The ERK1/2 inhibitor inhibited HRMEC migration and intersegmental vessel formation in zebrafish embryos. Conclusions/Interpretations: These data suggest that Gas6 plays a pivotal role in proliferation, migration, and sprouting of angiogenic endothelial cells in the retina and in zebrafish embryos. Furthermore, Gas6 induced angiogenic processes are induced via phosphorylation of ERK1/2.	[Kim, Young Sook; Jung, Seung-Hyun; Jung, Dong Ho; Choi, So-Jin; Lee, Yu-Ri; Kim, Jin Sook] KIOM, Herbal Med Res Div, Korean Med Based Herbal Drug Dev Grp, Taejon, South Korea	Korea Institute of Oriental Medicine (KIOM)	Kim, JS (corresponding author), KIOM, Herbal Med Res Div, Korean Med Based Herbal Drug Dev Grp, Taejon, South Korea.	jskim@kiom.re.kr		jeong, dongho/0000-0002-6250-5720	Korea Institute of Oriental Medicine (KIOM) [K12040, K13040]	Korea Institute of Oriental Medicine (KIOM)	This research was supported by grants [K12040 and K13040] from the Korea Institute of Oriental Medicine (KIOM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair TH, 2010, ANGIOGENESIS; Angelillo-Scherrer A, 2001, NAT MED, V7, P215, DOI 10.1038/84667; Bedogni B, 2004, CANCER RES, V64, P2552, DOI 10.1158/0008-5472.CAN-03-3327; Binu S, 2012, J PHYSL BIOCH; Boosani CS, 2010, CURR EYE RES, V35, P45, DOI 10.3109/02713680903374208; Castellon R, 2002, EXP EYE RES, V74, P523, DOI 10.1006/exer.2001.1161; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Gustafsson A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007575; Hall MO, 2005, EXP EYE RES, V81, P581, DOI 10.1016/j.exer.2005.03.017; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Jung SH, 2010, DEV DYNAM, V239, P592, DOI 10.1002/dvdy.22166; Kim YS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050297; Laurance S, 2012, ADV NUTR, V3, P196, DOI 10.3945/an.111.001826; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Nagai K, 2003, J BIOL CHEM, V278, P18229, DOI 10.1074/jbc.M213266200; Nagata K, 1996, J BIOL CHEM, V271, P30022, DOI 10.1074/jbc.271.47.30022; Nicholson BP, 2010, GRAEF ARCH CLIN EXP, V248, P915, DOI 10.1007/s00417-010-1315-z; Nicoli S, 2007, NAT PROTOC, V2, P2918, DOI 10.1038/nprot.2007.412; Nicosia RF, 1997, AM J PATHOL, V151, P1379; Perrin RM, 2005, DIABETOLOGIA, V48, P2422, DOI 10.1007/s00125-005-1951-8; Sainaghi PP, 2005, J CELL PHYSIOL, V204, P36, DOI 10.1002/jcp.20265; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; Sepe L, 2013, CELL PHYSIOL BIOCHEM, V31, P123, DOI 10.1159/000343355; Serbedzija G N, 1999, Angiogenesis, V3, P353, DOI 10.1023/A:1026598300052; Simo R, 2008, DIABETOLOGIA, V51, P1574, DOI 10.1007/s00125-008-0989-9; Yanagita Motoko, 2004, Clin Exp Nephrol, V8, P304; Zhang YX, 2008, CANCER RES, V68, P1905, DOI 10.1158/0008-5472.CAN-07-2661	30	9	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e83901	10.1371/journal.pone.0083901	http://dx.doi.org/10.1371/journal.pone.0083901			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409287	gold, Green Submitted, Green Published			2022-12-27	WOS:000329463500011
J	Ngufor, C; Tchicaya, E; Koudou, B; N'Fale, S; Dabire, R; Johnson, P; Ranson, H; Rowland, M				Ngufor, Corine; Tchicaya, Emile; Koudou, Benjamin; N'Fale, Sagnon; Dabire, Roch; Johnson, Paul; Ranson, Hilary; Rowland, Mark			Combining Organophosphate Treated Wall Linings and Long-lasting Insecticidal Nets for Improved Control of Pyrethroid Resistant Anopheles gambiae	PLOS ONE			English	Article							MALARIA CONTROL; INDOOR USE; EFFICACY; AREA; MOSQUITOS	Background: New approaches to delivering insecticides need to be developed to improve malaria vector control. Insecticidal durable wall lining (DL) and net wall hangings (NWH) are novel alternatives to indoor residual spraying which can be produced in a long-lasting format. Non-pyrethroid versions could be used in combination with long-lasting insecticidal nets for improved control and management of insecticide resistant vector populations. Methods: Experimental hut trials were carried out in Valley du Kou, Burkina Faso to evaluate the efficacy of pirimiphos methyl treated DL and NWH either alone or in combination with LLINs against pyrethroid resistant Anopheles gambiae ss. Comparison was made with pyrethroid DL. Mosquitoes were genotyped for kdr and ace-1R resistant genes to investigate the insecticide resistance management potential of the combination. Results: The overall kdr and ace-1(R) allele frequencies were 0.95 and 0.01 respectively. Mortality with p-methyl DL and NWH alone was higher than with pyrethroid DL alone (>95% vs 40%; P<0.001). Combining pyrethroid DL with LLINs did not show improvement in mortality (48%) compared to the LLIN alone (44%) (P>0.1). Combining p-methyl DL or NWH with LLINs reduced biting rates significantly (8-9%) compared to p-methyl DL and NWH alone (>40%) and killed all An gambiae that entered the huts. Mosquitoes bearing the ace-1(R) gene were more likely to survive in huts with p-methyl DL alone (p<0.03) whereas all resistant and susceptible genotypes were killed by the combination. Conclusion: P-methyl DL and NWH outperformed pyrethroid DL. Combining p-methyl DL and NWH with LLINs could provide significant epidemiological benefits against a vector population which is resistant to pyrethroids but susceptible to organophosphates. There was evidence that the single intervention would select kdr and ace-1(R) resistance genes and the combination intervention might select less strongly. Technology to bind organophosphates to plastic wall lining would be worth developing.	[Ngufor, Corine; Rowland, Mark] London Sch Hyg & Trop Med, London WC1, England; [Tchicaya, Emile; Koudou, Benjamin] Ctr Suisse Rech Sci, Abidjan, Cote Ivoire; [N'Fale, Sagnon] Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso; [Dabire, Roch] Ctr Muraz, Bobo Dioulasso, Burkina Faso; [Johnson, Paul] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; [Ranson, Hilary] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	University of London; London School of Hygiene & Tropical Medicine; Centre Muraz; University of Glasgow; Liverpool School of Tropical Medicine; University of Liverpool	Ngufor, C (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	corine.ngufor@lshtm.ac.uk	Johnson, Paul C D/O-9695-2014; Dabire, Roch Kounbobr/ABF-3525-2020	Johnson, Paul C D/0000-0001-6663-7520; Ngufor, Corine/0000-0002-7755-9609; Ranson, Hilary/0000-0003-2332-8247	European Union [265660 AvecNet]	European Union(European Commission)	The research leading to these results has received funding from the European Union Seventh Framework Programme FP7 (2007-2013) under grant agreement no 265660 AvecNet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 1996, INTRO CATEGORICAL DA; Alou LPA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-167; [Anonymous], 2011, R LANG ENV STAT COMP; [Anonymous], 2006, PESTICIDES THEIR APP; Asidi A, 2012, EMERG INFECT DIS, V18, P1101, DOI 10.3201/eid1807.120218; Bass C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-111; Chandre F, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-65; Dabire KR, 2009, T ROY SOC TROP MED H, V103, P1113, DOI 10.1016/j.trstmh.2009.01.008; Dabire KR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-188; DENHOLM I, 1992, ANNU REV ENTOMOL, V37, P91, DOI 10.1146/annurev.en.37.010192.000515; Diabate A, 2006, TROP MED INT HEALTH, V11, P597, DOI 10.1111/j.1365-3156.2006.01605.x; Djenontin A, 2010, AM J TROP MED HYG, V83, P266, DOI 10.4269/ajtmh.2010.10-0012; Djogbenou L, 2011, MED VET ENTOMOL, V25, P256, DOI 10.1111/j.1365-2915.2010.00925.x; Edi CVA, 2012, EMERG INFECT DIS, V18, P1508, DOI 10.3201/eid1809.120262; Hargreaves K, 2000, MED VET ENTOMOL, V14, P181, DOI 10.1046/j.1365-2915.2000.00234.x; *IRAC, 2010, VECT PUBL HLTH IMP I; LIVAK KJ, 1984, GENETICS, V107, P611; Messenger LA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-358; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; Ngufor C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-343; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Ranson H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-299; ROUSH RT, 1993, PARASITOL TODAY, V9, P174, DOI 10.1016/0169-4758(93)90141-2; Rowland M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069516; Sharma SK, 2009, INDIAN J MED RES, V130, P458; Sharp BL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-52; Vanlerberghe V, 2010, TROP MED INT HEALTH, V15, P1067, DOI 10.1111/j.1365-3156.2010.02582.x; Vanlerberghe V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000994; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2011, WORLD MALARIA REPORT 2011, P1; *WHO, 2010, GLOB MAL PROGR M REP; World Health Organization, 2012, WHO GLOB MAL PROGR G; Yakob L, 2011, J R SOC INTERFACE, V8, P799, DOI 10.1098/rsif.2010.0537	33	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e83897	10.1371/journal.pone.0083897	http://dx.doi.org/10.1371/journal.pone.0083897			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409286	Green Accepted, gold, Green Published			2022-12-27	WOS:000329463500010
J	Payne, BAI; Hollingsworth, KG; Baxter, J; Wilkins, E; Lee, V; Price, DA; Trenell, M; Chinnery, PF				Payne, Brendan A. I.; Hollingsworth, Kieren G.; Baxter, Joanne; Wilkins, Edmund; Lee, Vincent; Price, D. Ashley; Trenell, Michael; Chinnery, Patrick F.			In Vivo Mitochondrial Function in HIV-Infected Persons Treated with Contemporary Anti-Retroviral Therapy: A Magnetic Resonance Spectroscopy Study	PLOS ONE			English	Article							SKELETAL-MUSCLE; DNA; TOXICITY; STAVUDINE; FATIGUE	Modern anti-retroviral therapy is highly effective at suppressing viral replication and restoring immune function in HIV-infected persons. However, such individuals show reduced physiological performance and increased frailty compared with age-matched uninfected persons. Contemporary anti-retroviral therapy is thought to be largely free from neuromuscular complications, whereas several anti-retroviral drugs previously in common usage have been associated with mitochondrial toxicity. It has recently been established that patients with prior exposure to such drugs exhibit irreversible cellular and molecular mitochondrial defects. However the functional significance of such damage remains unknown. Here we use phosphorus magnetic resonance spectroscopy (P-31-MRS) to measure in vivo muscle mitochondrial oxidative function, in patients treated with contemporary anti-retroviral therapy, and compare with biopsy findings (cytochrome c oxidase (COX) histochemistry). We show that dynamic oxidative function (post-exertional ATP (adenosine triphosphate) resynthesis) was largely maintained in the face of mild to moderate COX defects (affecting up to similar to 10% of fibers): iota(1/2) ADP (half-life of adenosine diphosphate clearance), HIV-infected 22.1 +/- 9.9 s, HIV-uninfected 18.8 +/- 4.4 s, p = 0.09. In contrast, HIV-infected patients had a significant derangement of resting state ATP metabolism compared with controls: ADP/ATP ratio, HIV-infected 1.24 +/- 0.08x10(-3), HIV-uninfected 1.16 +/- 0.05x10(-3), p = 0.001. These observations are broadly reassuring in that they suggest that in vivo mitochondrial function in patients on contemporary anti-retroviral therapy is largely maintained at the whole organ level, despite histochemical (COX) defects within individual cells. Basal energy requirements may nevertheless be increased.	[Payne, Brendan A. I.; Chinnery, Patrick F.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Payne, Brendan A. I.; Price, D. Ashley] Royal Victoria Infirm, Dept Infect & Trop Med, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Hollingsworth, Kieren G.] Newcastle Univ, Newcastle Magnet Resonance Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Baxter, Joanne; Wilkins, Edmund] North Manchester Gen Hosp, Dept Infect Dis, Manchester, Lancs, England; [Lee, Vincent] Manchester Royal Infirm, Manchester Ctr Sexual Hlth, Manchester M13 9WL, Lancs, England; [Trenell, Michael] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; University of Manchester; Newcastle University - UK	Payne, BAI (corresponding author), Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	brendan.payne@ncl.ac.uk	Payne, Brendan/I-1233-2016	Payne, Brendan/0000-0002-3101-3512; Price, David/0000-0002-0562-7326; Trenell, Michael/0000-0001-8253-5620; Chinnery, Patrick/0000-0002-7065-6617	Medical Research Council (MRC, UK) [G1100160]; Newcastle National Institute for Health Research (NIHR) Biomedical Research Centre in Ageing and Age-Related Diseases; Medical Research Council (MRC, UK) Centre for Translational Muscle Disease; Wellcome Trust [084980/Z/08/Z, 096919Z/11/Z]; MRC [G0800470, G1100160, MC_G0802536, MR/K000608/1] Funding Source: UKRI; Medical Research Council [G0700718B, G0800470, MC_G0802536, MR/K000608/1, G1100160] Funding Source: researchfish; National Institute for Health Research [CL-2013-01-004, SRF-2011-04-017] Funding Source: researchfish; NIHR Newcastle Biomedical Research Centre [BH111030] Funding Source: researchfish	Medical Research Council (MRC, UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Newcastle National Institute for Health Research (NIHR) Biomedical Research Centre in Ageing and Age-Related Diseases(National Institute for Health Research (NIHR)); Medical Research Council (MRC, UK) Centre for Translational Muscle Disease(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NIHR Newcastle Biomedical Research Centre	This work received financial support from: Medical Research Council (MRC, UK) (BP)(www.mrc.ac.uk); Newcastle National Institute for Health Research (NIHR) Biomedical Research Centre in Ageing and Age-Related Diseases (BP, PFC) (http://www.ncl.ac.uk/biomedicine/research/brc); Medical Research Council (MRC, UK) Centre for Translational Muscle Disease (PFC); Wellcome Trust (084980/Z/08/Z & 096919Z/11/Z, PFC) (www.wellcome.ac.uk); Medical Research Council (MRC, UK) (G1100160, KGH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNAUDO E, 1991, LANCET, V337, P508, DOI 10.1016/0140-6736(91)91294-5; Birkus G, 2002, ANTIMICROB AGENTS CH, V46, P716, DOI 10.1128/AAC.46.3.716-723.2002; Brierley EJ, 1996, QJM-MON J ASSOC PHYS, V89, P251; Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132; Cherry CL, 2002, J ACQ IMMUN DEF SYND, V30, P271, DOI [10.1097/01.QAI.0000017962.22053.0E, 10.1097/00126334-200207010-00002]; Cote HCF, 2002, NEW ENGL J MED, V346, P811, DOI 10.1056/NEJMoa012035; Fleischman A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1666, DOI 10.1152/ajpendo.00550.2006; HARRIS RC, 1974, SCAND J CLIN LAB INV, V33, P109; Hoschele D, 2006, TOXICOL IN VITRO, V20, P535, DOI 10.1016/j.tiv.2005.11.007; Hollingsworth KG, 2008, CLIN GASTROENTEROL H, V6, P1041, DOI 10.1016/j.cgh.2008.04.013; Jeneson JAL, 1996, J BIOL CHEM, V271, P27995, DOI 10.1074/jbc.271.45.27995; Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200; McComsey GA, 2005, AIDS, V19, P15, DOI 10.1097/00002030-200501030-00002; Naressi A, 2001, COMPUT BIOL MED, V31, P269, DOI 10.1016/S0010-4825(01)00006-3; Payne BAI, 2013, HIV MED, V14, P247, DOI 10.1111/j.1468-1293.2012.01050.x; Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863; PENN AMW, 1992, NEUROLOGY, V42, P2147, DOI 10.1212/WNL.42.11.2147; SINNWELL TM, 1995, J CLIN INVEST, V96, P126, DOI 10.1172/JCI118012; Trenell MI, 2006, MUSCLE NERVE, V33, P524, DOI 10.1002/mus.20484; Yu-Wai-Man P, 2011, BRAIN, V134, DOI 10.1093/brain/awq288	20	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84678	10.1371/journal.pone.0084678	http://dx.doi.org/10.1371/journal.pone.0084678			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409305	Green Published, gold, Green Submitted			2022-12-27	WOS:000329463500029
J	Zhang, XJ; Li, YH; Romeis, J; Yin, XM; Wu, KM; Peng, YF				Zhang, Xiaojie; Li, Yunhe; Romeis, Joerg; Yin, Xinming; Wu, Kongming; Peng, Yufa			Use of a Pollen-Based Diet to Expose the Ladybird Beetle Propylea japonica to Insecticidal Proteins	PLOS ONE			English	Article							COLEOMEGILLA-MACULATA COLEOPTERA; TRANSGENIC CORN POLLEN; RISK-ASSESSMENT; NONTARGET ARTHROPODS; BORER LEPIDOPTERA; ADALIA-BIPUNCTATA; RICE POLLEN; BT MAIZE; COCCINELLIDAE; CRY1AB	A rape seed pollen-based diet was developed and found to be suitable for use in a dietary exposure assay for Propylea japonica. Using the diet, we established and validated a dietary exposure assay by using the protease inhibitor E-64 as positive control. Dose-dependent responses were documented for all observed life-table parameters of P. japonica including survival, pupation and eclosion rates, development time and adult weight. Results suggested that the dietary assay can detect the effects of insecticidal compounds on the survival and development of P. japonica. Using the established dietary assay, we subsequently tested the toxicity of Cry1Ab, Cry1Ac and Cry1F proteins that are expressed by transgenic maize, cotton or rice plants to P. japonica larvae. The diet containing E-64 was included as a positive control. Survival and development of P. japonica larvae were not adversely affected when the diet contained purified Cry1Ab, Cry1Ac, or Cry1F at 500 mg/g diet representing a worst-case exposure scenario. In contrast, P. japonica larvae were adversely affected when the diet contained E-64. The bioactivity and stability of the Cry proteins in the diet and Cry protein uptake by the ladybird larvae were confirmed by bioassay with a Cry-sensitive insect species and by ELISA. The current study describes a suitable experimental system for assessing the potential effects of gut-active insecticidal compounds on ladybird beetle larvae. The experiments with the Cry proteins demonstrate that P. japonica larvae are not sensitive to Cry1Ab, Cry1Ac and Cry1F.	[Zhang, Xiaojie; Yin, Xinming] Henan Agr Univ, Coll Life Sci, Zhengzhou, Peoples R China; [Zhang, Xiaojie; Li, Yunhe; Romeis, Joerg; Wu, Kongming; Peng, Yufa] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Romeis, Joerg] ISS, Agroscope, Zurich, Switzerland	Henan Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Swiss Federal Research Station Agroscope	Li, YH (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	yunhe.li@hotmail.com	peng, yu/GXW-2071-2022		National GMO New Variety Breeding Program of PRC [2013ZX08011-001]	National GMO New Variety Breeding Program of PRC	The study was supported by the National GMO New Variety Breeding Program of PRC (2013ZX08011-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Alfageme F, 2008, TRANSGENIC RES, V17, P943, DOI 10.1007/s11248-008-9177-4; Alvarez-Alfageme F, 2012, ENVIRON ENTOMOL, V41, P1687, DOI 10.1603/EN12032; Alvarez-Alfageme F, 2011, TRANSGENIC RES, V20, P467, DOI 10.1007/s11248-010-9430-5; Bai YY, 2006, ENVIRON ENTOMOL, V35, P1130, DOI 10.1603/0046-225X-35.4.1130; Bai YY, 2005, J PEST SCI, V78, P123, DOI 10.1007/s10340-004-0078-x; Center for Environmental Risk Assessment ILSI Research Foundation, 2011, Environ Biosafety Res, V10, P27, DOI 10.1051/ebr:2012002; CERA, 2013, REV ENV SAF CRY1F PR; Dhillon MK, 2009, BIOCONTROL SCI TECHN, V19, P407, DOI 10.1080/09583150902783801; Duan JJ, 2002, ENTOMOL EXP APPL, V104, P271, DOI 10.1023/A:1021258803866; Dutra CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044867; Garcia-Alonso Monica, 2006, Environmental Biosafety Research, V5, P57, DOI 10.1051/ebr:2006018; Garcia-Alonso M, 2014, TRANSGENIC RES, V23, P945, DOI 10.1007/s11248-013-9760-1; Han LZ, 2012, ANN ENTOMOL SOC AM, V105, P253, DOI 10.1603/AN10170; Hodek I, 2012, ECOLOGY BEHAV LADYBI, DOI DOI 10.1002/9781118223208; Huang FN, 2006, J ECON ENTOMOL, V99, P194, DOI 10.1603/0022-0493(2006)099[0194:CSOECB]2.0.CO;2; Li KS, 1992, SHANXI FOREST SCI TE, V2, P84; Li Y., 2011, P IEEE INT S ASS MAN, V1, P1, DOI DOI 10.1080/21573727.2011.601453; Li YH, 2014, INSECT SCI, V21, P125, DOI 10.1111/1744-7917.12044; Li YH, 2011, ENVIRON ENTOMOL, V40, P496, DOI 10.1603/EN10248; Li YH, 2010, BIOL CONTROL, V53, P337, DOI 10.1016/j.biocontrol.2009.12.003; Lundgren JG, 2004, J INSECT PHYSIOL, V50, P567, DOI 10.1016/j.jinsphys.2004.04.003; Lundgren JG, 2002, ENVIRON ENTOMOL, V31, P1213, DOI 10.1603/0046-225X-31.6.1213; Marcon PCRG, 1999, J ECON ENTOMOL, V92, P279, DOI 10.1093/jee/92.2.279; Mc Lean Morven, 2011, Environmental Biosafety Research, V10, P51, DOI [10.1051/ebr/2012003, 10.1051/ebr:2012003]; Moser SE, 2008, ENVIRON ENTOMOL, V37, P525, DOI 10.1603/0046-225X(2008)37[525:LFOBHA]2.0.CO;2; Nakasu EYT, 2013, ENTOMOL EXP APPL, V148, P105, DOI 10.1111/eea.12082; Naranjo S. E., 2009, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V4, P1, DOI 10.1079/PAVSNNR20094011; Niu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072988; Obrycki JJ, 1998, ANNU REV ENTOMOL, V43, P295, DOI 10.1146/annurev.ento.43.1.295; Perry JN, 2013, ECOL MODEL, V268, P103, DOI 10.1016/j.ecolmodel.2013.08.004; Porcar M, 2010, B ENTOMOL RES, V100, P297, DOI 10.1017/S0007485309990290; Rauschen S, 2010, TRANSGENIC RES, V19, P13, DOI 10.1007/s11248-009-9301-0; Raybould A, 2013, TRANSGENIC RES, V22, P445, DOI 10.1007/s11248-012-9658-3; Ricroch A, 2010, TRANSGENIC RES, V19, P1, DOI 10.1007/s11248-009-9297-5; Romeis J, 2011, J APPL ENTOMOL, V135, P1, DOI 10.1111/j.1439-0418.2010.01546.x; Romeis J, 2008, NAT BIOTECHNOL, V26, P203, DOI 10.1038/nbt1381; Romeis J, 2013, NAT BIOTECHNOL, V31, P386, DOI 10.1038/nbt.2578; Romeis J, 2013, CHEMOSPHERE, V90, P901, DOI 10.1016/j.chemosphere.2012.09.035; Romeis Joerg, 2012, Environmental Sciences Europe, V24, P1, DOI 10.1186/2190-4715-24-18; Romeis J, 2011, TRANSGENIC RES, V20, P1, DOI 10.1007/s11248-010-9446-x; Rose R., 2007, WHITE PAPER TIER BAS; Sanvido O, 2012, ENVIRON SCI POLICY, V15, P82, DOI 10.1016/j.envsci.2011.08.006; Schmidt JEU, 2009, ARCH ENVIRON CON TOX, V56, P221, DOI 10.1007/s00244-008-9191-9; Song H., 1988, Natural Enemies of Insects, V10, P22; Tian JC, 2012, TRANSGENIC RES, V21, P1303, DOI 10.1007/s11248-012-9604-4; Wang YY, 2012, BIOL CONTROL, V61, P246, DOI 10.1016/j.biocontrol.2012.02.011; Wolfenbarger LL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002118; Yang J. H., 1983, Insect Knowledge (Kunchong Zhishi), V20, P215; Yu HL, 2011, J INTEGR PLANT BIOL, V53, P520, DOI 10.1111/j.1744-7909.2011.01047.x; Zhang Gui-Fen, 2004, Acta Entomologica Sinica, V47, P334; Zhang Qing-ling, 2013, Yingyong Shengtai Xuebao, V24, P1647; Zhang SY, 2006, J APPL ENTOMOL, V130, P206, DOI 10.1111/j.1439-0418.2006.01049.x; Zhou K., 1987, Natural Enemies of Insects, V9, P17; Zou Y. D., 1986, Insect Knowledge, V23, P219	54	27	33	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e85395	10.1371/journal.pone.0085395	http://dx.doi.org/10.1371/journal.pone.0085395			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409328	Green Published, Green Submitted, gold			2022-12-27	WOS:000329463500052
J	Li, M; Hotaling, NA; Ku, DN; Forest, CR				Li, Melissa; Hotaling, Nathan A.; Ku, David N.; Forest, Craig R.			Microfluidic Thrombosis under Multiple Shear Rates and Antiplatelet Therapy Doses	PLOS ONE			English	Article							VARIABLE PLATELET RESPONSE; VON-WILLEBRAND-FACTOR; FLOW-CHAMBER SYSTEM; ASPIRIN RESISTANCE; BLOOD-FLOW; MYOCARDIAL-INFARCTION; GLYCOPROTEIN IIB/IIIA; FUNCTION TESTS; EPTIFIBATIDE; CLOPIDOGREL	The mainstay of treatment for thrombosis, the formation of occlusive platelet aggregates that often lead to heart attack and stroke, is antiplatelet therapy. Antiplatelet therapy dosing and resistance are poorly understood, leading to potential incorrect and ineffective dosing. Shear rate is also suspected to play a major role in thrombosis, but instrumentation to measure its influence has been limited by flow conditions, agonist use, and non-systematic and/or non-quantitative studies. In this work we measured occlusion times and thrombus detachment for a range of initial shear rates (500, 1500, 4000, and 10000 s(-1)) and therapy concentrations (0-2.4 mu M for eptifibatide, 0-2 mM for acetyl-salicylic acid (ASA), 3.5-40 Units/L for heparin) using a microfluidic device. We also measured complete blood counts (CBC) and platelet activity using whole blood impedance aggregometry. Effects of shear rate and dose were analyzed using general linear models, logistic regressions, and Cox proportional hazards models. Shear rates have significant effects on thrombosis/dose-response curves for all tested therapies. ASA has little effect on high shear occlusion times, even at very high doses (up to 20 times the recommended dose). Under ASA therapy, thrombi formed at high shear rates were 4 times more prone to detachment compared to those formed under control conditions. Eptifibatide reduced occlusion when controlling for shear rate and its efficacy increased with dose concentration. In contrast, the hazard of occlusion from ASA was several orders of magnitude higher than that of eptifibatide. Our results show similar dose efficacy to our low shear measurements using whole blood aggregometry. This quantitative and statistically validated study of the effects of a wide range of shear rate and antiplatelet therapy doses on occlusive thrombosis contributes to more accurate understanding of thrombosis and to models for optimizing patient treatment.	[Li, Melissa; Hotaling, Nathan A.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Ku, David N.; Forest, Craig R.] Georgia Inst Technol, George W Woodruff Dept Mech Engn, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Li, M (corresponding author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.	melli@uw.edu	Ku, David N./X-5216-2019; Hotaling, Nathan/F-2763-2014	Ku, David N./0000-0002-6034-8004; Hotaling, Nathan/0000-0001-8423-6464	Wallace H. Coulter Foundation; Georgia Institute of Technology	Wallace H. Coulter Foundation; Georgia Institute of Technology	This study was made possible by the American Heart Association (10GRNT4430029), the Wallace H. Coulter Foundation Translational Grant, and by a fellowship from the Technological Innovation Generating Economic Results (TI:GER) program at the Georgia Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barron HV, 2000, CIRCULATION, V102, P2329, DOI 10.1161/01.CIR.102.19.2329; Barstad RM, 1996, THROMB HAEMOSTASIS, V75, P827; BARSTAD RM, 1994, ARTERIOSCLER THROMB, V14, P1984, DOI 10.1161/01.ATV.14.12.1984; Bernardo A, 2004, J THROMB HAEMOST, V2, P660, DOI 10.1111/j.1538-7836.2004.00661.x; Breet NJ, 2010, JAMA-J AM MED ASSOC, V303, P754, DOI 10.1001/jama.2010.181; Colace TV, 2012, ARTERIOSCL THROM VAS, V32, P1466, DOI 10.1161/ATVBAHA.112.249789; Conant Carolyn G, 2009, J Vis Exp, DOI 10.3791/1644; Dalby M, 2004, J AM COLL CARDIOL, V43, P162, DOI 10.1016/j.jacc.2003.08.033; Dimov IK, 2011, LAB CHIP, V11, P845, DOI [10.1039/c0lc00403k, 10.1039/c01c00403k]; Eikelboom JW, 2012, CHEST, V141, pE89S, DOI 10.1378/chest.11-2293; Eikelboom JW, 2003, J AM COLL CARDIOL, V41, P966, DOI 10.1016/S0735-1097(02)03013-9; Gasparyan AY, 2008, J AM COLL CARDIOL, V51, P1829, DOI 10.1016/j.jacc.2007.11.080; Giugliano RP, 2009, NEW ENGL J MED, V360, P2176, DOI 10.1056/NEJMoa0901316; Goto S, 2003, J THROMB HAEMOST, V1, P2022, DOI 10.1046/j.1538-7836.2003.00349.x; Grosser T., 2012, CIRCULATION; Gum PA, 2003, J AM COLL CARDIOL, V41, P961, DOI 10.1016/S0735-1097(02)03014-0; Gutierrez E, 2008, LAB CHIP, V8, P1486, DOI 10.1039/b804795b; Hanson SR, 1998, AM HEART J, V135, pS132, DOI 10.1016/S0002-8703(98)70241-8; Hofer CK, 2010, EXPERT REV MED DEVIC, V7, P625, DOI [10.1586/erd.10.29, 10.1586/ERD.10.29]; Hosokawa K, 2011, J THROMB HAEMOST, V9, P2029, DOI 10.1111/j.1538-7836.2011.04464.x; Hosokawa K, 2012, MICROVASC RES, V83, P154, DOI 10.1016/j.mvr.2011.11.007; Jackson SP, 2009, J THROMB HAEMOST, V7, P17, DOI 10.1111/j.1538-7836.2009.03401.x; Jackson SP, 2007, BLOOD, V109, P5087, DOI 10.1182/blood-2006-12-027698; Jackson SP, 2003, J THROMB HAEMOST, V1, P1602, DOI 10.1046/j.1538-7836.2003.00267.x; Kita A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026437; Kottke-Marchant K, 1999, CLIN APPL THROMB-HEM, V5, P122, DOI 10.1177/107602969900500209; Li M, 2011, P 15 INT C MIN CHEM, P541; Li M, 2012, LAB CHIP, V12, P1355, DOI 10.1039/c2lc21145a; Li RZ, 2013, CLIN CHEM, V59, P1195, DOI 10.1373/clinchem.2012.198101; Looney MR, 2009, J CLIN INVEST; Lordkipanidze M, 2007, EUR HEART J, V28, P1702, DOI 10.1093/eurheartj/ehm226; Lucitt MB, 2013, ANAL BIOANAL CHEM, V405, P4823, DOI 10.1007/s00216-013-6897-y; Magallon J, 2011, CIRCULATION, V123, P319, DOI 10.1161/CIRCULATIONAHA.110.951970; Maree AO, 2007, CIRCULATION, V115, P2196, DOI 10.1161/CIRCULATIONAHA.106.675991; Mendolicchio GL, 2011, J THROMB HAEMOST, V9, P373, DOI 10.1111/j.1538-7836.2010.04144.x; Michelson AD, 2004, CIRCULATION, V110, pE489, DOI 10.1161/01.CIR.0000147228.29325.F9; Millenium Pharmaceuticals Inc. Merck and Co. Inc., 2011, INT EPT INJ INTR ADM; Mueller MR, 1997, THROMB HAEMOSTASIS, V78, P1003; Neeves KB, 2008, J THROMB HAEMOST, V6, P2193, DOI 10.1111/j.1538-7836.2008.03188.x; Neeves KB, 2008, LAB CHIP, V8, P701, DOI 10.1039/b717824g; Neeves KB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054680; Nesbitt WS, 2009, NAT MED, V15, P665, DOI 10.1038/nm.1955; Neumann FJ, 2001, J AM COLL CARDIOL, V37, P1323, DOI 10.1016/S0735-1097(01)01165-2; Para A, 2011, ANN BIOMED ENG, V39, P1961, DOI 10.1007/s10439-011-0296-3; Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290; ROALD HE, 1994, ARTERIOSCLER THROMB, V14, P617, DOI 10.1161/01.ATV.14.4.617; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Savage B, 2002, P NATL ACAD SCI USA, V99, P425, DOI 10.1073/pnas.012459599; Sodemann A, 2009, P ANN M AM SOC PREC, P4; Storey RF, 1998, CIRCULATION, V98, P1616, DOI 10.1161/01.CIR.98.16.1616; Topol E, 1998, NEW ENGL J MED, V339, P436; Tovar-Lopez FJ, 2010, LAB CHIP, V10, P291, DOI 10.1039/b916757a; Tsai M, 2012, J CLIN INVEST, V122, P408, DOI 10.1172/JCI58753; TURNER NA, 1995, CIRCULATION, V91, P1354, DOI 10.1161/01.CIR.91.5.1354; Vane JR, 2003, THROMB RES, V110, P255, DOI 10.1016/S0049-3848(03)00379-7; VEEN G, 1993, J AM COLL CARDIOL, V22, P1755, DOI 10.1016/0735-1097(93)90754-O; Wang TH, 2006, EUR HEART J, V27, P647, DOI 10.1093/eurheartj/ehi684; Wootton DM, 1999, ANNU REV BIOMED ENG, V1, P299, DOI 10.1146/annurev.bioeng.1.1.299; Zhao R, 2007, BIORHEOLOGY, V44, P161; Zwaginga JJ, 2006, J THROMB HAEMOST, V4, P2716, DOI 10.1111/j.1538-7836.2006.02178.x	60	57	60	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e82493	10.1371/journal.pone.0082493	http://dx.doi.org/10.1371/journal.pone.0082493			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404131	Green Published, Green Submitted			2022-12-27	WOS:000329460800010
J	Ludecke, C; Jandt, KD; Siegismund, D; Kujau, MJ; Zang, E; Rettenmayr, M; Bossert, J; Roth, M				Luedecke, Claudia; Jandt, Klaus D.; Siegismund, Daniel; Kujau, Marian J.; Zang, Emerson; Rettenmayr, Markus; Bossert, Joerg; Roth, Martin			Reproducible Biofilm Cultivation of Chemostat-Grown Escherichia coli and Investigation of Bacterial Adhesion on Biomaterials Using a Non-Constant-Depth Film Fermenter	PLOS ONE			English	Article							TITANIUM THIN-FILMS; SURFACE-ROUGHNESS; MICROBIAL ADHESION; QUANTIFICATION; TOPOGRAPHY; ATTACHMENT; SOFTWARE; CULTURE; PROTEIN; IMPACT	Biomaterials-associated infections are primarily initiated by the adhesion of microorganisms on the biomaterial surfaces and subsequent biofilm formation. Understanding the fundamental microbial adhesion mechanisms and biofilm development is crucial for developing strategies to prevent such infections. Suitable in vitro systems for biofilm cultivation and bacterial adhesion at controllable, constant and reproducible conditions are indispensable. This study aimed (i) to modify the previously described constant-depth film fermenter for the reproducible cultivation of biofilms at non-depth-restricted, constant and low shear conditions and (ii) to use this system to elucidate bacterial adhesion kinetics on different biomaterials, focusing on biomaterials surface nanoroughness and hydrophobicity. Chemostat-grown Escherichia coli were used for biofilm cultivation on titanium oxide and investigating bacterial adhesion over time on titanium oxide, poly(styrene), poly(tetrafluoroethylene) and glass. Using chemostat-grown microbial cells (single-species continuous culture) minimized variations between the biofilms cultivated during different experimental runs. Bacterial adhesion on biomaterials comprised an initial lag-phase I followed by a fast adhesion phase II and a phase of saturation III. With increasing biomaterials surface nanoroughness and increasing hydrophobicity, adhesion rates increased during phases I and II. The influence of materials surface hydrophobicity seemed to exceed that of nanoroughness during the lag-phase I, whereas it was vice versa during adhesion phase II. This study introduces the non-constant-depth film fermenter in combination with a chemostat culture to allow for a controlled approach to reproducibly cultivate biofilms and to investigate bacterial adhesion kinetics at constant and low shear conditions. The findings will support developing and adequate testing of biomaterials surface modifications eventually preventing biomaterial-associated infections.	[Luedecke, Claudia; Kujau, Marian J.; Zang, Emerson; Roth, Martin] HKI, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany; [Luedecke, Claudia; Jandt, Klaus D.; Bossert, Joerg] Univ Jena, Fac Phys & Astron, Chair Mat Sci, D-07743 Jena, Germany; [Siegismund, Daniel; Rettenmayr, Markus] Univ Jena, Dept Metall Mat, Otto Schott Inst Mat Res OSIM, Jena, Germany	Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Jandt, KD (corresponding author), Univ Jena, Fac Phys & Astron, Chair Mat Sci, Max Wien Pl 1, D-07743 Jena, Germany.	k.jandt@uni-jena.de; martin.roth@hki-jena.de	Jandt, Klaus D./C-8077-2016	Jandt, Klaus D./0000-0002-7537-5603	Excellence Graduate School "Jena School for Microbial Communication"; Thuringer Ministerium fur Bildung, Wissenschaft und Kultur TMBWK); German Excellence Initiative; Deutsche Forschungsgemeinschaft (DFG) [INST 275/241-1 FUGG]; Thuringer Ministerium fur Bildung, Wissenschaft und Kultur (TMBWK) [62-4264 925/1/10/1/01]	Excellence Graduate School "Jena School for Microbial Communication"; Thuringer Ministerium fur Bildung, Wissenschaft und Kultur TMBWK); German Excellence Initiative; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Thuringer Ministerium fur Bildung, Wissenschaft und Kultur (TMBWK)	This work was supported by the Excellence Graduate School "Jena School for Microbial Communication" (JSMC MikroInter supported by the Thuringer Ministerium fur Bildung, Wissenschaft und Kultur TMBWK) which is funded by the German Excellence Initiative. KDJ gratefully acknowledges, furthermore, the partial financial support of the Deutsche Forschungsgemeinschaft (DFG), grant reference INST 275/241-1 FUGG, and of the Thuringer Ministerium fur Bildung, Wissenschaft und Kultur (TMBWK), grant reference 62-4264 925/1/10/1/01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker DP, 2004, MICROBIOL-SGM, V150, P1779, DOI 10.1099/mic.0.26983-0; Bayoudh S, 2006, MAT SCI ENG C-BIO S, V26, P300, DOI 10.1016/j.msec.2005.10.045; Boks NP, 2008, MICROBIOL-SGM, V154, P3122, DOI 10.1099/mic.0.2008/018622-0; Boland T., 2000, HDB BACTERIAL ADHESI, P29; Bruinsma GM, 2001, BIOMATERIALS, V22, P3217, DOI 10.1016/S0142-9612(01)00159-4; BUCKINGHAMMEYER K, 2003, BIOFILM LAB STEP BY, P31; Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528; Cai KY, 2006, COLLOID SURFACE B, V49, P136, DOI 10.1016/j.colsurfb.2006.02.016; Cai KY, 2005, APPL SURF SCI, V250, P252, DOI 10.1016/j.apsusc.2005.01.013; Chen MY, 2010, BIOCHEM ENG J, V53, P121, DOI 10.1016/j.bej.2010.10.003; Christensen G.D., HDB BACTERIAL ADHESI, V1st ed., P213; Coenye T, 2010, J MICROBIOL METH, V83, P89, DOI 10.1016/j.mimet.2010.08.018; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; de Paz LEC, 2009, APPL ENVIRON MICROB, V75, P1734, DOI 10.1128/AEM.02000-08; Gadelmawla ES, 2002, J MATER PROCESS TECH, V123, P133, DOI 10.1016/S0924-0136(02)00060-2; Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004; GILBERT P, 1991, J ANTIMICROB CHEMOTH, V27, P550, DOI 10.1093/jac/27.4.550; Goeres, 2003, BIOFILM LAB STEP BY, P13; Goeres DM, 2009, NAT PROTOC, V4, P783, DOI 10.1038/nprot.2009.59; GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258; Hoffmann AS, 2004, INTRO MAT MED, P197; Honraet K, 2005, J MICROBIOL METH, V63, P287, DOI 10.1016/j.mimet.2005.03.014; Hope CK, 2012, J APPL MICROBIOL, V113, P601, DOI 10.1111/j.1365-2672.2012.05368.x; Hoskisson PA, 2005, MICROBIOL-SGM, V151, P3153, DOI 10.1099/mic.0.27924-0; Ivanova EP, 2010, LANGMUIR, V26, P1973, DOI 10.1021/la902623c; JASS J, 1995, J IND MICROBIOL, V15, P283, DOI 10.1007/BF01569981; Katsikogianni M, 2004, Eur Cell Mater, V8, P37; Kinniment SL, 1996, J APPL BACTERIOL, V81, P120, DOI 10.1111/j.1365-2672.1996.tb04488.x; Kinniment SL, 1996, MICROBIOL-SGM, V142, P631, DOI 10.1099/13500872-142-3-631; LIN FYH, 1993, J COLLOID INTERF SCI, V159, P86, DOI 10.1006/jcis.1993.1300; Lorite GS, 2011, J COLLOID INTERF SCI, V359, P289, DOI 10.1016/j.jcis.2011.03.066; Ludecke C, 2013, APPL SURF SCI, V280, P578, DOI 10.1016/j.apsusc.2013.05.030; Lynch AS, 2008, ANNU REV MED, V59, P415, DOI 10.1146/annurev.med.59.110106.132000; MAURER R, 1980, J MOL BIOL, V139, P147, DOI 10.1016/0022-2836(80)90302-2; McBain AJ, 2003, J APPL MICROBIOL, V94, P655, DOI 10.1046/j.1365-2672.2003.01876.x; MCCOY WF, 1981, CAN J MICROBIOL, V27, P910, DOI 10.1139/m81-143; Mitik-Dineva N, 2009, CURR MICROBIOL, V58, P268, DOI 10.1007/s00284-008-9320-8; Mitik-Dineva Natasa, 2008, Biotechnology Journal, V3, P536, DOI 10.1002/biot.200700244; Morgan TD, 2001, J APPL MICROBIOL, V91, P47, DOI 10.1046/j.1365-2672.2001.01338.x; Necas D, 2012, CENT EUR J PHYS, V10, P181, DOI 10.2478/s11534-011-0096-2; Noimark S, 2009, CHEM SOC REV, V38, P3435, DOI 10.1039/b908260c; Ong YL, 1999, LANGMUIR, V15, P2719, DOI 10.1021/la981104e; PETERS AC, 1988, BIOTECHNOL BIOENG, V32, P263, DOI 10.1002/bit.260320302; Peterson BW, 2012, APPL ENVIRON MICROB, V78, P120, DOI 10.1128/AEM.06780-11; Poncin-Epaillard F, 2013, MAT SCI ENG C-MATER, V33, P1152, DOI 10.1016/j.msec.2012.12.020; Pratten Jonathan, 2007, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01b05s6; Puckett SD, 2010, BIOMATERIALS, V31, P706, DOI 10.1016/j.biomaterials.2009.09.081; Siegismund D, 2014, ACTA BIOMATER, V10, P267, DOI 10.1016/j.actbio.2013.09.016; Singh AV, 2013, J NANOSCI NANOTECHNO, V13, P77, DOI 10.1166/jnn.2013.6727; Stewart PS, 2001, J APPL MICROBIOL, V91, P525, DOI 10.1046/j.1365-2672.2001.01413.x; Subbiahdoss G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024827; Taylor J.R., 1997, INTRO ERROR ANAL STU, P181; Truong VK, 2010, BIOMATERIALS, V31, P3674, DOI 10.1016/j.biomaterials.2010.01.071; Webb HK, 2013, BIOFOULING, V29, P163, DOI 10.1080/08927014.2012.757697; Webb HK, 2012, SCANNING, V34, P257, DOI 10.1002/sca.21002; WENZEL RN, 1949, J PHYS COLLOID CHEM, V53, P1466, DOI 10.1021/j150474a015; Wu Y, 2011, BIOMATERIALS, V32, P951, DOI 10.1016/j.biomaterials.2010.10.001; Zanin ICJ, 2005, J ANTIMICROB CHEMOTH, V56, P324, DOI 10.1093/jac/dki232	59	32	36	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84837	10.1371/journal.pone.0084837	http://dx.doi.org/10.1371/journal.pone.0084837			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404192	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460800071
J	Peinemann, F; Tushabe, DA; Kleijnen, J				Peinemann, Frank; Tushabe, Doreen Allen; Kleijnen, Jos			Using Multiple Types of Studies in Systematic Reviews of Health Care Interventions - A Systematic Review	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIALS; CLINICAL-TRIALS; OBSERVATIONAL DATA; MEDICAL INTERVENTIONS; THERAPY; CANCER; OUTCOMES; DESIGN; GENERALIZABILITY; CHALLENGES	Background: A systematic review may evaluate different aspects of a health care intervention. To accommodate the evaluation of various research questions, the inclusion of more than one study design may be necessary. One aim of this study is to find and describe articles on methodological issues concerning the incorporation of multiple types of study designs in systematic reviews on health care interventions. Another aim is to evaluate methods studies that have assessed whether reported effects differ by study types. Methods and Findings: We searched PubMed, the Cochrane Database of Systematic Reviews, and the Cochrane Methodology Register on 31 March 2012 and identified 42 articles that reported on the integration of single or multiple study designs in systematic reviews. We summarized the contents of the articles qualitatively and assessed theoretical and empirical evidence. We found that many examples of reviews incorporating multiple types of studies exist and that every study design can serve a specific purpose. The clinical questions of a systematic review determine the types of design that are necessary or sufficient to provide the best possible answers. In a second independent search, we identified 49 studies, 31 systematic reviews and 18 trials that compared the effect sizes between randomized and nonrandomized controlled trials, which were statistically different in 35%, and not different in 53%. Twelve percent of studies reported both, different and non-different effect sizes. Conclusions: Different study designs addressing the same question yielded varying results, with differences in about half of all examples. The risk of presenting uncertain results without knowing for sure the direction and magnitude of the effect holds true for both nonrandomized and randomized controlled trials. The integration of multiple study designs in systematic reviews is required if patients should be informed on the many facets of patient relevant issues of health care interventions.	[Peinemann, Frank; Kleijnen, Jos] Univ Maastricht, Sch Publ Hlth & Primary Care, Maastricht, Netherlands; [Peinemann, Frank] Univ Cologne, Childrens Hosp, D-50931 Cologne, Germany; [Tushabe, Doreen Allen] Univ Birmingham, Dept Publ Hlth Epidemiol & Biostat, Birmingham, W Midlands, England; [Kleijnen, Jos] Kleijnen Systemat Reviews Ltd, York, N Yorkshire, England	Maastricht University; University of Cologne; University of Birmingham; Kleijnen Systematic Reviews	Peinemann, F (corresponding author), Univ Maastricht, Sch Publ Hlth & Primary Care, Maastricht, Netherlands.	pubmedprjournal@gmail.com	Peinemann, Frank/H-2800-2019	Peinemann, Frank/0000-0002-4727-1313				Abraham NS, 2010, J CLIN EPIDEMIOL, V63, P238, DOI 10.1016/j.jclinepi.2009.04.005; Algra AM, 2012, LANCET ONCOL, V13, P518, DOI 10.1016/S1470-2045(12)70112-2; ANTMAN K, 1985, J CLIN ONCOL, V3, P1142, DOI 10.1200/JCO.1985.3.8.1142; AOKI K, 1994, AM J REPROD IMMUNOL, V32, P55; ARCHAMPONG D, 2012, COCHRANE DB SYST REV, V3; Aslani N, 2010, HERNIA, V14, P455, DOI 10.1007/s10029-010-0705-9; Atkins D, 2007, MED CARE, V45, pS16, DOI 10.1097/MLR.0b013e3180616c3f; Austvoll-Dahlgren A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007017; Benis Marilyn M, 2002, Adv Neonatal Care, V2, P259, DOI 10.1016/S1536-0903(02)70003-9; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; Bhandari M, 2004, ARCH ORTHOP TRAUM SU, V124, P10, DOI 10.1007/s00402-003-0559-z; Black N, 1996, BRIT MED J, V312, P1215; Britton A, 1998, HLTH TECHNOLOGY ASSE, V2, P1; Carroll D, 1996, BRIT J ANAESTH, V77, P798, DOI 10.1093/bja/77.6.798; *CEBM, 2009, LEV EV; Chambers D, 2010, EUR J VASC ENDOVASC, V39, P26, DOI 10.1016/j.ejvs.2009.09.010; Chambers D, 2009, J CLIN EPIDEMIOL, V62, P1253, DOI 10.1016/j.jclinepi.2008.12.010; Cheng Y, 2012, HEPATO-GASTROENTEROL, V59, P1727, DOI 10.5754/hge11688; Choi HJ, 2012, NEONATOLOGY, V101, P183, DOI 10.1159/000329822; Chou R, 2010, J CLIN EPIDEMIOL, V63, P502, DOI 10.1016/j.jclinepi.2008.06.007; Chumbler NR, 2008, TELEMED J E-HEALTH, V14, P986, DOI 10.1089/tmj.2008.0108; CLAGETT GP, 1984, SURGERY, V96, P823; COLDITZ GA, 1989, STAT MED, V8, P441, DOI 10.1002/sim.4780080408; Conaty S, 2004, VACCINE, V22, P3214, DOI 10.1016/j.vaccine.2003.08.050; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Concato J, 2010, AM J MED, V123, pE16, DOI 10.1016/j.amjmed.2010.10.004; Concato J, 2010, J INVEST MED, V58, P764, DOI 10.231/JIM.0b013e3181e3d2af; Deeks J J, 2003, Health Technol Assess, V7, piii; Djulbegovic B, 2011, JAMA-J AM MED ASSOC, V305, P2005, DOI 10.1001/jama.2011.650; Djulbegovic M, 2011, JAMA-J AM MED ASSOC, V305, P298, DOI 10.1001/jama.2010.2013; Edwards JP, 2012, CAN J SURG, V55, P155, DOI 10.1503/cjs.023410; Essock SM, 2003, SCHIZOPHRENIA BULL, V29, P115, DOI 10.1093/oxfordjournals.schbul.a006981; Fletcher AE, 2009, AM J OPHTHALMOL, V147, P384, DOI 10.1016/j.ajo.2008.04.024; Fletcher RH, 2002, J CLIN EPIDEMIOL, V55, P1183, DOI 10.1016/S0895-4356(02)00525-5; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; Franklin ME, 2000, J CONSULT CLIN PSYCH, V68, P594, DOI 10.1037//0022-006X.68.4.594; Fraser Cynthia, 2006, BMC Med Res Methodol, V6, P41, DOI 10.1186/1471-2288-6-41; Furlan AD, 2008, SPINE, V33, P339, DOI 10.1097/BRS.0b013e31816233b5; Furlan AD, 2008, J CLIN EPIDEMIOL, V61, P209, DOI 10.1016/j.jclinepi.2007.04.019; Gale RP, 2009, BONE MARROW TRANSPL, V43, P435, DOI 10.1038/bmt.2008.447; Golder S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001026; Gross CP, 2005, J CLIN EPIDEMIOL, V58, P130, DOI 10.1016/j.jclinepi.2004.10.001; Grzeskowiak LE, 2012, REPROD TOXICOL, V33, P280, DOI 10.1016/j.reprotox.2012.01.006; Guyatt GH, 2000, J CLIN EPIDEMIOL, V53, P167, DOI 10.1016/S0895-4356(99)00160-2; Hadley Gina, 2009, J Pain Palliat Care Pharmacother, V23, P106, DOI 10.1080/15360280902899921; Hadley J, 2010, JNCI-J NATL CANCER I, V102, P1780, DOI 10.1093/jnci/djq393; Hannan EL, 2008, JACC-CARDIOVASC INTE, V1, P211, DOI 10.1016/j.jcin.2008.01.008; Hartling L, 2005, ANN INTERN MED, V142, P1100, DOI 10.7326/0003-4819-142-12_Part_2-200506211-00010; Haynes B, 1999, BRIT MED J, V319, P652, DOI 10.1136/bmj.319.7211.652; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; HLATKY MA, 1988, J AM COLL CARDIOL, V11, P237, DOI 10.1016/0735-1097(88)90086-1; Hodgson R, 2007, BRIT J PSYCHIAT, V191, pS78, DOI 10.1192/bjp.191.50.s78; Hoppe DJ, 2009, J BONE JOINT SURG AM, V91A, P2, DOI 10.2106/JBJS.H.01571; Horn SD, 2010, STUD HEALTH TECHNOL, V151, P446, DOI 10.3233/978-1-60750-476-4-446; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V286, P821, DOI 10.1001/jama.286.7.821; Kovesdy CP, 2012, ADV CHRONIC KIDNEY D, V19, P11, DOI 10.1053/j.ackd.2011.09.004; Kunz R, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000012.pub2; Kunz R, 1998, BRIT MED J, V317, P1185, DOI 10.1136/bmj.317.7167.1185; Kuss O, 2011, J CLIN EPIDEMIOL, V64, P1076, DOI 10.1016/j.jclinepi.2011.01.005; Lawlor DA, 2004, LANCET, V363, P1724, DOI 10.1016/S0140-6736(04)16260-0; Lewsey J D, 2000, Health Technol Assess, V4, P1; Linde K, 2002, J CLIN EPIDEMIOL, V55, P77, DOI 10.1016/S0895-4356(01)00422-X; MacLehose R R, 2000, Health Technol Assess, V4, P1; McCarthy CM, 2008, PLAST RECONSTR SURG, V122, P1942, DOI 10.1097/PRS.0b013e31818d2098; Mercer SL, 2007, AM J PREV MED, V33, P139, DOI 10.1016/j.amepre.2007.04.005; MITCHELL AA, 1995, DRUG SAFETY, V13, P15, DOI 10.2165/00002018-199513010-00003; Muller D, 2010, J CLIN EPIDEMIOL, V63, P1082, DOI 10.1016/j.jclinepi.2009.12.009; Naudet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020811; *NCBI, 2011, MESH EP STUD CHAR TO; *NCBI, 2011, MESH RAND CONTR TRIA; Norris SL, 2005, ANN INTERN MED, V142, P1112, DOI 10.7326/0003-4819-142-12_Part_2-200506211-00011; Norris SL, 2011, J CLIN EPIDEMIOL, V64, P1178, DOI 10.1016/j.jclinepi.2010.04.027; Odgaard-Jensen J, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000012.pub3; Ogilvie D, 2005, J EPIDEMIOL COMMUN H, V59, P886, DOI 10.1136/jech.2005.034199; Olivier P, 2006, PHARMACOEPIDEM DR S, V15, P808, DOI 10.1002/pds.1248; Papanikolaou PN, 2006, CAN MED ASSOC J, V174, P635, DOI 10.1503/cmaj.050873; Phillips AN, 1999, AIDS, V13, P2075, DOI 10.1097/00002030-199910220-00010; Pibouleau L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4538; Reeves B., 2011, COCHRANE HDB SYSTEMA, V510; Reeves BC, 2005, EUR J CLIN NUTR, V59, pS155, DOI 10.1038/sj.ejcn.1602190; Rosendaal FR, 2001, CURR CONTR TRIALS C, V2, P109; Rovers MM, 2001, J CLIN EPIDEMIOL, V54, P789, DOI 10.1016/S0895-4356(01)00340-7; Savovic J, 2012, ANN INTERN MED, V157, P429, DOI 10.7326/0003-4819-157-6-201209180-00537; Schmoor C, 2008, AM J EPIDEMIOL, V167, P1120, DOI 10.1093/aje/kwn010; Sharma V, 2012, J ROY SOC MED, V105, P11, DOI 10.1258/jrsm.2011.110236; Shea MK, 2010, J GERONTOL A-BIOL, V65, P519, DOI 10.1093/gerona/glp217; Shikata S, 2006, ANN SURG, V244, P668, DOI 10.1097/01.sla.0000225356.04304.bc; Shrier I, 2007, AM J EPIDEMIOL, V166, P1203, DOI 10.1093/aje/kwm189; Silverman SL, 2009, AM J MED, V122, P114, DOI 10.1016/j.amjmed.2008.09.030; Tzoulaki I, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6829; Vandenbroucke JP, 2008, PLOS MED, V5, P339, DOI 10.1371/journal.pmed.0050067; Vandenbroucke JP, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7020; Vandenbroucke JP, 2009, LANCET, V373, P1233, DOI 10.1016/S0140-6736(09)60708-X; Vandenbroucke JP, 2004, LANCET, V363, P1728, DOI 10.1016/S0140-6736(04)16261-2; Vandenbroucke JP, 1998, J CLIN EPIDEMIOL, V51, P467; Victora CG, 2004, AM J PUBLIC HEALTH, V94, P400, DOI 10.2105/AJPH.94.3.400; Vis AN, 2008, EUR UROL, V53, P91, DOI 10.1016/j.eururo.2007.06.001; Wilcken B, 2001, J INHERIT METAB DIS, V24, P291, DOI 10.1023/A:1010387522195; Wilkes MM, 2010, OSTEOPOROSIS INT, V21, P679, DOI 10.1007/s00198-009-0991-1; Wolfe F, 2004, ANN RHEUM DIS, V63, P13, DOI 10.1136/ard.2004.028530; Zlowodzki M, 2006, MED PRIN PRACT, V15, P1, DOI 10.1159/000089379; 1984, J AM COLL CARDIOL, V3, P114, DOI DOI 10.1016/S0735-1097(84)80437-4.PUBMED:6361099	103	64	64	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e85035	10.1371/journal.pone.0085035	http://dx.doi.org/10.1371/journal.pone.0085035			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281QS	24416098	Green Published, Green Submitted, gold			2022-12-27	WOS:000329116700128
J	Curciarello, R; Smaldini, PL; Candreva, AM; Gonzalez, V; Parisi, G; Cauerhff, A; Barrios, I; Blanch, LB; Fossati, CA; Petruccelli, S; Docena, GH				Curciarello, Renata; Smaldini, Paola L.; Candreva, Angela M.; Gonzalez, Virginia; Parisi, Gustavo; Cauerhff, Ana; Barrios, Ivana; Bruno Blanch, Luis; Fossati, Carlos A.; Petruccelli, Silvana; Docena, Guillermo H.			Targeting a Cross-Reactive Gly m 5 Soy Peptide as Responsible for Hypersensitivity Reactions in a Milk Allergy Mouse Model	PLOS ONE			English	Article							IGG-BINDING EPITOPES; COWS MILK; BETA-CONGLYCININ; SECONDARY-STRUCTURE; FOOD ALLERGY; ALPHA-SUBUNIT; PROTEIN; PREDICTION; IDENTIFICATION; SEQUENCE	Background: Cross-reactivity between soybean allergens and bovine caseins has been previously reported. In this study we aimed to map epitopes of the major soybean allergen Gly m 5 that are co-recognized by casein specific antibodies, and to identify a peptide responsible for the cross-reactivity. Methods: Cow's milk protein (CMP)-specific antibodies were used in different immunoassays (immunoblotting, ELISA, ELISA inhibition test) to evaluate the in vitro recognition of soybean proteins (SP). Recombinant Gly m 5 (alpha), a truncated fragment containing the C-terminal domain (alpha-T) and peptides of alpha-T were obtained and epitope mapping was performed with an overlapping peptide assay. Bioinformatics tools were used for epitope prediction by sequence alignment, and for modelling the cross-recognized soy proteins and peptides. The binding of SP to a monoclonal antibody was studied by surface Plasmon resonance (SPR). Finally, the in vivo cross-recognition of SP was assessed in a mouse model of milk allergy. Results: Both alpha and alpha-T reacted with the different CMP-specific antibodies. alpha-T contains IgG and IgE epitopes in several peptides, particularly in the peptide named PA. Besides, we found similar values of association and dissociation constants between the alpha-casein specific mAb and the different milk and soy components. The food allergy mouse model showed that SP and PA contain the cross-reactive B and T epitopes, which triggered hypersensitivity reactions and a Th2-mediated response on CMP-sensitized mice. Conclusions: Gly m 5 is a cross-reactive soy allergen and the alpha-T portion of the molecule contains IgG and IgE immunodominant epitopes, confined to PA, a region with enough conformation to be bound by antibodies. These findings contribute to explain the intolerance to SP observed in IgE-mediated CMA patients, primarily not sensitised to SP, as well as it sets the basis to propose a mucosal immunotherapy for milk allergy using this soy peptide.	[Curciarello, Renata; Smaldini, Paola L.; Candreva, Angela M.; Fossati, Carlos A.; Docena, Guillermo H.] Univ Nacl La Plata, Fac Ciencias Exactas, Dept Ciencias Biol, Lab Invest Sistema Inmune LISIN, Buenos Aires, DF, Argentina; [Gonzalez, Virginia; Parisi, Gustavo] Univ Nacl Quilmes, Dept Ciencias & Tecnol, Ctr Estudios & Invest, Buenos Aires, DF, Argentina; [Cauerhff, Ana] UNLP, Ctr Invest & Desarrollo Fermentac Ind, CINDEFI, Buenos Aires, DF, Argentina; [Cauerhff, Ana] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Cauerhff, Ana] Fdn Inst Leloir, CONICET, IIBBA, Buenos Aires, DF, Argentina; [Barrios, Ivana; Bruno Blanch, Luis] Univ Nacl La Plata, Fac Ciencias Exactas, Dept Ciencias Biol, Catedra Quim Med, Buenos Aires, DF, Argentina; [Curciarello, Renata; Candreva, Angela M.; Petruccelli, Silvana; Docena, Guillermo H.] Univ Nacl La Plata, Fac Ciencias Exactas, CIDCA, Buenos Aires, DF, Argentina	National University of La Plata; National University of La Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; National University of La Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata	Docena, GH (corresponding author), Univ Nacl La Plata, Fac Ciencias Exactas, Dept Ciencias Biol, Lab Invest Sistema Inmune LISIN, Buenos Aires, DF, Argentina.	guidoc@biol.unlp.edu.ar	Petruccelli, Silvana/A-3083-2012; Petruccelli, Silvana/AAC-6826-2019	Petruccelli, Silvana/0000-0002-7072-0076; Petruccelli, Silvana/0000-0002-7072-0076; parisi, gustavo/0000-0001-7444-1624; Smaldini, Paola/0000-0002-2734-516X; Cauerhff, Ana/0000-0001-9686-9883; Gonzalez, Virginia/0000-0002-1725-001X; Candreva, Angela Maria/0000-0002-3407-9904	Consejo Nacional de Investigaciones Cientificas y Tecnicas de Argentina (CONICET) [PIP 5475]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT2007-0049, PICT 2010-2366, PICT 2008-2202]; Universidad Nacional de La Plata, Argentina [X498, X455]	Consejo Nacional de Investigaciones Cientificas y Tecnicas de Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Universidad Nacional de La Plata, Argentina(National University of La Plata)	This work was supported by the Consejo Nacional de Investigaciones Cientificas y Tecnicas de Argentina (CONICET) (grant PIP 5475), by Agencia Nacional de Promocion Cientifica y Tecnologica (grants PICT2007-0049 and PICT 2010-2366 to SP, PICT 2008-2202 to GHD) and by Universidad Nacional de La Plata, Argentina (grants X498 to SP and X455 to CAF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostoni C, 2006, J PEDIATR GASTR NUTR, V42, P352, DOI 10.1097/01.mpg.0000189358.38427.cd; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ballmer-Weber BK, 2007, J ALLERGY CLIN IMMUN, V119, P1489, DOI 10.1016/j.jaci.2007.01.049; Bhatia J, 2008, PEDIATRICS, V121, P1062, DOI 10.1542/peds.2008-0564; Cerecedo I, 2008, J ALLERGY CLIN IMMUN, V122, P589, DOI 10.1016/j.jaci.2008.06.040; Ceska M, 1981, Methods Enzymol, V73, P646; Chatchatee P, 2001, J ALLERGY CLIN IMMUN, V107, P379, DOI 10.1067/mai.2001.112372; Chatchatee P, 2001, CLIN EXP ALLERGY, V31, P1256, DOI 10.1046/j.1365-2222.2001.01167.x; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Cocco RR, 2003, J ALLERGY CLIN IMMUN, V112, P433, DOI 10.1067/mai.2003.1617; Codina R, 2002, CLIN EXP ALLERGY, V32, P1059, DOI 10.1046/j.1365-2222.2002.01411.x; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; COOK CD, 1960, NEW ENGL J MED, V263, P1076, DOI 10.1056/NEJM196011242632109; Curciarello R, 2008, CLIN EXP ALLERGY, V38, P1559, DOI 10.1111/j.1365-2222.2008.03062.x; Docena G, 2002, ALLERGY, V57, P83, DOI 10.1034/j.1398-9995.2002.1o3219.x; Docena GH, 1996, ALLERGY, V51, P412, DOI 10.1111/j.1398-9995.1996.tb04639.x; Dupont Christophe, 2011, Ann Nutr Metab, V59 Suppl 1, P8, DOI 10.1159/000334145; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; Fiocchi A, 2010, PEDIAT ALLERG IMM-UK, V21, P1, DOI [10.1097/WOX.0b013e3181defeb9, 10.1111/j.1399-3038.2010.01068.x]; Fu CJJ, 2007, J AGR FOOD CHEM, V55, P4014, DOI 10.1021/jf070211o; Handlogten MW, 2012, ACS CHEM BIOL, V7, P1796, DOI 10.1021/cb300193f; Holzhauser T, 2009, J ALLERGY CLIN IMMUN, V123, P452, DOI 10.1016/j.jaci.2008.09.034; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Jo S, 2008, NUCLEIC ACIDS RES, V36, pW270, DOI 10.1093/nar/gkn314; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768; Klemola T, 2002, J PEDIATR-US, V140, P219, DOI 10.1067/mpd.2002.121935; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; Koletzko S, 2012, J PEDIATR GASTR NUTR, V55, P221, DOI 10.1097/MPG.0b013e31825c9482; Krishnan HB, 2009, J AGR FOOD CHEM, V57, P938, DOI 10.1021/jf802451g; Marti-Renom MA, 2002, STRUCTURE, V10, P435, DOI 10.1016/S0969-2126(02)00731-1; Mills ENC, 2002, BIOCHEM SOC T, V30, P925, DOI 10.1042/BST0300925; Nallamsetty S, 2005, PROTEIN SCI, V14, P2964, DOI 10.1110/ps.051718605; OGAWA T, 1995, BIOSCI BIOTECH BIOCH, V59, P831, DOI 10.1271/bbb.59.831; Ogawa T, 2000, J NUTR SCI VITAMINOL, V46, P271, DOI 10.3177/jnsv.46.271; PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013; Peters B, 2005, PLOS BIOL, V3, P379, DOI 10.1371/journal.pbio.0030091; Petrucelli S, FOOD AGR IMMUNOL, V16, P17; Rona RJ, 2007, J ALLERGY CLIN IMMUN, V120, P638, DOI 10.1016/j.jaci.2007.05.026; Rozenfeld P, 2002, CLIN EXP IMMUNOL, V130, P49, DOI 10.1046/j.1365-2249.2002.t01-1-01935.x; Sicherer SH, 2011, MT SINAI J MED, V78, P683, DOI 10.1002/msj.20292; Smaldini P, 2012, INT ARCH ALLERGY IMM, V158, P335, DOI 10.1159/000333562; Vila L, 2001, CLIN EXP ALLERGY, V31, P1599, DOI 10.1046/j.1365-2222.2001.01218.x; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Zeiger RS, 1999, J PEDIATR-US, V134, P614, DOI 10.1016/S0022-3476(99)70249-0	47	16	16	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e82341	10.1371/journal.pone.0082341	http://dx.doi.org/10.1371/journal.pone.0082341			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416141	Green Published, gold, Green Submitted			2022-12-27	WOS:000329866300010
J	Durso, DF; Bydlowski, SP; Hutz, MH; Suarez-Kurtz, G; Magalhaes, TR; Pena, SDJ				Durso, Danielle Fernandes; Bydlowski, Sergio Paulo; Hutz, Mara Helena; Suarez-Kurtz, Guilherme; Magalhaes, Tiago R.; Junho Pena, Sergio Danilo			Association of Genetic Variants with Self-Assessed Color Categories in Brazilians	PLOS ONE			English	Article							HUMAN PIGMENTATION; GENOMIC ANCESTRY; SKIN COLOR; TRANSPORTER PROTEIN; POPULATION; SLC24A5; PHENOTYPE; GENOTYPE; POLYMORPHISMS; DETERMINANTS	The Brazilian population was formed by extensive admixture of three different ancestral roots: Amerindians, Europeans and Africans. Our previous work has shown that at an individual level, ancestry, as estimated using molecular markers, was a poor predictor of color in Brazilians. We now investigate if SNPs known to be associated with human skin pigmentation can be used to predict color in Brazilians. For that, we studied the association of fifteen SNPs, previously known to be linked with skin color, in 243 unrelated Brazilian individuals self-identified as White, Browns or Blacks from Rio de Janeiro and 212 unrelated Brazilian individuals self-identified as White or Blacks from Sao Paulo. The significance of association of SNP genotypes with self-assessed color was evaluated using partial regression analysis. After controlling for ancestry estimates as covariates, only four SNPs remained significantly associated with skin pigmentation: rs1426654 and rs2555364 within SLC24A5, rs16891982 at SLC45A2 and rs1042602 at TYR. These loci are known to be involved in melanin synthesis or transport of melanosomes. We found that neither genotypes of these SNPs, nor their combination with biogeographical ancestry in principal component analysis, could predict self-assessed color in Brazilians at an individual level. However, significant correlations did emerge at group level, demonstrating that even though elements other than skin, eye and hair pigmentation do influence self-assessed color in Brazilians, the sociological act of self-classification is still substantially dependent of genotype at these four SNPs.	[Durso, Danielle Fernandes; Junho Pena, Sergio Danilo] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Bydlowski, Sergio Paulo] Univ Sao Paulo, Fac Med, Lab Genet & Hematol Mol, Sao Paulo, Brazil; [Hutz, Mara Helena] Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil; [Suarez-Kurtz, Guilherme] Inst Nacl Canc INCA, Coordenacao Pesquisa Div Farmacol, Rio De Janeiro, RJ, Brazil; [Magalhaes, Tiago R.; Junho Pena, Sergio Danilo] Univ Fed Minas Gerais, Fac Med, Lab Genom Clin, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade de Sao Paulo; Universidade Federal do Rio Grande do Sul; National Cancer Institute (Inca); Universidade Federal de Minas Gerais	Pena, SDJ (corresponding author), Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil.	spena@dcc.ufmg.br	Hutz, Mara H/I-4070-2012; Suarez-Kurtz, Guilherme/P-4620-2019; Suarez-Kurtz, Guilherme/J-6648-2012	Suarez-Kurtz, Guilherme/0000-0002-1115-8319; Suarez-Kurtz, Guilherme/0000-0002-1115-8319; R Magalhaes, Tiago/0000-0002-5528-2119; Bydlowski, Sergio Paulo/0000-0002-7582-5942; Hutz, Mara/0000-0002-9146-1229	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Comissao de Aperfeicoamento de Pessoal de Nivel Superior (Capes); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Comissao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by grants from the following Brazilian agencies: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Comissao de Aperfeicoamento de Pessoal de Nivel Superior (Capes), and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastos João Luiz, 2008, Rev. Saúde Pública, V42, P324, DOI 10.1590/S0034-89102008005000005; Bastos-Rodrigues L, 2006, ANN HUM GENET, V70, P658, DOI 10.1111/j.1469-1809.2006.00287.x; Beleza S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003372; Beleza S, 2013, MOL BIOL EVOL, V30, P24, DOI 10.1093/molbev/mss207; Bonilla C, 2005, HUM GENET, V116, P402, DOI 10.1007/s00439-004-1251-2; Branicki W, 2009, ANN HUM GENET, V73, P160, DOI 10.1111/j.1469-1809.2009.00504.x; Bydlowski SP, 2003, FORENSIC SCI INT, V135, P67, DOI 10.1016/S0379-0738(03)00174-9; Cheng KC, 2006, EXP DERMATOL, V15, P836, DOI 10.1111/j.1600-0625.2006.00491.x; Cook AL, 2009, J INVEST DERMATOL, V129, P392, DOI 10.1038/jid.2008.211; Fukamachi S, 2001, NAT GENET, V28, P381, DOI 10.1038/ng584; Gaunt TR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-428; Giardina E, 2008, CURR GENOMICS, V9, P110, DOI 10.2174/138920208784139528; Ginger RS, 2008, J BIOL CHEM, V283, P5486, DOI 10.1074/jbc.M707521200; Goncalves VF, 2008, HUM HERED, V65, P23, DOI 10.1159/000106059; Graf J, 2005, HUM MUTAT, V25, P278, DOI 10.1002/humu.20143; Guimaraes ASA, 1996, RACA CIENCIA SOCIEDA, P143; Han JS, 2008, CELL MOL NEUROBIOL, V28, P5, DOI 10.1007/s10571-007-9211-8; Inagaki K, 2006, PIGM CELL RES, V19, P451, DOI 10.1111/j.1600-0749.2006.00332.x; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Nan H, 2009, J INVEST DERMATOL, V129, P2250, DOI 10.1038/jid.2009.62; Nikamo P, 2012, EXP DERMATOL, V21, P221, DOI 10.1111/j.1600-0625.2011.01423.x; Norton HL, 2007, MOL BIOL EVOL, V24, P710, DOI 10.1093/molbev/msl203; Osorio RG, 2003, SISTEMA CLASSIFICATO, P51; Ossorio PN, 2006, J LAW MED ETHICS, V34, P277, DOI 10.1111/j.1748-720X.2006.00033.x; Park HY, 1999, J BIOL CHEM, V274, P16470, DOI 10.1074/jbc.274.23.16470; Parra FC, 2003, P NATL ACAD SCI USA, V100, P177, DOI 10.1073/pnas.0126614100; Pena SDJ, 2009, BRAZ J MED BIOL RES, V42, P870, DOI 10.1590/S0100-879X2009005000026; Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063; Petruccelli JL, 2007, BRAZILIAN ETHNORACIA; Pimenta JR, 2006, HUM HERED, V62, P190, DOI 10.1159/000096872; Pneuman A, 2012, LEGAL MED-TOKYO, V14, P78, DOI 10.1016/j.legalmed.2011.12.005; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2021, R LANGUAGE ENV STAT; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Spichenok O, 2011, FORENSIC SCI INT-GEN, V5, P472, DOI 10.1016/j.fsigen.2010.10.005; Stokowski RP, 2007, AM J HUM GENET, V81, P1119, DOI 10.1086/522235; Sturm RA, 2009, PIGM CELL MELANOMA R, V22, P544, DOI 10.1111/j.1755-148X.2009.00606.x; Sturm RA, 2009, HUM MOL GENET, V18, pR9, DOI 10.1093/hmg/ddp003; Suarez-Kurtz G, 2007, PHARMACOGENOMICS, V8, P1299, DOI 10.2217/14622416.8.10.1299; Suarez-Kurtz G, 2007, PHARMACOGENET GENOM, V17, P765, DOI 10.1097/FPC.0b013e3281c10e52; Sulem P, 2008, NAT GENET, V40, P835, DOI 10.1038/ng.160; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Telles EE, 2002, ETHNIC RACIAL STUD, V25, P415, DOI 10.1080/01419870252932133; TRIPATHI RK, 1992, J BIOL CHEM, V267, P23707; Tsetskhladze ZR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047398; Tully G, 2007, FORENSIC SCI INT-GEN, V1, P105, DOI 10.1016/j.fsigen.2007.01.005; Valenzuela RK, 2011, J FORENSIC RES, V2, P1; Valenzuela RK, 2010, J FORENSIC SCI, V55, P315, DOI 10.1111/j.1556-4029.2009.01317.x; Visser M, 2012, GENOME RES, V22, P446, DOI 10.1101/gr.128652.111; Weber JL, 2002, AM J HUM GENET, V71, P854, DOI 10.1086/342727	51	31	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83926	10.1371/journal.pone.0083926	http://dx.doi.org/10.1371/journal.pone.0083926			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416183	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500085
J	Gaillard, PJ; Appeldoorn, CCM; Dorland, R; van Kregten, J; Manca, F; Vugts, DJ; Windhorst, B; van Dongen, GAMS; de Vries, HE; Maussang, D; van Tellingen, O				Gaillard, Pieter J.; Appeldoorn, Chantal C. M.; Dorland, Rick; van Kregten, Joan; Manca, Francesca; Vugts, Danielle J.; Windhorst, Bert; van Dongen, Guus A. M. S.; de Vries, Helga E.; Maussang, David; van Tellingen, Olaf			Pharmacokinetics, Brain Delivery, and Efficacy in Brain Tumor-Bearing Mice of Glutathione Pegylated Liposomal Doxorubicin (2B3-101)	PLOS ONE			English	Article							MALIGNANT GLIOMA; CHEMOTHERAPY; TRANSPORT; BARRIER; CELLS; MODEL; BIODISTRIBUTION; ADRIAMYCIN; PACLITAXEL; METASTASES	Brain cancer is a devastating disease affecting many people worldwide. Effective treatment with chemotherapeutics is limited due to the presence of the blood-brain barrier (BBB) that tightly regulates the diffusion of endogenous molecules but also xenobiotics. Glutathione pegylated liposomal doxorubicin (2B3-101) is being developed as a new treatment option for patients with brain cancer. It is based on already marketed pegylated liposomal doxorubicin (Doxil (R)/Caelyx (R)), with an additional glutathione coating that safely enhances drug delivery across the BBB. Uptake of 2B3-101 by human brain capillary endothelial cells in vitro was time-, concentration-and temperature-dependent, while pegylated liposomal doxorubicin mainly remained bound to the cells. In vivo, 2B3-101 and pegylated liposomal doxorubicin had a comparable plasma exposure in mice, yet brain retention 4 days after administration was higher for 2B3-101. 2B3-101 was overall well tolerated by athymic FVB mice with experimental human glioblastoma (luciferase transfected U87MG). In 2 independent experiments a strong inhibition of brain tumor growth was observed for 2B3-101 as measured by bioluminescence intensity. The effect of weekly administration of 5 mg/kg 2B3-101 was more pronounced compared to pegylated liposomal doxorubicin (p<0.05) and saline (p<0.01). Two out of 9 animals receiving 2B3-101 showed a complete tumor regression. Twice-weekly injections of 5 mg/kg 2B3-101 again had a significant effect in inhibiting brain tumor growth (p<0.001) compared to pegylated liposomal doxorubicin and saline, and a complete regression was observed in 1 animal treated with 2B3-101. In addition, twice-weekly dosing of 2B3-101 significantly increased the median survival time by 38.5% (p<0.001) and 16.1% (p<0.05) compared to saline and pegylated liposomal doxorubicin, respectively. Overall, these data demonstrate that glutathione pegylated liposomal doxorubicin enhances the effective delivery of doxorubicin to brain tumors and could become a promising new therapeutic option for the treatment of brain malignancies.	[Gaillard, Pieter J.; Appeldoorn, Chantal C. M.; Dorland, Rick; van Kregten, Joan; Manca, Francesca; Maussang, David] To BBB Technol BV, Leiden, Netherlands; [Vugts, Danielle J.; Windhorst, Bert; van Dongen, Guus A. M. S.] Vrije Univ Amsterdam Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands; [de Vries, Helga E.] Vrije Univ Amsterdam Med Ctr, Blood Brain Barrier Res Grp, Amsterdam, Netherlands; [van Tellingen, Olaf] Antoni van Leeuwenhoek Hosp NKI AvL, Netherlands Canc Inst, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Netherlands Cancer Institute	Gaillard, PJ (corresponding author), To BBB Technol BV, Leiden, Netherlands.	PieterGaillard@toBBB.com	Van Tellingen, Olaf/A-1344-2014	Van Tellingen, Olaf/0000-0002-1037-6269; de Vries, Helga/0000-0001-7904-7124; Vugts, Danielle/0000-0001-7068-8152; Windhorst, Albert/0000-0002-1250-7656	to-BBB technologies BV; to-BBB technologies	to-BBB technologies BV; to-BBB technologies	All of the work presented in this manuscript was supported by to-BBB technologies BV (http://www.tobbb.com/). DJ Vugts, B Windhorst, GAMS van Dongen, HE de Vries, and O van Tellingen have received research funding from to-BBB technologies for their part of the work. Other than through the scientific input of their participating employees, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2013, DRUG METAB DISPOS, V41, P33, DOI 10.1124/dmd.112.048322; Anders CK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061359; [Anonymous], 2012, Drug Discov Today Technol, V9, pe71, DOI 10.1016/j.ddtec.2011.12.002; Arnold RD, 2005, CLIN CANCER RES, V11, P8856, DOI 10.1158/1078-0432.CCR-05-1365; Aryal M, 2013, J CONTROL RELEASE, V169, P103, DOI 10.1016/j.jconrel.2013.04.007; Barenholz Y, 2012, J CONTROL RELEASE, V160, P117, DOI 10.1016/j.jconrel.2012.03.020; Block KI, 2008, INT J CANCER, V123, P1227, DOI 10.1002/ijc.23754; Che C, 2010, J MED CHEM, V53, P2814, DOI 10.1021/jm9016637; Dai HQ, 2003, J PHARMACOL EXP THER, V304, P1085, DOI 10.1124/jpet.102.045260; de Boer AG, 2007, ANNU REV PHARMACOL, V47, P323, DOI 10.1146/annurev.pharmtox.47.120505.105237; de Vries Nienke A, 2006, Expert Rev Neurother, V6, P1199, DOI 10.1586/14737175.6.8.1199; Fabel K, 2001, CANCER, V92, P1936, DOI 10.1002/1097-0142(20011001)92:7<1936::AID-CNCR1712>3.0.CO;2-H; Fidler IJ, 2011, SEMIN CANCER BIOL, V21, P107, DOI 10.1016/j.semcancer.2010.12.009; Gaillard PJ, 2012, J CONTROL RELEASE, V164, P364, DOI 10.1016/j.jconrel.2012.06.022; Gaillard PJ, 2013, DRUG DELIVERY BRAIN; Glas M, 2007, ONCOLOGY-BASEL, V72, P302, DOI 10.1159/000113052; Hau P, 2004, CANCER, V100, P1199, DOI 10.1002/cncr.20073; Joshi G, 2010, NEUROSCIENCE, V166, P796, DOI 10.1016/j.neuroscience.2010.01.021; Kannan R, 2000, BRAIN RES, V852, P374, DOI 10.1016/S0006-8993(99)02184-8; KANNAN R, 1990, J CLIN INVEST, V85, P2009, DOI 10.1172/JCI114666; Kemper EM, 2006, EUR J CANCER, V42, P3294, DOI 10.1016/j.ejca.2006.07.013; Klerk CPW, 2007, BIOTECHNIQUES, V43, P7, DOI 10.2144/000112515; Kurzrock R, 2009, MOL CANCER THER, V8, DOI 10.1158/1535-7163.TARG-09-B168; Kurzrock R, 2012, MOL CANCER THER, V11, P308, DOI 10.1158/1535-7163.MCT-11-0566; La Rocca RV, 2011, EXPERT OPIN PHARMACO, V12, P1325, DOI 10.1517/14656566.2011.580737; Laquintana V, 2009, EXPERT OPIN DRUG DEL, V6, P1017, DOI 10.1517/17425240903167942; Lesniak MS, 2005, ANTICANCER RES, V25, P3825; Liedtke C, 2010, BREAST CANCER RES TR, V121, P301, DOI 10.1007/s10549-009-0445-7; Lindqvist A, 2013, MOL PHARMACEUT, V10, P1533, DOI 10.1021/mp300272a; Lu-Emerson Christine, 2012, Continuum (Minneap Minn), V18, P295, DOI 10.1212/01.CON.0000413659.12304.a6; O'Brien MER, 2004, ANN ONCOL, V15, P440, DOI 10.1093/annonc/mdh097; Palmieri D, 2007, CLIN CANCER RES, V13, P1656, DOI 10.1158/1078-0432.CCR-06-2659; Pardridge WM, 2007, PHARM RES, V24, P1729, DOI 10.1007/s11095-007-9387-0; Perry J, 2007, Curr Oncol, V14, P189, DOI 10.3747/co.2007.147; Regina A, 2008, BRIT J PHARMACOL, V155, P185, DOI 10.1038/bjp.2008.260; Rip J, 2010, PHARM TOX BLOOD BRAI; SIEGAL T, 1995, J NEUROSURG, V83, P1029, DOI 10.3171/jns.1995.83.6.1029; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tardi PG, 1996, J DRUG TARGET, V4, P129, DOI 10.3109/10611869609015970; Tosoni A, 2008, CRIT REV ONCOL HEMAT, V68, P212, DOI 10.1016/j.critrevonc.2008.04.004; van Asperen J, 1998, J CHROMATOGR B, V712, P129, DOI 10.1016/S0378-4347(98)00165-0; VONHOLST H, 1990, ACTA NEUROCHIR, V104, P13, DOI 10.1007/BF01842886; Voulgaris S, 2002, AM J CLIN ONCOL-CANC, V25, P60, DOI 10.1097/00000421-200202000-00013; Walbert T, 2009, INT J CLIN ONCOL, V14, P299, DOI 10.1007/s10147-009-0916-1; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Whitaker G, 2010, J PHARMACEUT BIOMED, V53, P490, DOI 10.1016/j.jpba.2010.05.023; Wolff JEA, 1999, J CANCER RES CLIN, V125, P481, DOI 10.1007/s004320050305; ZLOKOVIC BV, 1994, BIOCHEM BIOPH RES CO, V201, P402, DOI 10.1006/bbrc.1994.1715	48	151	159	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e82331	10.1371/journal.pone.0082331	http://dx.doi.org/10.1371/journal.pone.0082331			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416140	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500014
J	Kurihara, C; Kusuoka, H; Ono, S; Kakee, N; Saito, K; Takehara, K; Tsujide, K; Nabeoka, Y; Sakuhiro, T; Aoki, H; Morishita, N; Suzuki, C; Kachi, S; Kondo, E; Komori, Y; Isobe, T; Kageyama, S; Watanabe, H				Kurihara, Chieko; Kusuoka, Hideo; Ono, Shunsuke; Kakee, Naoko; Saito, Kazuyuki; Takehara, Kenji; Tsujide, Kiyokazu; Nabeoka, Yuzo; Sakuhiro, Takuya; Aoki, Hiroshi; Morishita, Noriko; Suzuki, Chieko; Kachi, Shigeo; Kondo, Emiko; Komori, Yukiko; Isobe, Tetsu; Kageyama, Shigeru; Watanabe, Hiroshi			High Rate of Awarding Compensation for Claims of Injuries Related to Clinical Trials by Pharmaceutical Companies in Japan: A Questionnaire Survey	PLOS ONE			English	Article							POLICIES	Introduction: International norms and ethical standards have suggested that compensation for research-related injury should be provided to injured research volunteers. However, statistical data of incidence of compensation claims and the rate of awarding them have been rarely reported. Method: Questionnaire surveys were sent to pharmaceutical companies and medical institutions, focusing on industry-initiated clinical trials aiming at new drug applications (NDAs) on patient volunteers in Japan. Results: With the answers from pharmaceutical companies, the incidence of compensation was 0.8%, including 0.06% of monetary compensation. Of the cases of compensation claims, 99% were awarded. In turn, with the answers from medical institutions, the incidence of compensation was 0.6%, including 0.4% of serious but not death cases, and 0.04% of death cases. Furthermore, most claims for compensation were initiated by medical institutions, rather than by the patients. On the other hand, with the answers from clinical trial volunteers, 3% of respondents received compensations. These compensated cases were 25% of the injuries which cannot be ruled out from the scope of compensation. Conclusion: Our study results demonstrated that Japanese pharmaceutical companies have provided a high rate of compensation for clinical trial-related injuries despite the possibility of overestimation. In the era of global clinical development, our study indicates the importance of further surveys to find each country's compensation policy by determining how it is being implemented based on a survey of the actual status of compensation coming from statistical data.	[Kurihara, Chieko] Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 260, Japan; [Kusuoka, Hideo] Osaka Natl Hosp, Natl Hosp Org, Osaka, Japan; [Ono, Shunsuke] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan; [Kakee, Naoko; Takehara, Kenji] Natl Ctr Child Hlth & Dev, Dept Hlth Policy, Tokyo, Japan; [Saito, Kazuyuki] Pharmaceut & Med Devices Agcy, Off OTC Gener Drugs, Tokyo, Japan; [Tsujide, Kiyokazu; Aoki, Hiroshi] Japan Pharmaceut Manufacturers Assoc, Drug Evaluat Comm, Clin Evaluat Expert Comm, Tokyo, Japan; [Nabeoka, Yuzo] Chugai Pharmaceut Co Ltd, Clin Res Coordinat Dept, Tokyo, Japan; [Sakuhiro, Takuya] Mitsubishi Tanabe Pharma Corp, Dev Div, Tokyo, Japan; [Morishita, Noriko] Osaka Natl Hosp, Natl Hosp Org, Adm Ctr Clin Trials, Inst Clin Res, Osaka, Japan; [Suzuki, Chieko; Kachi, Shigeo] Hamamatsu Univ Sch Med, Clin Res Ctr, Hamamatsu, Shizuoka 4313192, Japan; [Kondo, Emiko] Pharmaceut & Med Devices Agcy, Off Conform Audit, Tokyo, Japan; [Komori, Yukiko] Pharmaceut & Med Devices Agcy, Off New Drug CNS PNS Anesthesia 3, Tokyo, Japan; [Isobe, Tetsu] Keio Univ, Keio Law Sch, Tokyo, Japan; [Kageyama, Shigeru] Jikei Univ, Sch Med, Div Clin Pharmacol & Therapeut, Tokyo, Japan; [Watanabe, Hiroshi] Hamamatsu Univ Sch Med, Dept Clin Pharmacol & Therapeut, Hamamatsu, Shizuoka 4313192, Japan	National Institutes for Quantum Science & Technology; Osaka National Hospital; University of Tokyo; National Center for Child Health & Development - Japan; Chugai Pharmaceutical Co., Ltd.; Roche Holding; Mitsubishi Tanabe Pharma Corporation; Osaka National Hospital; Hamamatsu University School of Medicine; Keio University; Jikei University; Hamamatsu University School of Medicine	Kurihara, C (corresponding author), Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 260, Japan.	chieko.kurihara@nifty.ne.jp		Takehara, Kenji/0000-0002-5957-600X	Ministry of Health, Labor and Welfare	Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan)	This survey was conducted as the task force titled "Research on protection of human subjects concerning clinical trial-related injuries", in the area of the grant for "General research project on regulatory science for drug and medical device" by the Ministry of Health, Labor and Welfare, in the fiscal year 2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, OFFICIAL J EUROPEA L, VL121, P34; [Anonymous], 2004, GUID COMP INJ RES PA; Association of the British Pharmaceutical Industry (ABPI), 1991, CLIN TRIAL COMP GUID; Association of the British Pharmaceutical Industry (ABPI), 1988, GUID MED EXP NONP HU; Bavdekar S B, 2009, Indian J Med Sci, V63, P455; CARDON PV, 1976, NEW ENGL J MED, V295, P650, DOI 10.1056/NEJM197609162951205; *CIOMS, 2002, INT ETH GUID BIOM RE; Council of Europe, 2005, EUR TREAT SER, V195; Department of Health, 2006, GUID GOOD PRACT COND; Gainotti S, 2010, J CLIN RES BIOETH, V1, P101, DOI [10.4172/2155-9627.1000101, DOI 10.4172/2155-9627.1000101]; hhs, 1979, BELM REP ETH PRINC G; International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH, 1996, ICH HARM TRIP GUID G; Japanese Pharmaceutical Industry Legal & Business Affairs Association, 2009, LEGAL MIND S, V35, P60; Japanese Pharmaceutical Industry Legal & Business Affairs Association, 2009, LEGAL MIND S, V35, P6; Kurihara C, 2011, RINSHO HYOKA CLIN EV, V39, P31; Ministry of Health and Family Welfare Government of India. The Drugs and Cosmetics (First Amendment) Rules, 2013, INS APP 12 COMP CAS; Ministry of Health and Welfare Japan, 1997, MIN ORD GOOD CLIN PR; Ministry of Health Labour and Welfare Japan, 2008, ETH GUID CLIN RES; Ministry of Health Singapore, 2007, NAT MED ETH COMM GUI; Munshi Renuka, 2013, Perspect Clin Res, V4, P61, DOI 10.4103/2229-3485.106392; Nabeoka Y, 2012, PHARM STAGE, V12, P26; Office for Drug-Induced Damages Pharmaceutical and Food Safety Bureau Ministry of Health Labor and Welfare, 8 STUD COMM REL HLTH; Paasche-Ortow MK, 2005, AM J MED, V118, P175, DOI 10.1016/j.amjmed.2004.03.045; President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, 1982, COMP RES INJ ETH LEG; Resnik DB, 2006, J LEGAL MED, V27, P263, DOI 10.1080/01947640600870866; ROYLE JM, 1986, BRIT J CLIN PHARMACO, V21, P548, DOI 10.1111/j.1365-2125.1986.tb02842.x; Slack C, 2012, S AFR J BIOETH LAW, V5, P91, DOI 10.7196/SAJBL.211; SPEIRS CJ, 1983, BRIT J CLIN PHARMACO, V15, P649, DOI 10.1111/j.1365-2125.1983.tb01545.x; Thatte UM, 2009, J MED ETHICS, V35, P133, DOI 10.1136/jme.2008.025155; The Association of the British Pharmaceutical Industry (ABPI), 2007, GUID PHAS 1 CLIN TRI; The Association of the British Pharmaceutical Industry (ABPI) BioIndustry Association Clinical Contract Research Association, 2012, INS COMP EV INJ PHAS; The Researched Medicines Industry Association of New Zealand Inc, 2008, RES MED IND GUID CLI; Watanabe H, 2011, RINSHO HYOKA CLIN EV, V39, P5; ZARAFONETIS CJD, 1978, CLIN PHARMACOL THER, V24, P127	34	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84998	10.1371/journal.pone.0084998	http://dx.doi.org/10.1371/journal.pone.0084998			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416332	Green Submitted, gold, Green Published			2022-12-27	WOS:000329862500204
J	McFarlin, KM; Prince, RC; Perkins, R; Leigh, MB				McFarlin, Kelly M.; Prince, Roger C.; Perkins, Robert; Leigh, Mary Beth			Biodegradation of Dispersed Oil in Arctic Seawater at-1 degrees C	PLOS ONE			English	Article							CRUDE-OIL; PETROLEUM-HYDROCARBONS; COREXIT 9500; BACTERIAL COMMUNITIES; N-ALKANES; BIOREMEDIATION; SEA; SPILL; DEGRADATION; MICROORGANISMS	As offshore oil and gas exploration expands in the Arctic, it is important to expand the scientific understanding of arctic ecology and environmental impact to mitigate operational risks. Understanding the fate of oil in arctic seawater is a key factor for consideration. Here we report the chemical loss due to the biodegradation of Alaska North Slope (ANS) crude oil that would occur in the water column following the successful dispersion of a surface oil slick. Primary biodegradation and mineralization were measured in mesocosms containing Arctic seawater collected from the Chukchi Sea, Alaska, incubated at -1 degrees C. Indigenous microorganisms degraded both fresh and weathered oil, in both the presence and absence of Corexit 9500, with oil losses ranging from 46-61% and up to 11% mineralization over 60 days. When tested alone, 14% of 50 ppm Corexit 9500 was mineralized within 60 days. Our study reveals that microorganisms indigenous to Arctic seawater are capable of performing extensive biodegradation of chemically and physically dispersed oil at an environmentally relevant temperature (-1 degrees C) without any additional nutrients.	[McFarlin, Kelly M.; Leigh, Mary Beth] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK 99775 USA; [Prince, Roger C.] ExxonMobil Biomed Sci Inc, Annandale, NJ USA; [Perkins, Robert] Univ Alaska Fairbanks, Inst Northern Engn, Fairbanks, AK USA	University of Alaska System; University of Alaska Fairbanks; Exxon Mobil Corporation; University of Alaska System; University of Alaska Fairbanks	McFarlin, KM (corresponding author), Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK 99775 USA.	kmmcfarlin@alaska.edu		Prince, Roger/0000-0002-5174-4216; McFarlin, Kelly/0000-0002-1543-7649	Shell; ExxonMobil; Statoil; ConocoPhillips; BP; National Institute of General Medical Sciences of the National Institutes of Health [P20GM103395]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103395] Funding Source: NIH RePORTER	Shell(Royal Dutch Shell); ExxonMobil(Exxon Mobil Corporation); Statoil; ConocoPhillips; BP; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was part of a Joint Industry Program funded by Shell, ExxonMobil, Statoil, ConocoPhillips and BP. Additional support was provided by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number P20GM103395. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATLAS RM, 1981, ESTUAR COAST SHELF S, V12, P589, DOI 10.1016/S0302-3524(81)80085-0; Baelum J, 2012, ENVIRON MICROBIOL, V14, P2405, DOI 10.1111/j.1462-2920.2012.02780.x; Belore R, 2005, SPILL SCI TECHNOL B; Belore RC, 2009, MAR POLLUT BULL, V58, P118, DOI 10.1016/j.marpolbul.2008.08.013; BRAGG JR, 1994, NATURE, V368, P413, DOI 10.1038/368413a0; Brakstad OG, 2006, BIODEGRADATION, V17, P71, DOI 10.1007/s10532-005-3342-8; Bushnell LD, 1941, J BACTERIOL, V41, P653, DOI 10.1128/JB.41.5.653-673.1941; Chakraborty R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00357; Codispoti LA, 2005, DEEP-SEA RES PT II, V52, P3199, DOI 10.1016/j.dsr2.2005.10.007; Davies L, 2001, BIODEGRADABILITY CHE; DAVIS JB, 1964, APPL MICROBIOL, V12, P210, DOI 10.1128/AEM.12.3.210-214.1964; Delille D, 1998, POLAR BIOL, V19, P237, DOI 10.1007/s003000050240; Deppe U, 2005, EXTREMOPHILES, V9, P461, DOI 10.1007/s00792-005-0463-2; Douglas G. S., 1992, Journal of Soil Contamination, V1, P197, DOI 10.1080/15320389209383411; ExxonMobil Corporation, 2013, AL N SLOP CRUD OIL; FOGHT JM, 1983, CAN J MICROBIOL, V29, P623, DOI 10.1139/m83-099; Garrett RM, 2003, SPILL SCI TECHNOL B, V8, P297, DOI 10.1016/S1353-2561(03)00037-9; Gerdes B, 2005, FEMS MICROBIOL ECOL, V53, P129, DOI 10.1016/j.femsec.2004.11.010; Government Accountability Office, 2012, GAO12585; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Lee K, 2013, MAR POLLUT BULL, V73, P314, DOI 10.1016/j.marpolbul.2013.06.005; Lessard RR, 2000, SPILL SCI TECHNOL B, V6, P59, DOI 10.1016/S1353-2561(99)00061-4; Li ZK, 2009, MAR POLLUT BULL, V58, P735, DOI 10.1016/j.marpolbul.2008.12.014; Lindstrom JE, 2002, MAR POLLUT BULL, V44, P739, DOI 10.1016/S0025-326X(02)00050-4; Lunel T, 1997, P 1997 INT OIL SPILL, P185; Mazzella N, 2005, J CHROMATOGR B, V822, P40, DOI 10.1016/j.jchromb.2005.05.014; Mearns AJ, 1997, SPILL SCI TECHNOL B, V4, P209, DOI 10.1016/S1353-2561(98)00026-7; MULKINSPHILLIPS GJ, 1974, CAN J MICROBIOL, V20, P955, DOI 10.1139/m74-147; Nalco, 2011, COREXIT INGREDIENTS; National Research Council, 1993, IN SIT BIOR DOES IT; National Research Council, 2005, OIL SPILL DISPERSANT; National Research Council, 2003, OIL SEA INP FAT EFF; OECD, 1992, TEST 301 READ BIOD O, DOI [10.1787/9789264070349-en, DOI 10.1787/9789264070349-EN]; Pelletier E, 2004, MAR ENVIRON RES, V57, P311, DOI 10.1016/j.marenvres.2003.07.001; PRINCE RC, 1994, ENVIRON SCI TECHNOL, V28, P142, DOI 10.1021/es00050a019; Prince RC, 2003, SPILL SCI TECHNOL B, V8, P303, DOI 10.1016/S1353-2561(03)00036-7; Prince RC., 2010, HDB HYDROCARBON LIPI, P1672; Prince RC, 2014, ENVIRON SCI POLLUT R, V21, P9506, DOI 10.1007/s11356-013-2053-7; Prince RC, 2013, CHEMOSPHERE, V90, P521, DOI 10.1016/j.chemosphere.2012.08.020; Ron EZ, 2002, CURR OPIN BIOTECH, V13, P249, DOI 10.1016/S0958-1669(02)00316-6; Rontani J. F., 2010, HDB HYDROCARBON LIPI, V34, P460; Santas R, 1999, MAR POLLUT BULL, V38, P44, DOI 10.1016/S0025-326X(98)00084-8; SIRON R, 1995, ARCH ENVIRON CON TOX, V28, P406, DOI 10.1007/BF00211621; Swannell RPJ, 1997, PROCEEDINGS OF THE TWENTIETH ARCTIC AND MARINE OILSPILL PROGRAM (AMOP) TECHNICAL SEMINAR, VOLS 1 AND 2, P617; Tavassoli T, 2012, FUEL, V93, P142, DOI 10.1016/j.fuel.2011.10.021; Tissot B.P., 1984, PETROLEUM FORMATION, DOI 10.1007/978-3-642-96446-6; Uribe-Alvarez C, 2011, MICROB BIOTECHNOL, V4, P663, DOI 10.1111/j.1751-7915.2011.00269.x; Venosa AD, 2007, MAR POLLUT BULL, V54, P545, DOI 10.1016/j.marpolbul.2006.12.013; Zahed MA, 2011, J HAZARD MATER, V185, P1027, DOI 10.1016/j.jhazmat.2010.10.009	49	94	95	2	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84297	10.1371/journal.pone.0084297	http://dx.doi.org/10.1371/journal.pone.0084297			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416211	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500109
J	Pacico, N; Mingorance-Le Meur, A				Pacico, Nathalie; Mingorance-Le Meur, Ana			New In Vitro Phenotypic Assay for Epilepsy: Fluorescent Measurement of Synchronized Neuronal Calcium Oscillations	PLOS ONE			English	Article							CULTURED HIPPOCAMPAL-NEURONS; ANTIEPILEPTIC DRUG DEVELOPMENT; HUMAN NEOCORTICAL SLICES; EPILEPTIFORM DISCHARGES; CORTICAL-NEURONS; RAT HIPPOCAMPUS; ANIMAL-MODELS; IDENTIFICATION; LEVETIRACETAM; RETIGABINE	Research in the epilepsy field is moving from a primary focus on controlling seizures to addressing disease pathophysiology. This requires the adoption of resource- and time-consuming animal models of chronic epilepsy which are no longer able to sustain the testing of even moderate numbers of compounds. Therefore, new in vitro functional assays of epilepsy are needed that are able to provide a medium throughput while still preserving sufficient biological context to allow for the identification of compounds with new modes of action. Here we describe a robust and simple fluorescence-based calcium assay to measure epileptiform network activity using rat primary cortical cultures in a 96-well format. The assay measures synchronized intracellular calcium oscillations occurring in the population of primary neurons and is amenable to medium throughput screening. We have adapted this assay format to the low magnesium and the 4-aminopyridine epilepsy models and confirmed the contribution of voltage-gated ion channels and AMPA, NMDA and GABA receptors to epileptiform activity in both models. We have also evaluated its translatability using a panel of antiepileptic drugs with a variety of modes of action. Given its throughput and translatability, the calcium oscillations assay bridges the gap between simplified target-based screenings and compound testing in animal models of epilepsy. This phenotypic assay also has the potential to be used directly as a functional screen to help identify novel antiepileptic compounds with new modes of action, as well as pathways with previously unknown contribution to disease pathophysiology.	[Pacico, Nathalie; Mingorance-Le Meur, Ana] UCB Pharma, Neurosci Therapeut Area, Braine Lalleud, Belgium	UCB Pharma SA	Mingorance-Le Meur, A (corresponding author), UCB Pharma, Neurosci Therapeut Area, Braine Lalleud, Belgium.	ana.mingorance@ucb.com		Mingorance, Ana/0000-0002-6213-6160	UCB Pharma SA	UCB Pharma SA(UCB Pharma SA)	This work was funded by UCB Pharma SA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias RL, 2005, BRAIN RES, V1047, P233, DOI 10.1016/j.brainres.2005.04.052; Arkin MR, 2004, NBK92012; AVOLI M, 1993, J NEUROPHYSIOL, V70, P1018, DOI 10.1152/jn.1993.70.3.1018; Bacci A, 1999, EUR J NEUROSCI, V11, P389, DOI 10.1046/j.1460-9568.1999.00440.x; Blair RE, 2009, NEUROPHARMACOLOGY, V57, P208, DOI 10.1016/j.neuropharm.2009.06.007; DeLorenzo RJ, 2000, EPILEPSIA, V41, pS40, DOI 10.1111/j.1528-1157.2000.tb06048.x; Dost R, 2000, EPILEPSY RES, V38, P53; Dravid SM, 2004, BRAIN RES, V1006, P8, DOI 10.1016/j.brainres.2004.01.059; Eggert US, 2013, NAT CHEM BIOL, V9, P206, DOI 10.1038/nchembio.1206; FUETA Y, 1992, EPILEPSY RES, V12, P207, DOI 10.1016/0920-1211(92)90075-5; Galanopoulou AS, 2012, EPILEPSIA, V53, P571, DOI 10.1111/j.1528-1167.2011.03391.x; Gorji A, 2002, EPILEPSIA, V43, P1480, DOI 10.1046/j.1528-1157.2002.23702.x; Heinemann U, 2006, MODELS OF SEIZURES AND EPILEPSY, P35, DOI 10.1016/B978-012088554-1/50006-2; Hemstapat Kamondanai, 2004, Journal of Pharmacological and Toxicological Methods, V49, P81, DOI 10.1016/j.vascn.2003.10.002; Kobow K, 2012, EPILEPSIA, V53, P1868, DOI 10.1111/j.1528-1167.2012.03716.x; Kupferberg H, 2001, EPILEPSIA, V42, P7, DOI 10.1046/j.1528-1157.2001.0420s4007.x; LaRoche SM, 2004, JAMA-J AM MED ASSOC, V291, P605, DOI 10.1001/jama.291.5.605; Loscher W, 2006, EPILEPSY RES, V69, P183, DOI 10.1016/j.eplepsyres.2006.03.014; Loscher W, 2011, EPILEPSIA, V52, P657, DOI 10.1111/j.1528-1167.2011.03024.x; LOSCHER W, 1988, EPILEPSY RES, V2, P145, DOI 10.1016/0920-1211(88)90054-X; LOSCHER W, 1994, EPILEPSY RES, V17, P95, DOI 10.1016/0920-1211(94)90012-4; Loscher Wolfgang, 2002, Novartis Found Symp, V243, P149; Lucke A, 1998, BRIT J PHARMACOL, V124, P370, DOI 10.1038/sj.bjp.0701825; Mangan PS, 2004, J NEUROPHYSIOL, V91, P946, DOI 10.1152/jn.00547.2003; Mezler M, 2012, COMB CHEM HIGH T SCR, V15, P372, DOI 10.2174/138620712800194503; Pisani A, 2004, EPILEPSIA, V45, P719, DOI 10.1111/j.0013-9580.2004.02204.x; Richards GR, 2006, METHOD ENZYMOL, V414, P335, DOI 10.1016/S0076-6879(06)14019-7; Rogawski MA, 2006, EPILEPSY RES, V68, P22, DOI 10.1016/j.eplepsyres.2005.09.012; Rogawski MA, 2004, NAT REV NEUROSCI, V5, P553, DOI 10.1038/nrn1430; Santos SF, 2009, J NEUROSCI, V29, P4708, DOI 10.1523/JNEUROSCI.4917-08.2009; Shen MX, 1996, J NEUROSCI, V16, P4322; Smetters D, 1999, METHODS, V18, P215, DOI 10.1006/meth.1999.0774; SOMBATI S, 1995, J NEUROPHYSIOL, V73, P1706, DOI 10.1152/jn.1995.73.4.1706; Straub H, 2001, EPILEPSY RES, V44, P155, DOI 10.1016/S0920-1211(01)00193-0; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Verderio C, 1999, EUR J NEUROSCI, V11, P2793, DOI 10.1046/j.1460-9568.1999.00697.x; Wang XS, 1997, BRAIN RES, V767, P239, DOI 10.1016/S0006-8993(97)00585-4	37	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84755	10.1371/journal.pone.0084755	http://dx.doi.org/10.1371/journal.pone.0084755			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416277	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500160
J	Shim, JW; Dodge, TR; Hammond, MA; Wallace, JM; Zhou, FC; Yokota, H				Shim, Joon W.; Dodge, Todd R.; Hammond, Max A.; Wallace, Joseph M.; Zhou, Feng C.; Yokota, Hiroki			Physical Weight Loading Induces Expression of Tryptophan Hydroxylase 2 in the Brain Stem	PLOS ONE			English	Article							DORSAL RAPHE NUCLEUS; BONE-FORMATION; AFFECTIVE-DISORDER; MICE; EXERCISE; TIBIAE; TARGET; LRP5; RATS	Sustaining brain serotonin is essential in mental health. Physical activities can attenuate mental problems by enhancing serotonin signaling. However, such activity is not always possible in disabled individuals or patients with dementia. Knee loading, a form of physical activity, has been found to mimic effects of voluntary exercise. Focusing on serotonergic signaling, we addressed a question: Does local mechanical loading to the skeleton elevate expression of tryptophan hydroxylase 2 (tph2) that is a rate-limiting enzyme for brain serotonin? A 5 min knee loading was applied to mice using 1 N force at 5 Hz for 1,500 cycles. A 5-min treadmill running was used as an exercise (positive) control, and a 90-min tail suspension was used as a stress (negative) control. Expression of tph2 was determined 30 min -2 h in three brain regions - frontal cortex (FC), ventromedial hypothalamus (VMH), and brain stem (BS). We demonstrated for the first time that knee loading and treadmill exercise upregulated the mRNA level of tph2 in the BS, while tail suspension downregulated it. The protein level of tph2 in the BS was also upregulated by knee loading and downregulated by tail suspension. Furthermore, the downregulation of tph2 mRNA by tail suspension can be partially suppressed by pre-application of knee loading. The expression of tph2 in the FC and VMH was not significantly altered with knee loading. In this study we provided evidence that peripheral mechanical loading can activate central tph2 expression, suggesting that physical cues may mediate tph2-cathalyzed serotonergic signaling in the brain.	[Shim, Joon W.; Dodge, Todd R.; Wallace, Joseph M.; Yokota, Hiroki] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA; [Hammond, Max A.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Wallace, Joseph M.] Indiana Univ Sch Med, Dept Orthopaed Surg, Indianapolis, IN 46202 USA; [Zhou, Feng C.; Yokota, Hiroki] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; [Zhou, Feng C.] Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Shim, JW (corresponding author), Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA.	shimjoon@iupui.edu; hyokota@iupui.edu	Shim, Joon W./AEW-0442-2022; Wallace, Joseph Michael/G-7906-2012	Wallace, Joseph Michael/0000-0001-6077-8058; Hammond, Max/0000-0003-2103-7884	National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health [AR052144]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052144] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the National Institutes of Health, under Award Number AR052144. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre JI, 2006, J BONE MINER RES, V21, P605, DOI 10.1359/JBMR.060107; Boldrini M, 2005, BRAIN RES, V1041, P19, DOI 10.1016/j.brainres.2005.01.083; Chabbi-Achengli Y, 2012, P NATL ACAD SCI USA, V109, P2567, DOI 10.1073/pnas.1117792109; Chen GL, 2013, BIOCHEM PHARMACOL, V85, P1227, DOI 10.1016/j.bcp.2013.02.018; Dodge T, 2012, BONE, V51, P810, DOI 10.1016/j.bone.2012.07.021; Ganzer PD, 2013, EXP NEUROL, V241, P84, DOI 10.1016/j.expneurol.2012.12.004; Greenwood BN, 2008, NEUROMOL MED, V10, P81, DOI 10.1007/s12017-008-8029-y; Ilic TV, 2002, NEUROSCI LETT, V319, P116, DOI 10.1016/S0304-3940(01)02563-0; Inose H, 2011, J BONE MINER RES, V26, P2002, DOI 10.1002/jbmr.439; Kumar Vinayak, 2012, J Pain Res, V5, P279, DOI 10.2147/JPR.S33408; Kurrasch DM, 2007, J NEUROSCI, V27, P13624, DOI 10.1523/JNEUROSCI.2858-07.2007; Lowry CA, 2008, ANN NY ACAD SCI, V1148, P86, DOI 10.1196/annals.1410.004; Ma Y, 2008, NEUROSCI BULL, V24, P265; Matthes S, 2010, PHARMACOLOGY, V85, P95, DOI 10.1159/000279322; Mattson Mark P, 2004, NeuroRx, V1, P111, DOI 10.1007/BF03206571; Moon HY, 2012, P NATL ACAD SCI USA, V109, P13094, DOI 10.1073/pnas.1205535109; Osterberg N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019239; Patel PD, 2007, J BIOL CHEM, V282, P26717, DOI 10.1074/jbc.M705120200; Popova NK, 2010, EXPERT OPIN THER TAR, V14, P1259, DOI 10.1517/14728222.2010.524208; Seo HY, 2005, EXP NEUROL, V193, P469, DOI 10.1016/j.expneurol.2004.11.017; Shim JW, 2006, BIOMECH MODEL MECHAN, V5, P247, DOI 10.1007/s10237-005-0013-y; Shim JW, 2013, EXP NEUROL, V247, P703, DOI 10.1016/j.expneurol.2013.03.011; Shim JW, 2013, J MUSCULOSK IN PRESS, V13; Soares DD, 2007, NEUROSCI LETT, V415, P274, DOI 10.1016/j.neulet.2007.01.035; Waider J, 2011, PSYCHONEUROENDOCRINO, V36, P393, DOI 10.1016/j.psyneuen.2010.12.012; Wallace JM, 2009, CALCIFIED TISSUE INT, V84, P297, DOI 10.1007/s00223-009-9228-8; Yadav VK, 2009, CELL, V138, P976, DOI 10.1016/j.cell.2009.06.051; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Yun Hyung-Mun, 2011, Exp Neurobiol, V20, P159, DOI 10.5607/en.2011.20.4.159; Zhang P, 2006, J APPL PHYSIOL, V100, P1452, DOI 10.1152/japplphysiol.00997.2005; Zhang P, 2011, BONE, V49, P867, DOI 10.1016/j.bone.2011.06.020; Zhang P, 2010, J BONE MINER METAB, V28, P268, DOI 10.1007/s00774-009-0135-x; Zhao LM, 2013, BONE, V54, P35, DOI 10.1016/j.bone.2013.01.033	33	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85095	10.1371/journal.pone.0085095	http://dx.doi.org/10.1371/journal.pone.0085095			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416346	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500215
J	Yoshimura, S; Tsunoda, T; Osawa, R; Harada, M; Watanabe, T; Hikichi, T; Katsuda, M; Miyazawa, M; Tani, M; Iwahashi, M; Takeda, K; Katagiri, T; Nakamura, Y; Yamaue, H				Yoshimura, Sachiko; Tsunoda, Takuya; Osawa, Ryuji; Harada, Makiko; Watanabe, Tomohisa; Hikichi, Tetsuro; Katsuda, Masahiro; Miyazawa, Motoki; Tani, Masaji; Iwahashi, Makoto; Takeda, Kazuyoshi; Katagiri, Toyomasa; Nakamura, Yusuke; Yamaue, Hiroki			Identification of an HLA-A2-Restricted Epitope Peptide Derived from Hypoxia-Inducible Protein 2 (HIG2)	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; CYTOTOXIC T-LYMPHOCYTES; INTERFERON-ALPHA; CLINICAL-TRIAL; DOUBLE-BLIND; HLA-B; CANCER; EXPRESSION; GENE; IMMUNOTHERAPY	We herein report the identification of an HLA-A2 supertype-restricted epitope peptide derived from hypoxia-inducible protein 2 (HIG2), which is known to be a diagnostic marker and a potential therapeutic target for renal cell carcinoma. Among several candidate peptides predicted by the HLA-binding prediction algorithm, HIG2-9-4 peptide (VLNLYLLGV) was able to effectively induce peptide-specific cytotoxic T lymphocytes (CTLs). The established HIG2-9-4 peptide-specific CTL clone produced interferon-gamma (IFN-gamma) in response to HIG2-9-4 peptide-pulsed HLA-A*02:01-positive cells, as well as to cells in which HLA-A*02:01 and HIG2 were exogenously introduced. Moreover, the HIG2-9-4 peptide-specific CTL clone exerted cytotoxic activity against HIG2-expressing HLA-A*02:01-positive renal cancer cells, thus suggesting that the HIG2-9-4 peptide is naturally presented on HLA-A*02:01 of HIG-2-expressing cancer cells and is recognized by CTLs. Furthermore, we found that the HIG2-9-4 peptide could also induce CTLs under HLA-A*02: 06 restriction. Taken together, these findings indicate that the HIG2-9-4 peptide is a novel HLA-A2 supertype-restricted epitope peptide that could be useful for peptide-based immunotherapy against cancer cells with HIG2 expression.	[Yoshimura, Sachiko; Tsunoda, Takuya; Osawa, Ryuji; Katsuda, Masahiro; Miyazawa, Motoki; Tani, Masaji; Iwahashi, Makoto; Yamaue, Hiroki] Wakayama Med Univ, Dept Surg 2, Wakayama, Japan; [Tsunoda, Takuya; Katagiri, Toyomasa; Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan; [Takeda, Kazuyoshi] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan; [Katagiri, Toyomasa] Univ Tokushima, Inst Genome Res, Div Genome Med, Tokushima 770, Japan; [Nakamura, Yusuke] Univ Chicago, Dept Med, Chicago, IL 60637 USA	Wakayama Medical University; University of Tokyo; Juntendo University; Tokushima University; University of Chicago	Yamaue, H (corresponding author), Wakayama Med Univ, Dept Surg 2, Wakayama, Japan.	yamaue-h@wakayama-med.ac.jp			Grants-in-Aid for Scientific Research [24791390, 23300355] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Amato RJ, 2009, J IMMUNOTHER, V32, P765, DOI 10.1097/CJI.0b013e3181ace876; Atzpodien J, 2004, J CLIN ONCOL, V22, P1188, DOI 10.1200/JCO.2004.06.155; Bleumer I, 2007, J IMMUNOTHER, V30, P116, DOI 10.1097/01.cji.0000211318.22902.ec; BOON T, 1993, INT J CANCER, V54, P177, DOI 10.1002/ijc.2910540202; Cao K, 2001, HUM IMMUNOL, V62, P1009, DOI 10.1016/S0198-8859(01)00298-1; CELIS E, 1994, P NATL ACAD SCI USA, V91, P2105, DOI 10.1073/pnas.91.6.2105; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Denko N, 2000, CLIN CANCER RES, V6, P480; DuPage M, 2012, NATURE, V482, P405, DOI 10.1038/nature10803; Escudier B, 2007, LANCET, V370, P2103, DOI 10.1016/S0140-6736(07)61904-7; Escudier B, 2009, J CLIN ONCOL, V27, P1280, DOI 10.1200/JCO.2008.19.3342; Fleischhauer K, 1997, J IMMUNOL, V159, P2513; FYFE G, 1995, J CLIN ONCOL, V13, P688, DOI 10.1200/JCO.1995.13.3.688; Gimm T, 2010, FASEB J, V24, P4443, DOI 10.1096/fj.10-159806; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Itoh Y, 2005, IMMUNOGENETICS, V57, P717, DOI 10.1007/s00251-005-0048-3; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kono K, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-141; McDermott DF, 2009, CANCER-AM CANCER SOC, V115, P2298, DOI 10.1002/cncr.24236; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Motzer RJ, 2010, CANCER-AM CANCER SOC, V116, P4256, DOI 10.1002/cncr.25219; Motzer RJ, 2009, J CLIN ONCOL, V27, P3584, DOI 10.1200/JCO.2008.20.1293; National Comprehensive Cancer Network, 2012, NCCN CLIN PRACT GUID; Obara W, 2012, JPN J CLIN ONCOL, V42, P591, DOI 10.1093/jjco/hys069; Okuno K, 2011, EXP THER MED, V2, P73, DOI 10.3892/etm.2010.182; Patil S, 2010, CANCER-AM CANCER SOC, V116, P347, DOI 10.1002/cncr.24713; Pecher G, 2002, CANCER IMMUNOL IMMUN, V51, P669, DOI 10.1007/s00262-002-0317-z; Rimoldi D, 2000, J IMMUNOL, V165, P7253, DOI 10.4049/jimmunol.165.12.7253; Rini BI, 2011, LANCET, V378, P1931, DOI 10.1016/S0140-6736(11)61613-9; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Rosenberg SA, 2003, CLIN CANCER RES, V9, P2973; Sampson JH, 2010, J CLIN ONCOL, V28, P4722, DOI 10.1200/JCO.2010.28.6963; Scanlan MJ, 2002, IMMUNOL REV, V188, P22, DOI 10.1034/j.1600-065X.2002.18803.x; Seo T, 2010, ONCOL LETT, V1, P697, DOI 10.3892/ol_00000122; Sidney J, 2001, HUM IMMUNOL, V62, P1200, DOI 10.1016/S0198-8859(01)00319-6; SPARANO JA, 1993, J CLIN ONCOL, V11, P1969, DOI 10.1200/JCO.1993.11.10.1969; Sternberg CN, 2010, J CLIN ONCOL, V28, P1061, DOI 10.1200/JCO.2009.23.9764; Suda T, 2007, CANCER SCI, V98, P1803, DOI 10.1111/j.1349-7006.2007.00603.x; Takeda K, 2004, J EXP MED, V199, P437, DOI 10.1084/jem.20031457; Togashi A, 2005, CANCER RES, V65, P4817, DOI 10.1158/0008-5472.CAN-05-0120; TSOMIDES TJ, 1994, J EXP MED, V180, P1283, DOI 10.1084/jem.180.4.1283; Tsuji T, 2011, J IMMUNOL, V186, P1218, DOI 10.4049/jimmunol.1000808; Uchida N, 2004, CLIN CANCER RES, V10, P8577, DOI 10.1158/1078-0432.CCR-04-0104	46	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85267	10.1371/journal.pone.0085267	http://dx.doi.org/10.1371/journal.pone.0085267			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416375	gold, Green Published, Green Submitted			2022-12-27	WOS:000329862500232
J	Ichimura, T; Chiu, LD; Fujita, K; Kawata, S; Watanabe, TM; Yanagida, T; Fujita, H				Ichimura, Taro; Chiu, Liang-da; Fujita, Katsumasa; Kawata, Satoshi; Watanabe, Tomonobu M.; Yanagida, Toshio; Fujita, Hideaki			Visualizing Cell State Transition Using Raman Spectroscopy	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; DIFFERENTIATION; PLURIPOTENT; DYNAMICS; NUCLEUS; PROTEIN; BODIES; CYCLE	System level understanding of the cell requires detailed description of the cell state, which is often characterized by the expression levels of proteins. However, understanding the cell state requires comprehensive information of the cell, which is usually obtained from a large number of cells and their disruption. In this study, we used Raman spectroscopy, which can report changes in the cell state without introducing any label, as a non-invasive method with single cell capability. Significant differences in Raman spectra were observed at the levels of both the cytosol and nucleus in different cell-lines from mouse, indicating that Raman spectra reflect differences in the cell state. Difference in cell state was observed before and after the induction of differentiation in neuroblastoma and adipocytes, showing that Raman spectra can detect subtle changes in the cell state. Cell state transitions during embryonic stem cell (ESC) differentiation were visualized when Raman spectroscopy was coupled with principal component analysis (PCA), which showed gradual transition in the cell states during differentiation. Detailed analysis showed that the diversity between cells are large in undifferentiated ESC and in mesenchymal stem cells compared with terminally differentiated cells, implying that the cell state in stem cells stochastically fluctuates during the self-renewal process. The present study strongly indicates that Raman spectral morphology, in combination with PCA, can be used to establish cells' fingerprints, which can be useful for distinguishing and identifying different cellular states.	[Ichimura, Taro; Watanabe, Tomonobu M.; Yanagida, Toshio; Fujita, Hideaki] RIKEN, Quantitat Biol Ctr, Suita, Osaka, Japan; [Chiu, Liang-da; Fujita, Katsumasa; Kawata, Satoshi] Osaka Univ, Dept Appl Phys, Suita, Osaka 565, Japan; [Kawata, Satoshi] RIKEN, Nanophoton Lab, Wako, Saitama, Japan; [Yanagida, Toshio; Fujita, Hideaki] Osaka Univ, Immunol Frontier Res Ctr, Suita, Osaka, Japan	RIKEN; Osaka University; RIKEN; Osaka University	Fujita, H (corresponding author), RIKEN, Quantitat Biol Ctr, Suita, Osaka, Japan.	hideaki.fujita@riken.jp	Fujita, Hideaki/B-7633-2008; Fujita, Katsumasa/F-6699-2015; Watanabe, Tomonobu/J-4812-2013; Chiu, Liang-da/H-4151-2015; Ichimura, Taro/E-2792-2010	Fujita, Hideaki/0000-0003-3430-5681; Chiu, Liang-da/0000-0002-8178-1800; Ichimura, Taro/0000-0002-3740-3634; Watanabe, Tomonobu/0000-0002-2420-4230	PRESTO, the Japan Science and Technology Agency	PRESTO, the Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	PRESTO, the Japan Science and Technology Agency (http://www.jst.go.jp/kisoken/presto/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Buckmaster R, 2009, ANALYST, V134, P1440, DOI 10.1039/b900420c; DARLINGTON GJ, 1980, J NATL CANCER I, V64, P809; Fialka I, 1996, J CELL BIOL, V132, P1115, DOI 10.1083/jcb.132.6.1115; Filzmoser P., 2009, MULTIVARIATE STAT AN, V66, P112; FRENSTER JH, 1973, NEW ENGL J MED, V288, P1224, DOI 10.1056/NEJM197306072882310; Gall JG, 2000, ANNU REV CELL DEV BI, V16, P273, DOI 10.1146/annurev.cellbio.16.1.273; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; Hamada K, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2952192; Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245; Karr JR, 2012, CELL, V150, P389, DOI 10.1016/j.cell.2012.05.044; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Lieber CA, 2003, APPL SPECTROSC, V57, P1363, DOI 10.1366/000370203322554518; Maul GG, 2000, J STRUCT BIOL, V129, P278, DOI 10.1006/jsbi.2000.4239; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Nakamura MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071739; NAKATSU SL, 1974, NATURE, V248, P334, DOI 10.1038/248334a0; Okada M, 2012, P NATL ACAD SCI USA, V109, P28, DOI 10.1073/pnas.1107524108; OLMSTED JB, 1970, P NATL ACAD SCI USA, V65, P129, DOI 10.1073/pnas.65.1.129; Pascut FC, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3570302; Pascut FC, 2011, BIOPHYS J, V100, P251, DOI 10.1016/j.bpj.2010.11.043; Pliss A, 2010, BIOPHYS J, V99, P3483, DOI 10.1016/j.bpj.2010.06.069; Poplineau M, 2011, EPIGENOMICS-UK, V3, P785, DOI [10.2217/EPI.11.102, 10.2217/epi.11.102]; PUPPELS GJ, 1991, BIOPHYS J, V60, P1046, DOI 10.1016/S0006-3495(91)82142-7; Shav-Tal Y, 2001, J CELL BIOCHEM, V81, P379, DOI 10.1002/1097-4644(20010601)81:3<379::AID-JCB1052>3.0.CO;2-8; SHEN MM, 1992, P NATL ACAD SCI USA, V89, P8240, DOI 10.1073/pnas.89.17.8240; SPECTOR DL, 1993, ANNU REV CELL BIOL, V9, P265, DOI 10.1146/annurev.cellbio.9.1.265; Swain RJ, 2008, J CELL BIOCHEM, V104, P1427, DOI 10.1002/jcb.21720; Waddington C., 1957, STRATEGY GENES; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9	32	68	69	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84478	10.1371/journal.pone.0084478	http://dx.doi.org/10.1371/journal.pone.0084478			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409302	Green Published, gold, Green Submitted			2022-12-27	WOS:000329463500026
J	Sathe, A; Reddy, KVR				Sathe, Ameya; Reddy, Kudumula Venkata Rami			TLR9 and RIG-I Signaling in Human Endocervical Epithelial Cells Modulates Inflammatory Responses of Macrophages and Dendritic Cells In Vitro	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; INNATE IMMUNITY; GENITAL-TRACT; RECOGNITION; EXPRESSION; TISSUE; ALPHA; QUANTIFICATION; PROTECTION; RECEPTORS	The innate immune system has evolved to recognize invading pathogens through pattern recognition receptors (PRRs). Among PRRs, Toll like receptors (TLRs 3, 7/8,9) and RIG-I like receptors (RLRs) have been shown to recognize viral components. Mucosal immune responses to viral infections require coordinated actions from epithelial as well as immune cells. In this respect, endocervical epithelial cells (EEC's) play an important role in initiating innate immune responses via PRRs. It is unknown whether EEC's can alter immune responses of macrophages and dendritic cells (DC's) like its counterparts in intestinal and respiratory systems. In this study, we show that endocervical epithelial cells (End1/E6E7) express two key receptors, TLR9 and RIG-I involved in anti-viral immunity. Stimulation of End1/E6E7 cells lead to the activation of NF-kappa B and increased secretion of pro-inflammatory cytokines, IL-6 and IL-8. Polarized End1/E6E7 cells responded to apical stimulation with ligands of TLR9 and RIG-I, CpG-ODN and Poly(I:C)LL respectively, without compromising End1/E6E7 cell integrity. At steady state, spent medium from End1/E6E7 cells significantly reduced secretion of pro-inflammatory cytokines from LPS treated human primary monocyte derived macrophages (MDMs) and DC: T cell co-cultures. Spent medium from End1/E6E7 cells stimulated with ligands of TLR9/RIG-I restored secretion of pro-inflammatory cytokines as well as enhanced phagocytosis and chemotaxis of monocytic U937 cells. Spent medium from CpG-ODN and Poly(I: C) LL stimulated End1/E6E7 cells showed significant increased secretion of IL-12p70 from DC: T cell co-cultures. The anti-inflammatory effect of spent media of End1/E6E7 cell was observed to be TGF-beta dependent. In summary, the results of our study indicate that EEC's play an indispensable role in modulating anti-viral immune responses at the female lower genital tract.	[Sathe, Ameya; Reddy, Kudumula Venkata Rami] Indian Council Med Res, NIRRH, Div Mol Immunol & Microbiol MIM, Mumbai, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH)	Reddy, KVR (corresponding author), Indian Council Med Res, NIRRH, Div Mol Immunol & Microbiol MIM, Mumbai, Maharashtra, India.	reddyk@nirrh.res.in		Sathe, Ameya/0000-0001-8343-1196	Indian Council of Medical Research (ICMR) [NIRRH/MS/92/2013]	Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR))	This study was partially supported by grants from Indian Council of Medical Research (ICMR)(NIRRH/MS/92/2013). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JM, 2006, BIOL REPROD, V74, P824, DOI 10.1095/biolreprod.105.048629; Fichorova RN, 2005, ANTIMICROB AGENTS CH, V49, P323, DOI 10.1128/AAC.49.1.323-335.2005; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; Galen B, 2006, J VIROL, V80, P12209, DOI 10.1128/JVI.01503-06; Grant KS, 2003, BIOL REPROD, V69, P1091, DOI 10.1095/biolreprod.103.015495; HEINONEN PK, 1985, OBSTET GYNECOL, V66, P384; Herbst-Kralovetz MM, 2008, AM J REPROD IMMUNOL, V59, P212, DOI 10.1111/j.1600-0897.2007.00566.x; Herbst-Kralovetz MM, 2006, J VIROL, V80, P9988, DOI 10.1128/JVI.01099-06; Hershberg RM, 2002, AM J PHYSIOL-GASTR L, V283, pG833, DOI 10.1152/ajpgi.00208.2002; Hibma Merilyn H, 2012, Open Virol J, V6, P241, DOI 10.2174/1874357901206010241; Hopper S, 2000, INFECT IMMUN, V68, P896, DOI 10.1128/IAI.68.2.896-905.2000; Horne AW, 2008, REPRODUCTION, V135, P739, DOI 10.1530/REP-07-0564; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim CH, 2010, ARCH DERMATOL RES, V302, P301, DOI 10.1007/s00403-009-1012-0; Kim JG, 2004, INFECT IMMUN, V72, P1487, DOI 10.1128/IAI.72.3.1487-1495.2004; Lamont RF, 2011, BJOG-INT J OBSTET GY, V118, P533, DOI 10.1111/j.1471-0528.2010.02840.x; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; MacDonald EM, 2007, BIOL REPROD, V77, P1049, DOI 10.1095/biolreprod.107.063933; Mayer AK, 2008, EUR J IMMUNOL, V38, P1689, DOI 10.1002/eji.200737936; Meylan E, 2006, MOL CELL, V22, P561, DOI 10.1016/j.molcel.2006.05.012; Naiki Y, 2005, J BIOL CHEM, V280, P5491, DOI 10.1074/jbc.C400503200; Niimi K, 2007, J IMMUNOL, V178, P489, DOI 10.4049/jimmunol.178.1.489; Patgaonkar MS, 2011, CLIN VACCINE IMMUNOL, V18, P1632, DOI 10.1128/CVI.00411-10; Puthenveedu MA, 2003, MOL BIOL CELL, V14, P1801, DOI 10.1091/mbc.E02-10-0692; Sajic D, 2003, J MED VIROL, V71, P561, DOI 10.1002/jmv.10518; Sato A, 2004, P NATL ACAD SCI USA, V101, P16274, DOI 10.1073/pnas.0406268101; Schaefer TM, 2005, J IMMUNOL, V174, P992, DOI 10.4049/jimmunol.174.2.992; Sharma S, 2011, MICROB PATHOGENESIS, V50, P179, DOI 10.1016/j.micpath.2010.12.007; Shaykhiev R, 2007, J LEUKOCYTE BIOL, V82, P1, DOI 10.1189/jlb.0207096; Smythies LE, 2010, J BIOL CHEM, V285, P19593, DOI 10.1074/jbc.M109.069955; STOLINE MR, 1981, AM STAT, V35, P134, DOI 10.2307/2683979; Takabayshi K, 2006, IMMUNITY, V24, P475, DOI 10.1016/j.immuni.2006.02.008; Wang H, 2009, THORAX, V64, P283, DOI 10.1136/thx.2007.094870; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Wira CR, 2005, IMMUNOL REV, V206, P306, DOI 10.1111/j.0105-2896.2005.00287.x; Zhang T, 2011, EUR J PHARM BIOPHARM, V79, P526, DOI 10.1016/j.ejpb.2011.06.007	39	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e83882	10.1371/journal.pone.0083882	http://dx.doi.org/10.1371/journal.pone.0083882			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409285	Green Submitted, Green Published, gold			2022-12-27	WOS:000329463500009
J	Schecklmann, M; Landgrebe, M; Kleinjung, T; Frank, E; Rupprecht, R; Sand, PG; Eichhammer, P; Hajak, G; Langguth, B				Schecklmann, Martin; Landgrebe, Michael; Kleinjung, Tobias; Frank, Elmar; Rupprecht, Rainer; Sand, Philipp G.; Eichhammer, Peter; Hajak, Goeran; Langguth, Berthold			State- and Trait-Related Alterations of Motor Cortex Excitability in Tinnitus Patients	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; CORTICAL EXCITABILITY; NETWORK CONNECTIVITY; SLEEP-DEPRIVATION; PLASTICITY; INHIBITION; MECHANISMS; TMS; CONSISTENCY; DISORDERS	Chronic tinnitus is a brain network disorder with involvement of auditory and non-auditory areas. Repetitive transcranial magnetic stimulation (rTMS) over the temporal cortex has been investigated for the treatment of tinnitus. Several small studies suggest that motor cortex excitability is altered in people with tinnitus. We retrospectively analysed data from 231 patients with chronic tinnitus and 120 healthy controls by pooling data from different studies. Variables of interest were resting motor threshold (RMT), short-interval intra-cortical inhibition (SICI), intra-cortical facilitation (ICF), and cortical silent period (CSP). 118 patients were tested twice - before and after ten rTMS treatment sessions over the left temporal cortex. In tinnitus patients SICI and ICF were increased and CSP was shortened as compared to healthy controls. There was no group difference in RMT. Treatment related amelioration of tinnitus symptoms were correlated with normalisations in SICI. These findings confirm earlier studies of abnormal motor cortex excitability in tinnitus patients. Moreover our longitudinal data suggest that altered SICI may reflect a state parameter, whereas CSP and ICF may rather mirror a trait-like predisposing factor of tinnitus. These findings are new and innovative as they enlarge the knowledge about basic physiologic and neuroplastic processes in tinnitus.	[Schecklmann, Martin; Frank, Elmar; Rupprecht, Rainer; Sand, Philipp G.; Eichhammer, Peter; Langguth, Berthold] Univ Regensburg, Dept Psychiat & Psychotherapy, D-93053 Regensburg, Germany; [Landgrebe, Michael] Social Fdn Bamberg, Dept Psychiat Psychosomat Med & Psychotherapy, Bamberg, Germany; [Kleinjung, Tobias] Univ Zurich, Dept Otorhinolaryngol, Zurich, Switzerland	University of Regensburg; University of Zurich	Schecklmann, M (corresponding author), Univ Regensburg, Dept Psychiat & Psychotherapy, D-93053 Regensburg, Germany.	martin.schecklmann@medbo.de	Kleinjung, Tobias/AAJ-3141-2020; Sand, Philipp G/C-1924-2009; Langguth, Berthold/AAP-2638-2021	Kleinjung, Tobias/0000-0003-3867-234X; Sand, Philipp G/0000-0001-5806-5841; 				Adjamian P, 2009, HEARING RES, V253, P15, DOI 10.1016/j.heares.2009.04.001; Baguley DM, 2003, J ROY SOC MED, V96, P582, DOI 10.1258/jrsm.96.12.582; Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Chen R, 1998, J NEUROSCI, V18, P3443; Chipchase L, 2012, CLIN NEUROPHYSIOL, V123, P1698, DOI 10.1016/j.clinph.2012.05.003; Cronlein T, 2007, PROG BRAIN RES, V166, P227, DOI 10.1016/S0079-6123(07)66021-X; De Gennaro L, 2004, NEUROSCI RES, V48, P129, DOI 10.1016/j.neures.2003.10.004; De Ridder D, 2011, P NATL ACAD SCI USA, V108, P8075, DOI 10.1073/pnas.1018466108; Dovern A, 2012, J NEUROSCI, V32, P7614, DOI 10.1523/JNEUROSCI.5401-11.2012; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Eichhammer P, 2007, PROG BRAIN RES, V166, P369, DOI 10.1016/S0079-6123(07)66035-X; GOEBEL G, 1994, HNO, V42, P166; Graziano MSA, 1999, NATURE, V397, P428, DOI 10.1038/17115; Guitton Matthieu J., 2007, Neural Plasticity, V2007, P1, DOI 10.1155/2007/80904; HALLAM RS, 1988, BRIT J CLIN PSYCHOL, V27, P213, DOI 10.1111/j.2044-8260.1988.tb00778.x; Khedr EM, 2008, NEUROPHYSIOL CLIN, V38, P243, DOI 10.1016/j.neucli.2008.03.004; Kreuzer P, 2011, NEUROSCI LETT, V493, P63, DOI 10.1016/j.neulet.2011.02.044; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Langguth B, 2005, NEUROSCI LETT, V380, P326, DOI 10.1016/j.neulet.2005.01.069; Langguth B, 2012, WORLD J BIOL PSYCHIA; Langguth B, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-45; Langguth B, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00015; Lehner A, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00011; Lemus L, 2009, P NATL ACAD SCI USA, V106, P14640, DOI 10.1073/pnas.0907505106; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Maudoux A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036222; Merabet LB, 2010, NAT REV NEUROSCI, V11, P44, DOI 10.1038/nrn2758; Petitjean M, 2013, CLIN NEUROPHYSIOL, V124, P346, DOI 10.1016/j.clinph.2012.07.006; Placidi F, 2013, SLEEP MED, V14, P288, DOI 10.1016/j.sleep.2012.11.020; Rauschecker JP, 2010, NEURON, V66, P819, DOI 10.1016/j.neuron.2010.04.032; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Rothen N, 2012, J NEUROSCI, V32, P13641, DOI 10.1523/JNEUROSCI.3577-12.2012; Salvi R, 2009, DRUG FUTURE, V34, P381, DOI 10.1358/dof.2009.034.05.1362442; Sanchez TG, 2011, CLINICS, V66, P1089, DOI 10.1590/S1807-59322011000600028; Sand PG, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00041; Schecklmann M, 2013, HUM BRAIN MAPP, V34, P233, DOI 10.1002/hbm.21426; Schecklmann M, 2012, INT J PSYCHOPHYSIOL, V83, P323, DOI 10.1016/j.ijpsycho.2011.11.013; Schlee W, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-11; Schwenkreis P, 2000, NEUROSCI LETT, V293, P143, DOI 10.1016/S0304-3940(00)01517-2; Vanneste S, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00031; Vielsmeier V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038887; Vielsmeier V, 2011, OTOLARYNG HEAD NECK, V145, P748, DOI 10.1177/0194599811413376; Wolters A., 2012, OXFORD HDB TRANSCRAN; Ziemann U, 2004, CLIN NEUROPHYSIOL, V115, P1717, DOI 10.1016/j.clinph.2004.03.006; Ziemann U, 1998, J NEUROSCI, V18, P7000; Ziemann U, 2006, NEUROREHAB NEURAL RE, V20, P243, DOI 10.1177/1545968306287154; Zoger S, 2006, PSYCHOSOMATICS, V47, P282, DOI 10.1176/appi.psy.47.4.282	47	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e85015	10.1371/journal.pone.0085015	http://dx.doi.org/10.1371/journal.pone.0085015			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409317	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000329463500041
J	Forlim, CG; Pinto, RD				Forlim, Caroline G.; Pinto, Reynaldo D.			Automatic Realistic Real Time Stimulation/Recording in Weakly Electric Fish: Long Time Behavior Characterization in Freely Swimming Fish and Stimuli Discrimination	PLOS ONE			English	Article							WAVE-FORM GENERATION; ACTIVE ELECTROLOCATION; JAMMING AVOIDANCE; ORGAN; COMMUNICATION; RECOGNITION; INFORMATION; ELECTROCOMMUNICATION; MECHANISMS; MORMYRIDAE	Weakly electric fish are unique model systems in neuroethology, that allow experimentalists to non-invasively, access, central nervous system generated spatio-temporal electric patterns of pulses with roles in at least 2 complex and incompletely understood abilities: electrocommunication and electrolocation. Pulse-type electric fish alter their inter pulse intervals (IPIs) according to different behavioral contexts as aggression, hiding and mating. Nevertheless, only a few behavioral studies comparing the influence of different stimuli IPIs in the fish electric response have been conducted. We developed an apparatus that allows real time automatic realistic stimulation and simultaneous recording of electric pulses in freely moving Gymnotus carapo for several days. We detected and recorded pulse timestamps independently of the fish's position for days. A stimulus fish was mimicked by a dipole electrode that reproduced the voltage time series of real conspecific according to previously recorded timestamp sequences. We characterized fish behavior and the eletrocommunication in 2 conditions: stimulated by IPIs pre-recorded from other fish and random IPI ones. All stimuli pulses had the exact Gymontus carapo waveform. All fish presented a surprisingly long transient exploratory behavior (more than 8 h) when exposed to a new environment in the absence of electrical stimuli. Further, we also show that fish are able to discriminate between real and random stimuli distributions by changing several characteristics of their IPI distribution.	[Forlim, Caroline G.] Univ Sao Paulo, Dept Fis Geral, Sao Paulo, Brazil; [Forlim, Caroline G.; Pinto, Reynaldo D.] Univ Sao Paulo, Lab Neurodinam Neurobiofis, Sao Carlos, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Pinto, RD (corresponding author), Univ Sao Paulo, Lab Neurodinam Neurobiofis, Sao Carlos, SP, Brazil.	reynaldo@ifsc.usp.br	Forlim, Caroline G/GLU-9139-2022; Pinto, Reynaldo D/K-7181-2014	Forlim, Caroline G/0000-0003-4709-7797	Brazilian agency: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP; Brazilian agency: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq	Brazilian agency: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian agency: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Brazilian agencies: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (www.fapesp.br), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES (www.capes.gov.br), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera PA, 2003, J EXP BIOL, V206, P989, DOI 10.1242/jeb.00198; Arnegard ME, 2005, P ROY SOC B-BIOL SCI, V272, P1305, DOI 10.1098/rspb.2005.3101; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; Brochini L, 2011, J NEUROSCI, V31, P12297, DOI 10.1523/JNEUROSCI.1568-11.2011; BULLOCK TH, 1969, BRAIN BEHAV EVOLUT, V2, P85, DOI 10.1159/000125815; Bullock TH, 1999, J EXP BIOL, V202, P1455; Capurro A, 2004, B MATH BIOL, V66, P885, DOI 10.1016/j.bulm.2004.02.002; CAPUTI A, 1995, J COMPUT NEUROSCI, V2, P131, DOI 10.1007/BF00961884; Caputi AA, 2004, J PHYSIOL-PARIS, V98, P81, DOI 10.1016/j.jphysparis.2004.03.002; Caputi AA, 2002, J PHYSIOLOGY-PARIS, V96, P493, DOI 10.1016/S0928-4257(03)00005-6; CAPUTI AA, 2012, SENSING NATURE; Carlson BA, 2002, J PHYSIOLOGY-PARIS, V96, P405, DOI 10.1016/S0928-4257(03)00019-6; Carlson BA, 2011, SCIENCE, V332, P583, DOI 10.1126/science.1201524; Carlson BA, 2009, J NEUROSCI, V29, P9417, DOI 10.1523/JNEUROSCI.1980-09.2009; Castello ME, 2009, J EXP BIOL, V212, P1351, DOI 10.1242/jeb.022566; CLEWORTH PA, 1970, ANIM BEHAV MONOGR, V3, P1; Cuddy M, 2012, HORM BEHAV, V61, P4, DOI 10.1016/j.yhbeh.2011.09.003; Dayan P, 2001, COMPUTATIONAL NEUROS; Doiron B, 2003, NATURE, V421, P539, DOI 10.1038/nature01360; Engelmann J, 2010, J NEUROPHYSIOL, V104, P1955, DOI 10.1152/jn.00503.2009; Engelmann J, 2008, BIOL CYBERN, V98, P519, DOI 10.1007/s00422-008-0213-5; FORLIM CG, 2008, THESIS U SAO PAULO; FORLIM CG, 2011, BMC NEUROSCIENCE S1, V12, pP253; FORLIM CG, 2013, BMC NEUROSCIENCE S1, V2013, pP405; FORLIM CG, 2012, 2012 NEUR M PLANN; Fortune ES, 2006, J COMP PHYSIOL A, V192, P625, DOI 10.1007/s00359-006-0102-0; HEILIGENBERG W, 1978, J COMP PHYSIOL, V124, P211, DOI 10.1007/BF00657053; Heiligenberg W, 1991, Curr Opin Neurobiol, V1, P187, DOI 10.1016/0959-4388(91)90076-J; Ho WW, 2010, ETHOLOGY, V116, P1050, DOI 10.1111/j.1439-0310.2010.01823.x; Jun JJ, 2012, J NEUROPHYSIOL, V107, P1996, DOI 10.1152/jn.00757.2011; Jun JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066596; KRAMER B, 1979, BEHAV ECOL SOCIOBIOL, V6, P67, DOI 10.1007/BF00293246; KRAMER B, 1994, ANIM BEHAV, V48, P435, DOI 10.1006/anbe.1994.1257; LISSMANN HW, 1958, J EXP BIOL, V35, P156; Nogueira J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022159; Nowotny T, 2006, J NEUROSCI METH, V158, P287, DOI 10.1016/j.jneumeth.2006.05.034; Perrone R, 2009, J COMP PHYSIOL A, V195, P501, DOI 10.1007/s00359-009-0427-6; Pinto RD, 2001, J NEUROSCI METH, V108, P39, DOI 10.1016/S0165-0270(01)00368-5; PINTO RD, 2007, 2007 NEUR M PLANN; Post N, 1999, PHYSIOL BEHAV, V68, P115, DOI 10.1016/S0031-9384(99)00153-5; Rieke F., 1999, SPIKES EXPLORING NEU; Schuster S, 2002, J EXP BIOL, V205, P3307; Schuster S, 2002, J EXP BIOL, V205, P2525; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SZABO T, 1975, BRAIN RES, V95, P459, DOI 10.1016/0006-8993(75)90121-3; TEYSSEDRE C, 1986, BEHAV PROCESS, V12, P77, DOI 10.1016/0376-6357(86)90073-2; vanSteveninck RRD, 1997, SCIENCE, V275, P1805, DOI 10.1126/science.275.5307.1805; Varona P., 2011, BMC NEUROSCI S1, V12, pP358, DOI [DOI 10.1186/1471-2202-12-S1-P358, 10.1186/1471-2202-12-S1-P358]; von der Emde G, 1998, NATURE, V395, P890, DOI 10.1038/27655; Von der Emde G, 1999, J EXP BIOL, V202, P1205; von der Emde G, 2007, J EXP BIOL, V210, P3082, DOI 10.1242/jeb.005694; von der Emde G, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00026; von der Emde G, 2008, J PHYSIOL-PARIS, V102, P279, DOI 10.1016/j.jphysparis.2008.10.017; WESTBY GWM, 1979, BEHAV ECOL SOCIOBIOL, V4, P381; WESTBY GWM, 1975, ANIM BEHAV, V23, P192, DOI 10.1016/0003-3472(75)90065-2; Wong RY, 2007, J EXP BIOL, V210, P2244, DOI 10.1242/jeb.003509	56	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84885	10.1371/journal.pone.0084885	http://dx.doi.org/10.1371/journal.pone.0084885			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400122	Green Published, Green Submitted, gold			2022-12-27	WOS:000329462700056
J	Knodler, LA; Nair, V; Steele-Mortimer, O				Knodler, Leigh A.; Nair, Vinod; Steele-Mortimer, Olivia			Quantitative Assessment of Cytosolic Salmonella in Epithelial Cells	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; INTRACELLULAR LIFE-STYLE; SHIGELLA-FLEXNERI; MYCOBACTERIUM-TUBERCULOSIS; CONTAINING VACUOLE; COXIELLA-BURNETII; III SECRETION; PHAGOLYSOSOMAL ALKALINIZATION; FRANCISELLA-TULARENSIS; ESCHERICHIA-COLI	Within mammalian cells, Salmonella enterica serovar Typhimurium (S. Typhimurium) inhabits a membrane-bound vacuole known as the Salmonella-containing vacuole (SCV). We have recently shown that wild type S. Typhimurium also colonizes the cytosol of epithelial cells. Here we sought to quantify the contribution of cytosolic Salmonella to the total population over a time course of infection in different epithelial cell lines and under conditions of altered vacuolar escape. We found that the lysosomotropic agent, chloroquine, acts on vacuolar, but not cytosolic, Salmonella. After chloroquine treatment, vacuolar bacteria are not transcriptionally active or replicative and appear degraded. Using a chloroquine resistance assay, in addition to digitonin permeabilization, we found that S. Typhimurium lyses its nascent vacuole in numerous epithelial cell lines, albeit with different frequencies, and hyper-replication in the cytosol is also widespread. At later times post-infection, cytosolic bacteria account for half of the total population in some epithelial cell lines, namely HeLa and Caco-2 C2Bbe1. Both techniques accurately measured increased vacuole lysis in epithelial cells upon treatment with wortmannin. By chloroquine resistance assay, we also determined that Salmonella pathogenicity island-1 (SPI-1), but not SPI-2, the virulence plasmid nor the flagellar apparatus, was required for vacuolar escape and cytosolic replication in epithelial cells. Together, digitonin permeabilization and the chloroquine resistance assay will be useful, complementary tools for deciphering the mechanisms of SCV lysis and Salmonella replication in the epithelial cell cytosol.	[Knodler, Leigh A.] Washington State Univ, Coll Vet Med, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA; [Knodler, Leigh A.; Steele-Mortimer, Olivia] NIAID, Rocky Mt Labs, Intracellular Parasites Lab, NIH, Hamilton, MT 59840 USA; [Nair, Vinod] NIAID, Res Technol Branch, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA	Washington State University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Knodler, LA (corresponding author), Washington State Univ, Coll Vet Med, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA.	lknodler@vetmed.wsu.edu		Knodler, Leigh/0000-0002-3028-2198	Paul G. Allen School for Global Animal Health; Stanley L. Adler Research Endowment; Intramural Research Program of NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000909, ZICAI001052] Funding Source: NIH RePORTER	Paul G. Allen School for Global Animal Health; Stanley L. Adler Research Endowment; Intramural Research Program of NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by the Paul G. Allen School for Global Animal Health, the Stanley L. Adler Research Endowment and the Intramural Research Program of NIAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiastui A, 2010, INFECT IMMUN, V78, P2700, DOI 10.1128/IAI.01389-09; Bakowski MA, 2008, TRAFFIC, V9, P2022, DOI 10.1111/j.1600-0854.2008.00827.x; Barzu S, 1997, INFECT IMMUN, V65, P1599; Beuzon CR, 2002, MICROBIOL-SGM, V148, P2705, DOI 10.1099/00221287-148-9-2705; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Birmingham CL, 2006, AUTOPHAGY, V2, P156, DOI 10.4161/auto.2825; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Brumell JH, 2001, CELL MICROBIOL, V3, P75, DOI 10.1046/j.1462-5822.2001.00087.x; Brumell JH, 2002, INFECT IMMUN, V70, P3264, DOI 10.1128/IAI.70.6.3264-3270.2002; BYRD TF, 1991, J CLIN INVEST, V88, P351, DOI 10.1172/JCI115301; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Cemma M, 2011, AUTOPHAGY, V7, P341, DOI 10.4161/auto.7.3.14046; Checroun C, 2006, P NATL ACAD SCI USA, V103, P14578, DOI 10.1073/pnas.0601838103; Chong A, 2008, INFECT IMMUN, V76, P5488, DOI 10.1128/IAI.00682-08; Chong A, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00138; CIAK J, 1966, SCIENCE, V151, P347, DOI 10.1126/science.151.3708.347; Coombes BK, 2004, J BIOL CHEM, V279, P49804, DOI 10.1074/jbc.M404299200; CROWLE AJ, 1990, ANTIMICROB AGENTS CH, V34, P2217, DOI 10.1128/AAC.34.11.2217; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Drecktrah D, 2006, TRAFFIC, V7, P39, DOI 10.1111/j.1600-0854.2005.00360.x; Drecktrah D, 2007, TRAFFIC, V8, P212, DOI 10.1111/j.1600-0854.2006.00529.x; Drecktrah D, 2008, TRAFFIC, V9, P2117, DOI 10.1111/j.1600-0854.2008.00830.x; Fernandez IM, 2001, J INFECT DIS, V184, P743, DOI 10.1086/323035; Fields KA, 2002, ANNU REV CELL DEV BI, V18, P221, DOI 10.1146/annurev.cellbio.18.012502.105845; GALAN JE, 1991, INFECT IMMUN, V59, P2901; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Giannasca KT, 1996, INFECT IMMUN, V64, P135, DOI 10.1128/IAI.64.1.135-145.1996; GULIG PA, 1987, INFECT IMMUN, V55, P2891, DOI 10.1128/IAI.55.12.2891-2901.1987; Hof H, 1997, CLIN MICROBIOL REV, V10, P345, DOI 10.1128/CMR.10.2.345; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Houben D, 2012, CELL MICROBIOL, V14, P1287, DOI 10.1111/j.1462-5822.2012.01799.x; Huett A, 2012, CELL HOST MICROBE, V12, P778, DOI 10.1016/j.chom.2012.10.019; Ibarra JA, 2010, MICROBIOL-SGM, V156, P1120, DOI 10.1099/mic.0.032896-0; Isberg RR, 2009, NAT REV MICROBIOL, V7, P12, DOI 10.1038/nrmicro1967; JONES S, 1994, INFECT IMMUN, V62, P5608, DOI 10.1128/IAI.62.12.5608-5613.1994; Knodler LA, 2010, P NATL ACAD SCI USA, V107, P17733, DOI 10.1073/pnas.1006098107; LEE CA, 1992, P NATL ACAD SCI USA, V89, P1847, DOI 10.1073/pnas.89.5.1847; Malik-Kale P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038732; Manzanillo PS, 2012, CELL HOST MICROBE, V11, P469, DOI 10.1016/j.chom.2012.03.007; MAURIN M, 1992, J INFECT DIS, V166, P1097, DOI 10.1093/infdis/166.5.1097; MAURIN M, 1994, J INFECT DIS, V169, P330, DOI 10.1093/infdis/169.2.330; MIDDLETON KR, 1974, J PHARM PHARMACOL, V26, pP99, DOI 10.1111/j.2042-7158.1974.tb10128.x; Mostowy S, 2012, CELL MICROBIOL; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Paz I, 2010, CELL MICROBIOL, V12, P530, DOI 10.1111/j.1462-5822.2009.01415.x; POPIEL I, 1985, INFECT IMMUN, V47, P786, DOI 10.1128/IAI.47.3.786-792.1985; Raffatellu M, 2005, INFECT IMMUN, V73, P146, DOI 10.1128/IAI.73.1.146-154.2005; RAOULT D, 1990, ANTIMICROB AGENTS CH, V34, P1512, DOI 10.1128/AAC.34.8.1512; Ray K, 2009, NAT REV MICROBIOL, V7, P333, DOI 10.1038/nrmicro2112; Roehrich AD, 2010, INFECT IMMUN, V78, P1682, DOI 10.1128/IAI.00645-09; Rosselin M, 2011, MICROBIOL-SGM, V157, P839, DOI 10.1099/mic.0.044941-0; Roy D, 2004, SCIENCE, V304, P1515, DOI 10.1126/science.1098371; Salcedo SP, 2001, CELL MICROBIOL, V3, P587, DOI 10.1046/j.1462-5822.2001.00137.x; Santos RL, 2009, TRENDS MICROBIOL, V17, P498, DOI 10.1016/j.tim.2009.08.008; Santos RL, 2004, INT J MED MICROBIOL, V294, P225, DOI 10.1016/j.ijmm.2004.06.029; Shaughnessy LM, 2006, CELL MICROBIOL, V8, P781, DOI 10.1111/j.1462-5822.2005.00665.x; Simeone R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002507; Starr T, 2012, CELL HOST MICROBE, V11, P33, DOI 10.1016/j.chom.2011.12.002; Steele-Mortimer O, 2002, CELL MICROBIOL, V4, P43, DOI 10.1046/j.1462-5822.2002.00170.x; Steele-Mortimer O, 2008, CURR OPIN MICROBIOL, V11, P38, DOI 10.1016/j.mib.2008.01.002; Stein MA, 1996, MOL MICROBIOL, V20, P151, DOI 10.1111/j.1365-2958.1996.tb02497.x; STEINBERG TH, 1994, CLIN INFECT DIS, V19, P916, DOI 10.1093/clinids/19.5.916; Tattoli I, 2012, CELL HOST MICROBE, V11, P563, DOI 10.1016/j.chom.2012.04.012; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; TULKENS P, 1978, BIOCHEM PHARMACOL, V27, P415, DOI 10.1016/0006-2952(78)90370-2; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015; Voth DE, 2007, CELL MICROBIOL, V9, P829, DOI 10.1111/j.1462-5822.2007.00901.x; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Zheng YT, 2009, J IMMUNOL, V183, P5909, DOI 10.4049/jimmunol.0900441; ZYCHLINSKY A, 1994, MOL MICROBIOL, V11, P619, DOI 10.1111/j.1365-2958.1994.tb00341.x	72	88	89	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84681	10.1371/journal.pone.0084681	http://dx.doi.org/10.1371/journal.pone.0084681			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400108	Green Published, Green Submitted, gold			2022-12-27	WOS:000329462700042
J	Sousa, A; Ribeiro, J; Sousa, M; Vilas-Boas, JP; Fernandes, RJ				Sousa, Ana; Ribeiro, Joao; Sousa, Marisa; Vilas-Boas, Joao Paulo; Fernandes, Ricardo J.			Influence of Prior Exercise on VO2 Kinetics Subsequent Exhaustive Rowing Performance	PLOS ONE			English	Article							PULMONARY O-2 UPTAKE; OXYGEN-UPTAKE KINETICS; PRIOR HEAVY EXERCISE; HIGH-INTENSITY EXERCISE; LINE METABOLIC-RATE; UPTAKE ON-KINETICS; PRIMING EXERCISE; DEOXYGENATION KINETICS; RECOVERY DURATION; SPRINT EXERCISE	Prior exercise has the potential to enhance subsequent performance by accelerating the oxygen uptake (VO2) kinetics. The present study investigated the effects of two different intensities of prior exercise on pulmonary VO2 kinetics and exercise time during subsequent exhaustive rowing exercise. It was hypothesized that in prior heavy, but not prior moderate exercise condition, overall VO2 kinetics would be faster and the VO2 primary amplitude would be higher, leading to longer exercise time at VO2max. Six subjects (mean +/- SD; age: 22.9 +/- 4.5 yr; height: 181.2 +/- 7.1 cm and body mass: 75.5 +/- 3.4 kg) completed square-wave transitions to 100% of VO2max from three different conditions: without prior exercise, with prior moderate and heavy exercise. VO2 was measured using a telemetric portable gas analyser (K4b(2), Cosmed, Rome, Italy) and the data were modelled using either mono or double exponential fittings. The use of prior moderate exercise resulted in a faster VO2 pulmonary kinetics response (tau(1) = 13.41 +/- 3.96 s), an improved performance in the time to exhaustion (238.8 +/- 50.2 s) and similar blood lactate concentrations ([La-]) values (11.8 +/- 1.7 mmol.L-1) compared to the condition without prior exercise (16.0 +/- 5.56 s, 215.3 +/- 60.1 s and 10.7 +/- 1.2 mmol.L-1, for tau(1), time sustained at VO2max and [La-], respectively). Performance of prior heavy exercise, although useful in accelerating the VO2 pulmonary kinetics response during a subsequent time to exhaustion exercise (tau(1) = 9.18 +/- 1.60 s), resulted in a shorter time sustained at VO2max (155.5 +/- 46.0 s), while [La-] was similar (13.5 +/- 1.7 mmol.L-1) compared to the other two conditions. Although both prior moderate and heavy exercise resulted in a faster pulmonary VO2 kinetics response, only prior moderate exercise lead to improved rowing performance.	[Sousa, Ana; Ribeiro, Joao; Sousa, Marisa; Vilas-Boas, Joao Paulo; Fernandes, Ricardo J.] Univ Porto, Fac Sport, Ctr Res Educ Innovat & Intervent Sport, P-4100 Oporto, Portugal; [Vilas-Boas, Joao Paulo; Fernandes, Ricardo J.] Univ Porto, LABIOMEP, Porto Biomech Lab, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto	Sousa, A (corresponding author), Univ Porto, Fac Sport, Ctr Res Educ Innovat & Intervent Sport, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	sousa.acm@gmail.com	Fernandes, Ricardo J./A-1040-2012	Fernandes, Ricardo J./0000-0002-5811-0443; Vilas-Boas, J. Paulo/0000-0002-4109-2939; Ribeiro, Joao/0000-0002-7658-4837	Portuguese Foundation for Science and Technology [SFRH/BD/72610/2010]	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	This work was funded by the Portuguese Foundation for Science and Technology - Ref. SFRH/BD/72610/2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey SJ, 2009, J APPL PHYSIOL, V107, P1743, DOI 10.1152/japplphysiol.00810.2009; Barker AR, 2010, J APPL PHYSIOL, V109, P491, DOI 10.1152/japplphysiol.00139.2010; BARSTOW TJ, 1991, J APPL PHYSIOL, V71, P2099, DOI 10.1152/jappl.1991.71.6.2099; Breese BC, 2012, RESP PHYSIOL NEUROBI, V180, P223, DOI 10.1016/j.resp.2011.11.013; Burnley M, 2005, MED SCI SPORT EXER, V37, P838, DOI 10.1249/01.MSS.0000162617.18250.77; Burnley M, 2002, J APPL PHYSIOL, V93, P167, DOI 10.1152/japplphysiol.01217.2001; Burnley M, 2002, EUR J APPL PHYSIOL, V87, P424, DOI 10.1007/s00421-002-0647-8; Burnley M, 2001, EXP PHYSIOL, V86, P417, DOI 10.1113/eph8602122; Burnley M, 2000, J APPL PHYSIOL, V89, P1387, DOI 10.1152/jappl.2000.89.4.1387; Burnley M, 2011, MED SCI SPORT EXER, V43, P2171, DOI 10.1249/MSS.0b013e31821ff26d; DiMenna FJ, 2008, J APPL PHYSIOL, V105, P538, DOI 10.1152/japplphysiol.90357.2008; DiMenna FJ, 2010, J APPL PHYSIOL, V109, P1148, DOI 10.1152/japplphysiol.00550.2010; DiMenna FJ, 2010, RESP PHYSIOL NEUROBI, V173, P138, DOI 10.1016/j.resp.2010.07.005; DiMenna FJ, 2010, RESP PHYSIOL NEUROBI, V172, P15, DOI 10.1016/j.resp.2010.04.017; DiMenna FJ, 2010, J APPL PHYSIOL, V108, P283, DOI 10.1152/japplphysiol.01047.2009; DiMenna FJ, 2009, RESP PHYSIOL NEUROBI, V169, P16, DOI 10.1016/j.resp.2009.08.001; Ferguson C, 2007, J APPL PHYSIOL, V103, P812, DOI 10.1152/japplphysiol.01410.2006; Fernandes RJ, 2008, INT J SPORTS MED, V29, P145, DOI 10.1055/s-2007-965113; Fernandes RJ, 2012, INT J SPORTS MED, V33, P1010, DOI 10.1055/s-0032-1316362; Gaesser G A, 1996, Exerc Sport Sci Rev, V24, P35; Gerbino A, 1996, J APPL PHYSIOL, V80, P99, DOI 10.1152/jappl.1996.80.1.99; Grassi B, 1996, J APPL PHYSIOL, V80, P988, DOI 10.1152/jappl.1996.80.3.988; HOWLEY ET, 1995, MED SCI SPORT EXER, V27, P1292; Jones A.M., 2005, OXYGEN UPTAKE KINETI; Jones AM, 2003, MED SCI SPORT EXER, V35, P2085, DOI 10.1249/01.MSS.0000099108.55944.C4; Jones AM, 2003, SPORTS MED, V33, P949, DOI 10.2165/00007256-200333130-00002; Jones AM, 2008, RESP PHYSIOL NEUROBI, V161, P182, DOI 10.1016/j.resp.2008.02.001; Jones AM, 2008, EXP PHYSIOL, V93, P468, DOI 10.1113/expphysiol.2007.041897; Jones AM, 2008, J PHYSIOL-LONDON, V586, P889, DOI 10.1113/jphysiol.2007.142026; Jones AM, 2006, J APPL PHYSIOL, V101, P1432, DOI 10.1152/japplphysiol.00436.2006; Koppo K, 2003, EUR J APPL PHYSIOL, V88, P593, DOI 10.1007/s00421-002-0735-9; Koppo K, 2002, RESP PHYSIOL NEUROBI, V133, P241, DOI 10.1016/S1569-9048(02)00184-2; Krustrup P, 2001, J PHYSIOL-LONDON, V536, P947, DOI 10.1111/j.1469-7793.2001.00947.x; Palmer CD, 2009, MED SCI SPORT EXER, V41, P221, DOI 10.1249/MSS.0b013e31818313b6; Pringle JSM, 2003, EUR J APPL PHYSIOL, V89, P289, DOI 10.1007/s00421-003-0799-1; Roberts CL, 2005, RESP PHYSIOL NEUROBI, V146, P247, DOI 10.1016/j.resp.2004.12.012; SECHER NH, 1977, ACTA PHYSIOL SCAND, V100, P288, DOI 10.1111/j.1748-1716.1977.tb05952.x; SECHER NH, 1993, SPORTS MED, V15, P24, DOI 10.2165/00007256-199315010-00004; Secher NH, 2006, MED SCI SPORT EXER, V38, P1797, DOI 10.1249/01.mss.0000230343.64000.ac; Simpson LP, 2012, EUR J APPL PHYSIOL, V112, P2467, DOI 10.1007/s00421-011-2214-7; Wilkerson DP, 2007, RESP PHYSIOL NEUROBI, V156, P203, DOI 10.1016/j.resp.2006.09.008; Wilkerson DP, 2004, J APPL PHYSIOL, V97, P1227, DOI 10.1152/japplphysiol.01325.2003	42	11	11	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84208	10.1371/journal.pone.0084208	http://dx.doi.org/10.1371/journal.pone.0084208			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404156	Green Submitted, Green Published, gold			2022-12-27	WOS:000329460800035
J	Lopez-Fernandez, L; Ruiz-Roldan, C; Pareja-Jaime, Y; Prieto, A; Khraiwesh, H; Roncero, MIG				Lopez-Fernandez, Loida; Ruiz-Roldan, Carmen; Pareja-Jaime, Yolanda; Prieto, Alicia; Khraiwesh, Husam; Roncero, M. Isabel G.			The Fusarium oxysporum gnt2, Encoding a Putative N-Acetylglucosamine Transferase, Is Involved in Cell Wall Architecture and Virulence	PLOS ONE			English	Article							PROTEIN O-MANNOSYLATION; OLIGOSACCHARIDE STRUCTURES; FUSARIUM-OXYSPORUM; CANDIDA-ALBICANS; GOLGI-APPARATUS; MANNOSYLTRANSFERASE PMT4; ENDOPLASMIC-RETICULUM; PATTERN-RECOGNITION; MOLECULAR-CLONING; USTILAGO-MAYDIS	With the aim to decipher the molecular dialogue and cross talk between Fusarium oxysporum f. sp. lycopersci and its host during infection and to understand the molecular bases that govern fungal pathogenicity, we analysed genes presumably encoding N-acetylglucosaminyl transferases, involved in glycosylation of glycoproteins, glycolipids, proteoglycans or small molecule acceptors in other microorganisms. In silico analysis revealed the existence of seven putative N-glycosyl transferase encoding genes (named gnt) in F. oxysporum f. sp. lycopersici genome. gnt2 deletion mutants showed a dramatic reduction in virulence on both plant and animal hosts. Delta gnt2 mutants had alpha alterations in cell wall properties related to terminal alpha or beta-linked N-acetyl glucosamine. Mutant conidia and germlings also showed differences in structure and physicochemical surface properties. Conidial and hyphal aggregation differed between the mutant and wild type strains, in a pH independent manner. Transmission electron micrographs of germlings showed strong cell-to-cell adherence and the presence of an extracellular chemical matrix. Delta gnt2 cell walls presented a significant reduction in N-linked oligosaccharides, suggesting the involvement of Gnt2 in N-glycosylation of cell wall proteins. Gnt2 was localized in Golgi-like sub-cellular compartments as determined by fluorescence microscopy of GFP:: Gnt2 fusion protein after treatment with the antibiotic brefeldin A or by staining with fluorescent sphingolipid BODIPY-TR ceramide. Furthermore, density gradient ultracentrifugation allowed co-localization of GFP:: Gnt2 fusion protein and Vps10p in subcellular fractions enriched in Golgi specific enzymatic activities. Our results suggest that N-acetylglucosaminyl transferases are key components for cell wall structure and influence interactions of F. oxysporum with both plant and animal hosts during pathogenicity.	[Lopez-Fernandez, Loida; Ruiz-Roldan, Carmen; Pareja-Jaime, Yolanda; Roncero, M. Isabel G.] Univ Cordoba, Dept Genet, Cordoba, Spain; [Lopez-Fernandez, Loida; Ruiz-Roldan, Carmen; Pareja-Jaime, Yolanda; Roncero, M. Isabel G.] Campus Excelencia Agroalimentario CeiA3, Cordoba, Spain; [Prieto, Alicia] CSIC, Ctr Invest Biol, Madrid, Spain; [Khraiwesh, Husam] Univ Cordoba, Dept Biol Celular Fisiol & Inmunol, Cordoba, Spain	Universidad de Cordoba; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Universidad de Cordoba	Roncero, MIG (corresponding author), Univ Cordoba, Dept Genet, Cordoba, Spain.	roncero@uco.es	Prieto, Alicia/M-7899-2017; Roldán, Carmen Ruiz/AAB-2100-2019; Roncero, M. Isabel G./M-2496-2014	Prieto, Alicia/0000-0002-5075-4025; Ruiz Roldan, M. Carmen/0000-0003-3427-2998; Lopez-Fernandez, Loida/0000-0002-6270-9301; Roncero, M. Isabel G./0000-0002-5283-7836	Ministerio de Ciencia y Tecnologia of Spain [BIO2010-015505]; Junta de Andalucia [P08-CVI-3847]; Ministerio de Ciencia y Tecnologia	Ministerio de Ciencia y Tecnologia of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia(Junta de Andalucia); Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This research was supported by the Ministerio de Ciencia y Tecnologia (BIO2010-015505) of Spain, and Junta de Andalucia (P08-CVI-3847). L.L.F. was supported by a PhD fellowship from the former Ministerio de Ciencia y Tecnologia. L.L.F. was supported by a PhD fellowship from the former Ministerio de Ciencia y Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrazem O, 2000, ARCH MICROBIOL, V173, P296, DOI 10.1007/s002030000149; Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANTEBI A, 1992, MOL BIOL CELL, V3, P633, DOI 10.1091/mbc.3.6.633; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Bai C, 2006, EUKARYOT CELL, V5, P238, DOI 10.1128/EC.5.2.238-247.2006; BALLOU L, 1990, P NATL ACAD SCI USA, V87, P3368, DOI 10.1073/pnas.87.9.3368; Bates S, 2006, J BIOL CHEM, V281, P90, DOI 10.1074/jbc.M510360200; Breton C, 2001, BIOCHIMIE, V83, P713, DOI 10.1016/S0300-9084(01)01298-6; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Buse E, 1998, HISTOCHEM J, V30, P819, DOI 10.1023/A:1003550612096; Buser R, 2010, J BIOL CHEM, V285, P10715, DOI 10.1074/jbc.M109.076075; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Caracuel Z, 2005, MOL PLANT MICROBE IN, V18, P1140, DOI 10.1094/MPMI-18-1140; CARROLL AM, 1994, FUNGAL GENET NEWSLET, V41, P22, DOI DOI 10.4148/1941-4765.1367; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chavan M, 2003, P NATL ACAD SCI USA, V100, P15381, DOI 10.1073/pnas.2536561100; Chen SH, 1999, J BIOL CHEM, V274, P288, DOI 10.1074/jbc.274.1.288; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Chou TY, 2001, ADV EXP MED BIOL, V491, P413; Cole L, 2000, FUNGAL GENET BIOL, V29, P95, DOI 10.1006/fgbi.2000.1190; Crocker PR, 1996, CURR OPIN STRUC BIOL, V6, P679, DOI 10.1016/S0959-440X(96)80036-4; DANHASH N, 1993, PLANT MOL BIOL, V22, P1017, DOI 10.1007/BF00028974; de Wit P J G M, 2007, Cell Mol Life Sci, V64, P2726; DEAN N, 1995, P NATL ACAD SCI USA, V92, P1287, DOI 10.1073/pnas.92.5.1287; Deshpande N, 2008, GLYCOBIOLOGY, V18, P626, DOI 10.1093/glycob/cwn044; Di Pietro A, 1998, MOL PLANT MICROBE IN, V11, P91, DOI 10.1094/MPMI.1998.11.2.91; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Fernandez-Alvarez A, 2010, PLANT SIGNAL BEHAV, V5, P412, DOI 10.4161/psb.5.4.10805; Fernandez-Alvarez A, 2010, FUNGAL GENET BIOL, V47, P727, DOI 10.1016/j.fgb.2010.06.004; Fernandez-Alvarez A, 2009, PLANT CELL, V21, P3397, DOI 10.1105/tpc.109.065839; Garcia-Pedrajas MD, 2010, METHODS MOL BIOL, V638, P55, DOI 10.1007/978-1-60761-611-5_5; Gemmill TR, 1999, BBA-GEN SUBJECTS, V1426, P227, DOI 10.1016/S0304-4165(98)00126-3; Gibson RP, 2002, CHEM BIOL, V9, P1337, DOI 10.1016/S1074-5521(02)00292-2; Guillen E, 1998, P NATL ACAD SCI USA, V95, P7888, DOI 10.1073/pnas.95.14.7888; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haweker H, 2010, J BIOL CHEM, V285, P4629, DOI 10.1074/jbc.M109.063073; Hall T., 2004, BIOEDIT; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; HERNANDEZ LM, 1992, BIOCHEMISTRY-US, V31, P9823, DOI 10.1021/bi00155a039; Herrero AB, 2002, EUKARYOT CELL, V1, P420, DOI 10.1128/EC.1.3.420-431.2002; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kotz A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015729; LEHLE L, 1979, J BIOL CHEM, V254, P2209; Lehle L, 2006, ANGEW CHEM INT EDIT, V45, P6802, DOI 10.1002/anie.200601645; Lengeler KB, 2008, CELL MOL LIFE SCI, V65, P528, DOI 10.1007/s00018-007-7409-z; Levine TP, 2000, MOL BIOL CELL, V11, P2267, DOI 10.1091/mbc.11.7.2267; Li DX, 2002, J BIOL CHEM, V277, P7905, DOI 10.1074/jbc.M108799200; LIS H, 1986, ANNU REV BIOCHEM, V55, P35, DOI 10.1146/annurev.bi.55.070186.000343; Lis H, 1998, CHEM REV, V98, P637, DOI 10.1021/cr940413g; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lommel M, 2009, GLYCOBIOLOGY, V19, P816, DOI 10.1093/glycob/cwp066; Lopez-Avalos MD, 2001, GLYCOBIOLOGY, V11, P413, DOI 10.1093/glycob/11.5.413; Lopez-Berges MS, 2012, PLANT CELL, V24, P3805, DOI 10.1105/tpc.112.098624; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Madrid MP, 2003, MOL MICROBIOL, V47, P257, DOI 10.1046/j.1365-2958.2003.03299.x; Motteram J, 2011, MOL MICROBIOL, V81, P415, DOI 10.1111/j.1365-2958.2011.07701.x; Mouyna I, 2010, MOL MICROBIOL, V76, P1205, DOI 10.1111/j.1365-2958.2010.07164.x; Navarro-Velasco GY, 2011, FUNGAL GENET BIOL, V48, P1124, DOI 10.1016/j.fgb.2011.08.004; Nothwehr SF, 1996, MOL CELL BIOL, V16, P2700; Odani T, 1997, FEBS LETT, V420, P186, DOI 10.1016/S0014-5793(97)01513-5; Olson GM, 2007, EUKARYOT CELL, V6, P222, DOI 10.1128/EC.00182-06; Ortoneda M, 2004, INFECT IMMUN, V72, P1760, DOI 10.1128/IAI.72.3.1760-1766.2004; PAGANO RE, 1991, J CELL BIOL, V113, P1267, DOI 10.1083/jcb.113.6.1267; Pareja-Jaime Y, 2010, MOL PLANT PATHOL, V11, P479, DOI [10.1111/j.1364-3703.2010.00624.x, 10.1111/J.1364-3703.2010.00624.X]; Parodi AJ, 2000, ANNU REV BIOCHEM, V69, P69, DOI 10.1146/annurev.biochem.69.1.69; Peumans WJ, 1998, CRIT REV BIOCHEM MOL, V33, P209; Priegnitz BE, 2012, FUNGAL GENET BIOL, V49, P30, DOI 10.1016/j.fgb.2011.12.002; Prill SKH, 2005, MOL MICROBIOL, V55, P546, DOI 10.1111/j.1365-2958.2004.04401.x; PUNT PJ, 1992, METHOD ENZYMOL, V216, P447; RAEDER U, 1985, LETT APPL MICROBIOL, V1, P17, DOI 10.1111/j.1472-765X.1985.tb01479.x; Rocha ALM, 2008, MOL PLANT PATHOL, V9, P293, DOI 10.1111/J.1364-3703.2007.00463.X; Rouabhia M, 2005, INFECT IMMUN, V73, P4571, DOI 10.1128/IAI.73.8.4571-4580.2005; Schirawski J, 2005, PLANT CELL, V17, P3532, DOI 10.1105/tpc.105.036285; Schoffelmeer EAM, 1999, FUNGAL GENET BIOL, V27, P275, DOI 10.1006/fgbi.1999.1153; Strasser R, 1999, GLYCOBIOLOGY, V9, P779, DOI 10.1093/glycob/9.8.779; Stukenbrock EH, 2009, MOL PLANT MICROBE IN, V22, P371, DOI 10.1094/MPMI-22-4-0371; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Timpel C, 2000, J BACTERIOL, V182, P3063, DOI 10.1128/JB.182.11.3063-3071.2000; Timpel C, 1998, J BIOL CHEM, V273, P20837, DOI 10.1074/jbc.273.33.20837; van de Veerdonk FL, 2008, CURR OPIN MICROBIOL, V11, P305, DOI 10.1016/j.mib.2008.06.002; VANKAN JAL, 1992, PLANT MOL BIOL, V20, P513, DOI 10.1007/BF00040610; Wenderoth I, 2000, PLANT PHYSIOL, V123, P1097, DOI 10.1104/pp.123.3.1097; YANAGISAWA K, 1990, J BIOL CHEM, V265, P19351; Yang DH, 2000, HISTOCHEM J, V32, P187, DOI 10.1023/A:1004051408239; Yoko-o T, 2003, GLYCOBIOLOGY, V13, P581, DOI 10.1093/glycob/cwg063	87	14	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84690	10.1371/journal.pone.0084690	http://dx.doi.org/10.1371/journal.pone.0084690			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24416097	Green Published, gold			2022-12-27	WOS:000329117900106
J	Fiorentino, M; Levine, MM; Sztein, MB; Fasano, A				Fiorentino, Maria; Levine, Myron M.; Sztein, Marcelo B.; Fasano, Alessio			Effect of Wild-Type Shigella Species and Attenuated Shigella Vaccine Candidates on Small Intestinal Barrier Function, Antigen Trafficking, and Cytokine Release	PLOS ONE			English	Article							TIGHT JUNCTION; EPITHELIAL-CELLS; OCCLUDIN PHOSPHORYLATION; RHESUS-MONKEYS; HUMAN-COLON; DYSENTERIAE TYPE-1; FLEXNERI INFECTION; TRAVELERS DIARRHEA; DIVERSE SEROTYPES; ESCHERICHIA-COLI	Bacterial dysentery due to Shigella species is a major cause of morbidity and mortality worldwide. The pathogenesis of Shigella is based on the bacteria's ability to invade and replicate within the colonic epithelium, resulting in severe intestinal inflammatory response and epithelial destruction. Although the mechanisms of pathogenesis of Shigella in the colon have been extensively studied, little is known on the effect of wild-type Shigella on the small intestine and the role of the host response in the development of the disease. Moreover, to the best of our knowledge no studies have described the effects of apically administered Shigella flexneri 2a and S. dysenteriae 1 vaccine strains on human small intestinal enterocytes. The aim of this study was to assess the coordinated functional and immunological human epithelial responses evoked by strains of Shigella and candidate vaccines on small intestinal enterocytes. To model the interactions of Shigella with the intestinal mucosa, we apically exposed monolayers of human intestinal Caco2 cells to increasing bacterial inocula. We monitored changes in paracellular permeability, examined the organization of tight-junctions and the pro-inflammatory response of epithelial cells. Shigella infection of Caco2 monolayers caused severe mucosal damage, apparent as a drastic increase in paracellular permeability and disruption of tight junctions at the cell-cell boundary. Secretion of pro-inflammatory IL-8 was independent of epithelial barrier dysfunction. Shigella vaccine strains elicited a pro-inflammatory response without affecting the intestinal barrier integrity. Our data show that wild-type Shigella infection causes a severe alteration of the barrier function of a small intestinal cell monolayer (a proxy for mucosa) and might contribute (along with enterotoxins) to the induction of watery diarrhea. Diarrhea may be a mechanism by which the host attempts to eliminate harmful bacteria and transport them from the small to the large intestine where they invade colonocytes inducing a strong inflammatory response.	[Fiorentino, Maria; Fasano, Alessio] Massachusetts Gen Hosp, Mucosal Immunol & Biol Res Ctr, Charlestown, MA 02129 USA; [Levine, Myron M.; Sztein, Marcelo B.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Levine, Myron M.; Sztein, Marcelo B.] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; [Levine, Myron M.; Sztein, Marcelo B.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA	Harvard University; Massachusetts General Hospital; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Fasano, A (corresponding author), Massachusetts Gen Hosp, Mucosal Immunol & Biol Res Ctr, Charlestown, MA 02129 USA.	afasano@mgh.harvard.edu	Fiorentino, Maria/AAV-9514-2020; Fasano, Alessio/K-5486-2016	Fasano, Alessio/0000-0002-2134-0261; Fiorentino, Maria R/0000-0001-5318-7313	NIAID, NIH, DHHS [U19 AI082655]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090873, U19AI082655] Funding Source: NIH RePORTER	NIAID, NIH, DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were funded by NIAID, NIH, DHHS grant U19 AI082655 (Cooperative Center for Translational Research in Human Immunology and Biodefense; CCHI) to M. B. S and A. F. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTURSSON P, 1990, J PHARM SCI-US, V79, P476, DOI 10.1002/jps.2600790604; Balda MS, 1996, J CELL BIOL, V134, P1031, DOI 10.1083/jcb.134.4.1031; BLACK RE, 1984, PEDIATRICS, V73, P799; Cersini A, 1998, INFECT IMMUN, V66, P549, DOI 10.1128/IAI.66.2.549-557.1998; COHEN D, 1991, J CLIN MICROBIOL, V29, P386, DOI 10.1128/JCM.29.2.386-389.1991; Coron E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004713; DINARI G, 1987, J INFECT DIS, V155, P1065, DOI 10.1093/infdis/155.5.1065; Dorfel MJ, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/807356; Dorfel MJ, 2013, CCS, V11; DUPONT HL, 1972, J INFECT DIS, V125, P12, DOI 10.1093/infdis/125.1.12; DUPONT HL, 1989, J INFECT DIS, V159, P1126, DOI 10.1093/infdis/159.6.1126; Faherty C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049980; Farfan MJ, 2011, FEMS IMMUNOL MED MIC, V61, P332, DOI 10.1111/j.1574-695X.2011.00778.x; FASANO A, 1995, J CLIN INVEST, V95, P2853, DOI 10.1172/JCI117991; Fasano A, 1997, GUT, V40, P505, DOI 10.1136/gut.40.4.505; Fiorentino M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00017; Flamant M, 2011, GUT, V60, P473, DOI 10.1136/gut.2010.229237; FORMAL SB, 1958, J BACTERIOL, V75, P604, DOI 10.1128/JB.75.5.604-610.1958; Gupta A, 2004, CLIN INFECT DIS, V38, P1372, DOI 10.1086/386326; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; Jeong KI, 2010, J INFECT DIS, V201, P903, DOI 10.1086/650995; JUNG HC, 1995, J CLIN INVEST, V95, P55, DOI 10.1172/JCI117676; KATAKURA S, 1990, APMIS, V98, P313, DOI 10.1111/j.1699-0463.1990.tb01038.x; Kotloff KL, 2007, HUM VACCINES, V3, P268, DOI 10.4161/hv.4746; KOTLOFF KL, 1995, VACCINE, V13, P495, DOI 10.1016/0264-410X(94)00011-B; KOTLOFF KL, 1995, VACCINE, V13, P1488, DOI 10.1016/0264-410X(95)00102-7; Kotloff KL, 2004, J INFECT DIS, V190, P1745, DOI 10.1086/424680; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; LEVINE MM, 1973, J INFECT DIS, V127, P261, DOI 10.1093/infdis/127.3.261; Levine MM, 2007, NAT REV MICROBIOL, V5, P540, DOI 10.1038/nrmicro1662; LINDBERG AA, 1988, VACCINE, V6, P146, DOI 10.1016/S0264-410X(88)80018-5; LINDBERG AA, 1990, MICROB PATHOGENESIS, V8, P433, DOI 10.1016/0882-4010(90)90030-T; McCarthy KM, 1996, J CELL SCI, V109, P2287; MOUNIER J, 1992, INFECT IMMUN, V60, P237, DOI 10.1128/IAI.60.1.237-248.1992; Murakami T, 2009, J BIOL CHEM, V284, P21036, DOI 10.1074/jbc.M109.016766; Nandakumar NS, 2009, INDIAN J MED RES, V130, P170; NATARO JP, 1995, INFECT IMMUN, V63, P4721, DOI 10.1128/IAI.63.12.4721-4728.1995; Niyogi SK, 2004, CLIN MICROBIOL INFEC, V10, P574, DOI 10.1111/j.1469-0691.2004.00897.x; NORIEGA FR, 1995, J INFECT DIS, V172, P1408, DOI 10.1093/infdis/172.5.1408; OAKS EV, 1986, INFECT IMMUN, V53, P57, DOI 10.1128/IAI.53.1.57-63.1986; PERDOMO OJJ, 1994, J EXP MED, V180, P1307, DOI 10.1084/jem.180.4.1307; PIGNATA S, 1994, CELL GROWTH DIFFER, V5, P967; Porter CK, 2012, EPIDEMIOLOGY INFECT, P1; Raleigh DR, 2011, J CELL BIOL, V193, P565, DOI 10.1083/jcb.201010065; Rao R, 2009, ANN NY ACAD SCI, V1165, P62, DOI 10.1111/j.1749-6632.2009.04054.x; ROUT WR, 1975, GASTROENTEROLOGY, V68, P270; Sakaguchi T, 2002, CELL MICROBIOL, V4, P367, DOI 10.1046/j.1462-5822.2002.00197.x; Sakakibara A, 1997, J CELL BIOL, V137, P1393, DOI 10.1083/jcb.137.6.1393; Seth A, 2007, J BIOL CHEM, V282, P11487, DOI 10.1074/jbc.M610597200; Shim DH, 2007, J IMMUNOL, V178, P2476, DOI 10.4049/jimmunol.178.4.2476; Shipley ST, 2010, COMPARATIVE MED, V60, P54; Sundstrom JM, 2009, J PROTEOME RES, V8, P808, DOI 10.1021/pr7007913; Suzuki T, 2009, P NATL ACAD SCI USA, V106, P61, DOI 10.1073/pnas.0802741106; TAYLOR DN, 1988, JAMA-J AM MED ASSOC, V260, P1245, DOI 10.1001/jama.260.9.1245; TAYLOR DN, 1986, REV INFECT DIS, V8, pS136; Vargas M, 1999, J CLIN MICROBIOL, V37, P3608, DOI 10.1128/JCM.37.11.3608-3611.1999; VASSELON T, 1992, INFECT IMMUN, V60, P1031, DOI 10.1128/IAI.60.3.1031-1040.1992; Venkatesan MM, 2002, INFECT IMMUN, V70, P2950, DOI 10.1128/IAI.70.6.2950-2958.2002; Wong V, 1997, AM J PHYSIOL-CELL PH, V273, pC1859, DOI 10.1152/ajpcell.1997.273.6.C1859; Wu T, 2011, INFECT IMMUN, V79, P4912, DOI 10.1128/IAI.05814-11; Yavzori M, 2002, EPIDEMIOL INFECT, V128, P533, DOI 10.1017/S0950268802006866; Zhang Z, 2001, INFECT IMMUN, V69, P3240, DOI 10.1128/IAI.69.5.3240-3247.2001; Zurawski DV, 2009, MOL MICROBIOL, V71, P350, DOI 10.1111/j.1365-2958.2008.06524.x	63	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85211	10.1371/journal.pone.0085211	http://dx.doi.org/10.1371/journal.pone.0085211			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416363	Green Published, Green Submitted, gold			2022-12-27	WOS:000329866300055
J	Hsiung, YC; Liu, JJ; Hou, YC; Yeh, CL; Yeh, SL				Hsiung, Yuan-Chin; Liu, Jun-Jen; Hou, Yu-Chen; Yeh, Chiu-Li; Yeh, Sung-Ling			Effects of Dietary Glutamine on the Homeostasis of CD4+T Cells in Mice with Dextran Sulfate Sodium-Induced Acute Colitis	PLOS ONE			English	Article							REGULATORY T-CELLS; INFLAMMATORY-BOWEL-DISEASE; HEAT-SHOCK PROTEINS; GENE-EXPRESSION; APOPTOSIS; SUPPLEMENTATION; PROLIFERATION; ACTIVATION; BREAKDOWN; PROFILES	This study investigated the effects of dietary glutamine (Gln) on T-helper (Th) and T regulatory (Treg) cell homeostasis and colonic inflammatory mediator expression in mice with dextran sulfate sodium (DSS)-induced colitis. Mice were randomly assigned to 4 groups with 2 normal control (C and G) and 2 DSS-treated groups (DC and DG). The C and DC groups were fed a common semipurified diet, while the G and DG groups received an identical diet except that part of the casein was replaced by Gln, which provided 25% of the total amino acid nitrogen. Mice were fed the diets for 10 days. On day 6, mice in the normal control groups were given distilled water, while those in the DSS groups were given distilled water containing 1.5% DSS for 5 d. At the end of the experiment, the mice were sacrificed for further examination. Results showed that DC group had higher plasma haptoglobin, colonic weight, immunoglobulin G, inflammatory cytokine and nuclear factor (NF)-kappa B protein levels. Gln administration lowered inflammatory mediators and NF-kappa B/I kappa B alpha ratio in colitis. Compared with the DC group, the percentages of interleukin-17F and interferon-gamma in blood and transcription factors, T-bet and RAR-related orphan receptor-gamma t, gene expressions in mesenteric lymph nodes were lower, whereas blood Foxp3 was higher in the DG group. Also, DG group had lower colon injury score. These results suggest that Gln administration suppressed Th1/Th17 and Th-associated cytokine expressions and upregulated the expression of Tregs, which may modulate the balance of Th/Treg and reduce inflammatory reactions in DSS-induced colitis.	[Hsiung, Yuan-Chin; Yeh, Sung-Ling] Taipei Med Univ, Sch Nutr & Hlth Sci, Taipei, Taiwan; [Liu, Jun-Jen] Taipei Med Univ, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan; [Hou, Yu-Chen] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Yeh, Chiu-Li] Chinese Culture Univ, Dept Food & Nutr, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; National Taiwan University; National Taiwan University Hospital; Chinese Culture University	Yeh, SL (corresponding author), Taipei Med Univ, Sch Nutr & Hlth Sci, Taipei, Taiwan.	sangling@tmu.edu.tw	Liu, Jun-Jen/AAP-1788-2021		National Science Council, Taipei, Taiwan [NSC100-2320-B-038-007-MY3]	National Science Council, Taipei, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the National Science Council grant NSC100-2320-B-038-007-MY3, Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Benson JM, 2011, TOXICOL SCI, V120, P68, DOI 10.1093/toxsci/kfq360; Boden EK, 2008, CURR OPIN GASTROEN, V24, P733, DOI 10.1097/MOG.0b013e328311f26e; Boirivant M, 2012, ORAL DIS, V18, P1, DOI 10.1111/j.1601-0825.2011.01811.x; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Chang WK, 2002, CLIN IMMUNOL, V104, P151, DOI 10.1006/clim.2002.5257; Chang WK, 1999, CLIN EXP IMMUNOL, V117, P482, DOI 10.1046/j.1365-2249.1999.01009.x; Chen Q, 2011, J IMMUNOL, V186, P6329, DOI 10.4049/jimmunol.1100061; CHOUDARI CP, 1993, GASTROENTEROLOGY, V104, P1064, DOI 10.1016/0016-5085(93)90275-H; Chu CC, 2012, J NUTR BIOCHEM, V23, P1092, DOI 10.1016/j.jnutbio.2011.06.002; Cuzzocrea S, 2003, BRIT J PHARMACOL, V138, P678, DOI 10.1038/sj.bjp.0705077; Eastaff-Leung N, 2010, J CLIN IMMUNOL, V30, P80, DOI 10.1007/s10875-009-9345-1; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Hoebler C, 2006, DIGEST DIS SCI, V51, P381, DOI 10.1007/s10620-006-3142-y; Iba Y, 2003, INT IMMUNOPHARMACOL, V3, P485, DOI 10.1016/S1567-5769(02)00299-0; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kew S, 1999, J NUTR, V129, P1524, DOI 10.1093/jn/129.8.1524; Kim H, 2011, YONSEI MED J, V52, P892, DOI 10.3349/ymj.2011.52.6.892; KINDON H, 1995, GASTROENTEROLOGY, V109, P516, DOI 10.1016/0016-5085(95)90340-2; Kretzmann NA, 2008, INFLAMM BOWEL DIS, V14, P1504, DOI 10.1002/ibd.20543; LACEY JM, 1990, NUTR REV, V48, P297, DOI 10.1111/j.1753-4887.1990.tb02967.x; Lanneau D, 2008, J CELL MOL MED, V12, P743, DOI 10.1111/j.1582-4934.2008.00273.x; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Leung JM, 2014, MUCOSAL IMMUNOL, V7, P124, DOI 10.1038/mi.2013.31; Macpherson A, 1996, GUT, V38, P365, DOI 10.1136/gut.38.3.365; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Maul J, 2005, GASTROENTEROLOGY, V128, P1868, DOI 10.1053/j.gastro.2005.03.043; Melgar S, 2005, AM J PHYSIOL-GASTR L, V288, pG1328, DOI 10.1152/ajpgi.00467.2004; Monteleone I, 2011, GASTROENTEROLOGY, V141, P237, DOI 10.1053/j.gastro.2011.04.007; Nielsen OH, 1996, DIGEST DIS SCI, V41, P1786, DOI 10.1007/BF02088746; PARRYBILLINGS M, 1990, LANCET, V336, P523, DOI 10.1016/0140-6736(90)92083-T; Renes IB, 2002, INT J COLORECTAL DIS, V17, P317, DOI 10.1007/s00384-002-0409-4; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Saruta M, 2007, CLIN IMMUNOL, V125, P281, DOI 10.1016/j.clim.2007.08.003; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Shiomi Y, 2011, INFLAMM BOWEL DIS, V17, P2261, DOI 10.1002/ibd.21616; Singh NP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023522; Sreedhar AS, 2004, PHARMACOL THERAPEUT, V101, P227, DOI 10.1016/j.pharmthera.2003.11.004; Takahashi M, 2006, DIGEST DIS SCI, V51, P677, DOI 10.1007/s10620-006-3191-2; Triantafillidis JK, 2009, ANTICANCER RES, V29, P2727; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wilmore DW, 2001, J NUTR, V131, p2543S, DOI 10.1093/jn/131.9.2543S; Wischmeyer PE, 1997, AM J PHYSIOL-GASTR L, V272, pG879, DOI 10.1152/ajpgi.1997.272.4.G879; Xue HY, 2011, JPEN-PARENTER ENTER, V35, P188, DOI 10.1177/0148607110381407; Yeh CL, 2006, NUTRITION, V22, P408, DOI 10.1016/j.nut.2005.10.007; Yu QT, 2007, INFLAMM BOWEL DIS, V13, P191, DOI 10.1002/ibd.20053; Zhang N, 2011, MOL CELL BIOCHEM, V353, P41, DOI 10.1007/s11010-011-0772-y	52	27	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84410	10.1371/journal.pone.0084410	http://dx.doi.org/10.1371/journal.pone.0084410			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416230	gold, Green Published, Green Submitted			2022-12-27	WOS:000329866300024
J	Ladda, AM; Pfannmoeller, JP; Kalisch, T; Roschka, S; Platz, T; Dinse, HR; Lotze, M				Ladda, Aija Marie; Pfannmoeller, Joerg Peter; Kalisch, Tobias; Roschka, Sybille; Platz, Thomas; Dinse, Hubert R.; Lotze, Martin			Effects of Combining 2 Weeks of Passive Sensory Stimulation with Active Hand Motor Training in Healthy Adults	PLOS ONE			English	Article							PRIMARY SOMATOSENSORY CORTEX; FUNCTIONAL MRI; CORTICAL REPRESENTATION; TACTILE DISCRIMINATION; SINGLE-BLIND; ARM PARESIS; PLASTICITY; PERFORMANCE; ACTIVATION; FINGER	The gold standard to acquire motor skills is through intensive training and practicing. Recent studies have demonstrated that behavioral gains can also be acquired by mere exposure to repetitive sensory stimulation to drive the plasticity processes. Single application of repetitive electric stimulation (rES) of the fingers has been shown to improve tactile perception in young adults as well as sensorimotor performance in healthy elderly individuals. The combination of repetitive motor training with a preceding rES has not been reported yet. In addition, the impact of such a training on somatosensory tactile and spatial sensitivity as well as on somatosensory cortical activation remains elusive. Therefore, we tested 15 right-handed participants who underwent repetitive electric stimulation of all finger tips of the left hand for 20 minutes prior to one hour of motor training of the left hand over the period of two weeks. Overall, participants substantially improved the motor performance of the left trained hand by 34%, but also showed a relevant transfer to the untrained right hand by 24%. Baseline ipsilateral activation fMRI-magnitude in BA 1 to sensory index finger stimulation predicted training outcome for somatosensory guided movements: those who showed higher ipsilateral activation were those who did profit less from training. Improvement of spatial tactile discrimination was positively associated with gains in pinch grip velocity. Overall, a combination of priming rES and repetitive motor training is capable to induce motor and somatosensory performance increase and representation changes in BA1 in healthy young subjects.	[Ladda, Aija Marie; Pfannmoeller, Joerg Peter; Lotze, Martin] Ernst Moritz Arndt Univ Greifswald, Ctr Diagnost Radiol, Funct Imaging Unit, Greifswald, Germany; [Kalisch, Tobias; Dinse, Hubert R.] Ruhr Univ Bochum, Neural Plast Lab, Inst Neuroinformat, Bochum, Germany; [Roschka, Sybille; Platz, Thomas] Ernst Moritz Arndt Univ Greifswald, BDH Klin Greifswald, Neurorehabil Ctr, Greifswald, Germany; [Roschka, Sybille; Platz, Thomas] Ernst Moritz Arndt Univ Greifswald, Spinal Cord Injury Unit, Greifswald, Germany	Ernst Moritz Arndt Universitat Greifswald; Ruhr University Bochum; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald	Lotze, M (corresponding author), Ernst Moritz Arndt Univ Greifswald, Ctr Diagnost Radiol, Funct Imaging Unit, Greifswald, Germany.	martin.lotze@uni-greifswald.de	Kalisch, Tobias/AAY-4182-2021; Lotze, Martin/D-2964-2012; Ladda, Aija/AAD-8784-2021	Kalisch, Tobias/0000-0003-4206-4283; Lotze, Martin/0000-0003-4519-4956; Ladda, Aija Marie/0000-0001-9897-7669; Roschka, Sybille/0000-0001-5987-9679; Platz, Thomas/0000-0003-2629-9744; dinse, hubert/0000-0001-9024-0451	University of Bochum; German Research Foundation (Deutsche Forschungsgemeinschaft) [LO795/7-1]; German Research Foundation [SFB 874]	University of Bochum; German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); German Research Foundation(German Research Foundation (DFG))	A.M. Ladda was supported by a grant from the University of Bochum. M. Lotze, S. Roschka and T. Platz were supported by a grant of the German Research Foundation (Deutsche Forschungsgemeinschaft (LO795/7-1). T. Kalisch and H. R. Dinse acknowledge support by the SFB 874 from the German Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beste C, 2013, CURR BIOL, V23, pR489, DOI 10.1016/j.cub.2013.04.044; Bodegard A, 2001, NEURON, V31, P317, DOI 10.1016/S0896-6273(01)00362-2; Classen J, 1998, J NEUROPHYSIOL, V79, P1117, DOI 10.1152/jn.1998.79.2.1117; Conforto AB, 2002, ANN NEUROL, V51, P122, DOI 10.1002/ana.10070; Conforto AB, 2007, J NEUROL, V254, P333, DOI 10.1007/s00415-006-0364-z; Dinse HR, 2011, AUGMENTING COGNITION, P11, DOI DOI 10.1201/B12162-3; Dinse HR, 2006, ANN NEUROL, V60, P88, DOI 10.1002/ana.20862; Dong Y, 2006, STROKE, V37, P1552, DOI 10.1161/01.STR.0000221281.69373.4e; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; Fischl B, 2008, CEREB CORTEX, V18, P1973, DOI 10.1093/cercor/bhm225; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Godde B, 2000, J NEUROSCI, V20, P1597; Grafton ST, 2002, EXP BRAIN RES, V146, P369, DOI 10.1007/s00221-002-1181-y; Hinder MR, 2011, J APPL PHYSIOL, V110, P166, DOI 10.1152/japplphysiol.00958.2010; Hodzic A, 2004, J NEUROSCI, V24, P442, DOI 10.1523/JNEUROSCI.3731-03.2004; Hoffken O, 2007, J PHYSIOL-LONDON, V584, P463, DOI 10.1113/jphysiol.2007.140079; HOLM S, 1979, SCAND J STAT, V6, P65; Hund-Georgiadis M, 1999, EXP BRAIN RES, V125, P417, DOI 10.1007/s002210050698; Kalisch T, 2010, NEURAL PLAST, V2010, DOI 10.1155/2010/690531; Kalisch T, 2008, CLIN INTERV AGING, V3, P673, DOI 10.2147/CIA.S3174; KARNI A, 1995, NATURE, V377, P155; Kattenstroth JC, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00244; Kirsch W, 2010, EXP BRAIN RES, V202, P927, DOI 10.1007/s00221-010-2184-8; Kowalewski R, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/974504; Lotze M, 2003, NEUROIMAGE, V20, P1817, DOI 10.1016/j.neuroimage.2003.07.018; Lotze M, 2003, BRAIN, V126, P866, DOI 10.1093/brain/awg079; Loubinoux I, 2001, J CEREBR BLOOD F MET, V21, P592, DOI 10.1097/00004647-200105000-00014; McGlone F, 2010, NEUROSCI BIOBEHAV R, V34, P148, DOI 10.1016/j.neubiorev.2009.08.004; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pantev C, 1998, NATURE, V392, P811, DOI 10.1038/33918; Pau S, 2013, NEUROIMAGE, V64, P379, DOI 10.1016/j.neuroimage.2012.09.012; Petoe MA, 2013, J NEUROPHYSIOL, V109, P1091, DOI 10.1152/jn.00813.2012; Platz T, 2001, ARCH PHYS MED REHAB, V82, P961, DOI 10.1053/apmr.2001.23982; Platz T, 2012, RESTOR NEUROL NEUROS, V30, P199, DOI 10.3233/RNN-2012-110204; Platz T, 2009, NEUROREHAB NEURAL RE, V23, P706, DOI 10.1177/1545968309335974; Pleger B, 2003, NEURON, V40, P643, DOI 10.1016/S0896-6273(03)00677-9; Pleger B, 2001, P NATL ACAD SCI USA, V98, P12255, DOI 10.1073/pnas.191176298; Ragert P, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-9; Reis J, 2011, CURR OPIN NEUROL, V24, P590, DOI 10.1097/WCO.0b013e32834c3db0; Sagi D, 2011, VISION RES, V51, P1552, DOI 10.1016/j.visres.2010.10.019; Sawaki L, 2006, STROKE, V37, P246, DOI 10.1161/01.STR.0000195130.16843.ac; Schweisfurth MA, 2011, NEUROIMAGE, V56, P2138, DOI 10.1016/j.neuroimage.2011.03.038; Schweizer R, 2008, NEUROIMAGE, V42, P28, DOI 10.1016/j.neuroimage.2008.04.184; Stefan K, 2008, NEUROIMAGE, V40, P265, DOI 10.1016/j.neuroimage.2007.11.037; Van Boven RW, 2000, NEUROLOGY, V54, P2230; Watanabe T, 2002, NAT NEUROSCI, V5, P1003, DOI 10.1038/nn915; Weibull A, 2008, MAGN RESON IMAGING, V26, P1342, DOI 10.1016/j.mri.2008.04.007; Yotsumoto Y, 2008, NEURON, V57, P827, DOI 10.1016/j.neuron.2008.02.034	48	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84402	10.1371/journal.pone.0084402	http://dx.doi.org/10.1371/journal.pone.0084402			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416229	gold, Green Published, Green Submitted			2022-12-27	WOS:000329866300023
J	Li, XH; Han, YH; Wei, YL; Acharya, A; Farmer, AD; Ho, J; Monteros, MJ; Brummer, EC				Li, Xuehui; Han, Yuanhong; Wei, Yanling; Acharya, Ananta; Farmer, Andrew D.; Ho, Julie; Monteros, Maria J.; Brummer, E. Charles			Development of an Alfalfa SNP Array and Its Use to Evaluate Patterns of Population Structure and Linkage Disequilibrium	PLOS ONE			English	Article							GENOMIC SELECTION; WINTER HARDINESS; MEDICAGO-SATIVA; ASSOCIATION; IDENTIFICATION; COMPLEX; POLYMORPHISM; PERSISTENCE; IMPROVEMENT; RESISTANCE	A large set of genome-wide markers and a high-throughput genotyping platform can facilitate the genetic dissection of complex traits and accelerate molecular breeding applications. Previously, we identified about 0.9 million SNP markers by sequencing transcriptomes of 27 diverse alfalfa genotypes. From this SNP set, we developed an Illumina Infinium array containing 9,277 SNPs. Using this array, we genotyped 280 diverse alfalfa genotypes and several genotypes from related species. About 81% (7,476) of the SNPs met the criteria for quality control and showed polymorphisms. The alfalfa SNP array also showed a high level of transferability for several closely related Medicago species. Principal component analysis and model-based clustering showed clear population structure corresponding to subspecies and ploidy levels. Within cultivated tetraploid alfalfa, genotypes from dormant and nondormant cultivars were largely assigned to different clusters; genotypes from semidormant cultivars were split between the groups. The extent of linkage disequilibrium (LD) across all genotypes rapidly decayed to 26 Kbp at r(2) = 0.2, but the rate varied across ploidy levels and subspecies. A high level of consistency in LD was found between and within the two subpopulations of cultivated dormant and nondormant alfalfa suggesting that genome-wide association studies (GWAS) and genomic selection (GS) could be conducted using alfalfa genotypes from throughout the fall dormancy spectrum. However, the relatively low LD levels would require a large number of markers to fully saturate the genome.	[Li, Xuehui; Han, Yuanhong; Wei, Yanling; Acharya, Ananta; Monteros, Maria J.; Brummer, E. Charles] Samuel Roberts Noble Fdn Inc, Forage Improvement Div, Ardmore, OK 73401 USA; [Farmer, Andrew D.] Natl Ctr Genome Resources, Santa Fe, NM USA; [Ho, Julie] Forage Genet Int, Davis, CA USA	Noble Research Institute; National Center for Genome Resources (NCGR)	Brummer, EC (corresponding author), Samuel Roberts Noble Fdn Inc, Forage Improvement Div, Ardmore, OK 73401 USA.	ecbrummer@noble.org	Li, Xuehui/D-4475-2014	Monteros, Maria/0000-0002-6061-3883	USDA-DOE Plant Feedstock Genomics for Bioenergy program [2009-65504-05809]	USDA-DOE Plant Feedstock Genomics for Bioenergy program	This research was funded by the USDA-DOE Plant Feedstock Genomics for Bioenergy program, award # 2009-65504-05809 to ECB and MJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachlava E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029814; Barnes DK, 1977, ALF GERMPL US GEN VU; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brouwer DJ, 2000, CROP SCI, V40, P1387, DOI 10.2135/cropsci2000.4051387x; Brummer EC, 1999, CROP SCI, V39, P943, DOI 10.2135/cropsci1999.0011183X003900040001x; Castonguay Y, 2006, ADV AGRON, V90, P203, DOI 10.1016/S0065-2113(06)90006-6; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Chagne D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031745; Dekkers JCM, 2002, NAT REV GENET, V3, P22, DOI 10.1038/nrg701; Famoso AN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002221; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Hamblin MT, 2010, CROP SCI, V50, P556, DOI 10.2135/cropsci2009.04.0198; Han YH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-350; Havananda T, 2011, AM J BOT, V98, P1633, DOI 10.3732/ajb.1000318; Hayes BJ, 2013, PLANT BREEDING, V132, P133, DOI 10.1111/pbr.12037; Heffner EL, 2010, CROP SCI, V50, P1681, DOI 10.2135/cropsci2009.11.0662; Herrmann D, 2010, THEOR APPL GENET, V121, P865, DOI 10.1007/s00122-010-1356-z; HILL WG, 1988, THEOR POPUL BIOL, V33, P54, DOI 10.1016/0040-5809(88)90004-4; Hirsch CN, 2013, G3-GENES GENOM GENET, V3, P1003, DOI 10.1534/g3.113.005595; Jackson S, 2010, CURR OPIN PLANT BIOL, V13, P153, DOI 10.1016/j.pbi.2009.11.004; Jannink JL, 2010, BRIEF FUNCT GENOMICS, V9, P166, DOI 10.1093/bfgp/elq001; Khu DM, 2013, CROP SCI, V53, P148, DOI 10.2135/cropsci2012.03.0181; Kump KL, 2011, NAT GENET, V43, P163, DOI 10.1038/ng.747; Lamb JFS, 2006, CROP SCI, V46, P902, DOI 10.2135/cropsci2005.08-0236; Li XH, 2012, AGRONOMY-BASEL, V2, P40, DOI 10.3390/agronomy2010040; Li XH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-568; Li XH, 2011, PLANT GENOME-US, V4, P24, DOI 10.3835/plantgenome2010.09.0022; Lorenzana RE, 2009, THEOR APPL GENET, V120, P151, DOI 10.1007/s00122-009-1166-3; MarquezOrtiz JJ, 1996, CROP SCI, V36, P766, DOI 10.2135/cropsci1996.0011183X003600030039x; McCaslin MH, 2003, N AM ALF IMPR C BELT; Meuwissen THE, 2001, GENETICS, V157, P1819; Muller MH, 2006, MOL ECOL, V15, P1589, DOI 10.1111/j.1365-294X.2006.02851.x; Musial JM, 2007, THEOR APPL GENET, V114, P1427, DOI 10.1007/s00122-007-0528-y; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Robins JG, 2008, CROP SCI, V48, P1780, DOI 10.2135/cropsci2008.02.0101; Robins JG, 2007, CROP SCI, V47, P1, DOI 10.2135/cropsci2005.11.0401; Sakiroglu M, 2012, THEOR APPL GENET, V125, P577, DOI 10.1007/s00122-012-1854-2; Sakiroglu M, 2010, THEOR APPL GENET, V121, P403, DOI 10.1007/s00122-010-1319-4; Schwab PM, 1996, CROP SCI, V36, P418, DOI 10.2135/cropsci1996.0011183X003600020034x; Sim SC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045520, 10.1371/journal.pone.0040563]; SMALL E, 1988, PLANT SYST EVOL, V160, P195, DOI 10.1007/BF00936047; SORENSEN EL, 1994, CROP SCI, V34, P544, DOI 10.2135/cropsci1994.0011183X003400020059x; Stupar RM, 2007, GENETICS, V176, P2055, DOI 10.1534/genetics.107.074286; SVED J A, 1971, Theoretical Population Biology, V2, P125; Teuber LR, 1998, N AM ALF IMPR C BELT; Verde I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035668; Volenec J, 2000, REPORT STATUS MEDICA; Yang SS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-199; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhong SQ, 2009, GENETICS, V182, P355, DOI 10.1534/genetics.108.098277; Zuniga BA, 2004, DEV PLANT BREED, V11, P97	51	45	46	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84329	10.1371/journal.pone.0084329	http://dx.doi.org/10.1371/journal.pone.0084329			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416217	Green Published, gold, Green Submitted			2022-12-27	WOS:000329866300022
J	Cebotaru, L; Rapino, D; Cebotaru, V; Guggino, WB				Cebotaru, Liudmila; Rapino, Daniele; Cebotaru, Valeriu; Guggino, William B.			Correcting the Cystic Fibrosis Disease Mutant, A455E CFTR	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; NUCLEOTIDE-BINDING DOMAIN; MUTATIONS; DELTA-F508; DYSFUNCTION; MECHANISMS; PHENOTYPE; GENE	Cystic fibrosis is caused by more than 1000 mutations, the most common being the Delta F508 mutation. These mutations have been divided into five classes [1], with Delta F508 CFTR in class II. Here we have studied the class V mutation A455E. We report that the mature and immature bands of A455E are rapidly degraded primarily by proteasomes; the short protein half-life of this mutant therefore resembles that of Delta F508 CFTR. A455E could be rescued by treatment of the cells with proteasome inhibitors. Furthermore, co-transfection of A455E with the truncation mutant Delta 264 CFTR also rescued the mature C band, indicating that A455E can be rescued by transcomplementation. We found that Delta 264 CFTR bound to A455E, forming a bimolecular complex. Treatment with the compound correctors C3 and C4 also rescued A455E. These results are significant because they show that although Delta F508 belongs to a different class than A455E, it can be rescued by the same strategies, offering therapeutic promise to patients with Class V mutations.	[Cebotaru, Liudmila; Rapino, Daniele] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Cebotaru, Liudmila; Rapino, Daniele; Guggino, William B.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Cebotaru, Valeriu] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Guggino, WB (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA.	wguggino@jhmi.edu			CFTR Folding Consortium from Cystic Fibrosis Foundation	CFTR Folding Consortium from Cystic Fibrosis Foundation	This work was supported in part by a CFTR Folding Consortium Grant from the Cystic Fibrosis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwell S, 2010, PROTEIN ENG DES SEL, V23, P375, DOI 10.1093/protein/gzq004; Boucher RC, 1996, TRENDS GENET, V12, P81, DOI 10.1016/0168-9525(96)81410-7; Cebotaru L, 2008, J BIOL CHEM, V283, P21926, DOI 10.1074/jbc.M709156200; Cebotaru L, 2013, J BIOL CHEM, V288, P10505, DOI 10.1074/jbc.M112.420489; Cheng J, 2002, J BIOL CHEM, V277, P3520, DOI 10.1074/jbc.M110177200; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Cormet-Boyaka E, 2004, P NATL ACAD SCI USA, V101, P8221, DOI 10.1073/pnas.0400459101; CUTTING GR, 1993, J BIOENERG BIOMEMBR, V25, P7, DOI 10.1007/BF00768062; DeBraekeleer M, 1997, HUM GENET, V101, P208, DOI 10.1007/s004390050616; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Fischer AC, 2007, MOL THER, V15, P756, DOI 10.1038/sj.mt.6300059; FULMER SB, 1995, P NATL ACAD SCI USA, V92, P6832, DOI 10.1073/pnas.92.15.6832; He LH, 2010, FASEB J, V24, P3103, DOI 10.1096/fj.09-141788; Kim SJ, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00201; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Mickle JE, 2000, MED CLIN N AM, V84, P597, DOI 10.1016/S0025-7125(05)70243-1; Pedemonte N, 2005, MOL PHARMACOL, V67, P1797, DOI 10.1124/mol.105.010959; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Rosenstein BJ, 1998, J PEDIATR-US, V132, P589, DOI 10.1016/S0022-3476(98)70344-0; Schwiebert Erik M., 1999, Physiological Reviews, V79, pS145; SHEPPARD DN, 1995, EMBO J, V14, P876, DOI 10.1002/j.1460-2075.1995.tb07069.x; SHEPPARD DN, 1993, NATURE, V362, P160, DOI 10.1038/362160a0; Stansberg PM, 1997, CLIN CHEM, V43, P1083; Sun F, 2008, FASEB J; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Van Oene M, 2000, J BIOL CHEM, V275, P19577, DOI 10.1074/jbc.M002186200; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R	31	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85183	10.1371/journal.pone.0085183	http://dx.doi.org/10.1371/journal.pone.0085183			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416359	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500224
J	Gan, HL; Zhang, JQ; Zhou, QW; Feng, L; Chen, F; Yang, Y				Gan, Hui-Li; Zhang, Jian-Qun; Zhou, Qi-Wen; Feng, Lei; Chen, Fei; Yang, Yi			Patients with Congenital Systemic-to-Pulmonary Shunts and Increased Pulmonary Vascular Resistance: What Predicts Postoperative Survival?	PLOS ONE			English	Article							VENTRICULAR SEPTAL-DEFECT; INHALED NITRIC-OXIDE; THORACIC SURGEONS; SURGICAL CLOSURE; RISK MODELS; HYPERTENSION; REPAIR; CHILDREN; SOCIETY; DISEASE	Background: We carried out a retrospective data review of patients with systemic to pulmonary shunts that underwent surgical repair between February 1990 and February 2012 in order to assess preoperative pulmonary vascular dynamic risk factors for predicting early and late deaths due presumably to pulmonary vascular disease. Methods and Results: A total of 1024 cases of congenital systemic-to-pulmonary shunt and advanced pulmonary vascular disease beyond infancy and early childhood were closed surgically. The mean follow up duration was 8.5 +/- 5.5 (range 0.7 to 20) years. Sixty-one in-hospital deaths (5.96%, 61/1024) occurred after the shunt closure procedure and there were 46 late deaths, yielding 107 total deaths. We analyzed preoperative pulmonary vascular resistance index (PVRI), pulmonary vascular resistance index on pure oxygen challenge (PVRIO), difference between PVRI and PVRIO (PVRID), Qp:Qs, and Rp:Rs as individual risk predictors. The results showed that these individual factors all predicted in-hospital death and total death with PVRIO showing better performance than other risk factors. A multivariable Cox regression model was built, and suggested that PVRID and Qp: Qs were informative factors for predicting survival time from late death and closure of congenital septal defects was safe with a PVRIO<10.3 WU.m(2) and PVRID>7.3 WU.m(2) on 100% oxygen. Conclusions: All 4 variables, PVRI, PVRIO, PVRID and Qp:Qs, should be considered in deciding surgical closure of congenital septal defects and a PVRIO<10.3 WU.m(2) and PVRID>7.3 WU.m(2) on 100% oxygen are associated with a favorable risk benefit profile for the procedure.	[Gan, Hui-Li; Zhang, Jian-Qun; Zhou, Qi-Wen; Feng, Lei; Chen, Fei; Yang, Yi] Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing Anzhen Hosp, Dept Cardiac Surg, Beijing, Peoples R China	Capital Medical University	Gan, HL (corresponding author), Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing Anzhen Hosp, Dept Cardiac Surg, Beijing, Peoples R China.	ganhuili@hotmail.com			China Nature Science Foundation Committee [81070041]; Beijing health system special foundation [2013-2-002]; Beijing Science and Technology Project [Z121107001012067]	China Nature Science Foundation Committee; Beijing health system special foundation; Beijing Science and Technology Project	This project was supported by of a grant (#81070041) from the China Nature Science Foundation Committee, a grant (#2013-2-002) from the Beijing health system special foundation for building high-level health personnel, and a grant (#Z121107001012067) from the Beijing Science and Technology Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balzer DT, 2002, CIRCULATION, V106, pI76, DOI 10.1161/01.cir.0000032875.55215.cb; Beghetti M, 2012, CONGENIT HEART DIS, V7, P3, DOI 10.1111/j.1747-0803.2011.00611.x; Berner M, 1996, AM J CARDIOL, V77, P532, DOI 10.1016/S0002-9149(97)89353-8; BLACKSTONE EH, 1976, J THORAC CARDIOV SUR, V72, P661; BRAUNWALD NS, 1962, CIRCULATION, V26, P1270, DOI 10.1161/01.CIR.26.6.1270; CARTMILL TB, 1966, J THORAC CARDIOV SUR, V52, P486, DOI 10.1016/S0022-5223(19)43393-X; Castaneda A R, 1971, Ann Thorac Surg, V12, P29; DuShane JW, 1976, CHILD CONGENITAL HEA, P299; FRIEDLI B, 1974, AM J CARDIOL, V33, P403, DOI 10.1016/0002-9149(74)90323-3; Gatzoulis MA, 2009, EUR RESPIR REV, V18, P154, DOI 10.1183/09059180.00003309; Giglia TM, 2010, PEDIATR CRIT CARE ME, V11, pS57, DOI 10.1097/PCC.0b013e3181d10cce; HALLIDIESMITH KA, 1969, BRIT HEART J, V31, P246; IKAWA S, 1995, J THORAC CARDIOV SUR, V109, P1218, DOI 10.1016/S0022-5223(95)70206-7; JOHN S, 1983, THORAX, V38, P279, DOI 10.1136/thx.38.4.279; Kannan Bhava R J, 2003, Indian Heart J, V55, P161; LOCK JE, 1982, PEDIATR CARDIOL, V3, P41, DOI 10.1007/BF02082331; MOMMA K, 1981, JPN CIRC J, V45, P230, DOI 10.1253/jcj.45.230; NEUTZE JM, 1989, AM J CARDIOL, V63, P327, DOI 10.1016/0002-9149(89)90340-8; Schroder MS, 2011, BIOINFORMATICS, V27, P3206, DOI 10.1093/bioinformatics/btr511; Shahian DM, 2009, ANN THORAC SURG, V88, pS2, DOI 10.1016/j.athoracsur.2009.05.053; Shroyer ALW, 2003, ANN THORAC SURG, V75, P1856, DOI 10.1016/S0003-4975(03)00179-6	21	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83976	10.1371/journal.pone.0083976	http://dx.doi.org/10.1371/journal.pone.0083976			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416187	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500088
J	Groger, A; Kolb, R; Schafer, R; Klose, U				Groeger, Adriane; Kolb, Rupert; Schaefer, Rita; Klose, Uwe			Dopamine Reduction in the Substantia Nigra of Parkinson's Disease Patients Confirmed by In Vivo Magnetic Resonance Spectroscopic Imaging	PLOS ONE			English	Article								Objectives: Metabolic changes in the substantia nigra of patients with Parkinson's disease were previously investigated in different molecular-pathological examinations. The aim of our study was the in vivo measurement of these alterations using three-dimensional magnetic resonance spectroscopic imaging. Methods: 21 patients with Parkinson's disease and 24 controls were examined using magnetic resonance spectroscopic imaging at 3 Tesla. The spectra of rostral and caudal substantia nigra regions were analyzed using LCModel. For spectral fitting, an adjusted basis data set with pathology-specific metabolites and macromolecules was used to better reproduce the in vivo spectra. To assess differences between both groups more accurately, especially in metabolites at lower concentrations, group-averaged spectra were evaluated in addition to the analysis of individual data. Results: We found significantly decreased N-acetylaspartate, choline, creatine, myo-inositol, glutathione and dopamine concentrations in patients with Parkinson's disease compared to controls, whereas glutamine+glutamate, gamma-aminobutyric acid, and homovanillic acid were slightly increased. According to anatomical features, clear differences in the biochemical profiles were found between rostral and caudal substantia nigra voxels in both groups. Conclusions: Reduced N-acetylaspartate and dopamine concentrations result from progressive degeneration of dopamine-producing neurons within the substantia nigra pars compacta. Decreased creatine levels can be interpreted as impaired energy metabolism due to mitochondrial dysfunction. Lower glutathione concentrations might be a cause or consequence of oxidative stress. Furthermore, slightly increased glutamine+glutamate and gamma-aminobutyric acid levels are expected based on post mortem data in Parkinson's disease. To the best of our knowledge, this is the first non-invasive confirmation of these metabolic changes.	[Groeger, Adriane; Kolb, Rupert; Schaefer, Rita; Klose, Uwe] Univ Tubingen Hosp, Magnet Resonance Res Grp, Dept Diagnost & Intervent Neuroradiol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Groger, A (corresponding author), Univ Tubingen Hosp, Magnet Resonance Res Grp, Dept Diagnost & Intervent Neuroradiol, Tubingen, Germany.	adriane.groeger@med.uni-tuebingen.de	Klose, Uwe/M-7110-2013	Klose, Uwe/0000-0001-5236-3450	Deutsche Forschungsgemeinschaft; Tuebingen University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Tuebingen University	This work was supported by the Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tuebingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bal D, 2002, MAGN RESON CHEM, V40, P533, DOI 10.1002/mrc.1053; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Choi C, 2012, NAT MED, V18, P624, DOI 10.1038/nm.2682; Delli Pizzi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056501; Emir UE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030918; Fayed N, 2009, NEUROL RES, V31, P472, DOI 10.1179/174313209X395481; Gerlach M, 1996, BRAIN RES, V741, P142, DOI 10.1016/S0006-8993(96)00915-8; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Groger A, 2011, EUR RADIOL, V21, P1962, DOI 10.1007/s00330-011-2123-5; Groger A, 2013, J NEUROL NEUROSURG P; Kirov II, 2012, MAGN RESON MED, V67, P27, DOI 10.1002/mrm.23001; Martin HL, 2009, FASEB J, V23, P3263, DOI 10.1096/fj.08-125443; Massey LA, 2010, NEUROIMAG CLIN N AM, V20, P7, DOI 10.1016/j.nic.2009.10.001; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Provencher SW, 2011, LCMODEL LCMGUI USERS; SOFIC E, 1992, NEUROSCI LETT, V142, P128, DOI 10.1016/0304-3940(92)90355-B; Soher BJ, 2011, VESPA INTEGRATED APP; Terpstra M, 2004, MAGN RESON MED, V51, P225, DOI 10.1002/mrm.10715	19	56	59	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84081	10.1371/journal.pone.0084081	http://dx.doi.org/10.1371/journal.pone.0084081			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416192	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500093
J	Hong, JY; Labus, JS; Jiang, ZG; Ashe-Mcnalley, C; Dinov, I; Gupta, A; Shi, YG; Stains, J; Heendeniya, N; Smith, SR; Tillisch, K; Mayer, EA				Hong, Jui-Yang; Labus, Jennifer S.; Jiang, Zhiguo; Ashe-Mcnalley, Cody; Dinov, Ivo; Gupta, Arpana; Shi, Yonggang; Stains, Jean; Heendeniya, Nuwanthi; Smith, Suzanne R.; Tillisch, Kirsten; Mayer, Emeran A.			Regional Neuroplastic Brain Changes in Patients with Chronic Inflammatory and Non-Inflammatory Visceral Pain	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; GRAY-MATTER DECREASE; CHRONIC BACK-PAIN; SOMATOSENSORY CORTEX; CORTICAL THICKNESS; ANTERIOR INSULA; ANXIETY; HYPERSENSITIVITY; FIBROMYALGIA; VALIDATION	Regional cortical thickness alterations have been reported in many chronic inflammatory and painful conditions, including inflammatory bowel diseases (IBD) and irritable bowel syndrome (IBS), even though the mechanisms underlying such neuroplastic changes remain poorly understood. In order to better understand the mechanisms contributing to grey matter changes, the current study sought to identify the differences in regional alterations in cortical thickness between healthy controls and two chronic visceral pain syndromes, with and without chronic gut inflammation. 41 healthy controls, 11 IBS subjects with diarrhea, and 16 subjects with ulcerative colitis (UC) underwent high-resolution T1-weighted magnetization-prepared rapid acquisition gradient echo scans. Structural image preprocessing and cortical thickness analysis within the region of interests were performed by using the Laboratory of Neuroimaging Pipeline. Group differences were determined using the general linear model and linear contrast analysis. The two disease groups differed significantly in several cortical regions. UC subjects showed greater cortical thickness in anterior cingulate cortical subregions, and in primary somatosensory cortex compared with both IBS and healthy subjects. Compared with healthy subjects, UC subjects showed lower cortical thickness in orbitofrontal cortex and in mid and posterior insula, while IBS subjects showed lower cortical thickness in the anterior insula. Large effects of correlations between symptom duration and thickness in the orbitofrontal cortex and postcentral gyrus were only observed in UC subjects. The findings suggest that the mechanisms underlying the observed gray matter changes in UC subjects represent a consequence of peripheral inflammation, while in IBS subjects central mechanisms may play a primary role.	[Hong, Jui-Yang; Labus, Jennifer S.; Ashe-Mcnalley, Cody; Gupta, Arpana; Stains, Jean; Heendeniya, Nuwanthi; Smith, Suzanne R.; Tillisch, Kirsten; Mayer, Emeran A.] Univ Calif Los Angeles, Gail & Gerald Oppenheimer Family Ctr Neurobiol St, Los Angeles, CA 90095 USA; [Labus, Jennifer S.; Ashe-Mcnalley, Cody; Gupta, Arpana; Tillisch, Kirsten; Mayer, Emeran A.] Univ Calif Los Angeles, Pain & Interocept Imaging Network PAIN, Los Angeles, CA USA; [Hong, Jui-Yang; Labus, Jennifer S.; Ashe-Mcnalley, Cody; Gupta, Arpana; Stains, Jean; Heendeniya, Nuwanthi; Smith, Suzanne R.; Tillisch, Kirsten; Mayer, Emeran A.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Mayer, Emeran A.] Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA USA; [Labus, Jennifer S.; Mayer, Emeran A.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [Hong, Jui-Yang; Labus, Jennifer S.; Ashe-Mcnalley, Cody; Gupta, Arpana; Stains, Jean; Heendeniya, Nuwanthi; Smith, Suzanne R.; Tillisch, Kirsten; Mayer, Emeran A.] Univ Calif Los Angeles, Div Digest Dis, Los Angeles, CA USA; [Mayer, Emeran A.] Univ Calif Los Angeles, David Geffen Sch Med, Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA 90095 USA; [Hong, Jui-Yang] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA; [Dinov, Ivo] Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA; [Jiang, Zhiguo] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA; [Jiang, Zhiguo] Kessler Fdn Res Ctr, Human Performance & Engn Lab, W Orange, NJ USA; [Shi, Yonggang] Univ So Calif, Lab Neuroimaging, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of Michigan System; University of Michigan; New Jersey Institute of Technology; Kessler Institute for Rehabilitation; University of Southern California	Hong, JY (corresponding author), Univ Calif Los Angeles, Gail & Gerald Oppenheimer Family Ctr Neurobiol St, Los Angeles, CA 90095 USA.	usagilberthong@hotmail.com	Tillisch, Kirsten/ABE-2174-2020; Labus, Jennifer S/M-4567-2017	Labus, Jennifer S/0000-0002-6634-2551; Jiang, Zhiguo/0000-0002-4415-0401	National Institutes of Health through Center for Neurobiology (CNS) [K08 DK071626, R03 DK084169, K23DK073451, R01 AT007137, P50 DK064539, R01 DK048351]; LONI [NIBIB 9P41EB015922-15, NCRR 2-P41-RR-013642-15, NCRR U54 RR021813, U24-RR025736, U24-RR021992]; National Center for Complementary & Integrative Health [R01AT007137] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U24RR021992, U54RR021813, P41RR013642, U24RR025736] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK084169, P30DK041301, P50DK064539, K08DK071626, R01DK048351, K23DK073451] Funding Source: NIH RePORTER	National Institutes of Health through Center for Neurobiology (CNS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LONI; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded in part by the National Institutes of Health through Center for Neurobiology (CNS) grants: K08 DK071626, R03 DK084169, K23DK073451, R01 AT007137, P50 DK064539, R01 DK048351, and LONI grants: NIBIB 9P41EB015922-15, NCRR 2-P41-RR-013642-15, NCRR U54 RR021813, U24-RR025736, U24-RR021992. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini A, 2013, NEUROGASTROENTEROL M; Agostini A, 2012, NEUROGASTROENTEROL M; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; Benjamini Y, 2000, J EDUC BEHAV STAT, V25, P60, DOI 10.3102/10769986025001060; Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; Berman SM, 2008, J NEUROSCI, V28, P349, DOI 10.1523/JNEUROSCI.2500-07.2008; Bernstein CN, 2002, AM J GASTROENTEROL, V97, P319; Bielefeldt K, 2009, INFLAMM BOWEL DIS, V15, P778, DOI 10.1002/ibd.20848; Blankstein U, 2010, GASTROENTEROLOGY, V138, P1783, DOI 10.1053/j.gastro.2009.12.043; Chang L, 2001, AM J GASTROENTEROL, V96, P3341; Chang L, 2000, GUT, V47, P497, DOI 10.1136/gut.47.4.497; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; DaSilva AFM, 2007, NEUROLOGY, V69, P1990, DOI 10.1212/01.wnl.0000291618.32247.2d; Davis KD, 2008, NEUROLOGY, V70, P153, DOI 10.1212/01.wnl.0000295509.30630.10; Dinov I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013070; Dinov ID, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-304; Drossman DA, 2000, ROME, Vxxvii; Drossman DA, 2006, GASTROENTEROLOGY, V130, P1377, DOI 10.1053/j.gastro.2006.03.008; Erpelding N, 2012, PAIN, V153, P1602, DOI 10.1016/j.pain.2012.03.012; Farb NAS, 2013, CEREB CORTEX, V23, P114, DOI 10.1093/cercor/bhr385; Farmer MA, 2011, J UROLOGY, V186, P117, DOI 10.1016/j.juro.2011.03.027; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Frokjaer JB, 2012, CLIN GASTROENTEROL H, V10, P434, DOI 10.1016/j.cgh.2011.11.024; Gustin SM, 2012, J NEUROSCI, V32, P14874, DOI 10.1523/JNEUROSCI.1733-12.2012; Gwilym SE, 2010, ARTHRITIS RHEUM-US, V62, P2930, DOI 10.1002/art.27585; Hsu MC, 2009, PAIN, V143, P262, DOI 10.1016/j.pain.2009.03.017; Jarcho JM, 2013, PAIN; Jiang ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073932; Jones AKP, 2012, CURR RHEUMATOL REP, V14, P557, DOI 10.1007/s11926-012-0287-x; Kim J, 2008, CEPHALALGIA, V28, P598, DOI 10.1111/j.1468-2982.2008.01550.x; Kuchinad A, 2007, J NEUROSCI, V27, P4004, DOI 10.1523/JNEUROSCI.0098-07.2007; Kwan CL, 2005, NEUROLOGY, V65, P1268, DOI 10.1212/01.wnl.0000180971.95473.cc; Labus J, 2013, PAIN; Labus JS, 2007, PSYCHOSOM MED, V69, P89, DOI 10.1097/PSY.0b013e31802e2f24; Labus JS, 2009, NEUROIMAGE, V47, P952, DOI 10.1016/j.neuroimage.2009.05.078; Labus JS, 2004, ALIMENT PHARM THER, V20, P89, DOI 10.1111/j.1365-2036.2004.02007.x; Lallemend F, 2003, J NEUROCHEM, V87, P508, DOI 10.1046/j.1471-4159.2003.02014.x; Leung KTK, 2011, PRINCIPAL RANKING ME; Lewis JD, 2008, INFLAMM BOWEL DIS, V14, P1660, DOI 10.1002/ibd.20520; Lewis M, 2008, HDB EMOTIONS, Vxvi; May A, 2008, PAIN, V137, P7, DOI 10.1016/j.pain.2008.02.034; Mayer E.A., 2009, FUNCTIONAL PAIN SYND; Mayer EA, 2005, PAIN, V115, P398, DOI 10.1016/j.pain.2005.03.023; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Meier ML, 2012, J CLIN PERIODONTOL, V39, P441, DOI 10.1111/j.1600-051X.2012.01863.x; Moayedi M, 2011, NEUROIMAGE, V55, P277, DOI 10.1016/j.neuroimage.2010.12.013; Moseley GL, 2012, NEUROREHAB NEURAL RE, V26, P646, DOI 10.1177/1545968311433209; MULDER W, 1992, J COMPUT PHYS, V100, P209, DOI 10.1016/0021-9991(92)90229-R; Mykletun A, 2001, BRIT J PSYCHIAT, V179, P540, DOI 10.1192/bjp.179.6.540; OSHER S, 1988, J COMPUT PHYS, V79, P12, DOI 10.1016/0021-9991(88)90002-2; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Pike N, 2011, METHODS ECOL EVOL, V2, P278, DOI 10.1111/j.2041-210X.2010.00061.x; Ray RD, 2005, COGN AFFECT BEHAV NE, V5, P156, DOI 10.3758/CABN.5.2.156; Rodriguez-Raecke R, 2009, J NEUROSCI, V29, P13746, DOI 10.1523/JNEUROSCI.3687-09.2009; Rolls ET, 2008, NEUROIMAGE, V41, P1504, DOI 10.1016/j.neuroimage.2008.03.005; Schmidt-Wilcke T, 2007, PAIN, V132, pS109, DOI 10.1016/j.pain.2007.05.010; Schmidt-Wilcke T, 2006, PAIN, V125, P89, DOI 10.1016/j.pain.2006.05.004; Schmidt-Wilcke T, 2005, NEUROLOGY, V65, P1483, DOI 10.1212/01.wnl.0000183067.94400.80; Seminowicz DA, 2011, J NEUROSCI, V31, P7540, DOI 10.1523/JNEUROSCI.5280-10.2011; Seminowicz DA, 2010, GASTROENTEROLOGY, V139, P48, DOI 10.1053/j.gastro.2010.03.049; Shi YG, 2011, LECT NOTES COMPUT SC, V6892, P327, DOI 10.1007/978-3-642-23629-7_40; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; Teutsch S, 2008, NEUROIMAGE, V42, P845, DOI 10.1016/j.neuroimage.2008.05.044; Tillisch K, 2011, GASTROENTEROLOGY, V140, P91, DOI 10.1053/j.gastro.2010.07.053; Tulloch I, 2011, BRAIN RES, V1399, P33, DOI 10.1016/j.brainres.2011.05.017; Ung H, 2012, CEREB CORTEX; Valfre W, 2008, HEADACHE, V48, P109, DOI 10.1111/j.1526-4610.2007.00723.x; Verne GN, 2003, PAIN, V103, P99, DOI 10.1016/S0304-3959(02)00416-5; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Vogt BA, 2003, EUR J NEUROSCI, V18, P3134, DOI 10.1111/j.1460-9568.2003.03034.x; Wang J, 2011, BRAIN RES, V1369, P131, DOI 10.1016/j.brainres.2010.11.017; Wartolowska K, 2012, ARTHRITIS RHEUM-US, V64, P371, DOI 10.1002/art.33326; Wiech K, 2010, J NEUROSCI, V30, P16324, DOI 10.1523/JNEUROSCI.2087-10.2010	74	42	45	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84564	10.1371/journal.pone.0084564	http://dx.doi.org/10.1371/journal.pone.0084564			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416245	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500137
J	Kansal, S; Bhatnagar, A; Agnihotri, N				Kansal, Shevali; Bhatnagar, Archana; Agnihotri, Navneet			Fish Oil Suppresses Cell Growth and Metastatic Potential by Regulating PTEN and NF-kappa B Signaling in Colorectal Cancer	PLOS ONE			English	Article							POLY(ADP-RIBOSE) POLYMERASE; UP-REGULATION; CHEMOPREVENTIVE ACTION; TRANSCRIPTION FACTOR; DIFFERENT RATIOS; CORN-OIL; PATHWAY; APOPTOSIS; EXPRESSION; INHIBITION	Homeostasis in eukaryotic tissues is tightly regulated by an intricate balance of the prosurvival and antisurvival signals. The tumor suppressor PTEN (phosphatase and tensin homolog deleted on chromosome 10), a dual-specificity phosphatase, plays a functional role in cell cycle arrest and apoptosis. NF-kappa B and its downstream regulators (such as VEGF) play a central role in prevention of apoptosis, promotion of inflammation and tumor growth. Therefore, we thought to estimate the expression of PTEN, Poly-ADP-ribose polymerase (PARP), NF-kappa Bp50, NF-kBp65 and VEGF to evaluate the effect of supplementation of fish oil on apoptotic and inflammatory signaling in colon carcinoma. Male wistar rats in Group I received purified diet while Group II and III received modified diet supplemented with FO:CO(1:1)&FO:CO(2.5:1) respectively. These were further subdivided into controls receiving ethylenediamine-tetra acetic-acid and treated groups received dimethylhydrazine-dihydrochloride (DMH)/week for 4 weeks. Animals sacrificed 48 hours after last injection constituted initiation phase and that sacrificed after 16 weeks constituted post-initiation phase. We have analysed expression of PTEN, NF-kappa Bp50, NF-kappa Bp65 by flowcytometer and nuclear localization of NF-kB by immunofluorescence. PARP and VEGF were assessed by immunohistochemistry. In the initiation phase, animals receiving DMH have shown increased % of apoptotic cells, PTEN, PARP, NF-kappa Bp50, NF-kappa Bp65 and VEGF however in post-initiation phase no significant alteration in apoptosis with decreased PTEN and increased PARP, NF-kappa Bp50, NF-kappa Bp65 and VEGF were observed as compared to control animals. On treatment with both ratios of fish oil in both the phases, augmentation in % of apoptotic cells, decreased PTEN, PARP, NF-kappa Bp50, NF-kappa Bp65 and VEGF were documented with respect to DMH treated animals with effect being more exerted with higher ration in post-initiation phase. Hence, fish oil activates apoptosis, diminishes DNA damage and inhibits inflammatory signalling in a dose and time dependent manner so as to inhibit progression of colon cancer.	[Kansal, Shevali; Bhatnagar, Archana; Agnihotri, Navneet] Panjab Univ, Dept Biochem, Chandigarh 160014, India	Panjab University	Agnihotri, N (corresponding author), Panjab Univ, Dept Biochem, Chandigarh 160014, India.	agnihotri.navneet@gmail.com		Agnihotri, Navneet/0000-0001-6063-3473	Indian Council of Medical Research [Immuno/18/11/27/2008-ECD-I]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	This work was supported by a grant from the Indian Council of Medical Research (Immuno/18/11/27/2008-ECD-I). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	21. Committee on Laboratory Animal Diets, 1978, CONTR DIETS LAB AN E; Akinsete JA, 2012, CARCINOGENESIS, V33, P140, DOI 10.1093/carcin/bgr238; American Cancer Society, 2012, CANC FACTS FIG 2012; Amiri KI, 2005, CANCER METAST REV, V24, P301, DOI 10.1007/s10555-005-1579-7; Barber TD, 2004, NEW ENGL J MED, V351, P2883, DOI 10.1056/NEJM200412303512724; Bond M, 1998, FEBS LETT, V435, P29, DOI 10.1016/S0014-5793(98)01034-5; Borghaei RC, 2004, BIOCHEM BIOPH RES CO, V316, P182, DOI 10.1016/j.bbrc.2004.02.030; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Catz SD, 2001, ONCOGENE, V20, P7342, DOI 10.1038/sj.onc.1204926; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; Corvera S, 1998, TRENDS CELL BIOL, V8, P442, DOI 10.1016/S0962-8924(98)01366-X; Das R, 2013, APOPTOSIS; Dedes KJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001538; Freshney RI, 1994, CULTURE ANIMAL CELLS, P287; Germain M, 1999, J BIOL CHEM, V274, P28379, DOI 10.1074/jbc.274.40.28379; Ghosh-Choudhury T, 2009, BREAST CANCER RES TR, V118, P213, DOI 10.1007/s10549-008-0227-7; Goulet AC, 2003, CANCER BIOL THER, V2, P713; Hu YP, 2010, NEOPLASIA, V12, P826, DOI 10.1593/neo.10586; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Jung YJ, 2003, FASEB J, V17, P2115, DOI 10.1096/fj.03-0329fje; Kansal S, 2012, NUTR CANCER, V64, P559, DOI 10.1080/01635581.2012.675619; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kummar S, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-25; Latham P, 1999, CARCINOGENESIS, V20, P645, DOI 10.1093/carcin/20.4.645; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Mangerich A, 2011, INT J CANCER, V128, P251, DOI 10.1002/ijc.25683; Matsuda Satoru, 2013, Open Med Chem J, V7, P23, DOI 10.2174/1874104501307010023; Megnin-Chanet F, 2010, CELL MOL LIFE SCI, V67, P3649, DOI 10.1007/s00018-010-0490-8; Melen-Mucha G, 2002, CANCER INVEST, V20, P700, DOI 10.1081/CNV-120003539; Mutter GL, 2000, JNCI-J NATL CANCER I, V92, P924, DOI 10.1093/jnci/92.11.924; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Ravi R, 2001, NAT CELL BIOL, V3, P409, DOI 10.1038/35070096; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Sanders LM, 2004, J NUTR, V134, P3233, DOI 10.1093/jn/134.12.3233; Sapieha P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001571; Sarotra P, 2010, LIPIDS, V45, P785, DOI 10.1007/s11745-010-3459-3; Sasaki N, 2001, CLIN CANCER RES, V7, P4136; Sawai H, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-56; Sharma G, 2013, CANCER INVEST, V31, P231, DOI 10.3109/07357907.2013.780076; Shibata A, 2002, BREAST CANCER RES TR, V73, P237, DOI 10.1023/A:1015872531675; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Smith TK, 1998, CARCINOGENESIS, V19, P267, DOI 10.1093/carcin/19.2.267; Steelman LS, 2004, EXPERT OPIN THER TAR, V8, P537, DOI 10.1517/14728222.8.6.537; Wang JT, 2006, BRAIN RES, V1081, P211, DOI 10.1016/j.brainres.2006.01.077; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Xia SH, 2006, P NATL ACAD SCI USA, V103, P12499, DOI 10.1073/pnas.0605394103; Zhao GX, 2005, BIOCHEM BIOPH RES CO, V336, P909, DOI 10.1016/j.bbrc.2005.08.204	51	19	20	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84627	10.1371/journal.pone.0084627	http://dx.doi.org/10.1371/journal.pone.0084627			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416253	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500142
J	Levy, H; Glinert, I; Weiss, S; Sittner, A; Schlomovitz, J; Altboum, Z; Kobiler, D				Levy, Haim; Glinert, Itai; Weiss, Shay; Sittner, Assa; Schlomovitz, Josef; Altboum, Zeev; Kobiler, David			Toxin-Independent Virulence of Bacillus anthracis in Rabbits	PLOS ONE			English	Article							GUINEA-PIGS; PROTECTIVE ANTIGEN; GENE; ANTIBODIES; IDENTIFICATION; PATHOGENICITY; INFECTION; ADHESIN; BSLA	The accepted paradigm states that anthrax is both an invasive and toxinogenic disease and that the toxins play a major role in pathogenicity. In the guinea pig (GP) model we have previously shown that deletion of all three toxin components results in a relatively moderate attenuation in virulence, indicating that B. anthracis possesses an additional toxin-independent virulence mechanism. To characterize this toxin-independent mechanism in anthrax disease, we developed a new rabbit model by intravenous injection (IV) of B. anthracis encapsulated vegetative cells, artificially creating bacteremia. Using this model we were able to demonstrate that also in rabbits, B. anthracis mutants lacking the toxins are capable of killing the host within 24 hours. This virulent trait depends on the activity of AtxA in the presence of pXO2, as, in the absence of the toxin genes, deletion of either component abolishes virulence. Furthermore, this IV virulence depends mainly on AtxA rather than the whole pXO1. A similar pattern was shown in the GP model using subcutaneous (SC) administration of spores of the mutant strains, demonstrating the generality of the phenomenon. The virulent strains showed higher bacteremia levels and more efficient tissue dissemination; however our interpretation is that tissue dissemination per se is not the main determinant of virulence whose exact nature requires further elucidation.	[Levy, Haim; Glinert, Itai; Weiss, Shay; Sittner, Assa; Schlomovitz, Josef; Altboum, Zeev; Kobiler, David] Israel Inst Biol Res, Dept Infect Dis, IL-70450 Ness Ziona, Israel		Levy, H (corresponding author), Israel Inst Biol Res, Dept Infect Dis, IL-70450 Ness Ziona, Israel.	haiml@iibr.gov.il		Sittner, Assa/0000-0002-1633-8191				Ariel N, 2003, INFECT IMMUN, V71, P4563, DOI 10.1128/IAI.71.8.4563-4579.2003; Chateau A, 2011, FASEB J, V25, P4445, DOI 10.1096/fj.11-188912; Chen ZC, 2011, TOXINS, V3, P1004, DOI 10.3390/toxins3081004; Cohen S, 2000, INFECT IMMUN, V68, P4549, DOI 10.1128/IAI.68.8.4549-4558.2000; Cote CK, 2011, MICROBES INFECT, V13, P1146, DOI 10.1016/j.micinf.2011.07.005; Ebrahimi CM, 2009, J BACTERIOL, V191, P7165, DOI 10.1128/JB.00903-09; Fouet A, 1996, INFECT IMMUN, V64, P4928, DOI 10.1128/IAI.64.12.4928-4932.1996; Fouet A, 2010, RES MICROBIOL, V161, P735, DOI 10.1016/j.resmic.2010.09.006; Froude JW, 2011, MABS-AUSTIN, V3, P517, DOI 10.4161/mabs.3.6.17621; Froude JW, 2011, TOXINS, V3, P1433, DOI 10.3390/toxins3111433; GREEN BD, 1985, INFECT IMMUN, V49, P291, DOI 10.1128/IAI.49.2.291-297.1985; Guichard A, 2012, MICROBES INFECT, V14, P97, DOI 10.1016/j.micinf.2011.08.016; Janes BK, 2006, INFECT IMMUN, V74, P1949, DOI 10.1128/IAI.74.3.1949-1953.2006; Kern J, 2010, J MOL BIOL, V401, P757, DOI 10.1016/j.jmb.2010.06.059; Kern J, 2010, MOL MICROBIOL, V75, P324, DOI 10.1111/j.1365-2958.2009.06958.x; Kern JW, 2008, MOL MICROBIOL, V68, P504, DOI 10.1111/j.1365-2958.2008.06169.x; Kobiler D, 2002, INFECT IMMUN, V70, P544, DOI 10.1128/IAI.70.2.544-550.2002; Kobiler D, 2006, INFECT IMMUN, V74, P5871, DOI 10.1128/IAI.00792-06; KOEHLER TM, 1994, J BACTERIOL, V176, P586, DOI 10.1128/jb.176.3.586-595.1994; Levy H, 2005, FEMS MICROBIOL LETT, V244, P199, DOI 10.1016/j.femsle.2005.01.039; Levy H, 2012, INFECT IMMUN, V80, P2623, DOI 10.1128/IAI.00244-12; Levy H, 2012, MICROB PATHOGENESIS, V52, P55, DOI 10.1016/j.micpath.2011.10.002; Levy H, 2011, MICROB PATHOGENESIS, V51, P345, DOI 10.1016/j.micpath.2011.07.004; Lovchik JA, 2012, INFECT IMMUN, V80, P2414, DOI 10.1128/IAI.06340-11; Moayeri M, 2009, MOL ASPECTS MED, V30, P439, DOI 10.1016/j.mam.2009.07.003; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sambrook J, 1989, MOL CLOINING LAB MAN; UCHIDA I, 1993, J BACTERIOL, V175, P5329, DOI 10.1128/JB.175.17.5329-5338.1993; Weiss S, 2011, ANTIMICROB AGENTS CH, V55, P1533, DOI 10.1128/AAC.01689-10; Welkos S, 2001, MICROBIOL-SGM, V147, P1677, DOI 10.1099/00221287-147-6-1677; Yoong P, 2006, J BACTERIOL, V188, P2711, DOI 10.1128/JB.188.7.2711-2714.2006	31	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84947	10.1371/journal.pone.0084947	http://dx.doi.org/10.1371/journal.pone.0084947			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416317	Green Submitted, gold, Green Published			2022-12-27	WOS:000329862500194
J	Maria-Ferreira, D; Da Silva, LM; Mendes, DAGB; Cabrini, DD; Nascimento, AM; Iacomini, M; Cipriani, TR; Santos, ARS; Werner, MFD; Baggio, CH				Maria-Ferreira, Daniele; Da Silva, Luisa Mota; Gasparin Bueno Mendes, Daniel Augusto; Cabrini, Daniela de Almeida; Nascimento, Adamara Machado; Iacomini, Marcello; Cipriani, Thales Ricardo; Soares Santos, Adair Roberto; de Paula Werner, Maria Fernanda; Baggio, Cristiane Hatsuko			Rhamnogalacturonan from Acmella oleracea (L.) RK Jansen: Gastroprotective and Ulcer Healing Properties in Rats	PLOS ONE			English	Article							SPILANTHES-ACMELLA; GASTRIC-ULCER; GASTROINTESTINAL-TRACT; POLYSACCHARIDES; MECHANISMS; EXTRACT; QUALITY; TISSUE; OXYGEN	A rhamnogalacturonan (RGal) isolated from Acmella oleracea (L.) R.K. Jansen administered by oral route showed gastroprotective activity against acute lesions induced by ethanol. In this study, we investigated the gastric ulcer healing effect of RGal and its mechanisms of action. Intraperitoneal treatment of animals with RGal protected the gastric mucosa against acute lesions induced by ethanol, with participation of gastric mucus. Furthermore, in the chronic ulcer model, oral administration of RGal accelerates the gastric ulcer healing, accompanied by increasing of cellular proliferation and gastric mucus content, reducing inflammatory parameters and oxidative stress. In addition, the repeated 7 days-treatment of animals with RGal did not show alterations of clinical and behavioral symptoms, body and organs weights or plasmatic biochemical parameters. Collectively, these results showed that RGal has an interesting antiulcerogenic activity and could constitute an attractive molecule of interest for the development of new antiulcer agents.	[Maria-Ferreira, Daniele; Da Silva, Luisa Mota; Gasparin Bueno Mendes, Daniel Augusto; Cabrini, Daniela de Almeida; de Paula Werner, Maria Fernanda; Baggio, Cristiane Hatsuko] Univ Fed Parana, Dept Pharmacol, Sect Biol Sci, BR-80060000 Curitiba, Parana, Brazil; [Nascimento, Adamara Machado; Iacomini, Marcello; Cipriani, Thales Ricardo] Univ Fed Parana, Dept Biochem & Mol Biol, Sect Biol Sci, BR-80060000 Curitiba, Parana, Brazil; [Soares Santos, Adair Roberto] Univ Fed Santa Catarina, Dept Physiol Sci, Ctr Biol Sci, Florianopolis, SC, Brazil	Universidade Federal do Parana; Universidade Federal do Parana; Universidade Federal de Santa Catarina (UFSC)	Baggio, CH (corresponding author), Univ Fed Parana, Dept Pharmacol, Sect Biol Sci, BR-80060000 Curitiba, Parana, Brazil.	crisbaggio@gmail.com	Maria-Ferreira, Daniele/AAE-9373-2020; da+Silva, Luisa/AAQ-1408-2020; Baggio, Cristiane H/C-5633-2013; Nascimento, Adamara/AAQ-4649-2020; Cabrini, Daniela A/I-4652-2014; Maria-Ferreira, Daniele/AAQ-2015-2020; Mendes, Daniel/AAY-4058-2020; Werner, Maria Fernanda P/G-1461-2012; Cipriani, Thales R/I-7195-2015; da Silva, Luisa Mota/P-5201-2018; Santos, Adair/C-5565-2013	Baggio, Cristiane H/0000-0001-5536-7561; Cabrini, Daniela A/0000-0002-7323-6933; Maria-Ferreira, Daniele/0000-0001-7992-510X; Werner, Maria Fernanda P/0000-0001-5979-8676; Santos, Adair/0000-0002-6435-4698	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); CNPq [150983/2012-4]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors wish to thank the Brazilian funding agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). C.H. Baggio is recipient of post-doctoral scholarship from the CNPq (no. 150983/2012-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa T, 2012, WORLD J GASTROENTERO, V18, P4811, DOI 10.3748/wjg.v18.i35.4811; Baggio CH, 2005, PLANTA MED, V71, P733, DOI 10.1055/s-2005-871286; Baggio CF, 2012, Z NATURFORSCH C, V67, P405; Baggio CH, 2012, INT J BIOL MACROMOL, V50, P872, DOI 10.1016/j.ijbiomac.2011.10.023; BLOIS MS, 1958, NATURE, V181, P1199, DOI 10.1038/1811199a0; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Chakraborty A., 2004, Indian Journal of Pharmacology, V36, P148; Chakraborty A, 2010, INDIAN J PHARMACOL, V42, P277, DOI 10.4103/0253-7613.70106; Chen FA, 2004, FOOD CHEM, V86, P479, DOI 10.1016/j.foodchem.2003.09.020; CORNE SJ, 1974, J PHYSIOL-LONDON, V242, pP116; Czyzewska J, 2009, FOLIA HISTOCHEM CYTO, V47, P289, DOI 10.2478/v10042-009-0042-y; DeVault KR, 2009, NAT REV GASTRO HEPAT, V6, P524, DOI 10.1038/nrgastro.2009.125; DEYOUNG LM, 1989, AGENTS ACTIONS, V26, P335; Ekanem AP, 2007, PHYTOTHER RES, V21, P1253, DOI 10.1002/ptr.2239; Fialkow L, 2007, FREE RADICAL BIO MED, V42, P153, DOI 10.1016/j.freeradbiomed.2006.09.030; Gao RM, 1998, BIOELECTROCH BIOENER, V45, P41, DOI 10.1016/S0302-4598(98)00072-5; Gao YH, 2004, J MED FOOD, V7, P417, DOI 10.1089/jmf.2004.7.417; HABIG WH, 1974, J BIOL CHEM, V249, P7130; HIRSCHOWITZ BI, 1983, J CLIN GASTROENTEROL, V5, P115, DOI 10.1097/00004836-198312001-00011; JIANG ZY, 1992, ANAL BIOCHEM, V202, P384, DOI 10.1016/0003-2697(92)90122-N; Ley Jakob P., 2006, V43, P21; Malfertheiner P, 2009, LANCET, V374, P1449, DOI 10.1016/S0140-6736(09)60938-7; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; MOWRY RW, 1956, AM J PATHOL, V32, P628; Naito Y, 1995, J CLIN GASTROENTEROL, V21, pS82; Nascimento AM, 2013, PHYTOCHEMISTRY, V85, P137, DOI 10.1016/j.phytochem.2012.08.024; Nergard CS, 2005, J ETHNOPHARMACOL, V96, P255, DOI 10.1016/j.jep.2004.09.018; Okabe S, 2012, FRONT GASTROINT RES, V30, P32; OKABE S, 1971, AM J DIG DIS, V16, P277, DOI 10.1007/BF02235252; Palileo C, 2011, CURR OPIN GASTROEN, V27, P543, DOI 10.1097/MOG.0b013e32834b3fcb; Pereira IT, 2013, PHYTOTHER RES, V27, P1067, DOI 10.1002/ptr.4835; Phillipson M, 2008, AM J PHYSIOL-GASTR L, V295, pG806, DOI 10.1152/ajpgi.90252.2008; Potrich FB, 2010, J ETHNOPHARMACOL, V130, P85, DOI 10.1016/j.jep.2010.04.014; Prachayasittikul S, 2009, MOLECULES, V14, P850, DOI 10.3390/molecules14020850; Ratnasooriya WD, 2004, J ETHNOPHARMACOL, V91, P317, DOI 10.1016/j.jep.2004.01.006; Repetto MG, 2002, BRAZ J MED BIOL RES, V35, P523, DOI 10.1590/S0100-879X2002000500003; ROBERT A, 1979, GASTROENTEROLOGY, V77, P433; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; SHAY H, 1945, GASTROENTEROLOGY, V5, P43; Srikanta BM, 2010, BIOCHIMIE, V92, P194, DOI 10.1016/j.biochi.2009.10.005; SRIVASTAVA R, 1989, PHYTOCHEMISTRY, V28, P2877, DOI 10.1016/0031-9422(89)80245-6; TAKAGI K, 1969, JPN J PHARMACOL, V19, P418, DOI 10.1254/jjp.19.418; Tarnawski AS, 2012, CURR MED CHEM, V19, P16; Wu LC, 2008, J AGR FOOD CHEM, V56, P2341, DOI 10.1021/jf073057e; YAMADA H, 1994, CARBOHYD POLYM, V25, P269, DOI 10.1016/0144-8617(94)90052-3; Ye YN, 2003, LIFE SCI, V72, P925, DOI 10.1016/S0024-3205(02)02332-9	46	28	28	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84762	10.1371/journal.pone.0084762	http://dx.doi.org/10.1371/journal.pone.0084762			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416280	gold, Green Submitted, Green Published			2022-12-27	WOS:000329862500163
J	McCoy, MD; Carpenter, J				McCoy, Mark D.; Carpenter, Jonathan			Strategies for Obtaining Obsidian in Pre-European Contact Era New Zealand	PLOS ONE			English	Article							PREHISTORY; EXCHANGE	Archaeological evidence of people's choices regarding how they supply themselves with obsidian through direct access and different types of exchanges gives us insight in to mobility, social networks, and property rights in the distant past. Here we use collections of obsidian artefacts that date to a period of endemic warfare among Maori during New Zealand's Late Period (1500-1769 A.D.) to determine what strategies people engaged in to obtain obsidian, namely (1) collecting raw material directly from a natural source, (2) informal trade and exchange, and (3) formal trade and exchange. These deposits represent a good cross-section of Late Period archaeology, including primary working of raw material at a natural source (Helena Bay), undefended sites where people discarded rubbish and worked obsidian (Bream Head), and a heavily fortified site (Mt. Wellington). We find that most of the obsidian described here was likely obtained directly from natural sources, especially those located on off-shore islands within about 60-70 km of sites. A smaller amount comes from blocks of material transported from an off-shore island a greater distance away, called Mayor Island, in a formal trade and exchange network. This study demonstrates the value of conducting tandem lithic technology and geochemical sourcing studies to understand how people create and maintain social networks during periods of warfare.	[McCoy, Mark D.] Univ Otago, Dept Anthropol & Archaeol, Dunedin, New Zealand; [Carpenter, Jonathan] Australian Natl Univ, Dept Archaeol & Nat Hist, Canberra, ACT, Australia	University of Otago; Australian National University	McCoy, MD (corresponding author), Univ Otago, Dept Anthropol & Archaeol, Dunedin, New Zealand.	mark.mccoy@otago.ac.nz		McCoy, Mark/0000-0002-1929-1579	Royal Society of New Zealand's Marsden Fund	Royal Society of New Zealand's Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	This research was funded by a grant from the Royal Society of New Zealand's Marsden Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrefsky W., 2005, CAMB MAN ARCHAEOL, DOI DOI 10.1017/CBO9780511810244; Browne GH, 1980, TANE, V26, P7; Carpenter J P-D, 2010, ARCHAEOLOGICAL MONIT; Carpenter J P-D, 2009, 200797 DEP CONS HPT; Carter T, 2013, J ARCHAEOL SCI, V40, P556, DOI 10.1016/j.jas.2012.08.003; Cruickshank A, 2011, THESIS U AUCKLAND AU; Davidson Janet, 2011, Tuhinga, P19; Dillian CD, 2010, TRADE AND EXCHANGE: ARCHAEOLOGICAL STUDIES FROM HISTORY AND PREHISTORY, P1, DOI 10.1007/978-1-4419-1072-1; Earle T, 1977, EXCHANGE SYSTEMS PRE; Empson L, 2002, GLOBAL PLANET CHANGE, V33, P329, DOI 10.1016/S0921-8181(02)00086-3; Ericson J.E., 1982, CONTEXTS PREHISTORIC; Freund KP, 2013, ARCHAEOMETRY, V55, P779, DOI 10.1111/j.1475-4754.2012.00708.x; Harris J, 2012, ARCHAEOLOGICAL UNPUB; Hodder I., 1982, CONTEXTS PREHISTORIC, P199; Hodder I., 1976, SPATIAL ANAL ARCHAEO; Irwin G, 2004, KOHIKA ARCHAEOLOGY L; Jones M, 2002, THESIS U AUCKLAND AU; Kawharu I. H., 1977, MAORI LAND TENURE ST; Kawharu M, 2000, J POLYNESIAN SOC, V109, P349; Mauss Marcel, 1990, GIFT FORM REASON EXC; McCoy MD, 2010, J PAC ARCHAEOL, V1, P174; Mccoy MD, 2011, J ARCHAEOL SCI, V38, P2547, DOI 10.1016/j.jas.2011.04.017; McCoy MD, 2009, J ARCHAEOL RES, V17, P263, DOI 10.1007/s10814-009-9030-1; McKay A, 1897, NZ PARLIAMENTARY P C, VC9, P75; Moore PR, 2013, J ROY SOC NEW ZEAL, V43, P38, DOI 10.1080/03036758.2011.576684; Moore PR, 2012, J PAC ARCHAEOL, V3, P17; Moore PR, 1982, NZ ARCHAEOLOGICAL AS, V25, P240; Mosley B, 2010, RAPA NUI J, V24, P6; Phillips C, 2009, ARCHAEOLOGICAL UNPUB; Renfrew C., 1977, EXCHANGE SYSTEMS PRE, P71, DOI DOI 10.1016/B978-0-12-227650-7.50010-9; Renfrew C., 1966, P PREHIST SOC, V32, P30, DOI DOI 10.1017/S0079497X0001433X; Schmidt M, 1996, J POLYNESIAN SOC, V105, P441; Seelenfreund A, 1989, SAYING SO DOESNT MAK, P168; Sheppard P, 2010, ARCHAEOL OCEAN, V45, P21, DOI 10.1002/j.1834-4453.2010.tb00074.x; Sheppard PJ, 2011, J ARCHAEOL SCI, V38, P45, DOI 10.1016/j.jas.2010.08.007; Sheppard PJ, 2004, NZ ARCHAEOLOGICAL AS, V26, P147; Speakman R.J., 2012, EVALUATION BRUKERS T; Sutton D., 2003, ARCHAEOLOGY POUERUA; Walter R, 2010, ANTIQUITY, V84, P497, DOI 10.1017/S0003598X00066734; Ward GK, 1972, OBSIDIAN NZ ARCHAEOL	40	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84302	10.1371/journal.pone.0084302	http://dx.doi.org/10.1371/journal.pone.0084302			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	291WL	24416213	gold, Green Published, Green Submitted			2022-12-27	WOS:000329862500111
J	Mori, AT; Kaale, EA; Ngalesoni, F; Norheim, OF; Robberstad, B				Mori, Amani Thomas; Kaale, Eliangiringa Amos; Ngalesoni, Frida; Norheim, Ole Frithjof; Robberstad, Bjarne			The Role of Evidence in the Decision-Making Process of Selecting Essential Medicines in Developing Countries: The Case of Tanzania	PLOS ONE			English	Article								Background: Insufficient access to essential medicines is a major health challenge in developing countries. Despite the importance of Standard Treatment Guidelines and National Essential Medicine Lists in facilitating access to medicines, little is known about how they are updated. This study aims to describe the process of updating the Standard Treatment Guidelines and National Essential Medicine List in Tanzania and further examines the criteria and the underlying evidence used in decision-making. Methods: This is a qualitative study in which data were collected by in-depth interviews and document reviews. Interviews were conducted with 18 key informants who were involved in updating the Standard Treatment Guidelines and National Essential Medicine List. We used a thematic content approach to analyse the data. Findings: The Standard Treatment Guidelines and National Essential Medicine List was updated by committees of experts who were recruited mostly from referral hospitals and the Ministry of Health and Social Welfare. Efficacy, safety, availability and affordability were the most frequently utilised criteria in decision-making, although these were largely based on experience rather than evidence. In addition, recommendations from international guidelines and medicine promotions also influenced decision-making. Cost-effectiveness, despite being an important criterion for formulary decisions, was not utilised. Conclusions: Recent decisions about the selection of essential medicines in Tanzania were made by committees of experts who largely used experience and discretionary judgement, leaving evidence with only a limited role in decision-making process. There may be several reasons for the current limited use of evidence in decision-making, but one hypothesis that remains to be explored is whether training experts in evidence-based decision-making would lead to a better and more explicit use of evidence.	[Mori, Amani Thomas; Ngalesoni, Frida; Norheim, Ole Frithjof; Robberstad, Bjarne] Univ Bergen, Ctr Int Hlth, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Mori, Amani Thomas; Kaale, Eliangiringa Amos] Muhimbili Univ Hlth & Allied Sci, Sch Pharm, Dar Es Salaam, Tanzania; [Ngalesoni, Frida] Minist Hlth & Social Welf, Dar Es Salaam, Tanzania	University of Bergen; Muhimbili University of Health & Allied Sciences	Mori, AT (corresponding author), Univ Bergen, Ctr Int Hlth, Dept Global Publ Hlth & Primary Care, Bergen, Norway.	pax_amani@yahoo.com	Robberstad, Bjarne/AAG-9322-2020; Norheim, Ole Frithjof/AAC-8771-2020; Kaale, Eliangiringa/AAC-8561-2019	Robberstad, Bjarne/0000-0002-0708-2016; Norheim, Ole Frithjof/0000-0002-5748-5956; Kaale, Eliangiringa/0000-0001-6008-3539; Mori, Amani/0000-0002-9968-3635	Norwegian State Education Loan Fund (Statens Lanekasse) through Quota Program	Norwegian State Education Loan Fund (Statens Lanekasse) through Quota Program	The study is part of a PhD training that is funded by the Norwegian State Education Loan Fund (Statens Lanekasse) through Quota Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin AA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-72; Anell Anders, 2004, Eur J Health Econ, V5, P28, DOI 10.1007/s10198-003-0195-0; [Anonymous], WORLD MED SIT; Baxter P, 2008, QUAL REP, V13, P544; Britten N, 1995, QUALITATIVE RES HLTH, P28; Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; Cameron A, 2011, B WORLD HEALTH ORGAN, V89, P412, DOI 10.2471/BLT.10.084327; Canadian Agency for Drugs and Technologies in Health (CADTH), 2006, GUID EC EV HLTH TECH; Chen LC, 2007, PHARM WORLD SCI, V29, P661, DOI 10.1007/s11096-007-9125-z; Department of Policy and Planning, 2008, ANN HLTH STAT ABSTR; Department of Policy and Planning Ministry of Health and Social Welfare, 2013, HLTH SECT PERF PROF, P55; Ellen ME, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-84; Euro Health Group, 2007, DRUG TRACK STUD ROYA; Green J, 2009, QUALITATIVE METHODS; Hogerzeil HV, 2004, BRIT MED J, V329, P1169, DOI 10.1136/bmj.329.7475.1169; Holloway C., 2003, MANAGING FORMULARY P; Holly AN, 2003, HLTH POLICY PLAN, V19, P356; Kafuko J, 1994, IMPACT NATL STANDARD; Laing R, 2003, LANCET, V361, P1723, DOI 10.1016/S0140-6736(03)13375-2; Laing RO, 2001, HEALTH POLICY PLANN, V16, P13, DOI 10.1093/heapol/16.1.13; McLellan E., 2003, FIELD METHOD, V15, P63, DOI [DOI 10.1177/1525822X02239573, 10.1177/1525822X02239573]; Ministry of Health, 1990, NAT HLTH POL; Ministry of Health, 1991, STAND TREATM GUID NA; Ministry of Health and Social Welfare, 2011, TANZ MAINL NAT HLTH, P20; Mori AT, 2013, FARMECONOMIA, V14, P3, DOI 10.7175/fe.v14i1.638; Mori AT, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-110; Mori AT, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-18; Nanyunja M, 2011, MALAR RES TREAT, DOI [10.4061/2011/683167., DOI 10.4061/2011/683167]; National Bureau of Statistics, 2011, TANZ DEM HLTH SURV 2; National Bureau of Statistics, 2013, 2012 POP HOUS CENS; National Institute for Health and Clinical Excellence (NICE), 2008, GUID METH TECHN APPR; Odedina FT, 2002, AM J HEALTH-SYST PH, V59, P1441, DOI 10.1093/ajhp/59.15.1441; Orem JN, 2011, IMPLEMENT SCI, V7, DOI [10.1186/1748-5908-1187-1198., DOI 10.1186/1748-5908-1187-1198]; Quick JD, 2003, HEALTH POLICY PLANN, V18, P1, DOI 10.1093/heapol/18.1.1; Quick JD, 2002, B WORLD HEALTH ORGAN, V80, P913; Robberstad B, 2010, EC EVALUATIONS HLTH, P548; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Robertson J, 2007, CLIN PHARMACOL THER, V82, P498, DOI 10.1038/sj.clpt.6100392; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Spath HM, 2003, PHARM WORLD SCI, V25, P269, DOI 10.1023/B:PHAR.0000006523.22131.69; Strauss A., 1990, BASICS QUALITATIVE R; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; United Nations, 2008, MILL DEV GOALS REP; WHO, 1977, TECHN REP SER WHO; WHO, 2002, REP WHO EXP COMM SEL; WHO, 2002, WHO POL PERSP MED SE; WHO, 2003, TECHN REP SER WHO, V914, P15; WHO, 2008, PHARMAFORUM 0121; WHO, 2012, SEL US ESS MED REP W; WHO UNESCO, 1978, PRIM HLTH CAR INT C; World Health Organization, 2004, EQ ACC ESS MED FRAM; Yin R. K., 2011, APPL CASE STUDY RES	52	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84824	10.1371/journal.pone.0084824	http://dx.doi.org/10.1371/journal.pone.0084824			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291WL	24416293	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500175
J	Xu, Y; Wang, J; Dong, WG				Xu, Yu; Wang, Jun; Dong, Weiguo			GSTM3 A/B Polymorphism and Risk for Head and Neck Cancer: A Meta-Analysis	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; SQUAMOUS-CELL CARCINOMA; ORAL-CANCER; GENE LOCI; SUSCEPTIBILITY; GSTT1; GENOTYPES; GSTP1; CYTOCHROME-P450; EPIDEMIOLOGY	Background: Glutathione S-transferase M3 (GSTM3) is an important member of the GSTs that plays a critical role in the development of head and neck cancer (HNC). Several studies have investigated between the GSTM3 A/B polymorphism and risk of HNC, however, the results remain controversial. The aim of this meta-analysis is to evaluate the association between the GSTM3 A/B polymorphism and the risk of HNC. Methods: All eligible case-control studies published up to July 2013 were identified by searching PubMed and Web of Science. The HNC risk associated with the GSTM3 A/B polymorphism was estimated for each study by odds ratios (OR) together with its 95% confidence interval (CI), respectively. Results: Fourteen studies from ten publications with 2110 patients and 2259 controls were included. Overall, the GSTM3 A/B polymorphism was associated with a decreased risk of HNC using the dominant model, homozygote comparison model and heterozygote comparison model (OR = 0.82, 95% CI: 0.71-0.94; OR = 0.67, 95% CI: 0.49-0.94; and OR = 0.84, 95% CI: 0.73-0.97, respectively); besides, in stratification analyses by ethnicity, similar results were observed in Caucasian populations. Stratification by tumor site indicated that the GSTM3 polymorphism was associated with a decreased risk of laryngeal cancer under recessive model and homozygote comparison (OR = 0.52, 95% CI: 0.30-0.89; and OR = 0.50, 95% CI: 0.29-0.87, respectively); By stratifying source of control, decreased cancer risk was observed in hospital-based population under all genetic models (OR = 0.67, 95% CI: 0.56-0.81 for the dominant model; OR = 0.66, 95% CI: 0.46-0.95 for the recessive model; OR = 0.55, 95% CI: 0.37-0.83 for the homozygote comparison model, and OR = 0.70, 95% CI: 0.58-0.84 for the heterozygote comparison model). Conclusions: This meta-analysis suggests that the GSTM3 A/B polymorphism may be an important protective factor for HNC, especially of laryngeal cancer and Caucasian populations.	[Xu, Yu] Wuhan Univ, Renmin Hosp, Dept Otolaryngol, Wuhan 430072, Hubei Province, Peoples R China; [Wang, Jun; Dong, Weiguo] Wuhan Univ, Renmin Hosp, Dept Gastroenterol, Wuhan 430072, Hubei Province, Peoples R China	Wuhan University; Wuhan University	Dong, WG (corresponding author), Wuhan Univ, Renmin Hosp, Dept Gastroenterol, Wuhan 430072, Hubei Province, Peoples R China.	dwg@whu.edu.cn						BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Buch SC, 2002, CARCINOGENESIS, V23, P803, DOI 10.1093/carcin/23.5.803; Butkiewicz D, 2000, ENVIRON MOL MUTAGEN, V35, P99, DOI 10.1002/(SICI)1098-2280(2000)35:2<99::AID-EM4>3.0.CO;2-2; Chatzimichalis M, 2010, J LARYNGOL OTOL, V124, P318, DOI 10.1017/S002221510999154X; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Hirvonen A, 1999, ENVIRON HEALTH PERSP, V107, P37, DOI 10.2307/3434470; Holley SL, 2006, INT J ONCOL, V28, P231; Inskip A, 1995, BIOCHEM J, V312, P713, DOI 10.1042/bj3120713; Jahnke V, 1996, AM J SURG, V172, P671, DOI 10.1016/S0002-9610(96)00298-X; Jahnke V, 1997, EUR ARCH OTO-RHINO-L, V254, pS147, DOI 10.1007/BF02439747; Jain M, 2007, CANCER EPIDEM BIOMAR, V16, P178, DOI 10.1158/1055-9965.EPI-06-0542; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jourenkova-Mironova N, 1999, CANCER EPIDEM BIOMAR, V8, P185; Jourenkova-Mironova N, 1999, INT J CANCER, V81, P44, DOI 10.1002/(SICI)1097-0215(19990331)81:1<44::AID-IJC9>3.0.CO;2-A; KETTERER B, 1988, MUTAT RES, V202, P343, DOI 10.1016/0027-5107(88)90197-2; Kim L, 2010, ONCOLOGY-NY, V24, P915; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Loktionov A, 2001, CARCINOGENESIS, V22, P1053, DOI 10.1093/carcin/22.7.1053; Majumder M, 2005, CANCER EPIDEM BIOMAR, V14, P2106, DOI 10.1158/1055-9965.EPI-05-0108; MANTEL N, 1959, J NATL CANCER I, V22, P719; Marques CFS, 2006, ORAL ONCOL, V42, P632, DOI 10.1016/j.oraloncology.2005.11.003; Matthias C, 1998, LARYNGO RHINO OTOL, V77, P201, DOI 10.1055/s-2007-996961; Matthias C, 1998, PHARMACOGENETICS, V8, P91; Matthias C, 2003, LARYNGO RHINO OTOL, V82, P25, DOI 10.1055/s-2003-36902; Pandey SN, 2006, BIOMARKERS, V11, P250, DOI 10.1080/13547500600648697; Park JY, 2000, PHARMACOGENETICS, V10, P123, DOI 10.1097/00008571-200003000-00004; Rydzanicz M, 2005, CANCER LETT, V224, P263, DOI 10.1016/j.canlet.2005.01.015; Saarikoski ST, 1998, INT J CANCER, V77, P516, DOI 10.1002/(SICI)1097-0215(19980812)77:4<516::AID-IJC7>3.0.CO;2-X; Sankaranarayanan R, 1998, ANTICANCER RES, V18, P4779; Schwartzbaum JA, 2007, CANCER EPIDEM BIOMAR, V16, P559, DOI 10.1158/1055-9965.EPI-06-0918; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; Sikdar N, 2004, INT J CANCER, V109, P95, DOI 10.1002/ijc.11610; To-Figueras J, 2002, CANCER LETT, V187, P95, DOI 10.1016/S0304-3835(02)00406-8; Wu XF, 2004, ONCOGENE, V23, P6500, DOI 10.1038/sj.onc.1207811; Yengi L, 1996, CANCER RES, V56, P1974	37	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83851	10.1371/journal.pone.0083851	http://dx.doi.org/10.1371/journal.pone.0083851			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416175	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500078
J	Castilla-Ortega, E; Escuredo, L; Bilbao, A; Pedraza, C; Orio, L; Estivill-Torrus, G; Santin, LJ; de Fonseca, FR; Pavon, FJ				Castilla-Ortega, Estela; Escuredo, Leticia; Bilbao, Ainhoa; Pedraza, Carmen; Orio, Laura; Estivill-Torrus, Guillermo; Santin, Luis J.; Rodriguez de Fonseca, Fernando; Javier Pavon, Francisco			1-Oleoyl Lysophosphatidic Acid: A New Mediator of Emotional Behavior in Rats	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; RECEPTOR-DEFICIENT MICE; ELEVATED PLUS-MAZE; PROTEIN-KINASE-C; PERIAQUEDUCTAL GRAY; ANXIOLYTIC-LIKE; LPA RECEPTORS; ANIMAL-MODELS; ANXIETY; ACTIVATION	The role of lysophosphatidic acid (LPA) in the control of emotional behavior remains to be determined. We analyzed the effects of the central administration of 1-oleoyl-LPA (LPA 18:1) in rats tested for food consumption and anxiety-like and depression-like behaviors. For this purpose, the elevated plus-maze, open field, Y maze, forced swimming and food intake tests were performed. In addition, c-Fos expression in the dorsal periaqueductal gray matter (DPAG) was also determined. The results revealed that the administration of LPA 18:1 reduced the time in the open arms of the elevated plus-maze and induced hypolocomotion in the open field, suggesting an anxiogenic-like phenotype. Interestingly, these effects were present following LPA 18:1 infusion under conditions of novelty but not under habituation conditions. In the forced swimming test, the administration of LPA 18:1 dose-dependently increased depression-like behavior, as evaluated according to immobility time. LPA treatment induced no effects on feeding. However, the immunohistochemical analysis revealed that LPA 18:1 increased c-Fos expression in the DPAG. The abundant expression of the LPA(1) receptor, one of the main targets for LPA 18:1, was detected in this brain area, which participates in the control of emotional behavior, using immunocytochemistry. These findings indicate that LPA is a relevant transmitter potentially involved in normal and pathological emotional responses, including anxiety and depression.	[Castilla-Ortega, Estela; Bilbao, Ainhoa; Orio, Laura; Rodriguez de Fonseca, Fernando; Javier Pavon, Francisco] Univ Malaga, Hosp Reg, Inst Invest Biomed Malaga IBIMA, Unidad Gest,Clin Salud Mental, E-29071 Malaga, Spain; [Castilla-Ortega, Estela; Pedraza, Carmen; Santin, Luis J.] Univ Malaga, Inst Invest Biomed Malaga IBIMA, Dept Psicobiol & Metodol Ciencias Comportamiento, E-29071 Malaga, Spain; [Escuredo, Leticia; Orio, Laura; Rodriguez de Fonseca, Fernando] Univ Complutense Madrid, Dept Psicobiol, Madrid, Spain; [Estivill-Torrus, Guillermo] Univ Malaga, Hosp Reg, Inst Invest Biomed Malaga IBIMA, Unidad Gest,Clin Neurociencias, E-29071 Malaga, Spain	Universidad de Malaga; Universidad de Malaga; Complutense University of Madrid; Universidad de Malaga	Santin, LJ (corresponding author), Univ Malaga, Inst Invest Biomed Malaga IBIMA, Dept Psicobiol & Metodol Ciencias Comportamiento, E-29071 Malaga, Spain.	luis@uma.es; fernando.rodriguez@fundacionimabis.org	Castilla-Ortega, Estela/K-2811-2015; Santin, Luis Javier LJ/G-4364-2011; Benitez, Carmen Pedraza/K-2328-2017; Torrús, Guillermo Estivill/L-5157-2015; Orio, Laura/F-4827-2016; Bilbao, Ainhoa/AAW-6230-2020; Pavón Morón, Francisco Javier/AAG-9721-2020; Santin, Luis Javier/G-4364-2011	Castilla-Ortega, Estela/0000-0002-4496-1167; Santin, Luis Javier LJ/0000-0003-0894-8536; Benitez, Carmen Pedraza/0000-0002-0011-2817; Torrús, Guillermo Estivill/0000-0002-7124-2678; Orio, Laura/0000-0002-9614-4062; Pavón Morón, Francisco Javier/0000-0002-5256-8904; Santin, Luis Javier/0000-0003-1755-6497; RODRIGUEZ DE FONSECA, FERNANDO/0000-0002-4516-5795	Instituto de Salud Carlos III, Red de Trastornos Adictivos UE-FEDER [RD06/0001/0000, RD12/0028/0001]; Ministerio de Ciencia e Innovacion [SEJ2007-61187, PSI2010-16160, SAF2010-20521]; I3SNS Programme; Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia [CTS-433, CTS-065]; Instituto de Salud Carlos III	Instituto de Salud Carlos III, Red de Trastornos Adictivos UE-FEDER(Instituto de Salud Carlos III); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); I3SNS Programme; Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia(Junta de Andalucia); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	The present study was supported through funding from the Instituto de Salud Carlos III, Red de Trastornos Adictivos UE-FEDER RD06/0001/0000 and RD12/0028/0001 (F.R.d.F. and F.J.P.), Ministerio de Ciencia e Innovacion SEJ2007-61187 and PSI2010-16160 (L.J.S.), and SAF2010-20521 (F.R.d.F.), I3SNS Programme (G.E.O.), and Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia (grants CTS-433 and CTS-065). E.C.O. received a 'Sara Borrell' fellowship from the Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alen F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060918; Aoki J, 2002, J BIOL CHEM, V277, P48737, DOI 10.1074/jbc.M206812200; Aoki J, 2008, BBA-MOL CELL BIOL L, V1781, P513, DOI 10.1016/j.bbalip.2008.06.005; Bandoh K, 2000, FEBS LETT, V478, P159, DOI 10.1016/S0014-5793(00)01827-5; Blanco E, 2012, PSYCHOPHARMACOLOGY, V220, P27, DOI 10.1007/s00213-011-2446-6; Brandao ML, 2003, EUR J PHARMACOL, V463, P225, DOI 10.1016/S0014-2999(03)01284-6; BRITTON DR, 1982, LIFE SCI, V31, P363, DOI 10.1016/0024-3205(82)90416-7; CALLAERTSVEGH Z, 2012, GENES BRAIN BEHAV; Casarotto PC, 2010, INT J NEUROPSYCHOPH, V13, P573, DOI 10.1017/S146114570999112X; Castagne Vincent, 2011, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0810as55; Castilla-Ortega E, 2012, BEHAV BRAIN RES, V232, P400, DOI 10.1016/j.bbr.2012.04.018; Castilla-Ortega E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025522; Castilla-Ortega E, 2010, NEUROBIOL LEARN MEM, V94, P73, DOI 10.1016/j.nlm.2010.04.003; Choi JW, 2013, BBA-MOL CELL BIOL L, V1831, P20, DOI 10.1016/j.bbalip.2012.07.015; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Chun J, 2010, PHARMACOL REV, V62, P579, DOI 10.1124/pr.110.003111; Contos JJA, 2000, P NATL ACAD SCI USA, V97, P13384, DOI 10.1073/pnas.97.24.13384; Dash PK, 2004, BIOCHEM BIOPH RES CO, V322, P893, DOI 10.1016/j.bbrc.2004.08.004; DRAGO F, 1986, BRAIN RES, V368, P287, DOI 10.1016/0006-8993(86)90573-1; Dubin AE, 1999, J NEUROSCI, V19, P1371; Dulawa SC, 2004, NEUROPSYCHOPHARMACOL, V29, P1321, DOI 10.1038/sj.npp.1300433; Estivill-Torrus G, 2008, CEREB CORTEX, V18, P938, DOI 10.1093/cercor/bhm132; Garcia-Fernandez M, 2012, INT J NEUROSCI, V122, P583, DOI 10.3109/00207454.2012.693998; Gomez R, 2002, J NEUROSCI, V22, P9612; Graeff FG, 2004, NEUROSCI BIOBEHAV R, V28, P239, DOI 10.1016/j.neubiorev.2003.12.004; GUNDERSEN HJG, 1988, J MICROSC-OXFORD, V151, P3, DOI 10.1111/j.1365-2818.1988.tb04609.x; Handford EJ, 2001, NEUROREPORT, V12, P757, DOI 10.1097/00001756-200103260-00029; Harrison SM, 2003, MOL CELL NEUROSCI, V24, P1170, DOI 10.1016/j.mcn.2003.09.001; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; HEILIG M, 1993, NEUROPSYCHOPHARMACOL, V8, P357, DOI 10.1038/npp.1993.35; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Hogg S, 2006, NEUROPHARMACOLOGY, V51, P141, DOI 10.1016/j.neuropharm.2006.03.009; Jimenez-Velazquez G, 2010, BRAIN RES, V1349, P11, DOI 10.1016/j.brainres.2010.06.014; Leussis MP, 2006, NEUROSCI BIOBEHAV R, V30, P1045, DOI 10.1016/j.neubiorev.2006.03.006; Litvin Y, 2007, HORM BEHAV, V52, P244, DOI 10.1016/j.yhbeh.2007.04.012; Matas-Rico E, 2008, MOL CELL NEUROSCI, V39, P342, DOI 10.1016/j.mcn.2008.07.014; Muscella A, 2003, J CELL PHYSIOL, V195, P234, DOI 10.1002/jcp.10242; Nagai J, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-78; Navarro M, 1996, J NEUROCHEM, V67, P1982; Navarro M, 1997, NEUROREPORT, V8, P491, DOI 10.1097/00001756-199701200-00023; Navarro M, 1996, BEHAV BRAIN RES, V75, P91, DOI 10.1016/0166-4328(96)00176-3; Nishikawa H, 2004, BIOL PHARM BULL, V27, P352, DOI 10.1248/bpb.27.352; Noguchi K, 2009, CURR OPIN PHARMACOL, V9, P15, DOI 10.1016/j.coph.2008.11.010; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PEDRAZA C, 2013, BRAIN STRUCT FUNCT; Pilpel Y, 2006, J NEUROCHEM, V97, P1379, DOI 10.1111/j.1471-4159.2006.03825.x; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Ramos A, 2008, TRENDS PHARMACOL SCI, V29, P493, DOI 10.1016/j.tips.2008.07.005; Ramos A, 2008, BEHAV BRAIN RES, V193, P277, DOI 10.1016/j.bbr.2008.06.007; Reyes-Cabello C, 2012, PHARMACOL BIOCHEM BE, V101, P1, DOI 10.1016/j.pbb.2011.11.011; Roberts C, 2005, NEUROCHEM RES, V30, P371, DOI 10.1007/s11064-005-2611-6; Ryan PJ, 2011, NEUROSCI BIOBEHAV R, V35, P1326, DOI 10.1016/j.neubiorev.2011.02.004; Saitoh A, 2006, PSYCHOPHARMACOLOGY, V188, P1, DOI 10.1007/s00213-006-0466-4; Sano T, 2002, J BIOL CHEM, V277, P21197, DOI 10.1074/jbc.M201289200; Santin LJ, 2009, GENES BRAIN BEHAV, V8, P772, DOI 10.1111/j.1601-183X.2009.00524.x; Santin LJ, 2003, PHYSIOL BEHAV, V78, P733, DOI 10.1016/S0031-9384(03)00060-X; Sato K, 2005, J NEUROCHEM, V92, P904, DOI 10.1111/j.1471-4159.2004.02933.x; Sela VR, 2011, NEUROSCI LETT, V495, P63, DOI 10.1016/j.neulet.2011.03.040; Shin TJ, 2012, MOL CELLS, V34, P563, DOI 10.1007/s10059-012-0254-4; TAKAHASHI LK, 1989, BEHAV NEUROSCI, V103, P648, DOI 10.1037/0735-7044.103.3.648; Trimbuch T, 2009, CELL, V138, P1222, DOI 10.1016/j.cell.2009.06.050; TSUDA T, 1986, FEBS LETT, V208, P39, DOI 10.1016/0014-5793(86)81527-7; Vahidy WH, 2006, EXP BRAIN RES, V174, P781, DOI 10.1007/s00221-006-0672-7; Veloso A, 2011, ANAL BIOANAL CHEM, V401, P89, DOI 10.1007/s00216-011-4882-x; Weiner JA, 1998, J COMP NEUROL, V398, P587; Xiao ZY, 2012, HIPPOCAMPUS, V22, P1438, DOI 10.1002/hipo.20984; Ye XQ, 2002, BBA-MOL CELL BIOL L, V1585, P108, DOI 10.1016/S1388-1981(02)00330-X; Yoshida K, 2003, CIRCULATION, V108, P1746, DOI 10.1161/01.CIR.0000089374.35455.F3; Zarrindast MR, 2001, PHARMACOL BIOCHEM BE, V69, P9, DOI 10.1016/S0091-3057(01)00518-4	69	25	25	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e85348	10.1371/journal.pone.0085348	http://dx.doi.org/10.1371/journal.pone.0085348			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409327	Green Submitted, Green Published, gold			2022-12-27	WOS:000329463500051
J	Vormoor, B; Knizia, HK; Batey, MA; Almeida, GS; Wilson, I; Dildey, P; Sharma, A; Blair, H; Hide, IG; Heidenreich, O; Vormoor, J; Maxwell, RJ; Bacon, CM				Vormoor, Britta; Knizia, Henrike K.; Batey, Michael A.; Almeida, Gilberto S.; Wilson, Ian; Dildey, Petra; Sharma, Abhishek; Blair, Helen; Hide, I. Geoff; Heidenreich, Olaf; Vormoor, Josef; Maxwell, Ross J.; Bacon, Chris M.			Development of a Preclinical Orthotopic Xenograft Model of Ewing Sarcoma and Other Human Malignant Bone Disease Using Advanced In Vivo Imaging	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; ZOLEDRONIC ACID; SURVIVAL ANALYSIS; STEM-CELLS; NUDE-MOUSE; GROWTH; TUMORS; MICE; ESTABLISHMENT; OSTEOSARCOMA	Ewing sarcoma and osteosarcoma represent the two most common primary bone tumours in childhood and adolescence, with bone metastases being the most adverse prognostic factor. In prostate cancer, osseous metastasis poses a major clinical challenge. We developed a preclinical orthotopic model of Ewing sarcoma, reflecting the biology of the tumour-bone interactions in human disease and allowing in vivo monitoring of disease progression, and compared this with models of osteosarcoma and prostate carcinoma. Human tumour cell lines were transplanted into non-obese diabetic/severe combined immunodeficient (NSG) and Rag2(-/-) gamma c(-/-) mice by intrafemoral injection. For Ewing sarcoma, minimal cell numbers (1000-5000) injected in small volumes were able to induce orthotopic tumour growth. Tumour progression was studied using positron emission tomography, computed tomography, magnetic resonance imaging and bioluminescent imaging. Tumours and their interactions with bones were examined by histology. Each tumour induced bone destruction and outgrowth of extramedullary tumour masses, together with characteristic changes in bone that were well visualised by computed tomography, which correlated with post-mortem histology. Ewing sarcoma and, to a lesser extent, osteosarcoma cells induced prominent reactive new bone formation. Osteosarcoma cells produced osteoid and mineralised "malignant'' bone within the tumour mass itself. Injection of prostate carcinoma cells led to osteoclast-driven osteolytic lesions. Bioluminescent imaging of Ewing sarcoma xenografts allowed easy and rapid monitoring of tumour growth and detection of tumour dissemination to lungs, liver and bone. Magnetic resonance imaging proved useful for monitoring soft tissue tumour growth and volume. Positron emission tomography proved to be of limited use in this model. Overall, we have developed an orthotopic in vivo model for Ewing sarcoma and other primary and secondary human bone malignancies, which resemble the human disease. We have shown the utility of small animal bioimaging for tracking disease progression, making this model a useful assay for preclinical drug testing.	[Vormoor, Britta; Knizia, Henrike K.; Batey, Michael A.; Almeida, Gilberto S.; Wilson, Ian; Sharma, Abhishek; Blair, Helen; Heidenreich, Olaf; Vormoor, Josef; Maxwell, Ross J.; Bacon, Chris M.] Newcastle Univ, Newcastle Canc Ctr, Northern Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Dildey, Petra; Hide, I. Geoff; Bacon, Chris M.] Newcastle Upon Tyne Hosp, NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England; [Vormoor, Britta; Vormoor, Josef] Great North Childrens Hosp, Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle Upon Tyne Hospitals NHS Foundation Trust	Bacon, CM (corresponding author), Newcastle Univ, Newcastle Canc Ctr, Northern Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	chris.bacon@ncl.ac.uk	Heidenreich, Olaf/AAP-5045-2021; Sharma, Abhishek/V-9874-2018; Vormoor, Josef/GPS-7248-2022	Heidenreich, Olaf/0000-0001-5404-6483; Sharma, Abhishek/0000-0003-2554-1025; Vormoor, Josef/0000-0002-1825-1890; Bacon, Chris/0000-0002-8268-2812	Bone Cancer Research Trust; Deutsche Krebshilfe/www.krebshilfe.de, North of England's Cancer Research Fund; Newcastle Healthcare Charity; Academy of medical Sciences/Wellcome Trust/; Wellcome trust [087961]; Cancer Research UK [10348] Funding Source: researchfish	Bone Cancer Research Trust; Deutsche Krebshilfe/www.krebshilfe.de, North of England's Cancer Research Fund; Newcastle Healthcare Charity; Academy of medical Sciences/Wellcome Trust/(Wellcome Trust); Wellcome trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK)	This work was generously supported by grants from the Bone Cancer Research Trust/www. bonecancerresearch.org.uk, Deutsche Krebshilfe/www.krebshilfe.de, North of England's Cancer Research Fund/www.neccr.org.uk and Newcastle Healthcare Charity (all to JV) and by a Clinical Lecturer's Starter Grant from the Academy of medical Sciences/Wellcome Trust/www.acmedsci.ac.uk (to BV). The IVIS Spectrum was funded by a grant from the Wellcome trust, grant 087961. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIRCHMEIER W, 1994, BBA-REV CANCER, V1198, P11, DOI 10.1016/0304-419X(94)90003-5; Bomken S, 2013, LEUKEMIA, V27, P718, DOI 10.1038/leu.2012.206; Christoph S, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-10; Coleman RE, 2001, CANCER TREAT REV, V27, P165, DOI 10.1053/ctrv.2000.0210; Coleman RE, 2006, CLIN CANCER RES, V12, p6243S, DOI 10.1158/1078-0432.CCR-06-0931; Corey E, 2002, PROSTATE, V52, P20, DOI 10.1002/pros.10091; Dalal S, 2009, EUR J CANCER, V45, P713, DOI 10.1016/j.ejca.2008.11.045; Erkizan HV, 2009, NAT MED, V15, P750, DOI 10.1038/nm.1983; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; Franzius C, 2006, EUR J NUCL MED MOL I, V33, P1432, DOI 10.1007/s00259-006-0106-6; Goldman JP, 1998, BRIT J HAEMATOL, V103, P335, DOI 10.1046/j.1365-2141.1998.00980.x; Hauer K, 2013, CANCER RES, V73, P967, DOI 10.1158/0008-5472.CAN-12-1492; Henry MD, 2005, PROSTATE, V65, P347, DOI 10.1002/pros.20300; KAIGHN ME, 1979, INVEST UROL, V17, P16; KOZLOWSKI JM, 1984, CANCER RES, V44, P3522; Labrinidis A, 2009, CLIN CANCER RES, V15, P3451, DOI 10.1158/1078-0432.CCR-08-1616; le Viseur C, 2008, CANCER CELL, V14, P47, DOI 10.1016/j.ccr.2008.05.015; LOKESHWAR BL, 1993, CANCER RES, V53, P4493; Mazurier F, 2003, NAT MED, V9, P959, DOI 10.1038/nm886; Montague R, 2004, EUR UROL, V46, P389, DOI 10.1016/j.eururo.2004.04.022; NAGLE RB, 1994, J CELL BIOCHEM, P232; Nargund VH, 2007, UROLOGICAL ONCOLOGY; Odri GA, 2010, CANCER RES, V70, P7610, DOI 10.1158/0008-5472.CAN-09-4272; Oefelein MG, 2002, J UROLOGY, V168, P1005, DOI 10.1016/S0022-5347(05)64561-2; Paulussen M, 1998, J CLIN ONCOL, V16, P3044, DOI 10.1200/JCO.1998.16.9.3044; Paulussen M, 2001, J CLIN ONCOL, V19, P1818, DOI 10.1200/JCO.2001.19.6.1818; Paulussen M, 1998, ANN ONCOL, V9, P275, DOI 10.1023/A:1008208511815; Reinus WR, 1984, RADIOGRAPHICS, V4, P929; Ritter J, 2010, ANN ONCOL, V21, P320, DOI 10.1093/annonc/mdq276; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Sampson ER, 2011, J BONE MINER RES, V26, P1283, DOI 10.1002/jbmr.336; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Soos G, 1997, ANTICANCER RES, V17, P4253; VANVALEN F, 1992, J CANCER RES CLIN, V118, P269, DOI 10.1007/BF01208615; Vormoor J, 2001, PEDIATR RES, V49, P332, DOI 10.1203/00006450-200103000-00006; Wang YX, 2009, IN VIVO, V23, P903; Weilbaecher KN, 2011, NAT REV CANCER, V11, P411, DOI 10.1038/nrc3055; WHANGPENG J, 1984, NEW ENGL J MED, V311, P584, DOI 10.1056/NEJM198408303110907; Winter GE, 2011, MOL CANCER THER, V10, P1846, DOI 10.1158/1535-7163.MCT-11-0100; YONEDA T, 1994, BREAST CANCER RES TR, V32, P73, DOI 10.1007/BF00666208; Zhou ZC, 2005, CANCER-AM CANCER SOC, V104, P1713, DOI 10.1002/cncr.21383	41	29	29	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e85128	10.1371/journal.pone.0085128	http://dx.doi.org/10.1371/journal.pone.0085128			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409320	gold, Green Published, Green Submitted			2022-12-27	WOS:000329463500044
J	Chen, W; Xu, YF; Li, H; Tao, WY; Xiang, Y; Huang, B; Niu, JQ; Zhong, J; Meng, GX				Chen, Wei; Xu, Yongfen; Li, Hua; Tao, Wanyin; Xiang, Yu; Huang, Bing; Niu, Junqi; Zhong, Jin; Meng, Guangxun			HCV Genomic RNA Activates the NLRP3 Inflammasome in Human Myeloid Cells	PLOS ONE			English	Article							HEPATITIS-C VIRUS; PLASMA INTERLEUKIN-18 LEVELS; INDUCIBLE GENE-I; RIG-I; INFECTION; REPLICATION; RECOGNITION; PROTEIN; ENHANCEMENT; ASSOCIATION	Background: Elevated plasma levels of IL-1 beta and IL-18 from patients with hepatitis C virus (HCV) infection indicate a possible activation of inflammasome by HCV. Methodology/Principal Findings: To demonstrate whether HCV infection activates the inflammasome, we investigated inflammasome activation from HCV infected hepatic Huh7 cells, or monocytic cells and THP-1 derived macrophages challenged with HCV virions, but no any inflammasome activation was detected in these cells. However, when we transfected HCV genomic RNA into monocytes or macrophages, IL-1 beta was secreted in a dose-dependent manner. We also detected ASC oligomerization and caspase-1 cleavage in HCV RNA transfected macrophages. Using shRNA-mediated gene silencing or specific inhibitors, we found that HCV RNA-induced IL-1 beta secretion was dependent on the presence of inflammasome components such as NLRP3, ASC and caspase-1. Furthermore, we also found that RIG-I was dispensable for HCV RNA-induced NLRP3 inflammasome activation, while reactive oxygen species (ROS) production was required. Conclusions: Our results indicate that HCV RNA activates the NLRP3 inflammasome in a ROS-dependent manner, and RIG-I is not required for this process.	[Chen, Wei; Xu, Yongfen; Li, Hua; Tao, Wanyin; Xiang, Yu; Huang, Bing; Zhong, Jin; Meng, Guangxun] Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China; [Niu, Junqi] Jilin Univ, Hosp 1, Dept Hepatol, Changchun 130023, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Jilin University	Zhong, J (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China.	jzhong@sibs.ac.cn; gxmeng@sibs.ac.cn	Xu, Yongfen/CAF-5582-2022; Zhong, Jin/J-4613-2019; li, hua/I-1881-2016; Tao, Wanyin/AAR-9230-2020; Zhong, Jin/M-6859-2018	Xu, Yongfen/0000-0002-2845-7753; li, hua/0000-0001-6367-4764; Xiang, Yu/0000-0001-8333-0782; Zhong, Jin/0000-0002-3554-1275	Chinese Academy of Sciences; Natural Science Foundation of China [91029707, 31170868]; Novo Nordisk-CAS Research Foundation; SA-SIBS Scholarship Program; National Key Programs on Infectious Disease [2012ZX10002007-003]	Chinese Academy of Sciences(Chinese Academy of Sciences); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Novo Nordisk-CAS Research Foundation(Novo Nordisk Foundation); SA-SIBS Scholarship Program; National Key Programs on Infectious Disease	This work was supported by grants from 100 Talent Program of the Chinese Academy of Sciences, Natural Science Foundation of China (91029707, 31170868), Novo Nordisk-CAS Research Foundation, SA-SIBS Scholarship Program, as well as grants from the National Key Programs on Infectious Disease (2012ZX10002007-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aroucha DCBL, 2013, CYTOKINE, V62, P421, DOI 10.1016/j.cyto.2013.03.024; Barlan AU, 2011, J VIROL, V85, P146, DOI 10.1128/JVI.01265-10; Bartenschlager R, 2000, J GEN VIROL, V81, P1631, DOI 10.1099/0022-1317-81-7-1631; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Boaru SG, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-49; Burdette D, 2012, J GEN VIROL, V93, P235, DOI 10.1099/vir.0.034033-0; Chattergoon MA, 2011, J INFECT DIS, V204, P1730, DOI 10.1093/infdis/jir642; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; de Veerdonk FLV, 2011, TRENDS IMMUNOL, V32, P110, DOI 10.1016/j.it.2011.01.003; Dental C, 2012, J VIROL, V86, P1090, DOI 10.1128/JVI.05444-11; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dreux M, 2012, CELL HOST MICROBE, V12, P558, DOI 10.1016/j.chom.2012.08.010; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201; Hirota JA, 2012, J ALLERGY CLIN IMMUN, V129, P1116, DOI 10.1016/j.jaci.2011.11.033; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Ito M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002857; Kanneganti TD, 2010, NAT REV IMMUNOL, V10, P688, DOI 10.1038/nri2851; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kato T, 2003, GASTROENTEROLOGY, V125, P1808, DOI 10.1053/j.gastro.2003.09.023; Kinoshita T, 2005, J BIOL CHEM, V280, P21720, DOI 10.1074/jbc.M410057200; Lapinski TW, 2001, ARCH IMMUNOL THER EX, V49, P311; Lawrence TM, 2013, J VIROL, V87, P5848, DOI 10.1128/JVI.00203-13; Lee GS, 2012, NATURE, V492, P123, DOI 10.1038/nature11588; Lei G, 2013, CELL RES; Li H, 2013, PROTEIN CELL, V4, P529, DOI 10.1007/s13238-013-2127-9; MADY BJ, 1993, J GEN VIROL, V74, P839, DOI 10.1099/0022-1317-74-5-839; Mao KR, 2013, CELL RES, V23, P201, DOI 10.1038/cr.2013.6; Meng GX, 2010, EUR J IMMUNOL, V40, P649, DOI 10.1002/eji.200940191; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mitoma H, 2013, IMMUNITY, V39, P123, DOI 10.1016/j.immuni.2013.07.001; Murakami T, 2012, P NATL ACAD SCI USA, V109, P11282, DOI 10.1073/pnas.1117765109; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Negash AA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003330; Nishitsuji H, 2013, J VIROL; Pawlotsky JM, 2004, TRENDS MICROBIOL, V12, P96, DOI 10.1016/j.tim.2003.12.005; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Poeck H, 2012, EUR J CELL BIOL, V91, P59, DOI 10.1016/j.ejcb.2011.01.013; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Rajan JV, 2011, J VIROL, V85, P4167, DOI 10.1128/JVI.01687-10; Ramakrishnaiah V, 2013, P NATL ACAD SCI USA, V110, P13109, DOI 10.1073/pnas.1221899110; Rossol M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2339; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Schnell G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002839; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sharma A, 2009, IMMUNOLOGY, V128, pe514, DOI 10.1111/j.1365-2567.2008.03021.x; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Shrivastava S, 2013, J VIROL; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Subramanian N, 2013, CELL, V153, P348, DOI 10.1016/j.cell.2013.02.054; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Vecchiet J, 2005, ANN CLIN LAB SCI, V35, P415; Wang HB, 2013, PROTEIN CELL, V4, P565, DOI 10.1007/s13238-013-3905-0; Watanabe H, 2007, J INVEST DERMATOL, V127, P1956, DOI 10.1038/sj.jid.5700819; Yoneda S, 2011, J INFECT DIS, V203, P1087, DOI 10.1093/infdis/jiq165; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	65	55	59	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84953	10.1371/journal.pone.0084953	http://dx.doi.org/10.1371/journal.pone.0084953			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400125	Green Submitted, Green Published, gold			2022-12-27	WOS:000329462700059
J	Pinatel, EM; Orso, F; Penna, E; Cimino, D; Elia, AR; Circosta, P; Dentelli, P; Brizzi, MF; Provero, P; Taverna, D				Pinatel, Eva Maria; Orso, Francesca; Penna, Elisa; Cimino, Daniela; Elia, Angela Rita; Circosta, Paola; Dentelli, Patrizia; Brizzi, Maria Felice; Provero, Paolo; Taverna, Daniela			miR-223 Is a Coordinator of Breast Cancer Progression as Revealed by Bioinformatics Predictions	PLOS ONE			English	Article							EXPRESSION SIGNATURE; DOWN-REGULATION; TUMOR PROGRESSION; INDUCED APOPTOSIS; STEM-CELLS; MICRORNA; INVASION; METASTASIS; PROLIFERATION; TRANSDUCER	MicroRNAs are single-stranded non-coding RNAs that simultaneously down-modulate the expression of multiple genes post-transcriptionally by binding to the 3'UTRs of target mRNAs. Here we used computational methods to predict microRNAs relevant in breast cancer progression. Specifically, we applied different microRNA target prediction algorithms to various groups of differentially expressed protein-coding genes obtained from four breast cancer datasets. Six potential candidates were identified, among them miR-223, previously described to be highly expressed in the tumor microenvironment and known to be actively transferred into breast cancer cells. To investigate the function of miR-223 in tumorigenesis and to define its molecular mechanism, we overexpressed miR-223 in breast cancer cells in a transient or stable manner. Alternatively we overexpressed miR-223 in mouse embryonic fibroblasts or HEK293 cells and used their conditioned medium to treat tumor cells. With both approaches, we obtained elevated levels of miR-223 in tumor cells and observed decreased migration, increased cell death in anoikis conditions and augmented sensitivity to chemotherapy but no effect on adhesion and proliferation. The analysis of miR-223 predicted targets revealed enrichment in cell death and survival-related genes and in pathways frequently altered in breast cancer. Among these genes, we showed that protein levels for STAT5A, ITGA3 and NRAS were modulated by miR-223. In addition, we proved that STAT5A is a direct miR-223 target and highlighted a possible correlation between miR-223 and STAT5A in migration and chemotherapy response. Our investigation revealed that a computational analysis of cancer gene expression datasets can be a relevant tool to identify microRNAs involved in cancer progression and that miR-223 has a prominent role in breast malignancy that could potentially be exploited therapeutically.	[Pinatel, Eva Maria; Orso, Francesca; Penna, Elisa; Cimino, Daniela; Elia, Angela Rita; Circosta, Paola; Provero, Paolo; Taverna, Daniela] Univ Turin, MBC, Turin, Italy; [Pinatel, Eva Maria; Orso, Francesca; Penna, Elisa; Cimino, Daniela; Provero, Paolo; Taverna, Daniela] Univ Turin, Dept Mol Biotechnol & Hlth Sci, Turin, Italy; [Orso, Francesca; Cimino, Daniela; Taverna, Daniela] Univ Turin, Ctr Mol Syst Biol, Turin, Italy; [Dentelli, Patrizia; Brizzi, Maria Felice] Univ Turin, Dept Med Sci, Turin, Italy; [Provero, Paolo] Ist Sci San Raffaele, Ctr Translat Genom & Bioinformat, I-20132 Milan, Italy	University of Turin; University of Turin; University of Turin; University of Turin; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Taverna, D (corresponding author), Univ Turin, MBC, Turin, Italy.	daniela.taverna@unito.it	Provero, Paolo/AAC-1930-2019; Brizzi, Maria Felice/J-7882-2016; taverna, daniela/J-8358-2016; Pinatel, Eva Maria/AAC-1365-2019; Orso, Francesca/B-1985-2014	taverna, daniela/0000-0002-6365-527X; Pinatel, Eva Maria/0000-0002-2544-4594; circosta, paola/0000-0001-8251-6905; Orso, Francesca/0000-0003-4706-6464	Compagnia San Paolo [2008.1054/DT]; PRIN; AIRC [IG10104/DT, IG5649/MFB]; FIRB giovani [RBFR08F2FS-002/FO]	Compagnia San Paolo(Compagnia di San Paolo); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); AIRC(Fondazione AIRC per la ricerca sul cancro); FIRB giovani	This work was supported by grants from the Compagnia San Paolo (2008.1054/DT), PRIN 2008/DT, AIRC (IG10104/DT; IG5649/MFB) and FIRB giovani 2008 (RBFR08F2FS-002/FO). EP is an FIRC fellow (2012-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agatheeswaran S, 2013, LEUKEMIA, V27, P1578, DOI 10.1038/leu.2012.339; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Baines AT, 2011, FUTURE MED CHEM, V3, P1787, DOI [10.4155/FMC.11.121, 10.4155/fmc.11.121]; Bhatnagar N, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.85; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Breakefield XO, 2011, MOL THER, V19, P1574, DOI 10.1038/mt.2011.169; Bronisz A, 2012, NAT CELL BIOL, V14, P159, DOI 10.1038/ncb2396; Buffa FM, 2011, CANCER RES, V71, P5635, DOI 10.1158/0008-5472.CAN-11-0489; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Cimino D, 2013, FASEB J, V27, P1223, DOI 10.1096/fj.12-214692; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Dentelli P, 2010, ARTERIOSCL THROM VAS, V30, P1562, DOI 10.1161/ATVBAHA.110.206201; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; DIPERSIO CM, 1995, J CELL SCI, V108, P2321; Dvinge H, 2013, NATURE, V497, P378, DOI 10.1038/nature12108; Enerly E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016915; Enright AJ, 2004, GENOME BIOL, V5; Farazi TA, 2011, CANCER RES, V71, P4443, DOI 10.1158/0008-5472.CAN-11-0608; Ferbeyre G, 2010, BIOCHIM BIOPHYS ACTA, V1815, P104; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Fox EM, 2008, MOL ENDOCRINOL, V22, P1781, DOI 10.1210/me.2007-0419; Fu XN, 2011, EUR J CLIN INVEST, V41, P1245, DOI 10.1111/j.1365-2362.2011.02535.x; Furth PA, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2921; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gong B, 2013, BIOMED PHARMACOTHER; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Heys SD, 2012, BREAST CANCER RES TR, V135, P539, DOI 10.1007/s10549-012-2190-6; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jia CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027008; Jiang SA, 2010, CANCER RES, V70, P3119, DOI 10.1158/0008-5472.CAN-09-4250; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Kopp F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050469; Kosova B, 2010, LEUKEMIA LYMPHOMA, V51, P1895, DOI 10.3109/10428194.2010.507830; KUENG W, 1989, ANAL BIOCHEM, V182, P16, DOI 10.1016/0003-2697(89)90710-0; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li SJ, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-24; Li XH, 2011, MOL CANCER RES, V9, P824, DOI 10.1158/1541-7786.MCR-10-0529; Lim PK, 2011, CANCER RES, V71, P1550, DOI 10.1158/0008-5472.CAN-10-2372; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ma XJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2222; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; Martins VR DM, 2013, CURRENT OPINION ONCO; Masciarelli S., 2013, ONCOGENE; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; Orso F, 2008, FASEB J, V22, P2702, DOI 10.1096/fj.08-106492; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Penna E, 2011, EMBO J, V30, P1990, DOI 10.1038/emboj.2011.102; Perou CM, 2011, ONCOLOGIST, V16, P61, DOI 10.1634/theoncologist.2011-S1-61; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Polyak K, 2011, J CLIN INVEST, V121, P3786, DOI 10.1172/JCI60534; Purclutepe O, 2012, ANTICANCER RES, V32, P2885; Rask L, 2011, APMIS, V119, P663, DOI 10.1111/j.1600-0463.2011.02782.x; Rasola A, 2001, CYTOMETRY, V45, P151, DOI 10.1002/1097-0320(20011001)45:2<151::AID-CYTO1157>3.0.CO;2-I; Re A, 2009, MOL BIOSYST, V5, P854, DOI 10.1039/b900177h; Shi Z, 2012, MOL CANCER RES, V8, P615; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Shirdel EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017429; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Subbaram S, 2011, EXPERT OPIN THER TAR, V15, P1197, DOI 10.1517/14728222.2011.609557; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Team RDC, 2008, R LANG ENV STAT COMP; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Viticchie G, 2011, CELL CYCLE, V10, P1121, DOI 10.4161/cc.10.7.15180; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Volinia S, 2012, P NATL ACAD SCI USA, V109, P3024, DOI 10.1073/pnas.1200010109; Volinia S, 2010, BIOINFORMATICS, V26, P91, DOI 10.1093/bioinformatics/btp598; Wang Y, 2009, EUR J NUCL MED MOL I, V36, P1977, DOI 10.1007/s00259-009-1201-2; Wu LH, 2012, FEBS LETT, V586, P1038, DOI 10.1016/j.febslet.2012.02.050; WU ZS, 2011, CANCER; Yang M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-117; Yang T, 2013, EXP BIOL MED MAYWOOD; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu ZR, 2008, J CELL BIOL, V182, P509, DOI 10.1083/jcb.200801079	85	49	52	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84859	10.1371/journal.pone.0084859	http://dx.doi.org/10.1371/journal.pone.0084859			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400121	Green Published, Green Submitted, gold			2022-12-27	WOS:000329462700055
J	Beier, HT; Ibey, BL				Beier, Hope T.; Ibey, Bennett L.			Experimental Comparison of the High-Speed Imaging Performance of an EM-CCD and sCMOS Camera in a Dynamic Live-Cell Imaging Test Case	PLOS ONE			English	Article							SUPERRESOLUTION MICROSCOPY; MEMBRANE PERMEABILIZATION; LOCALIZATION	The study of living cells may require advanced imaging techniques to track weak and rapidly changing signals. Fundamental to this need is the recent advancement in camera technology. Two camera types, specifically sCMOS and EM-CCD, promise both high signal-to-noise and high speed (>100 fps), leaving researchers with a critical decision when determining the best technology for their application. In this article, we compare two cameras using a live-cell imaging test case in which small changes in cellular fluorescence must be rapidly detected with high spatial resolution. The EM-CCD maintained an advantage of being able to acquire discernible images with a lower number of photons due to its EM-enhancement. However, if high-resolution images at speeds approaching or exceeding 1000 fps are desired, the flexibility of the full-frame imaging capabilities of sCMOS is superior.	[Beier, Hope T.; Ibey, Bennett L.] Air Force Res Lab, Bioeffects Div, Human Performance Wing 1, Ft Sam Houston, TX USA		Beier, HT (corresponding author), Air Force Res Lab, Bioeffects Div, Human Performance Wing 1, Ft Sam Houston, TX USA.	hope.beier.1@us.af.mil		Beier, Hope/0000-0002-6291-118X	National Research Council; Air Force Office of Scientific Research (AFOSR) LRIR [12RH01COR]	National Research Council(Consiglio Nazionale delle Ricerche (CNR)); Air Force Office of Scientific Research (AFOSR) LRIR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	HTB acknowledges support of a National Research Council Research Associateship Award. HTB ac- knowledges support of Air Force Office of Scientific Research (AFOSR) LRIR grant #12RH01COR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Beier HT, 2012, BIOCHEM BIOPH RES CO, V423, P863, DOI 10.1016/j.bbrc.2012.06.055; Craviso G, 2010, NEUROBIOLOGY, V30, P1259; Fullerton S.M., 2012, P SPIE, P8228; Holst G, 2009, LASER PHOTONICS, V5, P18; Huang ZL, 2011, OPT EXPRESS, V19, P19156, DOI 10.1364/OE.19.019156; Ibey BL, 2010, BBA-GEN SUBJECTS, V1800, P1210, DOI 10.1016/j.bbagen.2010.07.008; Ibey BL, 2009, BIOELECTROMAGNETICS, V30, P92, DOI 10.1002/bem.20451; Joubert JR, 2011, PHOTONIC SPECTRA, V45, P46; Long F, 2012, OPT EXPRESS, V20, P17741, DOI 10.1364/OE.20.017741; Pakhomov AG, 2007, ARCH BIOCHEM BIOPHYS, V465, P109, DOI 10.1016/j.abb.2007.05.003; Pakhomov AG, 2009, BIOCHEM BIOPH RES CO, V385, P181, DOI 10.1016/j.bbrc.2009.05.035; Rasband W., 2006, IMAGEJ; Robbins MS, 2003, IEEE T ELECTRON DEV, V50, P1227, DOI 10.1109/TED.2003.813462; Saurabh S, 2012, OPT EXPRESS, V20, P7338, DOI 10.1364/OE.20.007338; Vernier PT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-37	15	33	33	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84614	10.1371/journal.pone.0084614	http://dx.doi.org/10.1371/journal.pone.0084614			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404178	Green Published, Green Submitted, gold			2022-12-27	WOS:000329460800057
J	Chu, B; Yao, F; Cheng, C; Wu, Y; Mei, YL; Li, XJ; Liu, Y; Wang, PS; Hou, L; Zou, XY				Chu, Bing; Yao, Feng; Cheng, Cheng; Wu, Yang; Mei, Yanli; Li, Xuejie; Liu, Yan; Wang, Peisheng; Hou, Lin; Zou, Xiangyang			The Potential Role of As-sumo-1 in the Embryonic Diapause Process and Early Embryo Development of Artemia sinica	PLOS ONE			English	Article							SUMO-1; EXPRESSION; SUMOYLATION; ACTIVATION; COMPLEX; KINASE; PHASE; CRAB	During embryonic development of Artemia sinica, environmental stresses induce the embryo diapause phenomenon, required to resist apoptosis and regulate cell cycle activity. The small ubiquitin-related modifier-1 (SUMO), a reversible post-translational protein modifier, plays an important role in embryo development. SUMO regulates multiple cellular processes, including development and other biological processes. The molecular mechanism of diapause, diapause termination and the role of As-sumo-1 in this processes and in early embryo development of Artemia sinica still remains unknown. In this study, the complete cDNA sequences of the sumo-1 homolog, sumo ligase homolog, caspase-1 homolog and cyclin B homolog from Artemia sinica were cloned. The mRNA expression patterns of As-sumo-1, sumo ligase, caspase-1, cyclin B and the location of As-sumo-1 were investigated. SUMO-1, p53, Mdm2, Caspase-1, Cyclin B and Cyclin E proteins were analyzed during different developmental stages of the embryo of A. sinica. Small interfering RNA (siRNA) was used to verify the function of sumo-1 in A. sinica. The full-length cDNA of As-sumo-1 was 476 bp, encoding a 92 amino acid protein. The As-caspases-1 cDNA was 966 bp, encoding a 245 amino-acid protein. The As-sumo ligase cDNA was 1556 bp encoding, a 343 amino acid protein, and the cyclin B cDNA was 739 bp, encoding a 133 amino acid protein. The expressions of As-sumo-1, As-caspase-1 and As-cyclin B were highest at the 10 h stage of embryonic development, and As-sumo ligase showed its highest expression at 0 h. The expression of As-SUMO-1 showed no tissue or organ specificity. Western blotting showed high expression of As-SUMO-1, p53, Mdm2, Caspase-1, Cyclin B and Cyclin E at the 10 h stage. The siRNA caused abnormal development of the embryo, with increased malformation and mortality. As-SUMO-1 is a crucial regulation and modification protein resumption of embryonic diapause and early embryo development of A. sinica.	[Chu, Bing; Yao, Feng; Cheng, Cheng; Wu, Yang; Mei, Yanli; Li, Xuejie; Liu, Yan; Hou, Lin] Liaoning Normal Univ, Coll Life Sci, Dalian, Peoples R China; [Wang, Peisheng; Zou, Xiangyang] Dalian Med Univ, Dept Biol, Dalian, Peoples R China	Liaoning Normal University; Dalian Medical University	Hou, L (corresponding author), Liaoning Normal Univ, Coll Life Sci, Dalian, Peoples R China.	houlin@lnnu.edu.cn; zouxiangyang@126.com			National Natural Science Foundation of China [31272644]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (31272644). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarzguioui M, 2004, BIOCHEM BIOPH RES CO, V316, P1050, DOI 10.1016/j.bbrc.2004.02.157; Artus J, 2006, CELL CYCLE, V5, P499, DOI 10.4161/cc.5.5.2500; Bayer P, 1998, J MOL BIOL, V280, P275, DOI 10.1006/jmbi.1998.1839; Capili AD, 2007, CURR OPIN STRUC BIOL, V17, P726, DOI 10.1016/j.sbi.2007.08.018; Conte FP, 2007, INT REV CYTOL, V91, P46; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Dai YB, 2012, GENE, V503, P260, DOI 10.1016/j.gene.2012.04.056; DULIC V, 1992, SCIENCE, V257, P1958, DOI 10.1126/science.1329201; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gupta S, 2001, J BIOL CHEM, V276, P10585, DOI 10.1074/jbc.C100025200; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; Hua XH, 1997, J CELL BIOL, V137, P183, DOI 10.1083/jcb.137.1.183; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Jaclyn RG, 2012, J BIOL CHEM, V287, P4740; Jiang LJ, 2007, ACTA BIOCH BIOPH SIN, V39, P351, DOI 10.1111/j.1745-7270.2007.00287.x; Jingjing L, 2008, PLANT CELL, V20, P1536; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lacey KR, 1999, P NATL ACAD SCI USA, V96, P2817, DOI 10.1073/pnas.96.6.2817; Liao SH, 2010, EXP CELL RES, V316, P704, DOI 10.1016/j.yexcr.2009.12.017; Lorca Thierry, 2012, Genes Cancer, V3, P712, DOI 10.1177/1947601912473478; Los M, 1999, IMMUNITY, V10, P629, DOI 10.1016/S1074-7613(00)80062-X; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Robert VT, 1997, J BIOL CHEM, V272, P9677; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Rohit M, 2007, CELL, V88, P98; Stehmeier P, 2009, DNA REPAIR, V8, P491, DOI 10.1016/j.dnarep.2009.01.002; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; Verger A, 2003, EMBO REP, V4, P137, DOI 10.1038/sj.embor.embor738; Vigodner M, 2005, DEV BIOL, V282, P480, DOI 10.1016/j.ydbio.2005.03.034; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Wang Q, 2012, GENE, V501, P135, DOI 10.1016/j.gene.2012.04.016; Wang YG, 2009, J CELL SCI, V122, P4249, DOI 10.1242/jcs.050542; WESTENDORF JM, 1989, J CELL BIOL, V108, P1431, DOI 10.1083/jcb.108.4.1431; Yeh ETH, 2000, GENE, V248, P1, DOI 10.1016/S0378-1119(00)00139-6; Zheng TS, 2000, NAT MED, V6, P1241, DOI 10.1038/81343	43	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e85343	10.1371/journal.pone.0085343	http://dx.doi.org/10.1371/journal.pone.0085343			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404204	Green Published, Green Submitted, gold			2022-12-27	WOS:000329460800083
J	Li, Y; Wang, L; Zhao, SH; He, ZX; Wang, DY; Guo, F; Fang, W; Yang, MF				Li, Yan; Wang, Li; Zhao, Shi-Hua; He, Zuo-Xiang; Wang, Dao-Yu; Guo, Feng; Fang, Wei; Yang, Min-Fu			Gated F-18 FDG PET for Assessment of Left Ventricular Volumes and Ejection Fraction Using QGS and 4D-MSPECT in Patients with Heart Failure: A Comparison with Cardiac MRI	PLOS ONE			English	Article							EQUILIBRIUM RADIONUCLIDE ANGIOGRAPHY; MYOCARDIAL-PERFUSION SPECT; CORONARY-ARTERY-DISEASE; DILATED CARDIOMYOPATHY; EUROPEAN-SOCIETY; ASSOCIATION HFA; TASK-FORCE; VALIDATION; QUANTIFICATION; GUIDELINES	Purpose: Ventricular function is a powerful predictor of survival in patients with heart failure (HF). However, studies characterizing gated F-18 FDG PET for the assessment of the cardiac function are rare. The aim of this study was to prospectively compare gated F-18 FDG PET and cardiac MRI for the assessment of ventricular volume and ejection fraction (EF) in patients with HF. Methods: Eighty-nine patients with diagnosed HF who underwent both gated F-18 FDG PET/CT and cardiac MRI within 3 days were included in the analysis. Left ventricular (LV) end-diastolic volume (EDV), end-systolic volume (ESV), and EF were obtained from gated F-18 FDG PET/CT using the Quantitative Gated SPECT (QGS) and 4D-MSPECT software. Results: LV EDV and LV ESV measured by QGS were significantly lower than those measured by cardiac MRI (both P<0.0001). In contrast, the corresponding values for LV EDV for 4D-MSPECT were comparable, and LV ESV was underestimated with borderline significance compared with cardiac MRI (P = 0.047). LV EF measured by QGS and cardiac MRI showed no significant differences, whereas the corresponding values for 4D-MSPECT were lower than for cardiac MRI (P<0.0001). The correlations of LV EDV, LV ESV, and LV EF between gated F-18 FDG PET/CT and cardiac MRI were excellent for both QGS (r = 0.92, 0.92, and 0.76, respectively) and 4D-MSPECT (r = 0.93, 0.94, and 0.75, respectively). However, Bland-Altman analysis revealed a significant systemic error, where LV EDV (-27.9 +/- 37.0 mL) and ESV (-18.6 +/- 33.8 mL) were underestimated by QGS. Conclusion: Despite the observation that gated F-18 FDG PET/CT were well correlated with cardiac MRI for assessing LV function, variation was observed between the two imaging modalities, and so these imaging techniques should not be used interchangeably.	[Li, Yan; Wang, Li; He, Zuo-Xiang; Wang, Dao-Yu; Guo, Feng; Fang, Wei] Peking Union Med Coll, Cardiovasc Inst, Dept Nucl Med, Beijing 100021, Peoples R China; [Li, Yan; Wang, Li; Zhao, Shi-Hua; He, Zuo-Xiang; Wang, Dao-Yu; Guo, Feng; Fang, Wei] Peking Union Med Coll, Fu Wai Hosp, Beijing 100021, Peoples R China; [Li, Yan; Wang, Li; Zhao, Shi-Hua; He, Zuo-Xiang; Wang, Dao-Yu; Guo, Feng; Fang, Wei] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Zhao, Shi-Hua] Peking Union Med Coll, Cardiovasc Inst, Dept Radiol, Beijing 100021, Peoples R China; [Yang, Min-Fu] Capital Med Univ, Chaoyang Hosp, Dept Nucl Med, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Medical University	Fang, W (corresponding author), Peking Union Med Coll, Cardiovasc Inst, Dept Nucl Med, Beijing 100021, Peoples R China.	tsenyuan@yahoo.com.cn; yang_minfu@yahoo.com.cn	Lu, Minjie/AAF-5091-2020; Zhao, Shihua/A-7553-2019; Yang, min-fu/K-7438-2014	Lu, Minjie/0000-0001-8696-318X; Zhao, Shihua/0000-0003-1339-7476; 				BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Chander A, 2008, J NUCL MED, V49, P1643, DOI 10.2967/jnumed.108.053819; Dilsizian V, 2009, J NUCL CARDIOL, V16, P651, DOI DOI 10.1007/S12350-009-9094-9; DULCE MC, 1993, RADIOLOGY, V188, P371, DOI 10.1148/radiology.188.2.8327680; Faber TL, 2001, J NUCL CARDIOL, V8, P645, DOI 10.1067/mnc.2001.117173; Gaemperli O, 2011, ANN NY ACAD SCI, V1228, P109, DOI 10.1111/j.1749-6632.2011.06030.x; GERMANO G, 1995, J NUCL MED, V36, P2138; Hesse B, 2008, EUR J NUCL MED MOL I, V35, P851, DOI 10.1007/s00259-007-0694-9; Hundley WG, 2010, CIRCULATION, V121, P2462, DOI 10.1161/CIR.0b013e3181d44a8f; Ioannidis JPA, 2002, J AM COLL CARDIOL, V39, P2059, DOI 10.1016/S0735-1097(02)01882-X; Iskandrian AE, 1998, J NUCL CARDIOL, V5, P574, DOI 10.1016/S1071-3581(98)90111-8; Khorsand A, 2005, J NUCL MED, V46, P2009; Kostkiewicz Magdalena, 2012, Przegl Lek, V69, P80; Kumita S, 2001, J NUCL CARDIOL, V8, P568, DOI 10.1067/mnc.2001.116853; Mahmarian JJ, 2006, J AM COLL CARDIOL, V48, P2448, DOI 10.1016/j.jacc.2006.07.069; McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Moon JCC, 2002, RADIOLOGY, V223, P789, DOI 10.1148/radiol.2233011181; Okazawa H, 2002, J NUCL MED, V43, P999; Sandstede J, 2000, EUR RADIOL, V10, P438, DOI 10.1007/s003300050072; Schaefer WM, 2005, J NUCL MED, V46, P1256; Schaefer WM, 2004, J NUCL MED, V45, P74; Schaefer WM, 2003, EUR J NUCL MED MOL I, V30, P545, DOI 10.1007/s00259-003-1123-3; Slart RHJA, 2004, J NUCL MED, V45, P176; STARLING MR, 1981, CIRCULATION, V63, P1075, DOI 10.1161/01.CIR.63.5.1075; VANDERWALL EE, 1995, CIRCULATION, V92, P2723, DOI 10.1161/01.CIR.92.9.2723; WACKERS FJT, 1979, AM J CARDIOL, V43, P1159, DOI 10.1016/0002-9149(79)90148-6; Wang F, 2009, EUR J NUCL MED MOL I, V36, P1611, DOI 10.1007/s00259-009-1136-7; Wang L, 2012, CLIN NUCL MED, V37, P1163, DOI 10.1097/RLU.0b013e3182708794; Wang L, 2013, ANN NUCL MED, V27, P325, DOI 10.1007/s12149-013-0691-y; WHITE HD, 1987, CIRCULATION, V76, P44, DOI 10.1161/01.CIR.76.1.44; Xie BQ, 2012, J NUCL MED, V53, P584, DOI 10.2967/jnumed.111.096057; Yamaguchi A, 1998, ANN THORAC SURG, V65, P434, DOI 10.1016/S0003-4975(97)01155-7; Yang MF, 2007, CLIN NUCL MED, V32, P685, DOI 10.1097/RLU.0b013e318123f7d2	34	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e80227	10.1371/journal.pone.0080227	http://dx.doi.org/10.1371/journal.pone.0080227			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404123	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460800002
J	Srinivasan, S; Threet, D; Worton, LE; Ausk, BJ; Bain, SD; Gardiner, EM; Kwon, RY; Gross, TS				Srinivasan, Sundar; Threet, Dewayne; Worton, Leah E.; Ausk, Brandon J.; Bain, Steven D.; Gardiner, Edith M.; Kwon, Ronald Y.; Gross, Ted S.			Distinct Cyclosporin A Doses Are Required to Enhance Bone Formation Induced by Cyclic and Rest-Inserted Loading in the Senescent Skeleton	PLOS ONE			English	Article							AGE-RELATED DECLINE; OSTEOGENIC RESPONSE; RECOVERY PERIODS; MAP KINASE; FLUID-FLOW; OSTEOPOROSIS; OSTEOBLASTS; CELLS; MECHANOTRANSDUCTION; MECHANOSENSITIVITY	Age-related decline in periosteal adaptation negatively impacts the ability to utilize exercise to enhance bone mass and strength in the elderly. We recently observed that in senescent animals subject to cyclically applied loading, supplementation with Cyclosporin A (CsA) substantially enhanced the periosteal bone formation rates to levels observed in young animals. We therefore speculated that if the CsA supplement could enhance bone response to a variety of types of mechanical stimuli, this approach could readily provide the means to expand the range of mild stimuli that are robustly osteogenic at senescence. Here, we specifically hypothesized that a given CsA supplement would enhance bone formation induced in the senescent skeleton by both cyclic (1-Hz) and rest-inserted loading (wherein a 10-s unloaded rest interval is inserted between each load cycle). To examine this hypothesis, the right tibiae of senescent female C57BL/6 mice (22 Mo) were subjected to cyclic or rest-inserted loading supplemented with CsA at 3.0 mg/kg. As previously, we initially found that while the periosteal bone formation rate (p. BFR) induced by cyclic loading was enhanced when supplemented with 3.0 mg/kg CsA (by 140%), the response to rest-inserted loading was not augmented at this CsA dosage. In follow-up experiments, we observed that while a 30-fold lower CsA dosage (0.1 mg/kg) significantly enhanced p. BFR induced by rest-inserted loading (by 102%), it was ineffective as a supplement with cyclic loading. Additional experiments and statistical analysis confirmed that the dose-response relations were significantly different for cyclic versus rest-inserted loading, only because the two stimuli required distinct CsA dosages for efficacy. While not anticipated a priori, clarifying the complexity underlying the observed interaction between CsA dosage and loading type holds potential for insight into how bone response to a broad range of mechanical stimuli may be substantially enhanced in the senescent skeleton.	[Srinivasan, Sundar; Threet, Dewayne; Worton, Leah E.; Ausk, Brandon J.; Bain, Steven D.; Gardiner, Edith M.; Kwon, Ronald Y.; Gross, Ted S.] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Srinivasan, S (corresponding author), Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA.	sundars@uw.edu			National Institutes of Health [AR056235, AR056652]; Sigvard T. Hansen, Jr. Endowed Chair; Zimmer Fracture Biology Professorship; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056235, R01AR056652] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sigvard T. Hansen, Jr. Endowed Chair; Zimmer Fracture Biology Professorship; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported, in part, by funding from the National Institutes of Health (SS: AR056235; TSG: AR056652), the Sigvard T. Hansen, Jr. Endowed Chair (TSG) and the Zimmer Fracture Biology Professorship (SDB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron R, 2012, J CLIN ENDOCR METAB, V97, P311, DOI 10.1210/jc.2011-2332; Bass SL, 2002, J BONE MINER RES, V17, P2274, DOI 10.1359/jbmr.2002.17.12.2274; Batra NN, 2005, J BIOMECH, V38, P1909, DOI 10.1016/j.jbiomech.2004.08.009; Belz RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033432; BRAIN P, 1989, WEED RES, V29, P93, DOI 10.1111/j.1365-3180.1989.tb00845.x; Brodt MD, 2010, J BONE MINER RES, V25, P2006, DOI 10.1002/jbmr.96; Calabrese EJ, 2008, BRIT J CLIN PHARMACO, V66, P594, DOI 10.1111/j.1365-2125.2008.03243.x; Case N, 2008, J BIOL CHEM, V283, P29196, DOI 10.1074/jbc.M801907200; Chong CR, 2007, NATURE, V448, P645, DOI 10.1038/448645a; Cooper C, 2006, OSTEOPOROSIS INT, V17, P337, DOI 10.1007/s00198-005-2039-5; del Arco PG, 2000, J BIOL CHEM, V275, P13872, DOI 10.1074/jbc.275.18.13872; Donahue SW, 2001, AM J PHYSIOL-CELL PH, V281, pC1635, DOI 10.1152/ajpcell.2001.281.5.C1635; Gross TS, 2002, J BONE MINER RES, V17, P493, DOI 10.1359/jbmr.2002.17.3.493; Hosking D, 1998, NEW ENGL J MED, V338, P485, DOI 10.1056/NEJM199802193380801; Karinkanta S, 2007, OSTEOPOROSIS INT, V18, P453, DOI 10.1007/s00198-006-0256-1; Klein-Nulend J, 2002, OSTEOPOROSIS INT, V13, P137, DOI 10.1007/s001980200005; Kukuljan S, 2011, J CLIN ENDOCRINOL ME; LaMothe JM, 2004, J APPL PHYSIOL, V96, P1788, DOI 10.1152/japplphysiol.01145.2003; Leppanen OV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002540; Manolagas SC, 2007, MOL ENDOCRINOL; Matsuda S, 2000, IMMUNOPHARMACOLOGY, V47, P119, DOI 10.1016/S0162-3109(00)00192-2; Mosley JR, 1998, BONE, V23, P313, DOI 10.1016/S8756-3282(98)00113-6; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Nikander R, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-47; Ozcivici E, 2010, NAT REV RHEUMATOL, V6, P50, DOI 10.1038/nrrheum.2009.239; Pahlavani MA, 1999, MECH AGEING DEV, V112, P59, DOI 10.1016/S0047-6374(99)00077-9; PAHLAVANI MA, 1995, CELL IMMUNOL, V165, P84, DOI 10.1006/cimm.1995.1190; Qin YX, 1998, J ORTHOPAED RES, V16, P482, DOI 10.1002/jor.1100160414; Riddle RC, 2006, AM J PHYSIOL-CELL PH, V290, pC776, DOI 10.1152/ajpcell.00082.2005; Robling AG, 2001, J EXP BIOL, V204, P3389; RUBIN CT, 1992, CALCIFIED TISSUE INT, V50, P306, DOI 10.1007/BF00301627; Seeman E, 2001, Rev Endocr Metab Disord, V2, P45; Sen B, 2009, J BIOL CHEM, V284, P34607, DOI 10.1074/jbc.M109.039453; Srinivasan S, 2003, BONE, V33, P946, DOI 10.1016/j.bone.2003.07.009; Srinivasan S, 2002, J BONE MINER RES, V17, P1613, DOI 10.1359/jbmr.2002.17.9.1613; Srinivasan S, 2007, J APPL PHYSIOL, V102, P1945, DOI 10.1152/japplphysiol.00507.2006; Srinivasan S, 2012, AGEING RES REV, V11, P353, DOI 10.1016/j.arr.2011.12.007; Srinivasan S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000924; Sugiyama T, 2008, BONE, V43, P238, DOI 10.1016/j.bone.2008.04.012; TURNER CH, 1995, J BONE MINER RES, V10, P1544; Umemura Y, 2002, J APPL PHYSIOL, V93, P1345, DOI 10.1152/japplphysiol.00358.2002; Worton LE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074205; Yeo H, 2007, BONE, V40, P1502, DOI 10.1016/j.bone.2007.02.017; You J, 2001, J BIOL CHEM, V276, P13365, DOI 10.1074/jbc.M009846200; Zar J. H., 1996, BIOSTATISTICAL ANAL	45	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84868	10.1371/journal.pone.0084868	http://dx.doi.org/10.1371/journal.pone.0084868			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404194	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460800073
J	Wu, JY; Cheng, CC; Wang, JY; Wu, DC; Hsieh, JS; Lee, SC; Wang, WM				Wu, Jeng-Yih; Cheng, Chun-Chia; Wang, Jaw-Yuan; Wu, Deng-Chyang; Hsieh, Jan-Sing; Lee, Shui-Cheng; Wang, Wen-Ming			Discovery of Tumor Markers for Gastric Cancer by Proteomics	PLOS ONE			English	Article							REGULATED PROTEINS GRP78; S-TRANSFERASE-PI; HEPATOCELLULAR-CARCINOMA; EXPRESSION; GRP94; ALPHA-1-ANTITRYPSIN; OVEREXPRESSION; EPITHELIUM; DIAGNOSIS; SURVIVAL	Gastric cancer (GC) has a high rate of morbidity and mortality among various cancers worldwide. The development of noninvasive diagnostic methods or technologies for tracking the occurrence of GC is urgent, and searching reliable biomarkers is considered. This study intended to directly discover differential biomarkers from GC tissues by two-dimension-differential gel electrophoresis (2D-DIGE), and further validate protein expression by western blotting (WB) and immunohistochemistry (IHC). Pairs of GC tissues (gastric cancer tissues and the adjacent normal tissues) obtained from surgery was investigated for 2D-DIEG. Five proteins were confirmed by WB and IHC, including glucose-regulated protein 78 (GRP78), glutathione s-transferase pi (GSTpi), apolipoprotein AI (ApoAI), alpha-1 antitrypsin (A1AT) and gastrokine-1 (GKN-1). Among the results, GRP78, GSTpi and A1AT were significantly up-regulated and down-regulated respectively in gastric cancer patients. Moreover, GRP78 and ApoAI were correlated with A1AT for protein expressions. This study presumes these proteins could be candidates of reliable biomarkers for gastric cancer.	[Wu, Jeng-Yih; Wang, Wen-Ming] Kaohsiung Municipal Tatung Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Wu, Jeng-Yih; Wu, Deng-Chyang; Lee, Shui-Cheng; Wang, Wen-Ming] Kaohsiung Med Univ Hosp, Div Gastroenterol, Dept Internal Med, Kaohsiung, Taiwan; [Wu, Jeng-Yih; Wu, Deng-Chyang; Wang, Wen-Ming] Kaohsiung Med Univ, Dept Med, Coll Med, Fac Med, Kaohsiung, Taiwan; [Cheng, Chun-Chia] Atom Energy Council, Inst Nucl Energy Res, Executive Yuan, Taiwan; [Wang, Jaw-Yuan; Hsieh, Jan-Sing] Kaohsiung Med Univ Hosp, Dept Surg, Kaohsiung, Taiwan; [Wu, Deng-Chyang] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Internal Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Institute of Nuclear Energy Research - Taiwan; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital	Wang, WM (corresponding author), Kaohsiung Municipal Tatung Hosp, Dept Internal Med, Kaohsiung, Taiwan.	d680027@kmu.edu.tw	Jaw-Yuan, Wang/AFS-8845-2022	Jaw-Yuan, Wang/0000-0002-7705-2621	National Science Council of Republic of China; Kaohsiung Medical University Hospital [KMUH97-7R32, KMUH98-8R33];  [NSC96-3111-P-042A-004-Y];  [NSC100-2314-B-037-040]	National Science Council of Republic of China(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University Hospital; ; 	This work was supported by grants NSC96-3111-P-042A-004-Y, NSC100-2314-B-037-040, and by National Science Council of Republic of China. This work was also supported by Kaohsiung Medical University Hospital (KMUH97-7R32, KMUH98-8R33). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai ZG, 2011, INT J ONCOL, V38, P375, DOI 10.3892/ijo.2010.873; Befeler AS, 2002, GASTROENTEROLOGY, V122, P1609, DOI 10.1053/gast.2002.33411; Berbee JFP, 2005, J ENDOTOXIN RES, V11, P97, DOI 10.1179/096805105X35215; BERNACKA K, 1988, CANCER, V62, P1188, DOI 10.1002/1097-0142(19880915)62:6<1188::AID-CNCR2820620624>3.0.CO;2-E; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Ferlay J, GLOBOCAN 2008 V2 0 C; Fock KM, 2008, J GASTROEN HEPATOL, V23, P351, DOI 10.1111/j.1440-1746.2008.05314.x; Howlader N, 2010, J NATL CANCER I, V102, P1584, DOI 10.1093/jnci/djq366; LACY ER, 1993, J CLIN GASTROENTEROL, V17, pS125, DOI 10.1097/00004836-199312001-00023; Langer R, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-70; Little Edward, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P1; Liu H, 1998, J BIOL CHEM, V273, P12858, DOI 10.1074/jbc.273.21.12858; Locker GY, 2006, J CLIN ONCOL, V24, P5313, DOI 10.1200/JCO.2006.08.2644; Miki K, 2003, AM J GASTROENTEROL, V98, P735, DOI 10.1016/S0002-9270(03)00128-X; Miki Kazumasa, 2006, Gastric Cancer, V9, P245, DOI 10.1007/s10120-006-0397-0; Monden N, 1997, ONCOLOGY-BASEL, V54, P391; Nasrollahzadeh D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026957; NIITSU Y, 1989, CANCER-AM CANCER SOC, V63, P317, DOI 10.1002/1097-0142(19890115)63:2<317::AID-CNCR2820630219>3.0.CO;2-P; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Podolsky DK, 1997, J GASTROENTEROL, V32, P122, DOI 10.1007/BF01213309; Pott GB, 2009, J LEUKOCYTE BIOL, V85, P886, DOI 10.1189/jlb.0208145; Rippa E, 2011, J CELL PHYSIOL, V226, P2571, DOI 10.1002/jcp.22601; Sant M, 1998, INT J CANCER, V77, P679, DOI 10.1002/(SICI)1097-0215(19980831)77:5<679::AID-IJC3>3.0.CO;2-S; Takahashi H, 2011, HISTOL HISTOPATHOL, V26, P663, DOI 10.14670/HH-26.663; Tall AR, 2008, J INTERN MED, V263, P256, DOI 10.1111/j.1365-2796.2007.01898.x; Tashiro A, 2006, WORLD J GASTROENTERO, V12, P4873; Torpy Janet M, 2010, JAMA, V303, P1771, DOI 10.1001/jama.303.17.1771; TSUTSUMI M, 1987, JPN J CANCER RES, V78, P631; Zhang J, 2006, CLIN EXP METASTAS, V23, P401, DOI 10.1007/s10585-006-9051-9	30	28	30	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84158	10.1371/journal.pone.0084158	http://dx.doi.org/10.1371/journal.pone.0084158			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404153	Green Submitted, Green Published, gold			2022-12-27	WOS:000329460800032
J	Ammendolia, MG; Iosi, F; De Berardis, B; Guccione, G; Superti, F; Conte, MP; Longhi, C				Ammendolia, Maria Grazia; Iosi, Francesca; De Berardis, Barbara; Guccione, Giuliana; Superti, Fabiana; Conte, Maria Pia; Longhi, Catia			Listeria monocytogenes Behaviour in Presence of Non-UV-Irradiated Titanium Dioxide Nanoparticles	PLOS ONE			English	Article							FOOD-CONTACT SURFACES; ESCHERICHIA-COLI; BIOFILM FORMATION; FECAL CARRIAGE; TIO2; PARTICLES; PHOTOCATALYSIS; MICROPARTICLES; TRANSLOCATION; DISINFECTION	Listeria monocytogenes is the agent of listeriosis, a food-borne disease. It represents a serious problem for the food industry because of its environmental persistence mainly due to its ability to form biofilm on a variety of surfaces. Microrganisms attached on the surfaces are a potential source of contamination for environment and animals and humans. Titanium dioxide nanoparticles (TiO2 NPs) are used in food industry in a variety of products and it was reported that daily exposure to these nanomaterials is very high. Anti-listerial activity of TiO2 NPs was investigated only with UV-irradiated nanomaterials, based on generation of reactive oxigen species (ROS) with antibacterial effect after UV exposure. Since both Listeria monocytogenes and TiO2 NPs are veicolated with foods, this study explores the interaction between Listeria monocytogenes and non UV-irradiated TiO2 NPs, with special focus on biofilm formation and intestinal cell interaction. Scanning electron microscopy and quantitative measurements of biofilm mass indicate that NPs influence both production and structural architecture of listerial biofilm. Moreover, TiO2 NPs show to interfere with bacterial interaction to intestinal cells. Increased biofilm production due to TiO2 NPs exposure may favour bacterial survival in environment and its transmission to animal and human hosts.	[Ammendolia, Maria Grazia; Iosi, Francesca; Superti, Fabiana] Ist Super Sanita, Dept Technol & Hlth, I-00161 Rome, Italy; [De Berardis, Barbara] Ist Super Sanita, Dept Environm & Primary Prevent, I-00161 Rome, Italy; [Guccione, Giuliana; Conte, Maria Pia; Longhi, Catia] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, I-00185 Rome, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Sapienza University Rome	Ammendolia, MG (corresponding author), Ist Super Sanita, Dept Technol & Hlth, Viale Regina Elena 299, I-00161 Rome, Italy.	maria.ammendolia@iss.it	AMMENDOLIA, MARIA GRAZIA/F-2101-2015; DE BERARDIS, BARBARA/F-2105-2015; Superti, Fabiana/F-2100-2015; IOSI, FRANCESCA/F-2106-2015	AMMENDOLIA, MARIA GRAZIA/0000-0003-4121-3005; Superti, Fabiana/0000-0003-4909-7598; IOSI, FRANCESCA/0000-0002-5929-6833; De Berardis, Barbara/0000-0001-7857-9620				Adams LK, 2006, WATER RES, V40, P3527, DOI 10.1016/j.watres.2006.08.004; Allerberger F, 2010, CLIN MICROBIOL INFEC, V16, P16, DOI 10.1111/j.1469-0691.2009.03109.x; Ashwood P, 2007, EXP BIOL MED, V232, P107; Baan R, 2006, LANCET ONCOL, V7, P295, DOI 10.1016/S1470-2045(06)70651-9; Bae HS, 2003, COLLOID SURFACE A, V220, P169, DOI 10.1016/S0927-7757(03)00077-3; Bockmann J, 2000, PHARMAZIE, V55, P140; Briandet R, 1999, APPL ENVIRON MICROB, V65, P5328; Butler M, 2007, INFLAMM RES, V56, P353, DOI 10.1007/s00011-007-7068-4; Carpentier B, 2011, INT J FOOD MICROBIOL, V145, P1, DOI 10.1016/j.ijfoodmicro.2011.01.005; Chase-Topping M, 2008, NAT REV MICROBIOL, V6, P904, DOI 10.1038/nrmicro2029; Chorianopoulos NG, 2011, FOOD MICROBIOL, V28, P164, DOI 10.1016/j.fm.2010.07.025; Corr S, 2006, MICROB PATHOGENESIS, V41, P241, DOI 10.1016/j.micpath.2006.08.003; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Di Bonaventura G, 2008, J APPL MICROBIOL, V104, P1552, DOI 10.1111/j.1365-2672.2007.03688.x; Doyle MP, 2006, POULTRY SCI, V85, P960, DOI 10.1093/ps/85.6.960; EFSA,, 2004, EFSA J, V163, P1, DOI [10.2903/j.efsa.2005.163, DOI 10.2903/J.EFSA.2005.163]; European Parliament C, 1994, COM94314, P13; Fernandez-Ibanez P, 2003, WATER RES, V37, P3180, DOI 10.1016/S0043-1354(03)00157-X; Folsom JP, 2006, J FOOD PROTECT, V69, P1292, DOI 10.4315/0362-028X-69.6.1292; Garcia-Del Portillo Francisco, 2012, Commun Integr Biol, V5, P160, DOI 10.4161/cib.18678; GARCIADELPORTILLO F, 1995, TRENDS MICROBIOL, V3, P373, DOI 10.1016/S0966-842X(00)88982-9; Gogniat G, 2006, FEMS MICROBIOL LETT, V258, P18, DOI 10.1111/j.1574-6968.2006.00190.x; Gounadaki AS, 2008, FOOD MICROBIOL, V25, P313, DOI 10.1016/j.fm.2007.10.001; Grif K, 2003, EUR J CLIN MICROBIOL, V22, P16, DOI 10.1007/s10096-002-0835-9; Gumy D, 2006, APPL CATAL B-ENVIRON, V63, P76, DOI 10.1016/j.apcatb.2005.09.013; Henry R, 2006, CELL MICROBIOL, V8, P107, DOI 10.1111/j.1462-5822.2005.00604.x; Ivaneka R, 2007, J THEOR BIOL, V245, P44, DOI 10.1016/j.jtbi.2006.09.031; JANI PU, 1994, INT J PHARM, V105, P157, DOI 10.1016/0378-5173(94)90461-8; Kim B, 2003, CHEMOSPHERE, V52, P277, DOI 10.1016/S0045-6535(03)00051-1; Kim S, 2013, WATER RES, V47, P4403, DOI 10.1016/j.watres.2013.05.009; Kim Y, 2009, J FOOD PROTECT, V72, P1916, DOI 10.4315/0362-028X-72.9.1916; KOCKS C, 1992, CELL, V68, P521, DOI 10.1016/0092-8674(92)90188-I; Koutsoumanis K, 2010, APPL ENVIRON MICROB, V76, P2181, DOI 10.1128/AEM.02430-09; LINSEBIGLER AL, 1995, CHEM REV, V95, P735, DOI 10.1021/cr00035a013; Lomer MCE, 2004, BRIT J NUTR, V92, P947, DOI 10.1079/BJN20041276; Lomer MCE, 2002, P NUTR SOC, V61, P123, DOI 10.1079/PNS2001134; Longhi C, 2003, INT J IMMUNOPATH PH, V16, P119, DOI 10.1177/039463200301600205; Longhi C, 2008, MICROB PATHOGENESIS, V45, P45, DOI 10.1016/j.micpath.2008.01.007; MACGOWAN AP, 1991, EPIDEMIOL INFECT, V106, P157, DOI 10.1017/S0950268800056521; MAFU AA, 1991, APPL ENVIRON MICROB, V57, P1969, DOI 10.1128/AEM.57.7.1969-1973.1991; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Myers JT, 2003, J IMMUNOL, V171, P5447, DOI 10.4049/jimmunol.171.10.5447; Pigeot-Remy S, 2011, APPL CATAL B-ENVIRON, V104, P390, DOI 10.1016/j.apcatb.2011.03.001; Poimenidou S, 2009, APPL ENVIRON MICROB, V75, P7182, DOI 10.1128/AEM.01359-09; Powell JJ, 2000, J AUTOIMMUN, V14, P99, DOI 10.1006/jaut.1999.0342; Rincon AG, 2004, APPL CATAL B-ENVIRON, V49, P99, DOI 10.1016/j.apcatb.2003.11.013; Simon-Deckers A, 2009, ENVIRON SCI TECHNOL, V43, P8423, DOI 10.1021/es9016975; Tassinari R, 2014, NANOTOXICOLOGY, V8, P654, DOI 10.3109/17435390.2013.822114; Tessema GT, 2009, APPL ENVIRON MICROB, V75, P6973, DOI 10.1128/AEM.00608-09; Travier L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003131; URBANSKI SJ, 1989, MODERN PATHOL, V2, P222; Wang JX, 2007, TOXICOL LETT, V168, P176, DOI 10.1016/j.toxlet.2006.12.001; Weir A, 2012, ENVIRON SCI TECHNOL, V46, P2242, DOI 10.1021/es204168d	54	24	25	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84986	10.1371/journal.pone.0084986	http://dx.doi.org/10.1371/journal.pone.0084986			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416327	Green Submitted, Green Published, gold			2022-12-27	WOS:000329866300046
J	Gayevskiy, V; Klaere, S; Knight, S; Goddard, MR				Gayevskiy, Velimir; Klaere, Steffen; Knight, Sarah; Goddard, Matthew R.			ObStruct: A Method to Objectively Analyse Factors Driving Population Structure Using Bayesian Ancestry Profiles	PLOS ONE			English	Article							GENE-FLOW; SPECIATION; INFERENCE; SOFTWARE	Bayesian inference methods are extensively used to detect the presence of population structure given genetic data. The primary output of software implementing these methods are ancestry profiles of sampled individuals. While these profiles robustly partition the data into subgroups, currently there is no objective method to determine whether the fixed factor of interest (e. g. geographic origin) correlates with inferred subgroups or not, and if so, which populations are driving this correlation. We present OBSTRUCT, a novel tool to objectively analyse the nature of structure revealed in Bayesian ancestry profiles using established statistical methods. OBSTRUCT evaluates the extent of structural similarity between sampled and inferred populations, tests the significance of population differentiation, provides information on the contribution of sampled and inferred populations to the observed structure and crucially determines whether the predetermined factor of interest correlates with inferred population structure. Analyses of simulated and experimental data highlight OBSTRUCT's ability to objectively assess the nature of structure in populations. We show the method is capable of capturing an increase in the level of structure with increasing time since divergence between simulated populations. Further, we applied the method to a highly structured dataset of 1,484 humans from seven continents and a less structured dataset of 179 Saccharomyces cerevisiae from three regions in New Zealand. Our results show that OBSTRUCT provides an objective metric to classify the degree, drivers and significance of inferred structure, as well as providing novel insights into the relationships between sampled populations, and adds a final step to the pipeline for population structure analyses.	[Gayevskiy, Velimir; Klaere, Steffen; Knight, Sarah; Goddard, Matthew R.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Klaere, Steffen] Univ Auckland, Dept Stat, Auckland 1, New Zealand	University of Auckland; University of Auckland	Gayevskiy, V (corresponding author), Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand.	v.gayevskiy@auckland.ac.nz	Goddard, Matthew/C-7462-2014	Goddard, Matthew/0000-0002-7482-4438; Knight, Sarah/0000-0002-9856-3615; Klaere, Steffen/0000-0002-4570-6109	Faculty of Science, University of Auckland	Faculty of Science, University of Auckland	This work was funded by a grant to MG by the Faculty of Science, University of Auckland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Charlesworth B, 1998, MOL BIOL EVOL, V15, P538, DOI 10.1093/oxfordjournals.molbev.a025953; Corander J, 2004, BIOINFORMATICS, V20, P2363, DOI 10.1093/bioinformatics/bth250; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Coyne J.A., 2004, SPECIATION; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2011, BIOINFORMATICS, V27, P1332, DOI 10.1093/bioinformatics/btr124; Friendly M, 2007, J COMPUT GRAPH STAT, V16, P421, DOI 10.1198/106186007x208407; Gao H, 2007, GENETICS, V176, P1635, DOI 10.1534/genetics.107.072371; Gayevskiy V, 2012, ISME J, V6, P1281, DOI 10.1038/ismej.2011.195; Gittins R., 1985, CANONICAL ANAL REV A; Gray JC, 2012, ECOL LETT, V15, P955, DOI 10.1111/j.1461-0248.2012.01814.x; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; McGovern PE, 2004, P NATL ACAD SCI USA, V101, P17593, DOI 10.1073/pnas.0407921102; Papadopulos AST, 2011, P NATL ACAD SCI USA, V108, P13188, DOI 10.1073/pnas.1106085108; Pritchard JK, 2000, GENETICS, V155, P945; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Smadja CM, 2011, MOL ECOL, V20, P5123, DOI 10.1111/j.1365-294X.2011.05350.x; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185	21	37	37	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85196	10.1371/journal.pone.0085196	http://dx.doi.org/10.1371/journal.pone.0085196			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416362	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000329866300054
J	Karaca, G; Swiderska-Syn, M; Xie, GH; Syn, WK; Kruger, L; Machado, MV; Garman, K; Choi, SS; Michelotti, GA; Burkly, LC; Ochoa, B; Diehl, AM				Karaca, Gamze; Swiderska-Syn, Marzena; Xie, Guanhua; Syn, Wing-Kin; Krueger, Leandi; Machado, Mariana Verdelho; Garman, Katherine; Choi, Steve S.; Michelotti, Gregory A.; Burkly, Linda C.; Ochoa, Begona; Diehl, Anna Mae			TWEAK/Fn14 Signaling Is Required for Liver Regeneration after Partial Hepatectomy in Mice	PLOS ONE			English	Article							PROGENITOR CELLS; STEM-CELLS; DRIVEN	Background & Aims: Pro-inflammatory cytokines are important for liver regeneration after partial hepatectomy (PH). Expression of Fibroblast growth factor-inducible 14 (Fn14), the receptor for TNF-like weak inducer of apoptosis (TWEAK), is induced rapidly after PH and remains elevated throughout the period of peak hepatocyte replication. The role of Fn14 in post-PH liver regeneration is uncertain because Fn14 is expressed by liver progenitors and TWEAK-Fn14 interactions stimulate progenitor growth, but replication of mature hepatocytes is thought to drive liver regeneration after PH. Methods: To clarify the role of TWEAK-Fn14 after PH, we compared post-PH regenerative responses in wild type (WT) mice, Fn14 knockout (KO) mice, TWEAK KO mice, and WT mice treated with anti-TWEAK antibodies. Results: In WT mice, rare Fn14(+) cells localized with other progenitor markers in peri-portal areas before PH. PH rapidly increased proliferation of Fn14(+) cells; hepatocytic cells that expressed Fn14 and other progenitor markers, such as Lgr5, progressively accumulated from 12-8 h post-PH and then declined to baseline by 96 h. When TWEAK/Fn14 signaling was disrupted, progenitor accumulation, induction of pro-regenerative cytokines, hepatocyte and cholangiocyte proliferation, and over-all survival were inhibited, while post-PH liver damage and bilirubin levels were increased. TWEAK stimulated proliferation and increased Lgr5 expression in cultured liver progenitors, but had no effect on either parameter in cultured primary hepatocytes. Conclusions: TWEAK-FN14 signaling is necessary for the healthy adult liver to regenerate normally after acute partial hepatectomy.	[Karaca, Gamze; Swiderska-Syn, Marzena; Xie, Guanhua; Krueger, Leandi; Machado, Mariana Verdelho; Garman, Katherine; Choi, Steve S.; Michelotti, Gregory A.; Diehl, Anna Mae] Duke Univ, Med Ctr, Dept Med, Div Gastroenterol, Durham, NC 27710 USA; [Syn, Wing-Kin] Fdn Liver Res, Inst Hepatol, Regenerat & Repair Grp, London, England; [Syn, Wing-Kin] Barts Hlth NHS Trust, Dept Hepatol, London, England; [Burkly, Linda C.] Biogen Idec Inc, Dept Exploratory Sci, Cambridge, MA USA; [Burkly, Linda C.] Biogen Idec Inc, Dept Discovery Biol, Cambridge, MA USA; [Burkly, Linda C.] Biogen Idec Inc, Dept Validat Biol, Cambridge, MA USA; [Ochoa, Begona] Univ Basque Country, Fac Med, Dept Physiol, Bilbao, Spain	Duke University; University of London; University College London; Barts Health NHS Trust; Biogen; Biogen; Biogen; University of Basque Country	Diehl, AM (corresponding author), Duke Univ, Med Ctr, Dept Med, Div Gastroenterol, Durham, NC 27710 USA.	diehl004@mc.duke.edu	Choi, Steve/GZH-1598-2022; Syn, Wing-Kin/AAB-8406-2020; Ochoa, Begona/K-9123-2014	Ochoa, Begona/0000-0002-1580-7160; , Gregory/0000-0002-3936-4675	 [R37 AA010154];  [R01 DK077794]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007568, R01DK077794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA010154] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by R37 AA010154 and R01 DK077794 (to AMD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affo S, 2013, GUT, V62, P452, DOI 10.1136/gutjnl-2011-301146; Bird TG, 2013, P NATL ACAD SCI USA, V110, P6542, DOI 10.1073/pnas.1302168110; Campbell S, 2006, J IMMUNOL, V176, P1889, DOI 10.4049/jimmunol.176.3.1889; Fausto N, 2004, HEPATOLOGY, V39, P1477, DOI 10.1002/hep.20214; Feng SLY, 2000, AM J PATHOL, V156, P1253, DOI 10.1016/S0002-9440(10)64996-6; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Jakubowski A, 2005, J CLIN INVEST, V115, P2330, DOI 10.1172/JCI23486; Komuta M, 2008, HEPATOLOGY, V47, P1544, DOI 10.1002/hep.22238; Kuramitsu K, 2013, AM J PATHOL, V183, P182, DOI 10.1016/j.ajpath.2013.03.018; Kuramitsu K, 2011, HEPATOLOGY, V53, P2016, DOI 10.1002/hep.24317; Kuwahara R, 2008, HEPATOLOGY, V47, P1994, DOI 10.1002/hep.22218; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Michalopoulos GK, 2011, INT J BIOCHEM CELL B, V43, P173, DOI 10.1016/j.biocel.2009.09.014; Michelotti GA, 2013, J CLIN INVEST; Ochoa B, 2010, HEPATOLOGY, V51, P1712, DOI 10.1002/hep.23525; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; SWIDERSKASYN M, 2013, GUT; Tirnitz-Parker JEE, 2010, HEPATOLOGY, V52, P291, DOI 10.1002/hep.23663; Xie G, 2013, HEPATOLOGY	19	45	47	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e83987	10.1371/journal.pone.0083987	http://dx.doi.org/10.1371/journal.pone.0083987			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416188	Green Published, gold, Green Submitted			2022-12-27	WOS:000329866300018
J	Sommer, F; Adam, N; Johansson, MEV; Xia, LJ; Hansson, GC; Backhed, F				Sommer, Felix; Adam, Nina; Johansson, Malin E. V.; Xia, Lijun; Hansson, Gunnar C.; Backhed, Fredrik			Altered Mucus Glycosylation in Core 1 O-Glycan-Deficient Mice Affects Microbiota Composition and Intestinal Architecture	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; GUT MICROBIOTA; GERM-FREE; MUCIN; CELLS; EXTRACTION; DNA; INFLAMMATION; EXPRESSION; BACTERIA	A functional mucus layer is a key requirement for gastrointestinal health as it serves as a barrier against bacterial invasion and subsequent inflammation. Recent findings suggest that mucus composition may pose an important selection pressure on the gut microbiota and that altered mucus thickness or properties such as glycosylation lead to intestinal inflammation dependent on bacteria. Here we used TM-IEC C1galt(-/-) mice, which carry an inducible deficiency of core 1-derived O-glycans in intestinal epithelial cells, to investigate the effects of mucus glycosylation on susceptibility to intestinal inflammation, gut microbial ecology and host physiology. We found that TM-IEC C1galt(-/-) mice did not develop spontaneous colitis, but they were more susceptible to dextran sodium sulphate-induced colitis. Furthermore, loss of core 1-derived O-glycans induced inverse shifts in the abundance of the phyla Bacteroidetes and Firmicutes. We also found that mucus glycosylation impacts intestinal architecture as TM-IEC C1galt(-/-) mice had an elongated gastrointestinal tract with deeper ileal crypts, a small increase in the number of proliferative epithelial cells and thicker circular muscle layers in both the ileum and colon. Alterations in the length of the gastrointestinal tract were partly dependent on the microbiota. Thus, the mucus layer plays a role in the regulation of gut microbiota composition, balancing intestinal inflammation, and affects gut architecture.	[Sommer, Felix; Adam, Nina; Backhed, Fredrik] Univ Gothenburg, Wallenberg Lab, Gothenburg, Sweden; [Sommer, Felix; Adam, Nina; Backhed, Fredrik] Univ Gothenburg, Sahlgrenska Ctr Cardiovasc & Metab Res, Dept Mol & Clin Med, Gothenburg, Sweden; [Sommer, Felix; Johansson, Malin E. V.; Hansson, Gunnar C.] Univ Gothenburg, Dept Med Biochem, Mucin Biol Grp, Gothenburg, Sweden; [Xia, Lijun] Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; [Backhed, Fredrik] Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn, Ctr Basic Metab Res,Sect Metab Receptol & Enteroe, Copenhagen, Denmark	University of Gothenburg; University of Gothenburg; University of Gothenburg; Oklahoma Medical Research Foundation; Novo Nordisk Foundation; University of Copenhagen	Hansson, GC (corresponding author), Univ Gothenburg, Dept Med Biochem, Mucin Biol Grp, Gothenburg, Sweden.	gunnar.hansson@medkem.gu.se; fredrik.backhed@wlab.gu.se	Hansson, Gunnar C/A-1236-2009; Sommer, Felix/I-1706-2017; Johansson, Malin E. V./HCH-7451-2022; Sommer, Felix/AAL-1746-2020; Hansson, Gunnar C./AAF-7324-2019; Backhed, Fredrik/ABE-6613-2020	Hansson, Gunnar C/0000-0002-1900-1869; Sommer, Felix/0000-0002-6545-3487; Sommer, Felix/0000-0002-6545-3487; Hansson, Gunnar C./0000-0002-1900-1869; Backhed, Fredrik/0000-0002-4871-8818; Johansson, Malin E. V./0000-0002-4237-6677	Swedish Research Council; Torsten Soderberg foundation; Ragnar Soderberg foundation; IngaBritt and Arne Lundberg's foundation; Swedish Foundation for Strategic Research - The Mucus-Bacteria-Colitis Center (MBC); Knut and Alice Wallenberg foundation; National Institute of Health [U01AI095473, R01DK085691]; Region Vastra Gotaland; Sahlgrenska University Hospital; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095473] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085691] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Torsten Soderberg foundation; Ragnar Soderberg foundation; IngaBritt and Arne Lundberg's foundation; Swedish Foundation for Strategic Research - The Mucus-Bacteria-Colitis Center (MBC)(Swedish Foundation for Strategic Research); Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Region Vastra Gotaland; Sahlgrenska University Hospital; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the Swedish Research Council, Torsten and Ragnar Soderbergs' foundations, IngaBritt and Arne Lundberg's foundation, Swedish Foundation for Strategic Research - The Mucus-Bacteria-Colitis Center (MBC), Knut and Alice Wallenberg foundation, National Institute of Health (U01AI095473, R01DK085691), and the regional agreement on medical training and clinical research (ALF) between Region Vastra Gotaland and Sahlgrenska University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS GD, 1963, LAB INVEST, V12, P355; An GY, 2007, J EXP MED, V204, P1417, DOI 10.1084/jem.20061929; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Crawford PA, 2005, P NATL ACAD SCI USA, V102, P13254, DOI 10.1073/pnas.0504830102; Derrien M, 2010, GUT MICROBES, V1, P254, DOI 10.4161/gmic.1.4.12778; Fu JX, 2011, J CLIN INVEST, V121, P1657, DOI 10.1172/JCI45538; Fuhrer A, 2010, J EXP MED, V207, P2843, DOI 10.1084/jem.20101098; Graham ML, 2011, COMPARATIVE MED, V61, P356; GUM JR, 1994, J BIOL CHEM, V269, P2440; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Jeffery IB, 2012, GUT, V61, P997, DOI 10.1136/gutjnl-2011-301501; Jensen PH, 2010, FEBS J, V277, P81, DOI 10.1111/j.1742-4658.2009.07429.x; Johansson M. E. V., 2013, NAT REV GASTROENTERO; Johansson MEV, 2011, CELL MOL LIFE SCI, V68, P3635, DOI 10.1007/s00018-011-0822-3; Johansson MEV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012238; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Johansson ME, 2013, GUT; Juge N, 2012, TRENDS MICROBIOL, V20, P30, DOI 10.1016/j.tim.2011.10.001; Kashyap PC, 2013, P NATL ACAD SCI USA, V110, P17059, DOI 10.1073/pnas.1306070110; Kim JJ, 2013, J IMMUNOL, V190, P4795, DOI 10.4049/jimmunol.1201887; Kleiveland CR, 2013, APPL ENVIRON MICROB, V79, P48, DOI 10.1128/AEM.02464-12; Kriegel MA, 2011, P NATL ACAD SCI USA, V108, P11548, DOI 10.1073/pnas.1108924108; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Larsson JMH, 2009, GLYCOBIOLOGY, V19, P756, DOI 10.1093/glycob/cwp048; MANDEL U, 1991, J INVEST DERMATOL, V97, P713, DOI 10.1111/1523-1747.ep12484064; Nylund L, 2010, J MICROBIOL METH, V83, P231, DOI 10.1016/j.mimet.2010.09.003; Quigley EMM, 2012, J CLIN GASTROENTEROL, V46, P356, DOI 10.1097/MCG.0b013e318247157c; Rausch P, 2011, P NATL ACAD SCI USA, V108, P19030, DOI 10.1073/pnas.1106408108; Reinhardt C, 2012, NATURE, V483, P627, DOI 10.1038/nature10893; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; SAVAGE DC, 1981, APPL ENVIRON MICROB, V42, P996, DOI 10.1128/AEM.42.6.996-1001.1981; Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Sperandio B, 2013, INFECT IMMUN, V81, P3632, DOI 10.1128/IAI.00551-13; Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299; Staubach F, 2012, ISME J, V6, P1345, DOI 10.1038/ismej.2011.204; Thomsson KA, 2012, GLYCOBIOLOGY, V22, P1128, DOI 10.1093/glycob/cws083; Tornblom H, 2002, GASTROENTEROLOGY, V123, P1972, DOI 10.1053/gast.2002.37059; Ubeda C, 2012, J EXP MED, V209, P1445, DOI 10.1084/jem.20120504; Wrzosek L, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-61; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04	42	89	90	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85254	10.1371/journal.pone.0085254	http://dx.doi.org/10.1371/journal.pone.0085254			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416370	gold, Green Published, Green Submitted			2022-12-27	WOS:000329866300059
J	Brycki, B; Szulc, A				Brycki, Bogumil; Szulc, Adrianna			Gemini Alkyldeoxy-D-Glucitolammonium Salts as Modern Surfactants and Microbiocides: Synthesis, Antimicrobial and Surface Activity, Biodegradation	PLOS ONE			English	Article							TO-MICELLE TRANSITION; CATIONIC SURFACTANTS; ANTIFUNGAL ACTIVITY; PH; GLUCAMINES; BEHAVIOR	Dimeric quaternary alkylammonium salts possess a favourable surface and antimicrobial activity. In this paper we describe synthesis, spectroscopic analysis, surface and antimicrobial activity as well as biodegradability of polymethylene-alpha, omega-bis(N,N-dialkyl-N-deoxy-D-glucitolammonium iodides), a new group of dimeric quaternary ammonium salts. This new group of gemini surfactants can be produced from chemicals which come from renewable sources. The structure of products has been determined by the FTIR and H-1 and C-13 NMR spectroscopy. The biodegradability, surface activity and antimicrobial efficacy against Escherichia coli, Staphylococcus aureus, Candida albicans, Aspergillus niger and Penicillium chrysogenum were determined. The influence of the number of alkyl chains and their lengths on surface and antimicrobial properties has been shown. In general, dimeric quaternary alkyldeoxy-D-glucitolammonium salts with long alkyl substituents show favourable surface properties and an excellent antimicrobial activity.	[Brycki, Bogumil; Szulc, Adrianna] Adam Mickiewicz Univ, Fac Chem, Lab Microbiocides Chem, PL-60780 Poznan, Poland	Adam Mickiewicz University	Brycki, B (corresponding author), Adam Mickiewicz Univ, Fac Chem, Lab Microbiocides Chem, Grunwaldzka 6, PL-60780 Poznan, Poland.	brycki@amu.edu.pl		Brycki, Bogumil/0000-0002-5659-9847	International Project DPN/N [172/CHINA/2009]	International Project DPN/N	This work was supported by the funds International Project DPN/N 172/CHINA/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, OECD GUIDELINE TESTI; Banno T, 2010, J SURFACTANTS DETERG, V13, P387, DOI 10.1007/s11743-010-1224-5; Banno T, 2009, J SURFACTANTS DETERG, V12, P249, DOI 10.1007/s11743-009-1119-5; Bell PC, 2003, J AM CHEM SOC, V125, P1551, DOI 10.1021/ja020707g; BORCH RF, 1971, J AM CHEM SOC, V93, P2897, DOI 10.1021/ja00741a013; Brycki B, 2012, J MOL STRUCT, V1020, P41, DOI 10.1016/j.molstruc.2012.03.035; Brycki B, 2010, POL J MICROBIOL, V59, P227, DOI 10.33073/pjm-2010-035; Brycki B, 2011, MOLECULES, V16, P319, DOI 10.3390/molecules16010319; DIZ M, 1994, J CHEM SOC PERK T 2, P1871, DOI 10.1039/p29940001871; Fielden ML, 2001, EUR J BIOCHEM, V268, P1269, DOI 10.1046/j.1432-1327.2001.01995.x; Hait SK, 2002, CURR SCI INDIA, V82, P1101; Holmberg K., 2003, SURFACTANTS POLYM AQ; In M, 2001, SURF SCI SERIES, V100, P59; Johnsson M, 2003, LANGMUIR, V19, P4609, DOI 10.1021/la0343270; Kirby AJ, 2003, ANGEW CHEM INT EDIT, V42, P1448, DOI 10.1002/anie.200201597; Kuperkar K, 2012, J SURFACTANTS DETERG, V15, P107, DOI 10.1007/s11743-011-1269-0; Laatiris A, 2008, MICROBIOL RES, V163, P645, DOI 10.1016/j.micres.2006.09.006; Lambert PA, 2013, RUSSELL HUGO AYLIFFE; Laska U, 2006, J SURFACTANTS DETERG, V9, P115, DOI 10.1007/s11743-006-0380-0; Mayers D, 2006, SURFACTANT SCI TECHN; Menger FM, 2000, ANGEW CHEM INT EDIT, V39, P1907; MENGER FM, 1991, J AM CHEM SOC, V113, P1451, DOI 10.1021/ja00004a077; Ng CKL, 2006, J MED CHEM, V49, P811, DOI 10.1021/jm0508843; Para G, 2010, COLLOID SURFACE A, V365, P215, DOI 10.1016/j.colsurfa.2010.02.004; Pestman JM, 1997, LANGMUIR, V13, P6857, DOI 10.1021/la970681k; Pisarcik M., 2003, ACTA FACULT PHARM U, V50, P119; Rosen MJ, 2012, SURFACTANTS AND INTERFACIAL PHENOMENA, 4TH EDITION, P1, DOI 10.1002/9781118228920; Schramm LL, 2003, ANN RP CH C, V99, P3, DOI 10.1039/b208499f; Shukla D, 2006, J OLEO SCI, V55, P381, DOI DOI 10.5650/JOS.55.381; Takagi Y, 2004, SURF SCI CRC, V123, P129; Van Ginkel CG, 2004, HDB DETERGENTS B; Wagenaar A, 2007, TETRAHEDRON, V63, P10622, DOI 10.1016/j.tet.2007.08.023; Walker EB, 2003, HDB TOPICAL ANTIMICR; Warwel S, 2004, J SURFACTANTS DETERG, V7, P181, DOI 10.1007/s11743-004-0302-1; Warwel S, 2004, J SURFACTANTS DETERG, V7, P187, DOI 10.1007/s11743-004-0303-0; Wasungu L, 2006, BBA-BIOMEMBRANES, V1758, P1677, DOI 10.1016/j.bbamem.2006.06.019; Wasungu L, 2006, J MOL MED-JMM, V84, P774, DOI 10.1007/s00109-006-0067-z; Zana R., 2003, GEMINI SURFACTANTS S	38	22	22	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84936	10.1371/journal.pone.0084936	http://dx.doi.org/10.1371/journal.pone.0084936			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416314	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500191
J	Gong, PC; Zhao, M; He, CY				Gong, Pichang; Zhao, Man; He, Chaoying			Slow Co-Evolution of the MAGO and Y14 Protein Families Is Required for the Maintenance of Their Obligate Heterodimerization Mode	PLOS ONE			English	Article							EXON JUNCTION COMPLEX; OSKAR MESSENGER-RNA; EVOLUTIONARY RATE; BINDING PROTEIN; NASHI; GENE; OOCYTE; INTERACTS; SUBSTITUTION; DIFFERENTIATION	The exon junction complex (EJC) plays important roles in RNA metabolisms and the development of eukaryotic organisms. MAGO (short form of MAGO NASHI) and Y14 (also Tsunagi or RBM8) are the EJC core components. Their biological roles have been well investigated in various species, but the evolutionary patterns of the two gene families and their protein-protein interactions are poorly known. Genome-wide survey suggested that the MAGO and Y14 two gene families originated in eukaryotic organisms with the maintenance of a low copy. We found that the two protein families evolved slowly; however, the MAGO family under stringent purifying selection evolved more slowly than the Y14 family that was under relative relaxed purifying selection. MAGO and Y14 were obliged to form heterodimer in a eukaryotic organism, and this obligate mode was plesiomorphic. Lack of binding of MAGO to Y14 as functional barrier was observed only among distantly species, suggesting that a slow co-evolution of the two protein families. Inter-protein co-evolutionary signal was further quantified in analyses of the Tol-MirroTree and co-evolution analysis using protein sequences. About 20% of the 41 significantly correlated mutation groups (involving 97 residues) predicted between the two families was clade-specific. Moreover, around half of the predicted co-evolved groups and nearly all clade-specific residues fell into the minimal interaction domains of the two protein families. The mutagenesis effects of the clade-specific residues strengthened that the co-evolution is required for obligate MAGO-Y14 heterodimerization mode. In turn, the obliged heterodimerization in an organism serves as a strong functional constraint for the co-evolution of the MAGO and Y14 families. Such a co-evolution allows maintaining the interaction between the proteins through large evolutionary time scales. Our work shed a light on functional evolution of the EJC genes in eukaryotes, and facilitates to understand the co-evolutionary processes among protein families.	[Gong, Pichang; Zhao, Man; He, Chaoying] Chinese Acad Sci, State Key Lab Systemat & Evolutionary Bot, Inst Bot, Beijing, Peoples R China; [Gong, Pichang; Zhao, Man] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	He, CY (corresponding author), Chinese Acad Sci, State Key Lab Systemat & Evolutionary Bot, Inst Bot, Beijing, Peoples R China.	chaoying@ibcas.ac.cn	Gong, Pichang/GVT-9910-2022	Gong, Pichang/0000-0003-3322-9525	Chinese Ministry of Agriculture Transgenic Major Project [2009ZX08009-011B]; Chinese Academy of Sciences	Chinese Ministry of Agriculture Transgenic Major Project; Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by a grant (2009ZX08009-011B) from the Chinese Ministry of Agriculture Transgenic Major Project and by Hundred Talents Project of the Chinese Academy of Sciences to CYH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi CA, 2012, J GENET GENOMICS, V39, P157, DOI 10.1016/j.jgg.2012.02.008; Ashton-Beaucage D, 2010, CELL, V143, P251, DOI 10.1016/j.cell.2010.09.014; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Boothby TC, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-45; Burton RS, 1999, AM ZOOL, V39, P451; Chen YR, 2007, TREE PHYSIOL, V27, P1261, DOI 10.1093/treephys/27.9.1261; Chu FH, 2009, MYCOL RES, V113, P577, DOI 10.1016/j.mycres.2009.01.012; Clark NL, 2010, MOL BIOL EVOL, V27, P1152, DOI 10.1093/molbev/msp324; Clark NL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000570; de Juan D, 2013, NAT REV GENET, V14, P249, DOI 10.1038/nrg3414; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Fares MA, 2006, GENETICS, V173, P9, DOI 10.1534/genetics.105.053249; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Fraser HB, 2004, P NATL ACAD SCI USA, V101, P9033, DOI 10.1073/pnas.0402591101; Fraser HB, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-11; Fribourg S, 2003, NAT STRUCT BIOL, V10, P433, DOI 10.1038/nsb926; Fryxell KJ, 1996, TRENDS GENET, V12, P364, DOI 10.1016/S0168-9525(96)80020-5; Goh CS, 2000, J MOL BIOL, V299, P283, DOI 10.1006/jmbi.2000.3732; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haag ES, 2002, CURR BIOL, V12, P2035, DOI 10.1016/S0960-9822(02)01333-7; Hachet O, 2001, CURR BIOL, V11, P1666, DOI 10.1016/S0960-9822(01)00508-5; He CY, 2007, MOL BIOL EVOL, V24, P1229, DOI 10.1093/molbev/msm041; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Inaki M, 2011, GENES CELLS, V16, P166, DOI 10.1111/j.1365-2443.2010.01479.x; Jelinska C, 2005, STRUCTURE, V13, P963, DOI 10.1016/j.str.2005.04.016; Johnson MA, 2004, GENETICS, V168, P971, DOI 10.1534/genetics.104.029447; Kataoka N, 2001, EMBO J, V20, P6424, DOI 10.1093/emboj/20.22.6424; Kataoka N, 2000, MOL CELL, V6, P673, DOI 10.1016/S1097-2765(00)00065-4; Kawano T, 2004, MECH DEVELOP, V121, P27, DOI 10.1016/j.mod.2003.11.003; Kim VN, 2001, EMBO J, V20, P2062, DOI 10.1093/emboj/20.8.2062; Lau CK, 2003, CURR BIOL, V13, P933, DOI 10.1016/S0960-9822(03)00328-2; Le Hir H, 2001, EMBO REP, V2, P1119, DOI 10.1093/embo-reports/kve245; Lee HC, 2009, BIOCHEM BIOPH RES CO, V384, P334, DOI 10.1016/j.bbrc.2009.04.123; Lenser T, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000264; Lewandowski JP, 2010, DEV BIOL, V339, P307, DOI 10.1016/j.ydbio.2009.12.035; Li WQ, 2000, DEV BIOL, V218, P172, DOI 10.1006/dbio.1999.9593; Liu MA, 2010, PARASITOL RES, V107, P615, DOI 10.1007/s00436-010-1904-0; Micklem DR, 1997, CURR BIOL, V7, P468, DOI 10.1016/S0960-9822(06)00218-1; Mohr SE, 2001, GENE DEV, V15, P2886; Mufarrege EF, 2011, J EXP BOT, V62, P5025, DOI 10.1093/jxb/err202; NEWMARK PA, 1994, DEVELOPMENT, V120, P1303; Newmark PA, 1997, DEVELOPMENT, V124, P3197; Palacios IM, 2004, NATURE, V427, P753, DOI 10.1038/nature02351; Park NI, 2007, PLANTA, V225, P625, DOI 10.1007/s00425-006-0385-y; Park NI, 2009, PLANT SCI, V176, P461, DOI 10.1016/j.plantsci.2008.12.016; Parma DH, 2007, DEV BIOL, V308, P507, DOI 10.1016/j.ydbio.2007.06.007; Pazos F, 2005, J MOL BIOL, V352, P1002, DOI 10.1016/j.jmb.2005.07.005; Pazos F, 2008, EMBO J, V27, P2648, DOI 10.1038/emboj.2008.189; Rodionov A, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-17; Roignant JY, 2010, CELL, V143, P238, DOI 10.1016/j.cell.2010.09.036; Saeed R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-128; Sandler I, 2013, MOL BIOSYST, V9, P175, DOI 10.1039/c2mb25317h; Shi H, 2003, GENE DEV, V17, P971, DOI 10.1101/gad.260403; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD., 1994, COEVOLUTIONARY PROCE; van der Weele CM, 2007, MOL BIOL CELL, V18, P3711, DOI 10.1091/mbc.E06-11-0979; WEIGEL D, 1992, CELL, V69, P843, DOI 10.1016/0092-8674(92)90295-N; Winter KU, 2002, MOL BIOL EVOL, V19, P587, DOI 10.1093/oxfordjournals.molbev.a004118; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zamir L, 2012, P NATL ACAD SCI USA, V109, pE406, DOI 10.1073/pnas.1108633109; Zhao XF, 2000, GENOMICS, V63, P145, DOI 10.1006/geno.1999.6064	64	20	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84842	10.1371/journal.pone.0084842	http://dx.doi.org/10.1371/journal.pone.0084842			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416299	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500179
J	Harrop, TWR; Sztal, T; Lumb, C; Good, RT; Daborn, PJ; Batterham, P; Chung, H				Harrop, Thomas W. R.; Sztal, Tamar; Lumb, Christopher; Good, Robert T.; Daborn, Phillip J.; Batterham, Philip; Chung, Henry			Evolutionary Changes in Gene Expression, Coding Sequence and Copy-Number at the Cyp6g1 Locus Contribute to Resistance to Multiple Insecticides in Drosophila	PLOS ONE			English	Article							MELANOGASTER CYTOCHROME-P450 GENES; DETOXIFICATION GENE; CROSS-RESISTANCE; OVER-EXPRESSION; ESTERASE GENE; METABOLISM; AMPLIFICATION; PHYLOGENY; INDUCTION; ELEMENTS	Widespread use of insecticides has led to insecticide resistance in many populations of insects. In some populations, resistance has evolved to multiple pesticides. In Drosophila melanogaster, resistance to multiple classes of insecticide is due to the overexpression of a single cytochrome P450 gene, Cyp6g1. Overexpression of Cyp6g1 appears to have evolved in parallel in Drosophila simulans, a sibling species of D. melanogaster, where it is also associated with insecticide resistance. However, it is not known whether the ability of the CYP6G1 enzyme to provide resistance to multiple insecticides evolved recently in D. melanogaster or if this function is present in all Drosophila species. Here we show that duplication of the Cyp6g1 gene occurred at least four times during the evolution of different Drosophila species, and the ability of CYP6G1 to confer resistance to multiple insecticides exists in D. melanogaster and D. simulans but not in Drosophila willistoni or Drosophila virilis. In D. virilis, which has multiple copies of Cyp6g1, one copy confers resistance to DDT and another to nitenpyram, suggesting that the divergence of protein sequence between copies subsequent to the duplication affected the activity of the enzyme. All orthologs tested conferred resistance to one or more insecticides, suggesting that CYP6G1 had the capacity to provide resistance to anthropogenic chemicals before they existed. Finally, we show that expression of Cyp6g1 in the Malpighian tubules, which contributes to DDT resistance in D. melanogaster, is specific to the D. melanogaster-D. simulans lineage. Our results suggest that a combination of gene duplication, regulatory changes and protein coding changes has taken place at the Cyp6g1 locus during evolution and this locus may play a role in providing resistance to different environmental toxins in different Drosophila species.	[Harrop, Thomas W. R.; Sztal, Tamar; Lumb, Christopher; Good, Robert T.; Daborn, Phillip J.; Batterham, Philip; Chung, Henry] Univ Melbourne, Dept Genet, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic, Australia; [Sztal, Tamar] Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia; [Chung, Henry] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI USA; [Chung, Henry] Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA	University of Melbourne; Monash University; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Batterham, P (corresponding author), Univ Melbourne, Dept Genet, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic, Australia.	p.batterham@unimelb.edu.au; hwchung@wisc.edu	Harrop, Thomas/G-4024-2016; Chung, Henry/C-9374-2014; Batterham, Philip/G-5914-2012	Harrop, Thomas/0000-0001-6557-0440; Chung, Henry/0000-0001-5056-2755; Batterham, Philip/0000-0001-9840-9119; Sztal, Tamar/0000-0001-9745-3580	Australian Research Council	Australian Research Council(Australian Research Council)	Australian Research Council for funding support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Chung H, 2007, GENETICS, V175, P1071, DOI 10.1534/genetics.106.066597; Chung H, 2011, INSECT BIOCHEM MOLEC, V41, P863, DOI 10.1016/j.ibmb.2011.07.002; Chung H, 2009, P NATL ACAD SCI USA, V106, P5731, DOI 10.1073/pnas.0812141106; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Daborn P, 2001, MOL GENET GENOMICS, V266, P556, DOI 10.1007/s004380100531; Daborn PJ, 2007, INSECT BIOCHEM MOLEC, V37, P512, DOI 10.1016/j.ibmb.2007.02.008; Daborn PJ, 2012, INSECT BIOCHEM MOLEC, V42, P918, DOI 10.1016/j.ibmb.2012.09.003; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Feyereisen R., 2005, P1; Feyereisen R, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P236, DOI 10.1016/B978-0-12-384747-8.10008-X; FIELD LM, 1988, BIOCHEM J, V251, P309, DOI 10.1042/bj2510309; Jones RT, 2010, PEST MANAG SCI, V66, P1106, DOI 10.1002/ps.1986; Joussen N, 2008, PEST MANAG SCI, V64, P65, DOI 10.1002/ps.1472; Kirischian N, 2011, J MOL EVOL, V72, P56, DOI 10.1007/s00239-010-9402-7; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li XC, 2000, J ECON ENTOMOL, V93, P18, DOI 10.1603/0022-0493-93.1.18; Low WY, 2007, GENETICS, V177, P1363, DOI 10.1534/genetics.107.075838; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; MOUCHES C, 1986, SCIENCE, V233, P778, DOI 10.1126/science.3755546; Muller P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000286; Newcomb RD, 1997, P NATL ACAD SCI USA, V94, P7464, DOI 10.1073/pnas.94.14.7464; Puinean AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000999; Robertson J.L., 2007, BIOASSAYS ARTHROPODS, V2nd; RUSSO CAM, 1995, MOL BIOL EVOL, V12, P391; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sakuma M, 1998, APPL ENTOMOL ZOOL, V33, P339, DOI 10.1303/aez.33.339; Schlenke TA, 2004, P NATL ACAD SCI USA, V101, P1626, DOI 10.1073/pnas.0303793101; Schmidt JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000998; Sen Zeng R, 2007, J CHEM ECOL, V33, P449, DOI 10.1007/s10886-006-9238-1; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Thomas JH, 2007, PLOS GENET, V3, P720, DOI 10.1371/journal.pgen.0030067; Werck-Reichhart D, 2000, GENOME BIOL, V6, P1, DOI [10.1186/GB-2000-1-6-REVIEWS3003, DOI 10.1186/GB-2000-1-6-REVIEWS3003]; Willoughby L, 2006, INSECT BIOCHEM MOLEC, V36, P934, DOI 10.1016/j.ibmb.2006.09.004; Yang J, 2007, PHYSIOL GENOMICS, V30, P223, DOI 10.1152/physiolgenomics.00018.2007; Zhu F, 2010, P NATL ACAD SCI USA, V107, P8557, DOI 10.1073/pnas.1000059107	36	18	18	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84879	10.1371/journal.pone.0084879	http://dx.doi.org/10.1371/journal.pone.0084879			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416303	Green Submitted, gold, Green Published			2022-12-27	WOS:000329862500182
J	Nalawade-Chavan, S; McCullagh, J; Hedges, R				Nalawade-Chavan, Shweta; McCullagh, James; Hedges, Robert			New Hydroxyproline Radiocarbon Dates from Sungir, Russia, Confirm Early Mid Upper Palaeolithic Burials in Eurasia	PLOS ONE			English	Article							AMINO-ACIDS; BONE; PRETREATMENT; AGE; HAIR; SITE	Sungir (Russia) is a key Mid-Upper Palaeolithic site in Eurasia, containing several spectacular burials that disclose early evidence for complex burial rites in the form of a range of grave goods deposited along with the dead. Dating has been particularly challenging, with multiple radiocarbon dates ranging from 19,160 +/- 270 to 28,800 +/- 240 BP for burials that are believed to be closely similar in age. There are disparities in the radiocarbon dates of human bones, faunal remains and charcoal found on the floor of burials [1], [2], [3]. Our approach has been to develop compound-specific methods using High Performance Liquid Chromatography (HPLC) to separate single amino acids, such as hydroxyproline, and thereby avoid the known human contamination on the bones themselves. Previously, we applied this technique to obtain radiocarbon dates of similar to 30,000 BP for Sungir 2, Sungir 3 and a mammoth bone from the occupation levels of the site [4]. The single amino acid radiocarbon dates were in good agreement with each other compared to all the dates previously reported, supporting their reliability. Here we report new hydroxyproline dates for two more human burials from the same site, Sungir 1 and Sungir 4. All five hydroxyproline dates reported are statistically indistinguishable and support an identical age for the group. The results suggest that compound-specific radiocarbon analysis should be considered seriously as the method of choice when precious archaeological remains are to be dated because they give a demonstrably contaminant-free radiocarbon age. The new ages are, together with the previously dated 'Red Lady of Paviland' human in the British Isles, the earliest for Mid Upper Palaeolithic burial behaviour in Eurasia, and point to the precocious appearance of this form of rite in Europe Russia.	[Nalawade-Chavan, Shweta; McCullagh, James; Hedges, Robert] Univ Oxford, Oxford Radiocarbon Accelerator Unit, Lab Archaeol & Hist Art, Oxford, England	University of Oxford	Nalawade-Chavan, S (corresponding author), Univ Oxford, Oxford Radiocarbon Accelerator Unit, Lab Archaeol & Hist Art, Oxford, England.	shweta.chavan@rlaha.ox.ac.uk	McCullagh, James/AAD-2669-2022	McCullagh, James/0000-0003-4733-1205	NERC [NE/H004491/1]; Natural Environment Research Council [NE/H004491/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	NERC grant NE/H004491/1; http://www.nerc.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen KK, 2006, QUATERNARY SCI REV, V25, P3246, DOI 10.1016/j.quascirev.2006.08.002; Bradley BA, 1995, ANTIQUITY, V69, P989, DOI 10.1017/S0003598X00082521; Brock F, 2010, RADIOCARBON, V52, P103, DOI 10.1017/S0033822200045069; Collins MJ, 2002, ARCHAEOMETRY, V44, P383, DOI 10.1111/1475-4754.t01-1-00071; Dobrovolskaya M., 2012, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V24, P96, DOI 10.1007/s13219-011-0044-4; Einwogerer T, 2009, RADIOCARBON, V51, P847, DOI 10.1017/S0033822200056150; Formicola V, 2004, CURR ANTHROPOL, V45, P114, DOI 10.1086/381008; Grun R, 2006, YEARB PHYS ANTHROPOL, V49, P2, DOI 10.1002/ajpa.20516; HEDGES REM, 1992, RADIOCARBON, V34, P279, DOI 10.1017/S0033822200063438; Henry-Gambier D, 2002, PALEO, V14, P201; Higham T, 2012, J HUM EVOL, V62, P664, DOI 10.1016/j.jhevol.2012.03.003; Jacobi RM, 2008, J HUM EVOL, V55, P898, DOI 10.1016/j.jhevol.2008.08.007; Kuzmin YV, 2004, NUCL INSTRUM METH B, V223, P731, DOI 10.1016/j.nimb.2004.04.135; Marom A, 2012, P NATL ACAD SCI USA, V109, P6878, DOI 10.1073/pnas.1116328109; McCullagh JSO, 2010, RADIOCARBON, V52, P620, DOI 10.1017/S0033822200045653; Nalawade-Chavan S, 2013, RADIOCARBON, V55, P709, DOI 10.1017/S0033822200057866; O'Connell TC, 1999, J ARCHAEOL SCI, V26, P661, DOI 10.1006/jasc.1998.0383; O'Connell TC, 2001, J ARCHAEOL SCI, V28, P1247, DOI 10.1006/jasc.2001.0698; Pettitt PB, 2000, ANTIQUITY, V74, P269, DOI 10.1017/S0003598X00059196; Pettitt PB, 2003, ANTIQUITY, V77, P15, DOI 10.1017/S0003598X00061305; PETTITT PB, 2000, ANTHROPOLOGIE, V38, P149; PETTITT PB, 2002, TRABALHOS ARQUEOLOGI, V22, P132; Ramsey CB, 2004, RADIOCARBON, V46, P155, DOI 10.1017/S0033822200039473; Ramsey CB, 2009, RADIOCARBON, V51, P1023, DOI 10.1017/S0033822200034093; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Sinitsyn A., 2004, ERAUL, V106, P237; SINITSYN AA, 1996, PREHISTOIRE EUROPEEN, V9, P273; STAFFORD TW, 1991, J ARCHAEOL SCI, V18, P35, DOI 10.1016/0305-4403(91)90078-4; Svoboda JA, 2002, ANTIQUITY, V76, P957, DOI 10.1017/S0003598X00091754; Van Klinken GJ, 1998, RADIOCARBON, V40, P51; van Klinken GJ, 1994, GEOCHIMICA COSMOCHIM, V58, P2453	32	29	32	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e76896	10.1371/journal.pone.0076896	http://dx.doi.org/10.1371/journal.pone.0076896			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	291WL	24416120	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500001
J	Pendleton, RM; Hoeinghaus, DJ; Gomes, LC; Agostinho, AA				Pendleton, Richard M.; Hoeinghaus, David J.; Gomes, Luiz C.; Agostinho, Angelo A.			Loss of Rare Fish Species from Tropical Floodplain Food Webs Affects Community Structure and Ecosystem Multifunctionality in a Mesocosm Experiment	PLOS ONE			English	Article							TROPHIC CASCADES; PREDATOR DIVERSITY; FRESH-WATERS; CHAIN LENGTH; BIODIVERSITY; CONSEQUENCES; EXTINCTION; RICHNESS; IDENTITY; CONSERVATION	Experiments with realistic scenarios of species loss from multitrophic ecosystems may improve insight into how biodiversity affects ecosystem functioning. Using 1000 L mesocoms, we examined effects of nonrandom species loss on community structure and ecosystem functioning of experimental food webs based on multitrophic tropical floodplain lagoon ecosystems. Realistic biodiversity scenarios were developed based on long-term field surveys, and experimental assemblages replicated sequential loss of rare species which occurred across all trophic levels of these complex food webs. Response variables represented multiple components of ecosystem functioning, including nutrient cycling, primary and secondary production, organic matter accumulation and whole ecosystem metabolism. Species richness significantly affected ecosystem function, even after statistically controlling for potentially confounding factors such as total biomass and direct trophic interactions. Overall, loss of rare species was generally associated with lower nutrient concentrations, phytoplankton and zooplankton densities, and whole ecosystem metabolism when compared with more diverse assemblages. This pattern was also observed for overall ecosystem multifunctionality, a combined metric representing the ability of an ecosystem to simultaneously maintain multiple functions. One key exception was attributed to time-dependent effects of intraguild predation, which initially increased values for most ecosystem response variables, but resulted in decreases over time likely due to reduced nutrient remineralization by surviving predators. At the same time, loss of species did not result in strong trophic cascades, possibly a result of compensation and complexity of these multitrophic ecosystems along with a dominance of bottom-up effects. Our results indicate that although rare species may comprise minor components of communities, their loss can have profound ecosystem consequences across multiple trophic levels due to a combination of direct and indirect effects in diverse multitrophic ecosystems.	[Pendleton, Richard M.; Hoeinghaus, David J.] Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA; [Pendleton, Richard M.; Hoeinghaus, David J.] Univ N Texas, Inst Appl Sci, Denton, TX 76203 USA; [Gomes, Luiz C.; Agostinho, Angelo A.] Univ Estadual Maringa, Dept Biol, Maringa, Parana, Brazil; [Gomes, Luiz C.; Agostinho, Angelo A.] Univ Estadual Maringa, Nucleo Pesquisas Limnol Ictiol & Aquicultura Nupe, Maringa, Parana, Brazil	University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton; Universidade Estadual de Maringa; Universidade Estadual de Maringa	Pendleton, RM (corresponding author), Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA.	rich.pendleton@gmail.com	Agostini, Angelo/D-5888-2013; Gomes, Luiz/D-5886-2013; Agostinho, Angelo Antonio/S-1538-2019	Agostini, Angelo/0000-0002-4707-9444; Agostinho, Angelo Antonio/0000-0002-4707-9444; gomes, Luiz/0000-0001-7295-723X	UNT Office of the Provost and Vice President for Academic Affairs; Charn Uswachoke International Development Fund; Society of Wetland Scientists; CNPq/PELD through the Upper Parana Floodplain LTER	UNT Office of the Provost and Vice President for Academic Affairs; Charn Uswachoke International Development Fund; Society of Wetland Scientists; CNPq/PELD through the Upper Parana Floodplain LTER(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	Financial support was provided by the UNT Office of the Provost and Vice President for Academic Affairs and the Charn Uswachoke International Development Fund, the Society of Wetland Scientists, and CNPq/PELD through support of the Upper Parana Floodplain LTER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinho A.A., 2004, ECOHYDROL HYDROBIOL, V4, P255; Agostinho AA., 2013, PELD CNPQ DEZ ANOS P, P163; [Anonymous], 2005, EC HUM WELL BEING SY; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Baranyi C, 2002, FRESHWATER BIOL, V47, P473, DOI 10.1046/j.1365-2427.2002.00822.x; Borer ET, 2005, ECOLOGY, V86, P528, DOI 10.1890/03-0816; Bracken MES, 2008, P NATL ACAD SCI USA, V105, P924, DOI 10.1073/pnas.0704103105; Bracken MES, 2012, ECOL LETT, V15, P461, DOI 10.1111/j.1461-0248.2012.01758.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Byrnes J, 2006, ECOL LETT, V9, P61, DOI 10.1111/j.1461-0248.2005.00842.x; Capps KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054093; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Carey MP, 2011, OECOLOGIA, V167, P189, DOI 10.1007/s00442-011-1967-3; Clescheri LS, 1999, STANDARD METHODS EXA; Downing AL, 2005, ECOLOGY, V86, P701, DOI 10.1890/03-0239; Downing AL, 2002, NATURE, V416, P837, DOI 10.1038/416837a; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; Duffy JE, 2005, ECOL LETT, V8, P301, DOI 10.1111/j.1461-0248.2005.00725.x; Finke DL, 2005, ECOL LETT, V8, P1299, DOI 10.1111/j.1461-0248.2005.00832.x; Gamfeldt L, 2008, ECOLOGY, V89, P1223, DOI 10.1890/06-2091.1; Henry-Silva GG, 2008, HYDROBIOLOGIA, V610, P153, DOI 10.1007/s10750-008-9430-0; Hoeinghaus DJ, 2008, OIKOS, V117, P984, DOI 10.1111/j.0030-1299.2008.16459.x; Hoeinghaus DJ, 2007, ECOSYSTEMS, V10, P1019, DOI 10.1007/s10021-007-9075-2; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Julio HF, 2009, NEOTROP ICHTHYOL, V7, P709, DOI 10.1590/S1679-62252009000400021; KERY M, 2003, B ECOL SOC AM, V84, P92; Lyons KG, 2001, ECOL LETT, V4, P358, DOI 10.1046/j.1461-0248.2001.00235.x; Maestre FT, 2012, SCIENCE, V335, P214, DOI 10.1126/science.1215442; McIntyre PB, 2008, ECOLOGY, V89, P2335, DOI 10.1890/07-1552.1; McIntyre PB, 2007, P NATL ACAD SCI USA, V104, P4461, DOI 10.1073/pnas.0608148104; McKinney ML, 1997, ANNU REV ECOL SYST, V28, P495, DOI 10.1146/annurev.ecolsys.28.1.495; Naeem S, 2008, TRENDS ECOL EVOL, V23, P414, DOI 10.1016/j.tree.2008.05.003; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Reiss J, 2009, TRENDS ECOL EVOL, V24, P505, DOI 10.1016/j.tree.2009.03.018; Reynolds PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036196; Rooney N, 2012, TRENDS ECOL EVOL, V27, P40, DOI 10.1016/j.tree.2011.09.001; Schagerl M, 2009, J LIMNOL, V68, P274, DOI 10.4081/jlimnol.2009.274; Schmitz OJ, 2010, ECOL LETT, V13, P1199, DOI 10.1111/j.1461-0248.2010.01511.x; Small GE, 2011, ECOLOGY, V92, P386, DOI 10.1890/10-0081.1; Solan M, 2004, SCIENCE, V306, P1177, DOI 10.1126/science.1103960; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; Straub CS, 2006, ECOLOGY, V87, P277, DOI 10.1890/05-0599; THOMAZ S.M, 2004, UPPER PARANA RIVER I; Tilman D, 1997, OIKOS, V80, P185, DOI 10.2307/3546532; Vanni MJ, 2002, ECOL LETT, V5, P285, DOI 10.1046/j.1461-0248.2002.00314.x; Wardle DA, 2003, OIKOS, V102, P45, DOI 10.1034/j.1600-0706.2003.12481.x; Winemiller Kirk O., 2005, P10; Woodward G, 2009, FRESHWATER BIOL, V54, P2171, DOI 10.1111/j.1365-2427.2008.02081.x; Zavaleta ES, 2010, P NATL ACAD SCI USA, V107, P1443, DOI 10.1073/pnas.0906829107; Zavaleta ES, 2004, SCIENCE, V306, P1175, DOI 10.1126/science.1102643	53	29	31	1	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84568	10.1371/journal.pone.0084568	http://dx.doi.org/10.1371/journal.pone.0084568			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416246	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500138
J	Sargoy, A; Sun, XP; Barnes, S; Brecha, NC				Sargoy, Allison; Sun, Xiaoping; Barnes, Steven; Brecha, Nicholas C.			Differential Calcium Signaling Mediated by Voltage-Gated Calcium Channels in Rat Retinal Ganglion Cells and Their Unmyelinated Axons	PLOS ONE			English	Article							DISPLACED AMACRINE CELLS; BIPOLAR CELLS; MOUSE RETINA; OPTIC-NERVE; BETA-SUBUNITS; IN-VIVO; CURRENTS; NEURONS; MIBEFRADIL; EXPRESSION	Aberrant calcium regulation has been implicated as a causative factor in the degeneration of retinal ganglion cells (RGCs) in numerous injury models of optic neuropathy. Since calcium has dual roles in maintaining homeostasis and triggering apoptotic pathways in healthy and injured cells, respectively, investigation of voltage-gated Ca channel (VGCC) regulation as a potential strategy to reduce the loss of RGCs is warranted. The accessibility and structure of the retina provide advantages for the investigation of the mechanisms of calcium signalling in both the somata of ganglion cells as well as their unmyelinated axons. The goal of the present study was to determine the distribution of VGCC subtypes in the cell bodies and axons of ganglion cells in the normal retina and to define their contribution to calcium signals in these cellular compartments. We report L-type Ca channel alpha 1C and alpha 1D subunit immunoreactivity in rat RGC somata and axons. The N-type Ca channel alpha 1B subunit was in RGC somata and axons, while the P/Q-type Ca channel alpha 1A subunit was only in the RGC somata. We patch clamped isolated ganglion cells and biophysically identified T-type Ca channels. Calcium imaging studies of RGCs in wholemounted retinas showed that selective Ca channel antagonists reduced depolarization-evoked calcium signals mediated by L-, N-, P/Q- and T-type Ca channels in the cell bodies but only by L-type Ca channels in the axons. This differential contribution of VGCC subtypes to calcium signals in RGC somata and their axons may provide insight into the development of target-specific strategies to spare the loss of RGCs and their axons following injury.	[Sargoy, Allison; Sun, Xiaoping; Barnes, Steven; Brecha, Nicholas C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Sargoy, Allison; Sun, Xiaoping; Barnes, Steven; Brecha, Nicholas C.] Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Barnes, Steven; Brecha, Nicholas C.] Vet Adm Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; [Barnes, Steven] Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS, Canada; [Barnes, Steven] Dalhousie Univ, Dept Ophthalmol & Visual Sci, Halifax, NS, Canada	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Dalhousie University; Dalhousie University	Barnes, S (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA.	sbarnes@dal.ca		Barnes, Steven/0000-0003-0496-1645	NIH [EY04067]; VA Merit Review; CIHR; NSHRF Regional Partnership Program; NSERC; U.S. Army Medical Research & Materiel Command (USAMRMC); Telemedicine & Advanced Technology Research Center (TATRC) at Fort Detrick, MD [W81XWH-10-2-0077]; NATIONAL EYE INSTITUTE [R56EY004067, T32EY007026, R01EY004067] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000764] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Review(US Department of Veterans Affairs); CIHR(Canadian Institutes of Health Research (CIHR)); NSHRF Regional Partnership Program; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); U.S. Army Medical Research & Materiel Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Telemedicine & Advanced Technology Research Center (TATRC) at Fort Detrick, MD; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Veterans Affairs(US Department of Veterans Affairs)	Support for these studies came from NIH EY04067 (NCB), a VA Merit Review (NCB), a CIHR and NSHRF Regional Partnership Program grant (SB), and NSERC (SB). Part of this work was made possible by a contract agreement awarded to NCB and administered by the U.S. Army Medical Research & Materiel Command (USAMRMC) and the Telemedicine & Advanced Technology Research Center (TATRC) at Fort Detrick, MD under Contract Number: W81XWH-10-2-0077. NCB is a VA Senior Career Research Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer CS, 2010, CURR OPIN NEUROBIOL, V20, P563, DOI 10.1016/j.conb.2010.05.007; Bender KJ, 2009, NEURON, V61, P259, DOI 10.1016/j.neuron.2008.12.004; Berridge MJ, 2006, CELL CALCIUM, V40, P405, DOI 10.1016/j.ceca.2006.09.002; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Coleman MP, 2002, TRENDS NEUROSCI, V25, P532, DOI 10.1016/S0166-2236(02)02255-5; Crish SD, 2011, NEUROSCIENCE, V176, P1, DOI 10.1016/j.neuroscience.2010.12.036; Crossman DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017901; Davies A, 2007, TRENDS PHARMACOL SCI, V28, P220, DOI 10.1016/j.tips.2007.03.005; de la Villa P, 1998, EUR J NEUROSCI, V10, P317, DOI 10.1046/j.1460-9568.1998.00051.x; Dolphin AC, 2012, NAT REV NEUROSCI, V13, P542, DOI 10.1038/nrn3311; Dolphin AC, 2009, CURR OPIN NEUROBIOL, V19, P237, DOI 10.1016/j.conb.2009.06.006; Eller P, 2000, BRIT J PHARMACOL, V130, P669, DOI 10.1038/sj.bjp.0703352; Farrell SR, 2010, J NEUROPHYSIOL, V104, P1347, DOI 10.1152/jn.00098.2010; Firth SI, 2001, CLIN EXP OPHTHALMOL, V29, P183, DOI 10.1046/j.1442-9071.2001.00401.x; Fitzgerald M, 2009, INVEST OPHTH VIS SCI, V50, P5456, DOI 10.1167/iovs.09-3717; FLIEGNER KH, 1991, INT REV CYTOL, V131, P109, DOI 10.1016/S0074-7696(08)62018-5; Forti L, 2000, J PHYSIOL-LONDON, V527, P33, DOI 10.1111/j.1469-7793.2000.00033.x; GUENTHER E, 1994, BRAIN RES, V633, P223, DOI 10.1016/0006-8993(94)91543-1; Habermann CJ, 2003, J NEUROSCI, V23, P6904; Hartveit E, 1999, J NEUROPHYSIOL, V81, P2923, DOI 10.1152/jn.1999.81.6.2923; Hartwick ATE, 2008, J PHYSIOL-LONDON, V586, P3425, DOI 10.1113/jphysiol.2008.154609; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hu CP, 2009, VISUAL NEUROSCI, V26, P177, DOI 10.1017/S0952523809090026; ISHIDA AT, 1991, J NEUROPHYSIOL, V65, P968, DOI 10.1152/jn.1991.65.4.968; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Karim MD, 2006, CURR EYE RES, V31, P273, DOI 10.1080/02713680500536647; Karnas D, 2013, J COMP NEUROL, V521, P912, DOI 10.1002/cne.23210; KARSCHIN A, 1989, J PHYSIOL-LONDON, V418, P379, DOI 10.1113/jphysiol.1989.sp017847; Kawasaki A, 2000, INVEST OPHTH VIS SCI, V41, P3444; Knoferle J, 2010, P NATL ACAD SCI USA, V107, P6064, DOI 10.1073/pnas.0909794107; Kong GYX, 2009, J GLAUCOMA, V18, P93, DOI 10.1097/IJG.0b013e318181284f; Kong WC, 1999, LIFE SCI, V64, P1773, DOI 10.1016/S0024-3205(99)00115-0; Kwong JMK, 2011, INVEST OPHTH VIS SCI, V52, P9694, DOI 10.1167/iovs.11-7869; La Morgia C, 2010, BRAIN, V133, P2426, DOI 10.1093/brain/awq155; LoGiudice L, 2006, MOL VIS, V12, P184; Marambaud P, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-20; Margolis DJ, 2010, J NEUROSCI, V30, P7127, DOI 10.1523/JNEUROSCI.5694-09.2010; Mark MD, 2011, J NEUROSCI, V31, P4311, DOI 10.1523/JNEUROSCI.5342-10.2011; McNulty MM, 2004, MOL PHARMACOL, V66, P1652, DOI 10.1124/mol.66.6.1652; Muller LPD, 2007, J COMP NEUROL, V505, P177, DOI 10.1002/cne.21487; Nakano N, 2011, INVEST OPHTH VIS SCI, V52, P8754, DOI 10.1167/iovs.10-6654; Pan ZH, 2000, J NEUROPHYSIOL, V83, P513, DOI 10.1152/jn.2000.83.1.513; Pan ZH, 2001, NEURON, V32, P89, DOI 10.1016/S0896-6273(01)00454-8; PERRY VH, 1980, PROC R SOC SER B-BIO, V208, P415, DOI 10.1098/rspb.1980.0060; Prilloff S, 2007, EUR J NEUROSCI, V25, P3339, DOI 10.1111/j.1460-9568.2007.05550.x; Quigley HA, 1998, RET EYE RES, V18, P39; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Richards MW, 2004, TRENDS PHARMACOL SCI, V25, P626, DOI 10.1016/j.tips.2004.10.008; Rodriguez AR, 2013, J COMP NEUROL UNPUB; Ryskamp DA, 2011, J NEUROSCI, V31, P7089, DOI 10.1523/JNEUROSCI.0359-11.2011; Schmid S, 1999, J NEUROSCI, V19, P3486; Schmid S, 1996, NEUROREPORT, V7, P677, DOI 10.1097/00001756-199601310-00070; Staal JA, 2010, J NEUROCHEM, V112, P1147, DOI 10.1111/j.1471-4159.2009.06531.x; Sun BB, 1999, J NEUROSCI, V19, P5185; TASCHENBERGER H, 1995, J NEUROSCI, V15, P2240, DOI 10.1523/JNEUROSCI.15-03-02240.1995; Van Wyk M, 2009, VISUAL NEUROSCI, V26, P297, DOI 10.1017/S0952523809990137; Verkhratsky A, 2012, MOL CELL ENDOCRINOL, V353, P45, DOI 10.1016/j.mce.2011.08.039; Viana F, 1997, CELL CALCIUM, V22, P299, DOI 10.1016/S0143-4160(97)90068-3; Weber JT, 2001, J BIOL CHEM, V276, P1800, DOI 10.1074/jbc.M009209200; Witkovsky P, 2006, J COMP NEUROL, V497, P384, DOI 10.1002/cne.20995; Xu HP, 2003, NEUROSCIENCE, V118, P763, DOI 10.1016/S0306-4522(03)00022-8; Xu HP, 2002, NEUROSCI LETT, V329, P297, DOI 10.1016/S0304-3940(02)00688-2; Zhai QW, 2003, NEURON, V39, P217, DOI 10.1016/S0896-6273(03)00429-X; Zhang CL, 2006, J NEUROPHYSIOL, V96, P695, DOI 10.1152/jn.00083.2006	65	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84507	10.1371/journal.pone.0084507	http://dx.doi.org/10.1371/journal.pone.0084507			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416240	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500133
J	Tang, FY; Cheng, YJ; Bao, CJ; Hu, JL; Liu, WD; Liang, Q; Wu, Y; Norris, J; Peng, ZH; Yu, RB; Shen, HB; Chen, F				Tang, Fenyang; Cheng, Yuejia; Bao, Changjun; Hu, Jianli; Liu, Wendong; Liang, Qi; Wu, Ying; Norris, Jessie; Peng, Zhihang; Yu, Rongbin; Shen, Hongbing; Chen, Feng			Spatio-Temporal Trends and Risk Factors for Shigella from 2001 to 2011 in Jiangsu Province, People's Republic of China	PLOS ONE			English	Article							BACILLARY DYSENTERY; CHILDHOOD DIARRHEA; MODEL; INTERVENTIONS; TEMPERATURE; SALVADOR; HEALTH	Objective: This study aimed to describe the spatial and temporal trends of Shigella incidence rates in Jiangsu Province, People's Republic of China. It also intended to explore complex risk modes facilitating Shigella transmission. Methods: County-level incidence rates were obtained for analysis using geographic information system (GIS) tools. Trend surface and incidence maps were established to describe geographic distributions. Spatio-temporal cluster analysis and autocorrelation analysis were used for detecting clusters. Based on the number of monthly Shigella cases, an autoregressive integrated moving average (ARIMA) model successfully established a time series model. A spatial correlation analysis and a case-control study were conducted to identify risk factors contributing to Shigella transmissions. Results: The far southwestern and northwestern areas of Jiangsu were the most infected. A cluster was detected in southwestern Jiangsu (LLR = 11674.74, P<0.001). The time series model was established as ARIMA (1, 12, 0), which predicted well for cases from August to December, 2011. Highways and water sources potentially caused spatial variation in Shigella development in Jiangsu. The case-control study confirmed not washing hands before dinner (OR = 3.64) and not having access to a safe water source (OR = 2.04) as the main causes of Shigella in Jiangsu Province. Conclusion: Improvement of sanitation and hygiene should be strengthened in economically developed counties, while access to a safe water supply in impoverished areas should be increased at the same time.	[Cheng, Yuejia; Peng, Zhihang; Yu, Rongbin; Shen, Hongbing; Chen, Feng] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Tang, Fenyang; Bao, Changjun; Hu, Jianli; Liu, Wendong; Liang, Qi; Wu, Ying] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Norris, Jessie] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China	Nanjing Medical University; Jiangsu Provincial Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Peng, ZH (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China.	zhihangpeng@njmu.edu.cn			Natural Science Foundation Key Project of Jiangsu Province, China [BK2010079]; "National S&T Major Project Foundation of China" [2011ZX10004-902]; Jiangsu Province Health Development Project with Science and Education [ZX201109]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Natural Science Foundation Key Project of Jiangsu Province, China; "National S&T Major Project Foundation of China"; Jiangsu Province Health Development Project with Science and Education; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported in part by Natural Science Foundation Key Project of Jiangsu Province, China (BK2010079), "National S&T Major Project Foundation of China" (2011ZX10004-902), Jiangsu Province Health Development Project with Science and Education (NO. ZX201109), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Elyazeed RR, 2004, AM J TROP MED HYG, V71, P367, DOI 10.4269/ajtmh.2004.71.367; Ali Mohammad, 2006, Int J Health Geogr, V5, P45, DOI 10.1186/1476-072X-5-45; Allard R, 1998, B WORLD HEALTH ORGAN, V76, P327; [Anonymous], 2008, MODEL SELECTION MODE; Bardhan P, 2010, EMERG INFECT DIS, V16, P1718, DOI 10.3201/eid1611.090934; Bowerman Bruce L, 2003, FORECASTING TIME SER, P117; Checkley W, 2004, LANCET, V363, P112, DOI 10.1016/S0140-6736(03)15261-0; Cheng YJ, 2012, GEOSPATIAL HEALTH, V7, P63, DOI 10.4081/gh.2012.105; D'Souza RM, 2004, EPIDEMIOLOGY, V15, P86, DOI 10.1097/01.ede.0000101021.03453.3e; Emch M, 1999, SOC SCI MED, V49, P519, DOI 10.1016/S0277-9536(99)00146-X; Ferrer SR, 2008, INT J EPIDEMIOL, V37, P805, DOI 10.1093/ije/dyn093; Forrer A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001481; Gu B, 2012, INT J ANTIMICROB AG, V40, P9, DOI 10.1016/j.ijantimicag.2012.02.005; Hu JianLi, 2011, Chinese Preventive Medicine, V12, P419; Huang DS, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-130; Kulldorff M, 1998, AM J PUBLIC HEALTH, V88, P1377, DOI 10.2105/AJPH.88.9.1377; Li LF, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-951; Liu QY, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-218; Liu X.N., 2008, SPATIAL ANAL THEORIE, P189; LJUNG GM, 1978, BIOMETRIKA, V65, P297, DOI 10.2307/2335207; Loha E, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-166; [朋文佳 Peng Wenjia], 2011, [中国卫生统计, Chinese Journal of Health Statistics], V28, P645; Rego RF, 2005, T ROY SOC TROP MED H, V99, P48, DOI 10.1016/j.trstmh.2004.02.008; Strina A, 2003, AM J EPIDEMIOL, V157, P1032, DOI 10.1093/aje/kwg075; Vinceti M, 2012, Ann Ig, V24, P407; Wang XY, 2006, B WORLD HEALTH ORGAN, V84, P561, DOI 10.2471/BLT.05.023853; Yan WR, 2010, JPN J INFECT DIS, V63, P264; Yang G H, 1997, Biomed Environ Sci, V10, P1; Zhang Y, 2008, PUBLIC HEALTH REP, V123, P61, DOI 10.1177/003335490812300109; Zhang Y, 2012, J ENVIRON MONITOR, V14, P510, DOI 10.1039/c1em10391a; Zhou SD, 2009, JIANGSU SOCIAL SCI, V2, P212; Zhou XN, 2009, SPATIAL EPIDEMIOLOGY, P241	33	27	32	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83487	10.1371/journal.pone.0083487	http://dx.doi.org/10.1371/journal.pone.0083487			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416167	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500050
J	Kapoor, N; Maxwell, JT; Mignery, GA; Will, D; Blatter, LA; Banach, K				Kapoor, Nidhi; Maxwell, Joshua T.; Mignery, Gregory A.; Will, David; Blatter, Lothar A.; Banach, Kathrin			Spatially Defined InsP(3)-Mediated Signaling in Embryonic Stem Cell-Derived Cardiomyocytes	PLOS ONE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; INTRACELLULAR CA2+ OSCILLATIONS; VENTRICULAR CARDIAC MYOCYTES; SARCOPLASMIC-RETICULUM; ANKYRIN-B; RYANODINE RECEPTOR; HEART; ARRHYTHMIAS; 5-PHOSPHATASE; EXPRESSION	The functional role of inositol 1,4,5-trisphosphate (InsP(3)) signaling in cardiomyocytes is not entirely understood but it was linked to an increased propensity for triggered activity. The aim of this study was to determine how InsP(3) receptors can translate Ca2+ release into a depolarization of the plasma membrane and consequently arrhythmic activity. We used embryonic stem cell-derived cardiomyocytes (ESdCs) as a model system since their spontaneous electrical activity depends on InsP(3)-mediated Ca2+ release. [InsP(3)](i) was monitored with the FRET-based InsP(3)-biosensor FIRE-1 (Fluorescent InsP(3) Responsive Element) and heterogeneity in sub-cellular [InsP(3)](i) was achieved by targeted expression of FIRE-1 in the nucleus (FIRE-1nuc) or expression of InsP(3) 5-phosphatase (m43) localized to the plasma membrane. Spontaneous activity of ESdCs was monitored simultaneously as cytosolic Ca2+ transients (Fluo-4/AM) and action potentials (current clamp). During diastole, the diastolic depolarization was paralleled by an increase of [Ca2+] i and spontaneous activity was modulated by [InsP(3)](i). A 3.7% and 1.7% increase of FIRE-1 FRET ratio and 3.0 and 1.5 fold increase in beating frequency was recorded upon stimulation with endothelin-1 (ET-1, 100 nmol/L) or phenylephrine (PE, 10 mmol/L), respectively. Buffering of InsP(3) by FIRE-1nuc had no effect on the basal frequency while attenuation of InsP(3) signaling throughout the cell (FIRE-1), or at the plasma membrane (m43) resulted in a 53.7% and 54.0% decrease in beating frequency. In m43 expressing cells the response to ET-1 was completely suppressed. Ca2+ released from InsP(3)Rs is more effective than Ca2+ released from RyRs to enhance INCX. The results support the hypothesis that in ESdCs InsP(3)Rs form a functional signaling domain with NCX that translates Ca2+ release efficiently into a depolarization of the membrane potential.	[Kapoor, Nidhi] Cedars Sinai Med Ctr, Inst Heart, Los Angeles, CA 90048 USA; [Mignery, Gregory A.] Loyola Univ Chicago, Stritch Sch Med, Dept Cell & Mol Physiol, Maywood, IL USA; [Maxwell, Joshua T.; Blatter, Lothar A.] Rush Univ, Med Ctr, Dept Mol Biophys & Physiol, Chicago, IL 60612 USA; [Will, David; Banach, Kathrin] Univ Illinois, Dept Med, Cardiovasc Res Ctr, Cardiol Sect, Chicago, IL 60607 USA	Cedars Sinai Medical Center; Loyola University Chicago; Rush University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Banach, K (corresponding author), Univ Illinois, Dept Med, Cardiovasc Res Ctr, Cardiol Sect, Chicago, IL 60607 USA.	kbanach@uic.edu	Blatter, Lothar/AAC-8431-2020		NIH [HL89617, PO1HL080101, HL062231, HL080101]; AHA [0330393Z]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089617, P01HL080101, R01HL062231] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the NIH (HL89617 to KB; PO1HL080101 to GAM; HL062231 and HL080101 to LAB) and AHA (0330393Z to KB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banach K, 2003, AM J PHYSIOL-HEART C, V284, pH2114, DOI 10.1152/ajpheart.01106.2001; Bare DJ, 2005, J BIOL CHEM, V280, P15912, DOI 10.1074/jbc.M414212200; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bogdanov KY, 2001, CIRC RES, V88, P1254, DOI 10.1161/hh1201.092095; DeSmedt F, 1996, J BIOL CHEM, V271, P10419, DOI 10.1074/jbc.271.17.10419; Domeier TL, 2008, AM J PHYSIOL-HEART C, V294, pH596, DOI 10.1152/ajpheart.01155.2007; Escobar M, 2011, J MOL CELL CARDIOL, V50, P451, DOI 10.1016/j.yjmcc.2010.11.021; Franzini-Armstrong C, 2005, ANN NY ACAD SCI, V1047, P76, DOI 10.1196/annals.1341.007; Garcia KD, 2004, AM J PHYSIOL-CELL PH, V287, pC1048, DOI 10.1152/ajpcell.00004.2004; Gomes DA, 2006, CAN J PHYSIOL PHARM, V84, P325, DOI 10.1139/Y05-117; Harzheim D, 2009, P NATL ACAD SCI USA, V106, P11406, DOI 10.1073/pnas.0905485106; Horn T, 2013, J PHYSIOL-LONDON, V591, P2103, DOI 10.1113/jphysiol.2012.247288; Hund TJ, 2008, CHANNELS, V2, P404, DOI 10.4161/chan.2.6.7220; Huser J, 2000, J PHYSIOL-LONDON, V524, P415, DOI 10.1111/j.1469-7793.2000.00415.x; Itzhaki I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018037; Jaconi M, 2000, MOL BIOL CELL, V11, P1845, DOI 10.1091/mbc.11.5.1845; Janowski E, 2006, ANN NY ACAD SCI, V1080, P154, DOI 10.1196/annals.1380.014; Kapur N, 2007, AM J PHYSIOL-CELL PH, V292, pC1510, DOI 10.1152/ajpcell.00181.2006; Kapur N, 2007, J PHYSIOL-LONDON, V581, P1113, DOI 10.1113/jphysiol.2006.125955; Le Scouarnec S, 2008, P NATL ACAD SCI USA, V105, P15617, DOI 10.1073/pnas.0805500105; Lipp P, 2000, CURR BIOL, V10, P939, DOI 10.1016/S0960-9822(00)00624-2; LUO D, 2007, CELL CALCIUM; Mackenzie L, 2002, J PHYSIOL-LONDON, V541, P395, DOI 10.1113/jphysiol.2001.013411; McCarron JG, 2008, J BIOL CHEM, V283, P7206, DOI 10.1074/jbc.M708923200; Mery A, 2005, MOL BIOL CELL, V16, P2414, DOI 10.1091/mbc.E04-10-0883; Mohler PJ, 2004, J BIOL CHEM, V279, P12980, DOI 10.1074/jbc.M313979200; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Perez PJ, 1997, J BIOL CHEM, V272, P23961, DOI 10.1074/jbc.272.38.23961; Proven A, 2006, J CELL SCI, V119, P3363, DOI 10.1242/jcs.03073; Puceat M, 2005, CELL CALCIUM, V38, P383, DOI 10.1016/j.ceca.2005.06.016; Rapila R, 2008, J GEN PHYSIOL, V132, P397, DOI 10.1085/jgp.200809960; Remus TP, 2006, J BIOL CHEM, V281, P608, DOI 10.1074/jbc.M509645200; Rosemblit N, 1999, DEV BIOL, V206, P163, DOI 10.1006/dbio.1998.9120; Sasse P, 2007, J GEN PHYSIOL, V130, P133, DOI 10.1085/jgp.200609575; Satin J, 2008, STEM CELLS, V26, P1961, DOI 10.1634/stemcells.2007-0591; Sauer H, 2001, AM J PHYSIOL-HEART C, V281, pH411, DOI 10.1152/ajpheart.2001.281.1.H411; Slavikova J, 2006, LIFE SCI, V78, P1598, DOI 10.1016/j.lfs.2005.07.012; Speed CJ, 1996, EMBO J, V15, P4852, DOI 10.1002/j.1460-2075.1996.tb00866.x; Swietach P, 2008, BIOPHYS J, V95, P1412, DOI 10.1529/biophysj.108.130385; Vasilevski O, 2008, J MOL CELL CARDIOL, V45, P679, DOI 10.1016/j.yjmcc.2008.07.006; Viatchenko-Karpinski S, 1999, P NATL ACAD SCI USA, V96, P8259, DOI 10.1073/pnas.96.14.8259; Wu X, 2006, J CLIN INVEST, V116, P675, DOI 10.1172/JCI27374; Wu X, 2006, CIRC RES, V99, P283, DOI 10.1161/01.RES.0000233386.02708.72; Yang HT, 2002, P NATL ACAD SCI USA, V99, P9225, DOI 10.1073/pnas.142651999; Zima AV, 2008, CIRC RES, V103, pE105, DOI 10.1161/CIRCRESAHA.107.183236; Zima AV, 2007, J PHYSIOL-LONDON, V584, P601, DOI 10.1113/jphysiol.2007.140731; Zima AV, 2004, J PHYSIOL-LONDON, V555, P607, DOI 10.1113/jphysiol.2003.058529; Zima AV, 2007, J PHYSL	48	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e83715	10.1371/journal.pone.0083715	http://dx.doi.org/10.1371/journal.pone.0083715			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409283	gold, Green Published, Green Submitted			2022-12-27	WOS:000329463500007
J	He, MH; Pan, H; Chang, RCC; So, KF; Brecha, NC; Pu, ML				He, Meihua; Pan, Hong; Chang, Raymond Chuen-Chung; So, Kwok-Fai; Brecha, Nicholas C.; Pu, Mingliang			Activation of the Nrf2/HO-1 Antioxidant Pathway Contributes to the Protective Effects of Lycium Barbarum Polysaccharides in the Rodent Retina after Ischemia-Reperfusion-Induced Damage	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; HEME OXYGENASE-1; CAPILLARY DEGENERATION; GLUCOSE DEPRIVATION; GENE-EXPRESSION; CARBON-MONOXIDE; FREE-RADICALS; IN-VIVO; INJURY; CELLS	Lycium barbarum polysaccharides (LBP), extracts from the wolfberries, are protective to retina after ischemia-reperfusion (I/R). The antioxidant response element (ARE)-mediated antioxidant pathway plays an important role in maintaining the redox status of the retina. Heme oxygenase-1 (HO-1), combined with potent AREs in its promoter, is a highly effective therapeutic target for the protection against neurodegenerative diseases, including I/R-induced retinal damage. The aim of our present study was to investigate whether the protective effect of LBP after I/R damage was mediated via activation of the Nrf2/HO-1-antioxidant pathway in the retina. Retinal I/R was induced by an increase in intraocular pressure to 130 mm Hg for 60 minutes. Prior to the induction of ischemia, rats were orally treated with either vehicle (PBS) or LBP (1 mg/kg) once a day for 1 week. For specific experiments, zinc protoporphyrin (ZnPP, 20 mg/kg), an HO-1 inhibitor, was intraperitoneally administered at 24 h prior to ischemia. The protective effects of LBP were evaluated by quantifying ganglion cell and amacrine cell survival, and by measuring cell apoptosis in the retinal layers. In addition, HO-1 expression was examined using Western blotting and immunofluorescence analyses. Cytosolic and nuclear Nrf2 was measured using immunofluorescent staining. LBP treatment significantly increased Nrf2 nuclear accumulation and HO-1 expression in the retina after I/R injury. Increased apoptosis and a decrease in the number of viable cells were observed in the ganglion cell layer (GCL) and inner nuclear layer (INL) in the I/R retina, which were reversed by LBP treatment. The HO-1 inhibitor, ZnPP, diminished the LBP treatment-induced protective effects in the retina after I/R. Taken together, these results suggested that LBP partially exerted its beneficial neuroprotective effects via the activation of Nrf2 and an increase in HO-1 protein expression.	[He, Meihua; Pan, Hong; Pu, Mingliang] Peking Univ, Sch Basic Med Sci, Dept Anat Embryol, Beijing 100871, Peoples R China; [He, Meihua; Pan, Hong; Pu, Mingliang] Peking Univ, Minist Educ, Key Lab Machine Percept, Beijing 100871, Peoples R China; [He, Meihua; Pan, Hong; Pu, Mingliang] Peking Univ, Minist Educ, Key Lab Visual Impairment & Restorat, Beijing 100871, Peoples R China; [Chang, Raymond Chuen-Chung; So, Kwok-Fai] LKS Fac Med, Dept Anat, Pokfulam, Hong Kong, Peoples R China; [Chang, Raymond Chuen-Chung; So, Kwok-Fai] LKS Fac Med, Res Ctr Heart Brain Hormone & Hlth Aging, Pokfulam, Hong Kong, Peoples R China; [Chang, Raymond Chuen-Chung; So, Kwok-Fai] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Pokfulam, Hong Kong, Peoples R China; [So, Kwok-Fai] Jinan Univ, GHM Inst CNS Regenerat, Guangzhou, Guangdong, Peoples R China; [Brecha, Nicholas C.] Univ Hong Kong, Dept Ophthalmol, Pokfulam, Hong Kong, Peoples R China; [Brecha, Nicholas C.] Univ Calif Los Angeles, Jules Stein Eye Inst, David Geffen Sch Med Los Angeles, CURE Digest Dis Res Ctr,Dept Neurobiol,Dept Med, Los Angeles, CA 90024 USA; [Brecha, Nicholas C.] Greater Los Angeles Hlth Syst, Vet Adm, Los Angeles, CA USA	Peking University; Peking University; Peking University; University of Hong Kong; University of Hong Kong; University of Hong Kong; Jinan University; University of Hong Kong; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Pu, ML (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Anat Embryol, Beijing 100871, Peoples R China.	mpu@hsc.pku.edu.cn	Chang, Raymond Chuen-Chung/C-1107-2009; He, Meihua/D-4312-2017	Chang, Raymond Chuen-Chung/0000-0001-8538-7993; So, Kwok-Fai/0000-0003-4039-4246	National Basic Research Program of China (973 Program) [2009CB320900, 2011CB510206]; National Science Foundation of China [30831160516, 81200691]; Ministry of Education of China [20090001120075]; Azalea Endowment Fund; Fundamental Research Fund for the Central Universities [21609101]; NIH [EY04067]; VA Merit Review; NATIONAL EYE INSTITUTE [R01EY004067, R56EY004067] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Azalea Endowment Fund; Fundamental Research Fund for the Central Universities; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Review(US Department of Veterans Affairs); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by grants obtained from the National Basic Research Program of China (973 Program, 2009CB320900 [MP] and 2011CB510206 [MP]), the National Science Foundation of China (30831160516 [MP] and 81200691 [MH]), the Ministry of Education of China (20090001120075 [MH]), Azalea (1972) Endowment Fund (KS & RC), and the Fundamental Research Fund for the Central Universities (21609101, KS), NIH EY04067 (NCB) and VA Merit Review (NB). NCB is a VA Career Research Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam J, 2004, ANTIOXID REDOX SIGN, V6, P924, DOI 10.1089/1523086041798114; Amagase H, 2009, NUTR RES, V29, P19, DOI 10.1016/j.nutres.2008.11.005; Bonne C, 1998, GEN PHARMACOL, V30, P275, DOI 10.1016/S0306-3623(97)00357-1; Chang RCC, 2008, CELL MOL NEUROBIOL, V28, P643, DOI 10.1007/s10571-007-9181-x; Chao HM, 2013, J OCUL PHARMACOL TH, V29, P539, DOI 10.1089/jop.2012.0179; Cheng XH, 2011, ANTIOXID REDOX SIGN, V14, P469, DOI 10.1089/ars.2010.3283; Chiu Kin, 2009, J Ocul Biol Dis Infor, V2, P47; Danilov CA, 2009, GLIA, V57, P645, DOI 10.1002/glia.20793; Ghattas MH, 2002, INT J BIOCHEM CELL B, V34, P1619, DOI 10.1016/S1357-2725(02)00097-3; Goldblum D, 2002, VISION RES, V42, P471, DOI 10.1016/S0042-6989(01)00194-8; He M, 2011, NUTR METAB CARDIOVAS, V21, P277, DOI 10.1016/j.numecd.2009.12.008; Hornberg H, 2013, J NEUROSCI, V33, P10384, DOI 10.1523/JNEUROSCI.5858-12.2013; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jeong WS, 2006, ANTIOXID REDOX SIGN, V8, P99, DOI 10.1089/ars.2006.8.99; Junk AK, 2002, P NATL ACAD SCI USA, V99, P10659, DOI 10.1073/pnas.152321399; Kwong JMK, 2011, INVEST OPHTH VIS SCI, V52, P9694, DOI 10.1167/iovs.11-7869; Lau BWM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033374; Li SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016380; Li XM, 2007, INT J BIOL MACROMOL, V40, P461, DOI 10.1016/j.ijbiomac.2006.11.002; Li XM, 2007, J ETHNOPHARMACOL, V111, P504, DOI 10.1016/j.jep.2006.12.024; Liu XQ, 2013, J OCUL PHARMACOL TH, V29, P33, DOI 10.1089/jop.2012.0141; Lu SP, 2010, INT J BIOL MACROMOL, V47, P681, DOI 10.1016/j.ijbiomac.2010.08.016; Luo Q, 2009, J MED FOOD, V12, P695, DOI 10.1089/jmf.2008.1232; Mao F, 2011, MED ONCOL, V28, P121, DOI 10.1007/s12032-009-9415-5; Martin D, 2004, J BIOL CHEM, V279, P8919, DOI 10.1074/jbc.M309660200; Mi XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045469; Muller A, 1998, GEN PHARMACOL, V30, P315, DOI 10.1016/S0306-3623(97)00362-5; Niu AJ, 2008, INT J BIOL MACROMOL, V42, P447, DOI 10.1016/j.ijbiomac.2008.02.003; Osborne NN, 1999, SURV OPHTHALMOL, V43, pS102, DOI 10.1016/S0039-6257(99)00044-2; Panahian N, 1999, J NEUROCHEM, V72, P1187; Peng PH, 2011, CURR EYE RES, V36, P238, DOI 10.3109/02713683.2010.539760; rai-Gaun S, 2004, INVEST OPHTH VIS SCI, V45, P4226; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Shah ZA, 2010, J CEREBR BLOOD F MET, V30, P1951, DOI 10.1038/jcbfm.2010.53; Shan XZ, 2011, INT J MOL SCI, V12, P1081, DOI 10.3390/ijms12021081; Shibuki H, 2000, INVEST OPHTH VIS SCI, V41, P3607; Siow RCM, 1999, CARDIOVASC RES, V41, P385, DOI 10.1016/S0008-6363(98)00278-8; Siow RCM, 2007, REDOX REP, V12, P11, DOI 10.1179/135100007X162167; Soane L, 2010, J NEUROSCI RES, V88, P1355, DOI 10.1002/jnr.22307; Sun MH, 2010, INVEST OPHTH VIS SCI, V51, P4798, DOI 10.1167/iovs.09-4086; Szabo ME, 2004, INVEST OPHTH VIS SCI, V45, P3727, DOI 10.1167/iovs.03-1324; Tanito M, 2005, INVEST OPHTH VIS SCI, V46, P979, DOI 10.1167/iovs.04-1120; Varga B, 2013, J MOL NEUROSCI, V50, P558, DOI 10.1007/s12031-013-9998-3; Varga B, 2011, J MOL NEUROSCI, V43, P44, DOI 10.1007/s12031-010-9406-1; Wei YH, 2011, FREE RADICAL BIO MED, V51, P216, DOI 10.1016/j.freeradbiomed.2011.04.026; Wu HT, 2010, INT J BIOL MACROMOL, V46, P540, DOI 10.1016/j.ijbiomac.2010.02.010; Xiao J, 2012, J ETHNOPHARMACOL, V139, P462, DOI 10.1016/j.jep.2011.11.033; Xin YF, 2011, BIOL PHARM BULL, V34, P1523, DOI 10.1248/bpb.34.1523; Yang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033596; Yu MS, 2005, EXP GERONTOL, V40, P716, DOI 10.1016/j.exger.2005.06.010; Zheng L, 2007, INVEST OPHTH VIS SCI, V48, P361, DOI 10.1167/iovs.06-0510	51	120	141	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84800	10.1371/journal.pone.0084800	http://dx.doi.org/10.1371/journal.pone.0084800			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400114	Green Published, Green Submitted, gold			2022-12-27	WOS:000329462700048
J	Cheng, KD; Sloan, A; Avery, KM; Coulthart, M; Carpenter, M; Knox, JD				Cheng, Keding; Sloan, Angela; Avery, Kristen M.; Coulthart, Michael; Carpenter, Michael; Knox, J. David			Exploring Physical and Chemical Factors Influencing the Properties of Recombinant Prion Protein and the Real-Time Quaking-Induced Conversion (RT-QuIC) Assay	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; SEEDED CONVERSION	Real-time quaking-induced conversion (RT-QuIC), a highly specific and sensitive assay able to detect low levels of the disease-inducing isoform of the prion protein (PrPd) in brain tissue biopsies and cerebral spinal fluid, has great potential to become a method for diagnosing prion disease ante mortem. In order to standardize the assay method for routine analysis, an understanding of how physical and chemical factors affect the stability of the recombinant prion protein (rPrP) substrate and the RT-QuIC assay's sensitivity, specificity, and reproducibility is required. In this study, using sporadic Creutzfeldt-Jakob Disease brain homogenate to seed the reactions and an in vitro-expressed recombinant prion protein, hamster rPrP, as the substrate, the following factors affecting the RT-QuIC assay were examined: salt and substrate concentrations, substrate storage, and pH. Results demonstrated that both the generation of the quality and quantities of rPrP substrate critical to the reaction, as well as the RT-QuIC reaction itself required strict adherence to specific physical and chemical conditions. Once optimized, the RT-QuIC assay was confirmed to be a very specific and sensitive assay method for sCJD detection. Findings in this study indicate that further optimization and standardization of RT-QuIC assay is required before it can be adopted as a routine diagnostic test.	[Cheng, Keding; Sloan, Angela; Avery, Kristen M.; Carpenter, Michael; Knox, J. David] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Cheng, Keding] Univ Manitoba, Fac Med, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada; [Coulthart, Michael] Publ Hlth Agcy Canada, Ctr Food Borne Environm & Zoonot Infect Dis, Ottawa, ON, Canada; [Carpenter, Michael; Knox, J. David] Univ Manitoba, Fac Med, Dept Med Microbiol, Winnipeg, MB, Canada	Public Health Agency of Canada; University of Manitoba; Public Health Agency of Canada; University of Manitoba	Cheng, KD (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada.	Keding.Cheng@phac-aspc.gc.ca; David.Knox@phac-aspc.gc.ca						Atarashi R, 2008, NAT METHODS, V5, P211, DOI 10.1038/nmeth0308-211; Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Atarashi R, 2011, NAT MED, V17, P175, DOI 10.1038/nm.2294; Coulthart MB, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-133; McGuire LI, 2012, ANN NEUROL, V72, P278, DOI 10.1002/ana.23589; O'Callaghan T, 2011, NAT; Orru CD, 2011, TOP CURR CHEM, V305, P121, DOI 10.1007/128_2011_184; Orru CD, 2011, MBIO, V2, DOI 10.1128/mBio.00078-11; Peden AH, 2012, J GEN VIROL, V93, P438, DOI 10.1099/vir.0.033365-0; Riesner D, 2003, BRIT MED BULL, V66, P21, DOI 10.1093/bmb/66.1.21; Vascellari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048969; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217	12	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84812	10.1371/journal.pone.0084812	http://dx.doi.org/10.1371/journal.pone.0084812			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404191	gold, Green Published, Green Submitted			2022-12-27	WOS:000329460800070
J	Etebari, K; Asgari, S				Etebari, Kayvan; Asgari, Sassan			Accuracy of MicroRNA Discovery Pipelines in Non-Model Organisms Using Closely Related Species Genomes	PLOS ONE			English	Article							DEEP-SEQUENCING DATA; AEDES-AEGYPTI; DROSOPHILA-MELANOGASTER; EXPRESSION ANALYSIS; WOLBACHIA USES; IDENTIFICATION; MIRNAS; MIRANALYZER; BIOMARKERS; DISEASES	Mapping small reads to genome reference is an essential and more common approach to identify microRNAs (miRNAs) in an organism. Using closely related species genomes as proxy references can facilitate miRNA expression studies in non-model species that their genomes are not available. However, the level of error this introduces is mostly unknown, as this is the result of evolutionary distance between the proxy reference and the species of interest. To evaluate the accuracy of miRNA discovery pipelines in non-model organisms, small RNA library data from a mosquito, Aedes aegypti, were mapped to three well annotated insect genomes as proxy references using miRanalyzer with two strict and loose mapping criteria. In addition, another web-based miRNA discovery pipeline (DSAP) was used as a control for program performance. Using miRanalyzer, more than 80% reduction was observed in the number of mapped reads using strict criterion when proxy genome references were used; however, only 20% reduction was recorded for mapped reads to other species known mature miRNA datasets. Except a few changes in ranking, mapping criteria did not make any significant differences in the profile of the most abundant miRNAs in A. aegypti when its original or a proxy genome was used as reference. However, more variation was observed in miRNA ranking profile when DSAP was used as analysing tool. Overall, the results also suggested that using a proxy reference did not change the most abundant miRNAs' differential expression profiles when infected or non-infected libraries were compared. However, usage of a proxy reference could provide about 67% of the original outcome from more extremely up-or down-regulated miRNA profiles. Although using closely related species genome incurred some losses in the number of miRNAs, the most abundant miRNAs along with their differential expression profile would be acceptable based on the sensitivity level of each project.	[Etebari, Kayvan; Asgari, Sassan] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia	University of Queensland	Asgari, S (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia.	s.asgari@uq.edu.au	Etebari, Kayvan/C-6436-2008; Asgari, Sassan/G-2678-2011	Etebari, Kayvan/0000-0001-5213-6362; Asgari, Sassan/0000-0001-7885-6544	Australian Research Council [DP110102112]; University of Queensland	Australian Research Council(Australian Research Council); University of Queensland(University of Queensland)	This work was supported by an Australian Research Council (www.arc.gov.au) Discovery grant to S. A. (DP110102112) and a University of Queensland (www.uq.edu.au) PhD scholarship to K. E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Asgari S, 2013, INSECT BIOCHEM MOLEC, V43, P388, DOI 10.1016/j.ibmb.2012.10.005; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Behura SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021504; Belles X, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P30, DOI 10.1016/B978-0-12-384747-8.10002-9; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Etebari K, 2013, INSECT BIOCHEM MOLEC, V43, P309, DOI 10.1016/j.ibmb.2013.01.004; Freitak D, 2012, BIOL LETTERS, V8, P860, DOI 10.1098/rsbl.2012.0273; Frentiu FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013398; Fullaondo A, 2012, DEV COMP IMMUNOL, V36, P267, DOI 10.1016/j.dci.2011.03.034; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Gomez-Orte E, 2009, P NATL ACAD SCI USA, V106, P21678, DOI 10.1073/pnas.0907391106; Gu JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067638; Gu LQ, 2012, EXPERT REV MOL DIAGN, V12, P573, DOI [10.1586/erm.12.58, 10.1586/ERM.12.58]; Hackenberg M, 2011, NUCLEIC ACIDS RES, V39, pW132, DOI 10.1093/nar/gkr247; Hackenberg M, 2009, NUCLEIC ACIDS RES, V37, pW68, DOI 10.1093/nar/gkp347; Hertel J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-25; Hobert O, 2007, CELL, V131, P22, DOI 10.1016/j.cell.2007.09.031; Hornett EA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-361; Huang PJ, 2010, NUCLEIC ACIDS RES, V38, pW385, DOI 10.1093/nar/gkq392; Hussain M, 2011, P NATL ACAD SCI USA, V108, P9250, DOI 10.1073/pnas.1105469108; Ibanez-Ventoso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002818; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Li S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-581; Li SC, 2010, GENOMICS, V96, P1, DOI 10.1016/j.ygeno.2010.03.009; Li Y, 2012, NUCLEIC ACIDS RES, V40, P4298, DOI 10.1093/nar/gks043; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Mehrabadi M, 2013, J GEN VIROL, V94, P1385, DOI 10.1099/vir.0.051060-0; Skalsky RL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-119; Tanzer Andrea, 2006, V342, P335; Van Roosbroeck K, 2013, EXPERT REV MOL DIAGN, V13, P183, DOI [10.1586/ERM.12.134, 10.1586/erm.12.134]; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wang WC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-328; Wilbert ML, 2011, WIRES SYST BIOL MED, V3, P491, DOI 10.1002/wsbm.128; Williamson V, 2013, BRIEF BIOINFORM, V14, P36, DOI 10.1093/bib/bbs010; WU W, 2013, PLOS ONE, V8; Yu DB, 2013, J INTEGR AGR, V12, P136, DOI 10.1016/S2095-3119(13)60214-2; Yu XM, 2009, GENOMICS, V94, P438, DOI 10.1016/j.ygeno.2009.08.007; Yu XM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002997; Zhang G, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks196; Zhang GM, 2013, P NATL ACAD SCI USA, V110, P10276, DOI 10.1073/pnas.1303603110	42	14	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84747	10.1371/journal.pone.0084747	http://dx.doi.org/10.1371/journal.pone.0084747			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404190	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460800069
J	Romio, S; Weibel, D; Dieleman, JP; Olberg, HK; de Vries, CS; Sammon, C; Andrews, N; Svanstrom, H; Molgaard-Nielsen, D; Hviid, A; Lapeyre-Mestre, M; Sommet, A; Saussier, C; Castot, A; Heijbel, H; Arnheim-Dahlstrom, L; Sparen, P; Mosseveld, M; Schuemie, M; van der Mass, N; Jacobs, BC; Leino, T; Kilpi, T; Storsaeter, J; Johansen, K; Kramarz, P; Bonhoeffer, J; Sturkenboom, MCJM				Romio, Silvana; Weibel, Daniel; Dieleman, Jeanne P.; Olberg, Henning K.; de Vries, Corinne S.; Sammon, Cormac; Andrews, Nick; Svanstrom, Henrik; Molgaard-Nielsen, Ditte; Hviid, Anders; Lapeyre-Mestre, Maryse; Sommet, Agnes; Saussier, Christel; Castot, Anne; Heijbel, Harald; Arnheim-Dahlstrom, Lisen; Sparen, Par; Mosseveld, Mees; Schuemie, Martijn; van der Mass, Nicoline; Jacobs, Bart C.; Leino, Tuija; Kilpi, Terhi; Storsaeter, Jann; Johansen, Kari; Kramarz, Piotr; Bonhoeffer, Jan; Sturkenboom, Miriam C. J. M.			Guillain-Barre Syndrome and Adjuvanted Pandemic Influenza A (H1N1) 2009 Vaccines: A Multinational Self-Controlled Case Series in Europe	PLOS ONE			English	Article							MONOVALENT VACCINE; UNITED-STATES; SAFETY; RISK; IMMUNOGENICITY; EPIDEMIOLOGY; SURVEILLANCE; ASSOCIATION; ADOLESCENTS; CHILDREN	Background: The risk of Guillain-Barre syndrome (GBS) following the United States' 1976 swine flu vaccination campaign in the USA led to enhanced active surveillance during the pandemic influenza (A(H1N1)pdm09) immunization campaign. This study aimed to estimate the risk of GBS following influenza A(H1N1) pdm09 vaccination. Methods: A self-controlled case series (SCCS) analysis was performed in Denmark, Finland, France, Netherlands, Norway, Sweden, and the United Kingdom. Information was collected according to a common protocol and standardised procedures. Cases classified at levels 1-4a of the Brighton Collaboration case definition were included. The risk window was 42 days starting the day after vaccination. Conditional Poisson regression and pooled random effects models estimated adjusted relative incidences (RI). Pseudo likelihood and vaccinated-only methods addressed the potential contraindication for vaccination following GBS. Results: Three hundred and three (303) GBS and Miller Fisher syndrome cases were included. Ninety-nine (99) were exposed to A(H1N1) pdm09 vaccination, which was most frequently adjuvanted (Pandemrix and Focetria). The unadjusted pooled RI for A(H1N1) pdm09 vaccination and GBS was 3.5 (95% Confidence Interval (CI): 2.2-5.5), based on all countries. This lowered to 2.0 (95% CI: 1.2-3.1) after adjustment for calendartime and to 1.9 (95% CI: 1.1-3.2) when we accounted for contra-indications. In a subset (Netherlands, Norway, and United Kingdom) we further adjusted for other confounders and there the RI decreased from 1.7 (adjusted for calendar month) to 1.4 (95% CI: 0.7-2.8), which is the main finding. Conclusion: This study illustrates the potential of conducting European collaborative vaccine safety studies. The main, fully adjusted analysis, showed that the RI of GBS was not significantly elevated after influenza A(H1N1) pdm09 vaccination (RI = 1.4 (95% CI: 0.7-2.8). Based on the upper limits of the pooled estimate we can rule out with 95% certainty that the number of excess GBS cases after influenza A(H1N1) pdm09 vaccination would be more than 3 per million vaccinated.	[Romio, Silvana; Weibel, Daniel; Dieleman, Jeanne P.; Mosseveld, Mees; Schuemie, Martijn; Sturkenboom, Miriam C. J. M.] Erasmus MC, Dept Med Informat, Rotterdam, Netherlands; [Olberg, Henning K.] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway; [de Vries, Corinne S.; Sammon, Cormac] Univ Bath, Sch Pharm & Pharmacol, Bath BA2 7AY, Avon, England; [Andrews, Nick] Hlth Protect Agcy, London, England; [Svanstrom, Henrik; Molgaard-Nielsen, Ditte; Hviid, Anders] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Lapeyre-Mestre, Maryse; Sommet, Agnes] Toulouse Univ Hosp, Dept Clin Pharmacol, Toulouse, France; [Lapeyre-Mestre, Maryse; Sommet, Agnes] Fac Med Toulouse, INSERM, F-31073 Toulouse, France; [Saussier, Christel] French Natl Agcy Med & Hlth Prod Safety, St Denis, France; [Heijbel, Harald] Swedish Inst Infect Dis Control, Dept Vaccinol, Solna, Sweden; [Arnheim-Dahlstrom, Lisen; Sparen, Par] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [van der Mass, Nicoline] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; [Jacobs, Bart C.] Erasmus MC, Dept Neurol, Rotterdam, Netherlands; [Jacobs, Bart C.] Erasmus MC, Dept Immunol, Rotterdam, Netherlands; [Leino, Tuija; Kilpi, Terhi] Natl Inst Hlth & Welf, Dept Vaccinat & Immune Protect, Helsinki, Finland; [Storsaeter, Jann] Norwegian Inst Publ Hlth, Dept Vaccines, Oslo, Norway; [Johansen, Kari; Kramarz, Piotr] ECDC, European Ctr Dis Prevent & Control, Surveillance & Response Support Unit, Stockholm, Sweden; [Weibel, Daniel; Bonhoeffer, Jan] Brighton Collaborat Fdn, Basel, Switzerland; [Bonhoeffer, Jan] Univ Childrens Hosp, Dept Infect Dis & Vaccinol, Basel, Switzerland	Erasmus University Rotterdam; Erasmus MC; University of Bergen; Haukeland University Hospital; University of Bath; Health Protection Agency; Statens Serum Institut; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Swedish Institute for Infectious Disease Control; Karolinska Institutet; Netherlands National Institute for Public Health & the Environment; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Finland National Institute for Health & Welfare; Norwegian Institute of Public Health (NIPH); European Centre for Disease Prevention & Control	Weibel, D (corresponding author), Erasmus MC, Dept Med Informat, Rotterdam, Netherlands.	d.weibel@erasmusmc.nl	Sammon, Cormac/B-7340-2015; Lapeyre-Mestre, Maryse/C-8710-2012; Kramarz, Piotr/U-9442-2019; Bonhoeffer, Jan/E-5903-2014; Jacobs, Bart/ABE-2210-2021; Hviid, Anders/AAH-4319-2020	Sammon, Cormac/0000-0002-7921-4858; Lapeyre-Mestre, Maryse/0000-0002-5494-5873; Hviid, Anders/0000-0002-7509-9127; Olberg, Henning/0000-0002-0675-3690; Bonhoeffer, Jan/0000-0001-9704-8315; Sparen, Par/0000-0002-5184-8971; Schuemie, Martijn/0000-0002-0817-5361	European Centre for Disease Prevention and Control (ECDC)	European Centre for Disease Prevention and Control (ECDC)	The study was funded by European Centre for Disease Prevention and Control (ECDC) and co-funded by all participating centers from Denmark, Finland, France, Netherlands, Norway, Sweden, and the United Kingdom as specified in the Authors' affiliations. Funders have been involved in designing the study, collecting the data. analysis, decisions to publish, and in reviewing the manuscript.	Andrews N, 2011, VACCINE, V29, P7878, DOI 10.1016/j.vaccine.2011.08.069; Bardage C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5956; Coloma PM, 2011, PHARMACOEPIDEM DR S, V20, P1, DOI 10.1002/pds.2053; De Wals P, 2012, JAMA-J AM MED ASSOC, V308, P175, DOI 10.1001/jama.2012.7342; Dieleman J, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3908; Farrington CP, 2009, BIOSTATISTICS, V10, P3, DOI 10.1093/biostatistics/kxn013; Govoni V, 2001, CURR OPIN NEUROL, V14, P605, DOI 10.1097/00019052-200110000-00009; Greene SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067185; Greene SK, 2012, AM J EPIDEMIOL, V175, P1100, DOI 10.1093/aje/kws195; Grimaldi-Bensouda L, 2011, AM J EPIDEMIOL, V174, P326, DOI 10.1093/aje/kwr072; HURWITZ ES, 1981, NEW ENGL J MED, V304, P1557, DOI 10.1056/NEJM198106253042601; Juurlink DN, 2006, ARCH INTERN MED, V166, P2217, DOI 10.1001/archinte.166.20.2217; KAPLAN JE, 1982, JAMA-J AM MED ASSOC, V248, P698, DOI 10.1001/jama.248.6.698; Lasky T, 1998, NEW ENGL J MED, V339, P1797, DOI 10.1056/NEJM199812173392501; Lu CY, 2010, VACCINE, V28, P5864, DOI 10.1016/j.vaccine.2010.06.059; Lu W, 2010, EXPERT REV VACCINES, V9, P365, DOI 10.1586/ERV.10.23; McGrogan A, 2009, NEUROEPIDEMIOLOGY, V32, P150, DOI 10.1159/000184748; Paul-Ehrlich-Institut, 2012, ZUS ZWISCH PAND INFL; Poland GA, 2013, LANCET, V381, P1437, DOI 10.1016/S0140-6736(13)60182-8; Salmon DA, 2013, LANCET; SCHONBERGER LB, 1979, AM J EPIDEMIOL, V110, P105, DOI 10.1093/oxfordjournals.aje.a112795; Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003; Stowe J, 2009, AM J EPIDEMIOL, V169, P382, DOI 10.1093/aje/kwn310; Tokars JI, 2012, PHARMACOEPIDEM DR S, V21, P546, DOI 10.1002/pds.3220; van Doorn PA, 2008, LANCET NEUROL, V7, P939, DOI 10.1016/S1474-4422(08)70215-1; Wijnans L, 2011, VACCINE, V29, P7559, DOI 10.1016/j.vaccine.2011.08.016; Wise ME, 2012, AM J EPIDEMIOL, V175, P1110, DOI 10.1093/aje/kws196; Yih WK, 2012, AM J EPIDEMIOL, V175, P1120, DOI 10.1093/aje/kws197	28	45	45	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e82222	10.1371/journal.pone.0082222	http://dx.doi.org/10.1371/journal.pone.0082222			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404128	Green Published, Green Submitted, gold			2022-12-27	WOS:000329460800007
J	Aparicio, J; Garcia-Mora, C; Martin, M; Petriz, ML; Feliu, J; Sanchez-Santos, ME; Ayuso, JR; Fuster, D; Conill, C; Maurel, J				Aparicio, Jorge; Garcia-Mora, Carmen; Martin, Marta; Lourdes Petriz, Ma; Feliu, Jaime; Elena Sanchez-Santos, Ma; Ramon Ayuso, Juan; Fuster, David; Conill, Carlos; Maurel, Joan			A Phase I, Dose-Finding Study of Sorafenib in Combination with Gemcitabine and Radiation Therapy in Patients with Unresectable Pancreatic Adenocarcinoma: A Grupo Espanol Multidisciplinario en Cancer Digestivo (GEMCAD) Study	PLOS ONE			English	Article							TRIAL; ACTIVATION; CHEMORADIOTHERAPY; CHEMOTHERAPY; CAPECITABINE; BEVACIZUMAB; PATHWAY; GROWTH	Purpose: Sorafenib, an oral inhibitor of B-raf, VEGFR2, and PDGFR2-beta, acts against pancreatic cancer in preclinical models. Due to the radio-sensitization activity of both sorafenib and gemcitabine, we designed a multicenter, phase I trial to evaluate the safety profile and the recommended dose of this combination used with concomitant radiation therapy. Methods: Patients with biopsy-proven, unresectable pancreatic adenocarcinoma (based on vascular invasion detected by computed tomography) were treated with gemcitabine (300 mg/m2 i.v. weekly 65 weeks) concurrently with radiation therapy (45 Gy in 25 fractions) and sorafenib (escalated doses in a 3+3 design, from 200 to 800 mg/day). Radiation portals included the primary tumor but not the regional lymph nodes. Patients with planning target volumes (PTV) over 500 cc were excluded. Cases not progressing during chemoradiation were allowed to continue with sorafenib until disease progression. Results: Twelve patients were included. Three patients received 200 mg/day, 6 received 400 mg/day, and 3 received 800 mg/day; PTVs ranged from 105 to 500 cc. No dose-limiting toxicities occurred. The most common grade 2 toxicities were fatigue, neutropenia, nausea, and raised serum transaminases. Treatment was discontinued in one patient because of a reversible posterior leukoencephalopathy. There were no treatment-related deaths. Conclusion: The addition of sorafenib to concurrent gemcitabine and radiation therapy showed a favorable safety profile in unresectable pancreatic adenocarcinoma. A dose of 800 mg/day is recommended for phase II evaluation.	[Aparicio, Jorge] Hosp Univ & Politecn La Fe, Dept Med Oncol, Valencia, Spain; [Garcia-Mora, Carmen] Hosp Univ & Politecn La Fe, Dept Radiat Oncol, Valencia, Spain; [Martin, Marta] Hosp Santa Creu & Sant Pau, Dept Med Oncol, Barcelona, Spain; [Lourdes Petriz, Ma] Hosp Santa Creu & Sant Pau, Dept Radiat Oncol, Barcelona, Spain; [Feliu, Jaime] Hosp Univ La Paz, Dept Med Oncol, Madrid, Spain; [Elena Sanchez-Santos, Ma] Hosp Univ La Paz, Dept Radiat Oncol, Madrid, Spain; [Ramon Ayuso, Juan] Hosp Clin Barcelona, Dept Radiol, Barcelona, Spain; [Fuster, David] Hosp Clin Barcelona, Dept Nucl Med, Barcelona, Spain; [Conill, Carlos] Hosp Clin Barcelona, Dept Radiat Oncol, Barcelona, Spain; [Maurel, Joan] Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain	Hospital Universitari i Politecnic La Fe; Hospital Universitari i Politecnic La Fe; Hospital of Santa Creu i Sant Pau; Hospital of Santa Creu i Sant Pau; Hospital Universitario La Paz; Hospital Universitario La Paz; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona	Maurel, J (corresponding author), Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain.	jmaurel@clinic.ub.es			Bayer	Bayer(Bayer AG)	This work was supported by Bayer (http://www.bayer.es/): 1200(sic)/patient included. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Corcoran RB, 2011, CANCER RES, V71, P5020, DOI 10.1158/0008-5472.CAN-11-0908; Dawson LA, 2012, I J RAD BIOL PHYS, V84, p3S; Goncalves A, 2012, ANN ONCOL, V23, P2799, DOI 10.1093/annonc/mds135; Huang SB, 2010, MOL CANCER THER, V9, P742, DOI 10.1158/1535-7163.MCT-09-1004; Huguet F, 2007, J CLIN ONCOL, V25, P326, DOI 10.1200/JCO.2006.07.5663; Kindler HL, 2011, LANCET ONCOL, V12, P256, DOI 10.1016/S1470-2045(11)70004-3; Kindler HL, 2010, J CLIN ONCOL, V28, P3617, DOI 10.1200/JCO.2010.28.1386; Lawrence TS, 1996, INT J RADIAT ONCOL, V34, P867, DOI 10.1016/0360-3016(95)02134-5; Lim KH, 2006, CURR BIOL, V16, P2385, DOI 10.1016/j.cub.2006.10.023; LoConte NK, 2013, INVEST NEW DRUG, V31, P943, DOI 10.1007/s10637-012-9916-5; Loehrer PJ, 2011, J CLIN ONCOL; Martin TD, 2011, CANCER RES, V71, P206, DOI 10.1158/0008-5472.CAN-10-1517; McGinn CJ, 2001, J CLIN ONCOL, V19, P4202, DOI 10.1200/JCO.2001.19.22.4202; Mukherjee S, 2013, LANCET ONCOL, V14, P317, DOI 10.1016/S1470-2045(13)70021-4; Plastaras JP, 2007, CANCER RES, V67, P9443, DOI 10.1158/0008-5472.CAN-07-1473; Scotti ML, 2010, CANCER RES, V70, P2064, DOI 10.1158/0008-5472.CAN-09-2684; Senan S, 2007, ONCOLOGIST, V12, P465, DOI 10.1634/theoncologist.12-4-465; Small W, 2011, INT J RADIAT ONCOL, V80, P476, DOI 10.1016/j.ijrobp.2010.02.030; Sultana A, 2007, J CLIN ONCOL, V25, P2607, DOI 10.1200/JCO.2006.09.2551; Ulivi P, 2009, J CELL PHYSIOL, V220, P214, DOI 10.1002/jcp.21753; Von Hoff DD, 2013, RANDOMIZED PHASE 3 S; Wahl RL, 2009, J NUCL MED, V50, p122S, DOI 10.2967/jnumed.108.057307; Wee S, 2009, CANCER RES, V69, P4286, DOI 10.1158/0008-5472.CAN-08-4765; Wolff RA, 2001, CLIN CANCER RES, V7, P2246	25	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e82209	10.1371/journal.pone.0082209	http://dx.doi.org/10.1371/journal.pone.0082209			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416138	Green Published, gold, Green Submitted			2022-12-27	WOS:000329866300009
J	George, S; Paulick, S; Knutter, I; Rober, N; Hiemann, R; Roggenbuck, D; Conrad, K; Kupper, JH				George, Sandra; Paulick, Silvia; Knuetter, Ilka; Roeber, Nadja; Hiemann, Rico; Roggenbuck, Dirk; Conrad, Karsten; Kuepper, Jan-Heiner			Stable Expression of Human Muscle-Specific Kinase in HEp-2 M4 Cells for Automatic Immunofluorescence Diagnostics of Myasthenia Gravis	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTOR ANTIBODY; MUSK ANTIBODIES; HISTONE DEACETYLASE; AUTOANTIBODIES; FEATURES; IMMUNIZATION; PATTERNS; MECP2; DNA; MG	Muscle-specific kinase (MuSK) belongs to the nicotinic acetylcholine receptor complex which is targeted by pathogenic autoantibodies causing Myasthenia gravis. While up to 95% of patients with generalized Myasthenia gravis were shown to be positive for acetylcholine receptor-specific autoantibodies, up to 70% of the remaining patients develop autoantibodies against MuSK. Discrimination of the autoantibody specificity is important for therapy of Myasthenia gravis. Recently, the new automatic fluorescence assessment platform AKLIDES has been developed for immunofluorescence-based diagnostics of autoimmune diseases. In order to establish an AKLIDES procedure for the detection of MuSK-specific autoantibodies (anti-MuSK), we developed a recombinant HEp-2 cell clone expressing the human MuSK cDNA. Here we show at the mRNA and protein level that the cell clone HEp-2 M4 stably expresses human MuSK. We provide evidence for a localization of MuSK at the cell membrane. Using cell clone HEp-2 M4 on the AKLIDES system, we investigated 34 patient sera that were previously tested anti-MuSK positive by radioimmunoassay as positive controls. As negative controls, we tested 29 acetylcholine receptor-positive but MuSK-negative patient sera, 30 amytrophic lateral sclerosis (ALS) patient sera and 45 blood donors. HEp-2 M4 cells revealed a high specificity for the detection of MuSK autoantibodies from 25 patient sera assessed by a specific pattern on HEp-2 M4 cells. By using appropriate cell culture additives, the fraction of cells stained positive with anti-MuSK containing sera can be increased from 2-16% to 10-48%, depending on the serum. In conclusion, we provide data showing that the novel recombinant cell line HEp-2 M4 can be used to screen for anti-MuSK with the automatic AKLIDES system.	[George, Sandra; Paulick, Silvia; Roggenbuck, Dirk; Kuepper, Jan-Heiner] Brandenburg Univ Technol Cottbus Senftenberg, Fac Sci, Senftenberg, Germany; [Knuetter, Ilka; Hiemann, Rico; Roggenbuck, Dirk] GA Gener Assays GmbH, Dahlewitz Berlin, Germany; [George, Sandra; Roeber, Nadja; Conrad, Karsten] Tech Univ Dresden, Inst Immunol, D-01062 Dresden, Germany	Brandenburg University of Technology Cottbus; Technische Universitat Dresden	Kupper, JH (corresponding author), Brandenburg Univ Technol Cottbus Senftenberg, Fac Sci, Senftenberg, Germany.	Jan-Heiner.Kuepper@HS-Lausitz.de		Roggenbuck, Dirk/0000-0002-6861-6827	ZIM project [KF2088004AJ9]	ZIM project	This work was partially funded by ZIM project KF2088004AJ9. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartoccioni E, 2006, NEUROLOGY, V67, P505, DOI 10.1212/01.wnl.0000228225.23349.5d; Benatar M, 2012, MUSCLE NERVE, V45, P909, DOI 10.1002/mus.23330; Caress JB, 2005, ARCH NEUROL-CHICAGO, V62, P1002, DOI 10.1001/archneur.62.6.1002; Cavalcante P, 2012, CURR OPIN NEUROL, V25, P621, DOI 10.1097/WCO.0b013e328357a829; Cole RN, 2008, ANN NEUROL, V63, P782, DOI 10.1002/ana.21371; Conti-Fine BM, 2006, J CLIN INVEST, V116, P2843, DOI 10.1172/JCI29894; Deymeer F, 2007, NEUROLOGY, V68, P609, DOI 10.1212/01.wnl.0000254620.45529.97; Egerer K, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2949; Evoli A, 2003, BRAIN, V126, P2304, DOI 10.1093/brain/awg223; Evoli A, 2008, ANN NY ACAD SCI, V1132, P76, DOI 10.1196/annals.1405.012; Farrugia ME, 2006, MUSCLE NERVE, V33, P568, DOI 10.1002/mus.20491; Gerhauser C, 2013, BIOMEDICAL RES, V23, P91; Gilhus NE, 2012, CURR OPIN NEUROL, V25, P523, DOI 10.1097/WCO.0b013e3283572588; Grassi G, 2003, CARCINOGENESIS, V24, P1625, DOI 10.1093/carcin/bgg118; Grossmann K, 2011, CYTOM PART A, V79A, P118, DOI 10.1002/cyto.a.21009; Hiemann R, 2007, ANN NY ACAD SCI, V1109, P358, DOI 10.1196/annals.1398.042; Hiemann R, 2009, AUTOIMMUN REV, V9, P17, DOI 10.1016/j.autrev.2009.02.033; Hoch W, 2001, NAT MED, V7, P365, DOI 10.1038/85520; Jacob S, 2012, ARCH NEUROL-CHICAGO, V69, P994, DOI 10.1001/archneurol.2012.437; Jha S, 2006, J NEUROIMMUNOL, V175, P107, DOI 10.1016/j.jneuroim.2006.03.016; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kivity S, 2012, CLIN RHEUMATOL, V31, P503, DOI 10.1007/s10067-011-1884-1; Knutter I, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4119; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang B, 2009, CURR OPIN PHARMACOL, V9, P336, DOI 10.1016/j.coph.2009.04.005; Lavrnic D, 2005, J NEUROL NEUROSUR PS, V76, P1099, DOI 10.1136/jnnp.2004.052415; LEFVERT AK, 1978, SCAND J IMMUNOL, V8, P525; Leite MI, 2008, BRAIN, V131, P1940, DOI 10.1093/brain/awn092; Leite MI, 2005, ANN NEUROL, V57, P444, DOI 10.1002/ana.20386; LINDSTROM JM, 1976, NEUROLOGY, V26, P1054, DOI 10.1212/WNL.26.11.1054; McConville J, 2004, ANN NEUROL, V55, P580, DOI 10.1002/ana.20061; Meriggioli MN, 2012, EXPERT REV CLIN IMMU, V8, P427, DOI [10.1586/ECI.12.34, 10.1586/eci.12.34]; Meyer A, 2010, AUTOIMMUN REV, V9, pA383, DOI 10.1016/j.autrev.2009.11.011; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ohta K, 2007, EUR J NEUROL, V14, P1029, DOI 10.1111/j.1468-1331.2007.01870.x; Pasnoor M, 2010, MUSCLE NERVE, V41, P370, DOI 10.1002/mus.21533; Phillips LH, 2003, ANN NY ACAD SCI, V998, P407, DOI 10.1196/annals.1254.053; Pozarowski Piotr, 2004, Methods Mol Biol, V281, P301; Richman DP, 2012, ARCH NEUROL-CHICAGO, V69, P453, DOI 10.1001/archneurol.2011.2200; Rodiger S, 2013, ADV BIOCHEM ENG BIOT, V133, P35, DOI 10.1007/10_2011_132; Romi F, 2005, EUR J NEUROL, V12, P413, DOI 10.1111/j.1468-1331.2005.01137.x; Runge R, 2012, INT J RADIAT BIOL, V88, P439, DOI 10.3109/09553002.2012.658468; Sanders DB, 2003, NEUROLOGY, V60, P1978, DOI 10.1212/01.WNL.0000065882.63904.53; SANDERS DB, 1978, MUSCLE NERVE, V1, P146, DOI 10.1002/mus.880010207; Scuderi F, 2002, LAB INVEST, V82, P1139, DOI 10.1097/01.LAB.0000028144.48023.9B; Shigemoto K, 2006, J CLIN INVEST, V116, P1016, DOI 10.1172/JCI21545; Shigemoto K, 2008, ANN NY ACAD SCI, V1132, P93, DOI 10.1196/annals.1405.002; Simpson JA, 1960, SCOT MED J, V5, P419, DOI [10.1177/003693306000501001, DOI 10.1177/003693306000501001]; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vincent A, 2003, LANCET NEUROL, V2, P99, DOI 10.1016/S1474-4422(03)00306-5; Vincent A, 2004, SEMIN NEUROL, V24, P125, DOI 10.1055/s-2004-829589; Vincent AC, 2005, NEUROLOGY, V64, P399, DOI 10.1212/WNL.64.2.399; Willitzki A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/284740; Wolfe GI, 2008, ANN NY ACAD SCI, V1132, P71, DOI 10.1196/annals.1405.005	54	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e83924	10.1371/journal.pone.0083924	http://dx.doi.org/10.1371/journal.pone.0083924			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416182	Green Submitted, Green Published, gold			2022-12-27	WOS:000329866300016
J	Gomez-Pinilla, PJ; Farro, G; Di Giovangiulio, M; Stakenborg, N; Nemethova, A; de Vries, A; Liston, A; Feyerabend, TB; Rodewald, HR; Boeckxstaens, GE; Matteoli, G				Gomez-Pinilla, Pedro J.; Farro, Giovanna; Di Giovangiulio, Martina; Stakenborg, Nathalie; Nemethova, Andrea; de Vries, Annick; Liston, Adrian; Feyerabend, Thorsten B.; Rodewald, Hans-Reimwer; Boeckxstaens, Guy E.; Matteoli, Gianluca			Mast Cells Play No Role in the Pathogenesis of Postoperative Ileus Induced by Intestinal Manipulation	PLOS ONE			English	Article							INTERSTITIAL-CELLS; GENE-EXPRESSION; SH MICE; COMPOUND-48/80; STIMULATION; ACTIVATION; KETOTIFEN; CAJAL; DEGRANULATION; INFLAMMATION	Introduction: Intestinal manipulation (IM) during abdominal surgery results in intestinal inflammation leading to hypomotility or ileus. Mast cell activation is thought to play a crucial role in the pathophysiology of postoperative ileus (POI). However, this conclusion was mainly drawn using mast cell-deficient mouse models with abnormal Kit signaling. These mice also lack interstitial cells of Cajal (ICC) resulting in aberrant gastrointestinal motility even prior to surgery, compromising their use as model to study POI. To avoid these experimental weaknesses we took advantage of a newly developed knock-in mouse model, Cpa3(Cre/+), devoid of mast cells but with intact Kit signaling. Design: The role of mast cells in the development of POI and intestinal inflammation was evaluated assessing gastrointestinal transit and muscularis externa inflammation after IM in two strains of mice lacking mast cells, i.e. Kit(W-sh/W-sh) and Cpa3(Cre/+) mice, and by use of the mast cell stabilizer cromolyn. Results: Kit(W-sh/W-sh) mice lack ICC networks and already revealed significantly delayed gastrointestinal transit even before surgery. IM did not further delay intestinal transit, but induced infiltration of myeloperoxidase positive cells, expression of inflammatory cytokines and recruitment of monocytes and neutrophils into the muscularis externa. On the contrary, Cpa3(Cre/+) mice have a normal network of ICC and normal gastrointestinal. Surprisingly, IM in Cpa3(Cre/+) mice caused delay in gut motility and intestinal inflammation as in wild type littermates mice (Cpa3(+/+)). Furthermore, treatment with the mast cell inhibitor cromolyn resulted in an inhibition of mast cells without preventing POI. Conclusions: Here, we confirm that IM induced mast cell degranulation. However, our data demonstrate that mast cells are not required for the pathogenesis of POI in mice. Although there might be species differences between mouse and human, our results argue against mast cell inhibitors as a therapeutic approach to shorten POI.	[Gomez-Pinilla, Pedro J.; Farro, Giovanna; Di Giovangiulio, Martina; Stakenborg, Nathalie; Nemethova, Andrea; de Vries, Annick; Boeckxstaens, Guy E.; Matteoli, Gianluca] Katholieke Univ Leuven, Translat Res Ctr Gastrointestinal Disorders TARGI, Dept Clin & Expt Med, Louvain, Belgium; [Liston, Adrian] Katholieke Univ Leuven, Dept Microbiol & Immunol, Louvain, Belgium; [Liston, Adrian] Vlaams Inst Biotechnol VIB, Autoimmune Genet Lab, Louvain, Belgium; [Feyerabend, Thorsten B.; Rodewald, Hans-Reimwer] German Canc Res Ctr, Div Cellular Immunol, Heidelberg, Germany	KU Leuven; KU Leuven; Flanders Institute for Biotechnology (VIB); Helmholtz Association; German Cancer Research Center (DKFZ)	Matteoli, G (corresponding author), Katholieke Univ Leuven, Translat Res Ctr Gastrointestinal Disorders TARGI, Dept Clin & Expt Med, Louvain, Belgium.	gianluca.matteoli@med.kuleuven.be	Boeckxstaens, Guy/AAP-2502-2020; Liston, Adrian/G-8606-2013	Liston, Adrian/0000-0002-6272-4085; Di Giovangiulio, Martina/0000-0003-3004-578X; Matteoli, Gianluca/0000-0002-2902-4976	Research Foundation - Flanders (FWO) (Odysseus program); FWO postdoctoral research fellowship; FWO PhD fellowship; DFG [SFB 983 project L]; ERC [233074]	Research Foundation - Flanders (FWO) (Odysseus program)(FWO); FWO postdoctoral research fellowship; FWO PhD fellowship(FWO); DFG(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission)	Supported by grants from Research Foundation - Flanders (FWO) (Odysseus program to GEB), by a FWO postdoctoral research fellowship (to GM and PJG) by FWO PhD fellowship (to MDG), by DFG (SFB 983 project L to HRR) and by the ERC (grant no. 233074 to HRR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asgeirsson T, 2010, J AM COLL SURGEONS, V210, P228, DOI 10.1016/j.jamcollsurg.2009.09.028; Bauer AJ, 2004, NEUROGASTROENT MOTIL, V16, P54, DOI 10.1111/j.1743-3150.2004.00558.x; Boeckxstaens GE, 2009, GUT, V58, P1300, DOI 10.1136/gut.2008.169250; Bouchard JC, 2012, AM J PATHOL, V181, P845, DOI 10.1016/j.ajpath.2012.05.020; Byrne RD, 2007, CELL SIGNAL, V19, P321, DOI 10.1016/j.cellsig.2006.07.004; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; De Jonge WJ, 2004, GASTROENTEROLOGY, V127, P535, DOI 10.1053/j.gastro.2004.04.017; De Jonge WJ, 2003, GASTROENTEROLOGY, V125, P1137, DOI 10.1016/S0016-5085(03)01197-1; Feyerabend TB, 2011, IMMUNITY, V35, P832, DOI 10.1016/j.immuni.2011.09.015; Feyerabend TB, 2009, IMMUNITY, V30, P67, DOI 10.1016/j.immuni.2008.10.016; Fowler CJ, 2003, INFLAMM RES, V52, P461, DOI 10.1007/s00011-003-1202-8; GALLI SJ, 1984, PROG ALLERGY, V34, P1; Gomez-Pinilla PJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1370, DOI 10.1152/ajpgi.00074.2009; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; HUIZINGA JD, 1995, NATURE, V373, P347, DOI 10.1038/373347a0; Hung CH, 2007, PEDIAT ALLERG IMM-UK, V18, P378, DOI 10.1111/j.1399-3038.2007.00535.x; Iino S, 2009, NEUROSCI LETT, V459, P123, DOI 10.1016/j.neulet.2009.05.003; Kaida S, 2010, FREE RADICAL RES, V44, P171, DOI 10.3109/10715760903380466; KAKUTA Y, 1988, J ALLERGY CLIN IMMUN, V81, P469, DOI 10.1016/0091-6749(88)90919-0; Kalff JC, 1999, GASTROENTEROLOGY, V117, P378, DOI 10.1053/gast.1999.0029900378; Kalff JC, 1998, J LEUKOCYTE BIOL, V63, P683, DOI 10.1002/jlb.63.6.683; Kalff JC, 2000, GASTROENTEROLOGY, V118, P316, DOI 10.1016/S0016-5085(00)70214-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Michel A, 2013, J IMMUNOL, V190, P5534, DOI 10.4049/jimmunol.1203355; Nigrovic PA, 2008, AM J PATHOL, V173, P1693, DOI 10.2353/ajpath.2008.080407; Palomaki VAB, 2006, BRIT J PHARMACOL, V147, P596, DOI 10.1038/sj.bjp.0706671; Ramos L, 2010, J IMMUNOL, V185, P709, DOI 10.4049/jimmunol.1000273; Rodewald HR, 2012, IMMUNITY, V37, P13, DOI 10.1016/j.immuni.2012.07.007; Schemann M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052104; Schwarz NT, 2001, GASTROENTEROLOGY, V121, P1354, DOI 10.1053/gast.2001.29605; Snoek SA, 2012, NEUROGASTROENT MOTIL, V24, P172, DOI 10.1111/j.1365-2982.2011.01820.x; The FO, 2008, GUT, V57, P33, DOI 10.1136/gut.2007.120238; The FO, 2005, BRIT J PHARMACOL, V146, P252, DOI 10.1038/sj.bjp.0706303; van Bree SHW, 2012, NAT REV GASTRO HEPAT, V9, P675, DOI 10.1038/nrgastro.2012.134; van Bree Sjoerd Hw, 2012, Int J Physiol Pathophysiol Pharmacol, V4, P219; Viaro F, 2008, NITRIC OXIDE-BIOL CH, V18, P87, DOI 10.1016/j.niox.2007.11.004; Wehner S, 2007, GUT, V56, P176, DOI 10.1136/gut.2005.089615; Yamada Y, 2003, PHARMACOLOGY, V69, P138, DOI 10.1159/000072666; YAMAZAKI M, 1994, BLOOD, V83, P3509; Zhou JS, 2007, J EXP MED, V204, P2797, DOI 10.1084/jem.20071391	40	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85304	10.1371/journal.pone.0085304	http://dx.doi.org/10.1371/journal.pone.0085304			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416383	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000329866300066
J	Pretorius, E; Bester, J; Vermeulen, N; Lipinski, B; Gericke, GS; Kell, DB				Pretorius, Etheresia; Bester, Janette; Vermeulen, Natasha; Lipinski, Boguslaw; Gericke, George S.; Kell, Douglas B.			Profound Morphological Changes in the Erythrocytes and Fibrin Networks of Patients with Hemochromatosis or with Hyperferritinemia, and Their Normalization by Iron Chelators and Other Agents	PLOS ONE			English	Article							SICKLE-CELL-DISEASE; RED-BLOOD-CELL; HFE C282Y HOMOZYGOSITY; SERUM FERRITIN; HEREDITARY HEMOCHROMATOSIS; OXIDATIVE STRESS; SCANNING-ELECTRON; ASYMPTOMATIC SUBJECTS; BIOLOGICAL-MEMBRANES; PARKINSONS-DISEASE	It is well-known that individuals with increased iron levels are more prone to thrombotic diseases, mainly due to the presence of unliganded iron, and thereby the increased production of hydroxyl radicals. It is also known that erythrocytes (RBCs) may play an important role during thrombotic events. Therefore the purpose of the current study was to assess whether RBCs had an altered morphology in individuals with hereditary hemochromatosis (HH), as well as some who displayed hyperferritinemia (HF). Using scanning electron microscopy, we also assessed means by which the RBC and fibrin morphology might be normalized. An important objective was to test the hypothesis that the altered RBC morphology was due to the presence of excess unliganded iron by removing it through chelation. Very striking differences were observed, in that the erythrocytes from HH and HF individuals were distorted and had a much greater axial ratio compared to that accompanying the discoid appearance seen in the normal samples. The response to thrombin, and the appearance of a platelet-rich plasma smear, were also markedly different. These differences could largely be reversed by the iron chelator desferal and to some degree by the iron chelator clioquinol, or by the free radical trapping agents salicylate or selenite (that may themselves also be iron chelators). These findings are consistent with the view that the aberrant morphology of the HH and HF erythrocytes is caused, at least in part, by unliganded ('free') iron, whether derived directly via raised ferritin levels or otherwise, and that lowering it or affecting the consequences of its action may be of therapeutic benefit. The findings also bear on the question of the extent to which accepting blood donations from HH individuals may be desirable or otherwise.	[Pretorius, Etheresia; Bester, Janette; Vermeulen, Natasha] Univ Pretoria, Dept Physiol, Arcadia, South Africa; [Lipinski, Boguslaw] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02115 USA; [Gericke, George S.] AMPATH Natl Reference Lab, Centurion, South Africa; [Kell, Douglas B.] Univ Manchester, Sch Chem, Manchester M13 9PL, Lancs, England; [Kell, Douglas B.] Univ Manchester, Manchester Inst Biotechnol, Manchester M13 9PL, Lancs, England	University of Pretoria; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; University of Manchester; University of Manchester	Pretorius, E (corresponding author), Univ Pretoria, Dept Physiol, Arcadia, South Africa.	resia.pretorius@up.ac.za	Pretorius, Etheresia/ACH-6368-2022; Pretorius, Etheresia/P-2978-2016; Kell, Douglas/E-8318-2011	Pretorius, Etheresia/0000-0002-9108-2384; Pretorius, Etheresia/0000-0002-9108-2384; Bester, Janette/0000-0002-8931-9194; Kell, Douglas/0000-0001-5838-7963	National Research Foundation of South Africa (NRF); BBSRC [BB/L025752/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L025752/1] Funding Source: researchfish	National Research Foundation of South Africa (NRF)(National Research Foundation - South Africa); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding body: The National Research Foundation of South Africa (NRF): E Pretorius. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abergel RJ, 2006, J AM CHEM SOC, V128, P8920, DOI 10.1021/ja062046j; Acton RT, 2006, DIABETES CARE, V29, P2084, DOI 10.2337/dc05-1592; Adamkiewicz TV, 2009, BLOOD, V114, P4632, DOI 10.1182/blood-2009-02-203323; Adams PC, 2008, INT J LAB HEMATOL, V30, P300, DOI 10.1111/j.1751-553X.2007.00956.x; Adams Paul, 2008, Gastroenterol Hepatol (N Y), V4, P333; Adams PC, 2006, CLIN GASTROENTEROL H, V4, P918, DOI 10.1016/j.cgh.2006.04.013; Adams PC, 2005, NEW ENGL J MED, V352, P1769, DOI 10.1056/NEJMoa041534; Adams RJ, 2007, ARCH NEUROL-CHICAGO, V64, P1567, DOI 10.1001/archneur.64.11.1567; Ahluwalia N, 2010, J NUTR, V140, P812, DOI 10.3945/jn.109.110353; Akoev VR, 1997, B EXP BIOL MED+, V123, P242, DOI 10.1007/BF02445414; Allen KJ, 2008, NEW ENGL J MED, V358, P221, DOI 10.1056/NEJMoa073286; Altamura S, 2009, J ALZHEIMERS DIS, V16, P879, DOI 10.3233/JAD-2009-1010; Altes A, 2009, ANN HEMATOL, V88, P951, DOI 10.1007/s00277-009-0705-y; [Anonymous], 2006, FREE RADICALS BIOL M; Asberg A, 2007, SCAND J GASTROENTERO, V42, P1073, DOI 10.1080/00365520701245488; Ayonrinde OT, 2008, CRIT REV CL LAB SCI, V45, P451, DOI 10.1080/10408360802335716 ; Azizova OA, 2009, B EXP BIOL MED+, V148, P776, DOI 10.1007/s10517-010-0814-6; Babitt JL, 2011, SEMIN LIVER DIS, V31, P280, DOI 10.1055/s-0031-1286059; Bao GH, 2010, NAT CHEM BIOL, V6, P602, DOI [10.1038/nchembio.402, 10.1038/NCHEMBIO.402]; Bareggi SR, 2012, CNS NEUROSCI THER, V18, P41, DOI 10.1111/j.1755-5949.2010.00231.x; Barton JC, 2012, CLIN GASTROENTEROL H, V10, P412, DOI 10.1016/j.cgh.2011.11.032; Barton JC, 1998, ANN INTERN MED, V129, P932, DOI 10.7326/0003-4819-129-11_Part_2-199812011-00003; Barton JC, 2000, J LAB CLIN MED, V135, P96, DOI 10.1016/S0022-2143(00)70026-6; Bassett ML, 2001, INTERN MED J, V31, P237, DOI 10.1046/j.1445-5994.2001.00050.x; Brandhagen DJ, 2002, AM FAM PHYSICIAN, V65, P853; Brewer GJ, 2007, EXP BIOL MED, V232, P323; Bush AI, 2008, J ALZHEIMERS DIS, V15, P223; Buys AV, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-25; Cahoon L, 2009, NAT MED, V15, P356, DOI 10.1038/nm0409-356; Camaschella C, 2011, CURR OPIN PEDIATR, V23, P14, DOI 10.1097/MOP.0b013e3283425591; Castellani RJ, 2012, BIOFACTORS, V38, P133, DOI 10.1002/biof.1010; Chan MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054902; Chen JX, 2012, BBA-GEN SUBJECTS, V1820, P256, DOI 10.1016/j.bbagen.2011.07.015; Choi BY, 2013, NEUROBIOL DIS; Clark Paul, 2010, Clin Biochem Rev, V31, P3; Cooper GJS, 2011, DRUGS, V71, P1281, DOI 10.2165/11591370-000000000-00000; Crichton RR, 2011, J NEURAL TRANSM, V118, P301, DOI 10.1007/s00702-010-0470-z; Crownover BK, 2013, AM FAM PHYSICIAN, V87, P183; Daniels R., 2010, DELMARS GUIDE LAB DI; Darshan D, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001687; Davey HM, 1996, MICROBIOL REV, V60, P641, DOI 10.1128/MMBR.60.4.641-696.1996; Day SM, 2003, CIRCULATION, V107, P2601, DOI 10.1161/01.CIR.0000066910.02844.D0; DePalma RG, 2010, J VASC SURG, V51, P1498, DOI 10.1016/j.jvs.2009.12.068; Dhillon BK, 2007, WORLD J GASTROENTERO, V13, P2956, DOI 10.3748/wjg.v13.i21.2956; Double KL, 2008, CELL MOL LIFE SCI, V65, P1669, DOI 10.1007/s00018-008-7581-9; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Ferro E, 2012, FREE RADICAL BIO MED, V53, P1829, DOI 10.1016/j.freeradbiomed.2012.08.592; Finberg KE, 2013, J CLIN INVEST, V123, P1424, DOI 10.1172/JCI68889; Flaten TP, 2012, J TRACE ELEM MED BIO, V26, P127, DOI 10.1016/j.jtemb.2012.03.009; Fleming RE, 2005, SEMIN LIVER DIS, V25, P411, DOI 10.1055/s-2005-923313; Franchini M, 2008, ANN HEMATOL, V87, P167, DOI 10.1007/s00277-007-0416-1; Funke C, 2012, NEUROCHEM INT; Funke C, 2013, NEUROCHEM INT, V62, P637, DOI 10.1016/j.neuint.2012.11.015; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Girasole M, 2012, MICRON, V43, P1273, DOI 10.1016/j.micron.2012.03.019; Gordeuk VR, 2012, CAN J GASTROENTEROL, V26, P345, DOI 10.1155/2012/676824; Gotz ME, 2004, ANN NY ACAD SCI, V1012, P193, DOI 10.1196/annals.1306.017; Gurrin LC, 2008, GASTROENTEROLOGY, V135, P1945, DOI 10.1053/j.gastro.2008.08.056; Hardy G, 2012, NUTR CLIN PRACT, V27, P21, DOI 10.1177/0884533611434116; Huang JY, 2011, DIABETES, V60, P80, DOI 10.2337/db10-0593; Inati A, 2011, PEDIATR BLOOD CANCER, V56, P182, DOI 10.1002/pbc.22721; Inati A, 2010, AM J HEMATOL, V85, P782, DOI 10.1002/ajh.21806; Inati A, 2010, BLOOD, V115, P2980, DOI 10.1182/blood-2009-09-243568; Jacobs EMG, 2009, J HEPATOL, V50, P174, DOI 10.1016/j.jhep.2008.08.014; Jiang R, 2004, JAMA-J AM MED ASSOC, V291, P711, DOI 10.1001/jama.291.6.711; Jomova K, 2011, CURR PHARM DESIGN, V17, P3460, DOI 10.2174/138161211798072463; Kasvosve I, 2013, CLIN CHIM ACTA, V416, P20, DOI 10.1016/j.cca.2012.11.013; Kaur H, 1996, ANN RHEUM DIS, V55, P915, DOI 10.1136/ard.55.12.915; Kell DB, 2010, ARCH TOXICOL, V84, P825, DOI 10.1007/s00204-010-0577-x; Kell DB, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-2; KELLNER H, 1992, Z GASTROENTEROL, V30, P779; Kiechl S, 1997, CIRCULATION, V96, P3300; Konz T, 2013, ANAL CHEM, V85, P8334, DOI 10.1021/ac401692k; Kozlova EK, 2012, ANAL NANOSTRUCTURE R; Kurz T, 2008, HISTOCHEM CELL BIOL, V129, P389, DOI 10.1007/s00418-008-0394-y; Kwan T, 1998, CLIN INVEST MED, V21, P251; Lee DH, 2004, DIABETOLOGIA, V47, P185, DOI 10.1007/s00125-003-1307-1; Lee MT, 2006, BLOOD, V108, P847, DOI 10.1182/blood-2005-10-009506; Leitman SF, 2003, TRANSFUSION, V43, P1538, DOI 10.1046/j.1537-2995.2003.00570.x; Lim HWG, 2002, P NATL ACAD SCI USA, V99, P16766, DOI 10.1073/pnas.202617299; Limdi JK, 2004, QJM-INT J MED, V97, P315, DOI 10.1093/qjmed/hch065; Lipinski B, 2012, MICROSC RES TECHNIQ, V75, P1185, DOI 10.1002/jemt.22047; Lipinski B, 2012, ULTRASTRUCT PATHOL, V36, P79, DOI 10.3109/01913123.2011.627491; Lipinski B, 2012, POL ARCH MED WEWN, V122, P115, DOI 10.20452/pamw.1201; Luten M, 2008, TRANSFUSION, V48, P436, DOI 10.1111/j.1537-2995.2007.01547.x; Ma Y, 2012, CURR MED CHEM, V19, P2816, DOI 10.2174/092986712800609724; Madathil KS, 2013, SYNAPSE; Mangasser-Stephan K, 1999, CLIN CHEM, V45, P1875; Martines AM, 2013, NAT REV NEPHROL; Mazumdar M, 2007, PEDIATRICS, V120, pe1107, DOI 10.1542/peds.2006-2002; McCullen MA, 2002, CLIN CHIM ACTA, V315, P169, DOI 10.1016/S0009-8981(01)00711-2; McCune CA, 2006, GUT, V55, P554, DOI 10.1136/gut.2005.070342; McLaren CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017390; McLaren Gordon D, 2009, Hematology Am Soc Hematol Educ Program, P195, DOI 10.1182/asheducation-2009.1.195; Merono T, 2011, EUR J CLIN INVEST, V41, P479, DOI 10.1111/j.1365-2362.2010.02429.x; Mirre E, 2010, EUR J HAEMATOL, V84, P259, DOI 10.1111/j.1600-0609.2009.01379.x; Moczulski DK, 2001, DIABETES CARE, V24, P1187, DOI 10.2337/diacare.24.7.1187; Mohanakumar KP, 2000, BRAIN RES, V864, P281, DOI 10.1016/S0006-8993(00)02189-2; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; Nagy E, 2010, ARTERIOSCL THROM VAS, V30, P1347, DOI 10.1161/ATVBAHA.110.206433; Nielsen P, 2000, J LAB CLIN MED, V135, P413, DOI 10.1067/mlc.2000.106456; Nunez MT, 2012, BIOMETALS, V25, P761, DOI 10.1007/s10534-012-9523-0; Olynyk JK, 2008, HEPATOLOGY, V48, P991, DOI 10.1002/hep.22507; Oyama TM, 2012, LIFE SCI, V91, P1216, DOI 10.1016/j.lfs.2012.09.014; Pasini EM, 2010, J PROTEOMICS, V73, P403, DOI 10.1016/j.jprot.2009.06.005; Pietrangelo A, 2010, GASTROENTEROLOGY, V139, P393, DOI 10.1053/j.gastro.2010.06.013; Pra D, 2012, MUTAT RES-FUND MOL M, V733, P92, DOI 10.1016/j.mrfmmm.2012.02.001; Pretorius E, 2013, BLOOD, V121, P9, DOI 10.1182/blood-2012-09-454793; Pretorius E, 2007, PATHOPHYSIOL HAEMO T, V36, P251, DOI 10.1159/000252821; Pretorius E, 2013, TOXICOL MECH METHODS; Pretorius E, 2012, HEART LUNG CIRC; Pretorius E, 2013, TOXICOL MECH METHOD, V23, P352, DOI 10.3109/15376516.2012.762082; Pretorius E, 2013, MICROSC RES TECHNIQ, V76, P268, DOI 10.1002/jemt.22163; Pretorius E, 2013, CURR DRUG TARGETS, V14, P13, DOI 10.2174/138945013804806541; Prus E, 2010, ACTA HAEMATOL-BASEL, V123, P14, DOI 10.1159/000258958; Raghupathy R, 2010, ADV HEMATOL; RAI D, 1995, J SOLUTION CHEM, V24, P735, DOI 10.1007/BF01131042; Rajpathak SN, 2009, DIABETES OBES METAB, V11, P472, DOI 10.1111/j.1463-1326.2008.00985.x; Ritchie CW, 2003, ARCH NEUROL-CHICAGO, V60, P1685, DOI 10.1001/archneur.60.12.1685; Roetto A, 2005, BEST PRACT RES CL HA, V18, P235, DOI 10.1016/j.beha.2004.09.004; SALONEN JT, 1992, CIRCULATION, V86, P803, DOI 10.1161/01.CIR.86.3.803; Santos PCJL, 2012, INT J MOL SCI, V13, P1497, DOI 10.3390/ijms13021497; Santos PCJL, 2011, BLOOD CELL MOL DIS, V46, P302, DOI 10.1016/j.bcmd.2011.02.008; Schneider SA, 2012, SEMIN PEDIATR NEUROL, V19, P57, DOI 10.1016/j.spen.2012.03.005; Schneider SA, 2012, MOVEMENT DISORD, V27, P42, DOI 10.1002/mds.23971; SHEETZ MP, 1976, J CELL BIOL, V70, P193, DOI 10.1083/jcb.70.1.193; SHEETZ MP, 1976, J CELL BIOL, V70, P247, DOI 10.1083/jcb.70.1.247; SHEETZ MP, 1974, P NATL ACAD SCI USA, V71, P4457, DOI 10.1073/pnas.71.11.4457; Shizukuda Y, 2007, AM J HEMATOL, V82, P249, DOI 10.1002/ajh.20743; Shizukuda Y, 2006, AM J CARDIOL, V98, P954, DOI 10.1016/j.amjcard.2006.04.040; SIMON M, 1976, GUT, V17, P332, DOI 10.1136/gut.17.5.332; Smith-Whitley K, 2012, PEDIATR BLOOD CANCER, V59, P358, DOI 10.1002/pbc.24179; Superior Health Council, 2013, SHC PUBL, V8672; Swinkels DW, 2011, HAEMATOL-HEMATOL J, V96, P485, DOI 10.3324/haematol.2011.042036; Switzer JA, 2006, LANCET NEUROL, V5, P501, DOI 10.1016/S1474-4422(06)70469-0; Tachev KD, 2004, COLLOID SURFACE B, V34, P123, DOI 10.1016/j.colsurfb.2003.12.011; Tanaka T, 2010, BLOOD, V115, P94, DOI 10.1182/blood-2009-07-232496; Terman A, 2006, ANTIOXID REDOX SIGN, V8, P197, DOI 10.1089/ars.2006.8.197; Terman A, 2004, INT J BIOCHEM CELL B, V36, P1400, DOI 10.1016/j.biocel.2003.08.009; Tsuchiya K, 2013, THER APHER DIAL, V17, P1, DOI 10.1111/1744-9987.12001; Verduzco LA, 2009, BLOOD, V114, P5117, DOI 10.1182/blood-2009-05-220921; Vermeulen E, 2012, ACTA CLIN BELG, V67, P190, DOI 10.2143/ACB.67.3.2062654; Waalen J, 2008, BLOOD, V111, P3373, DOI 10.1182/blood-2007-07-102673; Walter PB, 2009, ACTA HAEMATOL-BASEL, V122, P174, DOI 10.1159/000243802; Wang Y, 2012, SEMIN ARTHRITIS RHEU, V41, P872, DOI 10.1016/j.semarthrit.2011.11.003; Weiss G, 2010, NAT REV GASTRO HEPAT, V7, P50, DOI 10.1038/nrgastro.2009.201; White AR, 2006, EXPERT REV NEUROTHER, V6, P711, DOI 10.1586/14737175.6.5.711; Wilson JG, 2003, AM J MED SCI, V325, P332, DOI 10.1097/00000441-200306000-00004; Wong B, 2011, NAT METHODS, V8, P365, DOI 10.1038/nmeth0511-365; Wood MJ, 2012, HEPATOLOGY, V56, P904, DOI 10.1002/hep.25720; Yamanishi H, 2002, CLIN BIOCHEM, V35, P523, DOI 10.1016/S0009-9120(02)00380-6; Yu Y, 2012, CURR MED CHEM, V19, P2689, DOI 10.2174/092986712800609706; Zeitz M, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.051904	154	47	47	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85271	10.1371/journal.pone.0085271	http://dx.doi.org/10.1371/journal.pone.0085271			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416376	Green Published, gold			2022-12-27	WOS:000329866300062
J	Xin, H; Wang, K; Hu, G; Xie, FB; Ouyang, KD; Tang, XZ; Wang, MJ; Wen, DY; Zhu, YZ; Qin, XR				Xin, Hong; Wang, Ke; Hu, Gang; Xie, Fubo; Ouyang, Kedong; Tang, Xuzhen; Wang, Minjun; Wen, Danyi; Zhu, Yizhun; Qin, Xiaoran			Establishment and Characterization of 7 Novel Hepatocellular Carcinoma Cell Lines from Patient-Derived Tumor Xenografts	PLOS ONE			English	Article							GAMMA-CARBOXY PROTHROMBIN; SERUM ALPHA-FETOPROTEIN; PRIMARY LIVER-CANCER; HEPATITIS-B-VIRUS; RISK-FACTORS; HETEROGENEITY; EPIDEMIOLOGY; PROGNOSIS; INFECTION; DIAGNOSIS	Hepatocellular carcinoma (HCC) is a common cancer with poor prognosis worldwide and the molecular mechanism is not well understood. This study aimed to establish a collection of human HCC cell lines from patient-derived xenograft (PDX) models. From the 20 surgical HCC sample collections, 7 tumors were successfully developed in immunodeficient mice and further established 7 novel HCC cell lines (LIXC002, LIXC003, LIXC004, LIXC006, LIXC011, LIXC012 and CPL0903) by primary culture. The characterization of cell lines was defined by morphology, growth kinetics, cell cycle, chromosome analysis, short tandem repeat (STR) analysis, molecular profile, and tumorigenicity. Additionally, response to clinical chemotherapeutics was validated both in vitro and in vivo. STR analysis indicated that all cell lines were unique cells different from known cell lines and free of contamination by bacteria or mycoplasma. The other findings were quite heterogeneous between individual lines. Chromosome aberration could be found in all cell lines. Alpha-fetoprotein was overexpressed only in 3 out of 7 cell lines. 4 cell lines expressed high level of vimentin. Ki67 was strongly stained in all cell lines. mRNA level of retinoic acid induced protein 3 (RAI3) was decreased in all cell lines. The 7 novel cell lines showed variable sensitivity to 8 tested compounds. LIXC011 and CPL0903 possessed multiple drug resistance property. Sorafenib inhibited xenograft tumor growth of LIXC006, but not of LIXC012. Our results indicated that the 7 novel cell lines with low passage maintaining their clinical and pathological characters could be good tools for further exploring the molecular mechanism of HCC and anti-cancer drug screening.	[Wang, Ke; Hu, Gang; Xie, Fubo; Ouyang, Kedong; Tang, Xuzhen; Wen, Danyi; Qin, Xiaoran] Shanghai ChemPartner Co LTD, Shanghai, Peoples R China; [Xin, Hong; Wang, Minjun; Zhu, Yizhun] Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai 200433, Peoples R China	Fudan University	Qin, XR (corresponding author), Shanghai ChemPartner Co LTD, Shanghai, Peoples R China.	xiaoran_qin@yahoo.com	Xin, Hong/AAF-5786-2020; Zhu, Yi Zhun/ABG-8449-2021	Zhu, Yi Zhun/0000-0001-7700-8041	Shanghai Science and Technology Committee [11140901400]	Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	Shanghai Science and Technology Committee research grant, 2011, No. 11140901400. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Carr BI, 2007, DIGEST DIS SCI, V52, P776, DOI 10.1007/s10620-006-9541-2; Chan SL, 2009, J CLIN ONCOL, V27, P446, DOI 10.1200/JCO.2008.18.8151; de Lera AR, 2007, NAT REV DRUG DISCOV, V6, P811, DOI 10.1038/nrd2398; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Ertle JM, 2013, DIGESTION, V87, P121, DOI 10.1159/000346080; Fransvea E, 2009, CELL ONCOL, V31, P227, DOI 10.3233/CLO-2009-0473; Gao TY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062950; Guzman G, 2005, MODERN PATHOL, V18, P1498, DOI 10.1038/modpathol.3800458; Hu G, 2012, INT J ONCOL, V40, P798, DOI 10.3892/ijo.2011.1254; Hu L, 2004, ONCOGENE, V23, P298, DOI 10.1038/sj.onc.1206483; Ivaska Johanna, 2011, Small GTPases, V2, P51; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Julien S, 2012, CLIN CANCER RES, V18, P5314, DOI 10.1158/1078-0432.CCR-12-0372; KAWAMATA N, 1995, CANCER RES, V55, P2266; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; LOK ASF, 1989, HEPATOLOGY, V9, P110, DOI 10.1002/hep.1840090119; Maletzki C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052485; Marquardt JU, 2012, J HEPATOL, V56, P267, DOI 10.1016/j.jhep.2011.07.007; Mizejewski G, 1997, BETA FETOPROTEIN BIO, P333; Mukhopadhyay B, 2010, J BIOL CHEM, V285, P19002, DOI 10.1074/jbc.M109.068460; Naguib A, 2013, TRENDS CELL BIOL; Ni XG, 2005, EJSO-EUR J SURG ONC, V31, P164, DOI 10.1016/j.ejso.2004.09.007; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Polakis P, 2000, GENE DEV, V14, P1837; Reid YA, 2011, METHODS MOL BIOL, V731, P35, DOI 10.1007/978-1-61779-080-5_4; Reig Maria, 2009, Gastroenterology, V137, P1171, DOI 10.1053/j.gastro.2009.07.008; Singal A, 2009, ALIMENT PHARM THER, V30, P37, DOI 10.1111/j.1365-2036.2009.04014.x; Siolas D, 2013, CANC RES; Sun SY, 2002, CRIT REV ONCOL HEMAT, V41, P41, DOI 10.1016/S1040-8428(01)00144-5; Tanaka M, 2011, J EPIDEMIOL, V21, P401, DOI 10.2188/jea.JE20100190; Tangkijvanich P, 2000, J CLIN GASTROENTEROL, V31, P302, DOI 10.1097/00004836-200012000-00007; Tao QG, 2004, GENOMICS, V83, P270, DOI 10.1016/S0888-7543(03)00237-4; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; TSUKUMA H, 1993, NEW ENGL J MED, V328, P1797, DOI 10.1056/NEJM199306243282501; Velazquez RF, 2003, HEPATOLOGY, V37, P520, DOI 10.1053/jhep.2003.50093; Venepalli NK, 2013, INT J HEPATOL, V2013, DOI 10.1155/2013/341636; Wiedmann MW, 2011, CURR CANCER DRUG TAR, V11, P714; YU MW, 1995, CANCER RES, V55, P1301	40	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85308	10.1371/journal.pone.0085308	http://dx.doi.org/10.1371/journal.pone.0085308			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416385	Green Published, Green Submitted, gold			2022-12-27	WOS:000329866300067
J	Farley, JH; Hoyle, SD; Eveson, JP; Williams, AJ; Davies, CR; Nicol, SJ				Farley, Jessica H.; Hoyle, Simon D.; Eveson, J. Paige; Williams, Ashley J.; Davies, Campbell R.; Nicol, Simon J.			Maturity Ogives for South Pacific Albacore Tuna (Thunnus alalunga) That Account for Spatial and Seasonal Variation in the Distributions of Mature and Immature Fish	PLOS ONE			English	Article							BLUEFIN TUNA; AGE; ATRESIA; SIZE; L.	Length and age at maturity are important life history parameters for estimating spawning stock biomass and reproductive potential of fish stocks. Bias in estimates of size and age at maturity can arise when disparate distributions of mature and immature fish within a population are not accounted for in the analysis. Here we investigate the spatial and temporal variability in observed size and age at maturity of female albacore tuna, Thunnus alalunga, using samples collected across the South Pacific. Maturity status was identified using consistent histological criteria that were precise enough to allow for mature but regenerating females to be distinguished from immature females during the non-spawning season, permitting year-round sampling for maturity estimation in albacore. Using generalised linear mixed models, we found that the proportion of mature females at length varied significantly with latitude and time of year. Specifically, females at northern latitudes (similar to 10-20 degrees S, where spawning occurs) were mature at significantly smaller lengths and ages than females at southern latitudes (similar to 20-40 degrees S), particularly during the spawning season (October-March). This variation was due to different geographic distributions of mature and immature fish during the year. We present a method for estimating an unbiased maturity ogive that takes into account the latitudinal variation in proportion mature at length during a given season (spawning or non-spawning). Applying this method to albacore samples from the western region of the South Pacific gave a predicted length at 50% mature of similar to 87 cm fork length (4.5 years).	[Farley, Jessica H.; Eveson, J. Paige; Davies, Campbell R.] CSIRO Marine & Atmospher Res, Wealth Oceans Flagship, Hobart, Tas, Australia; [Hoyle, Simon D.; Williams, Ashley J.; Nicol, Simon J.] Secretariat Pacific Community, Ocean Fisheries Programme, Noumea, New Caledonia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Farley, JH (corresponding author), CSIRO Marine & Atmospher Res, Wealth Oceans Flagship, Hobart, Tas, Australia.	Jessica.Farley@csiro.au	Hoyle, Simon D/G-1201-2015; Davies, Campbell R/N-8086-2013; Williams, Ashley J/G-2017-2014; Williams, Ashley J/J-7565-2013; Williams, Ashley/ABA-5921-2020; Farley, Jessica/E-4957-2014	Hoyle, Simon D/0000-0002-1787-6565; Davies, Campbell R/0000-0002-2028-1060; Williams, Ashley J/0000-0002-5530-0073; Williams, Ashley/0000-0002-5530-0073; Farley, Jessica/0000-0002-5047-746X; Eveson, Paige/0000-0002-1560-2093; Nicol, Simon/0000-0001-8193-8719	CSIRO Wealth from Oceans Flagship; Australian Fisheries Research and Development Corporation [2009/012]; European Union; Western and Central Pacific Fisheries Commission	CSIRO Wealth from Oceans Flagship(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Australian Fisheries Research and Development Corporation; European Union(European Commission); Western and Central Pacific Fisheries Commission	This work was supported by funding from CSIRO Wealth from Oceans Flagship, the Australian Fisheries Research and Development Corporation (Project #2009/012), the 9th European Union Development Fund (SCIFISH project), and the Western and Central Pacific Fisheries Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2000, CAN J FISH AQUAT SCI, V57, P1448, DOI 10.1139/cjfas-57-7-1448; [Anonymous], 2011, REPORT 2011 ICCAT S; Bates D, 2012, LME4 LINEAR MIXED EF; Begg Gavin A., 2009, P230, DOI 10.1002/9781444312133.ch6; Brown-Peterson NJ, 2011, MAR COAST FISH, V3, P52, DOI 10.1080/19425120.2011.555724; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Campbell R, 2011, IMPLEMENTATION ETBF; Chen KS, 2010, J FISH BIOL, V77, P119, DOI 10.1111/j.1095-8649.2010.02662.x; CHEN Y, 1994, AQUAT SCI, V56, P206, DOI 10.1007/BF00879965; Corriero A, 2005, J APPL ICHTHYOL, V21, P483, DOI 10.1111/j.1439-0426.2005.00700.x; Corriero A, 2003, J FISH BIOL, V63, P108, DOI 10.1046/j.1095-8649.2003.00132.x; Crabtree RE, 1997, FISH B-NOAA, V95, P456; Farley J, 2009, IND BASED SIZE MONIT; Farley JH, 2013, J FISH BIOL, V82, P1523, DOI 10.1111/jfb.12077; Farley JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060577; HILBORN R, 1992; Hillary RM, 2008, IOTC2008WPTE09; Hoyle S, 2012, WCPFCSC82012SAWP04RE; Hoyle S, 2011, 7 SCI COMM M W CENTR; Hoyle S.D., 2008, WCPFCSC4MEWP2; Hunter John Roe, 2003, Fisken og Havet, V12, P57; HUNTER JR, 1985, FISH B-NOAA, V83, P119; ICCAT, 2012, REP 2011 ICCAT S ATL, P491; ICCAT, 2010, ICCAT COLL VOL SCI P, V65, P1113; ICES, 2008, WORKSH MAT OG EST ST; ISC, 2010, REP ISC ALB WORK GRO; Langley A, 2005, 1 M SCI COMM W CENTR; Langley AD, 2006, 37 SECR PAC COMM; Langley AD, 2003, 16 M STAND COMM TUN; McDonough CJ, 2005, FISH B-NOAA, V103, P601; Murray T., 1994, 3362 FAO, V336, P188; Murua H., 2003, Journal of Northwest Atlantic Fishery Science, V33, P33, DOI 10.2960/J.v33.a3; Otsu T., 1959, Fishery Bulletin United States, V59, P287; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramon D, 1996, FISH B-NOAA, V94, P725; Saidapur S K, 1978, Int Rev Cytol, V54, P225, DOI 10.1016/S0074-7696(08)60169-2; Schaefer K. M., 1998, INT AM TROP TUNA COM, V21, P201; Schaefer Kurt M., 2005, Inter-American Tropical Tuna Commission Bulletin, V23, P3; Schaefer Kurt M., 2001, Fish Physiology, V19, P225; Schmitt CC, 1997, 35 IPHC; Ueyanagi S, 1957, REP NANKAI REG FISH, V6, P113; Williams AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039318	42	25	28	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83017	10.1371/journal.pone.0083017	http://dx.doi.org/10.1371/journal.pone.0083017			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416153	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000329862500025
J	Fenyvesi, F; Reti-Nagy, K; Bacso, Z; Gutay-Toth, Z; Malanga, M; Fenyvesi, E; Szente, L; Varadi, J; Ujhelyi, Z; Feher, P; Szabo, G; Vecsernyes, M; Bacskay, I				Fenyvesi, Ferenc; Reti-Nagy, Katalin; Bacso, Zsolt; Gutay-Toth, Zsuzsanna; Malanga, Milo; Fenyvesi, Eva; Szente, Lajos; Varadi, Judit; Ujhelyi, Zoltan; Feher, Palma; Szabo, Gabor; Vecsernyes, Miklos; Bacskay, Ildiko			Fluorescently Labeled Methyl-Beta-Cyclodextrin Enters Intestinal Epithelial Caco-2 Cells by Fluid-Phase Endocytosis	PLOS ONE			English	Article							P-GLYCOPROTEIN; PHARMACEUTICAL APPLICATIONS; DENDRITIC CELLS; CHOLESTEROL; PERMEATION; MACROPINOCYTOSIS; TRANSPORTER; INHIBITION; SOLUBILITY; MEMBRANE	Cyclodextrins are widely used excipients for increasing the bioavailability of poorly water-soluble drugs. Their effect on drug absorption in the gastrointestinal tract is explained by their solubility- and permeability-enhancement. The aims of this study were to investigate penetration properties of fluorescently labeled randomly methylated-beta-cyclodextrin (FITC-RAMEB) on Caco-2 cell layer and examine the cellular entry of cyclodextrins on intestinal cells. The permeability of FITCRAMEB through Caco-2 monolayers was very limited. Using this compound in 0.05 mM concentration the permeability coefficient was 3.35 +/- 1.29 x 10(-8) cm/s and its permeability did not change in the presence of 5 mM randomly methylated-beta-cyclodextrin. Despite of the low permeability, cellular accumulation of FITC-RAMEB in cytoplasmic vesicles was significant and showed strong time and concentration dependence, similar to the characteristics of the macropinocytosis marker Lucifer Yellow. The internalization process was fully inhibited at 0 degrees C and it was drastically reduced at 37 degrees C applying rottlerin, an inhibitor of macropinocytosis. Notably, FITC-RAMEB colocalized with the early endosome organizer Rab5a. These results have revealed that FITC-RAMEB is able to enter intestinal epithelial cells by fluid-phase endocytosis from the apical side. This mechanism can be an additional process which helps to overcome the intestinal barrier and contributes to the bioavailability enhancement of cyclodextrins.	[Fenyvesi, Ferenc; Reti-Nagy, Katalin; Varadi, Judit; Ujhelyi, Zoltan; Feher, Palma; Vecsernyes, Miklos; Bacskay, Ildiko] Univ Debrecen, Dept Pharmaceut Technol, H-4012 Debrecen, Hungary; [Bacso, Zsolt; Gutay-Toth, Zsuzsanna; Szabo, Gabor] Univ Debrecen, Dept Biophys & Cell Biol, H-4012 Debrecen, Hungary; [Malanga, Milo; Fenyvesi, Eva; Szente, Lajos] Cyclolab Cyclodextrin R&D Lab Ltd, Budapest, Hungary	University of Debrecen; University of Debrecen; CycloLab	Fenyvesi, F (corresponding author), Univ Debrecen, Dept Pharmaceut Technol, H-4012 Debrecen, Hungary.	fenyvesi.ferenc@pharm.unideb.hu	Bacso, Zsolt/A-3615-2009; Ujhelyi, Zoltan/AAF-7036-2021; Réti-Nagy, Katalin/AAR-7341-2021	Bacso, Zsolt/0000-0001-6885-3796; Ujhelyi, Zoltan/0000-0001-9724-0614; Varadi, Judit/0000-0003-1885-164X; Fenyvesi, Ferenc/0000-0003-2890-0783	European Union; State of Hungary; European Social Fund [TAMOP 4.2.4.A/2-11-1-2012-0001]; Marie Curie Program [237962 CYCLON];  [TAMOP-4.2.2.A- 11/1/KONV-2012-0025];  [OTKA 72762];  [OTKA-101337]	European Union(European Commission); State of Hungary; European Social Fund(European Social Fund (ESF)); Marie Curie Program(European Commission); ; ; 	This research was supported by the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TAMOP 4.2.4.A/2-11-1-2012-0001 National Excellence Program. This work was supported by the following grants: TAMOP-4.2.2.A- 11/1/KONV-2012-0025, OTKA 72762 and OTKA-101337. The preparation of FITC-RAMEB was supported by Marie Curie Program # 237962 CYCLON (FP7-PEOPLEITN-2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artursson P, 2001, ADV DRUG DELIVER REV, V46, P27, DOI 10.1016/S0169-409X(00)00128-9; Bacso Z, 2004, CYTOM PART A, V61A, P105, DOI 10.1002/cyto.a.20081; Chen FW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015054; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Deli MA, 2009, BBA-BIOMEMBRANES, V1788, P892, DOI 10.1016/j.bbamem.2008.09.016; Fenyvesi F, 2008, EUR J PHARM SCI, V34, P236, DOI 10.1016/j.ejps.2008.04.005; Garrigues A, 2002, P NATL ACAD SCI USA, V99, P10347, DOI 10.1073/pnas.162366399; Gonzalez-Gaitano G, 2002, J INCL PHENOM MACRO, V44, P101, DOI 10.1023/A:1023065823358; HEWLETT LJ, 1994, J CELL BIOL, V124, P689, DOI 10.1083/jcb.124.5.689; HOMOLYA L, 1993, J BIOL CHEM, V268, P21493; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Kiss T, 2010, EUR J PHARM SCI, V40, P376, DOI 10.1016/j.ejps.2010.04.014; Kurkov SV, 2012, INT J PHARM; Lambert D, 2005, BIOCHEM J, V387, P553, DOI 10.1042/BJ20041377; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Loftsson T, 1996, J PHARM SCI, V85, P1017, DOI 10.1021/js950534b; Loftsson Thorsteinn, 2005, Expert Opin Drug Deliv, V2, P335, DOI 10.1517/17425247.2.1.335; Loftsson T, 2011, J PHARM PHARMACOL, V63, P1119, DOI 10.1111/j.2042-7158.2011.01279.x; Matilainen L, 2008, J CONTROL RELEASE, V126, P10, DOI 10.1016/j.jconrel.2007.11.003; Matsuda H, 1999, ADV DRUG DELIVER REV, V36, P81, DOI 10.1016/S0169-409X(98)00056-8; ON MJ, 2011, MECH STUDIES UPTAKE; Plazzo AP, 2012, CHEM PHYS LIPIDS, V165, P505, DOI 10.1016/j.chemphyslip.2012.03.007; Puskas I, 2013, J INCL PHENOM MACRO, V75, P269, DOI 10.1007/s10847-012-0127-7; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rosenbaum AI, 2010, P NATL ACAD SCI USA, V107, P5477, DOI 10.1073/pnas.0914309107; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Sarkar K, 2005, IMMUNOLOGY, V116, P513, DOI 10.1111/j.1365-2567.2005.02253.x; SWANSON JA, 1985, J CELL BIOL, V100, P851, DOI 10.1083/jcb.100.3.851; SZEJTLI J, 1980, ARZNEIMITTEL-FORSCH, V30-1, P808; Szejtli J, 1998, CHEM REV, V98, P1743, DOI 10.1021/cr970022c; Wei H, 2011, INT J PHARMACEUT, V403, P15, DOI 10.1016/j.ijpharm.2010.09.032; Zuhorn IS, 2002, J BIOL CHEM, V277, P18021, DOI 10.1074/jbc.M111257200	32	39	41	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84856	10.1371/journal.pone.0084856	http://dx.doi.org/10.1371/journal.pone.0084856			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416301	Green Submitted, gold, Green Published			2022-12-27	WOS:000329862500181
J	Koolschijn, PCMP; Peper, JS; Crone, EA				Koolschijn, P. Cedric M. P.; Peper, Jiska S.; Crone, Eveline A.			The Influence of Sex Steroids on Structural Brain Maturation in Adolescence	PLOS ONE			English	Article							RIGHT ANTERIOR CINGULATE; HUMAN CEREBRAL-CORTEX; DIURNAL RHYTHM; TESTOSTERONE SECRETION; SALIVARY TESTOSTERONE; CORTICAL MATURATION; MENSTRUAL-CYCLE; HEALTHY GIRLS; WHITE-MATTER; GRAY-MATTER	Puberty reflects a period of hormonal changes, physical maturation and structural brain reorganization. However, little attention has been paid to what extent sex steroids and pituitary hormones are associated with the refinement of brain maturation across adolescent development. Here we used high-resolution structural MRI scans from 215 typically developing individuals between ages 8-25, to examine the association between cortical thickness, surface area and (sub) cortical brain volumes with luteinizing hormone, testosterone and estradiol, and pubertal stage based on self-reports. Our results indicate sex-specific differences in testosterone related influences on gray matter volumes of the anterior cingulate cortex after controlling for age effects. No significant associations between subcortical structures and sex hormones were found. Pubertal stage was not a stronger predictor than chronological age for brain anatomical differences. Our findings indicate that sex steroids are associated with cerebral gray matter morphology in a sex specific manner. These hormonal and morphological differences may explain in part differences in brain development between boys and girls.	[Koolschijn, P. Cedric M. P.; Peper, Jiska S.; Crone, Eveline A.] Leiden Univ, Brain & Dev Lab, Inst Psychol, Leiden, Netherlands; [Koolschijn, P. Cedric M. P.; Peper, Jiska S.; Crone, Eveline A.] Leiden Inst Brain & Cognit, Leiden, Netherlands; [Koolschijn, P. Cedric M. P.] Univ Amsterdam, Amsterdam, Netherlands; [Crone, Eveline A.] Univ Amsterdam, Dept Dev Psychol, Amsterdam, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); University of Amsterdam; University of Amsterdam	Koolschijn, PCMP (corresponding author), Leiden Univ, Brain & Dev Lab, Inst Psychol, Leiden, Netherlands.	koolschijnpcmp@gmail.com		Koolschijn, P Cedric/0000-0002-0625-1447; Crone, Eveline/0000-0002-7508-6078	Netherlands Organization for Scientific Research (NWO) [451-10-007]; European Research Council (ERC) [2010-StG-263234]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Research Council (ERC)(European Research Council (ERC)European Commission)	This work was supported by Netherlands Organization for Scientific Research (NWO) Innovational research grant 451-10-007(JSP), and an European Research Council (ERC) starting grant 2010-StG-263234(EAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankarberg C, 1999, J CLIN ENDOCR METAB, V84, P975, DOI 10.1210/jc.84.3.975; Ankarberg-Lindgren C, 2004, EUR J ENDOCRINOL, V151, P747, DOI 10.1530/eje.0.1510747; Blakemore SJ, 2012, NAT NEUROSCI, V15, P1184, DOI 10.1038/nn.3177; Blanton RE, 2012, NEUROSCIENCE, V217, P105, DOI 10.1016/j.neuroscience.2012.04.059; Boes AD, 2008, BEHAV NEUROSCI, V122, P677, DOI 10.1037/0735-7044.122.3.677; Bos PA, 2012, FRONT NEUROENDOCRIN, V33, P17, DOI 10.1016/j.yfrne.2011.01.002; Bramen JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033850; Bramen JE, 2011, CEREB CORTEX, V21, P636, DOI 10.1093/cercor/bhq137; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Bukovsky Antonin, 2003, Reprod Biol Endocrinol, V1, P13, DOI 10.1186/1477-7827-1-13; CARSKADON MA, 1993, J ADOLESCENT HEALTH, V14, P190, DOI 10.1016/1054-139X(93)90004-9; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; Crone EA, 2012, NAT REV NEUROSCI, V13, P636, DOI 10.1038/nrn3313; Crone EA, 2011, DEV COGN NEUROS-NETH, V1, P101, DOI 10.1016/j.dcn.2010.12.001; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; de Ronde W, 2011, PHARMACOTHERAPY, V31, P248, DOI 10.1592/phco.31.3.248; de Water E, 2013, HORM BEHAV, V63, P392, DOI 10.1016/j.yhbeh.2012.11.018; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dorn L. D., 2006, APPL DEV SCI, V10, P30, DOI [10.1207/s1532480xads1001_3, DOI 10.1207/S1532480XADS1001_3]; Ducharme S, 2011, BIOL PSYCHIAT, V70, P283, DOI 10.1016/j.biopsych.2011.03.015; Estrada M, 2006, J BIOL CHEM, V281, P25492, DOI 10.1074/jbc.M603193200; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Galvan A, 2006, J NEUROSCI, V26, P6885, DOI 10.1523/JNEUROSCI.1062-06.2006; Ghosh D, 2009, NATURE, V457, P219, DOI 10.1038/nature07614; Giedd JN, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-19; Giedd JN, 2010, NEURON, V67, P728, DOI 10.1016/j.neuron.2010.08.040; Gogtay N, 2010, BRAIN COGNITION, V72, P6, DOI 10.1016/j.bandc.2009.08.009; Granger DA, 2003, DEV PSYCHOPATHOL, V15, P431, DOI 10.1017/S0954579403000233; Haberecht MF, 2001, HUM BRAIN MAPP, V14, P96, DOI 10.1002/hbm.1044; Hagemann G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014655; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Josephs RA, 2006, J PERS SOC PSYCHOL, V90, P999, DOI 10.1037/0022-3514.90.6.999; Kesner JS, 1998, HUM REPROD, V13, P15, DOI 10.1093/humrep/13.1.15; Koolschijn PCMP, 2013, DEV COGN NEUROS-NETH, V5, P106, DOI 10.1016/j.dcn.2013.02.003; LEI ZM, 1993, ENDOCRINOLOGY, V132, P2262, DOI 10.1210/en.132.5.2262; Lombardo MV, 2012, J NEUROSCI, V32, P674, DOI 10.1523/JNEUROSCI.4389-11.2012; Luna B, 2009, ADV CHILD DEV BEHAV, V37, P233, DOI 10.1016/S0065-2407(09)03706-9; McCall C, 2012, NAT NEUROSCI, V15, P681, DOI 10.1038/nn.3084; McCarthy MM, 2012, J NEUROSCI, V32, P2241, DOI 10.1523/JNEUROSCI.5372-11.2012; McCarthy MM, 2009, J NEUROSCI, V29, P12815, DOI 10.1523/JNEUROSCI.3331-09.2009; McEwen B, 2002, RECENT PROG HORM RES, V57, P357, DOI 10.1210/rp.57.1.357; Mehta PH, 2008, J PERS SOC PSYCHOL, V94, P1078, DOI 10.1037/0022-3514.94.6.1078; Mehta PH, 2010, J COGNITIVE NEUROSCI, V22, P2357, DOI 10.1162/jocn.2009.21389; Mihm M, 2011, ANIM REPROD SCI, V124, P229, DOI 10.1016/j.anireprosci.2010.08.030; Mueller SC, 2013, J NEUROENDOCRINOL, V25, P762, DOI 10.1111/jne.12048; Neufang S, 2009, CEREB CORTEX, V19, P464, DOI 10.1093/cercor/bhn100; Norjavaara E, 1996, J CLIN ENDOCR METAB, V81, P4095, DOI 10.1210/jc.81.11.4095; Op de Macks ZA, 2011, DEV COGN NEUROS-NETH, V1, P506, DOI 10.1016/j.dcn.2011.06.003; Ossewaarde L, 2013, HUM BRAIN MAPP, V34, P1187, DOI 10.1002/hbm.21502; Ostby Y, 2009, J NEUROSCI, V29, P11772, DOI 10.1523/JNEUROSCI.1242-09.2009; Peper JS, 2008, PSYCHONEUROENDOCRINO, V33, P909, DOI 10.1016/j.psyneuen.2008.03.017; Peper JS, 2013, CURR DIR PSYCHOL SCI, V22, P134, DOI 10.1177/0963721412473755; Peper JS, 2012, J NEUROSCI, V32, P6745, DOI 10.1523/JNEUROSCI.1012-12.2012; Peper JS, 2009, PSYCHONEUROENDOCRINO, V34, P332, DOI 10.1016/j.psyneuen.2008.09.012; Peper JS, 2013, J COGN NEUR IN PRESS; Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108; PETERSEN AC, 1988, J YOUTH ADOLESCENCE, V17, P117, DOI 10.1007/BF01537962; PETERSEN AC, 1988, ANNU REV PSYCHOL, V39, P583, DOI 10.1146/annurev.psych.39.1.583; Raznahan A, 2010, P NATL ACAD SCI USA, V107, P16988, DOI 10.1073/pnas.1006025107; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Sisk CL, 2005, FRONT NEUROENDOCRIN, V26, P163, DOI 10.1016/j.yfrne.2005.10.003; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Tobler PN, 2007, J NEUROPHYSIOL, V97, P1621, DOI 10.1152/jn.00745.2006; Nguyen TV, 2013, CEREB CORTEX, V23, P1424, DOI 10.1093/cercor/bhs125; van Bokhoven I, 2006, HORM BEHAV, V50, P118, DOI 10.1016/j.yhbeh.2006.02.002; Van Leijenhorst L, 2008, DEV NEUROPSYCHOL, V33, P179, DOI 10.1080/87565640701884287; van Wingen G, 2010, PSYCHONEUROENDOCRINO, V35, P105, DOI 10.1016/j.psyneuen.2009.09.007; Veldhuis JD, 1996, PEDIATR NEPHROL, V10, P304; Westlye LT, 2010, CEREB CORTEX, V20, P2055, DOI 10.1093/cercor/bhp280; Witte AV, 2010, NEUROIMAGE, V49, P1205, DOI 10.1016/j.neuroimage.2009.09.046; Yakovlev P. I., 1967, REGIONAL DEV BRAIN E, P3; Zahn-Waxler C, 2008, ANNU REV CLIN PSYCHO, V4, P275, DOI 10.1146/annurev.clinpsy.3.022806.091358	75	65	68	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83929	10.1371/journal.pone.0083929	http://dx.doi.org/10.1371/journal.pone.0083929			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416184	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500086
J	Matsuda-Lennikov, M; Suizu, F; Hirata, N; Hashimoto, M; Kimura, K; Nagamine, T; Fujioka, Y; Ohba, Y; Iwanaga, T; Noguchi, M				Matsuda-Lennikov, Mami; Suizu, Futoshi; Hirata, Noriyuki; Hashimoto, Manabu; Kimura, Kohki; Nagamine, Tadashi; Fujioka, Yoichiro; Ohba, Yusuke; Iwanaga, Toshihiko; Noguchi, Masayuki			Lysosomal Interaction of Akt with Phafin2: A Critical Step in the Induction of Autophagy	PLOS ONE			English	Article							ISOLATED RAT HEPATOCYTES; FYVE DOMAINS; PROTEIN; PATHWAY; MACROAUTOPHAGY; VISUALIZATION; DEGRADATION; DOWNSTREAM; 3-KINASES; MECHANISM	Autophagy is an evolutionarily conserved mechanism for the gross disposal of intracellular proteins in mammalian cells and dysfunction in this pathway has been associated with human disease. Although the serine threonine kinase Akt is suggested to play a role in this process, little is known about the molecular mechanisms by which Akt induces autophagy. Using a yeast two-hybrid screen, Phafin2 (EAPF or PLEKHF2), a lysosomal protein with a unique structure of N-terminal PH (pleckstrin homology) domain and C-terminal FYVE (Fab 1, YOTB, Vac 1, and EEA1) domain was found to interact with Akt. A sucrose gradient fractionation experiment revealed that both Akt and Phafin2 co-existed in the same lysosome enriched fraction after autophagy induction. Confocal microscopic analysis and BiFC analysis demonstrated that both Akt and Phafin2 accumulate in the lysosome after induction of autophagy. BiFC analysis using PtdIns (3) P interaction defective mutant of Phafin2 demonstrated that lysosomal accumulation of the Akt-Phafin2 complex and subsequent induction of autophagy were lysosomal PtdIns (3) P dependent events. Furthermore, in murine macrophages, both Akt and Phafin2 were required for digestion of fluorescent bacteria and/or LPS-induced autophagy. Taken together, these findings establish that lysosomal accumulation of Akt and Phafin2 is a critical step in the induction of autophagy via an interaction with PtdIns (3)P.	[Matsuda-Lennikov, Mami; Suizu, Futoshi; Hirata, Noriyuki; Hashimoto, Manabu; Kimura, Kohki; Nagamine, Tadashi; Noguchi, Masayuki] Hokkaido Univ, Div Canc Biol, Inst Med Genet, Kita Ku, Sapporo, Hokkaido, Japan; [Fujioka, Yoichiro; Ohba, Yusuke] Hokkaido Univ, Lab Pathophysiol & Signal Transduct, Grad Sch Med, Kita Ku, Sapporo, Hokkaido, Japan; [Iwanaga, Toshihiko] Hokkaido Univ, Lab Histol & Cytol, Grad Sch Med, Kita Ku, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Noguchi, M (corresponding author), Hokkaido Univ, Div Canc Biol, Inst Med Genet, Kita Ku, Sapporo, Hokkaido, Japan.	m_noguch@igm.hokudai.ac.jp	Fujioka, Yoichiro/AAF-3313-2019; Suizu, Futoshi/G-3530-2019	Fujioka, Yoichiro/0000-0002-5760-9357; Suizu, Futoshi/0000-0003-0206-4289; Nagamine, Tadashi/0000-0002-8339-4177	Japanese Ministry Education; Takeda Science foundation	Japanese Ministry Education; Takeda Science foundation(Takeda Science Foundation (TSF))	M.N. and F. S. are supported by Grant Aid from the Japanese Ministry Education. M.N. is supported by Takeda Science foundation. M. M.-L. and Y.F. are JSPS research fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arico S, 2001, J BIOL CHEM, V276, P35243, DOI 10.1074/jbc.C100319200; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Chen W, 2005, J BIOL CHEM, V280, P40985, DOI 10.1074/jbc.M502190200; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Katome T, 2003, J BIOL CHEM, V278, P28312, DOI 10.1074/jbc.M302094200; Kerppola TK, 2008, METHOD CELL BIOL, V85, P431, DOI 10.1016/S0091-679X(08)85019-4; Klionsky DJ, 2005, CURR BIOL, V15, pR282, DOI 10.1016/j.cub.2005.04.013; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Kutateladze T, 2001, SCIENCE, V291, P1793, DOI 10.1126/science.291.5509.1793; Laine J, 2000, MOL CELL, V6, P395, DOI 10.1016/S1097-2765(00)00039-3; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Lin WJ, 2010, BIOCHEM BIOPH RES CO, V391, P1043, DOI 10.1016/j.bbrc.2009.12.016; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Pehar M, 2012, J BIOL CHEM, V287, P29921, DOI 10.1074/jbc.M112.363911; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Simonsen A, 2009, J CELL BIOL, V186, P773, DOI 10.1083/jcb.200907014; Stenmark H, 2002, FEBS LETT, V513, P77, DOI 10.1016/S0014-5793(01)03308-7; Suizu F, 2009, DEV CELL, V17, P800, DOI 10.1016/j.devcel.2009.09.007; Thomas CC, 2002, CURR BIOL, V12, P1256, DOI 10.1016/S0960-9822(02)00972-7; Tsutsumi K, 2009, CELL SIGNAL, V21, P1672, DOI 10.1016/j.cellsig.2009.07.004; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022	30	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e79795	10.1371/journal.pone.0079795	http://dx.doi.org/10.1371/journal.pone.0079795			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416124	Green Published, gold			2022-12-27	WOS:000329862500005
J	Nagumo, K; Tanaka, M; Chuang, VTG; Setoyama, H; Watanabe, H; Yamada, N; Kubota, K; Tanaka, M; Matsushita, K; Yoshida, A; Jinnouchi, H; Anraku, M; Kadowaki, D; Ishima, Y; Sasaki, Y; Otagiri, M; Maruyama, T				Nagumo, Kohei; Tanaka, Motohiko; Chuang, Victor Tuan Giam; Setoyama, Hiroko; Watanabe, Hiroshi; Yamada, Naoyuki; Kubota, Kazuyuki; Tanaka, Motoko; Matsushita, Kazutaka; Yoshida, Akira; Jinnouchi, Hideaki; Anraku, Makoto; Kadowaki, Daisuke; Ishima, Yu; Sasaki, Yutaka; Otagiri, Masaki; Maruyama, Toru			Cys34-Cysteinylated Human Serum Albumin Is a Sensitive Plasma Marker in Oxidative Stress-Related Chronic Diseases	PLOS ONE			English	Article							CHAIN AMINO-ACIDS; HEMODIALYSIS-PATIENTS; LIGAND-BINDING; SULFENIC ACID; REDOX STATE; PROTEIN; DYSFUNCTION	The degree of oxidized cysteine (Cys) 34 in human serum albumin (HSA), as determined by high performance liquid chromatography (HPLC), is correlated with oxidative stress related pathological conditions. In order to further characterize the oxidation of Cys34-HSA at the molecular level and to develop a suitable analytical method for a rapid and sensitive clinical laboratory analysis, the use of electrospray ionization time-of-flight mass spectrometer (ESI-TOFMS) was evaluated. A marked increase in the cysteinylation of Cys34 occurs in chronic liver and kidney diseases and diabetes mellitus. A significant positive correlation was observed between the Cys-Cys34-HSA fraction of plasma samples obtained from 229 patients, as determined by ESI-TOFMS, and the degree of oxidized Cys34-HSA determined by HPLC. The Cys-Cys34-HSA fraction was significantly increased with the progression of liver cirrhosis, and was reduced by branched chain amino acids (BCAA) treatment. The changes in the Cys-Cys34-HSA fraction were significantly correlated with the alternations of the plasma levels of advanced oxidized protein products, an oxidative stress marker for proteins. The binding ability of endogenous substances (bilirubin and tryptophan) and drugs (warfarin and diazepam) to HSA purified from chronic liver disease patients were significantly suppressed but significantly improved by BCAA supplementation. Interestingly, the changes in this physiological function of HSA in chronic liver disease were correlated with the Cys-Cys34-HSA fraction. In conclusion, ESI-TOFMS is a suitable high throughput method for the rapid and sensitive quantification of Cys-Cys34-HSA in a large number of samples for evaluating oxidative stress related chronic disease progression or in response to a treatment.	[Nagumo, Kohei; Watanabe, Hiroshi; Kadowaki, Daisuke; Ishima, Yu; Maruyama, Toru] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Chuo Ku, Kumamoto, Japan; [Tanaka, Motohiko; Setoyama, Hiroko; Sasaki, Yutaka] Kumamoto Univ, Grad Sch Med Sci, Dept Gastroenterol & Hepatol, Chuo Ku, Kumamoto, Japan; [Chuang, Victor Tuan Giam] Curtin Univ, Fac Hlth Sci, Curtin Hlth Innovat Res Inst, Sch Pharm, Perth, WA 6845, Australia; [Watanabe, Hiroshi; Kadowaki, Daisuke; Ishima, Yu; Maruyama, Toru] Kumamoto Univ, Ctr Clin Pharmaceut Sci, Chuo Ku, Kumamoto, Japan; [Yamada, Naoyuki; Kubota, Kazuyuki] Ajinomoto Co Inc, Inst Innovat, Kawasaki Ku, Kawasaki, Kanagawa, Japan; [Tanaka, Motoko; Matsushita, Kazutaka] Akebono Clin, Dept Nephrol, Minami Ku, Kumamoto, Japan; [Yoshida, Akira; Jinnouchi, Hideaki] Diabet Care Ctr, Jinnouchi Clin, Chuo Ku, Kumamoto, Japan; [Anraku, Makoto; Otagiri, Masaki] Sojo Univ, Fac Pharmaceut Sci, Nishi Ku, Kumamoto, Japan; [Otagiri, Masaki] Sojo Univ, DDS Res Inst, Nishi Ku, Kumamoto, Japan	Kumamoto University; Kumamoto University; Curtin University; Kumamoto University; Ajinomoto Co Inc; Sojo University; Sojo University	Maruyama, T (corresponding author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Chuo Ku, Kumamoto, Japan.	tomaru@gpo.kumamoto-u.ac.jp	Chuang, Victor/A-3644-2011; Anraku, Makoto/AAA-3935-2020; Chuang, Victor/A-3644-2011	Chuang, Victor/0000-0002-2141-630X; Chuang, Victor/0000-0003-4543-2256; Kadowaki, Daisuke/0000-0001-5166-7145				Alvarez B, 2010, METHOD ENZYMOL, V473, P117, DOI 10.1016/S0076-6879(10)73005-6; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Anraku M, 2004, KIDNEY INT, V66, P841, DOI 10.1111/j.1523-1755.2004.00813.x; Anraku M, 2013, BIOCH BIOPHYS ACTA; Anraku M, 2008, CLIN BIOCHEM, V41, P1168, DOI 10.1016/j.clinbiochem.2008.07.007; Anraku M, 2011, J PHARM SCI-US, V100, P3968, DOI 10.1002/jps.22571; Boisvert MR, 2010, ANAL CHEM, V82, P1133, DOI 10.1021/ac902322w; Borges CR, 2011, CLIN CHEM, V57, P719, DOI 10.1373/clinchem.2010.156976; Carballal S, 2003, BIOCHEMISTRY-US, V42, P9906, DOI 10.1021/bi027434m; Descamps-Latscha B, 2001, KIDNEY INT, V59, pS108; Furusyo N, 2013, BIOCH BIOPHYS ACTA; Ichikawa K, 2012, MOL BIOL REP, V39, P10803, DOI 10.1007/s11033-012-1974-4; Iwao Y, 2012, IUBMB LIFE, V64, P450, DOI 10.1002/iub.567; JAGANNATHAN V, 1995, BIOMED CHROMATOGR, V9, P305, DOI 10.1002/bmc.1130090626; Jalan R, 2009, HEPATOLOGY, V50, P555, DOI 10.1002/hep.22913; Kadowaki D, 2007, HYPERTENS RES, V30, P395, DOI 10.1291/hypres.30.395; Kawaguchi T, 2011, HEPATOLOGY, V54, P1063, DOI 10.1002/hep.24412; Kawakami A, 2006, FEBS J, V273, P3346, DOI 10.1111/j.1742-4658.2006.05341.x; Kubota Kazuyuki, 2009, Int J Biomed Sci, V5, P293; Kuwahata M, 2008, J NUTR BIOCHEM, V19, P438, DOI 10.1016/j.jnutbio.2007.05.011; Mera K, 2005, BIOCHEM BIOPH RES CO, V334, P1322, DOI 10.1016/j.bbrc.2005.07.035; Mera K, 2010, J PHARM SCI-US, V99, P1614, DOI 10.1002/jps.21927; Minomo A, 2011, FEBS J, V278, P4100, DOI 10.1111/j.1742-4658.2011.08316.x; Musante L, 2007, J AM SOC NEPHROL, V18, P799, DOI 10.1681/ASN.2006090965; Narazaki R, 1997, PHARMACEUT RES, V14, P351, DOI 10.1023/A:1012006306915; Nishitani S, 2004, BIOCHEM BIOPH RES CO, V313, P387, DOI 10.1016/j.bbrc.2003.11.023; Oettl K, 2007, BRIT J PHARMACOL, V151, P580, DOI 10.1038/sj.bjp.0707251; Oettl K, 2013, J HEPATOL; Pergola PE, 2011, NEW ENGL J MED, V365, P327, DOI 10.1056/NEJMoa1105351; Poli Giuseppe, 2000, Molecular Aspects of Medicine, V21, P49, DOI 10.1016/S0098-2997(00)00004-2; Regazzoni L, 2013, FREE RADICAL RES, V47, P172, DOI 10.3109/10715762.2012.756139; Sengupta S, 2001, J BIOL CHEM, V276, P30111, DOI 10.1074/jbc.M104324200; Shimoishi K, 2007, PHARM RES-DORDR, V24, P1283, DOI 10.1007/s11095-007-9248-x; SOGAMI M, 1985, J CHROMATOGR, V332, P19, DOI 10.1016/S0021-9673(01)83283-0; TAKIKAWA H, 1987, BIOCHIM BIOPHYS ACTA, V926, P145, DOI 10.1016/0304-4165(87)90231-5; Terawaki H, 2004, KIDNEY INT, V66, P1988, DOI 10.1111/j.1523-1755.2004.00969.x; Terawaki H, 2012, CLIN EXP NEPHROL, V16, P629, DOI 10.1007/s10157-012-0610-x; Watanabe H, 2000, BIOCHEM J, V349, P813, DOI 10.1042/bj3490813; WitkoSarsat V, 1996, KIDNEY INT, V49, P1304, DOI 10.1038/ki.1996.186; Yamasaki K, 2013, BIOCH BIOPHYS ACTA	40	109	113	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85216	10.1371/journal.pone.0085216	http://dx.doi.org/10.1371/journal.pone.0085216			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416365	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500228
J	Zhang, WJ; Niu, Y; Bu, SH; Li, M; Feng, JY; Zhang, J; Yang, SX; Odinga, MM; Wei, SP; Liu, XF; Zhang, YM				Zhang, Wen-Jie; Niu, Yuan; Bu, Su-Hong; Li, Meng; Feng, Jian-Ying; Zhang, Jin; Yang, Sheng-Xian; Odinga, Medrine Mmayi; Wei, Shi-Ping; Liu, Xiao-Feng; Zhang, Yuan-Ming			Epistatic Association Mapping for Alkaline and Salinity Tolerance Traits in the Soybean Germination Stage	PLOS ONE			English	Article							GLYCINE-SOJA SIEB.; SALT TOLERANCE; ARABIDOPSIS-THALIANA; LINKAGE DISEQUILIBRIUM; GENETIC ARCHITECTURE; QTL; MAIZE; LOCUS; RICE; PROTEIN	Soil salinity and alkalinity are important abiotic components that frequently have critical effects on crop growth, productivity and quality. Developing soybean cultivars with high salt tolerance is recognized as an efficient way to maintain sustainable soybean production in a salt stress environment. However, the genetic mechanism of the tolerance must first be elucidated. In this study, 257 soybean cultivars with 135 SSR markers were used to perform epistatic association mapping for salt tolerance. Tolerance was evaluated by assessing the main root length (RL), the fresh and dry weights of roots (FWR and DWR), the biomass of seedlings (BS) and the length of hypocotyls (LH) of healthy seedlings after treatments with control, 100 mM NaCl or 10 mM Na2CO3 solutions for approximately one week under greenhouse conditions. A total of 83 QTL-by-environment (QE) interactions for salt tolerance index were detected: 24 for LR, 12 for FWR, 11 for DWR, 15 for LH and 21 for BS, as well as one epistatic QTL for FWR. Furthermore, 86 QE interactions for alkaline tolerance index were found: 17 for LR, 16 for FWR, 17 for DWR, 18 for LH and 18 for BS. A total of 77 QE interactions for the original trait indicator were detected: 17 for LR, 14 for FWR, 4 for DWR, 21 for LH and 21 for BS, as well as 3 epistatic QTL for BS. Small-effect QTL were frequently observed. Several soybean genes with homology to Arabidopsis thaliana and soybean salt tolerance genes were found in close proximity to the above QTL. Using the novel alleles of the QTL detected above, some elite parental combinations were designed, although these QTL need to be further confirmed. The above results provide a valuable foundation for fine mapping, cloning and molecular breeding by design for soybean alkaline and salt tolerance.	[Zhang, Wen-Jie; Niu, Yuan; Bu, Su-Hong; Li, Meng; Feng, Jian-Ying; Zhang, Jin; Yang, Sheng-Xian; Odinga, Medrine Mmayi; Wei, Shi-Ping; Liu, Xiao-Feng; Zhang, Yuan-Ming] Nanjing Agr Univ, Sect Stat Genom, State Key Lab Crop Genet & Germplasm Enhancement, Dept Crop Genet & Breeding, Nanjing, Jiangsu, Peoples R China; [Zhang, Wen-Jie] Ningxia Acad Agr & Forestry Sci, Inst Crop Res, Yinchuan, Ningxia, Peoples R China	Nanjing Agricultural University	Zhang, YM (corresponding author), Nanjing Agr Univ, Sect Stat Genom, State Key Lab Crop Genet & Germplasm Enhancement, Dept Crop Genet & Breeding, Nanjing, Jiangsu, Peoples R China.	soyzhang@njau.edu.cn	Zhang, Yuan-Ming/AFQ-8637-2022; Zhang, Yuan-Ming/AAT-2899-2021	Zhang, Yuan-Ming/0000-0003-2317-2190	National Basic Research Program of China [2011CB109306]; National Natural Science Foundation of China [30971848, 31301004, 31301229]; Fundamental Research Funds for the Central Universities [KYT201002, KYZ201202-9]; Specialized Research Fund for the Doctoral Program of Higher Education [20100097110035, 20120097110023]; 111 project [B08025]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); 111 project(Ministry of Education, China - 111 Project); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by grant 2011CB109306 from the National Basic Research Program of China; grants 30971848, 31301004, and 31301229 from the National Natural Science Foundation of China; grants KYT201002 and KYZ201202-9 from the Fundamental Research Funds for the Central Universities; grants 20100097110035 and 20120097110023 from Specialized Research Fund for the Doctoral Program of Higher Education; 111 project (B08025); and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL GEORGE, 1964, CROP SCI, V4, P157, DOI 10.2135/cropsci1964.0011183X000400020010x; ABEL GH, 1969, CROP SCI, V9, P697, DOI 10.2135/cropsci1969.0011183X000900060006x; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Bianchi-Hall CM, 2000, CROP SCI, V40, P538, DOI 10.2135/cropsci2000.402538x; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Chen HT, 2008, AUST J AGR RES, V59, P1086, DOI 10.1071/AR08104; Chinnusamy V, 2005, CROP SCI, V45, P437, DOI 10.2135/cropsci2005.0437; Cho Youngkoo, 2002, Journal of Biomedicine & Biotechnology, V2, P151, DOI 10.1155/S1110724302204039; Clerkx EJM, 2004, PLANT PHYSIOL, V135, P432, DOI 10.1104/pp.103.036814; Cui ZL, 1999, RELEASED CHINESE SOY; DeRose-Wilson L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022832; El-Lithy ME, 2006, GENETICS, V172, P1867, DOI 10.1534/genetics.105.050617; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Foolad MR, 1997, MOL BREEDING, V3, P269, DOI 10.1023/A:1009668325331; Genc Y, 2010, THEOR APPL GENET, V121, P877, DOI 10.1007/s00122-010-1357-y; Hamwieh A, 2011, EUPHYTICA, V179, P451, DOI 10.1007/s10681-011-0347-8; Hamwieh A, 2008, BREEDING SCI, V58, P355, DOI 10.1270/jsbbs.58.355; Hansen M, 2001, GENET RES, V77, P61, DOI 10.1017/S0016672300004857; Hauser MT, 2001, MOL BIOL EVOL, V18, P1754, DOI 10.1093/oxfordjournals.molbev.a003963; He XH, 2011, THEOR APPL GENET, V122, P33, DOI 10.1007/s00122-010-1420-8; Huang XY, 2009, GENE DEV, V23, P1805, DOI 10.1101/gad.1812409; Jun TH, 2008, EUPHYTICA, V162, P179, DOI 10.1007/s10681-007-9491-6; Kaman H, 2011, J FOOD AGRIC ENVIRON, V9, P648; Katori T, 2010, J EXP BOT, V61, P1125, DOI 10.1093/jxb/erp376; Komeda Y, 2004, ANNU REV PLANT BIOL, V55, P521, DOI 10.1146/annurev.arplant.55.031903.141644; Lam HM, 2009, RES TOLERANCE STRESS; Lee GJ, 2004, THEOR APPL GENET, V109, P1610, DOI 10.1007/s00122-004-1783-9; Lee JD, 2009, J HERED, V100, P798, DOI 10.1093/jhered/esp027; Li M, 2011, THESIS NANJING AGR U; Li YH, 2011, CONSERV GENET, V12, P1145, DOI 10.1007/s10592-011-0216-y; Lin HX, 2004, THEOR APPL GENET, V108, P253, DOI 10.1007/s00122-003-1421-y; Lipp M, 1999, J AOAC INT, V82, P923; Liu JP, 2000, P NATL ACAD SCI USA, V97, P3730, DOI 10.1073/pnas.060034197; Lu HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017773; Munns R, 2005, NEW PHYTOL, V167, P645, DOI 10.1111/j.1469-8137.2005.01487.x; Niu Y, 2013, MOL BREEDING, V31, P785, DOI 10.1007/s11032-012-9833-5; Palaisa KA, 2003, PLANT CELL, V15, P1795, DOI 10.1105/tpc.012526; PARKER MB, 1987, J PLANT NUTR, V10, P517, DOI 10.1080/01904168709363589; Pritchard JK, 2000, GENETICS, V155, P945; Qin HD, 2008, THEOR APPL GENET, V117, P883, DOI 10.1007/s00122-008-0828-x; Qiu QS, 2002, P NATL ACAD SCI USA, V99, P8436, DOI 10.1073/pnas.122224699; Quesada V, 2002, PLANT PHYSIOL, V130, P951, DOI 10.1104/pp.006536; Ren ZH, 2005, NAT GENET, V37, P1141, DOI 10.1038/ng1643; Ren ZH, 2010, P NATL ACAD SCI USA, V107, P5669, DOI 10.1073/pnas.0910798107; Shao G. H., 1994, Acta Agronomica Sinica, V20, P721; Sharma AD, 2011, THEOR APPL GENET, V122, P687, DOI 10.1007/s00122-010-1478-3; Shi H, 2010, P NATL ACAD SCI USA, V97, P6896; Singh RK, 2008, NATL ACAD SCI LETT, V31, P281; Sobhanian H, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-19; Thomson MJ, 2010, RICE, V3, P148, DOI 10.1007/s12284-010-9053-8; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Tuyen DD, 2010, THEOR APPL GENET, V121, P229, DOI 10.1007/s00122-010-1304-y; Uwatoko N, 2008, EUPHYTICA, V163, P167, DOI 10.1007/s10681-007-9584-2; Wang J, 2008, THEOR APPL GENET, V116, P777, DOI 10.1007/s00122-008-0710-x; Wang ZF, 2011, EUPHYTICA, V178, P297, DOI 10.1007/s10681-010-0287-8; Wilson LM, 2004, PLANT CELL, V16, P2719, DOI 10.1105/tpc.104.025700; Xu Y, 2011, THEOR APPL GENET, V122, P581, DOI 10.1007/s00122-010-1471-x; Yamaguchi T, 2005, TRENDS PLANT SCI, V10, P615, DOI 10.1016/j.tplants.2005.10.002; Zhang YM, 2005, GENETICS, V169, P2267, DOI 10.1534/genetics.104.033217; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	61	19	26	6	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84750	10.1371/journal.pone.0084750	http://dx.doi.org/10.1371/journal.pone.0084750			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416275	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500158
J	Doughty, DM; Dieterle, M; Sessions, AL; Fischer, WW; Newman, DK				Doughty, David M.; Dieterle, Michael; Sessions, Alex L.; Fischer, Woodward W.; Newman, Dianne K.			Probing the Subcellular Localization of Hopanoid Lipids in Bacteria Using NanoSIMS	PLOS ONE			English	Article							ION MASS-SPECTROMETRY; PLASMA-MEMBRANES; RHODOPSEUDOMONAS-PALUSTRIS; SPHINGOLIPID DOMAINS; NOSTOC-PUNCTIFORME; PHASE; RAFTS; IDENTIFICATION; MICRODOMAINS; FIBROBLASTS	The organization of lipids within biological membranes is poorly understood. Some studies have suggested lipids group into microdomains within cells, but the evidence remains controversial due to non-native imaging techniques. A recently developed NanoSIMS technique indicated that sphingolipids group into microdomains within membranes of human fibroblast cells. We extended this NanoSIMS approach to study the localization of hopanoid lipids in bacterial cells by developing a stable isotope labeling method to directly detect subcellular localization of specific lipids in bacteria with ca. 60 nm resolution. Because of the relatively small size of bacterial cells and the relative abundance of hopanoid lipids in membranes, we employed a primary H-2-label to maximize our limit of detection. This approach permitted the analysis of multiple stable isotope labels within the same sample, enabling visualization of subcellular lipid microdomains within different cell types using a secondary label to mark the growing end of the cell. Using this technique, we demonstrate subcellular localization of hopanoid lipids within alpha-proteobacterial and cyanobacterial cells. Further, we provide evidence of hopanoid lipid domains in between cells of the filamentous cyanobacterium Nostoc punctiforme. More broadly, our method provides a means to image lipid microdomains in a wide range of cell types and test hypotheses for their functions in membranes.	[Doughty, David M.; Dieterle, Michael; Newman, Dianne K.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Sessions, Alex L.; Fischer, Woodward W.; Newman, Dianne K.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Doughty, David M.; Newman, Dianne K.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Fischer, WW (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	wfischer@caltech.edu; dkn@caltech.edu	Sessions, Alex/ABC-9207-2020	Sessions, Alex/0000-0001-6120-2763; Dieterle, Michael/0000-0002-3109-6151	Howard Hughes Medical Institute (HHMI); NASA Exobiology program [NNX12AD93G]	Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); NASA Exobiology program(National Aeronautics & Space Administration (NASA))	Grants to D.K.N. from the Howard Hughes Medical Institute (HHMI) and the NASA Exobiology program (NNX12AD93G) supported this work. D.K.N. is an HHMI Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacia K, 2005, P NATL ACAD SCI USA, V102, P3272, DOI 10.1073/pnas.0408215102; Bacia K, 2004, BIOPHYS J, V87, P1034, DOI 10.1529/biophysj.104.040519; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chen JC, 2005, MOL MICROBIOL, V55, P1085, DOI 10.1111/j.1365-2958.2004.04443.x; Doughty DM, 2009, GEOBIOLOGY, V7, P524, DOI 10.1111/j.1472-4669.2009.00217.x; Doughty DM, 2011, P NATL ACAD SCI USA, V108, pE1045, DOI 10.1073/pnas.1104209108; Frisz JF, 2013, J BIOL CHEM, V288, P16855, DOI 10.1074/jbc.M113.473207; Frisz JF, 2013, P NATL ACAD SCI USA, V110, pE613, DOI 10.1073/pnas.1216585110; Ghosal S, 2008, ANAL CHEM, V80, P5986, DOI 10.1021/ac8006279; Ginsbach G, 1987, HISTOCHEMISTRY, V86, P241; Koppelman CM, 2001, J BACTERIOL, V183, P6144, DOI 10.1128/JB.183.20.6144-6147.2001; Kraft ML, 2006, SCIENCE, V313, P1948, DOI 10.1126/science.1130279; Lopez D, 2010, GENE DEV, V24, P1893, DOI 10.1101/gad.1945010; Lozano MM, 2013, J AM CHEM SOC, V135, P5620, DOI 10.1021/ja310831m; Matsumoto K, 2006, MOL MICROBIOL, V61, P1110, DOI 10.1111/j.1365-2958.2006.05317.x; Meeks JC, 2002, ARCH MICROBIOL, V178, P395, DOI 10.1007/s00203-002-0476-5; Mileykovskaya E, 2009, BBA-BIOMEMBRANES, V1788, P2084, DOI 10.1016/j.bbamem.2009.04.003; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; OURISSON G, 1987, ANNU REV MICROBIOL, V41, P301, DOI 10.1146/annurev.mi.41.100187.001505; Owen DM, 2012, BIOESSAYS, V34, P739, DOI 10.1002/bies.201200044; Renner LD, 2011, P NATL ACAD SCI USA, V108, P6264, DOI 10.1073/pnas.1015757108; Saenz JP, 2012, P NATL ACAD SCI USA, V109, P14236, DOI 10.1073/pnas.1212141109; Sato S, 2012, J BIOL CHEM, V287, P24113, DOI 10.1074/jbc.M111.318311; Sessions AL, 2004, GEOCHIM COSMOCHIM AC, V68, P1545, DOI 10.1016/j.gca.2003.06.004; Suzuki KGN, 2012, BIOTECHNOL J, V7, P753, DOI 10.1002/biot.201100360; Welander PV, 2012, GEOBIOLOGY, V10, P163, DOI 10.1111/j.1472-4669.2011.00314.x; Welander PV, 2010, P NATL ACAD SCI USA, V107, P8537, DOI 10.1073/pnas.0912949107; Welander PV, 2009, J BACTERIOL, V191, P6145, DOI 10.1128/JB.00460-09; WESTMACOTT D, 1976, J GEN MICROBIOL, V94, P117, DOI 10.1099/00221287-94-1-117; Yeh YC, 2010, J BACTERIOL, V192, P4847, DOI 10.1128/JB.00607-10	30	32	32	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84455	10.1371/journal.pone.0084455	http://dx.doi.org/10.1371/journal.pone.0084455			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409299	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000329463500023
J	Banda, M; Speyer, CL; Semma, SN; Osuala, KO; Kounalakis, N; Torres, KET; Barnard, NJ; Kim, HJ; Sloane, BF; Miller, FR; Goydos, JS; Gorski, DH				Banda, Malathi; Speyer, Cecilia L.; Semma, Sara N.; Osuala, Kingsley O.; Kounalakis, Nicole; Torres, Keila E. Torres; Barnard, Nicola J.; Kim, Hyunjin J.; Sloane, Bonnie F.; Miller, Fred R.; Goydos, James S.; Gorski, David H.			Metabotropic Glutamate Receptor-1 Contributes to Progression in Triple Negative Breast Cancer	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; PROTEIN-COUPLED RECEPTORS; CELL-LINES; MOLECULAR PORTRAITS; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; XENOGRAFT MODEL; KINASE-C; MELANOMA; RAS	TNBC is an aggressive breast cancer subtype that does not express hormone receptors (estrogen and progesterone receptors, ER and PR) or amplified human epidermal growth factor receptor type 2 (HER2), and there currently exist no targeted therapies effective against it. Consequently, finding new molecular targets in triple negative breast cancer (TNBC) is critical to improving patient outcomes. Previously, we have detected the expression of metabotropic glutamate receptor-1 (gene: GRM1; protein: mGluR1) in TNBC and observed that targeting glutamatergic signaling inhibits TNBC growth both in vitro and in vivo. In this study, we explored how mGluR1 contributes to TNBC progression, using the isogenic MCF10 progression series, which models breast carcinogenesis from nontransformed epithelium to malignant basal-like breast cancer. We observed that mGluR1 is expressed in human breast cancer and that in MCF10A cells, which model nontransformed mammary epithelium, but not in MCF10AT1 cells, which model atypical ductal hyperplasia, mGluR1 overexpression results in increased proliferation, anchorage-independent growth, and invasiveness. In contrast, mGluR1 knockdown results in a decrease in these activities in malignant MCF10CA1d cells. Similarly, pharmacologic inhibition of glutamatergic signaling in MCF10CA1d cells results in a decrease in proliferation and anchorage-independent growth. Finally, transduction of MCF10AT1 cells, which express c-Ha-ras, using a lentiviral construct expressing GRM1 results in transformation to carcinoma in 90% of resultant xenografts. We conclude that mGluR1 cooperates with other factors in hyperplastic mammary epithelium to contribute to TNBC progression and therefore propose that glutamatergic signaling represents a promising new molecular target for TNBC therapy.	[Banda, Malathi; Speyer, Cecilia L.; Gorski, David H.] Wayne State Univ, Sch Med, Dept Surg, Detroit, MI 48201 USA; [Banda, Malathi; Speyer, Cecilia L.; Semma, Sara N.; Gorski, David H.] Barbara Ann Karmanos Canc Inst, Detroit, MI USA; [Osuala, Kingsley O.; Sloane, Bonnie F.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Kounalakis, Nicole; Torres, Keila E. Torres; Kim, Hyunjin J.; Goydos, James S.] UMDNJ Robert Wood Johnson Univ, Div Surg Oncol, Sch Med, New Brunswick, NJ USA; [Barnard, Nicola J.] UMDNJ Robert Wood Johnson Univ, Dept Pathol, Sch Med, New Brunswick, NJ USA; [Barnard, Nicola J.; Goydos, James S.] Canc Inst New Jersey, New Brunswick, NJ USA; [Miller, Fred R.; Gorski, David H.] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI USA	Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Wayne State University	Gorski, DH (corresponding author), Wayne State Univ, Sch Med, Dept Surg, Detroit, MI 48201 USA.	gorskid@med.wayne.edu	Sloane, Bonnie F/A-1050-2009; Goydos, James/AAR-8990-2020; Gorski, David/AAE-6399-2022	Goydos, James/0000-0001-9811-939X; Gorski, David/0000-0002-9805-6699; Torres, Keila E/0000-0002-1855-0989	Conquer Cancer Foundation of ASCO; "Grants4Targets" (G4T) program of Bayer Healthcare; Bayer Healthcare; NATIONAL CANCER INSTITUTE [R01CA140314, P30CA022453] Funding Source: NIH RePORTER	Conquer Cancer Foundation of ASCO; "Grants4Targets" (G4T) program of Bayer Healthcare; Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work described in this manuscript was supported by an Advanced Clinical Research Award in Breast Cancer from the Conquer Cancer Foundation of ASCO, as well as a grant from the "Grants4Targets" (G4T) program of Bayer Healthcare. David H. Gorski received a small amount of funding from Bayer Healthcare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOS JL, 1989, CANCER RES, V49, P4682; Cheah BC, 2010, CURR MED CHEM, V17, P1942, DOI 10.2174/092986710791163939; CIARDIELLO F, 1992, MOL CARCINOGEN, V6, P43, DOI 10.1002/mc.2940060108; Dawson PJ, 1996, AM J PATHOL, V148, P313; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Esseltine JL, 2013, MOL PHARMACOL, V83, P770, DOI 10.1124/mol.112.081695; Esseltine JL, 2012, J NEUROSCI, V32, P16933, DOI 10.1523/JNEUROSCI.0625-12.2012; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Francesconi A, 1998, J BIOL CHEM, V273, P5615, DOI 10.1074/jbc.273.10.5615; Gorski DH, 2003, J AM COLL SURGEONS, V197, P408, DOI 10.1016/S1072-7515(03)00388-0; Goydos JS, 2003, CLIN CANCER RES, V9, P5962; Hoenerhoff MJ, 2009, ONCOGENE, V28, P3022, DOI 10.1038/onc.2009.165; Kadota M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009201; Kim S, 2013, TUMOUR BIOL; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Li QW, 2008, NEOPLASIA, V10, P314, DOI 10.1593/neo.07970; Malaney S, 2001, J MAMMARY GLAND BIOL, V6, P101, DOI 10.1023/A:1009572700317; Marin YE, 2006, CELL SIGNAL, V18, P1279, DOI 10.1016/j.cellsig.2005.10.012; Marin YE, 2005, NEUROPHARMACOLOGY, V49, P70, DOI 10.1016/j.neuropharm.2005.05.018; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; MILLER FR, 1993, J NATL CANCER I, V85, P1725, DOI 10.1093/jnci/85.21.1725; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; Miller FR, 2000, J MAMMARY GLAND BIOL, V5, P379, DOI 10.1023/A:1009577811584; Miller RG, 2003, AMYOTROPH LATERAL SC, V4, P191; Mullins SR, 2012, BIOL CHEM IN PRESS; Namkoong J, 2007, CANCER RES, V67, P2298, DOI 10.1158/0008-5472.CAN-06-3665; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Noh KM, 2000, NEUROBIOL DIS, V7, P375, DOI 10.1006/nbdi.2000.0297; Pal SK, 2011, BREAST CANCER RES TR, V125, P627, DOI 10.1007/s10549-010-1293-1; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pollock PM, 2003, NAT GENET, V34, P108, DOI 10.1038/ng1148; Prakriya M, 2000, NEURON, V26, P671, DOI 10.1016/S0896-6273(00)81203-9; Sameni M, 2012, JOVE-J VIS EXP, DOI 10.3791/3661; Sameni M, 2009, CLIN EXP METASTAS, V26, P299, DOI 10.1007/s10585-008-9218-7; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Seidlitz EP, 2009, CLIN EXP METASTAS, V26, P781, DOI 10.1007/s10585-009-9277-4; Shah SP, 2012, NATURE; Shin SS, 2008, NEUROPHARMACOLOGY, V55, P396, DOI 10.1016/j.neuropharm.2008.04.021; Shin SS, 2008, PIGM CELL MELANOMA R, V21, P368, DOI 10.1111/j.1755-148X.2008.00452.x; Shin SS, 2010, PIGM CELL MELANOMA R, V23, P103, DOI 10.1111/j.1755-148X.2009.00648.x; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; SOULE HD, 1990, CANCER RES, V50, P6075; Speyer CL, 2012, BREAST CANCER RES TR, V132, P565, DOI 10.1007/s10549-011-1624-x; Tait LR, 2007, INT J CANCER, V120, P2127, DOI 10.1002/ijc.22572; THOR A, 1986, LAB INVEST, V55, P603; Wang JQ, 2004, MOL NEUROBIOL, V29, P1, DOI 10.1385/MN:29:1:01; Wang SJ, 2004, NEUROSCIENCE, V125, P191, DOI 10.1016/j.neuroscience.2004.01.019; Waters C, 2004, SEMIN CELL DEV BIOL, V15, P309, DOI 10.1016/j.semcdb.2003.12.020; Worsham MJ, 2006, BREAST CANCER RES TR, V96, P177, DOI 10.1007/s10549-005-9077-8; Yip D, 2009, CLIN CANCER RES, V15, P3896, DOI 10.1158/1078-0432.CCR-08-3303	53	30	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e81126	10.1371/journal.pone.0081126	http://dx.doi.org/10.1371/journal.pone.0081126			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404125	Green Published, Green Submitted, gold			2022-12-27	WOS:000329460800004
J	Cheng, KC; Asakawa, A; Li, YX; Chung, HH; Amitani, H; Ueki, T; Cheng, JT; Inui, A				Cheng, Kai-Chun; Asakawa, Akihiro; Li, Ying-Xiao; Chung, Hsien-Hui; Amitani, Haruka; Ueki, Takatoshi; Cheng, Juei-Tang; Inui, Akio			Silymarin Induces Insulin Resistance through an Increase of Phosphatase and Tensin Homolog in Wistar Rats	PLOS ONE			English	Article							GLUCOSE-UPTAKE; MILK THISTLE; CELL-PROLIFERATION; LIVER-DISEASE; SILIBININ; PTEN; ADIPOCYTES; INHIBITION; GROWTH; STIMULATION	Background and aims: Phosphatase and tensin homolog (PTEN) is a phosphoinositide phosphatase that regulates crucial cellular functions, including insulin signaling, lipid and glucose metabolism, as well as survival and apoptosis. Silymarin is the active ingredient in milk thistle and exerts numerous effects through the activation of PTEN. However, the effect of silymarin on the development of insulin resistance remains unknown. Methods: Wistar rats fed fructose-rich chow or normal chow were administered oral silymarin to identify the development of insulin resistance using the homeostasis model assessment of insulin resistance and hyperinsulinemic-euglycemic clamping. Changes in PTEN expression in skeletal muscle and liver were compared using western blotting analysis. Further investigation was performed in L6 cells to check the expression of PTEN and insulin-related signals. PTEN deletion in L6 cells was achieved by small interfering ribonucleic acid transfection. Results: Oral administration of silymarin at a dose of 200 mg/kg once daily induced insulin resistance in normal rats and enhanced insulin resistance in fructose-rich chow-fed rats. An increase of PTEN expression was observed in the skeletal muscle and liver of rats with insulin resistance. A decrease in the phosphorylation of Akt in L6 myotube cells, which was maintained in a high-glucose condition, was also observed. Treatment with silymarin aggravated high-glucose-induced insulin resistance. Deletion of PTEN in L6 cells reversed silymarin-induced impaired insulin signaling and glucose uptake. Conclusions: Silymarin has the ability to disrupt insulin signaling through increased PTEN expression. Therefore, silymarin should be used carefully in type-2 diabetic patients.	[Cheng, Kai-Chun; Asakawa, Akihiro; Li, Ying-Xiao; Amitani, Haruka; Inui, Akio] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Psychosomat Internal Med, Kagoshima 890, Japan; [Chung, Hsien-Hui] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan; [Ueki, Takatoshi] Hamamatsu Univ Sch Med, Dept Neuroanat, Hamamatsu, Shizuoka 4313192, Japan; [Cheng, Juei-Tang] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan	Kagoshima University; National Cheng Kung University; Hamamatsu University School of Medicine; Chi Mei Hospital	Inui, A (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Psychosomat Internal Med, Kagoshima 890, Japan.	inui@m.kufm.kagoshima-u.ac.jp	Chung, Hsien-Hui/W-4061-2019	Kai Chun, Cheng/0000-0003-4983-4666	Young Researcher Overseas Visits Program for Vitalizing Brain Circulation by the Japan society for the promotion of science	Young Researcher Overseas Visits Program for Vitalizing Brain Circulation by the Japan society for the promotion of science	This work was supported by the Young Researcher Overseas Visits Program for Vitalizing Brain Circulation by the Japan society for the promotion of science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov IM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002457; Alonso-Castro AJ, 2008, J ETHNOPHARMACOL, V118, P252, DOI 10.1016/j.jep.2008.04.007; Ashkavand Z, 2012, PHYTOMEDICINE, V19, P1200, DOI 10.1016/j.phymed.2012.07.008; Baluchnejadmojarad T, 2010, PHYTOTHER RES, V24, P1120, DOI 10.1002/ptr.3078; Blodgett AB, 2011, DIABETES TECHNOL THE, V13, P743, DOI 10.1089/dia.2011.0041; Bu ZQ, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-10; Butler M, 2002, DIABETES, V51, P1028, DOI 10.2337/diabetes.51.4.1028; Louzao MC, 2008, GLYCOCONJUGATE J, V25, P503, DOI 10.1007/s10719-007-9075-7; Cecen E, 2011, ASIAN PAC J CANCER P, V12, P2697; Chiu YJ, 2011, PHYTOTHER RES, V25, P1306, DOI 10.1002/ptr.3379; Contos Melissa J, 2004, Clin Liver Dis, V8, P481, DOI 10.1016/j.cld.2004.04.013; DEFRONZO RA, 1983, DIABETES, V32, P35, DOI 10.2337/diab.32.1.35; Flora K, 1998, AM J GASTROENTEROL, V93, P139, DOI 10.1111/j.1572-0241.1998.00139.x; Hawke RL, 2010, J CLIN PHARMACOL, V50, P434, DOI 10.1177/0091270009347475; Jacobs BP, 2002, AM J MED, V113, P506, DOI 10.1016/S0002-9343(02)01244-5; Alonso-Castro AJ, 2011, PHYTOMEDICINE, V18, P926, DOI 10.1016/j.phymed.2011.02.015; Kamezaki F, 2012, INTERNAL MED, V51, P2119, DOI 10.2169/internalmedicine.51.7235; Khan RA, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-114; Lah JJ, 2007, WORLD J GASTROENTERO, V13, P5299, DOI 10.3748/wjg.v13.i40.5299; Landau BR, 2007, AM J PHYSIOL-ENDOC M, V293, pE237, DOI 10.1152/ajpendo.00022.2007; LEBER HW, 1976, ARZNEIMITTEL-FORSCH, V26, P1603; Lee SK, 2011, J CELL BIOCHEM, V112, P1259, DOI 10.1002/jcb.23000; Lieber CS, 2003, J CLIN GASTROENTEROL, V37, P336, DOI 10.1097/00004836-200310000-00013; Mak Lok Hang, 2010, J Chem Biol, V3, P157, DOI 10.1007/s12154-010-0041-7; Malekinejad H, 2012, PHYTOMEDICINE, V19, P583, DOI 10.1016/j.phymed.2012.02.009; Marchesini G, 2006, Minerva Cardioangiol, V54, P229; Nandhini A. T. A., 2005, SMJ Singapore Medical Journal, V46, P82; Peyrou M, 2010, WORLD J GASTROENTERO, V16, P4627, DOI 10.3748/wjg.v16.i37.4627; SARABIA V, 1992, J CLIN INVEST, V90, P1386, DOI 10.1172/JCI116005; Schrieber SJ, 2011, DRUG METAB DISPOS, V39, P2182, DOI 10.1124/dmd.111.040212; Singh RP, 2008, CANCER RES, V68, P2043, DOI 10.1158/0008-5472.CAN-07-6247; Singh RP, 2003, CANCER EPIDEM BIOMAR, V12, P933; Singh RP, 2002, CANCER RES, V62, P3063; STEELE R, 1959, ANN NY ACAD SCI, V82, P420, DOI 10.1111/j.1749-6632.1959.tb44923.x; Su CH, 2009, NEUROSCI LETT, V457, P125, DOI 10.1016/j.neulet.2009.03.093; Tyagi A, 2002, PROSTATE, V53, P211, DOI 10.1002/pros.10146; Tyagi A, 2002, MOL CANCER THER, V1, P525; Tzeng JI, 2013, PHYTOTHER RES, V27, P1023, DOI 10.1002/ptr.4829; Varghese L, 2005, CLIN CANCER RES, V11, P8441, DOI 10.1158/1078-0432.CCR-05-1646; Vengerovskii AI, 2007, B EXP BIOL MED+, V144, P53, DOI 10.1007/s10517-007-0252-2; Vessal G, 2010, RENAL FAILURE, V32, P733, DOI 10.3109/0886022X.2010.486488; Vinciguerra Manlio, 2006, Archives of Physiology and Biochemistry, V112, P89, DOI 10.1080/13813450600711359; Wang L, 2007, HEPATOL RES, V37, P389, DOI 10.1111/j.1872-034X.2007.00042.x; Wang SH, 2011, J AGR FOOD CHEM, V59, P3686, DOI 10.1021/jf1048386; Wang XK, 2012, EXP DIABETES RES, DOI 10.1155/2012/847246; Wedin WK, 2012, DIABETES METAB SYNDR, V5, P219, DOI 10.2147/DMSO.S33478; Wijesekara N, 2005, MOL CELL BIOL, V25, P1135, DOI 10.1128/MCB.25.3.1135-1145.2005; Williams R, 2006, HEPATOLOGY, V44, P521, DOI 10.1002/hep.21347; Yu HC, 2012, PHYTOTHER RES, V26, P709, DOI 10.1002/ptr.3618; Zhang ZW, 2012, MOL CELL ENDOCRINOL, V361, P213, DOI 10.1016/j.mce.2012.04.012; Zhao D, 2012, J PHARMACOL EXP THER, V343, P206, DOI 10.1124/jpet.112.194738; Zou CH, 2005, J BIOCHEM BIOPH METH, V64, P207, DOI 10.1016/j.jbbm.2005.08.001; Zu LY, 2011, EUR J PHARMACOL, V650, P298, DOI 10.1016/j.ejphar.2010.09.069	53	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84550	10.1371/journal.pone.0084550	http://dx.doi.org/10.1371/journal.pone.0084550			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404172	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460800051
J	Liu, Y; Yin, Y; Sheng, Q; Lu, XT; Wang, F; Lin, ZY; Tian, HP; Xu, AJ; Zhang, J				Liu, Yan; Yin, You; Sheng, Qi; Lu, Xiaotong; Wang, Fang; Lin, Zhiyan; Tian, Huaiping; Xu, Ajing; Zhang, Jian			Association of ABCC2-24C > T Polymorphism with High-Dose Methotrexate Plasma Concentrations and Toxicities in Childhood Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							THERAPY; GENE; TRANSPORTERS; CHILDREN; TRIAL	Methotrexate (MTX) is a key agent for the treatment of childhood acute lymphoblastic leukemia (ALL). Increased MTX plasma concentrations are associated with a higher risk of adverse drug effects. ATP-binding cassette subfamily C member 2 (ABCC2) is important for excretion of MTX and its toxic metabolite. The ABCC2 -24C>T polymorphism (rs717620) reportedly contributes to variability of MTX kinetics. In the present study, we assessed the association between the ABCC2 -24C>T polymorphism and methotrexate (MTX) toxicities in childhood ALL patients treated with high-dose MTX. A total of 112 Han Chinese ALL patients were treated with high-dose MTX according to the ALL-Berlin-Frankfurt-Muenster 2000 protocol. Our results showed that presence of the -24T allele in ABCC2 gene led to significantly higher MTX plasma concentrations at 48 hours after the start of infusion, which would strengthen over repeated MTX infusion. The -24T allele in ABCC2 gene was significantly associated with higher risks of high-grade hematologic (leucopenia, anemia, and thrombocytopenia) and non-hematologic (gastrointestinal and mucosal damage/oral mucositis) MTX toxicities. This study provides the first evidence that the -24T allele in ABCC2 gene is associated with the severity of MTX toxicities, which add fresh insights into clinical application of high-dose MTX and individualization of MTX treatment.	[Liu, Yan; Lu, Xiaotong; Wang, Fang; Lin, Zhiyan; Tian, Huaiping; Xu, Ajing; Zhang, Jian] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Pharm, Shanghai 200030, Peoples R China; [Yin, You] Second Mil Med Univ, Changzheng Hosp, Dept Neurol, Shanghai, Peoples R China; [Sheng, Qi] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Pediat Hematol Oncol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Naval Medical University; Shanghai Jiao Tong University	Zhang, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Pharm, Shanghai 200030, Peoples R China.	zj_xhpharm@126.com			Research Award Fund for Outstanding Young Teachers of Shanghai [2007087]; Shanghai Municipal Health Bureau Research Foundation [2009068]	Research Award Fund for Outstanding Young Teachers of Shanghai; Shanghai Municipal Health Bureau Research Foundation	This study was supported by Research Award Fund for Outstanding Young Teachers of Shanghai (#2007087) and Shanghai Municipal Health Bureau Research Foundation (#2009068). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari M, 2009, BLOOD, V114, P1383, DOI 10.1182/blood-2008-11-191098; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; de Beaumais TA, 2012, CURR DRUG METAB, V13, P822; Dragun AE, 2013, INT J RADIAT ONCOL, V85, pE123, DOI 10.1016/j.ijrobp.2012.10.021; HAGLEITNER MM, 2010, J CLIN ONCOL, V28, pS15; Hampras SS, 2010, INT J MOL EPIDEMIOL, V1, P201; Huang Y, 2007, CANCER METAST REV, V26, P183, DOI 10.1007/s10555-007-9050-6; Kantar M, 2009, LEUKEMIA LYMPHOMA, V50, P912, DOI 10.1080/10428190902893819; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Longo-Sorbello GSA, 2001, HAEMATOLOGICA, V86, P121; Lopez-Lopez Elixabet, 2013, Pharmacogenet Genomics, V23, P53, DOI 10.1097/FPC.0b013e32835c3b24; Moricke A, 2008, BLOOD, V111, P4477, DOI 10.1182/blood-2007-09-112920; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Ramsey LB, 2013, BLOOD, V121, P898, DOI 10.1182/blood-2012-08-452839; Rau T, 2006, CLIN PHARMACOL THER, V80, P468, DOI 10.1016/j.clpt.2006.08.012; Simon N, 2013, PHARMACOGENOMICS J, V13, P507, DOI 10.1038/tpj.2012.37; Tanaka T, 1999, HEPATOLOGY, V30, P1507, DOI 10.1002/hep.510300617; Uga H, 2006, MOL PHARMACOL, V70, P1832, DOI 10.1124/mol.106.025866; van den Bongard HJGD, 2000, CLIN PHARMACOKINET, V39, P345, DOI 10.2165/00003088-200039050-00004; Zhang WX, 2008, XENOBIOTICA, V38, P1422, DOI 10.1080/00498250802488585	20	37	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e82681	10.1371/journal.pone.0082681	http://dx.doi.org/10.1371/journal.pone.0082681			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404132	Green Submitted, Green Published, gold			2022-12-27	WOS:000329460800011
J	Talaber, G; Miklossy, G; Oaks, Z; Liu, YX; Tooze, SA; Chudakov, DM; Banki, K; Perl, A				Talaber, Gergely; Miklossy, Gabriella; Oaks, Zachary; Liu, Yuxin; Tooze, Sharon A.; Chudakov, Dmitriy M.; Banki, Katalin; Perl, Andras			HRES-1/Rab4 Promotes the Formation of LC3(+) Autophagosomes and the Accumulation of Mitochondria during Autophagy	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; REDUCES DISEASE-ACTIVITY; BAFILOMYCIN A1; MAMMALIAN TARGET; RAB4 CONTROLS; T-CELLS; PATHWAY; RAPAMYCIN; COMPARTMENTS; TRAFFICKING	HRES-1/Rab4 is a small GTPase that regulates endocytic recycling. It has been colocalized to mitochondria and the mechanistic target of rapamycin (mTOR), a suppressor of autophagy. Since the autophagosomal membrane component microtubule-associated protein light chain 3 (LC3) is derived from mitochondria, we investigated the impact of HRES-1/Rab4 on the formation of LC3(+) autophagosomes, their colocalization with HRES-1/Rab4 and mitochondria, and the retention of mitochondria during autophagy induced by starvation and rapamycin. HRES-1/Rab4 exhibited minimal baseline colocalization with LC3, which was enhanced 22-fold upon starvation or 6-fold upon rapamycin treatment. Colocalization of HRES-1/Rab4 with mitochondria was increased >2-fold by starvation or rapamycin. HRES-1/Rab4 overexpression promoted the colocalization of mitochondria with LC3 upon starvation or rapamycin treatment. A dominant-negative mutant, HRES-1/Rab4(S27N) had reduced colocalization with LC3 and mitochondria upon starvation but not rapamycin treatment. A constitutively active mutant, HRES-1/Rab4(Q72L) showed diminished colocalization with LC3 but promoted the partitioning of mitochondria with LC3 upon starvation or rapamycin treatment. Phosphorylation-resistant mutant HRES-1/Rab4(S204Q) showed diminished colocalization with LC3 but increased partitioning to mitochondria. A newly discovered C-terminally truncated native isoform, HRES-1/Rab4(1-121), showed enhanced localization to LC3 and mitochondria without starvation or rapamycin treatment. HRES-1/Rab4(1-121) increased the formation of LC3(+) autophagosomes in resting cells, while other isoforms promoted autophagosome formation upon starvation. HRES-1/Rab4, HRES-1/Rab4(1-121), HRES-1/Rab4(Q72L) and HRES-1/Rab4(S204Q) promoted the accumulation of mitochondria during starvation. The specificity of HRES-1/Rab4-mediated mitochondrial accumulation is indicated by its abrogation by dominant-negative HRES-1/Rab4(S27N) mutation. The formation of interconnected mitochondrial tubular networks was markedly enhanced by HRES-1/Rab4(Q72L) upon starvation, which may contribute to the retention of mitochondria during autophagy. The present study thus indicates that HRES-1/Rab4 regulates autophagy through promoting the formation of LC3(+) autophagosomes and the preservation of mitochondria.	[Talaber, Gergely; Miklossy, Gabriella; Oaks, Zachary; Liu, Yuxin; Perl, Andras] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA; [Oaks, Zachary; Perl, Andras] SUNY Upstate Med Univ, Syracuse, NY 13210 USA; [Tooze, Sharon A.] Canc Res UK London Res Inst, London WC2A 3PX, England; [Chudakov, Dmitriy M.] RAS, Shemiakin Ovchinnikov Inst Bioorgan Chem, Moscow 117901, Russia; [Banki, Katalin] SUNY Upstate Med Univ, Dept Pathol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Cancer Research UK; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Perl, A (corresponding author), SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA.	perla@upstate.edu	Talaber, Gergely/C-2638-2013; Chudakov, Dmitriy M/G-7741-2014	Chudakov, Dmitriy M/0000-0003-0430-790X; Talaber, Gergely/0000-0003-2457-3236; Tooze, Sharon/0000-0002-2182-3116; Perl, Andras/0000-0002-5017-1348; Liu, Yuxin/0000-0002-0623-2561	National Institutes of Health [AI048079, AI072648]; Central New York Community Foundation; Cancer Research UK [15153] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI048079, R01AI048079] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Central New York Community Foundation; Cancer Research UK(Cancer Research UK); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by grants AI048079 and AI072648 from the National Institutes of Health and the Central New York Community Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandri C, 2012, FASEB J, V26, P4722, DOI 10.1096/fj.12-206060; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Calore F, 2010, CELL DEATH DIFFER, V17, P1707, DOI 10.1038/cdd.2010.42; Caza TN, 2013, ANN RHEUM D IN PRESS; Cormont M, 2003, TRAFFIC, V4, P97, DOI 10.1034/j.1600-0854.2003.40205.x; Fernandez D, 2006, ARTHRITIS RHEUM-US, V54, P2983, DOI 10.1002/art.22085; Fernandez DR, 2009, J IMMUNOL, V182, P2063, DOI 10.4049/jimmunol.0803600; Gao WT, 2010, J BIOL CHEM, V285, P1371, DOI 10.1074/jbc.M109.054197; Gutierrez MG, 2004, J CELL SCI, V117, P2687, DOI 10.1242/jcs.01114; Hadano S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009805; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Kim B, 2013, AM J PHYSIOL-REG I, V305, pR927, DOI 10.1152/ajpregu.00502.2012; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Klionsky DJ, 2011, AUTOPHAGY, V7, P1273, DOI 10.4161/auto.7.11.17661; Lai ZW, 2013, J IMMUNOL, V191, P2236, DOI 10.4049/jimmunol.1301005; Lai ZW, 2012, ARTHRITIS RHEUM-US, V64, P2937, DOI 10.1002/art.34502; Lazzarino DA, 1998, J EXP MED, V188, P1769, DOI 10.1084/jem.188.10.1769; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Longatti A, 2012, AUTOPHAGY, V8, P1682, DOI 10.4161/auto.21486; Longatti A, 2012, J CELL BIOL, V197, P659, DOI 10.1083/jcb.201111079; Mancuso MR, 2006, J CLIN INVEST, V116, P2610, DOI 10.1172/JCI24612; Marceau F, 2012, TOXICOL APPL PHARM, V259, P1, DOI 10.1016/j.taap.2011.12.004; Mari M, 2006, J CELL SCI, V119, P1297, DOI 10.1242/jcs.02850; Metcalf DJ, 2012, EXP NEUROL, V238, P22, DOI 10.1016/j.expneurol.2010.11.003; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nagy G, 2006, J BIOL CHEM, V281, P34574, DOI 10.1074/jbc.M606301200; Novak I, 2012, ANTIOXID REDOX SIGN, V17, P794, DOI 10.1089/ars.2011.4407; Perl A, 2013, NAT REV RHEUMATOL, V9, P674, DOI 10.1038/nrrheum.2013.147; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shcherbo D, 2010, NAT METHODS, V7, P827, DOI [10.1038/NMETH.1501, 10.1038/nmeth.1501]; Teplova VV, 2007, J BIOENERG BIOMEMBR, V39, P321, DOI 10.1007/s10863-007-9095-9; Thelen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035493; Tooze SA, 2010, IUBMB LIFE, V62, P503, DOI 10.1002/iub.334; VANDERSLUIJS P, 1992, CELL, V70, P729, DOI 10.1016/0092-8674(92)90307-X; Weidberg H, 2011, ANNU REV BIOCHEM, V80, P125, DOI 10.1146/annurev-biochem-052709-094552; Zhdanov AV, 2012, BIOSCIENCE REP, V32, P587, DOI 10.1042/BSR20120085; Zhdanov AV, 2011, CELL MOL LIFE SCI, V68, P903, DOI 10.1007/s00018-010-0502-8	40	31	31	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84392	10.1371/journal.pone.0084392	http://dx.doi.org/10.1371/journal.pone.0084392			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404161	Green Published, gold			2022-12-27	WOS:000329460800040
J	Chaffey, GS; Lloyd, DJB; Skeldon, AC; Kirkby, NF				Chaffey, Gary S.; Lloyd, David J. B.; Skeldon, Anne C.; Kirkby, Norman F.			The Effect of the G(1) - S transition Checkpoint on an Age Structured Cell Cycle Model	PLOS ONE			English	Article							POPULATION BALANCE MODEL; MATHEMATICAL-MODEL; LINES; PHASE; RADIATION; KINETICS; ARREST; FLOW	Knowledge of how a population of cancerous cells progress through the cell cycle is vital if the population is to be treated effectively, as treatment outcome is dependent on the phase distributions of the population. Estimates on the phase distribution may be obtained experimentally however the errors present in these estimates may effect treatment efficacy and planning. If mathematical models are to be used to make accurate, quantitative predictions concerning treatments, whose efficacy is phase dependent, knowledge of the phase distribution is crucial. In this paper it is shown that two different transition rates at the G(1)-S checkpoint provide a good fit to a growth curve obtained experimentally. However, the different transition functions predict a different phase distribution for the population, but both lying within the bounds of experimental error. Since treatment outcome is effected by the phase distribution of the population this difference may be critical in treatment planning. Using an age-structured population balance approach the cell cycle is modelled with particular emphasis on the G(1)-S checkpoint. By considering the probability of cells transitioning at the G(1)-S checkpoint, different transition functions are obtained. A suitable finite difference scheme for the numerical simulation of the model is derived and shown to be stable. The model is then fitted using the different probability transition functions to experimental data and the effects of the different probability transition functions on the model's results are discussed.	[Chaffey, Gary S.; Lloyd, David J. B.; Skeldon, Anne C.] Univ Surrey, Dept Math, Guildford GU2 5XH, Surrey, England; [Kirkby, Norman F.] Univ Surrey, Dept Chem Engn, Guildford GU2 5XH, Surrey, England	University of Surrey; University of Surrey	Chaffey, GS (corresponding author), Univ Surrey, Dept Math, Guildford GU2 5XH, Surrey, England.	g.chaffey@surrey.ac.uk	Kirkby, Norman/M-3739-2015	Kirkby, Norman/0000-0003-3984-0309; Kirkby, Norman/0000-0001-5352-8069; Lloyd, David/0000-0002-1902-0007; Skeldon, Anne/0000-0001-6387-4766	Engineering and Physical Sciences Research Council (EPSRC) [EP/P505755/1]; Engineering and Physical Sciences Research Council [1003347] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	GC's contribution was funded by an Engineering and Physical Sciences Research Council (EPSRC) supported Doctoral Training Centre, funded through EP/P505755/1. There was no other external funding for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B., 1994, MOL BIOL CELL; Basse B, 2005, B MATH BIOL, V67, P815, DOI 10.1016/j.bulm.2004.10.003; Basse B, 2004, J MATH BIOL, V49, P329, DOI 10.1007/s00285-003-0254-2; Basse B, 2003, J MATH BIOL, V47, P295, DOI 10.1007/s00285-003-0203-0; Basse B, 2007, B MATH BIOL, V69, P1673, DOI 10.1007/s11538-006-9185-6; Begg RE, 2008, EUR J APPL MATH, V19, P435, DOI 10.1017/S0956792508007535; BHUYAN BK, 1972, CANCER RES, V32, P398; Billy F., 2013, MATH METHODS MODELS; Brugarolas J, 1995, NATURE, V377, P12; Chaffey GS, 2013, SIMPLE MATLAB MODEL; Chapman SJ, 2007, ANZIAM J, V49, P151, DOI 10.1017/S144618110001275X; Darzynkiewicz Z, 2011, CRITICAL ASPECTS ANA; DEAN PN, 1982, CYTOMETRY, V3, P188, DOI 10.1002/cyto.990030309; Eakman J, 1966, CHEM ENG PROGR S SER, V69, P37; Faraday D, 1994, THESIS; Faraday DBF, 2001, BIOCHEM ENG J, V7, P49, DOI 10.1016/S1369-703X(00)00101-7; FREDERICKSON A. G., 1967, MATH BIO SCL, V1, P327, DOI 10.1016/0025-5564(67)90008-9; Fredrickson AG, 1963, AICHE J, V9, P359; Hayter P, 1989, INVESTIGATION FACTOR; Jackiewicz Z, 2009, MATH BIOSCI ENG, V6, P561, DOI 10.3934/mbe.2009.6.561; LACOMBE F, 1988, CYTOMETRY, V9, P245, DOI 10.1002/cyto.990090310; Liou JJ, 1997, CHEM ENG SCI, V52, P1529, DOI 10.1016/S0009-2509(96)00510-6; Liu YH, 2007, BIOTECHNOL PROGR, V23, P1198, DOI 10.1021/bp070152z; LOPES NM, 1993, CANCER CHEMOTH PHARM, V32, P235, DOI 10.1007/BF00685842; Mantzaris NV, 1999, J BIOTECHNOL, V71, P157, DOI 10.1016/S0168-1656(99)00020-6; Marples B, 2004, RADIAT RES, V161, P247, DOI 10.1667/RR3130; Mathworks, MATL R22012A; Novak B, 2004, J THEORETICAL BIOL; Owa T, 2001, CURR MED CHEM, V8, P1487, DOI 10.2174/0929867013371996; Powathil GG, 2013, J THEORETICAL BIOL; Slater G.R., 2004, THESIS; Smith GD, 2003, NUMERICAL SOLUTION P; SMITH JA, 1973, P NATL ACAD SCI USA, V70, P1263, DOI 10.1073/pnas.70.4.1263; Yao KC, 2003, J NEUROSURG, V98, P378, DOI 10.3171/jns.2003.98.2.0378	34	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e83477	10.1371/journal.pone.0083477	http://dx.doi.org/10.1371/journal.pone.0083477			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416166	Green Published, Green Submitted, gold			2022-12-27	WOS:000329866300015
J	Charaudeau, S; Pakdaman, K; Boelle, PY				Charaudeau, Segolene; Pakdaman, Khashayar; Boelle, Pierre-Yves			Commuter Mobility and the Spread of Infectious Diseases: Application to Influenza in France	PLOS ONE			English	Article							TRANSMISSION; NETWORKS; MODELS	Commuting data is increasingly used to describe population mobility in epidemic models. However, there is little evidence that the spatial spread of observed epidemics agrees with commuting. Here, using data from 25 epidemics for influenza-like illness in France (ILI) as seen by the Sentinelles network, we show that commuting volume is highly correlated with the spread of ILI. Next, we provide a systematic analysis of the spread of epidemics using commuting data in a mathematical model. We extract typical paths in the initial spread, related to the organization of the commuting network. These findings suggest that an alternative geographic distribution of GP accross France to the current one could be proposed. Finally, we show that change in commuting according to age (school or work commuting) impacts epidemic spread, and should be taken into account in realistic models.	[Charaudeau, Segolene; Boelle, Pierre-Yves] INSERM, UMR S 707, Paris, France; [Charaudeau, Segolene; Boelle, Pierre-Yves] Univ Paris 06, Paris, France; [Charaudeau, Segolene; Pakdaman, Khashayar] Inst Jacques Monod, F-75251 Paris, France; [Charaudeau, Segolene; Pakdaman, Khashayar] Univ Paris 07, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Charaudeau, S (corresponding author), INSERM, UMR S 707, Paris, France.	segolene.charaudeau@u707.jussieu.fr		Boelle, Pierre-Yves/0000-0002-5367-8232	Fondation pour la recherche medicale	Fondation pour la recherche medicale(Fondation pour la Recherche Medicale)	This work has been funded by the Fondation pour la recherche medicale (http://www.frm.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajelli M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-190; Balcan D, 2010, J COMPUT SCI-NETH, V1, P132, DOI 10.1016/j.jocs.2010.07.002; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Bavaud F, 1998, GEOGR ANAL, V30, P153; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bonabeau E, 1998, P ROY SOC B-BIOL SCI, V265, P2421, DOI 10.1098/rspb.1998.0593; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Cauchemez S, 2011, P NATL ACAD SCI USA, V108, P2825, DOI 10.1073/pnas.1008895108; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; Colizza V, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-34; Crepey P, 2007, AM J EPIDEMIOL, V166, P1244, DOI 10.1093/aje/kwm266; Eames KTD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002425; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Flahault A, 2006, VACCINE, V24, P6751, DOI 10.1016/j.vaccine.2006.05.079; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Hollingsworth TD, 2006, NAT MED, V12, P497, DOI 10.1038/nm0506-497; Khan K, 2009, NEW ENGL J MED, V361, P212, DOI 10.1056/NEJMc0904559; Lunelli A, 2009, MATH BIOSCI, V220, P24, DOI 10.1016/j.mbs.2009.03.008; Merler S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002205; Merler S, 2010, P ROY SOC B-BIOL SCI, V277, P557, DOI 10.1098/rspb.2009.1605; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Polgreen PM, 2009, AM J EPIDEMIOL, V170, P1300, DOI 10.1093/aje/kwp270; Truscott J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002699; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237	27	39	42	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e83002	10.1371/journal.pone.0083002	http://dx.doi.org/10.1371/journal.pone.0083002			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416152	Green Published, Green Submitted, gold			2022-12-27	WOS:000329866300012
J	Dogan, H; Can, HD; Otu, HH				Dogan, Haluk; Can, Handan; Otu, Hasan H.			Whole Genome Sequence of a Turkish Individual	PLOS ONE			English	Article							MASSIVELY-PARALLEL DNA; PROGRESSION; ALIGNMENT	Although whole human genome sequencing can be done with readily available technical and financial resources, the need for detailed analyses of genomes of certain populations still exists. Here we present, for the first time, sequencing and analysis of a Turkish human genome. We have performed 35x coverage using paired-end sequencing, where over 95% of sequencing reads are mapped to the reference genome covering more than 99% of the bases. The assembly of unmapped reads rendered 11,654 contigs, 2,168 of which did not reveal any homology to known sequences, resulting in similar to 1 Mbp of unmapped sequence. Single nucleotide polymorphism (SNP) discovery resulted in 3,537,794 SNP calls with 29,184 SNPs identified in coding regions, where 106 were nonsense and 259 were categorized as having a high-impact effect. The homo/hetero zygosity (1,415,123:2,122,671 or 1:1.5) and transition/transversion ratios (2,383,204:1,154,590 or 2.06:1) were within expected limits. Of the identified SNPs, 480,396 were potentially novel with 2,925 in coding regions, including 48 nonsense and 95 high-impact SNPs. Functional analysis of novel high-impact SNPs revealed various interaction networks, notably involving hereditary and neurological disorders or diseases. Assembly results indicated 713,640 indels (1:1.09 insertion/deletion ratio), ranging from -52 bp to 34 bp in length and causing about 180 codon insertion/deletions and 246 frame shifts. Using paired-end-and read-depth-based methods, we discovered 9,109 structural variants and compared our variant findings with other populations. Our results suggest that whole genome sequencing is a valuable tool for understanding variations in the human genome across different populations. Detailed analyses of genomes of diverse origins greatly benefits research in genetics and medicine and should be conducted on a larger scale.	[Dogan, Haluk; Can, Handan; Otu, Hasan H.] Istanbul Bilgi Univ, Dept Genet & Bioengn, Istanbul, Turkey	Istanbul Bilgi University	Otu, HH (corresponding author), Istanbul Bilgi Univ, Dept Genet & Bioengn, Istanbul, Turkey.	hasan.otu@bilgi.edu.tr	Dogan, Haluk/AAH-3873-2020	Dogan, Haluk/0000-0002-6547-6638; Otu, Hasan/0000-0002-9253-8152	Istanbul Bilgi University Research Fund	Istanbul Bilgi University Research Fund(Istanbul Bilgi University)	This work is funded by Istanbul Bilgi University Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Akin H, 2010, MOL BIOL REP, V37, P93, DOI 10.1007/s11033-009-9543-1; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Becamel C, 2002, EMBO J, V21, P2332, DOI 10.1093/emboj/21.10.2332; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bruderer R, 2011, EMBO REP, V12, P142, DOI 10.1038/embor.2010.206; Cheng NH, 2011, FEBS J, V278, P2525, DOI 10.1111/j.1742-4658.2011.08178.x; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Erbilgin Y, 2010, DIS MARKERS, V28, P353, DOI [10.3233/DMA-2010-0715, 10.1155/2010/740140]; Fujimoto A, 2010, NAT GENET, V42, P931, DOI 10.1038/ng.691; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Inoue H, 2003, EMBO J, V22, P6665, DOI 10.1093/emboj/cdg634; Ju YS, 2011, NAT GENET, V43, P745, DOI 10.1038/ng.872; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Krueger F, 2012, NAT METHODS, V9, P145, DOI [10.1038/NMETH.1828, 10.1038/nmeth.1828]; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lassmann T, 2011, BIOINFORMATICS, V27, P130, DOI 10.1093/bioinformatics/btq614; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marschall T, 2012, BIOINFORMATICS, V28, P2875, DOI 10.1093/bioinformatics/bts566; Ni ZY, 2005, P NATL ACAD SCI USA, V102, P14611, DOI 10.1073/pnas.0503070102; Ougolkov AV, 2007, BLOOD, V110, P735, DOI 10.1182/blood-2006-12-060947; Peng Y, 2010, LECT N BIOINFORMAT, V6044, P426, DOI 10.1007/978-3-642-12683-3_28; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2011, NAT GENET, V43, P923, DOI 10.1038/ng.953; Remmers EF, 2010, NAT GENET, V42, P698, DOI 10.1038/ng.625; Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020; Tong P, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r91; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Yazici Yusuf, 2010, Curr Rheumatol Rep, V12, P429, DOI 10.1007/s11926-010-0132-z	38	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85233	10.1371/journal.pone.0085233	http://dx.doi.org/10.1371/journal.pone.0085233			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416366	Green Published, gold			2022-12-27	WOS:000329866300056
J	Elfrink, K; Liao, WQ; Pieper, U; Oeding, SJ; Bahler, M				Elfrink, Kerstin; Liao, Wanqin; Pieper, Uwe; Oeding, Stefanie J.; Baehler, Martin			The Loop2 Insertion of Type IX Myosin Acts as an Electrostatic Actin Tether that Permits Processive Movement	PLOS ONE			English	Article							KINETIC MECHANISM; PLUS-END; MOTOR; KINESIN; SUPERFAMILY; BINDING; MUSCLE; DOMAIN; RHO	Although class IX myosins are single-headed, they demonstrate characteristics of processive movement along actin filaments. Double-headed myosins that move processively along actin filaments achieve this by successive binding of the two heads in a hand-over-hand mechanism. This mechanism, obviously, cannot operate in single-headed myosins. However, it has been proposed that a long class IX specific insertion in the myosin head domain at loop2 acts as an F-actin tether, allowing for single-headed processive movement. Here, we tested this proposal directly by analysing the movement of deletion constructs of the class IX myosin from Caenorhabditis elegans (Myo IX). Deletion of the large basic loop2 insertion led to a loss of processive behaviour, while deletion of the N-terminal head extension, a second unique domain of class IX myosins, did not influence the motility of Myo IX. The processive behaviour of Myo IX is also abolished with increasing salt concentrations. These observations directly demonstrate that the insertion located in loop2 acts as an electrostatic actin tether during movement of Myo IX along the actin track.	[Elfrink, Kerstin; Liao, Wanqin; Pieper, Uwe; Oeding, Stefanie J.; Baehler, Martin] Univ Munster, Inst Mol Cell Biol, D-48149 Munster, Germany	University of Munster	Bahler, M (corresponding author), Univ Munster, Inst Mol Cell Biol, D-48149 Munster, Germany.	baehler@uni-muenster.de			Deutsche Forschungsgemeinschaft [BA 1354/9-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by a grant from the Deutsche Forschungsgemeinschaft to Martin Bahler (Grant number BA 1354/9-2) (http://www.dfg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouhamed M, 2009, MOL BIOL CELL, V20, P5074, DOI 10.1091/mbc.E09-04-0291; Bahler M, 2000, BBA-MOL CELL RES, V1496, P52, DOI 10.1016/S0167-4889(00)00008-2; Baker JP, 1998, CURR OPIN CELL BIOL, V10, P80, DOI 10.1016/S0955-0674(98)80089-6; CANDE WZ, 1986, METHOD ENZYMOL, V134, P473; De la Cruz EM, 2001, J BIOL CHEM, V276, P32373, DOI 10.1074/jbc.M104136200; Furch M, 1998, BIOCHEMISTRY-US, V37, P6317, DOI 10.1021/bi972851y; Hancock WO, 1998, J CELL BIOL, V140, P1395, DOI 10.1083/jcb.140.6.1395; Hanley PJ, 2010, P NATL ACAD SCI USA, V107, P12145, DOI 10.1073/pnas.0911986107; Henn A, 2005, J BIOL CHEM, V280, P39665, DOI 10.1074/jbc.M507667200; Hodges AR, 2007, J BIOL CHEM, V282, P27192, DOI 10.1074/jbc.M703968200; Inoue A, 2002, NAT CELL BIOL, V4, P302, DOI 10.1038/ncb774; Kalhammer G, 1997, FEBS LETT, V414, P599, DOI 10.1016/S0014-5793(97)01076-4; Kambara T, 2006, J BIOL CHEM, V281, P4949, DOI 10.1074/jbc.M509141200; Liao WQ, 2010, J BIOL CHEM, V285, P24933, DOI 10.1074/jbc.M110.101105; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Mermall V, 1998, SCIENCE, V279, P527, DOI 10.1126/science.279.5350.527; Nalavadi V, 2005, J BIOL CHEM, V280, P38957, DOI 10.1074/jbc.M507161200; Nishikawa M, 2006, BIOCHEM BIOPH RES CO, V343, P1159, DOI 10.1016/j.bbrc.2006.03.057; O'Connell CB, 2003, NAT CELL BIOL, V5, P171, DOI 10.1038/ncb924; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Post PL, 1998, J CELL SCI, V111, P941; Post PL, 2002, J BIOL CHEM, V277, P11679, DOI 10.1074/jbc.M111173200; Reck-Peterson SL, 2001, J CELL BIOL, V153, P1121, DOI 10.1083/jcb.153.5.1121; REINHARD J, 1995, EMBO J, V14, P697, DOI 10.1002/j.1460-2075.1995.tb07048.x; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Struchholz S, 2009, J BIOL CHEM, V284, P3663, DOI 10.1074/jbc.M808338200; van den Boom F, 2007, MOL BIOL CELL, V18, P1507, DOI 10.1091/mbc.E06-08-0771; Volkmann N, 2005, MOL CELL, V19, P595, DOI 10.1016/j.molcel.2005.07.015; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Watanabe TM, 2004, P NATL ACAD SCI USA, V101, P9630, DOI 10.1073/pnas.0402914101; Xie P, 2010, BIOPHYS CHEM, V151, P71, DOI 10.1016/j.bpc.2010.05.007	35	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84874	10.1371/journal.pone.0084874	http://dx.doi.org/10.1371/journal.pone.0084874			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416302	Green Published, gold, Green Submitted			2022-12-27	WOS:000329866300040
J	McGarry, LJ; Krishnarajah, G; Hill, G; Masseria, C; Skornicki, M; Pruttivarasin, N; Arondekar, B; Roiz, J; Pelton, SI; Weinstein, MC				McGarry, Lisa J.; Krishnarajah, Girishanthy; Hill, Gregory; Masseria, Cristina; Skornicki, Michelle; Pruttivarasin, Narin; Arondekar, Bhakti; Roiz, Julie; Pelton, Stephen I.; Weinstein, Milton C.			Cost-Effectiveness of Tdap Vaccination of Adults Aged >= 65 Years in the Prevention of Pertussis in the US: A Dynamic Model of Disease Transmission	PLOS ONE			English	Article							BORDETELLA-PERTUSSIS; SEASONAL INFLUENZA; MORBIDITY; SPREAD	Objectives: In February 2012, the Advisory Committee on Immunization Practices (ACIP) advised that all adults aged >= 65 years receive a single dose of reduced-antigen-content tetanus, diphtheria, and acellular pertussis (Tdap), expanding on a 2010 recommendation for adults >= 65 that was limited to those with close contact with infants. We evaluated clinical and economic outcomes of adding Tdap booster of adults aged >= 65 to "baseline" practice [full-strength DTaP administered from 2 months to 4-6 years, and one dose of Tdap at 11-64 years replacing decennial Td booster], using a dynamic model. Methods: We constructed a population-level disease transmission model to evaluate the cost-effectiveness of supplementing baseline practice by vaccinating 10% of eligible adults aged >= 65 with Tdap replacing the decennial Td booster. US population effects, including indirect benefits accrued by unvaccinated persons, were estimated during a 1-year period after disease incidence reached a new steady state, with consequences of deaths and long-term pertussis sequelae projected over remaining lifetimes. Model outputs include: cases by severity, encephalopathy, deaths, costs (of vaccination and pertussis care) and quality-adjusted life-years (QALYs) associated with each strategy. Results in terms of incremental cost/QALY gained are presented from payer and societal perspectives. Sensitivity analyses vary key parameters within plausible ranges. Results: For the US population, the intervention is expected to prevent >97,000 cases (>4,000 severe and >5,000 among infants) of pertussis annually at steady state. Additional vaccination costs are $4.7 million. Net cost savings, including vaccination costs, are $47.7 million (societal perspective) and $44.8 million (payer perspective). From both perspectives, the intervention strategy is dominant (less costly, and more effective by >3,000 QALYs) versus baseline. Results are robust to sensitivity analyses and alternative scenarios. Conclusions: Immunization of eligible adults aged >65, consistent with the current ACIP recommendation, is cost saving from both payer and societal perspectives.	[McGarry, Lisa J.; Hill, Gregory; Skornicki, Michelle; Pruttivarasin, Narin; Weinstein, Milton C.] OptumInsight, Cambridge, MA USA; [Krishnarajah, Girishanthy; Masseria, Cristina; Arondekar, Bhakti; Roiz, Julie] GlaxoSmithKline, Philadelphia, PA USA; [Pelton, Stephen I.] Boston Univ, Boston, MA 02215 USA; [Weinstein, Milton C.] Harvard Univ, Harvard Sch Publ Hlth, Boston, MA 02115 USA	Optum; GlaxoSmithKline; Boston University; Harvard University; Harvard T.H. Chan School of Public Health	McGarry, LJ (corresponding author), OptumInsight, Cambridge, MA USA.	mcgarry.nagar@gmail.com		Pelton, Stephen/0000-0003-4862-5344	GlaxoSmithKline Group of Companies	GlaxoSmithKline Group of Companies(GlaxoSmithKline)	GH, LJM, NP, MS, MCW (OptumInsight) received funding from GlaxoSmithKline Group of Companies to complete the disclosed research. The GSK employees listed as coauthors (BA, GK, JR and CM) participated in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; [Anonymous], 2010, INF PRESCR INF; [Anonymous], 2010, PHYS FEE COD GUID; [Anonymous], 2012, ADV COMM IMM PRACT A; Arias Elizabeth, 2010, Natl Vital Stat Rep, V58, P1; Beeler Asay GR, 2011, TDAP VACCINATION PRE; Bureau of Labor Statistics, 2011, CONS PRIC IND; Bureau of Labor Statistics, 2010, CURR POP SURV 2010; Bureau of Labor Statistics, 2011, EMPL HOURS EARN CURR; California Department of Public Health, 2011, PERT REP SEPT 15 201; Caro J Jaime, 2005, Pediatr Infect Dis J, V24, pS75, DOI 10.1097/01.inf.0000160918.72953.51; Centers for Disease Control and Prevention, 2012, SURV REP TRENDS US R; Centers for Disease Control and Prevention, 2011, PERT SUMM VACC REC; Centers for Disease Control and Prevention, 2010, VACC PRIC LIST; Centers for Disease Control and Prevention, 2011, SUMM NOT DIS US, V58, P36; Cherry JD, 2005, PEDIATRICS, V115, P1422, DOI 10.1542/peds.2004-2648; Clements KM, 2011, VALUE HEALTH, V14, P800, DOI 10.1016/j.jval.2011.03.005; Cortese MM, 2007, AM J PREV MED, V32, P177, DOI 10.1016/j.amepre.2006.10.015; Coudeville L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006284; de Vries R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013392; DeBolt Chas, 2012, Morbidity and Mortality Weekly Report, V61, P517; Dorell C., 2010, Morbidity and Mortality Weekly Report, V59, P1018; Dorell Christina, 2012, Morbidity and Mortality Weekly Report, V61, P671; Epidemiology and Prevention of Vaccine-Preventable Diseases, 2012, PINK BOOK COURS TXB; Gold MR, 1996, COST EFFECTIVENESS H; Grenfell B, 2011, P NATL ACAD SCI USA, V108, P7279, DOI 10.1073/pnas.1103408108; GSK - data on file, PERT UN ROUT PROT LI; Hanmer J, 2006, MED DECIS MAKING, V26, P391, DOI 10.1177/0272989X06290497; Klein NP, 2012, NEW ENGL J MED, V367, P1012, DOI 10.1056/NEJMoa1200850; Lee GM, 2004, CLIN INFECT DIS, V39, P1572, DOI 10.1086/425006; Lee GM, 2007, AM J PREV MED, V32, P186, DOI 10.1016/j.amepre.2006.10.016; Lee LH, 2000, ARCH FAM MED, V9, P989, DOI 10.1001/archfami.9.10.989; McDowell Margaret A, 2009, Vital Health Stat 11, P1; McGarry LJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067260, 10.1371/journal.pone.0074170]; Miller B. L., 2010, Morbidity and Mortality Weekly Report, V59, P1302; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; National Network for Immunization Information, 2011, PERT WHOOP COUGH; O'Brien JA, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-57; Red Book, 2010, PHARM FUND REF; Rothberg MB, 2007, CLIN INFECT DIS, V44, P1280, DOI 10.1086/514342; Roush SW, 2007, JAMA-J AM MED ASSOC, V298, P2155, DOI 10.1001/jama.298.18.2155; Schmitt HJ, 1996, JAMA-J AM MED ASSOC, V275, P37, DOI 10.1001/jama.275.1.37; Smith KJ, 2012, JAMA-J AM MED ASSOC, V307, P804, DOI 10.1001/jama.2012.169; Wells CD, 2004, DIGEST DIS SCI, V49, P453, DOI 10.1023/B:DDAS.0000020502.46886.c1; Wendelboe Aaron M, 2005, Pediatr Infect Dis J, V24, pS58, DOI 10.1097/01.inf.0000160914.59160.41; Westra TA, 2010, CLIN THER, V32, P1479, DOI 10.1016/j.clinthera.2010.07.017; Williams WW, 2013, MMWR-MORBID MORTAL W, V62, P66; Williams Walter W., 2012, Morbidity and Mortality Weekly Report, V61, P66; Wooten K. G., 2010, Morbidity and Mortality Weekly Report, V59, P1171; Zagheni E, 2008, AM J EPIDEMIOL, V168, P1082, DOI 10.1093/aje/kwn220	51	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e72723	10.1371/journal.pone.0072723	http://dx.doi.org/10.1371/journal.pone.0072723			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416118	Green Submitted, Green Published, gold			2022-12-27	WOS:000329866300001
J	Waschke, N; Hardge, K; Hancock, C; Hilker, M; Obermaier, E; Meiners, T				Waeschke, Nicole; Hardge, Kristin; Hancock, Christine; Hilker, Monika; Obermaier, Elisabeth; Meiners, Torsten			Habitats as Complex Odour Environments: How Does Plant Diversity Affect Herbivore and Parasitoid Orientation?	PLOS ONE			English	Article							DENTICHASMIAS-BUSSEOLAE; INVERTEBRATE HERBIVORY; LOCATION BEHAVIOR; FORAGING BEHAVIOR; NATURAL ENEMIES; BACKGROUND ODOR; NONHOST PLANT; HOST; VOLATILES; SELECTION	Plant diversity is known to affect success of host location by pest insects, but its effect on olfactory orientation of non-pest insect species has hardly been addressed. First, we tested in laboratory experiments the hypothesis that non-host plants, which increase odour complexity in habitats, affect the host location ability of herbivores and parasitoids. Furthermore, we recorded field data of plant diversity in addition to herbivore and parasitoid abundance at 77 grassland sites in three different regions in Germany in order to elucidate whether our laboratory results reflect the field situation. As a model system we used the herb Plantago lanceolata, the herbivorous weevil Mecinus pascuorum, and its larval parasitoid Mesopolobus incultus. The laboratory bioassays revealed that both the herbivorous weevil and its larval parasitoid can locate their host plant and host via olfactory cues even in the presence of non-host odour. In a newly established two-circle olfactometer, the weevils capability to detect host plant odour was not affected by odours from non-host plants. However, addition of non-host plant odours to host plant odour enhanced the weevils foraging activity. The parasitoid was attracted by a combination of host plant and host volatiles in both the absence and presence of non-host plant volatiles in a Y-tube olfactometer. In dual choice tests the parasitoid preferred the blend of host plant and host volatiles over its combination with non-host plant volatiles. In the field, no indication was found that high plant diversity disturbs host (plant) location by the weevil and its parasitoid. In contrast, plant diversity was positively correlated with weevil abundance, whereas parasitoid abundance was independent of plant diversity. Therefore, we conclude that weevils and parasitoids showed the sensory capacity to successfully cope with complex vegetation odours when searching for hosts.	[Waeschke, Nicole; Hardge, Kristin; Hilker, Monika; Meiners, Torsten] Free Univ Berlin, Inst Biol, Berlin, Germany; [Hancock, Christine; Obermaier, Elisabeth] Univ Wurzburg, Dept Anim Ecol & Trop Biol, D-97070 Wurzburg, Germany	Free University of Berlin; University of Wurzburg	Meiners, T (corresponding author), Helmholtz Ctr Infect Res, Braunschweig, Germany.	meito@zedat.fu-berlin.de	Meiners, Torsten/C-7290-2013	Meiners, Torsten/0000-0002-6607-8463	Deutsche Forschungsgemeinschaft within the Priority Programme 1374 "Infrastructure-Biodiversity-Exploratories" [ME 1810/5-1, OB 185/2-1]	Deutsche Forschungsgemeinschaft within the Priority Programme 1374 "Infrastructure-Biodiversity-Exploratories"	This work was supported by Deutsche Forschungsgemeinschaft within the Priority Programme 1374 "Infrastructure-Biodiversity-Exploratories" (ME 1810/5-1, OB 185/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri M., 1995, ADV PLANT PATHOL, V11, P191; ANDOW DA, 1991, ANNU REV ENTOMOL, V36, P561, DOI 10.1146/annurev.en.36.010191.003021; [Anonymous], 2010, R LANG ENV STAT COMP; Barbosa P, 2009, ANNU REV ECOL EVOL S, V40, P1, DOI 10.1146/annurev.ecolsys.110308.120242; Beyaert I, 2014, BIOL REV, V89, P68, DOI 10.1111/brv.12043; Bezemer TM, 2010, ECOL ENTOMOL, V35, P341, DOI 10.1111/j.1365-2311.2010.01184.x; Bluthgen N, 2012, BASIC APPL ECOL, V13, P207, DOI 10.1016/j.baae.2012.04.001; Bruce TJA, 2005, TRENDS PLANT SCI, V10, P269, DOI 10.1016/j.tplants.2005.04.003; Bukovinszky T, 2007, J ANIM ECOL, V76, P845, DOI 10.1111/j.1365-2656.2007.01259.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Castelo MK, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.5301; Couty A, 2006, PHYSIOL ENTOMOL, V31, P134, DOI 10.1111/j.1365-3032.2006.00499.x; Crawley M.J., 2007, R BOOK; DICKASON E. A., 1968, COLEOPT BULL, V22, P11; Dicke M, 2003, OIKOS, V101, P38, DOI 10.1034/j.1600-0706.2003.12571.x; Elston DA, 2001, PARASITOLOGY, V122, P563, DOI 10.1017/S0031182001007740; Finch S, 2000, ENTOMOL EXP APPL, V96, P91, DOI 10.1023/A:1004058518179; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Fontana A, 2009, J CHEM ECOL, V35, P833, DOI 10.1007/s10886-009-9654-0; GILBERT LE, 1975, ANNU REV ECOL SYST, V6, P365, DOI 10.1146/annurev.es.06.110175.002053; GODFRAY HCJ, 1994, PARASITOIDS; Gohole LS, 2003, ENTOMOL EXP APPL, V107, P1, DOI 10.1046/j.1570-7458.2003.00030.x; Gohole LS, 2005, J INSECT BEHAV, V18, P149, DOI 10.1007/s10905-005-0472-0; Hamback PA, 2003, FUNCT ECOL, V17, P87, DOI 10.1046/j.1365-2435.2003.00699.x; Hilker Monika, 2008, P92, DOI 10.1002/9780470696200.ch5; Hori M, 1997, APPL ENTOMOL ZOOL, V32, P303, DOI 10.1303/aez.32.303; Janz N, 2002, CHEMOECOLOGY OF INSECT EGGS AND EGG DEPOSITION, P349; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Knudsen GK, 2008, PHYSIOL ENTOMOL, V33, P1, DOI 10.1111/j.1365-3032.2007.00592.x; Kostenko O, 2012, ENTOMOL EXP APPL, V144, P27, DOI 10.1111/j.1570-7458.2012.01251.x; Lotz T, 2012, ECOL INFORM, V8, P10, DOI 10.1016/j.ecoinf.2011.11.004; MACKINNON WJ, 1964, J AM STAT ASSOC, V59, P935, DOI 10.2307/2283112; Mozuraitis R, 2002, CHEM SENSES, V27, P505, DOI 10.1093/chemse/27.6.505; Muller C, 2000, NATURWISSENSCHAFTEN, V87, P216, DOI 10.1007/s001140050706; Mumm R, 2005, CHEM SENSES, V30, P337, DOI 10.1093/chemse/bji028; Norowi HM, 2000, ECOL ENTOMOL, V25, P188, DOI 10.1046/j.1365-2311.2000.00242.x; Pareja M, 2007, J CHEM ECOL, V33, P695, DOI 10.1007/s10886-007-9260-y; Perfecto I, 2003, ENVIRON ENTOMOL, V32, P163, DOI 10.1603/0046-225X-32.1.163; Petermann JS, 2010, J ANIM ECOL, V79, P709, DOI 10.1111/j.1365-2656.2010.01674.x; Pettersson J, 2008, APPL ENTOMOL ZOOL, V43, P315, DOI 10.1303/aez.2008.315; Randlkofer B, 2007, CHEMOECOLOGY, V17, P177, DOI 10.1007/s00049-007-0377-9; Randlkofer B, 2010, BASIC APPL ECOL, V11, P383, DOI 10.1016/j.baae.2010.03.003; Randlkofer B, 2010, ECOL ENTOMOL, V35, P446, DOI 10.1111/j.1365-2311.2010.01200.x; Reinecke A, 2002, NATURWISSENSCHAFTEN, V89, P265, DOI 10.1007/s00114-002-0314-2; ROOT RB, 1973, ECOL MONOGR, V43, P95, DOI 10.2307/1942161; Sachs L., 1984, ANGEW STAT ANWENDUNG, V6, DOI [10.1007/978-3-662-05748-3, DOI 10.1007/978-3-662-05748-3]; Sanon A, 2006, ENVIRON ENTOMOL, V35, P718, DOI 10.1603/0046-225X-35.3.718; Scherber C, 2006, OECOLOGIA, V147, P489, DOI 10.1007/s00442-005-0281-3; Schoonhoven L. M., 2005, Insect-plant biology; Schroeder R, 2008, BIOSCIENCE, V58, P308, DOI 10.1641/B580406; SCHUBERT R, 1990, EXKURSIONSFLORA DEUT, V4; SHEEHAN W, 1986, ENVIRON ENTOMOL, V15, P456, DOI 10.1093/ee/15.3.456; Siemann E, 1998, AM NAT, V152, P738, DOI 10.1086/286204; THIERY D, 1986, ENTOMOL EXP APPL, V41, P165, DOI 10.1007/BF00195573; Unsicker SB, 2006, OECOLOGIA, V150, P233, DOI 10.1007/s00442-006-0511-3; Unsicker SB, 2009, CURR OPIN PLANT BIOL, V12, P479, DOI 10.1016/j.pbi.2009.04.001; Van Nouhuys S, 1999, HEREDITY, V83, P127, DOI 10.1046/j.1365-2540.1999.00549.x; Vanbergen AJ, 2007, ECOL ENTOMOL, V32, P419, DOI 10.1111/j.1365-2311.2007.00885.x; VET LEM, 1992, ANNU REV ENTOMOL, V37, P141, DOI 10.1146/annurev.en.37.010192.001041; Vet Louise E.M., 1995, P65; VINSON SB, 1976, ANNU REV ENTOMOL, V21, P109, DOI 10.1146/annurev.en.21.010176.000545; VISSER JH, 1986, ANNU REV ENTOMOL, V31, P121, DOI 10.1146/annurev.en.31.010186.001005; Waschke N, 2013, RECENT ADV CHEM ECOL, P193; Zhang QH, 2004, AGR FOREST ENTOMOL, V6, P1, DOI 10.1111/j.1461-9555.2004.00202.x	64	29	33	1	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85152	10.1371/journal.pone.0085152	http://dx.doi.org/10.1371/journal.pone.0085152			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416354	gold, Green Published			2022-12-27	WOS:000329866300051
J	Belanger, F; Rajotte, V; Drobetsky, EA				Belanger, Francois; Rajotte, Vincent; Drobetsky, Elliot A.			A Majority of Human Melanoma Cell Lines Exhibits an S Phase-Specific Defect in Excision of UV-Induced DNA Photoproducts	PLOS ONE			English	Article							CUTANEOUS MALIGNANT-MELANOMA; REPAIR GENE POLYMORPHISMS; PIGMENTOSUM GROUP-A; XERODERMA-PIGMENTOSUM; ATR KINASE; MICROSATELLITE INSTABILITY; RADIOSENSITIZING AGENT; ATAXIA-TELANGIECTASIA; H2AX PHOSPHORYLATION; DAMAGE	It is well established that efficient removal of highly-promutagenic UV-induced dipyrimidine photoproducts via nucleotide excision repair (NER) is required for protection against sunlight-associated malignant melanoma. Nonetheless, the extent to which reduced NER capacity might contribute to individual melanoma susceptibility in the general population remains unclear. Here we show that among a panel of 14 human melanoma strains, 11 exhibit significant inhibition of DNA photoproduct removal during S phase relative to G0/G1 or G2/M. Evidence is presented that this cell cycle-specific NER defect correlates with enhanced apoptosis and reduced clonogenic survival following UV irradiation. In addition, melanoma strains deficient in S phase-specific DNA photoproduct removal manifest significantly lower levels of phosphorylated histone H2AX at 1 h post-UV, suggesting diminished activation of ataxia telangiectasia and Rad 3-related (ATR) kinase, i.e., a primary orchestrator of the cellular response to UV-induced DNA replication stress. Consistently, in the case of DNA photoproduct excision-proficient melanoma cells, siRNA-mediated depletion of ATR (but not of its immediate downstream effector kinase Chk1) engenders deficient NER specifically during S. On the other hand simultaneous siRNA-mediated depletion of ataxia telangiectasia mutated kinase (ATM) and DNA-dependent protein kinase catalytic subunit (DNA-PKcs) exerts no significant effect on either phosphorylation of H2AX at 1 h post-UV or the efficiency of DNA photoproduct removal. Our data suggest that defective NER exclusively during S phase, possibly associated with decreased ATR signaling, may constitute an heretofore unrecognized determinant in melanoma pathogenesis.	[Drobetsky, Elliot A.] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; Hop Maison Neuve Rosemont, Ctr Rech, Montreal, PQ H1T 2M4, Canada	Universite de Montreal; Universite de Montreal	Drobetsky, EA (corresponding author), Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada.	elliot.drobetsky@umontreal.ca			Canadian Cancer Society Research Institute [700749]	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	Canadian Cancer Society Research Institute (grant # 700749). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auclair Y, 2010, DNA REPAIR, V9, P754, DOI 10.1016/j.dnarep.2010.03.013; Auclair Y, 2008, P NATL ACAD SCI USA, V105, P17896, DOI 10.1073/pnas.0801585105; Berger AH, 2011, NATURE, V476, P163, DOI 10.1038/nature10275; Berger AH, 2011, J PATHOL, V223, P137, DOI 10.1002/path.2800; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; DiGiovanna JJ, 2012, J INVEST DERMATOL, V132, P785, DOI 10.1038/jid.2011.426; DROBETSKY EA, 1995, P NATL ACAD SCI USA, V92, P2350, DOI 10.1073/pnas.92.6.2350; Fang Y, 2004, EMBO J, V23, P3164, DOI 10.1038/sj.emboj.7600315; Fernandez AA, 2011, PHOTOCHEM PHOTOBIOL, V87, P335, DOI 10.1111/j.1751-1097.2010.00875.x; Ford JM, 2005, MUTAT RES-FUND MOL M, V577, P195, DOI 10.1016/j.mrfmmm.2005.04.005; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Gaddameedhi S, 2010, CANCER RES, V70, P4922, DOI 10.1158/0008-5472.CAN-10-0095; Gilchrest BA, 1999, NEW ENGL J MED, V340, P1341, DOI 10.1056/NEJM199904293401707; Hanasoge S, 2007, CARCINOGENESIS, V28, P2298, DOI 10.1093/carcin/bgm157; Ho H, 2012, CANCER RES, V72, P5516, DOI 10.1158/0008-5472.CAN-12-0775; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Kuluncsics Z, 1999, J PHOTOCH PHOTOBIO B, V49, P71, DOI 10.1016/S1011-1344(99)00034-2; Landi MT, 2002, JNCI-J NATL CANCER I, V94, P94, DOI 10.1093/jnci/94.2.94; Lee TH, 2014, ONCOGENE, V33, P19, DOI 10.1038/onc.2012.539; Leiter U, 2008, ADV EXP MED BIOL, V624, P89, DOI 10.1007/978-0-387-77574-6_8; Li CY, 2006, CANCER EPIDEM BIOMAR, V15, P2526, DOI 10.1158/1055-9965.EPI-06-0672; Loignon M, 2002, CARCINOGENESIS, V23, P35, DOI 10.1093/carcin/23.1.35; Marti TM, 2006, P NATL ACAD SCI USA, V103, P9891, DOI 10.1073/pnas.0603779103; Mathonnet R, 2003, P NATL ACAD SCI USA, V100, P7219, DOI 10.1073/pnas.123216100; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Menoyo A, 2001, CANCER RES, V61, P7727; Ming M, 2011, CANCER RES, V71, P5287, DOI 10.1158/0008-5472.CAN-10-4614; MITCHELL DL, 1985, MUTAT RES, V143, P109, DOI 10.1016/S0165-7992(85)80018-X; Mocellin S, 2009, CARCINOGENESIS, V30, P1735, DOI 10.1093/carcin/bgp207; Murga M, 2009, NAT GENET, V41, P891, DOI 10.1038/ng.420; Neudauer CL, 2003, EXP CELL RES, V286, P128, DOI 10.1016/S0014-4827(03)00049-1; Nogueira C, 2010, ONCOGENE, V29, P6222, DOI 10.1038/onc.2010.349; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Ogi T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002945; Papp T, 1996, J CANCER RES CLIN, V122, P541, DOI 10.1007/BF01213550; Paszkowska-Szczur K, 2013, INT J CANCER, V133, P1094, DOI 10.1002/ijc.28123; Povey JE, 2007, CARCINOGENESIS, V28, P1087, DOI 10.1093/carcin/bgl257; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Sarkaria JN, 1999, CANCER RES, V59, P4375; Sarkaria JN, 1998, CANCER RES, V58, P4375; Shell SM, 2009, J BIOL CHEM, V284, P24213, DOI 10.1074/jbc.M109.000745; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Stahl JM, 2004, CANCER RES, V64, P7002, DOI 10.1158/0008-5472.CAN-04-1399; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Thompson JF, 2005, LANCET, V365, P687, DOI 10.1016/S0140-6736(05)17951-3; Vassileva V, 2002, CANCER RES, V62, P4095; Wei QY, 2003, J NATL CANCER I, V95, P308, DOI 10.1093/jnci/95.4.308; Wu XM, 2006, CANCER RES, V66, P2997, DOI 10.1158/0008-5472.CAN-05-3403; Xu GG, 2000, J INVEST DERMATOL, V114, P628, DOI 10.1046/j.1523-1747.2000.00943.x; Yoon JH, 2000, J MOL BIOL, V299, P681, DOI 10.1006/jmbi.2000.3771; Zighelboim I, 2009, J CLIN ONCOL, V27, P3091, DOI 10.1200/JCO.2008.19.9802	55	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85294	10.1371/journal.pone.0085294	http://dx.doi.org/10.1371/journal.pone.0085294			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416382	gold, Green Published, Green Submitted			2022-12-27	WOS:000329862500235
J	Chan, MHT; Kim, PS				Chan, Matthew H. T.; Kim, Peter S.			An Age-Structured Approach to Modelling Behavioural Variation Maintained by Life-History Trade-Offs	PLOS ONE			English	Article							INTEGRODIFFERENCE EQUATIONS; ANIMAL PERSONALITIES; BOLDNESS; HERITABILITY; POPULATIONS; AGGRESSION; CONTEXT; SHYNESS; TRAITS	There have been numerous empirical studies on the fitness consequences of behavioural syndromes in various animal taxa; however, the ecological and evolutionary implications on a population level are still poorly understood. To better understand these implications, we develop a non-linear age-structured mathematical model to qualitatively examine the evolutionary consequences of a heritable boldness personality trait within an animal population. We assume that this heritable boldness trait is positively correlated with boldness towards predators and intraspecific aggressiveness. This assumption leads to a growth/reproductive success versus mortality trade-off, which is thoroughly investigated and documented in the literature. Another life-history trade-off we include in the model is future versus current reproduction, which was shown by Wolf et al. [1] to be a possible mechanism for the evolution of behavioural syndromes within an animal population. The stability of the system is analysed, whereby the characteristic equation is in the form of a homogeneous Fredholm equation of the second kind which depends on both the perturbation and equilibrium solution. The system is found to be stable due to the competition between individuals of similar boldness acting as a negative feedback mechanism. Using numerical simulations we examine the qualitative features of the solution to the system. In particular, we investigate the interplay between the mutation and competition strength between two individuals with different boldness, whereby we find that an increasing competition range acts to push individuals to both extremes of the shy-bold axis, while an increasing mutation range counteracts this effect. This qualitative trait of aggregation of individuals around the shy and bold extremes is also found when examining different birth, mortality and competition functions.	[Chan, Matthew H. T.; Kim, Peter S.] Univ Sydney, Sch Math & Stat, Sydney, NSW 2006, Australia	University of Sydney	Chan, MHT (corresponding author), Univ Sydney, Sch Math & Stat, Sydney, NSW 2006, Australia.	M.Chan@maths.usyd.edu.au		Kim, Peter/0000-0002-1492-4744	Australian Postgraduate Award (APA); Australian Research Council Discovery Early Career Research Award	Australian Postgraduate Award (APA)(Australian Government); Australian Research Council Discovery Early Career Research Award(Australian Research Council)	Matthew Chan was supported by the Australian Postgraduate Award (APA). Peter Kim was supported by the Australian Research Council Discovery Early Career Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell AM, 2005, J EVOLUTION BIOL, V18, P464, DOI 10.1111/j.1420-9101.2004.00817.x; Castanheira MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062037; Dingemanse NJ, 2007, J ANIM ECOL, V76, P1128, DOI 10.1111/j.1365-2656.2007.01284.x; Dingemanse NJ, 2002, ANIM BEHAV, V64, P929, DOI 10.1006/anbe.2002.2006; Dingemanse NJ, 2005, BEHAVIOUR, V142, P1159, DOI 10.1163/156853905774539445; Drent PJ, 2003, P ROY SOC B-BIOL SCI, V270, P45, DOI 10.1098/rspb.2002.2168; Dzieweczynski TL, 2011, J FISH BIOL, V79, P776, DOI 10.1111/j.1095-8649.2011.03064.x; Fraser DF, 2001, AM NAT, V158, P124, DOI 10.1086/321307; Hawkes C, 2009, J ANIM ECOL, V78, P894, DOI 10.1111/j.1365-2656.2009.01534.x; Johnson JC, 2005, BEHAV ECOL SOCIOBIOL, V58, P390, DOI 10.1007/s00265-005-0943-5; Kanda LL, 2012, ETHOLOGY, V118, P518, DOI 10.1111/j.1439-0310.2012.02038.x; Kanwal R. P., 1996, LINEAR INTEGRAL EQUA; Kiesel AL, 2012, BEHAVIOUR, V149, P1155, DOI 10.1163/1568539X-00003015; Kot M, 2008, B MATH BIOL, V70, P1790, DOI 10.1007/s11538-008-9325-2; Lovitt W. V., 1950, LINEAR INTEGRAL EQUA; Medlock J, 2003, MATH BIOSCI, V184, P201, DOI 10.1016/S0025-5564(03)00041-5; Norton WHJ, 2011, J NEUROSCI, V31, P13796, DOI 10.1523/JNEUROSCI.2892-11.2011; Pike TW, 2008, P ROY SOC B-BIOL SCI, V275, P2515, DOI 10.1098/rspb.2008.0744; Reale D, 2009, J EVOLUTION BIOL, V22, P1599, DOI 10.1111/j.1420-9101.2009.01781.x; RIECHERT SE, 1993, ANIM BEHAV, V46, P669, DOI 10.1006/anbe.1993.1243; Shigesada N., 1997, BIOL INVASIONS THEOR; Sinn DL, 2005, J COMP PSYCHOL, V119, P99, DOI 10.1037/0735-7036.119.1.99; van Oers K, 2005, BEHAVIOUR, V142, P1185, DOI 10.1163/156853905774539364; Wang MH, 2002, J MATH BIOL, V44, P150, DOI 10.1007/s002850100116; Wilson ADM, 2009, BEHAV ECOL, V20, P231, DOI 10.1093/beheco/arp018; WILSON DS, 1994, TRENDS ECOL EVOL, V9, P442, DOI 10.1016/0169-5347(94)90134-1; Wisenden BD, 2011, BEHAVIOUR, V148, P1443, DOI 10.1163/156853911X616530; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835; Wolf M, 2012, TRENDS ECOL EVOL, V27, P452, DOI 10.1016/j.tree.2012.05.001	29	2	2	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84774	10.1371/journal.pone.0084774	http://dx.doi.org/10.1371/journal.pone.0084774			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416284	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500167
J	Jayavelu, ND; Bar, N				Jayavelu, Naresh Doni; Bar, Nadav			Dynamics of Regulatory Networks in Gastrin-Treated Adenocarcinoma Cells	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; INTESTINAL EPITHELIAL-CELLS; GENE-EXPRESSION; RESPONSE ELEMENT; GENOMIC ANALYSIS; MAP KINASES; IN-VITRO; RECEPTOR; MOTIFS; GROWTH	Understanding gene transcription regulatory networks is critical to deciphering the molecular mechanisms of different cellular states. Most studies focus on static transcriptional networks. In the current study, we used the gastrin-regulated system as a model to understand the dynamics of transcriptional networks composed of transcription factors (TFs) and target genes (TGs). The hormone gastrin activates and stimulates signaling pathways leading to various cellular states through transcriptional programs. Dysregulation of gastrin can result in cancerous tumors, for example. However, the regulatory networks involving gastrin are highly complex, and the roles of most of the components of these networks are unknown. We used time series microarray data of AR42J adenocarcinoma cells treated with gastrin combined with static TF-TG relationships integrated from different sources, and we reconstructed the dynamic activities of TFs using network component analysis (NCA). Based on the peak expression of TGs and activity of TFs, we created active sub-networks at four time ranges after gastrin treatment, namely immediate-early (IE), mid-early (ME), mid-late (ML) and very late (VL). Network analysis revealed that the active sub-networks were topologically different at the early and late time ranges. Gene ontology analysis unveiled that each active sub-network was highly enriched in a particular biological process. Interestingly, network motif patterns were also distinct between the sub-networks. This analysis can be applied to other time series microarray datasets, focusing on smaller sub-networks that are activated in a cascade, allowing better overview of the mechanisms involved at each time range.	[Jayavelu, Naresh Doni; Bar, Nadav] Norwegian Univ Sci & Technol, Dept Chem Engn, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Jayavelu, ND (corresponding author), Norwegian Univ Sci & Technol, Dept Chem Engn, N-7034 Trondheim, Norway.	nareshd@chemeng.ntnu.no	Jayavelu, Naresh Doni/H-5376-2019		Research Council of Norway [70174300]	Research Council of Norway(Research Council of Norway)	This work was funded by Research Council of Norway (project number : 70174300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Bar-Joseph Z, 2012, NAT REV GENET, V13, P552, DOI 10.1038/nrg3244; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Boscolo R, 2005, IEEE ACM T COMPUT BI, V2, P289, DOI 10.1109/TCBB.2005.47; Cao J, 2006, WORLD J GASTROENTERO, V12, P7482, DOI 10.3748/wjg.v12.i46.7482; Clarke PA, 2006, CANCER RES, V66, P3504, DOI 10.1158/0008-5472.CAN-05-0280; Dabrowski A, 1997, DIGESTION, V58, P361, DOI 10.1159/000201466; Dufresne M, 2006, PHYSIOL REV, V86, P805, DOI 10.1152/physrev.00014.2005; Essaghir A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq149; Ferrand A, 2005, J BIOL CHEM, V280, P10710, DOI 10.1074/jbc.M413309200; Fjeldbo CS, 2012, AM J PHYSIOL-GASTR L, V302, pG21, DOI 10.1152/ajpgi.00197.2011; Goetze JP, 2013, SCAND J GASTROENTERO, V48, P688, DOI 10.3109/00365521.2013.783101; Gonzalez LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066465; Guo YS, 2002, J BIOL CHEM, V277, P48755, DOI 10.1074/jbc.M209016200; Hwang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046521; Ingram PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-108; Jain RN, 2007, PHYSIOL GENOMICS, V29, P1, DOI 10.1152/physiolgenomics.00176.2006; Jain RN, 2006, PHYSIOL GENOMICS, V24, P124, DOI 10.1152/physiolgenomics.00133.2005; Koh TJ, 1997, GASTROENTEROLOGY, V113, P1015, DOI 10.1016/S0016-5085(97)70199-9; Konturek PC, 2009, J PHYSIOL PHARMACOL, V60, P3; Lefranc F, 2004, CLIN CANCER RES, V10, P8250, DOI 10.1158/1078-0432.CCR-04-0343; Lepoivre C, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-19; Leung-Theung-Long S, 2005, J BIOL CHEM, V280, P7976, DOI 10.1074/jbc.M407485200; Liao JC, 2003, P NATL ACAD SCI USA, V100, P15522, DOI 10.1073/pnas.2136632100; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Matysiak-Budnik T, 2006, EUR J CANCER, V42, P708, DOI 10.1016/j.ejca.2006.01.020; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Muerkoster S, 2005, GASTROENTEROLOGY, V129, P952, DOI 10.1053/j.gastro.2005.06.059; Nagashima T, 2007, J BIOL CHEM, V282, P4045, DOI 10.1074/jbc.M608653200; Neph S, 2012, CELL, V150, P1274, DOI 10.1016/j.cell.2012.04.040; Noble F, 1999, PHARMACOL REV, V51, P745; Pagliocca A, 2002, AM J PHYSIOL-GASTR L, V283, pG292, DOI 10.1152/ajpgi.00056.2002; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Prill RJ, 2005, PLOS BIOL, V3, P1881, DOI 10.1371/journal.pbio.0030343; Raychowdhury R, 2002, MOL ENDOCRINOL, V16, P2802, DOI 10.1210/me.2001-0292; Rehfeld JF, 1998, PHYSIOL REV, V78, P1087, DOI 10.1152/physrev.1998.78.4.1087; Saeki Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-545; Selvik LKM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-429; Seok J, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-78; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shao LY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031984; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Stepan V, 2004, AM J PHYSIOL-GASTR L, V287, pG715, DOI 10.1152/ajpgi.00169.2003; Stepan VM, 1999, AM J PHYSIOL-GASTR L, V276, pG1363, DOI 10.1152/ajpgi.1999.276.6.G1363; Subramaniam D, 2008, GASTROENTEROLOGY, V134, P1070, DOI 10.1053/j.gastro.2008.01.040; Tateishi K, 1998, PANCREAS, V16, P499, DOI 10.1097/00006676-199805000-00007; Tran LM, 2005, METAB ENG, V7, P128, DOI 10.1016/j.ymben.2004.12.001; Wang JG, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S3-S8; Wang Z, 2003, WORLD J GASTROENTERO, V9, P1786, DOI 10.3748/wjg.v9.i8.1786; Wernicke S, 2006, BIOINFORMATICS, V22, P1152, DOI 10.1093/bioinformatics/btl038; Wernicke S, 2006, IEEE ACM T COMPUT BI, V3, P347, DOI 10.1109/TCBB.2006.51; Yeger-Lotem E, 2004, P NATL ACAD SCI USA, V101, P5934, DOI 10.1073/pnas.0306752101; Yu HG, 2005, CELL SIGNAL, V17, P1505, DOI 10.1016/j.cellsig.2005.03.009; Yu HY, 2003, TRENDS GENET, V19, P422, DOI 10.1016/S0168-9525(03)00175-6; Yu Jie-Ping, 2007, Zhonghua Zhongliu Zazhi, V29, P4; Zvelebil M.J., 2008, UNDERSTANDING BIOINF	58	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e78349	10.1371/journal.pone.0078349	http://dx.doi.org/10.1371/journal.pone.0078349			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416123	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500004
J	Pereira, MG; Baptista, IL; Carlassara, EOC; Moriscot, AS; Aoki, MS; Miyabara, EH				Pereira, Marcelo G.; Baptista, Igor L.; Carlassara, Eduardo O. C.; Moriscot, Anselmo S.; Aoki, Marcelo S.; Miyabara, Elen H.			Leucine Supplementation Improves Skeletal Muscle Regeneration after Cryolesion in Rats	PLOS ONE			English	Article							STIMULATES PROTEIN-SYNTHESIS; NEONATAL PIGS; MTOR; PHOSPHORYLATION; ASSOCIATION; INITIATION; EXERCISE; INJURY; 4E-BP1; EIF4G	This study was undertaken in order to provide further insight into the role of leucine supplementation in the skeletal muscle regeneration process, focusing on myofiber size and strength recovery. Young (2-month-old) rats were subjected or not to leucine supplementation (1.35 g/kg per day) started 3 days prior to cryolesion. Then, soleus muscles were cryolesioned and continued receiving leucine supplementation until 1, 3 and 10 days later. Soleus muscles from leucine-supplemented animals displayed an increase in myofiber size and a reduction in collagen type III expression on post-cryolesion day 10. Leucine was also effective in reducing FOXO3a activation and ubiquitinated protein accumulation in muscles at post-cryolesion days 3 and 10. In addition, leucine supplementation minimized the cryolesion-induced decrease in tetanic strength and increase in fatigue in regenerating muscles at post-cryolesion day 10. These beneficial effects of leucine were not accompanied by activation of any elements of the phosphoinositide 3-kinase/Akt/mechanistic target of rapamycin signalling pathway in the regenerating muscles. Our results show that leucine improves myofiber size gain and strength recovery in regenerating soleus muscles through attenuation of protein ubiquitination. In addition, leucine might have therapeutic effects for muscle recovery following injury and in some muscle diseases.	[Pereira, Marcelo G.; Baptista, Igor L.; Carlassara, Eduardo O. C.; Moriscot, Anselmo S.; Miyabara, Elen H.] Univ Sao Paulo, Inst Biomed Sci, Dept Anat, Sao Paulo, Brazil; [Aoki, Marcelo S.] Univ Sao Paulo, Sch Arts Sci & Humanities, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Miyabara, EH (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Anat, Sao Paulo, Brazil.	elenm@usp.br	Aoki, Marcelo Saldanha/K-5423-2016; Baptista, Igor Luchini/N-6442-2016; de Oliveira Cruz Carlassara, Eduardo/L-2766-2015; Gomes Pereira, Marcelo/D-7324-2015; Baptista, Igor/ABC-1551-2021; Miyabara, Elen H/E-8143-2012; Moriscot, Anselmo S./C-4506-2012	Aoki, Marcelo Saldanha/0000-0001-7803-6829; Baptista, Igor Luchini/0000-0001-5185-0185; Baptista, Igor/0000-0001-5185-0185; Miyabara, Elen H/0000-0002-2325-9571; Moriscot, Anselmo S./0000-0003-3098-4613; Gomes Pereira, Marcelo/0000-0002-6670-8031	FAPESP [2010/52520-0, 2012/15276-9]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by FAPESP, grant numbers 2010/52520-0 to MGP and 2012/15276-9 to EHM; URL: www.fapesp.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony JC, 2000, J NUTR, V130, P139, DOI 10.1093/jn/130.2.139; Balage M, 2011, J NUTR BIOCH; Baptista IL, 2010, MUSCLE NERVE, V41, P800, DOI 10.1002/mus.21578; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bolster DR, 2004, J NUTR, V134, P1704, DOI 10.1093/jn/134.7.1704; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cabello-Verrugio C, 2012, J BIOL CHEM, V287, P6773, DOI 10.1074/jbc.M111.312488; Chan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012345; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Ciciliot S, 2010, CURR PHARM DESIGN, V16, P906, DOI 10.2174/138161210790883453; Conte TC, 2012, J GERONTOL A; Crozier SJ, 2005, J NUTR, V135, P376, DOI 10.1093/jn/135.3.376; Pinheiro CHDJ, 2012, EUR J APPL PHYSIOL, V112, P2531, DOI 10.1007/s00421-011-2224-5; Dodd KM, 2012, AM J PHYSIOL-ENDOC M, V302, pE1329, DOI 10.1152/ajpendo.00525.2011; Drummond MJ, 2009, J APPL PHYSIOL, V106, P1374, DOI 10.1152/japplphysiol.91397.2008; Ge YJ, 2009, AM J PHYSIOL-CELL PH, V297, pC1434, DOI 10.1152/ajpcell.00248.2009; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002; Hornberger TA, 2006, CELL CYCLE, V5, P1391, DOI 10.4161/cc.5.13.2921; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Kragstrup TW, 2011, SCAND J MED SCI SPOR, V21, P749, DOI 10.1111/j.1600-0838.2011.01377.x; Lang CH, 2003, AM J PHYSIOL-ENDOC M, V285, pE1205, DOI 10.1152/ajpendo.00177.2003; Li FN, 2011, AMINO ACIDS, V41, P1185, DOI 10.1007/s00726-011-0983-2; Macotela Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021187; Magne H, 2012, J PHYSIOL-LONDON, V590, P2035, DOI 10.1113/jphysiol.2011.226266; MATHIEU O, 1981, J MICROSC-OXFORD, V121, P75, DOI 10.1111/j.1365-2818.1981.tb01200.x; Miyabara EH, 2010, MUSCLE NERVE, V42, P778, DOI 10.1002/mus.21754; Nedergaard A, 2007, J APPL PHYSIOL, V103, P1513, DOI 10.1152/japplphysiol.01445.2006; Nicastro H, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/136937; Perhonen M, 1996, J APPL PHYSIOL, V80, P2226, DOI 10.1152/jappl.1996.80.6.2226; Pizza FX, 2002, J APPL PHYSIOL, V92, P1873, DOI 10.1152/japplphysiol.01055.2001; Proud CG, 2004, BIOCHEM BIOPH RES CO, V313, P429, DOI 10.1016/j.bbrc.2003.07.015; Rennie MJ, 2000, ANNU REV NUTR, V20, P457, DOI 10.1146/annurev.nutr.20.1.457; Rogulska A, 1975, Pol Med Sci Hist Bull, V15, P245; Ryall JG, 2004, J PHYSIOL-LONDON, V555, P175, DOI 10.1113/jphysiol.2003.056770; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Sandri M, 2013, INT J BIOCHEM CELL B, V45, P2121, DOI 10.1016/j.biocel.2013.04.023; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Stipanuk MH, 2007, NUTR REV, V65, P122, DOI 10.1111/j.1753-4887.2007.tb00289.x; Suryawan A, 2011, J ANIM SCI, V89, P2004, DOI 10.2527/jas.2010-3400; Suryawan A, 2008, AM J PHYSIOL-ENDOC M, V295, pE868, DOI 10.1152/ajpendo.90314.2008; Taillandier D, 2004, P NUTR SOC, V63, P357, DOI 10.1079/PAR2004358; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; Tintignac LA, 2005, J BIOL CHEM, V280, P2847, DOI 10.1074/jbc.M411346200; Torrazza RM, 2010, J NUTR, V140, P2145, DOI 10.3945/jn.110.128421; Toumi H, 2006, J ANAT, V208, P459, DOI 10.1111/j.1469-7580.2006.00543.x; Vary TC, 2007, J NUTR, V137, P2074, DOI 10.1093/jn/137.9.2074; Vary TC, 2007, J NUTR, V137, P1835, DOI 10.1093/jn/137.8.1835; Wu M, 2010, J CELL PHYSL	49	45	45	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85283	10.1371/journal.pone.0085283	http://dx.doi.org/10.1371/journal.pone.0085283			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416379	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500233
J	Chang, JC; Ramasamy, S				Chang, Jian-Cheng; Ramasamy, Srinivasan			Identification and Expression Analysis of Diapause Hormone and Pheromone Biosynthesis Activating Neuropeptide (DH-PBAN) in the Legume Pod Borer, Maruca vitrata Fabricius	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; REFERENCE GENE SELECTION; MOLECULAR CHARACTERIZATION; SEX-PHEROMONE; SUBESOPHAGEAL GANGLION; ENCODING DH; HELICOVERPA-ARMIGERA; FXPRL NEUROPEPTIDES; FUNCTIONAL-ANALYSIS; CLEAVAGE SITES	Neuropeptides play essential roles in a variety of physiological responses that contribute to the development and reproduction of insects. Both the diapause hormone (DH) and pheromone biosynthesis activating neuropeptide (PBAN) belong to the PBAN/ pyrokinin neuropeptide family, which has a conserved pentapeptide motif FXPRL at the C-terminus. We identified the full-length cDNA encoding DH-PBAN in Maruca vitrata, a major lepidopteran pest of leguminous crops. The open reading frame of Marvi-DH-PBAN is 591 bp in length, encoding 197 amino acids, from which five putative neuropeptides [DH, PBAN, alpha-subesophageal ganglion neuropeptide (SGNP), beta-SGNP and gamma-SGNP] are derived. Marvi-DH-PBAN was highly similar (83%) to DH-PBAN of Omphisa fuscidentalis (Lepidoptera: Crambidae), but possesses a unique C-terminal FNPRL motif, where asparagine has replaced a serine residue present in other lepidopteran PBAN peptides. The genomic DNA sequence of Marvi-DH-PBAN is 6,231 bp in size and is composed of six exons. Phylogenetic analysis has revealed that the Marvi-DH-PBAN protein sequence is closest to its homolog in Crambidae, but distant from Diptera, Coleoptera and Hymenoptera DH-PBAN, which agrees with the current taxonomy. DH-PBAN transcripts were present in the head and thoracic complex, but absent in the abdomen of M. vitrata. Real-time quantitative PCR assays have demonstrated a relatively higher expression of Marvi-DH-PBAN mRNA in the latter half of the pupal stages and in adults. These findings represent a significant step forward in our understanding of the DH-PBAN gene architecture and phylogeny, and raise the possibility of using Marvi-DH-PBAN to manage M. vitrata populations through molecular techniques.	[Chang, Jian-Cheng; Ramasamy, Srinivasan] AVRDC World Vegetable Ctr, Tainan, Taiwan		Ramasamy, S (corresponding author), AVRDC World Vegetable Ctr, Tainan, Taiwan.	srini.ramasamy@worldveg.org	Ramasamy, Srinivasan/N-1686-2019; Chang, Jian-Cheng/L-4818-2013	Ramasamy, Srinivasan/0000-0002-8454-7331; Chang, Jian-Cheng/0000-0001-5241-8175	Federal Ministry for Economic Cooperation and Development, Germany	Federal Ministry for Economic Cooperation and Development, Germany	This study was supported by the financial support of the Federal Ministry for Economic Cooperation and Development, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adati T, 1999, J CHEM ECOL, V25, P105, DOI 10.1023/A:1020841217376; AFUN JVK, 1991, CROP PROT, V10, P363, DOI 10.1016/S0261-2194(06)80025-6; Altstein M, 1996, ARCH INSECT BIOCHEM, V31, P355, DOI 10.1002/(SICI)1520-6327(1996)31:4&lt;355::AID-ARCH1&gt;3.0.CO;2-V; Arabanian A, 2010, J IRAN CHEM SOC, V7, P840, DOI 10.1007/BF03246077; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Belth J.E., 2012, BUTTERFLIES INDIANA; Bober R, 2010, P NATL ACAD SCI USA, V107, P16858, DOI 10.1073/pnas.1008812107; Bock R, 2010, TRENDS PLANT SCI, V15, P11, DOI 10.1016/j.tplants.2009.10.001; Buljan M, 2009, BIOCHEM SOC T, V37, P751, DOI 10.1042/BST0370751; Burglin TR, 2002, INT J DEV BIOL, V46, P115; Choi MY, 2009, INSECT MOL BIOL, V18, P161, DOI 10.1111/j.1365-2583.2009.00867.x; Choi Man-Yeon, 2012, Front Endocrinol (Lausanne), V3, P32, DOI 10.3389/fendo.2012.00032; Choi MY, 2011, J INSECT PHYSIOL, V57, P161, DOI 10.1016/j.jinsphys.2010.10.008; Choi MY, 2010, ARCH INSECT BIOCHEM, V74, P67, DOI 10.1002/arch.20356; Choi MY, 2004, INSECT BIOCHEM MOLEC, V34, P927, DOI 10.1016/j.ibmb.2004.06.003; Choi MY, 2001, CELL TISSUE RES, V306, P459, DOI 10.1007/s00441-001-0467-x; Conant GC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r50; Cranston P.S., 2009, ENCY INSECTS, P780; DARBY NJ, 1990, BIOSCIENCE REP, V10, P1, DOI 10.1007/BF01116845; Downham MCA, 2004, ENTOMOL EXP APPL, V110, P151, DOI 10.1111/j.0013-8703.2004.00128.x; Downham MCA, 2003, J CHEM ECOL, V29, P989, DOI 10.1023/A:1022996103147; DREYER H, 1994, INT J PEST MANAGE, V40, P252, DOI 10.1080/09670879409371893; FONAGY A, 1992, J INSECT PHYSIOL, V38, P651, DOI 10.1016/0022-1910(92)90046-G; FOSTER SP, 1993, J INSECT PHYSIOL, V39, P267, DOI 10.1016/0022-1910(93)90098-C; FOSTER SP, 1994, ARCH INSECT BIOCHEM, V25, P271, DOI 10.1002/arch.940250404; GASTON KJ, 1991, CONSERV BIOL, V5, P283, DOI 10.1111/j.1523-1739.1991.tb00140.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Groot AT, 2005, J CHEM ECOL, V31, P14, DOI 10.1007/s10886-005-0970-8; Hassan MN, 2007, REINVESTIGATION FEMA; HOLMAN GM, 1986, COMP BIOCHEM PHYS C, V85, P219, DOI 10.1016/0742-8413(86)90077-0; HOROWITZ DS, 1994, TRENDS GENET, V10, P100, DOI 10.1016/0168-9525(94)90233-X; IMAI K, 1991, P JPN ACAD B-PHYS, V67, P98, DOI 10.2183/pjab.67.98; Irimia M, 2008, NUCLEIC ACIDS RES, V36, P1703, DOI 10.1093/nar/gkn012; Jing TZ, 2007, INSECT BIOCHEM MOLEC, V37, P1262, DOI 10.1016/j.ibmb.2007.07.012; Jurenka Russell, 2011, Front Endocrinol (Lausanne), V2, P46, DOI 10.3389/fendo.2011.00046; Kabir K H, 1996, BANGLADESH J AGR RES, V21, P241; Kawai T, 2007, INSECT BIOCHEM MOLEC, V37, P330, DOI 10.1016/j.ibmb.2006.12.002; Kitching IJ, 2011, VERTEBR PALEOBIOL PA, P549, DOI 10.1007/978-90-481-9962-4_20; Lassance JM, 2010, NATURE, V466, P486, DOI 10.1038/nature09058; Lee DW, 2005, PEPTIDES, V26, P2404, DOI 10.1016/j.peptides.2005.04.016; Li B, 2008, GENOME RES, V18, P113, DOI 10.1101/gr.6714008; Long MY, 1998, P NATL ACAD SCI USA, V95, P219, DOI 10.1073/pnas.95.1.219; Lu PF, 2007, PAN-PAC ENTOMOL, V83, P226, DOI 10.3956/0031-0603-83.3.226; Ma PWK, 1996, J INSECT PHYSIOL, V42, P257, DOI 10.1016/0022-1910(95)00114-X; MATSUMOTO S, 1990, J INSECT PHYSIOL, V36, P427, DOI 10.1016/0022-1910(90)90060-S; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; NACHMAN RJ, 1986, BIOCHEM BIOPH RES CO, V137, P936, DOI 10.1016/0006-291X(86)90315-3; Nassel DR, 2002, PROG NEUROBIOL, V68, P1, DOI 10.1016/S0301-0082(02)00057-6; New TR, 2004, J INSECT CONSERV, V8, P79, DOI 10.1023/B:JICO.0000045807.04047.bd; OKEYOOWUOR JB, 1981, INSECT SCI APPL, V1, P263, DOI 10.1017/S1742758400000503; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Predel R, 2001, J INSECT PHYSIOL, V47, P287, DOI 10.1016/S0022-1910(00)00113-X; RAINA AK, 1990, INSECT BIOCHEM, V20, P849, DOI 10.1016/0020-1790(90)90103-2; RAINA AK, 1989, SCIENCE, V244, P796, DOI 10.1126/science.244.4906.796; RAINA AK, 1992, INSECT BIOCHEM MOLEC, V22, P221, DOI 10.1016/0965-1748(92)90058-M; Ralser M, 2006, BIOCHEM BIOPH RES CO, V347, P747, DOI 10.1016/j.bbrc.2006.06.151; RASHID A, 2003, ASIAN J PLANT SCI, V2, P403; Riechmann L, 2000, P NATL ACAD SCI USA, V97, P10068, DOI 10.1073/pnas.170145497; SATO Y, 1993, P NATL ACAD SCI USA, V90, P3251, DOI 10.1073/pnas.90.8.3251; Scharlaken B, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3301; Singh SR, 1990, INSECT PESTS TROPICA, P43; Southey BR, 2008, BIOINFORMATICS, V24, P815, DOI 10.1093/bioinformatics/btn044; STEPHENS RM, 1992, J MOL BIOL, V228, P1124, DOI 10.1016/0022-2836(92)90320-J; Subramanian S, 2004, GENETICS, V168, P373, DOI 10.1534/genetics.104.028944; Sun JS, 2003, REGUL PEPTIDES, V116, P163, DOI 10.1016/j.regpep.2003.09.002; Sun W, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.20801; SUWAN S, 1994, INSECT BIOCHEM MOLEC, V24, P1001, DOI 10.1016/0965-1748(94)90137-6; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ulrichs C, 2004, J APPL ENTOMOL, V128, P426, DOI 10.1111/j.1439-0418.2004.00867.x; Urrutia AO, 2003, GENOME RES, V13, P2260, DOI 10.1101/gr.641103; Veenstra JA, 2000, ARCH INSECT BIOCHEM, V43, P49, DOI 10.1002/(SICI)1520-6327(200002)43:2&lt;49::AID-ARCH1&gt;3.0.CO;2-M; Wei ZJ, 2008, J APPL ENTOMOL, V132, P59, DOI 10.1111/j.1439-0418.2007.01249.x; Wei ZJ, 2004, J INSECT PHYSIOL, V50, P1151, DOI 10.1016/j.jinsphys.2004.10.007; Xu WH, 2004, PEPTIDES, V25, P1099, DOI 10.1016/j.peptides.2004.03.021; Xu WH, 2003, INSECT MOL BIOL, V12, P509, DOI 10.1046/j.1365-2583.2003.00437.x; XU WH, 1995, BBA-GENE STRUCT EXPR, V1261, P83, DOI 10.1016/0167-4781(94)00238-X; Zdarek J, 1997, ANN NY ACAD SCI, V814, P67, DOI 10.1111/j.1749-6632.1997.tb46145.x; Zhang TY, 2004, J INSECT PHYSIOL, V50, P547, DOI 10.1016/j.jinsphys.2004.03.011; Zhang TY, 2005, BBA-GENE STRUCT EXPR, V1728, P44, DOI 10.1016/j.bbaexp.2005.01.009; Zhang TY, 2004, J INSECT PHYSIOL, V50, P25, DOI 10.1016/j.jinsphys.2003.09.006; Zhao JY, 2004, REGUL PEPTIDES, V118, P25, DOI 10.1016/j.regpep.2003.10.024; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	85	16	17	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84916	10.1371/journal.pone.0084916	http://dx.doi.org/10.1371/journal.pone.0084916			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409312	Green Submitted, Green Published, gold			2022-12-27	WOS:000329463500036
J	Abbas, A; Aukrust, P; Russell, D; Krohg-Sorensen, K; Almas, T; Bundgaard, D; Bjerkeli, V; Sagen, EL; Michelsen, AE; Dahl, TB; Holm, S; Ueland, T; Skjelland, M; Halvorsen, B				Abbas, Azhar; Aukrust, Pal; Russell, David; Krohg-Sorensen, Kirsten; Almas, Trine; Bundgaard, Dorte; Bjerkeli, Vigdis; Sagen, Ellen Lund; Michelsen, Annika E.; Dahl, Tuva B.; Holm, Sverre; Ueland, Thor; Skjelland, Mona; Halvorsen, Bente			Matrix Metalloproteinase 7 Is Associated with Symptomatic Lesions and Adverse Events in Patients with Carotid Atherosclerosis	PLOS ONE			English	Article							ARTERY STENOSIS; PLAQUE; MACROPHAGES; INFLAMMATION; EXPRESSION; STABILITY	Background: Atherosclerosis is a major cause of cerebrovascular disease. Matrix metalloproteinases (MMPs) play an important role in matrix degradation within the atherosclerotic lesion leading to plaque destabilization and ischemic stroke. We hypothesized that MMP-7 could be involved in this process. Methods: Plasma levels of MMP-7 were measured in 182 consecutive patients with moderate (50-69%) or severe (>= 70%) internal carotid artery stenosis, and in 23 healthy controls. The mRNA levels of MMP-7 were measured in atherosclerotic carotid plaques with different symptomatology, and based on its localization to macrophages, the in vitro regulation of MMP-7 in primary monocytes was examined. Results: Our major findings were (i) Patients with carotid atherosclerosis had markedly increased plasma levels of MMP-7 compared to healthy controls, with particularly high levels in patients with recent symptoms (i. e., within the last 2 months). (ii) A similar pattern was found within carotid plaques with markedly higher mRNA levels of MMP-7 than in non-atherosclerotic vessels. Particularly high protein levels of MMP-7 levels were found in those with the most recent symptoms. (iii) Immunhistochemistry showed that MMP-7 was localized to macrophages, and in vitro studies in primary monocytes showed that the inflammatory cytokine tumor necrosis factor-a in combination with hypoxia and oxidized LDL markedly increased MMP-7 expression. (iv) During the follow-up of patients with carotid atherosclerosis, high plasma levels of MMP-7 were independently associated with total mortality. Conclusion: Our findings suggest that MMP-7 could contribute to plaque instability in carotid atherosclerosis, potentially involving macrophage-related mechanisms.	[Abbas, Azhar; Russell, David; Skjelland, Mona] Univ Oslo, Dept Neurol, Oslo, Norway; [Abbas, Azhar; Aukrust, Pal; Bjerkeli, Vigdis; Sagen, Ellen Lund; Michelsen, Annika E.; Dahl, Tuva B.; Holm, Sverre; Ueland, Thor; Skjelland, Mona; Halvorsen, Bente] Univ Oslo, Internal Med Res Inst, Oslo, Norway; [Krohg-Sorensen, Kirsten] Univ Oslo, Dept Thorac & Cardiovasc Surg, Oslo, Norway; [Aukrust, Pal] Univ Oslo, Rikshosp, Oslo Univ Hosp, Sect Clin Immunol & Infect Dis, N-0027 Oslo, Norway; [Aukrust, Pal; Russell, David; Bjerkeli, Vigdis; Sagen, Ellen Lund; Michelsen, Annika E.; Dahl, Tuva B.; Ueland, Thor; Halvorsen, Bente] Univ Oslo, Fac Med, Oslo, Norway; [Almas, Trine] Ostfold Hosp Trust, Dept Neurol, Fredrikstad, Norway; [Bundgaard, Dorte] Ostfold Hosp Trust, Dept Thorac & Cardiovasc Surg, Fredrikstad, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo	Abbas, A (corresponding author), Univ Oslo, Dept Neurol, Oslo, Norway.	azhar.abbas@ous-hf.no	Skjelland, Mona/B-7362-2016; Skjelland, Mona/Q-4674-2017	Dahl, Tuva/0000-0001-7818-9411; Holm, Sverre/0000-0003-1064-3926; Skjelland, Mona/0000-0001-7950-4882; Krohg-Sorensen, Kirsten/0000-0002-5713-809X	Norwegian Council of Cardiovascular Research; Research Council of Norway; University of Oslo; South-Eastern Norway Regional Health Authority	Norwegian Council of Cardiovascular Research; Research Council of Norway(Research Council of Norway); University of Oslo; South-Eastern Norway Regional Health Authority	This study was supported by grants from The Norwegian Council of Cardiovascular Research, Research Council of Norway, University of Oslo, and South-Eastern Norway Regional Health Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen F, 2005, INT J MOL MED, V15, P57; Dahl TB, 2007, CIRCULATION, V115, P972, DOI 10.1161/CIRCULATIONAHA.106.665893; Furman C, 2004, ATHEROSCLEROSIS, V174, P93, DOI 10.1016/j.atherosclerosis.2004.01.009; Grant EG, 2003, RADIOLOGY, V229, P340, DOI 10.1148/radiol.2292030516; Halpert I, 1996, P NATL ACAD SCI USA, V93, P9748, DOI 10.1073/pnas.93.18.9748; Halvorsen B, 1998, BIOCHEM J, V331, P743, DOI 10.1042/bj3310743; Halvorsen B, 2008, PROG CARDIOVASC DIS, V51, P183, DOI 10.1016/j.pcad.2008.09.001; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Hemingway H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000286; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Newby AC, 2012, VASC PHARMACOL, V56, P232, DOI 10.1016/j.vph.2012.01.007; Pelisek J, 2009, CEREBROVASC DIS, V28, P601, DOI 10.1159/000247605; Razuvaev A, 2011, EUR J VASC ENDOVASC, V42, P722, DOI 10.1016/j.ejvs.2011.05.023; Sapienza P, 2009, EUR J VASC ENDOVASC, V37, P525, DOI 10.1016/j.ejvs.2009.01.012; SILLESEN H, 1995, EUR J VASC ENDOVASC, V10, P23; Stylianou E, 2001, CYTOKINE, V14, P56, DOI 10.1006/cyto.2000.0850; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Williams H, 2010, CARDIOVASC RES, V87, P137, DOI 10.1093/cvr/cvq042	19	49	50	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84935	10.1371/journal.pone.0084935	http://dx.doi.org/10.1371/journal.pone.0084935			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400123	Green Published, Green Submitted, gold			2022-12-27	WOS:000329462700057
J	Fu, YQ; Jiang, JJ; Zhou, H; Jiang, Y; Fu, Y; Yu, YS; Zhou, JY				Fu, Yiqi; Jiang, Jingjin; Zhou, Hua; Jiang, Yan; Fu, Ying; Yu, Yunsong; Zhou, Jianying			Characterization of a Novel Plasmid Type and Various Genetic Contexts of bla(OXA-58) in Acinetobacter spp. from Multiple Cities in China	PLOS ONE			English	Article							HYDROLYZING OXACILLINASE OXA-58; D BETA-LACTAMASE; BAUMANNII; RESISTANCE; EMERGENCE; DISSEMINATION; SEQUENCE; CARBAPENEMASES; ACQUISITION; COMPLEX	Background/Objective: Several studies have described the epidemiological distribution of bla(OXA-58)-harboring Acinetobacter baumannii in China. However, there is limited data concerning the replicon types of bla(OXA-58)-carrying plasmids and the genetic context surrounding bla(OXA-58) in Acinetobacter spp. in China. Methodology/Principal Findings: Twelve non-duplicated bla(OXA-58)-harboring Acinetobacter spp. isolates were collected from six hospitals in five different cities between 2005 and 2010. The molecular epidemiology of the isolates was carried out using PFGE and multilocus sequence typing. Carbapenemase-encoding genes and plasmid replicase genes were identified by PCR. The genetic location of bla(OXA-58) was analyzed using S1-nuclease method. Plasmid conjugation and electrotransformation were performed to evaluate the transferability of bla(OXA-58)-harboring plasmids. The genetic structure surrounding bla(OXA-58) was determined by cloning experiments. The twelve isolates included two Acinetobacter pittii isolates (belong to one pulsotype), three Acinetobacter nosocomialis isolates (belong to two pulsotypes) and seven Acinetobacter baumannii isolates (belong to two pulsotypes/sequence types). A. baumannii ST91 was found to be a potential multidrug resistant risk clone carrying both bla(OXA-58) and bla(OXA-23). bla(OXA-58) located on plasmids varied from ca. 52 kb to ca. 143 kb. All plasmids can be electrotransformed to A. baumannii recipient, but were untypeable by the current replicon typing scheme. A novel plasmid replicase named repAci10 was identified in bla(OXA-58)-harboring plasmids of two A. pittii isolates, three A. nosocomialis isolates and two A. baumannii isolates. Four kinds of genetic contexts of bla(OXA-58) were identified. The transformants of plasmids with structure of IS6 family insertion sequence (ISOur1, IS1008 or IS15)-Delta ISAba3-like element-bla(OXA-58) displayed carbapenem nonsusceptible, while others with structure of intact ISAba3-like element-bla(OXA-58) were carbapenem susceptible. Conclusion: The study revealed the unique features of bla(OXA-58)-carrying plasmids in Acinetobacter spp. in China, which were different from that of Acinetobacter spp. found in European countries. The diversity of the genetic contexts of bla(OXA-58) contributed to various antibiotics resistance profiles.	[Fu, Yiqi; Zhou, Hua; Zhou, Jianying] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Resp Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Jiang, Jingjin] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept VIP, Hangzhou 310003, Zhejiang, Peoples R China; [Jiang, Yan; Fu, Ying; Yu, Yunsong] Zhejiang Univ, Sir Run Run Shaw Hosp, Coll Med, Dept Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Zhou, JY (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Resp Dis, Hangzhou 310003, Zhejiang, Peoples R China.	yvys119@163.com; zjyhz@zju.edu.cn		Zhou, Hua/0000-0001-6397-3203	National Natural Science Foundation of China [81230039, 81000757]; Science Technology Department of Zhejiang Province [2008C13029-1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Technology Department of Zhejiang Province	This work was funded by research grants from National Natural Science Foundation of China (nos. 81230039 and 81000757) and Science Technology Department of Zhejiang Province (no. 2008C13029-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Haduch JM, 2008, ANTIMICROB AGENTS CH, V52, P3837, DOI 10.1128/AAC.00570-08; BARTON BM, 1995, ANAL BIOCHEM, V226, P235, DOI 10.1006/abio.1995.1220; Bartual SG, 2005, J CLIN MICROBIOL, V43, P4382, DOI 10.1128/JCM.43.9.4382-4390.2005; Bertini A, 2010, ANTIMICROB AGENTS CH, V54, P4168, DOI 10.1128/AAC.00542-10; Boo TW, 2009, J MED MICROBIOL, V58, P839, DOI 10.1099/jmm.0.008904-0; Castanheira M, 2008, J CLIN MICROBIOL, V46, P3179, DOI 10.1128/JCM.00988-08; Chang HC, 2005, J CLIN MICROBIOL, V43, P1632, DOI 10.1128/JCM.43.4.1632-1639.2005; Chen TL, 2008, ANTIMICROB AGENTS CH, V52, P2573, DOI 10.1128/AAC.00393-08; Chen TL, 2010, ANTIMICROB AGENTS CH, V54, P3107, DOI 10.1128/AAC.00128-10; Chen Y, 2011, J ANTIMICROB CHEMOTH, V66, P1255, DOI 10.1093/jac/dkr082; Coelho J, 2006, ANTIMICROB AGENTS CH, V50, P756, DOI 10.1128/AAC.50.2.756-758.2006; D'Arezzo S, 2009, CLIN MICROBIOL INFEC, V15, P347, DOI 10.1111/j.1469-0691.2009.02668.x; Evans BA, 2010, J ANTIMICROB CHEMOTH, V65, P1586, DOI 10.1093/jac/dkq180; Fu YQ, 2010, J ANTIMICROB CHEMOTH, V65, P644, DOI 10.1093/jac/dkq027; Gogou V, 2011, J ANTIMICROB CHEMOTH, V66, P2767, DOI 10.1093/jac/dkr390; He C, 2011, INT J ANTIMICROB AG, V38, P257, DOI 10.1016/j.ijantimicag.2011.04.015; Higgins PG, 2009, ANTIMICROB AGENTS CH, V53, P5035, DOI 10.1128/AAC.00856-09; Karageorgopoulos DE, 2008, LANCET INFECT DIS, V8, P751, DOI 10.1016/S1473-3099(08)70279-2; Marti S, 2008, DIAGN MICR INFEC DIS, V61, P468, DOI 10.1016/j.diagmicrobio.2008.03.014; Marti S, 2008, ANTIMICROB AGENTS CH, V52, P2955, DOI 10.1128/AAC.00072-08; MARTIN P, 1988, MOL MICROBIOL, V2, P615, DOI 10.1111/j.1365-2958.1988.tb00070.x; Mendes RE, 2009, ANTIMICROB AGENTS CH, V53, P843, DOI 10.1128/AAC.00999-08; Mendes RE, 2009, J ANTIMICROB CHEMOTH, V63, P55, DOI 10.1093/jac/dkn434; Nigro SJ, 2011, J ANTIMICROB CHEMOTH, V66, P1504, DOI 10.1093/jac/dkr163; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Peleg AY, 2006, ANTIMICROB AGENTS CH, V50, P399, DOI 10.1128/AAC.50.1.399-400.2006; Poirel L, 2006, ANTIMICROB AGENTS CH, V50, P1442, DOI 10.1128/AAC.50.4.1442-1448.2006; Poirel L, 2005, ANTIMICROB AGENTS CH, V49, P202, DOI 10.1128/AAC.49.1.202-208.2005; Ravasi P, 2011, ANTIMICROB AGENTS CH, V55, P917, DOI 10.1128/AAC.00491-10; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Towner KJ, 2011, ANTIMICROB AGENTS CH, V55, P2154, DOI 10.1128/AAC.01661-10; Wang H, 2007, ANTIMICROB AGENTS CH, V51, P4022, DOI 10.1128/AAC.01259-06; Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x; Zhang JP, 2010, J MICROBIOL, V48, P689, DOI 10.1007/s12275-010-0137-3; Zhou H, 2007, J CLIN MICROBIOL, V45, P4054, DOI 10.1128/JCM.00343-07	35	38	38	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84680	10.1371/journal.pone.0084680	http://dx.doi.org/10.1371/journal.pone.0084680			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400107	Green Published, Green Submitted, gold			2022-12-27	WOS:000329462700041
J	Wu, BB; Yu, ZP; You, S; Zheng, YH; Liu, J; Gao, YJ; Lin, H; Lian, QQ				Wu, Binbin; Yu, Zipu; You, Shan; Zheng, Yihu; Liu, Jin; Gao, Yajing; Lin, Han; Lian, Qingquan			Physiological Disturbance May Contribute to Neurodegeneration Induced by Isoflurane or Sevoflurane in 14 Day Old Rats	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; NEURAL STEM-CELLS; INSULIN-SECRETION; NEURONAL DEGENERATION; AFFECTS NEUROGENESIS; ANESTHESIA; EXPOSURE; ADULT; BRAIN; METABOLISM	Background: Volatile anesthetics are widely used in pediatric anesthesia but their potential neurotoxicity raise significant concerns regarding sequelae after anesthesia. However, whether physiological disturbance during anesthetic exposure contributes to such side effects remains unknown. The aim of the current study is to compare the neurotoxic effects of isoflurane and sevoflurane in 14 day old rat pups under spontaneous breathing or ventilated conditions. Methods: Postnatal 14 day rats were assigned to one of five groups: 1) spontaneous breathing (SB) + room air (control, n = 17); 2) SB + isoflurane (n = 35); 3) SB + sevoflurane (n = 37); 4) mechanical ventilation (MV) + isoflurane (n = 29); 5) MV + sevoflurane (n = 32). Anesthetized animal received either 1.7% isoflurane or 2.4% seveoflurane for 4 hours. Arterial blood gases and blood pressure were monitored in the anesthetized groups. Neurodegeneration in the CA3 region of hippocampus was assessed with terminal deoxynucleotidyl transferase-mediated DNA nick-end labeling immediately after exposure. Spatial learning and memory were evaluated with the Morris water maze in other cohorts 14 days after experiments. Results: Most rats in the SB groups developed physiological disturbance whereas ventilated rats did not but become hyperglycemic. Mortality from anesthesia in the SB groups was significantly higher than that in the MV groups. Cell death in the SB but not MV groups was significantly higher than controls. SB + anesthesia groups performed worse on the Morris water maze behavioral test, but no deficits were found in the MV group compared with the controls. Conclusions: These findings could suggest that physiological disturbance induced by isoflurane or sevoflurane anesthesia may also contribute to their neurotoxicity.	[Wu, Binbin; Yu, Zipu; You, Shan; Liu, Jin; Gao, Yajing; Lin, Han; Lian, Qingquan] Wenzhou Med Univ, Affiliated Hosp 2, Dept Anesthesiol, Wenzhou, Peoples R China; [Zheng, Yihu] Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Wu, BB (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Dept Anesthesiol, Wenzhou, Peoples R China.	wbb19880117@163.com; lianqingquanmz@163.com	Wu, Binbin/AAT-7000-2021	Wu, Binbin/0000-0001-7953-0992	National Science Foundation of China [81271469]; Research Foundation of Doctor Program [20113321110003]; National Science Foundation of Zhejiang Province [Z2101211]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Foundation of Doctor Program; National Science Foundation of Zhejiang Province	The work was supported in part by National Science Foundation of China (81271469) and Research Foundation of Doctor Program (20113321110003) to QL, National Science Foundation of Zhejiang Province (Z2101211) to QL. The funder is the corresponding author of this study, and he gave final approval of the version to be published.	Bercker S, 2009, NEUROTOX RES, V16, P140, DOI 10.1007/s12640-009-9063-8; Brambrink AM, 2010, ANESTHESIOLOGY, V112, P834, DOI 10.1097/ALN.0b013e3181d049cd; Camu F, 1976, Acta Anaesthesiol Belg, V27 suppl, P267; Ceccom J, 2013, LEARN MEMORY, V20, P348, DOI 10.1101/lm.029017.112; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; DILTOER M, 1988, ANESTHESIOLOGY, V68, P880, DOI 10.1097/00000542-198806000-00008; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; EISENHAUER CL, 1994, LAB ANIM SCI, V44, P245; Fang F, 2012, NEUROSCI BULL, V28, P499, DOI 10.1007/s12264-012-1260-4; Hayashi H, 2002, PAEDIATR ANAESTH, V12, P770, DOI 10.1046/j.1460-9592.2002.00883.x; Holmstrom A, 2005, ACTA ANAESTH SCAND, V49, P754, DOI 10.1111/j.1399-6576.2005.00697.x; Jochems A, 2013, EUR J NEUROSCI, V38, P2250, DOI 10.1111/ejn.12236; Lattermann R, 2001, ANESTH ANALG, V93, P121; Lenz C, 1998, ANESTHESIOLOGY, V89, P1480, DOI 10.1097/00000542-199812000-00026; Liang G, 2010, ANESTHESIOLOGY, V112, P1325, DOI 10.1097/ALN.0b013e3181d94da5; Loepke AW, 2009, ANESTH ANALG, V108, P90, DOI 10.1213/ane.0b013e31818cdb29; Loepke AW, 2006, ANESTH ANALG, V102, P75, DOI 10.1213/01.ANE.0000181102.92729.B8; Lu H, 1998, ANESTH ANALG, V87, P854, DOI 10.1097/00000539-199810000-00020; Lu LX, 2006, APOPTOSIS, V11, P1603, DOI 10.1007/s10495-006-8762-3; Matta BF, 1999, ANESTHESIOLOGY, V91, P677, DOI 10.1097/00000542-199909000-00019; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; Nixon K, 2010, ALCOHOL, V44, P39, DOI 10.1016/j.alcohol.2009.11.001; Ogata ES., 1999, NEONATOLOGY PATHOPHY, V5th ed, P699; Orliaguet G, 2001, ANESTHESIOLOGY, V95, P734, DOI 10.1097/00000542-200109000-00028; Popic J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034396; Saho S, 1997, ANESTH ANALG, V84, P1359, DOI 10.1097/00000539-199706000-00034; Stanley CA, 1999, NEW ENGL J MED, V340, P1200, DOI 10.1056/NEJM199904153401510; Stratmann G, 2009, ANESTHESIOLOGY, V110, P849, DOI 10.1097/ALN.0b013e31819c7140; Stratmann G, 2009, ANESTHESIOLOGY, V110, P834, DOI 10.1097/ALN.0b013e31819c463d; Tanaka K, 2009, ANESTHESIOLOGY, V111, P1044, DOI 10.1097/ALN.0b013e3181bbcb0d; Tanaka Tadashi, 2005, J Anesth, V19, P277, DOI 10.1007/s00540-005-0341-1; Wang YH, 2012, NEUROL SCI, V33, P535, DOI 10.1007/s10072-011-0762-6; Wise-Faberowski L, 2005, ANESTH ANALG, V101, P651, DOI 10.1213/01.ane.0000167382.79889.7c; Wong CH, 2006, FOOD CHEM TOXICOL, V44, P1399, DOI 10.1016/j.fct.2006.03.004; Xiong LZ, 2003, ANESTH ANALG, V96, P233, DOI 10.1097/00000539-200301000-00047; Ying SW, 2009, NEUROPHARMACOLOGY, V56, P438, DOI 10.1016/j.neuropharm.2008.09.015; Zhang YY, 2012, ANN NEUROL, V71, P687, DOI 10.1002/ana.23536; Zhu CL, 2010, J CEREBR BLOOD F MET, V30, P1017, DOI 10.1038/jcbfm.2009.274	38	38	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84622	10.1371/journal.pone.0084622	http://dx.doi.org/10.1371/journal.pone.0084622			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400105	Green Submitted, Green Published, gold			2022-12-27	WOS:000329462700039
J	Yan, A; Wu, MJ; Yan, LM; Hu, R; Ali, I; Gan, YB				Yan, An; Wu, Minjie; Yan, Limei; Hu, Rui; Ali, Imran; Gan, Yinbo			AtEXP2 Is Involved in Seed Germination and Abiotic Stress Response in Arabidopsis	PLOS ONE			English	Article							CELL-WALL EXTENSIBILITY; EXPANSIN GENE; GIBBERELLIN BIOSYNTHESIS; MOLECULAR-CLONING; MULTIGENE FAMILY; LEAF DEVELOPMENT; EXPRESSION; THALIANA; PROTEINS; GROWTH	Expansins are cell wall proteins that promote cell wall loosening by inducing pH-dependent cell wall extension and stress relaxation. Expansins are required in a series of physiological developmental processes in higher plants such as seed germination. Here we identified an Arabidopsis expansin gene AtEXPA2 that is exclusively expressed in germinating seeds and the mutant shows delayed germination, suggesting that AtEXP2 is involved in controlling seed germination. Exogenous GA application increased the expression level of AtEXP2 during seed germination, while ABA application had no effect on AtEXP2 expression. Furthermore, the analysis of DELLA mutants show that RGL1, RGL2, RGA, GAI are all involved in repressing AtEXP2 expression, and RGL1 plays the most dominant role in controlling AtEXP2 expression. In stress response, exp2 mutant shows higher sensitivity than wild type in seed germination, while overexpression lines of AtEXP2 are less sensitive to salt stress and osmotic stress, exhibiting enhanced tolerance to stress treatment. Collectively, our results suggest that AtEXP2 is involved in the GA-mediated seed germination and confers salt stress and osmotic stress tolerance in Arabidopsis.	[Yan, An; Wu, Minjie; Yan, Limei; Ali, Imran; Gan, Yinbo] Zhejiang Univ, Zhejiang Key Lab Crop Germplasm, Dept Agron, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China; [Hu, Rui] Chinese Acad Sci, Inst Hydrobiol, Wuhan, Hubei, Peoples R China	Zhejiang University; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Gan, YB (corresponding author), Zhejiang Univ, Zhejiang Key Lab Crop Germplasm, Dept Agron, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China.	ygan@zju.edu.cn	Gan, Yinbo/N-1480-2015		International Scientific and Technological Cooperation Project of Science and Technology Department of Zhejiang Province [2013C34G2010017]; International Scientific and Technological Cooperation Project of the Ministry of Science and Technology of China [2010DFA34430]; National Natural Science Foundation of China [31370215, 31228002]; Zhejiang Provincial Natural Science Foundation of China [Z31100041]	International Scientific and Technological Cooperation Project of Science and Technology Department of Zhejiang Province; International Scientific and Technological Cooperation Project of the Ministry of Science and Technology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	The research was supported by International Scientific and Technological Cooperation Project of Science and Technology Department of Zhejiang Province (grant number 2013C34G2010017), the International Scientific and Technological Cooperation Project of the Ministry of Science and Technology of China (grant number 2010DFA34430), National Natural Science Foundation of China (Grant No. 31370215; 31228002), and Zhejiang Provincial Natural Science Foundation of China (Grant No. Z31100041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An LJ, 2012, PLANT J, V72, P474, DOI 10.1111/j.1365-313X.2012.05094.x; Bentsink L, 2008, BIOONE, P1; Bewley J. D., 2013, SEEDS, DOI [10.1017/S0960258513000287, DOI 10.1007/978-1-4614-4693-4_1]; Brummell DA, 1999, PLANT CELL, V11, P2203, DOI 10.1105/tpc.11.11.2203; Budzinski IGF, 2011, PLANT BIOLOGY, V13, P462, DOI 10.1111/j.1438-8677.2010.00400.x; Cao DN, 2005, PLANTA, V223, P105, DOI 10.1007/s00425-005-0057-3; Carrera E, 2008, PLANT J, V53, P214, DOI 10.1111/j.1365-313X.2007.03331.x; Chen F, 2000, PLANT PHYSIOL, V124, P1265, DOI 10.1104/pp.124.3.1265; Chen F, 2001, PLANT PHYSIOL, V127, P928, DOI 10.1104/pp.010259; Cho HT, 2000, P NATL ACAD SCI USA, V97, P9783, DOI 10.1073/pnas.160276997; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cosgrove DJ, 1997, P NATL ACAD SCI USA, V94, P5504, DOI 10.1073/pnas.94.11.5504; Cosgrove DJ, 1998, PLANT PHYSIOL, V118, P333, DOI 10.1104/pp.118.2.333; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Cosgrove DJ, 2000, CURR OPIN PLANT BIOL, V3, P73, DOI 10.1016/S1369-5266(99)00039-4; Cosgrove DJ, 1999, ANNU REV PLANT PHYS, V50, P391, DOI 10.1146/annurev.arplant.50.1.391; Cosgrove DJ, 2001, PLANT PHYSIOL, V125, P131, DOI 10.1104/pp.125.1.131; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Dai FW, 2012, PLANT PHYSIOL, V160, P2064, DOI 10.1104/pp.112.207720; Gal TZ, 2006, PLANTA, V224, P155, DOI 10.1007/s00425-005-0204-x; Gan YB, 2011, AGR SCI CHINA, V10, P335, DOI 10.1016/S1671-2927(11)60012-6; Gao Q, 2008, PROTOPLASMA, V233, P73, DOI 10.1007/s00709-008-0303-1; Goh HH, 2012, PLANT PHYSIOL, V159, P1759, DOI 10.1104/pp.112.200881; Guo WB, 2011, PLANT J, V66, P541, DOI 10.1111/j.1365-313X.2011.04511.x; Harb A, 2010, PLANT PHYSIOL, V154, P1254, DOI 10.1104/pp.110.161752; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Holdsworth MJ, 2008, NEW PHYTOL, V179, P33, DOI 10.1111/j.1469-8137.2008.02437.x; HOOLEY R, 1994, PLANT MOL BIOL, V26, P1529, DOI 10.1007/BF00016489; Hutchison KW, 1999, PLANT PHYSIOL, V120, P827, DOI 10.1104/pp.120.3.827; Josse EM, 2011, PLANT CELL, V23, P1337, DOI 10.1105/tpc.110.082594; Kende H, 2004, PLANT MOL BIOL, V55, P311, DOI 10.1007/s11103-004-0158-6; Kwasniewski M, 2006, PLANT PHYSIOL, V141, P1149, DOI 10.1104/pp.106.078626; Kwon YR, 2008, BIOTECHNOL LETT, V30, P1281, DOI 10.1007/s10529-008-9678-5; Lee Y, 2001, CURR OPIN PLANT BIOL, V4, P527, DOI 10.1016/S1369-5266(00)00211-9; Li F, 2011, J PLANT PHYSIOL, V168, P960, DOI 10.1016/j.jplph.2010.11.023; Li Y, 2002, PLANT PHYSIOL, V128, P854, DOI 10.1104/pp.010658; Lin C, 2011, MOL CELLS, V31, P393, DOI 10.1007/s10059-011-0046-2; Lin Z, 2005, MOL GENET GENOMICS, V274, P548, DOI 10.1007/s00438-005-0029-0; Linkies A, 2009, PLANT CELL, V21, P3803, DOI 10.1105/tpc.109.070201; Lu P, 2013, PLANTA, P1; Ma NN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075997; MCQUEENMASON S, 1992, PLANT CELL, V4, P1425, DOI 10.1105/tpc.4.11.1425; MCQUEENMASON SJ, 1995, PLANT PHYSIOL, V107, P87, DOI 10.1104/pp.107.1.87; Ogawa M, 2003, PLANT CELL, V15, P1591, DOI 10.1105/tpc.011650; Penfield S, 2006, PLANT CELL, V18, P1887, DOI 10.1105/tpc.106.041277; Peng JR, 2002, CURR OPIN PLANT BIOL, V5, P376, DOI 10.1016/S1369-5266(02)00279-0; Pien S, 2001, P NATL ACAD SCI USA, V98, P11812, DOI 10.1073/pnas.191380498; Sabirzhanova IB, 2005, PLANT PHYSIOL BIOCH, V43, P419, DOI 10.1016/j.plaphy.2005.01.021; Sasidharan R, 2011, CRIT REV PLANT SCI, V30, P548, DOI 10.1080/07352689.2011.615706; Schwechheimer C, 2009, CURR OPIN PLANT BIOL, V12, P57, DOI 10.1016/j.pbi.2008.09.004; SHCHERBAN TY, 1995, P NATL ACAD SCI USA, V92, P9245, DOI 10.1073/pnas.92.20.9245; Shin JH, 2005, MOL CELLS, V20, P210; Soltys D, 2012, PLANTA, V236, P1629, DOI 10.1007/s00425-012-1722-y; Stamm P, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-179; SUN TP, 1992, PLANT CELL, V4, P119, DOI 10.1105/tpc.4.2.119; Suzuki Y, 2004, BIOTECHNIQUES, V37, P542, DOI 10.2144/04374BM03; Tabuchi A, 2011, PLANT J, V68, P546, DOI 10.1111/j.1365-313X.2011.04705.x; Vreeburg RAM, 2005, PLANT J, V43, P597, DOI 10.1111/j.1365-313X.2005.02477.x; Wei PC, 2011, PLANT SIGNAL BEHAV, V6, P740, DOI 10.4161/psb.6.5.15144; Weitbrecht K, 2011, J EXP BOT, V62, P3289, DOI 10.1093/jxb/err030; Wieczorek K, 2006, PLANT J, V48, P98, DOI 10.1111/j.1365-313X.2006.02856.x; Won SK, 2010, MOL CELLS, V30, P369, DOI 10.1007/s10059-010-0127-7; Wu YJ, 2000, J EXP BOT, V51, P1543, DOI 10.1093/jexbot/51.350.1543; Xi WY, 2010, PLANT CELL, V22, P1733, DOI 10.1105/tpc.109.073072; Xu JC, 2007, J EXP BOT, V58, P3789, DOI 10.1093/jxb/erm229; Yamaguchi S, 2001, J PLANT GROWTH REGUL, V20, P369, DOI 10.1007/s003440010035; Yamauchi Y, 2004, PLANT CELL, V16, P367, DOI 10.1105/tpc.018143; Yu ZM, 2011, PLANT J, V66, P725, DOI 10.1111/j.1365-313X.2011.04533.x; Zhang XQ, 2011, PLANT CELL REP, V30, P27, DOI 10.1007/s00299-010-0937-2; Zhao MR, 2012, PLANT CELL REP, V31, P671, DOI 10.1007/s00299-011-1185-9; Zhou ZJ, 2011, PLANT PHYSIOL, V157, P673, DOI 10.1104/pp.111.180281	71	67	80	6	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e85208	10.1371/journal.pone.0085208	http://dx.doi.org/10.1371/journal.pone.0085208			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404203	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460800082
J	Nurzaman, SG; Culha, U; Brodbeck, L; Wang, LY; Iida, F				Nurzaman, Surya G.; Culha, Utku; Brodbeck, Luzius; Wang, Liyu; Iida, Fumiya			Active Sensing System with In Situ Adjustable Sensor Morphology	PLOS ONE			English	Article								Background: Despite the widespread use of sensors in engineering systems like robots and automation systems, the common paradigm is to have fixed sensor morphology tailored to fulfill a specific application. On the other hand, robotic systems are expected to operate in ever more uncertain environments. In order to cope with the challenge, it is worthy of note that biological systems show the importance of suitable sensor morphology and active sensing capability to handle different kinds of sensing tasks with particular requirements. Methodology: This paper presents a robotics active sensing system which is able to adjust its sensor morphology in situ in order to sense different physical quantities with desirable sensing characteristics. The approach taken is to use thermoplastic adhesive material, i.e. Hot Melt Adhesive (HMA). It will be shown that the thermoplastic and thermoadhesive nature of HMA enables the system to repeatedly fabricate, attach and detach mechanical structures with a variety of shape and size to the robot end effector for sensing purposes. Via active sensing capability, the robotic system utilizes the structure to physically probe an unknown target object with suitable motion and transduce the arising physical stimuli into information usable by a camera as its only built-in sensor. Conclusions/Significance: The efficacy of the proposed system is verified based on two results. Firstly, it is confirmed that suitable sensor morphology and active sensing capability enables the system to sense different physical quantities, i.e. softness and temperature, with desirable sensing characteristics. Secondly, given tasks of discriminating two visually indistinguishable objects with respect to softness and temperature, it is confirmed that the proposed robotic system is able to autonomously accomplish them. The way the results motivate new research directions which focus on in situ adjustment of sensor morphology will also be discussed.	[Nurzaman, Surya G.; Culha, Utku; Brodbeck, Luzius; Wang, Liyu; Iida, Fumiya] ETH, Dept Mech & Proc Engn, Inst Robot & Intelligent Syst, Bioinspired Robot Lab, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Nurzaman, SG (corresponding author), ETH, Dept Mech & Proc Engn, Inst Robot & Intelligent Syst, Bioinspired Robot Lab, Zurich, Switzerland.	surya.nurzaman@mavt.ethz.ch	Culha, Utku/S-8156-2019; Nurzaman, Surya G/G-9486-2017	Culha, Utku/0000-0002-7788-6124; Nurzaman, Surya G/0000-0002-8157-6495; Iida, Fumiya/0000-0001-9246-7190	Swiss National Science Foundation [PP00P2123387/1]; ETH Zurich Research Grant [ETH-23-10-3]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich Research Grant(ETH Zurich)	This study was supported by the Swiss National Science Foundation Grant No. PP00P2123387/1 and the ETH Zurich Research Grant ETH-23-10-3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blamires SJ, 2011, ANIM BEHAV, V81, P955, DOI 10.1016/j.anbehav.2011.01.022; BOCK WJ, 1980, AM ZOOL, V20, P217; Brodbeck L, 2012, IEEE INT CONF ROBOT, P4322, DOI 10.1109/ICRA.2012.6225258; Brown SS, 2013, INT POLIT ECON SER, P1, DOI 10.1007/978-3-642-38812-5_1; Dangles O, 2005, J EXP BIOL, V208, P461, DOI 10.1242/jeb.01369; FRANCESCHINI N, 1992, PHILOS T R SOC B, V337, P283, DOI 10.1098/rstb.1992.0106; Guerin F, 2013, IEEE T AUTON MENT DE, V5, P18, DOI 10.1109/TAMD.2012.2209879; Ingber D E, 2004, Mech Chem Biosyst, V1, P53; Jones R, 2011, ROBOTICA, V29, P177, DOI 10.1017/S026357471000069X; Kaminka GA, 2008, IEEE T ROBOT, V24, P271, DOI 10.1109/TRO.2008.918054; Klatzky RL, 2011, PHILOS T R SOC B, V366, P3097, DOI 10.1098/rstb.2011.0153; Leigh SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049365; Lyle AC, 2010, SENSORS-BASEL, V10, P7514, DOI 10.3390/s100807514; Malone E, 2007, RAPID PROTOTYPING J, V13, P245, DOI 10.1108/13552540710776197; Murata S, 2007, IEEE ROBOT AUTOM MAG, V14, P71, DOI 10.1109/MRA.2007.339607; Murr LE, 2010, PHILOS T R SOC A, V368, P1999, DOI 10.1098/rsta.2010.0010; Nakata K, 2010, P ROY SOC B-BIOL SCI, V277, P29, DOI 10.1098/rspb.2009.1583; Parker G., 2010, CONCURRENTLY EVOLVIN, P1; Pfeifer R, 2007, SCIENCE, V318, P1088, DOI 10.1126/science.1145803; Prescott TJ, 2011, PHILOS T R SOC B, V366, P2989, DOI 10.1098/rstb.2011.0167; Revzen S., 2011, 2011 IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS 2011), P4797, DOI 10.1109/IROS.2011.6048240; Sproewitz A, 2008, IEEE INT CONF ROBOT, P3508, DOI 10.1109/ROBOT.2008.4543747; Stamper SA, 2012, J EXP BIOL, V215, P1567, DOI 10.1242/jeb.068007; Turner JS, 2002, EXTENDED ORGANISM PH; Yim M, 2007, IEEE ROBOT AUTOM MAG, V14, P43, DOI 10.1109/MRA.2007.339623; Zuo YF, 2011, PHILOS T R SOC B, V366, P3058, DOI 10.1098/rstb.2011.0161	26	29	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84090	10.1371/journal.pone.0084090	http://dx.doi.org/10.1371/journal.pone.0084090			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24416094	Green Published, gold, Green Submitted			2022-12-27	WOS:000329116700097
J	Parsons, HT; Weinberg, CS; Macdonald, LJ; Adams, PD; Petzold, CJ; Strabala, TJ; Wagner, A; Heazlewood, JL				Parsons, Harriet T.; Weinberg, Cristina S.; Macdonald, Lucy J.; Adams, Paul D.; Petzold, Christopher J.; Strabala, Timothy J.; Wagner, Armin; Heazlewood, Joshua L.			Golgi Enrichment and Proteomic Analysis of Developing Pinus radiata Xylem by Free-Flow Electrophoresis	PLOS ONE			English	Article							TRACHEID CELL-WALLS; COMPRESSION WOOD; CELLULOSE SYNTHASE; BIOSYNTHESIS; EXPRESSION; PROTEINS; LOCALIZATION; APPARATUS; DATABASE	Our understanding of the contribution of Golgi proteins to cell wall and wood formation in any woody plant species is limited. Currently, little Golgi proteomics data exists for wood-forming tissues. In this study, we attempted to address this issue by generating and analyzing Golgi-enriched membrane preparations from developing xylem of compression wood from the conifer Pinus radiata. Developing xylem samples from 3-year-old pine trees were harvested for this purpose at a time of active growth and subjected to a combination of density centrifugation followed by free flow electrophoresis, a surface charge separation technique used in the enrichment of Golgi membranes. This combination of techniques was successful in achieving an approximately 200-fold increase in the activity of the Golgi marker galactan synthase and represents a significant improvement for proteomic analyses of the Golgi from conifers. A total of thirty known Golgi proteins were identified by mass spectrometry including glycosyltransferases from gene families involved in glucomannan and glucuronoxylan biosynthesis. The free flow electrophoresis fractions of enriched Golgi were highly abundant in structural proteins (actin and tubulin) indicating a role for the cytoskeleton during compression wood formation. The mass spectrometry proteomics data associated with this study have been deposited to the ProteomeXchange with identifier PXD000557.	[Weinberg, Cristina S.; Macdonald, Lucy J.; Strabala, Timothy J.; Wagner, Armin] Scion, Rotorua, New Zealand; [Parsons, Harriet T.; Adams, Paul D.; Petzold, Christopher J.; Heazlewood, Joshua L.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Joint BioEnergy Inst, Berkeley, CA 94720 USA; [Parsons, Harriet T.; Adams, Paul D.; Petzold, Christopher J.; Heazlewood, Joshua L.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Adams, Paul D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	Scion; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Heazlewood, JL (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Joint BioEnergy Inst, Berkeley, CA 94720 USA.	jlheazlewood@lbl.gov	Strabala, Timothy/B-4472-2008; Adams, Paul David/A-1977-2013; Heazlewood, Joshua L/A-2554-2008; Parsons, Harriet/J-9094-2016	Strabala, Timothy/0000-0002-0368-9400; Adams, Paul David/0000-0001-9333-8219; Heazlewood, Joshua L/0000-0002-2080-3826; Parsons, Harriet/0000-0003-1666-9123; Petzold, Christopher/0000-0002-8270-5228	AGMARDT Foundation; Royal Society of New Zealand; Office of Science, Office of Biological and Environmental Research, of the U.S. Department of Energy [DE-AC02-05CH11231]	AGMARDT Foundation; Royal Society of New Zealand(Royal Society of New Zealand); Office of Science, Office of Biological and Environmental Research, of the U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported in part by an AGMARDT Foundation postdoctoral fellowship to Cristina Weinberg and an International Mobility Fund Fellowship from the Royal Society of New Zealand. This work was conducted by the Joint BioEnergy Institute and is supported by the Office of Science, Office of Biological and Environmental Research, of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaner CM, 2010, TREE PHYSIOL, V30, P782, DOI 10.1093/treephys/tpq021; ANDERSEN RA, 1968, PHYTOCHEMISTRY, V7, P293, DOI 10.1016/S0031-9422(00)86327-X; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Caffall KH, 2009, MOL PLANT, V2, P1000, DOI 10.1093/mp/ssp062; Cown D. J., 1999, New Zealand Journal of Forestry Science, V29, P203; Cubbage F, 2010, BIOMASS BIOENERG, V34, P1667, DOI 10.1016/j.biombioe.2010.05.008; Doblin MS, 2010, FUNCT PLANT BIOL, V37, P357, DOI 10.1071/FP09279; Donaldson LA, 2004, IAWA J, V25, P253, DOI 10.1163/22941932-90000364; Donaldson LA, 2012, PLANT PHYSIOL, V158, P642, DOI 10.1104/pp.111.184036; Dunkley TPJ, 2006, P NATL ACAD SCI USA, V103, P6518, DOI 10.1073/pnas.0506958103; Floyd S, 2005, HEM WORKSH 2005, P115; Geisler-Lee J, 2006, PLANT PHYSIOL, V140, P946, DOI 10.1104/pp.105.072652; Gion JM, 2005, PROTEOMICS, V5, P3731, DOI 10.1002/pmic.200401197; Gorshkova T, 2006, PLANTA, V223, P149, DOI 10.1007/s00425-005-0118-7; GOUBET F, 1993, PLANT CELL PHYSIOL, V34, P1297; Hatfield RD, 1999, J SCI FOOD AGR, V79, P403, DOI 10.1002/(SICI)1097-0010(19990301)79:3&lt;403::AID-JSFA263&gt;3.0.CO;2-0; Heazlewood JL, 2007, NUCLEIC ACIDS RES, V35, pD213, DOI 10.1093/nar/gkl863; Kim JS, 2010, PLANTA, V232, P545, DOI 10.1007/s00425-010-1189-7; Lee CH, 2011, MOL PLANT, V4, P730, DOI 10.1093/mp/ssr035; Liepman AH, 2005, P NATL ACAD SCI USA, V102, P2221, DOI 10.1073/pnas.0409179102; Liwanag AJM, 2012, PLANT CELL, V24, P5024, DOI 10.1105/tpc.112.106625; Mast S, 2010, TREE PHYSIOL, V30, P1456, DOI 10.1093/treephys/tpq084; Mast SW, 2009, PLANT PHYSIOL, V150, P573, DOI 10.1104/pp.108.134379; Moller R, 2007, P 2 NZ GERM WORKSH P, P105; MORRE DJ, 1964, J CELL BIOL, V23, P295, DOI 10.1083/jcb.23.2.295; Nieminen K, 2012, NEW PHYTOL, V194, P46, DOI 10.1111/j.1469-8137.2011.04011.x; Parsons HT, 2014, METHODS MOL BIOL, V1072, P527, DOI 10.1007/978-1-62703-631-3_35; Parsons HT, 2012, PLANT PHYSIOL, V159, P12, DOI 10.1104/pp.111.193151; PETTERSEN RC, 1991, J WOOD CHEM TECHNOL, V11, P495, DOI 10.1080/02773819108051089; Plomion C, 2000, PLANT PHYSIOL, V123, P959, DOI 10.1104/pp.123.3.959; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Sampathkumar A, 2013, PLANT PHYSIOL, V162, P675, DOI 10.1104/pp.113.215277; Sandhu APS, 2009, MOL PLANT, V2, P840, DOI 10.1093/mp/ssp056; Scheller HV, 2007, PHYSIOL PLANTARUM, V129, P283, DOI 10.1111/j.1399-3054.2006.00834.x; Shepherd M, 2011, BIOFUELS-UK, V2, P639, DOI [10.4155/BFS.11.136, 10.4155/bfs.11.136]; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Villalobos DP, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-100; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; Wu AM, 2009, PLANT J, V57, P718, DOI 10.1111/j.1365-313X.2008.03724.x; Zhou GK, 2006, PLANT CELL PHYSIOL, V47, P1229, DOI 10.1093/pcp/pcj093	42	10	10	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84669	10.1371/journal.pone.0084669	http://dx.doi.org/10.1371/journal.pone.0084669			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24416096	Green Published, gold, Green Submitted			2022-12-27	WOS:000329116700114
J	Cornen, S; Guille, A; Adelaide, J; Addou-Klouche, L; Finetti, P; Saade, MR; Manai, M; Carbuccia, N; Bekhouche, I; Letessier, A; Raynaud, S; Charafe-Jauffret, E; Jacquemier, J; Spicuglia, S; de The, H; Viens, P; Bertucci, F; Birnbaum, D; Chaffanet, M				Cornen, Stephanie; Guille, Arnaud; Adelaide, Jose; Addou-Klouche, Lynda; Finetti, Pascal; Saade, Marie-Rose; Manai, Marwa; Carbuccia, Nadine; Bekhouche, Ismahane; Letessier, Anne; Raynaud, Stephane; Charafe-Jauffret, Emmanuelle; Jacquemier, Jocelyne; Spicuglia, Salvatore; de The, Hugues; Viens, Patrice; Bertucci, Francois; Birnbaum, Daniel; Chaffanet, Max			Candidate Luminal B Breast Cancer Genes Identified by Genome, Gene Expression and DNA Methylation Profiling	PLOS ONE			English	Article							ANTIESTROGEN RESISTANCE; MOLECULAR PORTRAITS; THERAPEUTIC TARGET; CELL-LINES; PATTERNS; MUTATIONS; SUBTYPES; PROTEIN; FOXM1; RISK	Breast cancers (BCs) of the luminal B subtype are estrogen receptor-positive (ER+), highly proliferative, resistant to standard therapies and have a poor prognosis. To better understand this subtype we compared DNA copy number aberrations (CNAs), DNA promoter methylation, gene expression profiles, and somatic mutations in nine selected genes, in 32 luminal B tumors with those observed in 156 BCs of the other molecular subtypes. Frequent CNAs included 8p11-p12 and 11q13.1-q13.2 amplifications, 7q11.22-q34, 8q21.12-q24.23, 12p12.3-p13.1, 12q13.11-q24.11, 14q21.1-q23.1, 17q11.1-q25.1, 20q11.23-q13.33 gains and 6q14.1-q24.2, 9p21.3-p24,3, 9q21.2, 18p11.31-p11.32 losses. A total of 237 and 101 luminal B-specific candidate oncogenes and tumor suppressor genes (TSGs) presented a deregulated expression in relation with their CNAs, including 11 genes previously reported associated with endocrine resistance. Interestingly, 88% of the potential TSGs are located within chromosome arm 6q, and seven candidate oncogenes are potential therapeutic targets. A total of 100 candidate oncogenes were validated in a public series of 5,765 BCs and the overexpression of 67 of these was associated with poor survival in luminal tumors. Twenty-four genes presented a deregulated expression in relation with a high DNA methylation level. FOXO3, PIK3CA and TP53 were the most frequent mutated genes among the nine tested. In a meta-analysis of next-generation sequencing data in 875 BCs, KCNB2 mutations were associated with luminal B cases while candidate TSGs MDN1 (6q15) and UTRN (6q24), were mutated in this subtype. In conclusion, we have reported luminal B candidate genes that may play a role in the development and/or hormone resistance of this aggressive subtype.	[Cornen, Stephanie; Guille, Arnaud; Adelaide, Jose; Addou-Klouche, Lynda; Finetti, Pascal; Saade, Marie-Rose; Manai, Marwa; Carbuccia, Nadine; Bekhouche, Ismahane; Letessier, Anne; Raynaud, Stephane; Charafe-Jauffret, Emmanuelle; Jacquemier, Jocelyne; Bertucci, Francois; Birnbaum, Daniel; Chaffanet, Max] Inst J Paoli I Calmettes, Dept Mol Oncol, Equipe Labellisee Ligue Canc, Marseille Canc Res Ctr,Inserm,UMR1068, F-13009 Marseille, France; [Addou-Klouche, Lynda] Univ Djillali Liabes Sidi Bel Abbes, Biotoxicol Lab, Sidi Bel Abbes, Algeria; [Manai, Marwa] Fac Sci El Manar, Biol Dpt, Biochem & Mol Biol Unit, Tunis, Tunisia; [Charafe-Jauffret, Emmanuelle; Jacquemier, Jocelyne] Inst J Paoli I Calmettes, Dept Biopathol, F-13009 Marseille, France; [Charafe-Jauffret, Emmanuelle; Spicuglia, Salvatore; Viens, Patrice; Bertucci, Francois] Aix Marseille Univ, Marseille, France; [Spicuglia, Salvatore] TAGC, INSERM, U1090, Marseille, France; [de The, Hugues] Univ Paris 07, Hop St Louis, INSERM 7212, CNRS,UMR 944, Paris, France; [Viens, Patrice; Bertucci, Francois] Inst J Paoli I Calmettes, Dept Mol Oncol, F-13009 Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); University Djillali Liabes Sidi Bel Abbes; Universite de Tunis-El-Manar; Faculte des Sciences de Tunis (FST); UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Institut Paoli-Calmette (IPC)	Chaffanet, M (corresponding author), Inst J Paoli I Calmettes, Dept Mol Oncol, Equipe Labellisee Ligue Canc, Marseille Canc Res Ctr,Inserm,UMR1068, F-13009 Marseille, France.	chaffanetm@ipc.unicancer.fr	Spicuglia, Salvatore/L-2268-2016; ADELAIDE, José JA/O-4390-2017; Guille, Arnaud/GZG-1785-2022; Carbuccia, Nadine/O-4459-2017; CHAFFANET, Max/AAU-5743-2020; Letessier, Anne/M-3431-2017; Viens, Patrice/Q-8499-2018; Charafe-Jauffret, emmanuelle/P-6009-2017; Finetti, Pascal/O-8669-2017	Spicuglia, Salvatore/0000-0002-8101-7108; ADELAIDE, José JA/0000-0003-4364-9857; Guille, Arnaud/0000-0001-5747-562X; Carbuccia, Nadine/0000-0002-3561-4315; Letessier, Anne/0000-0002-1894-4072; Viens, Patrice/0000-0003-1511-1048; Bertucci, Francois/0000-0002-0157-0959; CHAFFANET, Max/0000-0002-2344-1488; Charafe-Jauffret, emmanuelle/0000-0002-0286-1299; Finetti, Pascal/0000-0002-2674-3123; MANAI, Marwa/0000-0003-4037-3402	Inserm; Institut Paoli-Calmettes; Ligue Nationale Contre le Cancer; GEFLUC; Institut National du Cancer [ACI2007, AO2008, AO/R-TRANS09]; DGOS (SIRIC label) [INCa-DGOS-Inserm 6038]; Franco-Algerian program of high level formation in France (PROFAS); Algerian government; AVEROES European program	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut Paoli-Calmettes; Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); GEFLUC; Institut National du Cancer(Institut National du Cancer (INCA) France); DGOS (SIRIC label); Franco-Algerian program of high level formation in France (PROFAS); Algerian government; AVEROES European program	Financial support for this study came from Inserm, Institut Paoli-Calmettes, and grants from Ligue Nationale Contre le Cancer (Label DB), GEFLUC (MC), Institut National du Cancer (ACI2007, AO2008, AO/R-TRANS09 "identification, caracterisation et validation clinique de nouvelles cibles cellulaires et moleculaires dans les cancers du sein de mauvais pronostic" IVOIRES (INCA)) and DGOS (SIRIC label: grant INCa-DGOS-Inserm 6038). LAK and IB were supported by a fellowship from the Franco-Algerian program of high level formation in France (PROFAS) and the Algerian government, respectively. MM was supported by a fellowship from the AVEROES European program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Addou-Klouche L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-213; Adelaide J, 2007, CANCER RES, V67, P11565, DOI 10.1158/0008-5472.CAN-07-2536; Andre F, 2009, CLIN CANCER RES, V15, P441, DOI 10.1158/1078-0432.CCR-08-1791; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Bediaga NG, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2721; Bekhouche I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016950; Ben T, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2904; Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; Bergamaschi A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2913; Bernard-Pierrot I, 2008, CANCER RES, V68, P7165, DOI 10.1158/0008-5472.CAN-08-1360; Bertheau P, 2007, PLOS MED, V4, P585, DOI 10.1371/journal.pmed.0040090; Braun L, 2013, MODERN PATHOL, V26, P1161, DOI 10.1038/modpathol.2013.60; Cancello G, 2013, ANN ONCOL, V24, P661, DOI 10.1093/annonc/mds430; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chin SF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r215; Cornen S, 2012, ONCOGENE, V31, P4255, DOI 10.1038/onc.2011.598; Dadi S, 2012, CANCER CELL, V21, P563, DOI 10.1016/j.ccr.2012.02.013; Deng NT, 2012, GUT, V61, P673, DOI 10.1136/gutjnl-2011-301839; Dunn L, 2009, MOL DIAGN THER, V13, P73, DOI 10.2165/01250444-200913020-00002; Edgren H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r6; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Fackler MJ, 2011, CANCER RES, V71, P6195, DOI 10.1158/0008-5472.CAN-11-1630; Fang HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069600; FLAMAN JM, 1995, P NATL ACAD SCI USA, V92, P3963, DOI 10.1073/pnas.92.9.3963; Gelsi-Boyer W, 2005, MOL CANCER RES, V3, P655, DOI 10.1158/1541-7786.MCR-05-0128; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Ha KCH, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-75; Habashy HO, 2011, BREAST CANCER RES TR, V129, P11, DOI 10.1007/s10549-010-1161-z; Hill VK, 2011, CANCER RES, V71, P2988, DOI 10.1158/0008-5472.CAN-10-4026; Holland DG, 2011, EMBO MOL MED, V3, P167, DOI 10.1002/emmm.201100122; Holm K, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2590; Horlings HM, 2010, CLIN CANCER RES, V16, P651, DOI 10.1158/1078-0432.CCR-09-0709; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Huang B, 2012, ONCOGENE, V31, P527, DOI 10.1038/onc.2011.252; Ignatiadis M, 2013, NAT REV CLIN ONCOL, V10, P494, DOI 10.1038/nrclinonc.2013.124; Karlsson E, 2011, GENE CHROMOSOME CANC, V50, P775, DOI 10.1002/gcc.20900; Karn T, 2011, BREAST CANCER RES TR, V130, P409, DOI 10.1007/s10549-010-1333-x; KNIGHT WA, 1980, ANN CLIN RES, V12, P202; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Koo CY, 2012, BBA-GENE REGUL MECH, V1819, P28, DOI 10.1016/j.bbagrm.2011.09.004; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kwek SS, 2009, ONCOGENE, V28, P1892, DOI 10.1038/onc.2009.34; Lau QC, 2006, CANCER RES, V66, P6512, DOI 10.1158/0008-5472.CAN-06-0369; McShane LM, 2006, BREAST CANCER RES TR, V100, P229, DOI 10.1007/s10549-006-9242-8; Mitelman F, 2013, MITELMAN DATABASE CH; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Patel MN, 2013, NAT REV DRUG DISCOV, V12, P35, DOI 10.1038/nrd3913; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Sircoulomb F, 2011, EMBO MOL MED, V3, P153, DOI 10.1002/emmm.201100121; Sircoulomb F, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-539; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Stransky N, 2006, NAT GENET, V38, P1386, DOI 10.1038/ng1923; Teh MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034329; Turner N, 2010, CANCER RES, V70, P2085, DOI 10.1158/0008-5472.CAN-09-3746; van Agthoven T, 2009, BRIT J CANCER, V101, P1824, DOI 10.1038/sj.bjc.6605423; van Agthoven T, 2012, INT J CANCER, V131, P1998, DOI 10.1002/ijc.27489; Van der Auwera I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012616; Vincent-Salomon A, 2008, CLIN CANCER RES, V14, P1956, DOI 10.1158/1078-0432.CCR-07-1465; Wang M, 2011, MOL CANCER THER, V10, P2287, DOI 10.1158/1535-7163.MCT-11-0536; Weigelt B, 2010, LANCET ONCOL, V11, P339, DOI 10.1016/S1470-2045(10)70008-5; Yeang CH, 2008, FASEB J, V22, P2605, DOI 10.1096/fj.08-108985; Zhang JQ, 2009, J CLIN INVEST, V119, P2171, DOI 10.1172/JCI37622; Zou YY, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1872	68	44	48	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e81843	10.1371/journal.pone.0081843	http://dx.doi.org/10.1371/journal.pone.0081843			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416132	Green Submitted, Green Published, gold			2022-12-27	WOS:000329866300006
J	DeRubeis, RJ; Cohen, ZD; Forand, NR; Fournier, JC; Gelfand, LA; Lorenzo-Luaces, L				DeRubeis, Robert J.; Cohen, Zachary D.; Forand, Nicholas R.; Fournier, Jay C.; Gelfand, Lois A.; Lorenzo-Luaces, Lorenzo			The Personalized Advantage Index: Translating Research on Prediction into Individualized Treatment Recommendations. A Demonstration	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIALS; COGNITIVE THERAPY; SEVERE DEPRESSION; COVARIATE-INFORMATION; TREATMENT OUTCOMES; TREATMENT RESPONSE; MEDICINE; PHARMACOGENETICS; MEDICATIONS; MODERATE	Background: Advances in personalized medicine require the identification of variables that predict differential response to treatments as well as the development and refinement of methods to transform predictive information into actionable recommendations. Objective: To illustrate and test a new method for integrating predictive information to aid in treatment selection, using data from a randomized treatment comparison. Method: Data from a trial of antidepressant medications (N = 104) versus cognitive behavioral therapy (N = 50) for Major Depressive Disorder were used to produce predictions of post-treatment scores on the Hamilton Rating Scale for Depression (HRSD) in each of the two treatments for each of the 154 patients. The patient's own data were not used in the models that yielded these predictions. Five pre-randomization variables that predicted differential response (marital status, employment status, life events, comorbid personality disorder, and prior medication trials) were included in regression models, permitting the calculation of each patient's Personalized Advantage Index (PAI), in HRSD units. Results: For 60% of the sample a clinically meaningful advantage (PAI >= 3) was predicted for one of the treatments, relative to the other. When these patients were divided into those randomly assigned to their "Optimal" treatment versus those assigned to their "Non-optimal" treatment, outcomes in the former group were superior (d = 0.58, 95% CI .17-1.01). Conclusions: This approach to treatment selection, implemented in the context of two equally effective treatments, yielded effects that, if obtained prospectively, would rival those routinely observed in comparisons of active versus control treatments.	[DeRubeis, Robert J.; Cohen, Zachary D.; Gelfand, Lois A.; Lorenzo-Luaces, Lorenzo] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA; [Forand, Nicholas R.] Ohio State Univ, Dept Psychiat, Columbus, OH 43210 USA; [Fournier, Jay C.] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA	University of Pennsylvania; University System of Ohio; Ohio State University; University of Pennsylvania	DeRubeis, RJ (corresponding author), Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA.	derubeis@psych.upenn.edu	Cohen, Zachary/A-8946-2013; Fournier, Jay/AAG-8452-2019; Lorenzo-Luaces, Lorenzo/AAA-2070-2020	Cohen, Zachary/0000-0002-4883-1028; Fournier, Jay/0000-0001-8967-1668; Lorenzo-Luaces, Lorenzo/0000-0002-8882-0243; DeRubeis, Robert/0000-0003-3129-0277	NIMH [2-R01-MH-060998-06]; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH097889, R01MH060998] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Support provided by NIMH grant 2-R01-MH-060998-06, "Prevention of Recurrence in Depression with Drugs and CT" (http://www.nimh.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2010, ENCY RES DESIGN, P655; Arranz MJ, 2008, SCHIZOPHRENIA BULL, V34, P1130, DOI 10.1093/schbul/sbn114; Barber JP, 1996, J CONSULT CLIN PSYCH, V64, P951, DOI 10.1037/0022-006X.64.5.951; Baskaran A, 2012, NEUROPHARMACOLOGY, V63, P507, DOI 10.1016/j.neuropharm.2012.04.021; BYAR DP, 1985, STAT MED, V4, P255, DOI 10.1002/sim.4780040304; BYAR DP, 1977, J CHRON DIS, V30, P445, DOI 10.1016/0021-9681(77)90037-6; DeRubeis RJ, 2005, ARCH GEN PSYCHIAT, V62, P409, DOI 10.1001/archpsyc.62.4.409; DeRubeis RJ, 2008, NAT REV NEUROSCI, V9, P788, DOI 10.1038/nrn2345; Draper N.R., 2003, APPL REGRESSION ANAL; Dunlop BW, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-106; EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844; Fournier JC, 2008, BRIT J PSYCHIAT, V192, P124, DOI 10.1192/bjp.bp.107.037234; Fournier JC, 2009, J CONSULT CLIN PSYCH, V77, P775, DOI 10.1037/a0015401; Gong QY, 2011, NEUROIMAGE, V55, P1497, DOI 10.1016/j.neuroimage.2010.11.079; Guo Y, 2008, HUM BRAIN MAPP, V29, P1092, DOI 10.1002/hbm.20450; Hamburg MA, 2010, NEW ENGL J MED, V363, P301, DOI 10.1056/NEJMp1006304; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hollon SD, 2005, ARCH GEN PSYCHIAT, V62, P417, DOI 10.1001/archpsyc.62.4.417; Hollon SD, 1986, PREDICTING OUTCOME V; Ising M, 2009, ARCH GEN PSYCHIAT, V66, P966, DOI 10.1001/archgenpsychiatry.2009.95; Jarrett RB, 1999, ARCH GEN PSYCHIAT, V56, P431, DOI 10.1001/archpsyc.56.5.431; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Kraemer HC, 2004, INT J METH PSYCH RES, V13, P141, DOI 10.1002/mpr.170; Kraemer HC, 2002, ARCH GEN PSYCHIAT, V59, P877, DOI 10.1001/archpsyc.59.10.877; Kraemer HC, 2006, JAMA-J AM MED ASSOC, V296, P1286, DOI 10.1001/jama.296.10.1286; Leucht S, 2012, BRIT J PSYCHIAT, V200, P97, DOI 10.1192/bjp.bp.111.096594; Leykin Y, 2007, J CONSULT CLIN PSYCH, V75, P267, DOI 10.1037/0022-006X.75.2.267; Malhotra AK, 2012, MOL PSYCHIATR, V17, P760, DOI 10.1038/mp.2011.146; McClay JL, 2011, MOL PSYCHIATR, V16, P76, DOI 10.1038/mp.2009.89; McGrath CL, 2013, JAMA PSYCHIAT, V70, P821, DOI 10.1001/jamapsychiatry.2013.143; National Institute for Clinical Excellence, 2004, DEPR MAN DEPR PRIM S; Perlis RH, 2011, MOL PSYCHIATR, V16, P1076, DOI 10.1038/mp.2011.63; Schosser A, 2009, INT CLIN PSYCHOPHARM, V24, P277, DOI 10.1097/YIC.0b013e3283306a2f; Simon GE, 2010, AM J PSYCHIAT, V167, P1445, DOI 10.1176/appi.ajp.2010.09111680; Squassina A, 2010, PHARMACOGENOMICS, V11, P1149, DOI [10.2217/pgs.10.97, 10.2217/PGS.10.97]; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Uher R, 2011, HARVARD REV PSYCHIAT, V19, P109, DOI 10.3109/10673229.2011.586551; Uhr M, 2008, NEURON, V57, P203, DOI 10.1016/j.neuron.2007.11.017; YAKOVLEV AY, 1994, STAT MED, V13, P1575, DOI 10.1002/sim.4780131508; Zachary RA, 1991, W PSYCHOL SERVICES F	42	259	260	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83875	10.1371/journal.pone.0083875	http://dx.doi.org/10.1371/journal.pone.0083875			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291WL	24416178	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000329862500081
J	Haseleu, J; Omerbasic, D; Frenzel, H; Gross, M; Lewin, GR				Haseleu, Julia; Omerbasic, Damir; Frenzel, Henning; Gross, Manfred; Lewin, Gary R.			Water-Induced Finger Wrinkles Do Not Affect Touch Acuity or Dexterity in Handling Wet Objects	PLOS ONE			English	Article							SYMPATHETIC FUNCTION; REPLANTED FINGERS; NERVE INJURY; IMMERSION; VASOCONSTRICTION; TESTS; EMLA	Human non-hairy (glabrous) skin of the fingers, palms and soles wrinkles after prolonged exposure to water. Wrinkling is a sympathetic nervous system-dependent process but little is known about the physiology and potential functions of water-induced skin wrinkling. Here we investigated the idea that wrinkling might improve handling of wet objects by measuring the performance of a large cohort of human subjects (n = 40) in a manual dexterity task. We also tested the idea that skin wrinkling has an impact on tactile acuity or vibrotactile sensation using two independent sensory tasks. We found that skin wrinkling did not improve dexterity in handling wet objects nor did it affect any aspect of touch sensitivity measured. Thus water-induced wrinkling appears to have no significant impact on tactile driven performance or dexterity in handling wet or dry objects.	[Haseleu, Julia; Omerbasic, Damir; Frenzel, Henning; Lewin, Gary R.] Max Delbruck Ctr Mol Med, Dept Neurosci, Berlin, Germany; [Gross, Manfred] Charite, Dept Audiol & Phoniatr, D-13353 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Lewin, GR (corresponding author), Max Delbruck Ctr Mol Med, Dept Neurosci, Berlin, Germany.	glewin@mdc-berlin.de	Lewin, Gary R/B-8028-2011	Lewin, Gary/0000-0002-2890-6352; Haseleu, Julia/0000-0002-6827-074X; Omerbasic, Damir/0000-0003-1839-4856	European Research Council (ERC); Deutsche Forschungsgemeinschaft via collaborative research center 665	European Research Council (ERC)(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft via collaborative research center 665	The work was supported by grants from the European Research Council (ERC) and the Deutsche Forschungsgemeinschaft via collaborative research center 665. None of the the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ G, 1980, BRIT MED J, V281, P586, DOI 10.1136/bmj.281.6240.586-a; BRAHAM J, 1979, ARCH NEUROL-CHICAGO, V36, P113, DOI 10.1001/archneur.1979.00500380083013; BULL C, 1977, BRIT MED J, V1, P551, DOI 10.1136/bmj.1.6060.551-a; Cales L, 1997, J HAND SURG-AM, V22, P747, DOI 10.1016/S0363-5023(97)80141-4; Changizi M, 2011, BRAIN BEHAV EVOLUT, V77, P286, DOI 10.1159/000328223; Daanen HAM, 2003, EUR J APPL PHYSIOL, V89, P411, DOI 10.1007/s00421-003-0818-2; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Frenzel H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001318; Heidenreich M, 2012, NAT NEUROSCI, V15, P138, DOI 10.1038/nn.2985; Hsieh CH, 2007, J SURG RES, V143, P265, DOI 10.1016/j.jss.2006.07.042; Hsieh CH, 2006, CLIN AUTON RES, V16, P223, DOI 10.1007/s10286-006-0340-9; Johnson KO, 2001, CURR OPIN NEUROBIOL, V11, P455, DOI 10.1016/S0959-4388(00)00234-8; Kareklas K, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0999; Lechner SG, 2013, PHYSIOLOGY, V28, P142, DOI 10.1152/physiol.00059.2012; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Lewis T, 1936, CLIN SCI, V2, P149; Lumpkin EA, 2010, J CELL BIOL, V191, P237, DOI 10.1083/jcb.201006074; NAGASAKA T, 1986, PFLUG ARCH EUR J PHY, V407, P71, DOI 10.1007/BF00580723; NAGASAKA T, 1990, J APPL PHYSIOL, V68, P71, DOI 10.1152/jappl.1990.68.1.71; NAGASAKA T, 1987, JPN J PHYSIOL, V37, P425, DOI 10.2170/jjphysiol.37.425; ORIAIN S, 1973, BRIT MED J, V3, P615, DOI 10.1136/bmj.3.5881.615; PHELPS PE, 1977, AM J OCCUP THER, V31, P565; POULTON EC, 1966, PSYCHOL BULL, V66, P1, DOI 10.1037/h0023427; Tindall A, 2006, EMERG MED J, V23, P883, DOI 10.1136/emj.2005.031377; Tsai N, 2005, J HAND SURG-BRIT EUR, V30B, P273, DOI 10.1016/j.jhsb.2004.12.010; Vasudevan TM, 2000, AUST NZ J SURG, V70, P57, DOI 10.1046/j.1440-1622.2000.01744.x; Wende H, 2012, SCIENCE, V335, P1373, DOI 10.1126/science.1214314; Wilder-Smith E, 2003, MICROVASC RES, V66, P68, DOI 10.1016/S0026-2862(03)00020-7; Wilder-Smith EPV, 2004, CLIN AUTON RES, V14, P125, DOI 10.1007/s10286-004-0172-4; Wilder-Smith EPV, 2003, MUSCLE NERVE, V27, P307, DOI 10.1002/mus.10323; Zwislocki JJ, 2001, P NATL ACAD SCI USA, V98, P4811, DOI 10.1073/pnas.081082598	31	9	9	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84949	10.1371/journal.pone.0084949	http://dx.doi.org/10.1371/journal.pone.0084949			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416318	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500195
J	Muniz, S; Lacarta, J; Pata, MP; Jimenez, JJ; Navarro, E				Muniz, Selene; Lacarta, Juan; Pata, Maria P.; Jose Jimenez, Juan; Navarro, Enrique			Analysis of the Diversity of Substrate Utilisation of Soil Bacteria Exposed to Cd and Earthworm Activity Using Generalised Additive Models	PLOS ONE			English	Article							LEVEL PHYSIOLOGICAL PROFILES; MICROBIAL COMMUNITY; HEAVY-METALS; FUNCTIONAL DIVERSITY; UTILIZATION PATTERN; TOLERANCE; BIOMASS; EFFICIENCY; POLLUTION; CADMIUM	Biolog EcoPlates (TM) can be used to measure the carbon substrate utilisation patterns of microbial communities. This method results in a community-level physiological profile (CLPP), which yields a very large amount of data that may be difficult to interpret. In this work, we explore a combination of statistical techniques (particularly the use of generalised additive models [GAMs]) to improve the exploitation of CLPP data. The strength of GAMs lies in their ability to address highly non-linear relationships between the response and the set of explanatory variables. We studied the impact of earthworms (Aporrectodea caliginosa Savigny 1826) and cadmium (Cd) on the CLPP of soil bacteria. The results indicated that both Cd and earthworms modified the CLPP. GAMs were used to assess time-course changes in the diversity of substrate utilisation (DSU) using the Shannon-Wiener index. GAMs revealed significant differences for all treatments (compared to control -S-). The Cd exposed microbial community presented very high metabolic capacities on a few substrata, resulting in an initial acute decrease of DSU (i.e. intense utilization of a few carbon substrata). After 54 h, and over the next 43 h the increase of the DSU suggest that other taxa, less dominant, reached high numbers in the wells containing sources that are less suitable for the Cd-tolerant taxa. Earthworms were a much more determining factor in explaining time course changes in DSU than Cd. Accordingly, Ew and EwCd soils presented similar trends, regardless the presence of Cd. Moreover, both treatments presented similar number of bacteria and higher than Cd-treated soils. This experimental approach, based on the use of DSU and GAMs allowed for a global and statistically relevant interpretation of the changes in carbon source utilisation, highlighting the key role of earthworms on the protection of microbial communities against the Cd.	[Muniz, Selene; Lacarta, Juan; Pata, Maria P.; Jose Jimenez, Juan; Navarro, Enrique] Spanish Natl Res Council, Dept Biodivers & Conservat & Ecosyst Restorat, Pyrenean Inst Ecol, Zaragoza, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE)	Navarro, E (corresponding author), Spanish Natl Res Council, Dept Biodivers & Conservat & Ecosyst Restorat, Pyrenean Inst Ecol, Zaragoza, Spain.	enrique.navarro@ipe.csic.es	Navarro, Enrique/A-4869-2009; Jiménez, Juan J./B-9058-2013	Navarro, Enrique/0000-0002-3964-4431; Jiménez, Juan J./0000-0003-2398-0796; Muniz Cabrera, Selene/0000-0002-2741-1331	Spanish Ministry of Economy and Competitiveness (National Research Plan) [BFU2010-22053]; ARAID Foundation	Spanish Ministry of Economy and Competitiveness (National Research Plan); ARAID Foundation	This work was supported by Spanish Ministry of Economy and Competitiveness (National Research Plan, ref. BFU2010-22053, http://www.mineco.gob.es/portal/site/mineco/). The ARAID Foundation (http://www.araid.es/) is also acknowledged for support provided to J.J. JimA (c) nez. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akmal M, 2005, CHEMOSPHERE, V60, P508, DOI 10.1016/j.chemosphere.2005.01.001; Almas AR, 2004, SOIL BIOL BIOCHEM, V36, P805, DOI 10.1016/j.soilbio.2004.01.010; [Anonymous], 1998, D2216 ASTM INT, DOI [10.1520/D2216-98, http://www.astm.org, DOI 10.1520/D2216-98.AVAILABLE:HTTP://WWW.ASTM.0RG]; Bouche M.B., 1975, BIODEGRADATION HUMIF, P157; Classen AT, 2003, FEMS MICROBIOL ECOL, V44, P319, DOI 10.1016/S0168-6496(03)00068-0; Degens BP, 2001, SOIL BIOL BIOCHEM, V33, P1143, DOI 10.1016/S0038-0717(01)00018-9; DiazRavina M, 1996, APPL ENVIRON MICROB, V62, P2970, DOI 10.1128/AEM.62.8.2970-2977.1996; Dominici F, 2004, J AM STAT ASSOC, V99, P938, DOI 10.1198/016214504000000656; Friendly M, 2013, CANDISC VISUALIZING; Garland JL, 1997, FEMS MICROBIOL ECOL, V24, P289, DOI 10.1016/S0168-6496(97)00061-5; Gomez-Brandon M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031895; Gregori G, 2001, APPL ENVIRON MICROB, V67, P4662, DOI 10.1128/AEM.67.10.4662-4670.2001; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; HAACK SK, 1995, APPL ENVIRON MICROB, V61, P1458, DOI 10.1128/AEM.61.4.1458-1468.1995; Hackett CA, 1997, J MICROBIOL METH, V30, P63, DOI 10.1016/S0167-7012(97)00045-6; HASTIE T, 1990, BIOMETRICS, V46, P1005, DOI 10.2307/2532444; Hobbelen PHF, 2006, ENVIRON POLLUT, V144, P639, DOI 10.1016/j.envpol.2006.01.019; Ikeda H, 2004, P INT S ID US MICR R, P169; Insam H, 1997, MICROBIAL COMMUNITIES, P259; Insam H, 2004, MOL MICROBIAL ECOLOG, P1780; Jegou D, 2001, APPL SOIL ECOL, V17, P165, DOI 10.1016/S0929-1393(00)00136-0; Jiang W, 2010, ENVIRON EARTH SCI, V59, P1717, DOI 10.1007/s12665-009-0153-y; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; JOSCHKO M, 1989, BIOL FERT SOILS, V8, P191, DOI 10.1007/BF00266478; Kamitani T, 2006, WATER AIR SOIL POLL, V172, P185, DOI 10.1007/s11270-005-9073-y; Karaca A, 2010, SOIL BIOL, V19, P237, DOI 10.1007/978-3-642-02436-8_11; Katayama A, 1998, SOIL SCI PLANT NUTR, V44, P245, DOI 10.1080/00380768.1998.10414445; Khalil MA, 1996, PEDOBIOLOGIA, V40, P548; KLINGLER JM, 1992, APPL ENVIRON MICROB, V58, P2089, DOI 10.1128/AEM.58.6.2089-2092.1992; Lavelle P, 2006, EUR J SOIL BIOL, V42, pS3, DOI 10.1016/j.ejsobi.2006.10.002; Lavelle P., 2001, SOIL ECOLOGY; MARINISSEN JCY, 1990, BIOL FERT SOILS, V9, P163, DOI 10.1007/BF00335801; McLaughlin M.J., 1999, CADMIUM SOILS PLANTS; Ministry-of-Agriculture, 1975, B OFICIAL ESTADO BOE, V78, P6458; Moret-Fernandez D, 2011, TDR LAB VERSION 1 2; Muller AK, 2001, FEMS MICROBIOL LETT, V204, P49, DOI 10.1016/S0378-1097(01)00376-7; Nakatsu CH, 2005, APPL ENVIRON MICROB, V71, P7679, DOI 10.1128/AEM.71.12.7679-7689.2005; Niklinska M, 2005, SOIL BIOL BIOCHEM, V37, P2185, DOI 10.1016/j.soilbio.2005.03.020; Preston-Mafham J, 2002, FEMS MICROBIOL ECOL, V42, P1, DOI 10.1111/j.1574-6941.2002.tb00990.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Ritz C, 2005, J STAT SOFTW, V12, P1; Rombke J, 2006, HUM ECOL RISK ASSESS, V12, P84, DOI 10.1080/10807030500430427; Rutgers M, 1998, ENVIRON TOXICOL CHEM, V17, P2210, DOI [10.1002/etc.5620171111, 10.1897/1551-5028(1998)017&lt;2210:RMFAPI&gt;2.3.CO;2]; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; SHIPITALO MJ, 1989, GEODERMA, V45, P357, DOI 10.1016/0016-7061(89)90016-5; Sizmur T, 2009, ENVIRON POLLUT, V157, P1981, DOI 10.1016/j.envpol.2009.02.029; Smalla K, 1998, APPL ENVIRON MICROB, V64, P1220; Tam L, 2001, BIODIVERS CONSERV, V10, P1933, DOI 10.1023/A:1013143503902; Tuomisto H, 2010, OECOLOGIA, V164, P853, DOI 10.1007/s00442-010-1812-0; Udovic M, 2007, ENVIRON POLLUT, V148, P663, DOI 10.1016/j.envpol.2006.11.010; van Beelen P, 2004, ENVIRON TOXICOL CHEM, V23, P2769, DOI 10.1897/03-568; Violante A, 2008, WILEY-IUPAC SER BIOP, P1; Wang Y, 2011, J SOIL SEDIMENT, V11, P789, DOI 10.1007/s11368-011-0352-5; Wood SN, 2006, AUST NZ J STAT, V48, P445, DOI 10.1111/j.1467-842X.2006.00450.x; Wood SN, 2003, J ROY STAT SOC B, V65, P95, DOI 10.1111/1467-9868.00374; Yao HY, 2003, GEODERMA, V115, P139, DOI 10.1016/S0016-7061(03)00083-1; YEE TW, 1991, J VEG SCI, V2, P587, DOI 10.2307/3236170; ZHANG H, 1993, BIOL FERT SOILS, V15, P229, DOI 10.1007/BF00361617	58	41	41	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85057	10.1371/journal.pone.0085057	http://dx.doi.org/10.1371/journal.pone.0085057			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416339	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500209
J	Roden, DL; Sewell, GW; Lobley, A; Levine, AP; Smith, AM; Segal, AW				Roden, Daniel L.; Sewell, Gavin W.; Lobley, Anna; Levine, Adam P.; Smith, Andrew M.; Segal, Anthony W.			ZODET: Software for the Identification, Analysis and Visualisation of Outlier Genes in Microarray Expression Data	PLOS ONE			English	Article							CANCER; VARIABILITY; DISEASES	Complex human diseases can show significant heterogeneity between patients with the same phenotypic disorder. An outlier detection strategy was developed to identify variants at the level of gene transcription that are of potential biological and phenotypic importance. Here we describe a graphical software package (z-score outlier detection (ZODET)) that enables identification and visualisation of gross abnormalities in gene expression (outliers) in individuals, using whole genome microarray data. Mean and standard deviation of expression in a healthy control cohort is used to detect both over and under-expressed probes in individual test subjects. We compared the potential of ZODET to detect outlier genes in gene expression datasets with a previously described statistical method, gene tissue index (GTI), using a simulated expression dataset and a publicly available monocyte-derived macrophage microarray dataset. Taken together, these results support ZODET as a novel approach to identify outlier genes of potential pathogenic relevance in complex human diseases. The algorithm is implemented using R packages and Java.	[Roden, Daniel L.; Sewell, Gavin W.; Lobley, Anna; Levine, Adam P.; Smith, Andrew M.; Segal, Anthony W.] UCL, Div Med, London, England	University of London; University College London	Roden, DL (corresponding author), St Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia.	dlroden@gmail.com		Levine, Adam/0000-0003-1333-9938; Segal, Anthony/0000-0001-7602-9043; Sewell, Gavin/0000-0002-3002-9248; Smith, Andrew/0000-0002-4691-5973	Wellcome Trust [088683/Z/09/Z]; MRC [MR/L000261/1] Funding Source: UKRI; Medical Research Council [MR/L000261/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust grant number 088683/Z/09/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnevie-Nielsen V, 2005, AM J HUM GENET, V76, P623, DOI 10.1086/429391; Chase A, 2010, HAEMATOL-HEMATOL J, V95, P20, DOI 10.3324/haematol.2009.011536; DALLAL GE, 1986, AM STAT, V40, P294, DOI 10.2307/2684607; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ho JWK, 2008, BIOINFORMATICS, V24, pI390, DOI 10.1093/bioinformatics/btn142; Hulse AM, 2013, GENETICS, V193, P95, DOI 10.1534/genetics.112.146779; Li J, 2010, PLOS COMPUTATIONAL B, V6, P10, DOI DOI 10.1371/J0URNAL.PCBI.1000910.ACCESSED; MacDonald JW, 2006, BIOINFORMATICS, V22, P2950, DOI 10.1093/bioinformatics/btl433; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mar JC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002207; Montgomery SB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002144; Mpindi JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017259; Storey John D, 2003, Methods Mol Biol, V224, P149; Tibshirani R, 2007, BIOSTATISTICS, V8, P2, DOI 10.1093/biostatistics/kxl005; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wu BL, 2007, BIOSTATISTICS, V8, P566, DOI 10.1093/biostatistics/kxl029	17	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e81123	10.1371/journal.pone.0081123	http://dx.doi.org/10.1371/journal.pone.0081123			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416128	gold, Green Published			2022-12-27	WOS:000329862500008
J	Sogbohossou, EA; Bauer, H; Loveridge, A; Funston, PJ; De Snoo, GR; Sinsin, B; De Iongh, HH				Sogbohossou, Etotepe A.; Bauer, Hans; Loveridge, Andrew; Funston, Paul J.; De Snoo, Geert R.; Sinsin, Brice; De Iongh, Hans H.			Social Structure of Lions (Panthera leo) Is Affected by Management in Pendjari Biosphere Reserve, Benin	PLOS ONE			English	Article							NATIONAL-PARK; POPULATION; WEST; COALITIONS	Lion populations have undergone a severe decline in West Africa. As baseline for conservation management, we assessed the group structure of lions in the Pendjari Biosphere Reserve in Benin. This reserve, composed of one National Park and two Hunting Zones, is part of the WAP transboundary complex of protected areas. Overall mean group size was 2.6 +/- 1.7 individuals (n = 296), it was significantly higher in the National Park (2.7 +/- 1.7, n = 168) than in the Hunting Zones (2.2 +/- 1.5, n = 128). Overall adult sex ratio was even, but significantly biased towards females (0.67) in the National Park and towards males (1.67) in the Hunting Zones. Our results suggest that the Pendjari lion population is affected by perturbations, such as trophy hunting.	[Sogbohossou, Etotepe A.; Sinsin, Brice] Univ Abomey Calavi, Lab Appl Ecol, Cotonou, Benin; [Funston, Paul J.] Panthera, Kongola, Caprivi Region, Namibia; [De Snoo, Geert R.; De Iongh, Hans H.] Leiden Univ, Inst Environm Sci, Leiden, Netherlands	University of Abomey Calavi; Leiden University; Leiden University - Excl LUMC	Sogbohossou, EA (corresponding author), Univ Abomey Calavi, Lab Appl Ecol, Cotonou, Benin.	etotepe@gmail.com	SOGBOHOSSOU, Etotepe A/HDL-8938-2022	Bauer, Hans/0000-0001-5031-5842	Dutch Organisation for Cooperation in Higher Education (NUFFIC); African Wildlife Foundation (AWF)	Dutch Organisation for Cooperation in Higher Education (NUFFIC); African Wildlife Foundation (AWF)	This study was part of the PhD project of the first author, ES. Her scholarship costs were covered by the Dutch Organisation for Cooperation in Higher Education (NUFFIC). All operational costs for the collection of data for the present paper were covered by the African Wildlife Foundation (AWF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2004, Cat News, V41, P35; Bauer H, 2003, MAMM BIOL, V68, P239, DOI 10.1078/1616-5047-00090; Bauer H, 2008, MAMM BIOL, V73, P70, DOI 10.1016/j.mambio.2006.11.006; Bertola LD, 2011, J BIOGEOGR, V38, P1356, DOI 10.1111/j.1365-2699.2011.02500.x; Bertram BCR, 1975, J ZOOL LOND, V177, P483; Burton AC, 2011, AFR J ECOL, V49, P122, DOI 10.1111/j.1365-2028.2010.01234.x; BYGOTT JD, 1979, NATURE, V282, P839, DOI 10.1038/282839a0; Clerici N, 2005, C LANDSC EC PATT PRO; Creel S, 1997, AFR J ECOL, V35, P83, DOI 10.1111/j.1365-2028.1997.062-89062.x; Di Silvestre Ilaria, 2013, Cat News, V58, P16; Funston PJ, 2011, S AFR J WILDL RES, V41, P1, DOI 10.3957/056.041.0108; Funston PJ, 2001, J ZOOL, V253, P419, DOI 10.1017/S0952836901000395; Henschel Philipp, 2010, Cat News, V52, P34; IUCN, 2012, MOT WORLD CONS C JEJ; Loveridge AJ, 2007, BIOL CONSERV, V134, P548, DOI 10.1016/j.biocon.2006.09.010; Loveridge Andrew J., 2010, P283; Meena V., 2009, Journal of Threatened Taxa, V1, P158; Mills M.G.L., 1978, Koedoe, V21, P163; Mosser A, 2009, ANIM BEHAV, V78, P359, DOI 10.1016/j.anbehav.2009.04.024; Packer C, 2011, CONSERV BIOL, V25, P142, DOI 10.1111/j.1523-1739.2010.01576.x; PACKER C, 1990, AM NAT, V136, P1, DOI 10.1086/285079; PACKER C, 1982, NATURE, V296, P740, DOI 10.1038/296740a0; Riggio J, 2013, BIODIVERS CONSERV, V22, P17, DOI 10.1007/s10531-012-0381-4; Schaller G. B., 1972, SERENGETI LION; Sinsin B, 2002, MAMMALIA, V66, P369, DOI 10.1515/mamm.2002.66.3.369; SMUTS GL, 1978, CARNIVORE, V1, P17; Sogbohossou EA, 2011, ORYX, V45, P569, DOI 10.1017/S0030605310001109; STANDER P E, 1991, Madoqua, V18, P1; Tumenta PN, 2010, AFR J ECOL, V48, P888, DOI 10.1111/j.1365-2028.2009.01181.x; UICN/PACO, 2009, GRAND CHASS AFR OUES; Whitehead H, 1999, ADV STUD BEHAV, V28, P33, DOI 10.1016/S0065-3454(08)60215-6	31	15	15	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84674	10.1371/journal.pone.0084674	http://dx.doi.org/10.1371/journal.pone.0084674			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416263	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500148
J	Sproul, AA; Jacob, S; Pre, D; Kim, SH; Nestor, MW; Navarro-Sobrino, M; Santa-Maria, I; Zimmer, M; Aubry, S; Steele, JW; Kahler, DJ; Dranovsky, A; Arancio, O; Crary, JF; Gandy, S; Noggle, SA				Sproul, Andrew A.; Jacob, Samson; Pre, Deborah; Kim, Soong Ho; Nestor, Michael W.; Navarro-Sobrino, Miriam; Santa-Maria, Ismael; Zimmer, Matthew; Aubry, Soline; Steele, John W.; Kahler, David J.; Dranovsky, Alex; Arancio, Ottavio; Crary, John F.; Gandy, Sam; Noggle, Scott A.			Characterization and Molecular Profiling of PSEN1 Familial Alzheimer's Disease iPSC-Derived Neural Progenitors	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; 21ST-CENTURY BRAIN BANKING; NEURONAL GENE-EXPRESSION; COLUMBIA-UNIVERSITY; ADULT NEUROGENESIS; TRANSGENIC MICE; HUMAN ES; A-BETA; PRESENILIN-1; ACTIVATION	Presenilin 1 (PSEN1) encodes the catalytic subunit of gamma-secretase, and PSEN1 mutations are the most common cause of early onset familial Alzheimer's disease (FAD). In order to elucidate pathways downstream of PSEN1, we characterized neural progenitor cells (NPCs) derived from FAD mutant PSEN1 subjects. Thus, we generated induced pluripotent stem cells (iPSCs) from affected and unaffected individuals from two families carrying PSEN1 mutations. PSEN1 mutant fibroblasts, and NPCs produced greater ratios of A beta 42 to A beta 40 relative to their control counterparts, with the elevated ratio even more apparent in PSEN1 NPCs than in fibroblasts. Molecular profiling identified 14 genes differentially-regulated in PSEN1 NPCs relative to control NPCs. Five of these targets showed differential expression in late onset AD/Intermediate AD pathology brains. Therefore, in our PSEN1 iPSC model, we have reconstituted an essential feature in the molecular pathogenesis of FAD, increased generation of A beta 42/40, and have characterized novel expression changes.	[Sproul, Andrew A.; Jacob, Samson; Nestor, Michael W.; Zimmer, Matthew; Kahler, David J.; Noggle, Scott A.] New York Stem Cell Fdn, New York, NY 10023 USA; [Pre, Deborah; Santa-Maria, Ismael; Aubry, Soline; Arancio, Ottavio; Crary, John F.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Pre, Deborah; Santa-Maria, Ismael; Aubry, Soline; Arancio, Ottavio; Crary, John F.] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY USA; [Kim, Soong Ho; Steele, John W.; Gandy, Sam] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY USA; [Kim, Soong Ho; Steele, John W.; Gandy, Sam] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY USA; [Kim, Soong Ho; Steele, John W.; Gandy, Sam] Icahn Sch Med Mt Sinai, Alzheimers Dis Res Ctr, New York, NY USA; [Navarro-Sobrino, Miriam; Dranovsky, Alex] Columbia Univ, Dept Psychiat, New York, NY USA; [Gandy, Sam] James J Peters Vet Adm Med Ctr, Bronx, NY USA	The New York Stem Cell Foundation; Columbia University; Columbia University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Columbia University; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Sproul, AA (corresponding author), New York Stem Cell Fdn, New York, NY 10023 USA.	asproul@nsycf.org; snoggle@nyscf.org	Kahler, David J/I-9275-2019; Dranovsky, Alex/P-4357-2018; Santa-Maria, Ismael/AAI-7630-2020; arancio, ottavio/AAB-7959-2019	Kahler, David J/0000-0002-7144-2215; Dranovsky, Alex/0000-0001-7896-3243; arancio, ottavio/0000-0001-6335-164X; PRE, deborah/0000-0002-0163-9514; Noggle, Scott/0000-0002-0374-2240; Sproul, Andrew/0000-0001-6972-1592; Santa-Maria Perez, Ismael/0000-0003-2801-5020	Charles Evans Foundation; Alzheimer's Drug Discovery Foundation; NY Community Trust; National Institutes of Health (NIH) [R21AG042965, 1U01AG046170-01, NS049442, R01MH091844]; Cure Alzheimer's Fund; BrightFocus Foundation; Taub Institute; Aging Brain at Columbia University [P50AG08702, RO1AG037212, P01AG07232]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM068524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG046170, P50AG005138, P50AG008702, R01AG037212, P01AG007232] Funding Source: NIH RePORTER	Charles Evans Foundation; Alzheimer's Drug Discovery Foundation; NY Community Trust; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Alzheimer's Fund; BrightFocus Foundation(BrightFocus Foundation); Taub Institute; Aging Brain at Columbia University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is generously supported by grants to Scott Noggle by Charles Evans Foundation, Alzheimer's Drug Discovery Foundation, and NY Community Trust. Scott Noggle and Sam Gandy are jointly supported by National Institutes of Health (NIH) grants R21AG042965 and 1U01AG046170-01, and the Cure Alzheimer's Fund. Ottavio Arancio is supported by NIH grant NS049442. Alex Dranovsky is supported by NIH grant R01MH091844. Soong Ho Kim is supported by the BrightFocus Foundation. The authors express their sincerest gratitude to the patients and staff of the Taub Institute for Research on Alzheimer's Disease & the Aging Brain at Columbia University (P50AG08702, RO1AG037212, P01AG07232). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD SE, 1994, ARCH NEUROL-CHICAGO, V51, P145, DOI 10.1001/archneur.1994.00540140051014; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Beal MF, 2011, AMINO ACIDS, V40, P1305, DOI 10.1007/s00726-011-0851-0; Bekris LM, 2010, J GERIATR PSYCH NEUR, V23, P213, DOI 10.1177/0891988710383571; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Braunger BM, 2012, ADV EXP MED BIOL, V723, P679, DOI 10.1007/978-1-4614-0631-0_86; Bruey JM, 2004, J BIOL CHEM, V279, P51897, DOI 10.1074/jbc.M406741200; Castellano JM, 2012, P NATL ACAD SCI USA, V109, P15502, DOI 10.1073/pnas.1206446109; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Dagenais M, 2012, CELL DEATH DIFFER, V19, P5, DOI 10.1038/cdd.2011.159; Debrincat MA, 2007, J BIOL CHEM, V282, P4728, DOI 10.1074/jbc.M609164200; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Elder GA, 2010, BRAIN STRUCT FUNCT, V214, P127, DOI 10.1007/s00429-009-0227-3; Hata S, 2009, J BIOL CHEM, V284, P36024, DOI 10.1074/jbc.M109.057497; He P, 2009, J NEUROSCI, V29, P6545, DOI 10.1523/JNEUROSCI.0421-09.2009; HENEKA MT, 2012, NATURE, V493, P674, DOI DOI 10.1038/NATURE11729; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Imbimbo BP, 2011, CURR TOP MED CHEM, V11, P1555; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kim JH, 2012, J NEUROCHEM, V121, P751, DOI 10.1111/j.1471-4159.2012.07725.x; Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Kwok JBJ, 2003, J BIOL CHEM, V278, P6748, DOI 10.1074/jbc.M211827200; Kwon S, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-23; Lazarov O, 2010, EXP NEUROL, V223, P267, DOI 10.1016/j.expneurol.2009.08.009; Liang WS, 2008, PHYSIOL GENOMICS, V33, P240, DOI 10.1152/physiolgenomics.00242.2007; Liang WS, 2010, NEUROBIOL AGING, V31, P549, DOI 10.1016/j.neurobiolaging.2008.05.013; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Rubio-Perez JM, 2012, SCI WORLD J, DOI 10.1100/2012/756357; Mu YL, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-85; MURPHY TH, 1992, J NEUROSCI, V12, P4834; NIELSEN J, 1976, CLIN GENET, V10, P161; Ozair MZ, 2013, STEM CELLS, V31, P35, DOI 10.1002/stem.1246; Pruszak J, 2007, STEM CELLS, V25, P2257, DOI 10.1634/stemcells.2006-0744; Qiang L, 2011, CELL, V146, P359, DOI 10.1016/j.cell.2011.07.007; Quintero-Monzon O, 2011, BIOCHEMISTRY-US, V50, P9023, DOI 10.1021/bi2007146; Reiman EM, 2012, LANCET NEUROL, V11, P1048, DOI 10.1016/S1474-4422(12)70228-4; Santa-Maria I, 2012, ACTA NEUROPATHOL, V124, P693, DOI 10.1007/s00401-012-1017-1; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Sproul AA, 2009, CELL RES, V19, P950, DOI 10.1038/cr.2009.74; Thambisetty M, 2013, BIOL PSYCHIAT, V73, P422, DOI 10.1016/j.biopsych.2012.08.015; Verret L, 2007, J NEUROSCI, V27, P6771, DOI 10.1523/JNEUROSCI.5564-06.2007; Vonsattel JPG, 2008, CELL TISSUE BANK, V9, P247, DOI 10.1007/s10561-008-9079-y; Vonsattel JPG, 2008, ACTA NEUROPATHOL, V115, P509, DOI 10.1007/s00401-007-0311-9; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Yagi T, 2011, HUM MOL GENET, V20, P4530, DOI 10.1093/hmg/ddr394	52	120	122	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84547	10.1371/journal.pone.0084547	http://dx.doi.org/10.1371/journal.pone.0084547			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416243	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500135
J	Jimenez-Guri, E; Wotton, KR; Gavilan, B; Jaeger, J				Jimenez-Guri, Eva; Wotton, Karl R.; Gavilan, Brenda; Jaeger, Johannes			A Staging Scheme for the Development of the Moth Midge Clogmia albipunctata	PLOS ONE			English	Article							SEGMENTATION GENE-EXPRESSION; DROSOPHILA; EVOLUTION; LOCALIZATION; CYTOSKELETON; VARIABILITY; AMNIOSEROSA; SUFFICIENT; DOMAINS; SYSTEM	Model organisms, such as Drosophila melanogaster, allow us to address a wide range of biological questions with experimental rigour. However, studies in model species need to be complemented by comparative studies if we are to fully understand the functional properties and evolutionary history of developmental processes. The establishment of new model organisms is crucial for this purpose. One of the first essential steps to establish a species as an experimental model is to carefully describe its life cycle and development. The resulting staging scheme serves as a framework for molecular studies, and allows us to homologise developmental processes between species. In this paper, we have characterised the life cycle and development of an emerging non-drosophilid dipteran model system: the moth midge Clogmia albipunctata. In particular, we focus on early embryogenesis (cleavage and blastoderm cycles before gastrulation), on formation and retraction of extraembryonic tissues, and on formation of the germ line. Considering the large evolutionary distance between the two species (approximately 250 million years), we find that the development of C. albipunctata is remarkably conserved compared to D. melanogaster. On the other hand, we detect significant differences in morphology and timing affecting the development of extraembryonic tissues and the germ line. Moreover, C. albipunctata shows several heterochronic shifts, and lacks head involution and associated processes during late stages of development.	[Jimenez-Guri, Eva; Wotton, Karl R.; Gavilan, Brenda; Jaeger, Johannes] UPF, Ctr Genom Regulat CRG, EMBL CRG Res Unit Syst Biol, Barcelona, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); European Molecular Biology Laboratory (EMBL)	Jaeger, J (corresponding author), UPF, Ctr Genom Regulat CRG, EMBL CRG Res Unit Syst Biol, Barcelona, Spain.	yogi.jaeger@crg.eu		Jaeger, Johannes/0000-0002-2568-2103; jimenez-guri, eva/0000-0002-9592-1077; Wotton, Karl/0000-0002-8672-9948; Gavilan, Brenda/0000-0001-8708-7839	MEC-EMBL; SGR grant from the Catalan funding agency AGAUR [406]; Spanish Ministry of Science (MINECO) [BFU2009-10184, BFU2012-33775]; ERANet: ERASysBio+ grant [EUI2009-04045]	MEC-EMBL; SGR grant from the Catalan funding agency AGAUR; Spanish Ministry of Science (MINECO); ERANet: ERASysBio+ grant	The laboratory of Johannes Jaeger and this study in particular was funded by the MEC-EMBL agreement for the EMBL/CRG Research Unit in Systems Biology, by SGR grant 406 from the Catalan funding agency AGAUR, by grants BFU2009-10184 & BFU2012-33775 from the Spanish Ministry of Science (MICINN, now called MINECO), and by ERANet: ERASysBio+ grant EUI2009-04045 (MODHEART). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abzhanov A, 2008, TRENDS GENET, V24, P353, DOI 10.1016/j.tig.2008.04.002; Ashyraliyev M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000548; Becker K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003281; Bullock SL, 2004, DEVELOPMENT, V131, P4251, DOI 10.1242/dev.01289; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; Crombach A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046658; Crombach A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002589; FOE VE, 1983, J CELL SCI, V61, P31; FOE VE, 1989, DEVELOPMENT, V107, P1; Garcia-Solache M, 2010, DEV BIOL, V344, P306, DOI 10.1016/j.ydbio.2010.04.019; Goltsev Y, 2007, DEVELOPMENT, V134, P2415, DOI 10.1242/dev.02863; Jaeger J, 2004, GENETICS, V167, P1721, DOI 10.1534/genetics.104.027334; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Jaeger J, 2007, MECH DEVELOP, V124, P108, DOI 10.1016/j.mod.2006.11.001; Janssens H, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-1; Janssens H, 2013, DEV BIOL, V377, P305, DOI 10.1016/j.ydbio.2013.01.010; Jimenez-Guri E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-123; LASKO PF, 1990, GENE DEV, V4, P905, DOI 10.1101/gad.4.6.905; Marshall SA, 2012, FLIES NATURAL HIST D; Rafiqi AM, 2008, P NATL ACAD SCI USA, V105, P234, DOI 10.1073/pnas.0709145105; Rafiqi Ab Matteen, 2011, Cold Spring Harb Protoc, V2011, DOI 10.1101/pdb.prot5602; Rohr KB, 1999, DEV GENES EVOL, V209, P145, DOI 10.1007/s004270050238; SCHEJTER ED, 1993, ANNU REV CELL BIOL, V9, P67, DOI 10.1146/annurev.cellbio.9.1.67; Schmidt-Ott U, 2000, DEV GENES EVOL, V210, P373, DOI 10.1007/s004270000068; Schmidt-Ott U, 2010, ADV EXP MED BIOL, V689, P133; SCHMIDTOTT U, 1994, ROUX ARCH DEV BIOL, V203, P298, DOI 10.1007/BF00457800; Stauber M, 2002, P NATL ACAD SCI USA, V99, P274, DOI 10.1073/pnas.012292899; SULLIVAN W, 1995, CURR OPIN CELL BIOL, V7, P18, DOI 10.1016/0955-0674(95)80040-9; Surkova S, 2008, DEV BIOL, V313, P844, DOI 10.1016/j.ydbio.2007.10.037; Surkova S, 2008, FLY, V2, P58, DOI 10.4161/fly.6060; Surkova S, 2013, DEV BIOL, V376, P99, DOI 10.1016/j.ydbio.2013.01.008; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108; Wotton KR, 2013, DEV GENES EVOL, V223, P335, DOI 10.1007/s00427-013-0445-9; Wotton KR, 2013, PLOS ONE IN PRESS; Yeates DK, 1999, ANNU REV ENTOMOL, V44, P397, DOI 10.1146/annurev.ento.44.1.397	35	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84422	10.1371/journal.pone.0084422	http://dx.doi.org/10.1371/journal.pone.0084422			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409296	Green Published, gold, Green Submitted			2022-12-27	WOS:000329463500020
J	Avila-Cabadilla, LD; Stoner, KE; Nassar, JM; Espirito-Santo, MM; Alvarez-Anorve, MY; Aranguren, CI; Henry, M; Gonzalez-Carcacia, JA; Falcao, LAD; Sanchez-Azofeifa, GA				Daniel Avila-Cabadilla, Luis; Elizabeth Stoner, Kathryn; Nassar, Jafet M.; Espirito-Santo, Mario M.; Yolotl Alvarez-Anorve, Mariana; Aranguren, Carla I.; Henry, Mickael; Gonzalez-Carcacia, Jose A.; Dolabela Falcao, Luiz A.; Arturo Sanchez-Azofeifa, Gerardo			Phyllostomid Bat Occurrence in Successional Stages of Neotropical Dry Forests	PLOS ONE			English	Article							TROPICAL DECIDUOUS FOREST; LEPTONYCTERIS-CURASOAE; SPECIES RICHNESS; FRUGIVOROUS BATS; ABUNDANCE; LANDSCAPE; DIVERSITY; RESPONSES; PATTERNS; FRAGMENTATION	Tropical dry forests (TDFs) are highly endangered tropical ecosystems being replaced by a complex mosaic of patches of different successional stages, agricultural fields and pasturelands. In this context, it is urgent to understand how taxa playing critical ecosystem roles respond to habitat modification. Because Phyllostomid bats provide important ecosystem services (e. g. facilitate gene flow among plant populations and promote forest regeneration), in this study we aimed to identify potential patterns on their response to TDF transformation in sites representing four different successional stages (initial, early, intermediate and late) in three Neotropical regions: Mexico, Venezuela and Brazil. We evaluated bat occurrence at the species, ensemble (abundance) and assemblage level (species richness and composition, guild composition). We also evaluated how bat occurrence was modulated by the marked seasonality of TDFs. In general, we found high seasonal and regional specificities in phyllostomid occurrence, driven by specificities at species and guild levels. For example, highest frugivore abundance occurred in the early stage of the moistest TDF, while highest nectarivore abundance occurred in the same stage of the driest TDF. The high regional specificity of phyllostomid responses could arise from: (1) the distinctive environmental conditions of each region, (2) the specific behavior and ecological requirements of the regional bat species, (3) the composition, structure and phenological patterns of plant assemblages in the different stages, and (4) the regional landscape composition and configuration. We conclude that, in tropical seasonal environments, it is imperative to perform long-term studies considering seasonal variations in environmental conditions and plant phenology, as well as the role of landscape attributes. This approach will allow us to identify potential patterns in bat responses to habitat modification, which constitute an invaluable tool for not only bat biodiversity conservation but also for the conservation of the key ecological processes they provide.	[Daniel Avila-Cabadilla, Luis; Yolotl Alvarez-Anorve, Mariana] Univ Nacl Autonoma Mexico, Unidad Morelia, Escuela Nacl Estudios Super, Morelia, Michoacan, Mexico; [Daniel Avila-Cabadilla, Luis; Elizabeth Stoner, Kathryn] Univ Nacl Autonoma Mexico, Ctr Invest Ecosistemas, Morelia, Michoacan, Mexico; [Elizabeth Stoner, Kathryn] New Mexico State Univ, Dept Fish Wildlife & Conservat Ecol, Las Cruces, NM 88003 USA; [Nassar, Jafet M.; Aranguren, Carla I.; Gonzalez-Carcacia, Jose A.] Inst Venezolano Invest Cient Altos de Pipe, Ctr Ecol, Caracas, Venezuela; [Espirito-Santo, Mario M.; Dolabela Falcao, Luiz A.] Univ Estadual Montes Claros, Dept Biol Geral, Montes Claros, MG, Brazil; [Henry, Mickael] INRA, UR Abeilles & Environm 406, Avignon, France; [Arturo Sanchez-Azofeifa, Gerardo] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB, Canada	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; New Mexico State University; Universidade Estadual de Montes Claros; INRAE; University of Alberta	Avila-Cabadilla, LD (corresponding author), Univ Nacl Autonoma Mexico, Unidad Morelia, Escuela Nacl Estudios Super, Morelia, Michoacan, Mexico.	luis_avila@enesmorelia.unam.mx	Cabadilla, Luis Daniel Avila/AAK-9561-2020; caputo, carlo/N-3747-2014; Stoner, Kathryn E/E-1510-2015; Espirito-Santo, Mario/O-4813-2014; Falcão, Luiz/E-3234-2016; Sanchez-Azofeifa, Arturo/F-4700-2014	Cabadilla, Luis Daniel Avila/0000-0003-2501-5690; Stoner, Kathryn E/0000-0002-9964-1697; Espirito-Santo, Mario/0000-0001-8274-3075; Sanchez-Azofeifa, Arturo/0000-0001-7768-6600	University of Alberta; Inter American Institute for Global Change Research (IAI) [Tropi-Dry-CRN2-21]; SEMARNAT-CONACyT, Mexico [2002-C01-0597, CB-2005-51043]; "Fundacao de Amparo a Pesquisa do Estado de Minas Gerais" (FAPEMIG), Brazil [CRA-2288/07, CRA-3042-5.03/07]; "Universidad Nacional Autonoma de Mexico" (UNAM) [PAPITT-IA203413]; "Programa de Apoyo a los Estudios de Posgrado" (PAEP); "Programa de Movilidad Internacional de Estudiantes" of the "Direccion General de Estudios de Posgrado" (DGEP)	University of Alberta(University of Alberta); Inter American Institute for Global Change Research (IAI); SEMARNAT-CONACyT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); "Fundacao de Amparo a Pesquisa do Estado de Minas Gerais" (FAPEMIG), Brazil(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); "Universidad Nacional Autonoma de Mexico" (UNAM)(Universidad Nacional Autonoma de Mexico); "Programa de Apoyo a los Estudios de Posgrado" (PAEP); "Programa de Movilidad Internacional de Estudiantes" of the "Direccion General de Estudios de Posgrado" (DGEP)	Financial support was provided by the University of Alberta (www.ualberta.ca), the Inter American Institute for Global Change Research (IAI, http://www.iai.int), (Tropi-Dry-CRN2-21), SEMARNAT-CONACyT (http://www.semarnat.gob.mx, www.conacyt.mx), Mexico (2002-C01-0597 and CB-2005-51043), the "Fundacao de Amparo a Pesquisa do Estado de Minas Gerais" (FAPEMIG, www.fapemig.br), Brazil (CRA-2288/07 and CRA-3042-5.03/07), and "Universidad Nacional Autonoma de Mexico" (UNAM, http://www.unam.mx) through the "Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica" (PAPITT-IA203413), the "Programa de Apoyo a los Estudios de Posgrado" (PAEP) and the "Programa de Movilidad Internacional de Estudiantes" of the "Direccion General de Estudios de Posgrado" (DGEP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre LF, 2003, J TROP ECOL, V19, P367, DOI [10.1017/S0266467403003419, 10.1017/s0266467403003419]; Alvarez T., 1997, REV MEXICANA MASTOZO, V2, P113; ALVAREZ-ANORVE M, 2008, MANUAL METHODS HUMAN, P15; Antunes FZ., 1994, INF AGROPEC, V17, P15; Aranguren C, 2012, THESIS I VENEZOLANO; Ayala-Berdon J, 2009, J COMP PHYSIOL B, V179, P553, DOI 10.1007/s00360-008-0335-z; Balvanera P, 2002, J VEG SCI, V13, P145, DOI 10.1111/j.1654-1103.2002.tb02034.x; BONACCORSO F J, 1979, Bulletin of the Florida State Museum Biological Sciences, V24, P359; Brosset A, 1996, CAN J ZOOL, V74, P1974, DOI 10.1139/z96-224; BULLOCK SH, 1990, BIOTROPICA, V22, P22, DOI 10.2307/2388716; Carter DC, 1977, BIOL BATS NEW WORL 2, P351; Castro-Arellano I, 2007, BIOL CONSERV, V138, P269, DOI 10.1016/j.biocon.2007.04.025; Charles-Dominique P, 1986, FRUGIVORES SEED DISP, P119, DOI DOI 10.1007/978-94-009-4812-9_12; Chazdon Robin L., 2011, P195; CHEVAN A, 1991, AM STAT, V45, P90, DOI 10.2307/2684366; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Colwell RK, 2009, ESTIMATES STAT ESTIM; Cosson JF, 1999, J TROP ECOL, V15, P515, DOI 10.1017/S026646749900098X; Cosson JF, 1999, BIOL CONSERV, V91, P213, DOI 10.1016/S0006-3207(99)00091-9; Avila-Cabadilla LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035228; Avila-Cabadilla LD, 2009, FOREST ECOL MANAG, V258, P986, DOI 10.1016/j.foreco.2008.12.011; de la Pena-Cuellar E, 2012, BIODIVERS CONSERV, V21, P1381, DOI 10.1007/s10531-012-0249-7; Dos Reis NR, 2007, MORCEGOS BRASIL; ESTRADA A, 1993, ECOGRAPHY, V16, P309, DOI 10.1111/j.1600-0587.1993.tb00220.x; Fauth JE, 1996, AM NAT, V147, P282, DOI 10.1086/285850; Feinsinger P., 2001, DESIGNING FIELD STUD; FENTON MB, 1992, BIOTROPICA, V24, P440, DOI 10.2307/2388615; Fernandez-Hernandez P, 2008, PATRONES FENOLOGICOS; Fleming T.H., 1988, SHORT TAILED FRUIT B; Fleming Theodore H., 2002, P283; Fleming TH, 2009, ANN BOT-LONDON, V104, P1017, DOI 10.1093/aob/mcp197; FRANKIE GW, 1974, J ECOL, V62, P881, DOI 10.2307/2258961; Galicia L, 1999, CATENA, V36, P153, DOI 10.1016/S0341-8162(98)00121-0; Garcia AN, 2002, DIVERSIDAD ESTACIONA, P184; Geiselman C.K., 2002, DATABASE NEOTROPICAL; Geiser Fritz, 2004, Australian Mammalogy, V26, P125; Gorresen PM, 2004, J MAMMAL, V85, P688, DOI 10.1644/BWG-125; Gotelli N. J., 2010, ECOSIM NULL MODELS S; HEITHAUS ER, 1975, ECOLOGY, V56, P841, DOI 10.2307/1936295; Henry M, 2010, ECOL MODEL, V221, P2018, DOI 10.1016/j.ecolmodel.2010.05.011; Herrera LG, 2001, J MAMMAL, V82, P352, DOI 10.1644/1545-1542(2001)082&lt;0352:SOPITS&gt;2.0.CO;2; HOLDRIDGE LR, 1947, SCIENCE, V105, P367, DOI 10.1126/science.105.2727.367; Hothorn T, 2008, J STAT SOFTW, V28, P1; Hutson A, 2001, MICROCHIROPTERAN BAT; Instituto Estadual de Florestas [IEF], 2000, PAR TECN CRIAC PARQ; Jones Gareth, 2009, Endangered Species Research, V8, P93, DOI 10.3354/esr00182; Jordan F, 2009, PHILOS T R SOC B, V364, P1733, DOI 10.1098/rstb.2008.0335; Kalacska MER, 2005, BIOTROPICA, V37, P486, DOI 10.1111/j.1744-7429.2005.00067.x; Kalka MB, 2008, SCIENCE, V320, P71, DOI 10.1126/science.1153352; Kalko Elisabeth K.V., 1996, P503, DOI 10.1016/B978-012178075-3/50017-9; Kelm DH, 2007, J COMP PHYSIOL B, V177, P667, DOI 10.1007/s00360-007-0164-5; Kindt R., 2005, WORLD; Klingbeil BT, 2010, OIKOS, V119, P1654, DOI 10.1111/j.1600-0706.2010.18328.x; Linares O., 1998, MAMIFEROS VENEZUELA; Linares O. J., 1986, MURCIELAGOS VENEZUEL; Lobova TA, 2009, SEED DISPERSAL BATS; Lopezaraiza-Mikel M, 2014, TROPICAL DRY FORESTS IN THE AMERICAS: ECOLOGY, CONSERVATION, AND MANAGEMENT, P101; Lott EJ, 1993, OCCASIONAL PAPERS CA, V148, P1; Maass J. Manuel, 1995, P399, DOI 10.1017/CBO9780511753398.017; Mac Nally R, 2002, BIODIVERS CONSERV, V11, P1397, DOI 10.1023/A:1016250716679; MacArthur R.H., 1972, pvii; Madeira B, 2009, PLANT ECOL, V201, P291, DOI [10.1007/978-90-481-2795-5_22, 10.1007/s11258-009-9580-9]; Magurran A.E., 2004, MEASURING BIOL DIVER; Marques JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074505; McCune B, 2002, ANAL ECOLOGICAL COMM; Medellin R, 1997, IDENTIFICACION MURCI; Medellin RA, 2000, CONSERV BIOL, V14, P1666, DOI [10.1046/j.1523-1739.2000.99068.x, 10.1111/j.1523-1739.2000.99068.x]; Moreno CE, 2000, J APPL ECOL, V37, P149, DOI 10.1046/j.1365-2664.2000.00483.x; Murphy Peter G., 1995, P9, DOI 10.1017/CBO9780511753398.002; MURPHY PG, 1986, ANNU REV ECOL SYST, V17, P67, DOI 10.1146/annurev.es.17.110186.000435; Muscarella R, 2007, BIOL REV, V82, P573, DOI 10.1111/j.1469-185X.2007.00026.x; Nogueira M, 1998, THESIS U FEDERAL RUR; Noguera FA, 2002, HIST NATURAL CHAMELA, P379; Oksanen, 2010, MULTIVARIATE ANAL EC; Oksanen J., 2022, VEGAN COMMUNITY ECOL; Pezzini F, 2008, FENOLOGIA CARACTERIS; Portillo-Quintero CA, 2010, BIOL CONSERV, V143, P144, DOI 10.1016/j.biocon.2009.09.020; Primack R, 2001, FUNDAMENTOS CONSERVA, P183; QUESADA M, 2004, BIOD CONS COST RIC, P00266; Quesada M, 2009, FOREST ECOL MANAG, V258, P1014, DOI 10.1016/j.foreco.2009.06.023; Sanchez-Azofeifa GA, 2005, BIOTROPICA, V37, P477, DOI 10.1111/j.1744-7429.2005.00066.x; Scognamillo D, 2003, J ZOOL, V259, P269, DOI 10.1017/S0952836902003230; Simmons N., 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Sokal R.R., 2012, BIOMETRY; Stoner KE, 2005, BIOTROPICA, V37, P591, DOI 10.1111/j.1744-7429.2005.00076.x; Stoner KE, 2003, BIODIVERS CONSERV, V12, P357, DOI 10.1023/A:1021963819751; Stoner KE, 2001, CAN J ZOOL, V79, P1626, DOI 10.1139/cjz-79-9-1626; Timm Robert M., 1998, University of Kansas Center of Latin American Studies Occasional Publication Series, V22, P1; Walsh C., 2008, HIER PART HIERARCHIC; Wilkinson GS, 1996, MOL ECOL, V5, P329; WOLDA H, 1978, J ANIM ECOL, V47, P369, DOI 10.2307/3789; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751; [No title captured]	94	14	15	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84572	10.1371/journal.pone.0084572	http://dx.doi.org/10.1371/journal.pone.0084572			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404175	Green Published, Green Submitted, gold			2022-12-27	WOS:000329460800054
J	Hahn, MB; Gangnon, RE; Barcellos, C; Asner, GP; Patz, JA				Hahn, Micah B.; Gangnon, Ronald E.; Barcellos, Christovam; Asner, Gregory P.; Patz, Jonathan A.			Influence of Deforestation, Logging, and Fire on Malaria in the Brazilian Amazon	PLOS ONE			English	Article							ANOPHELES-DARLINGI; FUTURE; VECTOR; BIODIVERSITY; FEEDBACKS; ECOLOGY; FORESTS; FATE	Malaria is a significant public health threat in the Brazilian Amazon. Previous research has shown that deforestation creates breeding sites for the main malaria vector in Brazil, Anopheles darlingi, but the influence of selective logging, forest fires, and road construction on malaria risk has not been assessed. To understand these impacts, we constructed a negative binomial model of malaria counts at the municipality level controlling for human population and social and environmental risk factors. Both paved and unpaved roadways and fire zones in a municipality increased malaria risk. Within the timber production states where 90% of deforestation has occurred, compared with areas without selective logging, municipalities where 0-7% of the remaining forests were selectively logged had the highest malaria risk (1.72, 95% CI 1.18-2.51), and areas with higher rates of selective logging had the lowest risk (0.39, 95% CI 0.23-0.67). We show that roads, forest fires, and selective logging are previously unrecognized risk factors for malaria in the Brazilian Amazon and highlight the need for regulation and monitoring of sub-canopy forest disturbance.	[Hahn, Micah B.; Patz, Jonathan A.] Univ Wisconsin, Nelson Inst, SAGE Ctr Sustainabil & Global Environm, Madison, WI 53706 USA; [Hahn, Micah B.; Gangnon, Ronald E.; Patz, Jonathan A.] Univ Wisconsin, Dept Populat Hlth Sci, Sch Med & Publ Hlth, Madison, WI USA; [Barcellos, Christovam] Fundacao Oswaldo Cruz, Hlth Informat Res Dept, Rio De Janeiro, Brazil; [Asner, Gregory P.] Stanford Univ, Dept Global Ecol, Carnegie Inst Sci, Stanford, CA 94305 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Fundacao Oswaldo Cruz; Carnegie Institution for Science; Stanford University	Hahn, MB (corresponding author), Univ Wisconsin, Nelson Inst, SAGE Ctr Sustainabil & Global Environm, Madison, WI 53706 USA.	micah.hahn@gmail.com	Barcellos, Christovam/GQA-5106-2022; Asner, Gregory/G-9268-2013; Barcellos, Christovam/G-6856-2012	Barcellos, Christovam/0000-0002-1161-2753; Asner, Gregory/0000-0001-7893-6421; Barcellos, Christovam/0000-0002-1161-2753; Gangnon, Ronald/0000-0003-2587-6714	NSF IGERT [0549407: CHANGE-IGERT]	NSF IGERT(National Science Foundation (NSF))	This study was supported by the NSF IGERT grant number 0549407: CHANGE-IGERT in the Nelson Institute for Environmental Studies at the University of Wisconsin-Madison. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asner GP, 2005, SCIENCE, V310, P480, DOI 10.1126/science.1118051; Asner GP, 2006, P NATL ACAD SCI USA, V103, P12947, DOI 10.1073/pnas.0604093103; Asner GP, 2009, GEOPHYS MONOGR SER, V186, P25, DOI 10.1029/2008GM000723; Barat LM, 2006, AM J TROP MED HYG, V74, P12, DOI 10.4269/ajtmh.2006.74.12; Barbieri AF, 2005, HUM ECOL, V33, P847, DOI 10.1007/s10745-005-8213-8; Barreto P., 2006, HUMAN PRESSURE BRAZI; Beyer H. L, 2012, GEOSPATIAL MODELLING; Charlwood JD, 1996, MEM I OSWALDO CRUZ, V91, P391, DOI 10.1590/S0074-02761996000400001; Chowdhury J. A., 2006, BETTER FOREST MANAGE; Cochrane MA, 1999, SCIENCE, V284, P1832, DOI 10.1126/science.284.5421.1832; de Castro MC, 2006, P NATL ACAD SCI USA, V103, P2452, DOI 10.1073/pnas.0510576103; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Ferreira MU, 2010, J INFECT DEV COUNTR, V4, P533, DOI 10.3855/jidc.760; Ferreira NC, 2007, EARTH INTERACT, V11, DOI 10.1175/EI201.1; Foley JA, 2007, FRONT ECOL ENVIRON, V5, P25, DOI 10.1890/1540-9295(2007)5[25:ARFDAL]2.0.CO;2; Guarda JA, 1999, EMERG INFECT DIS, V5, P209; Hiwat H, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-177; Holdsworth AR, 1997, ECOL APPL, V7, P713, DOI 10.1890/1051-0761(1997)007[0713:FIASLR]2.0.CO;2; Instituto Nacional de Pesquisas Espaciais, 2012, PRODES PROGR CALC DE; International Tropical Timber Organization, 2013, RED IMP LOGG; Kirby KR, 2006, FUTURES, V38, P432, DOI 10.1016/j.futures.2005.07.011; Laporta GZ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002139; Laporte NT, 2007, SCIENCE, V316, P1451, DOI 10.1126/science.1141057; Laurance WF, 2001, SCIENCE, V291, P438, DOI 10.1126/science.291.5503.438; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; MARQUES AC, 1987, PARASITOL TODAY, V3, P166, DOI 10.1016/0169-4758(87)90170-0; Nepstad D, 2001, FOREST ECOL MANAG, V154, P395, DOI 10.1016/S0378-1127(01)00511-4; Nepstad DC, 1999, NATURE, V398, P505, DOI 10.1038/19066; Oliveira Brandao Junior A de, 2011, AN 15 S BRAS SENS RE; Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115; Olson SH, 2010, EMERG INFECT DIS, V16, P1108, DOI 10.3201/eid1607.091785; Sawyer D, 1992, INT M MAL PAN AM HLT; Singer BH, 2001, ANN NY ACAD SCI, V954, P184; Stone TA, 1998, INT J REMOTE SENS, V19, P2517, DOI 10.1080/014311698214604; Tadei WP, 1998, AM J TROP MED HYG, V59, P325, DOI 10.4269/ajtmh.1998.59.325; Vittor AY, 2009, AM J TROP MED HYG, V81, P5; Vittor AY, 2006, AM J TROP MED HYG, V74, P3, DOI 10.4269/ajtmh.2006.74.3; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Yasuoka J, 2007, AM J TROP MED HYG, V76, P450, DOI 10.4269/ajtmh.2007.76.450	39	82	86	5	247	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e85725	10.1371/journal.pone.0085725	http://dx.doi.org/10.1371/journal.pone.0085725			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404206	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460800085
J	Fan, HY; Sun, HW; Wang, Y; Zhang, YL; Wang, XB; Li, DW; Yu, JL; Han, CG				Fan, Huiyan; Sun, Haiwen; Wang, Ying; Zhang, Yongliang; Wang, Xianbing; Li, Dawei; Yu, Jialin; Han, Chenggui			Deep Sequencing-Based Transcriptome Profiling Reveals Comprehensive Insights into the Responses of Nicotiana benthamiana to Beet necrotic yellow vein virus Infections Containing or Lacking RNA4	PLOS ONE			English	Article							P25 PATHOGENICITY FACTOR; GENE-EXPRESSION; 26S PROTEASOME; DWARF VIRUS; PROTEIN; IDENTIFICATION; TARGETS; GIBBERELLINS; TRANSMISSION; SUPPRESSION	Background: Beet necrotic yellow vein virus (BNYVV), encodes either four or five plus-sense single stranded RNAs and is the causal agent of sugar beet rhizomania disease, which is widely distributed in most regions of the world. BNYVV can also infect Nicotiana benthamiana systemically, and causes severe curling and stunting symptoms in the presence of RNA4 or mild symptoms in the absence of RNA4. Results: Confocal laser scanning microscopy (CLSM) analyses showed that the RNA4-encoded p31 protein fused to the red fluorescent protein (RFP) accumulated mainly in the nuclei of N. benthamiana epidermal cells. This suggested that severe RNA4-induced symptoms might result from p31-dependent modifications of the transcriptome. Therefore, we used next-generation sequencing technologies to analyze the transcriptome profile of N. benthamiana in response to infection with different isolates of BNYVV. Comparisons of the transcriptomes of mock, BN3 (RNAs1+2+3), and BN34 (RNAs1+2+3+4) infected plants identified 3,016 differentially expressed transcripts, which provided a list of candidate genes that potentially are elicited in response to virus infection. Our data indicate that modifications in the expression of genes involved in RNA silencing, ubiquitin-proteasome pathway, cellulose synthesis, and metabolism of the plant hormone gibberellin may contribute to the severe symptoms induced by RNA4 from BNYVV. Conclusions: These results expand our understanding of the genetic architecture of N. benthamiana as well as provide valuable clues to identify genes potentially involved in resistance to BNYVV infection. Our global survey of gene expression changes in infected plants reveals new insights into the complicated molecular mechanisms underlying symptom development, and aids research into new strategies to protect crops against viruses.	[Han, Chenggui] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; China Agr Univ, Dept Plant Pathol, Beijing 100094, Peoples R China	China Agricultural University; China Agricultural University	Han, CG (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	hanchenggui@cau.edu.cn	Li, Dawei/CAJ-5076-2022; Wang, Xianbing/E-4831-2013; Li, Dawei/I-8751-2016; Zhang, Yongliang/AAE-7639-2021	Li, Dawei/0000-0003-4133-1263; Zhang, Yongliang/0000-0002-6790-1044; Wang, Xian-Bing/0000-0003-3082-2462	National Natural Science Foundation of China [30471136, 30671359]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1042]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was in part supported by the National Natural Science Foundation of China (30471136 and 30671359) and the Program for Changjiang Scholars and Innovative Research Team in University (IRT1042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alcaide-Loridan C, 2012, PLANT PHYSIOL, V160, P72, DOI 10.1104/pp.112.201905; Alvarado V, 2009, SEMIN CELL DEV BIOL, V20, P1032, DOI 10.1016/j.semcdb.2009.06.001; Andika IB, 2005, MOL PLANT MICROBE IN, V18, P194, DOI 10.1094/MPMI-18-0194; Aronson MN, 2000, J VIROL, V74, P2967, DOI 10.1128/JVI.74.7.2967-2972.2000; BAILISS KW, 1968, ANN BOT-LONDON, V32, P543, DOI 10.1093/oxfordjournals.aob.a084228; Banks L, 2003, TRENDS BIOCHEM SCI, V28, P452, DOI 10.1016/S0968-0004(03)00141-5; Bortolamiol D, 2007, CURR BIOL, V17, P1615, DOI 10.1016/j.cub.2007.07.061; Burn JE, 2002, PLANT J, V32, P949, DOI 10.1046/j.1365-313X.2002.01483.x; Canto T, 2006, J VIROL, V80, P9064, DOI 10.1128/JVI.00953-06; Cao DN, 2005, PLANTA, V223, P105, DOI 10.1007/s00425-005-0057-3; Catoni M, 2009, MOL PLANT MICROBE IN, V22, P1504, DOI 10.1094/MPMI-22-12-1504; Chiba S, 2011, MOL PLANT MICROBE IN, V24, P207, DOI 10.1094/MPMI-10-10-0241; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Collins LJ, 2008, GENOME INFORM SER, V21, P3; Dardick C, 2007, MOL PLANT MICROBE IN, V20, P1004, DOI 10.1094/MPMI-20-8-1004; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Dunoyer P, 2002, PLANT J, V29, P555, DOI 10.1046/j.0960-7412.2001.01242.x; Ellis C, 2002, PLANT MOL BIOL, V50, P971, DOI 10.1023/A:1021291522243; Faino L, 2012, PLANT SIGNAL BEHAV, V7, P1065, DOI 10.4161/psb.21014; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Golem S, 2003, MOL PLANT MICROBE IN, V16, P681, DOI 10.1094/MPMI.2003.16.8.681; Goodin MM, 2008, MOL PLANT MICROBE IN, V21, P1015, DOI 10.1094/MPMI-21-8-1015; Goodin MM, 2002, PLANT J, V31, P375, DOI 10.1046/j.1365-313X.2002.01360.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hanssen IM, 2011, PLANT PHYSIOL, V156, P301, DOI 10.1104/pp.111.173906; Hedden P, 2000, TRENDS PLANT SCI, V5, P523, DOI 10.1016/S1360-1385(00)01790-8; Huang J, 2010, J GENET GENOMICS, V37, P23, DOI 10.1016/S1673-8527(09)60022-9; Jia MA, 2012, MOL PLANT PATHOL, V13, P251, DOI 10.1111/j.1364-3703.2011.00743.x; JUPIN I, 1992, EMBO J, V11, P479, DOI 10.1002/j.1460-2075.1992.tb05078.x; KOENIG R, 1991, J GEN VIROL, V72, P2243, DOI 10.1099/0022-1317-72-9-2243; Li M, 2009, PLANT J, V60, P1055, DOI 10.1111/j.1365-313X.2009.04022.x; Link D, 2005, J GEN VIROL, V86, P2115, DOI 10.1099/vir.0.80937-0; Liu DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046451; Liu T, 2003, CHINESE SCI BULL, V48, P796, DOI 10.1360/02wc0502; Lu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043447; Lucy AP, 2000, EMBO J, V19, P1672, DOI 10.1093/emboj/19.7.1672; Mao YTS, 2011, TRENDS GENET, V27, P295, DOI 10.1016/j.tig.2011.05.006; Marathe R, 2004, PLANT MOL BIOL, V55, P501, DOI 10.1007/s11103-004-0439-0; Marguerat S, 2010, CELL MOL LIFE SCI, V67, P569, DOI 10.1007/s00018-009-0180-6; McGrann GRD, 2009, MOL PLANT PATHOL, V10, P129, DOI 10.1111/j.1364-3703.2008.00514.x; MOHANTY SK, 1979, PHYSIOL PLANTARUM, V45, P132, DOI 10.1111/j.1399-3054.1979.tb01677.x; Murase K, 2008, NATURE, V456, P459, DOI 10.1038/nature07519; Nakasugi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059534; Nie QH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041645; Pazhouhandeh M, 2006, P NATL ACAD SCI USA, V103, P1994, DOI 10.1073/pnas.0510784103; Peltier C, 2011, TRANSGENIC RES, V20, P443, DOI 10.1007/s11248-010-9424-3; Rahim MD, 2007, J GEN VIROL, V88, P1611, DOI 10.1099/vir.0.82720-0; RICHARDS KE, 1992, ANNU REV PHYTOPATHOL, V30, P291, DOI 10.1146/annurev.py.30.090192.001451; RUSSELL SL, 1971, ANN BOT-LONDON, V35, P1037, DOI 10.1093/oxfordjournals.aob.a084539; Sakamoto T, 2001, PLANT PHYSIOL, V125, P1508, DOI 10.1104/pp.125.3.1508; Satoh K, 2010, J GEN VIROL, V91, P294, DOI 10.1099/vir.0.015990-0; Schmidlin L, 2008, MOL PLANT PATHOL, V9, P741, DOI 10.1111/J.1364-3703.2008.00498.X; Senthil G, 2005, J GEN VIROL, V86, P2615, DOI 10.1099/vir.0.81043-0; Shaw PJ, 2004, CURR OPIN PLANT BIOL, V7, P614, DOI 10.1016/j.pbi.2004.09.011; Shimizu T, 2007, MOL PLANT MICROBE IN, V20, P247, DOI 10.1094/MPMI-20-3-0247; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; TAMADA T, 1989, J GEN VIROL, V70, P3391, DOI 10.1099/0022-1317-70-12-3391; TAMADA T, 1973, Annals of the Phytopathological Society of Japan, V39, P325, DOI 10.3186/jjphytopath.39.325; Thiel H, 2012, MOL PLANT MICROBE IN, V25, P1058, DOI 10.1094/MPMI-03-12-0057-R; Thiel H, 2009, MOL PLANT MICROBE IN, V22, P999, DOI 10.1094/MPMI-22-8-0999; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Valli A., 2009, ENCY LIFE SCI ELS, DOI 10.1002/9780470015902.a978047002126; Vetter G, 2004, J GEN VIROL, V85, P2459, DOI 10.1099/vir.0.80142-0; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Wang YN, 2011, STAT BIOPHARM RES, V3, P1, DOI 10.1198/sbr.2011.09051; Xu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030646; Xu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036238; Zhang LD, 2005, CHINESE SCI BULL, V50, P305, DOI 10.1360/982004-731; Zhang SC, 2009, PLANT MOL BIOL, V69, P745, DOI 10.1007/s11103-009-9452-7; Zhang YJ, 2011, VIRUS RES, V155, P307, DOI 10.1016/j.virusres.2010.10.029; Zhu SF, 2005, PLANT PHYSIOL, V139, P1935, DOI 10.1104/pp.105.072306	74	19	22	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85284	10.1371/journal.pone.0085284	http://dx.doi.org/10.1371/journal.pone.0085284			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416380	Green Published, gold, Green Submitted			2022-12-27	WOS:000329866300065
J	Back, E; Jordan, TR				Back, Elisa; Jordan, Timothy R.			Revealing Variations in Perception of Mental States from Dynamic Facial Expressions: A Cautionary Note	PLOS ONE			English	Article							ASPERGER-SYNDROME; NORMAL ADULTS; RECOGNITION; MIND; EYES; INDIVIDUALS; LANGUAGE; EMOTION; AUTISM; FACES	Although a great deal of research has been conducted on the recognition of basic facial emotions (e.g., anger, happiness, sadness), much less research has been carried out on the more subtle facial expressions of an individual's mental state (e.g., anxiety, disinterest, relief). Of particular concern is that these mental state expressions provide a crucial source of communication in everyday life but little is known about the accuracy with which natural dynamic facial expressions of mental states are identified and, in particular, the variability in mental state perception that is produced. Here we report the findings of two studies that investigated the accuracy and variability with which dynamic facial expressions of mental states were identified by participants. Both studies used stimuli carefully constructed using procedures adopted in previous research, and free-report (Study 1) and forced-choice (Study 2) measures of response accuracy and variability. The findings of both studies showed levels of response accuracy that were accompanied by substantial variation in the labels assigned by observers to each mental state. Thus, when mental states are identified from facial expressions in experiments, the identities attached to these expressions appear to vary considerably across individuals. This variability raises important issues for understanding the identification of mental states in everyday situations and for the use of responses in facial expression research.	[Back, Elisa] Kingston Univ London, Dept Psychol, Kingston Upon Thames, Surrey, England; [Jordan, Timothy R.] Zayed Univ, Dept Psychol, Dubai, U Arab Emirates	Kingston University; Zayed University	Back, E (corresponding author), Kingston Univ London, Dept Psychol, Kingston Upon Thames, Surrey, England.	e.back@kingston.ac.uk		Back, Elisa/0000-0002-9568-9351				[Anonymous], 2001, FIN CUT PRO VERS 3 1; [Anonymous], 2001, QUICKTIME PRO VERS 5; Back E, 2007, CHILD DEV, V78, P397, DOI 10.1111/j.1467-8624.2007.01005.x; Back E, 2009, VIS COGN, V17, P1271, DOI 10.1080/13506280802479998; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S., 2002, MIND READING INTERAC; BaronCohen S, 1996, VIS COGN, V3, P39, DOI 10.1080/713756728; BaronCohen S, 1997, VIS COGN, V4, P311, DOI 10.1080/713756761; Barrett LF, 2007, TRENDS COGN SCI, V11, P327, DOI 10.1016/j.tics.2007.06.003; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; EKMAN P, 1971, J PERS SOC PSYCHOL, V17, P124, DOI 10.1037/h0030377; Gendron M, 2012, EMOTION, V12, P314, DOI 10.1037/a0026007; Golan O, 2006, DEV PSYCHOPATHOL, V18, P591, DOI 10.1017/S0954579406060305; Hanley M, 2013, RES DEV DISABIL, V34, P4466, DOI 10.1016/j.ridd.2013.09.026; Harwood NK, 1999, AM J MENT RETARD, V104, P270, DOI 10.1352/0895-8017(1999)104<0270:ROFEEF>2.0.CO;2; Kaulard K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032321; Kington JM, 2000, J PSYCHIAT RES, V34, P341, DOI 10.1016/S0022-3956(00)00029-7; Lander K, 2003, VIS COGN, V10, P897, DOI 10.1080/13506280344000149; Lander K, 2000, ECOL PSYCHOL, V12, P259, DOI 10.1207/S15326969ECO1204_01; Ponnet KS, 2004, AUTISM, V8, P249, DOI 10.1177/1362361304045214; Riby DM, 2010, NEUROPSYCHOLOGIA, V48, P1914, DOI 10.1016/j.neuropsychologia.2010.03.010; Roeyers H, 2001, J CHILD PSYCHOL PSYC, V42, P271, DOI 10.1111/1469-7610.00718; RUSSELL JA, 1994, PSYCHOL BULL, V115, P102, DOI 10.1037/0033-2909.115.1.102; Stanislawski KS, 1975, WHAT FACE REVEALS BA; Yik M, 2013, COGNITION EMOTION, V27, P1062, DOI 10.1080/02699931.2013.763769	25	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84395	10.1371/journal.pone.0084395	http://dx.doi.org/10.1371/journal.pone.0084395			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291WL	24416226	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000329862500123
J	Dalton, ARH; Vamos, EP; Harris, MJ; Netuveli, G; Wachter, RM; Majeed, A; Millett, C				Dalton, Andrew R. H.; Vamos, Eszter P.; Harris, Matthew J.; Netuveli, Gopalakrishnan; Wachter, Robert M.; Majeed, Azeem; Millett, Christopher			Impact of Universal Health Insurance Coverage on Hypertension Management: A Cross-National Study in the United States and England	PLOS ONE			English	Article							HIGH BLOOD-PRESSURE; PRIMARY-CARE; POPULATION HEALTH; US ADULTS; DISEASE; DISADVANTAGE; MORTALITY; HEART	Background: The Patient Protection and Affordable Care Act (ACA) galvanised debate in the United States (US) over universal health coverage. Comparison with countries providing universal coverage may illustrate whether the ACA can improve health outcomes and reduce disparities. We aimed to compare quality and disparities in hypertension management by socio-economic position in the US and England, the latter of which has universal health care. Method: We used data from the Health and Retirement Survey in the US, and the English Longitudinal Study for Aging from England, including non-Hispanic White respondents aged 50-64 years (US market-based v NHS) and >65 years (US-Medicare v NHS) with diagnosed hypertension. We compared blood pressure control to clinical guideline (140/90 mmHg) and audit (150/90 mmHg) targets; mean systolic and diastolic blood pressure and antihypertensive prescribing, and disparities in each by educational attainment, income and wealth, using regression models. Results: There were no significant differences in aggregate achievement of clinical targets aged 50 to 65 years (US market-based vs. NHS-62.3% vs. 61.3% [p = 0.835]). There was, however, greater control in the US in patients aged 65 years and over (US Medicare vs. NHS-53.5% vs. 58.2% [p = 0.043]). England had no significant socioeconomic disparity in blood pressure control (60.9% vs. 63.5% [p = 0.588], high and low wealth aged >= 65 years). The US had socioeconomic differences in the 5064 years group (71.7% vs. 55.2% [p = 0.003], high and low wealth); these were attenuated but not abolished in Medicare beneficiaries. Conclusion: Moves towards universal health coverage in the US may reduce disparities in hypertension management. The current situation, providing universal coverage for residents aged 65 years and over, may not be sufficient for equality in care.	[Dalton, Andrew R. H.] Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England; [Vamos, Eszter P.; Harris, Matthew J.; Majeed, Azeem; Millett, Christopher] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London, England; [Netuveli, Gopalakrishnan] Univ E London, Inst Hlth & Human Dev, London E15 4LZ, England; [Wachter, Robert M.] Univ Calif San Francisco, Dept Med, Div Hosp Med, San Francisco, CA USA	University of Oxford; Imperial College London; University of East London; University of California System; University of California San Francisco	Dalton, ARH (corresponding author), Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England.	andrew.dalton@phc.ox.ac.uk		Majeed, Azeem/0000-0002-2357-9858; Millett, Christopher/0000-0002-0793-9884; Harris, Matthew/0000-0002-0005-9710	National Institute for Health Research Biomedical Research Centre scheme; National Institute for Health Research Collaboration for Leadership in Applied Health Research Care scheme; Imperial Centre for Patient Safety and Service Quality; Higher Education Funding Council for England; National Institute for Health Research; Economic & Social Research Council [RES-596-28-0001]	National Institute for Health Research Biomedical Research Centre scheme; National Institute for Health Research Collaboration for Leadership in Applied Health Research Care scheme; Imperial Centre for Patient Safety and Service Quality; Higher Education Funding Council for England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); National Institute for Health Research(National Institute for Health Research (NIHR)); Economic & Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	There was no direct external funding for this study. The Department of Primary Care & Public Health at Imperial College is grateful for support from the National Institute for Health Research Biomedical Research Centre scheme, the National Institute for Health Research Collaboration for Leadership in Applied Health Research & Care scheme and the Imperial Centre for Patient Safety and Service Quality. Prof Wachter was a US-UK Fulbright Scholar at Imperial College London in 2011. Dr Millett is funded by the Higher Education Funding Council for England and the National Institute for Health Research Collaboration for Leadership in Applied Health Research & Care scheme. Dr Vamos is partly funded by the National Institute for Health Research. Dr Netuveli is supported by a grant from the Economic & Social Research Council [RES-596-28-0001]. The funders had no part in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Anderson GF, 2005, HEALTH AFFAIR, V24, P903, DOI 10.1377/hlthaff.24.4.903; Asch SM, 2006, NEW ENGL J MED, V354, P1147, DOI 10.1056/NEJMsa044464; Avendano M, 2009, AM J PUBLIC HEALTH, V99, P540, DOI 10.2105/AJPH.2008.139469; Banks J, 2006, JAMA-J AM MED ASSOC, V295, P2037, DOI 10.1001/jama.295.17.2037; Caminal J, 2004, EUR J PUBLIC HEALTH, V14, P246, DOI 10.1093/eurpub/14.3.246; Cappuccio FP, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4995; Chobanian AV, 2009, NEW ARMEN MED J, V3, P60, DOI 10.1056/NEJMsa0903829; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P7, DOI 10.1136/jech.2004.023531; Gilmore I, 2010, 116366 DH; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; *I MED US, 2001, CROSS QUAL CHASM NEW; Jones DW, 2004, HYPERTENSION, V43, P1, DOI 10.1161/01.HYP.0000110061.06674.ca; Juster FT, 1995, J HUM RESOUR, V30, pS7, DOI 10.2307/146277; Levene LS, 2010, JAMA-J AM MED ASSOC, V304, P2028, DOI 10.1001/jama.2010.1636; Link BG, 2008, J HEALTH SOC BEHAV, V49, P367, DOI 10.1177/002214650804900401; Lloyd-Jones DM, 2005, JAMA-J AM MED ASSOC, V294, P466, DOI 10.1001/jama.294.4.466; Lu JFR, 2003, HEALTH AFFAIR, V22, P77, DOI 10.1377/hlthaff.22.3.77; Macinko J, 2007, INT J HEALTH SERV, V37, P111, DOI 10.2190/3431-G6T7-37M8-P224; Majeed A, 2009, J AMBUL CARE MANAG, V32, P280, DOI 10.1097/JAC.0b013e3181ba6f4b; Mancia G, 2002, ARCH INTERN MED, V162, P582, DOI 10.1001/archinte.162.5.582; Marmot M, 2003, HLTH WEALTH LIFESTYL; McWilliams JM, 2007, NEW ENGL J MED, V357, P143, DOI 10.1056/NEJMsa067712; McWilliams JM, 2009, ANN INTERN MED, V150, P505, DOI 10.7326/0003-4819-150-8-200904210-00005; Millett C, 2008, ANN FAM MED, V6, P490, DOI 10.1370/afm.907; Millett C, 2010, ARCH INTERN MED, V170, P1325, DOI 10.1001/archinternmed.2010.208; Moreno-Serra R, 2012, LANCET, V380, P917, DOI 10.1016/S0140-6736(12)61039-3; Papke LE, 2005, ECON LETT, V86, P413, DOI 10.1016/j.econlet.2004.07.022; Patel R, 2006, J HUM HYPERTENS, V20, P733, DOI 10.1038/sj.jhh.1002064; Roalfe AK, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-275; Schoen C, 2009, HEALTH AFFAIR, V28, pW1, DOI 10.1377/hlthaff.28.1.w1; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Williams B, 2004, J HUM HYPERTENS, V18, P139, DOI 10.1038/sj.jhh.1001683; Wilper AP, 2009, AM J PUBLIC HEALTH, V99, P2289, DOI 10.2105/AJPH.2008.157685; Wolf-Maier K, 2004, HYPERTENSION, V43, P10, DOI 10.1161/01.HYP.0000103630.72812.10; Yamey G, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1674	36	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83705	10.1371/journal.pone.0083705	http://dx.doi.org/10.1371/journal.pone.0083705			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291WL	24416171	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000329862500067
J	Donaldson, TM; Ting, LM; Zhan, CY; Shi, WX; Zheng, RJ; Almo, SC; Kim, K				Donaldson, Teraya M.; Ting, Li-Min; Zhan, Chenyang; Shi, Wuxian; Zheng, Renjian; Almo, Steven C.; Kim, Kami			Structural Determinants of the 5 '-Methylthioinosine Specificity of Plasmodium Purine Nucleoside Phosphorylase	PLOS ONE			English	Article							TRANSITION-STATE ANALOG; TRICHOMONAS-VAGINALIS; TOXOPLASMA-GONDII; IMMUCILLIN-H; FALCIPARUM; INHIBITORS; PATHWAY	Plasmodium parasites rely upon purine salvage for survival. Plasmodium purine nucleoside phosphorylase is part of the streamlined Plasmodium purine salvage pathway that leads to the phosphorylysis of both purines and 5 '-methylthiopurines, byproducts of polyamine synthesis. We have explored structural features in Plasmodium falciparum purine nucleoside phosphorylase ( PfPNP) that affect efficiency of catalysis as well as those that make it suitable for dual specificity. We used site directed mutagenesis to identify residues critical for PfPNP catalytic activity as well as critical residues within a hydrophobic pocket required for accommodation of the 5 '-methylthio group. Kinetic analysis data shows that several mutants had disrupted binding of the 5 '-methylthio group while retaining activity for inosine. A triple PfPNP mutant that mimics Toxoplasma gondii PNP had significant loss of 5 '-methylthio activity with retention of inosine activity. Crystallographic investigation of the triple mutant PfPNP with Tyr160Phe, Val66Ile, andVal73Ile in complex with the transition state inhibitor immucillin H reveals fewer hydrogen bond interactions for the inhibitor in the hydrophobic pocket.	[Donaldson, Teraya M.; Ting, Li-Min; Kim, Kami] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Donaldson, Teraya M.; Ting, Li-Min; Kim, Kami] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Donaldson, Teraya M.; Ting, Li-Min; Kim, Kami] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Zhan, Chenyang; Almo, Steven C.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA; [Shi, Wuxian] Brookhaven Natl Lab, Natl Synchrotron Light Source, Brookhaven, NY USA; [Zheng, Renjian] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; United States Department of Energy (DOE); Brookhaven National Laboratory; Yeshiva University; Albert Einstein College of Medicine	Kim, K (corresponding author), Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA.	kami.kim@einstein.yu.edu		Kim, Kami/0000-0003-3384-152X; Zucker-Scharff, Thomas/0000-0002-1790-7405; , Teraya/0000-0002-1635-8854	US Army Research [W81XWH-05-2-0025]; National Synchrotron Light Source comes principally from the Offices of Biological and Environmental Research; Basic Energy Sciences of the US Department of Energy; National Center for Research Resources of the National Institutes of Health; National Center for Research Resources at the National Institute of Health [RR-15301]; US Department of Energy, Office of Basic Energy Sciences [DE-AC02_06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER	US Army Research(United States Department of DefenseUS Army Research Laboratory (ARL)); National Synchrotron Light Source comes principally from the Offices of Biological and Environmental Research; Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Research Resources at the National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Part of this work was supported by US Army Research Grant W81XWH-05-2-0025 (to K. K.). Financial support of beamline X29A of the National Synchrotron Light Source comes principally from the Offices of Biological and Environmental Research and of Basic Energy Sciences of the US Department of Energy and from the National Center for Research Resources of the National Institutes of Health. The Northeastern Collaborative Access Team beamlines of the Advanced Photon Source are supported by award RR-15301 from the National Center for Research Resources at the National Institute of Health. Use of the Advanced Photon Source is supported by the US Department of Energy, Office of Basic Energy Sciences, under contract number DE-AC02_06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorena E, 2002, HEPATOLOGY, V35, P274, DOI 10.1053/jhep.2002.30419; Basu I, 2007, J BIOL CHEM, V282, P21477, DOI 10.1074/jbc.M702287200; Bennett EM, 2003, J BIOL CHEM, V278, P47110, DOI 10.1074/jbc.M304622200; Cassera MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026916; Chaudhary K, 2004, J BIOL CHEM, V279, P31221, DOI 10.1074/jbc.M404232200; Chaudhary K, 2006, J BIOL CHEM, V281, P25652, DOI 10.1074/jbc.M602624200; Cook T, 2007, MICROBIOL-SGM, V153, P1123, DOI 10.1099/mic.0.2006/001768-0; Das Gupta R, 2005, ANTIMICROB AGENTS CH, V49, P2857, DOI 10.1128/AAC.49.7.2857-2864.2005; DeLano WL, 2002, PYMOL USERS MANUAL; Evans GB, 2004, J MED CHEM, V47, P3275, DOI 10.1021/jm0306475; Evans GB, 2003, J MED CHEM, V46, P5271, DOI 10.1021/jm030305z; Evans GB, 2003, ORG LETT, V5, P3639, DOI 10.1021/ol035293q; Evans GB, 2003, J MED CHEM, V46, P3412, DOI 10.1021/jm030145r; Evans GB, 2003, J MED CHEM, V46, P155, DOI 10.1021/jm0203332; Gherardi A, 2007, TRENDS PARASITOL, V23, P384, DOI 10.1016/j.pt.2007.06.003; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Keithly JS, 1997, MOL BIOCHEM PARASIT, V88, P35, DOI 10.1016/S0166-6851(97)00063-7; Kicska GA, 2002, J BIOL CHEM, V277, P3226, DOI 10.1074/jbc.M105906200; Kicska GA, 2002, J BIOL CHEM, V277, P3219, DOI 10.1074/jbc.M105905200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lewandowicz A, 2004, BIOCHEMISTRY-US, V43, P1458, DOI 10.1021/bi0359123; Madrid DC, 2008, J BIOL CHEM; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Minor ZOaW, 1997, PROCESSING XRAY DIFF; Munagala N, 2002, BIOCHEMISTRY-US, V41, P10382, DOI 10.1021/bi026025n; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pugmire MJ, 2002, BIOCHEM J, V361, P1, DOI 10.1042/0264-6021:3610001; Rinaldo-Matthis A, 2007, BIOCHEMISTRY-US, V46, P659, DOI 10.1021/bi061515r; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shi WX, 2004, J BIOL CHEM, V279, P18103, DOI 10.1074/jbc.C400068200; Stoeckler JD, 1997, BIOCHEMISTRY-US, V36, P11749, DOI 10.1021/bi961971n; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; SUFRIN JR, 1995, ANTIMICROB AGENTS CH, V39, P2511, DOI 10.1128/AAC.39.11.2511; Takebe S, 2007, EUKARYOT CELL, V6, P584, DOI 10.1128/EC.00376-06; Ting LM, 2008, NAT MED, V14, P954, DOI 10.1038/nm.1867; Ting LM, 2005, J BIOL CHEM, V280, P9547, DOI 10.1074/jbc.M412693200; Wang F, 2000, PROTEIN SCI, V9, P1660, DOI 10.1110/ps.9.9.1660; WHO, 2012, WORLD MALARIA REPORT 2012, P1	38	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84384	10.1371/journal.pone.0084384	http://dx.doi.org/10.1371/journal.pone.0084384			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416224	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500121
J	Hagihara, A; Hasegawa, M; Abe, T; Nagata, T; Nabeshima, Y				Hagihara, Akihito; Hasegawa, Manabu; Abe, Takeru; Nagata, Takashi; Nabeshima, Yoshihiro			Physician Presence in an Ambulance Car Is Associated with Increased Survival in Out-of-Hospital Cardiac Arrest: A Prospective Cohort Analysis	PLOS ONE			English	Article							EUROPEAN-RESUSCITATION-COUNCIL; AMERICAN-HEART-ASSOCIATION; STROKE-FOUNDATION; CARDIOPULMONARY-RESUSCITATION; RECOMMENDED GUIDELINES; UTSTEIN-STYLE; TASK-FORCE; PROFESSIONALS; STATEMENT; CANADA	The presence of a physician seems to be beneficial for pre-hospital cardiopulmonary resuscitation (CPR) of patients with out-of-hospital cardiac arrest. However, the effectiveness of a physician's presence during CPR before hospital arrival has not been established. We conducted a prospective, non-randomized, observational study using national data from out-of-hospital cardiac arrests between 2005 and 2010 in Japan. We performed a propensity analysis and examined the association between a physician's presence during an ambulance car ride and short-and long-term survival from out-of-hospital cardiac arrest. Specifically, a full non-parsimonious logistic regression model was fitted with the physician presence in the ambulance as the dependent variable; the independent variables included all study variables except for endpoint variables plus dummy variables for the 47 prefectures in Japan (i.e., 46 variables). In total, 619,928 out-of-hospital cardiac arrest cases that met the inclusion criteria were analyzed. Among propensity-matched patients, a positive association was observed between a physician's presence during an ambulance car ride and return of spontaneous circulation (ROSC) before hospital arrival, 1-month survival, and 1-month survival with minimal neurological or physical impairment (ROSC: OR = 1.84, 95% CI 1.63-2.07, p = 0.00 in adjusted for propensity and all covariates); 1-month survival: OR = 1.29, 95% CI 1.04-1.61, p = 0.02 in adjusted for propensity and all covariates); cerebral performance category (1 or 2): OR = 1.54, 95% CI 1.03-2.29, p = 0.04 in adjusted for propensity and all covariates); and overall performance category (1 or 2): OR = 1.50, 95% CI 1.01-2.24, p = 0.05 in adjusted for propensity and all covariates). A prospective observational study using national data from out-of-hospital cardiac arrests shows that a physician's presence during an ambulance car ride was independently associated with increased short-and long-term survival.	[Hagihara, Akihito; Nabeshima, Yoshihiro] Kyushu Univ, Grad Sch Med, Dept Hlth Serv Management & Policy, Fukuoka 812, Japan; [Hasegawa, Manabu] Minist Internal Affairs & Commun, Ambulance Serv Planning Div, Fire & Disaster Management Agcy, Tokyo, Japan; [Abe, Takeru] Waseda Univ, Fac Human Sci, Tokorozawa, Saitama, Japan; [Nagata, Takashi] Kyushu Univ Hosp, Dept Emergency & Crit Care Ctr, Fukuoka 812, Japan	Kyushu University; Waseda University; Kyushu University	Hagihara, A (corresponding author), Kyushu Univ, Grad Sch Med, Dept Hlth Serv Management & Policy, Fukuoka 812, Japan.	hagihara@hsmp.med.kyushu-u.ac.jp	Abe, Takeru/J-9512-2014	Abe, Takeru/0000-0003-3496-1953				Abe T, 2012, RESUSCITATION, V83, P612, DOI 10.1016/j.resuscitation.2012.01.024; [Anonymous], 2007, JAP GUID EM CAR CARD; BAXT WG, 1987, JAMA-J AM MED ASSOC, V257, P3246, DOI 10.1001/jama.257.23.3246; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Botker MT, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-12; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; Cummins RO, 1997, CIRCULATION, V95, P2213, DOI 10.1161/01.CIR.95.8.2213; Dickinson E T, 1997, Prehosp Emerg Care, V1, P132, DOI 10.1080/10903129708958805; Edelson DP, 2008, ARCH INTERN MED, V168, P1063, DOI 10.1001/archinte.168.10.1063; FRANDSEN F, 1991, CARDIOLOGY, V79, P256, DOI 10.1159/000174888; Grogaard HK, 2007, J AM COLL CARDIOL, V50, P1093, DOI 10.1016/j.jacc.2007.05.028; Gum PA, 2001, JAMA-J AM MED ASSOC, V286, P1187, DOI 10.1001/jama.286.10.1187; Hagihara A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001394; Hagihara A, 2012, JAMA-J AM MED ASSOC, V307, P1161, DOI 10.1001/jama.2012.294; HAMPTON JR, 1977, LANCET, V1, P526; Hasegawa K, 2013, JAMA-J AM MED ASSOC, V309, P257, DOI 10.1001/jama.2012.187612; Holmberg M, 2002, RESUSCITATION, V54, P37, DOI 10.1016/S0300-9572(02)00048-5; Hsieh FY, 1998, STAT MED, V17, P1623, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; Kirves H, 2007, EUR J EMERG MED, V14, P75, DOI 10.1097/MEJ.0b013e328013f88c; Kitamura T, 2010, LANCET, V375, P1347, DOI 10.1016/S0140-6736(10)60064-5; Kitamura T, 2010, NEW ENGL J MED, V362, P994, DOI 10.1056/NEJMoa0906644; Lossius HM, 2002, ACTA ANAESTH SCAND, V46, P771, DOI 10.1034/j.1399-6576.2002.460703.x; Mitchell RG, 1997, RESUSCITATION, V35, P225, DOI 10.1016/S0300-9572(97)00072-5; Ogawa T, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7106; Olasveengen TM, 2009, RESUSCITATION, V80, P1248, DOI 10.1016/j.resuscitation.2009.07.018; Parsons LS, 21426 OV RES GROUP; Sasson C, 2010, CIRC-CARDIOVASC QUAL, V3, P63, DOI 10.1161/CIRCOUTCOMES.109.889576; Sipria A, 2000, AM J EMERG MED, V18, P469, DOI 10.1053/ajem.2000.7350; Skogvoll E, 2000, ACTA ANAESTH SCAND, V44, P972, DOI 10.1034/j.1399-6576.2000.440813.x; Soo LH, 1999, HEART, V81, P47, DOI 10.1136/hrt.81.1.47; Takei Y, 2010, J ANESTH, V24, P716, DOI 10.1007/s00540-010-0974-6; Yen ZS, 2006, J FORMOS MED ASSOC, V105, P1001, DOI 10.1016/S0929-6646(09)60284-9	34	29	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84424	10.1371/journal.pone.0084424	http://dx.doi.org/10.1371/journal.pone.0084424			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416232	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500127
J	Horga, G; Fernandez-Egea, E; Mane, A; Font, M; Schatz, KC; Falcon, C; Lomena, F; Bernardo, M; Parellada, E				Horga, Guillermo; Fernandez-Egea, Emilio; Mane, Anna; Font, Mireia; Schatz, Kelly C.; Falcon, Carles; Lomena, Francisco; Bernardo, Miguel; Parellada, Eduard			Brain Metabolism during Hallucination-Like Auditory Stimulation in Schizophrenia	PLOS ONE			English	Article							FDG-PET; AMYGDALA; ACTIVATION; NETWORKS; FEELINGS; PATTERNS; EMOTION; STATE; FMRI; CONNECTIVITY	Auditory verbal hallucinations (AVH) in schizophrenia are typically characterized by rich emotional content. Despite the prominent role of emotion in regulating normal perception, the neural interface between emotion-processing regions such as the amygdala and auditory regions involved in perception remains relatively unexplored in AVH. Here, we studied brain metabolism using FDG-PET in 9 remitted patients with schizophrenia that previously reported severe AVH during an acute psychotic episode and 8 matched healthy controls. Participants were scanned twice: (1) at rest and (2) during the perception of aversive auditory stimuli mimicking the content of AVH. Compared to controls, remitted patients showed an exaggerated response to the AVH-like stimuli in limbic and paralimbic regions, including the left amygdala. Furthermore, patients displayed abnormally strong connections between the amygdala and auditory regions of the cortex and thalamus, along with abnormally weak connections between the amygdala and medial prefrontal cortex. These results suggest that abnormal modulation of the auditory cortex by limbic-thalamic structures might be involved in the pathophysiology of AVH and may potentially account for the emotional features that characterize hallucinatory percepts in schizophrenia.	[Horga, Guillermo; Schatz, Kelly C.] Columbia Univ Med Ctr, New York State Psychiat Inst, Dept Psychiat, New York, NY USA; [Horga, Guillermo; Font, Mireia; Lomena, Francisco; Bernardo, Miguel; Parellada, Eduard] Hosp Clin Barcelona, Schizophrenia Unit, Neurosci Inst, Barcelona, Spain; [Horga, Guillermo; Bernardo, Miguel; Parellada, Eduard] Univ Barcelona, Dept Psychiat & Clin Psychobiol, Barcelona, Spain; [Fernandez-Egea, Emilio] Univ Cambridge, Dept Psychiat, Cambridge, England; [Fernandez-Egea, Emilio] Cambridgeshire & Peterborough NHS Fdn Trust, Huntingdon, England; [Fernandez-Egea, Emilio; Mane, Anna; Lomena, Francisco; Bernardo, Miguel; Parellada, Eduard] Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain; [Mane, Anna] Ctr Forum, Barcelona, Spain; [Falcon, Carles] CIBER BBN, GIB UB, Barcelona, Spain; [Lomena, Francisco; Bernardo, Miguel; Parellada, Eduard] Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain	Columbia University; New York State Psychiatry Institute; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; University of Cambridge; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Horga, G (corresponding author), Columbia Univ Med Ctr, New York State Psychiat Inst, Dept Psychiat, New York, NY USA.	guillermo.horga@gmail.com	Bernardo, Miquel/P-3049-2015; Parellada, Eduard/I-2675-2015; Horga, Guillermo/M-8036-2016	Bernardo, Miquel/0000-0001-8748-6717; Parellada, Eduard/0000-0003-1131-4980; Horga, Guillermo/0000-0002-9049-9786; falcon, carles/0000-0001-5564-2025; mane santacana, anna/0000-0003-2127-349X; Fernandez-Egea, Emilio/0000-0003-4128-8955	Fundacio Marato of TV3 [012410]; Janssen-Cilag; Ministerio de Ciencia y Tecnologia [SAF-2002-04270-C02 02]; Fondo de Investigacion Sanitaria [G03/185, C03/06]; DIUE (Government of Catalonia, Comissionat per Universitats I Recerca del Departament d'Innovacio, Universitats I Empresa) [2009SGR1295]; Instituto de Salud Carlos III, Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM); Medical Research Council [G0001354B, G1000183B, G0001354] Funding Source: researchfish	Fundacio Marato of TV3; Janssen-Cilag; Ministerio de Ciencia y Tecnologia; Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); DIUE (Government of Catalonia, Comissionat per Universitats I Recerca del Departament d'Innovacio, Universitats I Empresa); Instituto de Salud Carlos III, Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM)(Instituto de Salud Carlos III); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Fundacio Marato of TV3 (registered number 012410), Janssen-Cilag; Ministerio de Ciencia y Tecnologia (grant number SAF-2002-04270-C02 02); the Fondo de Investigacion Sanitaria (grant numbers G03/185, C03/06); DIUE (Government of Catalonia, Comissionat per Universitats I Recerca del Departament d'Innovacio, Universitats I Empresa, grant number 2009SGR1295); and the Instituto de Salud Carlos III, Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen P, 2008, NEUROSCI BIOBEHAV R, V32, P175, DOI 10.1016/j.neubiorev.2007.07.012; Anderson AK, 2001, NATURE, V411, P305, DOI 10.1038/35077083; ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P615; Anticevic A, 2012, SCHIZOPHRENIA BULL, V38, P608, DOI 10.1093/schbul/sbq131; Anticevic A, 2012, SCHIZOPHRENIA BULL, V38, P967, DOI 10.1093/schbul/sbq168; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Benes FM, 2010, NEUROPSYCHOPHARMACOL, V35, P239, DOI 10.1038/npp.2009.116; Bentaleb LA, 2006, ENCEPHALE, V32, P27; Calder AJ, 2001, NAT REV NEUROSCI, V2, P352, DOI 10.1038/35072584; DAVIS KL, 1991, AM J PSYCHIAT, V148, P1474; Di X, 2012, BRAIN CONNECT, V2, P275, DOI 10.1089/brain.2012.0086; Diederen KMJ, 2010, AM J PSYCHIAT, V167, P427, DOI 10.1176/appi.ajp.2009.09040456; Ellison-Wright I, 2008, AM J PSYCHIAT, V165, P1015, DOI 10.1176/appi.ajp.2008.07101562; Fernandez-Egea E, 2010, EUR ARCH PSY CLIN N, V260, P69, DOI 10.1007/s00406-009-0020-6; Fletcher PC, 2009, NAT REV NEUROSCI, V10, P48, DOI 10.1038/nrn2536; Grunder G, 2009, NEUROIMAGE, V45, P258, DOI 10.1016/j.neuroimage.2008.10.042; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Haddock G, 1999, PSYCHOL MED, V29, P879, DOI 10.1017/S0033291799008661; Holt DJ, 2006, SCHIZOPHR RES, V82, P153, DOI 10.1016/j.schres.2005.09.021; Holt DJ, 2005, BIOL PSYCHIAT, V57, P1011, DOI 10.1016/j.biopsych.2005.01.033; Horga G, 2011, J PSYCHIATR NEUROSCI, V36, P312, DOI 10.1503/jpn.100085; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kumar S, 2012, J NEUROSCI, V32, P14184, DOI 10.1523/JNEUROSCI.1759-12.2012; Lacadie CM, 2008, NEUROIMAGE, V42, P717, DOI 10.1016/j.neuroimage.2008.04.240; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Leaver AM, 2011, NEURON, V69, P33, DOI 10.1016/j.neuron.2010.12.002; Lee DS, 2008, EUR J NUCL MED MOL I, V35, P1681, DOI 10.1007/s00259-008-0808-z; Maudoux A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036222; Minzenberg MJ, 2009, ARCH GEN PSYCHIAT, V66, P811, DOI 10.1001/archgenpsychiatry.2009.91; Morbelli S, 2012, NEUROBIOL AGING, V33, P2533, DOI 10.1016/j.neurobiolaging.2012.01.005; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2004, J COGNITIVE NEUROSCI, V16, P1746, DOI 10.1162/0898929042947829; Pomarol-Clotet E, 2010, MOL PSYCHIATR, V15, P823, DOI 10.1038/mp.2009.146; Rauschecker JP, 2010, NEURON, V66, P819, DOI 10.1016/j.neuron.2010.04.032; Salgado-Pineda P, 2010, J PSYCHIATR NEUROSCI, V35, P41, DOI 10.1503/jpn.090017; Sanjuan J, 2007, PSYCHIAT RES-NEUROIM, V154, P21, DOI 10.1016/j.pscychresns.2006.04.011; Schneider F, 1998, SCHIZOPHR RES, V34, P133, DOI 10.1016/S0920-9964(98)00085-1; Taylor PA, 2012, BRAIN CONNECT, V2, P203, DOI 10.1089/brain.2012.0095; Taylor SF, 2005, NEUROPSYCHOPHARMACOL, V30, P984, DOI 10.1038/sj.npp.1300679; Taylor SF, 2002, SCHIZOPHR RES, V58, P159, DOI 10.1016/S0920-9964(01)00403-0; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Waters F, 2012, SCHIZOPHRENIA BULL, V38, P683, DOI 10.1093/schbul/sbs045; Weber WA, 2000, NUCL MED BIOL, V27, P683, DOI 10.1016/S0969-8051(00)00141-4; Wright IC, 2000, AM J PSYCHIAT, V157, P16, DOI 10.1176/ajp.157.1.16; Zhang ZQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028817	46	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84987	10.1371/journal.pone.0084987	http://dx.doi.org/10.1371/journal.pone.0084987			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416328	gold, Green Published, Green Submitted			2022-12-27	WOS:000329862500201
J	Hernandez-Bule, ML; Trillo, MA; Ubeda, A				Luisa Hernandez-Bule, Maria; Angeles Trillo, Maria; Ubeda, Alejandro			Molecular Mechanisms Underlying Antiproliferative and Differentiating Responses of Hepatocarcinoma Cells to Subthermal Electric Stimulation	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; RADIOFREQUENCY-OUTPUT POWER; PLUS REGIONAL HYPERTHERMIA; HUMAN NEUROBLASTOMA-CELLS; HEPATOCYTE GROWTH-FACTOR; HZ MAGNETIC-FIELD; C-MET; ELECTROMAGNETIC-FIELDS; LUNG-CANCER; P53	Capacitive Resistive Electric Transfer (CRET) therapy applies currents of 0.4-0.6 MHz to treatment of inflammatory and musculoskeletal injuries. Previous studies have shown that intermittent exposure to CRET currents at subthermal doses exert cytotoxic or antiproliferative effects in human neuroblastoma or hepatocarcinoma cells, respectively. It has been proposed that such effects would be mediated by cell cycle arrest and by changes in the expression of cyclins and cyclin-dependent kinase inhibitors. The present work focuses on the study of the molecular mechanisms involved in CRET-induced cytostasis and investigates the possibility that the cellular response to the treatment extends to other phenomena, including induction of apoptosis and/or of changes in the differentiation stage of hepatocarcinoma cells. The obtained results show that the reported antiproliferative action of intermittent stimulation (5 m On/4 h Off) with 0.57 MHz, sine wave signal at a current density of 50 mu A/mm(2), could be mediated by significant increase of the apoptotic rate as well as significant changes in the expression of proteins p53 and Bcl-2. The results also revealed a significantly decreased expression of alpha-fetoprotein in the treated samples, which, together with an increased concentration of albumin released into the medium by the stimulated cells, can be interpreted as evidence of a transient cytodifferentiating response elicited by the current. The fact that this type of electrical stimulation is capable of promoting both, differentiation and cell cycle arrest in human cancer cells, is of potential interest for a possible extension of the applications of CRET therapy towards the field of oncology.	[Luisa Hernandez-Bule, Maria; Angeles Trillo, Maria; Ubeda, Alejandro] Ramon y Cajal Univ Hosp, Ramon y Cajal Inst Med Res, Bioelectromagnet Serv, Madrid, Spain		Hernandez-Bule, ML (corresponding author), Ramon y Cajal Univ Hosp, Ramon y Cajal Inst Med Res, Bioelectromagnet Serv, Madrid, Spain.	mluisa.hernandez@hrc.es	Hernandez-Bule, Maria Luisa/AAE-4403-2022; Hernandez-Bule, Maria Luisa/A-5010-2019	Hernandez-Bule, Maria Luisa/0000-0002-1437-3452; Hernandez-Bule, Maria Luisa/0000-0002-1437-3452	Fundacion para la Investigacion Biomedica del Hospital Ramon y Cajal, through Project FiBio-HRC [2006/0158]	Fundacion para la Investigacion Biomedica del Hospital Ramon y Cajal, through Project FiBio-HRC	This work was financially supported by Fundacion para la Investigacion Biomedica del Hospital Ramon y Cajal, through Project FiBio-HRC No. 2006/0158. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cid MA, 2012, CELL PHYSIOL BIOCHEM, V30, P1502, DOI 10.1159/000343338; Martinez MA, 2012, CELL PHYSIOL BIOCHEM, V29, P675, DOI 10.1159/000178457; Barbault A, 2009, J EXP CLIN CANC RES, V14, P28; Beerheide W, 2000, BIOCHEM BIOPH RES CO, V273, P54, DOI 10.1006/bbrc.2000.2891; BOIX L, 1994, HEPATOLOGY, V19, P88, DOI 10.1016/0270-9139(94)90057-4; Brown L, 2007, CRIT REV EUKAR GENE, V17, P73, DOI 10.1615/CritRevEukarGeneExpr.v17.i1.50; Caldon CE, 2010, CELL CYCLE, V9, P1918, DOI 10.4161/cc.9.10.11474; Carvajal LA, 2013, EMBO REP, V14, P414, DOI 10.1038/embor.2013.25; Chen H, 2012, J INT MED RES, V40, P85, DOI 10.1177/147323001204000109; Cheuk W, 2004, INT J SURG PATHOL, V12, P185, DOI 10.1177/106689690401200301; Coffman FD, 1999, EXP CELL RES, V248, P58, DOI 10.1006/excr.1999.4457; Costa FP, 2011, BRIT J CANCER, V105, P640, DOI 10.1038/bjc.2011.292; Costin GE, 2012, CURR MOL MED, V12, P14, DOI 10.2174/156652412798376143; Grimnes S., 2000, BIOIMPEDANCE BIOELEC, P71; Gu JJ, 2000, MOL CELL BIOL, V20, P1243, DOI 10.1128/MCB.20.4.1243-1253.2000; Guo LF, 2011, ELECTROMAGN BIOL MED, V30, P21, DOI 10.3109/15368378.2011.566775; Heiser D, 2004, EXP GERONTOL, V39, P1125, DOI 10.1016/j.exger.2004.04.011; Hemann MT, 2006, CELL DEATH DIFFER, V13, P1256, DOI 10.1038/sj.cdd.4401962; Hernandez-Bule ML, 2004, NEUROCIRUGIA, V15, P366; Hernandez-Bule ML, 2007, INT J ONCOLOGY, V30, P583; Huang HP, 2010, J BIOL CHEM, V285, P33510, DOI 10.1074/jbc.M110.122093; Iseki K, 2000, INT J ONCOL, V16, P1141; Issels RD, 2010, LANCET ONCOL, V11, P561, DOI 10.1016/S1470-2045(10)70071-1; Kato S, 2011, CYTOTECHNOLOGY, V63, P425, DOI 10.1007/s10616-011-9363-8; Kong N, 2013, ASIAN PAC J CANCER P, V14, P747, DOI 10.7314/APJCP.2013.14.2.747; Kotnik T, 2000, BIOELECTROMAGNETICS, V21, P385, DOI 10.1002/1521-186X(200007)21:5<385::AID-BEM7>3.0.CO;2-F; Lee KH, 2008, CLIN EXP METASTAS, V25, P89, DOI 10.1007/s10585-007-9106-6; Li P, 2011, WORLD J GASTROENTERO, V17, P4563, DOI 10.3748/wjg.v17.i41.4563; Liang SH, 2001, EUR J BIOCHEM, V268, P2779, DOI 10.1046/j.1432-1327.2001.02227.x; Hernandez-Bule ML, 2012, INT J ONCOL, V41, P1251, DOI 10.3892/ijo.2012.1569; Hernandez-Bule ML, 2010, INT J ONCOL, V37, P1399, DOI 10.3892/ijo_00000791; Malmlof M, 2007, J BIOL CHEM, V282, P2288, DOI 10.1074/jbc.M604953200; Moon SD, 2011, LUNG CANCER, V71, P338, DOI 10.1016/j.lungcan.2010.06.007; O'Brate A, 2003, DRUG RESIST UPDATE, V6, P313, DOI 10.1016/j.drup.2003.10.004; Ohguri T, 2012, LUNG CANCER, V77, P140, DOI 10.1016/j.lungcan.2012.02.018; Ohguri T, 2011, INT J HYPERTHER, V27, P20, DOI 10.3109/02656736.2010.500644; Ohguri T, 2009, INT J RADIAT ONCOL, V73, P128, DOI 10.1016/j.ijrobp.2008.03.059; Ren W, 2011, APOPTOSIS, V16, P382, DOI 10.1007/s10495-010-0572-y; San BH, 2013, INT J HYPERTHER, V29, P99, DOI 10.3109/02656736.2012.760137; Sheikh AQ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0548; STECK KD, 1995, CYTOMETRY, V20, P154, DOI 10.1002/cyto.990200208; SUZUKI K, 1994, HEPATOLOGY, V20, P1231; Takahashi K, 2004, J PHYS THER SCI, V11, P45, DOI [DOI 10.1589/JPTS.11.45, 10.1589/jpts.11.45]; Takahashi M, 1999, J HEPATOL, V31, P315, DOI 10.1016/S0168-8278(99)80230-X; Takehara T, 2001, HEPATOLOGY, V34, P55, DOI 10.1053/jhep.2001.25387; Tomek M, 2012, J PHARM PHARMACOL, V64, P1695, DOI 10.1111/j.2042-7158.2012.01526.x; Wang SY, 2004, J HEPATOL, V41, P267, DOI 10.1016/j.jhep.2004.04.013; Yao DF, 2007, HEPATOB PANCREAT DIS, V6, P241	48	20	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84636	10.1371/journal.pone.0084636	http://dx.doi.org/10.1371/journal.pone.0084636			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416255	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500143
J	Notebaert, L; Chrystal, J; Clarke, PJF; Holmes, EA; MacLeod, C				Notebaert, Lies; Chrystal, Jessica; Clarke, Patrick J. F.; Holmes, Emily A.; MacLeod, Colin			When We Should Worry More: Using Cognitive Bias Modification to Drive Adaptive Health Behaviour	PLOS ONE			English	Article							METAANALYSIS; STRESS; FEAR	A lack of behavioural engagement in health promotion or disease prevention is a problem across many health domains. In these cases where people face a genuine danger, a reduced focus on threat and low levels of anxiety or worry are maladaptive in terms of promoting protection or prevention behaviour. Therefore, it is possible that increasing the processing of threat will increase worry and thereby enhance engagement in adaptive behaviour. Laboratory studies have shown that cognitive bias modification (CBM) can increase or decrease anxiety and worry when increased versus decreased processing of threat is encouraged. In the current study, CBM for interpretation (CBM-I) is used to target engagement in sun protection behaviour. The goal was to investigate whether inducing a negative rather than a positive interpretation bias for physical threat information can enhance worry elicited when viewing a health campaign video (warning against melanoma skin cancer), and consequently lead to more adaptive behaviour (sun protection). Participants were successfully trained to either adopt a positive or negative interpretation bias using physical threat scenarios. However, contrary to expectations results showed that participants in the positive training condition reported higher levels of worry elicited by the melanoma video than participants in the negative training condition. Video elicited worry was, however, positively correlated with a measure of engagement in sun protection behaviour, suggesting that higher levels of worry do promote adaptive behaviour. These findings imply that more research is needed to determine under which conditions increased versus decreased processing of threat can drive adaptive worry. Various potential explanations for the current findings and suggestions for future research are discussed.	[Notebaert, Lies; Chrystal, Jessica; Clarke, Patrick J. F.; MacLeod, Colin] Univ Western Australia, Sch Psychol, Crawley, WA, Australia; [Holmes, Emily A.] Univ Cambridge, MRC Cognit & Brain Sci Unit, Cambridge, England	University of Western Australia; University of Cambridge	Notebaert, L (corresponding author), Univ Western Australia, Sch Psychol, Crawley, WA, Australia.	lies.notebaert@uwa.edu.au	Clarke, Patrick/H-8998-2014; Notebaert, Lies/H-5546-2014; Holmes, Emily/ABD-4367-2020	Clarke, Patrick/0000-0003-0303-4479; Notebaert, Lies/0000-0002-5849-4045; Holmes, Emily/0000-0001-7319-3112; MacLeod, Colin/0000-0003-2407-7339	Australian Bushfire Cooperative Research Centre; Wellcome Trust [WT088217]; Medical Research Council; Lupina Foundation; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre based at Oxford University Hospitals Trust Oxford University; Australian Research Council [DP0879589]; Romanian National Authority for Scientific Research, CNCS - UEFISCDI [PNII-ID-PCCE-2011-2-0045]; Medical Research Council [MC_UP_0901/1] Funding Source: researchfish; MRC [MC_UP_0901/1] Funding Source: UKRI	Australian Bushfire Cooperative Research Centre(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lupina Foundation; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre based at Oxford University Hospitals Trust Oxford University; Australian Research Council(Australian Research Council); Romanian National Authority for Scientific Research, CNCS - UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Lies Notebaert is supported by an Australian Bushfire Cooperative Research Centre grant on managing threat through the modification of thought. Emily A. Holmes is supported by a Wellcome Trust Clinical Fellowship (WT088217), The Medical Research Council, The Lupina Foundation, and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre based at Oxford University Hospitals Trust Oxford University. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. Colin MacLeod is supported in part by Australian Research Council Grant DP0879589, and by a grant from the Romanian National Authority for Scientific Research, CNCS - UEFISCDI, project number PNII-ID-PCCE-2011-2-0045. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S, 2006, ACAD EMERG MED, V13, P427, DOI [10.1111/j.1553-2712.2006.tb00321.x, 10.1197/j.aem.2005.11.003]; Barnes LLB, 2002, EDUC PSYCHOL MEAS, V62, P603, DOI 10.1177/0013164402062004005; Ciarocco NJ, 2010, J SOC CLIN PSYCHOL, V29, P1057, DOI 10.1521/jscp.2010.29.10.1057; Clarke PJF, 2013, COGNIT THER RES; Dandeneau SD, 2007, J PERS SOC PSYCHOL, V93, P651, DOI 10.1037/0022-3514.93.4.651; deRooij MJM, 1997, ACTA DERM-VENEREOL, V77, P467; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fazio R. H., 1990, REV PERSONALITY SOCI, V11, P74, DOI DOI 10.1037/031329; Hayes S, 2010, BEHAV RES THER, V48, P171, DOI 10.1016/j.brat.2009.10.006; Hirsch CR, 2009, J ABNORM PSYCHOL, V118, P44, DOI 10.1037/a0013473; Hoppitt L, 2010, BEHAV THER, V41, P73, DOI 10.1016/j.beth.2009.01.002; Lange WG, 2010, APPL COGNITIVE PSYCH, V24, P326, DOI 10.1002/acp.1679; Lucas R., 2006, SOLAR ULTRAVIOLET RA; Mackintosh B, 2013, J EXP PSYCHOPATHOL, V4, P133, DOI 10.5127/jep.025711; MacLeod C, 2002, J ABNORM PSYCHOL, V111, P107, DOI 10.1037//0021-843X.111.1.107; MacLeod C, 2013, HDB COGNITION EMOTIO, P540; MacLeod C, 2012, CURR OPIN PSYCHIATR, V25, P114, DOI 10.1097/YCO.0b013e32834fda4a; Mathews A, 2000, J ABNORM PSYCHOL, V109, P602, DOI 10.1037//0021-843X.109.4.602; McCaul KD, 1996, HEALTH PSYCHOL, V15, P423, DOI 10.1037/0278-6133.15.6.423; McCaul KD, 2003, BLACKW SER HLTH PSYC, P137; Mermelstein R, 1999, CANC RES THER CONTR, V8, P69; MIKULINCER M, 1996, LEA SER PER CLIN PSY, P191; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Pictet A, 2011, BEHAV RES THER, V49, P885, DOI 10.1016/j.brat.2011.10.003; Rivkin ID, 1999, PERS SOC PSYCHOL B, V25, P1451, DOI 10.1177/01461672992510002; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Stober J, 2001, PERS INDIV DIFFER, V31, P591, DOI 10.1016/S0191-8869(00)00163-X; Teachman BA, 2008, COGNITIVE THER RES, V32, P448, DOI 10.1007/s10608-006-9084-z; Tukey JW, 1977, EXPLORATORY DATA ANA; Verkuil B, 2007, BEHAV RES THER, V45, P1835, DOI 10.1016/j.brat.2007.02.004; Webb TL, 2006, PSYCHOL BULL, V132, P249, DOI 10.1037/0033-2909.132.2.249; Witte K, 2000, HEALTH EDUC BEHAV, V27, P591, DOI 10.1177/109019810002700506	32	9	10	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85092	10.1371/journal.pone.0085092	http://dx.doi.org/10.1371/journal.pone.0085092			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291WL	24416344	gold, Green Submitted, Green Published			2022-12-27	WOS:000329862500213
J	Sanz, G; Leray, I; Dewaele, A; Sobilo, J; Lerondel, S; Bouet, S; Grebert, D; Monnerie, R; Pajot-Augy, E; Mir, LM				Sanz, Guenhael; Leray, Isabelle; Dewaele, Aurelie; Sobilo, Julien; Lerondel, Stephanie; Bouet, Stephan; Grebert, Denise; Monnerie, Regine; Pajot-Augy, Edith; Mir, Lluis M.			Promotion of Cancer Cell Invasiveness and Metastasis Emergence Caused by Olfactory Receptor Stimulation	PLOS ONE			English	Article							HUMAN PROSTATE-CANCER; MAMMALIAN ODORANT RECEPTORS; NEUROENDOCRINE CARCINOMAS; ENTEROCHROMAFFIN CELLS; FUNCTIONAL EXPRESSION; SEROTONIN RELEASE; PROTEIN; MOUSE; MODEL; INVASION	Olfactory receptors (ORs) are expressed in the olfactory epithelium, where they detect odorants, but also in other tissues with additional functions. Some ORs are even overexpressed in tumor cells. In this study, we identified ORs expressed in enterochromaffin tumor cells by RT-PCR, showing that single cells can co-express several ORs. Some of the receptors identified were already reported in other tumors, but they are orphan (without known ligand), as it is the case for most of the hundreds of human ORs. Thus, genes coding for human ORs with known ligands were transfected into these cells, expressing functional heterologous ORs. The in vitro stimulation of these cells by the corresponding OR odorant agonists promoted cell invasion of collagen gels. Using LNCaP prostate cancer cells, the stimulation of the PSGR (Prostate Specific G protein-coupled Receptor), an endogenously overexpressed OR, by beta-ionone, its odorant agonist, resulted in the same phenotypic change. We also showed the involvement of a PI3 kinase gamma dependent signaling pathway in this promotion of tumor cell invasiveness triggered by OR stimulation. Finally, after subcutaneous inoculation of LNCaP cells into NSG immunodeficient mice, the in vivo stimulation of these cells by the PSGR agonist beta-ionone significantly enhanced metastasis emergence and spreading.	[Sanz, Guenhael; Dewaele, Aurelie; Grebert, Denise; Monnerie, Regine; Pajot-Augy, Edith] INRA, Neurobiol Olfact & Modelisat Imagerie UR1197, Jouy En Josas, France; [Sanz, Guenhael; Dewaele, Aurelie; Grebert, Denise; Monnerie, Regine; Pajot-Augy, Edith] IFR 144 NeuroSud Paris, Gif Sur Yvette, France; [Leray, Isabelle; Mir, Lluis M.] CNRS, Vectorol & Therapeut Anticancereuses UMR8203, Inst Gustave Roussy, Villejuif, France; [Leray, Isabelle; Mir, Lluis M.] Univ Paris 11, UMR8203, Orsay, France; [Sobilo, Julien; Lerondel, Stephanie] CNRS TAAM, UPS44, Ctr Imagerie Petit Anim, Orleans, France; [Bouet, Stephan] INRA, UMR 1313, Jouy En Josas, France; [Bouet, Stephan] CEA, DSV, IRCM, SREIT,Lab Radiobiol & Etud Genome, Jouy En Josas, France; [Bouet, Stephan] AgroParisTech, UMR 1313, Jouy En Josas, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UNICANCER; Gustave Roussy; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Sanz, G (corresponding author), INRA, Neurobiol Olfact & Modelisat Imagerie UR1197, Jouy En Josas, France.	Guenhael.Sanz@jouy.inra.fr; Luis.MIR@gustaveroussy.fr	MIR, Lluis M/AAJ-9110-2020		INRA; CNRS (The National Centre for Scientific Research (France)	INRA; CNRS (The National Centre for Scientific Research (France)	This work was supported by INRA and CNRS (The National Centre for Scientific Research (France). This research was conducted in the scope of the LEA EBAM (The European Associated Laboratory (LEA) entitled "Pulsed Electric Fields Applications in Biology and Medicine"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attoub S, 2008, ANN NY ACAD SCI, V1138, P204, DOI 10.1196/annals.1414.027; Braun T, 2007, GASTROENTEROLOGY, V132, P1890, DOI 10.1053/j.gastro.2007.02.036; Brunert D, 2010, CHEM SENSES, V35, P301, DOI 10.1093/chemse/bjq020; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Cui T, 2013, EUR J ENDOCRINOL, V168, P253, DOI 10.1530/EJE-12-0814; De Wever O, 2010, INT J DEV BIOL, V54, P887, DOI 10.1387/ijdb.092948ow; EVERS BM, 1994, ANN NY ACAD SCI, V733, P393, DOI 10.1111/j.1749-6632.1994.tb17289.x; Flegel C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055368; Fukuda N, 2006, GENES CELLS, V11, P71, DOI 10.1111/j.1365-2443.2005.00915.x; Gershon MD, 2004, ALIMENT PHARM THER, V20, P3, DOI 10.1111/j.1365-2036.2004.02180.x; Giandomenico V, 2013, J MOL ENDOCRINOL; Griffin CA, 2009, DEV CELL, V17, P649, DOI 10.1016/j.devcel.2009.09.004; Kidd M, 2008, AM J PHYSIOL-GASTR L, V295, pG260, DOI 10.1152/ajpgi.00056.2008; Leja J, 2009, MODERN PATHOL, V22, P261, DOI 10.1038/modpathol.2008.174; Lin Y, 2011, MOL PHARMACOL, V80, P551, DOI 10.1124/mol.111.073072; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Modlin IM, 2005, GASTROENTEROLOGY, V128, P1717, DOI 10.1053/j.gastro.2005.03.038; Muranen TA, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3015; Neuhaus EM, 2009, J BIOL CHEM, V284, P16218, DOI 10.1074/jbc.M109.012096; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Regnauld K, 2002, ONCOGENE, V21, P4020, DOI 10.1038/sj.onc.1205498; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Sanz G, 2005, CHEM SENSES, V30, P69, DOI 10.1093/chemse/bji002; Sanz G, 2008, CHEM SENSES, V33, P639, DOI 10.1093/chemse/bjn032; Sato N, 1997, CANCER RES, V57, P1584; Scatena CD, 2004, PROSTATE, V59, P292, DOI 10.1002/pros.20003; Spehr M, 2004, CURR BIOL, V14, pR832, DOI 10.1016/j.cub.2004.09.034; Thalmann GN, 2000, PROSTATE, V44, P91; Ukhanov K, 2011, J NEUROSCI, V31, P273, DOI 10.1523/JNEUROSCI.3698-10.2011; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; von Mentzer B, 2007, BIOCHEM PHARMACOL, V73, P805, DOI 10.1016/j.bcp.2006.11.019; Wei P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046887; Weng JS, 2005, INT J CANCER, V113, P811, DOI 10.1002/ijc.20635; Wetzel CH, 1999, J NEUROSCI, V19, P7426, DOI 10.1523/JNEUROSCI.19-17-07426.1999; Zhang XH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r86; Zhang X, 2012, CYTOSKELETON, V69, P810, DOI 10.1002/cm.21055; Zhang XM, 2004, P NATL ACAD SCI USA, V101, P14168, DOI 10.1073/pnas.0405350101; Zhuang HY, 2007, J BIOL CHEM, V282, P15284, DOI 10.1074/jbc.M700386200	41	77	78	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85110	10.1371/journal.pone.0085110	http://dx.doi.org/10.1371/journal.pone.0085110			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416348	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500217
J	Bowers, E; Scamurra, RW; Asrani, A; Beniguel, L; MaWhinney, S; Keays, KM; Thurn, JR; Janoff, EN				Bowers, Elisabeth; Scamurra, Ronald W.; Asrani, Anil; Beniguel, Lydie; MaWhinney, Samantha; Keays, Kathryne M.; Thurn, Joseph R.; Janoff, Edward N.			Decreased Mutation Frequencies among Immunoglobulin G Variable Region Genes during Viremic HIV-1 Infection	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; INDUCED CYTIDINE DEAMINASE; B-CELLS; SOMATIC HYPERMUTATION; CAPSULAR POLYSACCHARIDE; PNEUMOCOCCAL VACCINE; ANTIBODY-RESPONSE; LYMPHOID-TISSUE; DNA-REPAIR; IN-VIVO	Background/Objective: HIV-1 infection is complicated by high rates of opportunistic infections against which specific antibodies contribute to immune defense. Antibody function depends on somatic hypermutation (SHM) of variable regions of immunoglobulin heavy chain genes (V-H-D-J). We characterized the frequency of SHM in expressed IgG mRNA immunoglobulin transcripts from control and HIV-1-infected patients. Design: We compared utilization of genes in the most prominent V-H family (V(H)3) and mutation frequencies and patterns of cDNA from V(H)3-IgG genes from 10 seronegative control subjects and 21 patients with HIV-1 infection (6 without and 15 patients with detectable plasma viremia). Methods: Unique IgG V(H)3 family cDNA sequences (n = 1,565) were PCR amplified, cloned, and sequenced from blood. Sequences were analyzed using online (Vbase) and in-house immunoglobulin alignment resources. Results: Mutation frequencies in the antigen-binding hypervariable complementarity determining regions (CDR1/2) of IgG class-switched B cells were lower among viremic HIV-1-infected patients vs. controls for nucleotides (CDR1/2: 10+/-5% vs. 13.5+/-6%, p = 0.03) and amino acids (CDR: 20%+/-10 vs. 25%+/-12, p = 0.02) and in structural framework regions. Mutation patterns were similar among groups. The most common V(H)3 gene, V(H)3-23, was utilized less frequently among viremic HIV-1-infected patients (p = 0.03), and overall, mutation frequencies were decreased in nearly all V(H)3 genes compared with controls. Conclusions: B cells from HIV-1-infected patients show decreased mutation frequencies, especially in antigen-binding V(H)3 CDR genes, and selective defects in gene utilization. Similar mutation patterns suggest defects in the quantity, but not quality, of mutator activity. Lower levels of SHM in IgG class-switched B cells from HIV-1-infected patients may contribute to the increased risk of opportunistic infections and impaired humoral responses to preventative vaccines.	[Bowers, Elisabeth; MaWhinney, Samantha; Keays, Kathryne M.; Janoff, Edward N.] Univ Colorado Denver, Mucosal & Vaccine Res Program Colorado MAVRC, Aurora, CO 80045 USA; [Bowers, Elisabeth; Keays, Kathryne M.; Janoff, Edward N.] Univ Colorado Denver, Div Infect Dis, Aurora, CO USA; [Bowers, Elisabeth; Janoff, Edward N.] Univ Colorado Denver, Dept Microbiol, Aurora, CO USA; [MaWhinney, Samantha] Univ Colorado Denver, Colorado Sch Publ Hlth, Aurora, CO USA; [Bowers, Elisabeth; Janoff, Edward N.] Denver Vet Affairs Med Ctr, Denver, CO USA; [Scamurra, Ronald W.; Asrani, Anil; Thurn, Joseph R.] Univ Minnesota, Minneapolis VA Hlth Care Syst, Minneapolis, MN USA; [Beniguel, Lydie] Univ St Etienne, Fac Med, GIMAP EA 3064, Saint Etienne, France	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; Universite Jean Monnet	Janoff, EN (corresponding author), Univ Colorado Denver, Mucosal & Vaccine Res Program Colorado MAVRC, Aurora, CO 80045 USA.	Edward.Janoff@ucdenver.edu			Veterans Affairs Research Service; University of Colorado Denver Mucosal and Vaccine Research Program Colorado (MAVRC); Colorado Center for AIDS Research Grant [P30 AI054907]; University of Colorado Cancer Center [P30CA046934]; Conseil Regional Rhone-Alpes; National Institutes of Health (NIH) [F32DE005703-01, RO1A10495752-01]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI054907, R01AI108479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [F32DE005703] Funding Source: NIH RePORTER	Veterans Affairs Research Service(US Department of Veterans Affairs); University of Colorado Denver Mucosal and Vaccine Research Program Colorado (MAVRC); Colorado Center for AIDS Research Grant; University of Colorado Cancer Center; Conseil Regional Rhone-Alpes(Region Auvergne-Rhone-Alpes); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work has been supported by the Veterans Affairs Research Service and the University of Colorado Denver Mucosal and Vaccine Research Program Colorado (MAVRC) (ENJ) and facilitated by the infrastructure and resources provided by the Colorado Center for AIDS Research Grant (P30 AI054907), the University of Colorado Cancer Center Core Sequencing Facility (P30CA046934), a grant from "Conseil Regional Rhone-Alpes'' (Recontres Regionales de la Recherche) (LB) and National Institutes of Health (NIH) grants F32DE005703-01 and RO1A10495752-01 (RWS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi J, 1998, J INFECT DIS, V178, P707, DOI 10.1086/515369; ADDERSON EE, 1993, J CLIN INVEST, V91, P2734, DOI 10.1172/JCI116514; BALLET JJ, 1987, CLIN EXP IMMUNOL, V68, P479; Beale RCL, 2004, J MOL BIOL, V337, P585, DOI 10.1016/j.jmb.2004.01.046; BERBERIAN L, 1993, SCIENCE, V261, P1588, DOI 10.1126/science.7690497; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; Brezinschek HP, 1997, J CLIN INVEST, V99, P2488, DOI 10.1172/JCI119433; BRUNELL PA, 1995, J ACQ IMMUN DEF SYND, V10, P540, DOI 10.1097/00042560-199510050-00007; Cagigi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005427; Casali P, 2006, TRENDS IMMUNOL, V27, P313, DOI 10.1016/j.it.2006.05.001; Chong Y, 2003, CLIN EXP IMMUNOL, V133, P59, DOI 10.1046/j.1365-2249.2003.02185.x; EISENBERG D, 1984, ANNU REV BIOCHEM, V53, P595, DOI 10.1146/annurev.bi.53.070184.003115; Epeldegui M, 2007, AIDS, V21, P2265, DOI 10.1097/QAD.0b013e3282ef9f59; Epeldegui M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011448; Fogelman I, 2000, J INFECT DIS, V182, P435, DOI 10.1086/315739; French N, 1998, AIDS, V12, P1683, DOI 10.1097/00002030-199813000-00017; French N, 2000, LANCET, V355, P2106, DOI 10.1016/S0140-6736(00)02377-1; Haase AT, 1996, SCIENCE, V274, P985, DOI 10.1126/science.274.5289.985; He B, 2006, J IMMUNOL, V176, P3931, DOI 10.4049/jimmunol.176.7.3931; Janoff EN, 1997, J INFECT DIS, V175, P975, DOI 10.1086/514004; JANOFF EN, 1994, J INFECT DIS, V170, P299, DOI 10.1093/infdis/170.2.299; Jiang N, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004794; Kabat EA, 1991, SEQUENCES PROTEINS I; Karray S, 1998, J IMMUNOL, V161, P6681; Kolar GR, 2006, SCAND J IMMUNOL, V64, P314, DOI 10.1111/j.1365-3083.2006.01817.x; KRISTIANSEN SV, 1994, J IMMUNOL, V153, P2974; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803; Langlois MA, 2005, NUCLEIC ACIDS RES, V33, P1913, DOI 10.1093/nar/gki343; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Luo ZH, 2004, J ALLERGY CLIN IMMUN, V114, P726, DOI 10.1016/j.jaci.2004.07.049; Matsuda F, 1998, J EXP MED, V188, P2151, DOI 10.1084/jem.188.11.2151; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; MORTARI F, 1993, J IMMUNOL, V150, P1348; Muto T, 2006, P NATL ACAD SCI USA, V103, P2752, DOI 10.1073/pnas.0510970103; Nair N, 2009, J INFECT DIS, V200, P1031, DOI 10.1086/605648; Neuberger MS, 2005, NAT REV IMMUNOL, V5, P171, DOI 10.1038/nri1553; Obaro SK, 2004, LANCET INFECT DIS, V4, P510, DOI 10.1016/S1473-3099(04)01106-5; Owens GP, 2003, J IMMUNOL, V171, P2725, DOI 10.4049/jimmunol.171.5.2725; Pancharoen C, 2004, CURR HIV RES, V2, P293, DOI 10.2174/1570162043351084; Pham P, 2008, J BIOL CHEM, V283, P31754, DOI 10.1074/jbc.M805524200; PIROFSKI L, 1995, INFECT IMMUN, V63, P3005, DOI 10.1128/IAI.63.8.3005-3014.1995; Qiao XG, 2006, NAT IMMUNOL, V7, P302, DOI 10.1038/ni1302; Rivas P, 2007, AIDS REV, V9, P173; Rogosch T, 2012, J IMMUNOL, V189, P5449, DOI 10.4049/jimmunol.1103347; Santa-Marta M, 2007, MOL IMMUNOL, V44, P583, DOI 10.1016/j.molimm.2006.02.005; Scamurra RW, 2000, J IMMUNOL, V164, P5482, DOI 10.4049/jimmunol.164.10.5482; Seki M, 2005, EMBO REP, V6, P1143, DOI 10.1038/sj.embor.7400582; Souto-Carneiro MM, 2004, J IMMUNOL, V172, P6790, DOI 10.4049/jimmunol.172.11.6790; Spencer J, 2005, J IMMUNOL, V175, P5170, DOI 10.4049/jimmunol.175.8.5170; Subramaniam K, 2005, CLIN DIAGN LAB IMMUN, V12, P1168, DOI 10.1128/CDLI.12.10.1168-1176.2005; TERPSTRA FG, 1989, EUR J IMMUNOL, V19, P667, DOI 10.1002/eji.1830190415; Wu XP, 2003, J CLIN IMMUNOL, V23, P235, DOI 10.1023/A:1024571714867; Wu YCB, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00193	54	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e81913	10.1371/journal.pone.0081913	http://dx.doi.org/10.1371/journal.pone.0081913			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409278	gold, Green Published, Green Submitted			2022-12-27	WOS:000329463500002
J	Little, FF; Delgado, DM; Wexler, PJ; Oppenheim, FG; Mitchell, P; Feldman, JA; Walt, DR; Peng, RD; Matsui, EC				Little, Frederic F.; Delgado, Diana M.; Wexler, Philip J.; Oppenheim, Frank G.; Mitchell, Patricia; Feldman, James A.; Walt, David R.; Peng, Roger D.; Matsui, Elizabeth C.			Salivary Inflammatory Mediator Profiling and Correlation to Clinical Disease Markers in Asthma	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; EOSINOPHIL CATIONIC PROTEIN; EXHALED NITRIC-OXIDE; NASAL LAVAGE; BIOMARKERS; URINE; CYTOKINES; HEALTHY; SPUTUM; IP-10	Rationale: There is a need for a readily available, non-invasive source of biomarkers that predict poor asthma control. Objectives: We sought to determine if there is an association between the salivary inflammatory profile and disease control in children and adults with asthma. Methods: In this cross-sectional study, we collected demographic and clinical information from two independent populations at different sites, resulting in convenience samples of 58 pediatric and 122 adult urban asthmatics. Control was assessed by symptom questionnaire (children) and by Asthma Control Questionnaire and current exacerbation (adults). Saliva was collected in all subjects. We applied principal component analysis to a 10-plex panel of relevant inflammatory markers to characterize marker profiles and determined if profiles were associated with asthma control. Results: There were similar, strong correlations amongst biologically related markers in both populations: eosinophil-related: eotaxin-1/CCL11, RANTES/CCL5, and IL-5 (p<.001); myeloid/innate: IL-1 beta, IL-6, MCP-1/CCL2, and IL-8/CXCL8 (p,. 001). The first three principal components captured >= 74% of variability across all ten analytes in both populations. In adults, the Principal Component 1 score, broadly reflective of all markers, but with greater weight given to myeloid/innate markers, was associated with Asthma Control Questionnaire score and exacerbation. The Principal Component 3 score, reflective of IP-10/CXCL10, was associated with current exacerbation. In children, the Principal Component 1, 2, and 3 scores were associated with recent asthma symptoms. The Principal Component 2 score, reflective of higher eosinophil markers, was inversely correlated with symptoms. The Principal Component 3 score was positively associated with all symptom outcomes. Conclusion: The salivary inflammatory profile is associated with disease control in children and adults with asthma.	[Little, Frederic F.; Delgado, Diana M.; Wexler, Philip J.] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA; [Oppenheim, Frank G.] Boston Univ, Goldman Sch Dent Med, Dept Periodontol & Oral Biol, Boston, MA 02215 USA; [Mitchell, Patricia; Feldman, James A.] Boston Univ, Sch Med, Dept Emergency Med, Boston, MA 02118 USA; [Walt, David R.] Tufts Univ, Dept Chem, Medford, MA USA; [Peng, Roger D.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Matsui, Elizabeth C.] Johns Hopkins Univ, Sch Med, Div Pediat Allergy & Immunol, Baltimore, MD USA	Boston University; Boston University; Boston University; Tufts University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Little, FF (corresponding author), Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA.	flittle@bu.edu		Matsui, Elizabeth/0000-0001-8134-5593; Feldman, James/0000-0003-3962-0189	NIH [U01-DE017788, U01-AI083238, P50-ES015903, P01-ES018176, R01-AI070630, M01-RR00052, R01-DE005672, EPA R832139]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI083238, R01AI070630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE005672, U01DE017788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES018176, P50ES015903] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding was provided by NIH U01-DE017788, NIH U01-AI083238, NIH P50-ES015903, NIH P01-ES018176, NIH R01-AI070630, NIH M01-RR00052, NIH R01-DE005672, and EPA R832139 (Environmental Protection Agency). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beirne P, 2009, EUR RESPIR J, V34, P1376, DOI 10.1183/09031936.00028209; Beydon N, 2007, AM J RESP CRIT CARE, V175, P1304, DOI 10.1164/rccm.200605-642ST; Bhandari V, 2006, P NATL ACAD SCI USA, V103, P11021, DOI 10.1073/pnas.0601057103; Blicharz TM, 2009, ANAL CHEM, V81, P2106, DOI 10.1021/ac802181j; Cannas A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-333; Centers for Disease Control and Prevention, 2011, MMWR-MORBID MORTAL W, V60, P547; Chapoval SP, 2009, CLIN IMMUNOL, V132, P371, DOI 10.1016/j.clim.2009.05.016; Chen YC, 2011, DIS MARKERS, V31, P101, DOI [10.3233/DMA-2011-0808, 10.1155/2011/938794]; Costa C, 2008, CHEST, V133, P26, DOI 10.1378/chest.07-0393; Cox AJ, 2008, EUR J APPL PHYSIOL, V103, P477, DOI 10.1007/s00421-008-0722-x; Dweik RA, 2011, AM J RESP CRIT CARE, V184, P602, DOI 10.1164/rccm.9120-11ST; Fleming HE, 1999, AM J RESP CRIT CARE, V160, P100, DOI 10.1164/ajrccm.160.1.9808074; Fonseca FJ, 2012, CLIN ORAL IMPLANTS R, V10; Jackson DJ, 2009, J ALLERGY CLIN IMMUN, V124, P949, DOI 10.1016/j.jaci.2009.07.024; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; Kamat A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030881; Kaushik R, 2011, J PERIODONTOL, V82, P1353, DOI 10.1902/jop.2011.100472; Kinney JS, 2011, J DENT RES, V90, P752, DOI 10.1177/0022034511399908; Lee A, 2012, J PERIODONTOL, V83, P79, DOI 10.1902/jop.2011.110060; Lee CG, 2004, NAT MED, V10, P1095, DOI 10.1038/nm1105; Lonnkvist K, 2004, PEDIAT ALLERG IMM-UK, V15, P351, DOI 10.1111/j.1399-3038.2004.00165.x; Mvula M, 2005, J ASTHMA, V42, P9, DOI 10.1081/JAS-200044746; Nagata K, 2012, INVEST OPHTH VIS SCI, V53, P3827, DOI 10.1167/iovs.11-9244; Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Ono Emiko, 2011, Allergology International, V60, P37, DOI 10.2332/allergolint.09-OA-0166; Pammer J, 1998, J PATHOL, V186, P186; Rathnayake N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061356; Rathnayake N, 2013, J CLIN PERIODONTOL, V40, P140, DOI 10.1111/jcpe.12038; Saude EJ, 2011, J ALLERGY CLIN IMMUN, V127, P757, DOI 10.1016/j.jaci.2010.12.1077; Schmekel B, 2001, RESP MED, V95, P670, DOI 10.1053/rmed.2001.1123; Szefler S, 2008, LANCET, V372, P1065, DOI 10.1016/S0140-6736(08)61448-8; Verrills NM, 2011, AM J RESP CRIT CARE, V183, P1633, DOI 10.1164/rccm.201010-1623OC; Wojnarowski C, 1999, CLIN EXP ALLERGY, V29, P926; Yao CJ, 2005, IMMUNOLOGY, V116, P213, DOI 10.1111/j.1365-2567.2005.02212.x; Yeh Chih-Ko, 2010, Tex Dent J, V127, P651	36	25	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84449	10.1371/journal.pone.0084449	http://dx.doi.org/10.1371/journal.pone.0084449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409298	Green Published, Green Submitted, gold			2022-12-27	WOS:000329463500022
J	Riera, M; Marquez, E; Clotet, S; Gimeno, J; Roca-Ho, H; Lloreta, J; Juanpere, N; Batlle, D; Pascual, J; Soler, MJ				Riera, Marta; Marquez, Eva; Clotet, Sergi; Gimeno, Javier; Roca-Ho, Heleia; Lloreta, Josep; Juanpere, Nuria; Batlle, Daniel; Pascual, Julio; Soler, Maria Jose			Effect of Insulin on ACE2 Activity and Kidney Function in the Non-Obese Diabetic Mouse	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME-2; GLOMERULAR-FILTRATION-RATE; NOD MICE; RENAL-DISEASE; BLOOD-PRESSURE; NEPHROPATHY; EXPRESSION; PODOCYTE; RAT; HYPERTROPHY	We studied the non-obese diabetic (NOD) mice model because it develops autoimmune diabetes that resembles human type 1 diabetes. In diabetic mice, urinary albumin excretion (UAE) was ten-fold increased at an "early stage" of diabetes, and twenty-fold increased at a "later stage" (21 and 40 days, respectively after diabetes diagnosis) as compared to non-obese resistant controls. In NOD Diabetic mice, glomerular enlargement, increased glomerular filtration rate (GFR) and increased blood pressure were observed in the early stage. In the late stage, NOD Diabetic mice developed mesangial expansion and reduced podocyte number. Circulating and urine ACE2 activity were markedly increased both, early and late in Diabetic mice. Insulin administration prevented albuminuria, markedly reduced GFR, blood pressure, and glomerular enlargement in the early stage; and prevented mesangial expansion and the reduced podocyte number in the late stage of diabetes. The increase in serum and urine ACE2 activity was normalized by insulin administration at the early and late stages of diabetes in Diabetic mice. We conclude that the Diabetic mice develops features of early kidney disease, including albuminuria and a marked increase in GFR. ACE2 activity is increased starting at an early stage in both serum and urine. Moreover, these alterations can be completely prevented by the chronic administration of insulin.	[Riera, Marta; Marquez, Eva; Clotet, Sergi; Pascual, Julio; Soler, Maria Jose] Hosp Mar, IMIM, Dept Nephrol, Barcelona, Spain; [Gimeno, Javier; Roca-Ho, Heleia; Lloreta, Josep; Juanpere, Nuria] Hosp Mar, IMIM, Dept Pathol, Barcelona, Spain; [Batlle, Daniel] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Nephrol & Hypertens, Chicago, IL 60611 USA	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Northwestern University; Feinberg School of Medicine	Soler, MJ (corresponding author), Hosp Mar, IMIM, Dept Nephrol, Barcelona, Spain.	92844@parcdesalutmar.cat	Lloreta-Trull, Josep/AAZ-1229-2020; Soler, Maria Jose/ABC-4410-2021; Lloreta-Trull, Josep/GRR-9682-2022; Riera, Marta/V-5016-2017; Lloreta, J/I-2112-2014; Soler, Maria José/AAP-4454-2020; Roca Ho, Heleia/M-9280-2017	Riera, Marta/0000-0003-4362-7965; Lloreta, J/0000-0003-1644-9470; Soler, Maria José/0000-0003-3621-0766; , Eva/0000-0001-8604-7878; Roca Ho, Heleia/0000-0001-7324-5234	Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation [ISCIII-FEDER. PI081688]; Fundacion Senefro;  [ISCIII-FEDER PI10/01370]	Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Senefro; 	This work was supported by grants from the Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation (ISCIII-FEDER. PI081688), and Fundacion Senefro. J.P. is funded in part through the project ISCIII-FEDER PI10/01370. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARON AD, 1993, HYPERTENSION, V21, P129, DOI 10.1161/01.HYP.21.2.129; Batlle D, 2008, CURR OPIN NEPHROL HY, V17, P250, DOI 10.1097/MNH.0b013e3282f945c2; Batlle D, 2012, KIDNEY INT, V81, P520, DOI 10.1038/ki.2011.381; Batlle D, 2010, DIABETES, V59, P2994, DOI 10.2337/db10-1205; Breyer MD, 2005, J AM SOC NEPHROL, V16, P27, DOI [10.1681/ASN.2009070721, 10.1681/ASN.2004080648]; Colucci JA, 2011, J RENIN-ANGIO-ALDO S, V12, P15, DOI 10.1177/1470320310375456; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; de Boer IH, 2011, NEW ENGL J MED, V365, P2366, DOI 10.1056/NEJMoa1111732; Deb DK, 2010, KIDNEY INT, V77, P1000, DOI 10.1038/ki.2010.22; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Drapeau N, 2013, AM J PHYSIOL-ENDOC M, V304, pE1188, DOI 10.1152/ajpendo.00560.2012; Eid AA, 2009, DIABETES, V58, P1201, DOI 10.2337/db08-1536; Epelman S, 2008, J AM COLL CARDIOL, V52, P750, DOI 10.1016/j.jacc.2008.02.088; Gurley SB, 2006, AM J PHYSIOL-RENAL, V290, pF214, DOI 10.1152/ajprenal.00204.2005; Hale LJ, 2013, AM J PHYSIOL-RENAL, V305, pF182, DOI 10.1152/ajprenal.00548.2012; He CJ, 2000, KIDNEY INT, V58, P1931, DOI 10.1046/j.1523-1755.2000.00365.x; HIROSE K, 1982, KIDNEY INT, V21, P689, DOI 10.1038/ki.1982.82; JENSEN EB, 1979, J MICROSC-OXFORD, V115, P19, DOI 10.1111/j.1365-2818.1979.tb00149.x; Soler MJ, 2012, EXP DIABETES RES, DOI 10.1155/2012/616313; Kim YH, 2001, KIDNEY INT, V60, P957, DOI 10.1046/j.1523-1755.2001.060003957.x; Lurbe E, 2002, NEW ENGL J MED, V347, P797, DOI 10.1056/NEJMoa013410; MacLeod JM, 1997, KIDNEY INT, V51, P1624, DOI 10.1038/ki.1997.224; MOGENSEN CE, 1973, DIABETES, V22, P706, DOI 10.2337/diab.22.9.706; PETERSEN J, 1988, DIABETES, V37, P1346, DOI 10.2337/diabetes.37.10.1346; PORCELLATI F, 1993, DIABETES, V42, P1055, DOI 10.2337/diabetes.42.7.1055; Qi ZH, 2004, AM J PHYSIOL-RENAL, V286, pF590, DOI 10.1152/ajprenal.00324.2003; Raij L, 2003, AM J HYPERTENS, V16, p46S, DOI 10.1016/S0895-7061(03)01068-9; Rosmalen JGM, 2001, LAB INVEST, V81, P231, DOI 10.1038/labinvest.3780231; Santos RAS, 2000, REGUL PEPTIDES, V91, P45, DOI 10.1016/S0167-0115(00)00138-5; Schmetterer L, 1997, DIABETES, V46, P1868, DOI 10.2337/diabetes.46.11.1868; Siu Brian, 2006, BMC Nephrol, V7, P6, DOI 10.1186/1471-2369-7-6; Soler MJ, 2007, KIDNEY INT, V72, P614, DOI 10.1038/sj.ki.5002373; Soler MJ, 2008, MED CLIN-BARCELONA, V131, P230; Soler MJ, 2008, EXP PHYSIOL, V93, P549, DOI 10.1113/expphysiol.2007.041350; Soro-Paavonen A, 2012, J HYPERTENS, V30, P375, DOI 10.1097/HJH.0b013e32834f04b6; STACKHOUSE S, 1990, DIABETES, V39, P989, DOI 10.2337/diabetes.39.8.989; Sturgeon C, 1998, J APPL PHYSIOL, V84, P2154, DOI 10.1152/jappl.1998.84.6.2154; Tikellis C, 2008, DIABETES, V57, P1018, DOI 10.2337/db07-1212; TUTTLE KR, 1991, NEW ENGL J MED, V324, P1626, DOI 10.1056/NEJM199106063242304; Vickers C, 2002, J BIOL CHEM, V277, P14838, DOI 10.1074/jbc.M200581200; WICKER LS, 1992, J EXP MED, V176, P67, DOI 10.1084/jem.176.1.67; Wiggins JE, 2005, J AM SOC NEPHROL, V16, P2953, DOI 10.1681/ASN.2005050488; Wong DW, 2007, AM J PATHOL, V171, P438, DOI 10.2353/ajpath.2007.060977; Wysocki J, 2006, DIABETES, V55, P2132, DOI 10.2337/db06-0033; Xiao XY, 2009, J AUTOIMMUN, V32, P85, DOI 10.1016/j.jaut.2008.12.003; Yamaleyeva LM, 2012, AM J PHYSL RENAL PHY; Ye MH, 2004, HYPERTENSION, V43, P1120, DOI 10.1161/01.HYP.0000126192.27644.76; Ye MH, 2006, J AM SOC NEPHROL, V17, P3067, DOI 10.1681/ASN.2006050423; ZATZ R, 1985, P NATL ACAD SCI USA, V82, P5963, DOI 10.1073/pnas.82.17.5963; Zimpelmann J, 2000, KIDNEY INT, V58, P2320, DOI 10.1046/j.1523-1755.2000.00416.x; Ziyadeh FN, 2004, J AM SOC NEPHROL, V15, pS55, DOI 10.1097/01.ASN.0000093460.24823.5B	51	37	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84683	10.1371/journal.pone.0084683	http://dx.doi.org/10.1371/journal.pone.0084683			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400109	Green Published, gold, Green Submitted			2022-12-27	WOS:000329462700043
J	Norrie, IC; Ohlsson, E; Nielsen, O; Hasemann, MS; Porse, BT				Norrie, Ida Christine; Ohlsson, Ewa; Nielsen, Olaf; Hasemann, Marie Sigurd; Porse, Bo T.			C/EBP alpha Is Dispensable for the Ontogeny of PD-1+CD4+Memory T Cells but Restricts Their Expansion in an Age-Dependent Manner	PLOS ONE			English	Article							BINDING-PROTEIN ALPHA; PERIPHERAL-BLOOD; IMMUNE-RESPONSES; GENE-EXPRESSION; IN-VIVO; B-CELLS; PROLIFERATION; CANCER; GROWTH; MICE	Ageing and cancer is often associated with altered T cell distributions and this phenomenon has been suggested to be the main driver in the development of immunosenescence. Memory phenotype PD-1+ CD4+ T cells accumulate with age and during leukemic development, and they might account for the attenuated T cell response in elderly or diseased individuals. The transcription factor C/EBP alpha has been suggested to be responsible for the accumulation as well as for the senescent features of these cells including impaired TCR signaling and decreased proliferation. Thus modulating the activity of C/EBP alpha could potentially target PD-1+ CD4+ T cells and consequently, impede the development of immunosenescence. To exploit this possibility we tested the importance of C/EBP alpha for the development of age-dependent PD-1+ CD4+ T cells as well as its role in the accumulation of PD-1+ CD4+ T cells during leukemic progression. In contrast to earlier suggestions, we find that loss of C/EBP alpha expression in the lymphoid compartment led to an increase of PD-1+ CD4+ T cells specifically in old mice, suggesting that C/EBP alpha repress the accumulation of these cells in elderly by inhibiting their proliferation. Furthermore, C/EBP alpha-deficiency in the lymphoid compartment had no effect on leukemic development and did not affect the accumulation of PD-1+ CD4+ T cells. Thus, in addition to contradict earlier suggestions of a role for C/EBP alpha in immunosenescence, these findings efficiently discard the potential of using C/EBP alpha as a target for the alleviation of ageing/cancer-associated immunosenescence.	[Norrie, Ida Christine; Ohlsson, Ewa; Hasemann, Marie Sigurd; Porse, Bo T.] Univ Copenhagen, Rigshosp, Fac Hlth Sci, Finsen Lab, DK-2100 Copenhagen, Denmark; [Norrie, Ida Christine; Ohlsson, Ewa; Hasemann, Marie Sigurd; Porse, Bo T.] Univ Copenhagen, BRIC, Copenhagen, Denmark; [Norrie, Ida Christine; Ohlsson, Ewa; Hasemann, Marie Sigurd; Porse, Bo T.] Univ Copenhagen, Fac Hlth Sci, Danish Stem Cell Ctr DanStem, Copenhagen, Denmark; [Norrie, Ida Christine; Nielsen, Olaf] Univ Copenhagen, Inst Biol, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen	Porse, BT (corresponding author), Univ Copenhagen, Rigshosp, Fac Hlth Sci, Finsen Lab, DK-2100 Copenhagen, Denmark.	bo.porse@finsenlab.dk	Nielsen, Olaf/G-4980-2012	Nielsen, Olaf/0000-0001-7440-5201; Porse, Bo/0000-0001-6043-0844	NovoNordisk Foundation - The Novo Nordisk Foundation Section for Stem Cell Biology in Human Disease; Lundbeck Foundation [R108-2012-10312] Funding Source: researchfish	NovoNordisk Foundation - The Novo Nordisk Foundation Section for Stem Cell Biology in Human Disease; Lundbeck Foundation(Lundbeckfonden)	This study was supported through a center grant from the NovoNordisk Foundation - The Novo Nordisk Foundation Section for Stem Cell Biology in Human Disease. Foundation website: http://www.novonordiskfonden.dk; no grant number is available. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagger FO, 2012, NUCL ACIDS RES; Bagger FO, 2012, BLOOD, V119, P6394, DOI 10.1182/blood-2012-05-427310; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Channappanavar R, 2009, MECH AGEING DEV, V130, P709, DOI 10.1016/j.mad.2009.08.006; Che KF, 2012, MOL MED, V18, P1169, DOI 10.2119/molmed.2012.00103; Chen WH, 2009, TRENDS IMMUNOL, V30, P351, DOI 10.1016/j.it.2009.05.002; Chiu BC, 2007, MECH AGEING DEV, V128, P618, DOI 10.1016/j.mad.2007.09.002; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Di Tullio A, 2011, P NATL ACAD SCI USA, V108, P17016, DOI 10.1073/pnas.1112169108; Figueroa ME, 2009, BLOOD, V113, P2795, DOI 10.1182/blood-2008-08-172387; Freeman GJ, 2006, J EXP MED, V203, P2223, DOI 10.1084/jem.20061800; Gorgun G, 2005, J CLIN INVEST, V115, P1797, DOI 10.1172/JCI24176; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hasemann MS, 2013, PLOS GENETI IN PRESS; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Johnson PF, 2005, J CELL SCI, V118, P2545, DOI 10.1242/jcs.02459; Kovaiou RD, 2005, INT IMMUNOL, V17, P1359, DOI 10.1093/intimm/dxh314; Lages CS, 2010, AGING CELL, V9, P785, DOI 10.1111/j.1474-9726.2010.00611.x; Laiosa CV, 2006, IMMUNITY, V25, P731, DOI 10.1016/j.immuni.2006.09.011; Lee YH, 1997, MOL CELL BIOL, V17, P6014, DOI 10.1128/MCB.17.10.6014; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; Lustgarten J, 2004, J IMMUNOL, V173, P4510, DOI 10.4049/jimmunol.173.7.4510; Myers CE, 2011, AGING DIS, V2, P512; Nishioka T, 2006, J IMMUNOL, V176, P6586, DOI 10.4049/jimmunol.176.11.6586; Onizuka S, 1999, CANCER RES, V59, P3128; Porse BT, 2006, MOL CELL BIOL, V26, P1028, DOI 10.1128/MCB.26.3.1028-1037.2006; Porse BT, 2005, J EXP MED, V202, P85, DOI 10.1084/jem.20050067; Porse BT, 2001, CELL, V107, P247, DOI 10.1016/S0092-8674(01)00516-5; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Schuster MB, 2006, BBA-REV CANCER, V1766, P88, DOI 10.1016/j.bbcan.2006.02.003; Shankar EM, 2011, MOL MED, V17, P229, DOI 10.2119/molmed.2010.00175; Sharma S, 2006, J IMMUNOL, V177, P8348, DOI 10.4049/jimmunol.177.12.8348; Shimada Y, 2009, EXP GERONTOL, V44, P517, DOI 10.1016/j.exger.2009.05.003; Shimatani K, 2009, P NATL ACAD SCI USA, V106, P15807, DOI 10.1073/pnas.0908805106; Shimizu J, 1999, J IMMUNOL, V163, P5211; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Street SEA, 2001, BLOOD, V97, P192, DOI 10.1182/blood.V97.1.192; Timchenko NA, 1996, GENE DEV, V10, P804, DOI 10.1101/gad.10.7.804; Timchenko NA, 1997, MOL CELL BIOL, V17, P7353, DOI 10.1128/MCB.17.12.7353; vandenBroek MF, 1996, J EXP MED, V184, P1781, DOI 10.1084/jem.184.5.1781; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wang HM, 2002, EMBO J, V21, P930, DOI 10.1093/emboj/21.5.930; Wang HM, 2001, MOL CELL, V8, P817, DOI 10.1016/S1097-2765(01)00366-5; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Wolf AM, 2003, CLIN CANCER RES, V9, P606; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569	51	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84728	10.1371/journal.pone.0084728	http://dx.doi.org/10.1371/journal.pone.0084728			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404186	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460800065
J	Suhandono, S; Apriyanto, A; Ihsani, N				Suhandono, Sony; Apriyanto, Ardha; Ihsani, Nisa			Isolation and Characterization of Three Cassava Elongation Factor 1 Alpha (MeEF1A) Promoters	PLOS ONE			English	Article							INTERSTITIAL TELOMERE MOTIFS; INTRON-MEDIATED ENHANCEMENT; CIS-ACTING ELEMENTS; PRE-MESSENGER-RNA; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; MOLECULAR-CLONING; FACTOR EF-1-ALPHA; PROTEIN; FACTOR-1-ALPHA	In plant genetic engineering, the identification of gene promoters leading to particular expression patterns is crucial for the development of new genetically modified plant generations. This research was conducted in order to isolate and characterize several new promoters from cassava (Manihot esculenta Crantz) elongation factor 1 alpha (EF1A) gene family. Three promoters MeEF1A3, MeEF1A4 and MeEF1A5 were successfully isolated. Sequence analyses showed that all of the promoters contain three conserved putative cis-acting elements which are located upstream of the transcription start site. These elements are included a TEF1, a TELO and TATA boxes. In addition, all of the promoters also have the 5'UTR intron but with a different lengths. These promoters were constructed translationally with gusA reporter gene (promoter:: gusA fusion) in pBI-121 binary vector to build a new binary vector using Overlap Extension PCR Cloning (OEPC) technique. Transient expression assay that was done by using agroinfiltration method was used to show functionality of these promoters. Qualitative and quantitative analysis from GUS assay showed that these promoters were functional and conferred a specific activity in tobacco seedlings (Nicotiana tabacum), tomato fruits (Solanum lycopersicum) and banana fruits (Musa acuminata). We hypothesized that MeEF1A6 could be categorized as a constitutive promoter because it was able to drive the gene expression in all transformed tissue described in here and also comparable to CaMV35S. On the other hand, MeEF1A3 drove specific expression in the aerial parts of seedlings such as hypocotyl and cotyledon thus MeEF1A5 drove specific expression in fruit tissue. The results obtained from transient analysis showed that these promoters had a distinct activity although they came from same gene family. The DNA sequences identified here are new promoters potentially use for genetic engineering in cassava or other plants.	[Suhandono, Sony; Apriyanto, Ardha; Ihsani, Nisa] Inst Teknol Bandung, Sch Life Sci & Technol, Bandung, Jawa Barat, Indonesia	Institute Technology of Bandung	Apriyanto, A (corresponding author), Inst Teknol Bandung, Sch Life Sci & Technol, Bandung, Jawa Barat, Indonesia.	ardha-s2@sith.itb.ac.id	Apriyanto, Ardha/ABC-6407-2021	Apriyanto, Ardha/0000-0001-9032-2983; Suhandono, Sony/0000-0002-2248-3520; Ihsani, Nisa/0000-0002-4595-0806	Hibah Kompetensi, Directorate General of Higher Education, Department of Education, Indonesia	Hibah Kompetensi, Directorate General of Higher Education, Department of Education, Indonesia	This research was partly funded by Hibah Kompetensi 2009-2010, Directorate General of Higher Education, Department of Education, Indonesia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILAR F, 1991, PLANT MOL BIOL, V17, P351, DOI 10.1007/BF00040630; Andersen GR, 2003, TRENDS BIOCHEM SCI, V28, P434, DOI 10.1016/S0968-0004(03)00162-2; AXELOS M, 1989, MOL GEN GENET, V219, P106, DOI 10.1007/BF00261164; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Berberich T, 1995, PLANT MOL BIOL, V29, P611, DOI 10.1007/BF00020988; Bouzaidi-Tiali N, 2007, EMBO J, V26, P4302, DOI 10.1038/sj.emboj.7601857; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Browning KS, 1996, PLANT MOL BIOL, V32, P107, DOI 10.1007/BF00039380; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; Bukovnik U, 2009, FUNCT PLANT BIOL, V36, P234, DOI 10.1071/FP08266; Bull SE, 2009, NAT PROTOC, V4, P1845, DOI 10.1038/nprot.2009.208; Carneiro NP, 1999, PLANT MOL BIOL, V41, P801, DOI 10.1023/A:1006391207980; Ceballos H, 2010, HANDB PLANT BREED; CHEN H, 1994, BIOTECHNIQUES, V16, P664; Chen PY, 2003, MOL BREEDING, V11, P287, DOI 10.1023/A:1023475710642; CURIE C, 1993, MOL GEN GENET, V238, P428, DOI 10.1007/BF00292002; CURIE C, 1991, NUCLEIC ACIDS RES, V19, P1305, DOI 10.1093/nar/19.6.1305; Doyle J. J., 1987, PHYTOCHEM B, P11; Drummond AJ, 2009, GENEIOUS; DURSO NA, 1994, PLANT CELL, V6, P893, DOI 10.1105/tpc.6.6.893; Ejiri S, 2002, BIOSCI BIOTECH BIOCH, V66, P1, DOI 10.1271/bbb.66.1; Gallia GL, 2000, NUCLEIC ACIDS RES, V28, P3197, DOI 10.1093/nar/28.17.3197; Gallie DR, 1998, BIOCHEM BIOPH RES CO, V245, P295, DOI 10.1006/bbrc.1998.8427; Gaspin C, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-283; GONEN H, 1994, P NATL ACAD SCI USA, V91, P7648, DOI 10.1073/pnas.91.16.7648; GOODALL GJ, 1991, EMBO J, V10, P2635, DOI 10.1002/j.1460-2075.1991.tb07806.x; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; Higo K, 1999, PLANT CIS ACTING REG; Hotokezaka Y, 2002, J BIOL CHEM, V277, P18545, DOI 10.1074/jbc.M201022200; Jefferson R A, 1987, EMBO J, V6, P3901; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; KAUR KJ, 1994, J BIOL CHEM, V269, P23045; KAWAHARA R, 1992, EUR J BIOCHEM, V209, P157, DOI 10.1111/j.1432-1033.1992.tb17272.x; Khacho M, 2008, MOL BIOL CELL, V19, P5296, DOI 10.1091/mbc.E08-06-0562; Kidou S, 1998, PLANT MOL BIOL, V36, P137, DOI 10.1023/A:1005960721762; Koehorst-van Putten HJJ, 2012, PLANTA, V236, P1955, DOI 10.1007/s00425-012-1796-6; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Li ZY, 1999, ACTA BOT SIN, V41, P800; Liu J, 2011, J INTEGR PLANT BIOL, V53, P552, DOI 10.1111/j.1744-7909.2011.01048.x; MAHE A, 1992, MOL PLANT MICROBE IN, V5, P242, DOI 10.1094/MPMI-5-242; Manevski A, 2000, FEBS LETT, V483, P43, DOI 10.1016/S0014-5793(00)02056-1; Manevski A, 1999, MOL GEN GENET, V261, P892, DOI 10.1007/s004380051036; MERRICK WC, 1992, MICROBIOL REV, V56, P291, DOI 10.1128/MMBR.56.2.291-315.1992; MORELLI JK, 1994, PLANT PHYSIOL, V106, P897, DOI 10.1104/pp.106.3.897; MOTORIN YA, 1988, FEBS LETT, V238, P262, DOI 10.1016/0014-5793(88)80492-7; Panasyuk G, 2008, INT J BIOCHEM CELL B, V40, P63, DOI 10.1016/j.biocel.2007.08.014; Parra G, 2011, NUCLEIC ACIDS RES, V39, P5328, DOI 10.1093/nar/gkr043; Peremarti A, 2010, PLANT MOL BIOL, V73, P363, DOI 10.1007/s11103-010-9628-1; POKALSKY AR, 1989, NUCLEIC ACIDS RES, V17, P4661, DOI 10.1093/nar/17.12.4661; Prochnik S, 2012, TROP PLANT BIOL, V5, P88, DOI 10.1007/s12042-011-9088-z; Ransom-Hodgkins WD, 2009, MOL GENET GENOMICS, V281, P391, DOI 10.1007/s00438-008-0418-2; REGAD F, 1995, MOL GEN GENET, V248, P703, DOI 10.1007/BF02191710; Rose AB, 2000, PLANT PHYSIOL, V122, P535, DOI 10.1104/pp.122.2.535; Rose AB, 2008, PLANT CELL, V20, P543, DOI 10.1105/tpc.107.057190; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sayre R, 2011, ANNU REV PLANT BIOL, V62, P251, DOI 10.1146/annurev-arplant-042110-103751; Shamovsky I, 2006, NATURE, V440, P556, DOI 10.1038/nature04518; SHEWMAKER CK, 1990, NUCLEIC ACIDS RES, V18, P4276, DOI 10.1093/nar/18.14.4276; Shin D, 2009, PLANT SCI, V177, P156, DOI 10.1016/j.plantsci.2009.05.003; Suhandono S, 2001, EUPHYTICA, V120, P49, DOI 10.1023/A:1017543318423; Suhandono S, 2000, THESIS U NEW CASTLE; Taylor N, 2012, TROP PLANT BIOL, V5, P127, DOI 10.1007/s12042-012-9099-4; Toueille M, 2007, PLANT PHYSIOL BIOCH, V45, P113, DOI 10.1016/j.plaphy.2007.01.006; Tremousaygue D, 1999, PLANT J, V20, P553, DOI 10.1046/j.1365-313X.1999.00627.x; VAYDA ME, 1995, PLANT MOL BIOL, V28, P751, DOI 10.1007/BF00021198; Vedel V, 2011, PLANT SCI, V180, P182, DOI 10.1016/j.plantsci.2010.09.009; Vijaykumar D, 2002, PLANT SCI, V162, P315, DOI 10.1016/S0168-9452(01)00579-9; Wang AiQin, 2008, Sugar Tech, V10, P119, DOI 10.1007/s12355-008-0020-2; Watillon B, 1998, PHYSIOL PLANTARUM, V104, P1, DOI 10.1034/j.1399-3054.1998.1040101.x; Xu WL, 2007, GENE, V389, P27, DOI 10.1016/j.gene.2006.09.014; Yamaji Y, 2010, ARCH VIROL, V155, P263, DOI 10.1007/s00705-009-0571-x; YANG F, 1990, NATURE, V347, P494, DOI 10.1038/347494a0; Yang MZ, 2003, CROP SCI, V43, P1805, DOI 10.2135/cropsci2003.1805; YANG WN, 1993, J BIOL CHEM, V268, P392	75	11	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84692	10.1371/journal.pone.0084692	http://dx.doi.org/10.1371/journal.pone.0084692			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404183	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460800062
J	Chen, Y; Zhou, ZQ; Zhao, G; Li, XH; Song, LY; Yan, N; Weng, JF; Hao, ZF; Zhang, DG; Li, MS; Zhang, SH				Chen, Yan; Zhou, Zhiqiang; Zhao, Gang; Li, Xinhai; Song, Liya; Yan, Na; Weng, Jianfeng; Hao, Zhuanfang; Zhang, Degui; Li, Mingshun; Zhang, Shihuang			Transposable Element rbg Induces the Differential Expression of opaque-2 Mutant Gene in Two Maize o2 NILs Derived from the Same Inbred Line	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVATOR; MOLECULAR ANALYSIS; LYSINE CONTENT; GAMMA-ZEIN; PROTEIN; LOCUS; INCREASE; ENCODES; SYSTEM	The recessive opaque-2 mutant gene (o2) reduces alpha-zeins accumulation in maize endosperm, changes the amino acid composition of maize kernels, induces an opaque endosperm, and increases the lysine content of kernels. The quality protein maize (QPM) inbred line CA339 (o2o2) and an elite normal inbred line liao2345 (O2O2) were used to construct o2 near-isogenic lines (NILs) by marker-assisted selection (MAS) using the co-dominant SSR marker phi057. Two specific o2 NILs were constructed, named liao2345/o2-1 and liao2345/o2-2. However, the kernel phenotypes of the two o2 NILs were different from each other. liao2345/o2-1 had the wild-type vitreous endosperm, which is similar to its recurrent parent liao2345, while the endosperm of liao2345/o2-2 was opaque, identical to typical o2 mutant individuals. In comparison to their recurrent parent liao2345, the lysine concentration of liao2345/o2-1 was similar and the lysine concentration in liao2345/o2-2 was doubled. SDS-PAGE analysis indicated that liao2345/o2-1 had the same zeins ratio as liao2345, whereas the zeins concentration of liao2345/o2-2 was markedly lower. Sequence and transcript abundance analyses indicated that the CDS of two o2 NILs are derived from CA339, but they have different promoters. The O2 transcript of liao2345/o2-2 is largely inhibited because of an rbg transposable element inserted between the TATA box and initiator codon of liao2345/o2-2. We concluded that different crossing-over patterns during the process of o2 NIL construction resulted in the different kernel phenotypes of the two o2 NILs. We surmise that the reversion of liao2345/o2-1 to wild type was due to the recombination with the wild type liao2345 promoter during introgression and backcrossing. The o2 mutant gene of donor (CA339) is a null mutant because of low O2 expression. However, its CDS probably encodes a protein with normal function which can maintain the normal accumulation of zeins in maize endosperm.	[Chen, Yan; Zhou, Zhiqiang; Zhao, Gang; Li, Xinhai; Yan, Na; Weng, Jianfeng; Hao, Zhuanfang; Zhang, Degui; Li, Mingshun; Zhang, Shihuang] Chinese Acad Agr Sci, Inst Crop Sci, Dept Crop Genet & Breeding, Beijing 100193, Peoples R China; [Song, Liya] Beijing Technol & Business Univ, Beijing Key Lab Plant Resource Res & Dev, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Beijing Technology & Business University	Li, MS (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Dept Crop Genet & Breeding, Beijing 100193, Peoples R China.	limingshun@caas.cn; zhangshihuang2013@163.com	yan, na/HDM-3747-2022		China Agriculture Research System [CARS-02-01]; Beijing Municipal Natural Science Foundation [6112003]	China Agriculture Research System; Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by the China Agriculture Research System (CARS-02-01), the Beijing Municipal Natural Science Foundation (6112003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASS HW, 1992, PLANT CELL, V4, P225, DOI 10.1105/tpc.4.2.225; Chin ECL, 1996, GENOME, V39, P866, DOI 10.1139/g96-109; Ciceri P, 2000, PLANT PHYSIOL, V124, P451, DOI 10.1104/pp.124.1.451; Damerval C, 1998, MOL GEN GENET, V257, P354, DOI 10.1007/s004380050657; de Leon DG, 1994, LAB PROTOCOLS CIMMYT, P38; GEETHA KB, 1991, PLANT CELL, V3, P1207, DOI 10.1105/tpc.3.11.1207; Guo XM, 2013, PLANT PHYSIOL, V162, P1359, DOI 10.1104/pp.113.218941; HARTINGS H, 1989, EMBO J, V8, P2795, DOI 10.1002/j.1460-2075.1989.tb08425.x; HARTINGS H, 1991, MOL GEN GENET, V227, P91, DOI 10.1007/BF00260712; Holding DR, 2008, THEOR APPL GENET, V117, P157, DOI 10.1007/s00122-008-0762-y; Hopkins C. G., 1899, J AM CHEM SOC, V21, P1039, DOI [10.1021/ja02061a012, DOI 10.2135/1974]; Hunter BG, 2002, PLANT CELL, V14, P2591, DOI 10.1105/tpc.003905; Jia H, 2007, CROP SCI, V47, pS45, DOI 10.2135/cropsci2006-00025tpg; Jia M, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-60; [雷开荣 LEI Kairong], 2006, [玉米科学, Maize Science], V14, P28; [卢振宇 LU Zhenyu], 2008, [玉米科学, Maize Science], V16, P50; Maddaloni M, 1996, MOL GEN GENET, V250, P647, DOI 10.1007/s004380050117; MADDALONI M, 1989, NUCLEIC ACIDS RES, V17, P7532, DOI 10.1093/nar/17.18.7532; McClintock B., 1948, Carnegie Institution of Washington. Yearbook No. 48: 1948-1949, P142; MCCLINTOCK B, 1950, P NATL ACAD SCI USA, V36, P344, DOI 10.1073/pnas.36.6.344; MCCLINTOCK B, 1951, COLD SPRING HARB SYM, V16, P13, DOI 10.1101/SQB.1951.016.01.004; MERTZ ET, 1964, SCIENCE, V145, P279, DOI 10.1126/science.145.3629.279; MONTANELLI C, 1984, MOL GEN GENET, V197, P209, DOI 10.1007/BF00330965; Moro GL, 1996, CROP SCI, V36, P1651, DOI 10.2135/cropsci1996.0011183X003600060039x; MOTTO M, 1986, GENETICS, V112, P121; SALAMI F, 1980, MOL GEN GENET, V179, P497, DOI 10.1007/BF00271739; SALAMINI F, 1980, COLD SPRING HARB SYM, V45, P467; SCHMIDT RJ, 1987, SCIENCE, V238, P960, DOI 10.1126/science.2823388; SCHMIDT RJ, 1990, P NATL ACAD SCI USA, V87, P46, DOI 10.1073/pnas.87.1.46; SCHMIDT RJ, 1992, PLANT CELL, V4, P689, DOI 10.1105/tpc.4.6.689; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Senior ML, 1997, 39 MAIZ GEN C; TB O, 1914, J BIOL CHEM, V18, P1; van Berloo R, 1999, J HERED, V90, P328, DOI 10.1093/jhered/90.2.328; Vasal SK, 1980, GENETIC MODIFIERS BR, P37; Vivek BS., 2008, BREEDING QUALITY PRO, P1; WALLACE JC, 1990, PLANT PHYSIOL, V92, P191, DOI 10.1104/pp.92.1.191; Wu YR, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-77; Wu YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032850; Wu YR, 2010, P NATL ACAD SCI USA, V107, P12810, DOI 10.1073/pnas.1004721107; Wu YR, 2010, PLANT PHYSIOL, V153, P337, DOI 10.1104/pp.110.154690; Wu YR, 2009, THEOR APPL GENET, V119, P721, DOI 10.1007/s00122-009-1083-5; Zhao G, 2012, PLANTA, V235, P205, DOI 10.1007/s00425-011-1491-z; [赵刚 Zhao Gang], 2010, [玉米科学, Maize Science], V40, P11	44	4	4	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85159	10.1371/journal.pone.0085159	http://dx.doi.org/10.1371/journal.pone.0085159			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416355	Green Submitted, gold, Green Published			2022-12-27	WOS:000329866300052
J	Fagen, JR; Leonard, MT; McCullough, CM; Edirisinghe, JN; Henry, CS; Davis, MJ; Triplett, EW				Fagen, Jennie R.; Leonard, Michael T.; McCullough, Connor M.; Edirisinghe, Janaka N.; Henry, Christopher S.; Davis, Michael J.; Triplett, Eric W.			Comparative Genomics of Cultured and Uncultured Strains Suggests Genes Essential for Free-Living Growth of Liberibacter	PLOS ONE			English	Article							ESCHERICHIA-COLI; GREENING DISEASE; CELL-DIVISION; UPTAKE SYSTEM; TRANSPORT; CITRUS; AGROBACTERIUM; BIOSYNTHESIS; PPGPP; PH	The full genomes of two uncultured plant pathogenic Liberibacter, Ca. Liberibacter asiaticus and Ca. Liberibacter solanacearum, are publicly available. Recently, the larger genome of a closely related cultured strain, Liberibacter crescens BT-1, was described. To gain insights into our current inability to culture most Liberibacter, a comparative genomics analysis was done based on the RAST, KEGG, and manual annotations of these three organisms. In addition, pathogenicity genes were examined in all three bacteria. Key deficiencies were identified in Ca. L. asiaticus and Ca. L. solanacearum that might suggest why these organisms have not yet been cultured. Over 100 genes involved in amino acid and vitamin synthesis were annotated exclusively in L. crescens BT-1. However, none of these deficiencies are limiting in the rich media used to date. Other genes exclusive to L. crescens BT-1 include those involved in cell division, the stringent response regulatory pathway, and multiple two component regulatory systems. These results indicate that L. crescens is capable of growth under a much wider range of conditions than the uncultured Liberibacter strains. No outstanding differences were noted in pathogenicity-associated systems, suggesting that L. crescens BT-1 may be a plant pathogen on an as yet unidentified host.	[Fagen, Jennie R.; Leonard, Michael T.; McCullough, Connor M.; Triplett, Eric W.] Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Edirisinghe, Janaka N.; Henry, Christopher S.] Argonne Natl Lab, Div Math & Comp Sci, Argonne, IL 60439 USA; [Davis, Michael J.] Univ Florida, Inst Food & Agr Sci, Dept Plant Pathol, Citrus Res & Dev Ctr, Lake Alfred, FL USA	State University System of Florida; University of Florida; United States Department of Energy (DOE); Argonne National Laboratory; State University System of Florida; University of Florida	Triplett, EW (corresponding author), Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA.	ewt@ufl.edu			Citrus Research and Development Foundation [336]	Citrus Research and Development Foundation	This work was funded by the Citrus Research and Development Foundation grant number 336. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMASINO RM, 1982, PLANT PHYSIOL, V69, P389, DOI 10.1104/pp.69.2.389; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Barabote RD, 2005, MICROBIOL MOL BIOL R, V69, P608, DOI 10.1128/MMBR.69.4.608-634.2005; Bernhardt TG, 2003, MOL MICROBIOL, V48, P1171, DOI 10.1046/j.1365-2958.2003.03511.x; Besemer J, 2005, NUCLEIC ACIDS RES, V33, pW451, DOI 10.1093/nar/gki487; Borisov VB, 2011, BBA-BIOENERGETICS, V1807, P1398, DOI 10.1016/j.bbabio.2011.06.016; Cabantous S, 2002, ACTA CRYSTALLOGR D, V58, P1249, DOI 10.1107/S0907444902008338; Cai SJ, 2002, J BIOL CHEM, V277, P24155, DOI 10.1074/jbc.M110715200; Cao J, 2007, MOL MICROBIOL, V65, P857, DOI 10.1111/j.1365-2958.2007.05802.x; CHARLES TC, 1993, J BACTERIOL, V175, P6614, DOI 10.1128/jb.175.20.6614-6625.1993; Cong Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041071; COTTER PA, 1990, J BACTERIOL, V172, P6333, DOI 10.1128/jb.172.11.6333-6338.1990; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; GOODELL EW, 1987, J BACTERIOL, V169, P3861, DOI 10.1128/jb.169.8.3861-3865.1987; Grass G, 2001, J BACTERIOL, V183, P2145, DOI 10.1128/JB.183.6.2145-2147.2001; Hafeez FY, 2005, ENVIRON EXP BOT, V54, P142, DOI 10.1016/j.envexpbot.2004.06.008; Hansen AK, 2008, APPL ENVIRON MICROB, V74, P5862, DOI 10.1128/AEM.01268-08; Hartung JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023289; HERNANDEZ VJ, 1991, J BIOL CHEM, V266, P5991; Hoffman MT, 2013, PHYTOPATHOLOGY, V103, P15, DOI 10.1094/PHYTO-06-12-0138-R; JAGOUEIX S, 1994, INT J SYST BACTERIOL, V44, P379, DOI 10.1099/00207713-44-3-379; Jain V, 2006, J MICROBIOL, V44, P1; Jeanguenin L, 2012, FUNCT INTEGR GENOMIC, V12, P25, DOI 10.1007/s10142-011-0255-y; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; KAROW M, 1992, J BACTERIOL, V174, P7407, DOI 10.1128/jb.174.22.7407-7418.1992; KOBAYASHI M, 1995, P NATL ACAD SCI USA, V92, P714, DOI 10.1073/pnas.92.3.714; KOSTER W, 1990, J BIOL CHEM, V265, P21407; Kusano T, 2008, PLANTA, V228, P367, DOI 10.1007/s00425-008-0772-7; Leonard MT, 2012, STAND GENOMIC SCI, V7, P271, DOI 10.4056/sigs.3326772; Li LP, 2002, P NATL ACAD SCI USA, V99, P12369, DOI 10.1073/pnas.192439499; Li WL, 2012, PROTEINS, V80, P2614, DOI 10.1002/prot.24147; Liefting LW, 2009, INT J SYST EVOL MICR, V59, P2274, DOI 10.1099/ijs.0.007377-0; Lin H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019135; MANULIS S, 1994, MICROBIOL-UK, V140, P1045, DOI 10.1099/13500872-140-5-1045; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Nogales J, 2009, FEMS MICROBIOL LETT, V293, P177, DOI 10.1111/j.1574-6968.2009.01527.x; Overbeek R, 2008, NUCLEIC ACIDS RES, V33, P5691; Patten CL, 1996, CAN J MICROBIOL, V42, P207, DOI 10.1139/m96-032; Patzer SI, 2000, J BIOL CHEM, V275, P24321, DOI 10.1074/jbc.M001775200; PAWLOWSKI K, 1991, MOL GEN GENET, V231, P124, DOI 10.1007/BF00293830; Pierce DL, 2006, J BACTERIOL, V188, P2473, DOI 10.1128/JB.188.7.2473-2482.2006; Raddadi N, 2011, ENVIRON MICROBIOL, V13, P414, DOI 10.1111/j.1462-2920.2010.02347.x; Sabri M, 2006, MICROBIOL-SGM, V152, P745, DOI 10.1099/mic.0.28682-0; Secor GA, 2009, PLANT DIS, V93, P574, DOI 10.1094/PDIS-93-6-0574; Shaw FL, 2010, J BIOL CHEM, V285, P14711, DOI 10.1074/jbc.M110.107219; Spaepen S, 2011, COLD SPRING HARB PER; TASCHNER PEM, 1988, J BACTERIOL, V170, P1533, DOI 10.1128/jb.170.4.1533-1540.1988; Tehranchi AK, 2010, CELL, V141, P595, DOI 10.1016/j.cell.2010.03.036; Teixeira DD, 2005, INT J SYST EVOL MICR, V55, P1857, DOI 10.1099/ijs.0.63677-0; Templin MF, 1999, EMBO J, V18, P4108, DOI 10.1093/emboj/18.15.4108; Thompson A, 2006, J BIOL CHEM, V281, P30112, DOI 10.1074/jbc.M605616200; Trchounian A, 1999, FEBS LETT, V447, P144, DOI 10.1016/S0014-5793(99)00288-4; Uehara T, 2007, J BACTERIOL, V189, P5634, DOI 10.1128/JB.00446-07; Ukai H, 1998, J BACTERIOL, V180, P3663, DOI 10.1128/JB.180.14.3663-3670.1998; Vahling CM, 2010, J BACTERIOL, V192, P834, DOI 10.1128/JB.01279-09; van Dongen JT, 2003, PLANT PHYSIOL, V131, P1529, DOI 10.1104/pp.102.017202; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Wang CX, 2010, MOL PLANT MICROBE IN, V23, P153, DOI 10.1094/MPMI-23-2-0153; White JP, 2009, J BACTERIOL, V191, P1547, DOI 10.1128/JB.00926-08	61	50	52	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84469	10.1371/journal.pone.0084469	http://dx.doi.org/10.1371/journal.pone.0084469			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416233	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500128
J	Selig, ER; Turner, WR; Troeng, S; Wallace, BP; Halpern, BS; Kaschner, K; Lascelles, BG; Carpenter, KE; Mittermeier, RA				Selig, Elizabeth R.; Turner, Will R.; Troeng, Sebastian; Wallace, Bryan P.; Halpern, Benjamin S.; Kaschner, Kristin; Lascelles, Ben G.; Carpenter, Kent E.; Mittermeier, Russell A.			Global Priorities for Marine Biodiversity Conservation	PLOS ONE			English	Article							SPECIES RICHNESS; HUMAN IMPACT; HOTSPOTS; AREAS; OCEAN; RESILIENCE; DIVERSITY; SEAMOUNTS; PATTERNS; DECLINE	In recent decades, many marine populations have experienced major declines in abundance, but we still know little about where management interventions may help protect the highest levels of marine biodiversity. We used modeled spatial distribution data for nearly 12,500 species to quantify global patterns of species richness and two measures of endemism. By combining these data with spatial information on cumulative human impacts, we identified priority areas where marine biodiversity is most and least impacted by human activities, both within Exclusive Economic Zones (EEZs) and Areas Beyond National Jurisdiction (ABNJ). Our analyses highlighted places that are both accepted priorities for marine conservation like the Coral Triangle, as well as less well-known locations in the southwest Indian Ocean, western Pacific Ocean, Arctic and Antarctic Oceans, and within semi-enclosed seas like the Mediterranean and Baltic Seas. Within highly impacted priority areas, climate and fishing were the biggest stressors. Although new priorities may arise as we continue to improve marine species range datasets, results from this work are an essential first step in guiding limited resources to regions where investment could best sustain marine biodiversity.	[Selig, Elizabeth R.; Turner, Will R.; Troeng, Sebastian] Conservat Int, Betty & Gordon Moore Ctr Sci & Oceans, Arlington, VA USA; [Troeng, Sebastian] Lund Univ, Dept Biol, Lund, Sweden; [Wallace, Bryan P.] Ocean Soc, Ross, CA USA; [Wallace, Bryan P.] Duke Univ, Marine Lab, Nicholas Sch Environm, Beaufort, NC 28516 USA; [Halpern, Benjamin S.] Natl Ctr Ecol Anal & Synth, Santa Barbara, CA USA; [Halpern, Benjamin S.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Halpern, Benjamin S.] Univ London Imperial Coll Sci Technol & Med, Ascot, Berks, England; [Kaschner, Kristin] Univ Freiburg, Dept Biometry & Environm Syst Anal, D-79106 Freiburg, Germany; [Kaschner, Kristin] Ctr Synth & Anal Biodiversite CESAB, Aix En Provence, France; [Lascelles, Ben G.] Birdlife Int, Global Seabird Programme, Cambridge, England; [Carpenter, Kent E.] Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA; [Carpenter, Kent E.] Int Union Conservat Nat, Global Species Programme, Gland, Switzerland; [Mittermeier, Russell A.] Conservat Int, Arlington, VA USA	Conservation International; Lund University; Duke University; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; Imperial College London; University of Freiburg; BirdLife International; Old Dominion University; Conservation International	Selig, ER (corresponding author), Conservat Int, Betty & Gordon Moore Ctr Sci & Oceans, Arlington, VA USA.	eselig@conservation.org	Kaschner, Kristin/GQQ-6475-2022	Kaschner, Kristin/0000-0002-4061-626X	Gordon and Betty Moore Foundation; Cinco Hermanos; Packard Foundation; New Hampshire Charitable Foundation; Thomas W. Haas Foundation; Fondation pour la Recherche en Biodiversite; Fondation Total	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Cinco Hermanos; Packard Foundation(The David & Lucile Packard Foundation); New Hampshire Charitable Foundation; Thomas W. Haas Foundation; Fondation pour la Recherche en Biodiversite(Fondation pour la Recherche Medicale); Fondation Total	Funding for this work was provided by the Gordon and Betty Moore Foundation, Cinco Hermanos, a grant from the Packard Foundation to the National Center for Ecological Analysis and Synthesis and support to the IUCN-GMSA from the New Hampshire Charitable Foundation and the Thomas W. Haas Foundation. K.K.'s work was conducted in part while working on the PELAGIC project co-financed by the Fondation pour la Recherche en Biodiversite and Fondation Total. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GR, 2008, AQUAT CONSERV, V18, P541, DOI 10.1002/aqc.880; ANGEL MV, 1993, CONSERV BIOL, V7, P760, DOI 10.1046/j.1523-1739.1993.740760.x; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Bellwood DR, 2003, ECOL LETT, V6, P281, DOI 10.1046/j.1461-0248.2003.00432.x; BirdLife International and Nature Serve, 2011, BIRD SPEC DISTR MAPS; Bouchet Philippe, 2006, P31; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; CBD, 2011, STRAT PLAN BIOD 2011, DOI DOI 10.1007/978-1-4020-6970-3_5; Costello MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012110; Danovaro R, 2008, CURR BIOL, V18, P1, DOI 10.1016/j.cub.2007.11.056; Duffy JE, 2003, ECOL LETT, V6, P680, DOI 10.1046/j.1461-0248.2003.00494.x; Edgar GJ, 2008, AQUAT CONSERV, V18, P969, DOI 10.1002/aqc.902; ESTES JA, 1995, ECOL MONOGR, V65, P75, DOI 10.2307/2937159; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Gray JS, 1997, BIODIVERS CONSERV, V6, P153, DOI 10.1023/A:1018335901847; Halpern BS, 2008, OCEAN COAST MANAGE, V51, P203, DOI 10.1016/j.ocecoaman.2007.08.002; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hughes TP, 2002, ECOL LETT, V5, P775, DOI 10.1046/j.1461-0248.2002.00383.x; Jenkins CN, 2013, P NATL ACAD SCI USA, V110, pE2602, DOI 10.1073/pnas.1302251110; Kaschner K, 2010, PREDICTED RANGE MAPS; Kaschner K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019653; Lascelles BG, 2012, BIOL CONSERV, V156, P5, DOI 10.1016/j.biocon.2011.12.008; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Lucifora LO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019356; McLeod K., 2009, ECOSYSTEM BASED MANA; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Mittermeier Russell A., 1999, P1; Moland E, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2679; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001127; Morato T, 2010, P NATL ACAD SCI USA, V107, P9707, DOI 10.1073/pnas.0910290107; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Pompa S, 2011, P NATL ACAD SCI USA, V108, P13600, DOI 10.1073/pnas.1101525108; Rayner NA, 2006, J CLIMATE, V19, P446, DOI 10.1175/JCLI3637.1; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Robertson DR, 2008, DIVERS DISTRIB, V14; Sala E, 2006, ANNU REV ENV RESOUR, V31, P93, DOI 10.1146/annurev.energy.31.020105.100235; Sanciangco JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056245; Secretariat of the Convention on Biological Diversity, 2009, AZ SCI CRIT GUID ID; Selig ER, 2012, GLOBAL CHANGE BIOL, V18, P1561, DOI 10.1111/j.1365-2486.2012.02658.x; Shenkar N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020657; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Springer AM, 2003, P NATL ACAD SCI USA, V100, P12223, DOI 10.1073/pnas.1635156100; Stattersfield A.J., 1998, ENDEMIC BIRD AREAS W, V115, P1089, DOI 10.2307/4089533; Swartz W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015143; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Trebilco R, 2011, BIOL CONSERV, V144, P1758, DOI 10.1016/j.biocon.2011.02.024; Wafar M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014613; Williams PH, 1996, BIOL J LINN SOC, V58, P125, DOI 10.1111/j.1095-8312.1996.tb01428.x; Williams R, ECOGRAPHY IN PRESS; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Yesson C, 2011, DEEP-SEA RES PT I, V58, P442, DOI 10.1016/j.dsr.2011.02.004	55	137	139	1	186	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e82898	10.1371/journal.pone.0082898	http://dx.doi.org/10.1371/journal.pone.0082898			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416151	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500023
J	Fok, WC; Chen, YD; Bokov, A; Zhang, YQ; Salmon, AB; Diaz, V; Javors, M; Wood, WH; Zhang, YQ; Becker, KG; Perez, VI; Richardson, A				Fok, Wilson C.; Chen, Yidong; Bokov, Alex; Zhang, Yiqiang; Salmon, Adam B.; Diaz, Vivian; Javors, Martin; Wood, William H., III; Zhang, Yongqing; Becker, Kevin G.; Perez, Viviana I.; Richardson, Arlan			Mice Fed Rapamycin Have an Increase in Lifespan Associated with Major Changes in the Liver Transcriptome	PLOS ONE			English	Article							GENETICALLY HETEROGENEOUS MICE; INDUCED INSULIN-RESISTANCE; LARGE GENE LISTS; GROWTH-FACTOR; C-ELEGANS; DIETARY RESTRICTION; PROTEIN-SYNTHESIS; MAMMALIAN TARGET; OXIDATIVE STRESS; DOWN-REGULATION	Rapamycin was found to increase (11% to 16%) the lifespan of male and female C57BL/6J mice most likely by reducing the increase in the hazard for mortality (i.e., the rate of aging) term in the Gompertz mortality analysis. To identify the pathways that could be responsible for rapamycin's longevity effect, we analyzed the transcriptome of liver from 25-month-old male and female mice fed rapamycin starting at 4 months of age. Few changes (<300 transcripts) were observed in transcriptome of rapamycin-fed males; however, a large number of transcripts (>4,500) changed significantly in females. Using multidimensional scaling and heatmap analyses, the male mice fed rapamycin were found to segregate into two groups: one group that is almost identical to control males (Rapa-1) and a second group (Rapa-2) that shows a change in gene expression (>4,000 transcripts) with more than 60% of the genes shared with female mice fed Rapa. Using ingenuity pathway analysis, 13 pathways were significantly altered in both Rapa-2 males and rapamycin-fed females with mitochondrial function as the most significantly changed pathway. Our findings show that rapamycin has a major effect on the transcriptome and point to several pathways that would likely impact the longevity.	[Fok, Wilson C.; Richardson, Arlan] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Bokov, Alex; Zhang, Yiqiang; Salmon, Adam B.; Diaz, Vivian; Richardson, Arlan] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA; [Chen, Yidong; Bokov, Alex] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [Chen, Yidong] Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Chen, Yidong] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA; [Zhang, Yiqiang] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Salmon, Adam B.] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA; [Javors, Martin] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA; [Wood, William H., III; Zhang, Yongqing; Becker, Kevin G.] NIA, Baltimore, MD 21224 USA; [Perez, Viviana I.] Oregon State Univ, Dept Biochem & Biophys, Linus Pauling Inst, Corvallis, OR 97331 USA; [Salmon, Adam B.; Richardson, Arlan] Audie Murphy VA Hosp STVHCS, Res Serv, San Antonio, TX USA; [Salmon, Adam B.; Richardson, Arlan] Audie Murphy VA Hosp STVHCS, Geriatr Res Educ & Clin Ctr, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Oregon State University; Geriatric Research Education & Clinical Center	Richardson, A (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA.	richardsona@uthscsa.edu	Zhang, Yiqiang/AAA-3143-2019; Bokov, Alex/O-9952-2014	Fok, Wilson Chun Yim/0000-0003-3289-2093; Bokov, Alex/0000-0002-0511-9815; Salmon, Adam/0000-0002-1475-7843; Becker, Kevin/0000-0002-6794-6656	San Antonio Nathan Shock Aging Center [1p30-AG-13319]; National Institutes of Health (NIH) [AG036613, AG021890]; Ellison Medical Foundation; Intramural Research Program of the NIH, National Institute on Aging; VA Merit grant from the Department of Veteran Affairs; National Institute on Minority Health and Health Disparities from the NIH [G12MD007591]; NATIONAL INSTITUTE ON AGING [RC2AG036613, ZICAG000616, T32AG021890] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007591] Funding Source: NIH RePORTER	San Antonio Nathan Shock Aging Center; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Intramural Research Program of the NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); VA Merit grant from the Department of Veteran Affairs; National Institute on Minority Health and Health Disparities from the NIH; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Financial support was provided by The San Antonio Nathan Shock Aging Center (1p30-AG-13319, AR), National Institutes of Health (NIH) RC2 Grand Opportunity grant (AG036613, AR), NIH T32 Training Grant (AG021890, WF), the Ellison Medical Foundation (VP), the Intramural Research Program of the NIH, National Institute on Aging, and VA Merit grant (Richardson) from the Department of Veteran Affairs. Computation Support was provided by the Computational System Biology Core funded by the National Institute on Minority Health and Health Disparities (G12MD007591) from the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimov VN, 2011, CELL CYCLE, V10, P4230, DOI 10.4161/cc.10.24.18486; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; Bokov A, 2004, MECH AGEING DEV, V125, P811, DOI 10.1016/j.mad.2004.07.009; Bronikowski Anne, 2010, NAT ED KNOWL, V1; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Chang SB, 2007, J SURG RES, V138, P37, DOI 10.1016/j.jss.2006.07.003; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Conn CS, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003520; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Deak F, 2012, J GERONTOL A-BIOL, V67, P611, DOI 10.1093/gerona/gls118; Ding QX, 2003, J NEUROCHEM, V86, P489, DOI 10.1046/j.1471-4159.2003.01885.x; Drake JC, 2013, J GERONTOL A; Felton-Edkins ZA, 2003, EMBO J, V22, P2422, DOI 10.1093/emboj/cdg240; Fok WC, 2013, J GERONTOL A-BIOL, V68, P108, DOI 10.1093/gerona/gls127; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Habib A, 2013, ARTERIOSCL THROM VAS, V33, P2425, DOI 10.1161/ATVBAHA.113.301659; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016; Hine Christopher M, 2012, J Clin Exp Pathol, VS4; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huyghe E, 2007, TRANSPL INT, V20, P305, DOI 10.1111/j.1432-2277.2006.00423.x; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; Iadevaia V, 2012, BIOCHEM SOC T, V40, P168, DOI 10.1042/BST20110682; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Kaeberlein M, 2011, AGING CELL, V10, P185, DOI 10.1111/j.1474-9726.2010.00665.x; Kassel O, 2001, EMBO J, V20, P7108, DOI 10.1093/emboj/20.24.7108; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Ladiges W, 2009, AGING CELL, V8, P346, DOI 10.1111/j.1474-9726.2009.00491.x; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586; Pletcher SD, 1999, J EVOLUTION BIOL, V12, P430, DOI 10.1046/j.1420-9101.1999.00058.x; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; Sharp ZD, 2005, J GERONTOL A-BIOL, V60, P293, DOI 10.1093/gerona/60.3.293; Siu ECK, 2007, MOL PHARMACOL, V71, P826, DOI 10.1124/mol.106.032086; Stanfel MN, 2009, BBA-GEN SUBJECTS, V1790, P1067, DOI 10.1016/j.bbagen.2009.06.007; Tan Y, 2011, DIABETES, V60, P625, DOI 10.2337/db10-1164; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Veilleux A, 2010, MOL ENDOCRINOL, V24, P766, DOI 10.1210/me.2009-0328; Wang LJ, 2002, CIRC RES, V91, P821, DOI 10.1161/01.RES.0000041029.97988.E9; Wilkinson JE, 2012, AGING CELL, V11, P675, DOI 10.1111/j.1474-9726.2012.00832.x; Wohlgemuth I, 2011, PHILOS T R SOC B, V366, P2979, DOI 10.1098/rstb.2011.0138; Zhang Y, 2013, J GERONTOL A	53	87	89	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e83988	10.1371/journal.pone.0083988	http://dx.doi.org/10.1371/journal.pone.0083988			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409289	Green Published, gold, Green Submitted			2022-12-27	WOS:000329463500013
J	Yamakawa, RH; Saito, PK; da Silva, WV; de Mattos, LC; Borelli, SD				Yamakawa, Roger Haruki; Saito, Patricia Keiko; da Silva Junior, Waldir Verissimo; de Mattos, Luiz Carlos; Borelli, Sueli Donizete			Polymorphism of Leukocyte and Erythrocyte Antigens in Chronic Kidney Disease Patients in Southern Brazil	PLOS ONE			English	Article							DUFFY BLOOD-GROUP; STAGE RENAL-DISEASE; NEGATIVE INDIVIDUALS; CHEMOKINE RECEPTOR; HLA POLYMORPHISM; VOLUNTEER DONORS; CODING SEQUENCE; 5 CONTINENTS; GENE; POPULATIONS	We investigated the polymorphism of human leukocyte antigens (HLA) and Duffy erythrocyte antigens in chronic kidney disease (CKD) patients in southern Brazil. One hundred and eighty-three CKD patients, over 18 years old, on hemodialysis, were included. HLA-A, -B and -DRB1 typing was performed using the LABType(R)SSO (One Lambda, Inc.). Duffy phenotypes were determined by gel column agglutination using anti-Fy(a) and anti-Fy(b) monoclonal anti-sera. The patients' predominant ages ranged between 51 and 70 years (43%) and the predominant gender, ethnic group and dialysis period were, respectively, male (62%), white (62%) and 1-3 years (40%). The highest and lowest frequencies of Duffy phenotypes were Fy(a+b+) and Fy(a-b-), respectively. Nineteen HLA-A, 30 HLA-B and 13 HLA-DRB1 allele groups were identified. The most frequent HLA allele groups were HLA-A*01, -A*02, -A*03, -A*11, -A*24; HLA-B*07, -B*15, -B*35, -B*44, -B*51; HLA-DRB1*03, -DRB1*04, -DRB1*07, -DRB1*11 and -DRB1*13. Statistically significant differences were observed in the Duffy and HLA polymorphisms compared between CKD patients and healthy subjects. The Fy(a+b-) phenotype (p<0.0001, OR = 2.56, 95% CI = 1.60-4.07) was the most frequent in the patients (p<0.05), and the Fy(a+b+) phenotype (p = 0.0039, OR = 1.71, 95% CI = 1.18-2.51) was the most frequent in the healthy subjects in the same region of Parana state (p<0.05). Regarding HLA, the HLA-B*42, -B*45, -B*51 and -DRB1*03 allele groups were the most frequent in the patients (p<0.05), and the HLA-B*44 allele group was the most frequent in the healthy subjects in the same region of Brazil (p<0.05). The polymorphism of these two markers among CKD patients in southern Brazil and healthy subjects of other studies, suggests that these markers might be involved with CKD development. Further studies should be undertaken to analyze the markers' influence on CKD and the long-term results from kidney transplantation.	[Yamakawa, Roger Haruki; Saito, Patricia Keiko; Borelli, Sueli Donizete] Univ Estadual Maringa, Dept Ciencias Basicas Saude, Maringa, Parana, Brazil; [da Silva Junior, Waldir Verissimo] Univ Estadual Maringa, Dept Estat, Maringa, Parana, Brazil; [de Mattos, Luiz Carlos] Fac Med Sao Jose Do Rio Preto, Dept Biol Mol, Sao Jose Do Rio Preto, SP, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade de Sao Paulo; Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP)	Borelli, SD (corresponding author), Univ Estadual Maringa, Dept Ciencias Basicas Saude, Maringa, Parana, Brazil.	sdborelli@uem.br	DE MATTOS, LUIZ CARLOS/F-6739-2010; de Mattos, Luiz Carlos/P-3574-2019; de Mattos, Luiz Carlos/P-4005-2019	DE MATTOS, LUIZ CARLOS/0000-0002-8572-8177; de Mattos, Luiz Carlos/0000-0002-8572-8177	Araucaria Foundation [18952 - 08/2009]	Araucaria Foundation(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FA)	This study was supported by the Araucaria Foundation (grant number 18952 - 08/2009). The funder's website is http://www.fappr.pr.gov.br/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almogren A, 2012, BRIT J BIOMED SCI, V69, P159, DOI 10.1080/09674845.2012.12069145; Bortolotto AS, 2012, HUM IMMUNOL, V73, P180, DOI 10.1016/j.humimm.2011.11.009; CHAUDHURI A, 1995, BLOOD, V85, P615, DOI 10.1182/blood.V85.3.615.bloodjournal853615; Crispim JC, 2008, TRANSPL P, V40, P1333, DOI 10.1016/j.transproceed.2008.02.086; Daniels G, 2002, TRANSFUSION MED, V12, P287, DOI 10.1046/j.1365-3148.2002.00399.x; Giarola Luciana Borges, 2012, BMC Res Notes, V5, P90, DOI 10.1186/1756-0500-5-90; Girard JP, 1999, AM J PATHOL, V155, P2043, DOI 10.1016/S0002-9440(10)65523-X; Gloor J, 2008, AM J TRANSPLANT, V8, P1367, DOI 10.1111/j.1600-6143.2008.02262.x; Guelsin Gláucia Andréia Soares, 2011, Rev. Bras. Hematol. Hemoter., V33, P21, DOI 10.5581/1516-8484.20110009; Hadley TJ, 1997, BLOOD, V89, P3077, DOI 10.1182/blood.V89.9.3077; Howes RE, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1265; Iwamoto S, 1996, BIOCHEM BIOPH RES CO, V222, P852, DOI 10.1006/bbrc.1996.0833; Janeway CA, 2002, IMUNOBIOLOGIA; Kaimen-Maciel DR, 2009, MOL MED REP, V2, P993, DOI 10.3892/mmr_00000204; Lerut E, 2007, TRANSFUSION, V47, P28, DOI 10.1111/j.1537-2995.2007.01060.x; Luo H, 2000, MOL CELL BIOL, V20, P3097, DOI 10.1128/MCB.20.9.3097-3101.2000; MALLINSON G, 1995, BRIT J HAEMATOL, V90, P823, DOI 10.1111/j.1365-2141.1995.tb05202.x; Meny G M, 2010, Immunohematology, V26, P51; Middleton D, 2000, HUM IMMUNOL, V61, P1048, DOI 10.1016/S0198-8859(00)00178-6; Nigam P, 2004, TISSUE ANTIGENS, V64, P204, DOI 10.1111/j.1399-0039.2004.00264.x; Novaretti MC, 2000, REV BRAS HEMATOL HEM, V22, P23; Parra FC, 2003, P NATL ACAD SCI USA, V100, P177, DOI 10.1073/pnas.0126614100; Probst CM, 2000, HUM BIOL, V72, P597; Rios M, 2000, BRIT J HAEMATOL, V108, P448; Ruiz TM, 2005, TRANSPL P, V37, P2293, DOI 10.1016/j.transproceed.2005.03.036; Segerer S, 2003, TRANSPLANTATION, V75, P1030, DOI 10.1097/01.TP.0000054679.91112.6F; TOURNAMILLE C, 1995, NAT GENET, V10, P224, DOI 10.1038/ng0695-224; TRACHTENBERG A, 1988, ANN HUM BIOL, V15, P213, DOI 10.1080/03014468800009651; Williams F, 2001, HUM IMMUNOL, V62, P645, DOI 10.1016/S0198-8859(01)00247-6; Zarbock A, 2007, CRIT CARE MED, V35, P2156, DOI 10.1097/01.CCM.0000280570.82885.32	30	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2014	9	1							e84456	10.1371/journal.pone.0084456	http://dx.doi.org/10.1371/journal.pone.0084456			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286JC	24409300	gold, Green Submitted, Green Published			2022-12-27	WOS:000329463500024
J	Lee, RTH; Asharani, PV; Carney, TJ				Lee, Raymond T. H.; Asharani, P. V.; Carney, Thomas J.			Basal Keratinocytes Contribute to All Strata of the Adult Zebrafish Epidermis	PLOS ONE			English	Article							EXPRESSION; SKIN; DIFFERENTIATION; SPECIFICATION; MORPHOGENESIS; MECHANISMS; PROTEINS; ENVELOPE; PROMOTER; MARKER	The epidermis of terrestrial vertebrates is a stratified epithelium and forms an essential protective barrier. It is continually renewed, with dead corneocytes shed from the surface and replaced from a basal keratinocyte stem cell population. Whilst mouse is the prime model system used for epidermal studies, there is increasing employment of the zebrafish to analyse epidermis development and homeostasis, however the architecture and ontogeny of the epidermis in this system are incompletely described. In particular, it is unclear if adult zebrafish epidermis is derived entirely from the basal epidermal stem cell layer, as in the mouse, or if the most superficial keratinocyte layer is a remnant of the embryonic periderm. Furthermore, a relative paucity of cellular markers and genetic reagents to label and manipulate the basal epidermal stem cell compartment has hampered research. Here we show that the type I keratin, krtt1c19e, is a suitable marker of the basal epidermal layer and identify a krtt1c19e promoter fragment able to drive strong and specific expression in this cell type. Use of this promoter to express an inducible Cre recombinase allowed permanent labelling of basal cells during embryogenesis, and demonstrated that these cells do indeed generate keratinocytes of all strata in the adult epidermis. Further deployment of the Cre-Lox system highlighted the transient nature of the embryonic periderm. We thus show that the epidermis of adult zebrafish, as in the mouse, derives from basal stem cells, further expanding the similarities of epidermal ontogeny across vertebrates. Future use of this promoter will assist genetic analysis of basal keratinocyte biology in zebrafish.	[Lee, Raymond T. H.; Asharani, P. V.; Carney, Thomas J.] ASTAR, IMCB, Div Discovery Res, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Carney, TJ (corresponding author), ASTAR, IMCB, Div Discovery Res, Singapore, Singapore.	tcarney@imcb.a-star.edu.sg	Carney, Tom J/H-4389-2011; RANI, ASHA/AAF-8641-2019	Carney, Tom J/0000-0003-2371-1924; RANI, ASHA/0000-0001-8215-5214; Lee, Raymond Teck Ho/0000-0001-6522-3043	Biomedical Research Council of A*STAR (Agency for Science, Technology and Research), Singapore	Biomedical Research Council of A*STAR (Agency for Science, Technology and Research), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Biomedical Research Council of A*STAR (Agency for Science, Technology and Research), Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama M, 1999, J INVEST DERMATOL, V112, P903, DOI 10.1046/j.1523-1747.1999.00592.x; Alibardi L, 2003, J EXP ZOOL PART B, V298B, P12, DOI 10.1002/jez.b.00024; Amsterdam A, 1999, GENE DEV, V13, P2713, DOI 10.1101/gad.13.20.2713; Asharani PV, 2012, AM J HUM GENET, V90, P661, DOI 10.1016/j.ajhg.2012.02.026; Bakkers J, 2002, DEV CELL, V2, P617, DOI 10.1016/S1534-5807(02)00163-6; BICKENBACH JR, 1995, J INVEST DERMATOL, V104, P405, DOI 10.1111/1523-1747.ep12665896; Bragulla HH, 2009, J ANAT, V214, P516, DOI 10.1111/j.1469-7580.2009.01066.x; Brend Tim, 2009, J Vis Exp, DOI 10.3791/1229; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Carney TJ, 2007, DEVELOPMENT, V134, P3461, DOI 10.1242/dev.004556; Carney TJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000907; Celli J, 1999, CELL, V99, P143, DOI 10.1016/S0092-8674(00)81646-3; Fukazawa C, 2010, DEV BIOL, V346, P272, DOI 10.1016/j.ydbio.2010.07.037; Galko MJ, 2004, PLOS BIOL, V2, P1114, DOI 10.1371/journal.pbio.0020239; GLOVER CN, 2013, J COMP PHYSL B; Gong ZY, 2002, DEV DYNAM, V223, P204, DOI 10.1002/dvdy.10051; Hsiao CD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000302; Imboden M, 1997, CR ACAD SCI III-VIE, V320, P689, DOI 10.1016/S0764-4469(97)84816-0; Janicke M, 2007, DEV BIOL, V307, P258, DOI 10.1016/j.ydbio.2007.04.044; Janicke M, 2010, INT J DEV BIOL, V54, P837, DOI 10.1387/ijdb.092877mj; Kemp Hilary A, 2009, J Vis Exp, DOI 10.3791/1394; Kiener TK, 2008, DEV BIOL, V316, P36, DOI 10.1016/j.ydbio.2007.12.047; Kim SH, 2010, MATRIX BIOL, V29, P629, DOI 10.1016/j.matbio.2010.07.002; KIMMEL CB, 1990, DEVELOPMENT, V108, P581; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koster MI, 2007, ANNU REV CELL DEV BI, V23, P93, DOI 10.1146/annurev.cellbio.23.090506.123357; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Le Guellec D, 2004, INT J DEV BIOL, V48, P217, DOI 10.1387/ijdb.15272388; Lecaudey V, 2008, DEVELOPMENT, V135, P2695, DOI 10.1242/dev.025981; Lee H, 2002, DEV CELL, V2, P607, DOI 10.1016/S1534-5807(02)00166-1; LEE RTH, 2013, CURRENT BIO IN PRESS, V23; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Mosimann C, 2011, DEVELOPMENT, V138, P169, DOI 10.1242/dev.059345; Padhi BK, 2006, GENE, V368, P37, DOI 10.1016/j.gene.2005.09.016; Postel R, 2013, J INVEST DERMATOL, V133, P2180, DOI 10.1038/jid.2013.154; Proksch E, 2008, EXP DERMATOL, V17, P1063, DOI 10.1111/j.1600-0625.2008.00786.x; Reischauer S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000720; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; Richardson R, 2013, J INVEST DERMATOL, V133, P1655, DOI 10.1038/jid.2013.16; Sabel JL, 2009, DEV BIOL, V325, P249, DOI 10.1016/j.ydbio.2008.10.031; Slanchev K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000563; Sonawane M, 2005, DEVELOPMENT, V132, P3255, DOI 10.1242/dev.01904; Soules KA, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-12; Thisse B, 2004, ZFIN DIRECT DATA SUB; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; vanEeden FJM, 1996, DEVELOPMENT, V123, P255	46	49	50	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84858	10.1371/journal.pone.0084858	http://dx.doi.org/10.1371/journal.pone.0084858			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400120	Green Submitted, Green Published, gold			2022-12-27	WOS:000329462700054
J	Chiandetti, C; Pecchia, T; Patt, F; Vallortigara, G				Chiandetti, Cinzia; Pecchia, Tommaso; Patt, Francesco; Vallortigara, Giorgio			Visual Hierarchical Processing and Lateralization of Cognitive Functions through Domestic Chicks' Eyes	PLOS ONE			English	Article							CHIMPANZEES PAN-TROGLODYTES; LIGHT EXPERIENCE; AVIAN BRAIN; PRECEDENCE; FEATURES; STIMULI; HUMANS; INFORMATION; ASYMMETRY; PIGEONS	Hierarchical stimuli have proven effective for investigating principles of visual organization in humans. A large body of evidence suggests that the analysis of the global forms precedes the analysis of the local forms in our species. Studies on lateralization also indicate that analytic and holistic encoding strategies are separated between the two hemispheres of the brain. This raises the question of whether precedence effects may reflect the activation of lateralized functions within the brain. Non-human animals have perceptual organization and functional lateralization that are comparable to that of humans. Here we trained the domestic chick in a concurrent discrimination task involving hierarchical stimuli. Then, we evaluated the animals for analytic and holistic encoding strategies in a series of transformational tests by relying on a monocular occlusion technique. A local precedence emerged in both the left and the right hemisphere, adding further evidence in favour of analytic processing in non-human animals.	[Chiandetti, Cinzia; Pecchia, Tommaso; Vallortigara, Giorgio] Univ Trento, Ctr Mind Brain Sci, Rovereto, Trento, Italy; [Chiandetti, Cinzia; Patt, Francesco] Univ Trieste, Psychol Unit, Dept Life Sci, Trieste, Italy	University of Trento; University of Trieste	Chiandetti, C (corresponding author), Univ Trento, Ctr Mind Brain Sci, Rovereto, Trento, Italy.	cinzia.chiandetti@unitn.it		CHIANDETTI, CINZIA/0000-0002-7774-6068	Fondazione Cassa di Risparmio di Trento e Rovereto; Provincia Autonoma di Trento	Fondazione Cassa di Risparmio di Trento e Rovereto(Fondazione Caritro); Provincia Autonoma di Trento(Autonomous Province of Trento)	This research was supported by Fondazione Cassa di Risparmio di Trento e Rovereto and Provincia Autonoma di Trento. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew RJ, 2004, BEHAV BRAIN RES, V155, P67, DOI 10.1016/j.bbr.2004.04.016; Andrew RJ, 1991, USE CHICK MODEL; Cavoto KK, 2001, J EXP PSYCHOL-ANIM B, V27, P3, DOI 10.1037//0097-7403.27.1.3; Chiandetti C, 2011, BEHAV NEUROSCI, V125, P775, DOI 10.1037/a0024721; DELIS DC, 1988, J CLIN EXP NEUROPSYC, V10, P421, DOI 10.1080/01688638808408250; Deruelle C, 1998, PSYCHON B REV, V5, P476, DOI 10.3758/BF03208825; Diekamp B, 2005, CURR BIOL, V15, pR372, DOI 10.1016/j.cub.2005.05.017; Fagot J, 1999, J COMP PSYCHOL, V113, P3, DOI 10.1037/0735-7036.113.1.3; Hopkins WD, 2002, ANIM COGN, V5, P27, DOI 10.1007/s10071-001-0121-8; KIMCHI R, 1992, PSYCHOL BULL, V112, P24, DOI 10.1037/0033-2909.112.1.24; Legge ELG, 2009, BEHAV PROCESS, V80, P128, DOI 10.1016/j.beproc.2008.10.011; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; NAVON D, 1981, PSYCHOL RES-PSYCH FO, V43, P1, DOI 10.1007/BF00309635; Neiworth JJ, 2006, J COMP PSYCHOL, V120, P323, DOI 10.1037/0735-7036.120.4.323; Rogers L.J., 2013, DIVIDED BRAINS BIOL; Rogers Lesley J., 2002, P126, DOI 10.1017/CBO9780511546372.006; ROGERS LJ, 1982, NATURE, V297, P223, DOI 10.1038/297223a0; ROGERS LJ, 1979, PHARMACOL BIOCHEM BE, V10, P679, DOI 10.1016/0091-3057(79)90320-4; Rugani R, 2010, BIOL LETTERS, V6, P290, DOI 10.1098/rsbl.2009.0960; Spinozzi G, 2003, J COMP PSYCHOL, V117, P15, DOI 10.1037/0735-7036.117.1.15; Tommasi L, 2001, BEHAV NEUROSCI, V115, P602, DOI 10.1037//0735-7044.115.3.602; Truppa V, 2010, BEHAV BRAIN RES, V207, P51, DOI 10.1016/j.bbr.2009.09.039; Vallortigara G, 2004, J COGNITIVE NEUROSCI, V16, P390, DOI 10.1162/089892904322926737; Vallortigara G, 2011, WIRES COGN SCI, V2, P146, DOI 10.1002/wcs.100; Yamazaki Y, 2007, COGNITION, V104, P315, DOI 10.1016/j.cognition.2006.07.004	25	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84435	10.1371/journal.pone.0084435	http://dx.doi.org/10.1371/journal.pone.0084435			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404163	gold, Green Published, Green Submitted			2022-12-27	WOS:000329460800042
J	Van der Auwera, S; Bulla, I; Ziller, M; Pohlmann, A; Harder, T; Stanke, M				Van der Auwera, Sandra; Bulla, Ingo; Ziller, Mario; Pohlmann, Anne; Harder, Timm; Stanke, Mario			ClassyFlu: Classification of Influenza A Viruses with Discriminatively Trained Profile-HMMs	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PANDEMIC INFLUENZA	Accurate and rapid characterization of influenza A virus (IAV) hemagglutinin (HA) and neuraminidase (NA) sequences with respect to subtype and clade is at the basis of extended diagnostic services and implicit to molecular epidemiologic studies. ClassyFlu is a new tool and web service for the classification of IAV sequences of the HA and NA gene into subtypes and phylogenetic clades using discriminatively trained profile hidden Markov models (HMMs), one for each subtype or clade. ClassyFlu merely requires as input unaligned, full-length or partial HA or NA DNA sequences. It enables rapid and highly accurate assignment of HA sequences to subtypes H1-H17 but particularly focusses on the finer grained assignment of sequences of highly pathogenic avian influenza viruses of subtype H5N1 according to the cladistics proposed by the H5N1 Evolution Working Group. NA sequences are classified into subtypes N1-N10. ClassyFlu was compared to semiautomatic classification approaches using BLAST and phylogenetics and additionally for H5 sequences to the new "Highly Pathogenic H5N1 Clade Classification Tool" (IRD-CT) proposed by the Influenza Research Database. Our results show that both web tools (ClassyFlu and IRD-CT), although based on different methods, are nearly equivalent in performance and both are more accurate and faster than semiautomatic classification. A retraining of ClassyFlu to altered cladistics as well as an extension of ClassyFlu to other IAV genome segments or fragments thereof is undemanding. This is exemplified by unambiguous assignment to a distinct cluster within subtype H7 of sequences of H7N9 viruses which emerged in China early in 2013 and caused more than 130 human infections. http://bioinf.uni-greifswald.de/ClassyFlu is a free web service. For local execution, the ClassyFlu source code in PERL is freely available.	[Van der Auwera, Sandra; Bulla, Ingo; Stanke, Mario] Ernst Moritz Arndt Univ Greifswald, Inst Math & Comp Sci, Greifswald, Germany; [Ziller, Mario; Pohlmann, Anne; Harder, Timm] Fed Res Inst Anim Hlth, Greifswald, Germany; [Bulla, Ingo] Los Alamos Natl Lab, Grp T6, Los Alamos, NM USA	Ernst Moritz Arndt Universitat Greifswald; United States Department of Energy (DOE); Los Alamos National Laboratory	Stanke, M (corresponding author), Ernst Moritz Arndt Univ Greifswald, Inst Math & Comp Sci, Greifswald, Germany.	mario.stanke@uni-greifswald.de	Stanke, Mario/P-7876-2019; Harder, Timm/AAE-2932-2019	Stanke, Mario/0000-0001-8696-0384; Harder, Timm/0000-0003-2387-378X	Deutsche Forschungsgemeinschaft [STA 1009/5-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft grant STA 1009/5-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gall A, 2009, J VIROL METHODS, V160, P200, DOI 10.1016/j.jviromet.2009.05.004; Guan Y, 2010, PROTEIN CELL, V1, P9, DOI 10.1007/s13238-010-0008-z; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Lam TTY, 2013, NATURE; Mak PWY, 2012, CLIN CHEM, V58, P1527, DOI 10.1373/clinchem.2012.182626; Meyer A, 2013, PHIL T R SOC B; Pleschka S, 2013, CURR TOP MICROBIOL, V370, P1, DOI 10.1007/82_2012_272; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Squires RB, 2012, INFLUENZA OTHER RESP, V6, P404, DOI 10.1111/j.1750-2659.2011.00331.x; Suarez David L., 2010, Animal Health Research Reviews, V11, P19, DOI 10.1017/S1466252310000095; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WHO, 2013, UPD UN NOM SYST HIGH; Yen HL, 2009, CURR TOP MICROBIOL, V333, P3, DOI 10.1007/978-3-540-92165-3_1; Zhu XY, 2012, P NATL ACAD SCI USA, V109, P18903, DOI 10.1073/pnas.1212579109	20	6	6	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84558	10.1371/journal.pone.0084558	http://dx.doi.org/10.1371/journal.pone.0084558			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404173	Green Submitted, Green Published, gold			2022-12-27	WOS:000329460800052
J	Sun, YY; Chen, LN; Xu, RD; Kong, RQ				Sun, Yuanyuan; Chen, Lina; Xu, Rudan; Kong, Ruiqing			An Image Encryption Algorithm Utilizing Julia Sets and Hilbert Curves	PLOS ONE			English	Article							CRYPTANALYSIS	Image encryption is an important and effective technique to protect image security. In this paper, a novel image encryption algorithm combining Julia sets and Hilbert curves is proposed. The algorithm utilizes Julia sets' parameters to generate a random sequence as the initial keys and gets the final encryption keys by scrambling the initial keys through the Hilbert curve. The final cipher image is obtained by modulo arithmetic and diffuse operation. In this method, it needs only a few parameters for the key generation, which greatly reduces the storage space. Moreover, because of the Julia sets' properties, such as infiniteness and chaotic characteristics, the keys have high sensitivity even to a tiny perturbation. The experimental results indicate that the algorithm has large key space, good statistical property, high sensitivity for the keys, and effective resistance to the chosen-plaintext attack.	[Sun, Yuanyuan; Xu, Rudan; Kong, Ruiqing] Dalian Univ Technol, Coll Comp Sci & Technol, Dalian, Peoples R China; [Chen, Lina] Chinese Acad Sci, Natl Astron Observ, Beijing, Peoples R China	Dalian University of Technology; Chinese Academy of Sciences; National Astronomical Observatory, CAS	Sun, YY (corresponding author), Dalian Univ Technol, Coll Comp Sci & Technol, Dalian, Peoples R China.	syuan@dlut.edu.cn			National Natural Science Foundation of China [61103147, 61075018, 61070098]; National Key Project of Science and Technology of China [2011ZX05039-003-4]; Fundamental Research Funds for the Central Universities [DUT12JB06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Project of Science and Technology of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research is supported by the National Natural Science Foundation of China (No. 61103147, 61075018, 61070098, http://www.nsfc.gov.cn), the National Key Project of Science and Technology of China (No. 2011ZX05039-003-4, http://www.most.gov.cn) and the Fundamental Research Funds for the Central Universities (No. DUT12JB06, http://www.dlut.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen GR, 2004, CHAOS SOLITON FRACT, V21, P749, DOI 10.1016/j.chaos.2003.12.022; Falconer KJ, 2003, FRACTAL MATH FDN APP; Hermassi H, 2010, COMMUN NONLINEAR SCI, V15, P2987, DOI 10.1016/j.cnsns.2009.11.022; Kumar S, 2006, MILCOM 2006, P1, DOI [10.1109/MILCOM.2006.302396, DOI 10.1109/MILCOM.2006.302396]; Li CQ, 2012, NONLINEAR DYNAM, V70, P2383, DOI 10.1007/s11071-012-0626-5; Li CQ, 2011, SIGNAL PROCESS, V91, P949, DOI 10.1016/j.sigpro.2010.09.014; Lin KT, 2012, OPT COMMUN, V285, P2335, DOI 10.1016/j.optcom.2012.01.028; Liu Wen-tao, 2008, Journal of China Academy of Electronics and Information Technology, V3, P580; Lock Abraham Jun Jiang, 2010, Proceedings Second International Conference on Computer Research and Development (ICCRD 2010), P213, DOI 10.1109/ICCRD.2010.40; Rozouvan V, 2009, OPT LASER ENG, V47, P1, DOI 10.1016/j.optlaseng.2008.09.001; Shyu SH, 2007, PATTERN RECOGN, V40, P1014, DOI 10.1016/j.patcog.2006.02.025; Tong XJ, 2009, SIGNAL PROCESS, V89, P480, DOI 10.1016/j.sigpro.2008.09.011; Yuan-yuan Sun, 2010, 2010 International Workshop on Chaos-Fractals Theories and Applications (IWCFTA 2010), P170, DOI 10.1109/IWCFTA.2010.70; Yuen CH, 2012, FRACTALS, V20, P41, DOI 10.1142/S0218348X12500041; Yuen CH, 2011, APPL SOFT COMPUT, V11, P5092, DOI 10.1016/j.asoc.2011.05.050	15	95	96	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84655	10.1371/journal.pone.0084655	http://dx.doi.org/10.1371/journal.pone.0084655			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404181	Green Published, gold			2022-12-27	WOS:000329460800060
J	Zhang, XC; Zhu, XL; Wang, X; Zhu, XZ; Zhong, MT; Yi, JY; Rao, HY; Yao, SQ				Zhang, Xiaocui; Zhu, Xueling; Wang, Xiang; Zhu, Xiongzhao; Zhong, Mingtian; Yi, Jinyao; Rao, Hengyi; Yao, Shuqiao			First-Episode Medication-Naive Major Depressive Disorder Is Associated with Altered Resting Brain Function in the Affective Network	PLOS ONE			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; POSITRON-EMISSION-TOMOGRAPHY; ORBITOFRONTAL CORTEX; SPONTANEOUS FLUCTUATIONS; TRYPTOPHAN DEPLETION; REGIONAL HOMOGENEITY; NEGATIVE AFFECT; DEFAULT MODE; STATE; CONNECTIVITY	Background: Major depressive disorder (MDD) has been associated with abnormal structure and function of the brain's affective network, including the amygdala and orbitofrontal cortex (OFC). However, it is unclear if alterations of resting-state function in this affective network are present at the initial onset of MDD. Aims: To examine resting-state function of the brain's affective network in first-episode, medication-naive patients with MDD compared to healthy controls (HCs). Methods: Resting-state functional magnetic resonance imaging (rs-fMRI) was performed on 32 first-episode, medication-naive young adult patients with MDD and 35 matched HCs. The amplitude of low-frequency fluctuations (ALFF) of the blood oxygen level-dependent (BOLD) signal and amygdala-seeded functional connectivity (FC) were investigated. Results: Compared to HC, MDD patients showed reduced ALFF in the bilateral OFC and increased ALFF in the bilateral temporal lobe extending to the insular and left fusiform cortices. Enhanced anti-correlation of activity between the left amygdala seed and the left OFC was found in MDD patients but not in HCs. Conclusions: Reduced ALFF in the OFC suggests hypo-functioning of emotion regulation in the affective network. Enhanced anti-correlation of activity between the amygdala and OFC may reflect dysfunction of the amygdala-OFC network and additionally represent a pathological process of MDD.	[Zhang, Xiaocui; Zhu, Xueling; Wang, Xiang; Zhu, Xiongzhao; Yi, Jinyao; Yao, Shuqiao] Cent S Univ, Xiangya Hosp 2, Inst Med Psychol, Changsha, Hunan, Peoples R China; [Zhang, Xiaocui; Rao, Hengyi] Univ Penn, Ctr Funct Neuroimaging, Dept Neurol, Philadelphia, PA 19104 USA; [Zhong, Mingtian] S China Normal Univ, Sch Psychol, Guangzhou, Guangdong, Peoples R China; [Rao, Hengyi] Sun Yat Sen Univ, Dept Psychol, Guangzhou 510275, Guangdong, Peoples R China	Central South University; University of Pennsylvania; Pennsylvania Medicine; South China Normal University; Sun Yat Sen University	Yao, SQ (corresponding author), Cent S Univ, Xiangya Hosp 2, Inst Med Psychol, Changsha, Hunan, Peoples R China.	shuqiaoyao@163.com	Rao, Hengyi/K-5152-2019; Rao, Hengyi/AAQ-4919-2020; Rao, Hengyi/A-7064-2009; Zhong, Mingtian/AAA-3305-2022	Rao, Hengyi/0000-0003-2735-2500; Rao, Hengyi/0000-0003-2735-2500; 	National Natural Science Foundation of China [30670709, 81071104, 30700236, 81301211, 31070984]; China Scholarship Council	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	This work was supported by the National Natural Science Foundation of China (Grant No. 30670709, 81071104 awarded to Shuqiao Yao, Grant No. 30700236 awarded to Xiang Wang, Grant No. 81301211 awarded to Xueling Zhu and Grant No. 31070984 awarded to Hengyi Rao). This work is partly supported by China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; BIVER F, 1994, BIOL PSYCHIAT, V36, P381, DOI 10.1016/0006-3223(94)91213-0; Bremner JD, 2002, BIOL PSYCHIAT, V51, P273, DOI 10.1016/S0006-3223(01)01336-1; Bremner JD, 2003, JAMA-J AM MED ASSOC, V289, P3125, DOI 10.1001/jama.289.23.3125; Bremner JD, 1997, ARCH GEN PSYCHIAT, V54, P364; BROZOSKI TJ, 1979, SCIENCE, V205, P929, DOI 10.1126/science.112679; de Almeida JRC, 2009, BIOL PSYCHIAT, V66, P451, DOI 10.1016/j.biopsych.2009.03.024; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Dichter GS, 2009, SOC COGN AFFECT NEUR, V4, P59, DOI 10.1093/scan/nsn037; Dougherty DD, 2004, ARCH GEN PSYCHIAT, V61, P795, DOI 10.1001/archpsyc.61.8.795; DREVETS WC, 1992, J NEUROSCI, V12, P3628; DREVETS WC, 1995, J CEREB BLOOD FLOW M, V15, pS93; Fales CL, 2008, BIOL PSYCHIAT, V63, P377, DOI 10.1016/j.biopsych.2007.06.012; First M.B., 2016, STRUCTURED CLIN INTE; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00019, 10.3389/fnsys.2010.0001]; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Galynker II, 1998, J NUCL MED, V39, P608; Gan ZY, 2011, J AFFECT DISORDERS, V134, P119, DOI 10.1016/j.jad.2011.05.054; Goncalves SI, 2006, NEUROIMAGE, V30, P203, DOI 10.1016/j.neuroimage.2005.09.062; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Guo WB, 2011, PROG NEURO-PSYCHOPH, V35, P1297, DOI 10.1016/j.pnpbp.2011.02.006; Hahn T, 2011, ARCH GEN PSYCHIAT, V68, P361, DOI 10.1001/archgenpsychiatry.2010.178; Jiao Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025159; Johnstone T, 2007, J NEUROSCI, V27, P8877, DOI 10.1523/JNEUROSCI.2063-07.2007; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Lacerda ALT, 2004, BIOL PSYCHIAT, V55, P353, DOI 10.1016/j.biopsych.2003.08.021; Liu ZF, 2010, PSYCHIAT RES-NEUROIM, V182, P211, DOI 10.1016/j.pscychresns.2010.03.004; Lui S, 2010, ARCH GEN PSYCHIAT, V67, P783, DOI 10.1001/archgenpsychiatry.2010.84; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Monkul ES, 2012, HUM BRAIN MAPP, V33, P272, DOI 10.1002/hbm.21212; Murray EA, 2007, ANN NY ACAD SCI, V1121, P273, DOI 10.1196/annals.1401.021; Nagafusa Y, 2012, J AFFECT DISORDERS, V140, P296, DOI 10.1016/j.jad.2012.03.026; Neumeister A, 2004, ARCH GEN PSYCHIAT, V61, P765, DOI 10.1001/archpsyc.61.8.765; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Phan KL, 2005, BIOL PSYCHIAT, V57, P210, DOI 10.1016/j.biopsych.2004.10.030; Phillips MR, 2009, LANCET, V373, P2041, DOI 10.1016/S0140-6736(09)60660-7; Price JL, 2007, ANN NY ACAD SCI, V1121, P54, DOI 10.1196/annals.1401.008; Quirk GJ, 2006, CURR OPIN NEUROBIOL, V16, P723, DOI 10.1016/j.conb.2006.07.004; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rajkowska G, 2000, BIOL PSYCHIAT, V48, P766, DOI 10.1016/S0006-3223(00)00950-1; Rajkowska G, 1999, BIOL PSYCHIAT, V45, P1085, DOI 10.1016/S0006-3223(99)00041-4; Rogers RD, 1999, NEUROPSYCHOPHARMACOL, V20, P322, DOI 10.1016/S0893-133X(98)00091-8; Rosenkranz JA, 2003, J NEUROSCI, V23, P11054; Salzman CD, 2010, ANNU REV NEUROSCI, V33, P173, DOI 10.1146/annurev.neuro.051508.135256; Scheuerecker J, 2010, J PSYCHIATR NEUROSCI, V35, P311, DOI 10.1503/jpn.090076; Shimamura AP, 2000, PSYCHOBIOLOGY, V28, P207; Shmuel A, 2008, HUM BRAIN MAPP, V29, P751, DOI 10.1002/hbm.20580; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Steingard RJ, 2000, BIOL PSYCHIAT, V48, P1053, DOI 10.1016/S0006-3223(00)00942-2; Tang Y, 2013, PSYCHOL MED, V43, P1921, DOI 10.1017/S0033291712002759; Tao H, 2013, MOL PSYCHIATR, V18, P101, DOI 10.1038/mp.2011.127; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; Veer IM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00041; Versace A, 2010, BIOL PSYCHIAT, V67, P422, DOI 10.1016/j.biopsych.2009.11.025; Victor TA, 2010, ARCH GEN PSYCHIAT, V67, P1128, DOI 10.1001/archgenpsychiatry.2010.144; Wang LH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039845, 10.1371/journal.pone.0051769, 10.1371/journal.pone.0045491, 10.1371/journal.pone.0044596]; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Wu QZ, 2011, HUM BRAIN MAPP, V32, P1290, DOI 10.1002/hbm.21108; Yang HJ, 2004, J AFFECT DISORDERS, V82, P419, DOI 10.1016/j.jad.2004.04.008; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059; Zhong MT, 2012, PSYCHIAT RES-NEUROIM, V201, P107, DOI 10.1016/j.pscychresns.2011.06.003; Zhu XL, 2012, BIOL PSYCHIAT, V71, P611, DOI 10.1016/j.biopsych.2011.10.035	69	206	219	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85241	10.1371/journal.pone.0085241	http://dx.doi.org/10.1371/journal.pone.0085241			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24933024	Green Submitted, Green Published, gold			2022-12-27	WOS:000329866300057
J	Park, S; Ang, RR; Duffy, SP; Bazov, J; Chi, KN; Black, PC; Ma, HS				Park, Sunyoung; Ang, Richard R.; Duffy, Simon P.; Bazov, Jenny; Chi, Kim N.; Black, Peter C.; Ma, Hongshen			Morphological Differences between Circulating Tumor Cells from Prostate Cancer Patients and Cultured Prostate Cancer Cells	PLOS ONE			English	Article							METASTATIC BREAST-CANCER; LABEL-FREE ISOLATION; PERIPHERAL-BLOOD; IMMUNOCYTOCHEMICAL DETECTION; BONE-MARROW; SEPARATION; SIZE; PROGRESSION; SURVIVAL; MICROCHANNEL	Circulating tumor cell (CTC) enumeration promises to be an important predictor of clinical outcome for a range of cancers. Established CTC enumeration methods primarily rely on affinity capture of cell surface antigens, and have been criticized for underestimation of CTC numbers due to antigenic bias. Emerging CTC capture strategies typically distinguish these cells based on their assumed biomechanical characteristics, which are often validated using cultured cancer cells. In this study, we developed a software tool to investigate the morphological properties of CTCs from patients with castrate resistant prostate cancer and cultured prostate cancer cells in order to establish whether the latter is an appropriate model for the former. We isolated both CTCs and cultured cancer cells from whole blood using the CellSearch (R) system and examined various cytomorphological characteristics. In contrast with cultured cancer cells, CTCs enriched by CellSearch (R) system were found to have significantly smaller size, larger nuclear-cytoplasmic ratio, and more elongated shape. These CTCs were also found to exhibit significantly more variability than cultured cancer cells in nuclear-cytoplasmic ratio and shape profile.	[Park, Sunyoung; Ang, Richard R.; Duffy, Simon P.; Ma, Hongshen] Univ British Columbia, Dept Mech Engn, Vancouver, BC V6T 1W5, Canada; [Duffy, Simon P.] Kwantlen Polytech Univ, Dept Biol, Surrey, BC, Canada; [Bazov, Jenny; Chi, Kim N.; Ma, Hongshen] Vancouver Gen Hosp, Vancouver Prostate Ctr, Vancouver, BC, Canada; [Chi, Kim N.; Black, Peter C.] BC Canc Agcy, Vancouver Canc Ctr, Vancouver, BC, Canada; [Chi, Kim N.; Black, Peter C.; Ma, Hongshen] Univ British Columbia, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia; British Columbia Cancer Agency; University of British Columbia	Ma, HS (corresponding author), Univ British Columbia, Dept Mech Engn, Vancouver, BC V6T 1W5, Canada.	hongma@mech.ubc.ca	Black, Peter/AAE-8424-2020	Black, Peter/0000-0002-2919-7068; Miller, Carol/0000-0002-3091-5602; Dobrowski, Solomon/0000-0003-2561-3850	Natural Science and Engineering Research Council of Canada; Canadian Institutes of Health Research; Vancouver Prostate Centre's Translational Research Initiative for Accelerated Discovery and Development; Terry Fox Research Institute; Movember Global Action Plan (GAP) Prostate Cancer Biomarker Initiative; Engineers-in-Scrubs training program at UBC; Prostate Cancer Canada	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Vancouver Prostate Centre's Translational Research Initiative for Accelerated Discovery and Development; Terry Fox Research Institute; Movember Global Action Plan (GAP) Prostate Cancer Biomarker Initiative; Engineers-in-Scrubs training program at UBC; Prostate Cancer Canada	This work was supported by grants from Natural Science and Engineering Research Council of Canada, Canadian Institutes of Health Research, Prostate Cancer Canada, Vancouver Prostate Centre's Translational Research Initiative for Accelerated Discovery and Development, Engineers-in-Scrubs training program at UBC, Terry Fox Research Institute, and an award from the Movember Global Action Plan (GAP) Prostate Cancer Biomarker Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alazzam A, 2011, ELECTROPHORESIS, V32, P1327, DOI 10.1002/elps.201000625; Alix-Panabieres C, 2012, ANNU REV MED, V63, P199, DOI 10.1146/annurev-med-062310-094219; Andreopoulou E, 2012, INT J CANCER, V130, P1590, DOI 10.1002/ijc.26111; Armstrong AJ, 2011, MOL CANCER RES, V9, P997, DOI 10.1158/1541-7786.MCR-10-0490; Bhagat AAS, 2008, LAB CHIP, V8, P1906, DOI 10.1039/b807107a; Borgen E, 1999, CYTOTHERAPY, V1, P377, DOI 10.1080/0032472031000141283; BREIER A, 1994, GEN PHYSIOL BIOPHYS, V13, P287; Chi KN, 2012, J CLIN ONCOL, V30; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Coumans FAW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061770; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Danila DC, 2007, CLIN CANCER RES, V13, P7053, DOI 10.1158/1078-0432.CCR-07-1506; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; Desitter I, 2011, ANTICANCER RES, V31, P427; DONG C, 1991, BIORHEOLOGY, V28, P557; Fehm T, 2005, CYTOTHERAPY, V7, P171, DOI 10.1080/14653240510027082; Gascoyne PRC, 2009, ELECTROPHORESIS, V30, P1388, DOI 10.1002/elps.200800373; Gerhardt T, 2011, LAB CHIP, V11, P2731, DOI 10.1039/c1lc20092e; Hofman V, 2011, INT J CANCER, V129, P1651, DOI 10.1002/ijc.25819; Huang SB, 2013, LAB CHIP, V13, P1371, DOI 10.1039/c3lc41256c; Hur SC, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3576780; Hyun KA, 2013, BIOSENS BIOELECTRON, V40, P206, DOI 10.1016/j.bios.2012.07.021; Jin C, 2013, LAB CHIP; Joosse SA, 2012, CLIN CANCER RES, V18, P993, DOI 10.1158/1078-0432.CCR-11-2100; Kraeft SK, 2000, CLIN CANCER RES, V6, P434; Lazar DC, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/1/016002; Ligthart ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067148; Lin HK, 2010, CLIN CANCER RES, V16, P5011, DOI 10.1158/1078-0432.CCR-10-1105; Marrinucci D, 2007, HUM PATHOL, V38, P514, DOI 10.1016/j.humpath.2006.08.027; Marrinucci D, 2010, J ONCOL, V2010, DOI 10.1155/2010/861341; Matrone MA, 2010, CANCER RES, V70, P7737, DOI 10.1158/0008-5472.CAN-10-1569; McFaul SM, 2012, LAB CHIP, V12, P2369, DOI 10.1039/c2lc21045b; Mehes G, 2001, AM J PATHOL, V159, P17, DOI 10.1016/S0002-9440(10)61667-7; Meng SD, 2004, CLIN CANCER RES, V10, P8152, DOI 10.1158/1078-0432.CCR-04-1110; Miller MC, 2010, J ONCOL, V2010, DOI 10.1155/2010/617421; Otsuka K, 2013, ANTICANCER RES, V33, P625; Pantel K, 2009, NAT REV CLIN ONCOL, V6, P339, DOI 10.1038/nrclinonc.2009.44; Pierga JY, 2004, CLIN CANCER RES, V10, P1392, DOI 10.1158/1078-0432.CCR-0102-03; Raimondi C, 2011, BREAST CANCER RES TR, V130, P449, DOI 10.1007/s10549-011-1373-x; Riethdorf S, 2007, CLIN CANCER RES, V13, P920, DOI 10.1158/1078-0432.CCR-06-1695; Rosenberg R, 2002, CYTOMETRY, V49, P150, DOI 10.1002/cyto.10161; Shaffer DR, 2007, CLIN CANCER RES, V13, P2023, DOI 10.1158/1078-0432.CCR-06-2701; SHI YA, 1993, BIOTECHNOL BIOENG, V41, P745, DOI 10.1002/bit.260410709; Shim S, 2011, INTEGR BIOL-UK, V3, P850, DOI 10.1039/c1ib00032b; Sim TS, 2011, LAB CHIP, V11, P93, DOI [10.1039/c0lc00109k, 10.1039/c01c00109k]; Song H, 2003, BIOTECHNOL PROGR, V19, P1742, DOI 10.1021/bp034061n; Sun JS, 2012, LAB CHIP, V12, P3952, DOI 10.1039/c2lc40679a; Tan SJ, 2010, BIOSENS BIOELECTRON, V26, P1701, DOI 10.1016/j.bios.2010.07.054; Vona G, 2000, AM J PATHOL, V156, P57, DOI 10.1016/S0002-9440(10)64706-2; WEISS L, 1992, CANCER METAST REV, V11, P227, DOI 10.1007/BF01307179; Willipinski-Stapelfeldt B, 2005, CLIN CANCER RES, V11, P8006, DOI 10.1158/1078-0432.CCR-05-0632; Yap TA, 2010, NAT REV CANCER, V10, P514, DOI 10.1038/nrc2870; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Zhe XN, 2011, AM J CANCER RES, V1, P740; Zheng SY, 2011, BIOMED MICRODEVICES, V13, P203, DOI 10.1007/s10544-010-9485-3; Zhou J, 2013, LAB CHIP, V13, P1919, DOI 10.1039/c3lc50101a	56	129	139	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85264	10.1371/journal.pone.0085264	http://dx.doi.org/10.1371/journal.pone.0085264			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24941290	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500231
J	Hu, JH; Liu, Y				Hu, Junhua; Liu, Yang			Unveiling the Conservation Biogeography of a Data-Deficient Endangered Bird Species under Climate Change	PLOS ONE			English	Article							HERON GORSACHIUS-MAGNIFICUS; RANGE SHIFTS; COUPLED MODEL; IMPROVE; NICHE; UNCERTAINTIES; DISTRIBUTIONS; PREDICTION; PATTERNS; MAXIMUM	It remains a challenge to identify the geographical patterns and underlying environmental associations of species with unique ecological niches and distinct behaviors. This in turn hinders our understanding of the ecology as well as effective conservation management of threatened species. The white-eared night heron (Gorsachius magnificus) is a non-migratory nocturnal bird species that has a patchy distribution in the mountainous forests of East Asia. It is currently categorized as "Endangered'' on the IUCN Red List, primarily due to its restricted range and fragmented habitat. To improve our knowledge of the biogeography and conservation of this species, we modeled the geographical pattern of its suitable habitat and evaluated the potential impacts of climate change using ecological niche modeling with a maximum entropy approach implemented in Maxent. Our results indicated that the amount of suitable habitat in all of East Asia was about 130 000 km(2), which can be spatially subdivided into several mountain ranges in southern and southwestern China and northern Vietnam. The extent of suitable habitat range may shrink by more than 35% under a predicted changing climate when assuming the most pessimistic condition of dispersal, while some more suitable habitat would be available if the heron could disperse unrestrainedly. The significant future changes in habitat suitability suggested for Gorsachius magnificus urge caution in any downgrading of Red List status that may be considered. Our results also discern potentially suitable areas for future survey efforts on new populations. Overall, this study demonstrates that ecological niche modeling offers an important tool for evaluating the habitat suitability and potential impacts of climate change on an enigmatic and endangered species based on limited presence data.	[Hu, Junhua] Chinese Acad Sci, Chengdu Inst Biol, Key Lab Mt Ecol Restorat & Bioresource Utilizat, Chengdu, Peoples R China; [Hu, Junhua] Chinese Acad Sci, Chengdu Inst Biol, Ecol Restorat Biodivers Conservat Key Lab Sichuan, Chengdu, Peoples R China; [Liu, Yang] Sun Yat Sen Univ, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Yang] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Sun Yat Sen University; Sun Yat Sen University	Liu, Y (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	liuy353@mail.sysu.edu.cn	hu, jh/B-4853-2010	hu, jh/0000-0002-6669-8443	National Natural Science Foundation of China [31270568, 31301875]; Sun Yat-sen University, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sun Yat-sen University, China	This project was supported by the National Natural Science Foundation of China (No. 31270568 to JHH; 31301875 to YL), and the "The One Hundred Talents Project (Bai Ren Ji Hua)" of Sun Yat-sen University, China to YL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2006, SCIENCE, V313, P1396, DOI 10.1126/science.1131758; Beaumont LJ, 2005, ECOL MODEL, V186, P250, DOI 10.1016/j.ecolmodel.2005.01.030; BirdLife International, 2012, IUCN 2012 IUCN RED L; Bosso L, 2013, J NAT CONSERV, V21, P72, DOI 10.1016/j.jnc.2012.10.003; Buisson L, 2010, GLOBAL CHANGE BIOL, V16, P1145, DOI 10.1111/j.1365-2486.2009.02000.x; Carvalho SB, 2010, BIOL CONSERV, V143, P426, DOI 10.1016/j.biocon.2009.11.010; Collins M, 2001, CLIM DYNAM, V17, P61, DOI 10.1007/s003820000094; CRETE M, 1991, ARCTIC, V44, P275; Crosby M, 2003, SAVING ASIAS THREATE; Davidson EA, 2012, NATURE, V481, P321, DOI 10.1038/nature10717; Doko T, 2011, ECOL MODEL, V222, P748, DOI 10.1016/j.ecolmodel.2010.11.005; Dong L, 2010, CONSERV GENET, V11, P2231, DOI 10.1007/s10592-010-0108-6; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Engler R, 2004, J APPL ECOL, V41, P263, DOI 10.1111/j.0021-8901.2004.00881.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Fellowes JR, 2001, BIRD CONSERV INT, V11, P101; Gao Jianyun, 2013, Chinese Birds, V4, P254; Gao Yu-Ren, 2000, Chinese Journal of Zoology, V35, P39; Gordon HB, 1997, MON WEATHER REV, V125, P875, DOI 10.1175/1520-0493(1997)125<0875:TCCITC>2.0.CO;2; Gu LY, 2013, MOL PHYLOGENET EVOL, V67, P129, DOI 10.1016/j.ympev.2012.12.013; Guisan A, 2006, CONSERV BIOL, V20, P501, DOI 10.1111/j.1523-1739.2006.00354.x; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; He FQ, 2007, BIRD CONSERV INT, V17, P93, DOI 10.1017/S0959270906000566; He Fen-Qi, 2007, Acta Zootaxonomica Sinica, V32, P802; He Fengqi, 2011, Chinese Birds, V2, P163; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hof AR, 2012, ECOL MODEL, V246, P86, DOI 10.1016/j.ecolmodel.2012.07.028; Hof C, 2011, NATURE, V480, P516, DOI 10.1038/nature10650; Hole DG, 2009, ECOL LETT, V12, P420, DOI 10.1111/j.1461-0248.2009.01297.x; Hu J, 2010, J ZOOL, V282, P54, DOI 10.1111/j.1469-7998.2010.00715.x; Hu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016061; Hu JH, 2010, OECOLOGIA, V164, P555, DOI 10.1007/s00442-010-1732-z; IUCN, 2012, IUCN RED LIST CATEGO, V2nd ed., P32; Jackson RM, 2006, WILDLIFE SOC B, V34, P772, DOI 10.2193/0091-7648(2006)34[772:ESLPAU]2.0.CO;2; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Kim SJ, 2003, CLIM DYNAM, V20, P635, DOI 10.1007/s00382-002-0292-2; La Sorte FA, 2007, ECOLOGY, V88, P1803, DOI 10.1890/06-1072.1; Ladle R. J., 2011, CONSERVATION BIOGEOG, DOI 10.1002/9781444390001; Lawler JJ, 2006, GLOBAL CHANGE BIOL, V12, P1568, DOI 10.1111/j.1365-2486.2006.01191.x; Li BC, 2007, WATERBIRDS, V30, P301, DOI 10.1675/1524-4695(2007)30[301:FBOAAN]2.0.CO;2; Liu HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046761; Liu Y, 2008, FORKTAIL, P80; Lu N, 2012, CONDOR, V114, P365, DOI 10.1525/cond.2012.110030; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Nakicenovic N., 2000, IPCC SPECIAL REPORT; Nenzen HK, 2011, ECOL MODEL, V222, P3346, DOI 10.1016/j.ecolmodel.2011.07.011; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pilgrim JD, 2009, FORKTAIL, P142; Poncet S, 2006, POLAR BIOL, V29, P772, DOI 10.1007/s00300-006-0114-9; Raes N, 2007, ECOGRAPHY, V30, P727, DOI 10.1111/j.2007.0906-7590.05041.x; Richardson DM, 2010, DIVERS DISTRIB, V16, P313, DOI 10.1111/j.1472-4642.2010.00660.x; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Sattler T, 2007, J APPL ECOL, V44, P1188, DOI 10.1111/j.1365-2664.2007.01328.x; Solomon S., 2007, PHYS SCI BASIS WORKI; Synes NW, 2011, GLOBAL ECOL BIOGEOGR, V20, P904, DOI 10.1111/j.1466-8238.2010.00635.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2006, GLOBAL CHANGE BIOL, V12, P424, DOI 10.1111/j.1365-2486.2006.01115.x; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; Virkkala R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063376; White C.M., 1994, NEW WORLD VULTURES G; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x; Zhou F, 2002, CHINA CRANE NEWS, V6, P30; Zhou GY, 2013, GLOBAL CHANGE BIOL, V19, P1197, DOI 10.1111/gcb.12128; Zimmermann NE, 2009, P NATL ACAD SCI USA, V106, P19723, DOI 10.1073/pnas.0901643106; 李筑眉, 2008, [动物学杂志, Chinese Journal of Zoology], V43, P139	73	66	73	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84529	10.1371/journal.pone.0084529	http://dx.doi.org/10.1371/journal.pone.0084529			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404169	gold, Green Submitted, Green Published			2022-12-27	WOS:000329460800048
J	Zhang, LF; Qi, J; Zuo, GL; Jia, P; Shen, X; Shao, J; Kang, H; Yang, HL; Deng, LF				Zhang, Lian-Fang; Qi, Jin; Zuo, GuiLai; Jia, Peng; Shen, Xing; Shao, Jin; Kang, Hui; Yang, HuiLin; Deng, LianFu			Osteoblast-Secreted Factors Promote Proliferation and Osteogenic Differentiation of Bone Marrow Stromal Cells via VEGF/Heme-Oxygenase-1 Pathway	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ENDOTHELIAL GROWTH-FACTOR; HEME OXYGENASE-1; FACTOR VEGF; IN-VITRO; MOUSE; ANGIOGENESIS; INHIBITION; EXPRESSION; SURVIVAL	The hypoxia-inducible factors (HIF alpha) are the critical factors that couple angiogenesis and osteogenesis by activating transcription of VEGF in osteoblasts. Mice lacking von Hippel-Lindau gene (Vhl), thus overexpressing HIF alpha in osteoblasts develop extremely dense and highly vascularized long bones. Here we provide evidence that osteoblasts lacking Vhl overexpress and secrete high levels of VEGF, which subsequently promotes the proliferation and osteogenic differentiation of bone marrow stromal cells (BMSC) by promoting expression of Heme oxygenase-1 (HO-1) in BMSC. Conditioned medium from osteoblasts Vhl (CM-CRE) promoted the proliferation and osteogenic differentiation of BMSC, in comparison with conditioned medium derived from normal osteoblasts (CM-GFP). Recombinant VEGF stimulated the proliferation and osteogenic differentiation of BMSC culturing in CM-GFP. By contrast, VEGF-neutralizing antibody inhibited the proliferation and osteogenic differentiation of BMSC culturing in CM-CRE. Treatment with a HO-1 inhibitor, SnPP, significantly inhibited VEGF-induced BMSC proliferation and osteogenic differentiation. On the contrary, activation of HO-1 with CoPP reversed the suppressing of VEGF-antibody on the proliferation and osteogesis of BMSC culturing in CM-CRE. These studies suggest that osteoblasts promote the proliferation and osteogenic differentiation of BMCS by VEGF/HO-1 pathway.	[Zhang, Lian-Fang; Qi, Jin; Zuo, GuiLai; Jia, Peng; Shen, Xing; Shao, Jin; Kang, Hui; Deng, LianFu] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Shanghai Inst Traumatol & Orthopaed,Shanghai Key, Shanghai 200030, Peoples R China; [Zhang, Lian-Fang; Yang, HuiLin] Soochow Univ, Affiliated Hosp 1, Dept Orthopaed, Suzhou, Peoples R China	Shanghai Jiao Tong University; Soochow University - China	Deng, LF (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Shanghai Inst Traumatol & Orthopaed,Shanghai Key, Shanghai 200030, Peoples R China.	deng_lianfu@hotmail.com		Xu, Yunan/0000-0001-6484-6118	International Cooperation and Exchange of the National Natural Science Foundation of China [81061160510]; Foundation of Science and Technology Commission of Shanghai Municipality [12JC1408200, 13431900702]; Graduate Student Innovation Fund of Shanghai Jiao Tong University School of Medicine [BXJ201242]	International Cooperation and Exchange of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Graduate Student Innovation Fund of Shanghai Jiao Tong University School of Medicine	This work was supported by the funds from the International Cooperation and Exchange of the National Natural Science Foundation of China (No. 81061160510), the Foundation of Science and Technology Commission of Shanghai Municipality (No. 12JC1408200, No. 13431900702), and the Graduate Student Innovation Fund of Shanghai Jiao Tong University School of Medicine (No. BXJ201242). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM NG, 1985, EXP HEMATOL, V13, P838; ABRAHAM NG, 1991, BLOOD REV, V5, P19, DOI 10.1016/0268-960X(91)90004-V; Armour KE, 2001, ENDOCRINOLOGY, V142, P760, DOI 10.1210/en.142.2.760; Ball SG, 2007, J CELL BIOL, V177, P489, DOI 10.1083/jcb.200608093; Barbagallo I, 2010, J BONE MINER METAB, V28, P276, DOI 10.1007/s00774-009-0134-y; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Bussolati B, 2004, BLOOD, V103, P761, DOI 10.1182/blood-2003-06-1974; Carlevaro MF, 2000, J CELL SCI, V113, P59; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Dennis JE, 1999, J BONE MINER RES, V14, P700, DOI 10.1359/jbmr.1999.14.5.700; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Garrett IR, 2001, CURR PHARM DESIGN, V7, P715, DOI 10.2174/1381612013397762; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Hiltunen MO, 2003, FASEB J, V17, P1147, DOI 10.1096/fj.02-0514fje; Hsiao FSH, 2010, CELL PROLIFERAT, V43, P235, DOI 10.1111/j.1365-2184.2010.00674.x; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Kweider N, 2011, J BIOL CHEM, V286, P42863, DOI 10.1074/jbc.M111.286880; Lin H, 2008, J CELL PHYSIOL, V216, P458, DOI 10.1002/jcp.21414; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; Marinissen MJ, 2006, J BIOL CHEM, V281, P11332, DOI 10.1074/jbc.M512199200; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; Peng HR, 2002, J CLIN INVEST, V110, P751, DOI 10.1172/JCI200215153; Penna C, 2013, J CELL MOL MED, V17, P192, DOI 10.1111/j.1582-4934.2012.01662.x; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Sass G, 2003, HEPATOLOGY, V38, P909, DOI 10.1053/jhep.2003.50386; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Sun J, 2012, CELLS TISSUES ORGANS, V196, P510, DOI 10.1159/000339245; Sun SK, 2003, STEM CELLS, V21, P527, DOI 10.1634/stemcells.21-5-527; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; Vanella L, 2010, BONE, V46, P236, DOI 10.1016/j.bone.2009.10.012; Wagner M, 2003, KIDNEY INT, V63, P1564, DOI 10.1046/j.1523-1755.2003.00897.x; Wan C, 2008, P NATL ACAD SCI USA, V105, P686, DOI 10.1073/pnas.0708474105; Wang Y, 2007, J CLIN INVEST, V117, P1616, DOI 10.1172/JCI31581; Yeh LCC, 1999, MOL CELL ENDOCRINOL, V153, P113, DOI 10.1016/S0303-7207(99)00076-3; Zhu H, 2010, NAT PROTOC, V5, P550, DOI 10.1038/nprot.2009.238	38	84	96	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99946	10.1371/journal.pone.0099946	http://dx.doi.org/10.1371/journal.pone.0099946			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940620	Green Published, gold, Green Submitted			2022-12-27	WOS:000338508200058
J	Macho, GA				Macho, Gabriele A.			Baboon Feeding Ecology Informs the Dietary Niche of Paranthropus boisei	PLOS ONE			English	Article							MODERN HUMAN TEETH; PAPIO-CYNOCEPHALUS; HOMINID EVOLUTION; DENTAL MICROWEAR; NATIONAL-PARK; FATTY-ACID; AMINO-ACID; BODY-SIZE; ENAMEL; PATTERNS	Hominins are generally considered eclectic omnivores like baboons, but recent isotope studies call into question the generalist status of some hominins. Paranthropus boisei and Australopithecus bahrelghazali derived 75%-80% of their tissues' delta C-13 from C-4 sources, i.e. mainly low-quality foods like grasses and sedges. Here I consider the energetics of P. boisei and the nutritional value of C-4 foods, taking into account scaling issues between the volume of food consumed and body mass, and P. boisei's food preference as inferred from dento-cranial morphology. Underlying the models are empirical data for Papio cynocephalus dietary ecology. Paranthropus boisei only needed to spend some 37%-42% of its daily feeding time (conservative estimate) on C-4 sources to meet 80% of its daily requirements of calories, and all its requirements for protein. The energetic requirements of 2-4 times the basal metabolic rate (BMR) common to mammals could therefore have been met within a 6-hour feeding/foraging day. The findings highlight the high nutritional yield of many C-4 foods eaten by baboons (and presumably hominins), explain the evolutionary success of P. boisei, and indicate that P. boisei was probably a generalist like other hominins. The diet proposed is consistent with the species' derived morphology and unique microwear textures. Finally, the results highlight the importance of baboon/hominin hand in food acquisition and preparation.	Res Lab Archaeol RLAHA, Oxford, England		Macho, GA (corresponding author), Res Lab Archaeol RLAHA, Oxford, England.	Gabriele.Macho@rlaha.ox.ac.uk			Ministerio de Ciencia e Innovacion [CGL2010-20868]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	Funding was provided by Ministerio de Ciencia e Innovacion (CGL2010-20868). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts SC, 2005, CAM S BIO EVOL ANTHR, V44, P157, DOI 10.1017/CBO9780511542343.007; Altmann S.A., 1998, FORAGING SURVIVAL, DOI University of Chicago Press; Altmann SA, 2009, AM J PHYS ANTHROPOL, V140, P615, DOI 10.1002/ajpa.21097; Arafat S. M., 2009, WORLD APPL SCI J, V7, P151; Ashley GM, 2010, QUATERNARY RES, V74, P304, DOI 10.1016/j.yqres.2010.07.015; Bentley-Condit VK, 2009, AM J PRIMATOL, V71, P432, DOI 10.1002/ajp.20670; Bond B, 2005, J FOOD COMPOS ANAL, V18, P675, DOI 10.1016/j.jfca.2004.06.006; Bonnefille R, 2010, GLOBAL PLANET CHANGE, V72, P390, DOI 10.1016/j.gloplacha.2010.01.015; Boyde A., 1989, HDB MICROSCOPIC ANAT, P309; Bronikowski AM, 1996, BEHAV ECOL SOCIOBIOL, V39, P11, DOI 10.1007/s002650050262; BYRNE RW, 1993, BEHAV ECOL SOCIOBIOL, V33, P233, DOI 10.1007/BF02027120; Cerling TE, 2013, P NATL ACAD SCI USA, V110, P10507, DOI 10.1073/pnas.1222571110; Cerling TE, 2013, P NATL ACAD SCI USA, V110, P10501, DOI 10.1073/pnas.1222568110; Cerling TE, 2011, P NATL ACAD SCI USA, V108, P9337, DOI 10.1073/pnas.1104627108; Chivers DJ, 1998, P NUTR SOC, V57, P321, DOI 10.1079/PNS19980047; Codron D, 2008, INT J PRIMATOL, V29, P757, DOI 10.1007/s10764-008-9261-x; COELHO A M JR, 1974, Primates, V15, P263, DOI 10.1007/BF01742287; Coelho A.M. Jr, 1986, P141; Deblauwe I, 2008, AM J PHYS ANTHROPOL, V135, P42, DOI 10.1002/ajpa.20703; DEMES B, 1988, J HUM EVOL, V17, P657, DOI 10.1016/0047-2484(88)90023-1; DEMMENT MW, 1983, AFR J ECOL, V21, P219, DOI 10.1111/j.1365-2028.1983.tb00323.x; Dominy NJ, 2008, EVOL BIOL, V35, P159, DOI 10.1007/s11692-008-9026-7; DUBRUL EL, 1977, AM J PHYS ANTHROPOL, V47, P305, DOI 10.1002/ajpa.1330470211; Elton S, 2006, J ROY ANTHROPOL INST, V12, P19, DOI 10.1111/j.1467-9655.2006.00279.x; Galbany J, 2011, AM J PHYS ANTHROPOL, V144, P51, DOI 10.1002/ajpa.21368; Glew RH, 2006, PLANT FOOD HUM NUTR, V61, P51, DOI 10.1007/s11130-006-0010-z; Grine FE, 2012, AM J PHYS ANTHROPOL, V148, P285, DOI 10.1002/ajpa.22086; HATLEY T, 1980, HUM ECOL, V8, P371, DOI 10.1007/BF01561000; Isler K, 2008, J HUM EVOL, V55, P967, DOI 10.1016/j.jhevol.2008.08.004; Jablonski N.G., 1993, THEROPITHECUS RISE F; Jablonski N.G., 2008, KOOBI FORA RES PROJE, V6; Jiang Y, 2003, ARCH ORAL BIOL, V48, P449, DOI 10.1016/S0003-9969(03)00040-2; JOLLY CJ, 1970, MAN, V5, P5, DOI 10.2307/2798801; Jolly CJ, 2001, YEARB PHYS ANTHROPOL, V44, P177, DOI 10.1002/ajpa.10021; Koch P.L., 1991, ANN REPORT DIRECTOR, P163; Lee-Thorp J, 2012, P NATL ACAD SCI USA, V109, P20369, DOI 10.1073/pnas.1204209109; Lee-Thorp J, 2011, P NATL ACAD SCI USA, V108, P9319, DOI 10.1073/pnas.1105808108; Leonard WR, 1997, AM J PHYS ANTHROPOL, V102, P265, DOI 10.1002/(SICI)1096-8644(199702)102:2<265::AID-AJPA8>3.0.CO;2-X; Lucas PW, 2000, ANN BOT-LONDON, V86, P913, DOI 10.1006/anbo.2000.1261; Macho GA, 2005, ANAT REC PART A, V283A, P310, DOI 10.1002/ar.a.20175; Macho GA, 2004, ANN ANAT, V186, P413, DOI 10.1016/S0940-9602(04)80073-6; Macho GA, 2003, J HUM EVOL, V45, P81, DOI 10.1016/S0047-2484(03)00083-6; Macho GA, 1996, J HUM EVOL, V30, P57, DOI 10.1006/jhev.1996.0004; Macho GA, 2010, J HUM EVOL, V58, P23, DOI 10.1016/j.jhevol.2009.07.004; Macho GA, 2009, J HUM EVOL, V57, P241, DOI 10.1016/j.jhevol.2009.05.003; McHenry HM, 2000, ANNU REV ANTHROPOL, V29, P125, DOI 10.1146/annurev.anthro.29.1.125; MILTON K, 1988, J NUTR, V118, P1082, DOI 10.1093/jn/118.9.1082; Milton K, 2003, COMP BIOCHEM PHYS A, V136, P47, DOI 10.1016/S1095-6433(03)00084-9; Navarrete A, 2011, NATURE, V480, P91, DOI 10.1038/nature10629; OSBORN JW, 1968, J DENT RES, V47, P217, DOI 10.1177/00220345680470020601; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Peters CR, 2005, J HUM EVOL, V48, P219, DOI 10.1016/j.jhevol.2004.11.003; Pochron ST, 2000, FOLIA PRIMATOL, V71, P346, DOI 10.1159/000021758; Pontzer H, 2009, P NATL ACAD SCI USA, V106, P192, DOI 10.1073/pnas.0806105106; Post D. G., 1982, INT J PRIMATOL, V3, P403; POST DG, 1981, ANIM BEHAV, V29, P357, DOI 10.1016/S0003-3472(81)80095-4; Reed KE, 1997, J HUM EVOL, V32, P289, DOI 10.1006/jhev.1996.0106; Rensberger J.M., 2000, P252, DOI 10.1017/CBO9780511542626.018; Robson SL, 2008, J ANAT, V212, P394, DOI 10.1111/j.1469-7580.2008.00867.x; Ross CF, 2009, J HUM EVOL, V56, P570, DOI 10.1016/j.jhevol.2009.02.007; Sage RF, 2011, J EXP BOT, V63, P6297; Shimizu D, 2005, AM J PHYS ANTHROPOL, V126, P427, DOI 10.1002/ajpa.20031; Shimizu D, 2008, ANAT REC, V291, P175, DOI 10.1002/ar.20633; Shipman P., 1988, P343; Shultz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076750; SMITH BH, 1984, AM J PHYS ANTHROPOL, V63, P39, DOI 10.1002/ajpa.1330630107; Swedell L, 2008, FOLIA PRIMATOL, V79, P476, DOI 10.1159/000164431; TAYLOR CR, 1970, AM J PHYSIOL, V219, P1104, DOI 10.1152/ajplegacy.1970.219.4.1104; Tobias P. V., 1967, CRANIUM MAXILLARY DE; TOBIAS PV, 1980, AM J PHYS ANTHROPOL, V53, P173, DOI 10.1002/ajpa.1330530202; Turesson H, 2010, AM J BOT, V97, P1884, DOI 10.3732/ajb.1000200; Umerie SC, 1997, BIORESOURCE TECHNOL, V62, P63, DOI 10.1016/S0960-8524(97)00040-0; Umerie SC, 2000, BIORESOURCE TECHNOL, V72, P193, DOI 10.1016/S0960-8524(99)00103-0; Ungar PS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002044; van Woerden JT, 2012, EVOLUTION, V66, P191, DOI 10.1111/j.1558-5646.2011.01434.x; van Woerden JT, 2010, AM NAT, V176, P758, DOI 10.1086/657045; VONKOENIGSWALD W, 1987, NATURE, V328, P150, DOI 10.1038/328150a0; WHITEN A, 1991, PHILOS T ROY SOC B, V334, P187, DOI 10.1098/rstb.1991.0108; WHITEN A, 1987, INT J PRIMATOL, V8, P367, DOI 10.1007/BF02737389; Wood B, 2004, J HUM EVOL, V46, P119, DOI 10.1016/j.jhevol.2003.11.004; Wood B., 1991, HOMINID CRANIAL REMA, V4; Wood B, 2007, YEARB PHYS ANTHROPOL, V50, P106, DOI 10.1002/ajpa.20732	83	33	34	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84942	10.1371/journal.pone.0084942	http://dx.doi.org/10.1371/journal.pone.0084942			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416315	gold, Green Published, Green Submitted			2022-12-27	WOS:000329862500192
J	Peng, JX; Jiang, XH; Zhang, JX; Xiao, RX; Song, YY; Feng, X; Zhang, Y; Miao, DM				Peng, Jiaxi; Jiang, Xihua; Zhang, Jiaxi; Xiao, Runxuan; Song, Yunyun; Feng, Xi; Zhang, Yan; Miao, Danmin			The Impact of Psychological Capital on Job Burnout of Chinese Nurses: The Mediator Role of Organizational Commitment	PLOS ONE			English	Article							PERFORMANCE; RESOURCES; WORK	Background: Nursing has a high risk of job burnout, but only a few studies have explored its influencing factors from an organizational perspective. Objective: The present study explores the impact of psychological capital on job burnout by investigating the mediating effect of organizational commitment on this relationship. Methods: A total of 473 female nurses from four large general hospitals in Xi'an City of China were selected as participants. Data were collected via the Psychological Capital Questionnaire, the Maslach Burnout Inventory-General Survey, and the Organizational Commitment Scale. Results: Both psychological capital and organizational commitment were significantly correlated to job burnout. Structural equation modelling indicated that organizational commitment partially mediated the relationship between psychological capital and job burnout. Conclusion: The final model revealed a significant path from psychological capital to job burnout through organizational commitment. These findings extended prior reports and shed some light on the influence of psychological capital on job burnout.	[Peng, Jiaxi; Jiang, Xihua; Zhang, Jiaxi; Xiao, Runxuan; Song, Yunyun; Feng, Xi; Zhang, Yan; Miao, Danmin] Fourth Mil Med Univ, Dept Psychol, Xian, Peoples R China	Air Force Military Medical University	Zhang, Y (corresponding author), Fourth Mil Med Univ, Dept Psychol, Xian, Peoples R China.	zhangyanfmmu@126.com; miaodamin@hotmail.com		su, li/0000-0002-1435-9669				Aiken LH, 2001, HEALTH AFFAIR, V20, P43, DOI 10.1377/hlthaff.20.3.43; ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411; Avey J.B., 2006, J LEADERSH ORG STUD, V13, P42, DOI [DOI 10.1177/10717919070130020401, 10.1177/10717919070130020401]; Badri S., 2012, INT C ED MAN INN SIN; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Chang EC, 2000, PERS INDIV DIFFER, V29, P255, DOI 10.1016/S0191-8869(99)00191-9; Cheung GW, 2008, ORGAN RES METHODS, V11, P296, DOI 10.1177/1094428107300343; de Jonge J, 2000, SOC SCI MED, V50, P1317, DOI 10.1016/S0277-9536(99)00388-3; Diener E, 2000, AM PSYCHOL, V55, P34, DOI 10.1037/0003-066X.55.1.34; DUNHAM RB, 1994, J APPL PSYCHOL, V79, P370, DOI 10.1037/0021-9010.79.3.370; Evers WJG, 2002, BRIT J EDUC PSYCHOL, V72, P227, DOI 10.1348/000709902158865; Fan Y, 2012, J XIAN JIAOTONG U SO, V32, P50; FREUDENBERGER HJ, 1974, J SOC ISSUES, V30, P159, DOI 10.1111/j.1540-4560.1974.tb00706.x; Hakanen JJ, 2008, J VOCAT BEHAV, V73, P78, DOI 10.1016/j.jvb.2008.01.003; HOBFOLL SE, 1990, J SOC PERS RELAT, V7, P465, DOI 10.1177/0265407590074004; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jackson D, 2007, J ADV NURS, V60, P1, DOI 10.1111/j.1365-2648.2007.04412.x; Judge TA, 2001, PSYCHOL BULL, V127, P376, DOI 10.1037//0033-2909.127.3.376; King RC, 1997, EUR J INFORM SYST, V6, P86, DOI 10.1057/palgrave.ejis.3000259; Kline R.B., 2011, PRINCIPLES PRACTICE; Larson M., 2006, J LEADERSH ORG STUD, V13, P45, DOI [10.1177/10717919070130020601, DOI 10.1177/10717919070130020601, 10.1177/10717919070130010701, DOI 10.1177/10717919070130010701]; [骆宏 Luo Hong], 2010, [中华护理杂志, Chinese Journal of Nursing], V45, P933; Luthans F, 2004, ORGAN DYN, V33, P143, DOI 10.1016/j.orgdyn.2004.01.003; Luthans F., 2005, MANAGE ORGAN REV, V1, P247, DOI DOI 10.1111/J.1740-8784.2005.00011.X; Luthans F., 2004, BUS HORIZONS, V47, P45, DOI [10.1016/j.bushor.2003.11.007, DOI 10.1016/J.BUSHOR.2003.11.007]; Luthans F., 2006, PSYCHOL CAPITAL DEV; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; MacKinnon D P, 2000, Prev Sci, V1, P173, DOI 10.1023/A:1026595011371; MacKinnon DP, 2004, MULTIVAR BEHAV RES, V39, P99, DOI 10.1207/s15327906mbr3901_4; MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037/1082-989X.7.1.83; MASLACH C, 1981, J OCCUP BEHAV, V2, P99, DOI 10.1002/job.4030020205; Meyer J.P., 1991, HUM RESOUR MANAGE R, V1, P61, DOI [10.1016/1053-4822(91)90011-Z, DOI 10.1016/1053-4822(91)90011-Z]; Meyer JP, 2002, J VOCAT BEHAV, V61, P20, DOI 10.1006/jvbe.2001.1842; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Riolli L., 2003, INT J STRESS MANAGE, V10, P235, DOI DOI 10.1037/1072-5245.10.3.235; Schaufeli W.B., 1996, MASLACH BURNOUT INVE, P19; SHELDON ME, 1971, ADMIN SCI QUART, V16, P143, DOI 10.2307/2391824; SHERWIN ED, 1992, J SOC CLIN PSYCHOL, V11, P129, DOI 10.1521/jscp.1992.11.2.129; Sivarajasingam V, 2002, J PUBLIC HEALTH MED, V24, P219, DOI 10.1093/pubmed/24.3.219; SNYDER CR, 1995, J COUNS DEV, V73, P355, DOI 10.1002/j.1556-6676.1995.tb01764.x; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI 10.2307/270723; Tan D., 1998, INT J ORGAN ANAL, V6, P310, DOI DOI 10.1108/EB028889; Wegge J, 2006, WORK STRESS, V20, P60, DOI 10.1080/02678370600655553; Wright T.A., 2004, J BUSINESS MANAGEMEN, V9, P389, DOI DOI 10.1007/s10869-015-9426-5; Wright TA, 2004, ORGAN DYN, V33, P338, DOI 10.1016/j.orgdyn.2004.09.002; Yan X, 2012, SOCIAL INDICATORS RE, V113, P299; Zhang JF, 2013, COMM COM INF SC, V396, P1; Zhao XS, 2010, J CONSUM RES, V37, P197, DOI 10.1086/651257; [仲理峰 Zhong Lifeng], 2007, [心理学报, Acta Psychologica Sinica], V39, P328	49	83	88	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84193	10.1371/journal.pone.0084193	http://dx.doi.org/10.1371/journal.pone.0084193			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281RE	24349292	Green Published, Green Submitted, gold			2022-12-27	WOS:000329117900084
J	Zhang, SB; Sun, M; Cao, KF; Hu, H; Zhang, JL				Zhang, Shi-Bao; Sun, Mei; Cao, Kun-Fang; Hu, Hong; Zhang, Jiao-Lin			Leaf Photosynthetic Rate of Tropical Ferns Is Evolutionarily Linked to Water Transport Capacity	PLOS ONE			English	Article							GENOME SIZE; HYDRAULIC CAPACITY; STOMATAL DENSITY; CELL-SIZE; VENATION; DIVERSIFICATION; XYLEM; ARCHITECTURE; CONDUCTANCE; SPOROPHYTES	Ferns usually have relatively lower photosynthetic potential than angiosperms. However, it is unclear whether low photosynthetic potential of ferns is linked to leaf water supply. We hypothesized that there is an evolutionary association of leaf water transport capacity with photosynthesis and stomatal density in ferns. In the present study, a series of functional traits relating to leaf anatomy, hydraulics and physiology were assessed in 19 terrestrial and 11 epiphytic ferns in a common garden, and analyzed by a comparative phylogenetics method. Compared with epiphytic ferns, terrestrial ferns had higher vein density (D-vein), stomatal density (SD), stomatal conductance (g(s)), and photosynthetic capacity (A(max)), but lower values for lower epidermal thickness (LET) and leaf thickness (LT). Across species, all traits varied significantly, but only stomatal length (SL) showed strong phylogenetic conservatism. A(max) was positively correlated with D-vein and g(s) with and without phylogenetic corrections. SD correlated positively with A(max), D-vein and g(s), with the correlation between SD and Dvein being significant after phylogenetic correction. Leaf water content showed significant correlations with LET, LT, and mesophyll thickness. Our results provide evidence that A(max) of the studied ferns is linked to leaf water transport capacity, and there was an evolutionary association between water supply and demand in ferns. These findings add new insights into the evolutionary correlations among traits involving carbon and water economy in ferns.	[Zhang, Shi-Bao; Hu, Hong] Chinese Acad Sci, Kunming Inst Bot, Key Lab Econ Plants & Biotechnol, Kunming, Yunnan, Peoples R China; [Zhang, Shi-Bao; Sun, Mei; Cao, Kun-Fang; Zhang, Jiao-Lin] Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Mengla, Yunnan, Peoples R China; [Sun, Mei] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, JL (corresponding author), Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Mengla, Yunnan, Peoples R China.	zjl@xtbg.org.cn	Cao, Kun-Fang/D-2157-2009	Cao, Kun-Fang/0000-0002-2253-7189; Xia, Ningshao/0000-0003-0179-5266; Ge, Shengxiang/0000-0002-7165-3004	National Natural Science Foundation of China [31170315, 30900174, 31270453, 31370362]; West Light Foundation of the Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); West Light Foundation of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work is financially supported by the National Natural Science Foundation of China (31170315, 30900174, 31270453, 31370362) and the West Light Foundation of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasamaa K, 2001, AUST J PLANT PHYSIOL, V28, P765, DOI 10.1071/PP00157; Ackerly DD, 1998, AM NAT, V152, P767, DOI 10.1086/286208; Beaulieu JM, 2008, NEW PHYTOL, V179, P975, DOI 10.1111/j.1469-8137.2008.02528.x; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Brodersen CR, 2012, PLANT CELL ENVIRON, V35, P1898, DOI 10.1111/j.1365-3040.2012.02524.x; Brodribb TJ, 2007, PLANT PHYSIOL, V144, P1890, DOI 10.1104/pp.107.101352; Brodribb TJ, 2013, NEW PHYTOL, V199, P559, DOI 10.1111/nph.12300; Brodribb TJ, 2011, SCIENCE, V331, P582, DOI 10.1126/science.1197985; Brodribb TJ, 2010, ECOL LETT, V13, P175, DOI 10.1111/j.1461-0248.2009.01410.x; Brodribb TJ, 2011, NEW PHYTOL, V192, P437, DOI 10.1111/j.1469-8137.2011.03795.x; Brodribb TJ, 2005, NEW PHYTOL, V165, P839, DOI 10.1111/j.1469-8137.2004.01259.x; Brodribb TJ, 2004, NEW PHYTOL, V162, P663, DOI 10.1111/j.1469-8137.2004.01060.x; Bucci SJ, 2004, TREE PHYSIOL, V24, P891, DOI 10.1093/treephys/24.8.891; Carins Murphy MR, 2014, PLANT CELL ENVIRON, V37, P124, DOI 10.1111/pce.12136; Carlquist S, 2001, AM J BOT, V88, P1, DOI 10.2307/2657121; Drake PL, 2013, J EXP BOT, V64, P495, DOI 10.1093/jxb/ers347; Dunbar-Co S, 2009, INT J PLANT SCI, V170, P61, DOI 10.1086/593111; Feild TS, 2013, NEW PHYTOL, V199, P720, DOI 10.1111/nph.12311; Feild TS, 2011, P NATL ACAD SCI USA, V108, P8363, DOI 10.1073/pnas.1014456108; Franks PJ, 2009, PLANT CELL ENVIRON, V32, P1737, DOI [10.1111/j.1365-3040.2009.02031.x, 10.1111/j.1365-3040.2009.002031.x]; Franks PJ, 2012, PHILOS T R SOC B, V367, P537, DOI 10.1098/rstb.2011.0270; Franks PJ, 2009, P NATL ACAD SCI USA, V106, P10343, DOI 10.1073/pnas.0904209106; Hietz P, 1998, OECOLOGIA, V114, P305, DOI 10.1007/s004420050452; HIETZ P., 2010, FERN ECOLOGY, P140, DOI DOI 10.1017/CB09780511844898; Hodgson JG, 2010, ANN BOT-LONDON, V105, P573, DOI 10.1093/aob/mcq011; Laube S, 2003, FUNCT ECOL, V17, P598, DOI 10.1046/j.1365-2435.2003.00760.x; Lo Gullo MA, 2010, FUNCT PLANT BIOL, V37, P566, DOI 10.1071/FP09303; Lomax BH, 2009, NEW PHYTOL, V181, P311, DOI 10.1111/j.1469-8137.2008.02700.x; McAdam SAM, 2013, NEW PHYTOL, V198, P429, DOI 10.1111/nph.12190; McAdam SAM, 2012, PLANT CELL, V24, P1510, DOI 10.1105/tpc.112.096404; McElwain JC, 2011, NEW PHYTOL, V192, P307, DOI 10.1111/j.1469-8137.2011.03865.x; Niinemets U, 1999, NEW PHYTOL, V144, P35, DOI 10.1046/j.1469-8137.1999.00466.x; Ogburn RM, 2012, PLANT CELL ENVIRON, V35, P1533, DOI 10.1111/j.1365-3040.2012.02503.x; Page CN, 2002, REV PALAEOBOT PALYNO, V119, P1, DOI 10.1016/S0034-6667(01)00127-0; Pittermann J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00285; Pittermann J, 2011, NEW PHYTOL, V192, P449, DOI 10.1111/j.1469-8137.2011.03817.x; Prado K, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00255; R Development Core Team, 2012, R LANG ENV STAT COMP; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Roth-Nebelsick A, 2001, ANN BOT-LONDON, V87, P553, DOI 10.1006/anbo.2001.1391; Sack L, 2006, ECOLOGY, V87, P483, DOI 10.1890/05-0710; Sack L, 2006, ANNU REV PLANT BIOL, V57, P361, DOI 10.1146/annurev.arplant.56.032604.144141; Sack L, 2013, NEW PHYTOL, V198, P983, DOI 10.1111/nph.12253; Schneider H, 2004, MOL PHYLOGENET EVOL, V31, P1041, DOI 10.1016/j.ympev.2003.09.018; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Tanaka Y, 2013, NEW PHYTOL, V198, P757, DOI 10.1111/nph.12186; Torre S, 2003, J AM SOC HORTIC SCI, V128, P598, DOI 10.21273/JASHS.128.4.0598; Uhl D, 1999, PALAEOGEOGR PALAEOCL, V149, P15, DOI 10.1016/S0031-0182(98)00189-8; Walls RL, 2011, AM J BOT, V98, P244, DOI 10.3732/ajb.1000154; Wang J-H, 2012, PHYSIOL PLANTARUM, V147, P283; Watkins JE, 2012, INT J PLANT SCI, V173, P695, DOI 10.1086/665974; Watkins JE, 2010, AM J BOT, V97, P2007, DOI 10.3732/ajb.1000124; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Wood TE, 2009, P NATL ACAD SCI USA, V106, P13875, DOI 10.1073/pnas.0811575106; Zhang SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040080	55	35	41	2	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84682	10.1371/journal.pone.0084682	http://dx.doi.org/10.1371/journal.pone.0084682			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	25029500	Green Published, gold, Green Submitted			2022-12-27	WOS:000329866300036
J	Qin, YW; Peng, J; Liang, BY; Su, L; Chen, Q; Xie, JJ; Gu, L				Qin, Yu-Wang; Peng, Jiao; Liang, Bao-Yun; Su, Li; Chen, Qing; Xie, Juan-Juan; Gu, Lian			The A930G Polymorphism of P22phox (CYBA) Gene but Not C242T Variation Is Associated with Hypertension: A Meta-Analysis	PLOS ONE			English	Article							BLOOD-PRESSURE; NAD(P)H OXIDASE; NITRIC-OXIDE; DIABETES-MELLITUS; OXIDATIVE STRESS; NADPH OXIDASE; GLOBAL BURDEN; DISEASE; MORTALITY; PEROXYNITRITE	Background: Recently, it has been reported that the A930G and C242T polymorphisms within p22phox (CYBA) gene are involved in the pathogenesis of hypertension. However, the results remain controversial. Furthermore, no previous meta-analysis has been conducted to evaluate the relationship between the A930G and C242T polymorphisms and hypertension. Therefore, we performed this meta-analysis to clarify these controversies. Objective and Methods: All of the included articles were retrieved from the PubMed and Embase databases, as well as the CNKI, CBM, Chongqing VIP and Wan Fang databases according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Odds ratios (OR) with corresponding 95% confidence intervals (CI) were used to assess the strength of the association. Accounting for heterogeneity, a fixed or random effects model was respectively adopted. Heterogeneity was checked using the Q test and the I-2 statistic. A cumulative meta-analysis was conducted to estimate the tendency of pooled OR. Funnel plots and Egger's tests were performed to test for possible publication bias. Results: Five articles on A930G with 2003 cases/2434 controls and eight articles on C242T with 2644 cases/1967 controls were identified. A significant association of A930G polymorphisms with the risk of hypertension was found in the dominant model (OR=0.59, 95% CI: 0.38-0.92, p=0.021) and allelic model (OR=0.66, 95% CI: 0.46-0.95, p=0.024). In the stratified analysis, a significant association could be found among the hospital-based and population-based studies. However, no evidence of a significant association of the C242T polymorphism with hypertension was found in the overall analysis and subgroup analysis. Conclusions: This meta-analysis indicates that the A930G polymorphism, but not the C242T variation, might be a protective factor for hypertension.	[Qin, Yu-Wang; Liang, Bao-Yun; Chen, Qing; Xie, Juan-Juan; Gu, Lian] Guangxi Univ Chinese Med, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China; [Peng, Jiao] Guangxi Med Univ, Preclin Fac, Nanning, Guangxi, Peoples R China; [Su, Li] Guangxi Med Univ, Sch Publ Hlth, Nanning, Guangxi, Peoples R China	Guangxi University of Chinese Medicine; Guangxi Medical University; Guangxi Medical University	Gu, L (corresponding author), Guangxi Univ Chinese Med, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China.	gulian2012@163.com		su, li/0000-0002-1435-9669	National Natural Science Foundation of China [81260594]; Guangxi National Natural Science Foundation [2013GXNSFAA019145]; significant scientific research foundation of the Guangxi health department [2012047]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi National Natural Science Foundation(National Natural Science Foundation of Guangxi Province); significant scientific research foundation of the Guangxi health department	This work was supported by grants from the National Natural Science Foundation of China (Grant No. 81260594); the Guangxi National Natural Science Foundation (Grant No. 2013GXNSFAA019145); and the significant scientific research foundation of the Guangxi health department (Grant No. 2012047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Arima H, 2011, J HYPERTENS, V29, pS3, DOI 10.1097/01.hjh.0000410246.59221.b1; Ballinger SW, 2000, CIRC RES, V86, P960, DOI 10.1161/01.RES.86.9.960; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Clark CE, 2012, LANCET, V379, P905, DOI 10.1016/S0140-6736(11)61710-8; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; DINAUER MC, 1990, J CLIN INVEST, V86, P1729, DOI 10.1172/JCI114898; Ehret GB, 2013, EUR HEART J, V34, P951, DOI 10.1093/eurheartj/ehs455; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; GRYGLEWSKI RJ, 1986, NATURE, V320, P454, DOI 10.1038/320454a0; Gu QP, 2010, AM J HYPERTENS, V23, P38, DOI 10.1038/ajh.2009.191; Guzik TJ, 2002, CIRCULATION, V105, P1656, DOI 10.1161/01.CIR.0000012748.58444.08; [哈黛文 Ha Daiwen], 2004, [中国老年学杂志, Chinese Journal of Gerontology], V24, P1122; Hsueh YM, 2005, J TOXICOL ENV HEAL A, V68, P1471, DOI 10.1080/15287390590967414; Iseki K, 2000, HYPERTENS RES, V23, P143, DOI 10.1291/hypres.23.143; Ji Z LB, 2003, CHIN J GERIATR CARDI, V5, P103; Katsuyama M, 2010, J PHARMACOL SCI, V114, P134, DOI 10.1254/jphs.10R01CR; Kokubo Y, 2005, CIRC J, V69, P138, DOI 10.1253/circj.69.138; Krzesinski J-M, 2012, Rev Med Liege, V67, P279; Kuznetsova TY, 2008, KARDIOLOGIYA, V48, P27; Lassegue B, 2003, AM J PHYSIOL-REG I, V285, pR277, DOI 10.1152/ajpregu.00758.2002; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Ma CH, 2012, J ADV NURS, V68, P1402, DOI 10.1111/j.1365-2648.2011.05835.x; MANTEL N, 1959, J NATL CANCER I, V22, P719; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moreno MU, 2007, J HYPERTENS, V25, P1620, DOI 10.1097/HJH.0b013e3281ac211d; Moreno MU, 2006, J HYPERTENS, V24, P1299, DOI 10.1097/01.hjh.0000234110.54110.56; Moreno MU, 2003, FEBS LETT, V542, P27, DOI 10.1016/S0014-5793(03)00331-4; Pang J HD, 2005, ASS NADPH OXIDASE SU; [庞静 Pang Jing], 2004, [高血压杂志, Chinese Journal of Hypertension], V12, P502; PANZA JA, 1990, NEW ENGL J MED, V323, P22, DOI 10.1056/NEJM199007053230105; Paravicini TM, 2008, DIABETES CARE, V31, pS170, DOI 10.2337/dc08-s247; Petrovic D, 2013, CLIN EXP HYPERTENS; Picon RV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048255; Rae J, 2000, BLOOD, V96, P1106, DOI 10.1182/blood.V96.3.1106.015k44_1106_1112; Redon J, 2003, HYPERTENSION, V41, P1096, DOI 10.1161/01.HYP.0000068370.21009.38; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Sales ML, 2007, J HUM HYPERTENS, V21, P504, DOI 10.1038/sj.jhh.1002170; Schreiber R, 2012, DIABETIC MED, V29, pE55, DOI 10.1111/j.1464-5491.2012.03594.x; Soccio M, 2005, EUR J CLIN INVEST, V35, P305, DOI 10.1111/j.1365-2362.2005.01500.x; Taniyama Y, 2003, HYPERTENSION, V42, P1075, DOI 10.1161/01.HYP.0000100443.09293.4F; Ushio-Fukai M, 2002, CIRC RES, V91, P1160, DOI 10.1161/01.RES.0000046227.65158.F8; UshioFukai M, 1996, J BIOL CHEM, V271, P23317, DOI 10.1074/jbc.271.38.23317; Valderrama Amy L., 2012, Morbidity and Mortality Weekly Report, V61, P703; Wang B WX, 2007, ASS WNK4 GENE CYBA G; Zalba G, 2001, CIRC RES, V88, P217	49	83	88	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82465	10.1371/journal.pone.0082465	http://dx.doi.org/10.1371/journal.pone.0082465			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349292	Green Published, Green Submitted, gold			2022-12-27	WOS:000328705200081
J	Dong, J; Han, QF; Zhu, TY; Ren, YP; Chen, JH; Zhao, HP; Chen, MH; Xu, R; Wang, Y; Hao, CM; Zhang, R; Zhang, XH; Wang, M; Tian, N; Wang, HY				Dong, Jie; Han, Qing-Feng; Zhu, Tong-Ying; Ren, Ye-Ping; Chen, Jiang-Hua; Zhao, Hui-Ping; Chen, Meng-Hua; Xu, Rong; Wang, Yue; Hao, Chuan-Ming; Zhang, Rui; Zhang, Xiao-Hui; Wang, Mei; Tian, Na; Wang, Hai-Yan			The Associations of Uric Acid, Cardiovascular and All-Cause Mortality in Peritoneal Dialysis Patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CORONARY-HEART-DISEASE; RENAL-FUNCTION DECLINE; HIGH BLOOD-PRESSURE; HEMODIALYSIS-PATIENTS; RISK-FACTOR; ENDOTHELIAL DYSFUNCTION; ATHEROSCLEROSIS RISK; LOWERING THERAPY; ARTERY-DISEASE	Aims: To investigate whether uric acid (UA) is an independent predictor of cardiovascular (CV) and all-cause mortality in peritoneal dialysis (PD) patients after controlling for recognized CV risk factors. Methods: A total of 2264 patients on chronic PD were collected from seven centers affiliated with the Socioeconomic Status on the Outcome of Peritoneal Dialysis (SSOP) Study. All demographic and laboratory data were recorded at baseline. Multivariate Cox regression was used to calculate the hazard ratio (HR) of CV and all-cause mortality with adjustments for recognized traditional and uremia-related CV factors. Results: There were no significant differences in baseline characteristics between patients with (n = 2193) and without (n = 71) UA measured. Each 1 mg/dL of increase in UA was associated with higher all-cause mortality with 1.05(1.00 similar to 1.10) of HR and higher CV mortality with 1.12 (1.05 similar to 1.20) of HR after adjusting for age, gender and center size. The highest gender-specific tertile of UA predicted higher all-cause mortality with 1.23(1.00 similar to 1.52) of HR and higher CV mortality with 1.69 (1.21 similar to 2.38) of HR after adjusting for age, gender and center size. The predictive value of UA was stronger in patients younger than 65 years without CV disease or diabetes at baseline. The prognostic value of UA as both continuous and categorical variable weakened or disappeared after further adjusted for uremia-related and traditional CV risk factors. Conclusions: The prognostic value of UA in CV and all-cause mortality was weak in PD patients generally, which was confounded by uremia-related and traditional CV risk factors.	[Dong, Jie; Xu, Rong; Wang, Hai-Yan] Peking Univ, Dept Med, Div Renal, Hosp 1, Beijing 100871, Peoples R China; [Dong, Jie; Xu, Rong; Wang, Hai-Yan] Peking Univ, Inst Nephrol, Beijing 100871, Peoples R China; [Dong, Jie; Xu, Rong; Wang, Hai-Yan] Minist Hlth, Key Lab Renal Dis, Beijing, Peoples R China; [Dong, Jie; Xu, Rong; Wang, Hai-Yan] Minist Educ, Key Lab Renal Dis, Beijing, Peoples R China; [Han, Qing-Feng; Wang, Yue] Peking Univ, Hosp 3, Dept Nephrol, Beijing 100871, Peoples R China; [Zhu, Tong-Ying] Fudan Univ, Dept Nephrol, Huashan Hosp, Shanghai 200433, Peoples R China; [Ren, Ye-Ping; Zhang, Rui] Harbin Med Univ, Dept Nephrol, Affiliated Hosp 2, Harbin, Heilongjiang, Peoples R China; [Zhang, Xiao-Hui] Zhejiang Univ, Affiliated Hosp 1, Kidney Dis Ctr, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Mei] Peking Univ, Peoples Hosp, Dept Nephrol, Beijing 100871, Peoples R China; [Chen, Meng-Hua; Tian, Na] Ningxia Med Univ, Gen Hosp, Dept Nephrol, Ningxia, Peoples R China	Peking University; Peking University; Peking University; Fudan University; Harbin Medical University; Zhejiang University; Peking University; Ningxia Medical University	Dong, J (corresponding author), Peking Univ, Dept Med, Div Renal, Hosp 1, Beijing 100871, Peoples R China.	dongjie@medmail.com.cn	tian, na/GVR-9226-2022; Dong, Jie/AFM-0048-2022; Dong, Jinwei/C-4949-2009	Biradar, Chandrashekhar/0000-0002-9532-9452; Xiao, Xiangming/0000-0003-0956-7428; Dong, Jinwei/0000-0001-5687-803X	Education Department, China; Baxer Clinical Research Award from Baxter Corp, China; ISN Research Award from the ISN GO RP Committee	Education Department, China; Baxer Clinical Research Award from Baxter Corp, China; ISN Research Award from the ISN GO RP Committee	This study is supported in part by New Century Excellent Talents from The Education Department, China, Baxer Clinical Research Award from Baxter Corp, China, and an ISN Research Award from the ISN GO R&P Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RW, 1994, NEW ENGL J MED, V331, P468, DOI 10.1056/NEJM199408183310709; Badve SV, 2011, NAT REV NEPHROL, V7, P295, DOI 10.1038/nrneph.2010.186; Caravaca F, 2005, NEFROLOGIA, V25, P645; Chen J, 2012, AM J CARDIOL, V110, P136, DOI 10.1016/j.amjcard.2012.02.061; Chen YM, 2011, AM J NEPHROL, V33, P97, DOI 10.1159/000322966; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Culleton BF, 1999, ANN INTERN MED, V131, P7, DOI 10.7326/0003-4819-131-1-199907060-00003; Elsayed EF, 2007, ARCH INTERN MED, V167, P1130, DOI 10.1001/archinte.167.11.1130; Garg JP, 2005, ARTHRITIS RHEUM-US, V52, P290, DOI 10.1002/art.20781; Hsu SP, 2004, NEPHROL DIAL TRANSPL, V19, P457, DOI 10.1093/ndt/gfg563; Iuliano L, 2001, LIPIDS, V36, pS41, DOI 10.1007/s11745-001-0680-1; Johnson RJ, 2003, HYPERTENSION, V41, P1183, DOI 10.1161/01.HYP.0000069700.62727.C5; Jonasson T, 2005, CLIN CHEM LAB MED, V43, P628, DOI 10.1515/CCLM.2005.108; Jun M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008176.pub2; Kanbay M, 2012, AM J NEPHROL, V36, P324, DOI 10.1159/000342390; Kanbay M, 2011, AM J NEPHROL, V33, P298, DOI 10.1159/000324847; Khosla UM, 2005, KIDNEY INT, V67, P1739, DOI 10.1111/j.1523-1755.2005.00273.x; Kuo CF, 2013, RHEUMATOLOGY, V52, P127, DOI 10.1093/rheumatology/kes223; Latif W, 2011, CLIN J AM SOC NEPHRO, V6, P2470, DOI 10.2215/CJN.00670111; Lee SMK, 2009, AM J NEPHROL, V29, P79, DOI 10.1159/000151292; Liu WC, 2012, CLIN J AM SOC NEPHRO, V7, P541, DOI 10.2215/CJN.09420911; Madero M, 2009, AM J KIDNEY DIS, V53, P796, DOI 10.1053/j.ajkd.2008.12.021; Melendez-Ramirez G, 2012, ENDOCR RES, V37, P1, DOI 10.3109/07435800.2011.566235; Moriarity JT, 2000, ANN EPIDEMIOL, V10, P136, DOI 10.1016/S1047-2797(99)00037-X; Muntner P, 2005, J AM SOC NEPHROL, V16, P529, DOI 10.1681/ASN.2004080656; Navaneethan SD, 2009, NEPHROL DIAL TRANSPL, V24, P1260, DOI 10.1093/ndt/gfn621; Navaneethan SD, 2009, COCHRANE DATABASE SY; Nieto FJ, 2000, ATHEROSCLEROSIS, V148, P131, DOI 10.1016/S0021-9150(99)00214-2; Niskanen LK, 2004, ARCH INTERN MED, V164, P1546, DOI 10.1001/archinte.164.14.1546; Palmer SC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001436; Pan Y, 2012, BRIT J NUTR, V108, P400, DOI 10.1017/S0007114511007033; Park JT, 2009, NEPHROL DIAL TRANSPL, V24, P3520, DOI 10.1093/ndt/gfp272; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Smith SC, 2004, CIRCULATION, V109, P3112, DOI 10.1161/01.CIR.0000133427.35111.67; Stenvinkel P, 2008, CLIN J AM SOC NEPHRO, V3, P505, DOI 10.2215/CJN.03670807; Suliman ME, 2006, AM J KIDNEY DIS, V48, P761, DOI 10.1053/j.ajkd.2006.08.019; Suzuki T, 2007, NITRIC OXIDE-BIOL CH, V16, P266, DOI 10.1016/j.niox.2006.10.008; Tangri N, 2010, AM J KIDNEY DIS, V56, P247, DOI 10.1053/j.ajkd.2010.06.004; Wang AYM, 2007, PERITON DIALYSIS INT, V27, pS228; Wannamethee SG, 1997, HEART, V78, P147, DOI 10.1136/hrt.78.2.147; Wen CP, 2010, AM J KIDNEY DIS, V56, P273, DOI 10.1053/j.ajkd.2010.01.024; Xu R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050766; Zhang LX, 2012, NEPHROL DIAL TRANSPL, V27, P1836, DOI 10.1093/ndt/gfr597	43	62	69	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e82342	10.1371/journal.pone.0082342	http://dx.doi.org/10.1371/journal.pone.0082342			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24465714	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500015
J	Fretwell, PT; Trathan, PN; Wienecke, B; Kooyman, GL				Fretwell, Peter T.; Trathan, Phil N.; Wienecke, Barbara; Kooyman, Gerald L.			Emperor Penguins Breeding on Iceshelves	PLOS ONE			English	Article							ANTARCTIC PENINSULA; SOUTHERN-OCEAN; CLIMATE-CHANGE; VARIABILITY; RESPONSES	We describe a new breeding behaviour discovered in emperor penguins; utilizing satellite and aerial-survey observations four emperor penguin breeding colonies have been recorded as existing on ice-shelves. Emperors have previously been considered as a sea-ice obligate species, with 44 of the 46 colonies located on sea-ice (the other two small colonies are on land). Of the colonies found on ice-shelves, two are newly discovered, and these have been recorded on shelves every season that they have been observed, the other two have been recorded both on ice-shelves and sea-ice in different breeding seasons. We conduct two analyses; the first using synthetic aperture radar data to assess why the largest of the four colonies, for which we have most data, locates sometimes on the shelf and sometimes on the sea-ice, and find that in years where the sea-ice forms late, the colony relocates onto the ice-shelf. The second analysis uses a number of environmental variables to test the habitat marginality of all emperor penguin breeding sites. We find that three of the four colonies reported in this study are in the most northerly, warmest conditions where sea-ice is often sub-optimal. The emperor penguin's reliance on sea-ice as a breeding platform coupled with recent concerns over changed sea-ice patterns consequent on regional warming, has led to their designation as "near threatened'' in the IUCN red list. Current climate models predict that future loss of sea-ice around the Antarctic coastline will negatively impact emperor numbers; recent estimates suggest a halving of the population by 2052. The discovery of this new breeding behaviour at marginal sites could mitigate some of the consequences of sea-ice loss; potential benefits and whether these are permanent or temporary need to be considered and understood before further attempts are made to predict the population trajectory of this iconic species.	[Fretwell, Peter T.; Trathan, Phil N.] British Antarctic Survey, Cambridge CB3 0ET, England; [Wienecke, Barbara] Australian Antarctic Div, Hobart, Tas, Australia; [Kooyman, Gerald L.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Australian Antarctic Division; University of California System; University of California San Diego; Scripps Institution of Oceanography	Fretwell, PT (corresponding author), British Antarctic Survey, Cambridge CB3 0ET, England.	ptf@bas.ac.uk		Staniland, Iain/0000-0003-2736-9134; , gerald/0000-0002-8872-2950	BAS-NERC ecosystems programme; NERC [bas0100025, bas010011] Funding Source: UKRI; Natural Environment Research Council [bas0100025, bas010011] Funding Source: researchfish	BAS-NERC ecosystems programme; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding for this study came internally from BAS-NERC ecosystems programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No current external funding sources for this study.	Ainley D, 2010, ECOL MONOGR, V80, P49, DOI 10.1890/08-2289.1; Ainley DG, 2005, ANTARCT SCI, V17, P171, DOI 10.1017/S0954102005002567; Augustin L, 2004, NATURE, V429, P623, DOI 10.1038/nature02599; Barbraud C, 2001, NATURE, V411, P183, DOI 10.1038/35075554; Barbraud C, 2012, MAR ECOL PROG SER, V454, P285, DOI 10.3354/meps09616; Barbraud C, 2011, ANTARCT SCI, V23, P461, DOI 10.1017/S0954102011000356; Comiso JC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031972; Cook AJ, 2010, CRYOSPHERE, V4, P77, DOI 10.5194/tc-4-77-2010; Forcada J, 2009, GLOBAL CHANGE BIOL, V15, P1618, DOI 10.1111/j.1365-2486.2009.01909.x; Fretwell PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033751; Fretwell PT, 2009, GLOBAL ECOL BIOGEOGR, V18, P543, DOI 10.1111/j.1466-8238.2009.00467.x; IUCN, 2013, IUCN RED LIST THREAT; Jenouvrier S, 2005, ECOLOGY, V86, P2889, DOI 10.1890/05-0514; Jenouvrier S, 2009, P NATL ACAD SCI USA, V106, P1844, DOI 10.1073/pnas.0806638106; KLAGES N, 1989, POLAR BIOL, V9, P385, DOI 10.1007/BF00442529; KOOYMAN GL, 1993, ANTARCT SCI, V5, P143, DOI 10.1017/S0954102093000203; Larsen C., 1894, GEOGR J, V4, P333, DOI [DOI 10.2307/1773537, 10.2307/1773537]; Massom RA, 2010, POLAR SCI, V4, P149, DOI 10.1016/j.polar.2010.05.001; Morris EM, 2003, ANTARCT RES SER, V79, P61; Rack W, 2004, ANN GLACIOL-SER, V39, P505, DOI 10.3189/172756404781814005; Serrezer MC, 2007, SCIENCE, V315, P5818; Sime LC, 2009, NATURE, V462, P342, DOI 10.1038/nature08564; Stammerjohn SE, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004269; Trathan PN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014738; Turner J., 2009, ANTARCTIC CLIMATE CH; van Lipzig NPM, 2002, INT J CLIMATOL, V22, P1197, DOI 10.1002/joc.798; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Wienecke B, 2012, POLAR BIOL, V35, P1289, DOI 10.1007/s00300-012-1172-9; Wienecke B, 2010, POLAR REC, V46, P271, DOI 10.1017/S0032247409990283	29	56	63	3	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85285	10.1371/journal.pone.0085285	http://dx.doi.org/10.1371/journal.pone.0085285			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24533131	Green Published, Green Accepted, gold			2022-12-27	WOS:000329862500234
J	Knudsen, JG; Murholm, M; Carey, AL; Bienso, RS; Basse, AL; Allen, TL; Hidalgo, J; Kingwell, BA; Febbraio, MA; Hansen, JB; Pilegaard, H				Knudsen, Jakob G.; Murholm, Maria; Carey, Andrew L.; Bienso, Rasmus S.; Basse, Astrid L.; Allen, Tamara L.; Hidalgo, Juan; Kingwell, Bronwyn A.; Febbraio, Mark A.; Hansen, Jacob B.; Pilegaard, Henriette			Role of IL-6 in Exercise Training- and Cold-Induced UCP1 Expression in Subcutaneous White Adipose Tissue	PLOS ONE			English	Article							INTERLEUKIN-6 STIMULATES LIPOLYSIS; HUMAN SKELETAL-MUSCLE; UNCOUPLING PROTEIN; INDUCED INCREASE; GENE-EXPRESSION; GAMMA; ADIPOCYTES; STRESS; MICE; FAT	Expression of brown adipose tissue (BAT) associated proteins like uncoupling protein 1 (UCP1) in inguinal WAT (iWAT) has been suggested to alter iWAT metabolism. The aim of this study was to investigate the role of interleukin-6 (IL-6) in exercise training and cold exposure-induced iWAT UCP1 expression. The effect of daily intraperitoneal injections of IL-6 (3 ng/g) in C57BL/6 mice for 7 days on iWAT UCP1 expression was examined. In addition, the expression of UCP1 in iWAT was determined in response to 3 days of cold exposure (4 degrees C) and 5 weeks of exercise training in wild type (WT) and whole body IL-6 knockout (KO) mice. Repeated injections of IL-6 in C57BL/6 mice increased UCP1 mRNA but not UCP1 protein content in iWAT. Cold exposure increased iWAT UCP1 mRNA content similarly in IL-6 KO and WT mice, while exercise training increased iWAT UCP1 mRNA in WT mice but not in IL-6 KO mice. Additionally, a cold exposure-induced increase in iWAT UCP1 protein content was blunted in IL-6 KO mice, while UCP1 protein content in iWAT was lower in both untrained and exercise trained IL-6 KO mice than in WT mice. In conclusion, repeated daily increases in plasma IL-6 can increase iWAT UCP1 mRNA content and IL-6 is required for an exercise training-induced increase in iWAT UCP1 mRNA content. In addition IL-6 is required for a full induction of UCP1 protein expression in response to cold exposure and influences the UCP1 protein content iWAT of both untrained and exercise trained animals.	[Knudsen, Jakob G.; Bienso, Rasmus S.; Pilegaard, Henriette] Univ Copenhagen, Ctr Inflammat & Metab, Dept Biol, Copenhagen, Denmark; [Murholm, Maria; Basse, Astrid L.; Hansen, Jacob B.] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Murholm, Maria; Basse, Astrid L.] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Carey, Andrew L.; Kingwell, Bronwyn A.] Baker IDI Heart & Diabet Inst, Metab & Vasc Physiol Lab, Melbourne, Vic, Australia; [Allen, Tamara L.; Febbraio, Mark A.] Baker IDI Heart & Diabet Inst, Cellular & Mol Metab Lab, Melbourne, Vic, Australia; [Hidalgo, Juan] Univ Autonoma Barcelona, Dept Neurosci, E-08193 Barcelona, Spain	University of Copenhagen; University of Copenhagen; University of Copenhagen; Baker Heart and Diabetes Institute; Baker Heart and Diabetes Institute; Autonomous University of Barcelona	Pilegaard, H (corresponding author), Univ Copenhagen, Ctr Inflammat & Metab, Dept Biol, Copenhagen, Denmark.	hpilegaard@bio.ku.dk	Hansen, Jacob B/F-3775-2010; Knudsen, Jakob G/Q-2227-2018; Basse, Astrid L/M-4630-2014; Hidalgo, Juan/C-9082-2011; Febbraio, Mark/AAE-9632-2019; Kingwell, Bronwyn A/B-1183-2009; Pilegaard, Henriette/M-2315-2014	Hansen, Jacob B/0000-0001-5249-2586; Knudsen, Jakob G/0000-0001-7237-8457; Basse, Astrid L/0000-0002-6532-9232; Hidalgo, Juan/0000-0003-0921-1122; Pilegaard, Henriette/0000-0002-1071-0327; Carey, Andrew/0000-0003-3452-1501; Febbraio, Mark/0000-0002-9296-4418; Andersen, Stig Ejdrup/0000-0002-1914-4720	Novo Nordisk Foundation; Lundbeck Foundation; Danish Research Foundation; Danish Council for Independent Research in the Natural Sciences; Augustinus Foundation; National Health and Medical Research Council of Australia (NHMRC) [526606]; EU [HEALTH-F2-2011-278373]; Danish National Research Foundation [02-512-55]; Danish Ministry of Science, Technology and Innovation	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Danish Research Foundation; Danish Council for Independent Research in the Natural Sciences; Augustinus Foundation; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); EU(European Commission); Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Ministry of Science, Technology and Innovation	The study was supported by grants from the Novo Nordisk Foundation, the Lundbeck Foundation, The Danish Research Foundation, The Danish Council for Independent Research in the Natural Sciences, the Augustinus Foundation, the National Health and Medical Research Council of Australia (NHMRC grant no. 526606) and the EU FP7 project DIABAT (HEALTH-F2-2011-278373). Centre of Inflammation and Metabolism (CIM) is supported by a grant from the Danish National Research Foundation (# 02-512-55). CIM is part of the UNIK Project: Food, Fitness & Pharma for Health and Disease, supported by the Danish Ministry of Science, Technology and Innovation. Mark A. Febbraio and Bronwyn A. Kingwell are Senior Principal Research Fellows of the NHMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adser H, 2011, ACTA PHYSL; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Brandt C, 2012, ACTA PHYSIOL, V205, P224, DOI 10.1111/j.1748-1716.2011.02373.x; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; COUSIN B, 1992, J CELL SCI, V103, P931; Di Gregorio GB, 2004, AM J PHYSIOL-ENDOC M, V287, pE182, DOI 10.1152/ajpendo.00189.2003; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Hidalgo J, 2010, BRAIN BEHAV IMMUN, V24, P119, DOI 10.1016/j.bbi.2009.09.002; HIMMSHAGEN J, 1994, AM J PHYSIOL, V266, pR1371, DOI 10.1152/ajpregu.1994.266.4.R1371; Iwen KA, 2011, METABOLISM, V60, P430, DOI 10.1016/j.metabol.2010.03.011; Ji CB, 2011, J BIOENERG BIOMEMBR, V43, P367, DOI 10.1007/s10863-011-9361-8; Kelly LJ, 1998, ENDOCRINOLOGY, V139, P4920, DOI 10.1210/en.139.12.4920; Klingenberg M, 1999, BBA-BIOMEMBRANES, V1415, P271, DOI 10.1016/S0005-2736(98)00232-6; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Lundby C, 2005, EUR J APPL PHYSIOL, V95, P351, DOI 10.1007/s00421-005-0022-7; Nedergaard J, 2013, BBA-MOL CELL BIOL L, V1831, P943, DOI 10.1016/j.bbalip.2013.01.009; Pedersen L, 2011, J PHYSL; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Pilegaard H, 2000, AM J PHYSIOL-ENDOC M, V279, pE806; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Ringholm S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064123; Seydoux J, 1978, Experientia Suppl, V32, P153; Steensberg A, 2000, J PHYSIOL-LONDON, V529, P237, DOI 10.1111/j.1469-7793.2000.00237.x; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; van Hall G, 2003, J CLIN ENDOCR METAB, V88, P3005, DOI 10.1210/jc.2002-021687; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Wan Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051233; Wan ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041719; Wernstedt I, 2006, AM J PHYSIOL-REG I, V291, pR551, DOI 10.1152/ajpregu.00514.2005; Wolsk E, 2010, AJP ENDOCRINOLOGY ME; Yang YQ, 2008, ENDOCRINE, V33, P261, DOI 10.1007/s12020-008-9085-7; Yildirim NC, 2010, CLIN EXP IMMUNOL, V161, P171, DOI 10.1111/j.1365-2249.2010.04156.x	32	160	167	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84910	10.1371/journal.pone.0084910	http://dx.doi.org/10.1371/journal.pone.0084910			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416310	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500189
J	Miller, CT; Fraser, SF; Levinger, I; Straznicky, NE; Dixon, JB; Reynolds, J; Selig, SE				Miller, Clint T.; Fraser, Steve F.; Levinger, Itamar; Straznicky, Nora E.; Dixon, John B.; Reynolds, John; Selig, Steve E.			The Effects of Exercise Training in Addition to Energy Restriction on Functional Capacities and Body Composition in Obese Adults during Weight Loss: A Systematic Review	PLOS ONE			English	Review							FAT-FREE MASS; PHYSICAL-ACTIVITY; MUSCLE STRENGTH; POSTMENOPAUSAL WOMEN; CALORIC RESTRICTION; SKELETAL-MUSCLE; OLDER PERSONS; ABDOMINAL FAT; RISK-FACTORS; HIGH-PROTEIN	Background: Obesity is associated with impairments of physical function, cardiovascular fitness, muscle strength and the capacity to perform activities of daily living. This review examines the specific effects of exercise training in relation to body composition and physical function demonstrated by changes in cardiovascular fitness, and muscle strength when obese adults undergo energy restriction. Methods: Electronic databases were searched for randomised controlled trials comparing energy restriction plus exercise training to energy restriction alone. Studies published to May 2013 were included if they used multi-component methods for analysing body composition and assessed measures of fitness in obese adults. Results: Fourteen RCTs met the inclusion criteria. Heterogeneity of study characteristics prevented meta-analysis. Energy restriction plus exercise training was more effective than energy restriction alone for improving cardiovascular fitness, muscle strength, and increasing fat mass loss and preserving lean body mass, depending on the type of exercise training. Conclusion: Adding exercise training to energy restriction for obese middle-aged and older individuals results in favourable changes to fitness and body composition. Whilst weight loss should be encouraged for obese individuals, exercise training should be included in lifestyle interventions as it offers additional benefits.	[Miller, Clint T.; Fraser, Steve F.; Selig, Steve E.] Deakin Univ, Sch Exercise & Nutr Sci, Ctr Exercise & Sports Sci, Melbourne, Vic, Australia; [Levinger, Itamar] Victoria Univ, Sch Sport & Exercise Sci, Inst Sport Exercise & Act Living, Melbourne, Vic 8001, Australia; [Straznicky, Nora E.] Baker IDI Heart & Diabet Inst, Human Neurotransmitters Lab, Melbourne, Vic, Australia; [Dixon, John B.] Baker IDI Heart & Diabet Inst, Clin Obes Res Lab, Melbourne, Vic, Australia; [Reynolds, John] Deakin Univ, Fac Hlth, Biostat Unit, Melbourne, Vic, Australia	Deakin University; Victoria University; Baker Heart and Diabetes Institute; Baker Heart and Diabetes Institute; Deakin University	Selig, SE (corresponding author), Deakin Univ, Sch Exercise & Nutr Sci, Ctr Exercise & Sports Sci, Melbourne, Vic, Australia.	steve.selig@deakin.edu.au	Dixon, John B/A-5318-2011; Wrighton, Kelly C/ABD-6621-2021; Reynolds, John/D-2591-2013	Dixon, John B/0000-0001-5391-4082; Wrighton, Kelly C/0000-0003-0434-4217; Reynolds, John/0000-0002-8825-8625; Fraser, Steve F/0000-0003-0202-9619; Miller, Clint/0000-0001-7743-6986; Banfield, Jill/0000-0001-8203-8771; Miller, Christopher/0000-0002-9448-8144; Handley, Kim/0000-0003-0531-3009; Levinger, Itamar/0000-0001-9194-2033	Heart Foundation [G11M5892]; Diabetes Australia Millennium Grant	Heart Foundation; Diabetes Australia Millennium Grant	Dr. Itamar Levinger is a Heart Foundation Research Fellow (PR 11M 6086 and Prof John Dixon is an NHMRC Senior Research Fellow. Dr. Nora Straznicky is funded by a Heart Foundation Grant-in-Aid (G11M5892) and a Diabetes Australia Millennium Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 1999, INT J OBESITY, V23, P603, DOI 10.1038/sj.ijo.0800875; Alvarez VP, 2007, OBES SURG, V17, P211, DOI 10.1007/s11695-007-9032-3; Amati F, 2008, J APPL PHYSIOL, V105, P825, DOI 10.1152/japplphysiol.90384.2008; Anandacoomarasamy A, 2009, CURR OPIN RHEUMATOL, V21, P71, DOI 10.1097/BOR.0b013e32831bc0d7; Beavers KM, 2011, AM J CLIN NUTR, V94, P767, DOI 10.3945/ajcn.110.004895; Beckman LM, 2010, J AM DIET ASSOC, V110, P571, DOI 10.1016/j.jada.2009.12.023; Blazer DG, 2006, J AM GERIATR SOC, V54, P502, DOI 10.1111/j.1532-5415.2005.00607.x; Bouchard DR, 2011, METAB SYNDR RELAT D, V9, P225, DOI 10.1089/met.2010.0101; Bouchard DR, 2009, MENOPAUSE, V16, P66, DOI 10.1097/gme.0b013e31817dacf7; BRAY GA, 1988, WESTERN J MED, V149, P429; Byrne NM, 2003, AM J CLIN NUTR, V77, P1368, DOI 10.1093/ajcn/77.6.1368; Campbell KL, 2012, J CLIN ONCOL, V30, P2314, DOI 10.1200/JCO.2011.37.9792; Capodaglio P, 2010, INT J OCCUP SAF ERGO, V16, P507, DOI 10.1080/10803548.2010.11076863; Chaston TB, 2007, INT J OBESITY, V31, P743, DOI 10.1038/sj.ijo.0803483; Chmelo E, 2012, J PHYS ACT HEALTH; Clemes SA, 2010, OCCUP MED-OXFORD, V60, P101, DOI 10.1093/occmed/kqp127; Coulson JC, 2008, INT J WORKPLACE HEAL, V1, P176, DOI 10.1108/17538350810926534; Craig BN, 2006, AM J IND MED, V49, P249, DOI 10.1002/ajim.20290; Daly RM, 2005, OSTEOPOROSIS INT, V16, P1703, DOI 10.1007/s00198-005-1906-4; Das SK, 2005, CURR OPIN CLIN NUTR, V8, P602, DOI 10.1097/01.mco.0000171122.60665.5f; DEMPSTER P, 1995, MED SCI SPORT EXER, V27, P1692; Dishman RK, 2006, OBESITY, V14, P345, DOI 10.1038/oby.2006.46; Dixon JB, 2010, MOL CELL ENDOCRINOL, V316, P104, DOI 10.1016/j.mce.2009.07.008; Donnelly JE, 2009, MED SCI SPORT EXER, V41, P459, DOI 10.1249/MSS.0b013e3181949333; Duvigneaud N, 2008, J SPORT MED PHYS FIT, V48, P201; Fields DA, 2005, CURR OPIN CLIN NUTR, V8, P624, DOI 10.1097/01.mco.0000171127.44525.07; Formiguera X, 2004, BEST PRACT RES CL GA, V18, P1125, DOI [10.1016/S1521-6918(04)00091-5, 10.1016/j.bpg.2004.06.030]; Foster-Schubert KE, 2012, OBESITY, V20, P1628, DOI 10.1038/oby.2011.76; Frimel TN, 2008, MED SCI SPORT EXER, V40, P1213, DOI 10.1249/MSS.0b013e31816a85ce; Fruhbeck G, 2004, NEW ENGL J MED, V350, P308, DOI 10.1056/NEJM200401153500323; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; GARROW JS, 1995, EUR J CLIN NUTR, V49, P1; GENAIDY AM, 1992, ERGONOMICS, V35, P1081, DOI 10.1080/00140139208967384; Glasziou P.P., 2001, SYSTEMATIC REV HLTH, DOI DOI 10.1017/CBO9780511543500; GOING SB, 1993, AM J CLIN NUTR, V57, P845, DOI 10.1093/ajcn/57.6.845; Guyenet SJ, 2012, J CLIN ENDOCR METAB, V97, P745, DOI 10.1210/jc.2011-2525; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; He XXZ, 2004, AM J PUBLIC HEALTH, V94, P1567, DOI 10.2105/AJPH.94.9.1567; Hills A P, 2002, Obes Rev, V3, P35, DOI 10.1046/j.1467-789X.2002.00054.x; Himes CL, 2000, DEMOGRAPHY, V37, P73, DOI 10.2307/2648097; Hulens M, 2003, SCAND J MED SCI SPOR, V13, P98, DOI 10.1034/j.1600-0838.2003.10273.x; Hulens M, 2001, INT J OBESITY, V25, P676, DOI 10.1038/sj.ijo.0801560; Ismail I, 2012, OBES REV, V13, P68, DOI 10.1111/j.1467-789X.2011.00931.x; Janssen I, 1999, INT J OBESITY, V23, P1035, DOI 10.1038/sj.ijo.0801038; Janssen I, 2002, DIABETES CARE, V25, P431, DOI 10.2337/diacare.25.3.431; Janssen I, 2011, J OBES, V2011, DOI 10.1155/2011/531403; Jebb SA, 1999, MED SCI SPORT EXER, V31, pS534, DOI 10.1097/00005768-199911001-00008; Kaila B, 2008, CAN J GASTROENTEROL, V22, P61, DOI 10.1155/2008/609039; Kraemer WJ, 2001, MED SCI SPORT EXER, V33, P1011, DOI 10.1097/00005768-200106000-00022; Larrieu S, 2004, INT J OBESITY, V28, P1555, DOI 10.1038/sj.ijo.0802755; Leone N, 2011, OBESITY; Maffiuletti NA, 2007, EUR J APPL PHYSIOL, V101, P51, DOI 10.1007/s00421-007-0471-2; Manini TM, 2010, OBESITY, V18, P1168, DOI 10.1038/oby.2009.317; Marks BL, 1996, SPORTS MED, V22, P273, DOI 10.2165/00007256-199622050-00001; Messier V, 2010, J SPORT SCI, V28, P83, DOI 10.1080/02640410903390105; Miller GD, 2006, OBESITY, V14, P1219, DOI 10.1038/oby.2006.139; Miller SL, 2008, J NUTR HEALTH AGING, V12, P487, DOI 10.1007/BF02982710; Monteiro Maria Silvia, 2011, Rev. esc. enferm. USP, V45, P1177; Nicklas BJ, 2009, AM J CLIN NUTR, V89, P1043, DOI 10.3945/ajcn.2008.26938; Payne RW, 2011, GUIDE GENSTAT RELEAS; Peppard PE, 2000, JAMA-J AM MED ASSOC, V284, P3015, DOI 10.1001/jama.284.23.3015; Rantanen T, 1999, JAMA-J AM MED ASSOC, V281, P558, DOI 10.1001/jama.281.6.558; Rantanen T, 1999, ARCH PHYS MED REHAB, V80, P130, DOI 10.1016/S0003-9993(99)90109-0; Ratamess NA, 2009, MED SCI SPORT EXER, V41, P687, DOI 10.1249/MSS.0b013e3181915670; Rice B, 1999, DIABETES CARE, V22, P684, DOI 10.2337/diacare.22.5.684; Ruiz JR, 2010, J PEDIATR-US, V157, P917, DOI 10.1016/j.jpeds.2010.06.026; Stenholm S, 2009, INT J OBESITY, V33, P635, DOI 10.1038/ijo.2009.62; Stenholm S, 2013, J GERONTOL A, P1079; Straznicky NE, 2010, DIABETES, V59, P71, DOI 10.2337/db09-0934; Toledo FGS, 2008, DIABETES, V57, P987, DOI 10.2337/db07-1429; Vargas CB, 2013, OBES SURG, V23, P1590, DOI 10.1007/s11695-013-0924-0; Vaynman S, 2006, J NEUROSCI RES, V84, P699, DOI 10.1002/jnr.20979; Vieira ER, 2008, INT J IND ERGONOM, V38, P143, DOI 10.1016/j.ergon.2006.02.001; Villareal DT, 2011, NEW ENGL J MED, V364, P1218, DOI 10.1056/NEJMoa1008234; Vingard E, 2009, WORK, V34, P339, DOI 10.3233/WOR-2009-0932; WEBSTER JD, 1984, HUM NUTR-CLIN NUTR, V38C, P299; Weinheimer EM, 2010, NUTR REV, V68, P375, DOI 10.1111/j.1753-4887.2010.00298.x; Weiss EP, 2007, J APPL PHYSIOL, V102, P634, DOI 10.1152/japplphysiol.00853.2006; Wilson JM, 2012, J STRENGTH COND RES, V26, P2293, DOI 10.1519/JSC.0b013e31823a3e2d; Woodrow G, 2007, PERITON DIALYSIS INT, V27, pS245; Wycherley TP, 2012, AM J CLIN NUTR, V96, P1281, DOI 10.3945/ajcn.112.044321; Wycherley TP, 2010, DIABETES CARE, V33, P969, DOI 10.2337/dc09-1974	82	194	199	4	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81692	10.1371/journal.pone.0081692	http://dx.doi.org/10.1371/journal.pone.0081692			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	259RH	23405248	gold, Green Published, Green Accepted			2022-12-27	WOS:000327543500119
J	Miller, CS; Handley, KM; Wrighton, KC; Frischkorn, KR; Thomas, BC; Banfield, JF				Miller, Christopher S.; Handley, Kim M.; Wrighton, Kelly C.; Frischkorn, Kyle R.; Thomas, Brian C.; Banfield, Jillian F.			Short-Read Assembly of Full-Length 16S Amplicons Reveals Bacterial Diversity in Subsurface Sediments	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; MICROBIAL DIVERSITY; RARE BIOSPHERE; ENVIRONMENTAL SURVEYS; SPECIES RICHNESS; BODY HABITATS; DEEP-SEA; SEQUENCE; COMMUNITIES; URANIUM	In microbial ecology, a fundamental question relates to how community diversity and composition change in response to perturbation. Most studies have had limited ability to deeply sample community structure (e.g. Sanger-sequenced 16S rRNA libraries), or have had limited taxonomic resolution (e. g. studies based on 16S rRNA hypervariable region sequencing). Here, we combine the higher taxonomic resolution of near-full-length 16S rRNA gene amplicons with the economics and sensitivity of short-read sequencing to assay the abundance and identity of organisms that represent as little as 0.01% of sediment bacterial communities. We used a new version of EMIRGE optimized for large data size to reconstruct near-full-length 16S rRNA genes from amplicons sheared and sequenced with Illumina technology. The approach allowed us to differentiate the community composition among samples acquired before perturbation, after acetate amendment shifted the predominant metabolism to iron reduction, and once sulfate reduction began. Results were highly reproducible across technical replicates, and identified specific taxa that responded to the perturbation. All samples contain very high alpha diversity and abundant organisms from phyla without cultivated representatives. Surprisingly, at the time points measured, there was no strong loss of evenness, despite the selective pressure of acetate amendment and change in the terminal electron accepting process. However, community membership was altered significantly. The method allows for sensitive, accurate profiling of the "long tail'' of low abundance organisms that exist in many microbial communities, and can resolve population dynamics in response to environmental change.	[Miller, Christopher S.; Handley, Kim M.; Wrighton, Kelly C.; Frischkorn, Kyle R.; Thomas, Brian C.; Banfield, Jillian F.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Miller, CS (corresponding author), Univ Colorado, Dept Integrat Biol, Denver, CO 80202 USA.	christopher.s.miller@ucdenver.edu	Dixon, John B/A-5318-2011; Wrighton, Kelly C/ABD-6621-2021; Reynolds, John/D-2591-2013	Dixon, John B/0000-0001-5391-4082; Wrighton, Kelly C/0000-0003-0434-4217; Reynolds, John/0000-0002-8825-8625; Fraser, Steve F/0000-0003-0202-9619; Miller, Clint/0000-0001-7743-6986; Banfield, Jill/0000-0001-8203-8771; Miller, Christopher/0000-0002-9448-8144; Handley, Kim/0000-0003-0531-3009; Levinger, Itamar/0000-0001-9194-2033	IFRC, Subsurface Biogeochemical Research Program; Office of Science, Biological and Environmental Research, US Department of Energy (DOE) [DE-AC02-05CH11231]	IFRC, Subsurface Biogeochemical Research Program; Office of Science, Biological and Environmental Research, US Department of Energy (DOE)	Funding was provided by the IFRC, Subsurface Biogeochemical Research Program and the Knowledgebase Program (DE-AC02-05CH11231), Office of Science, Biological and Environmental Research, US Department of Energy ( DOE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aklujkar M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-490; Anderson RT, 2003, APPL ENVIRON MICROB, V69, P5884, DOI 10.1128/AEM.69.10.5884-5891.2003; Angenent LT, 2005, P NATL ACAD SCI USA, V102, P4860, DOI 10.1073/pnas.0501235102; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Beman JM, 2012, LIMNOL OCEANOGR, V57, P711, DOI 10.4319/lo.2012.57.3.0711; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Degnan PH, 2012, ISME J, V6, P183, DOI 10.1038/ismej.2011.74; Denef VJ, 2010, P NATL ACAD SCI USA, V107, P2383, DOI 10.1073/pnas.0907041107; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406; Goltsman DSA, 2009, APPL ENVIRON MICROB, V75, P4599, DOI 10.1128/AEM.02943-08; Handley KM, 2012, FEMS MICROBIOL ECOL, V81, P188, DOI 10.1111/j.1574-6941.2012.01363.x; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Harismendy O, 2009, BIOTECHNIQUES, V46, P229, DOI 10.2144/000113082; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Holmes DE, 2007, ISME J, V1, P663, DOI 10.1038/ismej.2007.85; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Jeraldo P, 2011, ENVIRON MICROBIOL, V13, P3000, DOI 10.1111/j.1462-2920.2011.02577.x; Kauserud H, 2012, MYCORRHIZA, V22, P309, DOI 10.1007/s00572-011-0403-1; Kembel SW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002743; Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r134; Lazarevic V, 2009, J MICROBIOL METH, V79, P266, DOI 10.1016/j.mimet.2009.09.012; Li L, 2010, J CONTAM HYDROL, V112, P45, DOI 10.1016/j.jconhyd.2009.10.006; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Lo I, 2007, NATURE, V446, P537, DOI 10.1038/nature05624; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Marchetti A, 2012, P NATL ACAD SCI USA, V109, pE317, DOI 10.1073/pnas.1118408109; Miller CS, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r44; Morowitz MJ, 2011, P NATL ACAD SCI USA, V108, P1128, DOI 10.1073/pnas.1010992108; Mueller RS, 2011, ENVIRON MICROBIOL, V13, P2279, DOI 10.1111/j.1462-2920.2011.02486.x; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Sharpton TJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001061; Shrestha PM, 2007, ENVIRON MICROBIOL, V9, P2464, DOI 10.1111/j.1462-2920.2007.01364.x; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Spring S, 2009, STAND GENOMIC SCI, V1, P242, DOI 10.4056/sigs.39508; Stewart FJ, 2012, ENVIRON MICROBIOL, V14, P23, DOI 10.1111/j.1462-2920.2010.02400.x; Tringe SG, 2008, CURR OPIN MICROBIOL, V11, P442, DOI 10.1016/j.mib.2008.09.011; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vrionis HA, 2005, APPL ENVIRON MICROB, V71, P6308, DOI 10.1128/AEM.71.10.6308-6318.2005; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Werner JJ, 2012, ISME J, V6, P1273, DOI 10.1038/ismej.2011.186; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Wilkins MJ, 2009, APPL ENVIRON MICROB, V75, P6591, DOI 10.1128/AEM.01064-09; Williams KH, 2011, GEOMICROBIOL J, V28, P519, DOI 10.1080/01490451.2010.520074; Wrighton KC, 2012, SCIENCE, V337, P1661, DOI 10.1126/science.1224041; Youssef N, 2009, APPL ENVIRON MICROB, V75, P5227, DOI 10.1128/AEM.00592-09; Zhou HW, 2011, ISME J, V5, P741, DOI 10.1038/ismej.2010.160; Zhou JZ, 2011, ISME J, V5, P1303, DOI 10.1038/ismej.2011.11	67	194	199	4	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56018	10.1371/journal.pone.0056018	http://dx.doi.org/10.1371/journal.pone.0056018			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405248	Green Published, gold, Green Submitted			2022-12-27	WOS:000315153400193
J	Peng, Z; Wang, CX; Fang, EH; Lu, XM; Wang, GB; Tong, Q				Peng, Zhao; Wang, Chenxiao; Fang, Erhu; Lu, Xiaoming; Wang, Guobin; Tong, Qiang			Co-Delivery of Doxorubicin and SATB1 shRNA by Thermosensitive Magnetic Cationic Liposomes for Gastric Cancer Therapy	PLOS ONE			English	Article							OVERCOME DRUG-RESISTANCE; IN-VITRO; TEMPERATURE; GENE; RNA; ADENOCARCINOMA; NANOPARTICLES; EXPRESSION; RELEASE; CELLS	In previous a study, we had developed a novel thermosensitive magnetic delivery system based on liposomes. This study aimed to evaluate the efficiency of this system for the co-delivery of both drugs and genes to the same cell and its antitumor effects on gastric cancer. Doxorubicin (DOX) and SATB1 shRNA vector were loaded into the co-delivery system, and in vitro DOX thermosensitive release activity, targeted gene silencing efficiency, targeted cellular uptake, in vitro cytotoxicity, as well as in vivo anti-tumor activity were determined. The results showed that this co-delivery system had desirable targeted delivery efficacy, DOX thermosensitive release and SATB1 gene silencing. Moreover, the co-delivery of DOX and SATB1 shRNA exhibited enhanced activity to inhibit gastric cancer cell growth in vitro and in vivo, compared to single delivery. In conclusion, the novel thermosensitive magnetic drug and gene co-delivery system has promising application in combined chemotherapy and gene therapy for gastric cancer.	[Peng, Zhao; Wang, Chenxiao; Fang, Erhu; Lu, Xiaoming; Wang, Guobin; Tong, Qiang] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology	Wang, GB (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China.	guobinwang1954@gmail.com; qiangtong@hust.edu.cn	Li, Yilin/AAW-9533-2021		National Natural Science Foundation of China [81172186]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 81172186). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrelo R, 2009, DEV CELL, V16, P507, DOI 10.1016/j.devcel.2009.03.006; Alberts SR, 2003, ANN ONCOL, V14, P31, DOI 10.1093/annonc/mdg726; Alexiou C, 2000, CANCER RES, V60, P6641; Chen J, 2013, DRUG DEV IND PHARM, V39, P197, DOI 10.3109/03639045.2012.668912; Chen YC, 2010, J BIOL CHEM, V285, P22639, DOI 10.1074/jbc.M110.125906; Cheng C, 2010, APMIS, V118, P855, DOI 10.1111/j.1600-0463.2010.02673.x; Dicken BJ, 2005, ANN SURG, V241, P27, DOI 10.1097/01.sla.0000149300.28588.23; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; GABER MH, 1995, PHARMACEUT RES, V12, P1407, DOI 10.1023/A:1016206631006; Heger Z, 2013, INT J MOL SCI, V14, P21629, DOI 10.3390/ijms141121629; Huang B, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-8; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Juergen S, 2012, FUNDAMENTALS APPL CO, P291; Kohwi-Shigematsu T, 2013, SEMIN CANCER BIOL, V23, P72, DOI 10.1016/j.semcancer.2012.06.009; Kono K, 2004, METHODS ENZYMOL, V387, P73; Li Wei, 2011, Zhonghua Wei Chang Wai Ke Za Zhi, V14, P432; Liu CX, 2013, BIOMATERIALS, V34, P2547, DOI 10.1016/j.biomaterials.2012.12.038; Lu XM, 2010, ONCOL REP, V24, P981, DOI 10.3892/or_00000945; Mir R, 2012, CURR DRUG TARGETS, V13, P1603, DOI 10.2174/138945012803530008; Mykhaylyk O, 2010, METHODS MOL BIOL, V605, P487, DOI 10.1007/978-1-60327-360-2_34; Park SC, 2013, GUT LIVER, V7, P385, DOI 10.5009/gnl.2013.7.4.385; Patani N, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-18; Pradhan P, 2010, J CONTROL RELEASE, V142, P108, DOI 10.1016/j.jconrel.2009.10.002; Pradhan P, 2010, METHODS MOL BIOL, V605, P279, DOI 10.1007/978-1-60327-360-2_19; Shen JA, 2012, BIOMATERIALS, V33, P8613, DOI 10.1016/j.biomaterials.2012.08.007; Shim G, 2011, J CONTROL RELEASE, V155, P60, DOI 10.1016/j.jconrel.2010.10.017; Skeel R, 2011, HDB CANC CHEMOTHERAP; Stebbing J, 2002, CANCER TREAT REV, V28, P121, DOI 10.1053/ctrv.2002.0262; Ta T, 2013, J CONTROL RELEASE, V169, P112, DOI 10.1016/j.jconrel.2013.03.036; Takahashi Tsunehiro, 2013, Cancers (Basel), V5, P48, DOI 10.3390/cancers5010048; Torchilin Vladimir P, 2010, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-00477-3_1; Wang CM, 2011, BIOCHEM BIOPH RES CO, V410, P537, DOI 10.1016/j.bbrc.2011.06.019; Xiao YL, 2012, NANOSCALE, V4, P7185, DOI 10.1039/c2nr31853a; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Zhang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0047902; Zhao F, 2014, BIOMATERIALS, V35, P1050, DOI 10.1016/j.biomaterials.2013.10.044; Zheng XL, 2009, INT J PHARMACEUT, V366, P211, DOI 10.1016/j.ijpharm.2008.09.019; Zhou Lai-Yong, 2009, Nan Fang Yi Ke Da Xue Xue Bao, V29, P534; Zhu XD, 2010, ONCOL LETT, V1, P407, DOI 10.3892/ol_00000071	39	136	146	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92924	10.1371/journal.pone.0092924	http://dx.doi.org/10.1371/journal.pone.0092924			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24416238	Green Submitted, Green Published, gold			2022-12-27	WOS:000333677500056
J	Peng, Z; Zhu, Y; Wang, QQ; Gao, J; Li, YL; Li, YY; Ge, S; Shen, L				Peng, Zhi; Zhu, Yan; Wang, Qianqian; Gao, Jing; Li, Yilin; Li, Yanyan; Ge, Sai; Shen, Lin			Prognostic Significance of MET Amplification and Expression in Gastric Cancer: A Systematic Review with Meta-Analysis	PLOS ONE			English	Review							HEPATOCYTE GROWTH-FACTOR; C-MET; FACTOR-RECEPTOR; POOR-PROGNOSIS; E-CADHERIN; GENE; OVEREXPRESSION; MARKER; CARCINOMA; P53	Background and Aims: MET, the hepatocyte growth factor receptor, is a receptor tyrosine kinase overexpressed and activated in a subset of gastric cancer. Several studies investigated the relationship between MET amplification and expression with the clinical outcome in patients with gastric cancer, but yielded conflicting results. We performed a systematic review and meta-analysis to determine the influence of MET amplification and expression on prognosis in gastric cancer. Methods: MEDLINE and EMBASE were searched for studies that explored the association between MET amplification and expression with survival in patients with gastric cancer up to 1 April, 2013. Data of individual hazard ratios (HRs) and 95% confidence intervals (CIs) for meta-analyses were extracted from the publications and combined in pooled HRs. Results: Fourteen studies involving 2,258 patients with gastric cancer were included. It was suggested that MET overexpression had an unfavorable impact on survival of patients with gastric cancer, with HRs (95% CIs) of 2.57 (95% CI: 1.97-3.35) overall, 2.82 (95% CI: 1.86-4.27) among studies using amplification for measure scale of MET and 2.42 (95% CI: 1.66-3.54) for expression. The magnitude of association was reduced whereas remained statistically significant in high quality studies or in larger sample size studies and corresponding HRs were 2.18(1.76, 2.70) and 2.35(1.93, 2.87), respectively, without significant heterogeneity. Conclusion: The findings from present study indicated that higher MET gene amplification and expression in gastric cancer was an indicator of poor prognosis.	[Peng, Zhi; Zhu, Yan; Gao, Jing; Li, Yilin; Li, Yanyan; Ge, Sai; Shen, Lin] Peking Univ, Canc Hosp & Inst, Minist Educ, Dept Gastrointestinal Oncol,Key Lab Carcinogenesi, Beijing 100871, Peoples R China; [Wang, Qianqian] Peking Univ, Clin Med Coll 4, Beijing Jishuitan Hosp, Dept Epidemiol, Beijing 100871, Peoples R China	Peking University; Peking University	Shen, L (corresponding author), Peking Univ, Canc Hosp & Inst, Minist Educ, Dept Gastrointestinal Oncol,Key Lab Carcinogenesi, Beijing 100871, Peoples R China.	lin100@medmail.com.cn	Li, Yilin/AAW-9533-2021		National Natural Science Foundation of China [81172110]; National High Technology Research and Development Program [2006AA 02A 402-B02, 2012AA 02A 504]; China Postdoctoral Scientific Fund [2013M530494]; Beijing Municipal Science & Technology Commission Program "Exploring the utilization of molecular markers in the individual treatment of gastric cancer based on the clinical research cohort''	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program(National High Technology Research and Development Program of China); China Postdoctoral Scientific Fund; Beijing Municipal Science & Technology Commission Program "Exploring the utilization of molecular markers in the individual treatment of gastric cancer based on the clinical research cohort''	This work was supported by National Natural Science Foundation of China (No. 81172110), National High Technology Research and Development Program (No. 2006AA 02A 402-B02, 2012AA 02A 504), China Postdoctoral Scientific Fund (2013M530494) and Beijing Municipal Science & Technology Commission Program "Exploring the utilization of molecular markers in the individual treatment of gastric cancer based on the clinical research cohort''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amemiya H, 2010, INVEST CLIN, V51, P369; Asaoka Y, 2011, EXPERT OPIN INV DRUG, V20, P595, DOI 10.1517/13543784.2011.566863; Bamias A, 2010, CANCER CHEMOTH PHARM, V65, P1009, DOI 10.1007/s00280-010-1256-6; Bang YJ, 2010, LANCET, V376, P1302; Bertuccio P, 2009, INT J CANCER, V125, P666, DOI 10.1002/ijc.24290; Catenacci DVT, 2011, CANCER BIOL THER, V12, P9, DOI 10.4161/cbt.12.1.15747; de Graeff P, 2009, BRIT J CANCER, V101, P149, DOI 10.1038/sj.bjc.6605112; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Drebber U, 2008, ONCOL REP, V19, P1477; Egger M, 1998, BMJ-BRIT MED J, V316, P61, DOI 10.1136/bmj.316.7124.61; Ge SH, 2011, CHINESE J CANCER RES, V23, P153, DOI 10.1007/s11670-011-0153-9; Gooden MJM, 2011, BRIT J CANCER, V105, P93, DOI 10.1038/bjc.2011.189; Graziano F, 2011, J CLIN ONCOL, V29, P4789, DOI 10.1200/JCO.2011.36.7706; Hayes DF, 1996, JNCI-J NATL CANCER I, V88, P1456, DOI 10.1093/jnci/88.20.1456; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huang TJ, 2001, ACTA ONCOL, V40, P638; Janjigian YY, 2011, CANCER EPIDEM BIOMAR, V20, P1021, DOI 10.1158/1055-9965.EPI-10-1080; Jatoi Ismail, 2010, Curr Probl Surg, V47, P750, DOI 10.1067/j.cpsurg.2010.06.002; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kubicka S, 2002, DIGEST DIS SCI, V47, P114, DOI 10.1023/A:1013275706401; KUNIYASU H, 1992, BIOCHEM BIOPH RES CO, V189, P227, DOI 10.1016/0006-291X(92)91548-5; Lee HE, 2012, BRIT J CANCER, V107, P325, DOI 10.1038/bjc.2012.237; Lee J, 2011, ONCOL REP, V25, P1517, DOI 10.3892/or.2011.1219; Lennerz JK, 2011, J CLIN ONCOL, V29, P4803, DOI 10.1200/JCO.2011.35.4928; Li Y, 2012, J SURG ONCOL, V106, P304, DOI 10.1002/jso.23008; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Meert AP, 2002, EUR RESPIR J, V20, P975, DOI 10.1183/09031936.02.00296502; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Nakajima M, 1999, CANCER, V85, P1894; Oldenhuis CNAM, 2008, EUR J CANCER, V44, P946, DOI 10.1016/j.ejca.2008.03.006; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Peters S, 2012, NAT REV CLIN ONCOL, V9, P314, DOI 10.1038/nrclinonc.2012.71; Shi J, 2012, INT J MOL SCI, V13, P4714, DOI 10.3390/ijms13044714; Sierra J Rafael, 2011, Ther Adv Med Oncol, V3, pS21, DOI 10.1177/1758834011422557; Smith RA, 2011, BRIT J CANCER, V104, P1440, DOI 10.1038/bjc.2011.110; Taniguchi K, 1998, CANCER, V82, P2112, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2112::AID-CNCR5>3.3.CO;2-U; Toiyama Y, 2012, INT J CANCER, V130, P2912, DOI 10.1002/ijc.26330; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Tsugawa K, 1998, ONCOLOGY-BASEL, V55, P475, DOI 10.1159/000011898; Wu H, 2009, CONSERV GENET RESOUR, V1, P1, DOI 10.1007/s12686-009-9000-4; Yonemura Y, 1996, INT J ONCOL, V8, P555; Yonemura Y, 1997, ONCOL REP, V4, P743; Zhao J, 2011, HISTOL HISTOPATHOL, V26, P1111, DOI 10.14670/HH-26.1111; Zhuang X, 2000, Zhonghua Bing Li Xue Za Zhi, V29, P409	44	136	146	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84502	10.1371/journal.pone.0084502	http://dx.doi.org/10.1371/journal.pone.0084502			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416238	gold, Green Published, Green Submitted			2022-12-27	WOS:000329862500132
J	Wang, LL; Sun, XY; Li, SY; Zhang, T; Zhang, W; Zhai, PH				Wang, Linlin; Sun, Xiangyang; Li, Suyan; Zhang, Tao; Zhang, Wei; Zhai, Penghui			Application of Organic Amendments to a Coastal Saline Soil in North China: Effects on Soil Physical and Chemical Properties and Tree Growth	PLOS ONE			English	Article							BIOLOGICAL-PROPERTIES; MICROBIAL COMMUNITIES; CATION-EXCHANGE; SEWAGE-SLUDGE; BEET VINASSE; SODIC SOILS; NITROGEN; RECLAMATION; PHOSPHORUS; POTASSIUM	The ability of the following four organic amendments to ameliorate saline soil in coastal northern China was investigated from April 2010 to October 2012 in a field experiment: green waste compost (GWC), sedge peat (SP), furfural residue (FR), and a mixture of GWC, SP and FR (1: 1: 1 by volume) (GSF). Compared to a non-amended control (CK), the amendments, which were applied at 4.5 kg organic matter m(-3), dramatically promoted plant growth; improved soil structure; increased the cation exchange capacity (CEC), organic carbon, and available nutrients; and reduced the salt content, electrical conductivity (EC), and exchangeable sodium percentage (ESP). At the end of the experiment in soil amended with GSF, bulk density, EC, and ESP had decreased by 11, 87, and 71%, respectively, and total porosity and organic carbon had increased by 25 and 96% respectively, relative to the CK. The GSF treatment resulted in a significantly lower Na++K+ content than the other treatments. CEC and the contents of available N, P, and K were significantly higher in the GSF-treated soil than in the CK and were the highest in all treatments. The FR treatment resulted in the lowest pH value and Ca2+ concentration, which decreased by 8% and 39%, respectively, relative to the CK. Overall, the results indicate that a combination of green waste compost, sedge peat and furfural residue (GSF treatment) has substantial potential for ameliorating saline soils in the coastal areas of northern China, and it works better than each amendment alone. Utilization of GWC and FR can be an alternative organic amendment to substitute the nonrenewable SP in saline soil amelioration.	[Wang, Linlin; Sun, Xiangyang; Li, Suyan; Zhang, Tao; Zhang, Wei; Zhai, Penghui] Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China; [Wang, Linlin] Forestry Res Inst Hulun Buir, Hulun Buir, Inner Mongolia, Peoples R China	Beijing Forestry University	Sun, XY (corresponding author), Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China.	sunxy1965@126.com; lisuyan@bjfu.edu.cn	; Williams, Robert W./H-8789-2016	Deng, Hong-Wen/0000-0002-0387-8818; Williams, Robert W./0000-0001-8924-4447; Farber, Charles/0000-0002-6748-4711; Wang, Cong-Yi/0000-0001-7914-168X; Habibovic, Pamela/0000-0001-8249-5155	Eleventh Five-Year Plan of the National Scientific and Technical Supporting Programs [2009BADB2B0504]; Fundamental Research Funds for the Central Universities; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R03TW008221] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051190, R01AR050496, R01AR064825, R01AR057049, P50AR055081, R01AR050066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC2DE020756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026564, P01AG018397, R03AG020321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA016662] Funding Source: NIH RePORTER	Eleventh Five-Year Plan of the National Scientific and Technical Supporting Programs; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by the Eleventh Five-Year Plan of the National Scientific and Technical Supporting Programs (No. 2009BADB2B0504), and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi MK, 2007, COMMUN SOIL SCI PLAN, V38, P1691, DOI 10.1080/00103620701435464; Amezketa E, 2005, AGRON J, V97, P983, DOI 10.2134/agronj2004.0236; Antil Rajinder Singh, 2007, Archives of Agronomy and Soil Science, V53, P519, DOI 10.1080/03650340701571033; BAO SD, 2005, ANAL SOIL AGROCHEMIS; BARKHAM JP, 1993, BIODIVERS CONSERV, V2, P556, DOI 10.1007/BF00056749; Barzegar AR, 1997, SOIL SCI SOC AM J, V61, P1131, DOI 10.2136/sssaj1997.03615995006100040020x; Bhattacharyya P, 2007, CHEMOSPHERE, V66, P1789, DOI 10.1016/j.chemosphere.2006.07.062; Brady AC, 2002, NATURE PROPERTIES SO; Clark GJ, 2007, SOIL BIOL BIOCHEM, V39, P2806, DOI 10.1016/j.soilbio.2007.06.003; Cooperband L., 2002, BUILDING SOIL ORGANI; David R, 2002, GEODERMA, V107, P271, DOI 10.1016/S0016-7061(01)00152-5; Feng YJ, 2006, PEDOSPHERE, V16, P668, DOI 10.1016/S1002-0160(06)60101-X; Hahn AS, 2013, PLANT SOIL, V363, P331, DOI 10.1007/s11104-012-1306-4; Hanay A, 2004, COMPOST SCI UTIL, V12, P175, DOI 10.1080/1065657x.2004.10702177; Hyvonen R, 2008, BIOGEOCHEMISTRY, V89, P121, DOI 10.1007/s10533-007-9121-3; Jackson M. L., 1958, Soil Chemical Analysis.; Kahlown MA, 2003, AGR WATER MANAGE, V62, P127, DOI 10.1016/S0378-3774(03)00096-9; Kaya C, 2001, J PLANT NUTR, V24, P357, DOI 10.1081/PLN-100001394; Larney FJ, 2012, CAN J SOIL SCI, V92, P19, DOI [10.4141/cjss2010-064, 10.4141/CJSS2010-064]; Liang B, 2006, SOIL SCI SOC AM J, V70, P1719, DOI 10.2136/sssaj2005.0383; Liang YC, 2003, GEODERMA, V115, P149, DOI 10.1016/S0016-7061(03)00084-3; Liu GQ, 2009, BIORESOURCE TECHNOL, V100, P5103, DOI 10.1016/j.biortech.2009.03.081; Mamedov AI, 2002, SOIL TILL RES, V68, P121, DOI 10.1016/S0167-1987(02)00115-0; Melero S, 2007, EUR J AGRON, V26, P327, DOI 10.1016/j.eja.2006.11.004; Oo AN, 2013, LAND DEGRAD DEV, DOI 101002/ldr2208; Page A.L., 1982, AGRONOMY SERIES, V9, DOI DOI 10.1002/JP1N.19851480319; Pocknee S, 1997, SOIL SCI SOC AM J, V61, P86, DOI 10.2136/sssaj1997.03615995006100010014x; Qadir M, 2007, ADV AGRON, V96, P197, DOI 10.1016/S0065-2113(07)96006-X; Qadir M, 2004, SCI TOTAL ENVIRON, V323, P1, DOI 10.1016/j.scitotenv.2003.10.012; Qadir M, 1998, SOIL TILL RES, V45, P119, DOI 10.1016/S0933-3630(96)00130-4; Qadir M, 2000, LAND DEGRAD DEV, V11, P501, DOI 10.1002/1099-145X(200011/12)11:6<501::AID-LDR405>3.0.CO;2-S; RICHARDS LA, 1954, AGR HDB, V60, P98; Rietz DN, 2003, SOIL BIOL BIOCHEM, V35, P845, DOI 10.1016/S0038-0717(03)00125-1; Roca-Perez L, 2009, CHEMOSPHERE, V75, P781, DOI 10.1016/j.chemosphere.2008.12.058; Ros M, 2003, SOIL BIOL BIOCHEM, V35, P463, DOI 10.1016/S0038-0717(02)00298-5; Sumner M.E., 2000, HDB SOIL SCI; Sun R, 2011, BIORESOURCES, V6, P317; Tejada M, 2008, BIORESOURCE TECHNOL, V99, P1758, DOI 10.1016/j.biortech.2007.03.052; Tejada M, 2006, SOIL BIOL BIOCHEM, V38, P1413, DOI 10.1016/j.soilbio.2005.10.017; Tejada M, 2006, SOIL SCI SOC AM J, V70, P900, DOI 10.2136/sssaj2005.0271; Tejada M, 2005, EUR J AGRON, V23, P336, DOI 10.1016/j.eja.2005.02.005; TUCKER BM, 1954, AUST J AGR RES, V5, P706, DOI 10.1071/AR9540706; Wang Z.Q., 1993, SALINE SOIL IN CHINA; Warman PR, 2005, BIORESOURCE TECHNOL, V96, P955, DOI 10.1016/j.biortech.2004.08.003; Wichern J, 2006, GEODERMA, V137, P100, DOI 10.1016/j.geoderma.2006.08.001; Withers PJA, 2003, SOIL USE MANAGE, V19, P28, DOI 10.1111/j.1475-2743.2003.tb00276.x; Wong VNL, 2009, APPL SOIL ECOL, V41, P29, DOI 10.1016/j.apsoil.2008.08.006; Xing Y, 2012, CELL CHEM TECHNOL, V46, P249; Yazdanpanah N, 2013, AGR WATER MANAGE, V120, P39, DOI 10.1016/j.agwat.2012.08.017; Zhang L, 2013, BIORESOURCE TECHNOL, V131, P68, DOI 10.1016/j.biortech.2012.10.059; Zhang XC, 2002, J HYDROL, V260, P194, DOI 10.1016/S0022-1694(01)00612-6	51	125	145	9	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89185	10.1371/journal.pone.0089185	http://dx.doi.org/10.1371/journal.pone.0089185			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	25330365	Green Published, Green Submitted, gold			2022-12-27	WOS:000331706700132
J	Wang, LS; Lu, WL; Zhang, L; Huang, Y; Scheib, R; Liu, XY; Myers, L; Lu, L; Farber, CR; Liu, GF; Wang, CY; Deng, HW; Williams, RW; Wang, YJ; Gu, WK; Jiao, Y				Wang, Lishi; Lu, Wenli; Zhang, Lei; Huang, Yue; Scheib, Rachel; Liu, Xiaoyun; Myers, Linda; Lu, Lu; Farber, Charles R.; Liu, Gaifen; Wang, Cong-Yi; Deng, Hongwen; Williams, Robert W.; Wang, Yongjun; Gu, Weikuan; Jiao, Yan			Trps1 Differentially Modulates the Bone Mineral Density between Male and Female Mice and Its Polymorphism Associates with BMD Differently between Women and Men	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; TRICHORHINOPHALANGEAL-SYNDROME; MISSENSE MUTATION; GENE-EXPRESSION; POPULATION; IDENTIFICATION; METAANALYSIS; NETWORKS; LINKAGE; GROWTH	The objective of our study was to identify genetic factors that regulate bone mineral density (BMD) in mice using well defined recombinant inbred strains. For this purpose we chose the BXD recombinant inbred (RI) strains derived from progeny of the C57BL/6J (B6) and DBA/2J (D2) progenitor strains. We sampled both male and female mice (similar to 4 each) of 46 strains at 3 months-of-age, measured their BMD, and conducted QTL mapping. The data were analyzed to identify candidates genes contained within the most significant quantitative trait locus (QTL). Evaluation of candidate genes included functional assessment, single nucleotide polymorphism (SNP) genotyping and direct sequencing. We established that there was a QTL for BMD in males on chromosome 15 that has the impact larger than QTLs on all other chromosomes. The QTL on chromosome 15 was narrowed to a genomic region between 38 Mbp and 52 Mbp. By examining transcripts within this region, we found an important candidate gene: trichorhinophalangeal syndrome, type I (Trps1). SNP analysis identified a nonsynonymous SNP (rs32398060) in Trps1 that co-segregated with bone mineral density. Analysis of association between this SNP within TRPS1 and BMD in a human population confirmed its significance.	[Wang, Lishi; Lu, Wenli; Huang, Yue; Scheib, Rachel; Liu, Xiaoyun; Gu, Weikuan; Jiao, Yan] Univ Tennessee, Hlth Sci Ctr, Campbell Clin, Dept Orthoped Surg & BioMed Engn, Memphis, TN 38163 USA; [Wang, Lishi] Inner Mongolia Med Univ, Dept Basic Med, Hohhot, Inner Mongolia, Peoples R China; [Zhang, Lei; Deng, Hongwen] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Biostat & Bioinformat, New Orleans, LA USA; [Myers, Linda] Univ Tennessee, Hlth Sci Ctr, Dept Med, Memphis, TN USA; [Lu, Lu; Williams, Robert W.] Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Memphis, TN USA; [Farber, Charles R.] Univ Virginia, Dept Med, Div Cardiol, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Farber, Charles R.] Univ Virginia, Dept Biochem & Mol Genet, Div Cardiol, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Liu, Gaifen; Wang, Yongjun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China; [Wang, Cong-Yi] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Ctr Biomed Res, Wuhan 430074, Hubei, Peoples R China	University of Tennessee System; University of Tennessee Health Science Center; Inner Mongolia Medical University; Tulane University; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Virginia; University of Virginia; Capital Medical University; Huazhong University of Science & Technology	Gu, WK (corresponding author), Univ Tennessee, Hlth Sci Ctr, Campbell Clin, Dept Orthoped Surg & BioMed Engn, Memphis, TN 38163 USA.	wgu@uthsc.edu; yjiao2@utusc.edu	; Williams, Robert W./H-8789-2016	Deng, Hong-Wen/0000-0002-0387-8818; Williams, Robert W./0000-0001-8924-4447; Farber, Charles/0000-0002-6748-4711; Wang, Cong-Yi/0000-0001-7914-168X; Habibovic, Pamela/0000-0001-8249-5155	National Institute of Arthritis (NIA); Musculoskeletal and Skin Diseases, National Institutes of Health (NIH) [R01 AR51190]; Genediscovery Core at UTHSC; Veterans Administration Medical Center in Memphis, Tennessee; NIH [P50AR055081, R01AG026564, R01AR050496, RC2DE020756, R01AR057049, R03TW008221, R01 AR/AG 41398, R01 AR050066, R03 AG20321]; Franklin D. Dickson/Missouri Endowment; Edward G. Schlieder Endowment; National Natural Science Foundation of China [31100902]; National Heart, Lung, and Blood Institute (NHLBI); Boston University [N01-HC-25195]; NHLBI [N02-HL-64278]; NIA Division of Geriatrics and Clinical Gerontology; Genetic Determinants of Bone Fragility [P01-AG018397]; NIH NIA; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R03TW008221] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051190, R01AR050496, R01AR064825, R01AR057049, P50AR055081, R01AR050066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC2DE020756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026564, P01AG018397, R03AG020321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA016662] Funding Source: NIH RePORTER	National Institute of Arthritis (NIA); Musculoskeletal and Skin Diseases, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genediscovery Core at UTHSC; Veterans Administration Medical Center in Memphis, Tennessee; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Franklin D. Dickson/Missouri Endowment; Edward G. Schlieder Endowment; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Boston University; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA Division of Geriatrics and Clinical Gerontology; Genetic Determinants of Bone Fragility; NIH NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The study was partially supported by grants from the National Institute of Arthritis (NIA) and Musculoskeletal and Skin Diseases, National Institutes of Health (NIH)(R01 AR51190 to W.G.), Genediscovery Core at UTHSC, and the Veterans Administration Medical Center in Memphis, Tennessee. H. W. D. was partially supported by grants from NIH (P50AR055081, R01AG026564, R01AR050496, RC2DE020756, R01AR057049, and R03TW008221), the Franklin D. Dickson/Missouri Endowment and the Edward G. Schlieder Endowment. L.Z. was partially supported by National Natural Science Foundation of China (project 31100902). The Framingham Heart Study is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with Boston University (Contract No. N01-HC-25195). This manuscript was not prepared in collaboration with investigators of the Framingham Heart Study and does not necessarily reflect the opinions or views of the Framingham Heart Study, Boston University, or NHLBI. Funding for SHARe genotyping was provided by NHLBI Contract N02-HL-64278. Funding support for the Framingham Bone Mineral Density datasets was provided by NIH grants R01 AR/AG 41398, R01 AR050066 and R03 AG20321. Funding support for the Genetic Determinants of Bone Fragility (the Indiana fragility study) was provided through the NIA Division of Geriatrics and Clinical Gerontology. Genetic Determinants of Bone Fragility is a genome-wide association studies funded as part of the NIA Division of Geriatrics and Clinical Gerontology. Assistance with phenotype harmonization and genotype cleaning, as well as with general study coordination, was provided by the NIA Division of Geriatrics and Clinical Gerontology and the NIA Division of Aging Biology. Support for the collection of datasets and samples were provided by the parent grant, Genetic Determinants of Bone Fragility (P01-AG018397). Funding support for the genotyping which was performed at the Johns Hopkins University Center for Inherited Diseases Research was provided by the NIH NIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackert-Bicknell CL, 2012, BONE; Andreux PA, 2012, CELL, V150, P1287, DOI 10.1016/j.cell.2012.08.012; Beamer WG, 1999, MAMM GENOME, V10, P1043, DOI 10.1007/s003359901159; BONJOUR JP, 1994, OSTEOPOROSIS INT, V4, P7; Calabrese G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003150; CARRINGTON PR, 1994, J AM ACAD DERMATOL, V31, P331, DOI 10.1016/S0190-9622(94)70166-0; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Garnero P., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P50; Geisert EE, 2009, MOL VIS, V15, P1730; Grubb SC, 2004, BIOINFORMATICS, V20, P2857, DOI 10.1093/bioinformatics/bth299; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ishimori N, 2008, J BONE MINER RES, V23, P1529, DOI 10.1359/JBMR.080414; Jiao Y, 2008, GENOMICS, V91, P407, DOI 10.1016/j.ygeno.2007.12.010; Klein RF, 1998, J BONE MINER RES, V13, P1648, DOI 10.1359/jbmr.1998.13.11.1648; Kolta S, 2003, J CLIN DENSITOM, V6, P251, DOI 10.1385/JCD:6:3:251; Li GHY, 2011, HUM GENET, V130, P539, DOI 10.1007/s00439-011-0972-2; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Liu EY, 2013, GENET EPIDEMIOL, V37, P25, DOI 10.1002/gepi.21690; Lynch RM, 2010, PHYSIOL GENOMICS, V41, P244, DOI 10.1152/physiolgenomics.00020.2010; Milner LC, 2010, INT REV NEUROBIOL, V91, P173, DOI 10.1016/S0074-7742(10)91006-4; NOLTORP S, 1986, ANN RHEUM DIS, V45, P31, DOI 10.1136/ard.45.1.31; Orwoll ES, 2001, J BONE MINER RES, V16, P1962, DOI 10.1359/jbmr.2001.16.11.1962; Pei YF, 2013, HUM MOL GENET; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Rossi A, 2007, BRIT J DERMATOL, V157, P1021, DOI 10.1111/j.1365-2133.2007.08158.x; Sarafoglou K, 2010, CLIN GENET, V78, P591, DOI 10.1111/j.1399-0004.2010.01434.x; SCHNITZLER CM, 1993, CALCIFIED TISSUE INT, V53, pS27, DOI 10.1007/BF01673398; Soon G, 2006, CALCIFIED TISSUE INT, V78, P186, DOI 10.1007/s00223-005-0191-8; Suwanwela J, 2011, J BONE MINER RES, V26, P747, DOI 10.1002/jbmr.271; Tariq M, 2008, BRIT J DERMATOL, V159, P476, DOI 10.1111/j.1365-2133.2008.08658.x; Tremollieres F, 2010, MATURITAS, V65, P348, DOI 10.1016/j.maturitas.2009.12.023; Vaccaro M, 2009, PEDIATR DERMATOL, V26, P171, DOI 10.1111/j.1525-1470.2009.00905.x; Wang JT, 2003, NEUROINFORMATICS, V1, P299, DOI 10.1385/NI:1:4:299; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Xiong Q, 2008, BIOINFORMATICS, V24, P1011, DOI 10.1093/bioinformatics/btn002; Xiong Q, 2009, GENOMICS, V93, P401, DOI 10.1016/j.ygeno.2008.12.008; Yu H, 2007, CALCIFIED TISSUE INT, V80, P103, DOI 10.1007/s00223-006-0187-z; Zhang L, 2009, ANN HUM GENET, V73, P601, DOI 10.1111/j.1469-1809.2009.00539.x	42	125	145	9	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84485	10.1371/journal.pone.0084485	http://dx.doi.org/10.1371/journal.pone.0084485			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	25330365	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500131
